[	15678000	4	O
Autosomal	15678000	4	O
dominant	15678000	4	O
limb	15678000	4	O
-	15678000	4	O
girdle	15678000	4	O
muscular	15678000	4	O
dystrophy	15678000	4	O
associated	15678000	4	O
with	15678000	4	O
conduction	15678000	4	O
defects	15678000	4	O
(	15678000	4	O
LGMD1B	15678000	4	O
)	15678000	4	O
:	15678000	4	O
a	15678000	4	O
description	15678000	4	O
of	15678000	4	O
8	15678000	4	O
new	15678000	4	O
families	15678000	4	O
with	15678000	4	O
the	15678000	4	O
LMNA	15678000	4	O
gene	15678000	4	O
mutations	15678000	4	O
]	15678000	4	O
.	15678000	4	O
La	15678000	4	O
dystrophie	15678000	4	O
musculaire	15678000	4	O
des	15678000	4	O
ceintures	15678000	4	O
autosomique	15678000	4	O
dominante	15678000	4	O
associée	15678000	4	O
à	15678000	4	O
des	15678000	4	O
troubles	15678000	4	O
de	15678000	4	O
la	15678000	4	O
conduction	15678000	4	O
cardiaque	15678000	4	O
(	15678000	4	O
LGMD1B	15678000	4	O
)	15678000	4	O
.	15678000	4	O
Description	15678000	4	O
de	15678000	4	O
8	15678000	4	O
nouvelles	15678000	4	O
familles	15678000	4	O
avec	15678000	4	O
mutations	15678000	4	O
du	15678000	4	O
gène	15678000	4	O
LMNA	15678000	4	O
.	15678000	4	O
INTRODUCTION	15678000	4	O
:	15678000	4	O
Limb	15678000	4	B-Disease
girdle	15678000	4	I-Disease
muscular	15678000	4	I-Disease
dystrophy	15678000	4	I-Disease
type	15678000	4	I-Disease
1	15678000	4	I-Disease
b	15678000	4	I-Disease
(	15678000	4	O
LGMD1B	15678000	4	O
)	15678000	4	O
,	15678000	4	O
due	15678000	4	B-Reg
to	15678000	4	I-Reg
LMNA	15678000	4	B-Gene
gene	15678000	4	O
mutations	15678000	4	B-Var
,	15678000	4	O
is	15678000	4	O
a	15678000	4	O
relatively	15678000	4	O
rare	15678000	4	O
form	15678000	4	O
of	15678000	4	O
LGMD	15678000	4	O
characterized	15678000	4	O
by	15678000	4	O
proximal	15678000	4	O
muscle	15678000	4	O
involvement	15678000	4	O
associated	15678000	4	O
with	15678000	4	O
heart	15678000	4	O
involvement	15678000	4	O
comprising	15678000	4	O
atrio	15678000	4	O
-	15678000	4	O
ventricular	15678000	4	O
conduction	15678000	4	O
blocks	15678000	4	O
and	15678000	4	O
dilated	15678000	4	O
cardiomyopathy	15678000	4	O
.	15678000	4	O
Its	15678000	4	O
clinical	15678000	4	O
and	15678000	4	O
genetic	15678000	4	O
diagnosis	15678000	4	O
is	15678000	4	O
crucial	15678000	4	O
for	15678000	4	O
cardiac	15678000	4	O
management	15678000	4	O
and	15678000	4	O
genetic	15678000	4	O
counselling	15678000	4	O
.	15678000	4	O
Seven	15678000	4	O
LMNA	15678000	4	O
mutations	15678000	4	O
have	15678000	4	O
been	15678000	4	O
previously	15678000	4	O
reported	15678000	4	O
to	15678000	4	O
be	15678000	4	O
responsible	15678000	4	O
for	15678000	4	O
LGMD1B	15678000	4	O
.	15678000	4	O
PATIENTS	15678000	4	O
AND	15678000	4	O
METHODS	15678000	4	O
:	15678000	4	O
We	15678000	4	O
describe	15678000	4	O
the	15678000	4	O
neurological	15678000	4	O
and	15678000	4	O
cardiologic	15678000	4	O
features	15678000	4	O
of	15678000	4	O
14	15678000	4	O
patients	15678000	4	O
belonging	15678000	4	O
to	15678000	4	O
8	15678000	4	O
families	15678000	4	O
in	15678000	4	O
whom	15678000	4	O
we	15678000	4	O
identified	15678000	4	O
6	15678000	4	O
different	15678000	4	O
LMNA	15678000	4	O
mutations	15678000	4	O
,	15678000	4	O
4	15678000	4	O
of	15678000	4	O
them	15678000	4	O
having	15678000	4	O
never	15678000	4	O
been	15678000	4	O
reported	15678000	4	O
.	15678000	4	O
Results	15678000	4	O
.	15678000	4	O
Eleven	15678000	4	O
patients	15678000	4	O
had	15678000	4	O
an	15678000	4	O
LGMD1B	15678000	4	O
phenotype	15678000	4	O
with	15678000	4	O
scapulohumeral	15678000	4	O
and	15678000	4	O
pelvic	15678000	4	O
-	15678000	4	O
femoral	15678000	4	O
involvement	15678000	4	O
.	15678000	4	O
Thirteen	15678000	4	O
patients	15678000	4	O
had	15678000	4	O
cardiac	15678000	4	O
disease	15678000	4	O
associating	15678000	4	O
conduction	15678000	4	O
defects	15678000	4	O
(	15678000	4	O
12	15678000	4	O
patients	15678000	4	O
)	15678000	4	O
or	15678000	4	O
arrhythmias	15678000	4	O
(	15678000	4	O
9	15678000	4	O
patients	15678000	4	O
)	15678000	4	O
.	15678000	4	O
Seven	15678000	4	O
patients	15678000	4	O
needed	15678000	4	O
cardiac	15678000	4	O
device	15678000	4	O
(	15678000	4	O
pacemaker	15678000	4	O
or	15678000	4	O
implantable	15678000	4	O
cardiac	15678000	4	O
defibrillator	15678000	4	O
)	15678000	4	O
and	15678000	4	O
two	15678000	4	O
had	15678000	4	O
heart	15678000	4	O
transplantation	15678000	4	O
.	15678000	4	O
CONCLUSION	15678000	4	O
:	15678000	4	O
This	15678000	4	O
study	15678000	4	O
allowed	15678000	4	O
us	15678000	4	O
to	15678000	4	O
specify	15678000	4	O
the	15678000	4	O
clinical	15678000	4	O
characteristics	15678000	4	O
of	15678000	4	O
this	15678000	4	O
entity	15678000	4	O
and	15678000	4	O
to	15678000	4	O
outline	15678000	4	O
the	15678000	4	O
first	15678000	4	O
phenotype	15678000	4	O
/	15678000	4	O
genotype	15678000	4	O
relations	15678000	4	O
resulting	15678000	4	O
from	15678000	4	O
these	15678000	4	O
observations	15678000	4	O
.	15678000	4	O

Genetics	15773749	4	O
of	15773749	4	O
laminopathies	15773749	4	O
.	15773749	4	O
Laminopathies	15773749	4	O
are	15773749	4	O
now	15773749	4	O
recognized	15773749	4	O
as	15773749	4	O
a	15773749	4	O
group	15773749	4	O
of	15773749	4	O
disorders	15773749	4	O
due	15773749	4	O
to	15773749	4	O
mutations	15773749	4	O
of	15773749	4	O
the	15773749	4	O
LMNA	15773749	4	O
gene	15773749	4	O
,	15773749	4	O
which	15773749	4	O
encodes	15773749	4	O
A	15773749	4	O
-	15773749	4	O
type	15773749	4	O
lamins	15773749	4	O
.	15773749	4	O
Primarily	15773749	4	O
,	15773749	4	O
mutations	15773749	4	B-Var
in	15773749	4	O
LMNA	15773749	4	B-Gene
have	15773749	4	O
been	15773749	4	O
associated	15773749	4	B-Reg
to	15773749	4	I-Reg
the	15773749	4	O
autosomal	15773749	4	O
forms	15773749	4	O
of	15773749	4	O
Emery	15773749	4	B-Disease
-	15773749	4	I-Disease
Dreifuss	15773749	4	I-Disease
muscular	15773749	4	I-Disease
dystrophy	15773749	4	I-Disease
,	15773749	4	O
a	15773749	4	O
rare	15773749	4	O
slowly	15773749	4	O
progressive	15773749	4	O
humero	15773749	4	O
-	15773749	4	O
peroneal	15773749	4	O
muscular	15773749	4	O
dystrophy	15773749	4	O
accompanied	15773749	4	O
by	15773749	4	O
early	15773749	4	O
contractures	15773749	4	O
and	15773749	4	O
dilated	15773749	4	O
cardiomyopathy	15773749	4	O
with	15773749	4	O
conduction	15773749	4	O
defects	15773749	4	O
.	15773749	4	O
LMNA	15773749	4	O
mutations	15773749	4	O
have	15773749	4	O
been	15773749	4	O
reported	15773749	4	O
to	15773749	4	O
be	15773749	4	O
responsible	15773749	4	O
for	15773749	4	O
up	15773749	4	O
to	15773749	4	O
10	15773749	4	O
distinct	15773749	4	O
phenotypes	15773749	4	O
that	15773749	4	O
affect	15773749	4	O
specifically	15773749	4	O
either	15773749	4	O
the	15773749	4	O
skeletal	15773749	4	O
and	15773749	4	O
/	15773749	4	O
or	15773749	4	O
cardiac	15773749	4	O
muscle	15773749	4	O
,	15773749	4	O
the	15773749	4	O
adipose	15773749	4	O
tissue	15773749	4	O
,	15773749	4	O
the	15773749	4	O
peripheral	15773749	4	O
nervous	15773749	4	O
tissue	15773749	4	O
,	15773749	4	O
the	15773749	4	O
bone	15773749	4	O
tissue	15773749	4	O
or	15773749	4	O
more	15773749	4	O
recently	15773749	4	O
premature	15773749	4	O
ageing	15773749	4	O
.	15773749	4	O
So	15773749	4	O
far	15773749	4	O
more	15773749	4	O
than	15773749	4	O
180	15773749	4	O
different	15773749	4	O
LMNA	15773749	4	O
mutations	15773749	4	O
have	15773749	4	O
been	15773749	4	O
identified	15773749	4	O
in	15773749	4	O
903	15773749	4	O
individuals	15773749	4	O
.	15773749	4	O
The	15773749	4	O
first	15773749	4	O
studies	15773749	4	O
of	15773749	4	O
phenotype	15773749	4	O
/	15773749	4	O
genotype	15773749	4	O
relationships	15773749	4	O
revealed	15773749	4	O
no	15773749	4	O
dear	15773749	4	O
relation	15773749	4	O
between	15773749	4	O
the	15773749	4	O
phenotype	15773749	4	O
and	15773749	4	O
the	15773749	4	O
type	15773749	4	O
and	15773749	4	O
/	15773749	4	O
or	15773749	4	O
the	15773749	4	O
localization	15773749	4	O
of	15773749	4	O
the	15773749	4	O
mutation	15773749	4	O
,	15773749	4	O
except	15773749	4	O
perhaps	15773749	4	O
for	15773749	4	O
the	15773749	4	O
globular	15773749	4	O
tail	15773749	4	O
domain	15773749	4	O
of	15773749	4	O
lamins	15773749	4	O
A	15773749	4	O
/	15773749	4	O
C.	15773749	4	O
Studies	15773749	4	O
of	15773749	4	O
the	15773749	4	O
consequences	15773749	4	O
of	15773749	4	O
LMNA	15773749	4	O
mutations	15773749	4	O
in	15773749	4	O
the	15773749	4	O
skin	15773749	4	O
cultured	15773749	4	O
fibroblasts	15773749	4	O
from	15773749	4	O
the	15773749	4	O
patients	15773749	4	O
reveal	15773749	4	O
abnormal	15773749	4	O
nuclei	15773749	4	O
in	15773749	4	O
variable	15773749	4	O
proportions	15773749	4	O
,	15773749	4	O
with	15773749	4	O
dysmorphic	15773749	4	O
nuclei	15773749	4	O
exhibiting	15773749	4	O
abnormal	15773749	4	O
patterns	15773749	4	O
of	15773749	4	O
expression	15773749	4	O
of	15773749	4	O
B	15773749	4	O
-	15773749	4	O
type	15773749	4	O
lamins	15773749	4	O
and	15773749	4	O
emerin	15773749	4	O
.	15773749	4	O
Finally	15773749	4	O
,	15773749	4	O
the	15773749	4	O
development	15773749	4	O
of	15773749	4	O
KO	15773749	4	O
and	15773749	4	O
KI	15773749	4	O
LMNA	15773749	4	O
mice	15773749	4	O
,	15773749	4	O
will	15773749	4	O
certainly	15773749	4	O
give	15773749	4	O
further	15773749	4	O
insight	15773749	4	O
into	15773749	4	O
the	15773749	4	O
pathophysiological	15773749	4	O
mechanisms	15773749	4	O
associated	15773749	4	O
with	15773749	4	O
LMNA	15773749	4	O
mutations	15773749	4	O
.	15773749	4	O
For	15773749	4	O
example	15773749	4	O
,	15773749	4	O
Lmna	15773749	4	O
(	15773749	4	O
H222P	15773749	4	O
/	15773749	4	O
H222P	15773749	4	O
)	15773749	4	O
mice	15773749	4	O
harbour	15773749	4	O
phenotypes	15773749	4	O
reminiscent	15773749	4	O
of	15773749	4	O
Emery	15773749	4	O
-	15773749	4	O
Dreifuss	15773749	4	O
muscular	15773749	4	O
dystrophy	15773749	4	O
.	15773749	4	O

Mutations	15773758	4	B-Var
in	15773758	4	O
the	15773758	4	O
mouse	15773758	4	O
Lmna	15773758	4	B-Gene
gene	15773758	4	O
causing	15773758	4	B-Reg
progeria	15773758	4	B-Disease
,	15773758	4	O
muscular	15773758	4	B-Disease
dystrophy	15773758	4	I-Disease
and	15773758	4	O
cardiomyopathy	15773758	4	B-Disease
.	15773758	4	O
At	15773758	4	O
least	15773758	4	O
ten	15773758	4	O
different	15773758	4	O
diseases	15773758	4	O
have	15773758	4	O
been	15773758	4	O
linked	15773758	4	O
to	15773758	4	O
mutations	15773758	4	O
in	15773758	4	O
proteins	15773758	4	O
associated	15773758	4	O
with	15773758	4	O
the	15773758	4	O
nuclear	15773758	4	O
envelope	15773758	4	O
(	15773758	4	O
NE	15773758	4	O
)	15773758	4	O
.	15773758	4	O
Eight	15773758	4	O
of	15773758	4	O
these	15773758	4	O
diseases	15773758	4	O
are	15773758	4	O
associated	15773758	4	O
with	15773758	4	O
mutations	15773758	4	O
in	15773758	4	O
the	15773758	4	O
lamin	15773758	4	O
A	15773758	4	O
gene	15773758	4	O
(	15773758	4	O
LMNA	15773758	4	O
)	15773758	4	O
.	15773758	4	O
These	15773758	4	O
diseases	15773758	4	O
include	15773758	4	O
the	15773758	4	O
premature	15773758	4	O
ageing	15773758	4	O
or	15773758	4	O
progeric	15773758	4	O
diseases	15773758	4	O
Hutchinson	15773758	4	O
-	15773758	4	O
Gilford	15773758	4	O
progeria	15773758	4	O
and	15773758	4	O
atypical	15773758	4	O
Werner	15773758	4	O
'	15773758	4	O
s	15773758	4	O
syndrome	15773758	4	O
,	15773758	4	O
diseases	15773758	4	O
affecting	15773758	4	O
striated	15773758	4	O
and	15773758	4	O
cardiac	15773758	4	O
muscle	15773758	4	O
including	15773758	4	O
muscular	15773758	4	O
dystrophies	15773758	4	O
and	15773758	4	O
dilated	15773758	4	O
cardiomyopathies	15773758	4	O
,	15773758	4	O
lipodystrophies	15773758	4	O
affecting	15773758	4	O
white	15773758	4	O
fat	15773758	4	O
deposition	15773758	4	O
and	15773758	4	O
skeletal	15773758	4	O
development	15773758	4	O
and	15773758	4	O
a	15773758	4	O
peripheral	15773758	4	O
neuropathy	15773758	4	O
resulting	15773758	4	O
in	15773758	4	O
motor	15773758	4	O
neuron	15773758	4	O
demyelination	15773758	4	O
.	15773758	4	O
To	15773758	4	O
understand	15773758	4	O
how	15773758	4	O
these	15773758	4	O
diseases	15773758	4	O
arise	15773758	4	O
from	15773758	4	O
different	15773758	4	O
mutations	15773758	4	O
in	15773758	4	O
the	15773758	4	O
same	15773758	4	O
protein	15773758	4	O
,	15773758	4	O
we	15773758	4	O
established	15773758	4	O
mouse	15773758	4	O
lines	15773758	4	O
carrying	15773758	4	O
some	15773758	4	O
of	15773758	4	O
the	15773758	4	O
same	15773758	4	O
mutations	15773758	4	O
found	15773758	4	O
in	15773758	4	O
the	15773758	4	O
human	15773758	4	O
LMNA	15773758	4	O
gene	15773758	4	O
,	15773758	4	O
as	15773758	4	O
both	15773758	4	O
mouse	15773758	4	O
and	15773758	4	O
human	15773758	4	O
lamin	15773758	4	O
genes	15773758	4	O
show	15773758	4	O
a	15773758	4	O
very	15773758	4	O
high	15773758	4	O
degree	15773758	4	O
of	15773758	4	O
sequence	15773758	4	O
conservation	15773758	4	O
.	15773758	4	O
We	15773758	4	O
have	15773758	4	O
generated	15773758	4	O
mice	15773758	4	O
with	15773758	4	O
different	15773758	4	O
mutations	15773758	4	O
resulting	15773758	4	O
in	15773758	4	O
progeria	15773758	4	O
,	15773758	4	O
muscular	15773758	4	O
dystrophy	15773758	4	O
and	15773758	4	O
dilated	15773758	4	O
cardiomyopathy	15773758	4	O
.	15773758	4	O
Our	15773758	4	O
mouse	15773758	4	O
lines	15773758	4	O
are	15773758	4	O
providing	15773758	4	O
novel	15773758	4	O
insights	15773758	4	O
into	15773758	4	O
how	15773758	4	O
changes	15773758	4	O
to	15773758	4	O
the	15773758	4	O
nuclear	15773758	4	O
lamina	15773758	4	O
affect	15773758	4	O
the	15773758	4	O
mechanical	15773758	4	O
integrity	15773758	4	O
of	15773758	4	O
the	15773758	4	O
nucleus	15773758	4	O
and	15773758	4	O
in	15773758	4	O
turn	15773758	4	O
intracellular	15773758	4	O
signalling	15773758	4	O
,	15773758	4	O
such	15773758	4	O
as	15773758	4	O
the	15773758	4	O
NF	15773758	4	O
-	15773758	4	O
kappaB	15773758	4	O
pathway	15773758	4	O
,	15773758	4	O
as	15773758	4	O
well	15773758	4	O
as	15773758	4	O
cell	15773758	4	O
proliferation	15773758	4	O
and	15773758	4	O
survival	15773758	4	O
,	15773758	4	O
cellular	15773758	4	O
functions	15773758	4	O
that	15773758	4	O
,	15773758	4	O
when	15773758	4	O
disrupted	15773758	4	O
,	15773758	4	O
may	15773758	4	O
be	15773758	4	O
the	15773758	4	O
basis	15773758	4	O
for	15773758	4	O
the	15773758	4	O
origin	15773758	4	O
of	15773758	4	O
such	15773758	4	O
diseases	15773758	4	O
.	15773758	4	O

A	15857086	1	O
novel	15857086	1	O
mutation	15857086	1	B-Var
of	15857086	1	O
the	15857086	1	O
cathepsin	15857086	1	B-Gene
C	15857086	1	I-Gene
gene	15857086	1	O
in	15857086	1	O
a	15857086	1	O
thai	15857086	1	O
family	15857086	1	O
with	15857086	1	B-Reg
Papillon	15857086	1	B-Disease
-	15857086	1	I-Disease
Lefevre	15857086	1	I-Disease
syndrome	15857086	1	I-Disease
.	15857086	1	O
BACKGROUND	15857086	1	O
:	15857086	1	O
Papillon	15857086	1	O
-	15857086	1	O
Lefevre	15857086	1	O
syndrome	15857086	1	O
(	15857086	1	O
PLS	15857086	1	O
)	15857086	1	O
is	15857086	1	O
a	15857086	1	O
rare	15857086	1	O
autosomal	15857086	1	O
recessive	15857086	1	O
disorder	15857086	1	O
characterized	15857086	1	O
by	15857086	1	O
palmar	15857086	1	O
-	15857086	1	O
plantar	15857086	1	O
hyperkeratosis	15857086	1	O
and	15857086	1	O
rapid	15857086	1	O
periodontal	15857086	1	O
destruction	15857086	1	O
of	15857086	1	O
both	15857086	1	O
primary	15857086	1	O
and	15857086	1	O
permanent	15857086	1	O
dentitions	15857086	1	O
.	15857086	1	O
It	15857086	1	O
has	15857086	1	O
been	15857086	1	O
shown	15857086	1	O
that	15857086	1	O
the	15857086	1	O
disease	15857086	1	O
is	15857086	1	O
caused	15857086	1	O
by	15857086	1	O
cathepsin	15857086	1	O
C	15857086	1	O
gene	15857086	1	O
(	15857086	1	B-Gene
CTSC	15857086	1	I-Gene
)	15857086	1	I-Gene
mutation	15857086	1	B-Var
leading	15857086	1	O
to	15857086	1	O
the	15857086	1	O
deficiency	15857086	1	B-NegReg
of	15857086	1	O
cathepsin	15857086	1	O
C	15857086	1	O
enzymatic	15857086	1	O
activity	15857086	1	O
.	15857086	1	O
This	15857086	1	O
study	15857086	1	O
demonstrates	15857086	1	O
the	15857086	1	O
clinical	15857086	1	O
manifestations	15857086	1	O
and	15857086	1	O
CTSC	15857086	1	O
mutational	15857086	1	O
and	15857086	1	O
enzymatic	15857086	1	O
activity	15857086	1	O
analyses	15857086	1	O
in	15857086	1	O
a	15857086	1	O
5	15857086	1	O
-	15857086	1	O
year	15857086	1	O
-	15857086	1	O
old	15857086	1	O
Thai	15857086	1	O
male	15857086	1	O
PLS	15857086	1	O
patient	15857086	1	O
and	15857086	1	O
his	15857086	1	O
parents	15857086	1	O
.	15857086	1	O
METHODS	15857086	1	O
:	15857086	1	O
Peripheral	15857086	1	O
blood	15857086	1	O
samples	15857086	1	O
were	15857086	1	O
obtained	15857086	1	O
for	15857086	1	O
genomic	15857086	1	O
DNA	15857086	1	O
isolation	15857086	1	O
.	15857086	1	O
All	15857086	1	O
exons	15857086	1	O
of	15857086	1	O
the	15857086	1	O
CTSC	15857086	1	O
gene	15857086	1	O
were	15857086	1	O
amplified	15857086	1	O
by	15857086	1	O
polymerase	15857086	1	O
chain	15857086	1	O
reaction	15857086	1	O
(	15857086	1	O
PCR	15857086	1	O
)	15857086	1	O
using	15857086	1	O
specific	15857086	1	O
primers	15857086	1	O
.	15857086	1	O
Mutations	15857086	1	O
were	15857086	1	O
identified	15857086	1	O
by	15857086	1	O
DNA	15857086	1	O
sequencing	15857086	1	O
.	15857086	1	O
Verification	15857086	1	O
of	15857086	1	O
the	15857086	1	O
mutation	15857086	1	O
was	15857086	1	O
performed	15857086	1	O
by	15857086	1	O
digestion	15857086	1	O
of	15857086	1	O
PCR	15857086	1	O
products	15857086	1	O
by	15857086	1	O
restriction	15857086	1	O
endonucleases	15857086	1	O
.	15857086	1	O
The	15857086	1	O
cathepsin	15857086	1	O
C	15857086	1	O
enzymatic	15857086	1	O
activity	15857086	1	O
was	15857086	1	O
determined	15857086	1	O
using	15857086	1	O
the	15857086	1	O
synthetic	15857086	1	O
substrate	15857086	1	O
glycyl	15857086	1	O
-	15857086	1	O
L	15857086	1	O
-	15857086	1	O
arginine-7	15857086	1	O
-	15857086	1	O
amino-4	15857086	1	O
-	15857086	1	O
methylcoumarin	15857086	1	O
.	15857086	1	O
RESULTS	15857086	1	O
:	15857086	1	O
The	15857086	1	O
patient	15857086	1	O
demonstrated	15857086	1	O
classical	15857086	1	O
characteristics	15857086	1	O
of	15857086	1	O
PLS	15857086	1	O
,	15857086	1	O
including	15857086	1	O
hyperkeratotic	15857086	1	O
skin	15857086	1	O
lesions	15857086	1	O
.	15857086	1	O
By	15857086	1	O
the	15857086	1	O
age	15857086	1	O
of	15857086	1	O
5	15857086	1	O
,	15857086	1	O
all	15857086	1	O
of	15857086	1	O
his	15857086	1	O
primary	15857086	1	O
teeth	15857086	1	O
were	15857086	1	O
extracted	15857086	1	O
due	15857086	1	O
to	15857086	1	O
severe	15857086	1	O
periodontal	15857086	1	O
infection	15857086	1	O
.	15857086	1	O
The	15857086	1	O
parents	15857086	1	O
had	15857086	1	O
no	15857086	1	O
physical	15857086	1	O
abnormalities	15857086	1	O
.	15857086	1	O
The	15857086	1	O
periodontal	15857086	1	O
examination	15857086	1	O
revealed	15857086	1	O
localized	15857086	1	O
mild	15857086	1	O
periodontal	15857086	1	O
destruction	15857086	1	O
.	15857086	1	O
Sequence	15857086	1	O
analysis	15857086	1	O
showed	15857086	1	O
a	15857086	1	O
nucleotide	15857086	1	O
change	15857086	1	O
at	15857086	1	O
position	15857086	1	O
90	15857086	1	O
from	15857086	1	O
C	15857086	1	O
>	15857086	1	O
A	15857086	1	O
(	15857086	1	B-Var
c.90	15857086	1	I-Var
C	15857086	1	I-Var
>	15857086	1	I-Var
A	15857086	1	I-Var
)	15857086	1	I-Var
which	15857086	1	O
resulted	15857086	1	B-Reg
in	15857086	1	I-Reg
a	15857086	1	O
change	15857086	1	O
from	15857086	1	O
cysteine	15857086	1	O
residue	15857086	1	O
to	15857086	1	O
a	15857086	1	O
premature	15857086	1	O
stop	15857086	1	O
codon	15857086	1	O
at	15857086	1	O
the	15857086	1	O
amino	15857086	1	O
acid	15857086	1	O
position	15857086	1	O
30	15857086	1	O
in	15857086	1	O
the	15857086	1	O
exon	15857086	1	O
1	15857086	1	O
.	15857086	1	O
The	15857086	1	O
HpyCH4V	15857086	1	O
digestion	15857086	1	O
revealed	15857086	1	O
that	15857086	1	O
the	15857086	1	O
patient	15857086	1	O
was	15857086	1	O
homozygous	15857086	1	O
,	15857086	1	O
whereas	15857086	1	O
both	15857086	1	O
the	15857086	1	O
father	15857086	1	O
and	15857086	1	O
mother	15857086	1	O
were	15857086	1	O
heterozygous	15857086	1	O
carriers	15857086	1	O
of	15857086	1	O
this	15857086	1	O
mutation	15857086	1	O
.	15857086	1	O
The	15857086	1	O
cathepsin	15857086	1	O
C	15857086	1	O
activity	15857086	1	O
was	15857086	1	O
reduced	15857086	1	O
in	15857086	1	O
the	15857086	1	O
patient	15857086	1	O
'	15857086	1	O
s	15857086	1	O
mother	15857086	1	O
,	15857086	1	O
and	15857086	1	O
the	15857086	1	O
activity	15857086	1	O
in	15857086	1	O
the	15857086	1	O
patient	15857086	1	O
was	15857086	1	O
almost	15857086	1	O
completely	15857086	1	O
lost	15857086	1	O
.	15857086	1	O
CONCLUSIONS	15857086	1	O
:	15857086	1	O
This	15857086	1	O
is	15857086	1	O
the	15857086	1	O
first	15857086	1	O
study	15857086	1	O
to	15857086	1	O
demonstrate	15857086	1	O
a	15857086	1	O
CTSC	15857086	1	B-Gene
gene	15857086	1	O
mutation	15857086	1	O
in	15857086	1	O
a	15857086	1	O
Thai	15857086	1	O
family	15857086	1	O
with	15857086	1	O
PLS	15857086	1	O
.	15857086	1	O
The	15857086	1	O
identified	15857086	1	O
mutation	15857086	1	B-Var
is	15857086	1	O
novel	15857086	1	O
and	15857086	1	O
potentially	15857086	1	O
leads	15857086	1	O
to	15857086	1	O
the	15857086	1	O
drastic	15857086	1	O
reduction	15857086	1	B-NegReg
of	15857086	1	O
the	15857086	1	O
cathepsin	15857086	1	O
C	15857086	1	O
enzymatic	15857086	1	O
activity	15857086	1	O
.	15857086	1	O
This	15857086	1	O
suggests	15857086	1	O
that	15857086	1	O
the	15857086	1	O
mutation	15857086	1	O
is	15857086	1	O
pathogenetic	15857086	1	O
,	15857086	1	O
causing	15857086	1	B-Reg
the	15857086	1	O
PLS	15857086	1	B-Disease
.	15857086	1	O
Mutational	15857086	1	O
analysis	15857086	1	O
in	15857086	1	O
more	15857086	1	O
members	15857086	1	O
of	15857086	1	O
the	15857086	1	O
family	15857086	1	O
is	15857086	1	O
warranted	15857086	1	O
to	15857086	1	O
identify	15857086	1	O
whether	15857086	1	O
the	15857086	1	O
mutation	15857086	1	O
is	15857086	1	O
inherited	15857086	1	O
from	15857086	1	O
a	15857086	1	O
common	15857086	1	O
ancestor	15857086	1	O
.	15857086	1	O

Mutations	15880705	1	O
of	15880705	1	O
COL10A1	15880705	1	O
in	15880705	1	O
Schmid	15880705	1	O
metaphyseal	15880705	1	O
chondrodysplasia	15880705	1	O
.	15880705	1	O
Schmid	15880705	1	B-Disease
metaphyseal	15880705	1	I-Disease
chondrodysplasia	15880705	1	I-Disease
(	15880705	1	O
SMCD	15880705	1	O
)	15880705	1	O
is	15880705	1	O
a	15880705	1	O
dominantly	15880705	1	O
inherited	15880705	1	O
cartilage	15880705	1	O
disorder	15880705	1	O
caused	15880705	1	B-Reg
by	15880705	1	I-Reg
mutations	15880705	1	B-Var
in	15880705	1	O
the	15880705	1	O
gene	15880705	1	O
for	15880705	1	O
the	15880705	1	O
hypertrophic	15880705	1	O
cartilage	15880705	1	O
extracellular	15880705	1	O
matrix	15880705	1	O
structural	15880705	1	O
protein	15880705	1	O
,	15880705	1	O
collagen	15880705	1	O
X	15880705	1	O
(	15880705	1	B-Gene
COL10A1	15880705	1	I-Gene
)	15880705	1	I-Gene
.	15880705	1	O
Thirty	15880705	1	O
heterozygous	15880705	1	O
mutations	15880705	1	O
have	15880705	1	O
been	15880705	1	O
described	15880705	1	O
,	15880705	1	O
about	15880705	1	O
equally	15880705	1	O
divided	15880705	1	O
into	15880705	1	O
two	15880705	1	O
mutation	15880705	1	O
types	15880705	1	O
,	15880705	1	O
missense	15880705	1	O
mutations	15880705	1	O
,	15880705	1	O
and	15880705	1	O
mutations	15880705	1	O
that	15880705	1	O
introduce	15880705	1	O
premature	15880705	1	O
termination	15880705	1	O
signals	15880705	1	O
.	15880705	1	O
The	15880705	1	O
COL10A1	15880705	1	O
mutations	15880705	1	O
are	15880705	1	O
clustered	15880705	1	O
(	15880705	1	O
33	15880705	1	O
/	15880705	1	O
36	15880705	1	O
)	15880705	1	O
in	15880705	1	O
the	15880705	1	O
3	15880705	1	O
'	15880705	1	O
region	15880705	1	O
of	15880705	1	O
exon	15880705	1	O
3	15880705	1	O
,	15880705	1	O
which	15880705	1	O
codes	15880705	1	O
for	15880705	1	O
the	15880705	1	O
C	15880705	1	O
-	15880705	1	O
terminal	15880705	1	O
NC1	15880705	1	O
trimerization	15880705	1	O
domain	15880705	1	O
.	15880705	1	O
The	15880705	1	O
effect	15880705	1	O
of	15880705	1	O
COL10A1	15880705	1	O
missense	15880705	1	O
mutations	15880705	1	O
have	15880705	1	O
been	15880705	1	O
examined	15880705	1	O
by	15880705	1	O
in	15880705	1	O
vitro	15880705	1	O
expression	15880705	1	O
and	15880705	1	O
assembly	15880705	1	O
assays	15880705	1	O
and	15880705	1	O
cell	15880705	1	O
transfection	15880705	1	O
studies	15880705	1	O
,	15880705	1	O
which	15880705	1	O
suggest	15880705	1	O
that	15880705	1	O
a	15880705	1	O
common	15880705	1	O
consequence	15880705	1	O
is	15880705	1	O
the	15880705	1	O
disruption	15880705	1	O
of	15880705	1	O
collagen	15880705	1	O
X	15880705	1	O
trimerization	15880705	1	O
and	15880705	1	O
secretion	15880705	1	O
,	15880705	1	O
with	15880705	1	O
consequent	15880705	1	O
intracellular	15880705	1	O
degradation	15880705	1	O
.	15880705	1	O
The	15880705	1	O
effect	15880705	1	O
of	15880705	1	O
COL10A1	15880705	1	B-Gene
nonsense	15880705	1	B-Var
mutations	15880705	1	I-Var
in	15880705	1	O
cartilage	15880705	1	O
tissue	15880705	1	O
has	15880705	1	O
been	15880705	1	O
examined	15880705	1	O
in	15880705	1	O
two	15880705	1	O
patients	15880705	1	O
,	15880705	1	O
demonstrating	15880705	1	O
that	15880705	1	O
the	15880705	1	O
mutant	15880705	1	B-Var
mRNA	15880705	1	O
is	15880705	1	O
completely	15880705	1	O
removed	15880705	1	B-NegReg
by	15880705	1	O
nonsense	15880705	1	O
mediated	15880705	1	O
mRNA	15880705	1	O
decay	15880705	1	B-NegReg
.	15880705	1	O
Thus	15880705	1	O
for	15880705	1	O
both	15880705	1	O
classes	15880705	1	O
of	15880705	1	O
mutations	15880705	1	O
,	15880705	1	O
functional	15880705	1	O
haploinsufficiency	15880705	1	O
is	15880705	1	O
the	15880705	1	O
most	15880705	1	O
probable	15880705	1	O
cause	15880705	1	O
of	15880705	1	O
the	15880705	1	O
clinical	15880705	1	O
phenotype	15880705	1	O
in	15880705	1	O
SMCD	15880705	1	O
.	15880705	1	O

Sjögren	15931689	1	B-Disease
-	15931689	1	I-Disease
Larsson	15931689	1	I-Disease
syndrome	15931689	1	I-Disease
:	15931689	1	I-Disease
diversity	15931689	1	O
of	15931689	1	B-Reg
mutations	15931689	1	B-Var
and	15931689	1	O
polymorphisms	15931689	1	O
in	15931689	1	O
the	15931689	1	O
fatty	15931689	1	O
aldehyde	15931689	1	O
dehydrogenase	15931689	1	O
gene	15931689	1	O
(	15931689	1	B-Gene
ALDH3A2	15931689	1	I-Gene
)	15931689	1	I-Gene
.	15931689	1	O
Sjögren	15931689	1	B-Disease
-	15931689	1	I-Disease
Larsson	15931689	1	I-Disease
syndrome	15931689	1	I-Disease
(	15931689	1	O
SLS	15931689	1	O
)	15931689	1	O
is	15931689	1	O
an	15931689	1	O
autosomal	15931689	1	O
recessive	15931689	1	O
disorder	15931689	1	O
characterized	15931689	1	O
by	15931689	1	O
ichthyosis	15931689	1	O
,	15931689	1	O
mental	15931689	1	O
retardation	15931689	1	O
,	15931689	1	O
and	15931689	1	O
spastic	15931689	1	O
diplegia	15931689	1	O
or	15931689	1	O
tetraplegia	15931689	1	O
.	15931689	1	O
The	15931689	1	O
disease	15931689	1	O
is	15931689	1	O
caused	15931689	1	B-Reg
by	15931689	1	I-Reg
mutations	15931689	1	B-Var
in	15931689	1	O
the	15931689	1	O
ALDH3A2	15931689	1	B-Gene
gene	15931689	1	O
(	15931689	1	O
also	15931689	1	O
known	15931689	1	O
as	15931689	1	O
FALDH	15931689	1	B-Gene
and	15931689	1	O
ALDH10	15931689	1	B-Gene
)	15931689	1	I-Gene
on	15931689	1	O
chromosome	15931689	1	O
17	15931689	1	O
p11.2	15931689	1	O
that	15931689	1	O
encodes	15931689	1	O
fatty	15931689	1	O
aldehyde	15931689	1	O
dehydrogenase	15931689	1	O
(	15931689	1	O
FALDH	15931689	1	O
)	15931689	1	O
,	15931689	1	O
an	15931689	1	O
enzyme	15931689	1	O
that	15931689	1	O
catalyzes	15931689	1	O
the	15931689	1	O
oxidation	15931689	1	O
of	15931689	1	O
long	15931689	1	O
-	15931689	1	O
chain	15931689	1	O
aldehydes	15931689	1	O
derived	15931689	1	O
from	15931689	1	O
lipid	15931689	1	O
metabolism	15931689	1	O
.	15931689	1	O
In	15931689	1	O
SLS	15931689	1	O
patients	15931689	1	O
,	15931689	1	O
72	15931689	1	O
mutations	15931689	1	O
have	15931689	1	O
been	15931689	1	O
identified	15931689	1	O
,	15931689	1	O
with	15931689	1	O
a	15931689	1	O
distribution	15931689	1	O
that	15931689	1	O
is	15931689	1	O
scattered	15931689	1	O
throughout	15931689	1	O
the	15931689	1	O
ALDH3A2	15931689	1	O
gene	15931689	1	O
.	15931689	1	O
Most	15931689	1	O
mutations	15931689	1	O
are	15931689	1	O
private	15931689	1	O
but	15931689	1	O
several	15931689	1	O
common	15931689	1	O
mutations	15931689	1	O
have	15931689	1	O
been	15931689	1	O
detected	15931689	1	O
,	15931689	1	O
which	15931689	1	O
probably	15931689	1	O
reflect	15931689	1	O
founder	15931689	1	O
effects	15931689	1	O
or	15931689	1	O
recurrent	15931689	1	O
mutational	15931689	1	O
events	15931689	1	O
.	15931689	1	O
Missense	15931689	1	O
mutations	15931689	1	B-Var
comprise	15931689	1	O
the	15931689	1	O
most	15931689	1	O
abundant	15931689	1	O
class	15931689	1	O
(	15931689	1	O
38%	15931689	1	O
)	15931689	1	O
and	15931689	1	O
expression	15931689	1	O
studies	15931689	1	O
indicate	15931689	1	O
that	15931689	1	O
most	15931689	1	O
of	15931689	1	O
these	15931689	1	O
result	15931689	1	O
in	15931689	1	O
a	15931689	1	O
profound	15931689	1	O
reduction	15931689	1	B-NegReg
in	15931689	1	O
enzyme	15931689	1	O
activity	15931689	1	O
.	15931689	1	O
Deletions	15931689	1	O
account	15931689	1	O
for	15931689	1	O
about	15931689	1	O
25%	15931689	1	O
of	15931689	1	O
the	15931689	1	O
mutations	15931689	1	O
and	15931689	1	O
range	15931689	1	O
from	15931689	1	O
single	15931689	1	O
nucleotides	15931689	1	O
to	15931689	1	O
entire	15931689	1	O
exons	15931689	1	O
.	15931689	1	O
Twelve	15931689	1	O
splice	15931689	1	O
-	15931689	1	O
site	15931689	1	O
mutations	15931689	1	B-Var
have	15931689	1	O
been	15931689	1	O
demonstrated	15931689	1	O
to	15931689	1	O
cause	15931689	1	B-Reg
aberrant	15931689	1	O
splicing	15931689	1	O
in	15931689	1	O
cultured	15931689	1	O
fibroblasts	15931689	1	O
.	15931689	1	O
To	15931689	1	O
date	15931689	1	O
,	15931689	1	O
more	15931689	1	O
than	15931689	1	O
a	15931689	1	O
dozen	15931689	1	O
intragenic	15931689	1	O
ALDH3A2	15931689	1	O
polymorphisms	15931689	1	O
consisting	15931689	1	O
of	15931689	1	O
SNPs	15931689	1	O
and	15931689	1	O
one	15931689	1	O
microsatellite	15931689	1	O
marker	15931689	1	O
have	15931689	1	O
been	15931689	1	O
characterized	15931689	1	O
,	15931689	1	O
although	15931689	1	O
none	15931689	1	O
of	15931689	1	O
them	15931689	1	O
alter	15931689	1	O
the	15931689	1	O
FALDH	15931689	1	O
protein	15931689	1	O
sequence	15931689	1	O
.	15931689	1	O
The	15931689	1	O
striking	15931689	1	O
mutational	15931689	1	O
diversity	15931689	1	O
in	15931689	1	O
SLS	15931689	1	O
offers	15931689	1	O
a	15931689	1	O
challenge	15931689	1	O
for	15931689	1	O
DNA	15931689	1	O
-	15931689	1	O
based	15931689	1	O
diagnosis	15931689	1	O
,	15931689	1	O
but	15931689	1	O
promises	15931689	1	O
to	15931689	1	O
provide	15931689	1	O
a	15931689	1	O
wealth	15931689	1	O
of	15931689	1	O
information	15931689	1	O
about	15931689	1	O
enzyme	15931689	1	O
structure	15931689	1	O
-	15931689	1	O
function	15931689	1	O
correlations	15931689	1	O
.	15931689	1	O

Genetic	15951859	4	O
screening	15951859	4	O
of	15951859	4	O
familial	15951859	4	O
Mediterranean	15951859	4	O
fever	15951859	4	O
mutations	15951859	4	O
in	15951859	4	O
the	15951859	4	O
Palestinian	15951859	4	O
population	15951859	4	O
.	15951859	4	O
OBJECTIVE	15951859	4	O
:	15951859	4	O
To	15951859	4	O
investigate	15951859	4	O
the	15951859	4	O
spectrum	15951859	4	O
of	15951859	4	O
mutations	15951859	4	B-Var
and	15951859	4	O
genotypes	15951859	4	O
in	15951859	4	O
the	15951859	4	O
pyrin	15951859	4	B-Gene
gene	15951859	4	O
in	15951859	4	B-Reg
familial	15951859	4	B-Disease
Mediterranean	15951859	4	I-Disease
fever	15951859	4	I-Disease
(	15951859	4	O
FMF	15951859	4	O
)	15951859	4	O
patients	15951859	4	O
.	15951859	4	O
METHODS	15951859	4	O
:	15951859	4	O
Blood	15951859	4	O
samples	15951859	4	O
of	15951859	4	O
511	15951859	4	O
suspected	15951859	4	O
FMF	15951859	4	O
patients	15951859	4	O
,	15951859	4	O
received	15951859	4	O
from	15951859	4	O
the	15951859	4	O
Molecular	15951859	4	O
Genetics	15951859	4	O
Laboratory	15951859	4	O
,	15951859	4	O
Makassed	15951859	4	O
Islamic	15951859	4	O
Charitable	15951859	4	O
Hospital	15951859	4	O
,	15951859	4	O
Mount	15951859	4	O
Olives	15951859	4	O
,	15951859	4	O
Jerusalem	15951859	4	O
during	15951859	4	O
the	15951859	4	O
period	15951859	4	O
from	15951859	4	O
June	15951859	4	O
1999	15951859	4	O
to	15951859	4	O
August	15951859	4	O
2004	15951859	4	O
,	15951859	4	O
were	15951859	4	O
investigated	15951859	4	O
by	15951859	4	O
genotyping	15951859	4	O
24	15951859	4	O
different	15951859	4	O
MEFV	15951859	4	O
mutations	15951859	4	O
.	15951859	4	O
RESULTS	15951859	4	O
:	15951859	4	O
Our	15951859	4	O
work	15951859	4	O
revealed	15951859	4	O
the	15951859	4	O
presence	15951859	4	O
of	15951859	4	O
14	15951859	4	O
different	15951859	4	O
mutations	15951859	4	O
from	15951859	4	O
the	15951859	4	O
identified	15951859	4	O
24	15951859	4	O
mutations	15951859	4	O
in	15951859	4	O
the	15951859	4	O
gene	15951859	4	O
which	15951859	4	O
are	15951859	4	O
assembled	15951859	4	O
in	15951859	4	O
6	15951859	4	O
homozygous	15951859	4	O
,	15951859	4	O
9	15951859	4	O
heterozygous	15951859	4	O
and	15951859	4	O
16	15951859	4	O
compound	15951859	4	O
heterozygous	15951859	4	O
genotypes	15951859	4	O
.	15951859	4	O
The	15951859	4	O
homozygous	15951859	4	O
genotypes	15951859	4	O
represent	15951859	4	O
the	15951859	4	O
predominant	15951859	4	O
format	15951859	4	O
among	15951859	4	O
our	15951859	4	O
patients	15951859	4	O
representing	15951859	4	O
approximately	15951859	4	O
38%	15951859	4	O
of	15951859	4	O
the	15951859	4	O
revealed	15951859	4	O
genotypes	15951859	4	O
.	15951859	4	O
Interestingly	15951859	4	O
,	15951859	4	O
in	15951859	4	O
94	15951859	4	O
(	15951859	4	O
31.4%	15951859	4	O
)	15951859	4	O
of	15951859	4	O
the	15951859	4	O
tested	15951859	4	O
subjects	15951859	4	O
,	15951859	4	O
only	15951859	4	O
one	15951859	4	O
mutation	15951859	4	O
in	15951859	4	O
the	15951859	4	O
pyrin	15951859	4	O
gene	15951859	4	O
could	15951859	4	O
be	15951859	4	O
identified	15951859	4	O
while	15951859	4	O
the	15951859	4	O
other	15951859	4	O
mutant	15951859	4	O
allele	15951859	4	O
remains	15951859	4	O
unidentified	15951859	4	O
.	15951859	4	O
Moreover	15951859	4	O
,	15951859	4	O
the	15951859	4	O
genotype	15951859	4	O
of	15951859	4	O
3	15951859	4	O
(	15951859	4	O
1%	15951859	4	O
)	15951859	4	O
patients	15951859	4	O
revealed	15951859	4	O
the	15951859	4	O
presence	15951859	4	O
of	15951859	4	O
triplet	15951859	4	O
mutations	15951859	4	O
in	15951859	4	O
the	15951859	4	O
pyrin	15951859	4	O
gene	15951859	4	O
.	15951859	4	O
CONCLUSION	15951859	4	O
:	15951859	4	O
The	15951859	4	O
results	15951859	4	O
of	15951859	4	O
our	15951859	4	O
study	15951859	4	O
clearly	15951859	4	O
suggest	15951859	4	O
that	15951859	4	O
the	15951859	4	O
origin	15951859	4	O
of	15951859	4	O
FMF	15951859	4	O
among	15951859	4	O
the	15951859	4	O
Palestinian	15951859	4	O
population	15951859	4	O
is	15951859	4	O
mostly	15951859	4	O
homozygous	15951859	4	O
.	15951859	4	O
The	15951859	4	O
identification	15951859	4	O
of	15951859	4	O
a	15951859	4	O
significant	15951859	4	O
number	15951859	4	O
of	15951859	4	O
patients	15951859	4	O
with	15951859	4	O
one	15951859	4	O
known	15951859	4	O
mutation	15951859	4	O
indicates	15951859	4	O
potentially	15951859	4	O
the	15951859	4	O
presence	15951859	4	O
of	15951859	4	O
new	15951859	4	O
mutations	15951859	4	O
in	15951859	4	O
the	15951859	4	O
gene	15951859	4	O
which	15951859	4	O
will	15951859	4	O
be	15951859	4	O
investigated	15951859	4	O
in	15951859	4	O
the	15951859	4	O
future	15951859	4	O
.	15951859	4	O

Novel	16087292	1	O
CLN3	16087292	1	B-Gene
mutation	16087292	1	B-Var
predicted	16087292	1	O
to	16087292	1	O
cause	16087292	1	O
complete	16087292	1	O
loss	16087292	1	B-NegReg
of	16087292	1	O
protein	16087292	1	O
function	16087292	1	O
does	16087292	1	O
not	16087292	1	O
modify	16087292	1	O
the	16087292	1	O
classical	16087292	1	O
JNCL	16087292	1	O
phenotype	16087292	1	O
.	16087292	1	O
Juvenile	16087292	1	B-Disease
Neuronal	16087292	1	I-Disease
Ceroid	16087292	1	I-Disease
Lipofuscinosis	16087292	1	I-Disease
(	16087292	1	O
JNCL	16087292	1	O
)	16087292	1	O
,	16087292	1	O
or	16087292	1	O
Batten	16087292	1	O
disease	16087292	1	O
,	16087292	1	O
is	16087292	1	O
a	16087292	1	O
childhood	16087292	1	O
neurodegenerative	16087292	1	O
disease	16087292	1	O
that	16087292	1	O
is	16087292	1	O
characterized	16087292	1	O
clinically	16087292	1	O
by	16087292	1	O
progressive	16087292	1	O
visual	16087292	1	O
loss	16087292	1	O
,	16087292	1	O
seizures	16087292	1	O
,	16087292	1	O
dementia	16087292	1	O
,	16087292	1	O
and	16087292	1	O
motor	16087292	1	O
incoordination	16087292	1	O
.	16087292	1	O
Children	16087292	1	O
affected	16087292	1	O
with	16087292	1	O
this	16087292	1	O
disease	16087292	1	O
tend	16087292	1	O
to	16087292	1	O
develop	16087292	1	O
normally	16087292	1	O
for	16087292	1	O
the	16087292	1	O
first	16087292	1	O
5	16087292	1	O
years	16087292	1	O
of	16087292	1	O
life	16087292	1	O
.	16087292	1	O
However	16087292	1	O
,	16087292	1	O
once	16087292	1	O
disease	16087292	1	O
onset	16087292	1	O
occurs	16087292	1	O
,	16087292	1	O
they	16087292	1	O
decline	16087292	1	O
rapidly	16087292	1	O
and	16087292	1	O
die	16087292	1	O
in	16087292	1	O
their	16087292	1	O
late	16087292	1	O
20	16087292	1	O
s	16087292	1	O
to	16087292	1	O
early	16087292	1	O
30	16087292	1	O
s.	16087292	1	O
Though	16087292	1	O
this	16087292	1	O
represents	16087292	1	O
the	16087292	1	O
typical	16087292	1	O
disease	16087292	1	O
course	16087292	1	O
,	16087292	1	O
the	16087292	1	O
onset	16087292	1	O
and	16087292	1	O
severity	16087292	1	O
of	16087292	1	O
disease	16087292	1	O
symptoms	16087292	1	O
can	16087292	1	O
vary	16087292	1	O
.	16087292	1	O
This	16087292	1	O
variability	16087292	1	O
is	16087292	1	O
presumed	16087292	1	O
to	16087292	1	O
be	16087292	1	O
the	16087292	1	O
result	16087292	1	O
of	16087292	1	O
both	16087292	1	O
differences	16087292	1	O
in	16087292	1	O
the	16087292	1	O
causative	16087292	1	O
genetic	16087292	1	O
mutation	16087292	1	O
in	16087292	1	O
the	16087292	1	O
CLN3	16087292	1	O
gene	16087292	1	O
as	16087292	1	O
well	16087292	1	O
as	16087292	1	O
environmental	16087292	1	O
influences	16087292	1	O
.	16087292	1	O
Most	16087292	1	O
cases	16087292	1	O
of	16087292	1	O
JNCL	16087292	1	B-Disease
are	16087292	1	O
caused	16087292	1	B-Reg
by	16087292	1	I-Reg
a	16087292	1	O
1	16087292	1	O
kb	16087292	1	O
deletion	16087292	1	B-Var
in	16087292	1	O
the	16087292	1	O
CLN3	16087292	1	B-Gene
gene	16087292	1	O
,	16087292	1	O
resulting	16087292	1	B-Reg
in	16087292	1	I-Reg
a	16087292	1	O
frameshift	16087292	1	B-Var
mutation	16087292	1	I-Var
predicted	16087292	1	O
to	16087292	1	O
leave	16087292	1	O
the	16087292	1	O
first	16087292	1	O
153	16087292	1	O
amino	16087292	1	O
acids	16087292	1	O
of	16087292	1	O
the	16087292	1	O
CLN3	16087292	1	O
protein	16087292	1	O
intact	16087292	1	O
,	16087292	1	O
followed	16087292	1	O
by	16087292	1	O
the	16087292	1	O
addition	16087292	1	O
of	16087292	1	O
28	16087292	1	O
novel	16087292	1	O
amino	16087292	1	O
acids	16087292	1	O
.	16087292	1	O
Here	16087292	1	O
we	16087292	1	O
report	16087292	1	O
the	16087292	1	O
discovery	16087292	1	O
of	16087292	1	O
a	16087292	1	O
novel	16087292	1	O
mutation	16087292	1	O
identified	16087292	1	O
as	16087292	1	O
a	16087292	1	O
G	16087292	1	O
to	16087292	1	O
T	16087292	1	O
transversion	16087292	1	O
at	16087292	1	O
nucleotide	16087292	1	O
49	16087292	1	O
(	16087292	1	B-Var
G49T	16087292	1	I-Var
)	16087292	1	I-Var
in	16087292	1	O
exon	16087292	1	O
2	16087292	1	O
of	16087292	1	O
CLN3	16087292	1	B-Gene
,	16087292	1	O
introducing	16087292	1	B-Reg
a	16087292	1	O
premature	16087292	1	O
stop	16087292	1	O
codon	16087292	1	O
(	16087292	1	B-Var
E17X	16087292	1	I-Var
)	16087292	1	I-Var
near	16087292	1	O
the	16087292	1	O
N	16087292	1	O
-	16087292	1	O
terminus	16087292	1	O
.	16087292	1	O
This	16087292	1	O
mutation	16087292	1	O
represents	16087292	1	O
the	16087292	1	O
most	16087292	1	O
5	16087292	1	O
'	16087292	1	O
mutation	16087292	1	O
described	16087292	1	O
to	16087292	1	O
date	16087292	1	O
.	16087292	1	O
The	16087292	1	O
patient	16087292	1	O
examined	16087292	1	O
in	16087292	1	O
this	16087292	1	O
study	16087292	1	O
was	16087292	1	O
heterozygous	16087292	1	O
for	16087292	1	O
the	16087292	1	O
common	16087292	1	O
1	16087292	1	O
kb	16087292	1	O
deletion	16087292	1	O
and	16087292	1	O
E17X	16087292	1	O
.	16087292	1	O
She	16087292	1	O
had	16087292	1	O
classical	16087292	1	O
disease	16087292	1	O
progression	16087292	1	O
,	16087292	1	O
suggesting	16087292	1	O
that	16087292	1	O
this	16087292	1	O
mutation	16087292	1	O
in	16087292	1	O
CLN3	16087292	1	O
mimics	16087292	1	O
the	16087292	1	O
more	16087292	1	O
prevalent	16087292	1	O
1	16087292	1	O
kb	16087292	1	O
deletion	16087292	1	O
and	16087292	1	O
that	16087292	1	O
progression	16087292	1	O
of	16087292	1	O
JNCL	16087292	1	O
is	16087292	1	O
predominantly	16087292	1	O
the	16087292	1	O
result	16087292	1	O
of	16087292	1	O
loss	16087292	1	O
of	16087292	1	O
CLN3	16087292	1	O
function	16087292	1	O
.	16087292	1	O

Identification	16087766	4	O
of	16087766	4	O
a	16087766	4	O
novel	16087766	4	O
founder	16087766	4	O
mutation	16087766	4	O
in	16087766	4	O
the	16087766	4	O
DYSF	16087766	4	O
gene	16087766	4	O
causing	16087766	4	O
clinical	16087766	4	O
variability	16087766	4	O
in	16087766	4	O
the	16087766	4	O
Spanish	16087766	4	O
population	16087766	4	O
.	16087766	4	O
BACKGROUND	16087766	4	O
:	16087766	4	O
Mutations	16087766	4	B-Var
in	16087766	4	O
the	16087766	4	O
dysferlin	16087766	4	O
(	16087766	4	B-Gene
DYSF	16087766	4	I-Gene
)	16087766	4	I-Gene
gene	16087766	4	O
cause	16087766	4	B-Reg
3	16087766	4	O
different	16087766	4	O
phenotypes	16087766	4	O
of	16087766	4	O
muscular	16087766	4	O
dystrophies	16087766	4	O
:	16087766	4	O
Miyoshi	16087766	4	B-Disease
myopathy	16087766	4	I-Disease
,	16087766	4	O
limb	16087766	4	B-Disease
-	16087766	4	I-Disease
girdle	16087766	4	I-Disease
muscular	16087766	4	I-Disease
dystrophy	16087766	4	I-Disease
type	16087766	4	I-Disease
2	16087766	4	I-Disease
B	16087766	4	I-Disease
,	16087766	4	O
and	16087766	4	O
distal	16087766	4	B-Disease
anterior	16087766	4	I-Disease
compartment	16087766	4	I-Disease
myopathy	16087766	4	I-Disease
.	16087766	4	O
OBJECTIVE	16087766	4	O
:	16087766	4	O
To	16087766	4	O
present	16087766	4	O
the	16087766	4	O
results	16087766	4	O
of	16087766	4	O
clinical	16087766	4	O
and	16087766	4	O
molecular	16087766	4	O
analysis	16087766	4	O
of	16087766	4	O
8	16087766	4	O
patients	16087766	4	O
with	16087766	4	O
dysferlinopathy	16087766	4	O
from	16087766	4	O
5	16087766	4	O
unrelated	16087766	4	O
families	16087766	4	O
.	16087766	4	O
DESIGN	16087766	4	O
:	16087766	4	O
Clinical	16087766	4	O
assessment	16087766	4	O
was	16087766	4	O
performed	16087766	4	O
with	16087766	4	O
a	16087766	4	O
standardized	16087766	4	O
protocol	16087766	4	O
.	16087766	4	O
A	16087766	4	O
muscle	16087766	4	O
biopsy	16087766	4	O
specimen	16087766	4	O
was	16087766	4	O
obtained	16087766	4	O
and	16087766	4	O
studied	16087766	4	O
by	16087766	4	O
immunohistochemistry	16087766	4	O
.	16087766	4	O
Genetic	16087766	4	O
analysis	16087766	4	O
was	16087766	4	O
performed	16087766	4	O
using	16087766	4	O
single	16087766	4	O
-	16087766	4	O
stranded	16087766	4	O
conformation	16087766	4	O
polymorphism	16087766	4	O
and	16087766	4	O
direct	16087766	4	O
sequencing	16087766	4	O
of	16087766	4	O
genomic	16087766	4	O
DNA	16087766	4	O
.	16087766	4	O
RESULTS	16087766	4	O
:	16087766	4	O
All	16087766	4	O
the	16087766	4	O
patients	16087766	4	O
presented	16087766	4	O
the	16087766	4	O
R1905X	16087766	4	O
mutation	16087766	4	O
in	16087766	4	O
the	16087766	4	O
DYSF	16087766	4	O
gene	16087766	4	O
in	16087766	4	O
homozygosity	16087766	4	O
,	16087766	4	O
and	16087766	4	O
the	16087766	4	O
haplotype	16087766	4	O
analysis	16087766	4	O
at	16087766	4	O
the	16087766	4	O
DYSF	16087766	4	O
locus	16087766	4	O
revealed	16087766	4	O
that	16087766	4	O
it	16087766	4	O
was	16087766	4	O
a	16087766	4	O
novel	16087766	4	O
and	16087766	4	O
founder	16087766	4	O
mutation	16087766	4	O
.	16087766	4	O
A	16087766	4	O
C	16087766	4	B-Var
-	16087766	4	I-Var
to	16087766	4	I-Var
-	16087766	4	I-Var
T	16087766	4	I-Var
transition	16087766	4	I-Var
at	16087766	4	O
nucleotide	16087766	4	O
position	16087766	4	O
6086	16087766	4	O
changes	16087766	4	O
an	16087766	4	O
arginine	16087766	4	O
into	16087766	4	O
a	16087766	4	O
stop	16087766	4	O
codon	16087766	4	O
,	16087766	4	O
leading	16087766	4	B-Reg
to	16087766	4	I-Reg
premature	16087766	4	O
termination	16087766	4	O
of	16087766	4	O
translation	16087766	4	O
.	16087766	4	O
This	16087766	4	O
mutation	16087766	4	O
was	16087766	4	O
expressed	16087766	4	O
as	16087766	4	O
3	16087766	4	O
different	16087766	4	O
clinical	16087766	4	O
phenotypes	16087766	4	O
(	16087766	4	O
limb	16087766	4	O
-	16087766	4	O
girdle	16087766	4	O
muscular	16087766	4	O
dystrophy	16087766	4	O
type	16087766	4	O
2	16087766	4	O
B	16087766	4	O
,	16087766	4	O
Miyoshi	16087766	4	O
distal	16087766	4	O
myopathy	16087766	4	O
,	16087766	4	O
and	16087766	4	O
distal	16087766	4	O
anterior	16087766	4	O
dysferlinopathy	16087766	4	O
)	16087766	4	O
,	16087766	4	O
but	16087766	4	O
only	16087766	4	O
1	16087766	4	O
phenotype	16087766	4	O
was	16087766	4	O
found	16087766	4	O
in	16087766	4	O
the	16087766	4	O
same	16087766	4	O
family	16087766	4	O
.	16087766	4	O
CONCLUSIONS	16087766	4	O
:	16087766	4	O
The	16087766	4	O
new	16087766	4	O
R1905X	16087766	4	O
DYSF	16087766	4	O
founder	16087766	4	O
mutation	16087766	4	O
produced	16087766	4	O
the	16087766	4	O
3	16087766	4	O
possible	16087766	4	O
dysferlinopathy	16087766	4	O
phenotypes	16087766	4	O
without	16087766	4	O
intrafamilial	16087766	4	O
heterogeneity	16087766	4	O
.	16087766	4	O
This	16087766	4	O
homogeneous	16087766	4	O
population	16087766	4	O
in	16087766	4	O
Sueca	16087766	4	O
,	16087766	4	O
Spain	16087766	4	O
,	16087766	4	O
should	16087766	4	O
be	16087766	4	O
helpful	16087766	4	O
in	16087766	4	O
studying	16087766	4	O
the	16087766	4	O
modifying	16087766	4	O
factors	16087766	4	O
responsible	16087766	4	O
for	16087766	4	O
the	16087766	4	O
phenotypic	16087766	4	O
variability	16087766	4	O
.	16087766	4	O

A	16126871	1	O
novel	16126871	1	O
frameshift	16126871	1	B-Var
mutation	16126871	1	O
(	16126871	1	O
G	16126871	1	O
)	16126871	1	O
at	16126871	1	O
codons	16126871	1	O
15	16126871	1	O
/	16126871	1	O
16	16126871	1	O
in	16126871	1	O
a	16126871	1	O
beta0	16126871	1	B-Gene
thalassaemia	16126871	1	I-Gene
gene	16126871	1	I-Gene
results	16126871	1	O
in	16126871	1	O
a	16126871	1	O
significant	16126871	1	O
reduction	16126871	1	B-NegReg
of	16126871	1	O
beta	16126871	1	O
globin	16126871	1	O
mRNA	16126871	1	O
values	16126871	1	O
.	16126871	1	O
AIMS	16126871	1	O
:	16126871	1	O
To	16126871	1	O
identify	16126871	1	O
a	16126871	1	O
novel	16126871	1	O
beta	16126871	1	O
globin	16126871	1	O
gene	16126871	1	O
mutation	16126871	1	O
found	16126871	1	O
in	16126871	1	O
a	16126871	1	O
Chinese	16126871	1	O
family	16126871	1	O
,	16126871	1	O
and	16126871	1	O
also	16126871	1	O
to	16126871	1	O
assess	16126871	1	O
its	16126871	1	O
functional	16126871	1	O
consequences	16126871	1	O
.	16126871	1	O
METHODS	16126871	1	O
:	16126871	1	O
Haematological	16126871	1	O
analysis	16126871	1	O
was	16126871	1	O
performed	16126871	1	O
on	16126871	1	O
all	16126871	1	O
family	16126871	1	O
members	16126871	1	O
.	16126871	1	O
The	16126871	1	O
23	16126871	1	O
common	16126871	1	O
mutations	16126871	1	O
of	16126871	1	O
beta	16126871	1	O
thalassaemia	16126871	1	O
found	16126871	1	O
in	16126871	1	O
Chinese	16126871	1	O
populations	16126871	1	O
were	16126871	1	O
detected	16126871	1	O
by	16126871	1	O
means	16126871	1	O
of	16126871	1	O
a	16126871	1	O
reverse	16126871	1	O
dot	16126871	1	O
blot	16126871	1	O
method	16126871	1	O
.	16126871	1	O
Direct	16126871	1	O
DNA	16126871	1	O
sequencing	16126871	1	O
of	16126871	1	O
polymerase	16126871	1	O
chain	16126871	1	O
reaction	16126871	1	O
(	16126871	1	O
PCR	16126871	1	O
)	16126871	1	O
amplified	16126871	1	O
complete	16126871	1	O
beta	16126871	1	O
globin	16126871	1	O
gene	16126871	1	O
was	16126871	1	O
carried	16126871	1	O
out	16126871	1	O
to	16126871	1	O
identify	16126871	1	O
the	16126871	1	O
novel	16126871	1	O
mutation	16126871	1	O
.	16126871	1	O
A	16126871	1	O
real	16126871	1	O
time	16126871	1	O
,	16126871	1	O
one	16126871	1	O
step	16126871	1	O
reverse	16126871	1	O
transcription	16126871	1	O
PCR	16126871	1	O
assay	16126871	1	O
was	16126871	1	O
used	16126871	1	O
to	16126871	1	O
measure	16126871	1	O
beta	16126871	1	O
globin	16126871	1	O
mRNA	16126871	1	O
in	16126871	1	O
the	16126871	1	O
reticulocytes	16126871	1	O
of	16126871	1	O
heterozygous	16126871	1	O
patients	16126871	1	O
.	16126871	1	O
RESULTS	16126871	1	O
:	16126871	1	O
A	16126871	1	O
novel	16126871	1	O
frameshift	16126871	1	O
mutation	16126871	1	O
-	16126871	1	O
an	16126871	1	O
insertion	16126871	1	B-Var
of	16126871	1	O
G	16126871	1	O
between	16126871	1	O
codons	16126871	1	O
15	16126871	1	O
and	16126871	1	O
16	16126871	1	O
in	16126871	1	O
a	16126871	1	O
homonucleotide	16126871	1	O
run	16126871	1	O
of	16126871	1	O
four	16126871	1	O
guanines	16126871	1	O
-	16126871	1	O
was	16126871	1	O
determined	16126871	1	O
,	16126871	1	O
which	16126871	1	O
generates	16126871	1	B-Reg
a	16126871	1	O
new	16126871	1	O
premature	16126871	1	O
chain	16126871	1	O
terminator	16126871	1	O
at	16126871	1	O
the	16126871	1	O
22	16126871	1	O
nd	16126871	1	O
codon	16126871	1	O
.	16126871	1	O
Relative	16126871	1	O
quantitative	16126871	1	O
analysis	16126871	1	O
of	16126871	1	O
the	16126871	1	O
beta	16126871	1	O
globin	16126871	1	O
mRNA	16126871	1	O
in	16126871	1	O
heterozygous	16126871	1	O
subjects	16126871	1	O
demonstrated	16126871	1	O
a	16126871	1	O
39.83%	16126871	1	O
reduction	16126871	1	O
compared	16126871	1	O
normal	16126871	1	O
controls	16126871	1	O
.	16126871	1	O
CONCLUSIONS	16126871	1	O
:	16126871	1	O
The	16126871	1	O
significantly	16126871	1	O
lower	16126871	1	B-NegReg
amounts	16126871	1	O
of	16126871	1	O
beta	16126871	1	O
globin	16126871	1	O
mRNA	16126871	1	O
found	16126871	1	O
in	16126871	1	O
mutation	16126871	1	B-Var
carriers	16126871	1	O
is	16126871	1	O
probably	16126871	1	O
caused	16126871	1	B-Reg
by	16126871	1	I-Reg
the	16126871	1	O
rapid	16126871	1	O
nonsense	16126871	1	O
mediated	16126871	1	O
degradation	16126871	1	O
of	16126871	1	O
the	16126871	1	O
mutant	16126871	1	O
mRNA	16126871	1	O
.	16126871	1	O
These	16126871	1	O
data	16126871	1	O
,	16126871	1	O
combined	16126871	1	O
with	16126871	1	O
haematological	16126871	1	O
analysis	16126871	1	O
,	16126871	1	O
suggest	16126871	1	O
that	16126871	1	O
this	16126871	1	O
novel	16126871	1	O
mutation	16126871	1	B-Var
of	16126871	1	O
CDs	16126871	1	O
15	16126871	1	O
/	16126871	1	O
16	16126871	1	O
(	16126871	1	O
G	16126871	1	O
)	16126871	1	O
results	16126871	1	B-Reg
in	16126871	1	I-Reg
a	16126871	1	O
beta	16126871	1	B-Disease
(	16126871	1	I-Disease
0	16126871	1	I-Disease
)	16126871	1	I-Disease
thalassaemia	16126871	1	I-Disease
phenotype	16126871	1	O
.	16126871	1	O

Increased	16134171	4	O
risk	16134171	4	O
of	16134171	4	O
idiopathic	16134171	4	O
chronic	16134171	4	O
pancreatitis	16134171	4	O
in	16134171	4	O
cystic	16134171	4	O
fibrosis	16134171	4	O
carriers	16134171	4	O
.	16134171	4	O
Cystic	16134171	4	B-Disease
fibrosis	16134171	4	I-Disease
(	16134171	4	O
CF	16134171	4	O
)	16134171	4	O
is	16134171	4	O
a	16134171	4	O
recessive	16134171	4	O
disease	16134171	4	O
caused	16134171	4	B-Reg
by	16134171	4	I-Reg
mutations	16134171	4	B-Var
of	16134171	4	O
the	16134171	4	O
CF	16134171	4	O
transmembrane	16134171	4	O
conductance	16134171	4	O
regulator	16134171	4	O
(	16134171	4	B-Gene
CFTR	16134171	4	I-Gene
)	16134171	4	I-Gene
gene	16134171	4	O
.	16134171	4	O
The	16134171	4	O
risk	16134171	4	O
of	16134171	4	O
idiopathic	16134171	4	O
chronic	16134171	4	O
pancreatitis	16134171	4	O
(	16134171	4	O
ICP	16134171	4	O
)	16134171	4	O
is	16134171	4	O
increased	16134171	4	O
in	16134171	4	O
individuals	16134171	4	O
who	16134171	4	O
have	16134171	4	O
CFTR	16134171	4	O
genotypes	16134171	4	O
containing	16134171	4	O
a	16134171	4	O
CF	16134171	4	O
-	16134171	4	O
causing	16134171	4	O
mutation	16134171	4	O
plus	16134171	4	O
a	16134171	4	O
second	16134171	4	O
pathogenic	16134171	4	O
allele	16134171	4	O
.	16134171	4	O
It	16134171	4	O
is	16134171	4	O
unknown	16134171	4	O
whether	16134171	4	O
the	16134171	4	O
risk	16134171	4	O
of	16134171	4	O
ICP	16134171	4	O
is	16134171	4	O
increased	16134171	4	O
in	16134171	4	O
CF	16134171	4	O
carriers	16134171	4	O
who	16134171	4	O
have	16134171	4	O
one	16134171	4	O
CF	16134171	4	O
-	16134171	4	O
causing	16134171	4	O
mutation	16134171	4	O
plus	16134171	4	O
one	16134171	4	O
normal	16134171	4	O
allele	16134171	4	O
.	16134171	4	O
In	16134171	4	O
this	16134171	4	O
study	16134171	4	O
,	16134171	4	O
52	16134171	4	O
sporadic	16134171	4	O
cases	16134171	4	O
of	16134171	4	O
ICP	16134171	4	O
were	16134171	4	O
ascertained	16134171	4	O
through	16134171	4	O
the	16134171	4	O
European	16134171	4	O
Registry	16134171	4	O
of	16134171	4	O
Hereditary	16134171	4	O
Pancreatitis	16134171	4	O
and	16134171	4	O
Familial	16134171	4	O
Pancreatic	16134171	4	O
Cancer	16134171	4	O
.	16134171	4	O
Individuals	16134171	4	O
with	16134171	4	O
pathogenic	16134171	4	O
cationic	16134171	4	O
trypsinogen	16134171	4	O
mutations	16134171	4	O
were	16134171	4	O
excluded	16134171	4	O
.	16134171	4	O
DNA	16134171	4	O
was	16134171	4	O
comprehensively	16134171	4	O
tested	16134171	4	O
for	16134171	4	O
CFTR	16134171	4	O
mutations	16134171	4	O
using	16134171	4	O
a	16134171	4	O
robotically	16134171	4	O
enhanced	16134171	4	O
,	16134171	4	O
multiplexed	16134171	4	O
,	16134171	4	O
and	16134171	4	O
highly	16134171	4	O
redundant	16134171	4	O
form	16134171	4	O
of	16134171	4	O
single	16134171	4	O
-	16134171	4	O
strand	16134171	4	O
conformation	16134171	4	O
polymorphism	16134171	4	O
(	16134171	4	O
SSCP	16134171	4	O
)	16134171	4	O
analysis	16134171	4	O
followed	16134171	4	O
by	16134171	4	O
DNA	16134171	4	O
sequencing	16134171	4	O
.	16134171	4	O
Fifteen	16134171	4	O
subjects	16134171	4	O
had	16134171	4	O
a	16134171	4	O
total	16134171	4	O
of	16134171	4	O
18	16134171	4	O
pathogenic	16134171	4	O
CFTR	16134171	4	O
alleles	16134171	4	O
.	16134171	4	O
Eight	16134171	4	O
subjects	16134171	4	O
had	16134171	4	O
common	16134171	4	O
CF	16134171	4	O
-	16134171	4	O
causing	16134171	4	O
mutations	16134171	4	O
.	16134171	4	O
This	16134171	4	O
group	16134171	4	O
included	16134171	4	O
seven	16134171	4	O
CF	16134171	4	O
carriers	16134171	4	O
in	16134171	4	O
whom	16134171	4	O
the	16134171	4	O
second	16134171	4	O
CFTR	16134171	4	O
allele	16134171	4	O
was	16134171	4	O
normal	16134171	4	O
(	16134171	4	O
4.3	16134171	4	O
times	16134171	4	O
the	16134171	4	O
expected	16134171	4	O
frequency	16134171	4	O
,	16134171	4	O
P	16134171	4	O
=	16134171	4	O
0.0002	16134171	4	O
)	16134171	4	O
.	16134171	4	O
Three	16134171	4	O
subjects	16134171	4	O
had	16134171	4	O
compound	16134171	4	O
heterozygotes	16134171	4	O
genotypes	16134171	4	O
containing	16134171	4	O
two	16134171	4	O
pathogenic	16134171	4	O
alleles	16134171	4	O
(	16134171	4	O
31	16134171	4	O
times	16134171	4	O
the	16134171	4	O
expected	16134171	4	O
frequency	16134171	4	O
,	16134171	4	O
P	16134171	4	O
<	16134171	4	O
0.0001	16134171	4	O
)	16134171	4	O
.	16134171	4	O
A	16134171	4	O
variant	16134171	4	O
allele	16134171	4	O
of	16134171	4	O
uncertain	16134171	4	O
significance	16134171	4	O
(	16134171	4	O
p.R75Q	16134171	4	O
)	16134171	4	O
was	16134171	4	O
detected	16134171	4	O
in	16134171	4	O
eight	16134171	4	O
of	16134171	4	O
the	16134171	4	O
52	16134171	4	O
ICP	16134171	4	O
subjects	16134171	4	O
and	16134171	4	O
at	16134171	4	O
a	16134171	4	O
similar	16134171	4	O
frequency	16134171	4	O
(	16134171	4	O
13	16134171	4	O
/	16134171	4	O
96	16134171	4	O
)	16134171	4	O
in	16134171	4	O
random	16134171	4	O
donors	16134171	4	O
.	16134171	4	O
ICP	16134171	4	O
differs	16134171	4	O
from	16134171	4	O
other	16134171	4	O
established	16134171	4	O
CFTR	16134171	4	O
-	16134171	4	O
related	16134171	4	O
conditions	16134171	4	O
in	16134171	4	O
that	16134171	4	O
ICP	16134171	4	O
risk	16134171	4	O
is	16134171	4	O
increased	16134171	4	O
in	16134171	4	O
CF	16134171	4	O
carriers	16134171	4	O
who	16134171	4	O
have	16134171	4	O
one	16134171	4	O
documented	16134171	4	O
normal	16134171	4	O
CFTR	16134171	4	O
allele	16134171	4	O
.	16134171	4	O
Having	16134171	4	O
two	16134171	4	O
CFTR	16134171	4	O
mutations	16134171	4	O
imparts	16134171	4	O
a	16134171	4	O
higher	16134171	4	O
relative	16134171	4	O
risk	16134171	4	O
,	16134171	4	O
while	16134171	4	O
having	16134171	4	O
only	16134171	4	O
one	16134171	4	O
mutation	16134171	4	O
imparts	16134171	4	O
a	16134171	4	O
higher	16134171	4	O
attributable	16134171	4	O
risk	16134171	4	O
.	16134171	4	O

Mutation	16151697	1	O
identification	16151697	1	O
in	16151697	1	O
a	16151697	1	O
canine	16151697	1	O
model	16151697	1	O
of	16151697	1	O
X	16151697	1	O
-	16151697	1	O
linked	16151697	1	O
ectodermal	16151697	1	O
dysplasia	16151697	1	O
.	16151697	1	O
X	16151697	1	B-Disease
-	16151697	1	I-Disease
linked	16151697	1	I-Disease
hypohidrotic	16151697	1	I-Disease
ectodermal	16151697	1	I-Disease
dysplasia	16151697	1	I-Disease
(	16151697	1	O
XHED	16151697	1	O
)	16151697	1	O
,	16151697	1	O
an	16151697	1	O
inherited	16151697	1	O
disease	16151697	1	O
recognized	16151697	1	O
in	16151697	1	O
humans	16151697	1	O
,	16151697	1	O
mice	16151697	1	O
,	16151697	1	O
and	16151697	1	O
cattle	16151697	1	O
,	16151697	1	O
is	16151697	1	O
characterized	16151697	1	O
by	16151697	1	O
hypotrichosis	16151697	1	O
,	16151697	1	O
a	16151697	1	O
reduced	16151697	1	O
number	16151697	1	O
or	16151697	1	O
absence	16151697	1	O
of	16151697	1	O
sweat	16151697	1	O
glands	16151697	1	O
,	16151697	1	O
and	16151697	1	O
missing	16151697	1	O
or	16151697	1	O
malformed	16151697	1	O
teeth	16151697	1	O
.	16151697	1	O
In	16151697	1	O
a	16151697	1	O
subset	16151697	1	O
of	16151697	1	O
affected	16151697	1	O
individuals	16151697	1	O
and	16151697	1	O
animals	16151697	1	O
,	16151697	1	O
mutations	16151697	1	B-Var
in	16151697	1	O
the	16151697	1	O
EDA	16151697	1	B-Gene
gene	16151697	1	O
(	16151697	1	O
formerly	16151697	1	O
EDI	16151697	1	O
)	16151697	1	O
,	16151697	1	O
coding	16151697	1	O
for	16151697	1	O
ectodysplasin	16151697	1	O
,	16151697	1	O
have	16151697	1	O
been	16151697	1	O
found	16151697	1	O
to	16151697	1	O
cause	16151697	1	B-Reg
this	16151697	1	O
phenotype	16151697	1	O
.	16151697	1	O
Ectodysplasin	16151697	1	O
is	16151697	1	O
a	16151697	1	O
homotrimeric	16151697	1	O
transmembrane	16151697	1	O
protein	16151697	1	O
with	16151697	1	O
an	16151697	1	O
extracellular	16151697	1	O
TNF	16151697	1	O
-	16151697	1	O
like	16151697	1	O
domain	16151697	1	O
,	16151697	1	O
which	16151697	1	O
has	16151697	1	O
been	16151697	1	O
shown	16151697	1	O
to	16151697	1	O
be	16151697	1	O
involved	16151697	1	O
in	16151697	1	O
the	16151697	1	O
morphogenesis	16151697	1	O
of	16151697	1	O
hair	16151697	1	O
follicles	16151697	1	O
and	16151697	1	O
tooth	16151697	1	O
buds	16151697	1	O
during	16151697	1	O
fetal	16151697	1	O
development	16151697	1	O
.	16151697	1	O
Some	16151697	1	O
human	16151697	1	O
XHED	16151697	1	B-Disease
patients	16151697	1	O
also	16151697	1	O
have	16151697	1	O
concurrent	16151697	1	O
immunodeficiency	16151697	1	O
,	16151697	1	O
due	16151697	1	B-Reg
to	16151697	1	I-Reg
mutations	16151697	1	B-Var
in	16151697	1	O
the	16151697	1	O
NF	16151697	1	O
-	16151697	1	O
kappaB	16151697	1	O
essential	16151697	1	O
modulator	16151697	1	O
protein	16151697	1	O
(	16151697	1	B-Gene
IKBKG	16151697	1	I-Gene
;	16151697	1	I-Gene
formerly	16151697	1	O
NEMO	16151697	1	O
)	16151697	1	O
,	16151697	1	O
which	16151697	1	O
is	16151697	1	O
also	16151697	1	O
encoded	16151697	1	O
on	16151697	1	O
the	16151697	1	O
X	16151697	1	O
chromosome	16151697	1	O
.	16151697	1	O
In	16151697	1	O
a	16151697	1	O
breeding	16151697	1	O
colony	16151697	1	O
of	16151697	1	O
dogs	16151697	1	O
with	16151697	1	O
XHED	16151697	1	O
,	16151697	1	O
immune	16151697	1	O
system	16151697	1	O
defects	16151697	1	O
had	16151697	1	O
been	16151697	1	O
suspected	16151697	1	O
because	16151697	1	O
of	16151697	1	O
frequent	16151697	1	O
pulmonary	16151697	1	O
infections	16151697	1	O
and	16151697	1	O
unexpected	16151697	1	O
deaths	16151697	1	O
resulting	16151697	1	O
from	16151697	1	O
pneumonia	16151697	1	O
.	16151697	1	O
To	16151697	1	O
determine	16151697	1	O
if	16151697	1	O
defects	16151697	1	O
in	16151697	1	O
EDA	16151697	1	O
or	16151697	1	O
IKBKG	16151697	1	O
cause	16151697	1	O
XHED	16151697	1	O
in	16151697	1	O
the	16151697	1	O
dogs	16151697	1	O
,	16151697	1	O
linkage	16151697	1	O
analysis	16151697	1	O
and	16151697	1	O
sequencing	16151697	1	O
experiments	16151697	1	O
were	16151697	1	O
performed	16151697	1	O
.	16151697	1	O
A	16151697	1	O
polymorphic	16151697	1	O
marker	16151697	1	O
near	16151697	1	O
the	16151697	1	O
canine	16151697	1	O
EDA	16151697	1	O
gene	16151697	1	O
showed	16151697	1	O
significant	16151697	1	O
linkage	16151697	1	O
to	16151697	1	O
XHED	16151697	1	O
.	16151697	1	O
The	16151697	1	O
canine	16151697	1	O
EDA	16151697	1	B-Gene
gene	16151697	1	O
was	16151697	1	O
sequenced	16151697	1	O
and	16151697	1	O
a	16151697	1	O
nucleotide	16151697	1	B-Var
substitution	16151697	1	I-Var
(	16151697	1	O
G	16151697	1	O
to	16151697	1	O
A	16151697	1	O
)	16151697	1	O
in	16151697	1	O
the	16151697	1	O
splice	16151697	1	O
acceptor	16151697	1	O
site	16151697	1	O
of	16151697	1	O
intron	16151697	1	O
8	16151697	1	O
was	16151697	1	O
detected	16151697	1	O
in	16151697	1	O
affected	16151697	1	O
dogs	16151697	1	O
.	16151697	1	O
In	16151697	1	O
the	16151697	1	O
presence	16151697	1	O
of	16151697	1	O
the	16151697	1	O
A	16151697	1	O
residue	16151697	1	O
,	16151697	1	O
a	16151697	1	O
cryptic	16151697	1	O
acceptor	16151697	1	O
site	16151697	1	O
within	16151697	1	O
exon	16151697	1	O
9	16151697	1	O
is	16151697	1	O
used	16151697	1	O
,	16151697	1	O
leading	16151697	1	B-Reg
to	16151697	1	I-Reg
a	16151697	1	O
frame	16151697	1	O
shift	16151697	1	O
and	16151697	1	O
use	16151697	1	O
of	16151697	1	O
a	16151697	1	O
premature	16151697	1	O
stop	16151697	1	O
codon	16151697	1	O
that	16151697	1	O
truncates	16151697	1	B-NegReg
the	16151697	1	O
translation	16151697	1	O
of	16151697	1	O
both	16151697	1	O
isoforms	16151697	1	O
,	16151697	1	O
EDA	16151697	1	O
-	16151697	1	O
A1	16151697	1	O
and	16151697	1	O
EDA	16151697	1	O
-	16151697	1	O
A2	16151697	1	O
,	16151697	1	O
resulting	16151697	1	O
in	16151697	1	O
the	16151697	1	O
absence	16151697	1	B-NegReg
of	16151697	1	O
the	16151697	1	O
TNF	16151697	1	O
-	16151697	1	O
like	16151697	1	O
homology	16151697	1	O
domain	16151697	1	O
,	16151697	1	O
the	16151697	1	O
receptor	16151697	1	O
-	16151697	1	O
binding	16151697	1	O
site	16151697	1	O
of	16151697	1	O
ectodysplasin	16151697	1	O
.	16151697	1	O

Familial	16378925	4	O
Mediterranean	16378925	4	O
fever	16378925	4	O
(	16378925	4	O
FMF	16378925	4	O
)	16378925	4	O
in	16378925	4	O
Lebanon	16378925	4	O
and	16378925	4	O
Jordan	16378925	4	O
:	16378925	4	O
a	16378925	4	O
population	16378925	4	O
genetics	16378925	4	O
study	16378925	4	O
and	16378925	4	O
report	16378925	4	O
of	16378925	4	O
three	16378925	4	O
novel	16378925	4	O
mutations	16378925	4	O
.	16378925	4	O
Familial	16378925	4	B-Disease
Mediterranean	16378925	4	I-Disease
fever	16378925	4	I-Disease
(	16378925	4	O
FMF	16378925	4	O
)	16378925	4	O
is	16378925	4	O
an	16378925	4	O
autosomal	16378925	4	O
recessive	16378925	4	O
disease	16378925	4	O
mostly	16378925	4	O
frequent	16378925	4	O
in	16378925	4	O
Mediterranean	16378925	4	O
populations	16378925	4	O
.	16378925	4	O
Over	16378925	4	O
50	16378925	4	O
mutations	16378925	4	B-Var
have	16378925	4	O
been	16378925	4	O
identified	16378925	4	O
in	16378925	4	O
the	16378925	4	O
gene	16378925	4	O
responsible	16378925	4	B-Reg
for	16378925	4	I-Reg
the	16378925	4	O
disease	16378925	4	O
,	16378925	4	O
MEFV	16378925	4	B-Gene
.	16378925	4	O
The	16378925	4	O
present	16378925	4	O
study	16378925	4	O
reports	16378925	4	O
the	16378925	4	O
frequencies	16378925	4	O
of	16378925	4	O
MEFV	16378925	4	B-Gene
mutations	16378925	4	B-Var
in	16378925	4	B-Reg
558	16378925	4	O
Lebanese	16378925	4	O
and	16378925	4	O
55	16378925	4	O
Jordanian	16378925	4	O
FMF	16378925	4	B-Disease
patients	16378925	4	O
and	16378925	4	O
points	16378925	4	O
out	16378925	4	O
the	16378925	4	O
severity	16378925	4	O
of	16378925	4	O
the	16378925	4	O
M694V	16378925	4	O
frequently	16378925	4	O
observed	16378925	4	O
mutation	16378925	4	O
among	16378925	4	O
these	16378925	4	O
patients	16378925	4	O
.	16378925	4	O
Three	16378925	4	O
novel	16378925	4	O
mutations	16378925	4	O
,	16378925	4	O
T177I	16378925	4	O
,	16378925	4	O
S108R	16378925	4	O
and	16378925	4	O
E474K	16378925	4	O
were	16378925	4	O
also	16378925	4	O
identified	16378925	4	O
in	16378925	4	O
the	16378925	4	O
Lebanese	16378925	4	O
group	16378925	4	O
.	16378925	4	O
An	16378925	4	O
excess	16378925	4	O
of	16378925	4	O
homozygotes	16378925	4	O
and	16378925	4	O
a	16378925	4	O
deficit	16378925	4	O
of	16378925	4	O
heterozygotes	16378925	4	O
were	16378925	4	O
observed	16378925	4	O
in	16378925	4	O
both	16378925	4	O
samples	16378925	4	O
when	16378925	4	O
compared	16378925	4	O
to	16378925	4	O
the	16378925	4	O
expected	16378925	4	O
number	16378925	4	O
of	16378925	4	O
observed	16378925	4	O
genotypes	16378925	4	O
under	16378925	4	O
the	16378925	4	O
Hardy	16378925	4	O
-	16378925	4	O
Weinberg	16378925	4	O
hypothesis	16378925	4	O
.	16378925	4	O
Homozygotes	16378925	4	O
for	16378925	4	O
M694V	16378925	4	O
and	16378925	4	O
M694I	16378925	4	O
were	16378925	4	O
still	16378925	4	O
in	16378925	4	O
excess	16378925	4	O
in	16378925	4	O
the	16378925	4	O
Lebanese	16378925	4	O
group	16378925	4	O
of	16378925	4	O
patients	16378925	4	O
,	16378925	4	O
even	16378925	4	O
after	16378925	4	O
consanguinous	16378925	4	O
homozygotes	16378925	4	O
were	16378925	4	O
removed	16378925	4	O
,	16378925	4	O
or	16378925	4	O
population	16378925	4	O
structure	16378925	4	O
was	16378925	4	O
considered	16378925	4	O
.	16378925	4	O
This	16378925	4	O
excess	16378925	4	O
is	16378925	4	O
therefore	16378925	4	O
neither	16378925	4	O
due	16378925	4	O
to	16378925	4	O
consanguinity	16378925	4	O
nor	16378925	4	O
to	16378925	4	O
subgroups	16378925	4	O
in	16378925	4	O
the	16378925	4	O
Lebanese	16378925	4	O
population	16378925	4	O
,	16378925	4	O
but	16378925	4	O
rather	16378925	4	O
to	16378925	4	O
more	16378925	4	O
remote	16378925	4	O
consanguinity	16378925	4	O
or	16378925	4	O
to	16378925	4	O
a	16378925	4	O
selection	16378925	4	O
bias	16378925	4	O
favoring	16378925	4	O
the	16378925	4	O
census	16378925	4	O
of	16378925	4	O
these	16378925	4	O
genotypes	16378925	4	O
.	16378925	4	O
The	16378925	4	O
fact	16378925	4	O
that	16378925	4	O
FMF	16378925	4	O
female	16378925	4	O
patients	16378925	4	O
were	16378925	4	O
less	16378925	4	O
censed	16378925	4	O
than	16378925	4	O
male	16378925	4	O
patients	16378925	4	O
may	16378925	4	O
be	16378925	4	O
due	16378925	4	O
to	16378925	4	O
the	16378925	4	O
greater	16378925	4	O
resistance	16378925	4	O
of	16378925	4	O
females	16378925	4	O
to	16378925	4	O
pain	16378925	4	O
and	16378925	4	O
to	16378925	4	O
the	16378925	4	O
possibility	16378925	4	O
of	16378925	4	O
confusing	16378925	4	O
abdominal	16378925	4	O
and	16378925	4	O
gynecological	16378925	4	O
pain	16378925	4	O
.	16378925	4	O
The	16378925	4	O
phenotypic	16378925	4	O
heterogeneity	16378925	4	O
of	16378925	4	O
the	16378925	4	O
FMF	16378925	4	O
could	16378925	4	O
then	16378925	4	O
originate	16378925	4	O
both	16378925	4	O
from	16378925	4	O
genetic	16378925	4	O
causes	16378925	4	O
like	16378925	4	O
allelic	16378925	4	O
heterogeneity	16378925	4	O
or	16378925	4	O
modulating	16378925	4	O
genes	16378925	4	O
,	16378925	4	O
and	16378925	4	O
cultural	16378925	4	O
background	16378925	4	O
facing	16378925	4	O
the	16378925	4	O
physiological	16378925	4	O
consequences	16378925	4	O
of	16378925	4	O
genotypes	16378925	4	O
at	16378925	4	O
risk	16378925	4	O
.	16378925	4	O

[	16447768	4	O
Mutational	16447768	4	O
and	16447768	4	O
clinical	16447768	4	O
features	16447768	4	O
of	16447768	4	O
Japanese	16447768	4	O
patients	16447768	4	O
with	16447768	4	O
dysferlinopathy	16447768	4	O
(	16447768	4	O
Miyoshi	16447768	4	O
myopathy	16447768	4	O
and	16447768	4	O
limb	16447768	4	O
girdle	16447768	4	O
muscular	16447768	4	O
dystrophy	16447768	4	O
type	16447768	4	O
2	16447768	4	O
B	16447768	4	O
)	16447768	4	O
]	16447768	4	O
.	16447768	4	O
Mutations	16447768	4	B-Var
in	16447768	4	O
the	16447768	4	O
dysferlin	16447768	4	B-Gene
gene	16447768	4	O
cause	16447768	4	B-Reg
both	16447768	4	O
Miyoshi	16447768	4	B-Disease
myopathy	16447768	4	I-Disease
(	16447768	4	O
MM	16447768	4	O
)	16447768	4	O
and	16447768	4	O
limb	16447768	4	B-Disease
girdle	16447768	4	I-Disease
muscular	16447768	4	I-Disease
dystrophy	16447768	4	I-Disease
2	16447768	4	I-Disease
B	16447768	4	I-Disease
(	16447768	4	O
LGMD2B	16447768	4	O
)	16447768	4	O
.	16447768	4	O
We	16447768	4	O
examined	16447768	4	O
patients	16447768	4	O
with	16447768	4	O
dysferlinopathy	16447768	4	O
in	16447768	4	O
Japan	16447768	4	O
,	16447768	4	O
and	16447768	4	O
identified	16447768	4	O
28	16447768	4	O
and	16447768	4	O
12	16447768	4	O
different	16447768	4	O
mutations	16447768	4	O
respectively	16447768	4	O
in	16447768	4	O
MM	16447768	4	O
and	16447768	4	O
LGMD2B	16447768	4	O
patients	16447768	4	O
.	16447768	4	O
The	16447768	4	O
mean	16447768	4	O
age	16447768	4	O
at	16447768	4	O
onset	16447768	4	O
of	16447768	4	O
the	16447768	4	O
patients	16447768	4	O
with	16447768	4	O
MM	16447768	4	O
was	16447768	4	O
22	16447768	4	O
/	16447768	4	O
-	16447768	4	O
9	16447768	4	O
years	16447768	4	O
(	16447768	4	O
range	16447768	4	O
12	16447768	4	O
-	16447768	4	O
48	16447768	4	O
years	16447768	4	O
)	16447768	4	O
and	16447768	4	O
that	16447768	4	O
of	16447768	4	O
the	16447768	4	O
patients	16447768	4	O
with	16447768	4	O
LGMD2B	16447768	4	O
was	16447768	4	O
26	16447768	4	O
/	16447768	4	O
-	16447768	4	O
10	16447768	4	O
years	16447768	4	O
(	16447768	4	O
range	16447768	4	O
11	16447768	4	O
-	16447768	4	O
43	16447768	4	O
years	16447768	4	O
)	16447768	4	O
.	16447768	4	O
On	16447768	4	O
the	16447768	4	O
average	16447768	4	O
,	16447768	4	O
the	16447768	4	O
first	16447768	4	O
use	16447768	4	O
of	16447768	4	O
a	16447768	4	O
cane	16447768	4	O
was	16447768	4	O
at	16447768	4	O
33	16447768	4	O
years	16447768	4	O
(	16447768	4	O
14	16447768	4	O
years	16447768	4	O
after	16447768	4	O
the	16447768	4	O
onset	16447768	4	O
)	16447768	4	O
for	16447768	4	O
MM	16447768	4	O
and	16447768	4	O
39	16447768	4	O
years	16447768	4	O
(	16447768	4	O
15	16447768	4	O
years	16447768	4	O
after	16447768	4	O
onset	16447768	4	O
)	16447768	4	O
for	16447768	4	O
LGMD	16447768	4	O
2	16447768	4	O
B.	16447768	4	O
Patients	16447768	4	O
became	16447768	4	O
wheelchair	16447768	4	O
-	16447768	4	O
bound	16447768	4	O
at	16447768	4	O
41	16447768	4	O
years	16447768	4	O
(	16447768	4	O
21	16447768	4	O
years	16447768	4	O
after	16447768	4	O
onset	16447768	4	O
)	16447768	4	O
in	16447768	4	O
MM	16447768	4	O
and	16447768	4	O
45	16447768	4	O
years	16447768	4	O
(	16447768	4	O
21	16447768	4	O
years	16447768	4	O
after	16447768	4	O
onset	16447768	4	O
)	16447768	4	O
for	16447768	4	O
LGMD2B	16447768	4	O
.	16447768	4	O
The	16447768	4	O
mean	16447768	4	O
maximum	16447768	4	O
serum	16447768	4	O
CK	16447768	4	O
level	16447768	4	O
at	16447768	4	O
any	16447768	4	O
age	16447768	4	O
of	16447768	4	O
the	16447768	4	O
patients	16447768	4	O
was	16447768	4	O
5	16447768	4	O
,	16447768	4	O
829	16447768	4	O
/	16447768	4	O
-	16447768	4	O
4	16447768	4	O
,	16447768	4	O
273	16447768	4	O
IU	16447768	4	O
/	16447768	4	O
l	16447768	4	O
(	16447768	4	O
range	16447768	4	O
1	16447768	4	O
,	16447768	4	O
289	16447768	4	O
-	16447768	4	O
12	16447768	4	O
,	16447768	4	O
566	16447768	4	O
IU	16447768	4	O
/	16447768	4	O
l	16447768	4	O
)	16447768	4	O
for	16447768	4	O
MM	16447768	4	O
and	16447768	4	O
3	16447768	4	O
,	16447768	4	O
787	16447768	4	O
/	16447768	4	O
-	16447768	4	O
2	16447768	4	O
,	16447768	4	O
493	16447768	4	O
IU	16447768	4	O
/	16447768	4	O
l	16447768	4	O
(	16447768	4	O
627	16447768	4	O
-	16447768	4	O
10	16447768	4	O
,	16447768	4	O
000	16447768	4	O
IU	16447768	4	O
/	16447768	4	O
l	16447768	4	O
)	16447768	4	O
for	16447768	4	O
LGMD2B	16447768	4	O
:	16447768	4	O
in	16447768	4	O
both	16447768	4	O
disorders	16447768	4	O
,	16447768	4	O
the	16447768	4	O
serum	16447768	4	O
CK	16447768	4	O
level	16447768	4	O
fell	16447768	4	O
in	16447768	4	O
proportion	16447768	4	O
to	16447768	4	O
the	16447768	4	O
duration	16447768	4	O
of	16447768	4	O
the	16447768	4	O
illness	16447768	4	O
.	16447768	4	O
We	16447768	4	O
have	16447768	4	O
identified	16447768	4	O
four	16447768	4	O
common	16447768	4	O
four	16447768	4	O
mutations	16447768	4	O
(	16447768	4	O
C1939G	16447768	4	O
,	16447768	4	O
G3370T	16447768	4	O
,	16447768	4	O
3746	16447768	4	O
delG	16447768	4	O
,	16447768	4	O
and	16447768	4	O
4870	16447768	4	O
delT	16447768	4	O
)	16447768	4	O
in	16447768	4	O
Japanese	16447768	4	O
patients	16447768	4	O
with	16447768	4	O
MM	16447768	4	O
,	16447768	4	O
accounting	16447768	4	O
for	16447768	4	O
48	16447768	4	O
percent	16447768	4	O
of	16447768	4	O
all	16447768	4	O
MM	16447768	4	O
mutations	16447768	4	O
in	16447768	4	O
this	16447768	4	O
population	16447768	4	O
.	16447768	4	O
Two	16447768	4	O
of	16447768	4	O
the	16447768	4	O
four	16447768	4	O
mutations	16447768	4	O
(	16447768	4	O
G3370T	16447768	4	O
,	16447768	4	O
and	16447768	4	O
4870	16447768	4	O
delT	16447768	4	O
)	16447768	4	O
accounted	16447768	4	O
for	16447768	4	O
52	16447768	4	O
percent	16447768	4	O
of	16447768	4	O
the	16447768	4	O
mutations	16447768	4	O
in	16447768	4	O
LGMD2B	16447768	4	O
patients	16447768	4	O
,	16447768	4	O
while	16447768	4	O
the	16447768	4	O
3746	16447768	4	O
delG	16447768	4	O
mutation	16447768	4	O
was	16447768	4	O
not	16447768	4	O
found	16447768	4	O
in	16447768	4	O
patients	16447768	4	O
with	16447768	4	O
LGMD2B	16447768	4	O
.	16447768	4	O
The	16447768	4	O
G3370T	16447768	4	B-Var
mutation	16447768	4	O
may	16447768	4	O
be	16447768	4	O
associated	16447768	4	B-Reg
with	16447768	4	I-Reg
a	16447768	4	O
milder	16447768	4	O
form	16447768	4	O
of	16447768	4	O
MM	16447768	4	B-Disease
and	16447768	4	O
LGMD2B	16447768	4	B-Disease
.	16447768	4	O
By	16447768	4	O
contrast	16447768	4	O
,	16447768	4	O
the	16447768	4	O
G3510A	16447768	4	B-Var
mutation	16447768	4	O
appears	16447768	4	O
to	16447768	4	O
be	16447768	4	O
associated	16447768	4	B-Reg
with	16447768	4	I-Reg
a	16447768	4	O
severe	16447768	4	O
form	16447768	4	O
of	16447768	4	O
MM	16447768	4	B-Disease
.	16447768	4	O

[	16447769	4	O
Molecular	16447769	4	O
pathomechanism	16447769	4	O
of	16447769	4	O
distal	16447769	4	O
myopathy	16447769	4	O
with	16447769	4	O
rimmed	16447769	4	O
vacuoles	16447769	4	O
]	16447769	4	O
.	16447769	4	O
Distal	16447769	4	B-Disease
myopathy	16447769	4	I-Disease
with	16447769	4	I-Disease
rimmed	16447769	4	I-Disease
vacuoles	16447769	4	I-Disease
(	16447769	4	O
DMRV	16447769	4	O
)	16447769	4	O
and	16447769	4	O
hereditary	16447769	4	B-Disease
inclusion	16447769	4	I-Disease
body	16447769	4	I-Disease
myopathy	16447769	4	I-Disease
(	16447769	4	O
HIBM	16447769	4	O
)	16447769	4	O
are	16447769	4	O
genetically	16447769	4	O
identical	16447769	4	O
autosomal	16447769	4	O
recessive	16447769	4	O
muscle	16447769	4	O
disorders	16447769	4	O
caused	16447769	4	B-Reg
by	16447769	4	I-Reg
mutations	16447769	4	B-Var
in	16447769	4	O
the	16447769	4	O
GNE	16447769	4	B-Gene
gene	16447769	4	O
.	16447769	4	O
This	16447769	4	O
gene	16447769	4	O
encodes	16447769	4	O
a	16447769	4	O
bifunctional	16447769	4	O
protein	16447769	4	O
with	16447769	4	O
UDP	16447769	4	O
-	16447769	4	O
GlcNAc	16447769	4	O
2	16447769	4	O
-	16447769	4	O
epimerase	16447769	4	O
and	16447769	4	O
ManNAc	16447769	4	O
kinase	16447769	4	O
activities	16447769	4	O
that	16447769	4	O
catalyze	16447769	4	O
the	16447769	4	O
rate	16447769	4	O
limiting	16447769	4	O
step	16447769	4	O
and	16447769	4	O
the	16447769	4	O
succeeding	16447769	4	O
step	16447769	4	O
,	16447769	4	O
respectively	16447769	4	O
,	16447769	4	O
in	16447769	4	O
the	16447769	4	O
sialic	16447769	4	O
acid	16447769	4	O
biosynthetic	16447769	4	O
pathway	16447769	4	O
.	16447769	4	O
V572L	16447769	4	O
mutation	16447769	4	O
is	16447769	4	O
the	16447769	4	O
most	16447769	4	O
prevalent	16447769	4	O
among	16447769	4	O
Japanese	16447769	4	O
DMRV	16447769	4	O
patients	16447769	4	O
and	16447769	4	O
accounts	16447769	4	O
for	16447769	4	O
about	16447769	4	O
60%	16447769	4	O
of	16447769	4	O
mutant	16447769	4	O
alleles	16447769	4	O
.	16447769	4	O
Clinical	16447769	4	O
spectrum	16447769	4	O
of	16447769	4	O
DMRV	16447769	4	O
/	16447769	4	O
HIBM	16447769	4	O
seems	16447769	4	O
to	16447769	4	O
be	16447769	4	O
wider	16447769	4	O
than	16447769	4	O
previously	16447769	4	O
thought	16447769	4	O
in	16447769	4	O
terms	16447769	4	O
of	16447769	4	O
both	16447769	4	O
the	16447769	4	O
severity	16447769	4	O
of	16447769	4	O
the	16447769	4	O
disease	16447769	4	O
and	16447769	4	O
the	16447769	4	O
range	16447769	4	O
of	16447769	4	O
affected	16447769	4	O
organs	16447769	4	O
.	16447769	4	O
There	16447769	4	O
are	16447769	4	O
rare	16447769	4	O
asymptomatic	16447769	4	O
homozygotes	16447769	4	O
with	16447769	4	O
missense	16447769	4	O
GNE	16447769	4	O
mutations	16447769	4	O
,	16447769	4	O
indicating	16447769	4	O
the	16447769	4	O
presence	16447769	4	O
of	16447769	4	O
mitigating	16447769	4	O
factors	16447769	4	O
.	16447769	4	O
Surprisingly	16447769	4	O
,	16447769	4	O
more	16447769	4	O
than	16447769	4	O
10%	16447769	4	O
of	16447769	4	O
the	16447769	4	O
patients	16447769	4	O
had	16447769	4	O
a	16447769	4	O
variety	16447769	4	O
of	16447769	4	O
cardiac	16447769	4	O
abnormalities	16447769	4	O
,	16447769	4	O
suggesting	16447769	4	O
that	16447769	4	O
skeletal	16447769	4	O
muscle	16447769	4	O
may	16447769	4	O
not	16447769	4	O
be	16447769	4	O
the	16447769	4	O
only	16447769	4	O
organ	16447769	4	O
involved	16447769	4	O
.	16447769	4	O
Studies	16447769	4	O
on	16447769	4	O
recombinant	16447769	4	O
GNE	16447769	4	B-Gene
demonstrate	16447769	4	O
a	16447769	4	O
loss	16447769	4	B-NegReg
-	16447769	4	I-NegReg
of	16447769	4	I-NegReg
-	16447769	4	I-NegReg
function	16447769	4	I-NegReg
nature	16447769	4	O
of	16447769	4	O
the	16447769	4	O
missense	16447769	4	O
mutations	16447769	4	B-Var
identified	16447769	4	O
.	16447769	4	O
Patients	16447769	4	O
'	16447769	4	O
cells	16447769	4	O
show	16447769	4	O
decreased	16447769	4	B-NegReg
sialylation	16447769	4	O
status	16447769	4	O
which	16447769	4	O
can	16447769	4	O
be	16447769	4	O
recovered	16447769	4	O
by	16447769	4	O
adding	16447769	4	O
GNE	16447769	4	O
metabolites	16447769	4	O
,	16447769	4	O
such	16447769	4	O
as	16447769	4	O
ManNAc	16447769	4	O
and	16447769	4	O
NeuAc	16447769	4	O
.	16447769	4	O
This	16447769	4	O
indicates	16447769	4	O
the	16447769	4	O
possibility	16447769	4	O
of	16447769	4	O
developing	16447769	4	O
a	16447769	4	O
therapy	16447769	4	O
for	16447769	4	O
DMRV	16447769	4	O
/	16447769	4	O
HIBM	16447769	4	O
by	16447769	4	O
giving	16447769	4	O
these	16447769	4	O
metabolites	16447769	4	O
to	16447769	4	O
patients	16447769	4	O
although	16447769	4	O
we	16447769	4	O
have	16447769	4	O
to	16447769	4	O
await	16447769	4	O
the	16447769	4	O
model	16447769	4	O
mice	16447769	4	O
that	16447769	4	O
are	16447769	4	O
currently	16447769	4	O
being	16447769	4	O
produced	16447769	4	O
at	16447769	4	O
several	16447769	4	O
laboratories	16447769	4	O
.	16447769	4	O

X	16505158	4	B-Disease
linked	16505158	4	I-Disease
cone	16505158	4	I-Disease
-	16505158	4	I-Disease
rod	16505158	4	I-Disease
dystrophy	16505158	4	I-Disease
,	16505158	4	O
CORDX3	16505158	4	O
,	16505158	4	O
is	16505158	4	O
caused	16505158	4	B-Reg
by	16505158	4	I-Reg
a	16505158	4	O
mutation	16505158	4	B-Var
in	16505158	4	O
the	16505158	4	O
CACNA1F	16505158	4	B-Gene
gene	16505158	4	O
.	16505158	4	O
BACKGROUND	16505158	4	O
:	16505158	4	O
X	16505158	4	B-Disease
linked	16505158	4	I-Disease
cone	16505158	4	I-Disease
-	16505158	4	I-Disease
rod	16505158	4	I-Disease
dystrophy	16505158	4	I-Disease
(	16505158	4	O
CORDX	16505158	4	O
)	16505158	4	O
is	16505158	4	O
a	16505158	4	O
recessive	16505158	4	O
retinal	16505158	4	O
disease	16505158	4	O
characterised	16505158	4	O
by	16505158	4	O
progressive	16505158	4	O
dysfunction	16505158	4	O
of	16505158	4	O
photoreceptors	16505158	4	O
.	16505158	4	O
It	16505158	4	O
is	16505158	4	O
genetically	16505158	4	O
heterogeneous	16505158	4	O
,	16505158	4	O
showing	16505158	4	O
linkage	16505158	4	O
to	16505158	4	O
three	16505158	4	O
X	16505158	4	O
chromosomal	16505158	4	O
loci	16505158	4	O
.	16505158	4	O
CORDX1	16505158	4	B-Disease
is	16505158	4	O
caused	16505158	4	B-Reg
by	16505158	4	I-Reg
mutations	16505158	4	B-Var
in	16505158	4	O
the	16505158	4	O
RPGR	16505158	4	B-Gene
gene	16505158	4	O
(	16505158	4	O
Xp21.1	16505158	4	O
)	16505158	4	O
,	16505158	4	O
CORDX2	16505158	4	O
is	16505158	4	O
located	16505158	4	O
on	16505158	4	O
Xq27.2	16505158	4	O
-	16505158	4	O
28	16505158	4	O
,	16505158	4	O
and	16505158	4	O
we	16505158	4	O
recently	16505158	4	O
localised	16505158	4	O
CORDX3	16505158	4	O
to	16505158	4	O
Xp11.4	16505158	4	O
-	16505158	4	O
q13.1	16505158	4	O
.	16505158	4	O
We	16505158	4	O
aimed	16505158	4	O
to	16505158	4	O
identify	16505158	4	O
the	16505158	4	O
causative	16505158	4	O
gene	16505158	4	O
behind	16505158	4	O
the	16505158	4	O
CORDX3	16505158	4	O
phenotype	16505158	4	O
.	16505158	4	O
METHODS	16505158	4	O
:	16505158	4	O
All	16505158	4	O
48	16505158	4	O
exons	16505158	4	O
of	16505158	4	O
the	16505158	4	O
CACNA1F	16505158	4	O
gene	16505158	4	O
were	16505158	4	O
screened	16505158	4	O
for	16505158	4	O
mutations	16505158	4	O
by	16505158	4	O
DNA	16505158	4	O
sequencing	16505158	4	O
.	16505158	4	O
RNA	16505158	4	O
from	16505158	4	O
cultured	16505158	4	O
lymphoblasts	16505158	4	O
and	16505158	4	O
peripheral	16505158	4	O
blood	16505158	4	O
activated	16505158	4	O
T	16505158	4	O
lymphocytes	16505158	4	O
was	16505158	4	O
analysed	16505158	4	O
by	16505158	4	O
RT	16505158	4	O
-	16505158	4	O
PCR	16505158	4	O
and	16505158	4	O
sequencing	16505158	4	O
.	16505158	4	O
RESULTS	16505158	4	O
:	16505158	4	O
A	16505158	4	O
novel	16505158	4	O
CACNA1F	16505158	4	O
mutation	16505158	4	O
,	16505158	4	O
IVS28-1	16505158	4	O
GCGTC	16505158	4	O
>	16505158	4	O
TGG	16505158	4	O
,	16505158	4	O
in	16505158	4	O
the	16505158	4	O
splice	16505158	4	O
acceptor	16505158	4	O
site	16505158	4	O
of	16505158	4	O
intron	16505158	4	O
28	16505158	4	O
was	16505158	4	O
identified	16505158	4	O
.	16505158	4	O
Messenger	16505158	4	O
RNA	16505158	4	O
studies	16505158	4	O
indicated	16505158	4	O
that	16505158	4	O
the	16505158	4	O
identified	16505158	4	O
mutation	16505158	4	B-Var
leads	16505158	4	O
to	16505158	4	O
altered	16505158	4	B-Reg
splicing	16505158	4	O
of	16505158	4	O
the	16505158	4	O
CACNA1F	16505158	4	B-Gene
transcript	16505158	4	O
.	16505158	4	O
Aberrant	16505158	4	B-Var
splice	16505158	4	I-Var
variants	16505158	4	I-Var
are	16505158	4	O
predicted	16505158	4	O
to	16505158	4	O
result	16505158	4	B-Reg
in	16505158	4	I-Reg
premature	16505158	4	O
termination	16505158	4	O
and	16505158	4	O
deletions	16505158	4	B-Var
of	16505158	4	O
the	16505158	4	O
encoded	16505158	4	O
protein	16505158	4	O
,	16505158	4	O
Ca	16505158	4	O
(	16505158	4	O
v	16505158	4	O
)	16505158	4	O
1.4	16505158	4	O
alpha1	16505158	4	O
subunit	16505158	4	O
.	16505158	4	O
CONCLUSION	16505158	4	O
:	16505158	4	O
CACNA1F	16505158	4	B-Gene
mutations	16505158	4	B-Var
cause	16505158	4	B-Reg
the	16505158	4	O
retinal	16505158	4	B-Disease
disorder	16505158	4	I-Disease
,	16505158	4	O
incomplete	16505158	4	O
congenital	16505158	4	B-Disease
stationary	16505158	4	I-Disease
night	16505158	4	I-Disease
blindness	16505158	4	I-Disease
(	16505158	4	O
CSNB2	16505158	4	O
)	16505158	4	O
,	16505158	4	O
although	16505158	4	O
mutations	16505158	4	O
have	16505158	4	O
also	16505158	4	O
been	16505158	4	O
detected	16505158	4	O
in	16505158	4	O
patients	16505158	4	O
with	16505158	4	O
divergent	16505158	4	O
diagnoses	16505158	4	O
.	16505158	4	O
Our	16505158	4	O
results	16505158	4	O
indicate	16505158	4	O
that	16505158	4	O
yet	16505158	4	O
another	16505158	4	O
phenotype	16505158	4	O
,	16505158	4	O
CORDX3	16505158	4	B-Disease
,	16505158	4	O
is	16505158	4	O
caused	16505158	4	B-Reg
by	16505158	4	I-Reg
a	16505158	4	O
mutation	16505158	4	B-Var
in	16505158	4	O
CACNA1F	16505158	4	B-Gene
.	16505158	4	O
Clinically	16505158	4	O
,	16505158	4	O
CORDX3	16505158	4	O
shares	16505158	4	O
some	16505158	4	O
features	16505158	4	O
with	16505158	4	O
CSNB2	16505158	4	O
but	16505158	4	O
is	16505158	4	O
distinguishable	16505158	4	O
from	16505158	4	O
CSNB2	16505158	4	O
in	16505158	4	O
that	16505158	4	O
it	16505158	4	O
is	16505158	4	O
progressive	16505158	4	O
,	16505158	4	O
can	16505158	4	O
begin	16505158	4	O
in	16505158	4	O
adulthood	16505158	4	O
,	16505158	4	O
has	16505158	4	O
no	16505158	4	O
nystagmus	16505158	4	O
or	16505158	4	O
hyperopic	16505158	4	O
refraction	16505158	4	O
,	16505158	4	O
has	16505158	4	O
only	16505158	4	O
low	16505158	4	O
grade	16505158	4	O
astigmatism	16505158	4	O
,	16505158	4	O
and	16505158	4	O
in	16505158	4	O
dark	16505158	4	O
adaptation	16505158	4	O
lacks	16505158	4	O
cone	16505158	4	O
threshold	16505158	4	O
and	16505158	4	O
has	16505158	4	O
small	16505158	4	O
or	16505158	4	O
no	16505158	4	O
elevation	16505158	4	O
of	16505158	4	O
rod	16505158	4	O
threshold	16505158	4	O
.	16505158	4	O
Considering	16505158	4	O
all	16505158	4	O
features	16505158	4	O
,	16505158	4	O
CORDX3	16505158	4	O
is	16505158	4	O
more	16505158	4	O
similar	16505158	4	O
to	16505158	4	O
other	16505158	4	O
X	16505158	4	O
chromosomal	16505158	4	O
cone	16505158	4	O
-	16505158	4	O
rod	16505158	4	O
dystrophies	16505158	4	O
than	16505158	4	O
to	16505158	4	O
CSNB2	16505158	4	O
.	16505158	4	O

Novel	16541399	4	O
JARID1C	16541399	4	O
/	16541399	4	O
SMCX	16541399	4	O
mutations	16541399	4	O
in	16541399	4	O
patients	16541399	4	O
with	16541399	4	O
X	16541399	4	O
-	16541399	4	O
linked	16541399	4	O
mental	16541399	4	O
retardation	16541399	4	O
.	16541399	4	O
X	16541399	4	B-Disease
-	16541399	4	I-Disease
linked	16541399	4	I-Disease
mental	16541399	4	I-Disease
retardation	16541399	4	I-Disease
(	16541399	4	O
XLMR	16541399	4	O
)	16541399	4	O
is	16541399	4	O
a	16541399	4	O
heterogeneous	16541399	4	O
disorder	16541399	4	O
that	16541399	4	O
affects	16541399	4	O
approximately	16541399	4	O
2	16541399	4	O
in	16541399	4	O
1000	16541399	4	O
males	16541399	4	O
.	16541399	4	O
JARID1C	16541399	4	O
/	16541399	4	O
SMCX	16541399	4	O
is	16541399	4	O
relatively	16541399	4	O
new	16541399	4	O
among	16541399	4	O
the	16541399	4	O
known	16541399	4	O
XLMR	16541399	4	O
genes	16541399	4	O
,	16541399	4	O
and	16541399	4	O
seven	16541399	4	O
different	16541399	4	O
mutations	16541399	4	O
have	16541399	4	O
been	16541399	4	O
identified	16541399	4	O
previously	16541399	4	O
in	16541399	4	O
this	16541399	4	O
gene	16541399	4	O
[	16541399	4	O
Jensen	16541399	4	O
LR	16541399	4	O
et	16541399	4	O
al	16541399	4	O
.	16541399	4	O
,	16541399	4	O
Am	16541399	4	O
.	16541399	4	O
J.	16541399	4	O
Hum	16541399	4	O
.	16541399	4	O
Genet.76	16541399	4	O
:	16541399	4	O
227	16541399	4	O
-	16541399	4	O
236	16541399	4	O
,	16541399	4	O
2005	16541399	4	O
]	16541399	4	O
.	16541399	4	O
Here	16541399	4	O
,	16541399	4	O
we	16541399	4	O
report	16541399	4	O
five	16541399	4	O
novel	16541399	4	O
JARID1C	16541399	4	O
mutations	16541399	4	O
in	16541399	4	B-Gene
five	16541399	4	O
XLMR	16541399	4	B-Reg
families	16541399	4	O
.	16541399	4	B-Disease
The	16541399	4	O
changes	16541399	4	O
comprise	16541399	4	O
one	16541399	4	O
nonsense	16541399	4	O
mutation	16541399	4	O
(	16541399	4	O
p.Arg332X	16541399	4	O
)	16541399	4	B-Var
and	16541399	4	I-Var
four	16541399	4	I-Var
missense	16541399	4	O
mutations	16541399	4	O
(	16541399	4	O
p.Asp87Gly	16541399	4	O
;	16541399	4	B-Var
p.Phe642Leu	16541399	4	I-Var
;	16541399	4	I-Var
p.Arg750Trp	16541399	4	B-Var
;	16541399	4	I-Var
p.Tyr751Cys	16541399	4	B-Var
)	16541399	4	I-Var
affecting	16541399	4	B-Var
evolutionarily	16541399	4	I-Var
conserved	16541399	4	O
amino	16541399	4	O
acids	16541399	4	O
.	16541399	4	O
The	16541399	4	O
degree	16541399	4	O
of	16541399	4	O
mental	16541399	4	O
retardation	16541399	4	O
in	16541399	4	O
the	16541399	4	O
affected	16541399	4	O
males	16541399	4	O
ranged	16541399	4	O
from	16541399	4	O
mild	16541399	4	O
to	16541399	4	O
severe	16541399	4	O
,	16541399	4	O
and	16541399	4	O
some	16541399	4	O
patients	16541399	4	O
suffered	16541399	4	O
from	16541399	4	O
additional	16541399	4	O
disorders	16541399	4	O
such	16541399	4	O
as	16541399	4	O
epilepsy	16541399	4	O
,	16541399	4	O
short	16541399	4	O
stature	16541399	4	O
,	16541399	4	O
or	16541399	4	O
behavioral	16541399	4	O
problems	16541399	4	O
.	16541399	4	O
This	16541399	4	O
study	16541399	4	O
brings	16541399	4	O
the	16541399	4	O
total	16541399	4	O
number	16541399	4	O
of	16541399	4	O
reported	16541399	4	O
JARID1C	16541399	4	O
mutations	16541399	4	O
to	16541399	4	O
twelve	16541399	4	O
.	16541399	4	O
In	16541399	4	O
contrast	16541399	4	O
to	16541399	4	O
other	16541399	4	O
XLMR	16541399	4	O
genes	16541399	4	O
in	16541399	4	O
which	16541399	4	O
mutations	16541399	4	O
were	16541399	4	O
found	16541399	4	O
only	16541399	4	O
in	16541399	4	O
single	16541399	4	O
or	16541399	4	O
very	16541399	4	O
few	16541399	4	O
families	16541399	4	O
,	16541399	4	O
JARID1C	16541399	4	O
appears	16541399	4	O
to	16541399	4	O
be	16541399	4	O
one	16541399	4	O
of	16541399	4	O
the	16541399	4	O
more	16541399	4	O
frequently	16541399	4	O
mutated	16541399	4	O
genes	16541399	4	O
in	16541399	4	O
this	16541399	4	O
disorder	16541399	4	O
.	16541399	4	O

Missense	16720617	1	B-Var
mutations	16720617	1	I-Var
in	16720617	1	O
SH2D1A	16720617	1	B-Gene
identified	16720617	1	O
in	16720617	1	O
patients	16720617	1	O
with	16720617	1	B-Reg
X	16720617	1	B-Disease
-	16720617	1	I-Disease
linked	16720617	1	I-Disease
lymphoproliferative	16720617	1	I-Disease
disease	16720617	1	I-Disease
differentially	16720617	1	O
affect	16720617	1	O
the	16720617	1	O
expression	16720617	1	O
and	16720617	1	O
function	16720617	1	O
of	16720617	1	O
SAP	16720617	1	O
.	16720617	1	O
X	16720617	1	B-Disease
-	16720617	1	I-Disease
linked	16720617	1	I-Disease
lymphoproliferative	16720617	1	I-Disease
disease	16720617	1	I-Disease
(	16720617	1	O
XLP	16720617	1	O
)	16720617	1	O
is	16720617	1	O
an	16720617	1	O
immunodeficiency	16720617	1	O
resulting	16720617	1	B-Reg
from	16720617	1	I-Reg
mutations	16720617	1	B-Var
in	16720617	1	O
SH2D1A	16720617	1	B-Gene
,	16720617	1	O
which	16720617	1	O
encodes	16720617	1	O
signalling	16720617	1	O
lymphocytic	16720617	1	O
activation	16720617	1	O
molecule	16720617	1	O
(	16720617	1	O
SLAM	16720617	1	O
)	16720617	1	O
-	16720617	1	O
associated	16720617	1	O
protein	16720617	1	O
(	16720617	1	O
SAP	16720617	1	O
)	16720617	1	O
.	16720617	1	O
In	16720617	1	O
addition	16720617	1	O
to	16720617	1	O
SLAM	16720617	1	O
,	16720617	1	O
SAP	16720617	1	O
associates	16720617	1	O
with	16720617	1	O
several	16720617	1	O
other	16720617	1	O
cell	16720617	1	O
-	16720617	1	O
surface	16720617	1	O
receptors	16720617	1	O
including	16720617	1	O
2	16720617	1	O
B4	16720617	1	O
(	16720617	1	O
CD244	16720617	1	O
)	16720617	1	O
,	16720617	1	O
Ly9	16720617	1	O
(	16720617	1	O
CD229	16720617	1	O
)	16720617	1	O
,	16720617	1	O
CD84	16720617	1	O
and	16720617	1	O
NTB	16720617	1	O
-	16720617	1	O
A.	16720617	1	O
SAP	16720617	1	O
contains	16720617	1	O
a	16720617	1	O
single	16720617	1	O
src	16720617	1	O
-	16720617	1	O
homology-2	16720617	1	O
domain	16720617	1	O
and	16720617	1	O
acts	16720617	1	O
as	16720617	1	O
an	16720617	1	O
intracellular	16720617	1	O
adaptor	16720617	1	O
protein	16720617	1	O
by	16720617	1	O
recruiting	16720617	1	O
the	16720617	1	O
protein	16720617	1	O
tyrosine	16720617	1	O
kinase	16720617	1	O
FynT	16720617	1	O
to	16720617	1	O
the	16720617	1	O
cytoplasmic	16720617	1	O
domains	16720617	1	O
of	16720617	1	O
some	16720617	1	O
of	16720617	1	O
these	16720617	1	O
receptors	16720617	1	O
,	16720617	1	O
which	16720617	1	O
results	16720617	1	O
in	16720617	1	O
the	16720617	1	O
initiation	16720617	1	O
of	16720617	1	O
specific	16720617	1	O
downstream	16720617	1	O
signal	16720617	1	O
transduction	16720617	1	O
pathways	16720617	1	O
.	16720617	1	O
XLP	16720617	1	O
is	16720617	1	O
likely	16720617	1	O
to	16720617	1	O
result	16720617	1	O
from	16720617	1	O
perturbed	16720617	1	O
signalling	16720617	1	O
through	16720617	1	O
one	16720617	1	O
or	16720617	1	O
more	16720617	1	O
of	16720617	1	O
these	16720617	1	O
SAP	16720617	1	O
-	16720617	1	O
associating	16720617	1	O
receptors	16720617	1	O
.	16720617	1	O
In	16720617	1	O
this	16720617	1	O
study	16720617	1	O
,	16720617	1	O
we	16720617	1	O
identified	16720617	1	O
missense	16720617	1	O
(	16720617	1	O
Y54C	16720617	1	O
,	16720617	1	O
I84T	16720617	1	O
and	16720617	1	O
F87S	16720617	1	O
)	16720617	1	O
and	16720617	1	O
insertion	16720617	1	O
(	16720617	1	O
fs82	16720617	1	O
-	16720617	1	O
-	16720617	1	O
>	16720617	1	O
X103	16720617	1	O
)	16720617	1	O
mutations	16720617	1	O
in	16720617	1	O
four	16720617	1	O
different	16720617	1	O
kindreds	16720617	1	O
affected	16720617	1	O
by	16720617	1	O
XLP	16720617	1	O
.	16720617	1	O
Each	16720617	1	O
mutation	16720617	1	B-Var
dramatically	16720617	1	O
reduced	16720617	1	B-NegReg
the	16720617	1	O
half	16720617	1	O
-	16720617	1	O
life	16720617	1	O
of	16720617	1	O
SAP	16720617	1	O
,	16720617	1	O
thus	16720617	1	O
diminishing	16720617	1	B-NegReg
its	16720617	1	O
expression	16720617	1	O
in	16720617	1	O
primary	16720617	1	O
lymphocytes	16720617	1	O
as	16720617	1	O
well	16720617	1	O
as	16720617	1	O
in	16720617	1	O
transfected	16720617	1	O
cell	16720617	1	O
lines	16720617	1	O
.	16720617	1	O
Interestingly	16720617	1	O
,	16720617	1	O
although	16720617	1	O
the	16720617	1	O
Y54C	16720617	1	B-Var
and	16720617	1	O
F87S	16720617	1	B-Var
mutations	16720617	1	O
compromised	16720617	1	B-NegReg
the	16720617	1	O
ability	16720617	1	O
of	16720617	1	O
SAP	16720617	1	O
to	16720617	1	O
associate	16720617	1	O
with	16720617	1	O
different	16720617	1	O
receptors	16720617	1	O
,	16720617	1	O
the	16720617	1	O
I84T	16720617	1	O
mutation	16720617	1	O
had	16720617	1	O
no	16720617	1	O
effect	16720617	1	O
on	16720617	1	O
the	16720617	1	O
ability	16720617	1	O
of	16720617	1	O
SAP	16720617	1	O
to	16720617	1	O
bind	16720617	1	O
SLAM	16720617	1	O
,	16720617	1	O
CD84	16720617	1	O
or	16720617	1	O
2	16720617	1	O
B4	16720617	1	O
.	16720617	1	O
However	16720617	1	O
,	16720617	1	O
signalling	16720617	1	O
downstream	16720617	1	O
of	16720617	1	O
SLAM	16720617	1	O
was	16720617	1	O
reduced	16720617	1	B-NegReg
in	16720617	1	O
the	16720617	1	O
presence	16720617	1	O
of	16720617	1	O
SAP	16720617	1	O
bearing	16720617	1	O
the	16720617	1	O
I84T	16720617	1	B-Var
mutation	16720617	1	O
.	16720617	1	O
These	16720617	1	O
findings	16720617	1	O
indicate	16720617	1	O
that	16720617	1	O
,	16720617	1	O
irrespective	16720617	1	O
of	16720617	1	O
the	16720617	1	O
type	16720617	1	O
of	16720617	1	O
mutation	16720617	1	O
,	16720617	1	O
signalling	16720617	1	O
through	16720617	1	O
SAP	16720617	1	O
-	16720617	1	O
associating	16720617	1	O
receptors	16720617	1	O
in	16720617	1	O
XLP	16720617	1	O
can	16720617	1	O
be	16720617	1	O
impaired	16720617	1	O
by	16720617	1	O
reducing	16720617	1	O
the	16720617	1	O
expression	16720617	1	O
of	16720617	1	O
SAP	16720617	1	O
,	16720617	1	O
the	16720617	1	O
ability	16720617	1	O
of	16720617	1	O
SAP	16720617	1	O
to	16720617	1	O
bind	16720617	1	O
surface	16720617	1	O
receptors	16720617	1	O
and	16720617	1	O
/	16720617	1	O
or	16720617	1	O
its	16720617	1	O
ability	16720617	1	O
to	16720617	1	O
activate	16720617	1	O
signal	16720617	1	O
transduction	16720617	1	O
downstream	16720617	1	O
of	16720617	1	O
the	16720617	1	O
SLAM	16720617	1	O
-	16720617	1	O
SAP	16720617	1	O
complex	16720617	1	O
.	16720617	1	O

The	16730748	4	O
R110C	16730748	4	B-Var
mutation	16730748	4	O
in	16730748	4	O
Notch3	16730748	4	B-Gene
causes	16730748	4	B-Reg
variable	16730748	4	O
clinical	16730748	4	O
features	16730748	4	O
in	16730748	4	O
two	16730748	4	O
Turkish	16730748	4	O
families	16730748	4	O
with	16730748	4	O
CADASIL	16730748	4	B-Disease
syndrome	16730748	4	I-Disease
.	16730748	4	O
Mutations	16730748	4	B-Var
in	16730748	4	O
Notch3	16730748	4	B-Gene
gene	16730748	4	O
are	16730748	4	O
responsible	16730748	4	B-Reg
for	16730748	4	O
the	16730748	4	O
cerebral	16730748	4	B-Disease
autosomal	16730748	4	I-Disease
dominant	16730748	4	I-Disease
arteriopathy	16730748	4	I-Disease
with	16730748	4	I-Disease
subcortical	16730748	4	I-Disease
infarcts	16730748	4	I-Disease
and	16730748	4	I-Disease
leukoencephalopathy	16730748	4	I-Disease
(	16730748	4	O
CADASIL	16730748	4	O
)	16730748	4	O
.	16730748	4	O
It	16730748	4	O
is	16730748	4	O
a	16730748	4	O
late	16730748	4	O
onset	16730748	4	O
neurological	16730748	4	O
disorder	16730748	4	O
recognized	16730748	4	O
by	16730748	4	O
recurrent	16730748	4	O
strokes	16730748	4	O
and	16730748	4	O
dementia	16730748	4	O
.	16730748	4	O
We	16730748	4	O
describe	16730748	4	O
here	16730748	4	O
the	16730748	4	O
clinical	16730748	4	O
and	16730748	4	O
molecular	16730748	4	O
findings	16730748	4	O
of	16730748	4	O
three	16730748	4	O
unrelated	16730748	4	O
Turkish	16730748	4	O
families	16730748	4	O
with	16730748	4	O
CADASIL	16730748	4	O
syndrome	16730748	4	O
.	16730748	4	O
Two	16730748	4	O
of	16730748	4	O
the	16730748	4	O
families	16730748	4	O
were	16730748	4	O
identified	16730748	4	O
to	16730748	4	O
have	16730748	4	O
the	16730748	4	O
same	16730748	4	O
mutation	16730748	4	O
,	16730748	4	O
p.R110C	16730748	4	O
(	16730748	4	O
c.	16730748	4	O
C328T	16730748	4	O
)	16730748	4	O
,	16730748	4	O
located	16730748	4	O
in	16730748	4	O
exon	16730748	4	O
3	16730748	4	O
of	16730748	4	O
the	16730748	4	O
Notch3	16730748	4	O
gene	16730748	4	O
.	16730748	4	O
Interestingly	16730748	4	O
,	16730748	4	O
the	16730748	4	O
phenotypic	16730748	4	O
expression	16730748	4	O
of	16730748	4	O
the	16730748	4	O
disease	16730748	4	O
in	16730748	4	O
these	16730748	4	O
two	16730748	4	O
families	16730748	4	O
was	16730748	4	O
markedly	16730748	4	O
different	16730748	4	O
in	16730748	4	O
severity	16730748	4	O
and	16730748	4	O
age	16730748	4	O
of	16730748	4	O
onset	16730748	4	O
implicating	16730748	4	O
additional	16730748	4	O
genetic	16730748	4	O
and	16730748	4	O
/	16730748	4	O
or	16730748	4	O
non	16730748	4	O
-	16730748	4	O
genetic	16730748	4	O
modulating	16730748	4	O
factors	16730748	4	O
involved	16730748	4	O
in	16730748	4	O
the	16730748	4	O
pathogenesis	16730748	4	O
.	16730748	4	O
In	16730748	4	O
addition	16730748	4	O
,	16730748	4	O
we	16730748	4	O
identified	16730748	4	O
the	16730748	4	O
novel	16730748	4	O
p.C201R	16730748	4	O
(	16730748	4	O
c.	16730748	4	O
T601C	16730748	4	O
)	16730748	4	O
mutation	16730748	4	O
in	16730748	4	O
exon	16730748	4	O
4	16730748	4	O
of	16730748	4	O
the	16730748	4	O
Notch3	16730748	4	O
gene	16730748	4	O
in	16730748	4	O
a	16730748	4	O
proband	16730748	4	O
of	16730748	4	O
the	16730748	4	O
third	16730748	4	O
family	16730748	4	O
with	16730748	4	O
two	16730748	4	O
consecutive	16730748	4	O
stroke	16730748	4	O
-	16730748	4	O
like	16730748	4	O
episodes	16730748	4	O
and	16730748	4	O
typical	16730748	4	O
MRI	16730748	4	O
findings	16730748	4	O
.	16730748	4	O
Mutations	16730748	4	B-Var
described	16730748	4	O
here	16730748	4	O
cause	16730748	4	B-Reg
an	16730748	4	O
odd	16730748	4	O
number	16730748	4	O
of	16730748	4	O
cysteines	16730748	4	O
in	16730748	4	O
the	16730748	4	O
N	16730748	4	O
-	16730748	4	O
terminal	16730748	4	O
of	16730748	4	O
the	16730748	4	O
EGF	16730748	4	O
domain	16730748	4	O
of	16730748	4	O
Notch3	16730748	4	B-Gene
protein	16730748	4	O
,	16730748	4	O
which	16730748	4	O
seems	16730748	4	O
to	16730748	4	O
have	16730748	4	O
an	16730748	4	O
important	16730748	4	O
functional	16730748	4	O
effect	16730748	4	B-Reg
in	16730748	4	O
the	16730748	4	O
pathophysiology	16730748	4	O
of	16730748	4	O
CADASIL	16730748	4	B-Disease
.	16730748	4	O
The	16730748	4	O
phenotypic	16730748	4	O
variability	16730748	4	O
in	16730748	4	O
families	16730748	4	O
carrying	16730748	4	O
the	16730748	4	O
same	16730748	4	O
molecular	16730748	4	O
defect	16730748	4	O
as	16730748	4	O
presented	16730748	4	O
here	16730748	4	O
makes	16730748	4	O
the	16730748	4	O
prediction	16730748	4	O
of	16730748	4	O
prognosis	16730748	4	O
inconceivable	16730748	4	O
.	16730748	4	O
Although	16730748	4	O
DNA	16730748	4	O
analysis	16730748	4	O
is	16730748	4	O
effective	16730748	4	O
and	16730748	4	O
valuable	16730748	4	O
in	16730748	4	O
diagnosing	16730748	4	O
approximately	16730748	4	O
90%	16730748	4	O
of	16730748	4	O
the	16730748	4	O
CADASIL	16730748	4	O
patients	16730748	4	O
,	16730748	4	O
lack	16730748	4	O
of	16730748	4	O
genotype	16730748	4	O
-	16730748	4	O
phenotype	16730748	4	O
correlation	16730748	4	O
and	16730748	4	O
prognostic	16730748	4	O
parameters	16730748	4	O
makes	16730748	4	O
the	16730748	4	O
presymptomatic	16730748	4	O
genetic	16730748	4	O
counseling	16730748	4	O
very	16730748	4	O
difficult	16730748	4	O
.	16730748	4	O

Entries	16770791	3	O
in	16770791	3	O
the	16770791	3	O
Leiden	16770791	3	O
Duchenne	16770791	3	O
muscular	16770791	3	O
dystrophy	16770791	3	O
mutation	16770791	3	O
database	16770791	3	O
:	16770791	3	O
an	16770791	3	O
overview	16770791	3	O
of	16770791	3	O
mutation	16770791	3	O
types	16770791	3	O
and	16770791	3	O
paradoxical	16770791	3	O
cases	16770791	3	O
that	16770791	3	O
confirm	16770791	3	O
the	16770791	3	O
reading	16770791	3	O
-	16770791	3	O
frame	16770791	3	O
rule	16770791	3	O
.	16770791	3	O
The	16770791	3	O
severe	16770791	3	O
Duchenne	16770791	3	B-Disease
and	16770791	3	O
milder	16770791	3	O
Becker	16770791	3	B-Disease
muscular	16770791	3	I-Disease
dystrophy	16770791	3	I-Disease
are	16770791	3	O
both	16770791	3	O
caused	16770791	3	B-Reg
by	16770791	3	I-Reg
mutations	16770791	3	B-Var
in	16770791	3	O
the	16770791	3	O
DMD	16770791	3	B-Gene
gene	16770791	3	O
.	16770791	3	O
This	16770791	3	O
gene	16770791	3	O
codes	16770791	3	O
for	16770791	3	O
dystrophin	16770791	3	O
,	16770791	3	O
a	16770791	3	O
protein	16770791	3	O
important	16770791	3	O
for	16770791	3	O
maintaining	16770791	3	O
the	16770791	3	O
stability	16770791	3	O
of	16770791	3	O
muscle	16770791	3	O
-	16770791	3	O
fiber	16770791	3	O
membranes	16770791	3	O
.	16770791	3	O
In	16770791	3	O
1988	16770791	3	O
,	16770791	3	O
Monaco	16770791	3	O
and	16770791	3	O
colleagues	16770791	3	O
postulated	16770791	3	O
an	16770791	3	O
explanation	16770791	3	O
for	16770791	3	O
the	16770791	3	O
phenotypic	16770791	3	O
difference	16770791	3	O
between	16770791	3	O
Duchenne	16770791	3	O
and	16770791	3	O
Becker	16770791	3	O
patients	16770791	3	O
in	16770791	3	O
the	16770791	3	O
reading	16770791	3	O
-	16770791	3	O
frame	16770791	3	O
rule	16770791	3	O
:	16770791	3	O
In	16770791	3	O
Duchenne	16770791	3	B-Disease
patients	16770791	3	O
,	16770791	3	O
mutations	16770791	3	B-Var
induce	16770791	3	B-Reg
a	16770791	3	O
shift	16770791	3	O
in	16770791	3	O
the	16770791	3	O
reading	16770791	3	O
frame	16770791	3	O
leading	16770791	3	B-Reg
to	16770791	3	O
prematurely	16770791	3	O
truncated	16770791	3	O
,	16770791	3	O
dysfunctional	16770791	3	B-NegReg
dystrophins	16770791	3	O
.	16770791	3	O
In	16770791	3	O
Becker	16770791	3	B-Disease
patients	16770791	3	O
,	16770791	3	O
in	16770791	3	B-Var
-	16770791	3	I-Var
frame	16770791	3	I-Var
mutations	16770791	3	I-Var
allow	16770791	3	B-Reg
the	16770791	3	O
synthesis	16770791	3	O
of	16770791	3	O
internally	16770791	3	O
deleted	16770791	3	O
,	16770791	3	O
but	16770791	3	O
largely	16770791	3	B-PosReg
functional	16770791	3	I-PosReg
dystrophins	16770791	3	O
.	16770791	3	O
Currently	16770791	3	O
,	16770791	3	O
over	16770791	3	O
4700	16770791	3	O
mutations	16770791	3	O
have	16770791	3	O
been	16770791	3	O
reported	16770791	3	O
in	16770791	3	O
the	16770791	3	O
Leiden	16770791	3	O
DMD	16770791	3	O
mutation	16770791	3	O
database	16770791	3	O
,	16770791	3	O
of	16770791	3	O
which	16770791	3	O
91%	16770791	3	O
are	16770791	3	O
in	16770791	3	O
agreement	16770791	3	O
with	16770791	3	O
this	16770791	3	O
rule	16770791	3	O
.	16770791	3	O
In	16770791	3	O
this	16770791	3	O
study	16770791	3	O
we	16770791	3	O
provide	16770791	3	O
an	16770791	3	O
update	16770791	3	O
of	16770791	3	O
the	16770791	3	O
mutational	16770791	3	O
variability	16770791	3	O
in	16770791	3	O
the	16770791	3	O
DMD	16770791	3	O
gene	16770791	3	O
,	16770791	3	O
particularly	16770791	3	O
focusing	16770791	3	O
on	16770791	3	O
genotype	16770791	3	O
-	16770791	3	O
phenotype	16770791	3	O
correlations	16770791	3	O
and	16770791	3	O
mutations	16770791	3	O
that	16770791	3	O
appear	16770791	3	O
to	16770791	3	O
be	16770791	3	O
exceptions	16770791	3	O
to	16770791	3	O
the	16770791	3	O
reading	16770791	3	O
-	16770791	3	O
frame	16770791	3	O
rule	16770791	3	O
.	16770791	3	O

Prevalence	16799052	4	O
of	16799052	4	O
disease	16799052	4	O
-	16799052	4	O
causing	16799052	4	O
mutations	16799052	4	O
in	16799052	4	O
families	16799052	4	O
with	16799052	4	O
autosomal	16799052	4	O
dominant	16799052	4	O
retinitis	16799052	4	O
pigmentosa	16799052	4	O
:	16799052	4	O
a	16799052	4	O
screen	16799052	4	O
of	16799052	4	O
known	16799052	4	O
genes	16799052	4	O
in	16799052	4	O
200	16799052	4	O
families	16799052	4	O
.	16799052	4	O
PURPOSE	16799052	4	O
:	16799052	4	O
To	16799052	4	O
survey	16799052	4	O
families	16799052	4	O
with	16799052	4	O
clinical	16799052	4	O
evidence	16799052	4	O
of	16799052	4	O
autosomal	16799052	4	B-Disease
dominant	16799052	4	I-Disease
retinitis	16799052	4	I-Disease
pigmentosa	16799052	4	I-Disease
(	16799052	4	O
adRP	16799052	4	O
)	16799052	4	O
for	16799052	4	O
mutations	16799052	4	O
in	16799052	4	O
genes	16799052	4	O
known	16799052	4	O
to	16799052	4	O
cause	16799052	4	O
adRP	16799052	4	O
.	16799052	4	O
METHODS	16799052	4	O
:	16799052	4	O
Two	16799052	4	O
hundred	16799052	4	O
adRP	16799052	4	O
families	16799052	4	O
,	16799052	4	O
drawn	16799052	4	O
from	16799052	4	O
a	16799052	4	O
cohort	16799052	4	O
of	16799052	4	O
more	16799052	4	O
than	16799052	4	O
400	16799052	4	O
potential	16799052	4	O
families	16799052	4	O
,	16799052	4	O
were	16799052	4	O
selected	16799052	4	O
by	16799052	4	O
analysis	16799052	4	O
of	16799052	4	O
pedigrees	16799052	4	O
.	16799052	4	O
Minimum	16799052	4	O
criteria	16799052	4	O
for	16799052	4	O
inclusion	16799052	4	O
in	16799052	4	O
the	16799052	4	O
adRP	16799052	4	O
cohort	16799052	4	O
included	16799052	4	O
either	16799052	4	O
evidence	16799052	4	O
of	16799052	4	O
at	16799052	4	O
least	16799052	4	O
three	16799052	4	O
generations	16799052	4	O
of	16799052	4	O
affected	16799052	4	O
individuals	16799052	4	O
or	16799052	4	O
two	16799052	4	O
generations	16799052	4	O
with	16799052	4	O
evidence	16799052	4	O
of	16799052	4	O
male	16799052	4	O
-	16799052	4	O
to	16799052	4	O
-	16799052	4	O
male	16799052	4	O
transmission	16799052	4	O
.	16799052	4	O
Probands	16799052	4	O
from	16799052	4	O
each	16799052	4	O
family	16799052	4	O
were	16799052	4	O
screened	16799052	4	O
for	16799052	4	O
mutations	16799052	4	B-Var
in	16799052	4	O
13	16799052	4	O
genes	16799052	4	O
known	16799052	4	O
to	16799052	4	O
cause	16799052	4	B-Reg
adRP	16799052	4	B-Disease
:	16799052	4	I-Disease
CA4	16799052	4	B-Gene
,	16799052	4	O
CRX	16799052	4	B-Gene
,	16799052	4	O
FSCN2	16799052	4	B-Gene
,	16799052	4	O
IMPDH1	16799052	4	B-Gene
,	16799052	4	O
NRL	16799052	4	B-Gene
,	16799052	4	O
PRPF3	16799052	4	B-Gene
(	16799052	4	O
RP18	16799052	4	O
)	16799052	4	O
,	16799052	4	O
PRPF8	16799052	4	B-Gene
(	16799052	4	O
RP13	16799052	4	O
)	16799052	4	O
,	16799052	4	O
PRPF31	16799052	4	B-Gene
(	16799052	4	O
RP11	16799052	4	O
)	16799052	4	O
,	16799052	4	O
RDS	16799052	4	B-Gene
,	16799052	4	O
RHO	16799052	4	B-Gene
,	16799052	4	O
ROM1	16799052	4	B-Gene
,	16799052	4	O
RP1	16799052	4	B-Gene
,	16799052	4	O
and	16799052	4	O
RP9	16799052	4	B-Gene
.	16799052	4	O
Families	16799052	4	O
without	16799052	4	O
mutations	16799052	4	O
in	16799052	4	O
autosomal	16799052	4	O
genes	16799052	4	O
and	16799052	4	O
in	16799052	4	O
which	16799052	4	O
an	16799052	4	O
X	16799052	4	O
-	16799052	4	O
linked	16799052	4	O
mode	16799052	4	O
of	16799052	4	O
inheritance	16799052	4	O
could	16799052	4	O
not	16799052	4	O
be	16799052	4	O
excluded	16799052	4	O
were	16799052	4	O
tested	16799052	4	O
for	16799052	4	O
mutations	16799052	4	O
in	16799052	4	O
ORF	16799052	4	O
15	16799052	4	O
of	16799052	4	O
X	16799052	4	O
-	16799052	4	O
linked	16799052	4	O
RPGR	16799052	4	O
.	16799052	4	O
Potentially	16799052	4	O
pathogenic	16799052	4	O
variants	16799052	4	O
were	16799052	4	O
evaluated	16799052	4	O
based	16799052	4	O
on	16799052	4	O
a	16799052	4	O
variety	16799052	4	O
of	16799052	4	O
genetic	16799052	4	O
and	16799052	4	O
computational	16799052	4	O
criteria	16799052	4	O
,	16799052	4	O
to	16799052	4	O
confirm	16799052	4	O
or	16799052	4	O
exclude	16799052	4	O
pathogenicity	16799052	4	O
.	16799052	4	O
RESULTS	16799052	4	O
:	16799052	4	O
A	16799052	4	O
total	16799052	4	O
of	16799052	4	O
82	16799052	4	O
distinct	16799052	4	O
,	16799052	4	O
rare	16799052	4	O
(	16799052	4	O
nonpolymorphic	16799052	4	O
)	16799052	4	O
variants	16799052	4	O
were	16799052	4	O
detected	16799052	4	O
among	16799052	4	O
the	16799052	4	O
genes	16799052	4	O
tested	16799052	4	O
.	16799052	4	O
Of	16799052	4	O
these	16799052	4	O
,	16799052	4	O
57	16799052	4	O
are	16799052	4	O
clearly	16799052	4	O
pathogenic	16799052	4	O
based	16799052	4	O
on	16799052	4	O
multiple	16799052	4	O
criteria	16799052	4	O
,	16799052	4	O
10	16799052	4	O
are	16799052	4	O
probably	16799052	4	O
pathogenic	16799052	4	O
,	16799052	4	O
and	16799052	4	O
15	16799052	4	O
are	16799052	4	O
probably	16799052	4	O
benign	16799052	4	O
.	16799052	4	O
In	16799052	4	O
the	16799052	4	O
cohort	16799052	4	O
of	16799052	4	O
200	16799052	4	O
families	16799052	4	O
,	16799052	4	O
94	16799052	4	O
(	16799052	4	O
47%	16799052	4	O
)	16799052	4	O
have	16799052	4	O
one	16799052	4	O
of	16799052	4	O
the	16799052	4	O
clearly	16799052	4	O
pathogenic	16799052	4	O
variants	16799052	4	O
and	16799052	4	O
10	16799052	4	O
(	16799052	4	O
5%	16799052	4	O
)	16799052	4	O
have	16799052	4	O
one	16799052	4	O
of	16799052	4	O
the	16799052	4	O
probably	16799052	4	O
pathogenic	16799052	4	O
variants	16799052	4	O
.	16799052	4	O
One	16799052	4	O
family	16799052	4	O
(	16799052	4	O
0.5%	16799052	4	O
)	16799052	4	O
has	16799052	4	O
digenic	16799052	4	O
RDS	16799052	4	O
-	16799052	4	O
ROM1	16799052	4	O
mutations	16799052	4	O
.	16799052	4	O
Two	16799052	4	O
families	16799052	4	O
(	16799052	4	O
1%	16799052	4	O
)	16799052	4	O
have	16799052	4	O
a	16799052	4	O
pathogenic	16799052	4	O
RPGR	16799052	4	O
mutation	16799052	4	O
,	16799052	4	O
indicating	16799052	4	O
that	16799052	4	O
families	16799052	4	O
with	16799052	4	O
apparent	16799052	4	O
autosomal	16799052	4	O
transmission	16799052	4	O
of	16799052	4	O
RP	16799052	4	O
may	16799052	4	O
actually	16799052	4	O
have	16799052	4	O
X	16799052	4	O
-	16799052	4	O
linked	16799052	4	O
genetic	16799052	4	O
disease	16799052	4	O
.	16799052	4	O
Thus	16799052	4	O
,	16799052	4	O
107	16799052	4	O
families	16799052	4	O
(	16799052	4	O
53.5%	16799052	4	O
)	16799052	4	O
have	16799052	4	O
mutations	16799052	4	O
in	16799052	4	O
known	16799052	4	O
genes	16799052	4	O
,	16799052	4	O
leaving	16799052	4	O
93	16799052	4	O
whose	16799052	4	O
underlying	16799052	4	O
cause	16799052	4	O
is	16799052	4	O
still	16799052	4	O
unknown	16799052	4	O
.	16799052	4	O
CONCLUSIONS	16799052	4	O
:	16799052	4	O
Together	16799052	4	O
,	16799052	4	O
the	16799052	4	O
known	16799052	4	O
adRP	16799052	4	O
genes	16799052	4	O
account	16799052	4	O
for	16799052	4	O
retinal	16799052	4	O
disease	16799052	4	O
in	16799052	4	O
approximately	16799052	4	O
half	16799052	4	O
of	16799052	4	O
the	16799052	4	O
families	16799052	4	O
in	16799052	4	O
this	16799052	4	O
survey	16799052	4	O
,	16799052	4	O
mostly	16799052	4	O
Americans	16799052	4	O
of	16799052	4	O
European	16799052	4	O
origin	16799052	4	O
.	16799052	4	O
Among	16799052	4	O
the	16799052	4	O
adRP	16799052	4	O
genes	16799052	4	O
,	16799052	4	O
IMPDH1	16799052	4	O
,	16799052	4	O
PRPF8	16799052	4	O
,	16799052	4	O
PRPF31	16799052	4	O
,	16799052	4	O
RDS	16799052	4	O
,	16799052	4	O
RHO	16799052	4	O
,	16799052	4	O
and	16799052	4	O
RP1	16799052	4	O
each	16799052	4	O
accounts	16799052	4	O
for	16799052	4	O
more	16799052	4	O
than	16799052	4	O
2%	16799052	4	O
of	16799052	4	O
the	16799052	4	O
total	16799052	4	O
;	16799052	4	O
CRX	16799052	4	O
,	16799052	4	O
PRPF3	16799052	4	O
,	16799052	4	O
and	16799052	4	O
RPGR	16799052	4	O
each	16799052	4	O
accounts	16799052	4	O
for	16799052	4	O
roughly	16799052	4	O
1%	16799052	4	O
.	16799052	4	O
Disease	16799052	4	O
-	16799052	4	O
causing	16799052	4	O
mutations	16799052	4	O
were	16799052	4	O
not	16799052	4	O
found	16799052	4	O
in	16799052	4	O
CA4	16799052	4	O
,	16799052	4	O
FSCN2	16799052	4	O
,	16799052	4	O
NRL	16799052	4	O
,	16799052	4	O
or	16799052	4	O
RP9	16799052	4	O
.	16799052	4	O
Because	16799052	4	O
some	16799052	4	O
mutations	16799052	4	O
are	16799052	4	O
frequent	16799052	4	O
and	16799052	4	O
some	16799052	4	O
regions	16799052	4	O
are	16799052	4	O
more	16799052	4	O
likely	16799052	4	O
to	16799052	4	O
harbor	16799052	4	O
mutations	16799052	4	O
than	16799052	4	O
others	16799052	4	O
,	16799052	4	O
more	16799052	4	O
than	16799052	4	O
two	16799052	4	O
thirds	16799052	4	O
of	16799052	4	O
the	16799052	4	O
detected	16799052	4	O
mutations	16799052	4	O
can	16799052	4	O
be	16799052	4	O
found	16799052	4	O
by	16799052	4	O
screening	16799052	4	O
less	16799052	4	O
than	16799052	4	O
10%	16799052	4	O
of	16799052	4	O
the	16799052	4	O
total	16799052	4	O
gene	16799052	4	O
sequences	16799052	4	O
.	16799052	4	O
Among	16799052	4	O
the	16799052	4	O
remaining	16799052	4	O
families	16799052	4	O
,	16799052	4	O
mutations	16799052	4	O
may	16799052	4	O
lie	16799052	4	O
in	16799052	4	O
regions	16799052	4	O
of	16799052	4	O
known	16799052	4	O
genes	16799052	4	O
that	16799052	4	O
were	16799052	4	O
not	16799052	4	O
tested	16799052	4	O
,	16799052	4	O
mutations	16799052	4	O
may	16799052	4	O
not	16799052	4	O
be	16799052	4	O
detectable	16799052	4	O
by	16799052	4	O
PCR	16799052	4	O
-	16799052	4	O
based	16799052	4	O
sequencing	16799052	4	O
,	16799052	4	O
or	16799052	4	O
other	16799052	4	O
loci	16799052	4	O
may	16799052	4	O
be	16799052	4	O
involved	16799052	4	O
.	16799052	4	O

Clinical	16891820	4	O
and	16891820	4	O
genetic	16891820	4	O
analysis	16891820	4	O
of	16891820	4	O
Korean	16891820	4	O
patients	16891820	4	O
with	16891820	4	O
Miyoshi	16891820	4	O
myopathy	16891820	4	O
:	16891820	4	O
identification	16891820	4	O
of	16891820	4	O
three	16891820	4	O
novel	16891820	4	O
mutations	16891820	4	O
in	16891820	4	O
the	16891820	4	O
DYSF	16891820	4	O
gene	16891820	4	O
.	16891820	4	O
Miyoshi	16891820	4	B-Disease
myopathy	16891820	4	I-Disease
(	16891820	4	O
MM	16891820	4	O
)	16891820	4	O
is	16891820	4	O
an	16891820	4	O
autosomal	16891820	4	O
recessive	16891820	4	O
distal	16891820	4	O
muscular	16891820	4	O
dystrophy	16891820	4	O
caused	16891820	4	B-Reg
by	16891820	4	I-Reg
mutations	16891820	4	B-Var
in	16891820	4	O
the	16891820	4	O
dysferlin	16891820	4	O
gene	16891820	4	O
(	16891820	4	B-Gene
DYSF	16891820	4	I-Gene
)	16891820	4	I-Gene
on	16891820	4	O
chromosome	16891820	4	O
2	16891820	4	O
p13	16891820	4	O
.	16891820	4	O
Although	16891820	4	O
MM	16891820	4	O
patients	16891820	4	O
and	16891820	4	O
their	16891820	4	O
mutations	16891820	4	O
in	16891820	4	O
the	16891820	4	O
DYSF	16891820	4	O
gene	16891820	4	O
have	16891820	4	O
been	16891820	4	O
found	16891820	4	O
from	16891820	4	O
all	16891820	4	O
over	16891820	4	O
the	16891820	4	O
world	16891820	4	O
,	16891820	4	O
there	16891820	4	O
is	16891820	4	O
only	16891820	4	O
one	16891820	4	O
report	16891820	4	O
of	16891820	4	O
genetically	16891820	4	O
confirmed	16891820	4	O
case	16891820	4	O
of	16891820	4	O
MM	16891820	4	O
in	16891820	4	O
Korea	16891820	4	O
.	16891820	4	O
Recently	16891820	4	O
,	16891820	4	O
we	16891820	4	O
encountered	16891820	4	O
three	16891820	4	O
unrelated	16891820	4	O
Korean	16891820	4	O
patients	16891820	4	O
with	16891820	4	O
MM	16891820	4	O
and	16891820	4	O
two	16891820	4	O
of	16891820	4	O
them	16891820	4	O
have	16891820	4	O
previously	16891820	4	O
been	16891820	4	O
considered	16891820	4	O
as	16891820	4	O
having	16891820	4	O
a	16891820	4	O
type	16891820	4	O
of	16891820	4	O
inflammatory	16891820	4	O
myopathy	16891820	4	O
.	16891820	4	O
The	16891820	4	O
clinical	16891820	4	O
and	16891820	4	O
laboratory	16891820	4	O
evaluation	16891820	4	O
showed	16891820	4	O
typical	16891820	4	O
features	16891820	4	O
of	16891820	4	O
muscle	16891820	4	O
involvement	16891820	4	O
in	16891820	4	O
MM	16891820	4	O
in	16891820	4	O
all	16891820	4	O
patients	16891820	4	O
but	16891820	4	O
one	16891820	4	O
patient	16891820	4	O
initially	16891820	4	O
had	16891820	4	O
moderate	16891820	4	O
proximal	16891820	4	O
muscle	16891820	4	O
involvement	16891820	4	O
and	16891820	4	O
another	16891820	4	O
showed	16891820	4	O
incomplete	16891820	4	O
quadriparesis	16891820	4	O
with	16891820	4	O
rapid	16891820	4	O
progression	16891820	4	O
.	16891820	4	O
Direct	16891820	4	O
sequencing	16891820	4	O
analysis	16891820	4	O
of	16891820	4	O
the	16891820	4	O
DYSF	16891820	4	O
gene	16891820	4	O
revealed	16891820	4	O
that	16891820	4	O
each	16891820	4	O
patient	16891820	4	O
had	16891820	4	O
compound	16891820	4	O
heterozygous	16891820	4	O
mutations	16891820	4	O
(	16891820	4	O
Gln832X	16891820	4	O
and	16891820	4	O
Trp992Arg	16891820	4	O
,	16891820	4	O
Gln832X	16891820	4	O
and	16891820	4	O
Trp999Cys	16891820	4	O
,	16891820	4	O
and	16891820	4	O
Lys1103X	16891820	4	O
and	16891820	4	O
Ile1401HisfsX8	16891820	4	O
,	16891820	4	O
respectively	16891820	4	O
)	16891820	4	O
among	16891820	4	O
which	16891820	4	O
three	16891820	4	O
were	16891820	4	O
novel	16891820	4	O
.	16891820	4	O
Although	16891820	4	O
MM	16891820	4	O
has	16891820	4	O
been	16891820	4	O
thought	16891820	4	O
to	16891820	4	O
be	16891820	4	O
quite	16891820	4	O
rare	16891820	4	O
in	16891820	4	O
Korea	16891820	4	O
,	16891820	4	O
it	16891820	4	O
should	16891820	4	O
be	16891820	4	O
considered	16891820	4	O
in	16891820	4	O
a	16891820	4	O
differential	16891820	4	O
diagnosis	16891820	4	O
of	16891820	4	O
patients	16891820	4	O
exhibiting	16891820	4	O
distal	16891820	4	O
myopathy	16891820	4	O
.	16891820	4	O

UBE2A	16909393	4	B-Gene
,	16909393	4	O
which	16909393	4	O
encodes	16909393	4	O
a	16909393	4	O
ubiquitin	16909393	4	O
-	16909393	4	O
conjugating	16909393	4	O
enzyme	16909393	4	O
,	16909393	4	O
is	16909393	4	O
mutated	16909393	4	B-Var
in	16909393	4	B-Reg
a	16909393	4	O
novel	16909393	4	O
X	16909393	4	B-Disease
-	16909393	4	I-Disease
linked	16909393	4	I-Disease
mental	16909393	4	I-Disease
retardation	16909393	4	I-Disease
syndrome	16909393	4	I-Disease
.	16909393	4	O
We	16909393	4	O
report	16909393	4	O
a	16909393	4	O
mutation	16909393	4	B-Var
of	16909393	4	O
UBE2A	16909393	4	B-Gene
/	16909393	4	I-Gene
HR6A	16909393	4	I-Gene
,	16909393	4	O
which	16909393	4	O
encodes	16909393	4	O
a	16909393	4	O
ubiquitin	16909393	4	O
-	16909393	4	O
conjugating	16909393	4	O
enzyme	16909393	4	O
(	16909393	4	O
E2	16909393	4	O
)	16909393	4	O
,	16909393	4	O
a	16909393	4	O
member	16909393	4	O
of	16909393	4	O
the	16909393	4	O
ubiquitin	16909393	4	O
proteasome	16909393	4	O
pathway	16909393	4	O
,	16909393	4	O
as	16909393	4	O
the	16909393	4	O
cause	16909393	4	B-Reg
of	16909393	4	O
a	16909393	4	O
novel	16909393	4	O
X	16909393	4	B-Disease
-	16909393	4	I-Disease
linked	16909393	4	I-Disease
mental	16909393	4	I-Disease
retardation	16909393	4	I-Disease
(	16909393	4	I-Disease
XLMR	16909393	4	I-Disease
)	16909393	4	I-Disease
syndrome	16909393	4	I-Disease
that	16909393	4	O
affects	16909393	4	O
three	16909393	4	O
males	16909393	4	O
in	16909393	4	O
a	16909393	4	O
two	16909393	4	O
-	16909393	4	O
generation	16909393	4	O
family	16909393	4	O
.	16909393	4	O
A	16909393	4	O
single	16909393	4	O
-	16909393	4	O
nucleotide	16909393	4	O
substitution	16909393	4	O
,	16909393	4	O
c.382	16909393	4	B-Var
C	16909393	4	I-Var
-	16909393	4	I-Var
-	16909393	4	I-Var
>	16909393	4	I-Var
T	16909393	4	I-Var
in	16909393	4	O
UBE2A	16909393	4	B-Gene
,	16909393	4	O
led	16909393	4	B-Reg
to	16909393	4	I-Reg
a	16909393	4	O
premature	16909393	4	O
UAG	16909393	4	O
stop	16909393	4	O
codon	16909393	4	O
(	16909393	4	B-Var
Q128X	16909393	4	I-Var
)	16909393	4	I-Var
.	16909393	4	O
As	16909393	4	O
a	16909393	4	O
consequence	16909393	4	O
,	16909393	4	O
the	16909393	4	O
predicted	16909393	4	O
polypeptide	16909393	4	O
lacks	16909393	4	O
the	16909393	4	O
25	16909393	4	O
C	16909393	4	O
-	16909393	4	O
terminal	16909393	4	O
amino	16909393	4	O
acid	16909393	4	O
residues	16909393	4	O
.	16909393	4	O
The	16909393	4	O
importance	16909393	4	O
of	16909393	4	O
this	16909393	4	O
terminal	16909393	4	O
sequence	16909393	4	O
for	16909393	4	O
UBE2	16909393	4	O
function	16909393	4	O
is	16909393	4	O
inferred	16909393	4	O
by	16909393	4	O
its	16909393	4	O
conservation	16909393	4	O
in	16909393	4	O
vertebrates	16909393	4	O
and	16909393	4	O
in	16909393	4	O
Drosophila	16909393	4	O
.	16909393	4	O
UBE2A	16909393	4	O
mutations	16909393	4	O
do	16909393	4	O
not	16909393	4	O
appear	16909393	4	O
to	16909393	4	O
significantly	16909393	4	O
contribute	16909393	4	O
to	16909393	4	O
XLMR	16909393	4	O
,	16909393	4	O
since	16909393	4	O
no	16909393	4	O
UBE2A	16909393	4	O
mutations	16909393	4	O
were	16909393	4	O
identified	16909393	4	O
in	16909393	4	O
15	16909393	4	O
families	16909393	4	O
with	16909393	4	O
nonsyndromic	16909393	4	O
and	16909393	4	O
4	16909393	4	O
families	16909393	4	O
with	16909393	4	O
syndromic	16909393	4	O
idiopathic	16909393	4	O
XLMR	16909393	4	O
previously	16909393	4	O
mapped	16909393	4	O
to	16909393	4	O
intervals	16909393	4	O
encompassing	16909393	4	O
this	16909393	4	O
gene	16909393	4	O
.	16909393	4	O
This	16909393	4	O
is	16909393	4	O
the	16909393	4	O
first	16909393	4	O
description	16909393	4	O
of	16909393	4	O
a	16909393	4	O
mutation	16909393	4	O
in	16909393	4	O
a	16909393	4	O
ubiquitin	16909393	4	O
-	16909393	4	O
conjugating	16909393	4	O
enzyme	16909393	4	O
gene	16909393	4	O
as	16909393	4	O
the	16909393	4	O
cause	16909393	4	O
of	16909393	4	O
a	16909393	4	O
human	16909393	4	O
disease	16909393	4	O
.	16909393	4	O

Twenty	16941474	1	O
-	16941474	1	O
one	16941474	1	O
novel	16941474	1	O
mutations	16941474	1	B-Var
in	16941474	1	O
the	16941474	1	O
GLB1	16941474	1	B-Gene
gene	16941474	1	O
identified	16941474	1	O
in	16941474	1	B-Reg
a	16941474	1	O
large	16941474	1	O
group	16941474	1	O
of	16941474	1	O
GM1	16941474	1	B-Disease
-	16941474	1	I-Disease
gangliosidosis	16941474	1	I-Disease
and	16941474	1	O
Morquio	16941474	1	B-Disease
B	16941474	1	I-Disease
patients	16941474	1	O
:	16941474	1	O
possible	16941474	1	O
common	16941474	1	O
origin	16941474	1	O
for	16941474	1	O
the	16941474	1	O
prevalent	16941474	1	O
p.R59H	16941474	1	O
mutation	16941474	1	O
among	16941474	1	O
gypsies	16941474	1	O
.	16941474	1	O
GM1	16941474	1	B-Disease
-	16941474	1	I-Disease
gangliosidosis	16941474	1	I-Disease
and	16941474	1	O
Morquio	16941474	1	B-Disease
B	16941474	1	I-Disease
disease	16941474	1	O
are	16941474	1	O
rare	16941474	1	O
lysosomal	16941474	1	O
storage	16941474	1	O
disorders	16941474	1	O
caused	16941474	1	B-Reg
by	16941474	1	I-Reg
beta	16941474	1	O
-	16941474	1	O
galactosidase	16941474	1	O
deficiency	16941474	1	B-NegReg
due	16941474	1	O
to	16941474	1	O
mutations	16941474	1	B-Var
in	16941474	1	O
the	16941474	1	O
GLB1	16941474	1	B-Gene
gene	16941474	1	O
.	16941474	1	O
Three	16941474	1	O
major	16941474	1	O
clinical	16941474	1	O
forms	16941474	1	O
of	16941474	1	O
GM1	16941474	1	O
-	16941474	1	O
gangliosidosis	16941474	1	O
have	16941474	1	O
been	16941474	1	O
established	16941474	1	O
on	16941474	1	O
the	16941474	1	O
basis	16941474	1	O
of	16941474	1	O
age	16941474	1	O
of	16941474	1	O
onset	16941474	1	O
and	16941474	1	O
severity	16941474	1	O
of	16941474	1	O
symptoms	16941474	1	O
:	16941474	1	O
infantile	16941474	1	O
,	16941474	1	O
late	16941474	1	O
infantile	16941474	1	O
/	16941474	1	O
juvenile	16941474	1	O
,	16941474	1	O
and	16941474	1	O
adult	16941474	1	O
.	16941474	1	O
We	16941474	1	O
performed	16941474	1	O
mutation	16941474	1	O
analysis	16941474	1	O
on	16941474	1	O
30	16941474	1	O
GM1	16941474	1	O
-	16941474	1	O
gangliosidosis	16941474	1	O
and	16941474	1	O
five	16941474	1	O
Morquio	16941474	1	O
B	16941474	1	O
patients	16941474	1	O
,	16941474	1	O
mainly	16941474	1	O
of	16941474	1	O
Spanish	16941474	1	O
origin	16941474	1	O
,	16941474	1	O
and	16941474	1	O
all	16941474	1	O
the	16941474	1	O
causative	16941474	1	O
mutations	16941474	1	O
were	16941474	1	O
identified	16941474	1	O
.	16941474	1	O
Thirty	16941474	1	O
different	16941474	1	O
mutations	16941474	1	O
were	16941474	1	O
found	16941474	1	O
,	16941474	1	O
21	16941474	1	O
of	16941474	1	O
which	16941474	1	O
were	16941474	1	O
novel	16941474	1	O
.	16941474	1	O
With	16941474	1	O
the	16941474	1	O
exception	16941474	1	O
of	16941474	1	O
two	16941474	1	O
adults	16941474	1	O
and	16941474	1	O
one	16941474	1	O
juvenile	16941474	1	O
patient	16941474	1	O
,	16941474	1	O
all	16941474	1	O
the	16941474	1	O
GM1	16941474	1	O
-	16941474	1	O
gangliosidosis	16941474	1	O
patients	16941474	1	O
were	16941474	1	O
affected	16941474	1	O
by	16941474	1	O
the	16941474	1	O
infantile	16941474	1	O
form	16941474	1	O
.	16941474	1	O
Clinical	16941474	1	O
findings	16941474	1	O
are	16941474	1	O
presented	16941474	1	O
for	16941474	1	O
all	16941474	1	O
patients	16941474	1	O
.	16941474	1	O
We	16941474	1	O
report	16941474	1	O
the	16941474	1	O
association	16941474	1	O
of	16941474	1	O
the	16941474	1	O
novel	16941474	1	O
mutations	16941474	1	O
p.T420K	16941474	1	O
and	16941474	1	O
p.L264S	16941474	1	O
with	16941474	1	O
the	16941474	1	O
adult	16941474	1	O
form	16941474	1	O
and	16941474	1	O
the	16941474	1	O
juvenile	16941474	1	O
form	16941474	1	O
,	16941474	1	O
respectively	16941474	1	O
.	16941474	1	O
In	16941474	1	O
addition	16941474	1	O
,	16941474	1	O
the	16941474	1	O
novel	16941474	1	O
mutation	16941474	1	O
p.Y83C	16941474	1	B-Var
was	16941474	1	O
associated	16941474	1	B-Reg
with	16941474	1	I-Reg
Morquio	16941474	1	B-Disease
B	16941474	1	I-Disease
disease	16941474	1	O
.	16941474	1	O
Among	16941474	1	O
the	16941474	1	O
30	16941474	1	O
GM1	16941474	1	O
-	16941474	1	O
gangliosidosis	16941474	1	O
patients	16941474	1	O
,	16941474	1	O
6	16941474	1	O
were	16941474	1	O
of	16941474	1	O
Gypsy	16941474	1	O
origin	16941474	1	O
(	16941474	1	O
Roma	16941474	1	O
)	16941474	1	O
.	16941474	1	O
Moreover	16941474	1	O
,	16941474	1	O
those	16941474	1	O
six	16941474	1	O
Gypsy	16941474	1	O
patients	16941474	1	O
shared	16941474	1	O
not	16941474	1	O
only	16941474	1	O
the	16941474	1	O
same	16941474	1	O
mutation	16941474	1	O
(	16941474	1	O
p.R59H	16941474	1	O
)	16941474	1	O
but	16941474	1	O
also	16941474	1	O
a	16941474	1	O
common	16941474	1	O
haplotype	16941474	1	O
.	16941474	1	O
This	16941474	1	O
observation	16941474	1	O
indicates	16941474	1	O
a	16941474	1	O
possible	16941474	1	O
founder	16941474	1	O
effect	16941474	1	O
in	16941474	1	O
this	16941474	1	O
group	16941474	1	O
and	16941474	1	O
suggests	16941474	1	O
that	16941474	1	O
screening	16941474	1	O
of	16941474	1	O
the	16941474	1	O
p.R59H	16941474	1	O
mutation	16941474	1	O
may	16941474	1	O
be	16941474	1	O
appropriate	16941474	1	O
in	16941474	1	O
GM1	16941474	1	O
-	16941474	1	O
gangliosidosis	16941474	1	O
patients	16941474	1	O
of	16941474	1	O
Gypsy	16941474	1	O
origin	16941474	1	O
.	16941474	1	O
This	16941474	1	O
is	16941474	1	O
the	16941474	1	O
first	16941474	1	O
exhaustive	16941474	1	O
mutational	16941474	1	O
analysis	16941474	1	O
performed	16941474	1	O
in	16941474	1	O
a	16941474	1	O
large	16941474	1	O
group	16941474	1	O
of	16941474	1	O
Iberian	16941474	1	O
GM1	16941474	1	O
-	16941474	1	O
gangliosidosis	16941474	1	O
and	16941474	1	O
Morquio	16941474	1	O
B	16941474	1	O
patients	16941474	1	O
.	16941474	1	O

Misregulation	17076268	2	O
of	17076268	2	O
alternative	17076268	2	O
splicing	17076268	2	O
causes	17076268	2	O
pathogenesis	17076268	2	O
in	17076268	2	O
myotonic	17076268	2	O
dystrophy	17076268	2	O
.	17076268	2	O
Myotonic	17076268	2	B-Disease
dystrophy	17076268	2	I-Disease
(	17076268	2	O
DM	17076268	2	O
)	17076268	2	O
,	17076268	2	O
the	17076268	2	O
most	17076268	2	O
common	17076268	2	O
form	17076268	2	O
of	17076268	2	O
adult	17076268	2	O
onset	17076268	2	O
muscular	17076268	2	O
dystrophy	17076268	2	O
,	17076268	2	O
affects	17076268	2	O
skeletal	17076268	2	O
muscle	17076268	2	O
,	17076268	2	O
heart	17076268	2	O
,	17076268	2	O
and	17076268	2	O
the	17076268	2	O
central	17076268	2	O
nervous	17076268	2	O
system	17076268	2	O
(	17076268	2	O
CNS	17076268	2	O
)	17076268	2	O
.	17076268	2	O
Mortality	17076268	2	O
results	17076268	2	O
primarily	17076268	2	O
from	17076268	2	O
muscle	17076268	2	O
wasting	17076268	2	O
and	17076268	2	O
cardiac	17076268	2	O
arrhythmias	17076268	2	O
.	17076268	2	O
There	17076268	2	O
are	17076268	2	O
two	17076268	2	O
forms	17076268	2	O
of	17076268	2	O
the	17076268	2	O
disease	17076268	2	O
:	17076268	2	O
DM1	17076268	2	O
and	17076268	2	O
DM2	17076268	2	O
.	17076268	2	O
DM1	17076268	2	O
,	17076268	2	O
which	17076268	2	O
constitutes	17076268	2	O
98%	17076268	2	O
of	17076268	2	O
cases	17076268	2	O
,	17076268	2	O
is	17076268	2	O
caused	17076268	2	O
by	17076268	2	O
a	17076268	2	O
CTG	17076268	2	O
expansion	17076268	2	O
in	17076268	2	O
the	17076268	2	O
3	17076268	2	O
'	17076268	2	O
untranslated	17076268	2	O
region	17076268	2	O
(	17076268	2	O
UTR	17076268	2	O
)	17076268	2	O
of	17076268	2	O
the	17076268	2	O
DMPK	17076268	2	O
gene	17076268	2	O
.	17076268	2	O
DM2	17076268	2	B-Disease
is	17076268	2	O
caused	17076268	2	B-Reg
by	17076268	2	I-Reg
a	17076268	2	O
CCTG	17076268	2	B-Var
expansion	17076268	2	I-Var
in	17076268	2	O
the	17076268	2	O
first	17076268	2	O
intron	17076268	2	O
of	17076268	2	O
the	17076268	2	O
ZNF9	17076268	2	B-Gene
gene	17076268	2	O
.	17076268	2	O
RNA	17076268	2	O
containing	17076268	2	O
CUG	17076268	2	O
-	17076268	2	O
or	17076268	2	O
CCUG	17076268	2	O
-	17076268	2	O
expanded	17076268	2	O
repeats	17076268	2	O
are	17076268	2	O
transcribed	17076268	2	O
but	17076268	2	O
are	17076268	2	O
retained	17076268	2	O
in	17076268	2	O
the	17076268	2	O
nucleus	17076268	2	O
in	17076268	2	O
foci	17076268	2	O
.	17076268	2	O
Disease	17076268	2	O
pathogenesis	17076268	2	O
results	17076268	2	O
primarily	17076268	2	O
from	17076268	2	O
a	17076268	2	O
gain	17076268	2	B-PosReg
of	17076268	2	I-PosReg
function	17076268	2	I-PosReg
of	17076268	2	O
the	17076268	2	O
expanded	17076268	2	O
RNAs	17076268	2	O
,	17076268	2	O
which	17076268	2	O
alter	17076268	2	B-Reg
developmentally	17076268	2	O
regulated	17076268	2	O
alternative	17076268	2	O
splicing	17076268	2	O
as	17076268	2	O
well	17076268	2	O
as	17076268	2	O
pathways	17076268	2	O
of	17076268	2	O
muscle	17076268	2	O
differentiation	17076268	2	O
.	17076268	2	O
The	17076268	2	O
toxic	17076268	2	O
RNA	17076268	2	O
has	17076268	2	O
been	17076268	2	O
implicated	17076268	2	O
in	17076268	2	O
sequestration	17076268	2	O
of	17076268	2	O
splicing	17076268	2	O
regulators	17076268	2	O
and	17076268	2	O
transcription	17076268	2	O
factors	17076268	2	O
thereby	17076268	2	O
causing	17076268	2	O
specific	17076268	2	O
symptoms	17076268	2	O
of	17076268	2	O
the	17076268	2	O
disease	17076268	2	O
.	17076268	2	O
Here	17076268	2	O
we	17076268	2	O
review	17076268	2	O
the	17076268	2	O
proposed	17076268	2	O
mechanisms	17076268	2	O
for	17076268	2	O
the	17076268	2	O
toxic	17076268	2	O
effects	17076268	2	O
of	17076268	2	O
the	17076268	2	O
expanded	17076268	2	O
repeats	17076268	2	O
and	17076268	2	O
discuss	17076268	2	O
the	17076268	2	O
molecular	17076268	2	O
mechanisms	17076268	2	O
of	17076268	2	O
splicing	17076268	2	O
misregulation	17076268	2	O
and	17076268	2	O
disease	17076268	2	O
pathogenesis	17076268	2	O
.	17076268	2	O

Clinical	17111025	1	O
aspects	17111025	1	O
and	17111025	1	O
physiopathology	17111025	1	O
of	17111025	1	O
Brugada	17111025	1	O
syndrome	17111025	1	O
:	17111025	1	O
review	17111025	1	O
of	17111025	1	O
current	17111025	1	O
concepts	17111025	1	O
.	17111025	1	O
Brugada	17111025	1	B-Disease
syndrome	17111025	1	I-Disease
(	17111025	1	O
BS	17111025	1	O
)	17111025	1	O
is	17111025	1	O
an	17111025	1	O
inherited	17111025	1	O
cardiac	17111025	1	O
disorder	17111025	1	O
characterized	17111025	1	O
by	17111025	1	O
typical	17111025	1	O
electrocardiographic	17111025	1	O
patterns	17111025	1	O
of	17111025	1	O
ST	17111025	1	O
segment	17111025	1	O
elevation	17111025	1	O
in	17111025	1	O
the	17111025	1	O
precordial	17111025	1	O
leads	17111025	1	O
,	17111025	1	O
right	17111025	1	O
bundle	17111025	1	O
branch	17111025	1	O
block	17111025	1	O
,	17111025	1	O
fast	17111025	1	O
polymorphic	17111025	1	O
ventricular	17111025	1	O
tachycardia	17111025	1	O
in	17111025	1	O
patients	17111025	1	O
without	17111025	1	O
any	17111025	1	O
structural	17111025	1	O
heart	17111025	1	O
disease	17111025	1	O
,	17111025	1	O
and	17111025	1	O
a	17111025	1	O
high	17111025	1	O
risk	17111025	1	O
of	17111025	1	O
sudden	17111025	1	O
cardiac	17111025	1	O
death	17111025	1	O
.	17111025	1	O
The	17111025	1	O
incidence	17111025	1	O
of	17111025	1	O
BS	17111025	1	O
is	17111025	1	O
high	17111025	1	O
in	17111025	1	O
male	17111025	1	O
vs	17111025	1	O
.	17111025	1	O
female	17111025	1	O
(	17111025	1	O
i.e.	17111025	1	O
,	17111025	1	O
8	17111025	1	O
-	17111025	1	O
10	17111025	1	O
/	17111025	1	O
1	17111025	1	O
:	17111025	1	O
male	17111025	1	O
/	17111025	1	O
female	17111025	1	O
)	17111025	1	O
.	17111025	1	O
The	17111025	1	O
disorder	17111025	1	O
is	17111025	1	O
caused	17111025	1	O
by	17111025	1	O
mutations	17111025	1	O
in	17111025	1	O
the	17111025	1	O
SCN5A	17111025	1	O
gene	17111025	1	O
encoding	17111025	1	O
Nav1.5	17111025	1	O
,	17111025	1	O
the	17111025	1	O
cardiac	17111025	1	O
sodium	17111025	1	O
channel	17111025	1	O
,	17111025	1	O
which	17111025	1	O
is	17111025	1	O
the	17111025	1	O
only	17111025	1	O
gene	17111025	1	O
in	17111025	1	O
which	17111025	1	O
mutations	17111025	1	O
were	17111025	1	O
found	17111025	1	O
to	17111025	1	O
cause	17111025	1	O
the	17111025	1	O
disease	17111025	1	O
.	17111025	1	O
Mutations	17111025	1	B-Var
in	17111025	1	O
SCN5A	17111025	1	B-Gene
associated	17111025	1	O
with	17111025	1	O
the	17111025	1	O
BS	17111025	1	B-Disease
phenotype	17111025	1	O
usually	17111025	1	O
result	17111025	1	O
in	17111025	1	O
a	17111025	1	O
loss	17111025	1	B-NegReg
of	17111025	1	O
channel	17111025	1	O
function	17111025	1	O
by	17111025	1	O
a	17111025	1	O
reduction	17111025	1	B-NegReg
in	17111025	1	O
Na	17111025	1	O
currents	17111025	1	O
.	17111025	1	O
We	17111025	1	O
review	17111025	1	O
the	17111025	1	O
clinical	17111025	1	O
aspects	17111025	1	O
,	17111025	1	O
risk	17111025	1	O
stratification	17111025	1	O
,	17111025	1	O
and	17111025	1	O
therapeutic	17111025	1	O
management	17111025	1	O
of	17111025	1	O
this	17111025	1	O
important	17111025	1	O
syndrome	17111025	1	O
.	17111025	1	O

[	17277857	4	O
McLeod	17277857	4	O
syndrome	17277857	4	O
:	17277857	4	O
Multisystem	17277857	4	O
involvement	17277857	4	O
associated	17277857	4	O
with	17277857	4	O
neuroacanthocytosis	17277857	4	O
linked	17277857	4	O
to	17277857	4	O
X	17277857	4	O
chromosome	17277857	4	O
.	17277857	4	O
report	17277857	4	O
of	17277857	4	O
two	17277857	4	O
related	17277857	4	O
cases	17277857	4	O
]	17277857	4	O
.	17277857	4	O
Síndrome	17277857	4	O
de	17277857	4	O
McLeod	17277857	4	O
:	17277857	4	O
compromiso	17277857	4	O
multisistémico	17277857	4	O
asociado	17277857	4	O
a	17277857	4	O
neuroacantocitosis	17277857	4	O
ligada	17277857	4	O
al	17277857	4	O
cromosoma	17277857	4	O
X	17277857	4	O
,	17277857	4	O
en	17277857	4	O
una	17277857	4	O
familia	17277857	4	O
chilena	17277857	4	O
.	17277857	4	O
Neurological	17277857	4	O
abnormalities	17277857	4	O
associated	17277857	4	O
with	17277857	4	O
spiculated	17277857	4	O
,	17277857	4	O
"	17277857	4	O
acanthocytic	17277857	4	O
"	17277857	4	O
red	17277857	4	O
cells	17277857	4	O
in	17277857	4	O
blood	17277857	4	O
have	17277857	4	O
been	17277857	4	O
described	17277857	4	O
as	17277857	4	O
neuroacanthocytosis	17277857	4	O
.	17277857	4	O
This	17277857	4	O
is	17277857	4	O
a	17277857	4	O
heterogeneous	17277857	4	O
group	17277857	4	O
of	17277857	4	O
conditions	17277857	4	O
that	17277857	4	O
can	17277857	4	O
be	17277857	4	O
clearly	17277857	4	O
subdivided	17277857	4	O
on	17277857	4	O
the	17277857	4	O
basis	17277857	4	O
of	17277857	4	O
recent	17277857	4	O
genetic	17277857	4	O
findings	17277857	4	O
.	17277857	4	O
The	17277857	4	O
McLeod	17277857	4	B-Disease
Syndrome	17277857	4	I-Disease
,	17277857	4	O
one	17277857	4	O
of	17277857	4	O
the	17277857	4	O
core	17277857	4	O
neuroacanthocytosis	17277857	4	B-Disease
syndromes	17277857	4	I-Disease
,	17277857	4	O
is	17277857	4	O
a	17277857	4	O
rare	17277857	4	O
X	17277857	4	O
-	17277857	4	O
linked	17277857	4	O
disorder	17277857	4	O
caused	17277857	4	B-Reg
by	17277857	4	I-Reg
mutations	17277857	4	B-Var
of	17277857	4	O
the	17277857	4	O
XK	17277857	4	B-Gene
gene	17277857	4	O
,	17277857	4	O
an	17277857	4	O
X	17277857	4	O
-	17277857	4	O
chromosomal	17277857	4	O
gene	17277857	4	O
of	17277857	4	O
unknown	17277857	4	O
function	17277857	4	O
characterized	17277857	4	O
by	17277857	4	O
haemopoietic	17277857	4	O
abnormalities	17277857	4	O
and	17277857	4	O
late	17277857	4	O
-	17277857	4	O
onset	17277857	4	O
neurological	17277857	4	O
and	17277857	4	O
muscular	17277857	4	O
defects	17277857	4	O
.	17277857	4	O
We	17277857	4	O
report	17277857	4	O
two	17277857	4	O
Chilean	17277857	4	O
brothers	17277857	4	O
with	17277857	4	O
the	17277857	4	O
McLeod	17277857	4	O
phenotype	17277857	4	O
who	17277857	4	O
showed	17277857	4	O
important	17277857	4	O
psychiatric	17277857	4	O
features	17277857	4	O
.	17277857	4	O
The	17277857	4	O
diagnosis	17277857	4	O
may	17277857	4	O
be	17277857	4	O
elusive	17277857	4	O
if	17277857	4	O
the	17277857	4	O
presence	17277857	4	O
of	17277857	4	O
acanthocytosis	17277857	4	O
is	17277857	4	O
not	17277857	4	O
properly	17277857	4	O
studied	17277857	4	O
.	17277857	4	O
We	17277857	4	O
describe	17277857	4	O
a	17277857	4	O
method	17277857	4	O
which	17277857	4	O
allowed	17277857	4	O
the	17277857	4	O
diagnosis	17277857	4	O
that	17277857	4	O
unmasked	17277857	4	O
acanthocytosis	17277857	4	O
.	17277857	4	O
Otherwise	17277857	4	O
the	17277857	4	O
condition	17277857	4	O
could	17277857	4	O
have	17277857	4	O
remained	17277857	4	O
undiagnosed	17277857	4	O
as	17277857	4	O
it	17277857	4	O
had	17277857	4	O
been	17277857	4	O
for	17277857	4	O
decades	17277857	4	O
in	17277857	4	O
this	17277857	4	O
family	17277857	4	O
.	17277857	4	O
This	17277857	4	O
syndrome	17277857	4	O
must	17277857	4	O
be	17277857	4	O
considered	17277857	4	O
when	17277857	4	O
assessing	17277857	4	O
a	17277857	4	O
familial	17277857	4	O
movement	17277857	4	O
disorder	17277857	4	O
,	17277857	4	O
specially	17277857	4	O
affecting	17277857	4	O
males	17277857	4	O
with	17277857	4	O
relevant	17277857	4	O
psychiatric	17277857	4	O
features	17277857	4	O
.	17277857	4	O
A	17277857	4	O
reliable	17277857	4	O
test	17277857	4	O
for	17277857	4	O
acanthocytosis	17277857	4	O
assessment	17277857	4	O
is	17277857	4	O
available	17277857	4	O
.	17277857	4	O

A	17347989	4	O
new	17347989	4	O
variant	17347989	4	O
database	17347989	4	O
for	17347989	4	O
mismatch	17347989	4	O
repair	17347989	4	O
genes	17347989	4	O
associated	17347989	4	O
with	17347989	4	O
Lynch	17347989	4	O
syndrome	17347989	4	O
.	17347989	4	O
Mutations	17347989	4	B-Var
in	17347989	4	O
some	17347989	4	O
mismatch	17347989	4	O
repair	17347989	4	O
(	17347989	4	B-Gene
MMR	17347989	4	I-Gene
)	17347989	4	I-Gene
genes	17347989	4	O
are	17347989	4	O
associated	17347989	4	B-Reg
with	17347989	4	I-Reg
Lynch	17347989	4	B-Disease
syndrome	17347989	4	I-Disease
(	17347989	4	O
LS	17347989	4	O
;	17347989	4	O
also	17347989	4	O
called	17347989	4	O
hereditary	17347989	4	O
nonpolyposis	17347989	4	O
colorectal	17347989	4	O
cancer	17347989	4	O
[	17347989	4	O
HNPCC	17347989	4	O
]	17347989	4	O
)	17347989	4	O
,	17347989	4	O
an	17347989	4	O
autosomal	17347989	4	O
dominant	17347989	4	O
cancer	17347989	4	O
susceptibility	17347989	4	O
syndrome	17347989	4	O
.	17347989	4	O
Colorectal	17347989	4	O
cancer	17347989	4	O
(	17347989	4	O
CRC	17347989	4	O
)	17347989	4	O
is	17347989	4	O
the	17347989	4	O
most	17347989	4	O
frequent	17347989	4	O
cancer	17347989	4	O
observed	17347989	4	O
in	17347989	4	O
LS	17347989	4	O
.	17347989	4	O
However	17347989	4	O
,	17347989	4	O
tumors	17347989	4	O
occur	17347989	4	O
at	17347989	4	O
a	17347989	4	O
variety	17347989	4	O
of	17347989	4	O
extracolonic	17347989	4	O
sites	17347989	4	O
and	17347989	4	O
individuals	17347989	4	O
may	17347989	4	O
have	17347989	4	O
multiple	17347989	4	O
primary	17347989	4	O
cancers	17347989	4	O
.	17347989	4	O
LS	17347989	4	O
is	17347989	4	O
the	17347989	4	O
most	17347989	4	O
common	17347989	4	O
hereditary	17347989	4	O
form	17347989	4	O
of	17347989	4	O
CRC	17347989	4	O
,	17347989	4	O
accounting	17347989	4	O
for	17347989	4	O
approximately	17347989	4	O
1%	17347989	4	O
of	17347989	4	O
all	17347989	4	O
CRC	17347989	4	O
.	17347989	4	O
Since	17347989	4	O
the	17347989	4	O
first	17347989	4	O
account	17347989	4	O
of	17347989	4	O
mutations	17347989	4	B-Var
in	17347989	4	O
MSH2	17347989	4	B-Gene
causing	17347989	4	B-Reg
this	17347989	4	O
cancer	17347989	4	B-Disease
susceptibility	17347989	4	O
syndrome	17347989	4	O
in	17347989	4	O
1993	17347989	4	O
,	17347989	4	O
mutations	17347989	4	B-Var
in	17347989	4	O
three	17347989	4	O
additional	17347989	4	O
MMR	17347989	4	O
genes	17347989	4	O
,	17347989	4	O
MLH1	17347989	4	B-Gene
,	17347989	4	O
MSH6	17347989	4	B-Gene
,	17347989	4	O
and	17347989	4	O
PMS2	17347989	4	B-Gene
,	17347989	4	O
have	17347989	4	O
been	17347989	4	O
shown	17347989	4	O
to	17347989	4	O
cause	17347989	4	B-Reg
LS	17347989	4	B-Disease
.	17347989	4	O
More	17347989	4	O
than	17347989	4	O
1	17347989	4	O
,	17347989	4	O
500	17347989	4	O
different	17347989	4	O
variants	17347989	4	O
have	17347989	4	O
been	17347989	4	O
identified	17347989	4	O
in	17347989	4	O
these	17347989	4	O
four	17347989	4	O
genes	17347989	4	O
and	17347989	4	O
approximately	17347989	4	O
80%	17347989	4	O
of	17347989	4	O
the	17347989	4	O
alterations	17347989	4	O
have	17347989	4	O
been	17347989	4	O
identified	17347989	4	O
in	17347989	4	O
MLH1	17347989	4	O
and	17347989	4	O
MSH2	17347989	4	O
.	17347989	4	O
There	17347989	4	O
have	17347989	4	O
been	17347989	4	O
a	17347989	4	O
few	17347989	4	O
previous	17347989	4	O
attempts	17347989	4	O
to	17347989	4	O
systematically	17347989	4	O
record	17347989	4	O
MMR	17347989	4	O
variants	17347989	4	O
associated	17347989	4	O
with	17347989	4	O
LS	17347989	4	O
patients	17347989	4	O
;	17347989	4	O
however	17347989	4	O
,	17347989	4	O
they	17347989	4	O
were	17347989	4	O
not	17347989	4	O
complete	17347989	4	O
nor	17347989	4	O
were	17347989	4	O
they	17347989	4	O
continuously	17347989	4	O
updated	17347989	4	O
.	17347989	4	O
Thus	17347989	4	O
,	17347989	4	O
it	17347989	4	O
was	17347989	4	O
our	17347989	4	O
goal	17347989	4	O
to	17347989	4	O
generate	17347989	4	O
and	17347989	4	O
maintain	17347989	4	O
a	17347989	4	O
comprehensive	17347989	4	O
catalogue	17347989	4	O
of	17347989	4	O
MMR	17347989	4	O
variants	17347989	4	O
from	17347989	4	O
genes	17347989	4	O
known	17347989	4	O
to	17347989	4	O
be	17347989	4	O
mutated	17347989	4	O
in	17347989	4	O
LS	17347989	4	O
(	17347989	4	O
http	17347989	4	O
:	17347989	4	O
/	17347989	4	O
/	17347989	4	O
www	17347989	4	O
.	17347989	4	O
med	17347989	4	O
.	17347989	4	O
mun	17347989	4	O
.	17347989	4	O
ca	17347989	4	O
/	17347989	4	O
MMRvariants	17347989	4	O
;	17347989	4	O
last	17347989	4	O
accessed	17347989	4	O
8	17347989	4	O
February	17347989	4	O
2007	17347989	4	O
)	17347989	4	O
.	17347989	4	O
Providing	17347989	4	O
such	17347989	4	O
a	17347989	4	O
resource	17347989	4	O
should	17347989	4	O
aid	17347989	4	O
investigators	17347989	4	O
in	17347989	4	O
understanding	17347989	4	O
the	17347989	4	O
significance	17347989	4	O
of	17347989	4	O
the	17347989	4	O
variants	17347989	4	O
.	17347989	4	O

Complete	17408421	4	O
androgen	17408421	4	O
insensitivity	17408421	4	O
without	17408421	4	O
Wolffian	17408421	4	O
duct	17408421	4	O
development	17408421	4	O
:	17408421	4	O
the	17408421	4	O
AR	17408421	4	O
-	17408421	4	O
A	17408421	4	O
form	17408421	4	O
of	17408421	4	O
the	17408421	4	O
androgen	17408421	4	O
receptor	17408421	4	O
is	17408421	4	O
not	17408421	4	O
sufficient	17408421	4	O
for	17408421	4	O
male	17408421	4	O
genital	17408421	4	O
development	17408421	4	O
.	17408421	4	O
BACKGROUND	17408421	4	O
:	17408421	4	O
The	17408421	4	O
androgen	17408421	4	O
receptor	17408421	4	O
(	17408421	4	O
AR	17408421	4	O
)	17408421	4	O
is	17408421	4	O
essential	17408421	4	O
for	17408421	4	O
the	17408421	4	O
differentiation	17408421	4	O
of	17408421	4	O
male	17408421	4	O
external	17408421	4	O
and	17408421	4	O
internal	17408421	4	O
genitalia	17408421	4	O
.	17408421	4	O
It	17408421	4	O
is	17408421	4	O
normally	17408421	4	O
present	17408421	4	O
in	17408421	4	O
two	17408421	4	O
forms	17408421	4	O
,	17408421	4	O
a	17408421	4	O
full	17408421	4	O
-	17408421	4	O
length	17408421	4	O
form	17408421	4	O
B	17408421	4	O
and	17408421	4	O
an	17408421	4	O
N	17408421	4	O
-	17408421	4	O
terminal	17408421	4	O
truncated	17408421	4	O
form	17408421	4	O
A	17408421	4	O
with	17408421	4	O
still	17408421	4	O
unknown	17408421	4	O
function	17408421	4	O
.	17408421	4	O
Mutations	17408421	4	B-Var
in	17408421	4	O
the	17408421	4	O
AR	17408421	4	B-Gene
gene	17408421	4	O
cause	17408421	4	B-Reg
androgen	17408421	4	B-Disease
insensitivity	17408421	4	I-Disease
syndrome	17408421	4	I-Disease
(	17408421	4	O
AIS	17408421	4	O
)	17408421	4	O
,	17408421	4	O
which	17408421	4	O
is	17408421	4	O
divided	17408421	4	O
into	17408421	4	O
subgroups	17408421	4	O
according	17408421	4	O
to	17408421	4	O
the	17408421	4	O
degree	17408421	4	O
of	17408421	4	O
undermasculinization	17408421	4	O
.	17408421	4	O
Patients	17408421	4	O
with	17408421	4	O
completely	17408421	4	O
female	17408421	4	O
external	17408421	4	O
genitalia	17408421	4	O
are	17408421	4	O
classified	17408421	4	O
as	17408421	4	O
complete	17408421	4	O
AIS	17408421	4	O
(	17408421	4	O
CAIS	17408421	4	O
)	17408421	4	O
.	17408421	4	O
However	17408421	4	O
,	17408421	4	O
a	17408421	4	O
recent	17408421	4	O
study	17408421	4	O
has	17408421	4	O
shown	17408421	4	O
that	17408421	4	O
some	17408421	4	O
CAIS	17408421	4	O
patients	17408421	4	O
have	17408421	4	O
signs	17408421	4	O
of	17408421	4	O
internal	17408421	4	O
male	17408421	4	O
genital	17408421	4	O
differentiation	17408421	4	O
due	17408421	4	O
to	17408421	4	O
missense	17408421	4	O
mutations	17408421	4	O
that	17408421	4	O
show	17408421	4	O
some	17408421	4	O
degree	17408421	4	O
of	17408421	4	O
residual	17408421	4	O
function	17408421	4	O
.	17408421	4	O
OBJECTIVE	17408421	4	O
:	17408421	4	O
We	17408421	4	O
aimed	17408421	4	O
to	17408421	4	O
study	17408421	4	O
the	17408421	4	O
expression	17408421	4	O
of	17408421	4	O
the	17408421	4	O
different	17408421	4	O
forms	17408421	4	O
of	17408421	4	O
the	17408421	4	O
AR	17408421	4	O
in	17408421	4	O
two	17408421	4	O
CAIS	17408421	4	O
patients	17408421	4	O
in	17408421	4	O
relation	17408421	4	O
to	17408421	4	O
the	17408421	4	O
development	17408421	4	O
of	17408421	4	O
male	17408421	4	O
internal	17408421	4	O
genital	17408421	4	O
structures	17408421	4	O
.	17408421	4	O
One	17408421	4	O
patient	17408421	4	O
had	17408421	4	O
a	17408421	4	O
mutation	17408421	4	O
(	17408421	4	O
L7fsX33	17408421	4	O
)	17408421	4	O
that	17408421	4	O
affects	17408421	4	O
only	17408421	4	O
the	17408421	4	O
full	17408421	4	O
-	17408421	4	O
length	17408421	4	O
AR	17408421	4	O
-	17408421	4	O
B	17408421	4	O
form	17408421	4	O
of	17408421	4	O
the	17408421	4	O
AR	17408421	4	O
,	17408421	4	O
whereas	17408421	4	O
the	17408421	4	O
other	17408421	4	O
had	17408421	4	O
a	17408421	4	O
nonsense	17408421	4	O
mutation	17408421	4	O
(	17408421	4	O
Q733X	17408421	4	O
)	17408421	4	O
affecting	17408421	4	O
both	17408421	4	O
isoforms	17408421	4	O
.	17408421	4	O
MEASUREMENTS	17408421	4	O
AND	17408421	4	O
RESULTS	17408421	4	O
:	17408421	4	O
We	17408421	4	O
thoroughly	17408421	4	O
analysed	17408421	4	O
internal	17408421	4	O
genitalia	17408421	4	O
at	17408421	4	O
surgery	17408421	4	O
and	17408421	4	O
by	17408421	4	O
histological	17408421	4	O
examination	17408421	4	O
.	17408421	4	O
No	17408421	4	O
signs	17408421	4	O
of	17408421	4	O
Wolffian	17408421	4	O
duct	17408421	4	O
(	17408421	4	O
WD	17408421	4	O
)	17408421	4	O
development	17408421	4	O
were	17408421	4	O
present	17408421	4	O
in	17408421	4	O
any	17408421	4	O
of	17408421	4	O
the	17408421	4	O
patients	17408421	4	O
.	17408421	4	O
Western	17408421	4	O
blotting	17408421	4	O
of	17408421	4	O
proteins	17408421	4	O
from	17408421	4	O
gonadal	17408421	4	O
and	17408421	4	O
genital	17408421	4	O
skin	17408421	4	O
fibroblasts	17408421	4	O
was	17408421	4	O
performed	17408421	4	O
with	17408421	4	O
AR	17408421	4	O
antibodies	17408421	4	O
directed	17408421	4	O
against	17408421	4	O
different	17408421	4	O
AR	17408421	4	O
epitopes	17408421	4	O
.	17408421	4	O
The	17408421	4	O
N	17408421	4	O
-	17408421	4	O
terminally	17408421	4	O
truncated	17408421	4	O
A	17408421	4	O
form	17408421	4	O
was	17408421	4	O
expressed	17408421	4	O
in	17408421	4	O
normal	17408421	4	O
amounts	17408421	4	O
in	17408421	4	O
the	17408421	4	O
patient	17408421	4	O
with	17408421	4	O
the	17408421	4	O
L7fsX33	17408421	4	O
mutation	17408421	4	O
while	17408421	4	O
no	17408421	4	O
AR	17408421	4	O
was	17408421	4	O
detected	17408421	4	O
in	17408421	4	O
the	17408421	4	O
other	17408421	4	O
patient	17408421	4	O
.	17408421	4	O
CONCLUSION	17408421	4	O
:	17408421	4	O
The	17408421	4	O
presence	17408421	4	O
of	17408421	4	O
the	17408421	4	O
AR	17408421	4	O
-	17408421	4	O
A	17408421	4	O
form	17408421	4	O
does	17408421	4	O
not	17408421	4	O
seem	17408421	4	O
to	17408421	4	O
be	17408421	4	O
sufficient	17408421	4	O
for	17408421	4	O
WD	17408421	4	O
maintenance	17408421	4	O
and	17408421	4	O
differentiation	17408421	4	O
.	17408421	4	O

Comprehensive	17417636	1	O
analysis	17417636	1	O
of	17417636	1	O
the	17417636	1	O
gene	17417636	1	O
encoding	17417636	1	O
filaggrin	17417636	1	O
uncovers	17417636	1	O
prevalent	17417636	1	O
and	17417636	1	O
rare	17417636	1	O
mutations	17417636	1	O
in	17417636	1	O
ichthyosis	17417636	1	O
vulgaris	17417636	1	O
and	17417636	1	O
atopic	17417636	1	O
eczema	17417636	1	O
.	17417636	1	O
We	17417636	1	O
recently	17417636	1	O
reported	17417636	1	O
two	17417636	1	O
common	17417636	1	O
filaggrin	17417636	1	O
(	17417636	1	B-Gene
FLG	17417636	1	I-Gene
)	17417636	1	I-Gene
null	17417636	1	O
mutations	17417636	1	B-Var
that	17417636	1	O
cause	17417636	1	B-Reg
ichthyosis	17417636	1	B-Disease
vulgaris	17417636	1	I-Disease
and	17417636	1	O
predispose	17417636	1	B-Disease
to	17417636	1	I-Disease
eczema	17417636	1	I-Disease
and	17417636	1	O
secondary	17417636	1	B-Disease
allergic	17417636	1	I-Disease
diseases	17417636	1	I-Disease
.	17417636	1	O
We	17417636	1	O
show	17417636	1	O
here	17417636	1	O
that	17417636	1	O
these	17417636	1	O
common	17417636	1	O
European	17417636	1	O
mutations	17417636	1	O
are	17417636	1	O
ancestral	17417636	1	O
variants	17417636	1	O
carried	17417636	1	O
on	17417636	1	O
conserved	17417636	1	O
haplotypes	17417636	1	O
.	17417636	1	O
To	17417636	1	O
facilitate	17417636	1	O
comprehensive	17417636	1	O
analysis	17417636	1	O
of	17417636	1	O
other	17417636	1	O
populations	17417636	1	O
,	17417636	1	O
we	17417636	1	O
report	17417636	1	O
a	17417636	1	O
strategy	17417636	1	O
for	17417636	1	O
full	17417636	1	O
sequencing	17417636	1	O
of	17417636	1	O
this	17417636	1	O
large	17417636	1	O
,	17417636	1	O
highly	17417636	1	O
repetitive	17417636	1	O
gene	17417636	1	O
,	17417636	1	O
and	17417636	1	O
we	17417636	1	O
describe	17417636	1	O
15	17417636	1	O
variants	17417636	1	O
,	17417636	1	O
including	17417636	1	O
seven	17417636	1	O
that	17417636	1	O
are	17417636	1	O
prevalent	17417636	1	O
.	17417636	1	O
All	17417636	1	O
the	17417636	1	O
variants	17417636	1	B-Var
are	17417636	1	O
either	17417636	1	O
nonsense	17417636	1	O
or	17417636	1	O
frameshift	17417636	1	O
mutations	17417636	1	O
that	17417636	1	O
,	17417636	1	O
in	17417636	1	O
representative	17417636	1	O
cases	17417636	1	O
,	17417636	1	O
resulted	17417636	1	O
in	17417636	1	O
loss	17417636	1	B-NegReg
of	17417636	1	O
filaggrin	17417636	1	O
production	17417636	1	O
in	17417636	1	O
the	17417636	1	O
epidermis	17417636	1	O
.	17417636	1	O
In	17417636	1	O
an	17417636	1	O
Irish	17417636	1	O
case	17417636	1	O
-	17417636	1	O
control	17417636	1	O
study	17417636	1	O
,	17417636	1	O
the	17417636	1	O
five	17417636	1	O
most	17417636	1	O
common	17417636	1	O
European	17417636	1	O
mutations	17417636	1	O
showed	17417636	1	O
a	17417636	1	O
strong	17417636	1	O
association	17417636	1	O
with	17417636	1	O
moderate	17417636	1	O
-	17417636	1	O
to	17417636	1	O
-	17417636	1	O
severe	17417636	1	O
childhood	17417636	1	O
eczema	17417636	1	O
(	17417636	1	O
chi2	17417636	1	O
test	17417636	1	O
:	17417636	1	O
P	17417636	1	O
=	17417636	1	O
2.12	17417636	1	O
x	17417636	1	O
10	17417636	1	O
(	17417636	1	O
-	17417636	1	O
51	17417636	1	O
)	17417636	1	O
;	17417636	1	O
Fisher	17417636	1	O
'	17417636	1	O
s	17417636	1	O
exact	17417636	1	O
test	17417636	1	O
:	17417636	1	O
heterozygote	17417636	1	O
odds	17417636	1	O
ratio	17417636	1	O
(	17417636	1	O
OR	17417636	1	O
)	17417636	1	O
=	17417636	1	O
7.44	17417636	1	O
(	17417636	1	O
95%	17417636	1	O
confidence	17417636	1	O
interval	17417636	1	O
(	17417636	1	O
c.	17417636	1	O
i.	17417636	1	O
)	17417636	1	O
=	17417636	1	O
4.9	17417636	1	O
-	17417636	1	O
11.3	17417636	1	O
)	17417636	1	O
,	17417636	1	O
and	17417636	1	O
homozygote	17417636	1	O
OR	17417636	1	O
=	17417636	1	O
151	17417636	1	O
(	17417636	1	O
95%	17417636	1	O
c.	17417636	1	O
i.	17417636	1	O
=	17417636	1	O
20	17417636	1	O
-	17417636	1	O
1	17417636	1	O
,	17417636	1	O
136	17417636	1	O
)	17417636	1	O
)	17417636	1	O
.	17417636	1	O
We	17417636	1	O
found	17417636	1	O
three	17417636	1	O
additional	17417636	1	O
rare	17417636	1	O
null	17417636	1	O
mutations	17417636	1	O
in	17417636	1	O
this	17417636	1	O
case	17417636	1	O
series	17417636	1	O
,	17417636	1	O
suggesting	17417636	1	O
that	17417636	1	O
the	17417636	1	O
genetic	17417636	1	O
architecture	17417636	1	O
of	17417636	1	O
filaggrin	17417636	1	O
-	17417636	1	O
related	17417636	1	O
atopic	17417636	1	O
dermatitis	17417636	1	O
consists	17417636	1	O
of	17417636	1	O
both	17417636	1	O
prevalent	17417636	1	O
and	17417636	1	O
rare	17417636	1	O
risk	17417636	1	O
alleles	17417636	1	O
.	17417636	1	O

Increased	17449919	2	O
chromosome	17449919	2	O
instability	17449919	2	O
and	17449919	2	O
accumulation	17449919	2	O
of	17449919	2	O
DNA	17449919	2	O
double	17449919	2	O
-	17449919	2	O
strand	17449919	2	O
breaks	17449919	2	O
in	17449919	2	O
Werner	17449919	2	O
syndrome	17449919	2	O
cells	17449919	2	O
.	17449919	2	O
Werner	17449919	2	B-Disease
syndrome	17449919	2	I-Disease
(	17449919	2	O
WS	17449919	2	O
)	17449919	2	O
is	17449919	2	O
a	17449919	2	O
premature	17449919	2	O
aging	17449919	2	O
syndrome	17449919	2	O
caused	17449919	2	B-Reg
by	17449919	2	I-Reg
mutations	17449919	2	B-Var
of	17449919	2	O
the	17449919	2	O
WRN	17449919	2	B-Gene
gene	17449919	2	O
.	17449919	2	O
Here	17449919	2	O
,	17449919	2	O
we	17449919	2	O
demonstrate	17449919	2	O
that	17449919	2	O
a	17449919	2	O
strain	17449919	2	O
of	17449919	2	O
WS	17449919	2	O
fibroblast	17449919	2	O
cells	17449919	2	O
shows	17449919	2	O
abnormal	17449919	2	O
karyotypes	17449919	2	O
characterized	17449919	2	O
by	17449919	2	O
several	17449919	2	O
complex	17449919	2	O
translocations	17449919	2	O
and	17449919	2	O
50	17449919	2	O
-	17449919	2	O
fold	17449919	2	O
more	17449919	2	O
frequency	17449919	2	O
of	17449919	2	O
abnormal	17449919	2	O
metaphases	17449919	2	O
including	17449919	2	O
dicentric	17449919	2	O
chromosomes	17449919	2	O
without	17449919	2	O
fragments	17449919	2	O
than	17449919	2	O
normal	17449919	2	O
cells	17449919	2	O
when	17449919	2	O
examined	17449919	2	O
at	17449919	2	O
a	17449919	2	O
similar	17449919	2	O
culture	17449919	2	O
stage	17449919	2	O
.	17449919	2	O
Further	17449919	2	O
,	17449919	2	O
telomere	17449919	2	O
fluorescence	17449919	2	O
in	17449919	2	O
situ	17449919	2	O
hybridization	17449919	2	O
indicates	17449919	2	O
that	17449919	2	O
the	17449919	2	O
abnormal	17449919	2	O
signals	17449919	2	O
,	17449919	2	O
extra	17449919	2	O
telomere	17449919	2	O
signal	17449919	2	O
and	17449919	2	O
loss	17449919	2	O
of	17449919	2	O
telomere	17449919	2	O
signal	17449919	2	O
,	17449919	2	O
emerge	17449919	2	O
two	17449919	2	O
-	17449919	2	O
to	17449919	2	O
three	17449919	2	O
-	17449919	2	O
fold	17449919	2	O
more	17449919	2	O
frequently	17449919	2	O
in	17449919	2	O
WS	17449919	2	O
cells	17449919	2	O
than	17449919	2	O
in	17449919	2	O
normal	17449919	2	O
cells	17449919	2	O
.	17449919	2	O
Taken	17449919	2	O
together	17449919	2	O
,	17449919	2	O
these	17449919	2	O
results	17449919	2	O
indicate	17449919	2	O
that	17449919	2	O
chromosome	17449919	2	O
instability	17449919	2	O
including	17449919	2	O
dysfunction	17449919	2	O
of	17449919	2	O
telomere	17449919	2	O
maintenance	17449919	2	O
is	17449919	2	O
more	17449919	2	O
prominent	17449919	2	O
in	17449919	2	O
WS	17449919	2	O
cells	17449919	2	O
than	17449919	2	O
in	17449919	2	O
normal	17449919	2	O
cells	17449919	2	O
.	17449919	2	O
In	17449919	2	O
addition	17449919	2	O
,	17449919	2	O
the	17449919	2	O
accumulation	17449919	2	O
of	17449919	2	O
DNA	17449919	2	O
double	17449919	2	O
-	17449919	2	O
strand	17449919	2	O
breaks	17449919	2	O
(	17449919	2	O
DSBs	17449919	2	O
)	17449919	2	O
at	17449919	2	O
the	17449919	2	O
G	17449919	2	O
(	17449919	2	O
1	17449919	2	O
)	17449919	2	O
phase	17449919	2	O
,	17449919	2	O
including	17449919	2	O
those	17449919	2	O
at	17449919	2	O
telomeres	17449919	2	O
,	17449919	2	O
detected	17449919	2	O
by	17449919	2	O
phosphorylated	17449919	2	O
ATM	17449919	2	O
(	17449919	2	O
ataxia	17449919	2	O
telangiectasia	17449919	2	O
mutated	17449919	2	O
)	17449919	2	O
foci	17449919	2	O
is	17449919	2	O
accelerated	17449919	2	O
in	17449919	2	O
WS	17449919	2	O
cells	17449919	2	O
even	17449919	2	O
at	17449919	2	O
a	17449919	2	O
low	17449919	2	O
senescence	17449919	2	O
level	17449919	2	O
.	17449919	2	O
The	17449919	2	O
increased	17449919	2	O
accumulation	17449919	2	O
of	17449919	2	O
DSBs	17449919	2	O
in	17449919	2	O
WS	17449919	2	O
cells	17449919	2	O
is	17449919	2	O
reduced	17449919	2	O
in	17449919	2	O
the	17449919	2	O
presence	17449919	2	O
of	17449919	2	O
anti	17449919	2	O
-	17449919	2	O
oxidative	17449919	2	O
agents	17449919	2	O
,	17449919	2	O
suggesting	17449919	2	O
that	17449919	2	O
enhanced	17449919	2	O
oxidative	17449919	2	O
stress	17449919	2	O
in	17449919	2	O
WS	17449919	2	O
cells	17449919	2	O
is	17449919	2	O
involved	17449919	2	O
in	17449919	2	O
accelerated	17449919	2	O
accumulation	17449919	2	O
of	17449919	2	O
DSBs	17449919	2	O
.	17449919	2	O
These	17449919	2	O
results	17449919	2	O
indicate	17449919	2	O
that	17449919	2	O
WS	17449919	2	O
cells	17449919	2	O
are	17449919	2	O
prone	17449919	2	O
to	17449919	2	O
accumulate	17449919	2	B-PosReg
DSBs	17449919	2	O
spontaneously	17449919	2	O
due	17449919	2	O
to	17449919	2	O
a	17449919	2	O
defect	17449919	2	B-Var
of	17449919	2	O
WRN	17449919	2	B-Gene
,	17449919	2	O
which	17449919	2	O
leads	17449919	2	O
to	17449919	2	O
increased	17449919	2	B-PosReg
chromosome	17449919	2	O
instability	17449919	2	O
that	17449919	2	O
could	17449919	2	O
activate	17449919	2	B-PosReg
checkpoints	17449919	2	O
,	17449919	2	O
resulting	17449919	2	O
in	17449919	2	O
accelerated	17449919	2	B-PosReg
senescence	17449919	2	O
.	17449919	2	O

A	17551331	4	O
novel	17551331	4	O
mutation	17551331	4	B-Var
in	17551331	4	O
TRIM37	17551331	4	B-Gene
is	17551331	4	O
associated	17551331	4	B-Reg
with	17551331	4	I-Reg
mulibrey	17551331	4	B-Disease
nanism	17551331	4	I-Disease
in	17551331	4	O
a	17551331	4	O
Turkish	17551331	4	O
boy	17551331	4	O
.	17551331	4	O
Mulibrey	17551331	4	O
nanism	17551331	4	O
is	17551331	4	O
a	17551331	4	O
rare	17551331	4	O
autosomal	17551331	4	O
-	17551331	4	O
recessive	17551331	4	O
disorder	17551331	4	O
characterized	17551331	4	O
by	17551331	4	O
prenatal	17551331	4	O
onset	17551331	4	O
severe	17551331	4	O
growth	17551331	4	O
retardation	17551331	4	O
and	17551331	4	O
pericardial	17551331	4	O
constriction	17551331	4	O
associated	17551331	4	O
with	17551331	4	O
abnormalities	17551331	4	O
of	17551331	4	O
muscle	17551331	4	O
,	17551331	4	O
liver	17551331	4	O
,	17551331	4	O
brain	17551331	4	O
and	17551331	4	O
eye	17551331	4	O
.	17551331	4	O
More	17551331	4	O
than	17551331	4	O
80%	17551331	4	O
of	17551331	4	O
previously	17551331	4	O
reported	17551331	4	O
patients	17551331	4	O
are	17551331	4	O
of	17551331	4	O
Finnish	17551331	4	O
origin	17551331	4	O
in	17551331	4	O
whom	17551331	4	O
a	17551331	4	O
founder	17551331	4	O
mutation	17551331	4	O
in	17551331	4	O
the	17551331	4	O
TRIM37	17551331	4	O
gene	17551331	4	O
have	17551331	4	O
been	17551331	4	O
described	17551331	4	O
.	17551331	4	O
We	17551331	4	O
report	17551331	4	O
on	17551331	4	O
a	17551331	4	O
7	17551331	4	O
-	17551331	4	O
year	17551331	4	O
-	17551331	4	O
old	17551331	4	O
Turkish	17551331	4	O
boy	17551331	4	O
who	17551331	4	O
presented	17551331	4	O
with	17551331	4	O
classical	17551331	4	O
phenotypic	17551331	4	O
features	17551331	4	O
of	17551331	4	O
mulibrey	17551331	4	O
nanism	17551331	4	O
.	17551331	4	O
Mutation	17551331	4	O
screening	17551331	4	O
of	17551331	4	O
the	17551331	4	O
TRIM37	17551331	4	O
gene	17551331	4	O
revealed	17551331	4	O
that	17551331	4	O
the	17551331	4	O
proband	17551331	4	O
had	17551331	4	O
a	17551331	4	O
homozygous	17551331	4	O
two	17551331	4	O
base	17551331	4	O
pair	17551331	4	O
deletion	17551331	4	O
,	17551331	4	O
c.1894	17551331	4	B-Var
_1895delGA	17551331	4	I-Var
,	17551331	4	O
resulting	17551331	4	B-Reg
in	17551331	4	I-Reg
a	17551331	4	O
frame	17551331	4	B-Var
-	17551331	4	I-Var
shift	17551331	4	I-Var
and	17551331	4	O
a	17551331	4	O
premature	17551331	4	O
termination	17551331	4	O
codon	17551331	4	O
.	17551331	4	O
Our	17551331	4	O
proband	17551331	4	O
is	17551331	4	O
one	17551331	4	O
of	17551331	4	O
the	17551331	4	O
rare	17551331	4	O
examples	17551331	4	O
of	17551331	4	O
mulibrey	17551331	4	O
nanism	17551331	4	O
outside	17551331	4	O
Finland	17551331	4	O
and	17551331	4	O
extends	17551331	4	O
the	17551331	4	O
mutation	17551331	4	O
spectrum	17551331	4	O
in	17551331	4	O
this	17551331	4	O
disorder	17551331	4	O
.	17551331	4	O

Phenotype	17880458	1	O
-	17880458	1	O
genotype	17880458	1	O
correlation	17880458	1	O
in	17880458	1	O
eight	17880458	1	O
Polish	17880458	1	O
patients	17880458	1	O
with	17880458	1	O
inherited	17880458	1	O
Factor	17880458	1	O
XIII	17880458	1	O
deficiency	17880458	1	O
:	17880458	1	O
identification	17880458	1	O
of	17880458	1	O
three	17880458	1	O
novel	17880458	1	O
mutations	17880458	1	O
.	17880458	1	O
Inherited	17880458	1	B-Disease
factor	17880458	1	I-Disease
XIII	17880458	1	I-Disease
(	17880458	1	O
FXIII	17880458	1	O
)	17880458	1	O
deficiency	17880458	1	O
is	17880458	1	O
known	17880458	1	O
as	17880458	1	O
one	17880458	1	O
of	17880458	1	O
the	17880458	1	O
most	17880458	1	O
rare	17880458	1	O
blood	17880458	1	O
coagulation	17880458	1	O
disorder	17880458	1	O
in	17880458	1	O
humans	17880458	1	O
.	17880458	1	O
In	17880458	1	O
the	17880458	1	O
present	17880458	1	O
study	17880458	1	O
,	17880458	1	O
phenotype	17880458	1	O
and	17880458	1	O
genotype	17880458	1	O
of	17880458	1	O
eight	17880458	1	O
FXIII	17880458	1	O
deficient	17880458	1	O
Polish	17880458	1	O
patients	17880458	1	O
from	17880458	1	O
five	17880458	1	O
unrelated	17880458	1	O
families	17880458	1	O
were	17880458	1	O
compared	17880458	1	O
.	17880458	1	O
The	17880458	1	O
patients	17880458	1	O
presented	17880458	1	O
with	17880458	1	O
a	17880458	1	O
severe	17880458	1	O
phenotype	17880458	1	O
demonstrated	17880458	1	O
by	17880458	1	O
a	17880458	1	O
high	17880458	1	O
incidence	17880458	1	O
of	17880458	1	O
intracerebral	17880458	1	O
haemorrhages	17880458	1	O
(	17880458	1	O
seven	17880458	1	O
of	17880458	1	O
eight	17880458	1	O
patients	17880458	1	O
)	17880458	1	O
,	17880458	1	O
haemarthrosis	17880458	1	O
(	17880458	1	O
six	17880458	1	O
patients	17880458	1	O
)	17880458	1	O
and	17880458	1	O
bleeding	17880458	1	O
due	17880458	1	O
to	17880458	1	O
trauma	17880458	1	O
(	17880458	1	O
five	17880458	1	O
patients	17880458	1	O
)	17880458	1	O
.	17880458	1	O
Introduction	17880458	1	O
of	17880458	1	O
regular	17880458	1	O
substitution	17880458	1	O
with	17880458	1	O
FXIII	17880458	1	O
concentrate	17880458	1	O
prevented	17880458	1	O
spontaneous	17880458	1	O
bleeding	17880458	1	O
in	17880458	1	O
seven	17880458	1	O
patients	17880458	1	O
.	17880458	1	O
In	17880458	1	O
all	17880458	1	O
patients	17880458	1	O
,	17880458	1	O
mutations	17880458	1	O
within	17880458	1	O
the	17880458	1	O
F13A	17880458	1	B-Gene
gene	17880458	1	O
have	17880458	1	O
been	17880458	1	O
identified	17880458	1	O
revealing	17880458	1	O
four	17880458	1	O
missense	17880458	1	O
mutations	17880458	1	O
(	17880458	1	B-Var
Arg77Cys	17880458	1	I-Var
,	17880458	1	O
Arg260Cys	17880458	1	B-Var
,	17880458	1	O
Ala378Pro	17880458	1	B-Var
,	17880458	1	O
Gly420Ser	17880458	1	B-Var
)	17880458	1	I-Var
,	17880458	1	O
one	17880458	1	O
nonsense	17880458	1	O
mutation	17880458	1	O
(	17880458	1	B-Var
Arg661X	17880458	1	I-Var
)	17880458	1	I-Var
,	17880458	1	O
one	17880458	1	O
splice	17880458	1	O
site	17880458	1	O
mutation	17880458	1	O
(	17880458	1	B-Var
IVS5-1	17880458	1	I-Var
G	17880458	1	I-Var
>	17880458	1	I-Var
A	17880458	1	I-Var
)	17880458	1	I-Var
and	17880458	1	O
one	17880458	1	O
small	17880458	1	O
deletion	17880458	1	O
(	17880458	1	B-Var
c.499	17880458	1	I-Var
-	17880458	1	I-Var
512	17880458	1	I-Var
del	17880458	1	I-Var
)	17880458	1	I-Var
.	17880458	1	O
One	17880458	1	O
homozygous	17880458	1	O
large	17880458	1	O
deletion	17880458	1	O
involving	17880458	1	O
exon	17880458	1	O
15	17880458	1	O
was	17880458	1	O
detected	17880458	1	O
by	17880458	1	O
failure	17880458	1	O
of	17880458	1	O
PCR	17880458	1	O
product	17880458	1	O
.	17880458	1	O
The	17880458	1	O
corresponding	17880458	1	O
mutations	17880458	1	B-Var
resulted	17880458	1	O
in	17880458	1	O
severely	17880458	1	O
reduced	17880458	1	B-NegReg
FXIII	17880458	1	O
activity	17880458	1	O
and	17880458	1	O
FXIII	17880458	1	O
A	17880458	1	O
-	17880458	1	O
subunit	17880458	1	O
antigen	17880458	1	O
concentration	17880458	1	O
,	17880458	1	O
while	17880458	1	O
FXIII	17880458	1	O
B	17880458	1	O
-	17880458	1	O
subunit	17880458	1	O
antigen	17880458	1	O
remained	17880458	1	O
normal	17880458	1	O
or	17880458	1	O
mildly	17880458	1	O
decreased	17880458	1	O
.	17880458	1	O
Structural	17880458	1	O
analysis	17880458	1	O
demonstrated	17880458	1	O
that	17880458	1	O
the	17880458	1	O
novel	17880458	1	O
Ala378Pro	17880458	1	B-Var
mutation	17880458	1	O
may	17880458	1	O
cause	17880458	1	O
a	17880458	1	O
disruption	17880458	1	B-NegReg
of	17880458	1	O
the	17880458	1	O
FXIII	17880458	1	O
catalytic	17880458	1	O
triad	17880458	1	O
leading	17880458	1	O
to	17880458	1	O
a	17880458	1	O
non	17880458	1	B-NegReg
-	17880458	1	I-NegReg
functional	17880458	1	I-NegReg
protein	17880458	1	O
which	17880458	1	O
presumably	17880458	1	O
undergoes	17880458	1	O
premature	17880458	1	O
degradation	17880458	1	O
.	17880458	1	O
In	17880458	1	O
conclusion	17880458	1	O
,	17880458	1	O
the	17880458	1	O
severe	17880458	1	O
phenotype	17880458	1	O
with	17880458	1	O
high	17880458	1	O
incidence	17880458	1	O
of	17880458	1	O
intracranial	17880458	1	O
bleeding	17880458	1	O
and	17880458	1	O
haemarthrosis	17880458	1	O
was	17880458	1	O
in	17880458	1	O
accordance	17880458	1	O
with	17880458	1	O
laboratory	17880458	1	O
findings	17880458	1	O
on	17880458	1	O
FXIII	17880458	1	O
and	17880458	1	O
with	17880458	1	O
severe	17880458	1	O
molecular	17880458	1	O
defects	17880458	1	O
of	17880458	1	O
the	17880458	1	O
F13A	17880458	1	O
gene	17880458	1	O
.	17880458	1	O

Effects	17922155	4	O
of	17922155	4	O
prolonged	17922155	4	O
dark	17922155	4	O
adaptation	17922155	4	O
in	17922155	4	O
patients	17922155	4	O
with	17922155	4	O
retinitis	17922155	4	O
pigmentosa	17922155	4	O
of	17922155	4	O
Bothnia	17922155	4	O
type	17922155	4	O
:	17922155	4	O
an	17922155	4	O
electrophysiological	17922155	4	O
study	17922155	4	O
.	17922155	4	O
Bothnia	17922155	4	B-Disease
dystrophy	17922155	4	I-Disease
(	17922155	4	O
BD	17922155	4	O
)	17922155	4	O
is	17922155	4	O
a	17922155	4	O
variant	17922155	4	O
of	17922155	4	O
recessive	17922155	4	O
retinitis	17922155	4	O
punctata	17922155	4	O
albescens	17922155	4	O
(	17922155	4	O
RPA	17922155	4	O
)	17922155	4	O
,	17922155	4	O
caused	17922155	4	B-Reg
by	17922155	4	I-Reg
the	17922155	4	O
missense	17922155	4	O
mutation	17922155	4	O
R233W	17922155	4	B-Var
in	17922155	4	O
cellular	17922155	4	O
retinaldehyde	17922155	4	O
-	17922155	4	O
binding	17922155	4	O
protein	17922155	4	O
(	17922155	4	O
CRALBP	17922155	4	O
)	17922155	4	O
,	17922155	4	O
which	17922155	4	O
is	17922155	4	O
localized	17922155	4	O
in	17922155	4	O
the	17922155	4	O
retinal	17922155	4	O
pigment	17922155	4	O
epithelium	17922155	4	O
(	17922155	4	O
RPE	17922155	4	O
)	17922155	4	O
and	17922155	4	O
Müller	17922155	4	O
cells	17922155	4	O
of	17922155	4	O
the	17922155	4	O
retina	17922155	4	O
.	17922155	4	O
The	17922155	4	O
purpose	17922155	4	O
of	17922155	4	O
this	17922155	4	O
study	17922155	4	O
was	17922155	4	O
,	17922155	4	O
by	17922155	4	O
examining	17922155	4	O
the	17922155	4	O
electrophysiological	17922155	4	O
responses	17922155	4	O
of	17922155	4	O
the	17922155	4	O
retina	17922155	4	O
,	17922155	4	O
to	17922155	4	O
evaluate	17922155	4	O
the	17922155	4	O
capacity	17922155	4	O
of	17922155	4	O
recovery	17922155	4	O
of	17922155	4	O
the	17922155	4	O
whole	17922155	4	O
retinal	17922155	4	O
area	17922155	4	O
and	17922155	4	O
different	17922155	4	O
cell	17922155	4	O
types	17922155	4	O
induced	17922155	4	O
by	17922155	4	O
extremely	17922155	4	O
prolonged	17922155	4	O
dark	17922155	4	O
adaptation	17922155	4	O
(	17922155	4	O
DA	17922155	4	O
)	17922155	4	O
in	17922155	4	O
BD	17922155	4	O
disease	17922155	4	O
and	17922155	4	O
to	17922155	4	O
gain	17922155	4	O
further	17922155	4	O
understanding	17922155	4	O
of	17922155	4	O
the	17922155	4	O
pathogenesis	17922155	4	O
of	17922155	4	O
BD	17922155	4	O
.	17922155	4	O
Six	17922155	4	O
young	17922155	4	O
patients	17922155	4	O
underwent	17922155	4	O
bilateral	17922155	4	O
full	17922155	4	O
-	17922155	4	O
field	17922155	4	O
ERGs	17922155	4	O
after	17922155	4	O
24	17922155	4	O
h	17922155	4	O
of	17922155	4	O
DA	17922155	4	O
in	17922155	4	O
one	17922155	4	O
eye	17922155	4	O
and	17922155	4	O
standard	17922155	4	O
DA	17922155	4	O
in	17922155	4	O
the	17922155	4	O
fellow	17922155	4	O
eye	17922155	4	O
.	17922155	4	O
The	17922155	4	O
results	17922155	4	O
were	17922155	4	O
also	17922155	4	O
compared	17922155	4	O
with	17922155	4	O
the	17922155	4	O
effect	17922155	4	O
of	17922155	4	O
prolonged	17922155	4	O
DA	17922155	4	O
(	17922155	4	O
10	17922155	4	O
h	17922155	4	O
)	17922155	4	O
,	17922155	4	O
previously	17922155	4	O
studied	17922155	4	O
in	17922155	4	O
the	17922155	4	O
same	17922155	4	O
patients	17922155	4	O
.	17922155	4	O
After	17922155	4	O
extremely	17922155	4	O
prolonged	17922155	4	O
DA	17922155	4	O
(	17922155	4	O
24	17922155	4	O
h	17922155	4	O
)	17922155	4	O
the	17922155	4	O
rod	17922155	4	O
b	17922155	4	O
-	17922155	4	O
wave	17922155	4	O
and	17922155	4	O
the	17922155	4	O
mixed	17922155	4	O
rod	17922155	4	O
-	17922155	4	O
cone	17922155	4	O
a	17922155	4	O
-	17922155	4	O
wave	17922155	4	O
responses	17922155	4	O
reached	17922155	4	O
normal	17922155	4	O
though	17922155	4	O
delayed	17922155	4	O
amplitudes	17922155	4	O
.	17922155	4	O
An	17922155	4	O
increase	17922155	4	O
,	17922155	4	O
up	17922155	4	O
to	17922155	4	O
normal	17922155	4	O
level	17922155	4	O
,	17922155	4	O
in	17922155	4	O
the	17922155	4	O
oscillatory	17922155	4	O
response	17922155	4	O
was	17922155	4	O
found	17922155	4	O
.	17922155	4	O
There	17922155	4	O
was	17922155	4	O
no	17922155	4	O
obvious	17922155	4	O
recovery	17922155	4	O
of	17922155	4	O
the	17922155	4	O
cone	17922155	4	O
response	17922155	4	O
.	17922155	4	O
We	17922155	4	O
conclude	17922155	4	O
that	17922155	4	O
in	17922155	4	O
young	17922155	4	O
BD	17922155	4	O
patients	17922155	4	O
during	17922155	4	O
extremely	17922155	4	O
prolonged	17922155	4	O
DA	17922155	4	O
there	17922155	4	O
is	17922155	4	O
a	17922155	4	O
significant	17922155	4	O
additional	17922155	4	O
capacity	17922155	4	O
of	17922155	4	O
recovery	17922155	4	O
of	17922155	4	O
rod	17922155	4	O
function	17922155	4	O
and	17922155	4	O
also	17922155	4	O
significant	17922155	4	O
gain	17922155	4	O
of	17922155	4	O
activity	17922155	4	O
in	17922155	4	O
the	17922155	4	O
inner	17922155	4	O
retinal	17922155	4	O
layer	17922155	4	O
.	17922155	4	O
A	17922155	4	O
continuous	17922155	4	O
but	17922155	4	O
slow	17922155	4	O
regeneration	17922155	4	O
of	17922155	4	O
rod	17922155	4	O
photopigment	17922155	4	O
seems	17922155	4	O
to	17922155	4	O
occur	17922155	4	O
at	17922155	4	O
least	17922155	4	O
up	17922155	4	O
to	17922155	4	O
24	17922155	4	O
h.	17922155	4	O
The	17922155	4	O
visual	17922155	4	O
process	17922155	4	O
in	17922155	4	O
the	17922155	4	O
RPE	17922155	4	O
is	17922155	4	O
retarded	17922155	4	O
and	17922155	4	O
CRALBP	17922155	4	O
acts	17922155	4	O
in	17922155	4	O
this	17922155	4	O
process	17922155	4	O
;	17922155	4	O
also	17922155	4	O
,	17922155	4	O
the	17922155	4	O
Müller	17922155	4	O
cells	17922155	4	O
of	17922155	4	O
the	17922155	4	O
retina	17922155	4	O
seem	17922155	4	O
to	17922155	4	O
be	17922155	4	O
involved	17922155	4	O
.	17922155	4	O
The	17922155	4	O
findings	17922155	4	O
also	17922155	4	O
support	17922155	4	O
an	17922155	4	O
extremely	17922155	4	O
slow	17922155	4	O
synthesis	17922155	4	O
of	17922155	4	O
photopigments	17922155	4	O
and	17922155	4	O
irreversibly	17922155	4	O
disturbed	17922155	4	O
cone	17922155	4	O
function	17922155	4	O
early	17922155	4	O
in	17922155	4	O
BD	17922155	4	O
.	17922155	4	O

A	17922851	2	O
case	17922851	2	O
of	17922851	2	O
lethal	17922851	2	O
hypophosphatasia	17922851	2	O
providing	17922851	2	O
new	17922851	2	O
insights	17922851	2	O
into	17922851	2	O
the	17922851	2	O
perinatal	17922851	2	O
benign	17922851	2	O
form	17922851	2	O
of	17922851	2	O
hypophosphatasia	17922851	2	O
and	17922851	2	O
expression	17922851	2	O
of	17922851	2	O
the	17922851	2	O
ALPL	17922851	2	O
gene	17922851	2	O
.	17922851	2	O
Hypophosphatasia	17922851	2	B-Disease
is	17922851	2	O
a	17922851	2	O
rare	17922851	2	O
inherited	17922851	2	O
bone	17922851	2	O
disease	17922851	2	O
caused	17922851	2	B-Reg
by	17922851	2	I-Reg
mutations	17922851	2	B-Var
in	17922851	2	O
the	17922851	2	O
alkaline	17922851	2	O
phosphatase	17922851	2	O
liver	17922851	2	O
-	17922851	2	O
type	17922851	2	O
gene	17922851	2	O
(	17922851	2	B-Gene
ALPL	17922851	2	I-Gene
)	17922851	2	I-Gene
gene	17922851	2	O
,	17922851	2	O
with	17922851	2	O
extensive	17922851	2	O
allelic	17922851	2	O
heterogeneity	17922851	2	O
leading	17922851	2	O
to	17922851	2	O
a	17922851	2	O
range	17922851	2	O
of	17922851	2	O
clinical	17922851	2	O
phenotypes	17922851	2	O
.	17922851	2	O
We	17922851	2	O
report	17922851	2	O
here	17922851	2	O
a	17922851	2	O
patient	17922851	2	O
who	17922851	2	O
died	17922851	2	O
from	17922851	2	O
severe	17922851	2	O
lethal	17922851	2	O
hypophosphatasia	17922851	2	O
,	17922851	2	O
who	17922851	2	O
was	17922851	2	O
compound	17922851	2	O
heterozygous	17922851	2	O
for	17922851	2	O
the	17922851	2	O
mutation	17922851	2	O
c.1133	17922851	2	O
A	17922851	2	O
>	17922851	2	O
T	17922851	2	O
(	17922851	2	O
D361V	17922851	2	O
)	17922851	2	O
and	17922851	2	O
the	17922851	2	O
newly	17922851	2	O
detected	17922851	2	O
missense	17922851	2	O
mutation	17922851	2	O
c791A	17922851	2	O
>	17922851	2	O
G	17922851	2	O
,	17922851	2	O
and	17922851	2	O
whose	17922851	2	O
parents	17922851	2	O
were	17922851	2	O
both	17922851	2	O
healthy	17922851	2	O
.	17922851	2	O
Because	17922851	2	O
the	17922851	2	O
c.1133	17922851	2	O
A	17922851	2	O
>	17922851	2	O
T	17922851	2	O
(	17922851	2	O
D361V	17922851	2	O
)	17922851	2	O
mutation	17922851	2	O
was	17922851	2	O
previously	17922851	2	O
reported	17922851	2	O
to	17922851	2	O
have	17922851	2	O
a	17922851	2	O
dominant	17922851	2	O
-	17922851	2	O
negative	17922851	2	O
effect	17922851	2	O
and	17922851	2	O
to	17922851	2	O
be	17922851	2	O
responsible	17922851	2	O
for	17922851	2	O
the	17922851	2	O
uncommon	17922851	2	O
perinatal	17922851	2	O
benign	17922851	2	O
form	17922851	2	O
of	17922851	2	O
the	17922851	2	O
disease	17922851	2	O
,	17922851	2	O
we	17922851	2	O
studied	17922851	2	O
the	17922851	2	O
expression	17922851	2	O
of	17922851	2	O
the	17922851	2	O
ALPL	17922851	2	O
gene	17922851	2	O
in	17922851	2	O
this	17922851	2	O
family	17922851	2	O
.	17922851	2	O
Analysis	17922851	2	O
at	17922851	2	O
the	17922851	2	O
messenger	17922851	2	O
RNA	17922851	2	O
(	17922851	2	O
mRNA	17922851	2	O
)	17922851	2	O
level	17922851	2	O
,	17922851	2	O
both	17922851	2	O
quantitative	17922851	2	O
and	17922851	2	O
qualitative	17922851	2	O
,	17922851	2	O
showed	17922851	2	O
that	17922851	2	O
the	17922851	2	O
paternal	17922851	2	O
c.1133	17922851	2	B-Var
A	17922851	2	I-Var
>	17922851	2	I-Var
T	17922851	2	I-Var
(	17922851	2	O
D361V	17922851	2	O
)	17922851	2	O
mutation	17922851	2	O
was	17922851	2	O
associated	17922851	2	O
with	17922851	2	O
over	17922851	2	O
-	17922851	2	O
expression	17922851	2	O
of	17922851	2	O
the	17922851	2	O
ALPL	17922851	2	B-Gene
gene	17922851	2	O
and	17922851	2	O
that	17922851	2	O
the	17922851	2	O
maternal	17922851	2	O
c.791	17922851	2	B-Var
A	17922851	2	I-Var
>	17922851	2	I-Var
G	17922851	2	I-Var
mutation	17922851	2	O
lead	17922851	2	B-Reg
to	17922851	2	I-Reg
complete	17922851	2	O
skipping	17922851	2	B-Var
of	17922851	2	I-Var
exon	17922851	2	I-Var
7	17922851	2	I-Var
.	17922851	2	O
The	17922851	2	O
results	17922851	2	O
provide	17922851	2	O
an	17922851	2	O
explanation	17922851	2	O
of	17922851	2	O
the	17922851	2	O
lethal	17922851	2	O
phenotype	17922851	2	O
in	17922851	2	O
the	17922851	2	O
patient	17922851	2	O
where	17922851	2	O
the	17922851	2	O
two	17922851	2	O
ALPL	17922851	2	O
alleles	17922851	2	O
are	17922851	2	O
non	17922851	2	O
-	17922851	2	O
functional	17922851	2	O
and	17922851	2	O
in	17922851	2	O
the	17922851	2	O
asymptomatic	17922851	2	O
father	17922851	2	O
where	17922851	2	O
over	17922851	2	O
-	17922851	2	O
expression	17922851	2	O
of	17922851	2	O
the	17922851	2	O
normal	17922851	2	O
allele	17922851	2	O
could	17922851	2	O
counteract	17922851	2	O
the	17922851	2	O
effect	17922851	2	O
of	17922851	2	O
the	17922851	2	O
c.1133	17922851	2	O
A	17922851	2	O
>	17922851	2	O
T	17922851	2	O
(	17922851	2	O
D361V	17922851	2	O
)	17922851	2	O
mutation	17922851	2	O
by	17922851	2	O
providing	17922851	2	O
an	17922851	2	O
increased	17922851	2	O
level	17922851	2	O
of	17922851	2	O
normal	17922851	2	O
mRNA	17922851	2	O
.	17922851	2	O
This	17922851	2	O
may	17922851	2	O
also	17922851	2	O
explain	17922851	2	O
the	17922851	2	O
variable	17922851	2	O
expression	17922851	2	O
of	17922851	2	O
hypophosphatasia	17922851	2	O
observed	17922851	2	O
in	17922851	2	O
parents	17922851	2	O
of	17922851	2	O
patients	17922851	2	O
with	17922851	2	O
the	17922851	2	O
perinatal	17922851	2	O
benign	17922851	2	O
form	17922851	2	O
.	17922851	2	O

Choreoacanthocytosis	17998451	4	O
in	17998451	4	O
a	17998451	4	O
Mexican	17998451	4	O
family	17998451	4	O
.	17998451	4	O
BACKGROUND	17998451	4	O
:	17998451	4	O
Choreoacanthocytosis	17998451	4	B-Disease
(	17998451	4	O
CHAC	17998451	4	O
)	17998451	4	O
(	17998451	4	O
Online	17998451	4	O
Mendelian	17998451	4	O
Inheritance	17998451	4	O
in	17998451	4	O
Man	17998451	4	O
accession	17998451	4	O
No.200150	17998451	4	O
)	17998451	4	O
is	17998451	4	O
a	17998451	4	O
hereditary	17998451	4	O
neurodegenerative	17998451	4	O
syndrome	17998451	4	O
characterized	17998451	4	O
by	17998451	4	O
movement	17998451	4	O
disorders	17998451	4	O
,	17998451	4	O
cognitive	17998451	4	O
decline	17998451	4	O
,	17998451	4	O
myopathy	17998451	4	O
,	17998451	4	O
behavioral	17998451	4	O
changes	17998451	4	O
,	17998451	4	O
and	17998451	4	O
acanthocytosis	17998451	4	O
and	17998451	4	O
is	17998451	4	O
caused	17998451	4	O
by	17998451	4	O
mutations	17998451	4	B-Reg
in	17998451	4	I-Reg
the	17998451	4	B-Var
VPS13A	17998451	4	O
gene	17998451	4	O
.	17998451	4	B-Gene
OBJECTIVE	17998451	4	O
:	17998451	4	O
To	17998451	4	O
describe	17998451	4	O
the	17998451	4	O
cases	17998451	4	O
of	17998451	4	O
2	17998451	4	O
Mexican	17998451	4	O
women	17998451	4	O
with	17998451	4	O
clinical	17998451	4	O
and	17998451	4	O
molecular	17998451	4	O
characteristics	17998451	4	O
compatible	17998451	4	O
with	17998451	4	O
CHAC	17998451	4	O
.	17998451	4	O
DESIGN	17998451	4	O
:	17998451	4	O
Case	17998451	4	O
reports	17998451	4	O
.	17998451	4	O
Patients	17998451	4	O
Choreoacanthocytosis	17998451	4	O
was	17998451	4	O
identified	17998451	4	O
in	17998451	4	O
2	17998451	4	O
Mexican	17998451	4	O
mestizo	17998451	4	O
sisters	17998451	4	O
with	17998451	4	O
healthy	17998451	4	O
consanguineous	17998451	4	O
parents	17998451	4	O
.	17998451	4	O
Clinical	17998451	4	O
manifestations	17998451	4	O
began	17998451	4	O
at	17998451	4	O
different	17998451	4	O
ages	17998451	4	O
.	17998451	4	O
RESULTS	17998451	4	O
:	17998451	4	O
The	17998451	4	O
onset	17998451	4	O
of	17998451	4	O
signs	17998451	4	O
and	17998451	4	O
symptoms	17998451	4	O
of	17998451	4	O
CHAC	17998451	4	O
in	17998451	4	O
the	17998451	4	O
proband	17998451	4	O
was	17998451	4	O
at	17998451	4	O
age	17998451	4	O
32	17998451	4	O
years	17998451	4	O
and	17998451	4	O
was	17998451	4	O
characterized	17998451	4	O
by	17998451	4	O
balancing	17998451	4	O
problems	17998451	4	O
followed	17998451	4	O
by	17998451	4	O
chorea	17998451	4	O
,	17998451	4	O
compulsive	17998451	4	O
lip	17998451	4	O
and	17998451	4	O
tongue	17998451	4	O
biting	17998451	4	O
with	17998451	4	O
buccolingual	17998451	4	O
self	17998451	4	O
-	17998451	4	O
mutilation	17998451	4	O
,	17998451	4	O
dysarthria	17998451	4	O
,	17998451	4	O
dysphagia	17998451	4	O
,	17998451	4	O
and	17998451	4	O
weight	17998451	4	O
loss	17998451	4	O
.	17998451	4	O
The	17998451	4	O
first	17998451	4	O
clinical	17998451	4	O
manifestations	17998451	4	O
in	17998451	4	O
the	17998451	4	O
proband	17998451	4	O
'	17998451	4	O
s	17998451	4	O
sister	17998451	4	O
occurred	17998451	4	O
at	17998451	4	O
age	17998451	4	O
45	17998451	4	O
years	17998451	4	O
and	17998451	4	O
included	17998451	4	O
multiple	17998451	4	O
motor	17998451	4	O
and	17998451	4	O
verbal	17998451	4	O
tics	17998451	4	O
,	17998451	4	O
with	17998451	4	O
coprolalia	17998451	4	O
,	17998451	4	O
followed	17998451	4	O
by	17998451	4	O
lip	17998451	4	O
and	17998451	4	O
tongue	17998451	4	O
biting	17998451	4	O
,	17998451	4	O
self	17998451	4	O
-	17998451	4	O
mutilation	17998451	4	O
,	17998451	4	O
and	17998451	4	O
chorea	17998451	4	O
.	17998451	4	O
The	17998451	4	O
clinical	17998451	4	O
findings	17998451	4	O
in	17998451	4	O
both	17998451	4	O
sisters	17998451	4	O
were	17998451	4	O
remarkable	17998451	4	O
for	17998451	4	O
acanthocytosis	17998451	4	O
that	17998451	4	O
developed	17998451	4	O
late	17998451	4	O
,	17998451	4	O
when	17998451	4	O
neurologic	17998451	4	O
changes	17998451	4	O
were	17998451	4	O
already	17998451	4	O
evident	17998451	4	O
.	17998451	4	O
Mutation	17998451	4	O
screening	17998451	4	O
of	17998451	4	O
the	17998451	4	O
VPS13A	17998451	4	O
gene	17998451	4	O
revealed	17998451	4	O
homozygosity	17998451	4	O
for	17998451	4	O
the	17998451	4	O
frameshift	17998451	4	O
mutation	17998451	4	O
c.3556	17998451	4	O
_3557dupAC	17998451	4	O
in	17998451	4	O
exon	17998451	4	O
33	17998451	4	O
.	17998451	4	O
Currently	17998451	4	O
,	17998451	4	O
the	17998451	4	O
proband	17998451	4	O
'	17998451	4	O
s	17998451	4	O
sister	17998451	4	O
,	17998451	4	O
in	17998451	4	O
whom	17998451	4	O
neurologic	17998451	4	O
defects	17998451	4	O
developed	17998451	4	O
13	17998451	4	O
years	17998451	4	O
after	17998451	4	O
onset	17998451	4	O
of	17998451	4	O
CHAC	17998451	4	O
in	17998451	4	O
the	17998451	4	O
proband	17998451	4	O
,	17998451	4	O
is	17998451	4	O
the	17998451	4	O
least	17998451	4	O
affected	17998451	4	O
.	17998451	4	O
CONCLUSIONS	17998451	4	O
:	17998451	4	O
The	17998451	4	O
same	17998451	4	O
mutation	17998451	4	O
of	17998451	4	O
the	17998451	4	O
VPS13A	17998451	4	O
gene	17998451	4	O
can	17998451	4	O
be	17998451	4	O
expressed	17998451	4	O
differently	17998451	4	O
in	17998451	4	O
the	17998451	4	O
same	17998451	4	O
family	17998451	4	O
.	17998451	4	O
This	17998451	4	O
observation	17998451	4	O
confirms	17998451	4	O
the	17998451	4	O
notion	17998451	4	O
that	17998451	4	O
there	17998451	4	O
is	17998451	4	O
considerable	17998451	4	O
heterogeneity	17998451	4	O
in	17998451	4	O
the	17998451	4	O
clinical	17998451	4	O
manifestation	17998451	4	O
of	17998451	4	O
CHAC	17998451	4	O
.	17998451	4	O

[	18033041	4	O
Phenotype	18033041	4	O
-	18033041	4	O
genotype	18033041	4	O
study	18033041	4	O
in	18033041	4	O
154	18033041	4	O
French	18033041	4	O
NF2	18033041	4	O
mutation	18033041	4	O
carriers	18033041	4	O
]	18033041	4	O
.	18033041	4	O
Analyse	18033041	4	O
phénotypique	18033041	4	O
de	18033041	4	O
154	18033041	4	O
patients	18033041	4	O
porteurs	18033041	4	O
d	18033041	4	O
'	18033041	4	O
une	18033041	4	O
mutation	18033041	4	O
constitutionnelle	18033041	4	O
du	18033041	4	O
gène	18033041	4	O
NF2	18033041	4	O
.	18033041	4	O
INTRODUCTION	18033041	4	O
:	18033041	4	O
Germline	18033041	4	B-Var
mutations	18033041	4	I-Var
in	18033041	4	O
the	18033041	4	O
NF2	18033041	4	B-Gene
gene	18033041	4	O
are	18033041	4	O
responsible	18033041	4	B-Reg
for	18033041	4	O
80	18033041	4	O
p.cent	18033041	4	O
of	18033041	4	O
neurofibromatosis	18033041	4	B-Disease
type	18033041	4	I-Disease
2	18033041	4	I-Disease
typical	18033041	4	O
cases	18033041	4	O
.	18033041	4	O
Mutations	18033041	4	O
are	18033041	4	O
mainly	18033041	4	O
truncating	18033041	4	O
mutations	18033041	4	O
or	18033041	4	O
deletions	18033041	4	O
,	18033041	4	O
missense	18033041	4	O
mutations	18033041	4	O
having	18033041	4	O
been	18033041	4	O
reported	18033041	4	O
in	18033041	4	O
few	18033041	4	O
cases	18033041	4	O
.	18033041	4	O
An	18033041	4	O
important	18033041	4	O
phenotypic	18033041	4	O
variability	18033041	4	O
is	18033041	4	O
observed	18033041	4	O
among	18033041	4	O
gene	18033041	4	O
carriers	18033041	4	O
.	18033041	4	O
To	18033041	4	O
assess	18033041	4	O
whether	18033041	4	O
the	18033041	4	O
phenotypic	18033041	4	O
variability	18033041	4	O
of	18033041	4	O
neurofibromatosis	18033041	4	O
2	18033041	4	O
could	18033041	4	O
be	18033041	4	O
linked	18033041	4	O
to	18033041	4	O
genotype	18033041	4	O
,	18033041	4	O
clinical	18033041	4	O
data	18033041	4	O
of	18033041	4	O
154	18033041	4	O
patients	18033041	4	O
whose	18033041	4	O
NF2	18033041	4	O
germline	18033041	4	O
alteration	18033041	4	O
had	18033041	4	O
been	18033041	4	O
identified	18033041	4	O
in	18033041	4	O
our	18033041	4	O
laboratory	18033041	4	O
have	18033041	4	O
been	18033041	4	O
collected	18033041	4	O
.	18033041	4	O
METHODS	18033041	4	O
:	18033041	4	O
A	18033041	4	O
retrospective	18033041	4	O
questionnaire	18033041	4	O
was	18033041	4	O
sent	18033041	4	O
to	18033041	4	O
the	18033041	4	O
physicians	18033041	4	O
in	18033041	4	O
charge	18033041	4	O
of	18033041	4	O
these	18033041	4	O
patients	18033041	4	O
.	18033041	4	O
Statistical	18033041	4	O
analyses	18033041	4	O
regarding	18033041	4	O
genotypic	18033041	4	O
and	18033041	4	O
phenotypic	18033041	4	O
data	18033041	4	O
were	18033041	4	O
performed	18033041	4	O
by	18033041	4	O
comparisons	18033041	4	O
of	18033041	4	O
average	18033041	4	O
values	18033041	4	O
and	18033041	4	O
correlation	18033041	4	O
tests	18033041	4	O
.	18033041	4	O
RESULTS	18033041	4	O
:	18033041	4	O
In	18033041	4	O
French	18033041	4	O
patients	18033041	4	O
,	18033041	4	O
type	18033041	4	O
of	18033041	4	O
mutation	18033041	4	O
was	18033041	4	O
correlated	18033041	4	O
neither	18033041	4	O
with	18033041	4	O
patients	18033041	4	O
'	18033041	4	O
sex	18033041	4	O
,	18033041	4	O
nor	18033041	4	O
with	18033041	4	O
disease	18033041	4	O
occurrence	18033041	4	O
mode	18033041	4	O
(	18033041	4	O
de	18033041	4	O
novo	18033041	4	O
or	18033041	4	O
inherited	18033041	4	O
mutation	18033041	4	O
)	18033041	4	O
.	18033041	4	O
Disease	18033041	4	O
associated	18033041	4	O
with	18033041	4	O
missense	18033041	4	O
mutations	18033041	4	O
occurred	18033041	4	O
later	18033041	4	O
,	18033041	4	O
with	18033041	4	O
a	18033041	4	O
less	18033041	4	O
severe	18033041	4	O
symptomatology	18033041	4	O
.	18033041	4	O
Patients	18033041	4	O
with	18033041	4	O
nonsense	18033041	4	O
or	18033041	4	O
frameshift	18033041	4	O
mutations	18033041	4	O
were	18033041	4	O
more	18033041	4	O
frequently	18033041	4	O
affected	18033041	4	O
with	18033041	4	O
meningiomas	18033041	4	O
and	18033041	4	O
spinal	18033041	4	O
tumours	18033041	4	O
,	18033041	4	O
in	18033041	4	O
addition	18033041	4	O
to	18033041	4	O
VIII	18033041	4	O
nerve	18033041	4	O
schwannomas	18033041	4	O
,	18033041	4	O
an	18033041	4	O
observation	18033041	4	O
that	18033041	4	O
underlies	18033041	4	O
the	18033041	4	O
genetic	18033041	4	O
determination	18033041	4	O
of	18033041	4	O
the	18033041	4	O
number	18033041	4	O
and	18033041	4	O
type	18033041	4	O
of	18033041	4	O
NF2	18033041	4	O
-	18033041	4	O
related	18033041	4	O
tumours	18033041	4	O
.	18033041	4	O
CONCLUSION	18033041	4	O
:	18033041	4	O
Results	18033041	4	O
from	18033041	4	O
the	18033041	4	O
literature	18033041	4	O
as	18033041	4	O
well	18033041	4	O
as	18033041	4	O
from	18033041	4	O
our	18033041	4	O
study	18033041	4	O
tend	18033041	4	O
to	18033041	4	O
show	18033041	4	O
that	18033041	4	O
only	18033041	4	O
few	18033041	4	O
correlations	18033041	4	O
exist	18033041	4	O
between	18033041	4	O
genotype	18033041	4	O
and	18033041	4	O
phenotype	18033041	4	O
in	18033041	4	O
the	18033041	4	O
NF2	18033041	4	O
disease	18033041	4	O
.	18033041	4	O
It	18033041	4	O
also	18033041	4	O
recognizes	18033041	4	O
that	18033041	4	O
missense	18033041	4	O
mutations	18033041	4	O
have	18033041	4	O
a	18033041	4	O
lower	18033041	4	O
level	18033041	4	O
of	18033041	4	O
evolution	18033041	4	O
,	18033041	4	O
severity	18033041	4	O
and	18033041	4	O
mortality	18033041	4	O
risk	18033041	4	O
.	18033041	4	O
Nonsense	18033041	4	O
and	18033041	4	O
frameshift	18033041	4	O
mutations	18033041	4	O
seem	18033041	4	O
to	18033041	4	O
be	18033041	4	O
associated	18033041	4	O
with	18033041	4	O
a	18033041	4	O
higher	18033041	4	O
number	18033041	4	O
of	18033041	4	O
meningiomas	18033041	4	O
and	18033041	4	O
spinal	18033041	4	O
tumours	18033041	4	O
.	18033041	4	O
Therefore	18033041	4	O
,	18033041	4	O
NF2	18033041	4	O
gene	18033041	4	O
screening	18033041	4	O
keeps	18033041	4	O
its	18033041	4	O
indications	18033041	4	O
in	18033041	4	O
both	18033041	4	O
typical	18033041	4	O
and	18033041	4	O
moderate	18033041	4	O
forms	18033041	4	O
of	18033041	4	O
the	18033041	4	O
disease	18033041	4	O
.	18033041	4	O
Mutations	18033041	4	O
are	18033041	4	O
responsible	18033041	4	O
of	18033041	4	O
80	18033041	4	O
p.cent	18033041	4	O
of	18033041	4	O
typical	18033041	4	O
forms	18033041	4	O
;	18033041	4	O
in	18033041	4	O
moderate	18033041	4	O
forms	18033041	4	O
,	18033041	4	O
identification	18033041	4	O
of	18033041	4	O
a	18033041	4	O
missense	18033041	4	O
mutation	18033041	4	O
seems	18033041	4	O
linked	18033041	4	O
to	18033041	4	O
a	18033041	4	O
lower	18033041	4	O
disease	18033041	4	O
evolution	18033041	4	O
.	18033041	4	O
In	18033041	4	O
any	18033041	4	O
case	18033041	4	O
,	18033041	4	O
assessment	18033041	4	O
and	18033041	4	O
supervision	18033041	4	O
should	18033041	4	O
be	18033041	4	O
identical	18033041	4	O
.	18033041	4	O
Finally	18033041	4	O
,	18033041	4	O
in	18033041	4	O
a	18033041	4	O
small	18033041	4	O
number	18033041	4	O
of	18033041	4	O
cases	18033041	4	O
,	18033041	4	O
the	18033041	4	O
NF2	18033041	4	O
gene	18033041	4	O
appears	18033041	4	O
to	18033041	4	O
be	18033041	4	O
implicated	18033041	4	O
in	18033041	4	O
clinical	18033041	4	O
forms	18033041	4	O
different	18033041	4	O
from	18033041	4	O
those	18033041	4	O
defined	18033041	4	O
by	18033041	4	O
NIH	18033041	4	O
and	18033041	4	O
it	18033041	4	O
might	18033041	4	O
be	18033041	4	O
of	18033041	4	O
interest	18033041	4	O
to	18033041	4	O
enlarge	18033041	4	O
the	18033041	4	O
clinical	18033041	4	O
features	18033041	4	O
suggestive	18033041	4	O
of	18033041	4	O
the	18033041	4	O
disease	18033041	4	O
.	18033041	4	O

Do	18176357	4	O
we	18176357	4	O
know	18176357	4	O
all	18176357	4	O
there	18176357	4	O
is	18176357	4	O
to	18176357	4	O
know	18176357	4	O
about	18176357	4	O
Familial	18176357	4	O
Adenomatous	18176357	4	O
Polyposis	18176357	4	O
?	18176357	4	O
Familial	18176357	4	B-Disease
Adenomatous	18176357	4	I-Disease
Polyposis	18176357	4	I-Disease
(	18176357	4	O
FAP	18176357	4	O
)	18176357	4	O
and	18176357	4	O
Attenuated	18176357	4	B-Disease
FAP	18176357	4	I-Disease
(	18176357	4	O
AFAP	18176357	4	O
)	18176357	4	O
are	18176357	4	O
caused	18176357	4	B-Reg
by	18176357	4	I-Reg
a	18176357	4	O
germline	18176357	4	B-Var
mutation	18176357	4	I-Var
in	18176357	4	O
the	18176357	4	O
Adenomatous	18176357	4	O
polyposis	18176357	4	O
coli	18176357	4	O
(	18176357	4	B-Gene
APC	18176357	4	I-Gene
)	18176357	4	I-Gene
gene	18176357	4	O
.	18176357	4	O
Recently	18176357	4	O
,	18176357	4	O
a	18176357	4	O
new	18176357	4	O
pathway	18176357	4	O
characterized	18176357	4	O
by	18176357	4	O
a	18176357	4	O
biallelic	18176357	4	O
mutation	18176357	4	O
in	18176357	4	O
the	18176357	4	O
MYH	18176357	4	O
gene	18176357	4	O
,	18176357	4	O
with	18176357	4	O
a	18176357	4	O
recessive	18176357	4	O
model	18176357	4	O
of	18176357	4	O
inheritance	18176357	4	O
was	18176357	4	O
discovered	18176357	4	O
for	18176357	4	O
this	18176357	4	O
inherited	18176357	4	O
syndrome	18176357	4	O
.	18176357	4	O
This	18176357	4	O
report	18176357	4	O
describes	18176357	4	O
a	18176357	4	O
Tunisian	18176357	4	O
patient	18176357	4	O
with	18176357	4	O
an	18176357	4	O
attenuated	18176357	4	O
FAP	18176357	4	O
phenotype	18176357	4	O
,	18176357	4	O
presenting	18176357	4	O
seven	18176357	4	O
colon	18176357	4	O
polyps	18176357	4	O
and	18176357	4	O
an	18176357	4	O
adenocarcinoma	18176357	4	O
but	18176357	4	O
no	18176357	4	O
detectable	18176357	4	O
germline	18176357	4	O
mutations	18176357	4	O
in	18176357	4	O
the	18176357	4	O
FAP	18176357	4	O
target	18176357	4	O
genes	18176357	4	O
.	18176357	4	O
A	18176357	4	O
well	18176357	4	O
known	18176357	4	O
somatic	18176357	4	O
mutation	18176357	4	O
was	18176357	4	O
found	18176357	4	O
in	18176357	4	O
the	18176357	4	O
APC	18176357	4	O
mutation	18176357	4	O
cluster	18176357	4	O
region	18176357	4	O
(	18176357	4	O
MCR	18176357	4	O
)	18176357	4	O
.	18176357	4	O
This	18176357	4	O
case	18176357	4	O
shows	18176357	4	O
that	18176357	4	O
further	18176357	4	O
studies	18176357	4	O
are	18176357	4	O
needed	18176357	4	O
to	18176357	4	O
fully	18176357	4	O
understand	18176357	4	O
all	18176357	4	O
the	18176357	4	O
pathways	18176357	4	O
of	18176357	4	O
the	18176357	4	O
FAP	18176357	4	O
syndrome	18176357	4	O
.	18176357	4	O

Mutations	18230725	4	B-Var
in	18230725	4	O
NALP12	18230725	4	B-Gene
cause	18230725	4	B-Reg
hereditary	18230725	4	B-Disease
periodic	18230725	4	I-Disease
fever	18230725	4	I-Disease
syndromes	18230725	4	I-Disease
.	18230725	4	O
NALP	18230725	4	O
proteins	18230725	4	O
,	18230725	4	O
also	18230725	4	O
known	18230725	4	O
as	18230725	4	O
NLRPs	18230725	4	O
,	18230725	4	O
belong	18230725	4	O
to	18230725	4	O
the	18230725	4	O
CATERPILLER	18230725	4	O
protein	18230725	4	O
family	18230725	4	O
involved	18230725	4	O
,	18230725	4	O
like	18230725	4	O
Toll	18230725	4	O
-	18230725	4	O
like	18230725	4	O
receptors	18230725	4	O
,	18230725	4	O
in	18230725	4	O
the	18230725	4	O
recognition	18230725	4	O
of	18230725	4	O
microbial	18230725	4	O
molecules	18230725	4	O
and	18230725	4	O
the	18230725	4	O
subsequent	18230725	4	O
activation	18230725	4	O
of	18230725	4	O
inflammatory	18230725	4	O
and	18230725	4	O
immune	18230725	4	O
responses	18230725	4	O
.	18230725	4	O
Current	18230725	4	O
advances	18230725	4	O
in	18230725	4	O
the	18230725	4	O
function	18230725	4	O
of	18230725	4	O
NALPs	18230725	4	O
support	18230725	4	O
the	18230725	4	O
recently	18230725	4	O
proposed	18230725	4	O
model	18230725	4	O
of	18230725	4	O
a	18230725	4	O
disease	18230725	4	O
continuum	18230725	4	O
bridging	18230725	4	O
autoimmune	18230725	4	O
and	18230725	4	O
autoinflammatory	18230725	4	O
disorders	18230725	4	O
.	18230725	4	O
Among	18230725	4	O
these	18230725	4	O
diseases	18230725	4	O
,	18230725	4	O
hereditary	18230725	4	O
periodic	18230725	4	O
fevers	18230725	4	O
(	18230725	4	O
HPFs	18230725	4	O
)	18230725	4	O
are	18230725	4	O
Mendelian	18230725	4	O
disorders	18230725	4	O
associated	18230725	4	O
with	18230725	4	O
sequence	18230725	4	O
variations	18230725	4	O
in	18230725	4	O
very	18230725	4	O
few	18230725	4	O
genes	18230725	4	O
;	18230725	4	O
these	18230725	4	O
variations	18230725	4	O
are	18230725	4	O
mostly	18230725	4	O
missense	18230725	4	O
mutations	18230725	4	O
whose	18230725	4	O
deleterious	18230725	4	O
effect	18230725	4	O
,	18230725	4	O
which	18230725	4	O
is	18230725	4	O
particularly	18230725	4	O
difficult	18230725	4	O
to	18230725	4	O
assess	18230725	4	O
,	18230725	4	O
is	18230725	4	O
often	18230725	4	O
questionable	18230725	4	O
.	18230725	4	O
The	18230725	4	O
growing	18230725	4	O
number	18230725	4	O
of	18230725	4	O
identified	18230725	4	O
sporadic	18230725	4	O
cases	18230725	4	O
of	18230725	4	O
periodic	18230725	4	O
fever	18230725	4	O
syndrome	18230725	4	O
,	18230725	4	O
together	18230725	4	O
with	18230725	4	O
the	18230725	4	O
lack	18230725	4	O
of	18230725	4	O
discriminatory	18230725	4	O
clinical	18230725	4	O
criteria	18230725	4	O
,	18230725	4	O
has	18230725	4	O
greatly	18230725	4	O
hampered	18230725	4	O
the	18230725	4	O
identification	18230725	4	O
of	18230725	4	O
new	18230725	4	O
disease	18230725	4	O
-	18230725	4	O
causing	18230725	4	O
genes	18230725	4	O
,	18230725	4	O
a	18230725	4	O
step	18230725	4	O
that	18230725	4	O
is	18230725	4	O
,	18230725	4	O
however	18230725	4	O
,	18230725	4	O
essential	18230725	4	O
for	18230725	4	O
appropriate	18230725	4	O
management	18230725	4	O
of	18230725	4	O
these	18230725	4	O
disorders	18230725	4	O
.	18230725	4	O
Using	18230725	4	O
a	18230725	4	O
candidate	18230725	4	O
gene	18230725	4	O
approach	18230725	4	O
,	18230725	4	O
we	18230725	4	O
identified	18230725	4	O
nonambiguous	18230725	4	O
mutations	18230725	4	O
in	18230725	4	O
NALP12	18230725	4	O
(	18230725	4	O
i.e.	18230725	4	O
,	18230725	4	O
nonsense	18230725	4	O
and	18230725	4	O
splice	18230725	4	O
site	18230725	4	O
)	18230725	4	O
in	18230725	4	O
two	18230725	4	O
families	18230725	4	O
with	18230725	4	O
periodic	18230725	4	O
fever	18230725	4	O
syndromes	18230725	4	O
.	18230725	4	O
As	18230725	4	O
shown	18230725	4	O
by	18230725	4	O
means	18230725	4	O
of	18230725	4	O
functional	18230725	4	O
studies	18230725	4	O
,	18230725	4	O
these	18230725	4	O
two	18230725	4	O
NALP12	18230725	4	B-Gene
mutations	18230725	4	B-Var
have	18230725	4	O
a	18230725	4	O
deleterious	18230725	4	O
effect	18230725	4	B-Reg
on	18230725	4	O
NF	18230725	4	O
-	18230725	4	O
kappaB	18230725	4	O
signaling	18230725	4	O
.	18230725	4	O
Overall	18230725	4	O
,	18230725	4	O
these	18230725	4	O
data	18230725	4	O
identify	18230725	4	O
a	18230725	4	O
group	18230725	4	O
of	18230725	4	O
HPFs	18230725	4	O
defined	18230725	4	O
by	18230725	4	O
molecular	18230725	4	O
defects	18230725	4	O
in	18230725	4	O
NALP12	18230725	4	O
,	18230725	4	O
opening	18230725	4	O
up	18230725	4	O
new	18230725	4	O
ways	18230725	4	O
to	18230725	4	O
manage	18230725	4	O
these	18230725	4	O
disorders	18230725	4	O
.	18230725	4	O
The	18230725	4	O
identification	18230725	4	O
of	18230725	4	O
these	18230725	4	O
first	18230725	4	O
NALP12	18230725	4	B-Gene
mutations	18230725	4	B-Var
in	18230725	4	O
patients	18230725	4	O
with	18230725	4	B-Reg
autoinflammatory	18230725	4	O
disorder	18230725	4	O
also	18230725	4	O
clearly	18230725	4	O
demonstrates	18230725	4	O
the	18230725	4	O
crucial	18230725	4	O
role	18230725	4	O
of	18230725	4	O
NALP12	18230725	4	O
in	18230725	4	O
inflammatory	18230725	4	O
signaling	18230725	4	O
pathways	18230725	4	O
,	18230725	4	O
thereby	18230725	4	O
assigning	18230725	4	O
a	18230725	4	O
precise	18230725	4	O
function	18230725	4	O
to	18230725	4	O
this	18230725	4	O
particular	18230725	4	O
member	18230725	4	O
of	18230725	4	O
an	18230725	4	O
emerging	18230725	4	O
family	18230725	4	O
of	18230725	4	O
proteins	18230725	4	O
whose	18230725	4	O
putative	18230725	4	O
biological	18230725	4	O
properties	18230725	4	O
are	18230725	4	O
currently	18230725	4	O
inferred	18230725	4	O
essentially	18230725	4	O
through	18230725	4	O
in	18230725	4	O
vitro	18230725	4	O
means	18230725	4	O
.	18230725	4	O

ABCA4	18285826	4	O
gene	18285826	4	O
analysis	18285826	4	O
in	18285826	4	O
patients	18285826	4	O
with	18285826	4	O
autosomal	18285826	4	O
recessive	18285826	4	O
cone	18285826	4	O
and	18285826	4	O
cone	18285826	4	O
rod	18285826	4	O
dystrophies	18285826	4	O
.	18285826	4	O
The	18285826	4	O
ATP	18285826	4	O
-	18285826	4	O
binding	18285826	4	O
cassette	18285826	4	O
(	18285826	4	O
ABC	18285826	4	O
)	18285826	4	O
transporters	18285826	4	O
constitute	18285826	4	O
a	18285826	4	O
family	18285826	4	O
of	18285826	4	O
large	18285826	4	O
membrane	18285826	4	O
proteins	18285826	4	O
,	18285826	4	O
which	18285826	4	O
transport	18285826	4	O
a	18285826	4	O
variety	18285826	4	O
of	18285826	4	O
substrates	18285826	4	O
across	18285826	4	O
membranes	18285826	4	O
.	18285826	4	O
The	18285826	4	O
ABCA4	18285826	4	O
protein	18285826	4	O
is	18285826	4	O
expressed	18285826	4	O
in	18285826	4	O
photoreceptors	18285826	4	O
and	18285826	4	O
possibly	18285826	4	O
functions	18285826	4	O
as	18285826	4	O
a	18285826	4	O
transporter	18285826	4	O
for	18285826	4	O
N	18285826	4	O
-	18285826	4	O
retinylidene	18285826	4	O
-	18285826	4	O
phosphatidylethanolamine	18285826	4	O
(	18285826	4	O
N	18285826	4	O
-	18285826	4	O
retinylidene	18285826	4	O
-	18285826	4	O
PE	18285826	4	O
)	18285826	4	O
,	18285826	4	O
the	18285826	4	O
Schiff	18285826	4	O
base	18285826	4	O
adduct	18285826	4	O
of	18285826	4	O
all	18285826	4	O
-	18285826	4	O
trans	18285826	4	O
-	18285826	4	O
retinal	18285826	4	O
with	18285826	4	O
PE	18285826	4	O
.	18285826	4	O
Mutations	18285826	4	B-Var
in	18285826	4	O
the	18285826	4	O
ABCA4	18285826	4	B-Gene
gene	18285826	4	O
have	18285826	4	O
been	18285826	4	O
initially	18285826	4	O
associated	18285826	4	B-Reg
with	18285826	4	I-Reg
autosomal	18285826	4	O
recessive	18285826	4	O
Stargardt	18285826	4	B-Disease
disease	18285826	4	I-Disease
.	18285826	4	O
Subsequent	18285826	4	O
studies	18285826	4	O
have	18285826	4	O
shown	18285826	4	O
that	18285826	4	O
mutations	18285826	4	B-Var
in	18285826	4	O
ABCA4	18285826	4	B-Gene
can	18285826	4	O
also	18285826	4	O
cause	18285826	4	B-Reg
a	18285826	4	O
variety	18285826	4	O
of	18285826	4	O
other	18285826	4	O
retinal	18285826	4	B-Disease
dystrophies	18285826	4	I-Disease
including	18285826	4	O
cone	18285826	4	B-Disease
rod	18285826	4	I-Disease
dystrophy	18285826	4	I-Disease
and	18285826	4	O
retinitis	18285826	4	B-Disease
pigmentosa	18285826	4	I-Disease
.	18285826	4	O
To	18285826	4	O
determine	18285826	4	O
the	18285826	4	O
prevalence	18285826	4	O
and	18285826	4	O
mutation	18285826	4	O
spectrum	18285826	4	O
of	18285826	4	O
ABCA4	18285826	4	O
gene	18285826	4	O
mutations	18285826	4	O
in	18285826	4	O
non	18285826	4	O
-	18285826	4	O
Stargardt	18285826	4	O
phenotypes	18285826	4	O
,	18285826	4	O
we	18285826	4	O
have	18285826	4	O
screened	18285826	4	O
64	18285826	4	O
unrelated	18285826	4	O
patients	18285826	4	O
with	18285826	4	O
autosomal	18285826	4	O
recessive	18285826	4	O
cone	18285826	4	O
(	18285826	4	O
arCD	18285826	4	O
)	18285826	4	O
and	18285826	4	O
cone	18285826	4	O
rod	18285826	4	O
dystrophy	18285826	4	O
(	18285826	4	O
arCRD	18285826	4	O
)	18285826	4	O
applying	18285826	4	O
the	18285826	4	O
Asper	18285826	4	O
Ophthalmics	18285826	4	O
ABCR400	18285826	4	O
microarray	18285826	4	O
followed	18285826	4	O
by	18285826	4	O
DNA	18285826	4	O
sequencing	18285826	4	O
of	18285826	4	O
all	18285826	4	O
coding	18285826	4	O
exons	18285826	4	O
of	18285826	4	O
the	18285826	4	O
ABCA4	18285826	4	O
gene	18285826	4	O
in	18285826	4	O
subjects	18285826	4	O
with	18285826	4	O
single	18285826	4	O
heterozygous	18285826	4	O
mutations	18285826	4	O
.	18285826	4	O
Disease	18285826	4	O
-	18285826	4	O
associated	18285826	4	O
ABCA4	18285826	4	O
alleles	18285826	4	O
were	18285826	4	O
identified	18285826	4	O
in	18285826	4	O
20	18285826	4	O
of	18285826	4	O
64	18285826	4	O
patients	18285826	4	O
with	18285826	4	O
arCD	18285826	4	O
or	18285826	4	O
arCRD	18285826	4	O
.	18285826	4	O
In	18285826	4	O
four	18285826	4	O
of	18285826	4	O
64	18285826	4	O
patients	18285826	4	O
(	18285826	4	O
6%	18285826	4	O
)	18285826	4	O
only	18285826	4	O
one	18285826	4	O
mutant	18285826	4	O
ABCA4	18285826	4	O
allele	18285826	4	O
was	18285826	4	O
detected	18285826	4	O
and	18285826	4	O
in	18285826	4	O
16	18285826	4	O
patients	18285826	4	O
(	18285826	4	O
25%	18285826	4	O
)	18285826	4	O
,	18285826	4	O
mutations	18285826	4	O
on	18285826	4	O
both	18285826	4	O
ABCA4	18285826	4	O
alleles	18285826	4	O
were	18285826	4	O
identified	18285826	4	O
.	18285826	4	O
Based	18285826	4	O
on	18285826	4	O
these	18285826	4	O
data	18285826	4	O
we	18285826	4	O
estimate	18285826	4	O
a	18285826	4	O
prevalence	18285826	4	O
of	18285826	4	O
31%	18285826	4	O
for	18285826	4	O
ABCA4	18285826	4	O
mutations	18285826	4	O
in	18285826	4	O
arCD	18285826	4	O
and	18285826	4	O
arCRD	18285826	4	O
,	18285826	4	O
supporting	18285826	4	O
the	18285826	4	O
concept	18285826	4	O
that	18285826	4	O
the	18285826	4	O
ABCA4	18285826	4	O
gene	18285826	4	O
is	18285826	4	O
a	18285826	4	O
major	18285826	4	O
locus	18285826	4	O
for	18285826	4	O
various	18285826	4	O
types	18285826	4	O
of	18285826	4	O
degenerative	18285826	4	O
retinal	18285826	4	O
diseases	18285826	4	O
with	18285826	4	O
abnormalities	18285826	4	O
in	18285826	4	O
cone	18285826	4	O
or	18285826	4	O
both	18285826	4	O
cone	18285826	4	O
and	18285826	4	O
rod	18285826	4	O
function	18285826	4	O
.	18285826	4	O

Premature	18317597	1	O
termination	18317597	1	O
codons	18317597	1	O
in	18317597	1	O
PRPF31	18317597	1	O
cause	18317597	1	O
retinitis	18317597	1	O
pigmentosa	18317597	1	O
via	18317597	1	O
haploinsufficiency	18317597	1	O
due	18317597	1	O
to	18317597	1	O
nonsense	18317597	1	O
-	18317597	1	O
mediated	18317597	1	O
mRNA	18317597	1	O
decay	18317597	1	O
.	18317597	1	O
Dominant	18317597	1	B-Var
mutations	18317597	1	I-Var
in	18317597	1	O
the	18317597	1	O
gene	18317597	1	O
encoding	18317597	1	O
the	18317597	1	O
mRNA	18317597	1	O
splicing	18317597	1	O
factor	18317597	1	O
PRPF31	18317597	1	B-Gene
cause	18317597	1	B-Reg
retinitis	18317597	1	B-Disease
pigmentosa	18317597	1	I-Disease
,	18317597	1	O
a	18317597	1	O
hereditary	18317597	1	O
form	18317597	1	O
of	18317597	1	O
retinal	18317597	1	O
degeneration	18317597	1	O
.	18317597	1	O
Most	18317597	1	O
of	18317597	1	O
these	18317597	1	O
mutations	18317597	1	O
are	18317597	1	O
characterized	18317597	1	O
by	18317597	1	O
DNA	18317597	1	O
changes	18317597	1	O
that	18317597	1	O
lead	18317597	1	O
to	18317597	1	O
premature	18317597	1	O
termination	18317597	1	O
codons	18317597	1	O
.	18317597	1	O
We	18317597	1	O
investigated	18317597	1	O
6	18317597	1	O
different	18317597	1	O
PRPF31	18317597	1	O
mutations	18317597	1	O
,	18317597	1	O
represented	18317597	1	O
by	18317597	1	O
single	18317597	1	O
-	18317597	1	O
base	18317597	1	O
substitutions	18317597	1	O
or	18317597	1	O
microdeletions	18317597	1	O
,	18317597	1	O
in	18317597	1	O
cell	18317597	1	O
lines	18317597	1	O
derived	18317597	1	O
from	18317597	1	O
9	18317597	1	O
patients	18317597	1	O
with	18317597	1	O
dominant	18317597	1	O
retinitis	18317597	1	O
pigmentosa	18317597	1	O
.	18317597	1	O
Five	18317597	1	O
of	18317597	1	O
these	18317597	1	O
mutations	18317597	1	B-Var
lead	18317597	1	B-Reg
to	18317597	1	I-Reg
premature	18317597	1	O
termination	18317597	1	O
codons	18317597	1	O
,	18317597	1	O
and	18317597	1	O
1	18317597	1	O
leads	18317597	1	B-Reg
to	18317597	1	I-Reg
the	18317597	1	O
skipping	18317597	1	O
of	18317597	1	O
exon	18317597	1	O
2	18317597	1	O
.	18317597	1	O
Allele	18317597	1	O
-	18317597	1	O
specific	18317597	1	O
measurement	18317597	1	O
of	18317597	1	O
PRPF31	18317597	1	O
transcripts	18317597	1	O
revealed	18317597	1	O
a	18317597	1	O
strong	18317597	1	O
reduction	18317597	1	B-NegReg
in	18317597	1	O
the	18317597	1	O
expression	18317597	1	O
of	18317597	1	O
mutant	18317597	1	B-Var
alleles	18317597	1	O
.	18317597	1	O
As	18317597	1	O
a	18317597	1	O
consequence	18317597	1	O
,	18317597	1	O
total	18317597	1	O
PRPF31	18317597	1	B-Gene
protein	18317597	1	O
abundance	18317597	1	O
was	18317597	1	O
decreased	18317597	1	B-NegReg
,	18317597	1	O
and	18317597	1	O
no	18317597	1	O
truncated	18317597	1	O
proteins	18317597	1	O
were	18317597	1	O
detected	18317597	1	O
.	18317597	1	O
Subnuclear	18317597	1	O
localization	18317597	1	O
of	18317597	1	O
the	18317597	1	O
full	18317597	1	O
-	18317597	1	O
length	18317597	1	O
PRPF31	18317597	1	O
that	18317597	1	O
was	18317597	1	O
present	18317597	1	O
remained	18317597	1	O
unaffected	18317597	1	O
.	18317597	1	O
Blocking	18317597	1	O
nonsense	18317597	1	O
-	18317597	1	O
mediated	18317597	1	O
mRNA	18317597	1	O
decay	18317597	1	O
significantly	18317597	1	O
restored	18317597	1	O
the	18317597	1	O
amount	18317597	1	O
of	18317597	1	O
mutant	18317597	1	O
PRPF31	18317597	1	O
mRNA	18317597	1	O
but	18317597	1	O
did	18317597	1	O
not	18317597	1	O
restore	18317597	1	O
the	18317597	1	O
synthesis	18317597	1	O
of	18317597	1	O
mutant	18317597	1	O
proteins	18317597	1	O
,	18317597	1	O
even	18317597	1	O
in	18317597	1	O
conjunction	18317597	1	O
with	18317597	1	O
inhibitors	18317597	1	O
of	18317597	1	O
protein	18317597	1	O
degradation	18317597	1	O
pathways	18317597	1	O
.	18317597	1	O
Our	18317597	1	O
results	18317597	1	O
indicate	18317597	1	O
that	18317597	1	O
most	18317597	1	O
PRPF31	18317597	1	B-Gene
mutations	18317597	1	B-Var
ultimately	18317597	1	O
result	18317597	1	O
in	18317597	1	O
null	18317597	1	B-NegReg
alleles	18317597	1	O
through	18317597	1	O
the	18317597	1	O
activation	18317597	1	B-PosReg
of	18317597	1	O
surveillance	18317597	1	O
mechanisms	18317597	1	O
that	18317597	1	O
inactivate	18317597	1	B-NegReg
mutant	18317597	1	B-Var
mRNA	18317597	1	I-Var
and	18317597	1	O
,	18317597	1	O
possibly	18317597	1	O
,	18317597	1	O
proteins	18317597	1	O
.	18317597	1	O
Furthermore	18317597	1	O
,	18317597	1	O
these	18317597	1	O
data	18317597	1	O
provide	18317597	1	O
compelling	18317597	1	O
evidence	18317597	1	O
that	18317597	1	O
the	18317597	1	O
pathogenic	18317597	1	O
effect	18317597	1	O
of	18317597	1	O
PRPF31	18317597	1	O
mutations	18317597	1	O
is	18317597	1	O
likely	18317597	1	O
due	18317597	1	O
to	18317597	1	O
haploinsufficiency	18317597	1	O
rather	18317597	1	O
than	18317597	1	O
to	18317597	1	O
gain	18317597	1	O
of	18317597	1	O
function	18317597	1	O
.	18317597	1	O

Xeroderma	18368133	4	O
pigmentosum	18368133	4	O
-	18368133	4	O
variant	18368133	4	O
patients	18368133	4	O
from	18368133	4	O
America	18368133	4	O
,	18368133	4	O
Europe	18368133	4	O
,	18368133	4	O
and	18368133	4	O
Asia	18368133	4	O
.	18368133	4	O
Xeroderma	18368133	4	B-Disease
pigmentosum	18368133	4	I-Disease
-	18368133	4	I-Disease
variant	18368133	4	I-Disease
(	18368133	4	O
XP	18368133	4	O
-	18368133	4	O
V	18368133	4	O
)	18368133	4	O
patients	18368133	4	O
have	18368133	4	O
sun	18368133	4	O
sensitivity	18368133	4	O
and	18368133	4	O
increased	18368133	4	O
skin	18368133	4	O
cancer	18368133	4	O
risk	18368133	4	O
.	18368133	4	O
Their	18368133	4	O
cells	18368133	4	O
have	18368133	4	O
normal	18368133	4	O
nucleotide	18368133	4	O
excision	18368133	4	O
repair	18368133	4	O
,	18368133	4	O
but	18368133	4	O
have	18368133	4	O
defects	18368133	4	O
in	18368133	4	O
the	18368133	4	O
POLH	18368133	4	O
gene	18368133	4	O
encoding	18368133	4	O
an	18368133	4	O
error	18368133	4	O
-	18368133	4	O
prone	18368133	4	O
polymerase	18368133	4	O
,	18368133	4	O
DNA	18368133	4	O
polymerase	18368133	4	O
eta	18368133	4	O
(	18368133	4	O
pol	18368133	4	O
eta	18368133	4	O
)	18368133	4	O
.	18368133	4	O
To	18368133	4	O
survey	18368133	4	O
the	18368133	4	O
molecular	18368133	4	O
basis	18368133	4	O
of	18368133	4	O
XP	18368133	4	O
-	18368133	4	O
V	18368133	4	O
worldwide	18368133	4	O
,	18368133	4	O
we	18368133	4	O
measured	18368133	4	O
pol	18368133	4	O
eta	18368133	4	O
protein	18368133	4	O
in	18368133	4	O
skin	18368133	4	O
fibroblasts	18368133	4	O
from	18368133	4	O
putative	18368133	4	O
XP	18368133	4	O
-	18368133	4	O
V	18368133	4	O
patients	18368133	4	O
(	18368133	4	O
aged	18368133	4	O
8	18368133	4	O
-	18368133	4	O
66	18368133	4	O
years	18368133	4	O
)	18368133	4	O
from	18368133	4	O
10	18368133	4	O
families	18368133	4	O
in	18368133	4	O
North	18368133	4	O
America	18368133	4	O
,	18368133	4	O
Turkey	18368133	4	O
,	18368133	4	O
Israel	18368133	4	O
,	18368133	4	O
Germany	18368133	4	O
,	18368133	4	O
and	18368133	4	O
Korea	18368133	4	O
.	18368133	4	O
Pol	18368133	4	O
eta	18368133	4	O
was	18368133	4	O
undetectable	18368133	4	O
in	18368133	4	O
cells	18368133	4	O
from	18368133	4	O
patients	18368133	4	O
in	18368133	4	O
eight	18368133	4	O
families	18368133	4	O
,	18368133	4	O
whereas	18368133	4	O
two	18368133	4	O
showed	18368133	4	O
faint	18368133	4	O
bands	18368133	4	O
.	18368133	4	O
DNA	18368133	4	O
sequencing	18368133	4	O
identified	18368133	4	O
10	18368133	4	O
different	18368133	4	O
POLH	18368133	4	O
mutations	18368133	4	O
.	18368133	4	O
There	18368133	4	O
were	18368133	4	O
two	18368133	4	O
splicing	18368133	4	O
,	18368133	4	O
one	18368133	4	O
nonsense	18368133	4	O
,	18368133	4	O
five	18368133	4	O
frameshift	18368133	4	O
(	18368133	4	O
3	18368133	4	O
deletion	18368133	4	O
and	18368133	4	O
2	18368133	4	O
insertion	18368133	4	O
)	18368133	4	O
,	18368133	4	O
and	18368133	4	O
two	18368133	4	O
missense	18368133	4	O
mutations	18368133	4	O
.	18368133	4	O
Nine	18368133	4	O
of	18368133	4	O
these	18368133	4	O
mutations	18368133	4	O
involved	18368133	4	O
the	18368133	4	O
catalytic	18368133	4	O
domain	18368133	4	O
.	18368133	4	O
Although	18368133	4	O
affected	18368133	4	O
siblings	18368133	4	O
had	18368133	4	O
similar	18368133	4	O
clinical	18368133	4	O
features	18368133	4	O
,	18368133	4	O
the	18368133	4	O
relation	18368133	4	O
between	18368133	4	O
the	18368133	4	O
clinical	18368133	4	O
features	18368133	4	O
and	18368133	4	O
the	18368133	4	O
mutations	18368133	4	O
was	18368133	4	O
not	18368133	4	O
clear	18368133	4	O
.	18368133	4	O
POLH	18368133	4	O
mRNA	18368133	4	O
levels	18368133	4	O
were	18368133	4	O
normal	18368133	4	O
or	18368133	4	O
reduced	18368133	4	O
by	18368133	4	O
50%	18368133	4	O
in	18368133	4	O
three	18368133	4	O
cell	18368133	4	O
strains	18368133	4	O
with	18368133	4	O
undetectable	18368133	4	O
levels	18368133	4	O
of	18368133	4	O
pol	18368133	4	O
eta	18368133	4	O
protein	18368133	4	O
,	18368133	4	O
indicating	18368133	4	O
that	18368133	4	O
nonsense	18368133	4	O
-	18368133	4	O
mediated	18368133	4	O
message	18368133	4	O
decay	18368133	4	O
was	18368133	4	O
limited	18368133	4	O
.	18368133	4	O
We	18368133	4	O
found	18368133	4	O
a	18368133	4	O
wide	18368133	4	O
spectrum	18368133	4	O
of	18368133	4	O
mutations	18368133	4	B-Var
in	18368133	4	O
the	18368133	4	O
POLH	18368133	4	B-Gene
gene	18368133	4	O
among	18368133	4	B-Reg
XP	18368133	4	B-Disease
-	18368133	4	I-Disease
V	18368133	4	I-Disease
patients	18368133	4	O
in	18368133	4	O
different	18368133	4	O
countries	18368133	4	O
,	18368133	4	O
suggesting	18368133	4	O
that	18368133	4	O
many	18368133	4	O
of	18368133	4	O
these	18368133	4	O
mutations	18368133	4	O
arose	18368133	4	O
independently	18368133	4	O
.	18368133	4	O

Four	18388506	4	O
novel	18388506	4	O
FXI	18388506	4	B-Gene
gene	18388506	4	O
mutations	18388506	4	B-Var
in	18388506	4	B-Reg
three	18388506	4	O
factor	18388506	4	B-Disease
XI	18388506	4	I-Disease
-	18388506	4	I-Disease
deficient	18388506	4	I-Disease
patients	18388506	4	O
.	18388506	4	O
Hereditary	18388506	4	O
factor	18388506	4	O
XI	18388506	4	O
deficiency	18388506	4	O
is	18388506	4	O
a	18388506	4	O
mild	18388506	4	O
bleeding	18388506	4	O
disorder	18388506	4	O
,	18388506	4	O
which	18388506	4	O
is	18388506	4	O
highly	18388506	4	O
prevalent	18388506	4	O
among	18388506	4	O
Ashkenazi	18388506	4	O
Jews	18388506	4	O
,	18388506	4	O
but	18388506	4	O
has	18388506	4	O
been	18388506	4	O
reported	18388506	4	O
in	18388506	4	O
all	18388506	4	O
populations	18388506	4	O
.	18388506	4	O
In	18388506	4	O
Ashkenazi	18388506	4	O
Jews	18388506	4	O
,	18388506	4	O
two	18388506	4	O
factor	18388506	4	O
XI	18388506	4	O
gene	18388506	4	O
mutations	18388506	4	O
Glu	18388506	4	O
117	18388506	4	O
X	18388506	4	O
(	18388506	4	O
type	18388506	4	O
II	18388506	4	O
)	18388506	4	O
and	18388506	4	O
Phe283Leu	18388506	4	O
(	18388506	4	O
type	18388506	4	O
III	18388506	4	O
)	18388506	4	O
are	18388506	4	O
particularly	18388506	4	O
common	18388506	4	O
.	18388506	4	O
In	18388506	4	O
other	18388506	4	O
ethnic	18388506	4	O
groups	18388506	4	O
,	18388506	4	O
factor	18388506	4	B-Disease
XI	18388506	4	I-Disease
deficiency	18388506	4	I-Disease
is	18388506	4	O
a	18388506	4	O
rare	18388506	4	O
bleeding	18388506	4	O
disorder	18388506	4	O
and	18388506	4	O
is	18388506	4	O
related	18388506	4	B-Reg
to	18388506	4	I-Reg
a	18388506	4	O
variety	18388506	4	O
of	18388506	4	O
mutations	18388506	4	B-Var
throughout	18388506	4	O
the	18388506	4	O
factor	18388506	4	B-Gene
XI	18388506	4	I-Gene
gene	18388506	4	O
.	18388506	4	O
Three	18388506	4	O
cases	18388506	4	O
of	18388506	4	O
quantitative	18388506	4	O
factor	18388506	4	O
XI	18388506	4	O
deficiency	18388506	4	O
in	18388506	4	O
relation	18388506	4	O
with	18388506	4	O
four	18388506	4	O
novel	18388506	4	O
missense	18388506	4	O
mutations	18388506	4	O
are	18388506	4	O
reported	18388506	4	O
:	18388506	4	O
a	18388506	4	O
compound	18388506	4	O
heterozygosity	18388506	4	O
for	18388506	4	O
two	18388506	4	O
novel	18388506	4	O
mutations	18388506	4	O
(	18388506	4	B-Var
Ala	18388506	4	I-Var
181	18388506	4	I-Var
Val	18388506	4	I-Var
and	18388506	4	O
Ala	18388506	4	B-Var
412	18388506	4	I-Var
Thr	18388506	4	I-Var
)	18388506	4	I-Var
with	18388506	4	O
a	18388506	4	O
severe	18388506	4	O
factor	18388506	4	O
XI	18388506	4	O
deficiency	18388506	4	O
and	18388506	4	O
two	18388506	4	O
missense	18388506	4	O
mutations	18388506	4	O
(	18388506	4	B-Var
His	18388506	4	I-Var
388	18388506	4	I-Var
Pro	18388506	4	I-Var
and	18388506	4	O
Trp	18388506	4	B-Var
407	18388506	4	I-Var
Cys	18388506	4	I-Var
)	18388506	4	I-Var
in	18388506	4	B-Reg
heterozygous	18388506	4	O
patients	18388506	4	O
with	18388506	4	O
partial	18388506	4	O
factor	18388506	4	B-Disease
XI	18388506	4	I-Disease
deficiency	18388506	4	I-Disease
.	18388506	4	O

[	18393234	4	O
A	18393234	4	O
novel	18393234	4	O
mutation	18393234	4	B-Var
in	18393234	4	O
the	18393234	4	O
SEDL	18393234	4	B-Gene
gene	18393234	4	O
leading	18393234	4	B-Reg
to	18393234	4	I-Reg
X	18393234	4	B-Disease
-	18393234	4	I-Disease
linked	18393234	4	I-Disease
spondyloepiphyseal	18393234	4	I-Disease
dysplasia	18393234	4	I-Disease
tarda	18393234	4	I-Disease
in	18393234	4	O
a	18393234	4	O
large	18393234	4	O
Chinese	18393234	4	O
pedigree	18393234	4	O
]	18393234	4	O
.	18393234	4	O
OBJECTIVE	18393234	4	O
:	18393234	4	O
To	18393234	4	O
identify	18393234	4	O
the	18393234	4	O
genetic	18393234	4	O
defect	18393234	4	O
in	18393234	4	O
a	18393234	4	O
four	18393234	4	O
-	18393234	4	O
generation	18393234	4	O
pedigree	18393234	4	O
with	18393234	4	O
X	18393234	4	O
-	18393234	4	O
linked	18393234	4	O
recessive	18393234	4	O
spondyloepiphyseal	18393234	4	O
dysplasia	18393234	4	O
tarda	18393234	4	O
(	18393234	4	O
SEDT	18393234	4	O
)	18393234	4	O
from	18393234	4	O
Southwest	18393234	4	O
China	18393234	4	O
.	18393234	4	O
METHODS	18393234	4	O
:	18393234	4	O
Linkage	18393234	4	O
analysis	18393234	4	O
with	18393234	4	O
one	18393234	4	O
panel	18393234	4	O
of	18393234	4	O
fluorescently	18393234	4	O
labeled	18393234	4	O
microsatellite	18393234	4	O
markers	18393234	4	O
on	18393234	4	O
chromosome	18393234	4	O
X	18393234	4	O
and	18393234	4	O
mutation	18393234	4	O
screening	18393234	4	O
of	18393234	4	O
SEDL	18393234	4	O
gene	18393234	4	O
by	18393234	4	O
direct	18393234	4	O
sequencing	18393234	4	O
were	18393234	4	O
performed	18393234	4	O
.	18393234	4	O
RESULTS	18393234	4	O
:	18393234	4	O
Linkage	18393234	4	O
between	18393234	4	O
SEDT	18393234	4	O
and	18393234	4	O
Xp22.2	18393234	4	O
-	18393234	4	O
Xp23.1	18393234	4	O
was	18393234	4	O
established	18393234	4	O
with	18393234	4	O
maximum	18393234	4	O
LOD	18393234	4	O
score	18393234	4	O
of	18393234	4	O
3.82	18393234	4	O
(	18393234	4	O
theta	18393234	4	O
=	18393234	4	O
0	18393234	4	O
)	18393234	4	O
between	18393234	4	O
DXS987	18393234	4	O
and	18393234	4	O
DXS8051	18393234	4	O
.	18393234	4	O
Upon	18393234	4	O
sequence	18393234	4	O
analysis	18393234	4	O
,	18393234	4	O
a	18393234	4	O
point	18393234	4	O
mutation	18393234	4	O
within	18393234	4	O
exon	18393234	4	O
4	18393234	4	O
of	18393234	4	O
the	18393234	4	O
SEDL	18393234	4	B-Gene
gene	18393234	4	O
(	18393234	4	B-Var
c.239	18393234	4	I-Var
A	18393234	4	I-Var
to	18393234	4	I-Var
G	18393234	4	I-Var
)	18393234	4	I-Var
was	18393234	4	O
found	18393234	4	O
which	18393234	4	O
resulted	18393234	4	B-Reg
in	18393234	4	I-Reg
substitution	18393234	4	O
of	18393234	4	O
histidine	18393234	4	O
with	18393234	4	O
arginine	18393234	4	O
at	18393234	4	O
codon	18393234	4	O
80	18393234	4	O
(	18393234	4	B-Var
His80Arg	18393234	4	I-Var
)	18393234	4	I-Var
.	18393234	4	O
CONCLUSION	18393234	4	O
:	18393234	4	O
A	18393234	4	O
novel	18393234	4	O
missense	18393234	4	O
mutation	18393234	4	O
(	18393234	4	O
H80R	18393234	4	O
)	18393234	4	O
was	18393234	4	O
identified	18393234	4	O
for	18393234	4	O
SEDL	18393234	4	O
gene	18393234	4	O
in	18393234	4	O
the	18393234	4	O
large	18393234	4	O
Chinese	18393234	4	O
SEDT	18393234	4	O
pedigree	18393234	4	O
.	18393234	4	O

MLPA	18653336	4	O
analysis	18653336	4	O
/	18653336	4	O
complete	18653336	4	O
sequencing	18653336	4	O
of	18653336	4	O
the	18653336	4	O
DMD	18653336	4	O
gene	18653336	4	O
in	18653336	4	O
a	18653336	4	O
group	18653336	4	O
of	18653336	4	O
Bulgarian	18653336	4	O
Duchenne	18653336	4	O
/	18653336	4	O
Becker	18653336	4	O
muscular	18653336	4	O
dystrophy	18653336	4	O
patients	18653336	4	O
.	18653336	4	O
Duchenne	18653336	4	B-Disease
/	18653336	4	I-Disease
Becker	18653336	4	I-Disease
muscular	18653336	4	I-Disease
dystrophy	18653336	4	I-Disease
(	18653336	4	O
DMD	18653336	4	O
/	18653336	4	O
BMD	18653336	4	O
)	18653336	4	O
,	18653336	4	O
the	18653336	4	O
most	18653336	4	O
common	18653336	4	O
X	18653336	4	O
-	18653336	4	O
linked	18653336	4	O
muscular	18653336	4	O
dystrophy	18653336	4	O
is	18653336	4	O
caused	18653336	4	B-Reg
by	18653336	4	I-Reg
mutations	18653336	4	B-Var
in	18653336	4	O
the	18653336	4	O
enormously	18653336	4	O
large	18653336	4	O
DMD	18653336	4	B-Gene
gene	18653336	4	O
,	18653336	4	O
encoding	18653336	4	O
the	18653336	4	O
protein	18653336	4	O
called	18653336	4	O
dystrophin	18653336	4	O
.	18653336	4	O
This	18653336	4	O
gene	18653336	4	O
was	18653336	4	O
screened	18653336	4	O
in	18653336	4	O
a	18653336	4	O
group	18653336	4	O
of	18653336	4	O
27	18653336	4	O
unrelated	18653336	4	O
Bulgarian	18653336	4	O
DMD	18653336	4	O
/	18653336	4	O
BMD	18653336	4	O
patients	18653336	4	O
by	18653336	4	O
MLPA	18653336	4	O
analysis	18653336	4	O
/	18653336	4	O
complete	18653336	4	O
sequencing	18653336	4	O
.	18653336	4	O
We	18653336	4	O
managed	18653336	4	O
to	18653336	4	O
clarify	18653336	4	O
the	18653336	4	O
disease	18653336	4	O
-	18653336	4	O
causing	18653336	4	O
mutation	18653336	4	O
in	18653336	4	O
96.3%	18653336	4	O
of	18653336	4	O
the	18653336	4	O
analyzed	18653336	4	O
families	18653336	4	O
.	18653336	4	O
The	18653336	4	O
MLPA	18653336	4	O
analysis	18653336	4	O
revealed	18653336	4	O
17	18653336	4	O
deletions	18653336	4	O
(	18653336	4	O
including	18653336	4	O
a	18653336	4	O
deletion	18653336	4	O
of	18653336	4	O
the	18653336	4	O
very	18653336	4	O
last	18653336	4	O
exon	18653336	4	O
79	18653336	4	O
)	18653336	4	O
,	18653336	4	O
6	18653336	4	O
duplications	18653336	4	O
and	18653336	4	O
1	18653336	4	O
point	18653336	4	O
mutation	18653336	4	O
.	18653336	4	O
Two	18653336	4	O
additional	18653336	4	O
point	18653336	4	O
mutations	18653336	4	O
(	18653336	4	O
one	18653336	4	O
of	18653336	4	O
them	18653336	4	O
novel	18653336	4	O
)	18653336	4	O
were	18653336	4	O
detected	18653336	4	O
after	18653336	4	O
complete	18653336	4	O
sequencing	18653336	4	O
of	18653336	4	O
the	18653336	4	O
DMD	18653336	4	O
gene	18653336	4	O
.	18653336	4	O
Altogether	18653336	4	O
,	18653336	4	O
25	18653336	4	O
carriers	18653336	4	O
and	18653336	4	O
11	18653336	4	O
noncarriers	18653336	4	O
were	18653336	4	O
detected	18653336	4	O
in	18653336	4	O
our	18653336	4	O
families	18653336	4	O
.	18653336	4	O
The	18653336	4	O
MLPA	18653336	4	O
test	18653336	4	O
proved	18653336	4	O
to	18653336	4	O
be	18653336	4	O
a	18653336	4	O
powerful	18653336	4	O
tool	18653336	4	O
in	18653336	4	O
detecting	18653336	4	O
deletions	18653336	4	O
/	18653336	4	O
duplications	18653336	4	O
and	18653336	4	O
in	18653336	4	O
some	18653336	4	O
cases	18653336	4	O
point	18653336	4	O
mutations	18653336	4	O
/	18653336	4	O
polymorphisms	18653336	4	O
along	18653336	4	O
the	18653336	4	O
DMD	18653336	4	O
gene	18653336	4	O
.	18653336	4	O
Using	18653336	4	O
this	18653336	4	O
approach	18653336	4	O
in	18653336	4	O
combination	18653336	4	O
with	18653336	4	O
a	18653336	4	O
direct	18653336	4	O
gene	18653336	4	O
sequencing	18653336	4	O
a	18653336	4	O
number	18653336	4	O
of	18653336	4	O
Bulgarian	18653336	4	O
DMD	18653336	4	O
/	18653336	4	O
BMD	18653336	4	O
patients	18653336	4	O
are	18653336	4	O
genetically	18653336	4	O
clarified	18653336	4	O
and	18653336	4	O
prepared	18653336	4	O
for	18653336	4	O
gene	18653336	4	O
therapy	18653336	4	O
in	18653336	4	O
future	18653336	4	O
.	18653336	4	O

A	18791947	4	O
case	18791947	4	O
of	18791947	4	O
Bernard	18791947	4	B-Disease
-	18791947	4	I-Disease
Soulier	18791947	4	I-Disease
Syndrome	18791947	4	I-Disease
due	18791947	4	B-Reg
to	18791947	4	I-Reg
a	18791947	4	O
homozygous	18791947	4	O
four	18791947	4	O
bases	18791947	4	O
deletion	18791947	4	B-Var
(	18791947	4	O
TGAG	18791947	4	O
)	18791947	4	O
of	18791947	4	O
GPIbalpha	18791947	4	B-Gene
gene	18791947	4	I-Gene
:	18791947	4	I-Gene
lack	18791947	4	O
of	18791947	4	O
GPIbalpha	18791947	4	O
but	18791947	4	O
absence	18791947	4	O
of	18791947	4	O
bleeding	18791947	4	O
.	18791947	4	O
More	18791947	4	O
than	18791947	4	O
20	18791947	4	O
DNA	18791947	4	O
mutations	18791947	4	O
with	18791947	4	O
different	18791947	4	O
inheritance	18791947	4	O
pattern	18791947	4	O
have	18791947	4	O
been	18791947	4	O
described	18791947	4	O
in	18791947	4	O
patients	18791947	4	O
with	18791947	4	O
Bernard	18791947	4	O
-	18791947	4	O
Soulier	18791947	4	O
Syndrome	18791947	4	O
(	18791947	4	O
BSS	18791947	4	O
)	18791947	4	O
,	18791947	4	O
leading	18791947	4	O
to	18791947	4	O
abnormal	18791947	4	O
or	18791947	4	O
absent	18791947	4	O
synthesis	18791947	4	O
and	18791947	4	O
/	18791947	4	O
or	18791947	4	O
expression	18791947	4	O
of	18791947	4	O
GPIbalpha	18791947	4	O
.	18791947	4	O
Clinical	18791947	4	O
phenotype	18791947	4	O
shows	18791947	4	O
considerable	18791947	4	O
variation	18791947	4	O
between	18791947	4	O
individuals	18791947	4	O
,	18791947	4	O
such	18791947	4	O
as	18791947	4	O
bleeding	18791947	4	O
,	18791947	4	O
platelet	18791947	4	O
count	18791947	4	O
and	18791947	4	O
the	18791947	4	O
percentage	18791947	4	O
of	18791947	4	O
large	18791947	4	O
platelets	18791947	4	O
.	18791947	4	O
We	18791947	4	O
describe	18791947	4	O
in	18791947	4	O
a	18791947	4	O
BSS	18791947	4	O
patient	18791947	4	O
the	18791947	4	O
first	18791947	4	O
case	18791947	4	O
of	18791947	4	O
homozygous	18791947	4	O
four	18791947	4	O
bases	18791947	4	O
deletion	18791947	4	O
(	18791947	4	O
TGAG	18791947	4	O
)	18791947	4	O
in	18791947	4	O
the	18791947	4	O
gpIbalpha	18791947	4	O
gene	18791947	4	O
coding	18791947	4	O
sequence	18791947	4	O
,	18791947	4	O
leading	18791947	4	O
to	18791947	4	O
a	18791947	4	O
premature	18791947	4	O
stop	18791947	4	O
codon	18791947	4	O
.	18791947	4	O
In	18791947	4	O
the	18791947	4	O
propositus	18791947	4	O
,	18791947	4	O
blood	18791947	4	O
smears	18791947	4	O
revealed	18791947	4	O
giant	18791947	4	O
platelets	18791947	4	O
(	18791947	4	O
30	18791947	4	O
x	18791947	4	O
10	18791947	4	O
(	18791947	4	O
9	18791947	4	O
)	18791947	4	O
platelets	18791947	4	O
/	18791947	4	O
L	18791947	4	O
)	18791947	4	O
,	18791947	4	O
and	18791947	4	O
platelet	18791947	4	O
agglutination	18791947	4	O
to	18791947	4	O
ristocetin	18791947	4	O
was	18791947	4	O
absent	18791947	4	O
.	18791947	4	O
Propositus	18791947	4	O
'	18791947	4	O
parents	18791947	4	O
are	18791947	4	O
consanguineous	18791947	4	O
.	18791947	4	O
His	18791947	4	O
father	18791947	4	O
and	18791947	4	O
paternal	18791947	4	O
grandmother	18791947	4	O
showed	18791947	4	O
a	18791947	4	O
mild	18791947	4	O
thrombocytopenia	18791947	4	O
(	18791947	4	O
108	18791947	4	O
x	18791947	4	O
10	18791947	4	O
(	18791947	4	O
9	18791947	4	O
)	18791947	4	O
/	18791947	4	O
L	18791947	4	O
and	18791947	4	O
120	18791947	4	O
x	18791947	4	O
10	18791947	4	O
(	18791947	4	O
9	18791947	4	O
)	18791947	4	O
/	18791947	4	O
L	18791947	4	O
platelets	18791947	4	O
respectively	18791947	4	O
)	18791947	4	O
while	18791947	4	O
mothers	18791947	4	O
and	18791947	4	O
sister	18791947	4	O
'	18791947	4	O
s	18791947	4	O
referred	18791947	4	O
normal	18791947	4	O
platelet	18791947	4	O
counts	18791947	4	O
.	18791947	4	O
The	18791947	4	O
surface	18791947	4	O
expression	18791947	4	O
of	18791947	4	O
GPIbalpha	18791947	4	O
was	18791947	4	O
practically	18791947	4	O
undetectable	18791947	4	O
by	18791947	4	O
flow	18791947	4	O
-	18791947	4	O
cytometry	18791947	4	O
and	18791947	4	O
western	18791947	4	O
blot	18791947	4	O
in	18791947	4	O
the	18791947	4	O
patient	18791947	4	O
and	18791947	4	O
was	18791947	4	O
reduced	18791947	4	O
in	18791947	4	O
the	18791947	4	O
father	18791947	4	O
.	18791947	4	O
Proband	18791947	4	O
'	18791947	4	O
s	18791947	4	O
DNA	18791947	4	O
analysis	18791947	4	O
revealed	18791947	4	O
a	18791947	4	O
homozygous	18791947	4	O
four	18791947	4	O
-	18791947	4	O
base	18791947	4	O
-	18791947	4	O
pair	18791947	4	O
deletion	18791947	4	B-Var
(	18791947	4	O
TGAG	18791947	4	O
)	18791947	4	O
,	18791947	4	O
starting	18791947	4	O
from	18791947	4	O
the	18791947	4	O
last	18791947	4	O
base	18791947	4	O
of	18791947	4	O
the	18791947	4	O
codon	18791947	4	O
for	18791947	4	O
Ser39	18791947	4	O
,	18791947	4	O
leading	18791947	4	B-Reg
to	18791947	4	I-Reg
a	18791947	4	O
coding	18791947	4	O
frame	18791947	4	O
shift	18791947	4	O
with	18791947	4	O
a	18791947	4	O
new	18791947	4	O
termination	18791947	4	O
codon	18791947	4	O
after	18791947	4	O
11	18791947	4	O
novel	18791947	4	O
amino	18791947	4	O
acids	18791947	4	O
.	18791947	4	O
The	18791947	4	O
same	18791947	4	O
mutation	18791947	4	O
was	18791947	4	O
seen	18791947	4	O
in	18791947	4	O
heterozygosis	18791947	4	O
in	18791947	4	O
both	18791947	4	O
parents	18791947	4	O
.	18791947	4	O
This	18791947	4	O
is	18791947	4	O
the	18791947	4	O
first	18791947	4	O
report	18791947	4	O
of	18791947	4	O
GPIbalpha	18791947	4	O
TGAG	18791947	4	O
deletion	18791947	4	O
in	18791947	4	O
homozygous	18791947	4	O
state	18791947	4	O
even	18791947	4	O
if	18791947	4	O
the	18791947	4	O
defect	18791947	4	O
has	18791947	4	O
already	18791947	4	O
been	18791947	4	O
described	18791947	4	O
in	18791947	4	O
a	18791947	4	O
case	18791947	4	O
of	18791947	4	O
compound	18791947	4	O
heterozygosis	18791947	4	O
.	18791947	4	O
Surprisingly	18791947	4	O
,	18791947	4	O
the	18791947	4	O
propositus	18791947	4	O
does	18791947	4	O
not	18791947	4	O
report	18791947	4	O
any	18791947	4	O
spontaneous	18791947	4	O
bleeding	18791947	4	O
tendency	18791947	4	O
.	18791947	4	O

Common	18938114	4	O
mutations	18938114	4	B-Var
in	18938114	4	B-Reg
Cuban	18938114	4	O
cystic	18938114	4	B-Disease
fibrosis	18938114	4	I-Disease
patients	18938114	4	O
.	18938114	4	O
So	18938114	4	O
far	18938114	4	O
,	18938114	4	O
more	18938114	4	O
than	18938114	4	O
1500	18938114	4	O
mutations	18938114	4	O
have	18938114	4	O
been	18938114	4	O
reported	18938114	4	O
in	18938114	4	O
the	18938114	4	O
cystic	18938114	4	O
fibrosis	18938114	4	O
transmembrane	18938114	4	O
conductance	18938114	4	O
regulator	18938114	4	O
(	18938114	4	B-Gene
CFTR	18938114	4	I-Gene
)	18938114	4	I-Gene
gene	18938114	4	O
.	18938114	4	O
Mutational	18938114	4	O
spectrum	18938114	4	O
varies	18938114	4	O
in	18938114	4	O
accordance	18938114	4	O
with	18938114	4	O
geographic	18938114	4	O
and	18938114	4	O
/	18938114	4	O
or	18938114	4	O
ethnic	18938114	4	O
origin	18938114	4	O
.	18938114	4	O
In	18938114	4	O
this	18938114	4	O
study	18938114	4	O
,	18938114	4	O
we	18938114	4	O
have	18938114	4	O
analyzed	18938114	4	O
seven	18938114	4	O
common	18938114	4	B-Reg
CF	18938114	4	B-Disease
mutations	18938114	4	O
(	18938114	4	B-Var
p.F508del	18938114	4	I-Var
,	18938114	4	O
p.G542X	18938114	4	B-Var
,	18938114	4	O
p.R1162X	18938114	4	B-Var
,	18938114	4	O
p.N1303K	18938114	4	B-Var
,	18938114	4	O
p.R334W	18938114	4	B-Var
,	18938114	4	O
p.R553X	18938114	4	B-Var
and	18938114	4	O
c.3120	18938114	4	B-Var
1	18938114	4	I-Var
G	18938114	4	I-Var
>	18938114	4	I-Var
A	18938114	4	I-Var
)	18938114	4	I-Var
taking	18938114	4	O
into	18938114	4	O
account	18938114	4	O
the	18938114	4	O
ethnic	18938114	4	O
origin	18938114	4	O
of	18938114	4	O
the	18938114	4	O
Cuban	18938114	4	O
population	18938114	4	O
which	18938114	4	O
is	18938114	4	O
mainly	18938114	4	O
influenced	18938114	4	O
by	18938114	4	O
Spanish	18938114	4	O
and	18938114	4	O
sub	18938114	4	O
-	18938114	4	O
Sahara	18938114	4	O
African	18938114	4	O
contribution	18938114	4	O
.	18938114	4	O
All	18938114	4	O
but	18938114	4	O
p.N1303K	18938114	4	O
have	18938114	4	O
been	18938114	4	O
detected	18938114	4	O
in	18938114	4	O
our	18938114	4	O
patients	18938114	4	O
,	18938114	4	O
the	18938114	4	O
p.F508del	18938114	4	O
being	18938114	4	O
the	18938114	4	O
most	18938114	4	O
prevalent	18938114	4	O
(	18938114	4	O
37.9%	18938114	4	O
)	18938114	4	O
.	18938114	4	O
Overall	18938114	4	O
,	18938114	4	O
six	18938114	4	O
mutations	18938114	4	O
showed	18938114	4	O
frequencies	18938114	4	O
above	18938114	4	O
1%	18938114	4	O
accounting	18938114	4	O
for	18938114	4	O
55.5%	18938114	4	O
of	18938114	4	O
the	18938114	4	O
Cuban	18938114	4	O
CF	18938114	4	O
alleles	18938114	4	O
.	18938114	4	O

Mutation	19085932	4	B-Var
in	19085932	4	O
BAG3	19085932	4	B-Gene
causes	19085932	4	B-Reg
severe	19085932	4	O
dominant	19085932	4	O
childhood	19085932	4	B-Disease
muscular	19085932	4	I-Disease
dystrophy	19085932	4	I-Disease
.	19085932	4	O
OBJECTIVE	19085932	4	O
:	19085932	4	O
Myofibrillar	19085932	4	O
myopathies	19085932	4	O
(	19085932	4	O
MFMs	19085932	4	O
)	19085932	4	O
are	19085932	4	O
morphologically	19085932	4	O
distinct	19085932	4	O
but	19085932	4	O
genetically	19085932	4	O
heterogeneous	19085932	4	O
muscular	19085932	4	O
dystrophies	19085932	4	O
in	19085932	4	O
which	19085932	4	O
disintegration	19085932	4	O
of	19085932	4	O
Z	19085932	4	O
disks	19085932	4	O
and	19085932	4	O
then	19085932	4	O
of	19085932	4	O
myofibrils	19085932	4	O
is	19085932	4	O
followed	19085932	4	O
by	19085932	4	O
ectopic	19085932	4	O
accumulation	19085932	4	O
of	19085932	4	O
multiple	19085932	4	O
proteins	19085932	4	O
.	19085932	4	O
Cardiomyopathy	19085932	4	O
,	19085932	4	O
neuropathy	19085932	4	O
,	19085932	4	O
and	19085932	4	O
dominant	19085932	4	O
inheritance	19085932	4	O
are	19085932	4	O
frequent	19085932	4	O
associated	19085932	4	O
features	19085932	4	O
.	19085932	4	O
Mutations	19085932	4	O
in	19085932	4	O
alphaB	19085932	4	O
-	19085932	4	O
crystallin	19085932	4	O
,	19085932	4	O
desmin	19085932	4	O
,	19085932	4	O
myotilin	19085932	4	O
,	19085932	4	O
Zasp	19085932	4	O
,	19085932	4	O
or	19085932	4	O
filamin	19085932	4	O
-	19085932	4	O
C	19085932	4	O
can	19085932	4	O
cause	19085932	4	O
MFMs	19085932	4	O
and	19085932	4	O
were	19085932	4	O
detected	19085932	4	O
in	19085932	4	O
32	19085932	4	O
of	19085932	4	O
85	19085932	4	O
patients	19085932	4	O
of	19085932	4	O
the	19085932	4	O
Mayo	19085932	4	O
MFM	19085932	4	O
cohort	19085932	4	O
.	19085932	4	O
Bag3	19085932	4	O
,	19085932	4	O
another	19085932	4	O
Z	19085932	4	O
-	19085932	4	O
disk	19085932	4	O
-	19085932	4	O
associated	19085932	4	O
protein	19085932	4	O
,	19085932	4	O
has	19085932	4	O
antiapoptotic	19085932	4	O
properties	19085932	4	O
,	19085932	4	O
and	19085932	4	O
its	19085932	4	O
targeted	19085932	4	O
deletion	19085932	4	B-Var
in	19085932	4	O
mice	19085932	4	O
causes	19085932	4	B-Reg
fulminant	19085932	4	B-Disease
myopathy	19085932	4	I-Disease
with	19085932	4	O
early	19085932	4	O
lethality	19085932	4	O
.	19085932	4	O
We	19085932	4	O
therefore	19085932	4	O
searched	19085932	4	O
for	19085932	4	O
mutations	19085932	4	O
in	19085932	4	O
BAG3	19085932	4	O
in	19085932	4	O
53	19085932	4	O
unrelated	19085932	4	O
MFM	19085932	4	O
patients	19085932	4	O
.	19085932	4	O
METHODS	19085932	4	O
:	19085932	4	O
We	19085932	4	O
searched	19085932	4	O
for	19085932	4	O
mutations	19085932	4	O
in	19085932	4	O
BAG3	19085932	4	O
by	19085932	4	O
direct	19085932	4	O
sequencing	19085932	4	O
.	19085932	4	O
We	19085932	4	O
analyzed	19085932	4	O
structural	19085932	4	O
changes	19085932	4	O
in	19085932	4	O
muscle	19085932	4	O
by	19085932	4	O
histochemistry	19085932	4	O
,	19085932	4	O
immunocytochemistry	19085932	4	O
,	19085932	4	O
and	19085932	4	O
electron	19085932	4	O
microscopy	19085932	4	O
,	19085932	4	O
examined	19085932	4	O
mobility	19085932	4	O
of	19085932	4	O
the	19085932	4	O
mutant	19085932	4	O
Bag3	19085932	4	O
by	19085932	4	O
nondenaturing	19085932	4	O
electrophoresis	19085932	4	O
,	19085932	4	O
and	19085932	4	O
searched	19085932	4	O
for	19085932	4	O
abnormal	19085932	4	O
aggregation	19085932	4	O
of	19085932	4	O
the	19085932	4	O
mutant	19085932	4	O
protein	19085932	4	O
in	19085932	4	O
COS-7	19085932	4	O
(	19085932	4	O
SV-40	19085932	4	O
transformed	19085932	4	O
monkey	19085932	4	O
kidney	19085932	4	O
fibroblast-7	19085932	4	O
)	19085932	4	O
cells	19085932	4	O
.	19085932	4	O
RESULTS	19085932	4	O
:	19085932	4	O
We	19085932	4	O
identified	19085932	4	O
a	19085932	4	O
heterozygous	19085932	4	O
p.Pro209Leu	19085932	4	O
mutation	19085932	4	O
in	19085932	4	O
three	19085932	4	O
patients	19085932	4	O
.	19085932	4	O
All	19085932	4	O
presented	19085932	4	O
in	19085932	4	O
childhood	19085932	4	O
,	19085932	4	O
had	19085932	4	O
progressive	19085932	4	O
limb	19085932	4	O
and	19085932	4	O
axial	19085932	4	O
muscle	19085932	4	O
weakness	19085932	4	O
,	19085932	4	O
and	19085932	4	O
experienced	19085932	4	O
development	19085932	4	O
of	19085932	4	O
cardiomyopathy	19085932	4	O
and	19085932	4	O
severe	19085932	4	O
respiratory	19085932	4	O
insufficiency	19085932	4	O
in	19085932	4	O
their	19085932	4	O
teens	19085932	4	O
;	19085932	4	O
two	19085932	4	O
had	19085932	4	O
rigid	19085932	4	O
spines	19085932	4	O
,	19085932	4	O
and	19085932	4	O
one	19085932	4	O
a	19085932	4	O
peripheral	19085932	4	O
neuropathy	19085932	4	O
.	19085932	4	O
Electron	19085932	4	O
microscopy	19085932	4	O
showed	19085932	4	O
disintegration	19085932	4	O
of	19085932	4	O
Z	19085932	4	O
disks	19085932	4	O
,	19085932	4	O
extensive	19085932	4	O
accumulation	19085932	4	O
of	19085932	4	O
granular	19085932	4	O
debris	19085932	4	O
and	19085932	4	O
larger	19085932	4	O
inclusions	19085932	4	O
,	19085932	4	O
and	19085932	4	O
apoptosis	19085932	4	O
of	19085932	4	O
8%	19085932	4	O
of	19085932	4	O
the	19085932	4	O
nuclei	19085932	4	O
.	19085932	4	O
On	19085932	4	O
nondenaturing	19085932	4	O
electrophoresis	19085932	4	O
of	19085932	4	O
muscle	19085932	4	O
extracts	19085932	4	O
,	19085932	4	O
the	19085932	4	O
Bag3	19085932	4	O
complex	19085932	4	O
migrated	19085932	4	O
faster	19085932	4	O
in	19085932	4	O
patient	19085932	4	O
than	19085932	4	O
control	19085932	4	O
extracts	19085932	4	O
,	19085932	4	O
and	19085932	4	O
expression	19085932	4	O
of	19085932	4	O
FLAG	19085932	4	O
-	19085932	4	O
labeled	19085932	4	O
mutant	19085932	4	O
and	19085932	4	O
wild	19085932	4	O
-	19085932	4	O
type	19085932	4	O
Bag3	19085932	4	O
in	19085932	4	O
COS	19085932	4	O
cells	19085932	4	O
showed	19085932	4	O
abnormal	19085932	4	O
aggregation	19085932	4	O
of	19085932	4	O
the	19085932	4	O
mutant	19085932	4	O
protein	19085932	4	O
.	19085932	4	O
INTERPRETATION	19085932	4	O
:	19085932	4	O
We	19085932	4	O
conclude	19085932	4	O
mutation	19085932	4	O
in	19085932	4	O
Bag3	19085932	4	O
defines	19085932	4	O
a	19085932	4	O
novel	19085932	4	O
severe	19085932	4	O
autosomal	19085932	4	O
dominant	19085932	4	O
childhood	19085932	4	O
muscular	19085932	4	O
dystrophy	19085932	4	O
.	19085932	4	O

Network	19108832	3	O
analyses	19108832	3	O
of	19108832	3	O
differentially	19108832	3	O
expressed	19108832	3	O
proteins	19108832	3	O
in	19108832	3	O
amniotic	19108832	3	O
fluid	19108832	3	O
supernatant	19108832	3	O
associated	19108832	3	O
with	19108832	3	O
abnormal	19108832	3	O
human	19108832	3	O
karyotypes	19108832	3	O
.	19108832	3	O
OBJECTIVE	19108832	3	O
:	19108832	3	O
To	19108832	3	O
investigate	19108832	3	O
the	19108832	3	O
functional	19108832	3	O
roles	19108832	3	O
of	19108832	3	O
differentially	19108832	3	O
expressed	19108832	3	O
proteins	19108832	3	O
in	19108832	3	O
the	19108832	3	O
amniotic	19108832	3	B-Disease
fluid	19108832	3	I-Disease
supernatant	19108832	3	I-Disease
(	19108832	3	O
AFS	19108832	3	O
)	19108832	3	O
with	19108832	3	O
abnormal	19108832	3	O
karyotypes	19108832	3	O
.	19108832	3	O
DESIGN	19108832	3	O
:	19108832	3	O
Basic	19108832	3	O
and	19108832	3	O
clinical	19108832	3	O
research	19108832	3	O
.	19108832	3	O
SETTING	19108832	3	O
:	19108832	3	O
University	19108832	3	O
hospital	19108832	3	O
.	19108832	3	O
PATIENT	19108832	3	O
(	19108832	3	O
S	19108832	3	O
)	19108832	3	O
:	19108832	3	O
Samples	19108832	3	O
of	19108832	3	O
AFS	19108832	3	O
from	19108832	3	O
34	19108832	3	O
fetuses	19108832	3	O
with	19108832	3	O
normal	19108832	3	O
-	19108832	3	O
karyotype	19108832	3	O
,	19108832	3	O
17	19108832	3	O
with	19108832	3	O
trisomy	19108832	3	O
18	19108832	3	O
,	19108832	3	O
and	19108832	3	O
19	19108832	3	O
with	19108832	3	O
trisomy	19108832	3	O
21	19108832	3	O
.	19108832	3	O
INTERVENTION	19108832	3	O
(	19108832	3	O
S	19108832	3	O
)	19108832	3	O
:	19108832	3	O
Two	19108832	3	O
-	19108832	3	O
dimensional	19108832	3	O
chromatography	19108832	3	O
followed	19108832	3	O
by	19108832	3	O
mass	19108832	3	O
spectrometry	19108832	3	O
to	19108832	3	O
identify	19108832	3	O
the	19108832	3	O
proteins	19108832	3	O
differentially	19108832	3	O
expressed	19108832	3	O
in	19108832	3	O
AFS	19108832	3	O
of	19108832	3	O
trisomy-18	19108832	3	O
or	19108832	3	O
trisomy-21	19108832	3	O
fetuses	19108832	3	O
.	19108832	3	O
MAIN	19108832	3	O
OUTCOME	19108832	3	O
MEASURE	19108832	3	O
(	19108832	3	O
S	19108832	3	O
)	19108832	3	O
:	19108832	3	O
Differentially	19108832	3	O
expressed	19108832	3	O
proteins	19108832	3	O
were	19108832	3	O
confirmed	19108832	3	O
with	19108832	3	O
Western	19108832	3	O
blot	19108832	3	O
analysis	19108832	3	O
and	19108832	3	O
ELISA	19108832	3	O
.	19108832	3	O
The	19108832	3	O
roles	19108832	3	O
of	19108832	3	O
biologic	19108832	3	O
networks	19108832	3	O
in	19108832	3	O
the	19108832	3	O
pathophysiology	19108832	3	O
of	19108832	3	O
aneuploidies	19108832	3	O
were	19108832	3	O
analyzed	19108832	3	O
using	19108832	3	O
MetaCore	19108832	3	O
mapping	19108832	3	O
tools	19108832	3	O
.	19108832	3	O
RESULT	19108832	3	O
(	19108832	3	O
S	19108832	3	O
)	19108832	3	O
:	19108832	3	O
Levels	19108832	3	O
of	19108832	3	O
apolipoprotein	19108832	3	O
A1	19108832	3	O
,	19108832	3	O
AP-3	19108832	3	O
mu	19108832	3	O
,	19108832	3	O
and	19108832	3	O
antitrypsin	19108832	3	O
were	19108832	3	O
significantly	19108832	3	O
decreased	19108832	3	B-NegReg
in	19108832	3	O
trisomy-18	19108832	3	B-Var
AFS	19108832	3	O
,	19108832	3	O
whereas	19108832	3	O
placental	19108832	3	O
protein-14	19108832	3	O
was	19108832	3	O
increased	19108832	3	B-PosReg
.	19108832	3	O
On	19108832	3	O
the	19108832	3	O
other	19108832	3	O
hand	19108832	3	O
,	19108832	3	O
apolipoprotein	19108832	3	O
A1	19108832	3	O
was	19108832	3	O
decreased	19108832	3	B-NegReg
in	19108832	3	O
trisomy-21	19108832	3	B-Var
AFS	19108832	3	O
,	19108832	3	O
but	19108832	3	O
antitrypsin	19108832	3	O
,	19108832	3	O
prealbumin	19108832	3	O
,	19108832	3	O
and	19108832	3	O
transferrin	19108832	3	O
were	19108832	3	O
increased	19108832	3	B-PosReg
in	19108832	3	O
trisomy	19108832	3	B-Var
21	19108832	3	I-Var
.	19108832	3	O
Biologic	19108832	3	O
network	19108832	3	O
analyses	19108832	3	O
revealed	19108832	3	O
that	19108832	3	O
the	19108832	3	O
proteins	19108832	3	O
of	19108832	3	O
the	19108832	3	O
trisomy-18	19108832	3	O
AFS	19108832	3	O
network	19108832	3	O
were	19108832	3	O
involved	19108832	3	O
in	19108832	3	O
immune	19108832	3	O
processes	19108832	3	O
,	19108832	3	O
dysfunction	19108832	3	O
of	19108832	3	O
skin	19108832	3	O
pigmentation	19108832	3	O
,	19108832	3	O
and	19108832	3	O
platelet	19108832	3	O
disorders	19108832	3	O
,	19108832	3	O
whereas	19108832	3	O
those	19108832	3	O
of	19108832	3	O
trisomy	19108832	3	O
21	19108832	3	O
were	19108832	3	O
associated	19108832	3	O
with	19108832	3	O
dysfunctional	19108832	3	O
lipid	19108832	3	O
and	19108832	3	O
cholesterol	19108832	3	O
metabolism	19108832	3	O
,	19108832	3	O
processes	19108832	3	O
of	19108832	3	O
metal	19108832	3	O
ion	19108832	3	O
transport	19108832	3	O
,	19108832	3	O
adenosine	19108832	3	O
triphosphate	19108832	3	O
metabolism	19108832	3	O
,	19108832	3	O
and	19108832	3	O
energy	19108832	3	O
-	19108832	3	O
coupled	19108832	3	O
protein	19108832	3	O
transport	19108832	3	O
.	19108832	3	O
CONCLUSION	19108832	3	O
(	19108832	3	O
S	19108832	3	O
)	19108832	3	O
:	19108832	3	O
The	19108832	3	O
combined	19108832	3	O
use	19108832	3	O
of	19108832	3	O
quantitative	19108832	3	O
proteomics	19108832	3	O
and	19108832	3	O
functional	19108832	3	O
network	19108832	3	O
analyses	19108832	3	O
may	19108832	3	O
integrally	19108832	3	O
analyze	19108832	3	O
the	19108832	3	O
pathophysiology	19108832	3	O
of	19108832	3	O
abnormal	19108832	3	O
karyotypes	19108832	3	O
.	19108832	3	O

Canonical	19137020	0	O
WNT	19137020	0	O
signalling	19137020	0	O
determines	19137020	0	O
lineage	19137020	0	O
specificity	19137020	0	O
in	19137020	0	O
Wilms	19137020	0	O
tumour	19137020	0	O
.	19137020	0	O
Wilms	19137020	0	O
tumours	19137020	0	O
(	19137020	0	O
WTs	19137020	0	O
)	19137020	0	O
have	19137020	0	O
two	19137020	0	O
distinct	19137020	0	O
types	19137020	0	O
of	19137020	0	O
histology	19137020	0	O
with	19137020	0	O
or	19137020	0	O
without	19137020	0	O
ectopic	19137020	0	O
mesenchymal	19137020	0	O
elements	19137020	0	O
,	19137020	0	O
suggesting	19137020	0	O
that	19137020	0	O
WTs	19137020	0	O
arise	19137020	0	O
from	19137020	0	O
either	19137020	0	O
the	19137020	0	O
mesenchymal	19137020	0	O
or	19137020	0	O
epithelial	19137020	0	O
nephrogenic	19137020	0	O
lineages	19137020	0	O
.	19137020	0	O
Regardless	19137020	0	O
of	19137020	0	O
the	19137020	0	O
presence	19137020	0	O
or	19137020	0	O
absence	19137020	0	O
of	19137020	0	O
CTNNB1	19137020	0	O
mutations	19137020	0	O
,	19137020	0	O
nuclear	19137020	0	O
accumulation	19137020	0	O
of	19137020	0	O
beta	19137020	0	O
-	19137020	0	O
catenin	19137020	0	O
is	19137020	0	O
often	19137020	0	O
observed	19137020	0	O
in	19137020	0	O
WTs	19137020	0	O
with	19137020	0	O
ectopic	19137020	0	O
mesenchymal	19137020	0	O
elements	19137020	0	O
.	19137020	0	O
Here	19137020	0	O
,	19137020	0	O
we	19137020	0	O
addressed	19137020	0	O
the	19137020	0	O
relationship	19137020	0	O
between	19137020	0	O
the	19137020	0	O
WNT	19137020	0	O
-	19137020	0	O
signalling	19137020	0	O
pathway	19137020	0	O
and	19137020	0	O
lineage	19137020	0	O
in	19137020	0	O
WTs	19137020	0	O
by	19137020	0	O
examining	19137020	0	O
CTNNB1	19137020	0	O
and	19137020	0	O
WT1	19137020	0	O
mutations	19137020	0	O
,	19137020	0	O
nuclear	19137020	0	O
accumulation	19137020	0	O
of	19137020	0	O
beta	19137020	0	O
-	19137020	0	O
catenin	19137020	0	O
,	19137020	0	O
tumour	19137020	0	O
histology	19137020	0	O
and	19137020	0	O
gene	19137020	0	O
expression	19137020	0	O
profiles	19137020	0	O
.	19137020	0	O
In	19137020	0	O
addition	19137020	0	O
,	19137020	0	O
we	19137020	0	O
screened	19137020	0	O
for	19137020	0	O
mutations	19137020	0	B-Var
in	19137020	0	O
WTX	19137020	0	B-Gene
,	19137020	0	O
which	19137020	0	O
has	19137020	0	O
been	19137020	0	O
proposed	19137020	0	O
to	19137020	0	O
be	19137020	0	O
a	19137020	0	O
negative	19137020	0	B-NegReg
regulator	19137020	0	O
of	19137020	0	O
the	19137020	0	O
canonical	19137020	0	O
WNT	19137020	0	O
-	19137020	0	O
signalling	19137020	0	O
pathway	19137020	0	O
.	19137020	0	O
Unsupervised	19137020	0	O
clustering	19137020	0	O
analysis	19137020	0	O
identified	19137020	0	O
two	19137020	0	O
classes	19137020	0	O
of	19137020	0	O
tumours	19137020	0	O
:	19137020	0	O
mesenchymal	19137020	0	O
lineage	19137020	0	O
WNT	19137020	0	O
-	19137020	0	O
dependent	19137020	0	O
tumours	19137020	0	O
,	19137020	0	O
and	19137020	0	O
epithelial	19137020	0	O
lineage	19137020	0	O
WNT	19137020	0	O
-	19137020	0	O
independent	19137020	0	O
tumours	19137020	0	O
.	19137020	0	O
In	19137020	0	O
contrast	19137020	0	O
to	19137020	0	O
the	19137020	0	O
mesenchymal	19137020	0	O
lineage	19137020	0	O
specificity	19137020	0	O
of	19137020	0	O
CTNNB1	19137020	0	O
mutations	19137020	0	O
,	19137020	0	O
WTX	19137020	0	O
mutations	19137020	0	O
were	19137020	0	O
surprisingly	19137020	0	O
observed	19137020	0	O
in	19137020	0	O
both	19137020	0	O
lineages	19137020	0	O
.	19137020	0	O
WTX	19137020	0	B-Var
-	19137020	0	I-Var
mutant	19137020	0	I-Var
WTs	19137020	0	O
with	19137020	0	O
ectopic	19137020	0	O
mesenchymal	19137020	0	O
elements	19137020	0	O
had	19137020	0	O
nuclear	19137020	0	O
accumulation	19137020	0	B-PosReg
of	19137020	0	O
beta	19137020	0	O
-	19137020	0	O
catenin	19137020	0	O
,	19137020	0	O
upregulation	19137020	0	B-PosReg
of	19137020	0	O
WNT	19137020	0	B-Gene
target	19137020	0	I-Gene
genes	19137020	0	I-Gene
and	19137020	0	O
an	19137020	0	O
association	19137020	0	B-Reg
with	19137020	0	I-Reg
CTNNB1	19137020	0	B-Gene
mutations	19137020	0	B-Var
in	19137020	0	O
exon	19137020	0	O
7	19137020	0	O
or	19137020	0	O
8	19137020	0	O
.	19137020	0	O
However	19137020	0	O
,	19137020	0	O
epithelial	19137020	0	O
lineage	19137020	0	O
WTs	19137020	0	O
with	19137020	0	O
WTX	19137020	0	O
mutations	19137020	0	O
had	19137020	0	O
no	19137020	0	O
indications	19137020	0	O
of	19137020	0	O
active	19137020	0	O
WNT	19137020	0	O
signalling	19137020	0	O
,	19137020	0	O
suggesting	19137020	0	O
that	19137020	0	O
the	19137020	0	O
involvement	19137020	0	O
of	19137020	0	O
WTX	19137020	0	O
in	19137020	0	O
the	19137020	0	O
WNT	19137020	0	O
-	19137020	0	O
signalling	19137020	0	O
pathway	19137020	0	O
may	19137020	0	O
be	19137020	0	O
lineage	19137020	0	O
dependent	19137020	0	O
,	19137020	0	O
and	19137020	0	O
that	19137020	0	O
WTX	19137020	0	O
may	19137020	0	O
have	19137020	0	O
an	19137020	0	O
alternative	19137020	0	O
function	19137020	0	O
to	19137020	0	O
its	19137020	0	O
role	19137020	0	O
in	19137020	0	O
the	19137020	0	O
canonical	19137020	0	O
WNT	19137020	0	O
-	19137020	0	O
signalling	19137020	0	O
pathway	19137020	0	O
.	19137020	0	O

Apparent	19169481	2	B-Disease
mineralocorticoid	19169481	2	I-Disease
excess	19169481	2	I-Disease
syndrome	19169481	2	I-Disease
in	19169481	2	O
a	19169481	2	O
Brazilian	19169481	2	O
boy	19169481	2	O
caused	19169481	2	B-Reg
by	19169481	2	I-Reg
the	19169481	2	O
homozygous	19169481	2	O
missense	19169481	2	O
mutation	19169481	2	O
p.R186C	19169481	2	B-Var
in	19169481	2	O
the	19169481	2	O
HSD11B2	19169481	2	B-Gene
gene	19169481	2	O
.	19169481	2	O
The	19169481	2	O
apparent	19169481	2	O
mineralocorticoid	19169481	2	O
excess	19169481	2	O
syndrome	19169481	2	O
(	19169481	2	O
AME	19169481	2	O
)	19169481	2	O
is	19169481	2	O
a	19169481	2	O
rare	19169481	2	O
autosomal	19169481	2	O
recessive	19169481	2	O
disorder	19169481	2	O
due	19169481	2	O
to	19169481	2	O
the	19169481	2	O
deficiency	19169481	2	O
of	19169481	2	O
11	19169481	2	O
beta	19169481	2	O
-	19169481	2	O
hydroxysteroid	19169481	2	O
dehydrogenase	19169481	2	O
type	19169481	2	O
2	19169481	2	O
enzyme	19169481	2	O
(	19169481	2	O
11	19169481	2	O
beta	19169481	2	O
-	19169481	2	O
HSD2	19169481	2	O
)	19169481	2	O
.	19169481	2	O
The	19169481	2	O
11	19169481	2	O
beta	19169481	2	O
-	19169481	2	O
HSD2	19169481	2	O
enzyme	19169481	2	O
,	19169481	2	O
encoded	19169481	2	O
by	19169481	2	O
HSD11B2	19169481	2	O
gene	19169481	2	O
,	19169481	2	O
metabolizes	19169481	2	O
active	19169481	2	O
cortisol	19169481	2	O
in	19169481	2	O
cortisone	19169481	2	O
.	19169481	2	O
Mutations	19169481	2	B-Var
on	19169481	2	O
HSD11B2	19169481	2	B-Gene
gene	19169481	2	O
affect	19169481	2	B-Reg
the	19169481	2	O
enzyme	19169481	2	O
activity	19169481	2	O
by	19169481	2	O
leading	19169481	2	O
to	19169481	2	O
an	19169481	2	O
excess	19169481	2	B-PosReg
of	19169481	2	O
cortisol	19169481	2	O
,	19169481	2	O
which	19169481	2	O
causes	19169481	2	B-Reg
its	19169481	2	O
inappropriate	19169481	2	O
access	19169481	2	O
to	19169481	2	O
mineralocorticoid	19169481	2	O
receptor	19169481	2	O
.	19169481	2	O
Therefore	19169481	2	O
,	19169481	2	O
cortisol	19169481	2	O
will	19169481	2	O
bind	19169481	2	O
mineralocorticoid	19169481	2	O
receptor	19169481	2	O
.	19169481	2	O
The	19169481	2	O
human	19169481	2	O
HSD11B2	19169481	2	O
gene	19169481	2	O
maps	19169481	2	O
to	19169481	2	O
chromosome	19169481	2	O
16	19169481	2	O
q22	19169481	2	O
and	19169481	2	O
consists	19169481	2	O
of	19169481	2	O
five	19169481	2	O
exons	19169481	2	O
encoding	19169481	2	O
a	19169481	2	O
protein	19169481	2	O
of	19169481	2	O
405	19169481	2	O
amino	19169481	2	O
acids	19169481	2	O
.	19169481	2	O
We	19169481	2	O
present	19169481	2	O
here	19169481	2	O
clinical	19169481	2	O
and	19169481	2	O
molecular	19169481	2	O
studies	19169481	2	O
on	19169481	2	O
a	19169481	2	O
Brazilian	19169481	2	O
boy	19169481	2	O
who	19169481	2	O
was	19169481	2	O
born	19169481	2	O
pre	19169481	2	O
-	19169481	2	O
term	19169481	2	O
after	19169481	2	O
an	19169481	2	O
oligodramnious	19169481	2	O
pregnancy	19169481	2	O
.	19169481	2	O
He	19169481	2	O
was	19169481	2	O
diagnosed	19169481	2	O
as	19169481	2	O
having	19169481	2	O
AME	19169481	2	O
at	19169481	2	O
the	19169481	2	O
age	19169481	2	O
of	19169481	2	O
26	19169481	2	O
months	19169481	2	O
.	19169481	2	O
His	19169481	2	O
parents	19169481	2	O
are	19169481	2	O
second	19169481	2	O
cousins	19169481	2	O
.	19169481	2	O
Molecular	19169481	2	O
characterization	19169481	2	O
of	19169481	2	O
the	19169481	2	O
HSD11B2	19169481	2	O
gene	19169481	2	O
revealed	19169481	2	O
the	19169481	2	O
homozygous	19169481	2	O
mutation	19169481	2	O
p.R186C	19169481	2	O
.	19169481	2	O
The	19169481	2	O
patient	19169481	2	O
described	19169481	2	O
here	19169481	2	O
is	19169481	2	O
the	19169481	2	O
second	19169481	2	O
case	19169481	2	O
of	19169481	2	O
HDS11B2	19169481	2	B-Gene
gene	19169481	2	O
mutation	19169481	2	B-Var
reported	19169481	2	O
in	19169481	2	O
Brazilian	19169481	2	O
patients	19169481	2	O
with	19169481	2	B-Reg
AME	19169481	2	B-Disease
.	19169481	2	O

[	19245173	4	O
Primary	19245173	4	O
hiperoxaluria	19245173	4	O
:	19245173	4	O
a	19245173	4	O
new	19245173	4	O
mutation	19245173	4	O
in	19245173	4	O
gen	19245173	4	O
AGXT	19245173	4	B-Gene
(	19245173	4	B-Var
R197Q	19245173	4	I-Var
)	19245173	4	I-Var
cause	19245173	4	B-Reg
of	19245173	4	I-Reg
neonatal	19245173	4	B-Disease
convulsions	19245173	4	I-Disease
]	19245173	4	I-Disease
.	19245173	4	O
Hiperoxaluria	19245173	4	O
primaria	19245173	4	O
:	19245173	4	O
una	19245173	4	O
nueva	19245173	4	O
mutación	19245173	4	O
en	19245173	4	O
el	19245173	4	O
gen	19245173	4	O
AGXT	19245173	4	O
(	19245173	4	O
r197q	19245173	4	O
)	19245173	4	O
causante	19245173	4	O
de	19245173	4	O
convulsiones	19245173	4	O
neonatales	19245173	4	O
.	19245173	4	O
Primary	19245173	4	O
hyperoxaluria	19245173	4	O
is	19245173	4	O
a	19245173	4	O
congenital	19245173	4	O
innate	19245173	4	O
error	19245173	4	O
of	19245173	4	O
the	19245173	4	O
metabolism	19245173	4	O
of	19245173	4	O
the	19245173	4	O
amino	19245173	4	O
acids	19245173	4	O
,	19245173	4	O
that	19245173	4	O
is	19245173	4	O
transmitted	19245173	4	O
like	19245173	4	O
an	19245173	4	O
autosomal	19245173	4	O
recessive	19245173	4	O
character	19245173	4	O
.	19245173	4	O
Two	19245173	4	O
types	19245173	4	O
of	19245173	4	O
hyperoxaluria	19245173	4	O
exist	19245173	4	O
:	19245173	4	O
the	19245173	4	O
primary	19245173	4	O
type	19245173	4	O
I	19245173	4	O
,	19245173	4	O
that	19245173	4	O
corresponds	19245173	4	O
to	19245173	4	O
the	19245173	4	O
peroxisomal	19245173	4	O
enzymatic	19245173	4	O
deficit	19245173	4	O
of	19245173	4	O
the	19245173	4	O
alanine	19245173	4	O
glyoxylate	19245173	4	O
aminotransferase	19245173	4	O
in	19245173	4	O
the	19245173	4	O
liver	19245173	4	O
(	19245173	4	O
AGT	19245173	4	O
)	19245173	4	O
and	19245173	4	O
type	19245173	4	O
II	19245173	4	O
,	19245173	4	O
due	19245173	4	O
to	19245173	4	O
the	19245173	4	O
deficit	19245173	4	O
of	19245173	4	O
the	19245173	4	O
glyoxylate	19245173	4	O
reductase	19245173	4	O
/	19245173	4	O
hydroxypyruvate	19245173	4	O
reductase	19245173	4	O
deficiency	19245173	4	O
(	19245173	4	O
GRHPR	19245173	4	O
)	19245173	4	O
.	19245173	4	O
The	19245173	4	O
primary	19245173	4	O
type	19245173	4	O
I	19245173	4	O
(	19245173	4	O
AGT	19245173	4	O
)	19245173	4	O
is	19245173	4	O
the	19245173	4	O
most	19245173	4	O
frequenty	19245173	4	O
.	19245173	4	O
We	19245173	4	O
report	19245173	4	O
the	19245173	4	O
case	19245173	4	O
of	19245173	4	O
a	19245173	4	O
female	19245173	4	O
infant	19245173	4	O
of	19245173	4	O
one	19245173	4	O
month	19245173	4	O
of	19245173	4	O
age	19245173	4	O
,	19245173	4	O
that	19245173	4	O
on	19245173	4	O
her	19245173	4	O
first	19245173	4	O
day	19245173	4	O
post	19245173	4	O
birth	19245173	4	O
,	19245173	4	O
presented	19245173	4	O
myoclonic	19245173	4	O
convulsions	19245173	4	O
and	19245173	4	O
tonic	19245173	4	O
spasms	19245173	4	O
,	19245173	4	O
both	19245173	4	O
during	19245173	4	O
wakefullness	19245173	4	O
and	19245173	4	O
sleep	19245173	4	O
periods	19245173	4	O
,	19245173	4	O
that	19245173	4	O
became	19245173	4	O
more	19245173	4	O
frequent	19245173	4	O
and	19245173	4	O
did	19245173	4	O
not	19245173	4	O
respond	19245173	4	O
to	19245173	4	O
the	19245173	4	O
use	19245173	4	O
of	19245173	4	O
anticonvulsants	19245173	4	O
.	19245173	4	O
The	19245173	4	O
ictal	19245173	4	O
Electroencephalogram	19245173	4	O
presented	19245173	4	O
an	19245173	4	O
intermittent	19245173	4	O
activity	19245173	4	O
of	19245173	4	O
spikes	19245173	4	O
and	19245173	4	O
spike	19245173	4	O
-	19245173	4	O
waves	19245173	4	O
of	19245173	4	O
high	19245173	4	O
voltage	19245173	4	O
in	19245173	4	O
the	19245173	4	O
right	19245173	4	O
hemisphere	19245173	4	O
.	19245173	4	O
Eight	19245173	4	O
minutes	19245173	4	O
after	19245173	4	O
the	19245173	4	O
intravenous	19245173	4	O
administration	19245173	4	O
of	19245173	4	O
150	19245173	4	O
mg	19245173	4	O
of	19245173	4	O
pyridoxine	19245173	4	O
,	19245173	4	O
it	19245173	4	O
was	19245173	4	O
observed	19245173	4	O
a	19245173	4	O
diminution	19245173	4	O
of	19245173	4	O
the	19245173	4	O
epileptic	19245173	4	O
activity	19245173	4	O
,	19245173	4	O
as	19245173	4	O
well	19245173	4	O
as	19245173	4	O
the	19245173	4	O
clinical	19245173	4	O
manifestations	19245173	4	O
.	19245173	4	O
The	19245173	4	O
determination	19245173	4	O
of	19245173	4	O
organic	19245173	4	O
acids	19245173	4	O
in	19245173	4	O
urine	19245173	4	O
revealed	19245173	4	O
an	19245173	4	O
increase	19245173	4	O
in	19245173	4	O
the	19245173	4	O
concentration	19245173	4	O
levels	19245173	4	O
of	19245173	4	O
oxalic	19245173	4	O
acid	19245173	4	O
(	19245173	4	O
3064	19245173	4	O
mmol	19245173	4	O
/	19245173	4	O
mol	19245173	4	O
of	19245173	4	O
creatinine	19245173	4	O
)	19245173	4	O
.	19245173	4	O
The	19245173	4	O
molecular	19245173	4	O
genetic	19245173	4	O
study	19245173	4	O
of	19245173	4	O
the	19245173	4	O
AGXT	19245173	4	O
gene	19245173	4	O
,	19245173	4	O
showed	19245173	4	O
the	19245173	4	O
existence	19245173	4	O
of	19245173	4	O
a	19245173	4	O
R197Q	19245173	4	O
mutation	19245173	4	O
in	19245173	4	O
exón	19245173	4	O
5	19245173	4	O
of	19245173	4	O
the	19245173	4	O
patient	19245173	4	O
and	19245173	4	O
her	19245173	4	O
father	19245173	4	O
.	19245173	4	O
She	19245173	4	O
received	19245173	4	O
treatment	19245173	4	O
with	19245173	4	O
pyridoxine	19245173	4	O
at	19245173	4	O
a	19245173	4	O
dose	19245173	4	O
of	19245173	4	O
50	19245173	4	O
mg	19245173	4	O
/	19245173	4	O
day	19245173	4	O
.	19245173	4	O
When	19245173	4	O
she	19245173	4	O
reached	19245173	4	O
the	19245173	4	O
age	19245173	4	O
of	19245173	4	O
three	19245173	4	O
months	19245173	4	O
both	19245173	4	O
a	19245173	4	O
normal	19245173	4	O
electroencephalogram	19245173	4	O
and	19245173	4	O
biochemistry	19245173	4	O
were	19245173	4	O
obtained	19245173	4	O
.	19245173	4	O
Although	19245173	4	O
it	19245173	4	O
is	19245173	4	O
a	19245173	4	O
rare	19245173	4	O
cause	19245173	4	O
of	19245173	4	O
neonatal	19245173	4	O
convulsions	19245173	4	O
,	19245173	4	O
hyperoxaluria	19245173	4	O
,	19245173	4	O
due	19245173	4	O
to	19245173	4	O
new	19245173	4	O
mutations	19245173	4	O
is	19245173	4	O
an	19245173	4	O
underdiagnosed	19245173	4	O
disease	19245173	4	O
by	19245173	4	O
neonatologists	19245173	4	O
and	19245173	4	O
paediatricias	19245173	4	O
.	19245173	4	O

Identification	19288050	1	O
of	19288050	1	O
the	19288050	1	O
CLCN7	19288050	1	B-Gene
gene	19288050	1	O
mutations	19288050	1	B-Var
in	19288050	1	O
two	19288050	1	O
Chinese	19288050	1	O
families	19288050	1	O
with	19288050	1	B-Reg
autosomal	19288050	1	B-Disease
dominant	19288050	1	I-Disease
osteopetrosis	19288050	1	I-Disease
(	19288050	1	I-Disease
type	19288050	1	I-Disease
II	19288050	1	I-Disease
)	19288050	1	I-Disease
.	19288050	1	O
Here	19288050	1	O
we	19288050	1	O
report	19288050	1	O
the	19288050	1	O
identification	19288050	1	O
of	19288050	1	O
two	19288050	1	O
different	19288050	1	O
mutations	19288050	1	O
in	19288050	1	O
chloride	19288050	1	O
channel	19288050	1	O
7	19288050	1	O
gene	19288050	1	O
in	19288050	1	O
two	19288050	1	O
unrelated	19288050	1	O
patients	19288050	1	O
with	19288050	1	O
autosomal	19288050	1	O
dominant	19288050	1	O
osteopetrosis	19288050	1	O
type	19288050	1	O
II	19288050	1	O
.	19288050	1	O
We	19288050	1	O
determined	19288050	1	O
that	19288050	1	O
one	19288050	1	O
patient	19288050	1	O
(	19288050	1	O
a	19288050	1	O
32	19288050	1	O
-	19288050	1	O
year	19288050	1	O
-	19288050	1	O
old	19288050	1	O
woman	19288050	1	O
)	19288050	1	O
carried	19288050	1	O
a	19288050	1	O
heterozygous	19288050	1	O
gene	19288050	1	O
for	19288050	1	O
a	19288050	1	O
R767W	19288050	1	O
mutation	19288050	1	O
in	19288050	1	O
exon	19288050	1	O
24	19288050	1	O
,	19288050	1	O
and	19288050	1	O
another	19288050	1	O
patient	19288050	1	O
(	19288050	1	O
a	19288050	1	O
17	19288050	1	O
-	19288050	1	O
year	19288050	1	O
-	19288050	1	O
old	19288050	1	O
boy	19288050	1	O
)	19288050	1	O
carried	19288050	1	O
a	19288050	1	O
heterozygous	19288050	1	O
gene	19288050	1	O
for	19288050	1	O
a	19288050	1	O
novel	19288050	1	O
frameshift	19288050	1	O
mutation	19288050	1	O
(	19288050	1	O
Glu798FS	19288050	1	O
)	19288050	1	O
in	19288050	1	O
exon	19288050	1	O
25	19288050	1	O
.	19288050	1	O
Recent	19288050	1	O
studies	19288050	1	O
have	19288050	1	O
reported	19288050	1	O
loss	19288050	1	B-NegReg
-	19288050	1	I-NegReg
of	19288050	1	I-NegReg
-	19288050	1	I-NegReg
function	19288050	1	I-NegReg
mutations	19288050	1	B-Var
in	19288050	1	O
the	19288050	1	O
chloride	19288050	1	O
channel	19288050	1	O
7	19288050	1	O
(	19288050	1	B-Gene
CLCN7	19288050	1	I-Gene
)	19288050	1	I-Gene
gene	19288050	1	O
as	19288050	1	O
a	19288050	1	O
cause	19288050	1	O
of	19288050	1	O
autosomal	19288050	1	B-Disease
dominant	19288050	1	I-Disease
osteopetrosis	19288050	1	I-Disease
type	19288050	1	I-Disease
II	19288050	1	I-Disease
(	19288050	1	I-Disease
ADO	19288050	1	I-Disease
-	19288050	1	I-Disease
II	19288050	1	I-Disease
)	19288050	1	I-Disease
.	19288050	1	O
The	19288050	1	O
identification	19288050	1	O
of	19288050	1	O
gene	19288050	1	O
mutations	19288050	1	O
in	19288050	1	O
Chinese	19288050	1	O
with	19288050	1	O
ADO	19288050	1	O
has	19288050	1	O
not	19288050	1	O
been	19288050	1	O
reported	19288050	1	O
previously	19288050	1	O
.	19288050	1	O
In	19288050	1	O
this	19288050	1	O
study	19288050	1	O
,	19288050	1	O
we	19288050	1	O
identified	19288050	1	O
mutations	19288050	1	O
of	19288050	1	O
the	19288050	1	O
CLCN7	19288050	1	O
gene	19288050	1	O
in	19288050	1	O
two	19288050	1	O
unrelated	19288050	1	O
Chinese	19288050	1	O
families	19288050	1	O
with	19288050	1	O
ADO	19288050	1	O
-	19288050	1	O
II	19288050	1	O
.	19288050	1	O
Two	19288050	1	O
probands	19288050	1	O
with	19288050	1	O
ADO	19288050	1	O
-	19288050	1	O
II	19288050	1	O
were	19288050	1	O
diagnosed	19288050	1	O
based	19288050	1	O
on	19288050	1	O
their	19288050	1	O
bone	19288050	1	O
characteristics	19288050	1	O
on	19288050	1	O
X	19288050	1	O
-	19288050	1	O
rays	19288050	1	O
and	19288050	1	O
their	19288050	1	O
laboratory	19288050	1	O
results	19288050	1	O
.	19288050	1	O
All	19288050	1	O
25	19288050	1	O
exons	19288050	1	O
of	19288050	1	O
the	19288050	1	O
CLCN7	19288050	1	O
gene	19288050	1	O
,	19288050	1	O
including	19288050	1	O
the	19288050	1	O
exon	19288050	1	O
-	19288050	1	O
intron	19288050	1	O
boundaries	19288050	1	O
,	19288050	1	O
were	19288050	1	O
sequenced	19288050	1	O
.	19288050	1	O
We	19288050	1	O
found	19288050	1	O
in	19288050	1	O
family	19288050	1	O
1	19288050	1	O
that	19288050	1	O
the	19288050	1	O
proband	19288050	1	O
(	19288050	1	O
a	19288050	1	O
32	19288050	1	O
-	19288050	1	O
year	19288050	1	O
-	19288050	1	O
old	19288050	1	O
woman	19288050	1	O
)	19288050	1	O
was	19288050	1	O
heterozygous	19288050	1	O
for	19288050	1	O
a	19288050	1	O
CLCN7	19288050	1	O
mutation	19288050	1	O
.	19288050	1	O
The	19288050	1	O
nonsynonymous	19288050	1	O
mutation	19288050	1	O
consisted	19288050	1	O
of	19288050	1	O
a	19288050	1	O
heterozygous	19288050	1	O
C	19288050	1	O
/	19288050	1	O
T	19288050	1	O
transition	19288050	1	O
at	19288050	1	O
codon	19288050	1	O
2327	19288050	1	O
in	19288050	1	O
exon	19288050	1	O
24	19288050	1	O
,	19288050	1	O
which	19288050	1	O
resulted	19288050	1	O
in	19288050	1	O
an	19288050	1	O
arginine	19288050	1	O
(	19288050	1	O
CGG	19288050	1	O
)	19288050	1	O
-	19288050	1	O
to	19288050	1	O
tryptophan	19288050	1	O
(	19288050	1	O
TGG	19288050	1	O
)	19288050	1	O
substitution	19288050	1	O
at	19288050	1	O
position	19288050	1	O
767	19288050	1	O
(	19288050	1	O
R767W	19288050	1	O
)	19288050	1	O
.	19288050	1	O
The	19288050	1	O
same	19288050	1	O
heterozygous	19288050	1	O
mutation	19288050	1	O
(	19288050	1	O
C	19288050	1	O
/	19288050	1	O
T	19288050	1	O
)	19288050	1	O
was	19288050	1	O
determined	19288050	1	O
in	19288050	1	O
her	19288050	1	O
father	19288050	1	O
and	19288050	1	O
son	19288050	1	O
,	19288050	1	O
who	19288050	1	O
were	19288050	1	O
asymptomatic	19288050	1	O
with	19288050	1	O
normal	19288050	1	O
skeleton	19288050	1	O
radiography	19288050	1	O
.	19288050	1	O
In	19288050	1	O
family	19288050	1	O
2	19288050	1	O
,	19288050	1	O
we	19288050	1	O
found	19288050	1	O
that	19288050	1	O
the	19288050	1	O
proband	19288050	1	O
(	19288050	1	O
a	19288050	1	O
17	19288050	1	O
-	19288050	1	O
year	19288050	1	O
-	19288050	1	O
old	19288050	1	O
boy	19288050	1	O
)	19288050	1	O
carried	19288050	1	O
a	19288050	1	O
novel	19288050	1	O
frameshift	19288050	1	O
mutation	19288050	1	O
(	19288050	1	O
Glu798FS	19288050	1	O
)	19288050	1	O
resulting	19288050	1	O
from	19288050	1	O
a	19288050	1	O
G	19288050	1	O
insertion	19288050	1	O
between	19288050	1	O
codon	19288050	1	O
60	19288050	1	O
and	19288050	1	O
codon	19288050	1	O
61	19288050	1	O
in	19288050	1	O
exon	19288050	1	O
25	19288050	1	O
.	19288050	1	O
The	19288050	1	O
heterozygous	19288050	1	O
-	19288050	1	O
/	19288050	1	O
G	19288050	1	O
insertion	19288050	1	O
is	19288050	1	O
predicted	19288050	1	O
to	19288050	1	O
elongate	19288050	1	O
the	19288050	1	O
peptide	19288050	1	O
of	19288050	1	O
CLCN7	19288050	1	O
by	19288050	1	O
120	19288050	1	O
amino	19288050	1	O
acids	19288050	1	O
after	19288050	1	O
position	19288050	1	O
797	19288050	1	O
amino	19288050	1	O
acids	19288050	1	O
.	19288050	1	O
Similarly	19288050	1	O
,	19288050	1	O
some	19288050	1	O
individuals	19288050	1	O
of	19288050	1	O
this	19288050	1	O
family	19288050	1	O
carried	19288050	1	O
the	19288050	1	O
same	19288050	1	O
heterozygous	19288050	1	O
mutation	19288050	1	O
,	19288050	1	O
but	19288050	1	O
they	19288050	1	O
are	19288050	1	O
all	19288050	1	O
asymptomatic	19288050	1	O
.	19288050	1	O
Furthermore	19288050	1	O
,	19288050	1	O
the	19288050	1	O
R767W	19288050	1	O
and	19288050	1	O
Glu798FS	19288050	1	O
mutations	19288050	1	O
were	19288050	1	O
not	19288050	1	O
found	19288050	1	O
in	19288050	1	O
100	19288050	1	O
unrelated	19288050	1	O
controls	19288050	1	O
.	19288050	1	O
Our	19288050	1	O
present	19288050	1	O
findings	19288050	1	O
suggest	19288050	1	O
that	19288050	1	O
the	19288050	1	O
novel	19288050	1	O
Glu798FS	19288050	1	B-Var
mutation	19288050	1	O
in	19288050	1	O
exon	19288050	1	O
25	19288050	1	O
and	19288050	1	O
R767W	19288050	1	B-Var
in	19288050	1	O
exon	19288050	1	O
24	19288050	1	O
in	19288050	1	O
the	19288050	1	O
CLCN7	19288050	1	B-Gene
gene	19288050	1	O
were	19288050	1	O
responsible	19288050	1	B-Reg
for	19288050	1	O
ADO	19288050	1	B-Disease
-	19288050	1	I-Disease
II	19288050	1	I-Disease
in	19288050	1	O
these	19288050	1	O
Chinese	19288050	1	O
patients	19288050	1	O
.	19288050	1	O

A	19347998	3	O
case	19347998	3	O
of	19347998	3	O
factor	19347998	3	B-Disease
XI	19347998	3	I-Disease
deficiency	19347998	3	I-Disease
caused	19347998	3	B-Reg
by	19347998	3	I-Reg
compound	19347998	3	O
heterozygous	19347998	3	O
F11	19347998	3	B-Gene
gene	19347998	3	O
mutation	19347998	3	B-Var
.	19347998	3	O
Inherited	19347998	3	O
factor	19347998	3	O
XI	19347998	3	O
(	19347998	3	O
FXI	19347998	3	O
)	19347998	3	O
deficiency	19347998	3	O
is	19347998	3	O
a	19347998	3	O
rare	19347998	3	O
autosomal	19347998	3	O
recessive	19347998	3	O
bleeding	19347998	3	O
disorder	19347998	3	O
in	19347998	3	O
most	19347998	3	O
populations	19347998	3	O
except	19347998	3	O
for	19347998	3	O
Ashkenazi	19347998	3	O
Jews	19347998	3	O
.	19347998	3	O
In	19347998	3	O
this	19347998	3	O
report	19347998	3	O
,	19347998	3	O
a	19347998	3	O
25	19347998	3	O
-	19347998	3	O
year	19347998	3	O
-	19347998	3	O
old	19347998	3	O
Chinese	19347998	3	O
female	19347998	3	O
FXI	19347998	3	O
deficiency	19347998	3	O
case	19347998	3	O
has	19347998	3	O
been	19347998	3	O
studied	19347998	3	O
.	19347998	3	O
Routine	19347998	3	O
clotting	19347998	3	O
tests	19347998	3	O
showed	19347998	3	O
significantly	19347998	3	O
prolonged	19347998	3	O
activated	19347998	3	O
partial	19347998	3	O
thromboplastin	19347998	3	O
time	19347998	3	O
(	19347998	3	O
69.5	19347998	3	O
s	19347998	3	O
,	19347998	3	O
control	19347998	3	O
35	19347998	3	O
/	19347998	3	O
-	19347998	3	O
10	19347998	3	O
s	19347998	3	O
)	19347998	3	O
while	19347998	3	O
prothrombin	19347998	3	O
time	19347998	3	O
(	19347998	3	O
12.3	19347998	3	O
s	19347998	3	O
,	19347998	3	O
control	19347998	3	O
13	19347998	3	O
/	19347998	3	O
-	19347998	3	O
3	19347998	3	O
s	19347998	3	O
)	19347998	3	O
was	19347998	3	O
normal	19347998	3	O
.	19347998	3	O
FXI	19347998	3	O
:	19347998	3	O
C	19347998	3	O
and	19347998	3	O
FXI	19347998	3	O
:	19347998	3	O
Ag	19347998	3	O
were	19347998	3	O
2.6%	19347998	3	O
and	19347998	3	O
2.5%	19347998	3	O
,	19347998	3	O
respectively	19347998	3	O
,	19347998	3	O
indicating	19347998	3	O
that	19347998	3	O
this	19347998	3	O
case	19347998	3	O
was	19347998	3	O
cross	19347998	3	O
-	19347998	3	O
reacting	19347998	3	O
material	19347998	3	O
negative	19347998	3	O
.	19347998	3	O
The	19347998	3	O
activities	19347998	3	O
of	19347998	3	O
other	19347998	3	O
coagulation	19347998	3	O
factors	19347998	3	O
and	19347998	3	O
liver	19347998	3	O
function	19347998	3	O
were	19347998	3	O
in	19347998	3	O
normal	19347998	3	O
range	19347998	3	O
.	19347998	3	O
The	19347998	3	O
DNA	19347998	3	O
sequence	19347998	3	O
results	19347998	3	O
of	19347998	3	O
the	19347998	3	O
15	19347998	3	O
exons	19347998	3	O
and	19347998	3	O
their	19347998	3	O
boundaries	19347998	3	O
of	19347998	3	O
F11	19347998	3	O
gene	19347998	3	O
revealed	19347998	3	O
a	19347998	3	O
novel	19347998	3	O
G3733C	19347998	3	O
missense	19347998	3	O
mutation	19347998	3	O
in	19347998	3	O
exon	19347998	3	O
2	19347998	3	O
,	19347998	3	O
and	19347998	3	O
a	19347998	3	O
recurrent	19347998	3	O
C16642T	19347998	3	O
nonsense	19347998	3	O
mutation	19347998	3	O
in	19347998	3	O
exon	19347998	3	O
8	19347998	3	O
.	19347998	3	O
The	19347998	3	O
G3733C	19347998	3	B-Var
mutation	19347998	3	O
caused	19347998	3	B-Reg
G-1	19347998	3	B-Var
R	19347998	3	I-Var
substitution	19347998	3	I-Var
in	19347998	3	O
FXI	19347998	3	O
signal	19347998	3	O
peptide	19347998	3	O
,	19347998	3	O
which	19347998	3	O
might	19347998	3	O
impair	19347998	3	B-NegReg
the	19347998	3	O
protein	19347998	3	O
'	19347998	3	O
s	19347998	3	O
secretion	19347998	3	O
and	19347998	3	O
introduced	19347998	3	B-PosReg
a	19347998	3	O
new	19347998	3	O
BssSI	19347998	3	O
enzyme	19347998	3	O
digestion	19347998	3	O
site	19347998	3	O
.	19347998	3	O
The	19347998	3	O
C16642T	19347998	3	B-Var
mutation	19347998	3	O
led	19347998	3	B-Reg
a	19347998	3	O
premature	19347998	3	O
stop	19347998	3	O
codon	19347998	3	O
at	19347998	3	O
amino	19347998	3	O
acid	19347998	3	O
position	19347998	3	O
263	19347998	3	B-Var
(	19347998	3	I-Var
Q263Term	19347998	3	I-Var
)	19347998	3	I-Var
.	19347998	3	O
G-1	19347998	3	B-Var
R	19347998	3	I-Var
and	19347998	3	O
Q263Term	19347998	3	B-Var
compound	19347998	3	O
heterozygous	19347998	3	O
mutations	19347998	3	O
in	19347998	3	O
F11	19347998	3	B-Gene
gene	19347998	3	O
were	19347998	3	O
the	19347998	3	O
cause	19347998	3	B-Reg
of	19347998	3	O
FXI	19347998	3	B-Disease
deficiency	19347998	3	I-Disease
for	19347998	3	O
this	19347998	3	O
proband	19347998	3	O
.	19347998	3	O
G-1	19347998	3	B-Var
R	19347998	3	I-Var
mutation	19347998	3	O
was	19347998	3	O
a	19347998	3	O
novel	19347998	3	O
F11	19347998	3	B-Gene
gene	19347998	3	O
mutation	19347998	3	O
causing	19347998	3	B-Reg
inherited	19347998	3	O
FXI	19347998	3	B-Disease
deficiency	19347998	3	I-Disease
.	19347998	3	O

Accelerated	19358333	4	O
inactivation	19358333	4	O
of	19358333	4	O
the	19358333	4	O
L	19358333	4	O
-	19358333	4	O
type	19358333	4	O
calcium	19358333	4	O
current	19358333	4	O
due	19358333	4	O
to	19358333	4	O
a	19358333	4	O
mutation	19358333	4	O
in	19358333	4	O
CACNB2b	19358333	4	O
underlies	19358333	4	O
Brugada	19358333	4	O
syndrome	19358333	4	O
.	19358333	4	O
Recent	19358333	4	O
studies	19358333	4	O
have	19358333	4	O
demonstrated	19358333	4	O
an	19358333	4	O
association	19358333	4	B-Reg
between	19358333	4	O
mutations	19358333	4	B-Var
in	19358333	4	O
CACNA1c	19358333	4	B-Gene
or	19358333	4	O
CACNB2b	19358333	4	B-Gene
and	19358333	4	O
Brugada	19358333	4	B-Disease
syndrome	19358333	4	I-Disease
(	19358333	4	O
BrS	19358333	4	O
)	19358333	4	O
.	19358333	4	O
Previously	19358333	4	O
described	19358333	4	O
mutations	19358333	4	O
all	19358333	4	O
caused	19358333	4	O
a	19358333	4	O
loss	19358333	4	O
of	19358333	4	O
function	19358333	4	O
secondary	19358333	4	O
to	19358333	4	O
a	19358333	4	O
reduction	19358333	4	O
of	19358333	4	O
peak	19358333	4	O
calcium	19358333	4	O
current	19358333	4	O
(	19358333	4	O
I	19358333	4	O
(	19358333	4	O
Ca	19358333	4	O
)	19358333	4	O
)	19358333	4	O
.	19358333	4	O
We	19358333	4	O
describe	19358333	4	O
a	19358333	4	O
novel	19358333	4	O
CACNB2b	19358333	4	B-Gene
mutation	19358333	4	B-Var
associated	19358333	4	O
with	19358333	4	O
BrS	19358333	4	O
in	19358333	4	O
which	19358333	4	O
loss	19358333	4	O
of	19358333	4	O
function	19358333	4	O
is	19358333	4	O
caused	19358333	4	O
by	19358333	4	O
accelerated	19358333	4	O
inactivation	19358333	4	B-NegReg
of	19358333	4	O
I	19358333	4	O
(	19358333	4	O
Ca	19358333	4	O
)	19358333	4	O
.	19358333	4	O
The	19358333	4	O
proband	19358333	4	O
,	19358333	4	O
a	19358333	4	O
32	19358333	4	O
year	19358333	4	O
old	19358333	4	O
male	19358333	4	O
,	19358333	4	O
displayed	19358333	4	O
a	19358333	4	O
Type	19358333	4	O
I	19358333	4	O
ST	19358333	4	O
segment	19358333	4	O
elevation	19358333	4	O
in	19358333	4	O
two	19358333	4	O
right	19358333	4	O
precordial	19358333	4	O
ECG	19358333	4	O
leads	19358333	4	O
following	19358333	4	O
a	19358333	4	O
procainamide	19358333	4	O
challenge	19358333	4	O
.	19358333	4	O
EP	19358333	4	O
study	19358333	4	O
was	19358333	4	O
positive	19358333	4	O
with	19358333	4	O
induction	19358333	4	O
of	19358333	4	O
polymorphic	19358333	4	O
VT	19358333	4	O
/	19358333	4	O
VF	19358333	4	O
.	19358333	4	O
Interrogation	19358333	4	O
of	19358333	4	O
implanted	19358333	4	O
ICD	19358333	4	O
revealed	19358333	4	O
brief	19358333	4	O
episodes	19358333	4	O
of	19358333	4	O
very	19358333	4	O
rapid	19358333	4	O
ventricular	19358333	4	O
tachycardia	19358333	4	O
.	19358333	4	O
He	19358333	4	O
was	19358333	4	O
also	19358333	4	O
diagnosed	19358333	4	O
with	19358333	4	O
vasovagal	19358333	4	O
syncope	19358333	4	O
.	19358333	4	O
Genomic	19358333	4	O
DNA	19358333	4	O
was	19358333	4	O
isolated	19358333	4	O
from	19358333	4	O
lymphocytes	19358333	4	O
.	19358333	4	O
All	19358333	4	O
exons	19358333	4	O
and	19358333	4	O
intron	19358333	4	O
borders	19358333	4	O
of	19358333	4	O
15	19358333	4	O
ion	19358333	4	O
channel	19358333	4	O
genes	19358333	4	O
were	19358333	4	O
amplified	19358333	4	O
and	19358333	4	O
sequenced	19358333	4	O
.	19358333	4	O
The	19358333	4	O
only	19358333	4	O
mutation	19358333	4	O
uncovered	19358333	4	O
was	19358333	4	O
a	19358333	4	O
missense	19358333	4	O
mutation	19358333	4	O
(	19358333	4	O
T11I	19358333	4	O
)	19358333	4	O
in	19358333	4	O
CACNB2b	19358333	4	O
.	19358333	4	O
We	19358333	4	O
expressed	19358333	4	O
WT	19358333	4	O
or	19358333	4	O
T11I	19358333	4	O
CACNB2b	19358333	4	O
in	19358333	4	O
TSA201	19358333	4	O
cells	19358333	4	O
co	19358333	4	O
-	19358333	4	O
transfected	19358333	4	O
with	19358333	4	O
WT	19358333	4	O
CACNA1c	19358333	4	O
and	19358333	4	O
CACNA2d	19358333	4	O
.	19358333	4	O
Patch	19358333	4	O
clamp	19358333	4	O
analysis	19358333	4	O
showed	19358333	4	O
no	19358333	4	O
significant	19358333	4	O
difference	19358333	4	O
between	19358333	4	O
WT	19358333	4	O
and	19358333	4	O
T11I	19358333	4	O
in	19358333	4	O
peak	19358333	4	O
I	19358333	4	O
(	19358333	4	O
Ca	19358333	4	O
)	19358333	4	O
density	19358333	4	O
,	19358333	4	O
steady	19358333	4	O
-	19358333	4	O
state	19358333	4	O
inactivation	19358333	4	O
or	19358333	4	O
recovery	19358333	4	O
from	19358333	4	O
inactivation	19358333	4	O
.	19358333	4	O
However	19358333	4	O
,	19358333	4	O
both	19358333	4	O
fast	19358333	4	O
and	19358333	4	O
slow	19358333	4	O
decays	19358333	4	O
of	19358333	4	O
I	19358333	4	O
(	19358333	4	O
Ca	19358333	4	O
)	19358333	4	O
were	19358333	4	O
significantly	19358333	4	O
faster	19358333	4	O
in	19358333	4	O
mutant	19358333	4	O
channels	19358333	4	O
between	19358333	4	O
0	19358333	4	O
and	19358333	4	O
20	19358333	4	O
mV	19358333	4	O
.	19358333	4	O
Action	19358333	4	O
potential	19358333	4	O
voltage	19358333	4	O
clamp	19358333	4	O
experiments	19358333	4	O
showed	19358333	4	O
that	19358333	4	O
total	19358333	4	O
charge	19358333	4	O
was	19358333	4	O
reduced	19358333	4	O
by	19358333	4	O
almost	19358333	4	O
half	19358333	4	O
compared	19358333	4	O
to	19358333	4	O
WT	19358333	4	O
.	19358333	4	O
We	19358333	4	O
report	19358333	4	O
the	19358333	4	O
first	19358333	4	O
BrS	19358333	4	O
mutation	19358333	4	O
in	19358333	4	O
CaCNB2b	19358333	4	O
resulting	19358333	4	O
in	19358333	4	O
accelerated	19358333	4	O
inactivation	19358333	4	O
of	19358333	4	O
L	19358333	4	O
-	19358333	4	O
type	19358333	4	O
calcium	19358333	4	O
channel	19358333	4	O
current	19358333	4	O
.	19358333	4	O
Our	19358333	4	O
results	19358333	4	O
suggest	19358333	4	O
that	19358333	4	O
the	19358333	4	O
faster	19358333	4	O
current	19358333	4	O
decay	19358333	4	O
results	19358333	4	O
in	19358333	4	O
a	19358333	4	O
loss	19358333	4	O
-	19358333	4	O
of	19358333	4	O
-	19358333	4	O
function	19358333	4	O
responsible	19358333	4	O
for	19358333	4	O
the	19358333	4	O
Brugada	19358333	4	O
phenotype	19358333	4	O

Electrophysiological	19367640	1	O
studies	19367640	1	O
in	19367640	1	O
a	19367640	1	O
mouse	19367640	1	O
model	19367640	1	O
of	19367640	1	O
Schwartz	19367640	1	O
-	19367640	1	O
Jampel	19367640	1	O
syndrome	19367640	1	O
demonstrate	19367640	1	O
muscle	19367640	1	O
fiber	19367640	1	O
hyperactivity	19367640	1	O
of	19367640	1	O
peripheral	19367640	1	O
nerve	19367640	1	O
origin	19367640	1	O
.	19367640	1	O
Schwartz	19367640	1	B-Disease
-	19367640	1	I-Disease
Jampel	19367640	1	I-Disease
syndrome	19367640	1	I-Disease
(	19367640	1	O
SJS	19367640	1	O
)	19367640	1	O
is	19367640	1	O
an	19367640	1	O
autosomal	19367640	1	O
-	19367640	1	O
recessive	19367640	1	O
condition	19367640	1	O
characterized	19367640	1	O
by	19367640	1	O
muscle	19367640	1	O
stiffness	19367640	1	O
and	19367640	1	O
chondrodysplasia	19367640	1	O
.	19367640	1	O
It	19367640	1	O
is	19367640	1	O
due	19367640	1	O
to	19367640	1	O
loss	19367640	1	B-NegReg
-	19367640	1	I-NegReg
of	19367640	1	I-NegReg
-	19367640	1	I-NegReg
function	19367640	1	I-NegReg
hypomorphic	19367640	1	O
mutations	19367640	1	B-Var
in	19367640	1	O
the	19367640	1	O
HSPG2	19367640	1	B-Gene
gene	19367640	1	O
that	19367640	1	O
encodes	19367640	1	O
for	19367640	1	O
perlecan	19367640	1	O
,	19367640	1	O
a	19367640	1	O
proteoglycan	19367640	1	O
secreted	19367640	1	O
into	19367640	1	O
the	19367640	1	O
basement	19367640	1	O
membrane	19367640	1	O
.	19367640	1	O
The	19367640	1	O
origin	19367640	1	O
of	19367640	1	O
muscle	19367640	1	O
stiffness	19367640	1	O
in	19367640	1	O
SJS	19367640	1	O
is	19367640	1	O
debated	19367640	1	O
.	19367640	1	O
To	19367640	1	O
resolve	19367640	1	O
this	19367640	1	O
issue	19367640	1	O
,	19367640	1	O
we	19367640	1	O
performed	19367640	1	O
an	19367640	1	O
electrophysiological	19367640	1	O
investigation	19367640	1	O
of	19367640	1	O
an	19367640	1	O
SJS	19367640	1	O
mouse	19367640	1	O
model	19367640	1	O
with	19367640	1	O
a	19367640	1	O
missense	19367640	1	O
mutation	19367640	1	O
in	19367640	1	O
the	19367640	1	O
HSPG2	19367640	1	O
gene	19367640	1	O
.	19367640	1	O
Compound	19367640	1	O
muscle	19367640	1	O
action	19367640	1	O
potential	19367640	1	O
amplitudes	19367640	1	O
,	19367640	1	O
distal	19367640	1	O
motor	19367640	1	O
latencies	19367640	1	O
,	19367640	1	O
repetitive	19367640	1	O
nerve	19367640	1	O
stimulation	19367640	1	O
tests	19367640	1	O
,	19367640	1	O
and	19367640	1	O
sensory	19367640	1	O
nerve	19367640	1	O
conduction	19367640	1	O
velocities	19367640	1	O
of	19367640	1	O
SJS	19367640	1	O
mice	19367640	1	O
were	19367640	1	O
normal	19367640	1	O
.	19367640	1	O
On	19367640	1	O
electromyography	19367640	1	O
(	19367640	1	O
EMG	19367640	1	O
)	19367640	1	O
,	19367640	1	O
neuromyotonic	19367640	1	O
discharges	19367640	1	O
,	19367640	1	O
that	19367640	1	O
is	19367640	1	O
,	19367640	1	O
bursts	19367640	1	O
of	19367640	1	O
motor	19367640	1	O
unit	19367640	1	O
action	19367640	1	O
potentials	19367640	1	O
firing	19367640	1	O
at	19367640	1	O
high	19367640	1	O
rates	19367640	1	O
(	19367640	1	O
120	19367640	1	O
-	19367640	1	O
300	19367640	1	O
HZ	19367640	1	O
)	19367640	1	O
,	19367640	1	O
were	19367640	1	O
constantly	19367640	1	O
observed	19367640	1	O
in	19367640	1	O
SJS	19367640	1	O
mice	19367640	1	O
in	19367640	1	O
all	19367640	1	O
muscles	19367640	1	O
,	19367640	1	O
except	19367640	1	O
in	19367640	1	O
the	19367640	1	O
diaphragm	19367640	1	O
.	19367640	1	O
Neuromyotonic	19367640	1	O
discharges	19367640	1	O
were	19367640	1	O
not	19367640	1	O
influenced	19367640	1	O
by	19367640	1	O
general	19367640	1	O
anesthesia	19367640	1	O
and	19367640	1	O
disappeared	19367640	1	O
with	19367640	1	O
curare	19367640	1	O
administration	19367640	1	O
.	19367640	1	O
They	19367640	1	O
persisted	19367640	1	O
after	19367640	1	O
complete	19367640	1	O
motor	19367640	1	O
nerve	19367640	1	O
section	19367640	1	O
,	19367640	1	O
terminating	19367640	1	O
only	19367640	1	O
with	19367640	1	O
Wallerian	19367640	1	O
degeneration	19367640	1	O
.	19367640	1	O
These	19367640	1	O
results	19367640	1	O
demonstrate	19367640	1	O
that	19367640	1	O
perlecan	19367640	1	O
deficiency	19367640	1	O
in	19367640	1	O
SJS	19367640	1	O
provokes	19367640	1	O
a	19367640	1	O
neuromyotonic	19367640	1	O
syndrome	19367640	1	O
.	19367640	1	O
The	19367640	1	O
findings	19367640	1	O
further	19367640	1	O
suggest	19367640	1	O
a	19367640	1	O
distal	19367640	1	O
axonal	19367640	1	O
localization	19367640	1	O
of	19367640	1	O
the	19367640	1	O
generator	19367640	1	O
of	19367640	1	O
neuromyotonic	19367640	1	O
discharges	19367640	1	O
.	19367640	1	O
SJS	19367640	1	O
should	19367640	1	O
now	19367640	1	O
be	19367640	1	O
considered	19367640	1	O
as	19367640	1	O
an	19367640	1	O
inherited	19367640	1	O
disorder	19367640	1	O
with	19367640	1	O
peripheral	19367640	1	O
nerve	19367640	1	O
hyperexcitability	19367640	1	O
.	19367640	1	O

MEFV	19373257	4	B-Gene
mutation	19373257	4	B-Var
carriage	19373257	4	O
in	19373257	4	O
Israeli	19373257	4	O
Jewish	19373257	4	O
individuals	19373257	4	O
from	19373257	4	O
ethnicities	19373257	4	O
with	19373257	4	O
low	19373257	4	O
risk	19373257	4	O
for	19373257	4	B-Reg
familial	19373257	4	B-Disease
Mediterranean	19373257	4	I-Disease
fever	19373257	4	I-Disease
.	19373257	4	O
Familial	19373257	4	B-Disease
Mediterranean	19373257	4	I-Disease
fever	19373257	4	I-Disease
(	19373257	4	O
FMF	19373257	4	O
)	19373257	4	O
is	19373257	4	O
a	19373257	4	O
disease	19373257	4	O
caused	19373257	4	B-Reg
by	19373257	4	I-Reg
mutations	19373257	4	B-Var
in	19373257	4	O
the	19373257	4	O
MEditerranean	19373257	4	O
FeVer	19373257	4	O
gene	19373257	4	O
(	19373257	4	B-Gene
MEFV	19373257	4	I-Gene
)	19373257	4	I-Gene
,	19373257	4	O
and	19373257	4	O
in	19373257	4	O
Israel	19373257	4	O
it	19373257	4	O
most	19373257	4	O
commonly	19373257	4	O
affects	19373257	4	O
Jews	19373257	4	O
of	19373257	4	O
North	19373257	4	O
African	19373257	4	O
extraction	19373257	4	O
,	19373257	4	O
in	19373257	4	O
whom	19373257	4	O
the	19373257	4	O
mutation	19373257	4	O
carrier	19373257	4	O
rate	19373257	4	O
is	19373257	4	O
as	19373257	4	O
high	19373257	4	O
as	19373257	4	O
1	19373257	4	O
in	19373257	4	O
5	19373257	4	O
.	19373257	4	O
To	19373257	4	O
assess	19373257	4	O
the	19373257	4	O
protective	19373257	4	O
as	19373257	4	O
well	19373257	4	O
as	19373257	4	O
the	19373257	4	O
modulating	19373257	4	O
affect	19373257	4	O
of	19373257	4	O
MEFV	19373257	4	O
mutation	19373257	4	O
carriage	19373257	4	O
on	19373257	4	O
various	19373257	4	O
inflammatory	19373257	4	O
disease	19373257	4	O
states	19373257	4	O
,	19373257	4	O
we	19373257	4	O
sought	19373257	4	O
to	19373257	4	O
define	19373257	4	O
the	19373257	4	O
frequency	19373257	4	O
of	19373257	4	O
MEFV	19373257	4	O
mutations	19373257	4	O
in	19373257	4	O
Israeli	19373257	4	O
Jewish	19373257	4	O
individuals	19373257	4	O
of	19373257	4	O
various	19373257	4	O
ethnicities	19373257	4	O
,	19373257	4	O
including	19373257	4	O
those	19373257	4	O
with	19373257	4	O
low	19373257	4	O
frequency	19373257	4	O
of	19373257	4	O
FMF	19373257	4	O
,	19373257	4	O
which	19373257	4	O
were	19373257	4	O
not	19373257	4	O
in	19373257	4	O
the	19373257	4	O
focus	19373257	4	O
of	19373257	4	O
our	19373257	4	O
attention	19373257	4	O
hitherto	19373257	4	O
.	19373257	4	O
A	19373257	4	O
total	19373257	4	O
of	19373257	4	O
163	19373257	4	O
adults	19373257	4	O
of	19373257	4	O
Bucharian	19373257	4	O
,	19373257	4	O
Turkish	19373257	4	O
,	19373257	4	O
Georgian	19373257	4	O
,	19373257	4	O
Yemenite	19373257	4	O
and	19373257	4	O
Bulgarian	19373257	4	O
origin	19373257	4	O
comprised	19373257	4	O
the	19373257	4	O
study	19373257	4	O
group	19373257	4	O
.	19373257	4	O
The	19373257	4	O
prevalence	19373257	4	O
of	19373257	4	O
the	19373257	4	O
most	19373257	4	O
frequent	19373257	4	O
MEFV	19373257	4	O
mutations	19373257	4	O
in	19373257	4	O
the	19373257	4	O
Israeli	19373257	4	O
Jewish	19373257	4	O
population	19373257	4	O
,	19373257	4	O
namely	19373257	4	O
:	19373257	4	O
M694V	19373257	4	O
,	19373257	4	O
V726A	19373257	4	O
and	19373257	4	O
E148Q	19373257	4	O
,	19373257	4	O
was	19373257	4	O
assessed	19373257	4	O
.	19373257	4	O
The	19373257	4	O
association	19373257	4	O
of	19373257	4	O
mutation	19373257	4	O
carriage	19373257	4	O
with	19373257	4	O
a	19373257	4	O
personal	19373257	4	O
history	19373257	4	O
of	19373257	4	O
FMF	19373257	4	O
-	19373257	4	O
like	19373257	4	O
phenomena	19373257	4	O
,	19373257	4	O
as	19373257	4	O
well	19373257	4	O
as	19373257	4	O
various	19373257	4	O
inflammatory	19373257	4	O
and	19373257	4	O
non	19373257	4	O
-	19373257	4	O
inflammatory	19373257	4	O
diseases	19373257	4	O
,	19373257	4	O
was	19373257	4	O
evaluated	19373257	4	O
.	19373257	4	O
A	19373257	4	O
high	19373257	4	O
MEFV	19373257	4	O
mutation	19373257	4	O
frequency	19373257	4	O
was	19373257	4	O
found	19373257	4	O
among	19373257	4	O
Jews	19373257	4	O
of	19373257	4	O
Bucharian	19373257	4	O
,	19373257	4	O
Georgian	19373257	4	O
and	19373257	4	O
Bulgarian	19373257	4	O
origin	19373257	4	O
(	19373257	4	O
20%	19373257	4	O
)	19373257	4	O
,	19373257	4	O
whereas	19373257	4	O
intermediate	19373257	4	O
and	19373257	4	O
low	19373257	4	O
rates	19373257	4	O
were	19373257	4	O
detected	19373257	4	O
in	19373257	4	O
Jews	19373257	4	O
of	19373257	4	O
Turkish	19373257	4	O
and	19373257	4	O
Yemenite	19373257	4	O
extraction	19373257	4	O
(	19373257	4	O
14	19373257	4	O
and	19373257	4	O
8%	19373257	4	O
,	19373257	4	O
respectively	19373257	4	O
)	19373257	4	O
.	19373257	4	O
FMF	19373257	4	O
-	19373257	4	O
like	19373257	4	O
manifestations	19373257	4	O
and	19373257	4	O
related	19373257	4	O
diseases	19373257	4	O
were	19373257	4	O
observed	19373257	4	O
more	19373257	4	O
often	19373257	4	O
in	19373257	4	O
MEFV	19373257	4	O
mutation	19373257	4	O
carriers	19373257	4	O
than	19373257	4	O
in	19373257	4	O
their	19373257	4	O
counterparts	19373257	4	O
.	19373257	4	O
MEFV	19373257	4	O
mutation	19373257	4	O
frequency	19373257	4	O
,	19373257	4	O
directly	19373257	4	O
assessed	19373257	4	O
by	19373257	4	O
DNA	19373257	4	O
analysis	19373257	4	O
,	19373257	4	O
exceeds	19373257	4	O
the	19373257	4	O
rate	19373257	4	O
calculated	19373257	4	O
from	19373257	4	O
disease	19373257	4	O
prevalence	19373257	4	O
in	19373257	4	O
Israeli	19373257	4	O
Jewish	19373257	4	O
individuals	19373257	4	O
originated	19373257	4	O
from	19373257	4	O
ethnicities	19373257	4	O
with	19373257	4	O
a	19373257	4	O
low	19373257	4	O
prevalence	19373257	4	O
of	19373257	4	O
FMF	19373257	4	O
.	19373257	4	O
MEFV	19373257	4	O
mutation	19373257	4	O
carriage	19373257	4	O
in	19373257	4	O
this	19373257	4	O
subgroup	19373257	4	O
is	19373257	4	O
associated	19373257	4	O
with	19373257	4	O
various	19373257	4	O
inflammatory	19373257	4	O
disorders	19373257	4	O
.	19373257	4	O

In	19394700	4	O
vivo	19394700	4	O
laser	19394700	4	O
confocal	19394700	4	O
microscopy	19394700	4	O
findings	19394700	4	O
and	19394700	4	O
mutational	19394700	4	O
analysis	19394700	4	O
for	19394700	4	O
Schnyder	19394700	4	O
'	19394700	4	O
s	19394700	4	O
crystalline	19394700	4	O
corneal	19394700	4	O
dystrophy	19394700	4	O
.	19394700	4	O
OBJECTIVE	19394700	4	O
:	19394700	4	O
To	19394700	4	O
identify	19394700	4	O
any	19394700	4	O
mutation	19394700	4	O
of	19394700	4	O
the	19394700	4	O
UbiA	19394700	4	O
prenyltransferase	19394700	4	O
domain	19394700	4	O
-	19394700	4	O
containing	19394700	4	O
protein	19394700	4	O
1	19394700	4	O
(	19394700	4	O
UBIAD1	19394700	4	O
)	19394700	4	O
gene	19394700	4	O
in	19394700	4	O
Japanese	19394700	4	O
patients	19394700	4	O
with	19394700	4	O
Schnyder	19394700	4	B-Disease
'	19394700	4	I-Disease
s	19394700	4	I-Disease
crystalline	19394700	4	I-Disease
corneal	19394700	4	I-Disease
dystrophy	19394700	4	I-Disease
(	19394700	4	O
SCCD	19394700	4	O
)	19394700	4	O
and	19394700	4	O
to	19394700	4	O
investigate	19394700	4	O
in	19394700	4	O
vivo	19394700	4	O
microstructural	19394700	4	O
phenotype	19394700	4	O
and	19394700	4	O
genotype	19394700	4	O
correlations	19394700	4	O
using	19394700	4	O
laser	19394700	4	O
scanning	19394700	4	O
confocal	19394700	4	O
microscopy	19394700	4	O
(	19394700	4	O
Heidelberg	19394700	4	O
Retina	19394700	4	O
Tomograph	19394700	4	O
2	19394700	4	O
Rostock	19394700	4	O
Cornea	19394700	4	O
Module	19394700	4	O
;	19394700	4	O
Heidelberg	19394700	4	O
Engineering	19394700	4	O
GmbH	19394700	4	O
,	19394700	4	O
Dossenheim	19394700	4	O
,	19394700	4	O
Germany	19394700	4	O
)	19394700	4	O
.	19394700	4	O
DESIGN	19394700	4	O
:	19394700	4	O
Small	19394700	4	O
,	19394700	4	O
comparative	19394700	4	O
case	19394700	4	O
series	19394700	4	O
.	19394700	4	O
PARTICIPANTS	19394700	4	O
:	19394700	4	O
Three	19394700	4	O
patients	19394700	4	O
from	19394700	4	O
3	19394700	4	O
pedigrees	19394700	4	O
(	19394700	4	O
3	19394700	4	O
males	19394700	4	O
)	19394700	4	O
with	19394700	4	O
clinically	19394700	4	O
diagnosed	19394700	4	O
SCCD	19394700	4	O
and	19394700	4	O
their	19394700	4	O
relatives	19394700	4	O
(	19394700	4	O
2	19394700	4	O
males	19394700	4	O
,	19394700	4	O
1	19394700	4	O
female	19394700	4	O
)	19394700	4	O
participated	19394700	4	O
in	19394700	4	O
this	19394700	4	O
study	19394700	4	O
.	19394700	4	O
TESTING	19394700	4	O
:	19394700	4	O
All	19394700	4	O
participants	19394700	4	O
were	19394700	4	O
examined	19394700	4	O
genetically	19394700	4	O
and	19394700	4	O
by	19394700	4	O
slit	19394700	4	O
-	19394700	4	O
lamp	19394700	4	O
biomicroscopy	19394700	4	O
and	19394700	4	O
in	19394700	4	O
vivo	19394700	4	O
laser	19394700	4	O
confocal	19394700	4	O
microscopy	19394700	4	O
.	19394700	4	O
MAIN	19394700	4	O
OUTCOME	19394700	4	O
MEASURES	19394700	4	O
:	19394700	4	O
Genomic	19394700	4	O
DNA	19394700	4	O
from	19394700	4	O
the	19394700	4	O
patients	19394700	4	O
and	19394700	4	O
100	19394700	4	O
unrelated	19394700	4	O
healthy	19394700	4	O
volunteers	19394700	4	O
(	19394700	4	O
200	19394700	4	O
chromosomes	19394700	4	O
)	19394700	4	O
was	19394700	4	O
isolated	19394700	4	O
from	19394700	4	O
blood	19394700	4	O
samples	19394700	4	O
and	19394700	4	O
used	19394700	4	O
for	19394700	4	O
mutation	19394700	4	O
screening	19394700	4	O
of	19394700	4	O
the	19394700	4	O
UBIAD1	19394700	4	O
gene	19394700	4	O
.	19394700	4	O
Selected	19394700	4	O
confocal	19394700	4	O
images	19394700	4	O
of	19394700	4	O
corneal	19394700	4	O
layers	19394700	4	O
were	19394700	4	O
evaluated	19394700	4	O
qualitatively	19394700	4	O
for	19394700	4	O
shape	19394700	4	O
and	19394700	4	O
degree	19394700	4	O
of	19394700	4	O
light	19394700	4	O
reflection	19394700	4	O
of	19394700	4	O
deposits	19394700	4	O
.	19394700	4	O
RESULTS	19394700	4	O
:	19394700	4	O
Novel	19394700	4	O
mutations	19394700	4	O
in	19394700	4	O
the	19394700	4	O
UBIAD1	19394700	4	O
gene	19394700	4	O
(	19394700	4	O
Y174C	19394700	4	O
,	19394700	4	O
K181R	19394700	4	O
,	19394700	4	O
and	19394700	4	O
N233H	19394700	4	O
)	19394700	4	O
were	19394700	4	O
identified	19394700	4	O
.	19394700	4	O
Additionally	19394700	4	O
,	19394700	4	O
cosegregation	19394700	4	O
of	19394700	4	O
the	19394700	4	O
mutation	19394700	4	O
(	19394700	4	B-Var
Y174C	19394700	4	I-Var
)	19394700	4	I-Var
and	19394700	4	O
SCCD	19394700	4	O
was	19394700	4	O
confirmed	19394700	4	O
in	19394700	4	O
1	19394700	4	O
pedigree	19394700	4	O
,	19394700	4	O
indicating	19394700	4	O
that	19394700	4	O
the	19394700	4	O
mutation	19394700	4	O
of	19394700	4	O
the	19394700	4	O
UBIAD1	19394700	4	B-Gene
gene	19394700	4	O
is	19394700	4	O
causative	19394700	4	B-Reg
for	19394700	4	O
SCCD	19394700	4	B-Disease
.	19394700	4	O
The	19394700	4	O
3	19394700	4	O
mutations	19394700	4	O
were	19394700	4	O
absent	19394700	4	O
in	19394700	4	O
all	19394700	4	O
200	19394700	4	O
control	19394700	4	O
chromosomes	19394700	4	O
.	19394700	4	O
In	19394700	4	O
vivo	19394700	4	O
laser	19394700	4	O
confocal	19394700	4	O
microscopy	19394700	4	O
demonstrated	19394700	4	O
subepithelial	19394700	4	O
highly	19394700	4	O
reflective	19394700	4	O
crystals	19394700	4	O
in	19394700	4	O
4	19394700	4	O
cases	19394700	4	O
;	19394700	4	O
the	19394700	4	O
shapes	19394700	4	O
of	19394700	4	O
the	19394700	4	O
crystals	19394700	4	O
were	19394700	4	O
needle	19394700	4	O
-	19394700	4	O
shaped	19394700	4	O
(	19394700	4	O
3	19394700	4	O
cases	19394700	4	O
)	19394700	4	O
or	19394700	4	O
rectangular	19394700	4	O
(	19394700	4	O
1	19394700	4	O
case	19394700	4	O
)	19394700	4	O
.	19394700	4	O
A	19394700	4	O
phenotype	19394700	4	O
and	19394700	4	O
genotype	19394700	4	O
correlation	19394700	4	O
was	19394700	4	O
demonstrated	19394700	4	O
in	19394700	4	O
1	19394700	4	O
pedigree	19394700	4	O
,	19394700	4	O
and	19394700	4	O
phenotypic	19394700	4	O
heterogeneity	19394700	4	O
(	19394700	4	O
SCCD	19394700	4	O
with	19394700	4	O
or	19394700	4	O
without	19394700	4	O
crystals	19394700	4	O
caused	19394700	4	O
by	19394700	4	O
a	19394700	4	O
same	19394700	4	O
mutation	19394700	4	O
of	19394700	4	O
Y174C	19394700	4	O
in	19394700	4	O
the	19394700	4	O
UBIAD1	19394700	4	O
gene	19394700	4	O
)	19394700	4	O
also	19394700	4	O
was	19394700	4	O
demonstrated	19394700	4	O
in	19394700	4	O
1	19394700	4	O
pedigree	19394700	4	O
.	19394700	4	O
CONCLUSIONS	19394700	4	O
:	19394700	4	O
Nonsynonymous	19394700	4	O
novel	19394700	4	O
mutations	19394700	4	O
in	19394700	4	O
the	19394700	4	O
UBIAD1	19394700	4	O
gene	19394700	4	O
were	19394700	4	O
detected	19394700	4	O
in	19394700	4	O
3	19394700	4	O
unrelated	19394700	4	O
Japanese	19394700	4	O
pedigrees	19394700	4	O
with	19394700	4	O
SCCD	19394700	4	O
,	19394700	4	O
confirming	19394700	4	O
the	19394700	4	O
genetic	19394700	4	O
heterogeneity	19394700	4	O
of	19394700	4	O
this	19394700	4	O
disorder	19394700	4	O
.	19394700	4	O
In	19394700	4	O
vivo	19394700	4	O
laser	19394700	4	O
confocal	19394700	4	O
microscopy	19394700	4	O
is	19394700	4	O
capable	19394700	4	O
of	19394700	4	O
identifying	19394700	4	O
characteristic	19394700	4	O
corneal	19394700	4	O
microstructural	19394700	4	O
changes	19394700	4	O
related	19394700	4	O
to	19394700	4	O
genetically	19394700	4	O
mapped	19394700	4	O
SCCD	19394700	4	O
with	19394700	4	O
high	19394700	4	O
resolution	19394700	4	O
,	19394700	4	O
and	19394700	4	O
phenotypic	19394700	4	O
heterogeneity	19394700	4	O
was	19394700	4	O
presented	19394700	4	O
.	19394700	4	O
Further	19394700	4	O
confocal	19394700	4	O
and	19394700	4	O
mutational	19394700	4	O
analysis	19394700	4	O
using	19394700	4	O
a	19394700	4	O
larger	19394700	4	O
number	19394700	4	O
of	19394700	4	O
patients	19394700	4	O
with	19394700	4	O
SCCD	19394700	4	O
is	19394700	4	O
required	19394700	4	O
to	19394700	4	O
elucidate	19394700	4	O
in	19394700	4	O
vivo	19394700	4	O
microstructural	19394700	4	O
phenotype	19394700	4	O
and	19394700	4	O
genotype	19394700	4	O
correlations	19394700	4	O
.	19394700	4	O
FINANCIAL	19394700	4	O
DISCLOSURE	19394700	4	O
(	19394700	4	O
S	19394700	4	O
)	19394700	4	O
:	19394700	4	O
The	19394700	4	O
author	19394700	4	O
(	19394700	4	O
s	19394700	4	O
)	19394700	4	O
have	19394700	4	O
no	19394700	4	O
proprietary	19394700	4	O
or	19394700	4	O
commercial	19394700	4	O
interest	19394700	4	O
in	19394700	4	O
any	19394700	4	O
materials	19394700	4	O
discussed	19394700	4	O
in	19394700	4	O
this	19394700	4	O
article	19394700	4	O
.	19394700	4	O

Neutral	19401457	4	B-Disease
lipid	19401457	4	I-Disease
storage	19401457	4	I-Disease
disease	19401457	4	I-Disease
:	19401457	4	I-Disease
genetic	19401457	4	O
disorders	19401457	4	O
caused	19401457	4	B-Reg
by	19401457	4	I-Reg
mutations	19401457	4	B-Var
in	19401457	4	O
adipose	19401457	4	O
triglyceride	19401457	4	O
lipase	19401457	4	B-Gene
/	19401457	4	I-Gene
PNPLA2	19401457	4	I-Gene
or	19401457	4	O
CGI-58	19401457	4	B-Gene
/	19401457	4	I-Gene
ABHD5	19401457	4	I-Gene
.	19401457	4	O
Neutral	19401457	4	O
lipid	19401457	4	O
storage	19401457	4	O
disease	19401457	4	O
(	19401457	4	O
NLSD	19401457	4	O
)	19401457	4	O
is	19401457	4	O
a	19401457	4	O
group	19401457	4	O
of	19401457	4	O
autosomal	19401457	4	O
recessive	19401457	4	O
disorders	19401457	4	O
characterized	19401457	4	O
by	19401457	4	O
the	19401457	4	O
excessive	19401457	4	O
accumulation	19401457	4	O
of	19401457	4	O
neutral	19401457	4	O
lipids	19401457	4	O
in	19401457	4	O
multiple	19401457	4	O
tissues	19401457	4	O
.	19401457	4	O
Recently	19401457	4	O
,	19401457	4	O
two	19401457	4	O
genes	19401457	4	O
,	19401457	4	O
adipose	19401457	4	O
triglyceride	19401457	4	O
lipase	19401457	4	O
(	19401457	4	O
ATGL	19401457	4	O
/	19401457	4	O
PNPLA2	19401457	4	O
)	19401457	4	O
and	19401457	4	O
comparative	19401457	4	O
gene	19401457	4	O
identification-58	19401457	4	O
(	19401457	4	O
CGI-58	19401457	4	O
/	19401457	4	O
ABHD5	19401457	4	O
)	19401457	4	O
,	19401457	4	O
have	19401457	4	O
been	19401457	4	O
shown	19401457	4	O
to	19401457	4	O
cause	19401457	4	O
NLSD	19401457	4	O
.	19401457	4	O
ATGL	19401457	4	O
specifically	19401457	4	O
hydrolyzes	19401457	4	O
the	19401457	4	O
first	19401457	4	O
fatty	19401457	4	O
acid	19401457	4	O
from	19401457	4	O
triacylglycerols	19401457	4	O
(	19401457	4	O
TG	19401457	4	O
)	19401457	4	O
and	19401457	4	O
CGI-58	19401457	4	O
/	19401457	4	O
ABHD5	19401457	4	O
stimulates	19401457	4	O
ATGL	19401457	4	O
activity	19401457	4	O
by	19401457	4	O
a	19401457	4	O
currently	19401457	4	O
unknown	19401457	4	O
mechanism	19401457	4	O
.	19401457	4	O
Mutations	19401457	4	B-Var
in	19401457	4	O
both	19401457	4	O
the	19401457	4	O
ATGL	19401457	4	B-Gene
and	19401457	4	O
the	19401457	4	O
CGI-58	19401457	4	B-Gene
genes	19401457	4	O
are	19401457	4	O
associated	19401457	4	B-Reg
with	19401457	4	I-Reg
systemic	19401457	4	O
TG	19401457	4	O
accumulation	19401457	4	O
,	19401457	4	O
yet	19401457	4	O
the	19401457	4	O
resulting	19401457	4	O
clinical	19401457	4	O
manifestations	19401457	4	O
are	19401457	4	O
not	19401457	4	O
identical	19401457	4	O
.	19401457	4	O
Patients	19401457	4	O
with	19401457	4	O
defective	19401457	4	O
ATGL	19401457	4	O
function	19401457	4	O
suffer	19401457	4	O
from	19401457	4	O
more	19401457	4	O
severe	19401457	4	O
myopathy	19401457	4	O
(	19401457	4	O
NLSDM	19401457	4	O
)	19401457	4	O
than	19401457	4	O
patients	19401457	4	O
with	19401457	4	O
defective	19401457	4	O
CGI-58	19401457	4	O
function	19401457	4	O
.	19401457	4	O
On	19401457	4	O
the	19401457	4	O
other	19401457	4	O
hand	19401457	4	O
,	19401457	4	O
CGI-58	19401457	4	B-Gene
mutations	19401457	4	B-Var
are	19401457	4	O
always	19401457	4	O
associated	19401457	4	B-Reg
with	19401457	4	I-Reg
ichthyosis	19401457	4	O
(	19401457	4	B-Disease
NLSDI	19401457	4	I-Disease
)	19401457	4	I-Disease
,	19401457	4	O
which	19401457	4	O
was	19401457	4	O
not	19401457	4	O
observed	19401457	4	O
in	19401457	4	O
patients	19401457	4	O
with	19401457	4	O
defective	19401457	4	O
ATGL	19401457	4	O
function	19401457	4	O
.	19401457	4	O
These	19401457	4	O
observations	19401457	4	O
indicate	19401457	4	O
an	19401457	4	O
ATGL	19401457	4	O
-	19401457	4	O
independent	19401457	4	O
function	19401457	4	O
of	19401457	4	O
CGI-58	19401457	4	O
.	19401457	4	O
This	19401457	4	O
review	19401457	4	O
summarizes	19401457	4	O
recent	19401457	4	O
findings	19401457	4	O
with	19401457	4	O
the	19401457	4	O
goal	19401457	4	O
of	19401457	4	O
relating	19401457	4	O
structural	19401457	4	O
variants	19401457	4	O
of	19401457	4	O
ATGL	19401457	4	O
and	19401457	4	O
CGI-58	19401457	4	O
to	19401457	4	O
functional	19401457	4	O
consequences	19401457	4	O
in	19401457	4	O
lipid	19401457	4	O
metabolism	19401457	4	O
.	19401457	4	O

A	19438860	1	O
heterozygous	19438860	1	B-Var
null	19438860	1	I-Var
mutation	19438860	1	I-Var
combined	19438860	1	O
with	19438860	1	O
the	19438860	1	O
G1258A	19438860	1	B-Var
polymorphism	19438860	1	O
of	19438860	1	O
SPINK5	19438860	1	B-Gene
causes	19438860	1	O
impaired	19438860	1	B-NegReg
LEKTI	19438860	1	O
function	19438860	1	O
and	19438860	1	O
abnormal	19438860	1	O
expression	19438860	1	O
of	19438860	1	O
skin	19438860	1	O
barrier	19438860	1	O
proteins	19438860	1	O
.	19438860	1	O
BACKGROUND	19438860	1	O
:	19438860	1	O
Loss	19438860	1	B-NegReg
-	19438860	1	I-NegReg
of	19438860	1	I-NegReg
-	19438860	1	I-NegReg
function	19438860	1	I-NegReg
mutations	19438860	1	B-Var
in	19438860	1	O
the	19438860	1	O
Kazal	19438860	1	O
-	19438860	1	O
type	19438860	1	O
serine	19438860	1	O
protease	19438860	1	O
inhibitor	19438860	1	O
,	19438860	1	O
LEKTI	19438860	1	O
,	19438860	1	O
encoded	19438860	1	O
by	19438860	1	O
the	19438860	1	O
SPINK5	19438860	1	B-Gene
gene	19438860	1	O
cause	19438860	1	O
the	19438860	1	O
rare	19438860	1	O
autosomal	19438860	1	O
recessive	19438860	1	O
skin	19438860	1	O
disease	19438860	1	O
Netherton	19438860	1	B-Disease
syndrome	19438860	1	I-Disease
(	19438860	1	O
NS	19438860	1	O
)	19438860	1	O
.	19438860	1	O
G1258A	19438860	1	O
polymorphism	19438860	1	O
in	19438860	1	O
SPINK5	19438860	1	O
may	19438860	1	O
be	19438860	1	O
associated	19438860	1	O
with	19438860	1	O
atopic	19438860	1	O
dermatitis	19438860	1	O
,	19438860	1	O
which	19438860	1	O
shares	19438860	1	O
several	19438860	1	O
clinical	19438860	1	O
features	19438860	1	O
with	19438860	1	O
NS	19438860	1	O
.	19438860	1	O
OBJECTIVES	19438860	1	O
:	19438860	1	O
To	19438860	1	O
determine	19438860	1	O
if	19438860	1	O
the	19438860	1	O
phenotype	19438860	1	O
of	19438860	1	O
NS	19438860	1	O
can	19438860	1	O
be	19438860	1	O
caused	19438860	1	O
by	19438860	1	O
a	19438860	1	O
single	19438860	1	O
null	19438860	1	O
mutation	19438860	1	O
in	19438860	1	O
SPINK5	19438860	1	O
combined	19438860	1	O
with	19438860	1	O
the	19438860	1	O
homozygous	19438860	1	O
G1258A	19438860	1	O
polymorphism	19438860	1	O
.	19438860	1	O
METHODS	19438860	1	O
:	19438860	1	O
We	19438860	1	O
screened	19438860	1	O
mutations	19438860	1	O
in	19438860	1	O
the	19438860	1	O
gene	19438860	1	O
SPINK5	19438860	1	O
by	19438860	1	O
direct	19438860	1	O
DNA	19438860	1	O
sequencing	19438860	1	O
and	19438860	1	O
position	19438860	1	O
cloning	19438860	1	O
and	19438860	1	O
examined	19438860	1	O
the	19438860	1	O
expressions	19438860	1	O
of	19438860	1	O
the	19438860	1	O
SPINK5	19438860	1	O
-	19438860	1	O
encoded	19438860	1	O
protein	19438860	1	O
LEKTI	19438860	1	O
and	19438860	1	O
other	19438860	1	O
relevant	19438860	1	O
proteins	19438860	1	O
by	19438860	1	O
immunostaining	19438860	1	O
and	19438860	1	O
immunoblot	19438860	1	O
.	19438860	1	O
RESULTS	19438860	1	O
:	19438860	1	O
We	19438860	1	O
describe	19438860	1	O
here	19438860	1	O
a	19438860	1	O
patient	19438860	1	O
who	19438860	1	O
was	19438860	1	O
clinically	19438860	1	O
diagnosed	19438860	1	O
with	19438860	1	O
NS	19438860	1	O
and	19438860	1	O
carried	19438860	1	O
a	19438860	1	O
single	19438860	1	O
null	19438860	1	O
mutation	19438860	1	O
in	19438860	1	O
SPINK5	19438860	1	O
combined	19438860	1	O
with	19438860	1	O
the	19438860	1	O
homozygous	19438860	1	O
G1258A	19438860	1	O
polymorphism	19438860	1	O
.	19438860	1	O
SPINK5	19438860	1	O
mRNA	19438860	1	O
was	19438860	1	O
present	19438860	1	O
at	19438860	1	O
normal	19438860	1	O
levels	19438860	1	O
and	19438860	1	O
LEKTI	19438860	1	O
was	19438860	1	O
expressed	19438860	1	O
in	19438860	1	O
the	19438860	1	O
epidermis	19438860	1	O
.	19438860	1	O
Nonetheless	19438860	1	O
,	19438860	1	O
the	19438860	1	O
putative	19438860	1	O
downstream	19438860	1	O
LEKTI	19438860	1	O
substrates	19438860	1	O
stratum	19438860	1	O
corneum	19438860	1	O
trypsin	19438860	1	O
-	19438860	1	O
like	19438860	1	O
enzyme	19438860	1	O
(	19438860	1	O
SCTE	19438860	1	O
)	19438860	1	O
,	19438860	1	O
desmoglein	19438860	1	O
1	19438860	1	O
and	19438860	1	O
protein	19438860	1	O
markers	19438860	1	O
of	19438860	1	O
keratinocyte	19438860	1	O
differentiation	19438860	1	O
were	19438860	1	O
expressed	19438860	1	O
abnormally	19438860	1	O
,	19438860	1	O
similar	19438860	1	O
to	19438860	1	O
that	19438860	1	O
seen	19438860	1	O
in	19438860	1	O
NS	19438860	1	O
if	19438860	1	O
two	19438860	1	O
null	19438860	1	O
mutant	19438860	1	O
alleles	19438860	1	O
are	19438860	1	O
present	19438860	1	O
.	19438860	1	O
CONCLUSION	19438860	1	O
:	19438860	1	O
This	19438860	1	O
finding	19438860	1	O
indicates	19438860	1	O
that	19438860	1	O
haploinsufficiency	19438860	1	O
of	19438860	1	O
SPINK5	19438860	1	O
can	19438860	1	O
cause	19438860	1	O
the	19438860	1	O
NS	19438860	1	O
phenotype	19438860	1	O
in	19438860	1	O
the	19438860	1	O
presence	19438860	1	O
of	19438860	1	O
one	19438860	1	O
null	19438860	1	O
mutation	19438860	1	O
with	19438860	1	O
homozygous	19438860	1	O
G1258A	19438860	1	O
polymorphisms	19438860	1	O
in	19438860	1	O
SPINK5	19438860	1	O
,	19438860	1	O
and	19438860	1	O
this	19438860	1	O
could	19438860	1	O
impair	19438860	1	O
the	19438860	1	O
function	19438860	1	O
of	19438860	1	O
LEKTI	19438860	1	O
and	19438860	1	O
therefore	19438860	1	O
acts	19438860	1	O
as	19438860	1	O
a	19438860	1	O
true	19438860	1	O
mutation	19438860	1	O
.	19438860	1	O

MEFV	19449169	4	B-Gene
mutations	19449169	4	B-Var
in	19449169	4	O
patients	19449169	4	O
with	19449169	4	B-Reg
Familial	19449169	4	B-Disease
Mediterranean	19449169	4	I-Disease
Fever	19449169	4	I-Disease
from	19449169	4	O
the	19449169	4	O
Aegean	19449169	4	O
region	19449169	4	O
of	19449169	4	O
Turkey	19449169	4	O
.	19449169	4	O
Familial	19449169	4	B-Disease
Mediterranean	19449169	4	I-Disease
Fever	19449169	4	I-Disease
(	19449169	4	O
FMF	19449169	4	O
)	19449169	4	O
which	19449169	4	O
is	19449169	4	O
frequently	19449169	4	O
present	19449169	4	O
in	19449169	4	O
Mediterranean	19449169	4	O
populations	19449169	4	O
is	19449169	4	O
caused	19449169	4	B-Reg
by	19449169	4	I-Reg
mutations	19449169	4	B-Var
in	19449169	4	O
the	19449169	4	O
MEFV	19449169	4	B-Gene
gene	19449169	4	O
.	19449169	4	O
According	19449169	4	O
to	19449169	4	O
recent	19449169	4	O
data	19449169	4	O
,	19449169	4	O
MEFV	19449169	4	O
mutations	19449169	4	O
are	19449169	4	O
not	19449169	4	O
the	19449169	4	O
only	19449169	4	O
cause	19449169	4	O
of	19449169	4	O
FMF	19449169	4	O
,	19449169	4	O
but	19449169	4	O
these	19449169	4	O
are	19449169	4	O
major	19449169	4	O
genetic	19449169	4	O
determinants	19449169	4	O
which	19449169	4	O
cause	19449169	4	O
FMF	19449169	4	O
.	19449169	4	O
It	19449169	4	O
has	19449169	4	O
also	19449169	4	O
been	19449169	4	O
suggested	19449169	4	O
that	19449169	4	O
there	19449169	4	O
may	19449169	4	O
be	19449169	4	O
a	19449169	4	O
number	19449169	4	O
of	19449169	4	O
other	19449169	4	O
genes	19449169	4	O
causing	19449169	4	O
FMF	19449169	4	O
.	19449169	4	O
The	19449169	4	O
MEFV	19449169	4	O
gene	19449169	4	O
is	19449169	4	O
located	19449169	4	O
at	19449169	4	O
16	19449169	4	O
p13.3	19449169	4	O
and	19449169	4	O
encodes	19449169	4	O
a	19449169	4	O
protein	19449169	4	O
,	19449169	4	O
pyrin	19449169	4	O
/	19449169	4	O
marenostrin	19449169	4	O
.	19449169	4	O
More	19449169	4	O
than	19449169	4	O
70	19449169	4	O
disease	19449169	4	O
associated	19449169	4	O
mutations	19449169	4	O
and	19449169	4	O
totally	19449169	4	O
186	19449169	4	O
mutations	19449169	4	O
and	19449169	4	O
polymorphisms	19449169	4	O
have	19449169	4	O
been	19449169	4	O
defined	19449169	4	O
in	19449169	4	O
affected	19449169	4	O
individuals	19449169	4	O
.	19449169	4	O
We	19449169	4	O
have	19449169	4	O
retrospectively	19449169	4	O
evaluated	19449169	4	O
the	19449169	4	O
molecular	19449169	4	O
test	19449169	4	O
results	19449169	4	O
of	19449169	4	O
1	19449169	4	O
,	19449169	4	O
201	19449169	4	O
patients	19449169	4	O
identified	19449169	4	O
as	19449169	4	O
having	19449169	4	O
FMF	19449169	4	O
clinical	19449169	4	O
symptoms	19449169	4	O
referred	19449169	4	O
to	19449169	4	O
the	19449169	4	O
Molecular	19449169	4	O
Genetics	19449169	4	O
Laboratory	19449169	4	O
of	19449169	4	O
the	19449169	4	O
Department	19449169	4	O
of	19449169	4	O
Medical	19449169	4	O
Genetics	19449169	4	O
,	19449169	4	O
Faculty	19449169	4	O
of	19449169	4	O
Medicine	19449169	4	O
,	19449169	4	O
Ege	19449169	4	O
University	19449169	4	O
,	19449169	4	O
Izmir	19449169	4	O
/	19449169	4	O
Turkey	19449169	4	O
over	19449169	4	O
the	19449169	4	O
last	19449169	4	O
4	19449169	4	O
years	19449169	4	O
.	19449169	4	O
Patients	19449169	4	O
were	19449169	4	O
tested	19449169	4	O
for	19449169	4	O
12	19449169	4	O
common	19449169	4	O
mutations	19449169	4	O
in	19449169	4	O
the	19449169	4	O
MEFV	19449169	4	O
gene	19449169	4	O
using	19449169	4	O
a	19449169	4	O
strip	19449169	4	O
assay	19449169	4	O
method	19449169	4	O
(	19449169	4	O
Innogenetics	19449169	4	O
,	19449169	4	O
Belgium	19449169	4	O
)	19449169	4	O
.	19449169	4	O
Out	19449169	4	O
of	19449169	4	O
the	19449169	4	O
1	19449169	4	O
,	19449169	4	O
201	19449169	4	O
patients	19449169	4	O
tested	19449169	4	O
(	19449169	4	O
2	19449169	4	O
,	19449169	4	O
402	19449169	4	O
chromosomes	19449169	4	O
)	19449169	4	O
in	19449169	4	O
the	19449169	4	O
Aegean	19449169	4	O
region	19449169	4	O
in	19449169	4	O
Turkey	19449169	4	O
,	19449169	4	O
654	19449169	4	O
(	19449169	4	O
54.45%	19449169	4	O
)	19449169	4	O
did	19449169	4	O
not	19449169	4	O
carry	19449169	4	O
any	19449169	4	O
mutations	19449169	4	O
,	19449169	4	O
among	19449169	4	O
the	19449169	4	O
547	19449169	4	O
(	19449169	4	O
45.55%	19449169	4	O
)	19449169	4	O
patients	19449169	4	O
with	19449169	4	O
mutations	19449169	4	O
246	19449169	4	O
patients	19449169	4	O
were	19449169	4	O
either	19449169	4	O
homozygous	19449169	4	O
(	19449169	4	O
101	19449169	4	O
)	19449169	4	O
or	19449169	4	O
compound	19449169	4	O
heterozygous	19449169	4	O
(	19449169	4	O
145	19449169	4	O
)	19449169	4	O
,	19449169	4	O
296	19449169	4	O
carried	19449169	4	O
only	19449169	4	O
one	19449169	4	O
detected	19449169	4	O
mutation	19449169	4	O
,	19449169	4	O
and	19449169	4	O
five	19449169	4	O
patients	19449169	4	O
had	19449169	4	O
three	19449169	4	O
mutations	19449169	4	O
.	19449169	4	O
Allelic	19449169	4	O
frequencies	19449169	4	O
for	19449169	4	O
the	19449169	4	O
four	19449169	4	O
most	19449169	4	O
common	19449169	4	O
mutations	19449169	4	O
in	19449169	4	O
the	19449169	4	O
mutation	19449169	4	O
positive	19449169	4	O
groups	19449169	4	O
were	19449169	4	O
47.60%	19449169	4	O
(	19449169	4	O
M694V	19449169	4	O
)	19449169	4	O
,	19449169	4	O
16.75%	19449169	4	O
(	19449169	4	O
E148Q	19449169	4	O
)	19449169	4	O
,	19449169	4	O
12.95%	19449169	4	O
(	19449169	4	O
V726A	19449169	4	O
)	19449169	4	O
,	19449169	4	O
11.94%	19449169	4	O
(	19449169	4	O
M680I	19449169	4	O
G	19449169	4	O
/	19449169	4	O
C	19449169	4	O
)	19449169	4	O
.	19449169	4	O
The	19449169	4	O
remaining	19449169	4	O
alleles	19449169	4	O
(	19449169	4	O
10.76%	19449169	4	O
)	19449169	4	O
showed	19449169	4	O
rare	19449169	4	O
mutations	19449169	4	O
which	19449169	4	O
were	19449169	4	O
R761H	19449169	4	O
,	19449169	4	O
P369S	19449169	4	O
,	19449169	4	O
A744S	19449169	4	O
,	19449169	4	O
K695R	19449169	4	O
,	19449169	4	O
F479L	19449169	4	O
,	19449169	4	O
M694I	19449169	4	O
.	19449169	4	O
When	19449169	4	O
the	19449169	4	O
frequencies	19449169	4	O
of	19449169	4	O
mutations	19449169	4	O
detected	19449169	4	O
in	19449169	4	O
our	19449169	4	O
group	19449169	4	O
were	19449169	4	O
compared	19449169	4	O
to	19449169	4	O
the	19449169	4	O
frequencies	19449169	4	O
reported	19449169	4	O
in	19449169	4	O
the	19449169	4	O
other	19449169	4	O
regions	19449169	4	O
of	19449169	4	O
Turkey	19449169	4	O
,	19449169	4	O
an	19449169	4	O
increase	19449169	4	O
in	19449169	4	O
V726A	19449169	4	O
mutation	19449169	4	O
frequency	19449169	4	O
was	19449169	4	O
observed	19449169	4	O
.	19449169	4	O
No	19449169	4	O
patient	19449169	4	O
showed	19449169	4	O
a	19449169	4	O
I692del	19449169	4	O
mutation	19449169	4	O
which	19449169	4	O
is	19449169	4	O
sometimes	19449169	4	O
evident	19449169	4	O
in	19449169	4	O
other	19449169	4	O
Mediterranean	19449169	4	O
populations	19449169	4	O
.	19449169	4	O

Factor	19473408	4	O
VIII	19473408	4	O
mutations	19473408	4	B-Var
in	19473408	4	B-Reg
42	19473408	4	O
Moldovan	19473408	4	O
haemophilia	19473408	4	B-Disease
A	19473408	4	I-Disease
families	19473408	4	O
,	19473408	4	O
including	19473408	4	O
12	19473408	4	O
that	19473408	4	O
are	19473408	4	O
novel	19473408	4	O
.	19473408	4	O
Haemophilia	19473408	4	B-Disease
A	19473408	4	I-Disease
(	19473408	4	O
HA	19473408	4	O
)	19473408	4	O
is	19473408	4	O
a	19473408	4	O
bleeding	19473408	4	O
disorder	19473408	4	O
caused	19473408	4	B-Reg
by	19473408	4	I-Reg
mutations	19473408	4	B-Var
within	19473408	4	O
the	19473408	4	O
X	19473408	4	O
-	19473408	4	O
linked	19473408	4	O
F8	19473408	4	B-Gene
gene	19473408	4	O
.	19473408	4	O
A	19473408	4	O
series	19473408	4	O
of	19473408	4	O
42	19473408	4	O
unrelated	19473408	4	O
Moldovan	19473408	4	O
patients	19473408	4	O
with	19473408	4	O
HA	19473408	4	O
had	19473408	4	O
their	19473408	4	O
disease	19473408	4	O
-	19473408	4	O
causative	19473408	4	O
mutation	19473408	4	O
determined	19473408	4	O
to	19473408	4	O
provide	19473408	4	O
clinically	19473408	4	O
valuable	19473408	4	O
genotyping	19473408	4	O
information	19473408	4	O
for	19473408	4	O
a	19473408	4	O
historically	19473408	4	O
underserved	19473408	4	O
population	19473408	4	O
and	19473408	4	O
to	19473408	4	O
utilize	19473408	4	O
factor	19473408	4	O
VIII	19473408	4	O
(	19473408	4	O
FVIII	19473408	4	O
)	19473408	4	O
structural	19473408	4	O
information	19473408	4	O
to	19473408	4	O
analyse	19473408	4	O
the	19473408	4	O
effects	19473408	4	O
of	19473408	4	O
haemophilic	19473408	4	O
missense	19473408	4	O
substitutions	19473408	4	O
.	19473408	4	O
DNA	19473408	4	O
samples	19473408	4	O
were	19473408	4	O
analysed	19473408	4	O
to	19473408	4	O
detect	19473408	4	O
intron	19473408	4	O
22	19473408	4	O
and	19473408	4	O
intron	19473408	4	O
1	19473408	4	O
inversions	19473408	4	O
followed	19473408	4	O
by	19473408	4	O
heteroduplex	19473408	4	O
analysis	19473408	4	O
of	19473408	4	O
PCR	19473408	4	O
-	19473408	4	O
amplified	19473408	4	O
fragments	19473408	4	O
containing	19473408	4	O
all	19473408	4	O
exonic	19473408	4	O
sequences	19473408	4	O
.	19473408	4	O
Missense	19473408	4	O
sites	19473408	4	O
identified	19473408	4	O
by	19473408	4	O
DNA	19473408	4	O
sequencing	19473408	4	O
were	19473408	4	O
visualized	19473408	4	O
in	19473408	4	O
the	19473408	4	O
recently	19473408	4	O
described	19473408	4	O
crystal	19473408	4	O
structures	19473408	4	O
of	19473408	4	O
human	19473408	4	O
FVIII	19473408	4	O
.	19473408	4	O
Of	19473408	4	O
the	19473408	4	O
26	19473408	4	O
different	19473408	4	O
point	19473408	4	O
mutations	19473408	4	O
,	19473408	4	O
12	19473408	4	O
were	19473408	4	O
novel	19473408	4	O
.	19473408	4	O
Gel	19473408	4	O
electrophoresis	19473408	4	O
identified	19473408	4	O
samples	19473408	4	O
with	19473408	4	O
a	19473408	4	O
second	19473408	4	O
major	19473408	4	O
DNA	19473408	4	O
band	19473408	4	O
that	19473408	4	O
migrated	19473408	4	O
abnormally	19473408	4	O
;	19473408	4	O
these	19473408	4	O
amplified	19473408	4	O
products	19473408	4	O
were	19473408	4	O
sequenced	19473408	4	O
.	19473408	4	O
Thirteen	19473408	4	O
intron	19473408	4	O
22	19473408	4	O
inversions	19473408	4	O
and	19473408	4	O
one	19473408	4	O
intron	19473408	4	O
1	19473408	4	O
inversion	19473408	4	O
were	19473408	4	O
found	19473408	4	O
.	19473408	4	O
Two	19473408	4	O
patients	19473408	4	O
had	19473408	4	O
large	19473408	4	O
,	19473408	4	O
partial	19473408	4	O
gene	19473408	4	O
deletions	19473408	4	O
and	19473408	4	O
there	19473408	4	O
were	19473408	4	O
six	19473408	4	O
frameshift	19473408	4	O
,	19473408	4	O
two	19473408	4	O
non	19473408	4	O
-	19473408	4	O
sense	19473408	4	O
,	19473408	4	O
two	19473408	4	O
splicing	19473408	4	O
and	19473408	4	O
16	19473408	4	O
missense	19473408	4	O
genotypes	19473408	4	O
.	19473408	4	O
Two	19473408	4	O
subjects	19473408	4	O
with	19473408	4	O
an	19473408	4	O
intron	19473408	4	O
22	19473408	4	O
inversion	19473408	4	O
and	19473408	4	O
one	19473408	4	O
with	19473408	4	O
a	19473408	4	O
large	19473408	4	O
,	19473408	4	O
partial	19473408	4	O
gene	19473408	4	O
deletion	19473408	4	O
developed	19473408	4	O
an	19473408	4	O
alloimmune	19473408	4	O
inhibitor	19473408	4	O
.	19473408	4	O
Their	19473408	4	O
localization	19473408	4	O
suggests	19473408	4	O
intra	19473408	4	O
-	19473408	4	O
and	19473408	4	O
possibly	19473408	4	O
inter	19473408	4	O
-	19473408	4	O
molecular	19473408	4	O
interactions	19473408	4	O
that	19473408	4	O
are	19473408	4	O
important	19473408	4	O
for	19473408	4	O
the	19473408	4	O
structural	19473408	4	O
integrity	19473408	4	O
and	19473408	4	O
/	19473408	4	O
or	19473408	4	O
procoagulant	19473408	4	O
function	19473408	4	O
of	19473408	4	O
FVIII	19473408	4	O
.	19473408	4	O

Investigation	19657723	4	O
of	19657723	4	O
C5a	19657723	4	O
receptor	19657723	4	O
gene	19657723	4	O
450	19657723	4	O
C	19657723	4	O
/	19657723	4	O
T	19657723	4	O
polymorphism	19657723	4	O
in	19657723	4	O
Turkish	19657723	4	O
patients	19657723	4	O
with	19657723	4	O
familial	19657723	4	O
Mediterranean	19657723	4	O
fever	19657723	4	O
.	19657723	4	O
Familial	19657723	4	B-Disease
Mediterranean	19657723	4	I-Disease
fever	19657723	4	I-Disease
(	19657723	4	O
FMF	19657723	4	O
)	19657723	4	O
is	19657723	4	O
a	19657723	4	O
genetic	19657723	4	O
disorder	19657723	4	O
with	19657723	4	O
acute	19657723	4	O
inflammatory	19657723	4	O
serosal	19657723	4	O
attacks	19657723	4	O
due	19657723	4	B-Reg
to	19657723	4	I-Reg
MEFV	19657723	4	B-Gene
gene	19657723	4	O
mutations	19657723	4	B-Var
which	19657723	4	O
resides	19657723	4	O
in	19657723	4	O
chromosome	19657723	4	O
16	19657723	4	O
.	19657723	4	O
Lack	19657723	4	O
of	19657723	4	O
a	19657723	4	O
C5a	19657723	4	O
inhibitor	19657723	4	O
activity	19657723	4	O
in	19657723	4	O
the	19657723	4	O
peritoneum	19657723	4	O
has	19657723	4	O
previously	19657723	4	O
been	19657723	4	O
proposed	19657723	4	O
in	19657723	4	O
part	19657723	4	O
to	19657723	4	O
contribute	19657723	4	O
in	19657723	4	O
propagation	19657723	4	O
of	19657723	4	O
the	19657723	4	O
serosal	19657723	4	O
inflammation	19657723	4	O
in	19657723	4	O
FMF	19657723	4	O
attacks	19657723	4	O
.	19657723	4	O
The	19657723	4	O
aim	19657723	4	O
of	19657723	4	O
this	19657723	4	O
study	19657723	4	O
is	19657723	4	O
to	19657723	4	O
investigate	19657723	4	O
C5a	19657723	4	O
receptor	19657723	4	O
(	19657723	4	O
C5aR	19657723	4	O
)	19657723	4	O
gene	19657723	4	O
polymorphism	19657723	4	O
in	19657723	4	O
patients	19657723	4	O
with	19657723	4	O
FMF	19657723	4	O
and	19657723	4	O
its	19657723	4	O
relation	19657723	4	O
to	19657723	4	O
the	19657723	4	O
main	19657723	4	O
features	19657723	4	O
of	19657723	4	O
the	19657723	4	O
disease	19657723	4	O
.	19657723	4	O
A	19657723	4	O
polymorphism	19657723	4	O
in	19657723	4	O
the	19657723	4	O
coding	19657723	4	O
region	19657723	4	O
of	19657723	4	O
C5aR	19657723	4	O
gene	19657723	4	O
leading	19657723	4	O
to	19657723	4	O
C	19657723	4	O
to	19657723	4	O
T	19657723	4	O
transition	19657723	4	O
at	19657723	4	O
nucleotide	19657723	4	O
position	19657723	4	O
450	19657723	4	O
has	19657723	4	O
been	19657723	4	O
investigated	19657723	4	O
in	19657723	4	O
85	19657723	4	O
non	19657723	4	O
-	19657723	4	O
related	19657723	4	O
Turkish	19657723	4	O
FMF	19657723	4	O
patients	19657723	4	O
and	19657723	4	O
160	19657723	4	O
non	19657723	4	O
-	19657723	4	O
related	19657723	4	O
healthy	19657723	4	O
controls	19657723	4	O
by	19657723	4	O
using	19657723	4	O
PCR	19657723	4	O
-	19657723	4	O
RFLP	19657723	4	O
.	19657723	4	O
The	19657723	4	O
frequencies	19657723	4	O
of	19657723	4	O
C5aR	19657723	4	O
gene	19657723	4	O
450	19657723	4	O
CT	19657723	4	O
genotype	19657723	4	O
and	19657723	4	O
T	19657723	4	O
allele	19657723	4	O
were	19657723	4	O
not	19657723	4	O
significantly	19657723	4	O
different	19657723	4	O
between	19657723	4	O
Turkish	19657723	4	O
FMF	19657723	4	O
patients	19657723	4	O
and	19657723	4	O
healthy	19657723	4	O
subjects	19657723	4	O
(	19657723	4	O
14.12	19657723	4	O
and	19657723	4	O
8.24%	19657723	4	O
for	19657723	4	O
FMF	19657723	4	O
vs.10	19657723	4	O
and	19657723	4	O
5%	19657723	4	O
for	19657723	4	O
controls	19657723	4	O
,	19657723	4	O
respectively	19657723	4	O
)	19657723	4	O
.	19657723	4	O
C5aR	19657723	4	O
gene	19657723	4	O
450	19657723	4	O
CT	19657723	4	O
genotype	19657723	4	O
tended	19657723	4	O
to	19657723	4	O
associate	19657723	4	O
with	19657723	4	O
the	19657723	4	O
presence	19657723	4	O
Henoch	19657723	4	O
-	19657723	4	O
Schonlein	19657723	4	O
purpura	19657723	4	O
(	19657723	4	O
OR	19657723	4	O
:	19657723	4	O
1.25	19657723	4	O
,	19657723	4	O
95%	19657723	4	O
CI	19657723	4	O
:	19657723	4	O
0.917	19657723	4	O
-	19657723	4	O
1.704	19657723	4	O
,	19657723	4	O
P	19657723	4	O
=	19657723	4	O
0.017	19657723	4	O
)	19657723	4	O
but	19657723	4	O
with	19657723	4	O
no	19657723	4	O
other	19657723	4	O
clinical	19657723	4	O
findings	19657723	4	O
of	19657723	4	O
the	19657723	4	O
disease	19657723	4	O
.	19657723	4	O
C5aR	19657723	4	O
polymorphism	19657723	4	O
might	19657723	4	O
be	19657723	4	O
searched	19657723	4	O
in	19657723	4	O
populations	19657723	4	O
having	19657723	4	O
high	19657723	4	O
prevalence	19657723	4	O
of	19657723	4	O
FMF	19657723	4	O
.	19657723	4	O

Expression	19755381	4	O
of	19755381	4	O
the	19755381	4	O
familial	19755381	4	O
Mediterranean	19755381	4	O
fever	19755381	4	O
gene	19755381	4	O
is	19755381	4	O
regulated	19755381	4	O
by	19755381	4	O
nonsense	19755381	4	O
-	19755381	4	O
mediated	19755381	4	O
decay	19755381	4	O
.	19755381	4	O
Mutations	19755381	4	B-Var
in	19755381	4	O
the	19755381	4	O
MEditerranean	19755381	4	O
FeVer	19755381	4	O
(	19755381	4	B-Gene
MEFV	19755381	4	I-Gene
)	19755381	4	I-Gene
gene	19755381	4	O
are	19755381	4	O
responsible	19755381	4	B-Reg
for	19755381	4	O
familial	19755381	4	B-Disease
Mediterranean	19755381	4	I-Disease
fever	19755381	4	I-Disease
(	19755381	4	O
FMF	19755381	4	O
)	19755381	4	O
,	19755381	4	O
a	19755381	4	O
recessively	19755381	4	O
inherited	19755381	4	O
auto	19755381	4	O
-	19755381	4	O
inflammatory	19755381	4	O
disease	19755381	4	O
.	19755381	4	O
Cases	19755381	4	O
of	19755381	4	O
dominant	19755381	4	O
inheritance	19755381	4	O
and	19755381	4	O
phenotype	19755381	4	O
-	19755381	4	O
genotype	19755381	4	O
heterogeneity	19755381	4	O
have	19755381	4	O
been	19755381	4	O
reported	19755381	4	O
;	19755381	4	O
however	19755381	4	O
,	19755381	4	O
the	19755381	4	O
underlying	19755381	4	O
molecular	19755381	4	O
mechanism	19755381	4	O
is	19755381	4	O
not	19755381	4	O
currently	19755381	4	O
understood	19755381	4	O
.	19755381	4	O
The	19755381	4	O
FMF	19755381	4	O
protein	19755381	4	O
named	19755381	4	O
pyrin	19755381	4	O
or	19755381	4	O
marenostrin	19755381	4	O
(	19755381	4	O
P	19755381	4	O
/	19755381	4	O
M	19755381	4	O
)	19755381	4	O
is	19755381	4	O
thought	19755381	4	O
to	19755381	4	O
be	19755381	4	O
involved	19755381	4	O
in	19755381	4	O
regulating	19755381	4	O
innate	19755381	4	O
immunity	19755381	4	O
but	19755381	4	O
its	19755381	4	O
function	19755381	4	O
remains	19755381	4	O
subject	19755381	4	O
to	19755381	4	O
controversy	19755381	4	O
.	19755381	4	O
Recent	19755381	4	O
studies	19755381	4	O
postulate	19755381	4	O
that	19755381	4	O
a	19755381	4	O
defect	19755381	4	O
in	19755381	4	O
MEFV	19755381	4	O
expression	19755381	4	O
regulation	19755381	4	O
may	19755381	4	O
play	19755381	4	O
a	19755381	4	O
role	19755381	4	O
in	19755381	4	O
FMF	19755381	4	O
physiopathology	19755381	4	O
.	19755381	4	O
Our	19755381	4	O
group	19755381	4	O
,	19755381	4	O
along	19755381	4	O
with	19755381	4	O
others	19755381	4	O
,	19755381	4	O
has	19755381	4	O
identified	19755381	4	O
several	19755381	4	O
alternatively	19755381	4	O
spliced	19755381	4	O
MEFV	19755381	4	O
transcripts	19755381	4	O
in	19755381	4	O
leukocytes	19755381	4	O
.	19755381	4	O
Since	19755381	4	O
alternative	19755381	4	O
splicing	19755381	4	O
and	19755381	4	O
nonsense	19755381	4	O
-	19755381	4	O
mediated	19755381	4	O
decay	19755381	4	O
(	19755381	4	O
NMD	19755381	4	O
)	19755381	4	O
pathways	19755381	4	O
are	19755381	4	O
usually	19755381	4	O
coupled	19755381	4	O
in	19755381	4	O
the	19755381	4	O
post	19755381	4	O
-	19755381	4	O
transcriptional	19755381	4	O
regulation	19755381	4	O
of	19755381	4	O
gene	19755381	4	O
expression	19755381	4	O
,	19755381	4	O
we	19755381	4	O
hypothesized	19755381	4	O
that	19755381	4	O
NMD	19755381	4	O
could	19755381	4	O
contribute	19755381	4	O
to	19755381	4	O
the	19755381	4	O
regulation	19755381	4	O
of	19755381	4	O
the	19755381	4	O
MEFV	19755381	4	O
gene	19755381	4	O
.	19755381	4	O
To	19755381	4	O
address	19755381	4	O
this	19755381	4	O
issue	19755381	4	O
,	19755381	4	O
we	19755381	4	O
examined	19755381	4	O
the	19755381	4	O
effect	19755381	4	O
of	19755381	4	O
indirect	19755381	4	O
and	19755381	4	O
direct	19755381	4	O
inhibition	19755381	4	O
of	19755381	4	O
NMD	19755381	4	O
on	19755381	4	O
expression	19755381	4	O
of	19755381	4	O
the	19755381	4	O
MEFV	19755381	4	O
transcripts	19755381	4	O
in	19755381	4	O
THP1	19755381	4	O
,	19755381	4	O
monocyte	19755381	4	O
and	19755381	4	O
neutrophil	19755381	4	O
cells	19755381	4	O
.	19755381	4	O
We	19755381	4	O
showed	19755381	4	O
that	19755381	4	O
MEFV	19755381	4	O
is	19755381	4	O
the	19755381	4	O
first	19755381	4	O
auto	19755381	4	O
-	19755381	4	O
inflammatory	19755381	4	O
gene	19755381	4	O
regulated	19755381	4	O
by	19755381	4	O
NMD	19755381	4	O
in	19755381	4	O
both	19755381	4	O
a	19755381	4	O
cell	19755381	4	O
-	19755381	4	O
and	19755381	4	O
transcript	19755381	4	O
-	19755381	4	O
specific	19755381	4	O
manner	19755381	4	O
.	19755381	4	O
These	19755381	4	O
results	19755381	4	O
and	19755381	4	O
preliminary	19755381	4	O
western	19755381	4	O
-	19755381	4	O
blot	19755381	4	O
analyses	19755381	4	O
suggest	19755381	4	O
the	19755381	4	O
possible	19755381	4	O
translation	19755381	4	O
of	19755381	4	O
alternatively	19755381	4	O
spliced	19755381	4	O
MEFV	19755381	4	O
transcripts	19755381	4	O
into	19755381	4	O
several	19755381	4	O
P	19755381	4	O
/	19755381	4	O
M	19755381	4	O
variants	19755381	4	O
according	19755381	4	O
to	19755381	4	O
cell	19755381	4	O
type	19755381	4	O
and	19755381	4	O
inflammatory	19755381	4	O
state	19755381	4	O
.	19755381	4	O
Our	19755381	4	O
results	19755381	4	O
introduce	19755381	4	O
the	19755381	4	O
novel	19755381	4	O
hypothesis	19755381	4	O
that	19755381	4	O
variation	19755381	4	O
of	19755381	4	O
NMD	19755381	4	O
efficiency	19755381	4	O
could	19755381	4	O
play	19755381	4	O
an	19755381	4	O
important	19755381	4	O
role	19755381	4	O
in	19755381	4	O
FMF	19755381	4	O
physiopathology	19755381	4	O
as	19755381	4	O
a	19755381	4	O
potent	19755381	4	O
phenotypic	19755381	4	O
modifier	19755381	4	O
.	19755381	4	O

Novel	19863546	4	O
PORCN	19863546	4	B-Gene
mutations	19863546	4	B-Var
in	19863546	4	B-Reg
focal	19863546	4	B-Disease
dermal	19863546	4	I-Disease
hypoplasia	19863546	4	I-Disease
.	19863546	4	O
Focal	19863546	4	O
dermal	19863546	4	O
hypoplasia	19863546	4	O
(	19863546	4	O
FDH	19863546	4	O
)	19863546	4	O
,	19863546	4	O
Goltz	19863546	4	O
or	19863546	4	O
Goltz	19863546	4	O
-	19863546	4	O
Gorlin	19863546	4	O
syndrome	19863546	4	O
,	19863546	4	O
is	19863546	4	O
an	19863546	4	O
X	19863546	4	O
-	19863546	4	O
linked	19863546	4	O
dominant	19863546	4	O
multisystem	19863546	4	O
disorder	19863546	4	O
characterized	19863546	4	O
primarily	19863546	4	O
by	19863546	4	O
involvement	19863546	4	O
of	19863546	4	O
the	19863546	4	O
skin	19863546	4	O
,	19863546	4	O
skeletal	19863546	4	O
system	19863546	4	O
and	19863546	4	O
eyes	19863546	4	O
.	19863546	4	O
We	19863546	4	O
screened	19863546	4	O
for	19863546	4	O
mutations	19863546	4	B-Var
in	19863546	4	O
the	19863546	4	O
PORCN	19863546	4	B-Gene
gene	19863546	4	O
in	19863546	4	B-Reg
eight	19863546	4	O
patients	19863546	4	O
of	19863546	4	O
Belgian	19863546	4	O
and	19863546	4	O
Finnish	19863546	4	O
origin	19863546	4	O
with	19863546	4	O
firm	19863546	4	O
clinical	19863546	4	O
suspicion	19863546	4	O
of	19863546	4	O
FDH	19863546	4	B-Disease
.	19863546	4	O
First	19863546	4	O
,	19863546	4	O
we	19863546	4	O
performed	19863546	4	O
quantitative	19863546	4	O
PCR	19863546	4	O
(	19863546	4	O
qPCR	19863546	4	O
)	19863546	4	O
analysis	19863546	4	O
to	19863546	4	O
define	19863546	4	O
the	19863546	4	O
copy	19863546	4	O
number	19863546	4	O
at	19863546	4	O
this	19863546	4	O
locus	19863546	4	O
.	19863546	4	O
Next	19863546	4	O
,	19863546	4	O
we	19863546	4	O
sequenced	19863546	4	O
the	19863546	4	O
coding	19863546	4	O
regions	19863546	4	O
and	19863546	4	O
flanking	19863546	4	O
intronic	19863546	4	O
sequences	19863546	4	O
of	19863546	4	O
the	19863546	4	O
PORCN	19863546	4	O
gene	19863546	4	O
.	19863546	4	O
Three	19863546	4	O
de	19863546	4	O
novo	19863546	4	O
mutations	19863546	4	O
were	19863546	4	O
identified	19863546	4	O
in	19863546	4	O
our	19863546	4	O
patients	19863546	4	O
with	19863546	4	O
FDH	19863546	4	O
:	19863546	4	O
a	19863546	4	O
150	19863546	4	O
-	19863546	4	O
kb	19863546	4	O
deletion	19863546	4	O
removing	19863546	4	O
six	19863546	4	O
genes	19863546	4	O
including	19863546	4	O
PORCN	19863546	4	O
,	19863546	4	O
as	19863546	4	O
defined	19863546	4	O
by	19863546	4	O
qPCR	19863546	4	O
and	19863546	4	O
X	19863546	4	O
-	19863546	4	O
array	19863546	4	O
-	19863546	4	O
CGH	19863546	4	O
,	19863546	4	O
and	19863546	4	O
two	19863546	4	O
heterozygous	19863546	4	O
missense	19863546	4	O
mutations	19863546	4	O
;	19863546	4	O
c.992	19863546	4	O
T	19863546	4	O
>	19863546	4	O
G	19863546	4	O
(	19863546	4	O
p.L331R	19863546	4	O
)	19863546	4	O
in	19863546	4	O
exon	19863546	4	O
11	19863546	4	O
and	19863546	4	O
c.1094	19863546	4	O
G	19863546	4	O
>	19863546	4	O
A	19863546	4	O
(	19863546	4	O
p.R365Q	19863546	4	O
)	19863546	4	O
in	19863546	4	O
exon	19863546	4	O
13	19863546	4	O
of	19863546	4	O
the	19863546	4	O
gene	19863546	4	O
.	19863546	4	O
Both	19863546	4	O
point	19863546	4	O
mutations	19863546	4	O
changed	19863546	4	O
highly	19863546	4	O
conserved	19863546	4	O
amino	19863546	4	O
acids	19863546	4	O
and	19863546	4	O
were	19863546	4	O
not	19863546	4	O
found	19863546	4	O
in	19863546	4	O
300	19863546	4	O
control	19863546	4	O
X	19863546	4	O
chromosomes	19863546	4	O
.	19863546	4	O
The	19863546	4	O
three	19863546	4	O
patients	19863546	4	O
in	19863546	4	O
whom	19863546	4	O
mutations	19863546	4	O
were	19863546	4	O
identified	19863546	4	O
all	19863546	4	O
present	19863546	4	O
with	19863546	4	O
characteristic	19863546	4	O
dermal	19863546	4	O
findings	19863546	4	O
together	19863546	4	O
with	19863546	4	O
limb	19863546	4	O
manifestations	19863546	4	O
,	19863546	4	O
which	19863546	4	O
were	19863546	4	O
not	19863546	4	O
seen	19863546	4	O
in	19863546	4	O
our	19863546	4	O
mutation	19863546	4	O
-	19863546	4	O
negative	19863546	4	O
patients	19863546	4	O
.	19863546	4	O
The	19863546	4	O
clinical	19863546	4	O
characteristics	19863546	4	O
of	19863546	4	O
our	19863546	4	O
patients	19863546	4	O
with	19863546	4	O
PORCN	19863546	4	O
mutations	19863546	4	O
were	19863546	4	O
compared	19863546	4	O
with	19863546	4	O
the	19863546	4	O
previously	19863546	4	O
reported	19863546	4	O
mutation	19863546	4	O
-	19863546	4	O
positive	19863546	4	O
cases	19863546	4	O
.	19863546	4	O
In	19863546	4	O
this	19863546	4	O
report	19863546	4	O
,	19863546	4	O
we	19863546	4	O
summarize	19863546	4	O
the	19863546	4	O
literature	19863546	4	O
on	19863546	4	O
PORCN	19863546	4	O
mutations	19863546	4	O
and	19863546	4	O
associated	19863546	4	O
phenotypes	19863546	4	O
.	19863546	4	O

Longitudinal	19919001	2	O
course	19919001	2	O
of	19919001	2	O
cognitive	19919001	2	O
,	19919001	2	O
adaptive	19919001	2	O
,	19919001	2	O
and	19919001	2	O
behavioral	19919001	2	O
characteristics	19919001	2	O
in	19919001	2	O
Costello	19919001	2	O
syndrome	19919001	2	O
.	19919001	2	O
Costello	19919001	2	B-Disease
syndrome	19919001	2	I-Disease
is	19919001	2	O
a	19919001	2	O
rare	19919001	2	O
rasopathy	19919001	2	O
caused	19919001	2	B-Reg
by	19919001	2	I-Reg
germline	19919001	2	O
mutations	19919001	2	B-Var
in	19919001	2	O
the	19919001	2	O
oncogene	19919001	2	O
HRAS	19919001	2	B-Gene
resulting	19919001	2	O
in	19919001	2	O
increased	19919001	2	B-PosReg
signal	19919001	2	O
transduction	19919001	2	O
through	19919001	2	O
the	19919001	2	O
Ras	19919001	2	O
/	19919001	2	O
mitogen	19919001	2	O
-	19919001	2	O
activated	19919001	2	O
protein	19919001	2	O
kinase	19919001	2	O
pathway	19919001	2	O
.	19919001	2	O
In	19919001	2	O
contrast	19919001	2	O
to	19919001	2	O
the	19919001	2	O
more	19919001	2	O
common	19919001	2	O
rasopathies	19919001	2	O
,	19919001	2	O
such	19919001	2	O
as	19919001	2	O
neurofibromatosis	19919001	2	O
type	19919001	2	O
1	19919001	2	O
and	19919001	2	O
Noonan	19919001	2	O
syndrome	19919001	2	O
,	19919001	2	O
limited	19919001	2	O
information	19919001	2	O
is	19919001	2	O
available	19919001	2	O
on	19919001	2	O
standardized	19919001	2	O
cognitive	19919001	2	O
testing	19919001	2	O
in	19919001	2	O
this	19919001	2	O
cohort	19919001	2	O
.	19919001	2	O
Past	19919001	2	O
research	19919001	2	O
indicated	19919001	2	O
a	19919001	2	O
mean	19919001	2	O
average	19919001	2	O
IQ	19919001	2	O
in	19919001	2	O
the	19919001	2	O
mild	19919001	2	O
mental	19919001	2	O
retardation	19919001	2	O
range	19919001	2	O
,	19919001	2	O
with	19919001	2	O
strengths	19919001	2	O
in	19919001	2	O
fluid	19919001	2	O
reasoning	19919001	2	O
(	19919001	2	O
FR	19919001	2	O
)	19919001	2	O
and	19919001	2	O
weakness	19919001	2	O
in	19919001	2	O
expressive	19919001	2	O
language	19919001	2	O
,	19919001	2	O
as	19919001	2	O
well	19919001	2	O
as	19919001	2	O
static	19919001	2	O
skills	19919001	2	O
over	19919001	2	O
time	19919001	2	O
.	19919001	2	O
Here	19919001	2	O
we	19919001	2	O
report	19919001	2	O
on	19919001	2	O
standardized	19919001	2	O
IQ	19919001	2	O
and	19919001	2	O
adaptive	19919001	2	O
functioning	19919001	2	O
in	19919001	2	O
18	19919001	2	O
individuals	19919001	2	O
with	19919001	2	O
Costello	19919001	2	O
syndrome	19919001	2	O
,	19919001	2	O
nine	19919001	2	O
males	19919001	2	O
and	19919001	2	O
nine	19919001	2	O
females	19919001	2	O
,	19919001	2	O
and	19919001	2	O
longitudinal	19919001	2	O
development	19919001	2	O
for	19919001	2	O
11	19919001	2	O
who	19919001	2	O
had	19919001	2	O
previous	19919001	2	O
testing	19919001	2	O
.	19919001	2	O
The	19919001	2	O
overall	19919001	2	O
IQ	19919001	2	O
,	19919001	2	O
ranging	19919001	2	O
from	19919001	2	O
severe	19919001	2	O
mental	19919001	2	O
retardation	19919001	2	O
to	19919001	2	O
the	19919001	2	O
average	19919001	2	O
range	19919001	2	O
,	19919001	2	O
with	19919001	2	O
a	19919001	2	O
mean	19919001	2	O
in	19919001	2	O
the	19919001	2	O
mildly	19919001	2	O
mentally	19919001	2	O
retarded	19919001	2	O
range	19919001	2	O
,	19919001	2	O
was	19919001	2	O
again	19919001	2	O
found	19919001	2	O
to	19919001	2	O
be	19919001	2	O
stable	19919001	2	O
,	19919001	2	O
but	19919001	2	O
an	19919001	2	O
interesting	19919001	2	O
pattern	19919001	2	O
in	19919001	2	O
the	19919001	2	O
development	19919001	2	O
of	19919001	2	O
nonverbal	19919001	2	O
FR	19919001	2	O
was	19919001	2	O
identified	19919001	2	O
.	19919001	2	O
Participants	19919001	2	O
showed	19919001	2	O
an	19919001	2	O
improvement	19919001	2	O
in	19919001	2	O
nonverbal	19919001	2	O
FR	19919001	2	O
,	19919001	2	O
followed	19919001	2	O
by	19919001	2	O
stable	19919001	2	O
skills	19919001	2	O
thereafter	19919001	2	O
,	19919001	2	O
suggesting	19919001	2	O
a	19919001	2	O
"	19919001	2	O
late	19919001	2	O
bloomer	19919001	2	O
"	19919001	2	O
effect	19919001	2	O
in	19919001	2	O
late	19919001	2	O
childhood	19919001	2	O
/	19919001	2	O
early	19919001	2	O
adolescence	19919001	2	O
.	19919001	2	O
Overall	19919001	2	O
adaptive	19919001	2	O
functioning	19919001	2	O
fell	19919001	2	O
into	19919001	2	O
the	19919001	2	O
range	19919001	2	O
of	19919001	2	O
Intellectual	19919001	2	O
Disability	19919001	2	O
for	19919001	2	O
70%	19919001	2	O
of	19919001	2	O
subjects	19919001	2	O
,	19919001	2	O
with	19919001	2	O
Socialization	19919001	2	O
as	19919001	2	O
a	19919001	2	O
relative	19919001	2	O
strength	19919001	2	O
and	19919001	2	O
Daily	19919001	2	O
Living	19919001	2	O
Skills	19919001	2	O
an	19919001	2	O
area	19919001	2	O
of	19919001	2	O
relative	19919001	2	O
difficulty	19919001	2	O
.	19919001	2	O
Interestingly	19919001	2	O
,	19919001	2	O
females	19919001	2	O
were	19919001	2	O
found	19919001	2	O
to	19919001	2	O
be	19919001	2	O
higher	19919001	2	O
functioning	19919001	2	O
than	19919001	2	O
males	19919001	2	O
in	19919001	2	O
all	19919001	2	O
domains	19919001	2	O
,	19919001	2	O
including	19919001	2	O
Communication	19919001	2	O
,	19919001	2	O
Daily	19919001	2	O
Living	19919001	2	O
Skills	19919001	2	O
and	19919001	2	O
Socialization	19919001	2	O
.	19919001	2	O
Caregivers	19919001	2	O
reported	19919001	2	O
significantly	19919001	2	O
more	19919001	2	O
behavioral	19919001	2	O
concerns	19919001	2	O
in	19919001	2	O
males	19919001	2	O
,	19919001	2	O
including	19919001	2	O
internalizing	19919001	2	O
,	19919001	2	O
externalizing	19919001	2	O
,	19919001	2	O
and	19919001	2	O
other	19919001	2	O
maladaptive	19919001	2	O
behaviors	19919001	2	O
.	19919001	2	O
In	19919001	2	O
contrast	19919001	2	O
,	19919001	2	O
no	19919001	2	O
gender	19919001	2	O
differences	19919001	2	O
were	19919001	2	O
found	19919001	2	O
in	19919001	2	O
cognitive	19919001	2	O
or	19919001	2	O
visuomotor	19919001	2	O
functioning	19919001	2	O
.	19919001	2	O

Molecular	20015893	4	O
analysis	20015893	4	O
of	20015893	4	O
42	20015893	4	O
patients	20015893	4	O
with	20015893	4	B-Reg
congenital	20015893	4	B-Disease
dyserythropoietic	20015893	4	I-Disease
anemia	20015893	4	I-Disease
type	20015893	4	I-Disease
II	20015893	4	I-Disease
:	20015893	4	I-Disease
new	20015893	4	O
mutations	20015893	4	B-Var
in	20015893	4	O
the	20015893	4	O
SEC23B	20015893	4	B-Gene
gene	20015893	4	O
and	20015893	4	O
a	20015893	4	O
search	20015893	4	O
for	20015893	4	O
a	20015893	4	O
genotype	20015893	4	O
-	20015893	4	O
phenotype	20015893	4	O
relationship	20015893	4	O
.	20015893	4	O
BACKGROUND	20015893	4	O
:	20015893	4	O
The	20015893	4	O
most	20015893	4	O
frequent	20015893	4	O
form	20015893	4	O
of	20015893	4	O
congenital	20015893	4	O
dyserythropoietic	20015893	4	O
anemia	20015893	4	O
is	20015893	4	O
the	20015893	4	O
type	20015893	4	O
II	20015893	4	O
form	20015893	4	O
.	20015893	4	O
Recently	20015893	4	O
it	20015893	4	O
was	20015893	4	O
shown	20015893	4	O
that	20015893	4	O
the	20015893	4	O
vast	20015893	4	O
majority	20015893	4	O
of	20015893	4	O
patients	20015893	4	O
with	20015893	4	O
congenital	20015893	4	B-Disease
dyserythropoietic	20015893	4	I-Disease
anemia	20015893	4	I-Disease
type	20015893	4	I-Disease
II	20015893	4	I-Disease
carry	20015893	4	B-Reg
mutations	20015893	4	B-Var
in	20015893	4	O
the	20015893	4	O
SEC23B	20015893	4	B-Gene
gene	20015893	4	O
.	20015893	4	O
Here	20015893	4	O
we	20015893	4	O
established	20015893	4	O
the	20015893	4	O
molecular	20015893	4	O
basis	20015893	4	O
of	20015893	4	O
42	20015893	4	O
cases	20015893	4	O
of	20015893	4	O
congenital	20015893	4	O
dyserythropoietic	20015893	4	O
anemia	20015893	4	O
type	20015893	4	O
II	20015893	4	O
and	20015893	4	O
attempted	20015893	4	O
to	20015893	4	O
define	20015893	4	O
a	20015893	4	O
genotype	20015893	4	O
-	20015893	4	O
phenotype	20015893	4	O
relationship	20015893	4	O
.	20015893	4	O
DESIGN	20015893	4	O
AND	20015893	4	O
METHODS	20015893	4	O
:	20015893	4	O
SEC23B	20015893	4	O
gene	20015893	4	O
sequencing	20015893	4	O
analysis	20015893	4	O
was	20015893	4	O
performed	20015893	4	O
to	20015893	4	O
assess	20015893	4	O
the	20015893	4	O
diversity	20015893	4	O
and	20015893	4	O
incidence	20015893	4	O
of	20015893	4	O
each	20015893	4	O
mutation	20015893	4	O
in	20015893	4	O
42	20015893	4	O
patients	20015893	4	O
with	20015893	4	O
congenital	20015893	4	O
dyserythropoietic	20015893	4	O
anemia	20015893	4	O
type	20015893	4	O
II	20015893	4	O
(	20015893	4	O
25	20015893	4	O
described	20015893	4	O
exclusively	20015893	4	O
in	20015893	4	O
this	20015893	4	O
work	20015893	4	O
)	20015893	4	O
,	20015893	4	O
from	20015893	4	O
the	20015893	4	O
Italian	20015893	4	O
and	20015893	4	O
the	20015893	4	O
French	20015893	4	O
Registries	20015893	4	O
,	20015893	4	O
and	20015893	4	O
the	20015893	4	O
relationship	20015893	4	O
of	20015893	4	O
these	20015893	4	O
mutations	20015893	4	O
with	20015893	4	O
the	20015893	4	O
clinical	20015893	4	O
presentation	20015893	4	O
.	20015893	4	O
To	20015893	4	O
this	20015893	4	O
purpose	20015893	4	O
,	20015893	4	O
we	20015893	4	O
divided	20015893	4	O
the	20015893	4	O
patients	20015893	4	O
into	20015893	4	O
two	20015893	4	O
groups	20015893	4	O
:	20015893	4	O
(	20015893	4	O
i	20015893	4	O
)	20015893	4	O
patients	20015893	4	O
with	20015893	4	O
two	20015893	4	O
missense	20015893	4	O
mutations	20015893	4	O
and	20015893	4	O
(	20015893	4	O
ii	20015893	4	O
)	20015893	4	O
patients	20015893	4	O
with	20015893	4	O
one	20015893	4	O
nonsense	20015893	4	O
and	20015893	4	O
one	20015893	4	O
missense	20015893	4	O
mutation	20015893	4	O
.	20015893	4	O
RESULTS	20015893	4	O
:	20015893	4	O
We	20015893	4	O
found	20015893	4	O
22	20015893	4	O
mutations	20015893	4	O
of	20015893	4	O
uneven	20015893	4	O
frequency	20015893	4	O
,	20015893	4	O
including	20015893	4	O
seven	20015893	4	O
novel	20015893	4	O
mutations	20015893	4	O
.	20015893	4	O
Compound	20015893	4	O
heterozygosity	20015893	4	O
for	20015893	4	O
a	20015893	4	O
missense	20015893	4	O
and	20015893	4	O
a	20015893	4	O
nonsense	20015893	4	O
mutation	20015893	4	O
tended	20015893	4	O
to	20015893	4	O
produce	20015893	4	O
a	20015893	4	O
more	20015893	4	O
severe	20015893	4	O
clinical	20015893	4	O
presentation	20015893	4	O
,	20015893	4	O
a	20015893	4	O
lower	20015893	4	O
reticulocyte	20015893	4	O
count	20015893	4	O
,	20015893	4	O
a	20015893	4	O
higher	20015893	4	O
serum	20015893	4	O
ferritin	20015893	4	O
level	20015893	4	O
,	20015893	4	O
and	20015893	4	O
,	20015893	4	O
in	20015893	4	O
some	20015893	4	O
cases	20015893	4	O
,	20015893	4	O
more	20015893	4	O
pronounced	20015893	4	O
transfusion	20015893	4	O
needs	20015893	4	O
,	20015893	4	O
than	20015893	4	O
homozygosity	20015893	4	O
or	20015893	4	O
compound	20015893	4	O
heterozygosity	20015893	4	O
for	20015893	4	O
two	20015893	4	O
missense	20015893	4	O
mutations	20015893	4	O
.	20015893	4	O
Homozygosity	20015893	4	O
or	20015893	4	O
compound	20015893	4	O
heterozygosity	20015893	4	O
for	20015893	4	O
two	20015893	4	O
nonsense	20015893	4	O
mutations	20015893	4	O
was	20015893	4	O
never	20015893	4	O
found	20015893	4	O
.	20015893	4	O
CONCLUSIONS	20015893	4	O
:	20015893	4	O
This	20015893	4	O
study	20015893	4	O
allowed	20015893	4	O
us	20015893	4	O
to	20015893	4	O
determine	20015893	4	O
the	20015893	4	O
most	20015893	4	O
frequent	20015893	4	O
mutations	20015893	4	O
in	20015893	4	O
patients	20015893	4	O
with	20015893	4	O
congenital	20015893	4	O
dyserythropoietic	20015893	4	O
anemia	20015893	4	O
type	20015893	4	O
II	20015893	4	O
.	20015893	4	O
Correlations	20015893	4	O
between	20015893	4	O
the	20015893	4	O
mutations	20015893	4	O
and	20015893	4	O
various	20015893	4	O
biological	20015893	4	O
parameters	20015893	4	O
suggested	20015893	4	O
that	20015893	4	O
the	20015893	4	O
association	20015893	4	O
of	20015893	4	O
one	20015893	4	O
missense	20015893	4	O
mutation	20015893	4	O
and	20015893	4	O
one	20015893	4	O
nonsense	20015893	4	O
mutation	20015893	4	O
was	20015893	4	O
significantly	20015893	4	O
more	20015893	4	O
deleterious	20015893	4	O
that	20015893	4	O
the	20015893	4	O
association	20015893	4	O
of	20015893	4	O
two	20015893	4	O
missense	20015893	4	O
mutations	20015893	4	O
.	20015893	4	O
However	20015893	4	O
,	20015893	4	O
there	20015893	4	O
was	20015893	4	O
an	20015893	4	O
overlap	20015893	4	O
between	20015893	4	O
the	20015893	4	O
two	20015893	4	O
categories	20015893	4	O
.	20015893	4	O

Identification	20031356	4	O
and	20031356	4	O
characterization	20031356	4	O
of	20031356	4	O
novel	20031356	4	O
sequence	20031356	4	O
variations	20031356	4	O
in	20031356	4	O
MECP2	20031356	4	O
gene	20031356	4	O
in	20031356	4	O
Rett	20031356	4	O
syndrome	20031356	4	O
patients	20031356	4	O
.	20031356	4	O
Rett	20031356	4	B-Disease
syndrome	20031356	4	I-Disease
(	20031356	4	O
RS	20031356	4	O
)	20031356	4	O
is	20031356	4	O
a	20031356	4	O
neurodevelopmental	20031356	4	O
disorder	20031356	4	O
caused	20031356	4	B-Reg
by	20031356	4	I-Reg
mutations	20031356	4	B-Var
in	20031356	4	O
MECP2	20031356	4	B-Gene
gene	20031356	4	O
.	20031356	4	O
Exons	20031356	4	O
2	20031356	4	O
,	20031356	4	O
3	20031356	4	O
,	20031356	4	O
and	20031356	4	O
4	20031356	4	O
,	20031356	4	O
in	20031356	4	O
addition	20031356	4	O
to	20031356	4	O
intronic	20031356	4	O
and	20031356	4	O
3	20031356	4	O
'	20031356	4	O
UTR	20031356	4	O
adjacent	20031356	4	O
regions	20031356	4	O
,	20031356	4	O
were	20031356	4	O
sequenced	20031356	4	O
in	20031356	4	O
80	20031356	4	O
patients	20031356	4	O
with	20031356	4	O
RS	20031356	4	O
.	20031356	4	O
Twenty	20031356	4	O
-	20031356	4	O
nine	20031356	4	O
sequence	20031356	4	O
variations	20031356	4	O
were	20031356	4	O
detected	20031356	4	O
in	20031356	4	O
49	20031356	4	O
patients	20031356	4	O
,	20031356	4	O
34	20031356	4	O
(	20031356	4	O
69.4%	20031356	4	O
)	20031356	4	O
patients	20031356	4	O
with	20031356	4	O
the	20031356	4	O
classic	20031356	4	O
form	20031356	4	O
of	20031356	4	O
RS	20031356	4	O
,	20031356	4	O
and	20031356	4	O
15	20031356	4	O
(	20031356	4	O
30.6%	20031356	4	O
)	20031356	4	O
patients	20031356	4	O
with	20031356	4	O
atypical	20031356	4	O
forms	20031356	4	O
of	20031356	4	O
RS	20031356	4	O
.	20031356	4	O
Thirteen	20031356	4	O
of	20031356	4	O
the	20031356	4	O
29	20031356	4	O
detected	20031356	4	O
mutations	20031356	4	O
represent	20031356	4	O
novel	20031356	4	O
sequence	20031356	4	O
variations	20031356	4	O
.	20031356	4	O
Missense	20031356	4	O
mutation	20031356	4	O
T158M	20031356	4	O
was	20031356	4	O
the	20031356	4	O
most	20031356	4	O
commonly	20031356	4	O
observed	20031356	4	O
mutation	20031356	4	O
,	20031356	4	O
detected	20031356	4	O
in	20031356	4	O
nine	20031356	4	O
patients	20031356	4	O
(	20031356	4	O
11.2%	20031356	4	O
)	20031356	4	O
.	20031356	4	O
Six	20031356	4	O
hotspot	20031356	4	O
pathogenic	20031356	4	O
mutations	20031356	4	O
(	20031356	4	O
R133C	20031356	4	O
,	20031356	4	O
T158M	20031356	4	O
,	20031356	4	O
R168X	20031356	4	O
,	20031356	4	O
R255X	20031356	4	O
,	20031356	4	O
R270X	20031356	4	O
,	20031356	4	O
and	20031356	4	O
R294X	20031356	4	O
)	20031356	4	O
were	20031356	4	O
responsible	20031356	4	O
for	20031356	4	O
the	20031356	4	O
phenotype	20031356	4	O
in	20031356	4	O
26	20031356	4	O
/	20031356	4	O
80	20031356	4	O
patients	20031356	4	O
(	20031356	4	O
32.5%	20031356	4	O
)	20031356	4	O
.	20031356	4	O

Ribosomal	20116044	2	O
protein	20116044	2	O
genes	20116044	2	O
RPS10	20116044	2	B-Gene
and	20116044	2	O
RPS26	20116044	2	B-Gene
are	20116044	2	O
commonly	20116044	2	O
mutated	20116044	2	B-Var
in	20116044	2	B-Reg
Diamond	20116044	2	B-Disease
-	20116044	2	I-Disease
Blackfan	20116044	2	I-Disease
anemia	20116044	2	I-Disease
.	20116044	2	O
Diamond	20116044	2	O
-	20116044	2	O
Blackfan	20116044	2	O
anemia	20116044	2	O
(	20116044	2	O
DBA	20116044	2	O
)	20116044	2	O
,	20116044	2	O
an	20116044	2	O
inherited	20116044	2	O
bone	20116044	2	O
marrow	20116044	2	O
failure	20116044	2	O
syndrome	20116044	2	O
characterized	20116044	2	O
by	20116044	2	O
anemia	20116044	2	O
that	20116044	2	O
usually	20116044	2	O
presents	20116044	2	O
before	20116044	2	O
the	20116044	2	O
first	20116044	2	O
birthday	20116044	2	O
or	20116044	2	O
in	20116044	2	O
early	20116044	2	O
childhood	20116044	2	O
,	20116044	2	O
is	20116044	2	O
associated	20116044	2	O
with	20116044	2	O
birth	20116044	2	O
defects	20116044	2	O
and	20116044	2	O
an	20116044	2	O
increased	20116044	2	O
risk	20116044	2	O
of	20116044	2	O
cancer	20116044	2	O
.	20116044	2	O
Although	20116044	2	O
anemia	20116044	2	O
is	20116044	2	O
the	20116044	2	O
most	20116044	2	O
prominent	20116044	2	O
feature	20116044	2	O
of	20116044	2	O
DBA	20116044	2	O
,	20116044	2	O
the	20116044	2	O
disease	20116044	2	O
is	20116044	2	O
also	20116044	2	O
characterized	20116044	2	O
by	20116044	2	O
growth	20116044	2	O
retardation	20116044	2	O
and	20116044	2	O
congenital	20116044	2	O
malformations	20116044	2	O
,	20116044	2	O
in	20116044	2	O
particular	20116044	2	O
craniofacial	20116044	2	O
,	20116044	2	O
upper	20116044	2	O
limb	20116044	2	O
,	20116044	2	O
heart	20116044	2	O
,	20116044	2	O
and	20116044	2	O
urinary	20116044	2	O
system	20116044	2	O
defects	20116044	2	O
that	20116044	2	O
are	20116044	2	O
present	20116044	2	O
in	20116044	2	O
approximately	20116044	2	O
30%	20116044	2	O
-	20116044	2	O
50%	20116044	2	O
of	20116044	2	O
patients	20116044	2	O
.	20116044	2	O
DBA	20116044	2	O
has	20116044	2	O
been	20116044	2	O
associated	20116044	2	O
with	20116044	2	O
mutations	20116044	2	O
in	20116044	2	O
seven	20116044	2	O
ribosomal	20116044	2	O
protein	20116044	2	O
(	20116044	2	O
RP	20116044	2	O
)	20116044	2	O
genes	20116044	2	O
,	20116044	2	O
RPS19	20116044	2	O
,	20116044	2	O
RPS24	20116044	2	O
,	20116044	2	O
RPS17	20116044	2	O
,	20116044	2	O
RPL35A	20116044	2	O
,	20116044	2	O
RPL5	20116044	2	O
,	20116044	2	O
RPL11	20116044	2	O
,	20116044	2	O
and	20116044	2	O
RPS7	20116044	2	O
,	20116044	2	O
in	20116044	2	O
about	20116044	2	O
43%	20116044	2	O
of	20116044	2	O
patients	20116044	2	O
.	20116044	2	O
To	20116044	2	O
continue	20116044	2	O
our	20116044	2	O
large	20116044	2	O
-	20116044	2	O
scale	20116044	2	O
screen	20116044	2	O
of	20116044	2	O
RP	20116044	2	O
genes	20116044	2	O
in	20116044	2	O
a	20116044	2	O
DBA	20116044	2	O
population	20116044	2	O
,	20116044	2	O
we	20116044	2	O
sequenced	20116044	2	O
35	20116044	2	O
ribosomal	20116044	2	O
protein	20116044	2	O
genes	20116044	2	O
,	20116044	2	O
RPL15	20116044	2	O
,	20116044	2	O
RPL24	20116044	2	O
,	20116044	2	O
RPL29	20116044	2	O
,	20116044	2	O
RPL32	20116044	2	O
,	20116044	2	O
RPL34	20116044	2	O
,	20116044	2	O
RPL9	20116044	2	O
,	20116044	2	O
RPL37	20116044	2	O
,	20116044	2	O
RPS14	20116044	2	O
,	20116044	2	O
RPS23	20116044	2	O
,	20116044	2	O
RPL10A	20116044	2	O
,	20116044	2	O
RPS10	20116044	2	O
,	20116044	2	O
RPS12	20116044	2	O
,	20116044	2	O
RPS18	20116044	2	O
,	20116044	2	O
RPL30	20116044	2	O
,	20116044	2	O
RPS20	20116044	2	O
,	20116044	2	O
RPL12	20116044	2	O
,	20116044	2	O
RPL7A	20116044	2	O
,	20116044	2	O
RPS6	20116044	2	O
,	20116044	2	O
RPL27A	20116044	2	O
,	20116044	2	O
RPLP2	20116044	2	O
,	20116044	2	O
RPS25	20116044	2	O
,	20116044	2	O
RPS3	20116044	2	O
,	20116044	2	O
RPL41	20116044	2	O
,	20116044	2	O
RPL6	20116044	2	O
,	20116044	2	O
RPLP0	20116044	2	O
,	20116044	2	O
RPS26	20116044	2	O
,	20116044	2	O
RPL21	20116044	2	O
,	20116044	2	O
RPL36AL	20116044	2	O
,	20116044	2	O
RPS29	20116044	2	O
,	20116044	2	O
RPL4	20116044	2	O
,	20116044	2	O
RPLP1	20116044	2	O
,	20116044	2	O
RPL13	20116044	2	O
,	20116044	2	O
RPS15A	20116044	2	O
,	20116044	2	O
RPS2	20116044	2	O
,	20116044	2	O
and	20116044	2	O
RPL38	20116044	2	O
,	20116044	2	O
in	20116044	2	O
our	20116044	2	O
DBA	20116044	2	O
patient	20116044	2	O
cohort	20116044	2	O
of	20116044	2	O
117	20116044	2	O
probands	20116044	2	O
.	20116044	2	O
We	20116044	2	O
identified	20116044	2	O
three	20116044	2	O
distinct	20116044	2	O
mutations	20116044	2	O
of	20116044	2	O
RPS10	20116044	2	O
in	20116044	2	O
five	20116044	2	O
probands	20116044	2	O
and	20116044	2	O
nine	20116044	2	O
distinct	20116044	2	O
mutations	20116044	2	O
of	20116044	2	O
RPS26	20116044	2	O
in	20116044	2	O
12	20116044	2	O
probands	20116044	2	O
.	20116044	2	O
Pre	20116044	2	O
-	20116044	2	O
rRNA	20116044	2	O
analysis	20116044	2	O
in	20116044	2	O
lymphoblastoid	20116044	2	O
cells	20116044	2	O
from	20116044	2	O
patients	20116044	2	O
bearing	20116044	2	O
mutations	20116044	2	B-Var
in	20116044	2	O
RPS10	20116044	2	B-Gene
and	20116044	2	O
RPS26	20116044	2	B-Gene
showed	20116044	2	O
elevated	20116044	2	B-PosReg
levels	20116044	2	O
of	20116044	2	O
18	20116044	2	O
S	20116044	2	O
-	20116044	2	O
E	20116044	2	O
pre	20116044	2	O
-	20116044	2	O
rRNA	20116044	2	O
.	20116044	2	O
This	20116044	2	O
accumulation	20116044	2	O
is	20116044	2	O
consistent	20116044	2	O
with	20116044	2	O
the	20116044	2	O
phenotype	20116044	2	O
observed	20116044	2	O
in	20116044	2	O
HeLa	20116044	2	O
cells	20116044	2	O
after	20116044	2	O
knockdown	20116044	2	O
of	20116044	2	O
RPS10	20116044	2	O
or	20116044	2	O
RPS26	20116044	2	O
expression	20116044	2	O
with	20116044	2	O
siRNAs	20116044	2	O
,	20116044	2	O
which	20116044	2	O
indicates	20116044	2	O
that	20116044	2	O
mutations	20116044	2	B-Var
in	20116044	2	O
the	20116044	2	O
RPS10	20116044	2	B-Gene
and	20116044	2	O
RPS26	20116044	2	B-Gene
genes	20116044	2	O
in	20116044	2	O
DBA	20116044	2	O
patients	20116044	2	O
affect	20116044	2	B-Reg
the	20116044	2	O
function	20116044	2	O
of	20116044	2	O
the	20116044	2	O
proteins	20116044	2	O
in	20116044	2	O
rRNA	20116044	2	O
processing	20116044	2	O
.	20116044	2	O

Clinical	20132240	1	O
and	20132240	1	O
molecular	20132240	1	O
aspects	20132240	1	O
of	20132240	1	O
aniridia	20132240	1	O
.	20132240	1	O
Aniridia	20132240	1	O
is	20132240	1	O
a	20132240	1	O
severe	20132240	1	O
,	20132240	1	O
congenital	20132240	1	O
ocular	20132240	1	O
malformation	20132240	1	O
inherited	20132240	1	O
in	20132240	1	O
an	20132240	1	O
autosomal	20132240	1	O
-	20132240	1	O
dominant	20132240	1	O
fashion	20132240	1	O
with	20132240	1	O
high	20132240	1	O
penetrance	20132240	1	O
and	20132240	1	O
variable	20132240	1	O
expression	20132240	1	O
.	20132240	1	O
Eye	20132240	1	O
morphogenesis	20132240	1	O
in	20132240	1	O
humans	20132240	1	O
involves	20132240	1	O
a	20132240	1	O
molecular	20132240	1	O
genetic	20132240	1	O
cascade	20132240	1	O
in	20132240	1	O
which	20132240	1	O
a	20132240	1	O
number	20132240	1	O
of	20132240	1	O
developmental	20132240	1	O
genes	20132240	1	O
interact	20132240	1	O
in	20132240	1	O
a	20132240	1	O
highly	20132240	1	O
organized	20132240	1	O
process	20132240	1	O
during	20132240	1	O
the	20132240	1	O
embryonic	20132240	1	O
period	20132240	1	O
to	20132240	1	O
produce	20132240	1	O
functional	20132240	1	O
ocular	20132240	1	O
structures	20132240	1	O
.	20132240	1	O
Among	20132240	1	O
these	20132240	1	O
genes	20132240	1	O
,	20132240	1	O
paired	20132240	1	O
box	20132240	1	O
gene	20132240	1	O
6	20132240	1	O
(	20132240	1	O
PAX6	20132240	1	O
)	20132240	1	O
has	20132240	1	O
an	20132240	1	O
essential	20132240	1	O
role	20132240	1	O
as	20132240	1	O
it	20132240	1	O
encodes	20132240	1	O
a	20132240	1	O
phylogenetically	20132240	1	O
conserved	20132240	1	O
transcription	20132240	1	O
factor	20132240	1	O
almost	20132240	1	O
universally	20132240	1	O
employed	20132240	1	O
for	20132240	1	O
eye	20132240	1	O
formation	20132240	1	O
in	20132240	1	O
animals	20132240	1	O
with	20132240	1	O
bilateral	20132240	1	O
symmetry	20132240	1	O
,	20132240	1	O
despite	20132240	1	O
widely	20132240	1	O
different	20132240	1	O
embryological	20132240	1	O
origins	20132240	1	O
.	20132240	1	O
To	20132240	1	O
direct	20132240	1	O
eye	20132240	1	O
development	20132240	1	O
,	20132240	1	O
PAX6	20132240	1	O
regulates	20132240	1	O
the	20132240	1	O
tissue	20132240	1	O
-	20132240	1	O
specific	20132240	1	O
expression	20132240	1	O
of	20132240	1	O
diverse	20132240	1	O
molecules	20132240	1	O
,	20132240	1	O
hormones	20132240	1	O
,	20132240	1	O
and	20132240	1	O
structural	20132240	1	O
proteins	20132240	1	O
.	20132240	1	O
In	20132240	1	O
humans	20132240	1	O
,	20132240	1	O
PAX6	20132240	1	B-Gene
is	20132240	1	O
located	20132240	1	O
in	20132240	1	O
chromosome	20132240	1	O
11	20132240	1	O
p13	20132240	1	O
,	20132240	1	O
and	20132240	1	O
its	20132240	1	O
mutations	20132240	1	B-Var
lead	20132240	1	B-Reg
to	20132240	1	I-Reg
a	20132240	1	O
variety	20132240	1	O
of	20132240	1	O
hereditary	20132240	1	O
ocular	20132240	1	O
malformations	20132240	1	O
of	20132240	1	O
the	20132240	1	O
anterior	20132240	1	O
and	20132240	1	O
posterior	20132240	1	O
segment	20132240	1	O
,	20132240	1	O
among	20132240	1	O
which	20132240	1	O
aniridia	20132240	1	O
and	20132240	1	O
most	20132240	1	O
probably	20132240	1	O
foveal	20132240	1	O
hypoplasia	20132240	1	O
are	20132240	1	O
the	20132240	1	O
major	20132240	1	O
signs	20132240	1	O
.	20132240	1	O
Aniridia	20132240	1	B-Disease
occurs	20132240	1	O
due	20132240	1	B-Reg
to	20132240	1	I-Reg
decreased	20132240	1	B-NegReg
dosage	20132240	1	O
of	20132240	1	O
the	20132240	1	O
PAX6	20132240	1	B-Gene
gene	20132240	1	O
and	20132240	1	O
exists	20132240	1	O
in	20132240	1	O
both	20132240	1	O
sporadic	20132240	1	O
and	20132240	1	O
familial	20132240	1	O
forms	20132240	1	O
.	20132240	1	O
The	20132240	1	O
mutations	20132240	1	O
are	20132240	1	O
scattered	20132240	1	O
throughout	20132240	1	O
the	20132240	1	O
gene	20132240	1	O
and	20132240	1	O
the	20132240	1	O
vast	20132240	1	O
majority	20132240	1	O
of	20132240	1	O
those	20132240	1	O
reported	20132240	1	O
so	20132240	1	O
far	20132240	1	O
are	20132240	1	O
nonsense	20132240	1	B-Var
mutations	20132240	1	I-Var
,	20132240	1	O
frameshift	20132240	1	B-Var
mutations	20132240	1	I-Var
,	20132240	1	O
or	20132240	1	O
splicing	20132240	1	B-Var
errors	20132240	1	I-Var
that	20132240	1	O
are	20132240	1	O
predicted	20132240	1	O
to	20132240	1	O
cause	20132240	1	B-Reg
pre	20132240	1	O
-	20132240	1	O
mature	20132240	1	O
truncation	20132240	1	O
of	20132240	1	O
the	20132240	1	O
PAX6	20132240	1	B-Gene
protein	20132240	1	O
,	20132240	1	O
causing	20132240	1	B-Reg
haploinsufficiency	20132240	1	O
.	20132240	1	O
Here	20132240	1	O
we	20132240	1	O
review	20132240	1	O
the	20132240	1	O
data	20132240	1	O
regarding	20132240	1	O
the	20132240	1	O
mechanisms	20132240	1	O
and	20132240	1	O
the	20132240	1	O
mutations	20132240	1	O
that	20132240	1	O
relate	20132240	1	O
to	20132240	1	O
aniridia	20132240	1	B-Disease
.	20132240	1	O

GARS	20152552	4	O
axonopathy	20152552	4	O
:	20152552	4	O
not	20152552	4	O
every	20152552	4	O
neuron	20152552	4	O
'	20152552	4	O
s	20152552	4	O
cup	20152552	4	O
of	20152552	4	O
tRNA	20152552	4	O
.	20152552	4	O
Charcot	20152552	4	B-Disease
-	20152552	4	I-Disease
Marie	20152552	4	I-Disease
-	20152552	4	I-Disease
Tooth	20152552	4	I-Disease
disease	20152552	4	I-Disease
type	20152552	4	I-Disease
2	20152552	4	I-Disease
D	20152552	4	I-Disease
,	20152552	4	O
a	20152552	4	O
hereditary	20152552	4	O
axonal	20152552	4	O
neuropathy	20152552	4	O
,	20152552	4	O
is	20152552	4	O
caused	20152552	4	B-Reg
by	20152552	4	I-Reg
mutations	20152552	4	B-Var
in	20152552	4	O
glycyl	20152552	4	O
-	20152552	4	O
tRNA	20152552	4	O
synthetase	20152552	4	O
(	20152552	4	B-Gene
GARS	20152552	4	I-Gene
)	20152552	4	I-Gene
.	20152552	4	O
The	20152552	4	O
mutations	20152552	4	O
are	20152552	4	O
distributed	20152552	4	O
throughout	20152552	4	O
the	20152552	4	O
protein	20152552	4	O
in	20152552	4	O
multiple	20152552	4	O
functional	20152552	4	O
domains	20152552	4	O
.	20152552	4	O
In	20152552	4	O
biochemical	20152552	4	O
and	20152552	4	O
cell	20152552	4	O
culture	20152552	4	O
experiments	20152552	4	O
,	20152552	4	O
some	20152552	4	O
mutant	20152552	4	O
forms	20152552	4	O
of	20152552	4	O
GARS	20152552	4	O
have	20152552	4	O
been	20152552	4	O
indistinguishable	20152552	4	O
from	20152552	4	O
wild	20152552	4	O
-	20152552	4	O
type	20152552	4	O
protein	20152552	4	O
,	20152552	4	O
suggesting	20152552	4	O
that	20152552	4	O
these	20152552	4	O
in	20152552	4	O
vitro	20152552	4	O
tests	20152552	4	O
might	20152552	4	O
not	20152552	4	O
adequately	20152552	4	O
assess	20152552	4	O
the	20152552	4	O
aberrant	20152552	4	O
activity	20152552	4	O
responsible	20152552	4	O
for	20152552	4	O
axonal	20152552	4	O
degeneration	20152552	4	O
.	20152552	4	O
Recently	20152552	4	O
,	20152552	4	O
mouse	20152552	4	O
and	20152552	4	O
fly	20152552	4	O
models	20152552	4	O
have	20152552	4	O
offered	20152552	4	O
new	20152552	4	O
insights	20152552	4	O
into	20152552	4	O
the	20152552	4	O
disease	20152552	4	O
mechanism	20152552	4	O
.	20152552	4	O
There	20152552	4	O
are	20152552	4	O
still	20152552	4	O
gaps	20152552	4	O
in	20152552	4	O
our	20152552	4	O
understanding	20152552	4	O
of	20152552	4	O
how	20152552	4	O
mutations	20152552	4	O
in	20152552	4	O
a	20152552	4	O
ubiquitously	20152552	4	O
expressed	20152552	4	O
component	20152552	4	O
of	20152552	4	O
the	20152552	4	O
translation	20152552	4	O
machinery	20152552	4	O
result	20152552	4	O
in	20152552	4	O
axonal	20152552	4	O
neuropathy	20152552	4	O
.	20152552	4	O
Here	20152552	4	O
,	20152552	4	O
we	20152552	4	O
review	20152552	4	O
recent	20152552	4	O
reports	20152552	4	O
,	20152552	4	O
weigh	20152552	4	O
the	20152552	4	O
evidence	20152552	4	O
for	20152552	4	O
and	20152552	4	O
against	20152552	4	O
possible	20152552	4	O
mechanisms	20152552	4	O
and	20152552	4	O
suggest	20152552	4	O
areas	20152552	4	O
of	20152552	4	O
focus	20152552	4	O
for	20152552	4	O
future	20152552	4	O
work	20152552	4	O
.	20152552	4	O

Novel	20222934	4	O
and	20222934	4	O
recurrent	20222934	4	O
mutations	20222934	4	O
in	20222934	4	O
the	20222934	4	O
filaggrin	20222934	4	O
gene	20222934	4	O
in	20222934	4	O
Chinese	20222934	4	O
patients	20222934	4	O
with	20222934	4	O
ichthyosis	20222934	4	O
vulgaris	20222934	4	O
.	20222934	4	O
BACKGROUND	20222934	4	O
:	20222934	4	O
Ichthyosis	20222934	4	B-Disease
vulgaris	20222934	4	I-Disease
(	20222934	4	O
IV	20222934	4	O
)	20222934	4	O
is	20222934	4	O
a	20222934	4	O
common	20222934	4	O
inherited	20222934	4	O
skin	20222934	4	O
disorder	20222934	4	O
,	20222934	4	O
and	20222934	4	O
the	20222934	4	O
filament	20222934	4	O
aggregating	20222934	4	O
protein	20222934	4	O
(	20222934	4	O
filaggrin	20222934	4	O
)	20222934	4	O
is	20222934	4	O
a	20222934	4	O
key	20222934	4	O
protein	20222934	4	O
involved	20222934	4	O
in	20222934	4	O
skin	20222934	4	O
barrier	20222934	4	O
function	20222934	4	O
.	20222934	4	O
Mutations	20222934	4	B-Var
in	20222934	4	O
the	20222934	4	O
filaggrin	20222934	4	O
gene	20222934	4	O
(	20222934	4	B-Gene
FLG	20222934	4	I-Gene
)	20222934	4	I-Gene
have	20222934	4	O
recently	20222934	4	O
been	20222934	4	O
identified	20222934	4	O
as	20222934	4	O
the	20222934	4	O
cause	20222934	4	B-Reg
of	20222934	4	O
IV	20222934	4	B-Disease
.	20222934	4	O
However	20222934	4	O
,	20222934	4	O
there	20222934	4	O
have	20222934	4	O
been	20222934	4	O
no	20222934	4	O
reports	20222934	4	O
of	20222934	4	O
FLG	20222934	4	O
mutations	20222934	4	O
in	20222934	4	O
mainland	20222934	4	O
Chinese	20222934	4	O
families	20222934	4	O
with	20222934	4	O
IV	20222934	4	O
.	20222934	4	O
OBJECTIVES	20222934	4	O
:	20222934	4	O
To	20222934	4	O
identify	20222934	4	O
FLG	20222934	4	O
mutations	20222934	4	O
in	20222934	4	O
Chinese	20222934	4	O
patients	20222934	4	O
with	20222934	4	O
IV	20222934	4	O
.	20222934	4	O
METHODS	20222934	4	O
:	20222934	4	O
Eleven	20222934	4	O
unrelated	20222934	4	O
Chinese	20222934	4	O
families	20222934	4	O
with	20222934	4	O
IV	20222934	4	O
were	20222934	4	O
examined	20222934	4	O
for	20222934	4	O
FLG	20222934	4	O
mutations	20222934	4	O
with	20222934	4	O
denaturing	20222934	4	O
high	20222934	4	O
-	20222934	4	O
performance	20222934	4	O
liquid	20222934	4	O
chromatography	20222934	4	O
prescreening	20222934	4	O
and	20222934	4	O
sequencing	20222934	4	O
.	20222934	4	O
SNaPShot	20222934	4	O
was	20222934	4	O
employed	20222934	4	O
to	20222934	4	O
obtain	20222934	4	O
a	20222934	4	O
high	20222934	4	O
-	20222934	4	O
throughput	20222934	4	O
screening	20222934	4	O
for	20222934	4	O
the	20222934	4	O
identified	20222934	4	O
mutations	20222934	4	O
.	20222934	4	O
RESULTS	20222934	4	O
:	20222934	4	O
Three	20222934	4	O
mutations	20222934	4	O
-	20222934	4	O
one	20222934	4	O
novel	20222934	4	O
mutation	20222934	4	O
(	20222934	4	O
Q1256X	20222934	4	O
)	20222934	4	O
and	20222934	4	O
two	20222934	4	O
known	20222934	4	O
mutations	20222934	4	O
(	20222934	4	O
3321	20222934	4	O
delA	20222934	4	O
and	20222934	4	O
E2422X	20222934	4	O
)	20222934	4	O
-	20222934	4	O
were	20222934	4	O
identified	20222934	4	O
in	20222934	4	O
these	20222934	4	O
families	20222934	4	O
.	20222934	4	O
The	20222934	4	O
novel	20222934	4	O
mutation	20222934	4	O
,	20222934	4	O
Q1256X	20222934	4	O
,	20222934	4	O
found	20222934	4	O
in	20222934	4	O
a	20222934	4	O
Chinese	20222934	4	O
family	20222934	4	O
with	20222934	4	O
IV	20222934	4	O
,	20222934	4	O
was	20222934	4	O
located	20222934	4	O
in	20222934	4	O
filaggrin	20222934	4	O
repeat	20222934	4	O
3	20222934	4	O
.	20222934	4	O
Mutation	20222934	4	O
3321	20222934	4	O
delA	20222934	4	O
,	20222934	4	O
previously	20222934	4	O
found	20222934	4	O
in	20222934	4	O
Japanese	20222934	4	O
patients	20222934	4	O
,	20222934	4	O
was	20222934	4	O
present	20222934	4	O
in	20222934	4	O
eight	20222934	4	O
Chinese	20222934	4	O
families	20222934	4	O
with	20222934	4	O
IV	20222934	4	O
.	20222934	4	O
Mutation	20222934	4	O
E2422X	20222934	4	O
,	20222934	4	O
previously	20222934	4	O
found	20222934	4	O
in	20222934	4	O
a	20222934	4	O
Dutch	20222934	4	O
patient	20222934	4	O
of	20222934	4	O
Chinese	20222934	4	O
origin	20222934	4	O
,	20222934	4	O
was	20222934	4	O
present	20222934	4	O
in	20222934	4	O
two	20222934	4	O
Chinese	20222934	4	O
families	20222934	4	O
with	20222934	4	O
IV	20222934	4	O
.	20222934	4	O
Neither	20222934	4	O
of	20222934	4	O
the	20222934	4	O
null	20222934	4	O
mutations	20222934	4	O
,	20222934	4	O
Q1256X	20222934	4	O
and	20222934	4	O
E2422X	20222934	4	O
,	20222934	4	O
were	20222934	4	O
found	20222934	4	O
in	20222934	4	O
100	20222934	4	O
unrelated	20222934	4	O
control	20222934	4	O
cases	20222934	4	O
from	20222934	4	O
the	20222934	4	O
Chinese	20222934	4	O
population	20222934	4	O
;	20222934	4	O
however	20222934	4	O
,	20222934	4	O
the	20222934	4	O
mutation	20222934	4	O
ratio	20222934	4	O
for	20222934	4	O
3321	20222934	4	O
delA	20222934	4	O
was	20222934	4	O
3%	20222934	4	O
in	20222934	4	O
these	20222934	4	O
controls	20222934	4	O
.	20222934	4	O
CONCLUSIONS	20222934	4	O
:	20222934	4	O
Our	20222934	4	O
study	20222934	4	O
suggests	20222934	4	O
that	20222934	4	O
each	20222934	4	O
population	20222934	4	O
may	20222934	4	O
have	20222934	4	O
a	20222934	4	O
unique	20222934	4	O
and	20222934	4	O
prevalent	20222934	4	O
set	20222934	4	O
of	20222934	4	O
FLG	20222934	4	O
mutations	20222934	4	O
.	20222934	4	O

Genetic	20236351	4	O
analysis	20236351	4	O
of	20236351	4	O
haemophilia	20236351	4	O
A	20236351	4	O
in	20236351	4	O
Taiwan	20236351	4	O
.	20236351	4	O
Haemophilia	20236351	4	B-Disease
A	20236351	4	I-Disease
(	20236351	4	O
HA	20236351	4	O
)	20236351	4	O
is	20236351	4	O
an	20236351	4	O
X	20236351	4	O
-	20236351	4	O
linked	20236351	4	O
bleeding	20236351	4	O
disorder	20236351	4	O
caused	20236351	4	B-Reg
by	20236351	4	I-Reg
mutations	20236351	4	B-Var
in	20236351	4	O
the	20236351	4	O
factor	20236351	4	O
VIII	20236351	4	O
(	20236351	4	B-Gene
FVIII	20236351	4	I-Gene
)	20236351	4	I-Gene
gene	20236351	4	O
.	20236351	4	O
Identification	20236351	4	O
of	20236351	4	O
these	20236351	4	O
mutations	20236351	4	O
is	20236351	4	O
becoming	20236351	4	O
increasingly	20236351	4	O
important	20236351	4	O
in	20236351	4	O
a	20236351	4	O
variety	20236351	4	O
of	20236351	4	O
clinical	20236351	4	O
settings	20236351	4	O
.	20236351	4	O
The	20236351	4	O
purpose	20236351	4	O
of	20236351	4	O
this	20236351	4	O
report	20236351	4	O
is	20236351	4	O
to	20236351	4	O
describe	20236351	4	O
our	20236351	4	O
experience	20236351	4	O
of	20236351	4	O
FVIII	20236351	4	O
gene	20236351	4	O
mutation	20236351	4	O
analysis	20236351	4	O
in	20236351	4	O
the	20236351	4	O
largest	20236351	4	O
cohort	20236351	4	O
of	20236351	4	O
patients	20236351	4	O
in	20236351	4	O
Taiwan	20236351	4	O
including	20236351	4	O
the	20236351	4	O
discovery	20236351	4	O
of	20236351	4	O
21	20236351	4	O
novel	20236351	4	O
mutations	20236351	4	O
.	20236351	4	O
We	20236351	4	O
tested	20236351	4	O
115	20236351	4	O
HA	20236351	4	O
patients	20236351	4	O
from	20236351	4	O
91	20236351	4	O
unrelated	20236351	4	O
families	20236351	4	O
,	20236351	4	O
including	20236351	4	O
79	20236351	4	O
severe	20236351	4	O
,	20236351	4	O
15	20236351	4	O
moderate	20236351	4	O
and	20236351	4	O
21	20236351	4	O
mild	20236351	4	O
types	20236351	4	O
starting	20236351	4	O
with	20236351	4	O
an	20236351	4	O
assay	20236351	4	O
for	20236351	4	O
the	20236351	4	O
intron	20236351	4	O
22	20236351	4	O
inversion	20236351	4	O
by	20236351	4	O
long	20236351	4	O
range	20236351	4	O
-	20236351	4	O
PCR	20236351	4	O
followed	20236351	4	O
if	20236351	4	O
necessary	20236351	4	O
by	20236351	4	O
additional	20236351	4	O
genetic	20236351	4	O
studies	20236351	4	O
.	20236351	4	O
Intron	20236351	4	O
22	20236351	4	O
inversion	20236351	4	O
accounted	20236351	4	O
for	20236351	4	O
27.8%	20236351	4	O
of	20236351	4	O
the	20236351	4	O
total	20236351	4	O
and	20236351	4	O
36.7%	20236351	4	O
of	20236351	4	O
severe	20236351	4	O
HA	20236351	4	O
patients	20236351	4	O
respectively	20236351	4	O
while	20236351	4	O
intron	20236351	4	O
1	20236351	4	O
inversion	20236351	4	O
comprised	20236351	4	O
7.6%	20236351	4	O
of	20236351	4	O
severe	20236351	4	O
patients	20236351	4	O
.	20236351	4	O
These	20236351	4	O
were	20236351	4	O
clearly	20236351	4	O
different	20236351	4	O
from	20236351	4	O
the	20236351	4	O
known	20236351	4	O
data	20236351	4	O
in	20236351	4	O
caucasian	20236351	4	O
populations	20236351	4	O
.	20236351	4	O
Of	20236351	4	O
75	20236351	4	O
patients	20236351	4	O
without	20236351	4	O
intron	20236351	4	O
22	20236351	4	O
or	20236351	4	O
1	20236351	4	O
inversion	20236351	4	O
,	20236351	4	O
70	20236351	4	O
from	20236351	4	O
62	20236351	4	O
unrelated	20236351	4	O
families	20236351	4	O
revealed	20236351	4	O
56	20236351	4	O
different	20236351	4	O
mutations	20236351	4	O
by	20236351	4	O
denaturing	20236351	4	O
high	20236351	4	O
-	20236351	4	O
performance	20236351	4	O
liquid	20236351	4	O
chromatography	20236351	4	O
(	20236351	4	O
DHPLC	20236351	4	O
)	20236351	4	O
,	20236351	4	O
of	20236351	4	O
which	20236351	4	O
21	20236351	4	O
were	20236351	4	O
novel	20236351	4	O
.	20236351	4	O
Also	20236351	4	O
,	20236351	4	O
the	20236351	4	O
only	20236351	4	O
female	20236351	4	O
patient	20236351	4	O
with	20236351	4	O
severe	20236351	4	O
HA	20236351	4	O
was	20236351	4	O
found	20236351	4	O
to	20236351	4	O
have	20236351	4	O
heterozygous	20236351	4	O
non	20236351	4	O
-	20236351	4	O
sense	20236351	4	O
mutation	20236351	4	O
(	20236351	4	O
c.6683	20236351	4	O
G	20236351	4	O
>	20236351	4	O
A	20236351	4	O
)	20236351	4	O
of	20236351	4	O
exon	20236351	4	O
24	20236351	4	O
.	20236351	4	O
Seven	20236351	4	O
patients	20236351	4	O
,	20236351	4	O
including	20236351	4	O
five	20236351	4	O
without	20236351	4	O
amplified	20236351	4	O
PCR	20236351	4	O
product	20236351	4	O
and	20236351	4	O
two	20236351	4	O
without	20236351	4	O
encoded	20236351	4	O
DNA	20236351	4	O
defect	20236351	4	O
turned	20236351	4	O
out	20236351	4	O
to	20236351	4	O
have	20236351	4	O
exon	20236351	4	O
(	20236351	4	O
s	20236351	4	O
)	20236351	4	O
deletion	20236351	4	O
or	20236351	4	O
insertion	20236351	4	O
by	20236351	4	O
reverse	20236351	4	O
transcript	20236351	4	O
PCR	20236351	4	O
(	20236351	4	O
RT	20236351	4	O
-	20236351	4	O
PCR	20236351	4	O
)	20236351	4	O
.	20236351	4	O
In	20236351	4	O
our	20236351	4	O
study	20236351	4	O
,	20236351	4	O
the	20236351	4	O
combination	20236351	4	O
of	20236351	4	O
various	20236351	4	O
molecular	20236351	4	O
techniques	20236351	4	O
including	20236351	4	O
LR	20236351	4	O
-	20236351	4	O
PCR	20236351	4	O
,	20236351	4	O
multiplex	20236351	4	O
PCR	20236351	4	O
,	20236351	4	O
DHPLC	20236351	4	O
and	20236351	4	O
RT	20236351	4	O
-	20236351	4	O
PCR	20236351	4	O
analysis	20236351	4	O
enabled	20236351	4	O
definitive	20236351	4	O
detection	20236351	4	O
of	20236351	4	O
the	20236351	4	O
causative	20236351	4	O
FVIII	20236351	4	O
gene	20236351	4	O
defects	20236351	4	O
in	20236351	4	O
112	20236351	4	O
of	20236351	4	O
113	20236351	4	O
(	20236351	4	O
99%	20236351	4	O
)	20236351	4	O
HA	20236351	4	O
patients	20236351	4	O
.	20236351	4	O

Mutation	20238024	4	O
spectra	20238024	4	O
in	20238024	4	O
autosomal	20238024	4	O
dominant	20238024	4	O
and	20238024	4	O
recessive	20238024	4	O
retinitis	20238024	4	O
pigmentosa	20238024	4	O
in	20238024	4	O
northern	20238024	4	O
Sweden	20238024	4	O
.	20238024	4	O
Retinal	20238024	4	O
degenerations	20238024	4	O
represent	20238024	4	O
a	20238024	4	O
heterogeneous	20238024	4	O
group	20238024	4	O
of	20238024	4	O
disorders	20238024	4	O
affecting	20238024	4	O
the	20238024	4	O
function	20238024	4	O
of	20238024	4	O
the	20238024	4	O
retina	20238024	4	O
.	20238024	4	O
The	20238024	4	O
frequency	20238024	4	O
of	20238024	4	O
retinitis	20238024	4	O
pigmentosa	20238024	4	O
(	20238024	4	O
RP	20238024	4	O
)	20238024	4	O
is	20238024	4	O
1	20238024	4	O
/	20238024	4	O
3500	20238024	4	O
worldwide	20238024	4	O
,	20238024	4	O
however	20238024	4	O
,	20238024	4	O
in	20238024	4	O
northern	20238024	4	O
Sweden	20238024	4	O
it	20238024	4	O
is	20238024	4	O
1	20238024	4	O
/	20238024	4	O
2000	20238024	4	O
due	20238024	4	O
to	20238024	4	O
limited	20238024	4	O
migration	20238024	4	O
and	20238024	4	O
a	20238024	4	O
'	20238024	4	O
founder	20238024	4	O
'	20238024	4	O
effect	20238024	4	O
.	20238024	4	O
In	20238024	4	O
this	20238024	4	O
study	20238024	4	O
we	20238024	4	O
identified	20238024	4	O
genetic	20238024	4	O
mechanisms	20238024	4	O
underlying	20238024	4	O
autosomal	20238024	4	O
dominant	20238024	4	O
and	20238024	4	O
recessive	20238024	4	O
RP	20238024	4	O
present	20238024	4	O
in	20238024	4	O
northern	20238024	4	O
Sweden	20238024	4	O
.	20238024	4	O
Several	20238024	4	O
novel	20238024	4	O
mutations	20238024	4	O
unique	20238024	4	O
for	20238024	4	O
this	20238024	4	O
region	20238024	4	O
were	20238024	4	O
found	20238024	4	O
.	20238024	4	O
In	20238024	4	O
an	20238024	4	O
autosomal	20238024	4	O
recessive	20238024	4	O
form	20238024	4	O
of	20238024	4	O
RP	20238024	4	O
,	20238024	4	O
Bothnia	20238024	4	B-Disease
dystrophy	20238024	4	I-Disease
caused	20238024	4	B-Reg
by	20238024	4	I-Reg
mutations	20238024	4	B-Var
in	20238024	4	O
the	20238024	4	O
RLBP1	20238024	4	B-Gene
gene	20238024	4	O
,	20238024	4	O
bi	20238024	4	O
-	20238024	4	O
allelic	20238024	4	O
mutations	20238024	4	O
R234W	20238024	4	O
,	20238024	4	O
M226K	20238024	4	O
and	20238024	4	O
compound	20238024	4	O
heterozygosity	20238024	4	O
,	20238024	4	O
M226K	20238024	4	O
R234W	20238024	4	O
was	20238024	4	O
detected	20238024	4	O
.	20238024	4	O
In	20238024	4	O
dominant	20238024	4	O
form	20238024	4	O
of	20238024	4	O
RP	20238024	4	O
mapped	20238024	4	O
to	20238024	4	O
19	20238024	4	O
q13.42	20238024	4	O
a	20238024	4	O
59	20238024	4	O
kb	20238024	4	O
genomic	20238024	4	O
deletion	20238024	4	O
including	20238024	4	O
the	20238024	4	O
PRPF31	20238024	4	O
and	20238024	4	O
three	20238024	4	O
other	20238024	4	O
genes	20238024	4	O
was	20238024	4	O
found	20238024	4	O
.	20238024	4	O
These	20238024	4	O
data	20238024	4	O
provide	20238024	4	O
additional	20238024	4	O
information	20238024	4	O
on	20238024	4	O
the	20238024	4	O
molecular	20238024	4	O
mechanisms	20238024	4	O
of	20238024	4	O
RP	20238024	4	O
evolvement	20238024	4	O
and	20238024	4	O
in	20238024	4	O
the	20238024	4	O
future	20238024	4	O
might	20238024	4	O
be	20238024	4	O
useful	20238024	4	O
in	20238024	4	O
development	20238024	4	O
of	20238024	4	O
therapeutic	20238024	4	O
strategies	20238024	4	O
.	20238024	4	O
Identification	20238024	4	O
of	20238024	4	O
the	20238024	4	O
disease	20238024	4	O
-	20238024	4	O
causing	20238024	4	O
mutations	20238024	4	O
allowed	20238024	4	O
introducing	20238024	4	O
molecular	20238024	4	O
genetic	20238024	4	O
testing	20238024	4	O
of	20238024	4	O
the	20238024	4	O
patients	20238024	4	O
and	20238024	4	O
their	20238024	4	O
families	20238024	4	O
into	20238024	4	O
the	20238024	4	O
clinical	20238024	4	O
practice	20238024	4	O
.	20238024	4	O

Sequence	20352026	1	O
variants	20352026	1	B-Var
of	20352026	1	O
the	20352026	1	O
DFNB31	20352026	1	B-Gene
gene	20352026	1	O
among	20352026	1	B-Reg
Usher	20352026	1	B-Disease
syndrome	20352026	1	I-Disease
patients	20352026	1	O
of	20352026	1	O
diverse	20352026	1	O
origin	20352026	1	O
.	20352026	1	O
PURPOSE	20352026	1	O
:	20352026	1	O
It	20352026	1	O
has	20352026	1	O
been	20352026	1	O
demonstrated	20352026	1	O
that	20352026	1	O
mutations	20352026	1	B-Var
in	20352026	1	O
deafness	20352026	1	O
,	20352026	1	O
autosomal	20352026	1	O
recessive	20352026	1	O
31	20352026	1	O
(	20352026	1	B-Gene
DFNB31	20352026	1	I-Gene
)	20352026	1	I-Gene
,	20352026	1	O
the	20352026	1	O
gene	20352026	1	O
encoding	20352026	1	O
whirlin	20352026	1	O
,	20352026	1	O
is	20352026	1	O
responsible	20352026	1	B-Reg
for	20352026	1	O
nonsyndromic	20352026	1	B-Disease
hearing	20352026	1	I-Disease
loss	20352026	1	I-Disease
(	20352026	1	O
NSHL	20352026	1	O
;	20352026	1	O
DFNB31	20352026	1	O
)	20352026	1	O
and	20352026	1	O
Usher	20352026	1	B-Disease
syndrome	20352026	1	I-Disease
type	20352026	1	I-Disease
II	20352026	1	I-Disease
(	20352026	1	O
USH2D	20352026	1	O
)	20352026	1	O
.	20352026	1	O
We	20352026	1	O
screened	20352026	1	O
DFNB31	20352026	1	O
in	20352026	1	O
a	20352026	1	O
large	20352026	1	O
cohort	20352026	1	O
of	20352026	1	O
patients	20352026	1	O
with	20352026	1	O
different	20352026	1	O
clinical	20352026	1	O
subtypes	20352026	1	O
of	20352026	1	O
Usher	20352026	1	O
syndrome	20352026	1	O
(	20352026	1	O
USH	20352026	1	O
)	20352026	1	O
to	20352026	1	O
determine	20352026	1	O
the	20352026	1	O
prevalence	20352026	1	O
of	20352026	1	O
DFNB31	20352026	1	O
mutations	20352026	1	O
among	20352026	1	O
USH	20352026	1	O
patients	20352026	1	O
.	20352026	1	O
METHODS	20352026	1	O
:	20352026	1	O
DFNB31	20352026	1	O
was	20352026	1	O
screened	20352026	1	O
in	20352026	1	O
149	20352026	1	O
USH2	20352026	1	O
,	20352026	1	O
29	20352026	1	O
USH1	20352026	1	O
,	20352026	1	O
six	20352026	1	O
atypical	20352026	1	O
USH	20352026	1	O
,	20352026	1	O
and	20352026	1	O
11	20352026	1	O
unclassified	20352026	1	O
USH	20352026	1	O
patients	20352026	1	O
from	20352026	1	O
diverse	20352026	1	O
ethnic	20352026	1	O
backgrounds	20352026	1	O
.	20352026	1	O
Mutation	20352026	1	O
detection	20352026	1	O
was	20352026	1	O
performed	20352026	1	O
by	20352026	1	O
direct	20352026	1	O
sequencing	20352026	1	O
of	20352026	1	O
all	20352026	1	O
coding	20352026	1	O
exons	20352026	1	O
.	20352026	1	O
RESULTS	20352026	1	O
:	20352026	1	O
We	20352026	1	O
identified	20352026	1	O
38	20352026	1	O
different	20352026	1	O
variants	20352026	1	O
among	20352026	1	O
195	20352026	1	O
patients	20352026	1	O
.	20352026	1	O
Most	20352026	1	O
variants	20352026	1	O
were	20352026	1	O
clearly	20352026	1	O
polymorphic	20352026	1	O
,	20352026	1	O
but	20352026	1	O
at	20352026	1	O
least	20352026	1	O
two	20352026	1	O
out	20352026	1	O
of	20352026	1	O
the	20352026	1	O
15	20352026	1	O
nonsynonymous	20352026	1	O
variants	20352026	1	O
(	20352026	1	B-Var
p.R350W	20352026	1	I-Var
and	20352026	1	O
p.R882S	20352026	1	B-Var
)	20352026	1	I-Var
are	20352026	1	O
predicted	20352026	1	O
to	20352026	1	O
impair	20352026	1	B-NegReg
whirlin	20352026	1	O
structure	20352026	1	O
and	20352026	1	O
function	20352026	1	O
,	20352026	1	O
suggesting	20352026	1	O
eventual	20352026	1	O
pathogenicity	20352026	1	O
.	20352026	1	O
No	20352026	1	O
putatively	20352026	1	O
pathogenic	20352026	1	O
mutation	20352026	1	O
was	20352026	1	O
found	20352026	1	O
in	20352026	1	O
the	20352026	1	O
second	20352026	1	O
allele	20352026	1	O
of	20352026	1	O
patients	20352026	1	O
with	20352026	1	O
these	20352026	1	O
mutations	20352026	1	O
.	20352026	1	O
CONCLUSIONS	20352026	1	O
:	20352026	1	O
DFNB31	20352026	1	O
is	20352026	1	O
not	20352026	1	O
a	20352026	1	O
major	20352026	1	O
cause	20352026	1	O
of	20352026	1	O
USH	20352026	1	O
.	20352026	1	O

Partial	20448484	0	O
depletion	20448484	0	O
of	20448484	0	O
CREB	20448484	0	O
-	20448484	0	O
binding	20448484	0	O
protein	20448484	0	O
reduces	20448484	0	O
life	20448484	0	O
expectancy	20448484	0	O
in	20448484	0	O
a	20448484	0	O
mouse	20448484	0	O
model	20448484	0	O
of	20448484	0	O
Huntington	20448484	0	O
disease	20448484	0	O
.	20448484	0	O
Previous	20448484	0	O
studies	20448484	0	O
have	20448484	0	O
reported	20448484	0	O
that	20448484	0	O
mutant	20448484	0	B-Var
huntingtin	20448484	0	B-Gene
(	20448484	0	O
htt	20448484	0	O
)	20448484	0	O
interferes	20448484	0	B-Reg
with	20448484	0	O
cyclic	20448484	0	O
AMP	20448484	0	O
response	20448484	0	O
element	20448484	0	O
binding	20448484	0	O
protein	20448484	0	O
binding	20448484	0	O
protein	20448484	0	O
(	20448484	0	O
CBP	20448484	0	O
)	20448484	0	O
-	20448484	0	O
mediated	20448484	0	O
transcription	20448484	0	O
,	20448484	0	O
possibly	20448484	0	O
by	20448484	0	O
inhibiting	20448484	0	B-NegReg
the	20448484	0	O
acetylation	20448484	0	O
of	20448484	0	O
histones	20448484	0	O
.	20448484	0	O
In	20448484	0	O
Drosophila	20448484	0	O
models	20448484	0	O
that	20448484	0	O
express	20448484	0	O
fragments	20448484	0	O
of	20448484	0	O
mutant	20448484	0	O
htt	20448484	0	O
,	20448484	0	O
histone	20448484	0	O
deacetylase	20448484	0	O
inhibitors	20448484	0	O
reverse	20448484	0	O
deficits	20448484	0	O
in	20448484	0	O
histone	20448484	0	O
acetylation	20448484	0	O
,	20448484	0	O
rescue	20448484	0	O
photoreceptor	20448484	0	O
degeneration	20448484	0	O
,	20448484	0	O
and	20448484	0	O
prolong	20448484	0	O
their	20448484	0	O
survival	20448484	0	O
.	20448484	0	O
These	20448484	0	O
compounds	20448484	0	O
also	20448484	0	O
improve	20448484	0	O
motor	20448484	0	O
deficits	20448484	0	O
in	20448484	0	O
a	20448484	0	O
transgenic	20448484	0	O
mouse	20448484	0	O
model	20448484	0	O
of	20448484	0	O
Huntington	20448484	0	O
disease	20448484	0	O
(	20448484	0	O
HD	20448484	0	O
)	20448484	0	O
.	20448484	0	O
To	20448484	0	O
determine	20448484	0	O
whether	20448484	0	O
endogenous	20448484	0	O
CBP	20448484	0	O
depletion	20448484	0	O
contributes	20448484	0	O
to	20448484	0	O
HD	20448484	0	O
pathogenesis	20448484	0	O
,	20448484	0	O
we	20448484	0	O
crossed	20448484	0	O
HD	20448484	0	O
-	20448484	0	O
N171-82	20448484	0	O
Q	20448484	0	O
transgenic	20448484	0	O
mice	20448484	0	O
with	20448484	0	O
mice	20448484	0	O
harboring	20448484	0	O
a	20448484	0	O
disrupted	20448484	0	O
CBP	20448484	0	O
gene	20448484	0	O
and	20448484	0	O
produced	20448484	0	O
mice	20448484	0	O
with	20448484	0	O
partial	20448484	0	O
(	20448484	0	O
50%	20448484	0	O
)	20448484	0	O
depletion	20448484	0	O
of	20448484	0	O
CBP	20448484	0	O
.	20448484	0	O
This	20448484	0	O
reduction	20448484	0	O
of	20448484	0	O
CBP	20448484	0	O
levels	20448484	0	O
decreased	20448484	0	O
the	20448484	0	O
life	20448484	0	O
expectancy	20448484	0	O
of	20448484	0	O
the	20448484	0	O
HD	20448484	0	O
-	20448484	0	O
N171-82	20448484	0	O
Q	20448484	0	O
Line	20448484	0	O
6	20448484	0	O
mouse	20448484	0	O
model	20448484	0	O
.	20448484	0	O
The	20448484	0	O
loss	20448484	0	O
of	20448484	0	O
CBP	20448484	0	O
had	20448484	0	O
no	20448484	0	O
obvious	20448484	0	O
impact	20448484	0	O
on	20448484	0	O
the	20448484	0	O
severity	20448484	0	O
of	20448484	0	O
motor	20448484	0	O
impairment	20448484	0	O
,	20448484	0	O
degeneration	20448484	0	O
of	20448484	0	O
the	20448484	0	O
striatum	20448484	0	O
,	20448484	0	O
mutant	20448484	0	O
htt	20448484	0	O
inclusion	20448484	0	O
formation	20448484	0	O
,	20448484	0	O
or	20448484	0	O
global	20448484	0	O
levels	20448484	0	O
of	20448484	0	O
acetylated	20448484	0	O
histones	20448484	0	O
H3	20448484	0	O
or	20448484	0	O
H4	20448484	0	O
in	20448484	0	O
brain	20448484	0	O
.	20448484	0	O
In	20448484	0	O
cell	20448484	0	O
models	20448484	0	O
,	20448484	0	O
we	20448484	0	O
confirmed	20448484	0	O
that	20448484	0	O
mutant	20448484	0	O
htt	20448484	0	O
inclusions	20448484	0	O
recruit	20448484	0	O
human	20448484	0	O
CBP	20448484	0	O
but	20448484	0	O
found	20448484	0	O
no	20448484	0	O
evidence	20448484	0	O
for	20448484	0	O
interactions	20448484	0	O
between	20448484	0	O
soluble	20448484	0	O
forms	20448484	0	O
of	20448484	0	O
mutant	20448484	0	O
htt	20448484	0	O
and	20448484	0	O
CBP	20448484	0	O
.	20448484	0	O
Although	20448484	0	O
we	20448484	0	O
identified	20448484	0	O
no	20448484	0	O
neurological	20448484	0	O
explanation	20448484	0	O
for	20448484	0	O
the	20448484	0	O
decreased	20448484	0	O
life	20448484	0	O
expectancy	20448484	0	O
of	20448484	0	O
HD	20448484	0	O
-	20448484	0	O
N171-82	20448484	0	O
Q	20448484	0	O
mice	20448484	0	O
with	20448484	0	O
partial	20448484	0	O
depletion	20448484	0	O
of	20448484	0	O
CBP	20448484	0	O
,	20448484	0	O
the	20448484	0	O
data	20448484	0	O
are	20448484	0	O
consistent	20448484	0	O
with	20448484	0	O
the	20448484	0	O
notion	20448484	0	O
that	20448484	0	O
CBP	20448484	0	O
function	20448484	0	O
mitigates	20448484	0	O
mutant	20448484	0	O
htt	20448484	0	O
toxicity	20448484	0	O
by	20448484	0	O
a	20448484	0	O
currently	20448484	0	O
unidentified	20448484	0	O
mechanism	20448484	0	O
.	20448484	0	O

Type	20524212	1	O
I	20524212	1	O
hyperprolinemia	20524212	1	O
:	20524212	1	O
genotype	20524212	1	O
/	20524212	1	O
phenotype	20524212	1	O
correlations	20524212	1	O
.	20524212	1	O
Type	20524212	1	B-Disease
I	20524212	1	I-Disease
hyperprolinemia	20524212	1	I-Disease
(	20524212	1	O
HPI	20524212	1	O
)	20524212	1	O
is	20524212	1	O
an	20524212	1	O
autosomal	20524212	1	O
recessive	20524212	1	O
disorder	20524212	1	O
associated	20524212	1	O
with	20524212	1	O
cognitive	20524212	1	O
and	20524212	1	O
psychiatric	20524212	1	O
troubles	20524212	1	O
,	20524212	1	O
caused	20524212	1	O
by	20524212	1	O
alterations	20524212	1	O
of	20524212	1	O
the	20524212	1	O
Proline	20524212	1	O
Dehydrogenase	20524212	1	O
gene	20524212	1	O
(	20524212	1	O
PRODH	20524212	1	O
)	20524212	1	O
at	20524212	1	O
22	20524212	1	O
q11	20524212	1	O
.	20524212	1	O
HPI	20524212	1	B-Disease
results	20524212	1	B-Reg
from	20524212	1	I-Reg
PRODH	20524212	1	B-Gene
deletion	20524212	1	B-Var
and	20524212	1	O
/	20524212	1	O
or	20524212	1	O
missense	20524212	1	B-Var
mutations	20524212	1	I-Var
reducing	20524212	1	B-NegReg
proline	20524212	1	O
oxidase	20524212	1	O
(	20524212	1	O
POX	20524212	1	O
)	20524212	1	O
activity	20524212	1	O
.	20524212	1	O
The	20524212	1	O
goals	20524212	1	O
of	20524212	1	O
this	20524212	1	O
study	20524212	1	O
were	20524212	1	O
first	20524212	1	O
to	20524212	1	O
measure	20524212	1	O
in	20524212	1	O
controls	20524212	1	O
the	20524212	1	O
frequency	20524212	1	O
of	20524212	1	O
PRODH	20524212	1	O
variations	20524212	1	O
described	20524212	1	O
in	20524212	1	O
HPI	20524212	1	O
patients	20524212	1	O
,	20524212	1	O
second	20524212	1	O
to	20524212	1	O
assess	20524212	1	O
the	20524212	1	O
functional	20524212	1	O
effect	20524212	1	O
of	20524212	1	O
PRODH	20524212	1	O
mutations	20524212	1	O
on	20524212	1	O
POX	20524212	1	O
activity	20524212	1	O
,	20524212	1	O
and	20524212	1	O
finally	20524212	1	O
to	20524212	1	O
establish	20524212	1	O
genotype	20524212	1	O
/	20524212	1	O
enzymatic	20524212	1	O
activity	20524212	1	O
correlations	20524212	1	O
in	20524212	1	O
a	20524212	1	O
new	20524212	1	O
series	20524212	1	O
of	20524212	1	O
HPI	20524212	1	O
patients	20524212	1	O
.	20524212	1	O
Eight	20524212	1	O
of	20524212	1	O
14	20524212	1	O
variants	20524212	1	O
occurred	20524212	1	O
at	20524212	1	O
polymorphic	20524212	1	O
frequency	20524212	1	O
in	20524212	1	O
114	20524212	1	O
controls	20524212	1	O
.	20524212	1	O
POX	20524212	1	O
activity	20524212	1	O
was	20524212	1	O
determined	20524212	1	O
for	20524212	1	O
six	20524212	1	O
novel	20524212	1	O
mutations	20524212	1	O
and	20524212	1	O
two	20524212	1	O
haplotypes	20524212	1	O
.	20524212	1	O
The	20524212	1	O
c.1331	20524212	1	O
G	20524212	1	O
>	20524212	1	O
A	20524212	1	O
,	20524212	1	O
p.G444D	20524212	1	O
allele	20524212	1	O
has	20524212	1	O
a	20524212	1	O
drastic	20524212	1	O
effect	20524212	1	O
,	20524212	1	O
whereas	20524212	1	O
the	20524212	1	O
c.23	20524212	1	B-Var
C	20524212	1	I-Var
>	20524212	1	I-Var
T	20524212	1	I-Var
,	20524212	1	O
p.P8L	20524212	1	B-Var
allele	20524212	1	O
and	20524212	1	O
the	20524212	1	O
c.	20524212	1	B-Var
[	20524212	1	I-Var
56	20524212	1	I-Var
C	20524212	1	I-Var
>	20524212	1	I-Var
A	20524212	1	I-Var
;	20524212	1	I-Var
172	20524212	1	I-Var
G	20524212	1	I-Var
>	20524212	1	I-Var
A	20524212	1	I-Var
]	20524212	1	I-Var
,	20524212	1	O
p.	20524212	1	B-Var
[	20524212	1	I-Var
Q19P	20524212	1	I-Var
;	20524212	1	I-Var
A58T	20524212	1	I-Var
]	20524212	1	I-Var
haplotype	20524212	1	O
result	20524212	1	O
in	20524212	1	O
a	20524212	1	O
moderate	20524212	1	O
decrease	20524212	1	B-NegReg
in	20524212	1	O
activity	20524212	1	O
.	20524212	1	O
Among	20524212	1	O
the	20524212	1	O
19	20524212	1	O
HPI	20524212	1	O
patients	20524212	1	O
,	20524212	1	O
10	20524212	1	O
had	20524212	1	O
a	20524212	1	O
predicted	20524212	1	O
residual	20524212	1	O
activity	20524212	1	O
<	20524212	1	O
50%	20524212	1	O
.	20524212	1	O
Eight	20524212	1	O
out	20524212	1	O
of	20524212	1	O
nine	20524212	1	O
subjects	20524212	1	O
with	20524212	1	O
a	20524212	1	O
predicted	20524212	1	O
residual	20524212	1	O
activity	20524212	1	O
>	20524212	1	O
or	20524212	1	O
=	20524212	1	O
50%	20524212	1	O
bore	20524212	1	O
at	20524212	1	O
least	20524212	1	O
one	20524212	1	O
c.824	20524212	1	O
C	20524212	1	O
>	20524212	1	O
A	20524212	1	O
,	20524212	1	O
p.T275N	20524212	1	O
allele	20524212	1	O
,	20524212	1	O
which	20524212	1	O
has	20524212	1	O
no	20524212	1	O
detrimental	20524212	1	O
effect	20524212	1	O
on	20524212	1	O
activity	20524212	1	O
but	20524212	1	O
whose	20524212	1	O
frequency	20524212	1	O
in	20524212	1	O
controls	20524212	1	O
is	20524212	1	O
only	20524212	1	O
3%	20524212	1	O
.	20524212	1	O
Our	20524212	1	O
results	20524212	1	O
suggest	20524212	1	O
that	20524212	1	O
PRODH	20524212	1	B-Gene
mutations	20524212	1	B-Var
lead	20524212	1	O
to	20524212	1	O
a	20524212	1	O
decreased	20524212	1	B-NegReg
POX	20524212	1	O
activity	20524212	1	O
or	20524212	1	O
affect	20524212	1	B-Reg
other	20524212	1	O
biological	20524212	1	O
parameters	20524212	1	O
causing	20524212	1	B-Reg
hyperprolinemia	20524212	1	B-Disease
.	20524212	1	O

Dihydropyrimidine	20544545	4	B-Disease
dehydrogenase	20544545	4	I-Disease
deficiency	20544545	4	I-Disease
caused	20544545	4	B-Reg
by	20544545	4	I-Reg
a	20544545	4	O
novel	20544545	4	O
genomic	20544545	4	O
deletion	20544545	4	O
c.505	20544545	4	B-Var
_513del	20544545	4	I-Var
of	20544545	4	O
DPYD	20544545	4	B-Gene
.	20544545	4	O
Dihydropyrimidine	20544545	4	O
dehydrogenase	20544545	4	O
(	20544545	4	O
DPD	20544545	4	O
)	20544545	4	O
deficiency	20544545	4	O
is	20544545	4	O
an	20544545	4	O
autosomal	20544545	4	O
recessive	20544545	4	O
disorder	20544545	4	O
of	20544545	4	O
the	20544545	4	O
pyrimidine	20544545	4	O
degradation	20544545	4	O
pathway	20544545	4	O
.	20544545	4	O
In	20544545	4	O
a	20544545	4	O
patient	20544545	4	O
presenting	20544545	4	O
with	20544545	4	O
convulsions	20544545	4	O
,	20544545	4	O
psychomotor	20544545	4	O
retardation	20544545	4	O
and	20544545	4	O
Reye	20544545	4	O
like	20544545	4	O
syndrome	20544545	4	O
,	20544545	4	O
strongly	20544545	4	O
elevated	20544545	4	O
levels	20544545	4	O
of	20544545	4	O
uracil	20544545	4	O
and	20544545	4	O
thymine	20544545	4	O
were	20544545	4	O
detected	20544545	4	O
in	20544545	4	O
urine	20544545	4	O
.	20544545	4	O
No	20544545	4	O
DPD	20544545	4	O
activity	20544545	4	O
could	20544545	4	O
be	20544545	4	O
detected	20544545	4	O
in	20544545	4	O
peripheral	20544545	4	O
blood	20544545	4	O
mononuclear	20544545	4	O
cells	20544545	4	O
.	20544545	4	O
Analysis	20544545	4	O
of	20544545	4	O
the	20544545	4	O
gene	20544545	4	O
encoding	20544545	4	O
DPD	20544545	4	O
(	20544545	4	O
DPYD	20544545	4	O
)	20544545	4	O
showed	20544545	4	O
that	20544545	4	O
the	20544545	4	O
patient	20544545	4	O
was	20544545	4	O
homozygous	20544545	4	O
for	20544545	4	O
a	20544545	4	O
novel	20544545	4	O
c.505	20544545	4	O
_513del	20544545	4	O
(	20544545	4	O
p.169_171del	20544545	4	O
)	20544545	4	O
mutation	20544545	4	O
in	20544545	4	O
exon	20544545	4	O
6	20544545	4	O
of	20544545	4	O
DPYD	20544545	4	O
.	20544545	4	O

Analysis	20556795	1	O
of	20556795	1	O
mutations	20556795	1	B-Var
causing	20556795	1	B-Reg
biotinidase	20556795	1	B-Disease
deficiency	20556795	1	I-Disease
.	20556795	1	O
Biotinidase	20556795	1	O
deficiency	20556795	1	O
is	20556795	1	O
an	20556795	1	O
inherited	20556795	1	O
disorder	20556795	1	O
in	20556795	1	O
which	20556795	1	O
the	20556795	1	O
vitamin	20556795	1	O
,	20556795	1	O
biotin	20556795	1	O
,	20556795	1	O
is	20556795	1	O
not	20556795	1	O
recycled	20556795	1	O
.	20556795	1	O
Individuals	20556795	1	O
with	20556795	1	O
biotinidase	20556795	1	O
deficiency	20556795	1	O
can	20556795	1	O
develop	20556795	1	O
neurological	20556795	1	O
and	20556795	1	O
cutaneous	20556795	1	O
symptoms	20556795	1	O
if	20556795	1	O
they	20556795	1	O
are	20556795	1	O
not	20556795	1	O
treated	20556795	1	O
with	20556795	1	O
biotin	20556795	1	O
.	20556795	1	O
Biotinidase	20556795	1	O
deficiency	20556795	1	O
screening	20556795	1	O
has	20556795	1	O
been	20556795	1	O
incorporated	20556795	1	O
into	20556795	1	O
essentially	20556795	1	O
all	20556795	1	O
newborn	20556795	1	O
screening	20556795	1	O
programs	20556795	1	O
in	20556795	1	O
the	20556795	1	O
United	20556795	1	O
States	20556795	1	O
and	20556795	1	O
in	20556795	1	O
many	20556795	1	O
countries	20556795	1	O
.	20556795	1	O
We	20556795	1	O
now	20556795	1	O
report	20556795	1	O
140	20556795	1	O
known	20556795	1	O
mutations	20556795	1	B-Var
in	20556795	1	O
the	20556795	1	O
biotinidase	20556795	1	O
gene	20556795	1	O
(	20556795	1	B-Gene
BTD	20556795	1	I-Gene
)	20556795	1	I-Gene
that	20556795	1	O
cause	20556795	1	B-Reg
biotinidase	20556795	1	B-Disease
deficiency	20556795	1	I-Disease
.	20556795	1	O
All	20556795	1	O
types	20556795	1	O
of	20556795	1	O
mutations	20556795	1	B-Var
have	20556795	1	O
been	20556795	1	O
found	20556795	1	O
to	20556795	1	O
cause	20556795	1	B-Reg
biotinidase	20556795	1	B-Disease
deficiency	20556795	1	I-Disease
.	20556795	1	O
Variants	20556795	1	O
have	20556795	1	O
been	20556795	1	O
identified	20556795	1	O
throughout	20556795	1	O
the	20556795	1	O
coding	20556795	1	O
sequence	20556795	1	O
.	20556795	1	O
Essentially	20556795	1	O
all	20556795	1	O
the	20556795	1	O
variants	20556795	1	B-Var
result	20556795	1	O
in	20556795	1	O
enzymatic	20556795	1	O
activities	20556795	1	O
with	20556795	1	O
less	20556795	1	B-NegReg
than	20556795	1	O
10%	20556795	1	O
of	20556795	1	O
mean	20556795	1	O
normal	20556795	1	O
enzyme	20556795	1	O
activity	20556795	1	O
(	20556795	1	O
profound	20556795	1	O
biotinidase	20556795	1	O
deficiency	20556795	1	O
)	20556795	1	O
with	20556795	1	O
the	20556795	1	O
exception	20556795	1	O
of	20556795	1	O
the	20556795	1	O
c.1330	20556795	1	B-Var
G	20556795	1	I-Var
>	20556795	1	I-Var
C	20556795	1	I-Var
(	20556795	1	O
p.D444H	20556795	1	O
)	20556795	1	O
mutation	20556795	1	O
,	20556795	1	O
which	20556795	1	O
results	20556795	1	O
in	20556795	1	O
an	20556795	1	O
enzyme	20556795	1	O
having	20556795	1	O
50%	20556795	1	B-NegReg
of	20556795	1	O
mean	20556795	1	O
normal	20556795	1	O
serum	20556795	1	O
activity	20556795	1	O
.	20556795	1	O
The	20556795	1	O
putative	20556795	1	O
three	20556795	1	O
-	20556795	1	O
dimensional	20556795	1	O
structure	20556795	1	O
of	20556795	1	O
biotinidase	20556795	1	O
has	20556795	1	O
been	20556795	1	O
predicted	20556795	1	O
by	20556795	1	O
homology	20556795	1	O
to	20556795	1	O
that	20556795	1	O
of	20556795	1	O
nitrilases	20556795	1	O
/	20556795	1	O
amidases	20556795	1	O
.	20556795	1	O
The	20556795	1	O
effect	20556795	1	O
of	20556795	1	O
the	20556795	1	O
various	20556795	1	O
missense	20556795	1	O
mutations	20556795	1	O
can	20556795	1	O
be	20556795	1	O
predicted	20556795	1	O
to	20556795	1	O
affect	20556795	1	O
various	20556795	1	O
important	20556795	1	O
sites	20556795	1	O
within	20556795	1	O
the	20556795	1	O
structure	20556795	1	O
of	20556795	1	O
the	20556795	1	O
enzyme	20556795	1	O
.	20556795	1	O
This	20556795	1	O
compilation	20556795	1	O
of	20556795	1	O
variants	20556795	1	O
causing	20556795	1	O
biotinidase	20556795	1	O
deficiency	20556795	1	O
will	20556795	1	O
be	20556795	1	O
useful	20556795	1	O
to	20556795	1	O
clinical	20556795	1	O
laboratories	20556795	1	O
that	20556795	1	O
are	20556795	1	O
performing	20556795	1	O
mutation	20556795	1	O
analysis	20556795	1	O
for	20556795	1	O
confirmational	20556795	1	O
testing	20556795	1	O
when	20556795	1	O
the	20556795	1	O
enzymatic	20556795	1	O
results	20556795	1	O
are	20556795	1	O
equivocal	20556795	1	O
for	20556795	1	O
children	20556795	1	O
identified	20556795	1	O
through	20556795	1	O
newborn	20556795	1	O
screening	20556795	1	O
.	20556795	1	O

N88S	20598714	4	B-Var
mutation	20598714	4	O
in	20598714	4	O
the	20598714	4	O
BSCL2	20598714	4	B-Gene
gene	20598714	4	O
in	20598714	4	B-Reg
a	20598714	4	O
Serbian	20598714	4	O
family	20598714	4	O
with	20598714	4	O
distal	20598714	4	B-Disease
hereditary	20598714	4	I-Disease
motor	20598714	4	I-Disease
neuropathy	20598714	4	I-Disease
type	20598714	4	I-Disease
V	20598714	4	I-Disease
or	20598714	4	O
Silver	20598714	4	B-Disease
syndrome	20598714	4	I-Disease
.	20598714	4	O
BACKGROUND	20598714	4	O
:	20598714	4	O
Distal	20598714	4	B-Disease
hereditary	20598714	4	I-Disease
motor	20598714	4	I-Disease
neuropathy	20598714	4	I-Disease
type	20598714	4	I-Disease
V	20598714	4	I-Disease
(	20598714	4	O
dHMN	20598714	4	O
-	20598714	4	O
V	20598714	4	O
)	20598714	4	O
and	20598714	4	O
Silver	20598714	4	B-Disease
syndrome	20598714	4	I-Disease
are	20598714	4	O
rare	20598714	4	O
phenotypically	20598714	4	O
overlapping	20598714	4	O
diseases	20598714	4	O
which	20598714	4	O
can	20598714	4	O
be	20598714	4	O
caused	20598714	4	B-Reg
by	20598714	4	I-Reg
mutations	20598714	4	B-Var
in	20598714	4	O
the	20598714	4	O
Berardinelli	20598714	4	O
-	20598714	4	O
Seip	20598714	4	O
Congenital	20598714	4	O
Lipodystrophy	20598714	4	O
2	20598714	4	O
(	20598714	4	B-Gene
BSCL2	20598714	4	I-Gene
)	20598714	4	I-Gene
gene	20598714	4	O
or	20598714	4	O
Seipin	20598714	4	B-Gene
.	20598714	4	O
AIM	20598714	4	O
:	20598714	4	O
To	20598714	4	O
report	20598714	4	O
the	20598714	4	O
first	20598714	4	O
Serbian	20598714	4	O
family	20598714	4	O
with	20598714	4	O
a	20598714	4	O
BSCL2	20598714	4	O
mutation	20598714	4	O
showing	20598714	4	O
variable	20598714	4	O
expression	20598714	4	O
within	20598714	4	O
the	20598714	4	O
family	20598714	4	O
.	20598714	4	O
PATIENTS	20598714	4	O
AND	20598714	4	O
METHODS	20598714	4	O
:	20598714	4	O
A	20598714	4	O
55	20598714	4	O
-	20598714	4	O
year	20598714	4	O
-	20598714	4	O
old	20598714	4	O
woman	20598714	4	O
presented	20598714	4	O
with	20598714	4	O
weakness	20598714	4	O
of	20598714	4	O
both	20598714	4	O
hands	20598714	4	O
at	20598714	4	O
the	20598714	4	O
age	20598714	4	O
of	20598714	4	O
45	20598714	4	O
.	20598714	4	O
At	20598714	4	O
age	20598714	4	O
47	20598714	4	O
,	20598714	4	O
she	20598714	4	O
noticed	20598714	4	O
distal	20598714	4	O
muscle	20598714	4	O
weakness	20598714	4	O
and	20598714	4	O
atrophy	20598714	4	O
in	20598714	4	O
her	20598714	4	O
legs	20598714	4	O
.	20598714	4	O
Physical	20598714	4	O
examination	20598714	4	O
revealed	20598714	4	O
atrophy	20598714	4	O
and	20598714	4	O
weakness	20598714	4	O
of	20598714	4	O
small	20598714	4	O
hand	20598714	4	O
muscles	20598714	4	O
and	20598714	4	O
mild	20598714	4	O
atrophy	20598714	4	O
and	20598714	4	O
weakness	20598714	4	O
of	20598714	4	O
the	20598714	4	O
lower	20598714	4	O
limbs	20598714	4	O
.	20598714	4	O
There	20598714	4	O
was	20598714	4	O
generalized	20598714	4	O
hyperreflexia	20598714	4	O
with	20598714	4	O
the	20598714	4	O
exception	20598714	4	O
of	20598714	4	O
ankle	20598714	4	O
reflexes	20598714	4	O
which	20598714	4	O
were	20598714	4	O
diminished	20598714	4	O
.	20598714	4	O
Her	20598714	4	O
25	20598714	4	O
year	20598714	4	O
-	20598714	4	O
old	20598714	4	O
son	20598714	4	O
had	20598714	4	O
only	20598714	4	O
stiffness	20598714	4	O
of	20598714	4	O
both	20598714	4	O
legs	20598714	4	O
at	20598714	4	O
the	20598714	4	O
age	20598714	4	O
of	20598714	4	O
22	20598714	4	O
.	20598714	4	O
Physical	20598714	4	O
examination	20598714	4	O
revealed	20598714	4	O
only	20598714	4	O
generalized	20598714	4	O
hyporeflexia	20598714	4	O
.	20598714	4	O
The	20598714	4	O
third	20598714	4	O
affected	20598714	4	O
member	20598714	4	O
in	20598714	4	O
this	20598714	4	O
family	20598714	4	O
was	20598714	4	O
her	20598714	4	O
55	20598714	4	O
year	20598714	4	O
-	20598714	4	O
old	20598714	4	O
cousin	20598714	4	O
who	20598714	4	O
showed	20598714	4	O
a	20598714	4	O
more	20598714	4	O
prominent	20598714	4	O
involvement	20598714	4	O
of	20598714	4	O
leg	20598714	4	O
muscles	20598714	4	O
with	20598714	4	O
mild	20598714	4	O
asymmetrical	20598714	4	O
weakness	20598714	4	O
of	20598714	4	O
hand	20598714	4	O
muscles	20598714	4	O
and	20598714	4	O
no	20598714	4	O
pyramidal	20598714	4	O
tract	20598714	4	O
features	20598714	4	O
.	20598714	4	O
RESULTS	20598714	4	O
:	20598714	4	O
In	20598714	4	O
all	20598714	4	O
three	20598714	4	O
patients	20598714	4	O
sensory	20598714	4	O
nerve	20598714	4	O
conduction	20598714	4	O
velocities	20598714	4	O
(	20598714	4	O
NCV	20598714	4	O
)	20598714	4	O
were	20598714	4	O
normal	20598714	4	O
in	20598714	4	O
all	20598714	4	O
extremities	20598714	4	O
.	20598714	4	O
Compound	20598714	4	O
muscle	20598714	4	O
action	20598714	4	O
potential	20598714	4	O
(	20598714	4	O
CMAP	20598714	4	O
)	20598714	4	O
amplitudes	20598714	4	O
were	20598714	4	O
markedly	20598714	4	O
reduced	20598714	4	O
in	20598714	4	O
all	20598714	4	O
patients	20598714	4	O
.	20598714	4	O
Concentric	20598714	4	O
needle	20598714	4	O
EMG	20598714	4	O
showed	20598714	4	O
evidence	20598714	4	O
of	20598714	4	O
chronic	20598714	4	O
denervation	20598714	4	O
in	20598714	4	O
distal	20598714	4	O
muscles	20598714	4	O
.	20598714	4	O
DNA	20598714	4	O
sequencing	20598714	4	O
of	20598714	4	O
BSCL2	20598714	4	O
was	20598714	4	O
performed	20598714	4	O
and	20598714	4	O
a	20598714	4	O
heterozygous	20598714	4	O
N88S	20598714	4	O
missense	20598714	4	O
mutation	20598714	4	O
in	20598714	4	O
BSCL2	20598714	4	O
gene	20598714	4	O
was	20598714	4	O
detected	20598714	4	O
in	20598714	4	O
all	20598714	4	O
three	20598714	4	O
patients	20598714	4	O
.	20598714	4	O
CONCLUSION	20598714	4	O
:	20598714	4	O
This	20598714	4	O
report	20598714	4	O
is	20598714	4	O
further	20598714	4	O
confirmation	20598714	4	O
of	20598714	4	O
phenotypic	20598714	4	O
heterogenity	20598714	4	O
due	20598714	4	O
to	20598714	4	O
the	20598714	4	O
N88S	20598714	4	O
mutation	20598714	4	O
of	20598714	4	O
BSCL2	20598714	4	O
gene	20598714	4	O
in	20598714	4	O
the	20598714	4	O
same	20598714	4	O
family	20598714	4	O
.	20598714	4	O

DOK7	20610155	4	B-Gene
mutations	20610155	4	B-Var
presenting	20610155	4	B-Reg
as	20610155	4	I-Reg
a	20610155	4	O
proximal	20610155	4	B-Disease
myopathy	20610155	4	I-Disease
in	20610155	4	O
French	20610155	4	O
Canadians	20610155	4	O
.	20610155	4	O
DOK7	20610155	4	B-Gene
mutations	20610155	4	B-Var
cause	20610155	4	B-Reg
a	20610155	4	O
congenital	20610155	4	B-Disease
myasthenic	20610155	4	I-Disease
syndrome	20610155	4	I-Disease
(	20610155	4	O
OMIM	20610155	4	O
254300	20610155	4	O
)	20610155	4	O
characterized	20610155	4	O
by	20610155	4	O
a	20610155	4	O
"	20610155	4	O
limb	20610155	4	O
-	20610155	4	O
girdle	20610155	4	O
"	20610155	4	O
phenotype	20610155	4	O
.	20610155	4	O
We	20610155	4	O
identified	20610155	4	O
7	20610155	4	O
French	20610155	4	O
-	20610155	4	O
Canadian	20610155	4	O
patients	20610155	4	O
with	20610155	4	O
a	20610155	4	O
previously	20610155	4	O
undiagnosed	20610155	4	O
proximal	20610155	4	O
myopathy	20610155	4	O
.	20610155	4	O
A	20610155	4	O
genome	20610155	4	O
wide	20610155	4	O
scan	20610155	4	O
was	20610155	4	O
performed	20610155	4	O
.	20610155	4	O
Homozygosity	20610155	4	O
mapping	20610155	4	O
identified	20610155	4	O
a	20610155	4	O
locus	20610155	4	O
on	20610155	4	O
chromosome	20610155	4	O
4	20610155	4	O
p16.2	20610155	4	O
containing	20610155	4	O
DOK7	20610155	4	O
.	20610155	4	O
Sequencing	20610155	4	O
of	20610155	4	O
DOK7	20610155	4	O
revealed	20610155	4	O
homozygous	20610155	4	O
1124	20610155	4	O
_1127dupTGCC	20610155	4	O
mutations	20610155	4	O
in	20610155	4	O
all	20610155	4	O
individuals	20610155	4	O
.	20610155	4	O
SNP	20610155	4	O
genotyping	20610155	4	O
of	20610155	4	O
42	20610155	4	O
kb	20610155	4	O
surrounding	20610155	4	O
DOK7	20610155	4	O
in	20610155	4	O
our	20610155	4	O
cohort	20610155	4	O
and	20610155	4	O
in	20610155	4	O
9	20610155	4	O
patients	20610155	4	O
of	20610155	4	O
various	20610155	4	O
European	20610155	4	O
origins	20610155	4	O
demonstrated	20610155	4	O
a	20610155	4	O
shared	20610155	4	O
haplotype	20610155	4	O
suggesting	20610155	4	O
a	20610155	4	O
common	20610155	4	O
ancestral	20610155	4	O
European	20610155	4	O
mutation	20610155	4	O
.	20610155	4	O
In	20610155	4	O
our	20610155	4	O
cohort	20610155	4	O
,	20610155	4	O
fatigability	20610155	4	O
was	20610155	4	O
not	20610155	4	O
prominent	20610155	4	O
;	20610155	4	O
rather	20610155	4	O
patients	20610155	4	O
reported	20610155	4	O
prolonged	20610155	4	O
periods	20610155	4	O
of	20610155	4	O
increased	20610155	4	O
weakness	20610155	4	O
.	20610155	4	O
Abnormalities	20610155	4	O
on	20610155	4	O
repetitive	20610155	4	O
nerve	20610155	4	O
stimulation	20610155	4	O
and	20610155	4	O
single	20610155	4	O
fiber	20610155	4	O
EMG	20610155	4	O
were	20610155	4	O
not	20610155	4	O
invariably	20610155	4	O
present	20610155	4	O
.	20610155	4	O
There	20610155	4	O
was	20610155	4	O
considerable	20610155	4	O
intra	20610155	4	O
-	20610155	4	O
familial	20610155	4	O
phenotypic	20610155	4	O
variability	20610155	4	O
,	20610155	4	O
and	20610155	4	O
we	20610155	4	O
report	20610155	4	O
an	20610155	4	O
asymptomatic	20610155	4	O
individual	20610155	4	O
.	20610155	4	O
DOK7	20610155	4	O
mutations	20610155	4	O
should	20610155	4	O
be	20610155	4	O
considered	20610155	4	O
in	20610155	4	O
patients	20610155	4	O
with	20610155	4	O
early	20610155	4	O
-	20610155	4	O
onset	20610155	4	O
myopathy	20610155	4	O
,	20610155	4	O
even	20610155	4	O
in	20610155	4	O
the	20610155	4	O
absence	20610155	4	O
of	20610155	4	O
symptoms	20610155	4	O
suggesting	20610155	4	O
a	20610155	4	O
possible	20610155	4	O
myasthenia	20610155	4	O
.	20610155	4	O

Identification	20690502	4	O
of	20690502	4	O
known	20690502	4	O
and	20690502	4	O
novel	20690502	4	O
PTCH	20690502	4	B-Gene
mutations	20690502	4	B-Var
in	20690502	4	B-Reg
both	20690502	4	O
syndromic	20690502	4	O
and	20690502	4	O
non	20690502	4	O
-	20690502	4	O
syndromic	20690502	4	O
keratocystic	20690502	4	B-Disease
odontogenic	20690502	4	I-Disease
tumors	20690502	4	I-Disease
.	20690502	4	O
AIM	20690502	4	O
:	20690502	4	O
To	20690502	4	O
clarify	20690502	4	O
the	20690502	4	O
role	20690502	4	O
of	20690502	4	O
PTCH	20690502	4	O
in	20690502	4	O
patients	20690502	4	O
with	20690502	4	O
NBCCS	20690502	4	O
-	20690502	4	O
related	20690502	4	O
and	20690502	4	O
non	20690502	4	O
-	20690502	4	O
sydromic	20690502	4	O
keratocystic	20690502	4	O
odontogenic	20690502	4	O
tumors	20690502	4	O
.	20690502	4	O
METHODOLOGY	20690502	4	O
:	20690502	4	O
Mutation	20690502	4	O
analysis	20690502	4	O
was	20690502	4	O
undertaken	20690502	4	O
in	20690502	4	O
8	20690502	4	O
sporadic	20690502	4	O
and	20690502	4	O
4	20690502	4	O
NBCCS	20690502	4	O
-	20690502	4	O
associated	20690502	4	O
KCOTs	20690502	4	O
.	20690502	4	O
RESULTS	20690502	4	O
:	20690502	4	O
Four	20690502	4	O
novel	20690502	4	O
and	20690502	4	O
two	20690502	4	O
known	20690502	4	O
mutations	20690502	4	O
were	20690502	4	O
identified	20690502	4	O
in	20690502	4	O
2	20690502	4	O
sporadic	20690502	4	O
and	20690502	4	O
3	20690502	4	O
syndromic	20690502	4	O
cases	20690502	4	O
,	20690502	4	O
two	20690502	4	O
of	20690502	4	O
which	20690502	4	O
being	20690502	4	O
germline	20690502	4	O
mutations	20690502	4	O
(	20690502	4	O
c.2179	20690502	4	O
delT	20690502	4	O
,	20690502	4	O
c.2824	20690502	4	O
delC	20690502	4	O
)	20690502	4	O
and	20690502	4	O
4	20690502	4	O
somatic	20690502	4	O
mutations	20690502	4	O
(	20690502	4	O
c.3162	20690502	4	O
dupG	20690502	4	O
,	20690502	4	O
c.1362	20690502	4	O
-	20690502	4	O
1374	20690502	4	O
dup	20690502	4	O
,	20690502	4	O
c.1012	20690502	4	O
C	20690502	4	O
>	20690502	4	O
T	20690502	4	O
,	20690502	4	O
c.403	20690502	4	O
C	20690502	4	O
>	20690502	4	O
T	20690502	4	O
)	20690502	4	O
.	20690502	4	O
CONCLUSION	20690502	4	O
:	20690502	4	O
Our	20690502	4	O
findings	20690502	4	O
suggest	20690502	4	O
that	20690502	4	O
defects	20690502	4	O
of	20690502	4	O
PTCH	20690502	4	O
are	20690502	4	O
associated	20690502	4	O
with	20690502	4	O
the	20690502	4	O
pathogenesis	20690502	4	O
of	20690502	4	O
syndromic	20690502	4	O
as	20690502	4	O
well	20690502	4	O
as	20690502	4	O
a	20690502	4	O
subset	20690502	4	O
of	20690502	4	O
non	20690502	4	O
-	20690502	4	O
syndromic	20690502	4	O
KCOTs	20690502	4	O
.	20690502	4	O

Novel	21188847	4	O
and	21188847	4	O
recurrent	21188847	4	O
connexin	21188847	4	O
30.3	21188847	4	O
and	21188847	4	O
connexin	21188847	4	O
31	21188847	4	O
mutations	21188847	4	O
associated	21188847	4	O
with	21188847	4	O
erythrokeratoderma	21188847	4	O
variabilis	21188847	4	O
.	21188847	4	O
Erythrokeratoderma	21188847	4	B-Disease
variabilis	21188847	4	I-Disease
(	21188847	4	O
EKV	21188847	4	O
)	21188847	4	O
is	21188847	4	O
characterized	21188847	4	O
by	21188847	4	O
fixed	21188847	4	O
hyperkeratotic	21188847	4	O
plaques	21188847	4	O
and	21188847	4	O
transient	21188847	4	O
erythema	21188847	4	O
.	21188847	4	O
Mutations	21188847	4	B-Var
in	21188847	4	O
the	21188847	4	O
genes	21188847	4	O
GJB3	21188847	4	B-Gene
and	21188847	4	O
GJB4	21188847	4	B-Gene
,	21188847	4	O
which	21188847	4	O
encode	21188847	4	O
connexin	21188847	4	O
(	21188847	4	O
Cx	21188847	4	O
)	21188847	4	O
31	21188847	4	O
and	21188847	4	O
Cx30.3	21188847	4	O
,	21188847	4	O
are	21188847	4	O
associated	21188847	4	B-Reg
with	21188847	4	O
EKV	21188847	4	B-Disease
.	21188847	4	O
We	21188847	4	O
report	21188847	4	O
one	21188847	4	O
novel	21188847	4	O
mutation	21188847	4	O
in	21188847	4	O
Cx31	21188847	4	O
and	21188847	4	O
one	21188847	4	O
recurrent	21188847	4	O
mutation	21188847	4	O
in	21188847	4	O
Cx30.3	21188847	4	O
in	21188847	4	O
two	21188847	4	O
different	21188847	4	O
families	21188847	4	O
.	21188847	4	O
One	21188847	4	O
novel	21188847	4	O
rare	21188847	4	O
sequence	21188847	4	O
variant	21188847	4	O
of	21188847	4	O
unknown	21188847	4	O
clinical	21188847	4	O
significance	21188847	4	O
was	21188847	4	O
also	21188847	4	O
identified	21188847	4	O
.	21188847	4	O
This	21188847	4	O
finding	21188847	4	O
extends	21188847	4	O
the	21188847	4	O
spectrum	21188847	4	O
of	21188847	4	O
known	21188847	4	O
EKV	21188847	4	O
-	21188847	4	O
associated	21188847	4	O
mutations	21188847	4	O
.	21188847	4	O

Thyroid	21190448	1	O
pathology	21190448	1	O
in	21190448	1	O
PTEN	21190448	1	O
-	21190448	1	O
hamartoma	21190448	1	O
tumor	21190448	1	O
syndrome	21190448	1	O
:	21190448	1	O
characteristic	21190448	1	O
findings	21190448	1	O
of	21190448	1	O
a	21190448	1	O
distinct	21190448	1	O
entity	21190448	1	O
.	21190448	1	O
BACKGROUND	21190448	1	O
:	21190448	1	O
Phosphatase	21190448	1	O
and	21190448	1	O
tensin	21190448	1	O
homolog	21190448	1	O
deleted	21190448	1	O
on	21190448	1	O
chromosome	21190448	1	O
ten	21190448	1	O
(	21190448	1	B-Disease
PTEN	21190448	1	I-Disease
)	21190448	1	I-Disease
-	21190448	1	I-Disease
hamartoma	21190448	1	I-Disease
tumor	21190448	1	I-Disease
syndrome	21190448	1	I-Disease
(	21190448	1	O
PHTS	21190448	1	O
)	21190448	1	O
is	21190448	1	O
a	21190448	1	O
complex	21190448	1	O
disorder	21190448	1	O
caused	21190448	1	O
by	21190448	1	O
germline	21190448	1	O
inactivating	21190448	1	B-NegReg
mutations	21190448	1	B-Var
of	21190448	1	O
the	21190448	1	O
PTEN	21190448	1	B-Gene
tumor	21190448	1	O
suppressor	21190448	1	O
gene	21190448	1	O
.	21190448	1	O
PHTS	21190448	1	O
includes	21190448	1	O
Cowden	21190448	1	O
syndrome	21190448	1	O
(	21190448	1	O
CS	21190448	1	O
)	21190448	1	O
,	21190448	1	O
Bannayan	21190448	1	O
-	21190448	1	O
Riley	21190448	1	O
-	21190448	1	O
Ruvalcaba	21190448	1	O
syndrome	21190448	1	O
(	21190448	1	O
BRRS	21190448	1	O
)	21190448	1	O
,	21190448	1	O
and	21190448	1	O
Proteus	21190448	1	O
-	21190448	1	O
like	21190448	1	O
syndromes	21190448	1	O
.	21190448	1	O
Affected	21190448	1	O
individuals	21190448	1	O
develop	21190448	1	O
both	21190448	1	O
benign	21190448	1	O
and	21190448	1	O
malignant	21190448	1	O
tumors	21190448	1	O
in	21190448	1	O
a	21190448	1	O
variety	21190448	1	O
of	21190448	1	O
tissues	21190448	1	O
,	21190448	1	O
including	21190448	1	O
the	21190448	1	O
thyroid	21190448	1	O
.	21190448	1	O
This	21190448	1	O
study	21190448	1	O
is	21190448	1	O
to	21190448	1	O
better	21190448	1	O
characterize	21190448	1	O
and	21190448	1	O
describe	21190448	1	O
the	21190448	1	O
thyroid	21190448	1	O
pathology	21190448	1	O
within	21190448	1	O
the	21190448	1	O
different	21190448	1	O
entities	21190448	1	O
of	21190448	1	O
this	21190448	1	O
syndrome	21190448	1	O
,	21190448	1	O
and	21190448	1	O
examine	21190448	1	O
whether	21190448	1	O
there	21190448	1	O
is	21190448	1	O
an	21190448	1	O
association	21190448	1	O
between	21190448	1	O
specific	21190448	1	O
thyroid	21190448	1	O
findings	21190448	1	O
and	21190448	1	O
different	21190448	1	O
PTEN	21190448	1	O
mutations	21190448	1	O
.	21190448	1	O
METHODS	21190448	1	O
:	21190448	1	O
Twenty	21190448	1	O
patients	21190448	1	O
with	21190448	1	O
known	21190448	1	O
PTEN	21190448	1	O
mutations	21190448	1	O
,	21190448	1	O
and	21190448	1	O
/	21190448	1	O
or	21190448	1	O
clinical	21190448	1	O
diagnosis	21190448	1	O
of	21190448	1	O
PHTS	21190448	1	O
,	21190448	1	O
and	21190448	1	O
thyroid	21190448	1	O
pathology	21190448	1	O
were	21190448	1	O
identified	21190448	1	O
:	21190448	1	O
14	21190448	1	O
with	21190448	1	O
CS	21190448	1	O
and	21190448	1	O
6	21190448	1	O
with	21190448	1	O
BRRS	21190448	1	O
.	21190448	1	O
RESULTS	21190448	1	O
:	21190448	1	O
Thyroid	21190448	1	O
pathology	21190448	1	O
findings	21190448	1	O
were	21190448	1	O
as	21190448	1	O
follows	21190448	1	O
:	21190448	1	O
multiple	21190448	1	O
adenomatous	21190448	1	O
nodules	21190448	1	O
in	21190448	1	O
a	21190448	1	O
background	21190448	1	O
of	21190448	1	O
lymphocytic	21190448	1	O
thyroiditis	21190448	1	O
(	21190448	1	O
LT	21190448	1	O
)	21190448	1	O
in	21190448	1	O
75%	21190448	1	O
,	21190448	1	O
papillary	21190448	1	O
carcinoma	21190448	1	O
in	21190448	1	O
60%	21190448	1	O
,	21190448	1	O
LT	21190448	1	O
alone	21190448	1	O
in	21190448	1	O
55%	21190448	1	O
,	21190448	1	O
follicular	21190448	1	O
carcinoma	21190448	1	O
in	21190448	1	O
45%	21190448	1	O
,	21190448	1	O
C	21190448	1	O
-	21190448	1	O
cell	21190448	1	O
hyperplasia	21190448	1	O
in	21190448	1	O
55%	21190448	1	O
,	21190448	1	O
and	21190448	1	O
follicular	21190448	1	O
adenomas	21190448	1	O
in	21190448	1	O
25%	21190448	1	O
.	21190448	1	O
Within	21190448	1	O
the	21190448	1	O
papillary	21190448	1	O
carcinoma	21190448	1	O
group	21190448	1	O
,	21190448	1	O
there	21190448	1	O
were	21190448	1	O
6	21190448	1	O
microcarcinomas	21190448	1	O
,	21190448	1	O
5	21190448	1	O
follicular	21190448	1	O
variants	21190448	1	O
,	21190448	1	O
and	21190448	1	O
1	21190448	1	O
classical	21190448	1	O
type	21190448	1	O
.	21190448	1	O
CONCLUSIONS	21190448	1	O
:	21190448	1	O
There	21190448	1	O
were	21190448	1	O
no	21190448	1	O
morphologic	21190448	1	O
differences	21190448	1	O
between	21190448	1	O
the	21190448	1	O
thyroid	21190448	1	O
findings	21190448	1	O
in	21190448	1	O
CS	21190448	1	O
and	21190448	1	O
BRRS	21190448	1	O
.	21190448	1	O
Also	21190448	1	O
,	21190448	1	O
there	21190448	1	O
was	21190448	1	O
no	21190448	1	O
correlation	21190448	1	O
between	21190448	1	O
specific	21190448	1	O
PTEN	21190448	1	O
germline	21190448	1	O
mutations	21190448	1	O
(	21190448	1	O
exons	21190448	1	O
5	21190448	1	O
,	21190448	1	O
6	21190448	1	O
,	21190448	1	O
and	21190448	1	O
8	21190448	1	O
)	21190448	1	O
and	21190448	1	O
pathologic	21190448	1	O
findings	21190448	1	O
.	21190448	1	O
Distinctive	21190448	1	O
and	21190448	1	O
characteristic	21190448	1	O
findings	21190448	1	O
in	21190448	1	O
PHTS	21190448	1	O
include	21190448	1	O
multiple	21190448	1	O
unique	21190448	1	O
adenomatous	21190448	1	O
nodules	21190448	1	O
in	21190448	1	O
a	21190448	1	O
background	21190448	1	O
of	21190448	1	O
LT	21190448	1	O
,	21190448	1	O
and	21190448	1	O
C	21190448	1	O
-	21190448	1	O
cell	21190448	1	O
hyperplasia	21190448	1	O
;	21190448	1	O
it	21190448	1	O
is	21190448	1	O
vital	21190448	1	O
that	21190448	1	O
pathologists	21190448	1	O
recognize	21190448	1	O
the	21190448	1	O
classical	21190448	1	O
histologic	21190448	1	O
features	21190448	1	O
of	21190448	1	O
this	21190448	1	O
syndrome	21190448	1	O
to	21190448	1	O
alert	21190448	1	O
clinicians	21190448	1	O
to	21190448	1	O
the	21190448	1	O
possibility	21190448	1	O
of	21190448	1	O
this	21190448	1	O
syndrome	21190448	1	O
in	21190448	1	O
their	21190448	1	O
patients	21190448	1	O
.	21190448	1	O

Variable	21194947	4	O
phenotypes	21194947	4	O
are	21194947	4	O
associated	21194947	4	O
with	21194947	4	O
PMP22	21194947	4	O
missense	21194947	4	O
mutations	21194947	4	O
.	21194947	4	O
Charcot	21194947	4	B-Disease
-	21194947	4	I-Disease
Marie	21194947	4	I-Disease
-	21194947	4	I-Disease
Tooth	21194947	4	I-Disease
disease	21194947	4	I-Disease
(	21194947	4	O
CMT	21194947	4	O
)	21194947	4	O
is	21194947	4	O
the	21194947	4	O
commonest	21194947	4	O
hereditary	21194947	4	O
neuropathy	21194947	4	O
encompassing	21194947	4	O
a	21194947	4	O
large	21194947	4	O
group	21194947	4	O
of	21194947	4	O
clinically	21194947	4	O
and	21194947	4	O
genetically	21194947	4	O
heterogeneous	21194947	4	O
disorders	21194947	4	O
.	21194947	4	O
The	21194947	4	O
commonest	21194947	4	O
form	21194947	4	O
of	21194947	4	O
CMT	21194947	4	B-Disease
,	21194947	4	O
CMT1A	21194947	4	B-Disease
,	21194947	4	O
is	21194947	4	O
usually	21194947	4	O
caused	21194947	4	B-Reg
by	21194947	4	I-Reg
a	21194947	4	O
1.4	21194947	4	O
megabase	21194947	4	O
duplication	21194947	4	B-Var
of	21194947	4	O
chromosome	21194947	4	O
17	21194947	4	O
containing	21194947	4	O
the	21194947	4	O
PMP22	21194947	4	B-Gene
gene	21194947	4	O
.	21194947	4	O
Mutations	21194947	4	B-Var
of	21194947	4	O
PMP22	21194947	4	B-Gene
are	21194947	4	O
a	21194947	4	O
less	21194947	4	O
common	21194947	4	O
cause	21194947	4	B-Reg
of	21194947	4	O
CMT	21194947	4	B-Disease
.	21194947	4	O
We	21194947	4	O
describe	21194947	4	O
clinical	21194947	4	O
,	21194947	4	O
electrophysiological	21194947	4	O
and	21194947	4	O
molecular	21194947	4	O
findings	21194947	4	O
of	21194947	4	O
10	21194947	4	O
patients	21194947	4	O
carrying	21194947	4	O
PMP22	21194947	4	O
missense	21194947	4	O
mutations	21194947	4	O
.	21194947	4	O
The	21194947	4	O
phenotype	21194947	4	O
varied	21194947	4	O
from	21194947	4	O
mild	21194947	4	O
hereditary	21194947	4	O
neuropathy	21194947	4	O
with	21194947	4	O
liability	21194947	4	O
to	21194947	4	O
pressure	21194947	4	O
palsies	21194947	4	O
(	21194947	4	O
HNPP	21194947	4	O
)	21194947	4	O
to	21194947	4	O
severe	21194947	4	O
CMT1	21194947	4	O
.	21194947	4	O
We	21194947	4	O
identified	21194947	4	O
six	21194947	4	O
different	21194947	4	O
point	21194947	4	O
mutations	21194947	4	O
,	21194947	4	O
including	21194947	4	O
two	21194947	4	O
novel	21194947	4	O
mutations	21194947	4	O
.	21194947	4	O
Three	21194947	4	O
families	21194947	4	O
were	21194947	4	O
also	21194947	4	O
found	21194947	4	O
to	21194947	4	O
harbour	21194947	4	O
a	21194947	4	O
Thr118Met	21194947	4	O
mutation	21194947	4	O
.	21194947	4	O
Although	21194947	4	O
PMP22	21194947	4	O
point	21194947	4	O
mutations	21194947	4	O
are	21194947	4	O
not	21194947	4	O
common	21194947	4	O
,	21194947	4	O
our	21194947	4	O
findings	21194947	4	O
highlight	21194947	4	O
the	21194947	4	O
importance	21194947	4	O
of	21194947	4	O
sequencing	21194947	4	O
the	21194947	4	O
PMP22	21194947	4	O
gene	21194947	4	O
in	21194947	4	O
patients	21194947	4	O
with	21194947	4	O
variable	21194947	4	O
CMT	21194947	4	O
phenotypes	21194947	4	O
and	21194947	4	O
also	21194947	4	O
confirm	21194947	4	O
that	21194947	4	O
the	21194947	4	O
PMP22	21194947	4	B-Gene
Thr118Met	21194947	4	B-Var
mutation	21194947	4	O
is	21194947	4	O
associated	21194947	4	B-Reg
with	21194947	4	I-Reg
a	21194947	4	O
neuropathy	21194947	4	O
albeit	21194947	4	O
with	21194947	4	O
reduced	21194947	4	O
penetrance	21194947	4	O
.	21194947	4	O

Genotype	21204207	4	O
-	21204207	4	O
phenotype	21204207	4	O
analysis	21204207	4	O
of	21204207	4	O
the	21204207	4	O
branchio	21204207	4	O
-	21204207	4	O
oculo	21204207	4	O
-	21204207	4	O
facial	21204207	4	O
syndrome	21204207	4	O
.	21204207	4	O
Branchio	21204207	4	B-Disease
-	21204207	4	I-Disease
oculo	21204207	4	I-Disease
-	21204207	4	I-Disease
facial	21204207	4	I-Disease
syndrome	21204207	4	I-Disease
(	21204207	4	O
BOFS	21204207	4	O
;	21204207	4	O
OMIM	21204207	4	O
113620	21204207	4	O
)	21204207	4	O
is	21204207	4	O
a	21204207	4	O
rare	21204207	4	O
autosomal	21204207	4	O
dominant	21204207	4	O
craniofacial	21204207	4	O
disorder	21204207	4	O
with	21204207	4	O
variable	21204207	4	O
expression	21204207	4	O
.	21204207	4	O
Major	21204207	4	O
features	21204207	4	O
include	21204207	4	O
cutaneous	21204207	4	O
and	21204207	4	O
ocular	21204207	4	O
abnormalities	21204207	4	O
,	21204207	4	O
characteristic	21204207	4	O
facies	21204207	4	O
,	21204207	4	O
renal	21204207	4	O
,	21204207	4	O
ectodermal	21204207	4	O
,	21204207	4	O
and	21204207	4	O
temporal	21204207	4	O
bone	21204207	4	O
anomalies	21204207	4	O
.	21204207	4	O
Having	21204207	4	O
determined	21204207	4	O
that	21204207	4	O
mutations	21204207	4	B-Var
involving	21204207	4	O
TFAP2A	21204207	4	B-Gene
result	21204207	4	B-Reg
in	21204207	4	I-Reg
BOFS	21204207	4	B-Disease
,	21204207	4	O
we	21204207	4	O
studied	21204207	4	O
a	21204207	4	O
total	21204207	4	O
of	21204207	4	O
30	21204207	4	O
families	21204207	4	O
(	21204207	4	O
41	21204207	4	O
affected	21204207	4	O
individuals	21204207	4	O
)	21204207	4	O
;	21204207	4	O
26	21204207	4	O
/	21204207	4	O
30	21204207	4	O
(	21204207	4	O
87%	21204207	4	O
)	21204207	4	O
fulfilled	21204207	4	O
our	21204207	4	O
cardinal	21204207	4	O
diagnostic	21204207	4	O
criteria	21204207	4	O
.	21204207	4	O
The	21204207	4	O
original	21204207	4	O
family	21204207	4	O
with	21204207	4	O
the	21204207	4	O
3.2	21204207	4	O
Mb	21204207	4	O
deletion	21204207	4	O
including	21204207	4	O
the	21204207	4	O
TFAP2A	21204207	4	O
gene	21204207	4	O
remains	21204207	4	O
the	21204207	4	O
only	21204207	4	O
BOFS	21204207	4	O
family	21204207	4	O
without	21204207	4	O
the	21204207	4	O
typical	21204207	4	O
CL	21204207	4	O
/	21204207	4	O
P	21204207	4	O
and	21204207	4	O
the	21204207	4	O
only	21204207	4	O
family	21204207	4	O
with	21204207	4	O
a	21204207	4	O
deletion	21204207	4	O
.	21204207	4	O
We	21204207	4	O
have	21204207	4	O
identified	21204207	4	O
a	21204207	4	O
hotspot	21204207	4	O
region	21204207	4	O
in	21204207	4	O
the	21204207	4	O
highly	21204207	4	O
conserved	21204207	4	O
exons	21204207	4	O
4	21204207	4	O
and	21204207	4	O
5	21204207	4	O
of	21204207	4	O
TFAP2A	21204207	4	O
that	21204207	4	O
harbors	21204207	4	O
missense	21204207	4	O
mutations	21204207	4	O
in	21204207	4	O
27	21204207	4	O
/	21204207	4	O
30	21204207	4	O
(	21204207	4	O
90%	21204207	4	O
)	21204207	4	O
families	21204207	4	O
.	21204207	4	O
Several	21204207	4	O
of	21204207	4	O
these	21204207	4	O
mutations	21204207	4	O
are	21204207	4	O
recurrent	21204207	4	O
.	21204207	4	O
Mosaicism	21204207	4	O
was	21204207	4	O
detected	21204207	4	O
in	21204207	4	O
one	21204207	4	O
family	21204207	4	O
.	21204207	4	O
To	21204207	4	O
date	21204207	4	O
,	21204207	4	O
genetic	21204207	4	O
heterogeneity	21204207	4	O
has	21204207	4	O
not	21204207	4	O
been	21204207	4	O
observed	21204207	4	O
.	21204207	4	O
Although	21204207	4	O
the	21204207	4	O
cardinal	21204207	4	O
criteria	21204207	4	O
for	21204207	4	O
BOFS	21204207	4	O
have	21204207	4	O
been	21204207	4	O
based	21204207	4	O
on	21204207	4	O
the	21204207	4	O
presence	21204207	4	O
of	21204207	4	O
each	21204207	4	O
of	21204207	4	O
the	21204207	4	O
core	21204207	4	O
defects	21204207	4	O
,	21204207	4	O
an	21204207	4	O
affected	21204207	4	O
family	21204207	4	O
member	21204207	4	O
or	21204207	4	O
thymic	21204207	4	O
remnant	21204207	4	O
,	21204207	4	O
we	21204207	4	O
documented	21204207	4	O
TFAP2A	21204207	4	O
mutations	21204207	4	O
in	21204207	4	O
three	21204207	4	O
(	21204207	4	O
10%	21204207	4	O
)	21204207	4	O
probands	21204207	4	O
in	21204207	4	O
our	21204207	4	O
series	21204207	4	O
without	21204207	4	O
a	21204207	4	O
classic	21204207	4	O
cervical	21204207	4	O
cutaneous	21204207	4	O
defect	21204207	4	O
or	21204207	4	O
ectopic	21204207	4	O
thymus	21204207	4	O
.	21204207	4	O
Temporal	21204207	4	O
bone	21204207	4	O
anomalies	21204207	4	O
were	21204207	4	O
identified	21204207	4	O
in	21204207	4	O
3	21204207	4	O
/	21204207	4	O
5	21204207	4	O
patients	21204207	4	O
investigated	21204207	4	O
.	21204207	4	O
The	21204207	4	O
occurrence	21204207	4	O
of	21204207	4	O
CL	21204207	4	O
/	21204207	4	O
P	21204207	4	O
,	21204207	4	O
premature	21204207	4	O
graying	21204207	4	O
,	21204207	4	O
coloboma	21204207	4	O
,	21204207	4	O
heterochromia	21204207	4	O
irides	21204207	4	O
,	21204207	4	O
and	21204207	4	O
ectopic	21204207	4	O
thymus	21204207	4	O
,	21204207	4	O
are	21204207	4	O
evidence	21204207	4	O
for	21204207	4	O
BOFS	21204207	4	O
as	21204207	4	O
a	21204207	4	O
neurocristopathy	21204207	4	O
.	21204207	4	O
Intrafamilial	21204207	4	O
clinical	21204207	4	O
variability	21204207	4	O
can	21204207	4	O
be	21204207	4	O
marked	21204207	4	O
.	21204207	4	O
Although	21204207	4	O
there	21204207	4	O
does	21204207	4	O
not	21204207	4	O
appear	21204207	4	O
to	21204207	4	O
be	21204207	4	O
mutation	21204207	4	O
-	21204207	4	O
specific	21204207	4	O
genotype	21204207	4	O
-	21204207	4	O
phenotype	21204207	4	O
correlations	21204207	4	O
at	21204207	4	O
this	21204207	4	O
time	21204207	4	O
,	21204207	4	O
more	21204207	4	O
patients	21204207	4	O
need	21204207	4	O
to	21204207	4	O
be	21204207	4	O
studied	21204207	4	O
.	21204207	4	O
Clinical	21204207	4	O
testing	21204207	4	O
for	21204207	4	O
TFAP2A	21204207	4	O
mutations	21204207	4	O
is	21204207	4	O
now	21204207	4	O
available	21204207	4	O
and	21204207	4	O
will	21204207	4	O
assist	21204207	4	O
geneticists	21204207	4	O
in	21204207	4	O
confirming	21204207	4	O
the	21204207	4	O
typical	21204207	4	O
cases	21204207	4	O
or	21204207	4	O
excluding	21204207	4	O
the	21204207	4	O
diagnosis	21204207	4	O
in	21204207	4	O
atypical	21204207	4	O
cases	21204207	4	O
.	21204207	4	O

Twenty	21208200	1	O
-	21208200	1	O
five	21208200	1	O
novel	21208200	1	O
mutations	21208200	1	O
including	21208200	1	O
duplications	21208200	1	O
in	21208200	1	O
the	21208200	1	O
ATP7A	21208200	1	O
gene	21208200	1	O
.	21208200	1	O
Twenty	21208200	1	O
-	21208200	1	O
five	21208200	1	O
novel	21208200	1	O
mutations	21208200	1	O
including	21208200	1	O
duplications	21208200	1	O
in	21208200	1	O
the	21208200	1	O
ATP7A	21208200	1	O
gene	21208200	1	O
.	21208200	1	O
Menkes	21208200	1	B-Disease
disease	21208200	1	I-Disease
(	21208200	1	O
MD	21208200	1	O
)	21208200	1	O
and	21208200	1	O
occipital	21208200	1	B-Disease
horn	21208200	1	I-Disease
syndrome	21208200	1	I-Disease
(	21208200	1	O
OHS	21208200	1	O
)	21208200	1	O
are	21208200	1	O
allelic	21208200	1	O
X	21208200	1	O
-	21208200	1	O
linked	21208200	1	O
recessive	21208200	1	O
copper	21208200	1	O
deficiency	21208200	1	O
disorders	21208200	1	O
resulting	21208200	1	B-Reg
from	21208200	1	I-Reg
ATP7A	21208200	1	B-Gene
gene	21208200	1	O
mutations	21208200	1	B-Var
.	21208200	1	O
MD	21208200	1	O
is	21208200	1	O
a	21208200	1	O
severe	21208200	1	O
condition	21208200	1	O
leading	21208200	1	O
to	21208200	1	O
progressive	21208200	1	O
neurological	21208200	1	O
degeneration	21208200	1	O
and	21208200	1	O
death	21208200	1	O
in	21208200	1	O
early	21208200	1	O
childhood	21208200	1	O
,	21208200	1	O
whereas	21208200	1	O
OHS	21208200	1	O
has	21208200	1	O
a	21208200	1	O
milder	21208200	1	O
phenotype	21208200	1	O
with	21208200	1	O
mainly	21208200	1	O
connective	21208200	1	O
tissue	21208200	1	O
abnormalities	21208200	1	O
.	21208200	1	O
Until	21208200	1	O
now	21208200	1	O
,	21208200	1	O
molecular	21208200	1	O
analyses	21208200	1	O
have	21208200	1	O
revealed	21208200	1	O
only	21208200	1	O
deletions	21208200	1	O
and	21208200	1	O
point	21208200	1	O
mutations	21208200	1	O
in	21208200	1	O
both	21208200	1	O
diseases	21208200	1	O
.	21208200	1	O
This	21208200	1	O
study	21208200	1	O
reports	21208200	1	O
new	21208200	1	O
molecular	21208200	1	O
data	21208200	1	O
in	21208200	1	O
a	21208200	1	O
series	21208200	1	O
of	21208200	1	O
40	21208200	1	O
patients	21208200	1	O
referred	21208200	1	O
for	21208200	1	O
either	21208200	1	O
MD	21208200	1	O
or	21208200	1	O
OHS	21208200	1	O
.	21208200	1	O
We	21208200	1	O
describe	21208200	1	O
23	21208200	1	O
point	21208200	1	O
mutations	21208200	1	O
(	21208200	1	O
9	21208200	1	O
missense	21208200	1	O
mutations	21208200	1	O
,	21208200	1	O
7	21208200	1	O
splice	21208200	1	O
site	21208200	1	O
variants	21208200	1	O
,	21208200	1	O
4	21208200	1	O
nonsense	21208200	1	O
mutations	21208200	1	O
,	21208200	1	O
and	21208200	1	O
3	21208200	1	O
small	21208200	1	O
insertions	21208200	1	O
or	21208200	1	O
deletions	21208200	1	O
)	21208200	1	O
and	21208200	1	O
7	21208200	1	O
intragenic	21208200	1	O
deletions	21208200	1	O
.	21208200	1	O
Of	21208200	1	O
these	21208200	1	O
,	21208200	1	O
18	21208200	1	O
point	21208200	1	O
mutations	21208200	1	O
and	21208200	1	O
3	21208200	1	O
deletions	21208200	1	O
are	21208200	1	O
novel	21208200	1	O
.	21208200	1	O
Furthermore	21208200	1	O
,	21208200	1	O
our	21208200	1	O
finding	21208200	1	O
of	21208200	1	O
four	21208200	1	O
whole	21208200	1	O
exon	21208200	1	O
duplications	21208200	1	O
enlarges	21208200	1	O
the	21208200	1	O
mutation	21208200	1	O
spectrum	21208200	1	O
in	21208200	1	O
the	21208200	1	O
ATP7A	21208200	1	O
gene	21208200	1	O
.	21208200	1	O
ATP7A	21208200	1	O
alterations	21208200	1	O
were	21208200	1	O
found	21208200	1	O
in	21208200	1	O
85%	21208200	1	O
of	21208200	1	O
cases	21208200	1	O
.	21208200	1	O
Of	21208200	1	O
these	21208200	1	O
alterations	21208200	1	O
,	21208200	1	O
two	21208200	1	O
thirds	21208200	1	O
were	21208200	1	O
point	21208200	1	O
mutations	21208200	1	O
and	21208200	1	O
the	21208200	1	O
remaining	21208200	1	O
one	21208200	1	O
third	21208200	1	O
consisted	21208200	1	O
of	21208200	1	O
large	21208200	1	O
rearrangements	21208200	1	O
.	21208200	1	O
We	21208200	1	O
found	21208200	1	O
that	21208200	1	O
66.6%	21208200	1	O
of	21208200	1	O
point	21208200	1	O
mutations	21208200	1	B-Var
resulted	21208200	1	O
in	21208200	1	O
impaired	21208200	1	B-NegReg
ATP7A	21208200	1	B-Gene
transcript	21208200	1	O
splicing	21208200	1	O
,	21208200	1	O
a	21208200	1	O
phenomenon	21208200	1	O
more	21208200	1	O
frequent	21208200	1	O
than	21208200	1	O
expected	21208200	1	O
.	21208200	1	O
This	21208200	1	O
finding	21208200	1	O
enabled	21208200	1	O
us	21208200	1	O
to	21208200	1	O
confirm	21208200	1	O
the	21208200	1	O
pathogenic	21208200	1	O
role	21208200	1	O
of	21208200	1	O
ATP7A	21208200	1	O
mutations	21208200	1	O
,	21208200	1	O
particularly	21208200	1	O
in	21208200	1	O
missense	21208200	1	O
and	21208200	1	O
splice	21208200	1	O
site	21208200	1	O
variants	21208200	1	O
.	21208200	1	O

Phenotypic	21316238	4	O
heterogeneity	21316238	4	O
in	21316238	4	O
a	21316238	4	O
large	21316238	4	O
Thai	21316238	4	O
slow	21316238	4	O
-	21316238	4	O
channel	21316238	4	O
congenital	21316238	4	O
myasthenic	21316238	4	O
syndrome	21316238	4	O
kinship	21316238	4	O
.	21316238	4	O
The	21316238	4	O
slow	21316238	4	B-Disease
-	21316238	4	I-Disease
channel	21316238	4	I-Disease
congenital	21316238	4	I-Disease
myasthenic	21316238	4	I-Disease
syndrome	21316238	4	I-Disease
(	21316238	4	O
SCCMS	21316238	4	O
)	21316238	4	O
is	21316238	4	O
an	21316238	4	O
autosomal	21316238	4	O
dominant	21316238	4	O
neuromuscular	21316238	4	O
disorder	21316238	4	O
caused	21316238	4	B-Reg
by	21316238	4	I-Reg
mutations	21316238	4	B-Var
in	21316238	4	O
different	21316238	4	O
subunits	21316238	4	O
of	21316238	4	O
the	21316238	4	O
acetylcholine	21316238	4	O
receptor	21316238	4	O
(	21316238	4	B-Gene
AChR	21316238	4	I-Gene
)	21316238	4	I-Gene
.	21316238	4	O
We	21316238	4	O
here	21316238	4	O
report	21316238	4	O
our	21316238	4	O
clinical	21316238	4	O
findings	21316238	4	O
in	21316238	4	O
three	21316238	4	O
generations	21316238	4	O
of	21316238	4	O
a	21316238	4	O
large	21316238	4	O
Thai	21316238	4	O
kinship	21316238	4	O
suffering	21316238	4	O
from	21316238	4	O
SCCMS	21316238	4	O
and	21316238	4	O
trace	21316238	4	O
the	21316238	4	O
disease	21316238	4	O
to	21316238	4	O
the	21316238	4	O
p.Gly153Ser	21316238	4	O
mutation	21316238	4	O
in	21316238	4	O
the	21316238	4	O
AChR	21316238	4	O
α	21316238	4	O
subunit	21316238	4	O
.	21316238	4	O
The	21316238	4	O
same	21316238	4	O
mutation	21316238	4	O
had	21316238	4	O
previously	21316238	4	O
been	21316238	4	O
reported	21316238	4	O
only	21316238	4	O
in	21316238	4	O
Caucasian	21316238	4	O
but	21316238	4	O
not	21316238	4	O
in	21316238	4	O
Asian	21316238	4	O
patients	21316238	4	O
.	21316238	4	O
The	21316238	4	O
clinical	21316238	4	O
features	21316238	4	O
include	21316238	4	O
ptosis	21316238	4	O
,	21316238	4	O
ophthalmoparesis	21316238	4	O
,	21316238	4	O
and	21316238	4	O
weakness	21316238	4	O
of	21316238	4	O
the	21316238	4	O
cervical	21316238	4	O
and	21316238	4	O
finger	21316238	4	O
extensor	21316238	4	O
muscles	21316238	4	O
as	21316238	4	O
well	21316238	4	O
as	21316238	4	O
marked	21316238	4	O
phenotypic	21316238	4	O
heterogeneity	21316238	4	O
.	21316238	4	O

[	21342599	4	O
Anaemia	21342599	4	O
caused	21342599	4	O
by	21342599	4	O
a	21342599	4	O
congenital	21342599	4	O
haemoglobin	21342599	4	O
defect	21342599	4	O
can	21342599	4	O
also	21342599	4	O
occur	21342599	4	O
in	21342599	4	O
native	21342599	4	O
Dutch	21342599	4	O
patients	21342599	4	O
]	21342599	4	O
.	21342599	4	O
Anemie	21342599	4	O
door	21342599	4	O
aangeboren	21342599	4	O
afwijkingen	21342599	4	O
van	21342599	4	O
het	21342599	4	O
hemoglobine	21342599	4	O
,	21342599	4	O
ook	21342599	4	O
bij	21342599	4	O
autochtone	21342599	4	O
Nederlanders	21342599	4	O
.	21342599	4	O
An	21342599	4	O
11	21342599	4	O
-	21342599	4	O
year	21342599	4	O
-	21342599	4	O
old	21342599	4	O
boy	21342599	4	O
of	21342599	4	O
Dutch	21342599	4	O
descent	21342599	4	O
had	21342599	4	O
suffered	21342599	4	O
from	21342599	4	O
tiredness	21342599	4	O
,	21342599	4	O
pallor	21342599	4	O
and	21342599	4	O
poor	21342599	4	O
appetite	21342599	4	O
for	21342599	4	O
many	21342599	4	O
years	21342599	4	O
.	21342599	4	O
There	21342599	4	O
was	21342599	4	O
no	21342599	4	O
indication	21342599	4	O
of	21342599	4	O
chronic	21342599	4	O
infection	21342599	4	O
.	21342599	4	O
Iron	21342599	4	O
supplements	21342599	4	O
did	21342599	4	O
not	21342599	4	O
produce	21342599	4	O
sufficient	21342599	4	O
improvement	21342599	4	O
in	21342599	4	O
the	21342599	4	O
symptoms	21342599	4	O
.	21342599	4	O
Following	21342599	4	O
analysis	21342599	4	O
using	21342599	4	O
fast	21342599	4	O
protein	21342599	4	O
liquid	21342599	4	O
chromatography	21342599	4	O
and	21342599	4	O
DNA	21342599	4	O
sequencing	21342599	4	O
analysis	21342599	4	O
,	21342599	4	O
it	21342599	4	O
appeared	21342599	4	O
that	21342599	4	O
this	21342599	4	O
was	21342599	4	O
a	21342599	4	O
case	21342599	4	O
of	21342599	4	O
β	21342599	4	B-Disease
-	21342599	4	I-Disease
thalassaemia	21342599	4	I-Disease
intermedia	21342599	4	I-Disease
,	21342599	4	O
caused	21342599	4	B-Reg
by	21342599	4	I-Reg
a	21342599	4	O
point	21342599	4	B-Var
mutation	21342599	4	I-Var
in	21342599	4	O
the	21342599	4	O
promotor	21342599	4	O
region	21342599	4	O
of	21342599	4	O
the	21342599	4	O
β	21342599	4	B-Gene
-	21342599	4	I-Gene
globulin	21342599	4	I-Gene
gene	21342599	4	O
.	21342599	4	O
The	21342599	4	O
boy	21342599	4	O
'	21342599	4	O
s	21342599	4	O
parents	21342599	4	O
both	21342599	4	O
proved	21342599	4	O
to	21342599	4	O
be	21342599	4	O
heterozygotes	21342599	4	O
for	21342599	4	O
this	21342599	4	O
point	21342599	4	O
mutation	21342599	4	O
.	21342599	4	O
A	21342599	4	O
second	21342599	4	O
patient	21342599	4	O
,	21342599	4	O
a	21342599	4	O
5	21342599	4	O
-	21342599	4	O
year	21342599	4	O
-	21342599	4	O
old	21342599	4	O
girl	21342599	4	O
of	21342599	4	O
Dutch	21342599	4	O
descent	21342599	4	O
,	21342599	4	O
suffered	21342599	4	O
from	21342599	4	O
an	21342599	4	O
icterus	21342599	4	O
following	21342599	4	O
a	21342599	4	O
respiratory	21342599	4	O
tract	21342599	4	O
infection	21342599	4	O
.	21342599	4	O
Splenomegaly	21342599	4	O
,	21342599	4	O
hyperbilirubinaemia	21342599	4	O
and	21342599	4	O
microcytic	21342599	4	O
anaemia	21342599	4	O
with	21342599	4	O
raised	21342599	4	O
reticulocyte	21342599	4	O
values	21342599	4	O
were	21342599	4	O
observed	21342599	4	O
.	21342599	4	O
Because	21342599	4	O
of	21342599	4	O
the	21342599	4	O
presence	21342599	4	O
of	21342599	4	O
spherocytes	21342599	4	O
,	21342599	4	O
hereditary	21342599	4	O
spherocytosis	21342599	4	O
was	21342599	4	O
initially	21342599	4	O
suspected	21342599	4	O
.	21342599	4	O
On	21342599	4	O
further	21342599	4	O
analysis	21342599	4	O
Heinz	21342599	4	O
bodies	21342599	4	O
were	21342599	4	O
also	21342599	4	O
seen	21342599	4	O
,	21342599	4	O
following	21342599	4	O
which	21342599	4	O
DNA	21342599	4	O
sequencing	21342599	4	O
analysis	21342599	4	O
showed	21342599	4	O
a	21342599	4	O
de	21342599	4	O
novo	21342599	4	O
Hb	21342599	4	O
Köln	21342599	4	O
mutation	21342599	4	O
.	21342599	4	O
Congenital	21342599	4	O
haemoglobin	21342599	4	O
defects	21342599	4	O
are	21342599	4	O
usually	21342599	4	O
associated	21342599	4	O
with	21342599	4	O
people	21342599	4	O
originating	21342599	4	O
from	21342599	4	O
Africa	21342599	4	O
,	21342599	4	O
the	21342599	4	O
Mediterranean	21342599	4	O
,	21342599	4	O
the	21342599	4	O
Middle	21342599	4	O
-	21342599	4	O
East	21342599	4	O
or	21342599	4	O
South	21342599	4	O
-	21342599	4	O
East	21342599	4	O
Asia	21342599	4	O
.	21342599	4	O
That	21342599	4	O
such	21342599	4	O
abnormalities	21342599	4	O
can	21342599	4	O
also	21342599	4	O
occur	21342599	4	O
in	21342599	4	O
children	21342599	4	O
of	21342599	4	O
Dutch	21342599	4	O
descent	21342599	4	O
is	21342599	4	O
demonstrated	21342599	4	O
by	21342599	4	O
these	21342599	4	O
two	21342599	4	O
cases	21342599	4	O
.	21342599	4	O

Mild	21382783	4	O
recessive	21382783	4	O
dystrophic	21382783	4	B-Disease
epidermolysis	21382783	4	I-Disease
bullosa	21382783	4	I-Disease
associated	21382783	4	B-Reg
with	21382783	4	I-Reg
two	21382783	4	O
compound	21382783	4	O
heterozygous	21382783	4	O
COL7A1	21382783	4	B-Gene
mutations	21382783	4	B-Var
.	21382783	4	O
Dystrophic	21382783	4	B-Disease
epidermolysis	21382783	4	I-Disease
bullosa	21382783	4	I-Disease
is	21382783	4	O
a	21382783	4	O
group	21382783	4	O
of	21382783	4	O
inherited	21382783	4	O
skin	21382783	4	O
blistering	21382783	4	O
disorders	21382783	4	O
caused	21382783	4	B-Reg
by	21382783	4	I-Reg
mutations	21382783	4	B-Var
in	21382783	4	O
the	21382783	4	O
COL7A1	21382783	4	B-Gene
gene	21382783	4	O
coding	21382783	4	O
for	21382783	4	O
type	21382783	4	O
VII	21382783	4	O
collagen	21382783	4	O
.	21382783	4	O
More	21382783	4	O
than	21382783	4	O
500	21382783	4	O
different	21382783	4	O
COL7A1	21382783	4	B-Gene
mutations	21382783	4	B-Var
have	21382783	4	O
been	21382783	4	O
detected	21382783	4	B-Reg
in	21382783	4	O
dystrophic	21382783	4	B-Disease
epidermolysis	21382783	4	I-Disease
bullosa	21382783	4	I-Disease
to	21382783	4	O
date	21382783	4	O
.	21382783	4	O
Clarification	21382783	4	O
of	21382783	4	O
genotype	21382783	4	O
-	21382783	4	O
phenotype	21382783	4	O
correlations	21382783	4	O
is	21382783	4	O
of	21382783	4	O
particular	21382783	4	O
importance	21382783	4	O
for	21382783	4	O
the	21382783	4	O
development	21382783	4	O
of	21382783	4	O
novel	21382783	4	O
therapeutic	21382783	4	O
approaches	21382783	4	O
.	21382783	4	O
Here	21382783	4	O
we	21382783	4	O
report	21382783	4	O
a	21382783	4	O
female	21382783	4	O
patient	21382783	4	O
with	21382783	4	O
mild	21382783	4	O
dystrophic	21382783	4	O
epidermolysis	21382783	4	O
bullosa	21382783	4	O
harbouring	21382783	4	O
two	21382783	4	O
compound	21382783	4	O
heterozygous	21382783	4	O
COL7A1	21382783	4	O
mutations	21382783	4	O
,	21382783	4	O
namely	21382783	4	O
the	21382783	4	O
intronic	21382783	4	O
splice	21382783	4	O
site	21382783	4	O
mutation	21382783	4	O
c.3832	21382783	4	O
-	21382783	4	O
2	21382783	4	O
A	21382783	4	O
>	21382783	4	O
G	21382783	4	O
and	21382783	4	O
the	21382783	4	O
glycine	21382783	4	O
substitution	21382783	4	O
p.G1347W	21382783	4	O
.	21382783	4	O
Our	21382783	4	O
data	21382783	4	O
extend	21382783	4	O
the	21382783	4	O
current	21382783	4	O
knowledge	21382783	4	O
on	21382783	4	O
genotype	21382783	4	O
-	21382783	4	O
phenotype	21382783	4	O
correlations	21382783	4	O
in	21382783	4	O
dystrophic	21382783	4	O
epidermolysis	21382783	4	O
bullosa	21382783	4	O
.	21382783	4	O

[	21402533	4	O
Association	21402533	4	O
of	21402533	4	O
mutation	21402533	4	O
types	21402533	4	O
and	21402533	4	O
distribution	21402533	4	O
characteristics	21402533	4	O
of	21402533	4	O
dystrophin	21402533	4	O
gene	21402533	4	O
with	21402533	4	O
clinical	21402533	4	O
symptoms	21402533	4	O
in	21402533	4	O
Chinese	21402533	4	O
population	21402533	4	O
]	21402533	4	O
.	21402533	4	O
Duchenne	21402533	4	O
muscular	21402533	4	O
dystrophy	21402533	4	O
(	21402533	4	O
DMD	21402533	4	O
)	21402533	4	O
is	21402533	4	O
X	21402533	4	O
-	21402533	4	O
linked	21402533	4	O
disorder	21402533	4	O
caused	21402533	4	O
by	21402533	4	O
mutations	21402533	4	O
in	21402533	4	O
the	21402533	4	O
dystrophin	21402533	4	O
gene	21402533	4	O
.	21402533	4	O
To	21402533	4	O
investigate	21402533	4	O
mutation	21402533	4	O
types	21402533	4	O
and	21402533	4	O
distribution	21402533	4	O
characteristics	21402533	4	O
of	21402533	4	O
dystrophin	21402533	4	O
gene	21402533	4	O
in	21402533	4	O
Chinese	21402533	4	O
DMD	21402533	4	O
patients	21402533	4	O
,	21402533	4	O
we	21402533	4	O
used	21402533	4	O
Multiplex	21402533	4	O
Ligation	21402533	4	O
-	21402533	4	O
Dependent	21402533	4	O
Probe	21402533	4	O
Amplification	21402533	4	O
(	21402533	4	O
MLPA	21402533	4	O
)	21402533	4	O
to	21402533	4	O
analyze	21402533	4	O
the	21402533	4	O
dystrophin	21402533	4	O
gene	21402533	4	O
in	21402533	4	O
720	21402533	4	O
DMD	21402533	4	O
patients	21402533	4	O
,	21402533	4	O
their	21402533	4	O
mothers	21402533	4	O
,	21402533	4	O
and	21402533	4	O
20	21402533	4	O
normal	21402533	4	O
adult	21402533	4	O
males	21402533	4	O
.	21402533	4	O
Results	21402533	4	O
showed	21402533	4	O
that	21402533	4	O
detection	21402533	4	O
rate	21402533	4	O
was	21402533	4	O
64.9%	21402533	4	O
(	21402533	4	O
467	21402533	4	O
/	21402533	4	O
720	21402533	4	O
)	21402533	4	O
in	21402533	4	O
all	21402533	4	O
the	21402533	4	O
patients	21402533	4	O
,	21402533	4	O
gene	21402533	4	O
deletion	21402533	4	O
rate	21402533	4	O
was	21402533	4	O
54.3%	21402533	4	O
(	21402533	4	O
391	21402533	4	O
/	21402533	4	O
720	21402533	4	O
)	21402533	4	O
,	21402533	4	O
and	21402533	4	O
gene	21402533	4	O
duplication	21402533	4	O
rate	21402533	4	O
was	21402533	4	O
10.6%	21402533	4	O
(	21402533	4	O
76	21402533	4	O
/	21402533	4	O
720	21402533	4	O
)	21402533	4	O
.	21402533	4	O
The	21402533	4	O
rate	21402533	4	O
of	21402533	4	O
deletion	21402533	4	O
mutant	21402533	4	O
occurred	21402533	4	O
in	21402533	4	O
Exon	21402533	4	O
45	21402533	4	O
-	21402533	4	O
54	21402533	4	O
was	21402533	4	O
71.9%	21402533	4	O
(	21402533	4	O
281	21402533	4	O
/	21402533	4	O
391	21402533	4	O
)	21402533	4	O
in	21402533	4	O
all	21402533	4	O
gene	21402533	4	O
deletion	21402533	4	O
patients	21402533	4	O
;	21402533	4	O
meanwhile	21402533	4	O
,	21402533	4	O
the	21402533	4	O
rate	21402533	4	O
of	21402533	4	O
gene	21402533	4	O
duplication	21402533	4	O
occurred	21402533	4	O
in	21402533	4	O
Exon	21402533	4	O
1	21402533	4	O
-	21402533	4	O
40	21402533	4	O
was	21402533	4	O
82.9%	21402533	4	O
(	21402533	4	O
63	21402533	4	O
/	21402533	4	O
76	21402533	4	O
)	21402533	4	O
in	21402533	4	O
all	21402533	4	O
gene	21402533	4	O
duplication	21402533	4	O
ones	21402533	4	O
.	21402533	4	O
In	21402533	4	O
all	21402533	4	O
the	21402533	4	O
patients	21402533	4	O
with	21402533	4	O
gene	21402533	4	O
deletion	21402533	4	O
and	21402533	4	O
duplication	21402533	4	O
,	21402533	4	O
the	21402533	4	O
rate	21402533	4	O
of	21402533	4	O
DMD	21402533	4	O
and	21402533	4	O
IMD	21402533	4	O
was	21402533	4	O
90.6%	21402533	4	O
(	21402533	4	O
423	21402533	4	O
/	21402533	4	O
467	21402533	4	O
)	21402533	4	O
,	21402533	4	O
and	21402533	4	O
BMD	21402533	4	O
,	21402533	4	O
9.4%	21402533	4	O
(	21402533	4	O
44	21402533	4	O
/	21402533	4	O
467	21402533	4	O
)	21402533	4	O
.	21402533	4	O
This	21402533	4	O
indicates	21402533	4	O
that	21402533	4	O
the	21402533	4	O
main	21402533	4	O
reason	21402533	4	B-Reg
of	21402533	4	O
duchenne	21402533	4	B-Disease
muscular	21402533	4	I-Disease
dystrophy	21402533	4	I-Disease
is	21402533	4	O
dystrophin	21402533	4	B-Gene
gene	21402533	4	I-Gene
deletion	21402533	4	B-Var
mutation	21402533	4	O
,	21402533	4	O
which	21402533	4	O
would	21402533	4	O
occur	21402533	4	O
in	21402533	4	O
any	21402533	4	O
gene	21402533	4	O
unevenly	21402533	4	O
with	21402533	4	O
hot	21402533	4	O
spots	21402533	4	O
of	21402533	4	O
mutation	21402533	4	O
.	21402533	4	O
The	21402533	4	O
location	21402533	4	O
and	21402533	4	O
fragment	21402533	4	O
length	21402533	4	O
of	21402533	4	O
gene	21402533	4	O
deletion	21402533	4	O
and	21402533	4	O
duplication	21402533	4	O
cannot	21402533	4	O
decide	21402533	4	O
the	21402533	4	O
severity	21402533	4	O
of	21402533	4	O
clinical	21402533	4	O
symptoms	21402533	4	O
directly	21402533	4	O
.	21402533	4	O

AXIN2	21416598	1	O
-	21416598	1	O
associated	21416598	1	O
autosomal	21416598	1	O
dominant	21416598	1	O
ectodermal	21416598	1	O
dysplasia	21416598	1	O
and	21416598	1	O
neoplastic	21416598	1	O
syndrome	21416598	1	O
.	21416598	1	O
We	21416598	1	O
describe	21416598	1	O
a	21416598	1	O
family	21416598	1	O
with	21416598	1	O
a	21416598	1	O
novel	21416598	1	O
,	21416598	1	O
inherited	21416598	1	O
AXIN2	21416598	1	O
mutation	21416598	1	O
(	21416598	1	O
c.1989	21416598	1	O
G	21416598	1	O
>	21416598	1	O
A	21416598	1	O
)	21416598	1	O
segregating	21416598	1	O
in	21416598	1	O
an	21416598	1	O
autosomal	21416598	1	O
dominant	21416598	1	O
pattern	21416598	1	O
with	21416598	1	O
oligodontia	21416598	1	O
and	21416598	1	O
variable	21416598	1	O
other	21416598	1	O
findings	21416598	1	O
including	21416598	1	O
colonic	21416598	1	O
polyposis	21416598	1	O
,	21416598	1	O
gastric	21416598	1	O
polyps	21416598	1	O
,	21416598	1	O
a	21416598	1	O
mild	21416598	1	O
ectodermal	21416598	1	O
dysplasia	21416598	1	O
phenotype	21416598	1	O
with	21416598	1	O
sparse	21416598	1	O
hair	21416598	1	O
and	21416598	1	O
eyebrows	21416598	1	O
,	21416598	1	O
and	21416598	1	O
early	21416598	1	O
onset	21416598	1	O
colorectal	21416598	1	O
and	21416598	1	O
breast	21416598	1	O
cancers	21416598	1	O
.	21416598	1	O
This	21416598	1	O
novel	21416598	1	O
mutation	21416598	1	O
predicts	21416598	1	O
p.Trp663X	21416598	1	O
,	21416598	1	O
which	21416598	1	O
is	21416598	1	O
a	21416598	1	O
truncated	21416598	1	O
protein	21416598	1	O
that	21416598	1	O
is	21416598	1	O
missing	21416598	1	O
the	21416598	1	O
last	21416598	1	O
three	21416598	1	O
exons	21416598	1	O
,	21416598	1	O
including	21416598	1	O
the	21416598	1	O
DIX	21416598	1	O
(	21416598	1	O
Disheveled	21416598	1	O
and	21416598	1	O
AXIN	21416598	1	O
interacting	21416598	1	O
)	21416598	1	O
domain	21416598	1	O
.	21416598	1	O
This	21416598	1	O
nonsense	21416598	1	O
mutation	21416598	1	B-Var
is	21416598	1	O
predicted	21416598	1	O
to	21416598	1	O
destroy	21416598	1	B-NegReg
the	21416598	1	O
inhibitory	21416598	1	O
action	21416598	1	O
of	21416598	1	O
AXIN2	21416598	1	B-Gene
on	21416598	1	O
WNT	21416598	1	O
signaling	21416598	1	O
.	21416598	1	O
Previous	21416598	1	O
authors	21416598	1	O
have	21416598	1	O
described	21416598	1	O
an	21416598	1	O
unrelated	21416598	1	O
family	21416598	1	O
with	21416598	1	O
autosomal	21416598	1	O
dominant	21416598	1	O
oligodontia	21416598	1	O
and	21416598	1	O
a	21416598	1	O
variable	21416598	1	O
colorectal	21416598	1	O
phenotype	21416598	1	O
segregating	21416598	1	O
with	21416598	1	O
a	21416598	1	O
nonsense	21416598	1	O
mutation	21416598	1	O
of	21416598	1	O
AXIN2	21416598	1	O
,	21416598	1	O
as	21416598	1	O
well	21416598	1	O
as	21416598	1	O
a	21416598	1	O
frameshift	21416598	1	O
AXIN2	21416598	1	O
mutation	21416598	1	O
in	21416598	1	O
an	21416598	1	O
unrelated	21416598	1	O
individual	21416598	1	O
with	21416598	1	O
oligodontia	21416598	1	O
.	21416598	1	O
Our	21416598	1	O
report	21416598	1	O
provides	21416598	1	O
additional	21416598	1	O
evidence	21416598	1	O
supporting	21416598	1	O
an	21416598	1	O
autosomal	21416598	1	B-Var
dominant	21416598	1	I-Var
AXIN2	21416598	1	B-Reg
-	21416598	1	I-Reg
associated	21416598	1	I-Reg
ectodermal	21416598	1	B-Disease
dysplasia	21416598	1	I-Disease
and	21416598	1	O
neoplastic	21416598	1	B-Disease
syndrome	21416598	1	I-Disease
.	21416598	1	O

The	21490218	4	O
Down	21490218	4	O
syndrome	21490218	4	O
critical	21490218	4	O
region	21490218	4	O
regulates	21490218	4	O
retinogeniculate	21490218	4	O
refinement	21490218	4	O
.	21490218	4	O
Down	21490218	4	B-Disease
syndrome	21490218	4	I-Disease
(	21490218	4	O
DS	21490218	4	O
)	21490218	4	O
is	21490218	4	O
a	21490218	4	O
developmental	21490218	4	O
disorder	21490218	4	O
caused	21490218	4	B-Reg
by	21490218	4	I-Reg
a	21490218	4	O
third	21490218	4	O
chromosome	21490218	4	O
21	21490218	4	O
in	21490218	4	O
humans	21490218	4	O
(	21490218	4	B-Var
Trisomy	21490218	4	I-Var
21	21490218	4	I-Var
)	21490218	4	I-Var
,	21490218	4	O
leading	21490218	4	O
to	21490218	4	O
neurological	21490218	4	O
deficits	21490218	4	O
and	21490218	4	O
cognitive	21490218	4	O
impairment	21490218	4	O
.	21490218	4	O
Studies	21490218	4	O
in	21490218	4	O
mouse	21490218	4	O
models	21490218	4	O
of	21490218	4	O
DS	21490218	4	O
suggest	21490218	4	O
that	21490218	4	O
cognitive	21490218	4	O
deficits	21490218	4	O
in	21490218	4	O
the	21490218	4	O
adult	21490218	4	O
are	21490218	4	O
associated	21490218	4	O
with	21490218	4	O
deficits	21490218	4	O
in	21490218	4	O
synaptic	21490218	4	O
learning	21490218	4	O
and	21490218	4	O
memory	21490218	4	O
mechanisms	21490218	4	O
,	21490218	4	O
but	21490218	4	O
it	21490218	4	O
is	21490218	4	O
unclear	21490218	4	O
whether	21490218	4	O
alterations	21490218	4	O
in	21490218	4	O
the	21490218	4	O
early	21490218	4	O
wiring	21490218	4	O
and	21490218	4	O
refinement	21490218	4	O
of	21490218	4	O
neuronal	21490218	4	O
circuits	21490218	4	O
contribute	21490218	4	O
to	21490218	4	O
these	21490218	4	O
deficits	21490218	4	O
.	21490218	4	O
Here	21490218	4	O
,	21490218	4	O
we	21490218	4	O
show	21490218	4	O
that	21490218	4	O
early	21490218	4	O
developmental	21490218	4	O
refinement	21490218	4	O
of	21490218	4	O
visual	21490218	4	O
circuits	21490218	4	O
is	21490218	4	O
perturbed	21490218	4	O
in	21490218	4	O
mouse	21490218	4	O
models	21490218	4	O
of	21490218	4	O
Down	21490218	4	O
syndrome	21490218	4	O
.	21490218	4	O
Specifically	21490218	4	O
,	21490218	4	O
we	21490218	4	O
find	21490218	4	O
excessive	21490218	4	O
eye	21490218	4	O
-	21490218	4	O
specific	21490218	4	O
segregation	21490218	4	O
of	21490218	4	O
retinal	21490218	4	O
axons	21490218	4	O
in	21490218	4	O
the	21490218	4	O
dorsal	21490218	4	O
lateral	21490218	4	O
geniculate	21490218	4	O
nucleus	21490218	4	O
.	21490218	4	O
Indeed	21490218	4	O
,	21490218	4	O
the	21490218	4	O
degree	21490218	4	O
of	21490218	4	O
refinement	21490218	4	O
scales	21490218	4	O
with	21490218	4	O
defects	21490218	4	O
in	21490218	4	O
the	21490218	4	O
"	21490218	4	O
Down	21490218	4	O
syndrome	21490218	4	O
critical	21490218	4	O
region	21490218	4	O
"	21490218	4	O
(	21490218	4	O
DSCR	21490218	4	O
)	21490218	4	O
in	21490218	4	O
a	21490218	4	O
dose	21490218	4	O
-	21490218	4	O
dependent	21490218	4	O
manner	21490218	4	O
.	21490218	4	O
We	21490218	4	O
further	21490218	4	O
identify	21490218	4	O
Dscam	21490218	4	O
(	21490218	4	O
Down	21490218	4	O
syndrome	21490218	4	O
cell	21490218	4	O
adhesion	21490218	4	O
molecule	21490218	4	O
)	21490218	4	O
,	21490218	4	O
a	21490218	4	O
gene	21490218	4	O
within	21490218	4	O
the	21490218	4	O
DSCR	21490218	4	O
,	21490218	4	O
as	21490218	4	O
a	21490218	4	O
regulator	21490218	4	O
of	21490218	4	O
eye	21490218	4	O
-	21490218	4	O
specific	21490218	4	O
segregation	21490218	4	O
of	21490218	4	O
retinogeniculate	21490218	4	O
projections	21490218	4	O
.	21490218	4	O
Although	21490218	4	O
Dscam	21490218	4	O
is	21490218	4	O
not	21490218	4	O
the	21490218	4	O
sole	21490218	4	O
gene	21490218	4	O
in	21490218	4	O
the	21490218	4	O
DSCR	21490218	4	O
contributing	21490218	4	O
to	21490218	4	O
enhanced	21490218	4	O
refinement	21490218	4	O
in	21490218	4	O
trisomy	21490218	4	O
,	21490218	4	O
Dscam	21490218	4	O
dosage	21490218	4	O
clearly	21490218	4	O
regulates	21490218	4	O
cell	21490218	4	O
spacing	21490218	4	O
and	21490218	4	O
dendritic	21490218	4	O
fasciculation	21490218	4	O
in	21490218	4	O
a	21490218	4	O
specific	21490218	4	O
class	21490218	4	O
of	21490218	4	O
retinal	21490218	4	O
ganglion	21490218	4	O
cells	21490218	4	O
.	21490218	4	O
Thus	21490218	4	O
,	21490218	4	O
altered	21490218	4	O
developmental	21490218	4	O
refinement	21490218	4	O
of	21490218	4	O
visual	21490218	4	O
circuits	21490218	4	O
that	21490218	4	O
occurs	21490218	4	O
before	21490218	4	O
sensory	21490218	4	O
experience	21490218	4	O
is	21490218	4	O
likely	21490218	4	O
to	21490218	4	O
contribute	21490218	4	O
to	21490218	4	O
visual	21490218	4	O
impairment	21490218	4	O
in	21490218	4	O
individuals	21490218	4	O
with	21490218	4	O
Down	21490218	4	O
syndrome	21490218	4	O
.	21490218	4	O

Identification	21538323	4	O
and	21538323	4	O
functional	21538323	4	O
consequences	21538323	4	O
of	21538323	4	O
a	21538323	4	O
recurrent	21538323	4	O
NLRP12	21538323	4	B-Gene
missense	21538323	4	B-Var
mutation	21538323	4	I-Var
in	21538323	4	B-Reg
periodic	21538323	4	B-Disease
fever	21538323	4	I-Disease
syndromes	21538323	4	I-Disease
.	21538323	4	O
OBJECTIVE	21538323	4	O
:	21538323	4	O
To	21538323	4	O
gain	21538323	4	O
insight	21538323	4	O
into	21538323	4	O
the	21538323	4	O
molecular	21538323	4	O
bases	21538323	4	O
of	21538323	4	O
genetically	21538323	4	O
unexplained	21538323	4	O
periodic	21538323	4	O
fever	21538323	4	O
syndromes	21538323	4	O
(	21538323	4	O
PFS	21538323	4	O
)	21538323	4	O
by	21538323	4	O
screening	21538323	4	O
NLRP12	21538323	4	O
,	21538323	4	O
a	21538323	4	O
gene	21538323	4	O
in	21538323	4	O
which	21538323	4	O
only	21538323	4	O
a	21538323	4	O
nonsense	21538323	4	O
and	21538323	4	O
a	21538323	4	O
splice	21538323	4	O
site	21538323	4	O
mutation	21538323	4	O
have	21538323	4	O
so	21538323	4	O
far	21538323	4	O
been	21538323	4	O
identified	21538323	4	O
,	21538323	4	O
and	21538323	4	O
to	21538323	4	O
assess	21538323	4	O
the	21538323	4	O
functional	21538323	4	O
consequences	21538323	4	O
of	21538323	4	O
the	21538323	4	O
identified	21538323	4	O
missense	21538323	4	O
variation	21538323	4	O
.	21538323	4	O
METHODS	21538323	4	O
:	21538323	4	O
NLRP12	21538323	4	O
was	21538323	4	O
screened	21538323	4	O
for	21538323	4	O
mutations	21538323	4	O
by	21538323	4	O
direct	21538323	4	O
sequencing	21538323	4	O
.	21538323	4	O
Functional	21538323	4	O
assays	21538323	4	O
were	21538323	4	O
performed	21538323	4	O
in	21538323	4	O
HEK	21538323	4	O
293	21538323	4	O
T	21538323	4	O
cells	21538323	4	O
stably	21538323	4	O
expressing	21538323	4	O
the	21538323	4	O
proapoptotic	21538323	4	O
protein	21538323	4	O
ASC	21538323	4	O
and	21538323	4	O
procaspase	21538323	4	O
1	21538323	4	O
,	21538323	4	O
in	21538323	4	O
order	21538323	4	O
to	21538323	4	O
determine	21538323	4	O
the	21538323	4	O
effects	21538323	4	O
of	21538323	4	O
normal	21538323	4	O
and	21538323	4	O
mutated	21538323	4	O
NLRP12	21538323	4	O
proteins	21538323	4	O
on	21538323	4	O
speck	21538323	4	O
formation	21538323	4	O
,	21538323	4	O
caspase	21538323	4	O
1	21538323	4	O
signaling	21538323	4	O
,	21538323	4	O
and	21538323	4	O
NF	21538323	4	O
-	21538323	4	O
κB	21538323	4	O
activation	21538323	4	O
.	21538323	4	O
RESULTS	21538323	4	O
:	21538323	4	O
A	21538323	4	O
heterozygous	21538323	4	O
NLRP12	21538323	4	B-Gene
missense	21538323	4	O
mutation	21538323	4	O
involving	21538323	4	O
a	21538323	4	O
CpG	21538323	4	O
site	21538323	4	O
(	21538323	4	B-Var
c.1054	21538323	4	I-Var
C	21538323	4	I-Var
>	21538323	4	I-Var
T	21538323	4	I-Var
;	21538323	4	I-Var
p.Arg352Cys	21538323	4	O
)	21538323	4	O
was	21538323	4	O
identified	21538323	4	O
in	21538323	4	O
exon	21538323	4	O
3	21538323	4	O
,	21538323	4	O
which	21538323	4	O
encodes	21538323	4	B-Reg
the	21538323	4	O
nucleotide	21538323	4	O
-	21538323	4	O
binding	21538323	4	O
site	21538323	4	O
(	21538323	4	O
NBS	21538323	4	O
)	21538323	4	O
of	21538323	4	O
the	21538323	4	O
protein	21538323	4	O
,	21538323	4	O
in	21538323	4	O
2	21538323	4	O
patients	21538323	4	O
from	21538323	4	O
different	21538323	4	O
countries	21538323	4	O
and	21538323	4	O
carrying	21538323	4	O
different	21538323	4	O
NLRP12	21538323	4	O
haplotypes	21538323	4	O
.	21538323	4	O
The	21538323	4	O
mutation	21538323	4	B-Var
,	21538323	4	O
which	21538323	4	O
does	21538323	4	O
not	21538323	4	O
alter	21538323	4	O
the	21538323	4	O
inhibitory	21538323	4	O
effect	21538323	4	O
of	21538323	4	O
NLRP12	21538323	4	O
on	21538323	4	O
NF	21538323	4	O
-	21538323	4	O
κB	21538323	4	O
activation	21538323	4	O
,	21538323	4	O
increases	21538323	4	B-PosReg
speck	21538323	4	O
formation	21538323	4	O
and	21538323	4	O
activates	21538323	4	B-PosReg
caspase	21538323	4	O
1	21538323	4	O
signaling	21538323	4	O
.	21538323	4	O
To	21538323	4	O
define	21538323	4	O
this	21538323	4	O
new	21538323	4	O
class	21538323	4	O
of	21538323	4	O
PFS	21538323	4	O
,	21538323	4	O
we	21538323	4	O
propose	21538323	4	O
the	21538323	4	O
term	21538323	4	O
NLRP12	21538323	4	O
-	21538323	4	O
associated	21538323	4	O
disorders	21538323	4	O
(	21538323	4	O
NLRP12AD	21538323	4	O
)	21538323	4	O
.	21538323	4	O
CONCLUSION	21538323	4	O
:	21538323	4	O
Given	21538323	4	O
the	21538323	4	O
rarity	21538323	4	O
of	21538323	4	O
known	21538323	4	O
NLRP12	21538323	4	O
-	21538323	4	O
associated	21538323	4	O
disorders	21538323	4	O
,	21538323	4	O
the	21538323	4	O
identification	21538323	4	O
of	21538323	4	O
this	21538323	4	O
NLRP12	21538323	4	O
molecular	21538323	4	O
defect	21538323	4	O
contributes	21538323	4	O
to	21538323	4	O
the	21538323	4	O
delineation	21538323	4	O
of	21538323	4	O
the	21538323	4	O
clinical	21538323	4	O
spectrum	21538323	4	O
associated	21538323	4	O
with	21538323	4	O
mutations	21538323	4	O
in	21538323	4	O
this	21538323	4	O
gene	21538323	4	O
and	21538323	4	O
highlights	21538323	4	O
the	21538323	4	O
importance	21538323	4	O
of	21538323	4	O
screening	21538323	4	O
NLRP12	21538323	4	O
in	21538323	4	O
patients	21538323	4	O
presenting	21538323	4	O
with	21538323	4	O
unexplained	21538323	4	O
PFS	21538323	4	O
.	21538323	4	O
This	21538323	4	O
study	21538323	4	O
also	21538323	4	O
demonstrates	21538323	4	O
,	21538323	4	O
by	21538323	4	O
means	21538323	4	O
of	21538323	4	O
functional	21538323	4	O
assays	21538323	4	O
,	21538323	4	O
the	21538323	4	O
deleterious	21538323	4	O
effect	21538323	4	O
of	21538323	4	O
this	21538323	4	O
recurrent	21538323	4	O
missense	21538323	4	O
mutation	21538323	4	O
;	21538323	4	O
the	21538323	4	O
gain	21538323	4	B-PosReg
of	21538323	4	I-PosReg
function	21538323	4	I-PosReg
for	21538323	4	O
speck	21538323	4	O
formation	21538323	4	O
and	21538323	4	O
caspase	21538323	4	O
1	21538323	4	O
signaling	21538323	4	O
associated	21538323	4	O
with	21538323	4	O
this	21538323	4	O
NBS	21538323	4	O
mutation	21538323	4	B-Var
is	21538323	4	O
consistent	21538323	4	O
with	21538323	4	O
the	21538323	4	O
inflammatory	21538323	4	O
phenotype	21538323	4	O
of	21538323	4	O
PFS	21538323	4	O
.	21538323	4	O

New	21564178	1	O
homozygous	21564178	1	O
SPINK5	21564178	1	O
mutation	21564178	1	O
,	21564178	1	O
p.Gln333X	21564178	1	O
,	21564178	1	O
in	21564178	1	O
a	21564178	1	O
Turkish	21564178	1	O
pedigree	21564178	1	O
with	21564178	1	O
Netherton	21564178	1	O
syndrome	21564178	1	O
.	21564178	1	O
Netherton	21564178	1	B-Disease
syndrome	21564178	1	I-Disease
(	21564178	1	O
NS	21564178	1	O
)	21564178	1	O
is	21564178	1	O
a	21564178	1	O
rare	21564178	1	O
autosomal	21564178	1	O
recessive	21564178	1	O
genodermatosis	21564178	1	O
caused	21564178	1	O
by	21564178	1	O
loss	21564178	1	B-NegReg
-	21564178	1	I-NegReg
of	21564178	1	I-NegReg
-	21564178	1	I-NegReg
function	21564178	1	I-NegReg
mutations	21564178	1	B-Var
in	21564178	1	O
the	21564178	1	O
SPINK5	21564178	1	B-Gene
gene	21564178	1	O
.	21564178	1	O
The	21564178	1	O
clinical	21564178	1	O
features	21564178	1	O
include	21564178	1	O
congenital	21564178	1	O
ichthyosis	21564178	1	O
,	21564178	1	O
trichorrhexis	21564178	1	O
invaginata	21564178	1	O
and	21564178	1	O
atopy	21564178	1	O
.	21564178	1	O
In	21564178	1	O
this	21564178	1	O
study	21564178	1	O
,	21564178	1	O
we	21564178	1	O
report	21564178	1	O
a	21564178	1	O
new	21564178	1	O
homozygous	21564178	1	O
SPINK5	21564178	1	B-Gene
mutation	21564178	1	O
,	21564178	1	O
p.Gln333X	21564178	1	B-Var
,	21564178	1	O
responsible	21564178	1	B-Reg
for	21564178	1	O
NS	21564178	1	B-Disease
in	21564178	1	O
affected	21564178	1	O
members	21564178	1	O
of	21564178	1	O
two	21564178	1	O
closely	21564178	1	O
related	21564178	1	O
Turkish	21564178	1	O
families	21564178	1	O
,	21564178	1	O
and	21564178	1	O
provide	21564178	1	O
an	21564178	1	O
overview	21564178	1	O
of	21564178	1	O
the	21564178	1	O
genotype	21564178	1	O
-	21564178	1	O
phenotype	21564178	1	O
correlation	21564178	1	O
in	21564178	1	O
this	21564178	1	O
condition	21564178	1	O
.	21564178	1	O

Severer	21757863	4	O
phenotype	21757863	4	O
in	21757863	4	O
Unverricht	21757863	4	B-Disease
-	21757863	4	I-Disease
Lundborg	21757863	4	I-Disease
disease	21757863	4	I-Disease
(	21757863	4	O
EPM1	21757863	4	O
)	21757863	4	O
patients	21757863	4	O
compound	21757863	4	O
heterozygous	21757863	4	O
for	21757863	4	B-Reg
the	21757863	4	O
dodecamer	21757863	4	O
repeat	21757863	4	O
expansion	21757863	4	O
and	21757863	4	O
the	21757863	4	O
c.202	21757863	4	B-Var
C	21757863	4	I-Var
>	21757863	4	I-Var
T	21757863	4	I-Var
mutation	21757863	4	O
in	21757863	4	O
the	21757863	4	O
CSTB	21757863	4	B-Gene
gene	21757863	4	O
.	21757863	4	O
BACKGROUND	21757863	4	O
/	21757863	4	O
AIMS	21757863	4	O
:	21757863	4	O
Unverricht	21757863	4	B-Disease
-	21757863	4	I-Disease
Lundborg	21757863	4	I-Disease
disease	21757863	4	I-Disease
(	21757863	4	O
EPM1	21757863	4	O
)	21757863	4	O
is	21757863	4	O
caused	21757863	4	B-Reg
by	21757863	4	I-Reg
mutations	21757863	4	B-Var
in	21757863	4	O
the	21757863	4	O
cystatin	21757863	4	O
B	21757863	4	O
(	21757863	4	B-Gene
CSTB	21757863	4	I-Gene
)	21757863	4	I-Gene
gene	21757863	4	O
.	21757863	4	O
Most	21757863	4	O
patients	21757863	4	O
are	21757863	4	O
homozygous	21757863	4	O
for	21757863	4	O
the	21757863	4	O
expanded	21757863	4	O
dodecamer	21757863	4	O
repeat	21757863	4	O
mutation	21757863	4	O
alleles	21757863	4	O
,	21757863	4	O
but	21757863	4	O
9	21757863	4	O
other	21757863	4	O
EPM1	21757863	4	O
-	21757863	4	O
associated	21757863	4	O
mutations	21757863	4	O
have	21757863	4	O
also	21757863	4	O
been	21757863	4	O
identified	21757863	4	O
.	21757863	4	O
We	21757863	4	O
describe	21757863	4	O
the	21757863	4	O
clinical	21757863	4	O
,	21757863	4	O
cognitive	21757863	4	O
and	21757863	4	O
imaging	21757863	4	O
characteristics	21757863	4	O
of	21757863	4	O
5	21757863	4	O
Finnish	21757863	4	O
EPM1	21757863	4	O
patients	21757863	4	O
who	21757863	4	O
are	21757863	4	O
compound	21757863	4	O
heterozygous	21757863	4	O
for	21757863	4	O
the	21757863	4	O
dodecamer	21757863	4	O
repeat	21757863	4	O
expansion	21757863	4	O
and	21757863	4	O
the	21757863	4	O
c.202	21757863	4	O
C	21757863	4	O
>	21757863	4	O
T	21757863	4	O
mutations	21757863	4	O
.	21757863	4	O
METHODS	21757863	4	O
:	21757863	4	O
Five	21757863	4	O
compound	21757863	4	O
heterozygous	21757863	4	O
patients	21757863	4	O
and	21757863	4	O
21	21757863	4	O
patients	21757863	4	O
homozygous	21757863	4	O
for	21757863	4	O
the	21757863	4	O
expansion	21757863	4	O
mutation	21757863	4	O
,	21757863	4	O
participating	21757863	4	O
in	21757863	4	O
an	21757863	4	O
ongoing	21757863	4	O
nationwide	21757863	4	O
clinical	21757863	4	O
and	21757863	4	O
molecular	21757863	4	O
genetics	21757863	4	O
study	21757863	4	O
,	21757863	4	O
were	21757863	4	O
evaluated	21757863	4	O
using	21757863	4	O
the	21757863	4	O
Unified	21757863	4	O
Myoclonus	21757863	4	O
Rating	21757863	4	O
Scale	21757863	4	O
test	21757863	4	O
and	21757863	4	O
comprehensive	21757863	4	O
neuropsychological	21757863	4	O
testing	21757863	4	O
.	21757863	4	O
All	21757863	4	O
patients	21757863	4	O
underwent	21757863	4	O
MR	21757863	4	O
imaging	21757863	4	O
.	21757863	4	O
The	21757863	4	O
MR	21757863	4	O
data	21757863	4	O
were	21757863	4	O
also	21757863	4	O
compared	21757863	4	O
with	21757863	4	O
those	21757863	4	O
of	21757863	4	O
24	21757863	4	O
healthy	21757863	4	O
control	21757863	4	O
subjects	21757863	4	O
.	21757863	4	O
RESULTS	21757863	4	O
:	21757863	4	O
Age	21757863	4	O
at	21757863	4	O
onset	21757863	4	O
of	21757863	4	O
symptoms	21757863	4	O
was	21757863	4	O
significantly	21757863	4	O
lower	21757863	4	O
in	21757863	4	O
the	21757863	4	O
compound	21757863	4	O
heterozygotes	21757863	4	O
than	21757863	4	O
in	21757863	4	O
the	21757863	4	O
homozygous	21757863	4	O
EPM1	21757863	4	O
patients	21757863	4	O
.	21757863	4	O
They	21757863	4	O
also	21757863	4	O
had	21757863	4	O
severer	21757863	4	O
myoclonus	21757863	4	O
and	21757863	4	O
drug	21757863	4	O
-	21757863	4	O
resistant	21757863	4	O
tonic	21757863	4	O
-	21757863	4	O
clonic	21757863	4	O
seizures	21757863	4	O
.	21757863	4	O
Moreover	21757863	4	O
,	21757863	4	O
they	21757863	4	O
had	21757863	4	O
lower	21757863	4	O
cognitive	21757863	4	O
performance	21757863	4	O
.	21757863	4	O
In	21757863	4	O
MRI	21757863	4	O
a	21757863	4	O
voxel	21757863	4	O
-	21757863	4	O
based	21757863	4	O
morphometry	21757863	4	O
analysis	21757863	4	O
of	21757863	4	O
primary	21757863	4	O
and	21757863	4	O
premotor	21757863	4	O
cortex	21757863	4	O
,	21757863	4	O
supplementary	21757863	4	O
motor	21757863	4	O
cortex	21757863	4	O
and	21757863	4	O
thalami	21757863	4	O
revealed	21757863	4	O
gray	21757863	4	O
matter	21757863	4	O
volume	21757863	4	O
loss	21757863	4	O
when	21757863	4	O
compared	21757863	4	O
with	21757863	4	O
the	21757863	4	O
healthy	21757863	4	O
controls	21757863	4	O
,	21757863	4	O
similar	21757863	4	O
to	21757863	4	O
patients	21757863	4	O
homozygous	21757863	4	O
for	21757863	4	O
the	21757863	4	O
expansion	21757863	4	O
mutation	21757863	4	O
.	21757863	4	O
CONCLUSION	21757863	4	O
:	21757863	4	O
Patients	21757863	4	O
compound	21757863	4	O
heterozygous	21757863	4	O
for	21757863	4	O
the	21757863	4	O
dodecamer	21757863	4	O
repeat	21757863	4	O
expansion	21757863	4	O
and	21757863	4	O
the	21757863	4	O
c.202	21757863	4	O
C	21757863	4	O
>	21757863	4	O
T	21757863	4	O
mutations	21757863	4	O
seem	21757863	4	O
to	21757863	4	O
have	21757863	4	O
a	21757863	4	O
severer	21757863	4	O
form	21757863	4	O
of	21757863	4	O
EPM1	21757863	4	O
than	21757863	4	O
patients	21757863	4	O
homozygous	21757863	4	O
for	21757863	4	O
the	21757863	4	O
expansion	21757863	4	O
mutation	21757863	4	O
.	21757863	4	O
These	21757863	4	O
findings	21757863	4	O
have	21757863	4	O
implications	21757863	4	O
for	21757863	4	O
counseling	21757863	4	O
of	21757863	4	O
EPM1	21757863	4	O
patients	21757863	4	O
with	21757863	4	O
different	21757863	4	O
genetic	21757863	4	O
defects	21757863	4	O
.	21757863	4	O

Acquisition	21782837	0	O
of	21782837	0	O
steady	21782837	0	O
-	21782837	0	O
state	21782837	0	O
operant	21782837	0	O
behavior	21782837	0	O
in	21782837	0	O
long	21782837	0	O
-	21782837	0	O
living	21782837	0	O
Ames	21782837	0	O
Dwarf	21782837	0	O
mice	21782837	0	O
.	21782837	0	O
Ames	21782837	0	O
dwarf	21782837	0	O
mice	21782837	0	O
have	21782837	0	O
a	21782837	0	O
Prop-1	21782837	0	B-Gene
mutation	21782837	0	B-Var
that	21782837	0	O
has	21782837	0	O
been	21782837	0	O
identified	21782837	0	O
with	21782837	0	O
increased	21782837	0	B-PosReg
levels	21782837	0	O
of	21782837	0	O
IGF	21782837	0	O
-	21782837	0	O
I	21782837	0	O
in	21782837	0	O
the	21782837	0	O
central	21782837	0	O
nervous	21782837	0	O
system	21782837	0	O
,	21782837	0	O
upregulation	21782837	0	B-PosReg
of	21782837	0	O
neuroprotective	21782837	0	O
systems	21782837	0	O
,	21782837	0	O
and	21782837	0	O
increased	21782837	0	O
lifespan	21782837	0	O
.	21782837	0	O
To	21782837	0	O
elucidate	21782837	0	O
the	21782837	0	O
behavioral	21782837	0	O
effects	21782837	0	O
of	21782837	0	O
the	21782837	0	O
Prop-1	21782837	0	O
mutation	21782837	0	O
,	21782837	0	O
8	21782837	0	O
Ames	21782837	0	O
dwarf	21782837	0	O
and	21782837	0	O
7	21782837	0	O
normal	21782837	0	O
mice	21782837	0	O
(	21782837	0	O
all	21782837	0	O
of	21782837	0	O
whom	21782837	0	O
were	21782837	0	O
8	21782837	0	O
months	21782837	0	O
of	21782837	0	O
age	21782837	0	O
or	21782837	0	O
younger	21782837	0	O
)	21782837	0	O
were	21782837	0	O
compared	21782837	0	O
on	21782837	0	O
a	21782837	0	O
differential	21782837	0	O
-	21782837	0	O
reinforcement	21782837	0	O
-	21782837	0	O
of	21782837	0	O
-	21782837	0	O
low	21782837	0	O
-	21782837	0	O
rate	21782837	0	O
-	21782837	0	O
of	21782837	0	O
-	21782837	0	O
responding	21782837	0	O
schedule	21782837	0	O
of	21782837	0	O
reinforcement	21782837	0	O
and	21782837	0	O
a	21782837	0	O
matching	21782837	0	O
-	21782837	0	O
to	21782837	0	O
-	21782837	0	O
sample	21782837	0	O
task	21782837	0	O
.	21782837	0	O
On	21782837	0	O
both	21782837	0	O
tasks	21782837	0	O
,	21782837	0	O
nosepokes	21782837	0	O
were	21782837	0	O
reinforced	21782837	0	O
with	21782837	0	O
access	21782837	0	O
to	21782837	0	O
a	21782837	0	O
saccharin	21782837	0	O
solution	21782837	0	O
.	21782837	0	O
Comparisons	21782837	0	O
were	21782837	0	O
based	21782837	0	O
on	21782837	0	O
several	21782837	0	O
measures	21782837	0	O
of	21782837	0	O
behavioral	21782837	0	O
efficiency	21782837	0	O
:	21782837	0	O
pause	21782837	0	O
durations	21782837	0	O
,	21782837	0	O
intertrial	21782837	0	O
intervals	21782837	0	O
,	21782837	0	O
and	21782837	0	O
numbers	21782837	0	O
of	21782837	0	O
responses	21782837	0	O
.	21782837	0	O
Ames	21782837	0	O
dwarf	21782837	0	O
mice	21782837	0	O
were	21782837	0	O
generally	21782837	0	O
less	21782837	0	O
efficient	21782837	0	O
than	21782837	0	O
normal	21782837	0	O
mice	21782837	0	O
.	21782837	0	O
One	21782837	0	O
possible	21782837	0	O
cause	21782837	0	O
of	21782837	0	O
this	21782837	0	O
outcome	21782837	0	O
is	21782837	0	O
that	21782837	0	O
relatively	21782837	0	O
young	21782837	0	O
Ames	21782837	0	O
dwarf	21782837	0	O
mice	21782837	0	O
show	21782837	0	O
less	21782837	0	O
cognitive	21782837	0	O
development	21782837	0	O
than	21782837	0	O
age	21782837	0	O
-	21782837	0	O
matched	21782837	0	O
normal	21782837	0	O
mice	21782837	0	O
.	21782837	0	O

[	21868336	4	B-Gene
GNE	21868336	4	I-Gene
gene	21868336	4	O
mutation	21868336	4	B-Var
analysis	21868336	4	O
in	21868336	4	O
5	21868336	4	O
patients	21868336	4	O
with	21868336	4	B-Reg
distal	21868336	4	B-Disease
myopathy	21868336	4	I-Disease
with	21868336	4	I-Disease
rimmed	21868336	4	I-Disease
vacuoles	21868336	4	I-Disease
]	21868336	4	I-Disease
.	21868336	4	O
OBJECTIVE	21868336	4	O
:	21868336	4	O
To	21868336	4	O
investigate	21868336	4	O
GNE	21868336	4	O
gene	21868336	4	O
mutations	21868336	4	O
in	21868336	4	O
5	21868336	4	O
Chinese	21868336	4	O
patients	21868336	4	O
with	21868336	4	O
distal	21868336	4	O
myopathy	21868336	4	O
with	21868336	4	O
rimmed	21868336	4	O
vacuoles	21868336	4	O
(	21868336	4	O
DMRV	21868336	4	O
)	21868336	4	O
.	21868336	4	O
METHODS	21868336	4	O
:	21868336	4	O
Five	21868336	4	O
patients	21868336	4	O
with	21868336	4	O
typical	21868336	4	O
clinical	21868336	4	O
and	21868336	4	O
pathological	21868336	4	O
features	21868336	4	O
of	21868336	4	O
DMRV	21868336	4	O
were	21868336	4	O
studied	21868336	4	O
.	21868336	4	O
All	21868336	4	O
the	21868336	4	O
11	21868336	4	O
coding	21868336	4	O
exons	21868336	4	O
and	21868336	4	O
the	21868336	4	O
flanking	21868336	4	O
intron	21868336	4	O
sequences	21868336	4	O
of	21868336	4	O
GNE	21868336	4	O
gene	21868336	4	O
were	21868336	4	O
amplified	21868336	4	O
by	21868336	4	O
PCR	21868336	4	O
and	21868336	4	O
sequenced	21868336	4	O
.	21868336	4	O
Four	21868336	4	O
family	21868336	4	O
members	21868336	4	O
of	21868336	4	O
case	21868336	4	O
5	21868336	4	O
were	21868336	4	O
also	21868336	4	O
examined	21868336	4	O
for	21868336	4	O
GNE	21868336	4	O
gene	21868336	4	O
mutations	21868336	4	O
.	21868336	4	O
RESULTS	21868336	4	O
:	21868336	4	O
All	21868336	4	O
the	21868336	4	O
patients	21868336	4	O
were	21868336	4	O
identified	21868336	4	O
to	21868336	4	O
have	21868336	4	O
different	21868336	4	O
GNE	21868336	4	O
gene	21868336	4	O
mutations	21868336	4	O
:	21868336	4	O
Cases	21868336	4	O
1	21868336	4	O
-	21868336	4	O
4	21868336	4	O
had	21868336	4	O
complex	21868336	4	O
heterozygous	21868336	4	O
mutations	21868336	4	O
and	21868336	4	O
case	21868336	4	O
5	21868336	4	O
had	21868336	4	O
homozygous	21868336	4	O
mutation	21868336	4	O
.	21868336	4	O
Six	21868336	4	O
reported	21868336	4	O
mutations	21868336	4	O
had	21868336	4	O
been	21868336	4	O
identified	21868336	4	O
,	21868336	4	O
including	21868336	4	O
1	21868336	4	O
nonsense	21868336	4	O
mutation	21868336	4	O
(	21868336	4	O
p.R8X	21868336	4	O
)	21868336	4	O
and	21868336	4	O
5	21868336	4	O
missense	21868336	4	O
mutations	21868336	4	O
(	21868336	4	O
p.D176V	21868336	4	O
,	21868336	4	O
p.I298T	21868336	4	O
,	21868336	4	O
p.A591T	21868336	4	O
,	21868336	4	O
P.	21868336	4	O
A631V	21868336	4	O
,	21868336	4	O
and	21868336	4	O
p.V696M	21868336	4	O
)	21868336	4	O
.	21868336	4	O
A	21868336	4	O
novel	21868336	4	O
mutation	21868336	4	O
(	21868336	4	O
c.317	21868336	4	O
T	21868336	4	O
>	21868336	4	O
C	21868336	4	O
,	21868336	4	O
p.I106T	21868336	4	O
)	21868336	4	O
was	21868336	4	O
identified	21868336	4	O
in	21868336	4	O
case	21868336	4	O
2	21868336	4	O
.	21868336	4	O
CONCLUSION	21868336	4	O
:	21868336	4	O
This	21868336	4	O
is	21868336	4	O
the	21868336	4	O
first	21868336	4	O
report	21868336	4	O
of	21868336	4	O
p.R8X	21868336	4	B-Var
,	21868336	4	O
p.I298T	21868336	4	B-Var
,	21868336	4	O
p.A591T	21868336	4	B-Var
and	21868336	4	O
p.V696M	21868336	4	B-Var
mutations	21868336	4	O
in	21868336	4	O
GNE	21868336	4	B-Gene
gene	21868336	4	O
in	21868336	4	O
Chinese	21868336	4	O
population	21868336	4	O
,	21868336	4	O
and	21868336	4	O
a	21868336	4	O
novel	21868336	4	O
mutation	21868336	4	O
p.I106T	21868336	4	B-Var
was	21868336	4	O
identified	21868336	4	O
.	21868336	4	O
These	21868336	4	O
findings	21868336	4	O
further	21868336	4	O
expand	21868336	4	O
the	21868336	4	O
clinical	21868336	4	O
and	21868336	4	O
genetic	21868336	4	O
spectrum	21868336	4	O
of	21868336	4	B-Reg
DMRV	21868336	4	B-Disease
in	21868336	4	O
China	21868336	4	O
.	21868336	4	O

Congenital	22001500	4	O
variant	22001500	4	O
of	22001500	4	O
Rett	22001500	4	O
syndrome	22001500	4	O
due	22001500	4	O
to	22001500	4	O
an	22001500	4	O
intragenic	22001500	4	O
large	22001500	4	O
deletion	22001500	4	O
in	22001500	4	O
MECP2	22001500	4	O
.	22001500	4	O
Rett	22001500	4	B-Disease
syndrome	22001500	4	I-Disease
(	22001500	4	O
RTT	22001500	4	O
)	22001500	4	O
is	22001500	4	O
a	22001500	4	O
neurodevelopmental	22001500	4	O
disorder	22001500	4	O
that	22001500	4	O
is	22001500	4	O
one	22001500	4	O
of	22001500	4	O
the	22001500	4	O
most	22001500	4	O
common	22001500	4	O
causes	22001500	4	O
of	22001500	4	O
mental	22001500	4	O
retardation	22001500	4	O
in	22001500	4	O
females	22001500	4	O
.	22001500	4	O
RTT	22001500	4	O
diagnosis	22001500	4	O
is	22001500	4	O
based	22001500	4	O
on	22001500	4	O
distinct	22001500	4	O
clinical	22001500	4	O
criteria	22001500	4	O
.	22001500	4	O
We	22001500	4	O
describe	22001500	4	O
here	22001500	4	O
a	22001500	4	O
female	22001500	4	O
patient	22001500	4	O
with	22001500	4	O
severe	22001500	4	O
phenotype	22001500	4	O
of	22001500	4	O
congenital	22001500	4	O
variant	22001500	4	O
RTT	22001500	4	O
.	22001500	4	O
The	22001500	4	O
patient	22001500	4	O
originally	22001500	4	O
presented	22001500	4	O
with	22001500	4	O
severe	22001500	4	O
developmental	22001500	4	O
delay	22001500	4	O
prior	22001500	4	O
to	22001500	4	O
the	22001500	4	O
age	22001500	4	O
of	22001500	4	O
6	22001500	4	O
months	22001500	4	O
and	22001500	4	O
later	22001500	4	O
exhibited	22001500	4	O
characteristic	22001500	4	O
features	22001500	4	O
of	22001500	4	O
RTT	22001500	4	O
that	22001500	4	O
included	22001500	4	O
air	22001500	4	O
swallowing	22001500	4	O
,	22001500	4	O
bruxism	22001500	4	O
,	22001500	4	O
and	22001500	4	O
hand	22001500	4	O
stereotypies	22001500	4	O
.	22001500	4	O
Results	22001500	4	O
of	22001500	4	O
an	22001500	4	O
array	22001500	4	O
-	22001500	4	O
based	22001500	4	O
comparative	22001500	4	O
genomic	22001500	4	O
hybridization	22001500	4	O
analysis	22001500	4	O
indicated	22001500	4	O
there	22001500	4	O
was	22001500	4	O
a	22001500	4	O
very	22001500	4	O
small	22001500	4	O
microdeletion	22001500	4	O
in	22001500	4	O
Xq28	22001500	4	O
.	22001500	4	O
Multiplex	22001500	4	O
ligation	22001500	4	O
-	22001500	4	O
dependent	22001500	4	O
probe	22001500	4	O
amplification	22001500	4	O
analysis	22001500	4	O
further	22001500	4	O
confirmed	22001500	4	O
there	22001500	4	O
were	22001500	4	O
heterozygous	22001500	4	O
deletions	22001500	4	O
of	22001500	4	O
intron	22001500	4	O
2	22001500	4	O
,	22001500	4	O
exon	22001500	4	O
3	22001500	4	O
,	22001500	4	O
intron	22001500	4	O
3	22001500	4	O
,	22001500	4	O
and	22001500	4	O
part	22001500	4	O
of	22001500	4	O
exon	22001500	4	O
4	22001500	4	O
in	22001500	4	O
MECP2	22001500	4	O
.	22001500	4	O
Findings	22001500	4	O
in	22001500	4	O
the	22001500	4	O
present	22001500	4	O
patient	22001500	4	O
confirm	22001500	4	O
the	22001500	4	O
view	22001500	4	O
that	22001500	4	O
large	22001500	4	O
MECP2	22001500	4	B-Gene
deletions	22001500	4	B-Var
are	22001500	4	O
an	22001500	4	O
important	22001500	4	O
cause	22001500	4	B-Reg
of	22001500	4	O
severe	22001500	4	O
congenital	22001500	4	O
variant	22001500	4	O
RTT	22001500	4	B-Disease
.	22001500	4	O
To	22001500	4	O
ensure	22001500	4	O
an	22001500	4	O
accurate	22001500	4	O
diagnosis	22001500	4	O
of	22001500	4	O
congenital	22001500	4	O
variant	22001500	4	O
RTT	22001500	4	O
,	22001500	4	O
a	22001500	4	O
multiplex	22001500	4	O
ligation	22001500	4	O
-	22001500	4	O
dependent	22001500	4	O
probe	22001500	4	O
amplification	22001500	4	O
analysis	22001500	4	O
of	22001500	4	O
MECP2	22001500	4	O
should	22001500	4	O
be	22001500	4	O
performed	22001500	4	O
in	22001500	4	O
patients	22001500	4	O
suspected	22001500	4	O
of	22001500	4	O
having	22001500	4	O
this	22001500	4	O
disorder	22001500	4	O
.	22001500	4	O

A	22340355	4	O
new	22340355	4	O
frame	22340355	4	B-Var
-	22340355	4	I-Var
shifting	22340355	4	I-Var
mutation	22340355	4	O
of	22340355	4	O
UGT1A1	22340355	4	B-Gene
gene	22340355	4	O
causes	22340355	4	B-Reg
type	22340355	4	B-Disease
I	22340355	4	I-Disease
Crigler	22340355	4	I-Disease
-	22340355	4	I-Disease
Najjar	22340355	4	I-Disease
syndrome	22340355	4	I-Disease
.	22340355	4	O
We	22340355	4	O
present	22340355	4	O
a	22340355	4	O
case	22340355	4	O
of	22340355	4	O
severe	22340355	4	O
persisting	22340355	4	O
unconjugated	22340355	4	O
hyperbilirubinemia	22340355	4	O
in	22340355	4	O
a	22340355	4	O
Uigur	22340355	4	O
infant	22340355	4	O
boy	22340355	4	O
,	22340355	4	O
eventually	22340355	4	O
diagnosed	22340355	4	O
as	22340355	4	O
Crigler	22340355	4	O
-	22340355	4	O
Najjar	22340355	4	O
syndrome	22340355	4	O
type	22340355	4	O
I.	22340355	4	O
DNA	22340355	4	O
analysis	22340355	4	O
of	22340355	4	O
his	22340355	4	O
blood	22340355	4	O
of	22340355	4	O
the	22340355	4	O
UGT1A1	22340355	4	O
gene	22340355	4	O
sequence	22340355	4	O
demonstrated	22340355	4	O
that	22340355	4	O
he	22340355	4	O
was	22340355	4	O
homozygous	22340355	4	O
for	22340355	4	O
an	22340355	4	O
insertion	22340355	4	O
mutation	22340355	4	O
causing	22340355	4	O
a	22340355	4	O
change	22340355	4	O
of	22340355	4	O
the	22340355	4	O
coding	22340355	4	O
exons	22340355	4	O
with	22340355	4	O
a	22340355	4	O
frame	22340355	4	O
-	22340355	4	O
shift	22340355	4	O
,	22340355	4	O
resulting	22340355	4	O
in	22340355	4	O
the	22340355	4	O
substitution	22340355	4	O
of	22340355	4	O
27	22340355	4	O
abnormal	22340355	4	O
amino	22340355	4	O
acid	22340355	4	O
residues	22340355	4	O
in	22340355	4	O
his	22340355	4	O
hepatic	22340355	4	O
bilirubin	22340355	4	O
uridine	22340355	4	O
diphosphoglucuronyl	22340355	4	O
transferase	22340355	4	O
enzyme	22340355	4	O
.	22340355	4	O
Both	22340355	4	O
of	22340355	4	O
his	22340355	4	O
parents	22340355	4	O
were	22340355	4	O
heterozygous	22340355	4	O
for	22340355	4	O
the	22340355	4	O
same	22340355	4	O
mutation	22340355	4	O
.	22340355	4	O
A	22340355	4	O
novel	22340355	4	O
frame	22340355	4	O
-	22340355	4	O
shifting	22340355	4	O
mutation	22340355	4	O
of	22340355	4	O
the	22340355	4	O
UGT1A1	22340355	4	O
gene	22340355	4	O
was	22340355	4	O
found	22340355	4	O
,	22340355	4	O
confirming	22340355	4	O
the	22340355	4	O
diagnosis	22340355	4	O
of	22340355	4	O
Crigler	22340355	4	O
-	22340355	4	O
Najjar	22340355	4	O
syndrome	22340355	4	O
type	22340355	4	O
I	22340355	4	O
for	22340355	4	O
this	22340355	4	O
patient	22340355	4	O
.	22340355	4	O

X	22483671	4	O
inactivation	22483671	4	O
in	22483671	4	O
females	22483671	4	O
with	22483671	4	O
X	22483671	4	O
-	22483671	4	O
linked	22483671	4	O
Charcot	22483671	4	O
-	22483671	4	O
Marie	22483671	4	O
-	22483671	4	O
Tooth	22483671	4	O
disease	22483671	4	O
.	22483671	4	O
X	22483671	4	B-Disease
-	22483671	4	I-Disease
linked	22483671	4	I-Disease
Charcot	22483671	4	I-Disease
-	22483671	4	I-Disease
Marie	22483671	4	I-Disease
-	22483671	4	I-Disease
Tooth	22483671	4	I-Disease
disease	22483671	4	I-Disease
(	22483671	4	O
CMT1X	22483671	4	O
)	22483671	4	O
is	22483671	4	O
the	22483671	4	O
second	22483671	4	O
most	22483671	4	O
common	22483671	4	O
inherited	22483671	4	O
neuropathy	22483671	4	O
,	22483671	4	O
caused	22483671	4	B-Reg
by	22483671	4	I-Reg
mutations	22483671	4	B-Var
in	22483671	4	O
gap	22483671	4	O
junction	22483671	4	O
beta-1	22483671	4	O
(	22483671	4	B-Gene
GJB1	22483671	4	I-Gene
)	22483671	4	I-Gene
.	22483671	4	O
Males	22483671	4	O
have	22483671	4	O
a	22483671	4	O
uniformly	22483671	4	O
moderately	22483671	4	O
severe	22483671	4	O
phenotype	22483671	4	O
while	22483671	4	O
females	22483671	4	O
have	22483671	4	O
a	22483671	4	O
variable	22483671	4	O
phenotype	22483671	4	O
,	22483671	4	O
suggested	22483671	4	O
to	22483671	4	O
be	22483671	4	O
due	22483671	4	O
to	22483671	4	O
X	22483671	4	O
inactivation	22483671	4	O
.	22483671	4	O
We	22483671	4	O
aimed	22483671	4	O
to	22483671	4	O
assess	22483671	4	O
X	22483671	4	O
inactivation	22483671	4	O
pattern	22483671	4	O
in	22483671	4	O
females	22483671	4	O
with	22483671	4	O
CMT1X	22483671	4	O
and	22483671	4	O
correlate	22483671	4	O
this	22483671	4	O
with	22483671	4	O
phenotype	22483671	4	O
using	22483671	4	O
the	22483671	4	O
CMT	22483671	4	O
examination	22483671	4	O
score	22483671	4	O
to	22483671	4	O
determine	22483671	4	O
whether	22483671	4	O
the	22483671	4	O
X	22483671	4	O
inactivation	22483671	4	O
pattern	22483671	4	O
accounted	22483671	4	O
for	22483671	4	O
the	22483671	4	O
variable	22483671	4	O
phenotype	22483671	4	O
in	22483671	4	O
females	22483671	4	O
with	22483671	4	O
CMT1X	22483671	4	O
.	22483671	4	O
We	22483671	4	O
determined	22483671	4	O
X	22483671	4	O
inactivation	22483671	4	O
pattern	22483671	4	O
in	22483671	4	O
67	22483671	4	O
females	22483671	4	O
with	22483671	4	O
CMT1X	22483671	4	O
and	22483671	4	O
24	22483671	4	O
controls	22483671	4	O
using	22483671	4	O
the	22483671	4	O
androgen	22483671	4	O
receptor	22483671	4	O
assay	22483671	4	O
.	22483671	4	O
We	22483671	4	O
were	22483671	4	O
able	22483671	4	O
to	22483671	4	O
determine	22483671	4	O
which	22483671	4	O
X	22483671	4	O
chromosome	22483671	4	O
carried	22483671	4	O
the	22483671	4	O
GJB1	22483671	4	O
mutation	22483671	4	O
in	22483671	4	O
30	22483671	4	O
females	22483671	4	O
.	22483671	4	O
There	22483671	4	O
was	22483671	4	O
no	22483671	4	O
difference	22483671	4	O
in	22483671	4	O
X	22483671	4	O
inactivation	22483671	4	O
pattern	22483671	4	O
between	22483671	4	O
patients	22483671	4	O
and	22483671	4	O
controls	22483671	4	O
.	22483671	4	O
In	22483671	4	O
addition	22483671	4	O
,	22483671	4	O
there	22483671	4	O
was	22483671	4	O
no	22483671	4	O
correlation	22483671	4	O
between	22483671	4	O
X	22483671	4	O
inactivation	22483671	4	O
pattern	22483671	4	O
in	22483671	4	O
blood	22483671	4	O
and	22483671	4	O
phenotype	22483671	4	O
.	22483671	4	O
A	22483671	4	O
possible	22483671	4	O
explanation	22483671	4	O
for	22483671	4	O
these	22483671	4	O
findings	22483671	4	O
is	22483671	4	O
that	22483671	4	O
the	22483671	4	O
X	22483671	4	O
inactivation	22483671	4	O
pattern	22483671	4	O
in	22483671	4	O
Schwann	22483671	4	O
cells	22483671	4	O
rather	22483671	4	O
than	22483671	4	O
in	22483671	4	O
blood	22483671	4	O
may	22483671	4	O
explain	22483671	4	O
the	22483671	4	O
variable	22483671	4	O
phenotype	22483671	4	O
in	22483671	4	O
females	22483671	4	O
with	22483671	4	O
CMT1X	22483671	4	O
.	22483671	4	O

Autosomal	22508176	4	B-Disease
dominant	22508176	4	I-Disease
polycystic	22508176	4	I-Disease
kidney	22508176	4	I-Disease
disease	22508176	4	I-Disease
:	22508176	4	I-Disease
comprehensive	22508176	4	O
mutation	22508176	4	B-Var
analysis	22508176	4	O
of	22508176	4	O
PKD1	22508176	4	B-Gene
and	22508176	4	O
PKD2	22508176	4	B-Gene
in	22508176	4	B-Reg
700	22508176	4	O
unrelated	22508176	4	O
patients	22508176	4	O
.	22508176	4	O
Autosomal	22508176	4	B-Disease
dominant	22508176	4	I-Disease
polycystic	22508176	4	I-Disease
kidney	22508176	4	I-Disease
disease	22508176	4	I-Disease
(	22508176	4	O
ADPKD	22508176	4	O
)	22508176	4	O
,	22508176	4	O
the	22508176	4	O
most	22508176	4	O
common	22508176	4	O
inherited	22508176	4	O
kidney	22508176	4	O
disorder	22508176	4	O
,	22508176	4	O
is	22508176	4	O
caused	22508176	4	B-Reg
by	22508176	4	I-Reg
mutations	22508176	4	B-Var
in	22508176	4	O
PKD1	22508176	4	B-Gene
or	22508176	4	O
PKD2	22508176	4	B-Gene
.	22508176	4	O
The	22508176	4	O
molecular	22508176	4	O
diagnosis	22508176	4	O
of	22508176	4	O
ADPKD	22508176	4	O
is	22508176	4	O
complicated	22508176	4	O
by	22508176	4	O
extensive	22508176	4	O
allelic	22508176	4	O
heterogeneity	22508176	4	O
and	22508176	4	O
particularly	22508176	4	O
by	22508176	4	O
the	22508176	4	O
presence	22508176	4	O
of	22508176	4	O
six	22508176	4	O
highly	22508176	4	O
homologous	22508176	4	O
sequences	22508176	4	O
of	22508176	4	O
PKD1	22508176	4	O
exons	22508176	4	O
1	22508176	4	O
-	22508176	4	O
33	22508176	4	O
.	22508176	4	O
Here	22508176	4	O
,	22508176	4	O
we	22508176	4	O
screened	22508176	4	O
PKD1	22508176	4	O
and	22508176	4	O
PKD2	22508176	4	O
for	22508176	4	O
both	22508176	4	O
conventional	22508176	4	O
mutations	22508176	4	O
and	22508176	4	O
gross	22508176	4	O
genomic	22508176	4	O
rearrangements	22508176	4	O
in	22508176	4	O
up	22508176	4	O
to	22508176	4	O
700	22508176	4	O
unrelated	22508176	4	O
ADPKD	22508176	4	O
patients	22508176	4	O
-	22508176	4	O
-	22508176	4	O
the	22508176	4	O
largest	22508176	4	O
patient	22508176	4	O
cohort	22508176	4	O
to	22508176	4	O
date	22508176	4	O
-	22508176	4	O
-	22508176	4	O
by	22508176	4	O
means	22508176	4	O
of	22508176	4	O
direct	22508176	4	O
sequencing	22508176	4	O
,	22508176	4	O
followed	22508176	4	O
by	22508176	4	O
quantitative	22508176	4	O
fluorescent	22508176	4	O
multiplex	22508176	4	O
polymerase	22508176	4	O
chain	22508176	4	O
reaction	22508176	4	O
or	22508176	4	O
array	22508176	4	O
-	22508176	4	O
comparative	22508176	4	O
genomic	22508176	4	O
hybridization	22508176	4	O
.	22508176	4	O
This	22508176	4	O
resulted	22508176	4	O
in	22508176	4	O
the	22508176	4	O
identification	22508176	4	O
of	22508176	4	O
the	22508176	4	O
largest	22508176	4	O
number	22508176	4	O
of	22508176	4	O
new	22508176	4	O
pathogenic	22508176	4	O
mutations	22508176	4	O
(	22508176	4	O
n	22508176	4	O
=	22508176	4	O
351	22508176	4	O
)	22508176	4	O
in	22508176	4	O
a	22508176	4	O
single	22508176	4	O
publication	22508176	4	O
,	22508176	4	O
expanded	22508176	4	O
the	22508176	4	O
spectrum	22508176	4	O
of	22508176	4	O
known	22508176	4	O
ADPKD	22508176	4	O
pathogenic	22508176	4	O
mutations	22508176	4	O
by	22508176	4	O
41.8%	22508176	4	O
for	22508176	4	O
PKD1	22508176	4	O
and	22508176	4	O
by	22508176	4	O
23.8%	22508176	4	O
for	22508176	4	O
PKD2	22508176	4	O
,	22508176	4	O
and	22508176	4	O
provided	22508176	4	O
new	22508176	4	O
insights	22508176	4	O
into	22508176	4	O
several	22508176	4	O
issues	22508176	4	O
,	22508176	4	O
such	22508176	4	O
as	22508176	4	O
the	22508176	4	O
population	22508176	4	O
-	22508176	4	O
dependent	22508176	4	O
distribution	22508176	4	O
of	22508176	4	O
recurrent	22508176	4	O
mutations	22508176	4	O
compared	22508176	4	O
with	22508176	4	O
founder	22508176	4	O
mutations	22508176	4	O
and	22508176	4	O
the	22508176	4	O
relative	22508176	4	O
paucity	22508176	4	O
of	22508176	4	O
pathogenic	22508176	4	O
missense	22508176	4	O
mutations	22508176	4	O
in	22508176	4	O
the	22508176	4	O
PKD2	22508176	4	O
gene	22508176	4	O
.	22508176	4	O
Our	22508176	4	O
study	22508176	4	O
,	22508176	4	O
together	22508176	4	O
with	22508176	4	O
others	22508176	4	O
,	22508176	4	O
highlights	22508176	4	O
the	22508176	4	O
importance	22508176	4	O
of	22508176	4	O
developing	22508176	4	O
novel	22508176	4	O
approaches	22508176	4	O
for	22508176	4	O
both	22508176	4	O
mutation	22508176	4	O
detection	22508176	4	O
and	22508176	4	O
functional	22508176	4	O
validation	22508176	4	O
of	22508176	4	O
nondefinite	22508176	4	O
pathogenic	22508176	4	O
mutations	22508176	4	O
to	22508176	4	O
increase	22508176	4	O
the	22508176	4	O
diagnostic	22508176	4	O
value	22508176	4	O
of	22508176	4	O
molecular	22508176	4	O
testing	22508176	4	O
for	22508176	4	O
ADPKD	22508176	4	O
.	22508176	4	O

A	22539353	4	O
novel	22539353	4	O
classification	22539353	4	O
system	22539353	4	O
to	22539353	4	O
predict	22539353	4	O
the	22539353	4	O
pathogenic	22539353	4	O
effects	22539353	4	O
of	22539353	4	O
CHD7	22539353	4	B-Gene
missense	22539353	4	B-Var
variants	22539353	4	I-Var
in	22539353	4	B-Reg
CHARGE	22539353	4	B-Disease
syndrome	22539353	4	I-Disease
.	22539353	4	O
CHARGE	22539353	4	B-Disease
syndrome	22539353	4	I-Disease
is	22539353	4	O
characterized	22539353	4	O
by	22539353	4	O
the	22539353	4	O
variable	22539353	4	O
occurrence	22539353	4	O
of	22539353	4	O
multisensory	22539353	4	O
impairment	22539353	4	O
,	22539353	4	O
congenital	22539353	4	O
anomalies	22539353	4	O
,	22539353	4	O
and	22539353	4	O
developmental	22539353	4	O
delay	22539353	4	O
,	22539353	4	O
and	22539353	4	O
is	22539353	4	O
caused	22539353	4	B-Reg
by	22539353	4	I-Reg
heterozygous	22539353	4	B-Var
mutations	22539353	4	I-Var
in	22539353	4	O
the	22539353	4	O
CHD7	22539353	4	B-Gene
gene	22539353	4	O
.	22539353	4	O
Correct	22539353	4	O
interpretation	22539353	4	O
of	22539353	4	O
CHD7	22539353	4	O
variants	22539353	4	O
is	22539353	4	O
essential	22539353	4	O
for	22539353	4	O
genetic	22539353	4	O
counseling	22539353	4	O
.	22539353	4	O
This	22539353	4	O
is	22539353	4	O
particularly	22539353	4	O
difficult	22539353	4	O
for	22539353	4	O
missense	22539353	4	O
variants	22539353	4	O
because	22539353	4	O
most	22539353	4	O
variants	22539353	4	O
in	22539353	4	O
the	22539353	4	O
CHD7	22539353	4	O
gene	22539353	4	O
are	22539353	4	O
private	22539353	4	O
and	22539353	4	O
a	22539353	4	O
functional	22539353	4	O
assay	22539353	4	O
is	22539353	4	O
not	22539353	4	O
yet	22539353	4	O
available	22539353	4	O
.	22539353	4	O
We	22539353	4	O
have	22539353	4	O
therefore	22539353	4	O
developed	22539353	4	O
a	22539353	4	O
novel	22539353	4	O
classification	22539353	4	O
system	22539353	4	O
to	22539353	4	O
predict	22539353	4	O
the	22539353	4	O
pathogenic	22539353	4	O
effects	22539353	4	O
of	22539353	4	O
CHD7	22539353	4	O
missense	22539353	4	O
variants	22539353	4	O
that	22539353	4	O
can	22539353	4	O
be	22539353	4	O
used	22539353	4	O
in	22539353	4	O
a	22539353	4	O
diagnostic	22539353	4	O
setting	22539353	4	O
.	22539353	4	O
Our	22539353	4	O
classification	22539353	4	O
system	22539353	4	O
combines	22539353	4	O
the	22539353	4	O
results	22539353	4	O
from	22539353	4	O
two	22539353	4	O
computational	22539353	4	O
algorithms	22539353	4	O
(	22539353	4	O
PolyPhen-2	22539353	4	O
and	22539353	4	O
Align	22539353	4	O
-	22539353	4	O
GVGD	22539353	4	O
)	22539353	4	O
and	22539353	4	O
the	22539353	4	O
prediction	22539353	4	O
of	22539353	4	O
a	22539353	4	O
newly	22539353	4	O
developed	22539353	4	O
structural	22539353	4	O
model	22539353	4	O
of	22539353	4	O
the	22539353	4	O
chromo	22539353	4	O
-	22539353	4	O
and	22539353	4	O
helicase	22539353	4	O
domains	22539353	4	O
of	22539353	4	O
CHD7	22539353	4	O
with	22539353	4	O
segregation	22539353	4	O
and	22539353	4	O
phenotypic	22539353	4	O
data	22539353	4	O
.	22539353	4	O
The	22539353	4	O
combination	22539353	4	O
of	22539353	4	O
different	22539353	4	O
variables	22539353	4	O
will	22539353	4	O
lead	22539353	4	O
to	22539353	4	O
a	22539353	4	O
more	22539353	4	O
confident	22539353	4	O
prediction	22539353	4	O
of	22539353	4	O
pathogenicity	22539353	4	O
than	22539353	4	O
was	22539353	4	O
previously	22539353	4	O
possible	22539353	4	O
.	22539353	4	O
We	22539353	4	O
have	22539353	4	O
used	22539353	4	O
our	22539353	4	O
system	22539353	4	O
to	22539353	4	O
classify	22539353	4	O
145	22539353	4	O
CHD7	22539353	4	O
missense	22539353	4	O
variants	22539353	4	O
.	22539353	4	O
Our	22539353	4	O
data	22539353	4	O
show	22539353	4	O
that	22539353	4	O
pathogenic	22539353	4	O
missense	22539353	4	O
mutations	22539353	4	O
are	22539353	4	O
mainly	22539353	4	O
present	22539353	4	O
in	22539353	4	O
the	22539353	4	O
middle	22539353	4	O
of	22539353	4	O
the	22539353	4	O
CHD7	22539353	4	O
gene	22539353	4	O
,	22539353	4	O
whereas	22539353	4	O
benign	22539353	4	O
variants	22539353	4	O
are	22539353	4	O
mainly	22539353	4	O
clustered	22539353	4	O
in	22539353	4	O
the	22539353	4	O
5	22539353	4	O
'	22539353	4	O
and	22539353	4	O
3	22539353	4	O
'	22539353	4	O
regions	22539353	4	O
.	22539353	4	O
Finally	22539353	4	O
,	22539353	4	O
we	22539353	4	O
show	22539353	4	O
that	22539353	4	O
CHD7	22539353	4	O
missense	22539353	4	O
mutations	22539353	4	O
are	22539353	4	O
,	22539353	4	O
in	22539353	4	O
general	22539353	4	O
,	22539353	4	O
associated	22539353	4	O
with	22539353	4	O
a	22539353	4	O
milder	22539353	4	O
phenotype	22539353	4	O
than	22539353	4	O
truncating	22539353	4	O
mutations	22539353	4	O
.	22539353	4	O

Novel	22541666	4	O
mutation	22541666	4	O
in	22541666	4	O
SLC9A6	22541666	4	O
gene	22541666	4	O
in	22541666	4	O
a	22541666	4	O
patient	22541666	4	O
with	22541666	4	O
Christianson	22541666	4	O
syndrome	22541666	4	O
and	22541666	4	O
retinitis	22541666	4	O
pigmentosum	22541666	4	O
.	22541666	4	O
Mutations	22541666	4	B-Var
in	22541666	4	O
the	22541666	4	O
SLC9A6	22541666	4	B-Gene
gene	22541666	4	O
cause	22541666	4	B-Reg
Christianson	22541666	4	B-Disease
syndrome	22541666	4	I-Disease
in	22541666	4	O
boys	22541666	4	O
.	22541666	4	O
This	22541666	4	O
X	22541666	4	O
-	22541666	4	O
linked	22541666	4	O
syndrome	22541666	4	O
is	22541666	4	O
characterized	22541666	4	O
by	22541666	4	O
profound	22541666	4	O
mental	22541666	4	O
retardation	22541666	4	O
with	22541666	4	O
autistic	22541666	4	O
behavior	22541666	4	O
,	22541666	4	O
microcephaly	22541666	4	O
,	22541666	4	O
epilepsy	22541666	4	O
,	22541666	4	O
ophthalmoplegia	22541666	4	O
,	22541666	4	O
and	22541666	4	O
ataxia	22541666	4	O
.	22541666	4	O
Progressive	22541666	4	O
cerebellar	22541666	4	O
atrophy	22541666	4	O
with	22541666	4	O
motor	22541666	4	O
regression	22541666	4	O
is	22541666	4	O
a	22541666	4	O
remarkable	22541666	4	O
feature	22541666	4	O
in	22541666	4	O
some	22541666	4	O
patients	22541666	4	O
.	22541666	4	O
We	22541666	4	O
report	22541666	4	O
on	22541666	4	O
a	22541666	4	O
22	22541666	4	O
year	22541666	4	O
-	22541666	4	O
old	22541666	4	O
male	22541666	4	O
patient	22541666	4	O
with	22541666	4	O
Christianson	22541666	4	O
syndrome	22541666	4	O
carrying	22541666	4	O
the	22541666	4	O
novel	22541666	4	O
p.Gln306X	22541666	4	O
mutation	22541666	4	O
.	22541666	4	O
The	22541666	4	O
infantile	22541666	4	O
phenotype	22541666	4	O
suggested	22541666	4	O
pervasive	22541666	4	O
developmental	22541666	4	O
disorder	22541666	4	O
,	22541666	4	O
then	22541666	4	O
profound	22541666	4	O
mental	22541666	4	O
retardation	22541666	4	O
ensued	22541666	4	O
.	22541666	4	O
In	22541666	4	O
later	22541666	4	O
childhood	22541666	4	O
,	22541666	4	O
progressive	22541666	4	O
cerebellar	22541666	4	O
atrophy	22541666	4	O
was	22541666	4	O
diagnosed	22541666	4	O
on	22541666	4	O
serial	22541666	4	O
brain	22541666	4	O
MRIs	22541666	4	O
and	22541666	4	O
motor	22541666	4	O
regression	22541666	4	O
occurred	22541666	4	O
.	22541666	4	O
Furthermore	22541666	4	O
,	22541666	4	O
ophthalmological	22541666	4	O
evaluations	22541666	4	O
showed	22541666	4	O
a	22541666	4	O
retinitis	22541666	4	O
pigmentosum	22541666	4	O
previously	22541666	4	O
unreported	22541666	4	O
in	22541666	4	O
this	22541666	4	O
condition	22541666	4	O
.	22541666	4	O
We	22541666	4	O
conclude	22541666	4	O
that	22541666	4	O
the	22541666	4	O
natural	22541666	4	O
history	22541666	4	O
of	22541666	4	O
the	22541666	4	O
disease	22541666	4	O
in	22541666	4	O
this	22541666	4	O
patient	22541666	4	O
tends	22541666	4	O
to	22541666	4	O
confirm	22541666	4	O
the	22541666	4	O
degenerative	22541666	4	O
nature	22541666	4	O
of	22541666	4	O
Christianson	22541666	4	O
syndrome	22541666	4	O
,	22541666	4	O
and	22541666	4	O
that	22541666	4	O
retinal	22541666	4	O
degeneration	22541666	4	O
may	22541666	4	O
be	22541666	4	O
part	22541666	4	O
of	22541666	4	O
the	22541666	4	O
condition	22541666	4	O
.	22541666	4	O
Before	22541666	4	O
the	22541666	4	O
onset	22541666	4	O
of	22541666	4	O
degeneration	22541666	4	O
,	22541666	4	O
the	22541666	4	O
syndromic	22541666	4	O
association	22541666	4	O
of	22541666	4	O
severe	22541666	4	O
mental	22541666	4	O
retardation	22541666	4	O
,	22541666	4	O
autistic	22541666	4	O
behavior	22541666	4	O
,	22541666	4	O
external	22541666	4	O
ophthalmoplegia	22541666	4	O
,	22541666	4	O
and	22541666	4	O
facial	22541666	4	O
dysmorphism	22541666	4	O
in	22541666	4	O
male	22541666	4	O
patients	22541666	4	O
is	22541666	4	O
a	22541666	4	O
clue	22541666	4	O
to	22541666	4	O
the	22541666	4	O
diagnosis	22541666	4	O
.	22541666	4	O

Mutation	22666734	4	B-Var
analysis	22666734	4	O
in	22666734	4	O
two	22666734	4	O
Chinese	22666734	4	O
families	22666734	4	O
with	22666734	4	B-Reg
multiple	22666734	4	B-Disease
endocrine	22666734	4	I-Disease
neoplasia	22666734	4	I-Disease
type	22666734	4	I-Disease
1	22666734	4	I-Disease
.	22666734	4	O
OBJECTIVE	22666734	4	O
:	22666734	4	O
This	22666734	4	O
study	22666734	4	O
aimed	22666734	4	O
at	22666734	4	O
identifing	22666734	4	O
mutations	22666734	4	O
in	22666734	4	O
two	22666734	4	O
Chinese	22666734	4	O
genealogies	22666734	4	O
with	22666734	4	O
MEN1	22666734	4	B-Gene
.	22666734	4	O
SUBJECTS	22666734	4	O
AND	22666734	4	O
METHODS	22666734	4	O
:	22666734	4	O
Three	22666734	4	O
members	22666734	4	O
of	22666734	4	O
two	22666734	4	O
Chinese	22666734	4	O
families	22666734	4	O
with	22666734	4	O
MEN1	22666734	4	O
were	22666734	4	O
enrolled	22666734	4	O
in	22666734	4	O
this	22666734	4	O
study	22666734	4	O
,	22666734	4	O
and	22666734	4	O
all	22666734	4	O
of	22666734	4	O
the	22666734	4	O
coding	22666734	4	O
regions	22666734	4	O
and	22666734	4	O
adjacent	22666734	4	O
sequences	22666734	4	O
of	22666734	4	O
the	22666734	4	O
MEN1	22666734	4	O
gene	22666734	4	O
were	22666734	4	O
amplified	22666734	4	O
and	22666734	4	O
sequenced	22666734	4	O
.	22666734	4	O
RESULTS	22666734	4	O
:	22666734	4	O
A	22666734	4	O
recurrent	22666734	4	O
mutation	22666734	4	O
of	22666734	4	O
heterozygous	22666734	4	O
change	22666734	4	O
T	22666734	4	O
>	22666734	4	O
A	22666734	4	O
at	22666734	4	O
IVS	22666734	4	O
4	22666734	4	O
1	22666734	4	O
was	22666734	4	O
found	22666734	4	O
in	22666734	4	O
family	22666734	4	O
I	22666734	4	O
,	22666734	4	O
and	22666734	4	O
a	22666734	4	O
novel	22666734	4	O
insGAGGTGG	22666734	4	O
mutation	22666734	4	O
(	22666734	4	O
c.703	22666734	4	O
-	22666734	4	O
709	22666734	4	O
dup7bp	22666734	4	O
)	22666734	4	O
resulted	22666734	4	O
in	22666734	4	O
a	22666734	4	O
frameshift	22666734	4	O
(	22666734	4	O
p.A237Gfsx13	22666734	4	O
)	22666734	4	O
in	22666734	4	O
family	22666734	4	O
II	22666734	4	O
.	22666734	4	O
CONCLUSION	22666734	4	O
:	22666734	4	O
We	22666734	4	O
are	22666734	4	O
able	22666734	4	O
to	22666734	4	O
add	22666734	4	O
a	22666734	4	O
new	22666734	4	O
mutation	22666734	4	O
of	22666734	4	O
MEN1	22666734	4	O
gene	22666734	4	O
in	22666734	4	O
Chinese	22666734	4	O
patients	22666734	4	O
with	22666734	4	O
MEN1	22666734	4	O
that	22666734	4	O
will	22666734	4	O
be	22666734	4	O
useful	22666734	4	O
for	22666734	4	O
the	22666734	4	O
diagnosis	22666734	4	O
and	22666734	4	O
treatment	22666734	4	O
of	22666734	4	O
the	22666734	4	O
disease	22666734	4	O
.	22666734	4	O

Two	22688420	4	O
novel	22688420	4	O
mutations	22688420	4	O
in	22688420	4	O
the	22688420	4	O
lactase	22688420	4	O
gene	22688420	4	O
in	22688420	4	O
a	22688420	4	O
Japanese	22688420	4	O
infant	22688420	4	O
with	22688420	4	O
congenital	22688420	4	O
lactase	22688420	4	O
deficiency	22688420	4	O
.	22688420	4	O
Intestinal	22688420	4	O
lactase	22688420	4	O
is	22688420	4	O
required	22688420	4	O
for	22688420	4	O
the	22688420	4	O
hydrolysis	22688420	4	O
of	22688420	4	O
lactose	22688420	4	O
that	22688420	4	O
is	22688420	4	O
the	22688420	4	O
most	22688420	4	O
essential	22688420	4	O
carbohydrate	22688420	4	O
in	22688420	4	O
milk	22688420	4	O
and	22688420	4	O
the	22688420	4	O
primary	22688420	4	O
diet	22688420	4	O
source	22688420	4	O
of	22688420	4	O
newborn	22688420	4	O
.	22688420	4	O
Congenital	22688420	4	B-Disease
lactase	22688420	4	I-Disease
deficiency	22688420	4	I-Disease
[	22688420	4	O
CLD	22688420	4	O
(	22688420	4	O
MIM	22688420	4	O
223000	22688420	4	O
)	22688420	4	O
]	22688420	4	O
is	22688420	4	O
a	22688420	4	O
severe	22688420	4	O
gastrointestinal	22688420	4	O
disorder	22688420	4	O
and	22688420	4	O
is	22688420	4	O
characterized	22688420	4	O
by	22688420	4	O
watery	22688420	4	O
diarrhea	22688420	4	O
due	22688420	4	O
to	22688420	4	O
an	22688420	4	O
extremely	22688420	4	O
low	22688420	4	O
or	22688420	4	O
the	22688420	4	O
lack	22688420	4	O
of	22688420	4	O
lactase	22688420	4	O
activity	22688420	4	O
in	22688420	4	O
the	22688420	4	O
intestinal	22688420	4	O
wall	22688420	4	O
from	22688420	4	O
birth	22688420	4	O
.	22688420	4	O
CLD	22688420	4	O
is	22688420	4	O
a	22688420	4	O
rare	22688420	4	O
disease	22688420	4	O
and	22688420	4	O
occurs	22688420	4	O
more	22688420	4	O
frequently	22688420	4	O
in	22688420	4	O
Finland	22688420	4	O
.	22688420	4	O
Recent	22688420	4	O
studies	22688420	4	O
have	22688420	4	O
shown	22688420	4	O
that	22688420	4	O
mutations	22688420	4	B-Var
in	22688420	4	O
the	22688420	4	O
coding	22688420	4	O
region	22688420	4	O
of	22688420	4	O
the	22688420	4	O
lactase	22688420	4	O
(	22688420	4	B-Gene
LCT	22688420	4	I-Gene
)	22688420	4	I-Gene
gene	22688420	4	O
underlie	22688420	4	B-Reg
CLD	22688420	4	B-Disease
in	22688420	4	O
patients	22688420	4	O
from	22688420	4	O
Finland	22688420	4	O
and	22688420	4	O
other	22688420	4	O
European	22688420	4	O
countries	22688420	4	O
.	22688420	4	O
Here	22688420	4	O
,	22688420	4	O
we	22688420	4	O
report	22688420	4	O
two	22688420	4	O
novel	22688420	4	O
mutations	22688420	4	O
in	22688420	4	O
the	22688420	4	O
LCT	22688420	4	O
gene	22688420	4	O
in	22688420	4	O
a	22688420	4	O
Japanese	22688420	4	O
female	22688420	4	O
infant	22688420	4	O
with	22688420	4	O
clinical	22688420	4	O
features	22688420	4	O
consistent	22688420	4	O
with	22688420	4	O
those	22688420	4	O
of	22688420	4	O
CLD	22688420	4	O
.	22688420	4	O
She	22688420	4	O
suffered	22688420	4	O
from	22688420	4	O
severe	22688420	4	O
watery	22688420	4	O
diarrhea	22688420	4	O
from	22688420	4	O
the	22688420	4	O
age	22688420	4	O
of	22688420	4	O
2	22688420	4	O
days	22688420	4	O
on	22688420	4	O
breast	22688420	4	O
milk	22688420	4	O
/	22688420	4	O
lactose	22688420	4	O
containing	22688420	4	O
cow	22688420	4	O
'	22688420	4	O
s	22688420	4	O
milk	22688420	4	O
formula	22688420	4	O
.	22688420	4	O
With	22688420	4	O
the	22688420	4	O
lactose	22688420	4	O
-	22688420	4	O
free	22688420	4	O
hydrolyzed	22688420	4	O
cow	22688420	4	O
'	22688420	4	O
s	22688420	4	O
milk	22688420	4	O
formula	22688420	4	O
,	22688420	4	O
diarrhea	22688420	4	O
was	22688420	4	O
stopped	22688420	4	O
,	22688420	4	O
and	22688420	4	O
she	22688420	4	O
has	22688420	4	O
now	22688420	4	O
developed	22688420	4	O
well	22688420	4	O
on	22688420	4	O
a	22688420	4	O
lactose	22688420	4	O
-	22688420	4	O
free	22688420	4	O
diet	22688420	4	O
.	22688420	4	O
She	22688420	4	O
shows	22688420	4	O
a	22688420	4	O
lactose	22688420	4	O
-	22688420	4	O
intolerance	22688420	4	O
pattern	22688420	4	O
on	22688420	4	O
the	22688420	4	O
lactose	22688420	4	O
challenge	22688420	4	O
test	22688420	4	O
.	22688420	4	O
Sequence	22688420	4	O
analysis	22688420	4	O
revealed	22688420	4	O
the	22688420	4	O
two	22688420	4	O
mutations	22688420	4	O
in	22688420	4	O
her	22688420	4	O
LCT	22688420	4	B-Gene
gene	22688420	4	O
:	22688420	4	O
c.4419	22688420	4	B-Var
C	22688420	4	I-Var
>	22688420	4	I-Var
G	22688420	4	I-Var
(	22688420	4	O
p.Y1473X	22688420	4	O
)	22688420	4	O
in	22688420	4	O
exon	22688420	4	O
10	22688420	4	O
transmitted	22688420	4	O
from	22688420	4	O
her	22688420	4	O
mother	22688420	4	O
and	22688420	4	O
c.5387	22688420	4	B-Var
delA	22688420	4	I-Var
(	22688420	4	O
p.D1796fs	22688420	4	O
)	22688420	4	O
in	22688420	4	O
exon	22688420	4	O
16	22688420	4	O
transmitted	22688420	4	O
from	22688420	4	O
her	22688420	4	O
father	22688420	4	O
.	22688420	4	O
Both	22688420	4	O
mutations	22688420	4	O
cause	22688420	4	B-Reg
premature	22688420	4	O
truncation	22688420	4	O
of	22688420	4	O
lactase	22688420	4	O
polypeptide	22688420	4	O
and	22688420	4	O
are	22688420	4	O
supposed	22688420	4	O
to	22688420	4	O
be	22688420	4	B-Reg
responsible	22688420	4	I-Reg
for	22688420	4	I-Reg
CLD	22688420	4	B-Disease
.	22688420	4	O
To	22688420	4	O
our	22688420	4	O
knowledge	22688420	4	O
,	22688420	4	O
this	22688420	4	O
is	22688420	4	O
the	22688420	4	O
first	22688420	4	O
report	22688420	4	O
on	22688420	4	O
mutations	22688420	4	O
in	22688420	4	O
the	22688420	4	O
LCT	22688420	4	O
gene	22688420	4	O
in	22688420	4	O
Japan	22688420	4	O
.	22688420	4	O
We	22688420	4	O
suggest	22688420	4	O
that	22688420	4	O
an	22688420	4	O
increased	22688420	4	O
awareness	22688420	4	O
is	22688420	4	O
required	22688420	4	O
regarding	22688420	4	O
CLD	22688420	4	O
.	22688420	4	O

Analysis	22727569	4	O
of	22727569	4	O
gene	22727569	4	O
mutations	22727569	4	O
in	22727569	4	O
Chinese	22727569	4	O
patients	22727569	4	O
with	22727569	4	O
maple	22727569	4	O
syrup	22727569	4	O
urine	22727569	4	O
disease	22727569	4	O
.	22727569	4	O
OBJECTIVE	22727569	4	O
:	22727569	4	O
Maple	22727569	4	B-Disease
syrup	22727569	4	I-Disease
urine	22727569	4	I-Disease
disease	22727569	4	I-Disease
(	22727569	4	O
MSUD	22727569	4	O
)	22727569	4	O
is	22727569	4	O
predominantly	22727569	4	O
caused	22727569	4	B-Reg
by	22727569	4	I-Reg
mutations	22727569	4	B-Var
in	22727569	4	O
the	22727569	4	O
BCKDHA	22727569	4	B-Gene
,	22727569	4	O
BCKDHB	22727569	4	B-Gene
and	22727569	4	O
DBT	22727569	4	B-Gene
genes	22727569	4	O
,	22727569	4	O
which	22727569	4	O
encode	22727569	4	O
for	22727569	4	O
the	22727569	4	O
E1α	22727569	4	O
,	22727569	4	O
E1β	22727569	4	O
and	22727569	4	O
E2	22727569	4	O
subunits	22727569	4	O
of	22727569	4	O
the	22727569	4	O
branched	22727569	4	O
-	22727569	4	O
chain	22727569	4	O
α	22727569	4	O
-	22727569	4	O
keto	22727569	4	O
acid	22727569	4	O
dehydrogenase	22727569	4	O
complex	22727569	4	O
,	22727569	4	O
respectively	22727569	4	O
.	22727569	4	O
The	22727569	4	O
aim	22727569	4	O
of	22727569	4	O
this	22727569	4	O
study	22727569	4	O
was	22727569	4	O
to	22727569	4	O
screen	22727569	4	O
DNA	22727569	4	O
samples	22727569	4	O
from	22727569	4	O
16	22727569	4	O
Chinese	22727569	4	O
MSUD	22727569	4	O
patients	22727569	4	O
and	22727569	4	O
assess	22727569	4	O
a	22727569	4	O
potential	22727569	4	O
correlation	22727569	4	O
between	22727569	4	O
genotype	22727569	4	O
and	22727569	4	O
phenotype	22727569	4	O
.	22727569	4	O
METHODS	22727569	4	O
:	22727569	4	O
BCKDHA	22727569	4	O
,	22727569	4	O
BCKDHB	22727569	4	O
and	22727569	4	O
DBT	22727569	4	O
genes	22727569	4	O
were	22727569	4	O
analyzed	22727569	4	O
by	22727569	4	O
polymerase	22727569	4	O
chain	22727569	4	O
reaction	22727569	4	O
(	22727569	4	O
PCR	22727569	4	O
)	22727569	4	O
and	22727569	4	O
direct	22727569	4	O
sequencing	22727569	4	O
.	22727569	4	O
Segments	22727569	4	O
bearing	22727569	4	O
novel	22727569	4	O
mutations	22727569	4	O
were	22727569	4	O
identified	22727569	4	O
by	22727569	4	O
PCR	22727569	4	O
-	22727569	4	O
restriction	22727569	4	O
fragment	22727569	4	O
length	22727569	4	O
polymorphism	22727569	4	O
(	22727569	4	O
PCR	22727569	4	O
-	22727569	4	O
RFLP	22727569	4	O
)	22727569	4	O
analysis	22727569	4	O
.	22727569	4	O
RESULTS	22727569	4	O
:	22727569	4	O
Within	22727569	4	O
the	22727569	4	O
variant	22727569	4	O
alleles	22727569	4	O
,	22727569	4	O
28	22727569	4	O
mutations	22727569	4	O
(	22727569	4	O
28	22727569	4	O
/	22727569	4	O
32	22727569	4	O
,	22727569	4	O
87.5%	22727569	4	O
)	22727569	4	O
,	22727569	4	O
were	22727569	4	O
detected	22727569	4	O
in	22727569	4	O
15	22727569	4	O
patients	22727569	4	O
,	22727569	4	O
while	22727569	4	O
one	22727569	4	O
patient	22727569	4	O
displayed	22727569	4	O
no	22727569	4	O
mutations	22727569	4	O
.	22727569	4	O
Mutations	22727569	4	O
were	22727569	4	O
comprised	22727569	4	O
of	22727569	4	O
20	22727569	4	O
different	22727569	4	O
:	22727569	4	O
6	22727569	4	O
BCKDHA	22727569	4	O
gene	22727569	4	O
mutations	22727569	4	O
in	22727569	4	O
4	22727569	4	O
cases	22727569	4	O
,	22727569	4	O
10	22727569	4	O
BCKDHB	22727569	4	O
gene	22727569	4	O
mutations	22727569	4	O
in	22727569	4	O
8	22727569	4	O
cases	22727569	4	O
and	22727569	4	O
4	22727569	4	O
DBT	22727569	4	O
gene	22727569	4	O
mutations	22727569	4	O
in	22727569	4	O
3	22727569	4	O
cases	22727569	4	O
.	22727569	4	O
From	22727569	4	O
these	22727569	4	O
,	22727569	4	O
14	22727569	4	O
were	22727569	4	O
novel	22727569	4	O
,	22727569	4	O
which	22727569	4	O
included	22727569	4	O
3	22727569	4	O
mutations	22727569	4	O
in	22727569	4	O
the	22727569	4	O
BCKDHA	22727569	4	O
gene	22727569	4	O
,	22727569	4	O
7	22727569	4	O
in	22727569	4	O
the	22727569	4	O
BCKDHB	22727569	4	O
gene	22727569	4	O
and	22727569	4	O
4	22727569	4	O
in	22727569	4	O
the	22727569	4	O
DBT	22727569	4	O
gene	22727569	4	O
.	22727569	4	O
Only	22727569	4	O
two	22727569	4	O
patients	22727569	4	O
with	22727569	4	O
mutations	22727569	4	O
in	22727569	4	O
the	22727569	4	O
BCKDHB	22727569	4	O
and	22727569	4	O
DBT	22727569	4	O
genes	22727569	4	O
were	22727569	4	O
thiamine	22727569	4	O
-	22727569	4	O
responsive	22727569	4	O
and	22727569	4	O
presented	22727569	4	O
a	22727569	4	O
better	22727569	4	O
clinical	22727569	4	O
outcome	22727569	4	O
.	22727569	4	O
CONCLUSION	22727569	4	O
:	22727569	4	O
We	22727569	4	O
identified	22727569	4	O
20	22727569	4	O
different	22727569	4	O
mutations	22727569	4	O
within	22727569	4	O
the	22727569	4	O
BCKDHA	22727569	4	O
,	22727569	4	O
BCKDHB	22727569	4	O
and	22727569	4	O
DBT	22727569	4	O
genes	22727569	4	O
among	22727569	4	O
16	22727569	4	O
Chinese	22727569	4	O
MSUD	22727569	4	O
patients	22727569	4	O
,	22727569	4	O
including	22727569	4	O
14	22727569	4	O
novel	22727569	4	O
mutations	22727569	4	O
.	22727569	4	O
The	22727569	4	O
majority	22727569	4	O
were	22727569	4	O
non	22727569	4	O
-	22727569	4	O
responsive	22727569	4	O
to	22727569	4	O
thiamine	22727569	4	O
,	22727569	4	O
associating	22727569	4	O
with	22727569	4	O
a	22727569	4	O
worse	22727569	4	O
clinical	22727569	4	O
outcome	22727569	4	O
.	22727569	4	O
Our	22727569	4	O
data	22727569	4	O
provide	22727569	4	O
the	22727569	4	O
basis	22727569	4	O
for	22727569	4	O
further	22727569	4	O
genotype	22727569	4	O
-	22727569	4	O
phenotype	22727569	4	O
correlation	22727569	4	O
studies	22727569	4	O
in	22727569	4	O
these	22727569	4	O
patients	22727569	4	O
,	22727569	4	O
which	22727569	4	O
will	22727569	4	O
be	22727569	4	O
beneficial	22727569	4	O
for	22727569	4	O
early	22727569	4	O
diagnosis	22727569	4	O
and	22727569	4	O
in	22727569	4	O
directing	22727569	4	O
the	22727569	4	O
approach	22727569	4	O
to	22727569	4	O
clinical	22727569	4	O
intervention	22727569	4	O
.	22727569	4	O

Cell	22818872	4	O
models	22818872	4	O
for	22818872	4	O
McArdle	22818872	4	O
disease	22818872	4	O
and	22818872	4	O
aminoglycoside	22818872	4	O
-	22818872	4	O
induced	22818872	4	O
read	22818872	4	O
-	22818872	4	O
through	22818872	4	O
of	22818872	4	O
a	22818872	4	O
premature	22818872	4	O
termination	22818872	4	O
codon	22818872	4	O
.	22818872	4	O
McArdle	22818872	4	B-Disease
disease	22818872	4	I-Disease
results	22818872	4	B-Reg
from	22818872	4	I-Reg
mutations	22818872	4	O
in	22818872	4	O
the	22818872	4	O
gene	22818872	4	O
encoding	22818872	4	O
muscle	22818872	4	O
glycogen	22818872	4	O
phosphorylase	22818872	4	O
(	22818872	4	B-Gene
PYGM	22818872	4	I-Gene
)	22818872	4	I-Gene
protein	22818872	4	O
and	22818872	4	O
the	22818872	4	O
two	22818872	4	O
most	22818872	4	O
common	22818872	4	O
mutations	22818872	4	O
are	22818872	4	O
a	22818872	4	O
premature	22818872	4	O
termination	22818872	4	O
codon	22818872	4	O
(	22818872	4	B-Var
R50X	22818872	4	I-Var
)	22818872	4	I-Var
and	22818872	4	O
a	22818872	4	O
missense	22818872	4	O
mutation	22818872	4	O
(	22818872	4	B-Var
G205S	22818872	4	I-Var
)	22818872	4	I-Var
.	22818872	4	O
Myoblasts	22818872	4	O
from	22818872	4	O
patients	22818872	4	O
cannot	22818872	4	O
be	22818872	4	O
used	22818872	4	O
to	22818872	4	O
create	22818872	4	O
a	22818872	4	O
cell	22818872	4	O
model	22818872	4	O
of	22818872	4	O
McArdle	22818872	4	O
disease	22818872	4	O
because	22818872	4	O
even	22818872	4	O
normal	22818872	4	O
myoblasts	22818872	4	O
produce	22818872	4	O
little	22818872	4	O
or	22818872	4	O
no	22818872	4	O
PYGM	22818872	4	O
protein	22818872	4	O
in	22818872	4	O
cell	22818872	4	O
culture	22818872	4	O
.	22818872	4	O
We	22818872	4	O
therefore	22818872	4	O
created	22818872	4	O
cell	22818872	4	O
models	22818872	4	O
by	22818872	4	O
expressing	22818872	4	O
wild	22818872	4	O
-	22818872	4	O
type	22818872	4	O
or	22818872	4	O
mutant	22818872	4	O
(	22818872	4	O
R50X	22818872	4	O
or	22818872	4	O
G205S	22818872	4	O
)	22818872	4	O
PYGM	22818872	4	O
from	22818872	4	O
cDNA	22818872	4	O
integrated	22818872	4	O
into	22818872	4	O
the	22818872	4	O
genome	22818872	4	O
of	22818872	4	O
Chinese	22818872	4	O
hamster	22818872	4	O
ovary	22818872	4	O
cells	22818872	4	O
.	22818872	4	O
These	22818872	4	O
cell	22818872	4	O
lines	22818872	4	O
enable	22818872	4	O
the	22818872	4	O
study	22818872	4	O
of	22818872	4	O
McArdle	22818872	4	O
mutations	22818872	4	O
in	22818872	4	O
the	22818872	4	O
absence	22818872	4	O
of	22818872	4	O
nonsense	22818872	4	O
-	22818872	4	O
mediated	22818872	4	O
decay	22818872	4	O
of	22818872	4	O
mRNA	22818872	4	O
transcripts	22818872	4	O
.	22818872	4	O
Although	22818872	4	O
all	22818872	4	O
cell	22818872	4	O
lines	22818872	4	O
produced	22818872	4	O
stable	22818872	4	O
mRNA	22818872	4	O
,	22818872	4	O
only	22818872	4	O
wild	22818872	4	O
-	22818872	4	O
type	22818872	4	O
produced	22818872	4	O
detectable	22818872	4	O
PYGM	22818872	4	O
protein	22818872	4	O
.	22818872	4	O
Our	22818872	4	O
data	22818872	4	O
suggest	22818872	4	O
that	22818872	4	O
the	22818872	4	O
G205S	22818872	4	B-Var
mutation	22818872	4	O
affects	22818872	4	O
PYGM	22818872	4	B-Gene
by	22818872	4	O
causing	22818872	4	B-Reg
misfolding	22818872	4	O
and	22818872	4	O
accelerated	22818872	4	B-Reg
protein	22818872	4	O
turnover	22818872	4	O
.	22818872	4	O
Using	22818872	4	O
the	22818872	4	O
N	22818872	4	O
-	22818872	4	O
terminal	22818872	4	O
region	22818872	4	O
of	22818872	4	O
PYGM	22818872	4	O
containing	22818872	4	O
the	22818872	4	O
R50X	22818872	4	O
mutation	22818872	4	O
fused	22818872	4	O
to	22818872	4	O
green	22818872	4	O
fluorescent	22818872	4	O
protein	22818872	4	O
,	22818872	4	O
we	22818872	4	O
were	22818872	4	O
able	22818872	4	O
to	22818872	4	O
demonstrate	22818872	4	O
both	22818872	4	O
small	22818872	4	O
amounts	22818872	4	O
of	22818872	4	O
truncated	22818872	4	O
protein	22818872	4	O
production	22818872	4	O
and	22818872	4	O
read	22818872	4	O
-	22818872	4	O
through	22818872	4	O
of	22818872	4	O
the	22818872	4	O
R50X	22818872	4	O
premature	22818872	4	O
termination	22818872	4	O
codon	22818872	4	O
induced	22818872	4	O
by	22818872	4	O
the	22818872	4	O
aminoglycoside	22818872	4	O
,	22818872	4	O
G418	22818872	4	O
.	22818872	4	O

Origins	22916206	0	O
of	22916206	0	O
albino	22916206	0	O
and	22916206	0	O
hooded	22916206	0	O
rats	22916206	0	O
:	22916206	0	O
implications	22916206	0	O
from	22916206	0	O
molecular	22916206	0	O
genetic	22916206	0	O
analysis	22916206	0	O
across	22916206	0	O
modern	22916206	0	O
laboratory	22916206	0	O
rat	22916206	0	O
strains	22916206	0	O
.	22916206	0	O
Albino	22916206	0	O
and	22916206	0	O
hooded	22916206	0	O
(	22916206	0	O
or	22916206	0	O
piebald	22916206	0	O
)	22916206	0	O
rats	22916206	0	O
are	22916206	0	O
one	22916206	0	O
of	22916206	0	O
the	22916206	0	O
most	22916206	0	O
frequently	22916206	0	O
used	22916206	0	O
laboratory	22916206	0	O
animals	22916206	0	O
for	22916206	0	O
the	22916206	0	O
past	22916206	0	O
150	22916206	0	O
years	22916206	0	O
.	22916206	0	O
Despite	22916206	0	O
this	22916206	0	O
fact	22916206	0	O
,	22916206	0	O
the	22916206	0	O
origin	22916206	0	O
of	22916206	0	O
the	22916206	0	O
albino	22916206	0	O
mutation	22916206	0	O
as	22916206	0	O
well	22916206	0	O
as	22916206	0	O
the	22916206	0	O
genetic	22916206	0	O
basis	22916206	0	O
of	22916206	0	O
the	22916206	0	O
hooded	22916206	0	O
phenotype	22916206	0	O
remained	22916206	0	O
unclear	22916206	0	O
.	22916206	0	O
Recently	22916206	0	O
,	22916206	0	O
the	22916206	0	O
albino	22916206	0	O
mutation	22916206	0	O
has	22916206	0	O
been	22916206	0	O
identified	22916206	0	O
as	22916206	0	B-Reg
the	22916206	0	O
Arg299His	22916206	0	B-Var
missense	22916206	0	I-Var
mutation	22916206	0	I-Var
in	22916206	0	O
the	22916206	0	O
Tyrosinase	22916206	0	B-Gene
gene	22916206	0	I-Gene
and	22916206	0	O
the	22916206	0	O
hooded	22916206	0	O
(	22916206	0	O
H	22916206	0	O
)	22916206	0	O
locus	22916206	0	O
has	22916206	0	O
been	22916206	0	O
mapped	22916206	0	O
to	22916206	0	O
the	22916206	0	O
460	22916206	0	O
-	22916206	0	O
kb	22916206	0	O
region	22916206	0	O
in	22916206	0	O
which	22916206	0	O
only	22916206	0	O
the	22916206	0	O
Kit	22916206	0	O
gene	22916206	0	O
exists	22916206	0	O
.	22916206	0	O
Here	22916206	0	O
,	22916206	0	O
we	22916206	0	O
surveyed	22916206	0	O
172	22916206	0	O
laboratory	22916206	0	O
rat	22916206	0	O
strains	22916206	0	O
for	22916206	0	O
the	22916206	0	O
albino	22916206	0	O
mutation	22916206	0	O
and	22916206	0	O
the	22916206	0	O
hooded	22916206	0	O
(	22916206	0	O
h	22916206	0	O
)	22916206	0	O
mutation	22916206	0	O
that	22916206	0	O
we	22916206	0	O
identified	22916206	0	O
by	22916206	0	O
positional	22916206	0	O
cloning	22916206	0	O
approach	22916206	0	O
to	22916206	0	O
investigate	22916206	0	O
possible	22916206	0	O
genetic	22916206	0	O
roots	22916206	0	O
and	22916206	0	O
relationships	22916206	0	O
of	22916206	0	O
albino	22916206	0	O
and	22916206	0	O
hooded	22916206	0	O
rats	22916206	0	O
.	22916206	0	O
All	22916206	0	O
of	22916206	0	O
117	22916206	0	O
existing	22916206	0	O
laboratory	22916206	0	O
albino	22916206	0	O
rats	22916206	0	O
shared	22916206	0	O
the	22916206	0	O
same	22916206	0	O
albino	22916206	0	O
missense	22916206	0	O
mutation	22916206	0	O
,	22916206	0	O
indicating	22916206	0	O
they	22916206	0	O
had	22916206	0	O
only	22916206	0	O
one	22916206	0	O
single	22916206	0	O
ancestor	22916206	0	O
.	22916206	0	O
Genetic	22916206	0	O
fine	22916206	0	O
mapping	22916206	0	O
followed	22916206	0	O
by	22916206	0	O
de	22916206	0	O
novo	22916206	0	O
sequencing	22916206	0	O
of	22916206	0	O
BAC	22916206	0	O
inserts	22916206	0	O
covering	22916206	0	O
the	22916206	0	O
H	22916206	0	O
locus	22916206	0	O
revealed	22916206	0	O
that	22916206	0	O
an	22916206	0	O
endogenous	22916206	0	O
retrovirus	22916206	0	O
(	22916206	0	O
ERV	22916206	0	O
)	22916206	0	O
element	22916206	0	O
was	22916206	0	O
inserted	22916206	0	O
into	22916206	0	O
the	22916206	0	O
first	22916206	0	O
intron	22916206	0	O
of	22916206	0	O
the	22916206	0	O
Kit	22916206	0	O
gene	22916206	0	O
where	22916206	0	O
the	22916206	0	O
hooded	22916206	0	O
allele	22916206	0	O
maps	22916206	0	O
.	22916206	0	O
A	22916206	0	O
solitary	22916206	0	O
long	22916206	0	O
terminal	22916206	0	O
repeat	22916206	0	O
(	22916206	0	O
LTR	22916206	0	O
)	22916206	0	O
was	22916206	0	O
found	22916206	0	O
at	22916206	0	O
the	22916206	0	O
same	22916206	0	O
position	22916206	0	O
to	22916206	0	O
the	22916206	0	O
ERV	22916206	0	O
insertion	22916206	0	O
in	22916206	0	O
another	22916206	0	O
allele	22916206	0	O
of	22916206	0	O
the	22916206	0	O
H	22916206	0	O
locus	22916206	0	O
,	22916206	0	O
which	22916206	0	O
causes	22916206	0	O
the	22916206	0	O
so	22916206	0	O
called	22916206	0	O
Irish	22916206	0	O
(	22916206	0	O
h	22916206	0	O
(	22916206	0	O
i	22916206	0	O
)	22916206	0	O
)	22916206	0	O
phenotype	22916206	0	O
.	22916206	0	O
The	22916206	0	O
ERV	22916206	0	O
and	22916206	0	O
the	22916206	0	O
solitary	22916206	0	O
LTR	22916206	0	O
insertions	22916206	0	O
were	22916206	0	O
completely	22916206	0	O
associated	22916206	0	O
with	22916206	0	O
the	22916206	0	O
hooded	22916206	0	O
and	22916206	0	O
Irish	22916206	0	O
coat	22916206	0	O
patterns	22916206	0	O
,	22916206	0	O
respectively	22916206	0	O
,	22916206	0	O
across	22916206	0	O
all	22916206	0	O
colored	22916206	0	O
rat	22916206	0	O
strains	22916206	0	O
examined	22916206	0	O
.	22916206	0	O
Interestingly	22916206	0	O
,	22916206	0	O
all	22916206	0	O
117	22916206	0	O
albino	22916206	0	O
rat	22916206	0	O
strains	22916206	0	O
shared	22916206	0	O
the	22916206	0	O
ERV	22916206	0	O
insertion	22916206	0	O
without	22916206	0	O
any	22916206	0	O
exception	22916206	0	O
,	22916206	0	O
which	22916206	0	O
strongly	22916206	0	O
suggests	22916206	0	O
that	22916206	0	O
the	22916206	0	O
albino	22916206	0	O
mutation	22916206	0	O
had	22916206	0	O
originally	22916206	0	O
occurred	22916206	0	O
in	22916206	0	O
hooded	22916206	0	O
rats	22916206	0	O
.	22916206	0	O

Identification	23023219	3	O
of	23023219	3	O
a	23023219	3	O
novel	23023219	3	O
arylsulfatase	23023219	3	B-Gene
B	23023219	3	I-Gene
gene	23023219	3	I-Gene
mutation	23023219	3	B-Var
in	23023219	3	B-Reg
three	23023219	3	O
unrelated	23023219	3	O
Iranian	23023219	3	O
mucopolysaccharidosis	23023219	3	B-Disease
type	23023219	3	I-Disease
-	23023219	3	I-Disease
VI	23023219	3	I-Disease
patients	23023219	3	O
with	23023219	3	O
different	23023219	3	O
phenotype	23023219	3	O
severity	23023219	3	O
.	23023219	3	O
BACKGROUND	23023219	3	O
:	23023219	3	O
Mucopolysaccharidosis	23023219	3	B-Disease
type	23023219	3	I-Disease
-	23023219	3	I-Disease
VI	23023219	3	I-Disease
(	23023219	3	O
MPS	23023219	3	O
-	23023219	3	O
VI	23023219	3	O
)	23023219	3	O
,	23023219	3	O
which	23023219	3	O
is	23023219	3	O
inherited	23023219	3	O
as	23023219	3	O
an	23023219	3	O
autosomal	23023219	3	O
recessive	23023219	3	O
trait	23023219	3	O
,	23023219	3	O
results	23023219	3	B-Reg
from	23023219	3	I-Reg
the	23023219	3	O
deficiency	23023219	3	B-NegReg
of	23023219	3	O
N	23023219	3	O
-	23023219	3	O
acetylgalactosamine	23023219	3	O
4	23023219	3	O
-	23023219	3	O
sulfatase	23023219	3	O
(	23023219	3	O
arylsulfatase	23023219	3	O
B	23023219	3	O
)	23023219	3	O
activity	23023219	3	O
and	23023219	3	O
the	23023219	3	O
lysosomal	23023219	3	O
accumulation	23023219	3	B-PosReg
of	23023219	3	O
dermatan	23023219	3	O
sulfate	23023219	3	O
.	23023219	3	O
In	23023219	3	O
this	23023219	3	O
study	23023219	3	O
,	23023219	3	O
ARSB	23023219	3	O
mutation	23023219	3	O
analysis	23023219	3	O
was	23023219	3	O
performed	23023219	3	O
on	23023219	3	O
three	23023219	3	O
unrelated	23023219	3	O
patients	23023219	3	O
who	23023219	3	O
were	23023219	3	O
originally	23023219	3	O
from	23023219	3	O
the	23023219	3	O
West	23023219	3	O
Azerbaijan	23023219	3	O
province	23023219	3	O
of	23023219	3	O
Iran	23023219	3	O
.	23023219	3	O
METHODS	23023219	3	O
:	23023219	3	O
After	23023219	3	O
PCR	23023219	3	O
and	23023219	3	O
direct	23023219	3	O
DNA	23023219	3	O
sequencing	23023219	3	O
,	23023219	3	O
DNA	23023219	3	O
extraction	23023219	3	O
was	23023219	3	O
performed	23023219	3	O
.	23023219	3	O
RESULTS	23023219	3	O
:	23023219	3	O
Sequencing	23023219	3	O
analysis	23023219	3	O
revealed	23023219	3	O
a	23023219	3	O
novel	23023219	3	O
homozygous	23023219	3	O
missense	23023219	3	O
mutation	23023219	3	O
in	23023219	3	O
the	23023219	3	O
ARSB	23023219	3	O
gene	23023219	3	O
at	23023219	3	O
c.1457	23023219	3	O
A	23023219	3	O
<	23023219	3	O
G	23023219	3	O
[	23023219	3	O
p.D486V	23023219	3	O
]	23023219	3	O
in	23023219	3	O
three	23023219	3	O
unrelated	23023219	3	O
Iranian	23023219	3	O
MPS	23023219	3	O
-	23023219	3	O
VI	23023219	3	O
patients	23023219	3	O
with	23023219	3	O
different	23023219	3	O
phenotype	23023219	3	O
severity	23023219	3	O
.	23023219	3	O
CONCLUSION	23023219	3	O
:	23023219	3	O
The	23023219	3	O
mutation	23023219	3	O
type	23023219	3	O
in	23023219	3	O
three	23023219	3	O
patients	23023219	3	O
was	23023219	3	O
the	23023219	3	O
same	23023219	3	O
;	23023219	3	O
probably	23023219	3	O
,	23023219	3	O
because	23023219	3	O
of	23023219	3	O
a	23023219	3	O
foundation	23023219	3	O
effect	23023219	3	O
on	23023219	3	O
their	23023219	3	O
population	23023219	3	O
.	23023219	3	O

C.	23072184	4	O
428	23072184	4	O
_451	23072184	4	O
dup	23072184	4	O
(	23072184	4	O
24	23072184	4	O
bp	23072184	4	O
)	23072184	4	O
mutation	23072184	4	O
of	23072184	4	O
the	23072184	4	O
ARX	23072184	4	O
gene	23072184	4	O
detected	23072184	4	O
in	23072184	4	O
a	23072184	4	O
Turkish	23072184	4	O
family	23072184	4	O
.	23072184	4	O
ARX	23072184	4	B-Gene
mutations	23072184	4	B-Var
give	23072184	4	B-Reg
rise	23072184	4	I-Reg
to	23072184	4	I-Reg
both	23072184	4	O
syndromic	23072184	4	O
and	23072184	4	O
nonsyndromic	23072184	4	O
forms	23072184	4	O
of	23072184	4	O
mental	23072184	4	B-Disease
retardation	23072184	4	I-Disease
(	23072184	4	O
MR	23072184	4	O
)	23072184	4	O
.	23072184	4	O
We	23072184	4	O
investigated	23072184	4	O
the	23072184	4	O
most	23072184	4	O
common	23072184	4	O
ARX	23072184	4	O
mutations	23072184	4	O
,	23072184	4	O
c.428	23072184	4	O
_451	23072184	4	O
dup	23072184	4	O
(	23072184	4	O
24	23072184	4	O
bp	23072184	4	O
)	23072184	4	O
and	23072184	4	O
c.333	23072184	4	O
ins	23072184	4	O
(	23072184	4	O
GCG	23072184	4	O
)	23072184	4	O
7	23072184	4	O
in	23072184	4	O
a	23072184	4	O
series	23072184	4	O
of	23072184	4	O
370	23072184	4	O
mentally	23072184	4	O
retarded	23072184	4	O
FMR1	23072184	4	O
(	23072184	4	O
CGG	23072184	4	O
)	23072184	4	O
n	23072184	4	O
expansion	23072184	4	O
mutation	23072184	4	O
negative	23072184	4	O
Turkish	23072184	4	O
patients	23072184	4	O
using	23072184	4	O
PCR	23072184	4	O
amplification	23072184	4	O
and	23072184	4	O
high	23072184	4	O
resolution	23072184	4	O
MetaPhor	23072184	4	O
agarose	23072184	4	O
gel	23072184	4	O
electrophoresis	23072184	4	O
.	23072184	4	O
Sequence	23072184	4	O
analysis	23072184	4	O
was	23072184	4	O
also	23072184	4	O
performed	23072184	4	O
for	23072184	4	O
confirmation	23072184	4	O
and	23072184	4	O
discrimination	23072184	4	O
of	23072184	4	O
the	23072184	4	O
mutations	23072184	4	O
.	23072184	4	O
One	23072184	4	O
patient	23072184	4	O
representing	23072184	4	O
non	23072184	4	O
-	23072184	4	O
syndromic	23072184	4	O
X	23072184	4	O
-	23072184	4	O
linked	23072184	4	O
MR	23072184	4	B-Disease
showed	23072184	4	B-Reg
an	23072184	4	O
abnormal	23072184	4	O
band	23072184	4	O
pattern	23072184	4	O
on	23072184	4	O
agarose	23072184	4	O
gel	23072184	4	O
and	23072184	4	O
sequence	23072184	4	O
analysis	23072184	4	O
of	23072184	4	O
exon	23072184	4	O
2	23072184	4	O
of	23072184	4	O
the	23072184	4	O
ARX	23072184	4	B-Gene
gene	23072184	4	O
revealed	23072184	4	O
that	23072184	4	O
the	23072184	4	O
patient	23072184	4	O
had	23072184	4	O
the	23072184	4	O
c.428	23072184	4	B-Var
_451	23072184	4	I-Var
dup	23072184	4	I-Var
(	23072184	4	I-Var
24	23072184	4	I-Var
bp	23072184	4	I-Var
)	23072184	4	I-Var
mutation	23072184	4	O
.	23072184	4	O
When	23072184	4	O
we	23072184	4	O
screened	23072184	4	O
the	23072184	4	O
family	23072184	4	O
members	23072184	4	O
,	23072184	4	O
we	23072184	4	O
found	23072184	4	O
that	23072184	4	O
his	23072184	4	O
sister	23072184	4	O
and	23072184	4	O
mother	23072184	4	O
were	23072184	4	O
also	23072184	4	O
carrier	23072184	4	O
for	23072184	4	O
the	23072184	4	O
same	23072184	4	O
mutation	23072184	4	O
.	23072184	4	O
The	23072184	4	O
proband	23072184	4	O
showed	23072184	4	O
mild	23072184	4	O
MR	23072184	4	O
and	23072184	4	O
subtle	23072184	4	O
clinical	23072184	4	O
findings	23072184	4	O
like	23072184	4	O
dysarthria	23072184	4	O
and	23072184	4	O
lack	23072184	4	O
of	23072184	4	O
fine	23072184	4	O
motor	23072184	4	O
functions	23072184	4	O
.	23072184	4	O
In	23072184	4	O
conclusion	23072184	4	O
,	23072184	4	O
the	23072184	4	O
patients	23072184	4	O
with	23072184	4	O
weak	23072184	4	O
fine	23072184	4	O
motor	23072184	4	O
skills	23072184	4	O
and	23072184	4	O
positive	23072184	4	O
family	23072184	4	O
history	23072184	4	O
for	23072184	4	O
X	23072184	4	O
-	23072184	4	O
linked	23072184	4	O
MR	23072184	4	O
should	23072184	4	O
be	23072184	4	O
screened	23072184	4	O
for	23072184	4	O
the	23072184	4	O
most	23072184	4	O
common	23072184	4	O
ARX	23072184	4	O
gene	23072184	4	O
mutations	23072184	4	O
.	23072184	4	O

Analysis	23247051	4	O
of	23247051	4	O
a	23247051	4	O
Chinese	23247051	4	O
pedigree	23247051	4	O
with	23247051	4	O
Zellweger	23247051	4	B-Disease
syndrome	23247051	4	I-Disease
reveals	23247051	4	B-Reg
a	23247051	4	O
novel	23247051	4	O
PEX1	23247051	4	B-Gene
mutation	23247051	4	B-Var
by	23247051	4	O
next	23247051	4	O
-	23247051	4	O
generation	23247051	4	O
sequencing	23247051	4	O
.	23247051	4	O
BACKGROUND	23247051	4	O
:	23247051	4	O
Autosomal	23247051	4	O
recessive	23247051	4	O
Zellweger	23247051	4	B-Disease
spectrum	23247051	4	I-Disease
disorder	23247051	4	I-Disease
(	23247051	4	O
ZSD	23247051	4	O
)	23247051	4	O
,	23247051	4	O
the	23247051	4	O
main	23247051	4	O
subgroup	23247051	4	O
of	23247051	4	O
the	23247051	4	O
peroxisome	23247051	4	O
biogenesis	23247051	4	O
disorders	23247051	4	O
(	23247051	4	O
PBDs	23247051	4	O
)	23247051	4	O
,	23247051	4	O
can	23247051	4	O
be	23247051	4	O
caused	23247051	4	B-Reg
by	23247051	4	I-Reg
mutations	23247051	4	B-Var
in	23247051	4	O
any	23247051	4	O
of	23247051	4	O
the	23247051	4	O
13	23247051	4	O
PEX	23247051	4	B-Gene
genes	23247051	4	O
.	23247051	4	O
Zellweger	23247051	4	O
syndrome	23247051	4	O
(	23247051	4	O
ZS	23247051	4	O
)	23247051	4	O
is	23247051	4	O
the	23247051	4	O
most	23247051	4	O
common	23247051	4	O
and	23247051	4	O
severe	23247051	4	O
phenotype	23247051	4	O
in	23247051	4	O
the	23247051	4	O
heterogeneous	23247051	4	O
ZSD	23247051	4	O
.	23247051	4	O
For	23247051	4	O
the	23247051	4	O
large	23247051	4	O
number	23247051	4	O
genes	23247051	4	O
involved	23247051	4	O
,	23247051	4	O
it	23247051	4	O
is	23247051	4	O
difficult	23247051	4	O
to	23247051	4	O
make	23247051	4	O
a	23247051	4	O
precise	23247051	4	O
genetic	23247051	4	O
diagnosis	23247051	4	O
by	23247051	4	O
traditional	23247051	4	O
methods	23247051	4	O
at	23247051	4	O
a	23247051	4	O
time	23247051	4	O
.	23247051	4	O
A	23247051	4	O
combination	23247051	4	O
of	23247051	4	O
enrichment	23247051	4	O
of	23247051	4	O
targeted	23247051	4	O
genes	23247051	4	O
and	23247051	4	O
next	23247051	4	O
-	23247051	4	O
generation	23247051	4	O
sequencing	23247051	4	O
(	23247051	4	O
NGS	23247051	4	O
)	23247051	4	O
would	23247051	4	O
result	23247051	4	O
in	23247051	4	O
both	23247051	4	O
high	23247051	4	O
efficiency	23247051	4	O
and	23247051	4	O
low	23247051	4	O
cost	23247051	4	O
for	23247051	4	O
targeted	23247051	4	O
sequencing	23247051	4	O
of	23247051	4	O
genes	23247051	4	O
of	23247051	4	O
interest	23247051	4	O
.	23247051	4	O
METHODS	23247051	4	O
:	23247051	4	O
To	23247051	4	O
identify	23247051	4	O
potential	23247051	4	O
mutations	23247051	4	O
in	23247051	4	O
a	23247051	4	O
Chinese	23247051	4	O
family	23247051	4	O
associated	23247051	4	O
with	23247051	4	O
Zellweger	23247051	4	O
syndrome	23247051	4	O
,	23247051	4	O
1930	23247051	4	O
kb	23247051	4	O
of	23247051	4	O
all	23247051	4	O
the	23247051	4	O
targeted	23247051	4	O
region	23247051	4	O
of	23247051	4	O
PEX	23247051	4	O
genes	23247051	4	O
were	23247051	4	O
captured	23247051	4	O
and	23247051	4	O
sequenced	23247051	4	O
using	23247051	4	O
NGS	23247051	4	O
.	23247051	4	O
We	23247051	4	O
also	23247051	4	O
performed	23247051	4	O
Sanger	23247051	4	O
sequencing	23247051	4	O
to	23247051	4	O
validate	23247051	4	O
the	23247051	4	O
NGS	23247051	4	O
results	23247051	4	O
.	23247051	4	O
RESULTS	23247051	4	O
:	23247051	4	O
Here	23247051	4	O
,	23247051	4	O
we	23247051	4	O
reported	23247051	4	O
a	23247051	4	O
Chinese	23247051	4	O
patient	23247051	4	O
diagnosed	23247051	4	O
as	23247051	4	O
a	23247051	4	O
severe	23247051	4	O
classic	23247051	4	O
type	23247051	4	O
of	23247051	4	O
PBD	23247051	4	O
based	23247051	4	O
on	23247051	4	O
a	23247051	4	O
clinical	23247051	4	O
investigation	23247051	4	O
.	23247051	4	O
We	23247051	4	O
then	23247051	4	O
performed	23247051	4	O
microarray	23247051	4	O
-	23247051	4	O
based	23247051	4	O
NGS	23247051	4	O
to	23247051	4	O
detect	23247051	4	O
the	23247051	4	O
variants	23247051	4	O
in	23247051	4	O
PEX	23247051	4	O
genes	23247051	4	O
of	23247051	4	O
the	23247051	4	O
whole	23247051	4	O
family	23247051	4	O
.	23247051	4	O
One	23247051	4	O
reported	23247051	4	O
heterozygosis	23247051	4	O
mutation	23247051	4	O
(	23247051	4	O
c.782	23247051	4	O
_783delAA	23247051	4	O
)	23247051	4	O
was	23247051	4	O
identified	23247051	4	O
in	23247051	4	O
the	23247051	4	O
patient	23247051	4	O
'	23247051	4	O
s	23247051	4	O
father	23247051	4	O
and	23247051	4	O
one	23247051	4	O
novel	23247051	4	O
heterozygosis	23247051	4	O
missense	23247051	4	O
mutation	23247051	4	O
(	23247051	4	O
c.475	23247051	4	O
G	23247051	4	O
>	23247051	4	O
C	23247051	4	O
)	23247051	4	O
was	23247051	4	O
found	23247051	4	O
in	23247051	4	O
the	23247051	4	O
patient	23247051	4	O
'	23247051	4	O
s	23247051	4	O
mother	23247051	4	O
,	23247051	4	O
the	23247051	4	O
patient	23247051	4	O
inherited	23247051	4	O
both	23247051	4	O
mutations	23247051	4	O
.	23247051	4	O
CONCLUSIONS	23247051	4	O
:	23247051	4	O
The	23247051	4	O
results	23247051	4	O
proved	23247051	4	O
that	23247051	4	O
the	23247051	4	O
application	23247051	4	O
of	23247051	4	O
target	23247051	4	O
sequence	23247051	4	O
capture	23247051	4	O
using	23247051	4	O
chip	23247051	4	O
and	23247051	4	O
high	23247051	4	O
-	23247051	4	O
throughput	23247051	4	O
NGS	23247051	4	O
is	23247051	4	O
a	23247051	4	O
valuable	23247051	4	O
tool	23247051	4	O
for	23247051	4	O
the	23247051	4	O
molecular	23247051	4	O
diagnosis	23247051	4	O
of	23247051	4	O
peroxisome	23247051	4	O
biogenesis	23247051	4	O
disorders	23247051	4	O
.	23247051	4	O
The	23247051	4	O
accuracy	23247051	4	O
,	23247051	4	O
high	23247051	4	O
-	23247051	4	O
throughput	23247051	4	O
and	23247051	4	O
speed	23247051	4	O
of	23247051	4	O
the	23247051	4	O
method	23247051	4	O
make	23247051	4	O
it	23247051	4	O
suitable	23247051	4	O
for	23247051	4	O
clinical	23247051	4	O
application	23247051	4	O
.	23247051	4	O

Aspartylglucosaminuria	23271757	4	B-Disease
:	23271757	4	I-Disease
unusual	23271757	4	O
neonatal	23271757	4	O
presentation	23271757	4	O
in	23271757	4	O
Qatari	23271757	4	O
twins	23271757	4	O
with	23271757	4	B-Reg
a	23271757	4	O
novel	23271757	4	O
aspartylglucosaminidase	23271757	4	B-Gene
gene	23271757	4	I-Gene
mutation	23271757	4	B-Var
and	23271757	4	O
3	23271757	4	O
new	23271757	4	O
cases	23271757	4	O
in	23271757	4	O
a	23271757	4	O
Turkish	23271757	4	O
family	23271757	4	O
.	23271757	4	O
Aspartylglucosaminuria	23271757	4	O
is	23271757	4	O
a	23271757	4	O
rare	23271757	4	O
autosomal	23271757	4	O
recessive	23271757	4	O
lysosomal	23271757	4	O
storage	23271757	4	O
disorder	23271757	4	O
leading	23271757	4	O
early	23271757	4	O
to	23271757	4	O
a	23271757	4	O
progressive	23271757	4	O
intellectual	23271757	4	O
disability	23271757	4	O
.	23271757	4	O
Monozygous	23271757	4	O
Qatari	23271757	4	O
twins	23271757	4	O
presented	23271757	4	O
with	23271757	4	O
an	23271757	4	O
unusual	23271757	4	O
perinatal	23271757	4	O
manifestation	23271757	4	O
characterized	23271757	4	O
by	23271757	4	O
severe	23271757	4	O
muscular	23271757	4	O
hypotonia	23271757	4	O
,	23271757	4	O
scarce	23271757	4	O
spontaneous	23271757	4	O
movements	23271757	4	O
,	23271757	4	O
multiple	23271757	4	O
contractures	23271757	4	O
,	23271757	4	O
and	23271757	4	O
respiratory	23271757	4	O
insufficiency	23271757	4	O
.	23271757	4	O
Biochemical	23271757	4	O
investigations	23271757	4	O
suggested	23271757	4	B-Reg
aspartylglucosaminuria	23271757	4	B-Disease
,	23271757	4	O
and	23271757	4	O
a	23271757	4	O
novel	23271757	4	O
homozygous	23271757	4	O
mutation	23271757	4	O
c.439	23271757	4	B-Var
T	23271757	4	I-Var
>	23271757	4	I-Var
C	23271757	4	I-Var
(	23271757	4	O
p.S147P	23271757	4	O
)	23271757	4	O
was	23271757	4	O
found	23271757	4	O
in	23271757	4	O
the	23271757	4	O
aspartylglucosaminidase	23271757	4	B-Gene
gene	23271757	4	I-Gene
.	23271757	4	O
However	23271757	4	O
,	23271757	4	O
it	23271757	4	O
cannot	23271757	4	O
be	23271757	4	O
excluded	23271757	4	O
that	23271757	4	O
the	23271757	4	O
unusual	23271757	4	O
neonatal	23271757	4	O
presentation	23271757	4	O
is	23271757	4	O
due	23271757	4	O
to	23271757	4	O
an	23271757	4	O
additional	23271757	4	O
autosomal	23271757	4	O
recessive	23271757	4	O
disease	23271757	4	O
in	23271757	4	O
this	23271757	4	O
multiply	23271757	4	O
consanguineous	23271757	4	O
family	23271757	4	O
.	23271757	4	O
The	23271757	4	O
classical	23271757	4	O
aspartylglucosaminuria	23271757	4	O
phenotype	23271757	4	O
(	23271757	4	O
progressive	23271757	4	O
speech	23271757	4	O
delay	23271757	4	O
,	23271757	4	O
psychomotor	23271757	4	O
retardation	23271757	4	O
,	23271757	4	O
and	23271757	4	O
behavioral	23271757	4	O
abnormalities	23271757	4	O
)	23271757	4	O
was	23271757	4	O
observed	23271757	4	O
in	23271757	4	O
3	23271757	4	O
Turkish	23271757	4	O
siblings	23271757	4	O
.	23271757	4	O
Although	23271757	4	O
aspartylglucosaminuria	23271757	4	O
was	23271757	4	O
suspected	23271757	4	O
early	23271757	4	O
,	23271757	4	O
the	23271757	4	O
definite	23271757	4	O
diagnosis	23271757	4	O
was	23271757	4	O
not	23271757	4	O
confirmed	23271757	4	O
until	23271757	4	O
the	23271757	4	O
age	23271757	4	O
of	23271757	4	O
18	23271757	4	O
years	23271757	4	O
.	23271757	4	O
A	23271757	4	O
novel	23271757	4	O
homozygous	23271757	4	O
mutation	23271757	4	O
c.346	23271757	4	O
C	23271757	4	O
>	23271757	4	O
T	23271757	4	O
(	23271757	4	O
p.R116W	23271757	4	O
)	23271757	4	O
was	23271757	4	O
found	23271757	4	O
.	23271757	4	O
These	23271757	4	O
5	23271757	4	O
cases	23271757	4	O
emphasize	23271757	4	O
that	23271757	4	O
aspartylglucosaminuria	23271757	4	O
is	23271757	4	O
panethnic	23271757	4	O
and	23271757	4	O
may	23271757	4	O
possibly	23271757	4	O
present	23271757	4	O
with	23271757	4	O
prenatal	23271757	4	O
manifestation	23271757	4	O
.	23271757	4	O
Screening	23271757	4	O
for	23271757	4	O
aspartylglucosaminuria	23271757	4	O
should	23271757	4	O
be	23271757	4	O
done	23271757	4	O
in	23271757	4	O
all	23271757	4	O
patients	23271757	4	O
with	23271757	4	O
unexplained	23271757	4	O
psychomotor	23271757	4	O
retardation	23271757	4	O
.	23271757	4	O

Mutations	23329183	4	O
of	23329183	4	O
the	23329183	4	O
thyroid	23329183	4	O
peroxidase	23329183	4	O
gene	23329183	4	O
in	23329183	4	O
Chinese	23329183	4	O
siblings	23329183	4	O
with	23329183	4	O
congenital	23329183	4	O
goitrous	23329183	4	O
hypothyroidism	23329183	4	O
.	23329183	4	O
OBJECTIVES	23329183	4	O
:	23329183	4	O
To	23329183	4	O
investigate	23329183	4	O
thyroid	23329183	4	O
peroxidase	23329183	4	O
gene	23329183	4	O
(	23329183	4	B-Gene
TPO	23329183	4	I-Gene
)	23329183	4	I-Gene
mutations	23329183	4	B-Var
in	23329183	4	B-Reg
a	23329183	4	O
Chinese	23329183	4	O
siblings	23329183	4	O
with	23329183	4	O
congenital	23329183	4	B-Disease
goitrous	23329183	4	I-Disease
hypothyroidism	23329183	4	I-Disease
(	23329183	4	O
CGH	23329183	4	O
)	23329183	4	O
.	23329183	4	O
SUBJECTS	23329183	4	O
AND	23329183	4	O
METHODS	23329183	4	O
:	23329183	4	O
The	23329183	4	O
proband	23329183	4	O
,	23329183	4	O
his	23329183	4	O
sister	23329183	4	O
,	23329183	4	O
and	23329183	4	O
their	23329183	4	O
parents	23329183	4	O
were	23329183	4	O
enrolled	23329183	4	O
.	23329183	4	O
All	23329183	4	O
subjects	23329183	4	O
underwent	23329183	4	O
clinical	23329183	4	O
examination	23329183	4	O
and	23329183	4	O
laboratory	23329183	4	O
tests	23329183	4	O
.	23329183	4	O
Mutation	23329183	4	O
screening	23329183	4	O
of	23329183	4	O
the	23329183	4	O
TPO	23329183	4	O
gene	23329183	4	O
was	23329183	4	O
performed	23329183	4	O
by	23329183	4	O
sequencing	23329183	4	O
fragments	23329183	4	O
amplified	23329183	4	O
from	23329183	4	O
extracted	23329183	4	O
genomic	23329183	4	O
DNA	23329183	4	O
.	23329183	4	O
RESULTS	23329183	4	O
:	23329183	4	O
The	23329183	4	O
siblings	23329183	4	O
were	23329183	4	O
diagnosed	23329183	4	O
as	23329183	4	O
CGH	23329183	4	O
with	23329183	4	O
neurodevelopmental	23329183	4	O
deficits	23329183	4	O
.	23329183	4	O
Two	23329183	4	O
compound	23329183	4	O
heterozygous	23329183	4	O
inactivating	23329183	4	O
mutations	23329183	4	O
were	23329183	4	O
found	23329183	4	O
in	23329183	4	O
the	23329183	4	O
two	23329183	4	O
patients	23329183	4	O
:	23329183	4	O
a	23329183	4	O
frameshift	23329183	4	O
mutation	23329183	4	O
between	23329183	4	O
positions	23329183	4	O
2268	23329183	4	O
and	23329183	4	O
2269	23329183	4	O
(	23329183	4	O
c.2268	23329183	4	O
-	23329183	4	O
2269	23329183	4	O
insT	23329183	4	O
)	23329183	4	O
and	23329183	4	O
a	23329183	4	O
missense	23329183	4	O
mutation	23329183	4	O
at	23329183	4	O
c.2089	23329183	4	O
G	23329183	4	O
>	23329183	4	O
A	23329183	4	O
(	23329183	4	O
p.G667S	23329183	4	O
)	23329183	4	O
of	23329183	4	O
the	23329183	4	O
TPO	23329183	4	O
gene	23329183	4	O
.	23329183	4	O
Their	23329183	4	O
parents	23329183	4	O
,	23329183	4	O
with	23329183	4	O
normal	23329183	4	O
thyroid	23329183	4	O
hormone	23329183	4	O
levels	23329183	4	O
,	23329183	4	O
were	23329183	4	O
heterozygous	23329183	4	O
for	23329183	4	O
mutations	23329183	4	O
c.2268	23329183	4	O
-	23329183	4	O
2269	23329183	4	O
insT	23329183	4	O
and	23329183	4	O
c.2089	23329183	4	O
G	23329183	4	O
>	23329183	4	O
A	23329183	4	O
,	23329183	4	O
respectively	23329183	4	O
.	23329183	4	O
The	23329183	4	O
polymorphisms	23329183	4	O
of	23329183	4	O
c.1207	23329183	4	O
G	23329183	4	O
>	23329183	4	O
T	23329183	4	O
,	23329183	4	O
c.1283	23329183	4	O
G	23329183	4	O
>	23329183	4	O
C	23329183	4	O
,	23329183	4	O
and	23329183	4	O
c.2088	23329183	4	O
C	23329183	4	O
>	23329183	4	O
T	23329183	4	O
were	23329183	4	O
detected	23329183	4	O
in	23329183	4	O
the	23329183	4	O
family	23329183	4	O
.	23329183	4	O
CONCLUSIONS	23329183	4	O
:	23329183	4	O
CGH	23329183	4	B-Disease
of	23329183	4	O
the	23329183	4	O
Chinese	23329183	4	O
siblings	23329183	4	O
was	23329183	4	O
due	23329183	4	B-Reg
to	23329183	4	I-Reg
the	23329183	4	O
TPO	23329183	4	B-Gene
gene	23329183	4	O
mutations	23329183	4	O
(	23329183	4	B-Var
c.2268	23329183	4	I-Var
-	23329183	4	I-Var
2269	23329183	4	I-Var
insT	23329183	4	I-Var
and	23329183	4	O
c.2089	23329183	4	B-Var
G	23329183	4	I-Var
>	23329183	4	I-Var
A	23329183	4	I-Var
)	23329183	4	I-Var
.	23329183	4	O

Nebulin	23443021	4	O
(	23443021	4	O
NEB	23443021	4	O
)	23443021	4	O
mutations	23443021	4	O
in	23443021	4	O
a	23443021	4	O
childhood	23443021	4	O
onset	23443021	4	O
distal	23443021	4	O
myopathy	23443021	4	O
with	23443021	4	O
rods	23443021	4	O
and	23443021	4	O
cores	23443021	4	O
uncovered	23443021	4	O
by	23443021	4	O
next	23443021	4	O
generation	23443021	4	O
sequencing	23443021	4	O
.	23443021	4	O
Recessive	23443021	4	O
nebulin	23443021	4	O
(	23443021	4	B-Gene
NEB	23443021	4	I-Gene
)	23443021	4	I-Gene
mutations	23443021	4	B-Var
are	23443021	4	O
a	23443021	4	O
common	23443021	4	O
cause	23443021	4	B-Reg
of	23443021	4	O
nemaline	23443021	4	B-Disease
myopathy	23443021	4	I-Disease
(	23443021	4	O
NM	23443021	4	O
)	23443021	4	O
,	23443021	4	O
typically	23443021	4	O
characterized	23443021	4	O
by	23443021	4	O
generalized	23443021	4	O
weakness	23443021	4	O
of	23443021	4	O
early	23443021	4	O
-	23443021	4	O
onset	23443021	4	O
and	23443021	4	O
nemaline	23443021	4	O
rods	23443021	4	O
on	23443021	4	O
muscle	23443021	4	O
biopsy	23443021	4	O
.	23443021	4	O
Exceptional	23443021	4	O
adult	23443021	4	O
cases	23443021	4	O
with	23443021	4	O
additional	23443021	4	O
cores	23443021	4	O
and	23443021	4	O
an	23443021	4	O
isolated	23443021	4	O
distal	23443021	4	O
weakness	23443021	4	O
have	23443021	4	O
been	23443021	4	O
reported	23443021	4	O
.	23443021	4	O
The	23443021	4	O
large	23443021	4	O
NEB	23443021	4	O
gene	23443021	4	O
with	23443021	4	O
183	23443021	4	O
exons	23443021	4	O
has	23443021	4	O
been	23443021	4	O
an	23443021	4	O
obstacle	23443021	4	O
for	23443021	4	O
the	23443021	4	O
genetic	23443021	4	O
work	23443021	4	O
-	23443021	4	O
up	23443021	4	O
.	23443021	4	O
Here	23443021	4	O
we	23443021	4	O
report	23443021	4	O
a	23443021	4	O
childhood	23443021	4	O
-	23443021	4	O
onset	23443021	4	O
case	23443021	4	O
with	23443021	4	O
distal	23443021	4	O
weakness	23443021	4	O
and	23443021	4	O
a	23443021	4	O
core	23443021	4	O
-	23443021	4	O
rod	23443021	4	O
myopathy	23443021	4	O
,	23443021	4	O
associated	23443021	4	O
with	23443021	4	O
recessive	23443021	4	O
NEB	23443021	4	O
mutations	23443021	4	O
identified	23443021	4	O
by	23443021	4	O
next	23443021	4	O
generation	23443021	4	O
sequencing	23443021	4	O
(	23443021	4	O
NGS	23443021	4	O
)	23443021	4	O
.	23443021	4	O
This	23443021	4	O
6	23443021	4	O
-	23443021	4	O
year	23443021	4	O
-	23443021	4	O
old	23443021	4	O
boy	23443021	4	O
presented	23443021	4	O
with	23443021	4	O
a	23443021	4	O
history	23443021	4	O
of	23443021	4	O
gross	23443021	4	O
-	23443021	4	O
motor	23443021	4	O
difficulties	23443021	4	O
following	23443021	4	O
a	23443021	4	O
normal	23443021	4	O
early	23443021	4	O
development	23443021	4	O
.	23443021	4	O
He	23443021	4	O
had	23443021	4	O
distal	23443021	4	O
leg	23443021	4	O
weakness	23443021	4	O
with	23443021	4	O
bilateral	23443021	4	O
foot	23443021	4	O
drop	23443021	4	O
,	23443021	4	O
as	23443021	4	O
well	23443021	4	O
as	23443021	4	O
axial	23443021	4	O
muscle	23443021	4	O
weakness	23443021	4	O
,	23443021	4	O
scoliosis	23443021	4	O
and	23443021	4	O
spinal	23443021	4	O
rigidity	23443021	4	O
;	23443021	4	O
additionally	23443021	4	O
he	23443021	4	O
required	23443021	4	O
nocturnal	23443021	4	O
respiratory	23443021	4	O
support	23443021	4	O
.	23443021	4	O
Muscle	23443021	4	O
magnetic	23443021	4	O
resonance	23443021	4	O
(	23443021	4	O
MR	23443021	4	O
)	23443021	4	O
imaging	23443021	4	O
showed	23443021	4	O
distal	23443021	4	O
involvement	23443021	4	O
in	23443021	4	O
the	23443021	4	O
medial	23443021	4	O
and	23443021	4	O
anterior	23443021	4	O
compartment	23443021	4	O
of	23443021	4	O
the	23443021	4	O
lower	23443021	4	O
leg	23443021	4	O
.	23443021	4	O
A	23443021	4	O
muscle	23443021	4	O
biopsy	23443021	4	O
featured	23443021	4	O
both	23443021	4	O
rods	23443021	4	O
and	23443021	4	O
cores	23443021	4	O
.	23443021	4	O
Initial	23443021	4	O
targeted	23443021	4	O
testing	23443021	4	O
identified	23443021	4	O
a	23443021	4	O
heterozygous	23443021	4	O
Nebulin	23443021	4	O
exon	23443021	4	O
55	23443021	4	O
deletion	23443021	4	O
.	23443021	4	O
Further	23443021	4	O
analysis	23443021	4	O
using	23443021	4	O
NGS	23443021	4	O
revealed	23443021	4	O
a	23443021	4	O
frameshifting	23443021	4	O
4	23443021	4	O
bp	23443021	4	O
duplication	23443021	4	O
,	23443021	4	O
c.24372	23443021	4	O
_24375dup	23443021	4	O
(	23443021	4	O
P.	23443021	4	O
Val8126fs	23443021	4	O
)	23443021	4	O
,	23443021	4	O
on	23443021	4	O
the	23443021	4	O
opposite	23443021	4	O
allele	23443021	4	O
.	23443021	4	O
This	23443021	4	O
case	23443021	4	O
illustrates	23443021	4	O
that	23443021	4	O
NEB	23443021	4	B-Gene
mutations	23443021	4	B-Var
can	23443021	4	O
cause	23443021	4	B-Reg
childhood	23443021	4	O
onset	23443021	4	O
distal	23443021	4	O
NM	23443021	4	B-Disease
,	23443021	4	O
with	23443021	4	O
additional	23443021	4	O
cores	23443021	4	O
on	23443021	4	O
muscle	23443021	4	O
biopsy	23443021	4	O
and	23443021	4	O
proves	23443021	4	O
the	23443021	4	O
diagnostic	23443021	4	O
utility	23443021	4	O
of	23443021	4	O
NGS	23443021	4	O
for	23443021	4	O
myopathies	23443021	4	O
,	23443021	4	O
particularly	23443021	4	O
when	23443021	4	O
large	23443021	4	O
genes	23443021	4	O
are	23443021	4	O
implicated	23443021	4	O
.	23443021	4	O

EDM1	23506586	4	O
:	23506586	4	O
a	23506586	4	O
novel	23506586	4	O
point	23506586	4	B-Var
mutation	23506586	4	I-Var
in	23506586	4	O
cartilage	23506586	4	O
oligomeric	23506586	4	O
matrix	23506586	4	O
protein	23506586	4	O
gene	23506586	4	O
in	23506586	4	O
a	23506586	4	O
Chinese	23506586	4	O
family	23506586	4	O
with	23506586	4	B-Reg
multiple	23506586	4	B-Disease
epiphyseal	23506586	4	I-Disease
dysplasia	23506586	4	I-Disease
.	23506586	4	O
BACKGROUND	23506586	4	O
:	23506586	4	O
Multiple	23506586	4	B-Disease
epiphysis	23506586	4	I-Disease
dysplasia	23506586	4	I-Disease
(	23506586	4	O
MED	23506586	4	O
)	23506586	4	O
is	23506586	4	O
a	23506586	4	O
common	23506586	4	O
skeletal	23506586	4	O
dysplasia	23506586	4	O
with	23506586	4	O
a	23506586	4	O
significant	23506586	4	O
locus	23506586	4	O
heterogeneity	23506586	4	O
.	23506586	4	O
In	23506586	4	B-Reg
the	23506586	4	O
majority	23506586	4	O
of	23506586	4	O
clinically	23506586	4	O
defined	23506586	4	O
cases	23506586	4	O
,	23506586	4	O
mutations	23506586	4	B-Var
have	23506586	4	O
been	23506586	4	O
identified	23506586	4	O
in	23506586	4	O
the	23506586	4	O
gene	23506586	4	O
encoding	23506586	4	O
cartilage	23506586	4	O
algometric	23506586	4	O
matrix	23506586	4	O
protein	23506586	4	O
(	23506586	4	B-Gene
COMP	23506586	4	I-Gene
)	23506586	4	I-Gene
.	23506586	4	O
METHODS	23506586	4	O
:	23506586	4	O
Five	23506586	4	O
patients	23506586	4	O
were	23506586	4	O
included	23506586	4	O
in	23506586	4	O
the	23506586	4	O
study	23506586	4	O
.	23506586	4	O
Linkage	23506586	4	O
analysis	23506586	4	O
and	23506586	4	O
mutation	23506586	4	O
analysis	23506586	4	O
of	23506586	4	O
the	23506586	4	O
COMP	23506586	4	O
gene	23506586	4	O
were	23506586	4	O
conducted	23506586	4	O
in	23506586	4	O
the	23506586	4	O
patients	23506586	4	O
and	23506586	4	O
their	23506586	4	O
family	23506586	4	O
members	23506586	4	O
.	23506586	4	O
RESULTS	23506586	4	O
:	23506586	4	O
We	23506586	4	O
have	23506586	4	O
identified	23506586	4	O
a	23506586	4	O
novel	23506586	4	O
mutation	23506586	4	O
in	23506586	4	O
axon	23506586	4	O
14	23506586	4	O
of	23506586	4	O
COMP	23506586	4	O
gene	23506586	4	O
in	23506586	4	O
the	23506586	4	O
family	23506586	4	O
.	23506586	4	O
CONCLUSIONS	23506586	4	O
:	23506586	4	O
This	23506586	4	O
mutation	23506586	4	O
produced	23506586	4	O
a	23506586	4	O
severe	23506586	4	O
MED	23506586	4	O
phenotype	23506586	4	O
with	23506586	4	O
marked	23506586	4	O
short	23506586	4	O
stature	23506586	4	O
,	23506586	4	O
early	23506586	4	O
onset	23506586	4	O
osteoarthritis	23506586	4	O
,	23506586	4	O
and	23506586	4	O
remarkable	23506586	4	O
radiographic	23506586	4	O
changes	23506586	4	O
.	23506586	4	O
Our	23506586	4	O
results	23506586	4	O
extended	23506586	4	O
the	23506586	4	O
range	23506586	4	O
of	23506586	4	O
disease	23506586	4	O
-	23506586	4	O
causing	23506586	4	O
mutations	23506586	4	O
in	23506586	4	O
COMP	23506586	4	O
gene	23506586	4	O
and	23506586	4	O
contributed	23506586	4	O
more	23506586	4	O
information	23506586	4	O
about	23506586	4	O
relationship	23506586	4	O
between	23506586	4	O
mutations	23506586	4	O
and	23506586	4	O
phenotype	23506586	4	O
.	23506586	4	O

A	23541687	4	O
patient	23541687	4	O
with	23541687	4	O
limb	23541687	4	B-Disease
girdle	23541687	4	I-Disease
muscular	23541687	4	I-Disease
dystrophy	23541687	4	I-Disease
carries	23541687	4	B-Reg
a	23541687	4	O
TRIM32	23541687	4	B-Gene
deletion	23541687	4	B-Var
,	23541687	4	O
detected	23541687	4	O
by	23541687	4	O
a	23541687	4	O
novel	23541687	4	O
CGH	23541687	4	O
array	23541687	4	O
,	23541687	4	O
in	23541687	4	O
compound	23541687	4	O
heterozygosis	23541687	4	O
with	23541687	4	O
a	23541687	4	O
nonsense	23541687	4	O
mutation	23541687	4	O
.	23541687	4	O
Limb	23541687	4	B-Disease
girdle	23541687	4	I-Disease
muscular	23541687	4	I-Disease
dystrophy	23541687	4	I-Disease
2	23541687	4	I-Disease
H	23541687	4	I-Disease
is	23541687	4	O
a	23541687	4	O
rare	23541687	4	O
autosomal	23541687	4	O
recessive	23541687	4	O
muscular	23541687	4	O
dystrophy	23541687	4	O
,	23541687	4	O
clinically	23541687	4	O
highly	23541687	4	O
variable	23541687	4	O
,	23541687	4	O
caused	23541687	4	B-Reg
by	23541687	4	I-Reg
mutations	23541687	4	B-Var
in	23541687	4	O
the	23541687	4	O
TRIM32	23541687	4	B-Gene
gene	23541687	4	O
.	23541687	4	O
Here	23541687	4	O
we	23541687	4	O
describe	23541687	4	O
a	23541687	4	O
35	23541687	4	O
-	23541687	4	O
years	23541687	4	O
-	23541687	4	O
old	23541687	4	O
who	23541687	4	O
experienced	23541687	4	O
progressive	23541687	4	O
muscle	23541687	4	O
weakness	23541687	4	O
.	23541687	4	O
The	23541687	4	O
muscle	23541687	4	O
biopsy	23541687	4	O
revealed	23541687	4	O
an	23541687	4	O
unspecific	23541687	4	O
pattern	23541687	4	O
of	23541687	4	O
atrophic	23541687	4	O
and	23541687	4	O
hypertrophic	23541687	4	O
fibers	23541687	4	O
;	23541687	4	O
the	23541687	4	O
immunohistochemistry	23541687	4	O
for	23541687	4	O
several	23541687	4	O
proteins	23541687	4	O
was	23541687	4	O
normal	23541687	4	O
.	23541687	4	O
Comparative	23541687	4	O
genomic	23541687	4	O
hybridization	23541687	4	O
(	23541687	4	O
CGH	23541687	4	O
)	23541687	4	O
analysis	23541687	4	O
showed	23541687	4	O
a	23541687	4	O
heterozygous	23541687	4	O
deletion	23541687	4	O
of	23541687	4	O
the	23541687	4	O
entire	23541687	4	O
TRIM32	23541687	4	O
gene	23541687	4	O
.	23541687	4	O
On	23541687	4	O
the	23541687	4	O
other	23541687	4	O
allele	23541687	4	O
we	23541687	4	O
identified	23541687	4	O
the	23541687	4	O
R316X	23541687	4	O
nonsense	23541687	4	O
mutation	23541687	4	O
.	23541687	4	O
The	23541687	4	O
genetic	23541687	4	O
diagnosis	23541687	4	O
of	23541687	4	O
LGMD2H	23541687	4	O
in	23541687	4	O
this	23541687	4	O
case	23541687	4	O
was	23541687	4	O
reached	23541687	4	O
by	23541687	4	O
using	23541687	4	O
a	23541687	4	O
novel	23541687	4	O
high	23541687	4	O
throughput	23541687	4	O
diagnostic	23541687	4	O
tool	23541687	4	O
.	23541687	4	O

Epigenetic	23719190	3	O
and	23719190	3	O
genetic	23719190	3	O
alterations	23719190	3	O
of	23719190	3	O
the	23719190	3	O
imprinting	23719190	3	O
disorder	23719190	3	O
Beckwith	23719190	3	O
-	23719190	3	O
Wiedemann	23719190	3	O
syndrome	23719190	3	O
and	23719190	3	O
related	23719190	3	O
disorders	23719190	3	O
.	23719190	3	O
Genomic	23719190	3	O
imprinting	23719190	3	O
is	23719190	3	O
an	23719190	3	O
epigenetic	23719190	3	O
phenomenon	23719190	3	O
that	23719190	3	O
leads	23719190	3	O
to	23719190	3	O
parent	23719190	3	O
-	23719190	3	O
specific	23719190	3	O
differential	23719190	3	O
expression	23719190	3	O
of	23719190	3	O
a	23719190	3	O
subset	23719190	3	O
of	23719190	3	O
genes	23719190	3	O
.	23719190	3	O
Most	23719190	3	O
imprinted	23719190	3	O
genes	23719190	3	O
form	23719190	3	O
clusters	23719190	3	O
,	23719190	3	O
or	23719190	3	O
imprinting	23719190	3	O
domains	23719190	3	O
,	23719190	3	O
and	23719190	3	O
are	23719190	3	O
regulated	23719190	3	O
by	23719190	3	O
imprinting	23719190	3	O
control	23719190	3	O
regions	23719190	3	O
.	23719190	3	O
As	23719190	3	O
imprinted	23719190	3	O
genes	23719190	3	O
have	23719190	3	O
an	23719190	3	O
important	23719190	3	O
role	23719190	3	O
in	23719190	3	O
growth	23719190	3	O
and	23719190	3	O
development	23719190	3	O
,	23719190	3	O
aberrant	23719190	3	O
expression	23719190	3	O
of	23719190	3	O
imprinted	23719190	3	O
genes	23719190	3	O
due	23719190	3	O
to	23719190	3	O
genetic	23719190	3	O
or	23719190	3	O
epigenetic	23719190	3	O
abnormalities	23719190	3	O
is	23719190	3	O
involved	23719190	3	O
in	23719190	3	O
the	23719190	3	O
pathogenesis	23719190	3	O
of	23719190	3	O
human	23719190	3	O
disorders	23719190	3	O
,	23719190	3	O
or	23719190	3	O
imprinting	23719190	3	O
disorders	23719190	3	O
.	23719190	3	O
Beckwith	23719190	3	B-Disease
-	23719190	3	I-Disease
Wiedemann	23719190	3	I-Disease
syndrome	23719190	3	I-Disease
(	23719190	3	O
BWS	23719190	3	O
)	23719190	3	O
is	23719190	3	O
a	23719190	3	O
representative	23719190	3	O
imprinting	23719190	3	O
disorder	23719190	3	O
characterized	23719190	3	O
by	23719190	3	O
macrosomia	23719190	3	O
,	23719190	3	O
macroglossia	23719190	3	O
and	23719190	3	O
abdominal	23719190	3	O
wall	23719190	3	O
defects	23719190	3	O
,	23719190	3	O
and	23719190	3	O
exhibits	23719190	3	O
a	23719190	3	O
predisposition	23719190	3	O
to	23719190	3	O
tumorigenesis	23719190	3	O
.	23719190	3	O
The	23719190	3	O
relevant	23719190	3	O
imprinted	23719190	3	O
chromosomal	23719190	3	O
region	23719190	3	O
in	23719190	3	O
BWS	23719190	3	O
is	23719190	3	O
11	23719190	3	O
p15.5	23719190	3	O
,	23719190	3	O
which	23719190	3	O
consists	23719190	3	O
of	23719190	3	O
two	23719190	3	O
imprinting	23719190	3	O
domains	23719190	3	O
,	23719190	3	O
IGF2	23719190	3	O
/	23719190	3	O
H19	23719190	3	O
and	23719190	3	O
CDKN1C	23719190	3	O
/	23719190	3	O
KCNQ1OT1	23719190	3	O
.	23719190	3	O
BWS	23719190	3	O
has	23719190	3	O
five	23719190	3	O
known	23719190	3	O
causative	23719190	3	O
epigenetic	23719190	3	O
and	23719190	3	O
genetic	23719190	3	O
alterations	23719190	3	O
:	23719190	3	O
loss	23719190	3	O
of	23719190	3	O
methylation	23719190	3	O
(	23719190	3	O
LOM	23719190	3	O
)	23719190	3	O
at	23719190	3	O
KvDMR1	23719190	3	O
,	23719190	3	O
gain	23719190	3	O
of	23719190	3	O
methylation	23719190	3	O
(	23719190	3	O
GOM	23719190	3	O
)	23719190	3	O
at	23719190	3	O
H19DMR	23719190	3	O
,	23719190	3	O
paternal	23719190	3	O
uniparental	23719190	3	O
disomy	23719190	3	O
,	23719190	3	O
CDKN1C	23719190	3	O
mutations	23719190	3	O
and	23719190	3	O
chromosomal	23719190	3	O
rearrangements	23719190	3	O
.	23719190	3	O
Opposite	23719190	3	O
methylation	23719190	3	O
defects	23719190	3	O
,	23719190	3	O
GOM	23719190	3	O
and	23719190	3	O
LOM	23719190	3	O
,	23719190	3	O
at	23719190	3	O
H19DMR	23719190	3	O
are	23719190	3	O
known	23719190	3	O
to	23719190	3	O
cause	23719190	3	O
clinically	23719190	3	O
opposite	23719190	3	O
disorders	23719190	3	O
:	23719190	3	O
BWS	23719190	3	O
and	23719190	3	O
Silver	23719190	3	O
-	23719190	3	O
Russell	23719190	3	O
syndrome	23719190	3	O
,	23719190	3	O
respectively	23719190	3	O
.	23719190	3	O
Interestingly	23719190	3	O
,	23719190	3	O
a	23719190	3	O
recent	23719190	3	O
study	23719190	3	O
discovered	23719190	3	O
that	23719190	3	O
loss	23719190	3	B-NegReg
of	23719190	3	I-NegReg
function	23719190	3	I-NegReg
or	23719190	3	O
gain	23719190	3	B-PosReg
of	23719190	3	I-PosReg
function	23719190	3	I-PosReg
of	23719190	3	O
CDKN1C	23719190	3	B-Gene
also	23719190	3	O
causes	23719190	3	O
clinically	23719190	3	O
opposite	23719190	3	O
disorders	23719190	3	O
,	23719190	3	O
BWS	23719190	3	B-Disease
and	23719190	3	O
IMAGe	23719190	3	B-Disease
(	23719190	3	I-Disease
intrauterine	23719190	3	I-Disease
growth	23719190	3	I-Disease
restriction	23719190	3	I-Disease
,	23719190	3	O
metaphyseal	23719190	3	I-Disease
dysplasia	23719190	3	I-Disease
,	23719190	3	O
adrenal	23719190	3	I-Disease
hypoplasia	23719190	3	I-Disease
congenita	23719190	3	I-Disease
,	23719190	3	O
and	23719190	3	I-Disease
genital	23719190	3	I-Disease
anomalies	23719190	3	I-Disease
)	23719190	3	I-Disease
syndrome	23719190	3	I-Disease
,	23719190	3	O
respectively	23719190	3	O
.	23719190	3	O
Furthermore	23719190	3	O
,	23719190	3	O
several	23719190	3	O
clinical	23719190	3	O
studies	23719190	3	O
have	23719190	3	O
suggested	23719190	3	O
a	23719190	3	O
relationship	23719190	3	O
between	23719190	3	O
assisted	23719190	3	O
reproductive	23719190	3	O
technology	23719190	3	O
(	23719190	3	O
ART	23719190	3	O
)	23719190	3	O
and	23719190	3	O
the	23719190	3	O
risk	23719190	3	O
of	23719190	3	O
imprinting	23719190	3	O
disorders	23719190	3	O
,	23719190	3	O
along	23719190	3	O
with	23719190	3	O
the	23719190	3	O
existence	23719190	3	O
of	23719190	3	O
trans	23719190	3	O
-	23719190	3	O
acting	23719190	3	O
factors	23719190	3	O
that	23719190	3	O
regulate	23719190	3	O
multiple	23719190	3	O
imprinted	23719190	3	O
differentially	23719190	3	O
methylated	23719190	3	O
regions	23719190	3	O
.	23719190	3	O
In	23719190	3	O
this	23719190	3	O
review	23719190	3	O
,	23719190	3	O
we	23719190	3	O
describe	23719190	3	O
the	23719190	3	O
latest	23719190	3	O
knowledge	23719190	3	O
surrounding	23719190	3	O
the	23719190	3	O
imprinting	23719190	3	O
mechanism	23719190	3	O
of	23719190	3	O
11	23719190	3	O
p15.5	23719190	3	O
,	23719190	3	O
in	23719190	3	O
addition	23719190	3	O
to	23719190	3	O
epigenetic	23719190	3	O
and	23719190	3	O
genetic	23719190	3	O
etiologies	23719190	3	O
of	23719190	3	O
BWS	23719190	3	O
,	23719190	3	O
associated	23719190	3	O
childhood	23719190	3	O
tumors	23719190	3	O
,	23719190	3	O
the	23719190	3	O
effects	23719190	3	O
of	23719190	3	O
ART	23719190	3	O
and	23719190	3	O
multilocus	23719190	3	O
hypomethylation	23719190	3	O
disorders	23719190	3	O
.	23719190	3	O

Familial	23761384	3	B-Disease
lipoprotein	23761384	3	I-Disease
lipase	23761384	3	I-Disease
deficiency	23761384	3	I-Disease
:	23761384	3	I-Disease
a	23761384	3	O
case	23761384	3	O
of	23761384	3	O
compound	23761384	3	O
heterozygosity	23761384	3	O
of	23761384	3	O
a	23761384	3	O
novel	23761384	3	O
duplication	23761384	3	O
(	23761384	3	O
R44Kfs	23761384	3	O
*	23761384	3	O
4	23761384	3	O
)	23761384	3	O
and	23761384	3	O
a	23761384	3	O
common	23761384	3	O
mutation	23761384	3	O
(	23761384	3	B-Var
N291S	23761384	3	I-Var
)	23761384	3	I-Var
in	23761384	3	B-Reg
the	23761384	3	O
lipoprotein	23761384	3	B-Gene
lipase	23761384	3	I-Gene
gene	23761384	3	I-Gene
.	23761384	3	O
Familial	23761384	3	B-Disease
lipoprotein	23761384	3	I-Disease
lipase	23761384	3	I-Disease
(	23761384	3	I-Disease
LPL	23761384	3	I-Disease
)	23761384	3	I-Disease
deficiency	23761384	3	I-Disease
(	23761384	3	O
FLLD	23761384	3	O
)	23761384	3	O
is	23761384	3	O
a	23761384	3	O
rare	23761384	3	O
autosomal	23761384	3	O
recessive	23761384	3	O
genetic	23761384	3	O
disorder	23761384	3	O
caused	23761384	3	B-Reg
by	23761384	3	I-Reg
homozygous	23761384	3	O
or	23761384	3	O
compound	23761384	3	O
heterozygous	23761384	3	O
mutations	23761384	3	B-Var
in	23761384	3	O
the	23761384	3	O
LPL	23761384	3	B-Gene
gene	23761384	3	O
.	23761384	3	O
FLLD	23761384	3	O
individuals	23761384	3	O
usually	23761384	3	O
express	23761384	3	O
an	23761384	3	O
impaired	23761384	3	O
or	23761384	3	O
non	23761384	3	O
-	23761384	3	O
functional	23761384	3	O
LPL	23761384	3	O
enzyme	23761384	3	O
with	23761384	3	O
low	23761384	3	O
or	23761384	3	O
absent	23761384	3	O
triglyceride	23761384	3	O
(	23761384	3	O
TG	23761384	3	O
)	23761384	3	O
hydrolysis	23761384	3	O
activity	23761384	3	O
causing	23761384	3	O
severe	23761384	3	O
hypertriglyceridaemia	23761384	3	O
.	23761384	3	O
Here	23761384	3	O
we	23761384	3	O
report	23761384	3	O
a	23761384	3	O
case	23761384	3	O
of	23761384	3	O
FLLD	23761384	3	O
in	23761384	3	O
a	23761384	3	O
29	23761384	3	O
-	23761384	3	O
year	23761384	3	O
-	23761384	3	O
old	23761384	3	O
man	23761384	3	O
,	23761384	3	O
who	23761384	3	O
initially	23761384	3	O
presented	23761384	3	O
with	23761384	3	O
eruptive	23761384	3	O
cutaneous	23761384	3	O
xanthomata	23761384	3	O
,	23761384	3	O
elevated	23761384	3	O
plasma	23761384	3	O
TG	23761384	3	O
concentration	23761384	3	O
but	23761384	3	O
no	23761384	3	O
other	23761384	3	O
co	23761384	3	O
-	23761384	3	O
morbidities	23761384	3	O
.	23761384	3	O
Subsequent	23761384	3	O
genetic	23761384	3	O
testing	23761384	3	O
of	23761384	3	O
the	23761384	3	O
patient	23761384	3	O
revealed	23761384	3	O
compound	23761384	3	O
heterozygosity	23761384	3	O
of	23761384	3	O
a	23761384	3	O
novel	23761384	3	O
duplication	23761384	3	O
(	23761384	3	B-Var
p.R44Kfs*4	23761384	3	I-Var
)	23761384	3	I-Var
leading	23761384	3	B-Reg
to	23761384	3	I-Reg
a	23761384	3	O
premature	23761384	3	O
stop	23761384	3	O
codon	23761384	3	O
in	23761384	3	O
exon	23761384	3	O
2	23761384	3	O
and	23761384	3	O
a	23761384	3	O
known	23761384	3	O
mutation	23761384	3	O
(	23761384	3	B-Var
N291S	23761384	3	I-Var
)	23761384	3	I-Var
in	23761384	3	O
exon	23761384	3	O
5	23761384	3	O
of	23761384	3	O
the	23761384	3	O
LPL	23761384	3	B-Gene
gene	23761384	3	O
.	23761384	3	O
Further	23761384	3	O
biochemical	23761384	3	O
analysis	23761384	3	O
of	23761384	3	O
the	23761384	3	O
patient	23761384	3	O
'	23761384	3	O
s	23761384	3	O
postheparin	23761384	3	O
plasma	23761384	3	O
confirmed	23761384	3	O
a	23761384	3	O
reduction	23761384	3	B-NegReg
of	23761384	3	O
total	23761384	3	O
lipase	23761384	3	O
activity	23761384	3	O
compared	23761384	3	O
with	23761384	3	O
his	23761384	3	O
heterozygous	23761384	3	O
father	23761384	3	O
carrying	23761384	3	O
the	23761384	3	O
common	23761384	3	O
N291S	23761384	3	B-Var
mutation	23761384	3	O
and	23761384	3	O
to	23761384	3	O
a	23761384	3	O
healthy	23761384	3	O
control	23761384	3	O
.	23761384	3	O
Also	23761384	3	O
the	23761384	3	O
patient	23761384	3	O
showed	23761384	3	O
increased	23761384	3	B-PosReg
(	23761384	3	O
1.85	23761384	3	O
-	23761384	3	O
fold	23761384	3	O
)	23761384	3	O
activity	23761384	3	O
of	23761384	3	O
hepatic	23761384	3	O
lipase	23761384	3	O
(	23761384	3	O
HL	23761384	3	O
)	23761384	3	O
,	23761384	3	O
indicating	23761384	3	O
a	23761384	3	O
functional	23761384	3	O
link	23761384	3	O
between	23761384	3	O
HL	23761384	3	O
and	23761384	3	O
LPL	23761384	3	O
.	23761384	3	O
In	23761384	3	O
summary	23761384	3	O
,	23761384	3	O
we	23761384	3	O
report	23761384	3	O
a	23761384	3	O
case	23761384	3	O
of	23761384	3	O
FLLD	23761384	3	B-Disease
caused	23761384	3	B-Reg
by	23761384	3	I-Reg
compound	23761384	3	O
heterozygosity	23761384	3	O
of	23761384	3	O
a	23761384	3	O
new	23761384	3	O
duplication	23761384	3	B-Var
and	23761384	3	O
a	23761384	3	O
common	23761384	3	O
mutation	23761384	3	B-Var
in	23761384	3	O
the	23761384	3	O
LPL	23761384	3	B-Gene
gene	23761384	3	O
,	23761384	3	O
resulting	23761384	3	O
in	23761384	3	O
residual	23761384	3	B-NegReg
LPL	23761384	3	O
activity	23761384	3	O
.	23761384	3	O
With	23761384	3	O
such	23761384	3	O
mutations	23761384	3	O
,	23761384	3	O
individuals	23761384	3	O
may	23761384	3	O
not	23761384	3	O
receive	23761384	3	O
a	23761384	3	O
diagnosis	23761384	3	O
before	23761384	3	O
classical	23761384	3	O
FLLD	23761384	3	O
symptoms	23761384	3	O
appear	23761384	3	O
later	23761384	3	O
in	23761384	3	O
adulthood	23761384	3	O
.	23761384	3	O
Nevertheless	23761384	3	O
,	23761384	3	O
early	23761384	3	O
diagnosis	23761384	3	O
and	23761384	3	O
lipid	23761384	3	O
-	23761384	3	O
lowering	23761384	3	O
treatment	23761384	3	O
may	23761384	3	O
favour	23761384	3	O
a	23761384	3	O
reduced	23761384	3	O
risk	23761384	3	O
of	23761384	3	O
premature	23761384	3	O
cardiovascular	23761384	3	O
disease	23761384	3	O
or	23761384	3	O
acute	23761384	3	O
pancreatitis	23761384	3	O
in	23761384	3	O
such	23761384	3	O
individuals	23761384	3	O
.	23761384	3	O

Microarray	23782367	4	O
analysis	23782367	4	O
of	23782367	4	O
unbalanced	23782367	4	O
translocation	23782367	4	O
in	23782367	4	O
Wolf	23782367	4	O
-	23782367	4	O
Hirschhorn	23782367	4	O
syndrome	23782367	4	O
.	23782367	4	O
Wolf	23782367	4	B-Disease
-	23782367	4	I-Disease
Hirschhorn	23782367	4	I-Disease
syndrome	23782367	4	I-Disease
(	23782367	4	O
WHS	23782367	4	O
)	23782367	4	O
is	23782367	4	O
caused	23782367	4	B-Reg
by	23782367	4	I-Reg
deletions	23782367	4	B-Var
involving	23782367	4	O
chromosome	23782367	4	O
region	23782367	4	O
4	23782367	4	B-Gene
p16.3	23782367	4	I-Gene
,	23782367	4	O
which	23782367	4	O
is	23782367	4	O
characterized	23782367	4	O
by	23782367	4	O
growth	23782367	4	O
delay	23782367	4	O
,	23782367	4	O
mild	23782367	4	O
-	23782367	4	O
to	23782367	4	O
-	23782367	4	O
severe	23782367	4	O
mental	23782367	4	O
retardation	23782367	4	O
,	23782367	4	O
hypotonia	23782367	4	O
,	23782367	4	O
facial	23782367	4	O
dysmorphisms	23782367	4	O
and	23782367	4	O
shows	23782367	4	O
extensive	23782367	4	O
phenotypic	23782367	4	O
variability	23782367	4	O
include	23782367	4	O
feeding	23782367	4	O
difficulties	23782367	4	O
,	23782367	4	O
epilepsy	23782367	4	O
and	23782367	4	O
congenital	23782367	4	O
anomalies	23782367	4	O
.	23782367	4	O
Variation	23782367	4	O
in	23782367	4	O
the	23782367	4	O
size	23782367	4	O
of	23782367	4	O
the	23782367	4	O
deletion	23782367	4	O
involving	23782367	4	O
chromosome	23782367	4	O
region	23782367	4	O
4	23782367	4	O
p16.3	23782367	4	O
may	23782367	4	O
explain	23782367	4	O
the	23782367	4	O
clinical	23782367	4	O
variation	23782367	4	O
.	23782367	4	O
However	23782367	4	O
,	23782367	4	O
previous	23782367	4	O
studies	23782367	4	O
indicate	23782367	4	O
that	23782367	4	O
duplication	23782367	4	O
for	23782367	4	O
another	23782367	4	O
chromosome	23782367	4	O
region	23782367	4	O
due	23782367	4	O
to	23782367	4	O
an	23782367	4	O
unbalanced	23782367	4	O
translocation	23782367	4	O
elucidate	23782367	4	O
approximately	23782367	4	O
40	23782367	4	O
-	23782367	4	O
45%	23782367	4	O
WHS	23782367	4	O
patients	23782367	4	O
.	23782367	4	O
Therefore	23782367	4	O
,	23782367	4	O
we	23782367	4	O
used	23782367	4	O
whole	23782367	4	O
genomic	23782367	4	O
cytogenetics	23782367	4	O
array	23782367	4	O
to	23782367	4	O
analyze	23782367	4	O
the	23782367	4	O
entire	23782367	4	O
genome	23782367	4	O
at	23782367	4	O
a	23782367	4	O
significantly	23782367	4	O
higher	23782367	4	O
resolution	23782367	4	O
over	23782367	4	O
conventional	23782367	4	O
cytogenetics	23782367	4	O
to	23782367	4	O
characterize	23782367	4	O
the	23782367	4	O
exact	23782367	4	O
subtelomeric	23782367	4	O
aberration	23782367	4	O
region	23782367	4	O
of	23782367	4	O
one	23782367	4	O
patient	23782367	4	O
with	23782367	4	O
developmental	23782367	4	O
delay	23782367	4	O
and	23782367	4	O
several	23782367	4	O
facial	23782367	4	O
characteristics	23782367	4	O
reminiscent	23782367	4	O
Wolf	23782367	4	O
-	23782367	4	O
Hirschhorn	23782367	4	O
syndrome	23782367	4	O
.	23782367	4	O
Here	23782367	4	O
we	23782367	4	O
report	23782367	4	O
that	23782367	4	O
our	23782367	4	O
patient	23782367	4	O
had	23782367	4	O
3.7	23782367	4	O
Mb	23782367	4	O
deletion	23782367	4	O
at	23782367	4	O
the	23782367	4	O
4	23782367	4	O
p16.2	23782367	4	O
and	23782367	4	O
6.8	23782367	4	O
Mb	23782367	4	O
duplication	23782367	4	O
at	23782367	4	O
8	23782367	4	O
p23.1	23782367	4	O
resulted	23782367	4	O
from	23782367	4	O
the	23782367	4	O
unbalanced	23782367	4	O
translocations	23782367	4	O
der	23782367	4	O
(	23782367	4	O
4	23782367	4	O
)	23782367	4	O
t	23782367	4	O
(	23782367	4	O
4	23782367	4	O
;	23782367	4	O
8	23782367	4	O
)	23782367	4	O
(	23782367	4	O
p16.2	23782367	4	O
;	23782367	4	O
p23.1	23782367	4	O
)	23782367	4	O
.	23782367	4	O
We	23782367	4	O
confirmed	23782367	4	O
that	23782367	4	O
our	23782367	4	O
patient	23782367	4	O
with	23782367	4	O
monosomy	23782367	4	O
4	23782367	4	O
p16.2	23782367	4	O
which	23782367	4	O
is	23782367	4	O
consistent	23782367	4	O
with	23782367	4	O
Wolf	23782367	4	O
-	23782367	4	O
Hirschhorn	23782367	4	O
syndrome	23782367	4	O
and	23782367	4	O
trisomy	23782367	4	O
8	23782367	4	O
p23.1	23782367	4	O
.	23782367	4	O
The	23782367	4	O
combination	23782367	4	O
of	23782367	4	O
the	23782367	4	O
4	23782367	4	O
p	23782367	4	O
deletion	23782367	4	O
with	23782367	4	O
8	23782367	4	O
p	23782367	4	O
partial	23782367	4	O
trisomy	23782367	4	O
explains	23782367	4	O
the	23782367	4	O
complex	23782367	4	O
phenotype	23782367	4	O
presented	23782367	4	O
by	23782367	4	O
our	23782367	4	O
patient	23782367	4	O
.	23782367	4	O

Novel	23791648	1	O
ALPL	23791648	1	O
genetic	23791648	1	O
alteration	23791648	1	O
associated	23791648	1	O
with	23791648	1	O
an	23791648	1	O
odontohypophosphatasia	23791648	1	O
phenotype	23791648	1	O
.	23791648	1	O
Hypophosphatasia	23791648	1	B-Disease
(	23791648	1	O
HPP	23791648	1	O
)	23791648	1	O
is	23791648	1	O
an	23791648	1	O
inherited	23791648	1	O
disorder	23791648	1	O
of	23791648	1	O
mineral	23791648	1	O
metabolism	23791648	1	O
caused	23791648	1	B-Reg
by	23791648	1	I-Reg
mutations	23791648	1	B-Var
in	23791648	1	O
ALPL	23791648	1	B-Gene
,	23791648	1	O
encoding	23791648	1	O
tissue	23791648	1	O
non	23791648	1	O
-	23791648	1	O
specific	23791648	1	O
alkaline	23791648	1	O
phosphatase	23791648	1	O
(	23791648	1	O
TNAP	23791648	1	O
)	23791648	1	O
.	23791648	1	O
Here	23791648	1	O
,	23791648	1	O
we	23791648	1	O
report	23791648	1	O
the	23791648	1	O
molecular	23791648	1	O
findings	23791648	1	O
from	23791648	1	O
monozygotic	23791648	1	O
twins	23791648	1	O
,	23791648	1	O
clinically	23791648	1	O
diagnosed	23791648	1	O
with	23791648	1	O
tooth	23791648	1	O
-	23791648	1	O
specific	23791648	1	O
odontohypophosphatasia	23791648	1	O
(	23791648	1	O
odonto	23791648	1	O
-	23791648	1	O
HPP	23791648	1	O
)	23791648	1	O
.	23791648	1	O
Sequencing	23791648	1	O
of	23791648	1	O
ALPL	23791648	1	O
identified	23791648	1	O
two	23791648	1	O
genetic	23791648	1	O
alterations	23791648	1	O
in	23791648	1	O
the	23791648	1	O
probands	23791648	1	O
,	23791648	1	O
including	23791648	1	O
a	23791648	1	O
heterozygous	23791648	1	O
missense	23791648	1	O
mutation	23791648	1	O
c.454	23791648	1	B-Var
C	23791648	1	I-Var
>	23791648	1	I-Var
T	23791648	1	I-Var
,	23791648	1	O
leading	23791648	1	B-Reg
to	23791648	1	I-Reg
change	23791648	1	O
of	23791648	1	O
arginine	23791648	1	O
152	23791648	1	O
to	23791648	1	O
cysteine	23791648	1	O
(	23791648	1	B-Var
p.R152C	23791648	1	I-Var
)	23791648	1	I-Var
,	23791648	1	O
and	23791648	1	O
a	23791648	1	O
novel	23791648	1	O
heterozygous	23791648	1	O
gene	23791648	1	O
deletion	23791648	1	O
c.1318	23791648	1	B-Var
_1320delAAC	23791648	1	I-Var
,	23791648	1	O
leading	23791648	1	B-Reg
to	23791648	1	I-Reg
the	23791648	1	O
loss	23791648	1	O
of	23791648	1	O
an	23791648	1	O
asparagine	23791648	1	O
residue	23791648	1	O
at	23791648	1	O
codon	23791648	1	O
440	23791648	1	O
(	23791648	1	B-Var
p.N440del	23791648	1	I-Var
)	23791648	1	I-Var
.	23791648	1	O
Clinical	23791648	1	O
identification	23791648	1	O
of	23791648	1	O
low	23791648	1	O
serum	23791648	1	O
TNAP	23791648	1	O
activity	23791648	1	O
,	23791648	1	O
dental	23791648	1	O
abnormalities	23791648	1	O
,	23791648	1	O
and	23791648	1	O
pedigree	23791648	1	O
data	23791648	1	O
strongly	23791648	1	O
suggests	23791648	1	O
a	23791648	1	O
genotype	23791648	1	O
-	23791648	1	O
phenotype	23791648	1	O
correlation	23791648	1	O
between	23791648	1	O
p.N440del	23791648	1	O
and	23791648	1	O
odonto	23791648	1	O
-	23791648	1	O
HPP	23791648	1	O
in	23791648	1	O
this	23791648	1	O
family	23791648	1	O
.	23791648	1	O
Computational	23791648	1	O
analysis	23791648	1	O
of	23791648	1	O
the	23791648	1	O
p.N440del	23791648	1	B-Var
protein	23791648	1	O
structure	23791648	1	O
revealed	23791648	1	O
an	23791648	1	O
alteration	23791648	1	B-Reg
in	23791648	1	O
the	23791648	1	O
tertiary	23791648	1	O
structure	23791648	1	O
affecting	23791648	1	B-Reg
the	23791648	1	O
collagen	23791648	1	O
-	23791648	1	O
binding	23791648	1	O
site	23791648	1	O
(	23791648	1	O
loop	23791648	1	O
422	23791648	1	O
-	23791648	1	O
452	23791648	1	O
)	23791648	1	O
,	23791648	1	O
which	23791648	1	O
could	23791648	1	O
potentially	23791648	1	O
impair	23791648	1	B-NegReg
the	23791648	1	O
mineralization	23791648	1	O
process	23791648	1	O
.	23791648	1	O
Nevertheless	23791648	1	O
,	23791648	1	O
the	23791648	1	O
probands	23791648	1	O
(	23791648	1	O
compound	23791648	1	O
heterozygous	23791648	1	O
:	23791648	1	O
p.	23791648	1	O
[	23791648	1	O
N440del	23791648	1	O
]	23791648	1	O
;	23791648	1	O
[	23791648	1	O
R152C	23791648	1	O
]	23791648	1	O
)	23791648	1	O
feature	23791648	1	O
early	23791648	1	O
-	23791648	1	O
onset	23791648	1	O
and	23791648	1	O
severe	23791648	1	O
odonto	23791648	1	O
-	23791648	1	O
HPP	23791648	1	O
phenotype	23791648	1	O
,	23791648	1	O
whereas	23791648	1	O
the	23791648	1	O
father	23791648	1	O
(	23791648	1	O
p.	23791648	1	O
[	23791648	1	O
N440del	23791648	1	O
]	23791648	1	O
;	23791648	1	O
[	23791648	1	O
=	23791648	1	O
]	23791648	1	O
)	23791648	1	O
has	23791648	1	O
only	23791648	1	O
moderate	23791648	1	O
symptoms	23791648	1	O
,	23791648	1	O
suggesting	23791648	1	O
p.R152C	23791648	1	O
may	23791648	1	O
contribute	23791648	1	O
or	23791648	1	O
predispose	23791648	1	O
to	23791648	1	O
a	23791648	1	O
more	23791648	1	O
severe	23791648	1	O
dental	23791648	1	O
phenotype	23791648	1	O
in	23791648	1	O
combination	23791648	1	O
with	23791648	1	O
the	23791648	1	O
deletion	23791648	1	O
.	23791648	1	O
These	23791648	1	O
results	23791648	1	O
assist	23791648	1	O
in	23791648	1	O
defining	23791648	1	O
the	23791648	1	O
genotype	23791648	1	O
-	23791648	1	O
phenotype	23791648	1	O
associations	23791648	1	O
for	23791648	1	O
odonto	23791648	1	O
-	23791648	1	O
HPP	23791648	1	O
,	23791648	1	O
and	23791648	1	O
further	23791648	1	O
identify	23791648	1	O
the	23791648	1	O
collagen	23791648	1	O
-	23791648	1	O
binding	23791648	1	O
site	23791648	1	O
as	23791648	1	O
a	23791648	1	O
region	23791648	1	O
of	23791648	1	O
potential	23791648	1	O
structural	23791648	1	O
importance	23791648	1	O
for	23791648	1	O
TNAP	23791648	1	O
function	23791648	1	O
in	23791648	1	O
the	23791648	1	O
biomineralization	23791648	1	O
.	23791648	1	O

Analysis	23892522	4	O
of	23892522	4	O
STK11	23892522	4	O
gene	23892522	4	O
variant	23892522	4	O
in	23892522	4	O
five	23892522	4	O
Chinese	23892522	4	O
patients	23892522	4	O
with	23892522	4	O
Peutz	23892522	4	O
-	23892522	4	O
Jeghers	23892522	4	O
syndrome	23892522	4	O
.	23892522	4	O
BACKGROUND	23892522	4	O
:	23892522	4	O
Peutz	23892522	4	B-Disease
-	23892522	4	I-Disease
Jeghers	23892522	4	I-Disease
syndrome	23892522	4	I-Disease
(	23892522	4	O
PJS	23892522	4	O
)	23892522	4	O
is	23892522	4	O
a	23892522	4	O
rare	23892522	4	O
autosomal	23892522	4	O
dominant	23892522	4	O
inherited	23892522	4	O
disorder	23892522	4	O
characterized	23892522	4	O
by	23892522	4	O
gastrointestinal	23892522	4	O
hamartomatous	23892522	4	O
polyps	23892522	4	O
and	23892522	4	O
mucocutaneous	23892522	4	O
pigmentation	23892522	4	O
.	23892522	4	O
Germline	23892522	4	O
mutation	23892522	4	B-Var
of	23892522	4	O
a	23892522	4	O
serine	23892522	4	O
/	23892522	4	O
threonine	23892522	4	O
kinase	23892522	4	O
11	23892522	4	B-Gene
(	23892522	4	I-Gene
STK11	23892522	4	I-Gene
)	23892522	4	I-Gene
gene	23892522	4	O
has	23892522	4	O
been	23892522	4	O
identified	23892522	4	O
as	23892522	4	O
a	23892522	4	O
cause	23892522	4	B-Reg
of	23892522	4	O
PJS	23892522	4	O
.	23892522	4	O
In	23892522	4	O
this	23892522	4	O
study	23892522	4	O
,	23892522	4	O
we	23892522	4	O
investigated	23892522	4	O
the	23892522	4	O
molecular	23892522	4	O
basis	23892522	4	O
of	23892522	4	O
five	23892522	4	O
Chinese	23892522	4	O
PJS	23892522	4	O
patients	23892522	4	O
.	23892522	4	O
METHODS	23892522	4	O
:	23892522	4	O
Blood	23892522	4	O
samples	23892522	4	O
were	23892522	4	O
collected	23892522	4	O
from	23892522	4	O
five	23892522	4	O
unrelated	23892522	4	O
Chinese	23892522	4	O
PJS	23892522	4	O
patients	23892522	4	O
and	23892522	4	O
their	23892522	4	O
parents	23892522	4	O
.	23892522	4	O
The	23892522	4	O
entire	23892522	4	O
coding	23892522	4	O
region	23892522	4	O
of	23892522	4	O
the	23892522	4	O
STK11	23892522	4	O
gene	23892522	4	O
was	23892522	4	O
amplified	23892522	4	O
by	23892522	4	O
polymerase	23892522	4	O
chain	23892522	4	O
reaction	23892522	4	O
and	23892522	4	O
analyzed	23892522	4	O
by	23892522	4	O
direct	23892522	4	O
sequencing	23892522	4	O
.	23892522	4	O
RESULTS	23892522	4	O
:	23892522	4	O
Three	23892522	4	O
different	23892522	4	O
frameshift	23892522	4	O
mutations	23892522	4	O
(	23892522	4	O
c.519	23892522	4	O
insTGTG	23892522	4	O
,	23892522	4	O
c.792	23892522	4	O
_793insT	23892522	4	O
,	23892522	4	O
and	23892522	4	O
c.334	23892522	4	O
_335insC	23892522	4	O
)	23892522	4	O
,	23892522	4	O
all	23892522	4	O
of	23892522	4	O
which	23892522	4	O
would	23892522	4	O
cause	23892522	4	O
truncation	23892522	4	O
of	23892522	4	O
the	23892522	4	O
gene	23892522	4	O
product	23892522	4	O
,	23892522	4	O
were	23892522	4	O
found	23892522	4	O
in	23892522	4	O
three	23892522	4	O
patients	23892522	4	O
.	23892522	4	O
One	23892522	4	O
missense	23892522	4	O
mutation	23892522	4	O
(	23892522	4	O
p.Ser307Thr	23892522	4	O
)	23892522	4	O
and	23892522	4	O
one	23892522	4	O
3	23892522	4	O
bp	23892522	4	O
deletion	23892522	4	O
mutation	23892522	4	O
(	23892522	4	O
c.228	23892522	4	O
-	23892522	4	O
230	23892522	4	O
del	23892522	4	O
CGT	23892522	4	O
)	23892522	4	O
were	23892522	4	O
identified	23892522	4	O
in	23892522	4	O
the	23892522	4	O
remaining	23892522	4	O
two	23892522	4	O
patients	23892522	4	O
.	23892522	4	O
All	23892522	4	O
of	23892522	4	O
the	23892522	4	O
five	23892522	4	O
investigated	23892522	4	O
patients	23892522	4	O
carried	23892522	4	O
de	23892522	4	O
novo	23892522	4	O
mutations	23892522	4	O
.	23892522	4	O
CONCLUSIONS	23892522	4	O
:	23892522	4	O
The	23892522	4	O
results	23892522	4	O
support	23892522	4	O
that	23892522	4	O
mutation	23892522	4	B-Var
of	23892522	4	O
the	23892522	4	O
LKB1	23892522	4	B-Gene
gene	23892522	4	O
is	23892522	4	O
a	23892522	4	O
cause	23892522	4	B-Reg
of	23892522	4	O
PJS	23892522	4	B-Disease
,	23892522	4	O
and	23892522	4	O
expand	23892522	4	O
the	23892522	4	O
spectrum	23892522	4	O
of	23892522	4	O
the	23892522	4	O
STK11	23892522	4	O
gene	23892522	4	O
mutations	23892522	4	O
.	23892522	4	O

Late	24488655	1	O
adult	24488655	1	O
-	24488655	1	O
onset	24488655	1	O
of	24488655	1	O
X	24488655	1	O
-	24488655	1	O
linked	24488655	1	O
myopathy	24488655	1	O
with	24488655	1	O
excessive	24488655	1	O
autophagy	24488655	1	O
.	24488655	1	O
INTRODUCTION	24488655	1	O
:	24488655	1	O
X	24488655	1	B-Disease
-	24488655	1	I-Disease
linked	24488655	1	I-Disease
myopathy	24488655	1	I-Disease
with	24488655	1	I-Disease
excessive	24488655	1	I-Disease
autophagy	24488655	1	I-Disease
(	24488655	1	O
XMEA	24488655	1	O
)	24488655	1	O
is	24488655	1	O
characterized	24488655	1	O
by	24488655	1	O
autophagic	24488655	1	O
vacuoles	24488655	1	O
with	24488655	1	O
sarcolemmal	24488655	1	O
features	24488655	1	O
.	24488655	1	O
Mutations	24488655	1	B-Var
in	24488655	1	O
VMA21	24488655	1	B-Gene
result	24488655	1	O
in	24488655	1	O
insufficient	24488655	1	B-NegReg
lysosome	24488655	1	O
acidification	24488655	1	O
,	24488655	1	O
causing	24488655	1	B-Reg
progressive	24488655	1	O
proximal	24488655	1	O
weakness	24488655	1	O
with	24488655	1	O
onset	24488655	1	O
before	24488655	1	O
age	24488655	1	O
20	24488655	1	O
years	24488655	1	O
and	24488655	1	O
loss	24488655	1	O
of	24488655	1	O
ambulation	24488655	1	O
by	24488655	1	O
middle	24488655	1	O
age	24488655	1	O
.	24488655	1	O
METHODS	24488655	1	O
:	24488655	1	O
We	24488655	1	O
describe	24488655	1	O
a	24488655	1	O
patient	24488655	1	O
with	24488655	1	O
onset	24488655	1	O
of	24488655	1	O
slowly	24488655	1	O
progressive	24488655	1	O
proximal	24488655	1	O
weakness	24488655	1	O
of	24488655	1	O
the	24488655	1	O
lower	24488655	1	O
limbs	24488655	1	O
after	24488655	1	O
age	24488655	1	O
50	24488655	1	O
,	24488655	1	O
who	24488655	1	O
maintains	24488655	1	O
ambulation	24488655	1	O
with	24488655	1	O
the	24488655	1	O
assistance	24488655	1	O
of	24488655	1	O
a	24488655	1	O
cane	24488655	1	O
at	24488655	1	O
age	24488655	1	O
71	24488655	1	O
.	24488655	1	O
RESULTS	24488655	1	O
:	24488655	1	O
Muscle	24488655	1	O
biopsy	24488655	1	O
at	24488655	1	O
age	24488655	1	O
66	24488655	1	O
showed	24488655	1	O
complex	24488655	1	O
muscle	24488655	1	O
fiber	24488655	1	O
splitting	24488655	1	O
,	24488655	1	O
internalized	24488655	1	O
capillaries	24488655	1	O
,	24488655	1	O
and	24488655	1	O
vacuolar	24488655	1	O
changes	24488655	1	O
characteristic	24488655	1	O
of	24488655	1	O
autophagic	24488655	1	O
vacuolar	24488655	1	O
myopathy	24488655	1	O
.	24488655	1	O
Vacuoles	24488655	1	O
stained	24488655	1	O
positive	24488655	1	O
for	24488655	1	O
sarcolemmal	24488655	1	O
proteins	24488655	1	O
,	24488655	1	O
LAMP2	24488655	1	O
,	24488655	1	O
and	24488655	1	O
complement	24488655	1	O
C5b-9	24488655	1	O
.	24488655	1	O
Ultrastructural	24488655	1	O
evaluation	24488655	1	O
further	24488655	1	O
revealed	24488655	1	O
basal	24488655	1	O
lamina	24488655	1	O
reduplication	24488655	1	O
and	24488655	1	O
extensive	24488655	1	O
autophagosome	24488655	1	O
extrusion	24488655	1	O
.	24488655	1	O
Sanger	24488655	1	O
sequencing	24488655	1	O
identified	24488655	1	O
a	24488655	1	O
known	24488655	1	O
pathologic	24488655	1	O
splice	24488655	1	O
site	24488655	1	O
mutation	24488655	1	O
in	24488655	1	O
VMA21	24488655	1	O
(	24488655	1	O
c.164	24488655	1	O
-	24488655	1	O
7	24488655	1	O
T	24488655	1	O
>	24488655	1	O
G	24488655	1	O
)	24488655	1	O
.	24488655	1	O
CONCLUSIONS	24488655	1	O
:	24488655	1	O
This	24488655	1	O
case	24488655	1	O
expands	24488655	1	O
the	24488655	1	O
clinical	24488655	1	O
phenotype	24488655	1	O
of	24488655	1	O
XMEA	24488655	1	O
and	24488655	1	O
suggests	24488655	1	O
VMA21	24488655	1	O
sequencing	24488655	1	O
be	24488655	1	O
considered	24488655	1	O
in	24488655	1	O
evaluating	24488655	1	O
men	24488655	1	O
with	24488655	1	O
LAMP2	24488655	1	O
-	24488655	1	O
positive	24488655	1	O
autophagic	24488655	1	O
vacuolar	24488655	1	O
myopathy	24488655	1	O
.	24488655	1	O

Novel	24655737	4	O
homozygous	24655737	4	O
PANK2	24655737	4	B-Gene
mutation	24655737	4	B-Var
causing	24655737	4	B-Reg
atypical	24655737	4	O
pantothenate	24655737	4	B-Disease
kinase	24655737	4	I-Disease
-	24655737	4	I-Disease
associated	24655737	4	I-Disease
neurodegeneration	24655737	4	I-Disease
(	24655737	4	O
PKAN	24655737	4	O
)	24655737	4	O
in	24655737	4	O
a	24655737	4	O
Cypriot	24655737	4	O
family	24655737	4	O
.	24655737	4	O
Pantothenate	24655737	4	B-Disease
kinase	24655737	4	I-Disease
-	24655737	4	I-Disease
associated	24655737	4	I-Disease
neurodegeneration	24655737	4	I-Disease
(	24655737	4	O
PKAN	24655737	4	O
)	24655737	4	O
is	24655737	4	O
the	24655737	4	O
commonest	24655737	4	O
,	24655737	4	O
recessively	24655737	4	O
inherited	24655737	4	O
form	24655737	4	O
of	24655737	4	O
neurodegeneration	24655737	4	O
with	24655737	4	O
brain	24655737	4	O
iron	24655737	4	O
accumulation	24655737	4	O
(	24655737	4	O
NBIA	24655737	4	O
)	24655737	4	O
resulting	24655737	4	B-Reg
from	24655737	4	I-Reg
mutations	24655737	4	B-Var
in	24655737	4	O
the	24655737	4	O
pantothenate	24655737	4	O
kinase	24655737	4	O
2	24655737	4	O
(	24655737	4	B-Gene
PANK2	24655737	4	I-Gene
)	24655737	4	I-Gene
gene	24655737	4	O
on	24655737	4	O
chromosome	24655737	4	O
20	24655737	4	O
.	24655737	4	O
PKAN	24655737	4	O
is	24655737	4	O
usually	24655737	4	O
rapidly	24655737	4	O
progressive	24655737	4	O
,	24655737	4	O
presenting	24655737	4	O
in	24655737	4	O
the	24655737	4	O
vast	24655737	4	O
majority	24655737	4	O
in	24655737	4	O
the	24655737	4	O
first	24655737	4	O
decade	24655737	4	O
of	24655737	4	O
life	24655737	4	O
(	24655737	4	O
classic	24655737	4	O
form	24655737	4	O
)	24655737	4	O
.	24655737	4	O
A	24655737	4	O
rarer	24655737	4	O
,	24655737	4	O
later	24655737	4	O
onset	24655737	4	O
and	24655737	4	O
slowly	24655737	4	O
progressive	24655737	4	O
(	24655737	4	O
atypical	24655737	4	O
)	24655737	4	O
PKAN	24655737	4	O
form	24655737	4	O
also	24655737	4	O
exists	24655737	4	O
.	24655737	4	O
We	24655737	4	O
present	24655737	4	O
two	24655737	4	O
siblings	24655737	4	O
of	24655737	4	O
Cypriot	24655737	4	O
descent	24655737	4	O
,	24655737	4	O
a	24655737	4	O
27	24655737	4	O
-	24655737	4	O
year	24655737	4	O
-	24655737	4	O
old	24655737	4	O
man	24655737	4	O
and	24655737	4	O
his	24655737	4	O
clinically	24655737	4	O
asymptomatic	24655737	4	O
younger	24655737	4	O
sister	24655737	4	O
,	24655737	4	O
both	24655737	4	O
of	24655737	4	O
whom	24655737	4	O
were	24655737	4	O
found	24655737	4	O
to	24655737	4	O
be	24655737	4	O
homozygous	24655737	4	O
for	24655737	4	O
a	24655737	4	O
novel	24655737	4	O
c.695	24655737	4	O
A	24655737	4	O
>	24655737	4	O
G	24655737	4	O
(	24655737	4	O
p.Asp232Gly	24655737	4	O
)	24655737	4	O
missense	24655737	4	O
mutation	24655737	4	O
in	24655737	4	O
exon	24655737	4	O
2	24655737	4	O
of	24655737	4	O
the	24655737	4	O
PANK2	24655737	4	O
gene	24655737	4	O
.	24655737	4	O
The	24655737	4	O
index	24655737	4	O
patient	24655737	4	O
presented	24655737	4	O
with	24655737	4	O
a	24655737	4	O
5	24655737	4	O
-	24655737	4	O
year	24655737	4	O
history	24655737	4	O
of	24655737	4	O
slowly	24655737	4	O
progressive	24655737	4	O
gait	24655737	4	O
disturbance	24655737	4	O
,	24655737	4	O
dysarthria	24655737	4	O
,	24655737	4	O
mild	24655737	4	O
axial	24655737	4	O
rigidity	24655737	4	O
and	24655737	4	O
bradykinesia	24655737	4	O
.	24655737	4	O
His	24655737	4	O
brain	24655737	4	O
MRI	24655737	4	O
scan	24655737	4	O
revealed	24655737	4	O
the	24655737	4	O
characteristic	24655737	4	O
"	24655737	4	O
eye	24655737	4	O
-	24655737	4	O
of	24655737	4	O
-	24655737	4	O
the	24655737	4	O
-	24655737	4	O
tiger	24655737	4	O
"	24655737	4	O
sign	24655737	4	O
.	24655737	4	O
Atypical	24655737	4	O
genetically	24655737	4	O
confirmed	24655737	4	O
PKAN	24655737	4	O
cases	24655737	4	O
are	24655737	4	O
sparsely	24655737	4	O
reported	24655737	4	O
and	24655737	4	O
should	24655737	4	O
be	24655737	4	O
considered	24655737	4	O
in	24655737	4	O
the	24655737	4	O
differential	24655737	4	O
diagnosis	24655737	4	O
of	24655737	4	O
patients	24655737	4	O
presenting	24655737	4	O
with	24655737	4	O
a	24655737	4	O
progressive	24655737	4	O
extrapyramidal	24655737	4	O
syndrome	24655737	4	O
particularly	24655737	4	O
if	24655737	4	O
the	24655737	4	O
radiographic	24655737	4	O
findings	24655737	4	O
are	24655737	4	O
suggestive	24655737	4	O
of	24655737	4	O
iron	24655737	4	O
accumulation	24655737	4	O
.	24655737	4	O
Effective	24655737	4	O
treatment	24655737	4	O
strategies	24655737	4	O
for	24655737	4	O
PKAN	24655737	4	O
are	24655737	4	O
not	24655737	4	O
currently	24655737	4	O
available	24655737	4	O
and	24655737	4	O
symptomatic	24655737	4	O
therapy	24655737	4	O
is	24655737	4	O
often	24655737	4	O
unsatisfactory	24655737	4	O
.	24655737	4	O
However	24655737	4	O
,	24655737	4	O
early	24655737	4	O
diagnosis	24655737	4	O
including	24655737	4	O
the	24655737	4	O
presymptomatic	24655737	4	O
stage	24655737	4	O
is	24655737	4	O
important	24655737	4	O
for	24655737	4	O
genetic	24655737	4	O
counseling	24655737	4	O
and	24655737	4	O
will	24655737	4	O
be	24655737	4	O
crucial	24655737	4	O
for	24655737	4	O
testing	24655737	4	O
novel	24655737	4	O
therapeutics	24655737	4	O
in	24655737	4	O
the	24655737	4	O
future	24655737	4	O
.	24655737	4	O

A	24659738	4	O
novel	24659738	4	O
SUCLA2	24659738	4	B-Gene
mutation	24659738	4	B-Var
in	24659738	4	O
a	24659738	4	O
Portuguese	24659738	4	O
child	24659738	4	O
associated	24659738	4	O
with	24659738	4	B-Reg
"	24659738	4	O
mild	24659738	4	O
"	24659738	4	O
methylmalonic	24659738	4	B-Disease
aciduria	24659738	4	I-Disease
.	24659738	4	O
Succinyl	24659738	4	O
-	24659738	4	O
coenzyme	24659738	4	O
A	24659738	4	O
synthase	24659738	4	O
is	24659738	4	O
a	24659738	4	O
mitochondrial	24659738	4	O
matrix	24659738	4	O
enzyme	24659738	4	O
that	24659738	4	O
catalyzes	24659738	4	O
the	24659738	4	O
reversible	24659738	4	O
synthesis	24659738	4	O
of	24659738	4	O
succinate	24659738	4	O
and	24659738	4	O
adenosine	24659738	4	O
triphosphate	24659738	4	O
(	24659738	4	O
ATP	24659738	4	O
)	24659738	4	O
from	24659738	4	O
succinyl	24659738	4	O
-	24659738	4	O
coenzyme	24659738	4	O
A	24659738	4	O
and	24659738	4	O
adenosine	24659738	4	O
diphosphate	24659738	4	O
(	24659738	4	O
ADP	24659738	4	O
)	24659738	4	O
in	24659738	4	O
the	24659738	4	O
tricarboxylic	24659738	4	O
acid	24659738	4	O
cycle	24659738	4	O
.	24659738	4	O
This	24659738	4	O
enzyme	24659738	4	O
is	24659738	4	O
made	24659738	4	O
up	24659738	4	O
of	24659738	4	O
α	24659738	4	O
and	24659738	4	O
β	24659738	4	O
subunits	24659738	4	O
encoded	24659738	4	O
by	24659738	4	O
SUCLG1	24659738	4	O
and	24659738	4	O
SUCLA2	24659738	4	O
,	24659738	4	O
respectively	24659738	4	O
.	24659738	4	O
We	24659738	4	O
present	24659738	4	O
a	24659738	4	O
child	24659738	4	O
with	24659738	4	O
severe	24659738	4	O
muscular	24659738	4	O
hypotonia	24659738	4	O
,	24659738	4	O
dystonia	24659738	4	O
,	24659738	4	O
failure	24659738	4	O
to	24659738	4	O
thrive	24659738	4	O
,	24659738	4	O
sensorineural	24659738	4	O
deafness	24659738	4	O
,	24659738	4	O
and	24659738	4	O
dysmorphism	24659738	4	O
.	24659738	4	O
Metabolic	24659738	4	O
investigations	24659738	4	O
disclosed	24659738	4	O
hyperlactacidemia	24659738	4	O
,	24659738	4	O
moderate	24659738	4	O
urinary	24659738	4	O
excretion	24659738	4	O
of	24659738	4	O
methylmalonic	24659738	4	O
acid	24659738	4	O
,	24659738	4	O
and	24659738	4	O
elevated	24659738	4	O
levels	24659738	4	O
of	24659738	4	O
C4	24659738	4	O
-	24659738	4	O
dicarboxylic	24659738	4	O
carnitine	24659738	4	O
in	24659738	4	O
blood	24659738	4	O
.	24659738	4	O
We	24659738	4	O
identified	24659738	4	O
a	24659738	4	O
novel	24659738	4	O
homozygous	24659738	4	O
p.M329V	24659738	4	O
in	24659738	4	O
SUCLA2	24659738	4	B-Gene
.	24659738	4	O
In	24659738	4	O
cultured	24659738	4	O
cells	24659738	4	O
,	24659738	4	O
the	24659738	4	O
p.M329V	24659738	4	B-Var
resulted	24659738	4	O
in	24659738	4	O
a	24659738	4	O
reduced	24659738	4	B-NegReg
amount	24659738	4	O
of	24659738	4	O
the	24659738	4	O
SUCLA2	24659738	4	B-Gene
protein	24659738	4	O
,	24659738	4	O
impaired	24659738	4	B-NegReg
production	24659738	4	O
of	24659738	4	O
mitochondrial	24659738	4	O
ATP	24659738	4	O
,	24659738	4	O
and	24659738	4	O
enhanced	24659738	4	B-PosReg
production	24659738	4	O
of	24659738	4	O
reactive	24659738	4	O
oxygen	24659738	4	O
species	24659738	4	O
,	24659738	4	O
which	24659738	4	O
was	24659738	4	O
partially	24659738	4	O
reduced	24659738	4	O
by	24659738	4	O
using	24659738	4	O
5	24659738	4	O
-	24659738	4	O
aminoimidazole-4	24659738	4	O
-	24659738	4	O
carboxamide	24659738	4	O
ribonucleotide	24659738	4	O
in	24659738	4	O
the	24659738	4	O
culture	24659738	4	O
medium	24659738	4	O
.	24659738	4	O
Expanding	24659738	4	O
the	24659738	4	O
array	24659738	4	O
of	24659738	4	O
SUCLA2	24659738	4	O
mutations	24659738	4	O
,	24659738	4	O
we	24659738	4	O
suggested	24659738	4	O
that	24659738	4	O
reactive	24659738	4	O
oxygen	24659738	4	O
species	24659738	4	O
scavengers	24659738	4	O
are	24659738	4	O
likely	24659738	4	O
to	24659738	4	O
impact	24659738	4	O
on	24659738	4	O
disease	24659738	4	O
prognosis	24659738	4	O
.	24659738	4	O

Molecular	24715752	4	O
profiling	24715752	4	O
of	24715752	4	O
complete	24715752	4	O
congenital	24715752	4	O
stationary	24715752	4	O
night	24715752	4	O
blindness	24715752	4	O
:	24715752	4	O
a	24715752	4	O
pilot	24715752	4	O
study	24715752	4	O
on	24715752	4	O
an	24715752	4	O
Indian	24715752	4	O
cohort	24715752	4	O
.	24715752	4	O
PURPOSE	24715752	4	O
:	24715752	4	O
Congenital	24715752	4	B-Disease
stationary	24715752	4	I-Disease
night	24715752	4	I-Disease
blindness	24715752	4	I-Disease
(	24715752	4	O
CSNB	24715752	4	O
)	24715752	4	O
is	24715752	4	O
a	24715752	4	O
non	24715752	4	O
-	24715752	4	O
progressive	24715752	4	O
retinal	24715752	4	O
disorder	24715752	4	O
that	24715752	4	O
shows	24715752	4	O
genetic	24715752	4	O
and	24715752	4	O
clinical	24715752	4	O
heterogeneity	24715752	4	O
.	24715752	4	O
CSNB	24715752	4	O
is	24715752	4	O
inherited	24715752	4	O
as	24715752	4	O
an	24715752	4	O
autosomal	24715752	4	O
recessive	24715752	4	O
,	24715752	4	O
autosomal	24715752	4	O
dominant	24715752	4	O
,	24715752	4	O
or	24715752	4	O
X	24715752	4	O
-	24715752	4	O
linked	24715752	4	O
recessive	24715752	4	O
trait	24715752	4	O
and	24715752	4	O
shows	24715752	4	O
a	24715752	4	O
good	24715752	4	O
genotype	24715752	4	O
-	24715752	4	O
phenotype	24715752	4	O
correlation	24715752	4	O
.	24715752	4	O
Clinically	24715752	4	O
,	24715752	4	O
CSNB	24715752	4	O
is	24715752	4	O
classified	24715752	4	O
as	24715752	4	O
the	24715752	4	O
Riggs	24715752	4	O
type	24715752	4	O
and	24715752	4	O
the	24715752	4	O
Schubert	24715752	4	O
-	24715752	4	O
Bornschein	24715752	4	O
type	24715752	4	O
.	24715752	4	O
The	24715752	4	O
latter	24715752	4	O
form	24715752	4	O
is	24715752	4	O
further	24715752	4	O
sub	24715752	4	O
-	24715752	4	O
classified	24715752	4	O
into	24715752	4	O
complete	24715752	4	O
and	24715752	4	O
incomplete	24715752	4	O
forms	24715752	4	O
based	24715752	4	O
on	24715752	4	O
specific	24715752	4	O
waveforms	24715752	4	O
on	24715752	4	O
the	24715752	4	O
electroretinogram	24715752	4	O
(	24715752	4	O
ERG	24715752	4	O
)	24715752	4	O
.	24715752	4	O
There	24715752	4	O
are	24715752	4	O
no	24715752	4	O
molecular	24715752	4	O
genetic	24715752	4	O
data	24715752	4	O
for	24715752	4	O
CSNB	24715752	4	O
in	24715752	4	O
the	24715752	4	O
Indian	24715752	4	O
population	24715752	4	O
.	24715752	4	O
Therefore	24715752	4	O
,	24715752	4	O
we	24715752	4	O
present	24715752	4	O
for	24715752	4	O
the	24715752	4	O
first	24715752	4	O
time	24715752	4	O
molecular	24715752	4	O
profiling	24715752	4	O
of	24715752	4	O
eight	24715752	4	O
families	24715752	4	O
with	24715752	4	O
complete	24715752	4	O
CSNB	24715752	4	O
(	24715752	4	O
cCSNB	24715752	4	O
)	24715752	4	O
.	24715752	4	O
METHODS	24715752	4	O
:	24715752	4	O
The	24715752	4	O
index	24715752	4	O
patients	24715752	4	O
and	24715752	4	O
their	24715752	4	O
other	24715752	4	O
affected	24715752	4	O
family	24715752	4	O
members	24715752	4	O
were	24715752	4	O
comprehensively	24715752	4	O
evaluated	24715752	4	O
for	24715752	4	O
the	24715752	4	O
phenotype	24715752	4	O
,	24715752	4	O
including	24715752	4	O
complete	24715752	4	O
ophthalmic	24715752	4	O
evaluation	24715752	4	O
,	24715752	4	O
ERG	24715752	4	O
,	24715752	4	O
fundus	24715752	4	O
autofluorescence	24715752	4	O
,	24715752	4	O
optical	24715752	4	O
coherence	24715752	4	O
tomography	24715752	4	O
,	24715752	4	O
and	24715752	4	O
color	24715752	4	O
vision	24715752	4	O
test	24715752	4	O
.	24715752	4	O
The	24715752	4	O
known	24715752	4	O
gene	24715752	4	O
defects	24715752	4	O
for	24715752	4	O
cCSNB	24715752	4	O
,	24715752	4	O
LRIT3	24715752	4	O
,	24715752	4	O
TRPM1	24715752	4	O
,	24715752	4	O
GRM6	24715752	4	O
,	24715752	4	O
GPR179	24715752	4	O
,	24715752	4	O
and	24715752	4	O
NYX	24715752	4	O
,	24715752	4	O
were	24715752	4	O
screened	24715752	4	O
by	24715752	4	O
PCR	24715752	4	O
direct	24715752	4	O
sequencing	24715752	4	O
.	24715752	4	O
Bioinformatic	24715752	4	O
analyses	24715752	4	O
were	24715752	4	O
performed	24715752	4	O
using	24715752	4	O
SIFT	24715752	4	O
and	24715752	4	O
PolyPhen	24715752	4	O
for	24715752	4	O
the	24715752	4	O
identified	24715752	4	O
missense	24715752	4	O
mutations	24715752	4	O
.	24715752	4	O
RESULTS	24715752	4	O
:	24715752	4	O
All	24715752	4	O
eight	24715752	4	O
affected	24715752	4	O
index	24715752	4	O
patients	24715752	4	O
and	24715752	4	O
affected	24715752	4	O
family	24715752	4	O
members	24715752	4	O
were	24715752	4	O
identified	24715752	4	O
as	24715752	4	O
having	24715752	4	B-Reg
cCSNB	24715752	4	B-Disease
based	24715752	4	O
on	24715752	4	O
their	24715752	4	O
ERG	24715752	4	O
waveforms	24715752	4	O
.	24715752	4	O
Mutations	24715752	4	B-Var
in	24715752	4	O
the	24715752	4	O
TRPM1	24715752	4	B-Gene
gene	24715752	4	O
were	24715752	4	O
identified	24715752	4	O
in	24715752	4	O
six	24715752	4	O
index	24715752	4	O
patients	24715752	4	O
.	24715752	4	O
The	24715752	4	O
two	24715752	4	O
remaining	24715752	4	O
index	24715752	4	O
patients	24715752	4	O
each	24715752	4	O
carried	24715752	4	O
a	24715752	4	O
GPR179	24715752	4	B-Gene
and	24715752	4	O
GRM6	24715752	4	B-Gene
mutation	24715752	4	B-Var
.	24715752	4	O
Seven	24715752	4	O
of	24715752	4	O
the	24715752	4	O
patients	24715752	4	O
revealed	24715752	4	O
homozygous	24715752	4	O
mutations	24715752	4	O
,	24715752	4	O
while	24715752	4	O
one	24715752	4	O
patient	24715752	4	O
showed	24715752	4	O
a	24715752	4	O
compound	24715752	4	O
heterozygous	24715752	4	O
mutation	24715752	4	O
.	24715752	4	O
Six	24715752	4	O
of	24715752	4	O
the	24715752	4	O
eight	24715752	4	O
mutations	24715752	4	O
identified	24715752	4	O
are	24715752	4	O
novel	24715752	4	O
.	24715752	4	O
CONCLUSIONS	24715752	4	O
:	24715752	4	O
This	24715752	4	O
is	24715752	4	O
the	24715752	4	O
first	24715752	4	O
report	24715752	4	O
on	24715752	4	O
molecular	24715752	4	O
profiling	24715752	4	O
of	24715752	4	O
candidate	24715752	4	O
genes	24715752	4	O
in	24715752	4	O
CSNB	24715752	4	O
in	24715752	4	O
an	24715752	4	O
Indian	24715752	4	O
cohort	24715752	4	O
.	24715752	4	O
As	24715752	4	O
shown	24715752	4	O
for	24715752	4	O
other	24715752	4	O
cohorts	24715752	4	O
,	24715752	4	O
TRPM1	24715752	4	B-Gene
seems	24715752	4	O
to	24715752	4	O
be	24715752	4	O
a	24715752	4	O
major	24715752	4	O
gene	24715752	4	O
defect	24715752	4	B-Var
in	24715752	4	O
patients	24715752	4	O
with	24715752	4	B-Reg
cCSNB	24715752	4	B-Disease
in	24715752	4	O
India	24715752	4	O
.	24715752	4	O

UBQLN2	24771548	2	B-Gene
mutation	24771548	2	B-Var
causing	24771548	2	B-Reg
heterogeneous	24771548	2	B-Disease
X	24771548	2	I-Disease
-	24771548	2	I-Disease
linked	24771548	2	I-Disease
dominant	24771548	2	I-Disease
neurodegeneration	24771548	2	I-Disease
.	24771548	2	O
We	24771548	2	O
report	24771548	2	O
a	24771548	2	O
5	24771548	2	O
-	24771548	2	O
generation	24771548	2	O
family	24771548	2	O
with	24771548	2	O
phenotypically	24771548	2	O
diverse	24771548	2	O
neurodegenerative	24771548	2	O
disease	24771548	2	O
including	24771548	2	O
relentlessly	24771548	2	O
progressive	24771548	2	O
choreoathetoid	24771548	2	O
movements	24771548	2	O
,	24771548	2	O
dysarthria	24771548	2	O
,	24771548	2	O
dysphagia	24771548	2	O
,	24771548	2	O
spastic	24771548	2	O
paralysis	24771548	2	O
,	24771548	2	O
and	24771548	2	O
behavioral	24771548	2	O
dementia	24771548	2	O
in	24771548	2	O
descendants	24771548	2	O
of	24771548	2	O
a	24771548	2	O
67	24771548	2	O
-	24771548	2	O
year	24771548	2	O
-	24771548	2	O
old	24771548	2	O
woman	24771548	2	O
with	24771548	2	O
amyotrophic	24771548	2	O
lateral	24771548	2	O
sclerosis	24771548	2	O
.	24771548	2	O
Disease	24771548	2	O
onset	24771548	2	O
varied	24771548	2	O
with	24771548	2	O
gender	24771548	2	O
,	24771548	2	O
occurring	24771548	2	O
in	24771548	2	O
male	24771548	2	O
children	24771548	2	O
and	24771548	2	O
adult	24771548	2	O
women	24771548	2	O
.	24771548	2	O
Exome	24771548	2	O
sequence	24771548	2	O
analyses	24771548	2	O
revealed	24771548	2	O
a	24771548	2	O
novel	24771548	2	O
mutation	24771548	2	O
(	24771548	2	O
c.1490	24771548	2	O
C	24771548	2	O
>	24771548	2	O
T	24771548	2	O
,	24771548	2	O
p.P497L	24771548	2	O
)	24771548	2	O
in	24771548	2	O
the	24771548	2	O
ubiquilin-2	24771548	2	O
gene	24771548	2	O
(	24771548	2	O
UBQLN2	24771548	2	O
)	24771548	2	O
with	24771548	2	O
X	24771548	2	O
-	24771548	2	O
linked	24771548	2	O
inheritance	24771548	2	O
in	24771548	2	O
all	24771548	2	O
studied	24771548	2	O
affected	24771548	2	O
individuals	24771548	2	O
.	24771548	2	O
As	24771548	2	O
ubiquilin-2	24771548	2	O
-	24771548	2	O
positive	24771548	2	O
inclusions	24771548	2	O
were	24771548	2	O
identified	24771548	2	O
in	24771548	2	O
brain	24771548	2	O
,	24771548	2	O
we	24771548	2	O
suggest	24771548	2	O
that	24771548	2	O
mutant	24771548	2	B-Var
peptide	24771548	2	O
predisposes	24771548	2	B-Reg
to	24771548	2	I-Reg
protein	24771548	2	O
misfolding	24771548	2	O
and	24771548	2	O
accumulation	24771548	2	B-PosReg
.	24771548	2	O
Our	24771548	2	O
findings	24771548	2	O
expand	24771548	2	O
the	24771548	2	O
spectrum	24771548	2	O
of	24771548	2	O
neurodegenerative	24771548	2	O
phenotypes	24771548	2	O
caused	24771548	2	O
by	24771548	2	O
UBQLN2	24771548	2	O
mutations	24771548	2	O
.	24771548	2	O

Splicing	24781643	4	B-Var
mutation	24781643	4	I-Var
in	24781643	4	O
MVK	24781643	4	B-Gene
is	24781643	4	O
a	24781643	4	O
cause	24781643	4	B-Reg
of	24781643	4	O
porokeratosis	24781643	4	B-Disease
of	24781643	4	I-Disease
Mibelli	24781643	4	I-Disease
.	24781643	4	O
Porokeratosis	24781643	4	O
is	24781643	4	O
a	24781643	4	O
chronic	24781643	4	O
skin	24781643	4	O
disorder	24781643	4	O
characterized	24781643	4	O
by	24781643	4	O
the	24781643	4	O
presence	24781643	4	O
of	24781643	4	O
patches	24781643	4	O
with	24781643	4	O
elevated	24781643	4	O
,	24781643	4	O
thick	24781643	4	O
,	24781643	4	O
keratotic	24781643	4	O
borders	24781643	4	O
,	24781643	4	O
with	24781643	4	O
histological	24781643	4	O
cornoid	24781643	4	O
lamella	24781643	4	O
.	24781643	4	O
Classic	24781643	4	O
porokeratosis	24781643	4	O
of	24781643	4	O
Mibelli	24781643	4	O
(	24781643	4	O
PM	24781643	4	O
)	24781643	4	O
frequently	24781643	4	O
appears	24781643	4	O
in	24781643	4	O
childhood	24781643	4	O
with	24781643	4	O
a	24781643	4	O
risk	24781643	4	O
of	24781643	4	O
malignant	24781643	4	O
transformation	24781643	4	O
.	24781643	4	O
Disseminated	24781643	4	O
superficial	24781643	4	O
actinic	24781643	4	O
porokeratosis	24781643	4	O
(	24781643	4	O
DSAP	24781643	4	O
)	24781643	4	O
is	24781643	4	O
the	24781643	4	O
most	24781643	4	O
common	24781643	4	O
subtype	24781643	4	O
of	24781643	4	O
porokeratosis	24781643	4	O
with	24781643	4	O
genetic	24781643	4	O
heterogeneities	24781643	4	O
,	24781643	4	O
and	24781643	4	O
mevalonate	24781643	4	O
kinase	24781643	4	O
gene	24781643	4	O
(	24781643	4	O
MVK	24781643	4	O
)	24781643	4	O
mutations	24781643	4	O
have	24781643	4	O
been	24781643	4	O
identified	24781643	4	O
in	24781643	4	O
minor	24781643	4	O
portion	24781643	4	O
of	24781643	4	O
DSAP	24781643	4	O
families	24781643	4	O
of	24781643	4	O
Chinese	24781643	4	O
origin	24781643	4	O
.	24781643	4	O
To	24781643	4	O
confirm	24781643	4	O
the	24781643	4	O
previous	24781643	4	O
findings	24781643	4	O
about	24781643	4	O
MVK	24781643	4	O
mutations	24781643	4	O
in	24781643	4	O
DSAP	24781643	4	O
patients	24781643	4	O
and	24781643	4	O
test	24781643	4	O
MVK	24781643	4	O
'	24781643	4	O
s	24781643	4	O
role	24781643	4	O
(	24781643	4	O
s	24781643	4	O
)	24781643	4	O
in	24781643	4	O
PM	24781643	4	O
development	24781643	4	O
,	24781643	4	O
we	24781643	4	O
performed	24781643	4	O
genomic	24781643	4	O
sequence	24781643	4	O
analysis	24781643	4	O
for	24781643	4	O
3	24781643	4	O
DSAP	24781643	4	O
families	24781643	4	O
and	24781643	4	O
1	24781643	4	O
PM	24781643	4	O
family	24781643	4	O
of	24781643	4	O
Chinese	24781643	4	O
origin	24781643	4	O
.	24781643	4	O
We	24781643	4	O
identified	24781643	4	O
a	24781643	4	O
splicing	24781643	4	O
mutation	24781643	4	O
of	24781643	4	O
MVK	24781643	4	O
gene	24781643	4	O
,	24781643	4	O
designated	24781643	4	O
as	24781643	4	O
c.1039	24781643	4	O
1	24781643	4	O
G	24781643	4	O
>	24781643	4	O
A	24781643	4	O
,	24781643	4	O
in	24781643	4	O
the	24781643	4	O
PM	24781643	4	O
family	24781643	4	O
.	24781643	4	O
No	24781643	4	O
MVK	24781643	4	O
mutations	24781643	4	O
were	24781643	4	O
found	24781643	4	O
in	24781643	4	O
three	24781643	4	O
DSAP	24781643	4	O
families	24781643	4	O
.	24781643	4	O
Sequence	24781643	4	O
analysis	24781643	4	O
for	24781643	4	O
complementary	24781643	4	O
DNA	24781643	4	O
templates	24781643	4	O
from	24781643	4	O
PM	24781643	4	O
lesions	24781643	4	O
of	24781643	4	O
all	24781643	4	O
patients	24781643	4	O
revealed	24781643	4	O
a	24781643	4	O
mutation	24781643	4	O
at	24781643	4	O
splice	24781643	4	O
donor	24781643	4	O
site	24781643	4	O
of	24781643	4	O
intron	24781643	4	O
10	24781643	4	O
,	24781643	4	O
designated	24781643	4	O
as	24781643	4	O
c.1039	24781643	4	B-Var
1	24781643	4	I-Var
G	24781643	4	I-Var
>	24781643	4	I-Var
A	24781643	4	I-Var
,	24781643	4	O
leading	24781643	4	B-Reg
to	24781643	4	I-Reg
the	24781643	4	O
splicing	24781643	4	O
defect	24781643	4	O
and	24781643	4	O
termination	24781643	4	O
codon	24781643	4	O
52	24781643	4	O
amino	24781643	4	O
acids	24781643	4	O
after	24781643	4	O
exon	24781643	4	O
10	24781643	4	O
.	24781643	4	O
Although	24781643	4	O
no	24781643	4	O
MVK	24781643	4	O
mutations	24781643	4	O
in	24781643	4	O
DSAP	24781643	4	O
patients	24781643	4	O
were	24781643	4	O
found	24781643	4	O
as	24781643	4	O
reported	24781643	4	O
previously	24781643	4	O
,	24781643	4	O
we	24781643	4	O
identified	24781643	4	O
MVK	24781643	4	O
simultaneously	24781643	4	O
responsible	24781643	4	O
for	24781643	4	O
PM	24781643	4	O
development	24781643	4	O
.	24781643	4	O

Whole	24885126	4	O
exome	24885126	4	O
sequencing	24885126	4	O
reveals	24885126	4	O
concomitant	24885126	4	O
mutations	24885126	4	B-Var
of	24885126	4	O
multiple	24885126	4	O
FA	24885126	4	B-Gene
genes	24885126	4	O
in	24885126	4	B-Reg
individual	24885126	4	O
Fanconi	24885126	4	B-Disease
anemia	24885126	4	I-Disease
patients	24885126	4	O
.	24885126	4	O
BACKGROUND	24885126	4	O
:	24885126	4	O
Fanconi	24885126	4	O
anemia	24885126	4	O
(	24885126	4	O
FA	24885126	4	O
)	24885126	4	O
is	24885126	4	O
a	24885126	4	O
rare	24885126	4	O
inherited	24885126	4	O
genetic	24885126	4	O
syndrome	24885126	4	O
with	24885126	4	O
highly	24885126	4	O
variable	24885126	4	O
clinical	24885126	4	O
manifestations	24885126	4	O
.	24885126	4	O
Fifteen	24885126	4	O
genetic	24885126	4	O
subtypes	24885126	4	O
of	24885126	4	O
FA	24885126	4	O
have	24885126	4	O
been	24885126	4	O
identified	24885126	4	O
.	24885126	4	O
Traditional	24885126	4	O
complementation	24885126	4	O
tests	24885126	4	O
for	24885126	4	O
grouping	24885126	4	O
studies	24885126	4	O
have	24885126	4	O
been	24885126	4	O
used	24885126	4	O
generally	24885126	4	O
in	24885126	4	O
FA	24885126	4	O
patients	24885126	4	O
and	24885126	4	O
in	24885126	4	O
stepwise	24885126	4	O
methods	24885126	4	O
to	24885126	4	O
identify	24885126	4	O
the	24885126	4	O
FA	24885126	4	O
type	24885126	4	O
,	24885126	4	O
which	24885126	4	O
can	24885126	4	O
result	24885126	4	O
in	24885126	4	O
incomplete	24885126	4	O
genetic	24885126	4	O
information	24885126	4	O
from	24885126	4	O
FA	24885126	4	O
patients	24885126	4	O
.	24885126	4	O
METHODS	24885126	4	O
:	24885126	4	O
We	24885126	4	O
diagnosed	24885126	4	O
five	24885126	4	O
pediatric	24885126	4	O
patients	24885126	4	O
with	24885126	4	O
FA	24885126	4	O
based	24885126	4	O
on	24885126	4	O
clinical	24885126	4	O
manifestations	24885126	4	O
,	24885126	4	O
and	24885126	4	O
we	24885126	4	O
performed	24885126	4	O
exome	24885126	4	O
sequencing	24885126	4	O
of	24885126	4	O
peripheral	24885126	4	O
blood	24885126	4	O
specimens	24885126	4	O
from	24885126	4	O
these	24885126	4	O
patients	24885126	4	O
and	24885126	4	O
their	24885126	4	O
family	24885126	4	O
members	24885126	4	O
.	24885126	4	O
The	24885126	4	O
related	24885126	4	O
sequencing	24885126	4	O
data	24885126	4	O
were	24885126	4	O
then	24885126	4	O
analyzed	24885126	4	O
by	24885126	4	O
bioinformatics	24885126	4	O
,	24885126	4	O
and	24885126	4	O
the	24885126	4	O
FANC	24885126	4	O
gene	24885126	4	O
mutations	24885126	4	O
identified	24885126	4	O
by	24885126	4	O
exome	24885126	4	O
sequencing	24885126	4	O
were	24885126	4	O
confirmed	24885126	4	O
by	24885126	4	O
PCR	24885126	4	O
re	24885126	4	O
-	24885126	4	O
sequencing	24885126	4	O
.	24885126	4	O
RESULTS	24885126	4	O
:	24885126	4	O
Homozygous	24885126	4	O
and	24885126	4	O
compound	24885126	4	O
heterozygous	24885126	4	O
mutations	24885126	4	O
of	24885126	4	O
FANC	24885126	4	O
genes	24885126	4	O
were	24885126	4	O
identified	24885126	4	O
in	24885126	4	O
all	24885126	4	O
of	24885126	4	O
the	24885126	4	O
patients	24885126	4	O
.	24885126	4	O
The	24885126	4	O
FA	24885126	4	O
subtypes	24885126	4	O
of	24885126	4	O
the	24885126	4	O
patients	24885126	4	O
included	24885126	4	O
FANCA	24885126	4	O
,	24885126	4	O
FANCM	24885126	4	O
and	24885126	4	O
FANCD2	24885126	4	O
.	24885126	4	O
Interestingly	24885126	4	O
,	24885126	4	O
four	24885126	4	O
FA	24885126	4	O
patients	24885126	4	O
harbored	24885126	4	O
multiple	24885126	4	O
mutations	24885126	4	O
in	24885126	4	O
at	24885126	4	O
least	24885126	4	O
two	24885126	4	O
FA	24885126	4	O
genes	24885126	4	O
,	24885126	4	O
and	24885126	4	O
some	24885126	4	O
of	24885126	4	O
these	24885126	4	O
mutations	24885126	4	O
have	24885126	4	O
not	24885126	4	O
been	24885126	4	O
previously	24885126	4	O
reported	24885126	4	O
.	24885126	4	O
These	24885126	4	O
patients	24885126	4	O
'	24885126	4	O
clinical	24885126	4	O
manifestations	24885126	4	O
were	24885126	4	O
vastly	24885126	4	O
different	24885126	4	O
from	24885126	4	O
each	24885126	4	O
other	24885126	4	O
,	24885126	4	O
as	24885126	4	O
were	24885126	4	O
their	24885126	4	O
treatment	24885126	4	O
responses	24885126	4	O
to	24885126	4	O
androstanazol	24885126	4	O
and	24885126	4	O
prednisone	24885126	4	O
.	24885126	4	O
This	24885126	4	O
finding	24885126	4	O
suggests	24885126	4	O
that	24885126	4	O
heterozygous	24885126	4	O
mutation	24885126	4	O
(	24885126	4	O
s	24885126	4	O
)	24885126	4	O
in	24885126	4	O
FA	24885126	4	O
genes	24885126	4	O
could	24885126	4	O
also	24885126	4	O
have	24885126	4	O
diverse	24885126	4	O
biological	24885126	4	O
and	24885126	4	O
/	24885126	4	O
or	24885126	4	O
pathophysiological	24885126	4	O
effects	24885126	4	O
on	24885126	4	O
FA	24885126	4	O
patients	24885126	4	O
or	24885126	4	O
FA	24885126	4	O
gene	24885126	4	O
carriers	24885126	4	O
.	24885126	4	O
Interestingly	24885126	4	O
,	24885126	4	O
we	24885126	4	O
were	24885126	4	O
not	24885126	4	O
able	24885126	4	O
to	24885126	4	O
identify	24885126	4	O
de	24885126	4	O
novo	24885126	4	O
mutations	24885126	4	O
in	24885126	4	O
the	24885126	4	O
genes	24885126	4	O
implicated	24885126	4	O
in	24885126	4	O
DNA	24885126	4	O
repair	24885126	4	O
pathways	24885126	4	O
when	24885126	4	O
the	24885126	4	O
sequencing	24885126	4	O
data	24885126	4	O
of	24885126	4	O
patients	24885126	4	O
were	24885126	4	O
compared	24885126	4	O
with	24885126	4	O
those	24885126	4	O
of	24885126	4	O
their	24885126	4	O
parents	24885126	4	O
.	24885126	4	O
CONCLUSIONS	24885126	4	O
:	24885126	4	O
Our	24885126	4	O
results	24885126	4	O
indicate	24885126	4	O
that	24885126	4	O
Chinese	24885126	4	O
FA	24885126	4	O
patients	24885126	4	O
and	24885126	4	O
carriers	24885126	4	O
might	24885126	4	O
have	24885126	4	O
higher	24885126	4	O
and	24885126	4	O
more	24885126	4	O
complex	24885126	4	O
mutation	24885126	4	O
rates	24885126	4	O
in	24885126	4	O
FANC	24885126	4	O
genes	24885126	4	O
than	24885126	4	O
have	24885126	4	O
been	24885126	4	O
conventionally	24885126	4	O
recognized	24885126	4	O
.	24885126	4	O
Testing	24885126	4	O
of	24885126	4	O
the	24885126	4	O
fifteen	24885126	4	O
FANC	24885126	4	O
genes	24885126	4	O
in	24885126	4	O
FA	24885126	4	O
patients	24885126	4	O
and	24885126	4	O
their	24885126	4	O
family	24885126	4	O
members	24885126	4	O
should	24885126	4	O
be	24885126	4	O
a	24885126	4	O
regular	24885126	4	O
clinical	24885126	4	O
practice	24885126	4	O
to	24885126	4	O
determine	24885126	4	O
the	24885126	4	O
optimal	24885126	4	O
care	24885126	4	O
for	24885126	4	O
the	24885126	4	O
individual	24885126	4	O
patient	24885126	4	O
,	24885126	4	O
to	24885126	4	O
counsel	24885126	4	O
the	24885126	4	O
family	24885126	4	O
and	24885126	4	O
to	24885126	4	O
obtain	24885126	4	O
a	24885126	4	O
better	24885126	4	O
understanding	24885126	4	O
of	24885126	4	O
FA	24885126	4	O
pathophysiology	24885126	4	O
.	24885126	4	O

Mutations	24909267	1	B-Var
in	24909267	1	O
SMARCAD1	24909267	1	B-Gene
cause	24909267	1	B-Reg
autosomal	24909267	1	B-Disease
dominant	24909267	1	I-Disease
adermatoglyphia	24909267	1	I-Disease
and	24909267	1	O
perturb	24909267	1	B-Reg
the	24909267	1	O
expression	24909267	1	O
of	24909267	1	O
epidermal	24909267	1	O
differentiation	24909267	1	O
-	24909267	1	O
associated	24909267	1	O
genes	24909267	1	O
.	24909267	1	O
BACKGROUND	24909267	1	O
:	24909267	1	O
Autosomal	24909267	1	O
dominant	24909267	1	O
adermatoglyphia	24909267	1	O
(	24909267	1	O
ADG	24909267	1	O
)	24909267	1	O
is	24909267	1	O
characterized	24909267	1	O
by	24909267	1	O
lack	24909267	1	O
of	24909267	1	O
palmoplantar	24909267	1	O
epidermal	24909267	1	O
ridges	24909267	1	O
.	24909267	1	O
Recently	24909267	1	O
,	24909267	1	O
ADG	24909267	1	O
was	24909267	1	O
found	24909267	1	O
to	24909267	1	O
be	24909267	1	O
caused	24909267	1	O
in	24909267	1	O
one	24909267	1	O
family	24909267	1	O
by	24909267	1	O
a	24909267	1	O
mutation	24909267	1	O
in	24909267	1	O
SMARCAD1	24909267	1	O
,	24909267	1	O
a	24909267	1	O
member	24909267	1	O
of	24909267	1	O
the	24909267	1	O
SNF	24909267	1	O
subfamily	24909267	1	O
of	24909267	1	O
the	24909267	1	O
helicase	24909267	1	O
protein	24909267	1	O
superfamily	24909267	1	O
.	24909267	1	O
OBJECTIVES	24909267	1	O
:	24909267	1	O
To	24909267	1	O
investigate	24909267	1	O
the	24909267	1	O
genetic	24909267	1	O
basis	24909267	1	O
of	24909267	1	O
ADG	24909267	1	O
.	24909267	1	O
METHODS	24909267	1	O
:	24909267	1	O
We	24909267	1	O
used	24909267	1	O
direct	24909267	1	O
sequencing	24909267	1	O
and	24909267	1	O
global	24909267	1	O
gene	24909267	1	O
expression	24909267	1	O
analysis	24909267	1	O
.	24909267	1	O
RESULTS	24909267	1	O
:	24909267	1	O
We	24909267	1	O
identified	24909267	1	O
three	24909267	1	O
novel	24909267	1	O
heterozygous	24909267	1	O
mutations	24909267	1	O
in	24909267	1	O
SMARCAD1	24909267	1	O
(	24909267	1	O
c.378	24909267	1	O
2	24909267	1	O
T	24909267	1	O
>	24909267	1	O
C	24909267	1	O
,	24909267	1	O
c.378	24909267	1	O
5	24909267	1	O
G	24909267	1	O
>	24909267	1	O
C	24909267	1	O
and	24909267	1	O
c.378	24909267	1	O
1	24909267	1	O
G	24909267	1	O
>	24909267	1	O
A	24909267	1	O
)	24909267	1	O
in	24909267	1	O
a	24909267	1	O
total	24909267	1	O
of	24909267	1	O
six	24909267	1	O
patients	24909267	1	O
.	24909267	1	O
Surprisingly	24909267	1	O
,	24909267	1	O
all	24909267	1	O
four	24909267	1	O
ADG	24909267	1	O
-	24909267	1	O
causing	24909267	1	O
mutations	24909267	1	B-Var
identified	24909267	1	O
to	24909267	1	O
date	24909267	1	O
disrupt	24909267	1	B-NegReg
a	24909267	1	O
single	24909267	1	O
conserved	24909267	1	O
donor	24909267	1	O
splice	24909267	1	O
site	24909267	1	O
adjacent	24909267	1	O
to	24909267	1	O
the	24909267	1	O
3	24909267	1	O
'	24909267	1	O
end	24909267	1	O
of	24909267	1	O
a	24909267	1	O
noncoding	24909267	1	O
exon	24909267	1	O
and	24909267	1	O
are	24909267	1	O
predicted	24909267	1	O
to	24909267	1	O
result	24909267	1	O
in	24909267	1	O
haploinsufficiency	24909267	1	B-NegReg
for	24909267	1	O
a	24909267	1	O
skin	24909267	1	O
-	24909267	1	O
specific	24909267	1	O
isoform	24909267	1	O
of	24909267	1	O
SMARCAD1	24909267	1	B-Gene
.	24909267	1	O
These	24909267	1	O
data	24909267	1	O
indicate	24909267	1	O
a	24909267	1	O
pivotal	24909267	1	O
role	24909267	1	O
for	24909267	1	O
the	24909267	1	O
SMARCAD1	24909267	1	O
-	24909267	1	O
skin	24909267	1	O
specific	24909267	1	O
isoform	24909267	1	O
in	24909267	1	O
dermatoglyph	24909267	1	O
formation	24909267	1	O
.	24909267	1	O
In	24909267	1	O
order	24909267	1	O
to	24909267	1	O
better	24909267	1	O
understand	24909267	1	O
the	24909267	1	O
consequences	24909267	1	O
of	24909267	1	O
ADG	24909267	1	O
-	24909267	1	O
associated	24909267	1	O
mutations	24909267	1	O
,	24909267	1	O
we	24909267	1	O
ascertained	24909267	1	O
the	24909267	1	O
global	24909267	1	O
transcription	24909267	1	O
profiles	24909267	1	O
of	24909267	1	O
primary	24909267	1	O
keratinocytes	24909267	1	O
downregulated	24909267	1	O
for	24909267	1	O
SMARCAD1	24909267	1	O
and	24909267	1	O
of	24909267	1	O
patient	24909267	1	O
-	24909267	1	O
derived	24909267	1	O
keratinocytes	24909267	1	O
.	24909267	1	O
A	24909267	1	O
total	24909267	1	O
of	24909267	1	O
eight	24909267	1	O
genes	24909267	1	O
were	24909267	1	O
found	24909267	1	O
to	24909267	1	O
be	24909267	1	O
differentially	24909267	1	O
expressed	24909267	1	O
in	24909267	1	O
both	24909267	1	O
patient	24909267	1	O
-	24909267	1	O
derived	24909267	1	O
and	24909267	1	O
knocked	24909267	1	O
down	24909267	1	O
keratinocytes	24909267	1	O
.	24909267	1	O
Of	24909267	1	O
interest	24909267	1	O
,	24909267	1	O
these	24909267	1	O
differentially	24909267	1	O
expressed	24909267	1	O
genes	24909267	1	O
have	24909267	1	O
been	24909267	1	O
implicated	24909267	1	O
in	24909267	1	O
epidermal	24909267	1	O
ontogenesis	24909267	1	O
and	24909267	1	O
differentiation	24909267	1	O
,	24909267	1	O
and	24909267	1	O
in	24909267	1	O
psoriasis	24909267	1	O
,	24909267	1	O
which	24909267	1	O
is	24909267	1	O
characterized	24909267	1	O
by	24909267	1	O
abnormal	24909267	1	O
finger	24909267	1	O
ridge	24909267	1	O
patterns	24909267	1	O
.	24909267	1	O
CONCLUSIONS	24909267	1	O
:	24909267	1	O
The	24909267	1	O
present	24909267	1	O
data	24909267	1	O
suggest	24909267	1	O
that	24909267	1	O
ADG	24909267	1	O
is	24909267	1	O
genetically	24909267	1	O
homogeneous	24909267	1	O
and	24909267	1	O
result	24909267	1	O
from	24909267	1	O
perturbed	24909267	1	O
expression	24909267	1	O
of	24909267	1	O
epidermal	24909267	1	O
differentiation	24909267	1	O
-	24909267	1	O
associated	24909267	1	O
genes	24909267	1	O
.	24909267	1	O

Genetics	25192508	1	O
and	25192508	1	O
pathophysiology	25192508	1	O
of	25192508	1	O
primary	25192508	1	O
dystonia	25192508	1	O
with	25192508	1	O
special	25192508	1	O
emphasis	25192508	1	O
on	25192508	1	O
DYT1	25192508	1	O
and	25192508	1	O
DYT5	25192508	1	O
.	25192508	1	O
DYT1	25192508	1	O
and	25192508	1	O
DYT5	25192508	1	O
are	25192508	1	O
early	25192508	1	O
-	25192508	1	O
onset	25192508	1	O
dominant	25192508	1	O
inherited	25192508	1	O
dystonias	25192508	1	O
.	25192508	1	O
DYT1	25192508	1	B-Disease
is	25192508	1	O
caused	25192508	1	B-Reg
by	25192508	1	I-Reg
mutations	25192508	1	B-Var
of	25192508	1	O
the	25192508	1	O
TOR1A	25192508	1	B-Gene
gene	25192508	1	O
,	25192508	1	O
located	25192508	1	O
on	25192508	1	O
9	25192508	1	O
q34	25192508	1	O
,	25192508	1	O
which	25192508	1	O
causes	25192508	1	O
dysfunction	25192508	1	B-NegReg
of	25192508	1	O
the	25192508	1	O
D1	25192508	1	O
direct	25192508	1	O
pathway	25192508	1	O
or	25192508	1	O
the	25192508	1	O
indirect	25192508	1	O
pathway	25192508	1	O
.	25192508	1	O
Dysfunction	25192508	1	O
of	25192508	1	O
the	25192508	1	O
former	25192508	1	O
causes	25192508	1	O
postural	25192508	1	B-Disease
-	25192508	1	I-Disease
type	25192508	1	I-Disease
and	25192508	1	I-Disease
segmental	25192508	1	I-Disease
dystonia	25192508	1	I-Disease
;	25192508	1	I-Disease
the	25192508	1	O
latter	25192508	1	O
causes	25192508	1	O
action	25192508	1	B-Disease
-	25192508	1	I-Disease
type	25192508	1	I-Disease
dystonia	25192508	1	I-Disease
.	25192508	1	O
In	25192508	1	O
families	25192508	1	O
with	25192508	1	O
action	25192508	1	O
-	25192508	1	O
type	25192508	1	O
dystonia	25192508	1	O
,	25192508	1	O
there	25192508	1	O
are	25192508	1	O
cases	25192508	1	O
with	25192508	1	O
focal	25192508	1	O
and	25192508	1	O
segmental	25192508	1	O
dystonia	25192508	1	O
.	25192508	1	O
Ages	25192508	1	O
of	25192508	1	O
onset	25192508	1	O
of	25192508	1	O
postural	25192508	1	O
-	25192508	1	O
type	25192508	1	O
dystonia	25192508	1	O
are	25192508	1	O
around	25192508	1	O
6	25192508	1	O
years	25192508	1	O
,	25192508	1	O
and	25192508	1	O
8	25192508	1	O
to	25192508	1	O
10	25192508	1	O
years	25192508	1	O
in	25192508	1	O
cases	25192508	1	O
of	25192508	1	O
action	25192508	1	O
-	25192508	1	O
type	25192508	1	O
dystonia	25192508	1	O
.	25192508	1	O
Focal	25192508	1	O
and	25192508	1	O
segmental	25192508	1	O
dystonia	25192508	1	O
develops	25192508	1	O
in	25192508	1	O
the	25192508	1	O
teens	25192508	1	O
.	25192508	1	O
Mental	25192508	1	O
and	25192508	1	O
psychological	25192508	1	O
functions	25192508	1	O
are	25192508	1	O
preserved	25192508	1	O
.	25192508	1	O
DYT5	25192508	1	B-Disease
is	25192508	1	O
caused	25192508	1	B-Reg
by	25192508	1	I-Reg
heterozygous	25192508	1	O
mutations	25192508	1	B-Var
of	25192508	1	O
the	25192508	1	O
GCH1	25192508	1	B-Gene
gene	25192508	1	O
,	25192508	1	O
located	25192508	1	O
on	25192508	1	O
14	25192508	1	O
q22.1	25192508	1	O
-	25192508	1	O
q22.2	25192508	1	O
.	25192508	1	O
Again	25192508	1	O
,	25192508	1	O
mental	25192508	1	O
and	25192508	1	O
psychological	25192508	1	O
functions	25192508	1	O
are	25192508	1	O
preserved	25192508	1	O
.	25192508	1	O
Clinically	25192508	1	O
,	25192508	1	O
there	25192508	1	O
are	25192508	1	O
two	25192508	1	O
types	25192508	1	O
:	25192508	1	O
postural	25192508	1	O
and	25192508	1	O
action	25192508	1	O
.	25192508	1	O
Postural	25192508	1	O
-	25192508	1	O
type	25192508	1	O
dystonia	25192508	1	O
occurs	25192508	1	O
around	25192508	1	O
6	25192508	1	O
years	25192508	1	O
of	25192508	1	O
age	25192508	1	O
,	25192508	1	O
with	25192508	1	O
postural	25192508	1	O
dystonia	25192508	1	O
of	25192508	1	O
one	25192508	1	O
leg	25192508	1	O
,	25192508	1	O
and	25192508	1	O
all	25192508	1	O
extremities	25192508	1	O
and	25192508	1	O
trunk	25192508	1	O
muscles	25192508	1	O
are	25192508	1	O
involved	25192508	1	O
by	25192508	1	O
the	25192508	1	O
late	25192508	1	O
teens	25192508	1	O
.	25192508	1	O
Action	25192508	1	O
-	25192508	1	O
type	25192508	1	O
dystonia	25192508	1	O
shows	25192508	1	O
dystonic	25192508	1	O
movements	25192508	1	O
from	25192508	1	O
around	25192508	1	O
8	25192508	1	O
to	25192508	1	O
10	25192508	1	O
years	25192508	1	O
of	25192508	1	O
age	25192508	1	O
.	25192508	1	O
In	25192508	1	O
both	25192508	1	O
types	25192508	1	O
,	25192508	1	O
all	25192508	1	O
symptoms	25192508	1	O
show	25192508	1	O
diurnal	25192508	1	O
fluctuations	25192508	1	O
that	25192508	1	O
diminish	25192508	1	O
with	25192508	1	O
age	25192508	1	O
and	25192508	1	O
are	25192508	1	O
no	25192508	1	O
longer	25192508	1	O
apparent	25192508	1	O
in	25192508	1	O
the	25192508	1	O
late	25192508	1	O
teens	25192508	1	O
.	25192508	1	O
L	25192508	1	O
-	25192508	1	O
dopa	25192508	1	O
produces	25192508	1	O
dramatic	25192508	1	O
effects	25192508	1	O
,	25192508	1	O
which	25192508	1	O
continue	25192508	1	O
throughout	25192508	1	O
the	25192508	1	O
course	25192508	1	O
of	25192508	1	O
the	25192508	1	O
illness	25192508	1	O
.	25192508	1	O
In	25192508	1	O
both	25192508	1	O
postural	25192508	1	O
and	25192508	1	O
action	25192508	1	O
types	25192508	1	O
,	25192508	1	O
each	25192508	1	O
family	25192508	1	O
or	25192508	1	O
sporadic	25192508	1	O
case	25192508	1	O
has	25192508	1	O
a	25192508	1	O
particular	25192508	1	O
mutation	25192508	1	O
.	25192508	1	O
It	25192508	1	O
remains	25192508	1	O
unclear	25192508	1	O
why	25192508	1	O
specific	25192508	1	O
mutations	25192508	1	O
cause	25192508	1	O
certain	25192508	1	O
age	25192508	1	O
-	25192508	1	O
and	25192508	1	O
gender	25192508	1	O
-	25192508	1	O
specific	25192508	1	O
symptoms	25192508	1	O
.	25192508	1	O

First	25233259	4	O
report	25233259	4	O
of	25233259	4	O
a	25233259	4	O
deletion	25233259	4	O
encompassing	25233259	4	O
an	25233259	4	O
entire	25233259	4	O
exon	25233259	4	O
in	25233259	4	O
the	25233259	4	O
homogentisate	25233259	4	O
1	25233259	4	O
,	25233259	4	O
2	25233259	4	O
-	25233259	4	O
dioxygenase	25233259	4	O
gene	25233259	4	O
causing	25233259	4	O
alkaptonuria	25233259	4	O
.	25233259	4	O
Alkaptonuria	25233259	4	B-Disease
is	25233259	4	O
often	25233259	4	O
diagnosed	25233259	4	O
clinically	25233259	4	O
with	25233259	4	O
episodes	25233259	4	O
of	25233259	4	O
dark	25233259	4	O
urine	25233259	4	O
,	25233259	4	O
biochemically	25233259	4	O
by	25233259	4	O
the	25233259	4	O
accumulation	25233259	4	O
of	25233259	4	O
peripheral	25233259	4	O
homogentisic	25233259	4	O
acid	25233259	4	O
and	25233259	4	O
molecularly	25233259	4	O
by	25233259	4	B-Reg
the	25233259	4	I-Reg
presence	25233259	4	I-Reg
of	25233259	4	I-Reg
mutations	25233259	4	B-Var
in	25233259	4	O
the	25233259	4	O
homogentisate	25233259	4	O
1	25233259	4	O
,	25233259	4	O
2	25233259	4	O
-	25233259	4	O
dioxygenase	25233259	4	O
gene	25233259	4	O
(	25233259	4	B-Gene
HGD	25233259	4	I-Gene
)	25233259	4	I-Gene
.	25233259	4	O
Alkaptonuria	25233259	4	B-Disease
is	25233259	4	O
invariably	25233259	4	O
associated	25233259	4	B-Reg
with	25233259	4	I-Reg
HGD	25233259	4	B-Gene
mutations	25233259	4	B-Var
,	25233259	4	O
which	25233259	4	O
consist	25233259	4	O
of	25233259	4	O
single	25233259	4	B-Var
nucleotide	25233259	4	I-Var
variants	25233259	4	I-Var
and	25233259	4	O
small	25233259	4	B-Var
insertions	25233259	4	I-Var
/	25233259	4	I-Var
deletions	25233259	4	I-Var
.	25233259	4	O
Surprisingly	25233259	4	O
,	25233259	4	O
the	25233259	4	O
presence	25233259	4	O
of	25233259	4	O
deletions	25233259	4	O
beyond	25233259	4	O
a	25233259	4	O
few	25233259	4	O
nucleotides	25233259	4	O
among	25233259	4	O
over	25233259	4	O
150	25233259	4	O
reported	25233259	4	O
deleterious	25233259	4	O
mutations	25233259	4	O
has	25233259	4	O
not	25233259	4	O
been	25233259	4	O
described	25233259	4	O
,	25233259	4	O
raising	25233259	4	O
the	25233259	4	O
suspicion	25233259	4	O
that	25233259	4	O
this	25233259	4	O
gene	25233259	4	O
might	25233259	4	O
be	25233259	4	O
protected	25233259	4	O
against	25233259	4	O
the	25233259	4	O
detrimental	25233259	4	O
mechanisms	25233259	4	O
of	25233259	4	O
gene	25233259	4	O
rearrangements	25233259	4	O
.	25233259	4	O
The	25233259	4	O
quest	25233259	4	O
for	25233259	4	O
an	25233259	4	O
HGD	25233259	4	O
mutation	25233259	4	O
in	25233259	4	O
a	25233259	4	O
proband	25233259	4	O
with	25233259	4	O
AKU	25233259	4	O
revealed	25233259	4	O
with	25233259	4	O
a	25233259	4	O
SNP	25233259	4	O
array	25233259	4	O
five	25233259	4	O
large	25233259	4	O
regions	25233259	4	O
of	25233259	4	O
homozygosity	25233259	4	O
(	25233259	4	O
5	25233259	4	O
-	25233259	4	O
16	25233259	4	O
Mb	25233259	4	O
)	25233259	4	O
,	25233259	4	O
one	25233259	4	O
of	25233259	4	O
which	25233259	4	O
includes	25233259	4	O
the	25233259	4	O
HGD	25233259	4	O
gene	25233259	4	O
.	25233259	4	O
A	25233259	4	O
homozygous	25233259	4	O
deletion	25233259	4	O
of	25233259	4	O
649	25233259	4	O
bp	25233259	4	O
deletion	25233259	4	O
that	25233259	4	O
encompasses	25233259	4	O
the	25233259	4	O
72	25233259	4	O
nucleotides	25233259	4	O
of	25233259	4	O
exon	25233259	4	O
2	25233259	4	O
and	25233259	4	O
surrounding	25233259	4	O
DNA	25233259	4	O
sequences	25233259	4	O
in	25233259	4	O
flanking	25233259	4	O
introns	25233259	4	O
of	25233259	4	O
the	25233259	4	O
HGD	25233259	4	O
gene	25233259	4	O
was	25233259	4	O
unveiled	25233259	4	O
in	25233259	4	O
a	25233259	4	O
proband	25233259	4	O
with	25233259	4	O
AKU	25233259	4	O
.	25233259	4	O
The	25233259	4	O
nature	25233259	4	O
of	25233259	4	O
this	25233259	4	O
deletion	25233259	4	O
suggests	25233259	4	O
that	25233259	4	O
this	25233259	4	O
in	25233259	4	O
-	25233259	4	O
frame	25233259	4	O
deletion	25233259	4	O
could	25233259	4	O
generate	25233259	4	O
a	25233259	4	O
protein	25233259	4	O
without	25233259	4	O
exon	25233259	4	O
2	25233259	4	O
.	25233259	4	O
Thus	25233259	4	O
,	25233259	4	O
we	25233259	4	O
modeled	25233259	4	O
the	25233259	4	O
tertiary	25233259	4	O
structure	25233259	4	O
of	25233259	4	O
the	25233259	4	O
mutant	25233259	4	O
protein	25233259	4	O
structure	25233259	4	O
to	25233259	4	O
determine	25233259	4	O
the	25233259	4	O
effect	25233259	4	O
of	25233259	4	O
exon	25233259	4	O
2	25233259	4	O
deletion	25233259	4	O
.	25233259	4	O
While	25233259	4	O
the	25233259	4	O
two	25233259	4	O
β	25233259	4	O
-	25233259	4	O
pleated	25233259	4	O
sheets	25233259	4	O
encoded	25233259	4	O
by	25233259	4	O
exon	25233259	4	O
2	25233259	4	O
were	25233259	4	O
missing	25233259	4	O
in	25233259	4	O
the	25233259	4	O
mutant	25233259	4	O
structure	25233259	4	O
,	25233259	4	O
other	25233259	4	O
β	25233259	4	O
-	25233259	4	O
pleated	25233259	4	O
sheets	25233259	4	O
are	25233259	4	O
largely	25233259	4	O
unaffected	25233259	4	O
by	25233259	4	O
the	25233259	4	O
deletion	25233259	4	O
.	25233259	4	O
However	25233259	4	O
,	25233259	4	O
nine	25233259	4	O
novel	25233259	4	O
α	25233259	4	O
-	25233259	4	O
helical	25233259	4	O
coils	25233259	4	O
substituted	25233259	4	O
the	25233259	4	O
eight	25233259	4	O
coils	25233259	4	O
present	25233259	4	O
in	25233259	4	O
the	25233259	4	O
native	25233259	4	O
HGD	25233259	4	O
crystal	25233259	4	O
structure	25233259	4	O
.	25233259	4	O
Thus	25233259	4	O
,	25233259	4	O
this	25233259	4	O
deletion	25233259	4	B-Var
results	25233259	4	B-Reg
in	25233259	4	I-Reg
a	25233259	4	O
deleterious	25233259	4	O
enzyme	25233259	4	O
,	25233259	4	O
which	25233259	4	O
is	25233259	4	O
consistent	25233259	4	O
with	25233259	4	O
the	25233259	4	O
proband	25233259	4	O
'	25233259	4	O
s	25233259	4	O
phenotype	25233259	4	O
.	25233259	4	O
Screening	25233259	4	O
for	25233259	4	O
mutations	25233259	4	O
in	25233259	4	O
the	25233259	4	O
HGD	25233259	4	O
gene	25233259	4	O
,	25233259	4	O
particularly	25233259	4	O
in	25233259	4	O
the	25233259	4	O
Middle	25233259	4	O
East	25233259	4	O
,	25233259	4	O
ought	25233259	4	O
to	25233259	4	O
include	25233259	4	O
this	25233259	4	O
exon	25233259	4	O
2	25233259	4	O
deletion	25233259	4	O
in	25233259	4	O
order	25233259	4	O
to	25233259	4	O
determine	25233259	4	O
its	25233259	4	O
frequency	25233259	4	O
and	25233259	4	O
uncover	25233259	4	O
its	25233259	4	O
origin	25233259	4	O
.	25233259	4	O

Identification	25353698	4	O
of	25353698	4	O
two	25353698	4	O
novel	25353698	4	O
mutations	25353698	4	O
in	25353698	4	O
patients	25353698	4	O
with	25353698	4	O
X	25353698	4	O
-	25353698	4	O
linked	25353698	4	O
primary	25353698	4	O
immunodeficiencies	25353698	4	O
.	25353698	4	O
Primary	25353698	4	B-Disease
immunodeficiency	25353698	4	I-Disease
diseases	25353698	4	I-Disease
(	25353698	4	O
PID	25353698	4	O
)	25353698	4	O
are	25353698	4	O
a	25353698	4	O
heterogeneous	25353698	4	O
group	25353698	4	O
of	25353698	4	O
inherited	25353698	4	O
disorders	25353698	4	O
with	25353698	4	O
defects	25353698	4	O
in	25353698	4	O
one	25353698	4	O
or	25353698	4	O
more	25353698	4	O
component	25353698	4	O
of	25353698	4	O
the	25353698	4	O
immune	25353698	4	O
system	25353698	4	O
.	25353698	4	O
In	25353698	4	O
this	25353698	4	O
study	25353698	4	O
,	25353698	4	O
we	25353698	4	O
analyzed	25353698	4	O
gene	25353698	4	O
mutations	25353698	4	O
in	25353698	4	O
four	25353698	4	O
X	25353698	4	O
-	25353698	4	O
linked	25353698	4	O
PID	25353698	4	O
pedigrees	25353698	4	O
,	25353698	4	O
which	25353698	4	O
include	25353698	4	O
one	25353698	4	O
X	25353698	4	O
-	25353698	4	O
linked	25353698	4	O
agammaglobulinemia	25353698	4	O
(	25353698	4	O
XLA	25353698	4	O
)	25353698	4	O
pedigree	25353698	4	O
,	25353698	4	O
one	25353698	4	O
X	25353698	4	O
-	25353698	4	O
linked	25353698	4	O
chronic	25353698	4	O
granulomatous	25353698	4	O
disease	25353698	4	O
(	25353698	4	O
XCGD	25353698	4	O
)	25353698	4	O
pedigree	25353698	4	O
,	25353698	4	O
and	25353698	4	O
two	25353698	4	O
X	25353698	4	O
-	25353698	4	O
linked	25353698	4	O
Hyper	25353698	4	O
IgM	25353698	4	O
syndrome	25353698	4	O
(	25353698	4	O
XHIGM	25353698	4	O
)	25353698	4	O
pedigrees	25353698	4	O
.	25353698	4	O
Sequence	25353698	4	O
analysis	25353698	4	O
of	25353698	4	O
the	25353698	4	O
BTK	25353698	4	B-Gene
gene	25353698	4	O
revealed	25353698	4	O
a	25353698	4	O
novel	25353698	4	O
mutation	25353698	4	O
(	25353698	4	B-Var
c.1802	25353698	4	I-Var
_1803delinsGCC	25353698	4	I-Var
,	25353698	4	O
p.Phe601CysfsX3	25353698	4	O
)	25353698	4	O
which	25353698	4	O
results	25353698	4	B-Reg
in	25353698	4	O
the	25353698	4	O
developmental	25353698	4	O
arrest	25353698	4	O
of	25353698	4	O
B	25353698	4	O
cells	25353698	4	O
in	25353698	4	O
the	25353698	4	O
bone	25353698	4	O
marrow	25353698	4	O
.	25353698	4	O
Sequence	25353698	4	O
analysis	25353698	4	O
of	25353698	4	O
the	25353698	4	O
CYBB	25353698	4	B-Gene
gene	25353698	4	O
revealed	25353698	4	O
a	25353698	4	O
recurrent	25353698	4	O
frameshift	25353698	4	O
mutation	25353698	4	O
(	25353698	4	B-Var
c.1313	25353698	4	I-Var
_1314delinsT	25353698	4	I-Var
)	25353698	4	I-Var
in	25353698	4	O
exon	25353698	4	O
10	25353698	4	O
,	25353698	4	O
which	25353698	4	O
generates	25353698	4	B-Reg
a	25353698	4	O
premature	25353698	4	O
stop	25353698	4	O
codon	25353698	4	O
(	25353698	4	O
p.Lys438IlefsX63	25353698	4	O
)	25353698	4	O
.	25353698	4	O
One	25353698	4	O
novel	25353698	4	O
frameshift	25353698	4	O
mutation	25353698	4	O
(	25353698	4	B-Var
c.114	25353698	4	I-Var
delG	25353698	4	I-Var
,	25353698	4	O
p.Ser39GlnfsX14	25353698	4	O
)	25353698	4	O
and	25353698	4	O
one	25353698	4	O
recurrent	25353698	4	O
missense	25353698	4	O
mutation	25353698	4	O
(	25353698	4	B-Var
c.499	25353698	4	I-Var
G	25353698	4	I-Var
>	25353698	4	I-Var
C	25353698	4	I-Var
,	25353698	4	O
p.Gly167Arg	25353698	4	O
)	25353698	4	O
were	25353698	4	O
found	25353698	4	O
in	25353698	4	O
the	25353698	4	O
CD40LG	25353698	4	B-Gene
gene	25353698	4	O
and	25353698	4	O
cause	25353698	4	O
defective	25353698	4	B-NegReg
T	25353698	4	O
cell	25353698	4	O
functioning	25353698	4	O
.	25353698	4	O
In	25353698	4	O
conclusion	25353698	4	O
,	25353698	4	O
our	25353698	4	O
study	25353698	4	O
identified	25353698	4	O
two	25353698	4	O
novel	25353698	4	O
mutations	25353698	4	O
on	25353698	4	O
the	25353698	4	O
BTK	25353698	4	O
and	25353698	4	O
CD40LG	25353698	4	O
genes	25353698	4	O
in	25353698	4	O
Chinese	25353698	4	O
patients	25353698	4	O
and	25353698	4	O
established	25353698	4	O
accurate	25353698	4	O
and	25353698	4	O
simple	25353698	4	O
genetic	25353698	4	O
diagnostic	25353698	4	O
methods	25353698	4	O
for	25353698	4	O
three	25353698	4	O
X	25353698	4	O
-	25353698	4	O
linked	25353698	4	O
PID	25353698	4	O
.	25353698	4	O

Novel	25381065	4	O
COL9A3	25381065	4	B-Gene
mutation	25381065	4	B-Var
in	25381065	4	O
a	25381065	4	O
family	25381065	4	O
diagnosed	25381065	4	O
with	25381065	4	B-Reg
multiple	25381065	4	B-Disease
epiphyseal	25381065	4	I-Disease
dysplasia	25381065	4	I-Disease
:	25381065	4	I-Disease
a	25381065	4	O
case	25381065	4	O
report	25381065	4	O
.	25381065	4	O
BACKGROUND	25381065	4	O
:	25381065	4	O
Multiple	25381065	4	O
epiphyseal	25381065	4	O
dysplasia	25381065	4	O
is	25381065	4	O
a	25381065	4	O
common	25381065	4	O
skeletal	25381065	4	O
dysplasia	25381065	4	O
characterized	25381065	4	O
by	25381065	4	O
mild	25381065	4	O
short	25381065	4	O
stature	25381065	4	O
,	25381065	4	O
early	25381065	4	O
-	25381065	4	O
onset	25381065	4	O
osteoarthritis	25381065	4	O
mainly	25381065	4	O
involving	25381065	4	O
the	25381065	4	O
hip	25381065	4	O
and	25381065	4	O
knee	25381065	4	O
joints	25381065	4	O
,	25381065	4	O
and	25381065	4	O
abnormally	25381065	4	O
small	25381065	4	O
and	25381065	4	O
/	25381065	4	O
or	25381065	4	O
irregular	25381065	4	O
epiphyses	25381065	4	O
.	25381065	4	O
Multiple	25381065	4	O
epiphyseal	25381065	4	O
dysplasia	25381065	4	O
is	25381065	4	O
clinically	25381065	4	O
and	25381065	4	O
genetically	25381065	4	O
heterogeneous	25381065	4	O
and	25381065	4	O
six	25381065	4	O
genes	25381065	4	O
are	25381065	4	O
associated	25381065	4	O
with	25381065	4	O
the	25381065	4	O
phenotype	25381065	4	O
of	25381065	4	O
multiple	25381065	4	O
epiphyseal	25381065	4	O
dysplasia	25381065	4	O
.	25381065	4	O
CASE	25381065	4	O
PRESENTATION	25381065	4	O
:	25381065	4	O
A	25381065	4	O
12	25381065	4	O
-	25381065	4	O
year	25381065	4	O
-	25381065	4	O
old	25381065	4	O
Korean	25381065	4	O
boy	25381065	4	O
presented	25381065	4	O
with	25381065	4	O
intermittent	25381065	4	O
knee	25381065	4	O
pain	25381065	4	O
.	25381065	4	O
His	25381065	4	O
height	25381065	4	O
was	25381065	4	O
144.6	25381065	4	O
cm	25381065	4	O
(	25381065	4	O
20	25381065	4	O
th	25381065	4	O
percentile	25381065	4	O
)	25381065	4	O
and	25381065	4	O
family	25381065	4	O
history	25381065	4	O
was	25381065	4	O
notable	25381065	4	O
for	25381065	4	O
early	25381065	4	O
-	25381065	4	O
onset	25381065	4	O
osteoarthritis	25381065	4	O
in	25381065	4	O
his	25381065	4	O
father	25381065	4	O
.	25381065	4	O
The	25381065	4	O
proband	25381065	4	O
'	25381065	4	O
s	25381065	4	O
x	25381065	4	O
-	25381065	4	O
rays	25381065	4	O
revealed	25381065	4	O
epiphyseal	25381065	4	O
changes	25381065	4	O
characteristic	25381065	4	O
of	25381065	4	O
multiple	25381065	4	O
epiphyseal	25381065	4	O
dysplasia	25381065	4	O
associated	25381065	4	O
with	25381065	4	O
a	25381065	4	O
collagen	25381065	4	O
IX	25381065	4	O
defect	25381065	4	O
,	25381065	4	O
with	25381065	4	O
manifestations	25381065	4	O
primarily	25381065	4	O
restricted	25381065	4	O
to	25381065	4	O
the	25381065	4	O
knees	25381065	4	O
.	25381065	4	O
Mutational	25381065	4	O
analysis	25381065	4	O
identified	25381065	4	O
a	25381065	4	O
novel	25381065	4	O
c.104	25381065	4	B-Var
G	25381065	4	I-Var
>	25381065	4	I-Var
A	25381065	4	I-Var
substitution	25381065	4	O
in	25381065	4	O
exon	25381065	4	O
2	25381065	4	O
of	25381065	4	O
COL9A3	25381065	4	B-Gene
,	25381065	4	O
resulting	25381065	4	B-Reg
in	25381065	4	I-Reg
p.Gly35Asp	25381065	4	B-Var
in	25381065	4	O
the	25381065	4	O
proband	25381065	4	O
and	25381065	4	O
his	25381065	4	O
father	25381065	4	O
.	25381065	4	O
In	25381065	4	O
silico	25381065	4	O
analyses	25381065	4	O
predicted	25381065	4	O
the	25381065	4	O
p.Gly35Asp	25381065	4	O
amino	25381065	4	O
acid	25381065	4	O
change	25381065	4	O
to	25381065	4	O
be	25381065	4	O
detelerious	25381065	4	O
,	25381065	4	O
and	25381065	4	O
molecular	25381065	4	O
dynamics	25381065	4	O
simulation	25381065	4	O
demonstrated	25381065	4	O
a	25381065	4	O
major	25381065	4	O
structural	25381065	4	O
change	25381065	4	O
in	25381065	4	O
the	25381065	4	O
heterotrimeric	25381065	4	O
collagen	25381065	4	O
IX	25381065	4	O
.	25381065	4	O
CONCLUSION	25381065	4	O
:	25381065	4	O
So	25381065	4	O
far	25381065	4	O
,	25381065	4	O
three	25381065	4	O
COL9A3	25381065	4	O
mutations	25381065	4	O
,	25381065	4	O
have	25381065	4	O
been	25381065	4	O
reported	25381065	4	O
.	25381065	4	O
These	25381065	4	O
three	25381065	4	O
mutations	25381065	4	B-Var
are	25381065	4	O
located	25381065	4	O
at	25381065	4	O
the	25381065	4	O
splice	25381065	4	O
donor	25381065	4	O
or	25381065	4	O
acceptor	25381065	4	O
site	25381065	4	O
of	25381065	4	O
COL9A3	25381065	4	B-Gene
and	25381065	4	O
cause	25381065	4	B-Reg
skipping	25381065	4	O
of	25381065	4	O
exon	25381065	4	O
3	25381065	4	O
,	25381065	4	O
resulting	25381065	4	B-Reg
in	25381065	4	I-Reg
the	25381065	4	O
deletion	25381065	4	B-Var
of	25381065	4	O
12	25381065	4	O
aminoacids	25381065	4	O
in	25381065	4	O
the	25381065	4	O
COL3	25381065	4	O
domain	25381065	4	O
of	25381065	4	O
COL9A3	25381065	4	B-Gene
.	25381065	4	O
In	25381065	4	O
contrast	25381065	4	O
,	25381065	4	O
the	25381065	4	O
novel	25381065	4	O
missense	25381065	4	O
mutation	25381065	4	O
identified	25381065	4	O
in	25381065	4	O
this	25381065	4	O
two	25381065	4	O
-	25381065	4	O
generation	25381065	4	O
family	25381065	4	O
with	25381065	4	O
multiple	25381065	4	O
epiphyseal	25381065	4	O
dysplasia	25381065	4	O
is	25381065	4	O
a	25381065	4	O
missense	25381065	4	O
mutation	25381065	4	B-Var
affecting	25381065	4	B-Reg
the	25381065	4	O
Gly	25381065	4	O
residue	25381065	4	O
of	25381065	4	O
the	25381065	4	O
Pro	25381065	4	O
-	25381065	4	O
Pro	25381065	4	O
-	25381065	4	O
Gly	25381065	4	O
repeat	25381065	4	O
sequence	25381065	4	O
in	25381065	4	O
the	25381065	4	O
COL3	25381065	4	O
domain	25381065	4	O
of	25381065	4	O
collage	25381065	4	O
IX	25381065	4	O
,	25381065	4	O
with	25381065	4	O
accompanying	25381065	4	O
major	25381065	4	O
structural	25381065	4	O
change	25381065	4	O
of	25381065	4	O
the	25381065	4	O
collagen	25381065	4	O
peptide	25381065	4	O
.	25381065	4	O

Rett	25439737	4	O
-	25439737	4	O
like	25439737	4	O
onset	25439737	4	O
in	25439737	4	O
late	25439737	4	B-Disease
-	25439737	4	I-Disease
infantile	25439737	4	I-Disease
neuronal	25439737	4	I-Disease
ceroid	25439737	4	I-Disease
lipofuscinosis	25439737	4	I-Disease
(	25439737	4	O
CLN7	25439737	4	O
)	25439737	4	O
caused	25439737	4	B-Reg
by	25439737	4	I-Reg
compound	25439737	4	O
heterozygous	25439737	4	O
mutation	25439737	4	B-Var
in	25439737	4	O
the	25439737	4	O
MFSD8	25439737	4	B-Gene
gene	25439737	4	O
and	25439737	4	O
review	25439737	4	O
of	25439737	4	O
the	25439737	4	O
literature	25439737	4	O
data	25439737	4	O
on	25439737	4	O
clinical	25439737	4	O
onset	25439737	4	O
signs	25439737	4	O
.	25439737	4	O
BACKGROUND	25439737	4	O
:	25439737	4	O
We	25439737	4	O
present	25439737	4	O
clinical	25439737	4	O
and	25439737	4	O
molecular	25439737	4	O
findings	25439737	4	O
of	25439737	4	O
a	25439737	4	O
patient	25439737	4	O
with	25439737	4	O
ceroid	25439737	4	O
-	25439737	4	O
lipofuscinosis	25439737	4	O
CLN7	25439737	4	B-Disease
,	25439737	4	O
with	25439737	4	B-Reg
a	25439737	4	O
compound	25439737	4	O
heterozygous	25439737	4	O
mutation	25439737	4	B-Var
of	25439737	4	O
the	25439737	4	O
MFSD8	25439737	4	B-Gene
gene	25439737	4	O
,	25439737	4	O
with	25439737	4	O
Rett	25439737	4	O
syndrome	25439737	4	O
clinical	25439737	4	O
signs	25439737	4	O
onset	25439737	4	O
and	25439737	4	O
a	25439737	4	O
later	25439737	4	O
development	25439737	4	O
of	25439737	4	O
full	25439737	4	O
picture	25439737	4	O
of	25439737	4	O
vLINCL	25439737	4	O
.	25439737	4	O
CASE	25439737	4	O
PRESENTATION	25439737	4	O
:	25439737	4	O
A	25439737	4	O
7	25439737	4	O
years	25439737	4	O
-	25439737	4	O
old	25439737	4	O
female	25439737	4	O
patient	25439737	4	O
with	25439737	4	O
normal	25439737	4	O
development	25439737	4	O
until	25439737	4	O
the	25439737	4	O
age	25439737	4	O
12	25439737	4	O
months	25439737	4	O
,	25439737	4	O
developed	25439737	4	O
Rett	25439737	4	O
like	25439737	4	O
clinical	25439737	4	O
picture	25439737	4	O
(	25439737	4	O
psychomotor	25439737	4	O
regression	25439737	4	O
,	25439737	4	O
microcephaly	25439737	4	O
,	25439737	4	O
stereotypic	25439737	4	O
hands	25439737	4	O
movements	25439737	4	O
in	25439737	4	O
the	25439737	4	O
midline	25439737	4	O
,	25439737	4	O
hyperventilation	25439737	4	O
episodes	25439737	4	O
)	25439737	4	O
present	25439737	4	O
at	25439737	4	O
the	25439737	4	O
onset	25439737	4	O
of	25439737	4	O
her	25439737	4	O
condition	25439737	4	O
(	25439737	4	O
age	25439737	4	O
18	25439737	4	O
months	25439737	4	O
)	25439737	4	O
,	25439737	4	O
features	25439737	4	O
still	25439737	4	O
present	25439737	4	O
at	25439737	4	O
the	25439737	4	O
initial	25439737	4	O
evaluation	25439737	4	O
in	25439737	4	O
our	25439737	4	O
clinic	25439737	4	O
at	25439737	4	O
age	25439737	4	O
5	25439737	4	O
years	25439737	4	O
.	25439737	4	O
RESULTS	25439737	4	O
:	25439737	4	O
MECP2	25439737	4	O
(	25439737	4	O
methyl	25439737	4	O
CpG	25439737	4	O
binding	25439737	4	O
protein	25439737	4	O
2	25439737	4	O
)	25439737	4	O
gene	25439737	4	O
mutation	25439737	4	O
was	25439737	4	O
negative	25439737	4	O
.	25439737	4	O
At	25439737	4	O
age	25439737	4	O
6	25439737	4	O
years	25439737	4	O
she	25439737	4	O
was	25439737	4	O
readmitted	25439737	4	O
for	25439737	4	O
severe	25439737	4	O
ataxia	25439737	4	O
and	25439737	4	O
blindness	25439737	4	O
,	25439737	4	O
seizures	25439737	4	O
,	25439737	4	O
and	25439737	4	O
severe	25439737	4	O
developmental	25439737	4	O
regression	25439737	4	O
leading	25439737	4	O
to	25439737	4	O
NCL	25439737	4	O
(	25439737	4	O
neuronal	25439737	4	O
ceroid	25439737	4	O
lipofuscinosis	25439737	4	O
)	25439737	4	O
suspicion	25439737	4	O
.	25439737	4	O
EEG	25439737	4	O
showed	25439737	4	O
slow	25439737	4	O
background	25439737	4	O
with	25439737	4	O
IRDA	25439737	4	O
(	25439737	4	O
intermittent	25439737	4	O
rhythmic	25439737	4	O
delta	25439737	4	O
activity	25439737	4	O
)	25439737	4	O
.	25439737	4	O
A	25439737	4	O
conjunctive	25439737	4	O
biopsy	25439737	4	O
showed	25439737	4	O
abnormal	25439737	4	O
curvilinear	25439737	4	O
and	25439737	4	O
fingerprint	25439737	4	O
lysosomal	25439737	4	O
deposits	25439737	4	O
,	25439737	4	O
and	25439737	4	O
genetic	25439737	4	O
analysis	25439737	4	O
revealed	25439737	4	O
two	25439737	4	O
heterozygous	25439737	4	O
mutations	25439737	4	O
of	25439737	4	O
MFSD8	25439737	4	O
gene	25439737	4	O
(	25439737	4	O
c.881	25439737	4	O
C	25439737	4	O
>	25439737	4	O
A	25439737	4	O
p.Thr294Lys	25439737	4	O
and	25439737	4	O
c.754	25439737	4	O
2	25439737	4	O
T	25439737	4	O
>	25439737	4	O
A	25439737	4	O
)	25439737	4	O
each	25439737	4	O
inherited	25439737	4	O
from	25439737	4	O
carrier	25439737	4	O
parents	25439737	4	O
and	25439737	4	O
a	25439737	4	O
heterozygous	25439737	4	O
variant	25439737	4	O
(	25439737	4	O
c.470	25439737	4	O
A	25439737	4	O
>	25439737	4	O
C	25439737	4	O
p.Asp157Ala	25439737	4	O
)	25439737	4	O
of	25439737	4	O
CLN5	25439737	4	O
gene	25439737	4	O
.	25439737	4	O
CONCLUSION	25439737	4	O
:	25439737	4	O
NCL	25439737	4	O
should	25439737	4	O
be	25439737	4	O
suspected	25439737	4	O
and	25439737	4	O
MFSD8	25439737	4	O
genetic	25439737	4	O
testing	25439737	4	O
should	25439737	4	O
also	25439737	4	O
be	25439737	4	O
considered	25439737	4	O
in	25439737	4	O
patients	25439737	4	O
with	25439737	4	O
Rett	25439737	4	O
like	25439737	4	O
phenotype	25439737	4	O
at	25439737	4	O
onset	25439737	4	O
and	25439737	4	O
negative	25439737	4	O
MECP2	25439737	4	O
mutation	25439737	4	O
.	25439737	4	O
Such	25439737	4	O
cases	25439737	4	O
should	25439737	4	O
be	25439737	4	O
carefully	25439737	4	O
and	25439737	4	O
frequently	25439737	4	O
re	25439737	4	O
-	25439737	4	O
evaluated	25439737	4	O
in	25439737	4	O
order	25439737	4	O
to	25439737	4	O
avoid	25439737	4	O
delayed	25439737	4	O
diagnosis	25439737	4	O
and	25439737	4	O
offer	25439737	4	O
proper	25439737	4	O
genetic	25439737	4	O
advice	25439737	4	O
to	25439737	4	O
the	25439737	4	O
family	25439737	4	O
.	25439737	4	O
In	25439737	4	O
our	25439737	4	O
knowledge	25439737	4	O
,	25439737	4	O
this	25439737	4	O
might	25439737	4	O
be	25439737	4	O
the	25439737	4	O
first	25439737	4	O
case	25439737	4	O
of	25439737	4	O
CLN7	25439737	4	O
disease	25439737	4	O
with	25439737	4	O
Rett	25439737	4	O
like	25439737	4	O
onset	25439737	4	O
described	25439737	4	O
in	25439737	4	O
the	25439737	4	O
literature	25439737	4	O
,	25439737	4	O
which	25439737	4	O
developed	25439737	4	O
typical	25439737	4	O
vLINCL	25439737	4	O
clinical	25439737	4	O
phenotype	25439737	4	O
after	25439737	4	O
age	25439737	4	O
5.5	25439737	4	O
years	25439737	4	O
.	25439737	4	O
A	25439737	4	O
short	25439737	4	O
review	25439737	4	O
of	25439737	4	O
the	25439737	4	O
literature	25439737	4	O
showing	25439737	4	O
NCL	25439737	4	O
onset	25439737	4	O
modalities	25439737	4	O
is	25439737	4	O
presented	25439737	4	O
.	25439737	4	O

Novel	25597551	4	O
homozygous	25597551	4	B-Var
deletion	25597551	4	I-Var
of	25597551	4	O
segmental	25597551	4	O
KAL1	25597551	4	B-Gene
and	25597551	4	O
entire	25597551	4	O
STS	25597551	4	B-Gene
cause	25597551	4	B-Reg
Kallmann	25597551	4	B-Disease
syndrome	25597551	4	I-Disease
and	25597551	4	O
X	25597551	4	B-Disease
-	25597551	4	I-Disease
linked	25597551	4	I-Disease
ichthyosis	25597551	4	I-Disease
in	25597551	4	O
a	25597551	4	O
Chinese	25597551	4	O
family	25597551	4	O
.	25597551	4	O
Kallmann	25597551	4	O
syndrome	25597551	4	O
(	25597551	4	O
KS	25597551	4	O
)	25597551	4	O
is	25597551	4	O
a	25597551	4	O
genetically	25597551	4	O
heterogeneous	25597551	4	O
disease	25597551	4	O
characterised	25597551	4	O
by	25597551	4	O
hypogonadotrophic	25597551	4	O
hypogonadism	25597551	4	O
in	25597551	4	O
association	25597551	4	O
with	25597551	4	O
anosmia	25597551	4	O
or	25597551	4	O
hyposmia	25597551	4	O
.	25597551	4	O
This	25597551	4	O
condition	25597551	4	O
affects	25597551	4	O
1	25597551	4	O
in	25597551	4	O
10	25597551	4	O
000	25597551	4	O
men	25597551	4	O
and	25597551	4	O
1	25597551	4	O
in	25597551	4	O
50	25597551	4	O
000	25597551	4	O
women	25597551	4	O
.	25597551	4	O
Defects	25597551	4	O
in	25597551	4	O
seventeen	25597551	4	O
genes	25597551	4	O
including	25597551	4	O
KAL1	25597551	4	O
gene	25597551	4	O
contribute	25597551	4	O
to	25597551	4	O
the	25597551	4	O
molecular	25597551	4	O
basis	25597551	4	O
of	25597551	4	O
KS	25597551	4	O
.	25597551	4	O
We	25597551	4	O
report	25597551	4	O
the	25597551	4	O
clinical	25597551	4	O
characteristics	25597551	4	O
,	25597551	4	O
molecular	25597551	4	O
causes	25597551	4	O
and	25597551	4	O
treatment	25597551	4	O
outcome	25597551	4	O
of	25597551	4	O
two	25597551	4	O
Chinese	25597551	4	O
brothers	25597551	4	O
with	25597551	4	O
KS	25597551	4	O
and	25597551	4	O
X	25597551	4	O
-	25597551	4	O
linked	25597551	4	O
ichthyosis	25597551	4	O
.	25597551	4	O
The	25597551	4	O
phenotypes	25597551	4	O
of	25597551	4	O
the	25597551	4	O
patients	25597551	4	O
were	25597551	4	O
characterised	25597551	4	O
by	25597551	4	O
bilateral	25597551	4	O
cryptorchidism	25597551	4	O
,	25597551	4	O
unilateral	25597551	4	O
renal	25597551	4	O
agenesis	25597551	4	O
in	25597551	4	O
one	25597551	4	O
patient	25597551	4	O
but	25597551	4	O
normal	25597551	4	O
kidney	25597551	4	O
development	25597551	4	O
in	25597551	4	O
another	25597551	4	O
.	25597551	4	O
The	25597551	4	O
patients	25597551	4	O
had	25597551	4	O
low	25597551	4	O
serum	25597551	4	O
testosterone	25597551	4	O
,	25597551	4	O
follicle	25597551	4	O
-	25597551	4	O
stimulating	25597551	4	O
hormone	25597551	4	O
and	25597551	4	O
luteinising	25597551	4	O
hormone	25597551	4	O
levels	25597551	4	O
and	25597551	4	O
a	25597551	4	O
blunt	25597551	4	O
response	25597551	4	O
to	25597551	4	O
the	25597551	4	O
gonadotrophin	25597551	4	O
-	25597551	4	O
releasing	25597551	4	O
hormone	25597551	4	O
stimulation	25597551	4	O
test	25597551	4	O
.	25597551	4	O
After	25597551	4	O
human	25597551	4	O
chorionic	25597551	4	O
gonadotrophin	25597551	4	O
treatment	25597551	4	O
,	25597551	4	O
the	25597551	4	O
serum	25597551	4	O
testosterone	25597551	4	O
levels	25597551	4	O
were	25597551	4	O
normalized	25597551	4	O
,	25597551	4	O
and	25597551	4	O
the	25597551	4	O
pubic	25597551	4	O
hair	25597551	4	O
,	25597551	4	O
penis	25597551	4	O
length	25597551	4	O
and	25597551	4	O
testicular	25597551	4	O
volumes	25597551	4	O
were	25597551	4	O
greatly	25597551	4	O
improved	25597551	4	O
in	25597551	4	O
both	25597551	4	O
of	25597551	4	O
the	25597551	4	O
patients	25597551	4	O
.	25597551	4	O
The	25597551	4	O
two	25597551	4	O
affected	25597551	4	O
siblings	25597551	4	O
had	25597551	4	O
the	25597551	4	O
same	25597551	4	O
novel	25597551	4	O
deletion	25597551	4	O
at	25597551	4	O
Xp22.3	25597551	4	O
including	25597551	4	O
exons	25597551	4	O
9	25597551	4	O
-	25597551	4	O
14	25597551	4	O
of	25597551	4	O
KAL1	25597551	4	O
gene	25597551	4	O
and	25597551	4	O
entire	25597551	4	O
STS	25597551	4	O
gene	25597551	4	O
.	25597551	4	O
Our	25597551	4	O
study	25597551	4	O
broadens	25597551	4	O
the	25597551	4	O
mutation	25597551	4	B-Var
spectrum	25597551	4	O
in	25597551	4	O
the	25597551	4	O
KAL1	25597551	4	B-Gene
gene	25597551	4	O
associated	25597551	4	B-Reg
with	25597551	4	I-Reg
KS	25597551	4	B-Disease
and	25597551	4	O
facilitates	25597551	4	O
the	25597551	4	O
genetic	25597551	4	O
diagnosis	25597551	4	O
and	25597551	4	O
counselling	25597551	4	O
for	25597551	4	O
KS	25597551	4	O
.	25597551	4	O

[	25604326	4	O
Heterozygote	25604326	4	O
forms	25604326	4	O
of	25604326	4	O
familial	25604326	4	O
Mediterranean	25604326	4	O
fever	25604326	4	O
can	25604326	4	O
be	25604326	4	O
manifested	25604326	4	O
in	25604326	4	O
adults	25604326	4	O
as	25604326	4	O
myofacial	25604326	4	O
pain	25604326	4	O
syndrome	25604326	4	O
]	25604326	4	O
.	25604326	4	O
Heterozygote	25604326	4	O
Formen	25604326	4	O
des	25604326	4	O
familiären	25604326	4	O
Mittelmeerfiebers	25604326	4	O
können	25604326	4	O
beim	25604326	4	O
Erwachsenen	25604326	4	O
als	25604326	4	O
myofasziales	25604326	4	O
Schmerzsyndrom	25604326	4	O
imponieren	25604326	4	O
.	25604326	4	O
BACKGROUND	25604326	4	O
:	25604326	4	O
Familial	25604326	4	B-Disease
Mediterranean	25604326	4	I-Disease
fever	25604326	4	I-Disease
(	25604326	4	O
FMF	25604326	4	O
)	25604326	4	O
is	25604326	4	O
a	25604326	4	O
disease	25604326	4	O
characterized	25604326	4	O
by	25604326	4	O
recurrent	25604326	4	O
fever	25604326	4	O
,	25604326	4	O
serositis	25604326	4	O
,	25604326	4	O
arthritis	25604326	4	O
and	25604326	4	O
unspecific	25604326	4	O
myalgia	25604326	4	O
.	25604326	4	O
It	25604326	4	O
is	25604326	4	O
prevalent	25604326	4	O
among	25604326	4	O
Mediterranean	25604326	4	O
people	25604326	4	O
and	25604326	4	O
has	25604326	4	O
been	25604326	4	O
shown	25604326	4	O
to	25604326	4	O
be	25604326	4	O
associated	25604326	4	B-Reg
with	25604326	4	O
mutations	25604326	4	B-Var
in	25604326	4	O
the	25604326	4	O
Mediterranean	25604326	4	O
fever	25604326	4	O
(	25604326	4	B-Gene
MEFV	25604326	4	I-Gene
)	25604326	4	I-Gene
gene	25604326	4	O
which	25604326	4	O
,	25604326	4	O
encodes	25604326	4	O
pyrin	25604326	4	O
a	25604326	4	O
regulatory	25604326	4	O
protein	25604326	4	O
of	25604326	4	O
the	25604326	4	O
inflammasome	25604326	4	O
.	25604326	4	O
As	25604326	4	O
heterozygous	25604326	4	B-Var
mutations	25604326	4	I-Var
in	25604326	4	O
MEFV	25604326	4	B-Gene
can	25604326	4	O
be	25604326	4	O
associated	25604326	4	B-Reg
with	25604326	4	O
only	25604326	4	O
mild	25604326	4	O
inflammatory	25604326	4	O
symptoms	25604326	4	O
,	25604326	4	O
such	25604326	4	O
as	25604326	4	O
arthralgia	25604326	4	O
or	25604326	4	O
chronic	25604326	4	O
fibromyalgic	25604326	4	O
pain	25604326	4	O
,	25604326	4	O
FMF	25604326	4	O
may	25604326	4	O
be	25604326	4	O
underdiagnosed	25604326	4	O
in	25604326	4	O
the	25604326	4	O
current	25604326	4	O
diagnostic	25604326	4	O
work	25604326	4	O
-	25604326	4	O
up	25604326	4	O
of	25604326	4	O
musculoskeletal	25604326	4	O
diseases	25604326	4	O
.	25604326	4	O
METHODS	25604326	4	O
:	25604326	4	O
The	25604326	4	O
selection	25604326	4	O
of	25604326	4	O
patients	25604326	4	O
was	25604326	4	O
carried	25604326	4	O
out	25604326	4	O
according	25604326	4	O
to	25604326	4	O
the	25604326	4	O
following	25604326	4	O
criteria	25604326	4	O
:	25604326	4	O
myofacial	25604326	4	O
pain	25604326	4	O
syndrome	25604326	4	O
,	25604326	4	O
seronegative	25604326	4	O
oligoarthralgia	25604326	4	O
,	25604326	4	O
a	25604326	4	O
slight	25604326	4	O
inflammatory	25604326	4	O
constellation	25604326	4	O
and	25604326	4	O
ethnic	25604326	4	O
origin	25604326	4	O
from	25604326	4	O
the	25604326	4	O
Mediterranean	25604326	4	O
area	25604326	4	O
.	25604326	4	O
When	25604326	4	O
these	25604326	4	O
criteria	25604326	4	O
were	25604326	4	O
fulfilled	25604326	4	O
a	25604326	4	O
molecular	25604326	4	O
genetic	25604326	4	O
investigation	25604326	4	O
was	25604326	4	O
carried	25604326	4	O
out	25604326	4	O
RESULTS	25604326	4	O
:	25604326	4	O
This	25604326	4	O
article	25604326	4	O
presents	25604326	4	O
evidence	25604326	4	O
that	25604326	4	O
9	25604326	4	O
out	25604326	4	O
of	25604326	4	O
12	25604326	4	O
Mediterranean	25604326	4	O
patients	25604326	4	O
with	25604326	4	O
recurrent	25604326	4	O
myofascial	25604326	4	B-Disease
pain	25604326	4	I-Disease
syndrome	25604326	4	I-Disease
and	25604326	4	O
mild	25604326	4	O
inflammation	25604326	4	O
revealed	25604326	4	B-Reg
heterozygote	25604326	4	B-Var
mutations	25604326	4	I-Var
in	25604326	4	O
the	25604326	4	O
MEFV	25604326	4	B-Gene
gene	25604326	4	O
and	25604326	4	O
7	25604326	4	O
of	25604326	4	O
these	25604326	4	O
patients	25604326	4	O
benefitted	25604326	4	O
from	25604326	4	O
treatment	25604326	4	O
with	25604326	4	O
colchicine	25604326	4	O
.	25604326	4	O
DISCUSSION	25604326	4	O
:	25604326	4	O
As	25604326	4	O
colchicine	25604326	4	O
treatment	25604326	4	O
not	25604326	4	O
only	25604326	4	O
improved	25604326	4	O
the	25604326	4	O
myofascial	25604326	4	O
pain	25604326	4	O
but	25604326	4	O
also	25604326	4	O
prevented	25604326	4	O
FMF	25604326	4	O
-	25604326	4	O
associated	25604326	4	O
amyloidosis	25604326	4	O
and	25604326	4	O
nephropathy	25604326	4	O
,	25604326	4	O
differential	25604326	4	O
diagnosis	25604326	4	O
of	25604326	4	O
fibromyalgia	25604326	4	O
in	25604326	4	O
patients	25604326	4	O
of	25604326	4	O
Mediterranean	25604326	4	O
origin	25604326	4	O
should	25604326	4	O
include	25604326	4	O
FMF	25604326	4	O
and	25604326	4	O
a	25604326	4	O
genetic	25604326	4	O
screening	25604326	4	O
of	25604326	4	O
the	25604326	4	O
MEFV	25604326	4	O
locus	25604326	4	O
.	25604326	4	O

In	25854144	4	O
silico	25854144	4	O
analyses	25854144	4	O
of	25854144	4	O
missense	25854144	4	O
mutations	25854144	4	O
in	25854144	4	O
coagulation	25854144	4	O
factor	25854144	4	O
VIII	25854144	4	O
:	25854144	4	O
identification	25854144	4	O
of	25854144	4	O
severity	25854144	4	O
determinants	25854144	4	O
of	25854144	4	O
haemophilia	25854144	4	O
A.	25854144	4	O
Factor	25854144	4	O
VIII	25854144	4	O
(	25854144	4	B-Gene
FVIII	25854144	4	I-Gene
)	25854144	4	I-Gene
mutations	25854144	4	B-Var
cause	25854144	4	B-Reg
haemophilia	25854144	4	B-Disease
A	25854144	4	I-Disease
(	25854144	4	O
HA	25854144	4	O
)	25854144	4	O
,	25854144	4	O
an	25854144	4	O
X	25854144	4	O
-	25854144	4	O
linked	25854144	4	O
recessive	25854144	4	O
coagulation	25854144	4	O
disorder	25854144	4	O
.	25854144	4	O
Over	25854144	4	O
1000	25854144	4	O
missense	25854144	4	O
mutations	25854144	4	O
in	25854144	4	O
FVIII	25854144	4	O
are	25854144	4	O
known	25854144	4	O
and	25854144	4	O
they	25854144	4	O
lead	25854144	4	O
to	25854144	4	O
variable	25854144	4	O
clinical	25854144	4	O
phenotypes	25854144	4	O
(	25854144	4	O
severe	25854144	4	O
,	25854144	4	O
moderate	25854144	4	O
and	25854144	4	O
mild	25854144	4	O
)	25854144	4	O
.	25854144	4	O
The	25854144	4	O
exact	25854144	4	O
molecular	25854144	4	O
basis	25854144	4	O
of	25854144	4	O
this	25854144	4	O
phenotypic	25854144	4	O
heterogeneity	25854144	4	O
by	25854144	4	O
FVIII	25854144	4	O
missense	25854144	4	O
mutations	25854144	4	O
is	25854144	4	O
elusive	25854144	4	O
to	25854144	4	O
date	25854144	4	O
.	25854144	4	O
In	25854144	4	O
this	25854144	4	O
study	25854144	4	O
,	25854144	4	O
we	25854144	4	O
aimed	25854144	4	O
to	25854144	4	O
identify	25854144	4	O
the	25854144	4	O
severity	25854144	4	O
determinants	25854144	4	O
that	25854144	4	O
cause	25854144	4	O
phenotypic	25854144	4	O
heterogeneity	25854144	4	O
of	25854144	4	O
HA	25854144	4	O
.	25854144	4	O
We	25854144	4	O
compiled	25854144	4	O
and	25854144	4	O
curated	25854144	4	O
a	25854144	4	O
data	25854144	4	O
set	25854144	4	O
of	25854144	4	O
766	25854144	4	O
missense	25854144	4	O
mutations	25854144	4	O
from	25854144	4	O
the	25854144	4	O
repertoire	25854144	4	O
of	25854144	4	O
missense	25854144	4	O
mutations	25854144	4	O
in	25854144	4	O
FVIII	25854144	4	O
.	25854144	4	O
We	25854144	4	O
analysed	25854144	4	O
these	25854144	4	O
mutations	25854144	4	O
by	25854144	4	O
computational	25854144	4	O
programs	25854144	4	O
(	25854144	4	O
e.g.	25854144	4	O
Swiss	25854144	4	O
-	25854144	4	O
PdbViewer	25854144	4	O
)	25854144	4	O
and	25854144	4	O
different	25854144	4	O
mutation	25854144	4	O
analysis	25854144	4	O
servers	25854144	4	O
(	25854144	4	O
e.g.	25854144	4	O
SIFT	25854144	4	O
,	25854144	4	O
PROVEAN	25854144	4	O
,	25854144	4	O
CUPSAT	25854144	4	O
,	25854144	4	O
PolyPhen2	25854144	4	O
,	25854144	4	O
MutPred	25854144	4	O
)	25854144	4	O
;	25854144	4	O
and	25854144	4	O
various	25854144	4	O
sequence	25854144	4	O
-	25854144	4	O
and	25854144	4	O
structure	25854144	4	O
-	25854144	4	O
based	25854144	4	O
parameters	25854144	4	O
were	25854144	4	O
assessed	25854144	4	O
for	25854144	4	O
any	25854144	4	O
significant	25854144	4	O
distribution	25854144	4	O
bias	25854144	4	O
among	25854144	4	O
different	25854144	4	O
HA	25854144	4	O
phenotypes	25854144	4	O
.	25854144	4	O
Our	25854144	4	O
analyses	25854144	4	O
suggest	25854144	4	O
that	25854144	4	O
'	25854144	4	O
mutations	25854144	4	O
in	25854144	4	O
evolutionary	25854144	4	O
conserved	25854144	4	O
residues	25854144	4	O
'	25854144	4	O
,	25854144	4	O
'	25854144	4	O
mutations	25854144	4	O
in	25854144	4	O
buried	25854144	4	O
residues	25854144	4	O
'	25854144	4	O
,	25854144	4	O
mutation	25854144	4	B-Reg
-	25854144	4	I-Reg
induced	25854144	4	I-Reg
'	25854144	4	O
steric	25854144	4	O
clash	25854144	4	O
'	25854144	4	O
and	25854144	4	O
'	25854144	4	O
surface	25854144	4	O
electrostatic	25854144	4	O
potential	25854144	4	O
alteration	25854144	4	O
'	25854144	4	O
act	25854144	4	O
as	25854144	4	O
risk	25854144	4	O
factors	25854144	4	B-Reg
towards	25854144	4	O
severe	25854144	4	O
HA	25854144	4	B-Disease
.	25854144	4	O
We	25854144	4	O
have	25854144	4	O
developed	25854144	4	O
a	25854144	4	O
grading	25854144	4	O
system	25854144	4	O
for	25854144	4	O
FVIII	25854144	4	O
mutations	25854144	4	O
combining	25854144	4	O
the	25854144	4	O
severity	25854144	4	O
determinants	25854144	4	O
,	25854144	4	O
and	25854144	4	O
the	25854144	4	O
grading	25854144	4	O
pattern	25854144	4	O
correlates	25854144	4	O
with	25854144	4	O
HA	25854144	4	O
phenotype	25854144	4	O
.	25854144	4	O
This	25854144	4	O
study	25854144	4	O
will	25854144	4	O
help	25854144	4	O
to	25854144	4	O
correctly	25854144	4	O
associate	25854144	4	O
the	25854144	4	O
HA	25854144	4	O
phenotype	25854144	4	O
with	25854144	4	O
a	25854144	4	O
mutation	25854144	4	O
and	25854144	4	O
aid	25854144	4	O
early	25854144	4	O
characterization	25854144	4	O
of	25854144	4	O
novel	25854144	4	O
variants	25854144	4	O
.	25854144	4	O

X	25993682	4	B-Disease
-	25993682	4	I-Disease
linked	25993682	4	I-Disease
adrenal	25993682	4	I-Disease
hypoplasia	25993682	4	I-Disease
congenita	25993682	4	I-Disease
:	25993682	4	I-Disease
clinical	25993682	4	O
and	25993682	4	O
follow	25993682	4	O
-	25993682	4	O
up	25993682	4	O
findings	25993682	4	O
of	25993682	4	O
two	25993682	4	O
kindreds	25993682	4	O
,	25993682	4	O
one	25993682	4	O
with	25993682	4	B-Reg
a	25993682	4	O
novel	25993682	4	O
NR0B1	25993682	4	B-Gene
mutation	25993682	4	B-Var
.	25993682	4	O
X	25993682	4	B-Disease
-	25993682	4	I-Disease
linked	25993682	4	I-Disease
adrenal	25993682	4	I-Disease
hypoplasia	25993682	4	I-Disease
congenita	25993682	4	I-Disease
typically	25993682	4	O
manifests	25993682	4	O
as	25993682	4	O
primary	25993682	4	O
adrenal	25993682	4	B-Disease
insufficiency	25993682	4	I-Disease
in	25993682	4	O
the	25993682	4	O
newborn	25993682	4	O
age	25993682	4	O
and	25993682	4	O
hypogonadotropic	25993682	4	B-Disease
hypogonadism	25993682	4	I-Disease
in	25993682	4	O
males	25993682	4	O
,	25993682	4	O
being	25993682	4	O
caused	25993682	4	B-Reg
by	25993682	4	I-Reg
mutations	25993682	4	B-Var
in	25993682	4	O
NR0B1	25993682	4	B-Gene
gene	25993682	4	O
.	25993682	4	O
We	25993682	4	O
present	25993682	4	O
the	25993682	4	O
clinical	25993682	4	O
and	25993682	4	O
follow	25993682	4	O
-	25993682	4	O
up	25993682	4	O
findings	25993682	4	O
of	25993682	4	O
two	25993682	4	O
kindreds	25993682	4	O
with	25993682	4	O
NR0B1	25993682	4	O
mutations	25993682	4	O
.	25993682	4	O
The	25993682	4	O
proband	25993682	4	O
of	25993682	4	O
kindred	25993682	4	O
A	25993682	4	O
had	25993682	4	O
a	25993682	4	O
diagnosis	25993682	4	O
of	25993682	4	O
primary	25993682	4	O
adrenal	25993682	4	O
insufficiency	25993682	4	O
when	25993682	4	O
he	25993682	4	O
was	25993682	4	O
a	25993682	4	O
newborn	25993682	4	O
.	25993682	4	O
Family	25993682	4	O
history	25993682	4	O
was	25993682	4	O
relevant	25993682	4	O
for	25993682	4	O
a	25993682	4	O
maternal	25993682	4	O
uncle	25993682	4	O
death	25993682	4	O
at	25993682	4	O
the	25993682	4	O
newborn	25993682	4	O
age	25993682	4	O
.	25993682	4	O
Beyond	25993682	4	O
2	25993682	4	O
year	25993682	4	O
-	25993682	4	O
old	25993682	4	O
steroid	25993682	4	O
measurements	25993682	4	O
rendered	25993682	4	O
undetectable	25993682	4	O
and	25993682	4	O
delayed	25993682	4	O
bone	25993682	4	O
age	25993682	4	O
was	25993682	4	O
noticed	25993682	4	O
.	25993682	4	O
Molecular	25993682	4	O
analysis	25993682	4	O
of	25993682	4	O
NR0B1	25993682	4	B-Gene
gene	25993682	4	O
revealed	25993682	4	O
a	25993682	4	O
previously	25993682	4	O
unreported	25993682	4	O
mutation	25993682	4	O
(	25993682	4	B-Var
c.1084	25993682	4	I-Var
A	25993682	4	I-Var
>	25993682	4	I-Var
T	25993682	4	I-Var
)	25993682	4	I-Var
,	25993682	4	O
leading	25993682	4	B-Reg
to	25993682	4	I-Reg
a	25993682	4	O
premature	25993682	4	O
stop	25993682	4	O
codon	25993682	4	O
,	25993682	4	O
p.Lys362*	25993682	4	O
,	25993682	4	O
in	25993682	4	O
exon	25993682	4	O
1	25993682	4	O
.	25993682	4	O
His	25993682	4	O
mother	25993682	4	O
and	25993682	4	O
sister	25993682	4	O
were	25993682	4	O
asymptomatic	25993682	4	O
carriers	25993682	4	O
.	25993682	4	O
At	25993682	4	O
14	25993682	4	O
year	25993682	4	O
-	25993682	4	O
old	25993682	4	O
he	25993682	4	O
had	25993682	4	O
3	25993682	4	O
mL	25993682	4	O
of	25993682	4	O
testicular	25993682	4	O
volume	25993682	4	O
and	25993682	4	O
biochemical	25993682	4	O
surveys	25993682	4	O
(	25993682	4	O
LH	25993682	4	O
<	25993682	4	O
0.1	25993682	4	O
UI	25993682	4	O
/	25993682	4	O
L	25993682	4	O
,	25993682	4	O
total	25993682	4	O
testosterone	25993682	4	O
<	25993682	4	O
10	25993682	4	O
ng	25993682	4	O
/	25993682	4	O
dL	25993682	4	O
)	25993682	4	O
concordant	25993682	4	O
with	25993682	4	O
hypogonadotrophic	25993682	4	O
hypogonadism	25993682	4	O
.	25993682	4	O
Kindred	25993682	4	O
B	25993682	4	O
had	25993682	4	O
two	25993682	4	O
males	25993682	4	O
diagnosed	25993682	4	O
with	25993682	4	O
adrenal	25993682	4	O
insufficiency	25993682	4	O
at	25993682	4	O
the	25993682	4	O
newborn	25993682	4	O
age	25993682	4	O
.	25993682	4	O
By	25993682	4	O
3	25993682	4	O
year	25993682	4	O
-	25993682	4	O
old	25993682	4	O
both	25993682	4	O
siblings	25993682	4	O
had	25993682	4	O
undetectable	25993682	4	O
androgen	25993682	4	O
levels	25993682	4	O
and	25993682	4	O
delayed	25993682	4	O
bone	25993682	4	O
age	25993682	4	O
.	25993682	4	O
NR0B1	25993682	4	O
molecular	25993682	4	O
analysis	25993682	4	O
identified	25993682	4	O
a	25993682	4	O
nonsense	25993682	4	O
mutation	25993682	4	O
in	25993682	4	O
both	25993682	4	O
cases	25993682	4	O
,	25993682	4	O
c.243	25993682	4	O
C	25993682	4	O
>	25993682	4	O
G	25993682	4	O
;	25993682	4	O
p.Tyr81*	25993682	4	O
,	25993682	4	O
in	25993682	4	O
exon	25993682	4	O
1	25993682	4	O
.	25993682	4	O
Their	25993682	4	O
mother	25993682	4	O
and	25993682	4	O
sister	25993682	4	O
were	25993682	4	O
asymptomatic	25993682	4	O
carriers	25993682	4	O
.	25993682	4	O
At	25993682	4	O
14	25993682	4	O
year	25993682	4	O
-	25993682	4	O
old	25993682	4	O
(	25993682	4	O
Tanner	25993682	4	O
stage	25993682	4	O
1	25993682	4	O
)	25993682	4	O
hypothalamic	25993682	4	O
-	25993682	4	O
pituitary	25993682	4	O
-	25993682	4	O
gonadal	25993682	4	O
axis	25993682	4	O
evaluation	25993682	4	O
in	25993682	4	O
both	25993682	4	O
males	25993682	4	O
(	25993682	4	O
LH	25993682	4	O
<	25993682	4	O
0.1	25993682	4	O
UI	25993682	4	O
/	25993682	4	O
L	25993682	4	O
,	25993682	4	O
total	25993682	4	O
testosterone	25993682	4	O
<	25993682	4	O
10	25993682	4	O
ng	25993682	4	O
/	25993682	4	O
dL	25993682	4	O
)	25993682	4	O
confirmed	25993682	4	O
hypogonadotropic	25993682	4	O
hypogonadism	25993682	4	O
.	25993682	4	O
In	25993682	4	O
conclusion	25993682	4	O
,	25993682	4	O
biochemical	25993682	4	O
profiles	25993682	4	O
,	25993682	4	O
bone	25993682	4	O
age	25993682	4	O
and	25993682	4	O
an	25993682	4	O
X	25993682	4	O
-	25993682	4	O
linked	25993682	4	O
inheritance	25993682	4	O
led	25993682	4	O
to	25993682	4	O
suspicion	25993682	4	O
of	25993682	4	O
NR0B1	25993682	4	O
mutations	25993682	4	O
.	25993682	4	O
Two	25993682	4	O
nonsense	25993682	4	O
mutations	25993682	4	O
were	25993682	4	O
detected	25993682	4	O
in	25993682	4	O
both	25993682	4	O
kindreds	25993682	4	O
,	25993682	4	O
one	25993682	4	O
previously	25993682	4	O
unreported	25993682	4	O
(	25993682	4	O
c.1084	25993682	4	O
A	25993682	4	O
>	25993682	4	O
T	25993682	4	O
;	25993682	4	O
p.Lys362*	25993682	4	O
)	25993682	4	O
.	25993682	4	O
Mutation	25993682	4	O
identification	25993682	4	O
allowed	25993682	4	O
the	25993682	4	O
timely	25993682	4	O
institution	25993682	4	O
of	25993682	4	O
testosterone	25993682	4	O
in	25993682	4	O
patients	25993682	4	O
at	25993682	4	O
puberty	25993682	4	O
and	25993682	4	O
an	25993682	4	O
appropriate	25993682	4	O
genetic	25993682	4	O
counselling	25993682	4	O
for	25993682	4	O
relatives	25993682	4	O
.	25993682	4	O

Phenotypic	26018748	4	O
Variability	26018748	4	O
and	26018748	4	O
Newly	26018748	4	O
Identified	26018748	4	O
Mutations	26018748	4	B-Var
of	26018748	4	O
the	26018748	4	O
IVD	26018748	4	B-Gene
Gene	26018748	4	O
in	26018748	4	O
Japanese	26018748	4	O
Patients	26018748	4	O
with	26018748	4	B-Reg
Isovaleric	26018748	4	B-Disease
Acidemia	26018748	4	I-Disease
.	26018748	4	O
Isovaleric	26018748	4	O
acidemia	26018748	4	O
(	26018748	4	O
IVA	26018748	4	O
)	26018748	4	O
is	26018748	4	O
an	26018748	4	O
autosomal	26018748	4	O
recessive	26018748	4	O
inborn	26018748	4	O
error	26018748	4	O
affecting	26018748	4	O
leucine	26018748	4	O
metabolism	26018748	4	O
.	26018748	4	O
It	26018748	4	O
is	26018748	4	O
caused	26018748	4	O
by	26018748	4	O
a	26018748	4	O
deficiency	26018748	4	O
in	26018748	4	O
isovaleryl	26018748	4	O
-	26018748	4	O
CoA	26018748	4	O
dehydrogenase	26018748	4	O
(	26018748	4	O
IVD	26018748	4	O
)	26018748	4	O
,	26018748	4	O
a	26018748	4	O
mitochondrial	26018748	4	O
matrix	26018748	4	O
enzyme	26018748	4	O
that	26018748	4	O
catalyzes	26018748	4	O
the	26018748	4	O
oxidation	26018748	4	O
of	26018748	4	O
isovaleryl	26018748	4	O
-	26018748	4	O
CoA	26018748	4	O
to	26018748	4	O
3	26018748	4	O
-	26018748	4	O
methylcrotonyl	26018748	4	O
-	26018748	4	O
CoA	26018748	4	O
.	26018748	4	O
IVD	26018748	4	O
is	26018748	4	O
a	26018748	4	O
FAD	26018748	4	O
-	26018748	4	O
containing	26018748	4	O
enzyme	26018748	4	O
,	26018748	4	O
consisting	26018748	4	O
of	26018748	4	O
four	26018748	4	O
identical	26018748	4	O
subunits	26018748	4	O
.	26018748	4	O
Clinical	26018748	4	O
features	26018748	4	O
of	26018748	4	O
IVA	26018748	4	O
include	26018748	4	O
poor	26018748	4	O
feeding	26018748	4	O
,	26018748	4	O
vomiting	26018748	4	O
,	26018748	4	O
lethargy	26018748	4	O
,	26018748	4	O
developmental	26018748	4	O
delay	26018748	4	O
,	26018748	4	O
metabolic	26018748	4	O
acidosis	26018748	4	O
,	26018748	4	O
and	26018748	4	O
a	26018748	4	O
characteristic	26018748	4	O
"	26018748	4	O
sweaty	26018748	4	O
foot	26018748	4	O
"	26018748	4	O
odor	26018748	4	O
.	26018748	4	O
IVA	26018748	4	O
is	26018748	4	O
one	26018748	4	O
of	26018748	4	O
the	26018748	4	O
target	26018748	4	O
disorders	26018748	4	O
for	26018748	4	O
newborn	26018748	4	O
screening	26018748	4	O
by	26018748	4	O
tandem	26018748	4	O
mass	26018748	4	O
spectrometry	26018748	4	O
(	26018748	4	O
MS	26018748	4	O
/	26018748	4	O
MS	26018748	4	O
)	26018748	4	O
.	26018748	4	O
The	26018748	4	O
human	26018748	4	O
IVD	26018748	4	O
gene	26018748	4	O
is	26018748	4	O
located	26018748	4	O
on	26018748	4	O
chromosome	26018748	4	O
15	26018748	4	O
q.	26018748	4	O
To	26018748	4	O
date	26018748	4	O
,	26018748	4	O
over	26018748	4	O
50	26018748	4	O
disease	26018748	4	O
-	26018748	4	O
causing	26018748	4	O
mutations	26018748	4	O
have	26018748	4	O
been	26018748	4	O
reported	26018748	4	O
worldwide	26018748	4	O
.	26018748	4	O
In	26018748	4	O
this	26018748	4	O
study	26018748	4	O
,	26018748	4	O
we	26018748	4	O
searched	26018748	4	O
for	26018748	4	O
IVD	26018748	4	O
mutations	26018748	4	O
in	26018748	4	O
five	26018748	4	O
Japanese	26018748	4	O
patients	26018748	4	O
with	26018748	4	O
IVA	26018748	4	O
(	26018748	4	O
neonatal	26018748	4	O
type	26018748	4	O
,	26018748	4	O
two	26018748	4	O
patients	26018748	4	O
;	26018748	4	O
chronic	26018748	4	O
intermittent	26018748	4	O
type	26018748	4	O
,	26018748	4	O
two	26018748	4	O
patients	26018748	4	O
;	26018748	4	O
and	26018748	4	O
mild	26018748	4	O
biochemical	26018748	4	O
type	26018748	4	O
,	26018748	4	O
one	26018748	4	O
patient	26018748	4	O
)	26018748	4	O
.	26018748	4	O
The	26018748	4	O
diagnosis	26018748	4	O
of	26018748	4	O
IVA	26018748	4	O
was	26018748	4	O
confirmed	26018748	4	O
by	26018748	4	O
urinary	26018748	4	O
organic	26018748	4	O
acid	26018748	4	O
analysis	26018748	4	O
using	26018748	4	O
gas	26018748	4	O
chromatography	26018748	4	O
and	26018748	4	O
mass	26018748	4	O
spectrometry	26018748	4	O
.	26018748	4	O
All	26018748	4	O
coding	26018748	4	O
exons	26018748	4	O
and	26018748	4	O
the	26018748	4	O
flanking	26018748	4	O
introns	26018748	4	O
in	26018748	4	O
the	26018748	4	O
IVD	26018748	4	O
gene	26018748	4	O
were	26018748	4	O
amplified	26018748	4	O
by	26018748	4	O
PCR	26018748	4	O
and	26018748	4	O
were	26018748	4	O
directly	26018748	4	O
sequenced	26018748	4	O
.	26018748	4	O
We	26018748	4	O
thus	26018748	4	O
identified	26018748	4	O
six	26018748	4	O
hitherto	26018748	4	O
unknown	26018748	4	O
mutations	26018748	4	O
(	26018748	4	O
p.G94D	26018748	4	O
,	26018748	4	O
p.E116K	26018748	4	O
,	26018748	4	O
p.M167T	26018748	4	O
,	26018748	4	O
p.L243P	26018748	4	O
,	26018748	4	O
p.L246P	26018748	4	O
,	26018748	4	O
and	26018748	4	O
c.696	26018748	4	O
1	26018748	4	O
G	26018748	4	O
>	26018748	4	O
T	26018748	4	O
)	26018748	4	O
and	26018748	4	O
four	26018748	4	O
previously	26018748	4	O
reported	26018748	4	O
(	26018748	4	O
p.R53P	26018748	4	O
,	26018748	4	O
p.R395C	26018748	4	O
,	26018748	4	O
p.Y403C	26018748	4	O
,	26018748	4	O
and	26018748	4	O
p.E411K	26018748	4	O
)	26018748	4	O
pathogenic	26018748	4	O
mutations	26018748	4	O
.	26018748	4	O
All	26018748	4	O
patients	26018748	4	O
were	26018748	4	O
compound	26018748	4	O
heterozygotes	26018748	4	O
,	26018748	4	O
and	26018748	4	O
each	26018748	4	O
mutation	26018748	4	O
was	26018748	4	O
identified	26018748	4	O
in	26018748	4	O
a	26018748	4	O
single	26018748	4	O
patient	26018748	4	O
.	26018748	4	O
Pathogenicity	26018748	4	O
of	26018748	4	O
newly	26018748	4	O
identified	26018748	4	O
mutations	26018748	4	O
was	26018748	4	O
validated	26018748	4	O
using	26018748	4	O
computational	26018748	4	O
programs	26018748	4	O
.	26018748	4	O
Among	26018748	4	O
them	26018748	4	O
,	26018748	4	O
the	26018748	4	O
p.M167T	26018748	4	B-Var
is	26018748	4	O
believed	26018748	4	O
to	26018748	4	O
influence	26018748	4	B-Reg
FAD	26018748	4	O
binding	26018748	4	O
,	26018748	4	O
as	26018748	4	O
the	26018748	4	O
position	26018748	4	O
167	26018748	4	O
is	26018748	4	O
present	26018748	4	O
in	26018748	4	O
one	26018748	4	O
of	26018748	4	O
the	26018748	4	O
FAD	26018748	4	O
-	26018748	4	O
binding	26018748	4	O
sites	26018748	4	O
.	26018748	4	O
Our	26018748	4	O
results	26018748	4	O
have	26018748	4	O
illustrated	26018748	4	O
the	26018748	4	O
heterogeneous	26018748	4	O
mutation	26018748	4	O
spectrum	26018748	4	O
and	26018748	4	O
clinical	26018748	4	O
presentation	26018748	4	O
of	26018748	4	O
IVA	26018748	4	O
in	26018748	4	O
the	26018748	4	O
Japanese	26018748	4	O
patients	26018748	4	O
.	26018748	4	O

Molecular	26076881	4	O
and	26076881	4	O
clinical	26076881	4	O
features	26076881	4	O
of	26076881	4	O
inherited	26076881	4	O
neuropathies	26076881	4	O
due	26076881	4	O
to	26076881	4	O
PMP22	26076881	4	O
duplication	26076881	4	O
.	26076881	4	O
PMP22	26076881	4	O
is	26076881	4	O
a	26076881	4	O
transmembrane	26076881	4	O
glycoprotein	26076881	4	O
component	26076881	4	O
of	26076881	4	O
myelin	26076881	4	O
,	26076881	4	O
important	26076881	4	O
for	26076881	4	O
myelin	26076881	4	O
functioning	26076881	4	O
.	26076881	4	O
Mutation	26076881	4	B-Var
of	26076881	4	O
PMP22	26076881	4	B-Gene
gene	26076881	4	O
which	26076881	4	O
encodes	26076881	4	O
for	26076881	4	O
the	26076881	4	O
production	26076881	4	O
of	26076881	4	O
PMP22	26076881	4	O
glycoprotein	26076881	4	O
is	26076881	4	O
associated	26076881	4	B-Reg
with	26076881	4	I-Reg
a	26076881	4	O
variety	26076881	4	O
of	26076881	4	O
inherited	26076881	4	O
neuropathies	26076881	4	B-Disease
.	26076881	4	O
This	26076881	4	O
literature	26076881	4	O
review	26076881	4	O
sought	26076881	4	O
to	26076881	4	O
review	26076881	4	O
the	26076881	4	O
molecular	26076881	4	O
mechanism	26076881	4	O
and	26076881	4	O
clinical	26076881	4	O
features	26076881	4	O
of	26076881	4	O
inherited	26076881	4	O
neuropathies	26076881	4	O
caused	26076881	4	O
by	26076881	4	O
PMP22	26076881	4	O
duplication	26076881	4	O
.	26076881	4	O
PMP22	26076881	4	O
duplication	26076881	4	O
causes	26076881	4	O
CMT1A	26076881	4	O
which	26076881	4	O
accounts	26076881	4	O
for	26076881	4	O
more	26076881	4	O
than	26076881	4	O
half	26076881	4	O
of	26076881	4	O
all	26076881	4	O
CMT	26076881	4	O
cases	26076881	4	O
and	26076881	4	O
about	26076881	4	O
70%	26076881	4	O
of	26076881	4	O
CMT1	26076881	4	O
cases	26076881	4	O
.	26076881	4	O
It	26076881	4	O
manifests	26076881	4	O
with	26076881	4	O
muscle	26076881	4	O
weakness	26076881	4	O
,	26076881	4	O
depressed	26076881	4	O
reflexes	26076881	4	O
,	26076881	4	O
impaired	26076881	4	O
distal	26076881	4	O
sensation	26076881	4	O
,	26076881	4	O
hand	26076881	4	O
and	26076881	4	O
foot	26076881	4	O
deformities	26076881	4	O
,	26076881	4	O
slowing	26076881	4	O
of	26076881	4	O
NCV	26076881	4	O
and	26076881	4	O
onion	26076881	4	O
bulbs	26076881	4	O
.	26076881	4	O
With	26076881	4	O
no	26076881	4	O
specific	26076881	4	O
treatment	26076881	4	O
available	26076881	4	O
,	26076881	4	O
it	26076881	4	O
is	26076881	4	O
managed	26076881	4	O
conservatively	26076881	4	O
.	26076881	4	O
Future	26076881	4	O
treatment	26076881	4	O
may	26076881	4	O
be	26076881	4	O
based	26076881	4	O
on	26076881	4	O
the	26076881	4	O
molecular	26076881	4	O
genetics	26076881	4	O
of	26076881	4	O
the	26076881	4	O
disease	26076881	4	O
.	26076881	4	O

A	26083983	2	O
novel	26083983	2	O
gene	26083983	2	O
insertion	26083983	2	B-Var
combined	26083983	2	O
with	26083983	2	O
a	26083983	2	O
missense	26083983	2	O
mutation	26083983	2	O
causing	26083983	2	B-Reg
factor	26083983	2	B-Disease
VII	26083983	2	I-Disease
deficiency	26083983	2	I-Disease
in	26083983	2	O
two	26083983	2	O
unrelated	26083983	2	O
Chinese	26083983	2	O
families	26083983	2	O
.	26083983	2	O
Hereditary	26083983	2	O
coagulation	26083983	2	O
factor	26083983	2	O
VII	26083983	2	O
(	26083983	2	O
FVII	26083983	2	O
)	26083983	2	O
deficiency	26083983	2	O
is	26083983	2	O
a	26083983	2	O
rare	26083983	2	O
bleeding	26083983	2	O
disorder	26083983	2	O
characterized	26083983	2	O
by	26083983	2	O
reduced	26083983	2	O
FVII	26083983	2	O
activity	26083983	2	O
(	26083983	2	O
FVII	26083983	2	O
:	26083983	2	O
C	26083983	2	O
)	26083983	2	O
and	26083983	2	O
inconsistent	26083983	2	O
FVII	26083983	2	O
antigen	26083983	2	O
(	26083983	2	O
FVII	26083983	2	O
:	26083983	2	O
Ag	26083983	2	O
)	26083983	2	O
.	26083983	2	O
In	26083983	2	O
our	26083983	2	O
study	26083983	2	O
,	26083983	2	O
two	26083983	2	O
pregnant	26083983	2	O
probands	26083983	2	O
were	26083983	2	O
diagnosed	26083983	2	O
with	26083983	2	O
FVII	26083983	2	O
deficiency	26083983	2	O
,	26083983	2	O
based	26083983	2	O
on	26083983	2	O
the	26083983	2	O
tests	26083983	2	O
that	26083983	2	O
FVII	26083983	2	O
:	26083983	2	O
C	26083983	2	O
were	26083983	2	O
both	26083983	2	O
3%	26083983	2	O
and	26083983	2	O
FVII	26083983	2	O
:	26083983	2	O
Ag	26083983	2	O
were	26083983	2	O
less	26083983	2	O
than	26083983	2	O
7.5%	26083983	2	O
.	26083983	2	O
Gene	26083983	2	O
sequencing	26083983	2	O
revealed	26083983	2	O
the	26083983	2	O
same	26083983	2	O
compound	26083983	2	O
mutations	26083983	2	O
,	26083983	2	O
a	26083983	2	O
recurrent	26083983	2	O
missense	26083983	2	O
mutation	26083983	2	O
p.Arg277Cys	26083983	2	O
and	26083983	2	O
a	26083983	2	O
novel	26083983	2	O
insertion	26083983	2	O
mutation	26083983	2	O
g.	26083983	2	O
11520	26083983	2	O
-	26083983	2	O
11521	26083983	2	O
insT	26083983	2	O
.	26083983	2	O
What	26083983	2	O
is	26083983	2	O
more	26083983	2	O
,	26083983	2	O
haplotype	26083983	2	O
analysis	26083983	2	O
of	26083983	2	O
SNPs	26083983	2	O
excluded	26083983	2	O
the	26083983	2	O
possibility	26083983	2	O
of	26083983	2	O
consanguinity	26083983	2	O
between	26083983	2	O
the	26083983	2	O
two	26083983	2	O
families	26083983	2	O
.	26083983	2	O
According	26083983	2	O
to	26083983	2	O
the	26083983	2	O
model	26083983	2	O
,	26083983	2	O
we	26083983	2	O
speculated	26083983	2	O
that	26083983	2	O
although	26083983	2	O
the	26083983	2	O
insertion	26083983	2	B-Var
mutation	26083983	2	O
was	26083983	2	O
close	26083983	2	O
to	26083983	2	O
the	26083983	2	O
carboxy	26083983	2	O
-	26083983	2	O
terminal	26083983	2	O
,	26083983	2	O
it	26083983	2	O
induced	26083983	2	B-PosReg
the	26083983	2	O
protein	26083983	2	O
extension	26083983	2	O
and	26083983	2	O
affected	26083983	2	B-Reg
the	26083983	2	O
3	26083983	2	O
'	26083983	2	O
untranslated	26083983	2	O
region	26083983	2	O
of	26083983	2	O
F7	26083983	2	B-Gene
gene	26083983	2	O
,	26083983	2	O
which	26083983	2	O
is	26083983	2	O
significant	26083983	2	O
to	26083983	2	O
posttranscriptional	26083983	2	O
regulation	26083983	2	O
.	26083983	2	O
Hypothetically	26083983	2	O
,	26083983	2	O
the	26083983	2	O
stability	26083983	2	O
or	26083983	2	O
translational	26083983	2	O
efficiency	26083983	2	O
of	26083983	2	O
mRNA	26083983	2	O
may	26083983	2	O
be	26083983	2	O
influenced	26083983	2	O
,	26083983	2	O
resulting	26083983	2	O
in	26083983	2	O
reducing	26083983	2	O
FVII	26083983	2	O
:	26083983	2	O
C.	26083983	2	O

Hereditary	26094131	1	O
spastic	26094131	1	O
paraplegia	26094131	1	O
SPG4	26094131	1	O
:	26094131	1	O
what	26094131	1	O
is	26094131	1	O
known	26094131	1	O
and	26094131	1	O
not	26094131	1	O
known	26094131	1	O
about	26094131	1	O
the	26094131	1	O
disease	26094131	1	O
.	26094131	1	O
Mutations	26094131	1	O
in	26094131	1	O
more	26094131	1	O
than	26094131	1	O
70	26094131	1	O
distinct	26094131	1	O
loci	26094131	1	O
and	26094131	1	O
more	26094131	1	O
than	26094131	1	O
50	26094131	1	O
mutated	26094131	1	O
gene	26094131	1	O
products	26094131	1	O
have	26094131	1	O
been	26094131	1	O
identified	26094131	1	O
in	26094131	1	O
patients	26094131	1	O
with	26094131	1	O
hereditary	26094131	1	B-Disease
spastic	26094131	1	I-Disease
paraplegias	26094131	1	I-Disease
,	26094131	1	O
a	26094131	1	O
diverse	26094131	1	O
group	26094131	1	O
of	26094131	1	O
neurological	26094131	1	O
disorders	26094131	1	O
characterized	26094131	1	O
predominantly	26094131	1	O
,	26094131	1	O
but	26094131	1	O
not	26094131	1	O
exclusively	26094131	1	O
,	26094131	1	O
by	26094131	1	O
progressive	26094131	1	O
lower	26094131	1	O
limb	26094131	1	O
spasticity	26094131	1	O
and	26094131	1	O
weakness	26094131	1	O
resulting	26094131	1	O
from	26094131	1	O
distal	26094131	1	O
degeneration	26094131	1	O
of	26094131	1	O
corticospinal	26094131	1	O
tract	26094131	1	O
axons	26094131	1	O
.	26094131	1	O
Mutations	26094131	1	B-Var
in	26094131	1	O
the	26094131	1	O
SPAST	26094131	1	B-Gene
(	26094131	1	O
previously	26094131	1	O
known	26094131	1	O
as	26094131	1	O
SPG4	26094131	1	B-Gene
)	26094131	1	I-Gene
gene	26094131	1	O
that	26094131	1	O
encodes	26094131	1	O
the	26094131	1	O
microtubule	26094131	1	O
-	26094131	1	O
severing	26094131	1	O
protein	26094131	1	O
called	26094131	1	O
spastin	26094131	1	O
,	26094131	1	O
are	26094131	1	O
the	26094131	1	O
most	26094131	1	O
common	26094131	1	O
cause	26094131	1	B-Reg
of	26094131	1	O
the	26094131	1	O
disease	26094131	1	B-Disease
.	26094131	1	O
The	26094131	1	O
aetiology	26094131	1	O
of	26094131	1	O
the	26094131	1	O
disease	26094131	1	O
is	26094131	1	O
poorly	26094131	1	O
understood	26094131	1	O
,	26094131	1	O
but	26094131	1	O
partial	26094131	1	O
loss	26094131	1	B-NegReg
of	26094131	1	O
microtubule	26094131	1	O
-	26094131	1	O
severing	26094131	1	O
activity	26094131	1	O
resulting	26094131	1	O
from	26094131	1	O
inactivating	26094131	1	B-Var
mutations	26094131	1	I-Var
in	26094131	1	O
one	26094131	1	O
SPAST	26094131	1	B-Gene
allele	26094131	1	O
is	26094131	1	O
the	26094131	1	O
most	26094131	1	O
postulated	26094131	1	O
explanation	26094131	1	O
.	26094131	1	O
Microtubule	26094131	1	O
severing	26094131	1	O
is	26094131	1	O
important	26094131	1	O
for	26094131	1	O
regulating	26094131	1	O
various	26094131	1	O
aspects	26094131	1	O
of	26094131	1	O
the	26094131	1	O
microtubule	26094131	1	O
array	26094131	1	O
,	26094131	1	O
including	26094131	1	O
microtubule	26094131	1	O
number	26094131	1	O
,	26094131	1	O
length	26094131	1	O
,	26094131	1	O
and	26094131	1	O
mobility	26094131	1	O
.	26094131	1	O
In	26094131	1	O
addition	26094131	1	O
,	26094131	1	O
higher	26094131	1	O
numbers	26094131	1	O
of	26094131	1	O
dynamic	26094131	1	O
plus	26094131	1	O
-	26094131	1	O
ends	26094131	1	O
of	26094131	1	O
microtubules	26094131	1	O
,	26094131	1	O
resulting	26094131	1	O
from	26094131	1	O
microtubule	26094131	1	O
-	26094131	1	O
severing	26094131	1	O
events	26094131	1	O
,	26094131	1	O
may	26094131	1	O
play	26094131	1	O
a	26094131	1	O
role	26094131	1	O
in	26094131	1	O
endosomal	26094131	1	O
tubulation	26094131	1	O
and	26094131	1	O
fission	26094131	1	O
.	26094131	1	O
Even	26094131	1	O
so	26094131	1	O
,	26094131	1	O
there	26094131	1	O
is	26094131	1	O
growing	26094131	1	O
evidence	26094131	1	O
that	26094131	1	O
decreased	26094131	1	O
severing	26094131	1	O
of	26094131	1	O
microtubules	26094131	1	O
does	26094131	1	O
not	26094131	1	O
fully	26094131	1	O
explain	26094131	1	O
HSP	26094131	1	O
-	26094131	1	O
SPG4	26094131	1	O
.	26094131	1	O
The	26094131	1	O
presence	26094131	1	O
of	26094131	1	O
two	26094131	1	O
translation	26094131	1	O
initiation	26094131	1	O
codons	26094131	1	O
in	26094131	1	O
SPAST	26094131	1	O
allows	26094131	1	O
synthesis	26094131	1	O
of	26094131	1	O
two	26094131	1	O
spastin	26094131	1	O
isoforms	26094131	1	O
:	26094131	1	O
a	26094131	1	O
full	26094131	1	O
-	26094131	1	O
length	26094131	1	O
isoform	26094131	1	O
called	26094131	1	O
M1	26094131	1	O
and	26094131	1	O
a	26094131	1	O
slightly	26094131	1	O
shorter	26094131	1	O
isoform	26094131	1	O
called	26094131	1	O
M87	26094131	1	O
.	26094131	1	O
M87	26094131	1	O
is	26094131	1	O
more	26094131	1	O
abundant	26094131	1	O
in	26094131	1	O
both	26094131	1	O
neuronal	26094131	1	O
and	26094131	1	O
non	26094131	1	O
-	26094131	1	O
neuronal	26094131	1	O
tissues	26094131	1	O
.	26094131	1	O
Studies	26094131	1	O
on	26094131	1	O
rodents	26094131	1	O
suggest	26094131	1	O
that	26094131	1	O
M1	26094131	1	O
is	26094131	1	O
only	26094131	1	O
readily	26094131	1	O
detected	26094131	1	O
in	26094131	1	O
adult	26094131	1	O
spinal	26094131	1	O
cord	26094131	1	O
,	26094131	1	O
which	26094131	1	O
is	26094131	1	O
where	26094131	1	O
nerve	26094131	1	O
degeneration	26094131	1	O
mainly	26094131	1	O
occurs	26094131	1	O
in	26094131	1	O
humans	26094131	1	O
with	26094131	1	O
HSP	26094131	1	O
-	26094131	1	O
SPG4	26094131	1	O
.	26094131	1	O
M1	26094131	1	O
,	26094131	1	O
due	26094131	1	O
to	26094131	1	O
its	26094131	1	O
hydrophobic	26094131	1	O
N	26094131	1	O
-	26094131	1	O
terminal	26094131	1	O
domain	26094131	1	O
not	26094131	1	O
shared	26094131	1	O
by	26094131	1	O
M87	26094131	1	O
,	26094131	1	O
may	26094131	1	O
insert	26094131	1	O
into	26094131	1	O
endoplasmic	26094131	1	O
reticulum	26094131	1	O
membrane	26094131	1	O
,	26094131	1	O
and	26094131	1	O
together	26094131	1	O
with	26094131	1	O
reticulons	26094131	1	O
,	26094131	1	O
atlastin	26094131	1	O
and	26094131	1	O
REEP1	26094131	1	O
,	26094131	1	O
may	26094131	1	O
play	26094131	1	O
a	26094131	1	O
role	26094131	1	O
in	26094131	1	O
the	26094131	1	O
morphogenesis	26094131	1	O
of	26094131	1	O
this	26094131	1	O
organelle	26094131	1	O
.	26094131	1	O
Some	26094131	1	B-Var
mutated	26094131	1	I-Var
spastins	26094131	1	O
may	26094131	1	O
act	26094131	1	O
in	26094131	1	O
dominant	26094131	1	O
-	26094131	1	O
negative	26094131	1	O
fashion	26094131	1	O
to	26094131	1	O
lower	26094131	1	B-NegReg
microtubule	26094131	1	O
-	26094131	1	O
severing	26094131	1	O
activity	26094131	1	O
,	26094131	1	O
but	26094131	1	O
others	26094131	1	B-Var
have	26094131	1	O
detrimental	26094131	1	B-NegReg
effects	26094131	1	I-NegReg
on	26094131	1	O
neurons	26094131	1	O
without	26094131	1	O
further	26094131	1	O
lowering	26094131	1	O
microtubule	26094131	1	O
severing	26094131	1	O
.	26094131	1	O
The	26094131	1	O
observed	26094131	1	O
adverse	26094131	1	B-NegReg
effects	26094131	1	I-NegReg
on	26094131	1	O
microtubule	26094131	1	O
dynamics	26094131	1	O
,	26094131	1	O
axonal	26094131	1	O
transport	26094131	1	O
,	26094131	1	O
endoplasmic	26094131	1	O
reticulum	26094131	1	O
,	26094131	1	O
and	26094131	1	O
endosomal	26094131	1	O
trafficking	26094131	1	O
are	26094131	1	O
likely	26094131	1	O
caused	26094131	1	O
not	26094131	1	O
only	26094131	1	O
by	26094131	1	O
diminished	26094131	1	B-NegReg
severing	26094131	1	O
of	26094131	1	O
microtubules	26094131	1	O
,	26094131	1	O
but	26094131	1	O
also	26094131	1	O
by	26094131	1	O
neurotoxicity	26094131	1	O
of	26094131	1	B-Reg
mutant	26094131	1	B-Var
spastin	26094131	1	O
proteins	26094131	1	O
,	26094131	1	O
chiefly	26094131	1	O
M1	26094131	1	O
.	26094131	1	O
Some	26094131	1	O
large	26094131	1	O
deletions	26094131	1	O
in	26094131	1	O
SPAST	26094131	1	O
might	26094131	1	O
also	26094131	1	O
affect	26094131	1	O
the	26094131	1	O
function	26094131	1	O
of	26094131	1	O
adjacent	26094131	1	O
genes	26094131	1	O
,	26094131	1	O
further	26094131	1	O
complicating	26094131	1	O
the	26094131	1	O
aetiology	26094131	1	O
of	26094131	1	O
the	26094131	1	O
disease	26094131	1	O
.	26094131	1	O

Clinical	26207643	1	O
phenotype	26207643	1	O
in	26207643	1	O
genetically	26207643	1	O
confirmed	26207643	1	O
von	26207643	1	O
Willebrand	26207643	1	O
disease	26207643	1	O
type	26207643	1	O
2	26207643	1	O
N	26207643	1	O
patients	26207643	1	O
reflects	26207643	1	O
a	26207643	1	O
haemophilia	26207643	1	O
A	26207643	1	O
phenotype	26207643	1	O
.	26207643	1	O
INTRODUCTION	26207643	1	O
:	26207643	1	O
Von	26207643	1	B-Disease
Willebrand	26207643	1	I-Disease
disease	26207643	1	I-Disease
(	26207643	1	I-Disease
VWD	26207643	1	I-Disease
)	26207643	1	I-Disease
type	26207643	1	I-Disease
2	26207643	1	I-Disease
N	26207643	1	I-Disease
is	26207643	1	O
characterized	26207643	1	O
by	26207643	1	O
a	26207643	1	O
defective	26207643	1	B-NegReg
binding	26207643	1	O
of	26207643	1	O
factor	26207643	1	O
VIII	26207643	1	O
(	26207643	1	O
FVIII	26207643	1	O
)	26207643	1	O
to	26207643	1	O
von	26207643	1	O
Willebrand	26207643	1	O
factor	26207643	1	O
(	26207643	1	O
VWF	26207643	1	O
)	26207643	1	O
resulting	26207643	1	O
in	26207643	1	O
diminished	26207643	1	B-NegReg
plasma	26207643	1	O
FVIII	26207643	1	O
levels	26207643	1	O
and	26207643	1	O
a	26207643	1	O
clinical	26207643	1	O
phenotype	26207643	1	O
mimicking	26207643	1	O
mild	26207643	1	O
haemophilia	26207643	1	O
A.	26207643	1	O
Several	26207643	1	O
mutations	26207643	1	B-Var
in	26207643	1	O
the	26207643	1	O
FVIII	26207643	1	O
binding	26207643	1	O
site	26207643	1	O
of	26207643	1	O
VWF	26207643	1	B-Gene
have	26207643	1	O
been	26207643	1	O
reported	26207643	1	O
.	26207643	1	O
AIM	26207643	1	O
:	26207643	1	O
This	26207643	1	O
study	26207643	1	O
aims	26207643	1	O
to	26207643	1	O
examine	26207643	1	O
the	26207643	1	O
effect	26207643	1	O
of	26207643	1	O
genotype	26207643	1	O
on	26207643	1	O
clinical	26207643	1	O
phenotype	26207643	1	O
in	26207643	1	O
a	26207643	1	O
cohort	26207643	1	O
of	26207643	1	O
VWD	26207643	1	O
2	26207643	1	O
N	26207643	1	O
patients	26207643	1	O
.	26207643	1	O
METHODS	26207643	1	O
:	26207643	1	O
Patients	26207643	1	O
with	26207643	1	O
at	26207643	1	O
least	26207643	1	O
one	26207643	1	O
genetically	26207643	1	O
confirmed	26207643	1	O
2	26207643	1	O
N	26207643	1	O
mutation	26207643	1	O
were	26207643	1	O
selected	26207643	1	O
retrospectively	26207643	1	O
from	26207643	1	O
a	26207643	1	O
cohort	26207643	1	O
of	26207643	1	O
patients	26207643	1	O
with	26207643	1	O
suspected	26207643	1	O
VWD	26207643	1	O
.	26207643	1	O
Clinical	26207643	1	O
and	26207643	1	O
laboratory	26207643	1	O
phenotypes	26207643	1	O
including	26207643	1	O
bleeding	26207643	1	O
scores	26207643	1	O
(	26207643	1	O
BS	26207643	1	O
)	26207643	1	O
were	26207643	1	O
obtained	26207643	1	O
and	26207643	1	O
analysed	26207643	1	O
.	26207643	1	O
RESULTS	26207643	1	O
:	26207643	1	O
Forty	26207643	1	O
-	26207643	1	O
two	26207643	1	O
VWD	26207643	1	O
2	26207643	1	O
N	26207643	1	O
patients	26207643	1	O
with	26207643	1	O
a	26207643	1	O
mean	26207643	1	O
age	26207643	1	O
of	26207643	1	O
44	26207643	1	O
years	26207643	1	O
were	26207643	1	O
included	26207643	1	O
.	26207643	1	O
Eleven	26207643	1	O
patients	26207643	1	O
were	26207643	1	O
homozygous	26207643	1	O
or	26207643	1	O
compound	26207643	1	O
heterozygous	26207643	1	O
(	26207643	1	O
genetically	26207643	1	O
confirmed	26207643	1	O
group	26207643	1	O
)	26207643	1	O
and	26207643	1	O
31	26207643	1	O
patients	26207643	1	O
were	26207643	1	O
heterozygously	26207643	1	O
affected	26207643	1	O
(	26207643	1	O
carriers	26207643	1	O
group	26207643	1	O
)	26207643	1	O
.	26207643	1	O
Statistically	26207643	1	O
significant	26207643	1	O
differences	26207643	1	O
between	26207643	1	O
genetically	26207643	1	O
confirmed	26207643	1	O
VWD	26207643	1	O
2	26207643	1	O
N	26207643	1	O
patients	26207643	1	O
and	26207643	1	O
carriers	26207643	1	O
were	26207643	1	O
found	26207643	1	O
in	26207643	1	O
FVIII	26207643	1	O
activity	26207643	1	O
,	26207643	1	O
VWF	26207643	1	O
antigen	26207643	1	O
levels	26207643	1	O
,	26207643	1	O
VWF	26207643	1	O
-	26207643	1	O
FVIII	26207643	1	O
binding	26207643	1	O
capacity	26207643	1	O
,	26207643	1	O
FVIII	26207643	1	O
/	26207643	1	O
VWF	26207643	1	O
antigen	26207643	1	O
ratio	26207643	1	O
(	26207643	1	O
all	26207643	1	O
P	26207643	1	O
<	26207643	1	O
0.001	26207643	1	O
)	26207643	1	O
,	26207643	1	O
VWF	26207643	1	O
-	26207643	1	O
ristocetin	26207643	1	O
activity	26207643	1	O
(	26207643	1	O
p	26207643	1	O
=	26207643	1	O
0.001	26207643	1	O
)	26207643	1	O
and	26207643	1	O
VWF	26207643	1	O
collagen	26207643	1	O
binding	26207643	1	O
(	26207643	1	O
P	26207643	1	O
=	26207643	1	O
0.002	26207643	1	O
)	26207643	1	O
.	26207643	1	O
Median	26207643	1	O
BS	26207643	1	O
was	26207643	1	O
6	26207643	1	O
in	26207643	1	O
genetically	26207643	1	O
confirmed	26207643	1	O
VWD	26207643	1	O
2	26207643	1	O
N	26207643	1	O
patients	26207643	1	O
compared	26207643	1	O
with	26207643	1	O
3	26207643	1	O
in	26207643	1	O
carriers	26207643	1	O
(	26207643	1	O
P	26207643	1	O
=	26207643	1	O
0.047	26207643	1	O
)	26207643	1	O
.	26207643	1	O
Haemarthrosis	26207643	1	O
,	26207643	1	O
muscle	26207643	1	O
haematomas	26207643	1	O
and	26207643	1	O
postpartum	26207643	1	O
haemorrhage	26207643	1	O
were	26207643	1	O
only	26207643	1	O
reported	26207643	1	O
in	26207643	1	O
genetically	26207643	1	O
confirmed	26207643	1	O
2	26207643	1	O
N	26207643	1	O
patients	26207643	1	O
.	26207643	1	O
CONCLUSION	26207643	1	O
:	26207643	1	O
Phenotypic	26207643	1	O
analysis	26207643	1	O
showed	26207643	1	O
that	26207643	1	O
all	26207643	1	O
laboratory	26207643	1	O
parameters	26207643	1	O
are	26207643	1	O
lower	26207643	1	O
in	26207643	1	O
genetically	26207643	1	O
confirmed	26207643	1	O
VWD	26207643	1	O
2	26207643	1	O
N	26207643	1	O
patients	26207643	1	O
compared	26207643	1	O
with	26207643	1	O
heterozygous	26207643	1	O
2	26207643	1	O
N	26207643	1	O
carriers	26207643	1	O
.	26207643	1	O
The	26207643	1	O
clinical	26207643	1	O
phenotype	26207643	1	O
in	26207643	1	O
genetically	26207643	1	O
confirmed	26207643	1	O
VWD	26207643	1	O
2	26207643	1	O
N	26207643	1	O
patients	26207643	1	O
is	26207643	1	O
comparable	26207643	1	O
to	26207643	1	O
mild	26207643	1	O
haemophilia	26207643	1	O
A	26207643	1	O
patients	26207643	1	O
and	26207643	1	O
more	26207643	1	O
severe	26207643	1	O
than	26207643	1	O
heterozygous	26207643	1	O
2	26207643	1	O
N	26207643	1	O
carriers	26207643	1	O
.	26207643	1	O

A	26260218	4	O
novel	26260218	4	O
SLC12A3	26260218	4	B-Gene
gene	26260218	4	O
homozygous	26260218	4	O
mutation	26260218	4	B-Var
of	26260218	4	B-Reg
Gitelman	26260218	4	B-Disease
syndrome	26260218	4	I-Disease
in	26260218	4	O
an	26260218	4	O
Asian	26260218	4	O
pedigree	26260218	4	O
and	26260218	4	O
literature	26260218	4	O
review	26260218	4	O
.	26260218	4	O
OBJECTIVES	26260218	4	O
:	26260218	4	O
Gitelman	26260218	4	B-Disease
syndrome	26260218	4	I-Disease
(	26260218	4	O
GS	26260218	4	O
)	26260218	4	O
is	26260218	4	O
an	26260218	4	O
autosomal	26260218	4	O
recessive	26260218	4	O
disease	26260218	4	O
characterized	26260218	4	O
by	26260218	4	O
hypokalemic	26260218	4	O
metabolic	26260218	4	O
alkalosis	26260218	4	O
in	26260218	4	O
combination	26260218	4	O
with	26260218	4	O
significant	26260218	4	O
hypomagnesemia	26260218	4	O
and	26260218	4	O
hypocalciuria	26260218	4	O
which	26260218	4	O
is	26260218	4	O
caused	26260218	4	B-Reg
by	26260218	4	I-Reg
mutations	26260218	4	B-Var
in	26260218	4	O
the	26260218	4	O
SLC12A3	26260218	4	B-Gene
gene	26260218	4	O
.	26260218	4	O
In	26260218	4	O
this	26260218	4	O
study	26260218	4	O
,	26260218	4	O
we	26260218	4	O
reported	26260218	4	O
a	26260218	4	O
case	26260218	4	O
of	26260218	4	O
GS	26260218	4	O
pedigree	26260218	4	O
and	26260218	4	O
reviewed	26260218	4	O
pertinent	26260218	4	O
literature	26260218	4	O
so	26260218	4	O
as	26260218	4	O
to	26260218	4	O
explore	26260218	4	O
the	26260218	4	O
relationship	26260218	4	O
between	26260218	4	O
clinical	26260218	4	O
characteristics	26260218	4	O
and	26260218	4	O
genotype	26260218	4	O
meanwhile	26260218	4	O
provide	26260218	4	O
recommendations	26260218	4	O
for	26260218	4	O
the	26260218	4	O
diagnosis	26260218	4	O
and	26260218	4	O
treatment	26260218	4	O
of	26260218	4	O
GS	26260218	4	O
.	26260218	4	O
DESIGN	26260218	4	O
AND	26260218	4	O
METHODS	26260218	4	O
:	26260218	4	O
This	26260218	4	O
is	26260218	4	O
a	26260218	4	O
pedigree	26260218	4	O
-	26260218	4	O
based	26260218	4	O
genetic	26260218	4	O
study	26260218	4	O
of	26260218	4	O
GS	26260218	4	O
and	26260218	4	O
11	26260218	4	O
members	26260218	4	O
from	26260218	4	O
one	26260218	4	O
family	26260218	4	O
were	26260218	4	O
included	26260218	4	O
.	26260218	4	O
We	26260218	4	O
summarized	26260218	4	O
their	26260218	4	O
clinical	26260218	4	O
features	26260218	4	O
,	26260218	4	O
analyzed	26260218	4	O
laboratory	26260218	4	O
parameters	26260218	4	O
related	26260218	4	O
to	26260218	4	O
GS	26260218	4	O
and	26260218	4	O
SLC12A3	26260218	4	O
gene	26260218	4	O
.	26260218	4	O
RESULTS	26260218	4	O
:	26260218	4	O
The	26260218	4	O
proband	26260218	4	O
experienced	26260218	4	O
intermittent	26260218	4	O
severe	26260218	4	O
symptoms	26260218	4	O
of	26260218	4	O
weakness	26260218	4	O
accompanied	26260218	4	O
by	26260218	4	O
significant	26260218	4	O
hypokalemia	26260218	4	O
,	26260218	4	O
hypomagnesemia	26260218	4	O
and	26260218	4	O
hypocalciuria	26260218	4	O
in	26260218	4	O
laboratory	26260218	4	O
test	26260218	4	O
with	26260218	4	O
poor	26260218	4	O
treatments	26260218	4	O
.	26260218	4	O
His	26260218	4	O
mother	26260218	4	O
had	26260218	4	O
more	26260218	4	O
slight	26260218	4	O
symptoms	26260218	4	O
of	26260218	4	O
weakness	26260218	4	O
than	26260218	4	O
him	26260218	4	O
with	26260218	4	O
mild	26260218	4	O
hypokalemia	26260218	4	O
and	26260218	4	O
hypocalciuria	26260218	4	O
.	26260218	4	O
Mild	26260218	4	O
hypomagnesemia	26260218	4	O
was	26260218	4	O
also	26260218	4	O
observed	26260218	4	O
in	26260218	4	O
his	26260218	4	O
sister	26260218	4	O
with	26260218	4	O
occasional	26260218	4	O
weakness	26260218	4	O
.	26260218	4	O
All	26260218	4	O
other	26260218	4	O
pedigree	26260218	4	O
members	26260218	4	O
had	26260218	4	O
normal	26260218	4	O
laboratory	26260218	4	O
test	26260218	4	O
with	26260218	4	O
no	26260218	4	O
GS	26260218	4	O
-	26260218	4	O
related	26260218	4	O
symptoms	26260218	4	O
.	26260218	4	O
A	26260218	4	O
homozygous	26260218	4	O
mutation	26260218	4	O
of	26260218	4	O
SLC12A3	26260218	4	O
gene	26260218	4	O
(	26260218	4	O
c.488	26260218	4	O
C	26260218	4	O
>	26260218	4	O
T	26260218	4	O
)	26260218	4	O
was	26260218	4	O
detected	26260218	4	O
by	26260218	4	O
genetic	26260218	4	O
testing	26260218	4	O
in	26260218	4	O
three	26260218	4	O
members	26260218	4	O
,	26260218	4	O
and	26260218	4	O
six	26260218	4	O
were	26260218	4	O
carriers	26260218	4	O
of	26260218	4	O
this	26260218	4	O
mutation	26260218	4	O
.	26260218	4	O
CONCLUSIONS	26260218	4	O
:	26260218	4	O
Genotype	26260218	4	O
and	26260218	4	O
phenotype	26260218	4	O
vary	26260218	4	O
significantly	26260218	4	O
among	26260218	4	O
GS	26260218	4	O
patients	26260218	4	O
.	26260218	4	O
Male	26260218	4	O
patients	26260218	4	O
tend	26260218	4	O
to	26260218	4	O
experience	26260218	4	O
more	26260218	4	O
severe	26260218	4	O
symptoms	26260218	4	O
and	26260218	4	O
poor	26260218	4	O
treatment	26260218	4	O
effect	26260218	4	O
.	26260218	4	O
Further	26260218	4	O
large	26260218	4	O
-	26260218	4	O
scale	26260218	4	O
population	26260218	4	O
,	26260218	4	O
animal	26260218	4	O
,	26260218	4	O
and	26260218	4	O
molecular	26260218	4	O
biology	26260218	4	O
experiments	26260218	4	O
are	26260218	4	O
required	26260218	4	O
to	26260218	4	O
investigate	26260218	4	O
the	26260218	4	O
complexity	26260218	4	O
of	26260218	4	O
GS	26260218	4	O
and	26260218	4	O
to	26260218	4	O
find	26260218	4	O
a	26260218	4	O
better	26260218	4	O
treatment	26260218	4	O
regimen	26260218	4	O
for	26260218	4	O
this	26260218	4	O
disease	26260218	4	O
.	26260218	4	O

Darier	26471493	4	O
disease	26471493	4	O
in	26471493	4	O
israel	26471493	4	O
:	26471493	4	O
combined	26471493	4	O
evaluation	26471493	4	O
of	26471493	4	O
genetic	26471493	4	O
and	26471493	4	O
neuropsychiatric	26471493	4	O
aspects	26471493	4	O
.	26471493	4	O
BACKGROUND	26471493	4	O
:	26471493	4	O
Darier	26471493	4	B-Disease
disease	26471493	4	I-Disease
(	26471493	4	O
DD	26471493	4	O
)	26471493	4	O
is	26471493	4	O
a	26471493	4	O
rare	26471493	4	O
genodermatose	26471493	4	O
caused	26471493	4	B-Reg
by	26471493	4	I-Reg
heterozygous	26471493	4	O
mutations	26471493	4	B-Var
in	26471493	4	O
the	26471493	4	O
ATP2A2	26471493	4	B-Gene
gene	26471493	4	O
and	26471493	4	O
has	26471493	4	O
been	26471493	4	O
associated	26471493	4	O
with	26471493	4	O
neuropsychiatric	26471493	4	O
manifestations	26471493	4	O
.	26471493	4	O
OBJECTIVES	26471493	4	O
:	26471493	4	O
To	26471493	4	O
investigate	26471493	4	O
the	26471493	4	O
genetic	26471493	4	O
basis	26471493	4	O
of	26471493	4	O
Israeli	26471493	4	O
patients	26471493	4	O
with	26471493	4	O
DD	26471493	4	O
,	26471493	4	O
and	26471493	4	O
its	26471493	4	O
association	26471493	4	O
with	26471493	4	O
neuropsychiatric	26471493	4	O
phenotype	26471493	4	O
.	26471493	4	O
METHODS	26471493	4	O
:	26471493	4	O
A	26471493	4	O
cohort	26471493	4	O
of	26471493	4	O
32	26471493	4	O
families	26471493	4	O
comprising	26471493	4	O
74	26471493	4	O
affected	26471493	4	O
individuals	26471493	4	O
and	26471493	4	O
13	26471493	4	O
unaffected	26471493	4	O
family	26471493	4	O
members	26471493	4	O
recruited	26471493	4	O
from	26471493	4	O
the	26471493	4	O
Haemek	26471493	4	O
Dermatology	26471493	4	O
Department	26471493	4	O
and	26471493	4	O
other	26471493	4	O
dermatology	26471493	4	O
clinics	26471493	4	O
in	26471493	4	O
Israel	26471493	4	O
were	26471493	4	O
evaluated	26471493	4	O
by	26471493	4	O
detailed	26471493	4	O
questionnaires	26471493	4	O
,	26471493	4	O
physical	26471493	4	O
examination	26471493	4	O
,	26471493	4	O
and	26471493	4	O
genetic	26471493	4	O
analysis	26471493	4	O
.	26471493	4	O
Main	26471493	4	O
outcome	26471493	4	O
measures	26471493	4	O
were	26471493	4	O
genetic	26471493	4	O
mutations	26471493	4	O
,	26471493	4	O
psychiatric	26471493	4	O
profile	26471493	4	O
,	26471493	4	O
and	26471493	4	O
their	26471493	4	O
association	26471493	4	O
.	26471493	4	O
RESULTS	26471493	4	O
:	26471493	4	O
23	26471493	4	O
mutations	26471493	4	O
in	26471493	4	O
ATP2A2	26471493	4	O
gene	26471493	4	O
were	26471493	4	O
scattered	26471493	4	O
over	26471493	4	O
the	26471493	4	O
entire	26471493	4	O
gene	26471493	4	O
,	26471493	4	O
14	26471493	4	O
of	26471493	4	O
them	26471493	4	O
novel	26471493	4	O
.	26471493	4	O
Two	26471493	4	O
families	26471493	4	O
shared	26471493	4	O
the	26471493	4	O
same	26471493	4	O
mutation	26471493	4	O
.	26471493	4	O
Twenty	26471493	4	O
-	26471493	4	O
one	26471493	4	O
patients	26471493	4	O
(	26471493	4	O
28.3%	26471493	4	O
)	26471493	4	O
had	26471493	4	O
a	26471493	4	O
history	26471493	4	O
of	26471493	4	O
psychiatric	26471493	4	O
disorder	26471493	4	O
,	26471493	4	O
most	26471493	4	O
of	26471493	4	O
them	26471493	4	O
mood	26471493	4	O
disorders	26471493	4	O
;	26471493	4	O
another	26471493	4	O
7	26471493	4	O
(	26471493	4	O
9.4%	26471493	4	O
)	26471493	4	O
patients	26471493	4	O
were	26471493	4	O
highly	26471493	4	O
suspected	26471493	4	O
of	26471493	4	O
having	26471493	4	O
a	26471493	4	O
psychiatric	26471493	4	O
disorder	26471493	4	O
;	26471493	4	O
21	26471493	4	O
(	26471493	4	O
27.6%	26471493	4	O
)	26471493	4	O
reported	26471493	4	O
suicidal	26471493	4	O
thoughts	26471493	4	O
;	26471493	4	O
and	26471493	4	O
5	26471493	4	O
(	26471493	4	O
6.6%	26471493	4	O
)	26471493	4	O
had	26471493	4	O
attempted	26471493	4	O
suicide	26471493	4	O
.	26471493	4	O
Psychiatric	26471493	4	O
phenotype	26471493	4	O
demonstrated	26471493	4	O
inter	26471493	4	O
-	26471493	4	O
and	26471493	4	O
intra	26471493	4	O
-	26471493	4	O
familial	26471493	4	O
variability	26471493	4	O
,	26471493	4	O
and	26471493	4	O
was	26471493	4	O
not	26471493	4	O
associated	26471493	4	O
with	26471493	4	O
disease	26471493	4	O
severity	26471493	4	O
,	26471493	4	O
family	26471493	4	O
history	26471493	4	O
of	26471493	4	O
psychiatric	26471493	4	O
disease	26471493	4	O
,	26471493	4	O
or	26471493	4	O
mutation	26471493	4	O
location	26471493	4	O
.	26471493	4	O
CONCLUSIONS	26471493	4	O
:	26471493	4	O
The	26471493	4	O
cohort	26471493	4	O
demonstrated	26471493	4	O
genetic	26471493	4	O
heterogeneity	26471493	4	O
with	26471493	4	O
no	26471493	4	O
mutation	26471493	4	O
cluster	26471493	4	O
along	26471493	4	O
the	26471493	4	O
gene	26471493	4	O
,	26471493	4	O
and	26471493	4	O
high	26471493	4	O
prevalence	26471493	4	O
of	26471493	4	O
psychiatric	26471493	4	O
disorders	26471493	4	O
.	26471493	4	O
Although	26471493	4	O
no	26471493	4	O
clear	26471493	4	O
genotype	26471493	4	O
-	26471493	4	O
phenotype	26471493	4	O
correlation	26471493	4	O
was	26471493	4	O
found	26471493	4	O
,	26471493	4	O
the	26471493	4	O
results	26471493	4	O
point	26471493	4	O
to	26471493	4	O
a	26471493	4	O
major	26471493	4	O
effect	26471493	4	O
of	26471493	4	O
genetic	26471493	4	O
background	26471493	4	O
on	26471493	4	O
psychiatric	26471493	4	O
phenotype	26471493	4	O
,	26471493	4	O
together	26471493	4	O
with	26471493	4	O
other	26471493	4	O
modifiers	26471493	4	O
.	26471493	4	O
This	26471493	4	O
article	26471493	4	O
is	26471493	4	O
protected	26471493	4	O
by	26471493	4	O
copyright	26471493	4	O
.	26471493	4	O
All	26471493	4	O
rights	26471493	4	O
reserved	26471493	4	O
.	26471493	4	O

Incontinentia	26564087	1	O
pigmenti	26564087	1	O
(	26564087	1	O
Bloch	26564087	1	O
-	26564087	1	O
Sulzberger	26564087	1	O
syndrome	26564087	1	O
)	26564087	1	O
.	26564087	1	O
Incontinentia	26564087	1	B-Disease
pigmenti	26564087	1	I-Disease
(	26564087	1	O
IP	26564087	1	O
;	26564087	1	O
Bloch	26564087	1	O
-	26564087	1	O
Sulzberger	26564087	1	O
syndrome	26564087	1	O
;	26564087	1	O
OMIM	26564087	1	O
308300	26564087	1	O
)	26564087	1	O
is	26564087	1	O
an	26564087	1	O
X	26564087	1	O
-	26564087	1	O
linked	26564087	1	O
dominant	26564087	1	O
neurocutaneous	26564087	1	O
disorder	26564087	1	O
with	26564087	1	O
presumed	26564087	1	O
male	26564087	1	O
lethality	26564087	1	O
.	26564087	1	O
It	26564087	1	O
is	26564087	1	O
usually	26564087	1	O
diagnosed	26564087	1	O
in	26564087	1	O
female	26564087	1	O
newborns	26564087	1	O
based	26564087	1	O
on	26564087	1	O
skin	26564087	1	O
features	26564087	1	O
(	26564087	1	O
erythematous	26564087	1	O
,	26564087	1	O
vesicular	26564087	1	O
,	26564087	1	O
or	26564087	1	O
bullous	26564087	1	O
eruption	26564087	1	O
in	26564087	1	O
linear	26564087	1	O
streaks	26564087	1	O
)	26564087	1	O
.	26564087	1	O
The	26564087	1	O
skin	26564087	1	O
lesions	26564087	1	O
evolve	26564087	1	O
into	26564087	1	O
a	26564087	1	O
verrucous	26564087	1	O
stage	26564087	1	O
,	26564087	1	O
followed	26564087	1	O
by	26564087	1	O
atrophy	26564087	1	O
and	26564087	1	O
scarring	26564087	1	O
,	26564087	1	O
leaving	26564087	1	O
linear	26564087	1	O
areas	26564087	1	O
of	26564087	1	O
hypopigmentation	26564087	1	O
and	26564087	1	O
hyperpigmented	26564087	1	O
macules	26564087	1	O
in	26564087	1	O
bizarre	26564087	1	O
patterns	26564087	1	O
following	26564087	1	O
Blaschko	26564087	1	O
'	26564087	1	O
s	26564087	1	O
lines	26564087	1	O
.	26564087	1	O
Systemic	26564087	1	O
and	26564087	1	O
neurologic	26564087	1	O
complications	26564087	1	O
include	26564087	1	O
focal	26564087	1	O
seizures	26564087	1	O
and	26564087	1	O
hemorrhagic	26564087	1	O
cerebral	26564087	1	O
infarction	26564087	1	O
in	26564087	1	O
infants	26564087	1	O
,	26564087	1	O
and	26564087	1	O
retinal	26564087	1	O
vasculopathy	26564087	1	O
leading	26564087	1	O
to	26564087	1	O
blindness	26564087	1	O
.	26564087	1	O
Hypodontia	26564087	1	O
,	26564087	1	O
conical	26564087	1	O
or	26564087	1	O
pegged	26564087	1	O
teeth	26564087	1	O
,	26564087	1	O
and	26564087	1	O
linear	26564087	1	O
areas	26564087	1	O
of	26564087	1	O
alopecia	26564087	1	O
persist	26564087	1	O
into	26564087	1	O
adulthood	26564087	1	O
.	26564087	1	O
IP	26564087	1	B-Disease
is	26564087	1	O
caused	26564087	1	B-Reg
by	26564087	1	I-Reg
mutation	26564087	1	B-Var
of	26564087	1	O
the	26564087	1	O
IKBKG	26564087	1	B-Gene
/	26564087	1	I-Gene
NEMO	26564087	1	I-Gene
gene	26564087	1	O
on	26564087	1	O
Xq28	26564087	1	O
.	26564087	1	O
Deletion	26564087	1	O
of	26564087	1	O
exons	26564087	1	O
4	26564087	1	O
to	26564087	1	O
10	26564087	1	O
(	26564087	1	O
NEMOΔ4-10	26564087	1	O
)	26564087	1	O
accounts	26564087	1	O
for	26564087	1	O
about	26564087	1	O
80%	26564087	1	O
of	26564087	1	O
cases	26564087	1	O
(	26564087	1	O
familial	26564087	1	O
and	26564087	1	O
sporadic	26564087	1	O
)	26564087	1	O
.	26564087	1	O
NEMO	26564087	1	B-Gene
mutation	26564087	1	B-Var
leads	26564087	1	O
to	26564087	1	O
loss	26564087	1	B-NegReg
of	26564087	1	I-NegReg
function	26564087	1	I-NegReg
of	26564087	1	O
NF	26564087	1	O
-	26564087	1	O
κB	26564087	1	O
,	26564087	1	O
a	26564087	1	O
critical	26564087	1	O
protein	26564087	1	O
that	26564087	1	O
modulates	26564087	1	O
cellular	26564087	1	O
proliferation	26564087	1	O
,	26564087	1	O
apoptosis	26564087	1	O
,	26564087	1	O
and	26564087	1	O
response	26564087	1	O
to	26564087	1	O
proinflammatory	26564087	1	O
factors	26564087	1	O
,	26564087	1	O
leading	26564087	1	B-Reg
to	26564087	1	I-Reg
the	26564087	1	O
characteristic	26564087	1	O
features	26564087	1	O
of	26564087	1	O
IP	26564087	1	B-Disease
.	26564087	1	O
In	26564087	1	O
female	26564087	1	O
carriers	26564087	1	O
,	26564087	1	O
selective	26564087	1	O
loss	26564087	1	O
of	26564087	1	O
cells	26564087	1	O
expressing	26564087	1	O
the	26564087	1	O
mutant	26564087	1	O
X	26564087	1	O
-	26564087	1	O
chromosome	26564087	1	O
results	26564087	1	O
in	26564087	1	O
completely	26564087	1	O
skewed	26564087	1	O
X	26564087	1	O
-	26564087	1	O
inactivation	26564087	1	O
in	26564087	1	O
the	26564087	1	O
majority	26564087	1	O
of	26564087	1	O
cases	26564087	1	O
.	26564087	1	O
Study	26564087	1	O
of	26564087	1	O
mouse	26564087	1	O
models	26564087	1	O
in	26564087	1	O
which	26564087	1	O
various	26564087	1	O
components	26564087	1	O
of	26564087	1	O
the	26564087	1	O
NF	26564087	1	O
-	26564087	1	O
κB	26564087	1	O
pathway	26564087	1	O
(	26564087	1	O
including	26564087	1	O
NEMO	26564087	1	O
)	26564087	1	O
have	26564087	1	O
been	26564087	1	O
knocked	26564087	1	O
out	26564087	1	O
has	26564087	1	O
contributed	26564087	1	O
significantly	26564087	1	O
to	26564087	1	O
our	26564087	1	O
understanding	26564087	1	O
of	26564087	1	O
disease	26564087	1	O
pathogenesis	26564087	1	O
.	26564087	1	O

Lipoid	26564090	4	O
proteinosis	26564090	4	O
.	26564090	4	O
Lipoid	26564090	4	B-Disease
proteinosis	26564090	4	I-Disease
is	26564090	4	O
a	26564090	4	O
rare	26564090	4	O
autosomal	26564090	4	O
recessive	26564090	4	O
disorder	26564090	4	O
caused	26564090	4	B-Reg
by	26564090	4	I-Reg
mutations	26564090	4	B-Var
in	26564090	4	O
ECM1	26564090	4	B-Gene
,	26564090	4	O
encoding	26564090	4	O
extracellular	26564090	4	O
matrix	26564090	4	O
protein	26564090	4	O
1	26564090	4	O
,	26564090	4	O
a	26564090	4	O
glycoprotein	26564090	4	O
expressed	26564090	4	O
in	26564090	4	O
many	26564090	4	O
organs	26564090	4	O
and	26564090	4	O
which	26564090	4	O
has	26564090	4	O
important	26564090	4	O
protein	26564090	4	O
-	26564090	4	O
protein	26564090	4	O
interactions	26564090	4	O
in	26564090	4	O
tissue	26564090	4	O
homeostasis	26564090	4	O
.	26564090	4	O
Although	26564090	4	O
the	26564090	4	O
disease	26564090	4	O
usually	26564090	4	O
presents	26564090	4	O
clinically	26564090	4	O
with	26564090	4	O
warty	26564090	4	O
infiltration	26564090	4	O
of	26564090	4	O
the	26564090	4	O
skin	26564090	4	O
and	26564090	4	O
mucous	26564090	4	O
membranes	26564090	4	O
and	26564090	4	O
a	26564090	4	O
hoarse	26564090	4	O
voice	26564090	4	O
,	26564090	4	O
neuropsychological	26564090	4	O
and	26564090	4	O
neuropsychiatric	26564090	4	O
abnormalities	26564090	4	O
are	26564090	4	O
often	26564090	4	O
prominent	26564090	4	O
features	26564090	4	O
.	26564090	4	O
There	26564090	4	O
may	26564090	4	O
be	26564090	4	O
bean	26564090	4	O
-	26564090	4	O
or	26564090	4	O
comma	26564090	4	O
-	26564090	4	O
shaped	26564090	4	O
intracranial	26564090	4	O
calcifications	26564090	4	O
,	26564090	4	O
often	26564090	4	O
selectively	26564090	4	O
affecting	26564090	4	O
the	26564090	4	O
amygdala	26564090	4	O
.	26564090	4	O
Patients	26564090	4	O
with	26564090	4	O
lipoid	26564090	4	O
proteinosis	26564090	4	O
therefore	26564090	4	O
have	26564090	4	O
been	26564090	4	O
used	26564090	4	O
as	26564090	4	O
models	26564090	4	O
for	26564090	4	O
demonstrating	26564090	4	O
physiologic	26564090	4	O
and	26564090	4	O
pathologic	26564090	4	O
abnormalities	26564090	4	O
of	26564090	4	O
the	26564090	4	O
amygdala	26564090	4	O
with	26564090	4	O
respect	26564090	4	O
to	26564090	4	O
fear	26564090	4	O
processing	26564090	4	O
,	26564090	4	O
affect	26564090	4	O
and	26564090	4	O
cognition	26564090	4	O
,	26564090	4	O
anxiety	26564090	4	O
and	26564090	4	O
memory	26564090	4	O
.	26564090	4	O
Clinically	26564090	4	O
,	26564090	4	O
patients	26564090	4	O
may	26564090	4	O
also	26564090	4	O
have	26564090	4	O
epilepsy	26564090	4	O
,	26564090	4	O
especially	26564090	4	O
involving	26564090	4	O
the	26564090	4	O
temporal	26564090	4	O
lobes	26564090	4	O
.	26564090	4	O
Less	26564090	4	O
common	26564090	4	O
or	26564090	4	O
rare	26564090	4	O
disease	26564090	4	O
associations	26564090	4	O
are	26564090	4	O
headache	26564090	4	O
(	26564090	4	O
including	26564090	4	O
migraine	26564090	4	O
)	26564090	4	O
,	26564090	4	O
ataxia	26564090	4	O
,	26564090	4	O
dizziness	26564090	4	O
,	26564090	4	O
schizophrenia	26564090	4	O
,	26564090	4	O
generalized	26564090	4	O
dystonia	26564090	4	O
,	26564090	4	O
transient	26564090	4	O
brachiofacial	26564090	4	O
paralysis	26564090	4	O
,	26564090	4	O
and	26564090	4	O
intracerebral	26564090	4	O
hemorrhage	26564090	4	O
.	26564090	4	O
Beyond	26564090	4	O
the	26564090	4	O
foci	26564090	4	O
of	26564090	4	O
calcification	26564090	4	O
,	26564090	4	O
the	26564090	4	O
cause	26564090	4	O
of	26564090	4	O
the	26564090	4	O
neurologic	26564090	4	O
abnormalities	26564090	4	O
in	26564090	4	O
lipoid	26564090	4	O
proteinosis	26564090	4	O
is	26564090	4	O
unknown	26564090	4	O
,	26564090	4	O
although	26564090	4	O
the	26564090	4	O
ECM1	26564090	4	O
protein	26564090	4	O
can	26564090	4	O
normally	26564090	4	O
bind	26564090	4	O
to	26564090	4	O
various	26564090	4	O
extracellular	26564090	4	O
matrix	26564090	4	O
proteins	26564090	4	O
and	26564090	4	O
glycosaminoglycans	26564090	4	O
as	26564090	4	O
well	26564090	4	O
as	26564090	4	O
certain	26564090	4	O
enzymes	26564090	4	O
,	26564090	4	O
including	26564090	4	O
matrix	26564090	4	O
metalloproteinase	26564090	4	O
9	26564090	4	O
.	26564090	4	O
Loss	26564090	4	O
of	26564090	4	O
key	26564090	4	O
protein	26564090	4	O
-	26564090	4	O
protein	26564090	4	O
interactions	26564090	4	O
may	26564090	4	O
underscore	26564090	4	O
some	26564090	4	O
of	26564090	4	O
the	26564090	4	O
disease	26564090	4	O
pathophysiology	26564090	4	O
.	26564090	4	O
There	26564090	4	O
is	26564090	4	O
currently	26564090	4	O
no	26564090	4	O
effective	26564090	4	O
treatment	26564090	4	O
for	26564090	4	O
lipoid	26564090	4	O
proteinosis	26564090	4	O
and	26564090	4	O
clinical	26564090	4	O
care	26564090	4	O
is	26564090	4	O
largely	26564090	4	O
supportive	26564090	4	O
.	26564090	4	O

Paternal	26572961	2	O
uniparental	26572961	2	O
disomy	26572961	2	O
11	26572961	2	O
p15.5	26572961	2	O
in	26572961	2	O
the	26572961	2	O
pancreatic	26572961	2	O
nodule	26572961	2	O
of	26572961	2	O
an	26572961	2	O
infant	26572961	2	O
with	26572961	2	O
Costello	26572961	2	O
syndrome	26572961	2	O
:	26572961	2	O
Shared	26572961	2	O
mechanism	26572961	2	O
for	26572961	2	O
hyperinsulinemic	26572961	2	O
hypoglycemia	26572961	2	O
in	26572961	2	O
neonates	26572961	2	O
with	26572961	2	O
Costello	26572961	2	O
and	26572961	2	O
Beckwith	26572961	2	O
-	26572961	2	O
Wiedemann	26572961	2	O
syndrome	26572961	2	O
and	26572961	2	O
somatic	26572961	2	O
loss	26572961	2	O
of	26572961	2	O
heterozygosity	26572961	2	O
in	26572961	2	O
Costello	26572961	2	O
syndrome	26572961	2	O
driving	26572961	2	O
clonal	26572961	2	O
expansion	26572961	2	O
.	26572961	2	O
Costello	26572961	2	B-Disease
syndrome	26572961	2	I-Disease
(	26572961	2	O
CS	26572961	2	O
)	26572961	2	O
entails	26572961	2	O
a	26572961	2	O
cancer	26572961	2	O
predisposition	26572961	2	O
and	26572961	2	O
is	26572961	2	O
caused	26572961	2	O
by	26572961	2	O
activating	26572961	2	B-PosReg
HRAS	26572961	2	B-Gene
mutations	26572961	2	B-Var
,	26572961	2	O
typically	26572961	2	O
arising	26572961	2	O
de	26572961	2	O
novo	26572961	2	O
in	26572961	2	O
the	26572961	2	O
paternal	26572961	2	O
germline	26572961	2	O
.	26572961	2	O
Hypoglycemia	26572961	2	O
is	26572961	2	O
common	26572961	2	O
in	26572961	2	O
CS	26572961	2	O
neonates	26572961	2	O
.	26572961	2	O
A	26572961	2	O
previously	26572961	2	O
reported	26572961	2	O
individual	26572961	2	O
with	26572961	2	O
the	26572961	2	O
rare	26572961	2	O
HRAS	26572961	2	O
p.Gln22Lys	26572961	2	O
had	26572961	2	O
hyperinsulinemic	26572961	2	O
hypoglycemia	26572961	2	O
.	26572961	2	O
Autopsy	26572961	2	O
showed	26572961	2	O
a	26572961	2	O
discrete	26572961	2	O
pancreatic	26572961	2	O
nodule	26572961	2	O
.	26572961	2	O
The	26572961	2	O
morphologic	26572961	2	O
and	26572961	2	O
immunohistochemistry	26572961	2	O
findings	26572961	2	O
,	26572961	2	O
including	26572961	2	O
loss	26572961	2	O
of	26572961	2	O
p57	26572961	2	O
(	26572961	2	O
Kip2	26572961	2	O
)	26572961	2	O
protein	26572961	2	O
,	26572961	2	O
were	26572961	2	O
identical	26572961	2	O
to	26572961	2	O
a	26572961	2	O
focal	26572961	2	O
lesion	26572961	2	O
of	26572961	2	O
congenital	26572961	2	O
hyperinsulinism	26572961	2	O
,	26572961	2	O
however	26572961	2	O
,	26572961	2	O
no	26572961	2	O
KCNJ11	26572961	2	O
or	26572961	2	O
ABCC8	26572961	2	O
mutation	26572961	2	O
was	26572961	2	O
identified	26572961	2	O
and	26572961	2	O
germline	26572961	2	O
derived	26572961	2	O
DNA	26572961	2	O
showed	26572961	2	O
no	26572961	2	O
alternation	26572961	2	O
of	26572961	2	O
the	26572961	2	O
maternal	26572961	2	O
or	26572961	2	O
paternal	26572961	2	O
11	26572961	2	O
p15	26572961	2	O
alleles	26572961	2	O
.	26572961	2	O
Here	26572961	2	O
we	26572961	2	O
report	26572961	2	O
paternal	26572961	2	O
uniparental	26572961	2	O
disomy	26572961	2	O
(	26572961	2	O
pUPD	26572961	2	O
)	26572961	2	O
within	26572961	2	O
the	26572961	2	O
lesion	26572961	2	O
,	26572961	2	O
similar	26572961	2	O
to	26572961	2	O
the	26572961	2	O
pUPD11p15.5	26572961	2	O
in	26572961	2	O
Beckwith	26572961	2	O
-	26572961	2	O
Wiedemann	26572961	2	O
syndrome	26572961	2	O
(	26572961	2	O
BWS	26572961	2	O
)	26572961	2	O
.	26572961	2	O
The	26572961	2	O
similar	26572961	2	O
extent	26572961	2	O
of	26572961	2	O
the	26572961	2	O
pUPD	26572961	2	O
suggests	26572961	2	O
a	26572961	2	O
similar	26572961	2	O
mechanism	26572961	2	O
driving	26572961	2	O
hyperinsulinemia	26572961	2	O
in	26572961	2	O
both	26572961	2	O
conditions	26572961	2	O
.	26572961	2	O
After	26572961	2	O
coincidental	26572961	2	O
somatic	26572961	2	O
LOH	26572961	2	O
and	26572961	2	O
pUPD	26572961	2	O
,	26572961	2	O
the	26572961	2	O
growth	26572961	2	O
promoting	26572961	2	O
effects	26572961	2	O
of	26572961	2	O
the	26572961	2	O
paternally	26572961	2	O
derived	26572961	2	O
HRAS	26572961	2	O
mutation	26572961	2	O
,	26572961	2	O
in	26572961	2	O
combination	26572961	2	O
with	26572961	2	O
the	26572961	2	O
increased	26572961	2	O
function	26572961	2	O
of	26572961	2	O
the	26572961	2	O
adjacent	26572961	2	O
paternally	26572961	2	O
expressed	26572961	2	O
IGF2	26572961	2	O
,	26572961	2	O
may	26572961	2	O
together	26572961	2	O
result	26572961	2	O
in	26572961	2	O
clonal	26572961	2	O
expansion	26572961	2	O
.	26572961	2	O
Although	26572961	2	O
this	26572961	2	O
somatic	26572961	2	O
LOH	26572961	2	O
within	26572961	2	O
pancreatic	26572961	2	O
tissue	26572961	2	O
resulted	26572961	2	O
in	26572961	2	O
hyperinsulinism	26572961	2	O
,	26572961	2	O
similar	26572961	2	O
LOH	26572961	2	O
in	26572961	2	O
mesenchymal	26572961	2	O
cells	26572961	2	O
may	26572961	2	O
drive	26572961	2	O
embryonal	26572961	2	O
rhabdomyosarcoma	26572961	2	O
(	26572961	2	O
ERMS	26572961	2	O
)	26572961	2	O
.	26572961	2	O
Interestingly	26572961	2	O
,	26572961	2	O
biallelic	26572961	2	O
IGF2	26572961	2	O
expression	26572961	2	O
has	26572961	2	O
been	26572961	2	O
linked	26572961	2	O
to	26572961	2	O
rhabdomyosarcoma	26572961	2	O
tumorigenesis	26572961	2	O
and	26572961	2	O
pUPD11	26572961	2	O
occurred	26572961	2	O
in	26572961	2	O
all	26572961	2	O
8	26572961	2	O
ERMS	26572961	2	O
samples	26572961	2	O
from	26572961	2	O
CS	26572961	2	O
individuals	26572961	2	O
.	26572961	2	O
Somatic	26572961	2	O
KRAS	26572961	2	O
and	26572961	2	O
HRAS	26572961	2	O
mutations	26572961	2	O
occur	26572961	2	O
with	26572961	2	O
comparable	26572961	2	O
frequency	26572961	2	O
in	26572961	2	O
isolated	26572961	2	O
malignancies	26572961	2	O
.	26572961	2	O
Yet	26572961	2	O
,	26572961	2	O
the	26572961	2	O
malignancy	26572961	2	O
risk	26572961	2	O
in	26572961	2	O
CS	26572961	2	O
is	26572961	2	O
notably	26572961	2	O
higher	26572961	2	O
than	26572961	2	O
in	26572961	2	O
Noonan	26572961	2	O
syndrome	26572961	2	O
with	26572961	2	O
a	26572961	2	O
KRAS	26572961	2	O
mutation	26572961	2	O
.	26572961	2	O
It	26572961	2	O
is	26572961	2	O
conceivable	26572961	2	O
that	26572961	2	O
HRAS	26572961	2	O
co	26572961	2	O
-	26572961	2	O
localization	26572961	2	O
with	26572961	2	O
IGF2	26572961	2	O
and	26572961	2	O
the	26572961	2	O
combined	26572961	2	O
effect	26572961	2	O
of	26572961	2	O
pUPD	26572961	2	O
11	26572961	2	O
p15.5	26572961	2	O
on	26572961	2	O
both	26572961	2	O
genes	26572961	2	O
contributes	26572961	2	O
to	26572961	2	O
the	26572961	2	O
oncogenic	26572961	2	O
potential	26572961	2	O
.	26572961	2	O
2015	26572961	2	O
Wiley	26572961	2	O
Periodicals	26572961	2	O
,	26572961	2	O
Inc	26572961	2	O
.	26572961	2	O

Progranulin	26624524	1	O
deficiency	26624524	1	O
induces	26624524	1	O
overactivation	26624524	1	O
of	26624524	1	O
WNT5A	26624524	1	O
expression	26624524	1	O
via	26624524	1	O
TNF	26624524	1	O
-	26624524	1	O
α	26624524	1	O
/	26624524	1	O
NF	26624524	1	O
-	26624524	1	O
κB	26624524	1	O
pathway	26624524	1	O
in	26624524	1	O
peripheral	26624524	1	O
cells	26624524	1	O
from	26624524	1	O
frontotemporal	26624524	1	O
dementia	26624524	1	O
-	26624524	1	O
linked	26624524	1	O
granulin	26624524	1	O
mutation	26624524	1	O
carriers	26624524	1	O
.	26624524	1	O
BACKGROUND	26624524	1	O
:	26624524	1	O
Loss	26624524	1	B-NegReg
-	26624524	1	I-NegReg
of	26624524	1	I-NegReg
-	26624524	1	I-NegReg
function	26624524	1	I-NegReg
progranulin	26624524	1	O
gene	26624524	1	O
(	26624524	1	B-Gene
GRN	26624524	1	I-Gene
)	26624524	1	I-Gene
mutations	26624524	1	B-Var
have	26624524	1	O
been	26624524	1	O
identified	26624524	1	O
as	26624524	1	O
the	26624524	1	O
major	26624524	1	O
cause	26624524	1	O
of	26624524	1	O
frontotemporal	26624524	1	B-Disease
lobar	26624524	1	I-Disease
degeneration	26624524	1	I-Disease
with	26624524	1	O
transactive	26624524	1	O
response	26624524	1	O
(	26624524	1	O
TAR	26624524	1	O
)	26624524	1	O
DNA	26624524	1	O
-	26624524	1	O
binding	26624524	1	O
protein	26624524	1	O
43	26624524	1	O
(	26624524	1	O
TDP-43	26624524	1	O
)	26624524	1	O
pathology	26624524	1	O
(	26624524	1	O
frontotemporal	26624524	1	O
lobar	26624524	1	O
degeneration	26624524	1	O
[	26624524	1	O
FTLD	26624524	1	O
]	26624524	1	O
-	26624524	1	O
TDP	26624524	1	O
)	26624524	1	O
;	26624524	1	O
however	26624524	1	O
,	26624524	1	O
little	26624524	1	O
is	26624524	1	O
known	26624524	1	O
about	26624524	1	O
the	26624524	1	O
association	26624524	1	O
between	26624524	1	O
progranulin	26624524	1	O
(	26624524	1	O
PGRN	26624524	1	O
)	26624524	1	O
deficiency	26624524	1	O
and	26624524	1	O
neuronal	26624524	1	O
loss	26624524	1	O
in	26624524	1	O
individuals	26624524	1	O
with	26624524	1	O
FTLD	26624524	1	O
-	26624524	1	O
TDP	26624524	1	O
.	26624524	1	O
Previously	26624524	1	O
we	26624524	1	O
reported	26624524	1	O
enhanced	26624524	1	O
proliferative	26624524	1	O
activity	26624524	1	O
associated	26624524	1	O
with	26624524	1	O
the	26624524	1	O
activation	26624524	1	O
of	26624524	1	O
WNT5A	26624524	1	O
/	26624524	1	O
CDK6	26624524	1	O
/	26624524	1	O
pRb	26624524	1	O
signalling	26624524	1	O
in	26624524	1	O
PGRN	26624524	1	O
-	26624524	1	O
deficient	26624524	1	O
cells	26624524	1	O
.	26624524	1	O
The	26624524	1	O
objective	26624524	1	O
of	26624524	1	O
this	26624524	1	O
work	26624524	1	O
was	26624524	1	O
to	26624524	1	O
elucidate	26624524	1	O
the	26624524	1	O
association	26624524	1	O
between	26624524	1	O
PGRN	26624524	1	O
deficiency	26624524	1	O
,	26624524	1	O
WNT5A	26624524	1	O
signalling	26624524	1	O
and	26624524	1	O
cell	26624524	1	O
proliferation	26624524	1	O
in	26624524	1	O
immortalized	26624524	1	O
lymphoblasts	26624524	1	O
from	26624524	1	O
carriers	26624524	1	O
of	26624524	1	O
the	26624524	1	O
c.709	26624524	1	O
-	26624524	1	O
1	26624524	1	O
G	26624524	1	O
>	26624524	1	O
A	26624524	1	O
GRN	26624524	1	O
mutation	26624524	1	O
(	26624524	1	O
asymptomatic	26624524	1	O
and	26624524	1	O
FTLD	26624524	1	O
-	26624524	1	O
TDP	26624524	1	O
)	26624524	1	O
.	26624524	1	O
METHODS	26624524	1	O
:	26624524	1	O
We	26624524	1	O
assessed	26624524	1	O
cell	26624524	1	O
proliferation	26624524	1	O
in	26624524	1	O
carriers	26624524	1	O
of	26624524	1	O
the	26624524	1	O
c.709	26624524	1	O
-	26624524	1	O
1	26624524	1	O
G	26624524	1	O
>	26624524	1	O
A	26624524	1	O
GRN	26624524	1	O
gene	26624524	1	O
mutation	26624524	1	O
and	26624524	1	O
controls	26624524	1	O
without	26624524	1	O
GRN	26624524	1	O
mutation	26624524	1	O
and	26624524	1	O
without	26624524	1	O
sign	26624524	1	O
of	26624524	1	O
neurologic	26624524	1	O
degeneration	26624524	1	O
by	26624524	1	O
cell	26624524	1	O
counting	26624524	1	O
or	26624524	1	O
using	26624524	1	O
an	26624524	1	O
MTT	26624524	1	O
assay	26624524	1	O
.	26624524	1	O
We	26624524	1	O
used	26624524	1	O
a	26624524	1	O
luciferase	26624524	1	O
assay	26624524	1	O
to	26624524	1	O
measure	26624524	1	O
the	26624524	1	O
nuclear	26624524	1	O
factor	26624524	1	O
-	26624524	1	O
κ	26624524	1	O
(	26624524	1	O
NF	26624524	1	O
-	26624524	1	O
κ	26624524	1	O
)	26624524	1	O
activity	26624524	1	O
.	26624524	1	O
We	26624524	1	O
evaluated	26624524	1	O
messenger	26624524	1	O
RNA	26624524	1	O
levels	26624524	1	O
using	26624524	1	O
quantitative	26624524	1	O
real	26624524	1	O
-	26624524	1	O
time	26624524	1	O
polymerase	26624524	1	O
chain	26624524	1	O
reaction	26624524	1	O
and	26624524	1	O
protein	26624524	1	O
levels	26624524	1	O
by	26624524	1	O
immunoblotting	26624524	1	O
.	26624524	1	O
Co	26624524	1	O
-	26624524	1	O
immunoprecipitation	26624524	1	O
was	26624524	1	O
used	26624524	1	O
to	26624524	1	O
analyze	26624524	1	O
the	26624524	1	O
interaction	26624524	1	O
between	26624524	1	O
PGRN	26624524	1	O
and	26624524	1	O
its	26624524	1	O
receptors	26624524	1	O
.	26624524	1	O
RESULTS	26624524	1	O
:	26624524	1	O
We	26624524	1	O
enrolled	26624524	1	O
19	26624524	1	O
carriers	26624524	1	O
of	26624524	1	O
the	26624524	1	O
GRN	26624524	1	O
gene	26624524	1	O
mutation	26624524	1	O
and	26624524	1	O
10	26624524	1	O
controls	26624524	1	O
in	26624524	1	O
this	26624524	1	O
study	26624524	1	O
.	26624524	1	O
The	26624524	1	O
PGRN	26624524	1	B-Var
-	26624524	1	I-Var
deficient	26624524	1	I-Var
cells	26624524	1	O
showed	26624524	1	O
increased	26624524	1	B-PosReg
expression	26624524	1	O
of	26624524	1	O
WNT5A	26624524	1	B-Gene
due	26624524	1	O
to	26624524	1	O
NF	26624524	1	O
-	26624524	1	O
κB	26624524	1	O
signalling	26624524	1	O
overactivation	26624524	1	B-PosReg
.	26624524	1	O
We	26624524	1	O
observed	26624524	1	O
a	26624524	1	O
competition	26624524	1	O
between	26624524	1	O
PGRN	26624524	1	O
and	26624524	1	O
tumour	26624524	1	O
necrosis	26624524	1	O
factor	26624524	1	O
-	26624524	1	O
α	26624524	1	O
(	26624524	1	O
TNF	26624524	1	O
-	26624524	1	O
α	26624524	1	O
)	26624524	1	O
for	26624524	1	O
binding	26624524	1	O
both	26624524	1	O
TNF	26624524	1	O
receptors	26624524	1	O
(	26624524	1	O
TNFR	26624524	1	O
)	26624524	1	O
I	26624524	1	O
and	26624524	1	O
II	26624524	1	O
.	26624524	1	O
Blocking	26624524	1	O
NF	26624524	1	O
-	26624524	1	O
κB	26624524	1	O
signalling	26624524	1	O
using	26624524	1	O
wedelolactone	26624524	1	O
or	26624524	1	O
specific	26624524	1	O
antibodies	26624524	1	O
against	26624524	1	O
TNFRs	26624524	1	O
inhibited	26624524	1	O
WNT5A	26624524	1	O
overexpression	26624524	1	O
and	26624524	1	O
proliferation	26624524	1	O
of	26624524	1	O
PGRN	26624524	1	O
-	26624524	1	O
deficient	26624524	1	O
cells	26624524	1	O
.	26624524	1	O
Conversely	26624524	1	O
,	26624524	1	O
the	26624524	1	O
activation	26624524	1	O
of	26624524	1	O
NF	26624524	1	O
-	26624524	1	O
κB	26624524	1	O
signalling	26624524	1	O
by	26624524	1	O
TNF	26624524	1	O
-	26624524	1	O
α	26624524	1	O
increased	26624524	1	O
WNT5A	26624524	1	O
-	26624524	1	O
dependent	26624524	1	O
proliferation	26624524	1	O
of	26624524	1	O
control	26624524	1	O
cells	26624524	1	O
.	26624524	1	O
LIMITATIONS	26624524	1	O
:	26624524	1	O
All	26624524	1	O
cell	26624524	1	O
lines	26624524	1	O
were	26624524	1	O
derived	26624524	1	O
from	26624524	1	O
individuals	26624524	1	O
harboring	26624524	1	O
the	26624524	1	O
same	26624524	1	O
splicing	26624524	1	O
GRN	26624524	1	O
mutation	26624524	1	O
.	26624524	1	O
Nevertheless	26624524	1	O
,	26624524	1	O
most	26624524	1	O
of	26624524	1	O
the	26624524	1	O
known	26624524	1	O
GRN	26624524	1	B-Gene
mutations	26624524	1	B-Var
lead	26624524	1	B-Reg
to	26624524	1	I-Reg
haploinsufficiency	26624524	1	B-Var
of	26624524	1	O
the	26624524	1	O
protein	26624524	1	O
.	26624524	1	O
CONCLUSION	26624524	1	O
:	26624524	1	O
Our	26624524	1	O
results	26624524	1	O
revealed	26624524	1	O
an	26624524	1	O
important	26624524	1	O
role	26624524	1	O
of	26624524	1	O
NF	26624524	1	O
-	26624524	1	O
κB	26624524	1	O
signalling	26624524	1	O
in	26624524	1	O
PGRN	26624524	1	O
-	26624524	1	O
associated	26624524	1	O
FTLD	26624524	1	O
-	26624524	1	O
TDP	26624524	1	O
and	26624524	1	O
confirm	26624524	1	O
that	26624524	1	O
PGRN	26624524	1	O
can	26624524	1	O
bind	26624524	1	O
to	26624524	1	O
TNF	26624524	1	O
-	26624524	1	O
a	26624524	1	O
receptors	26624524	1	O
regulating	26624524	1	O
the	26624524	1	O
expression	26624524	1	O
of	26624524	1	O
WNT5A	26624524	1	O
,	26624524	1	O
suggesting	26624524	1	O
novel	26624524	1	O
targets	26624524	1	O
for	26624524	1	O
treatment	26624524	1	O
of	26624524	1	O
FTLD	26624524	1	O
-	26624524	1	O
TDP	26624524	1	O
linked	26624524	1	O
to	26624524	1	O
GRN	26624524	1	O
mutations	26624524	1	O
.	26624524	1	O

ADIPOR1	26662040	4	B-Gene
is	26662040	4	O
Mutated	26662040	4	B-Var
in	26662040	4	B-Reg
Syndromic	26662040	4	O
Retinitis	26662040	4	B-Disease
Pigmentosa	26662040	4	I-Disease
.	26662040	4	O
Retinitis	26662040	4	O
pigmentosa	26662040	4	O
(	26662040	4	O
RP	26662040	4	O
)	26662040	4	O
is	26662040	4	O
a	26662040	4	O
genetically	26662040	4	O
heterogeneous	26662040	4	O
retinal	26662040	4	O
disorder	26662040	4	O
.	26662040	4	O
Despite	26662040	4	O
the	26662040	4	O
numerous	26662040	4	O
genes	26662040	4	O
associated	26662040	4	O
with	26662040	4	O
RP	26662040	4	O
already	26662040	4	O
identified	26662040	4	O
,	26662040	4	O
the	26662040	4	O
genetic	26662040	4	O
basis	26662040	4	O
remains	26662040	4	O
unknown	26662040	4	O
in	26662040	4	O
a	26662040	4	O
substantial	26662040	4	O
number	26662040	4	O
of	26662040	4	O
patients	26662040	4	O
and	26662040	4	O
families	26662040	4	O
.	26662040	4	O
In	26662040	4	O
this	26662040	4	O
study	26662040	4	O
,	26662040	4	O
we	26662040	4	O
performed	26662040	4	O
whole	26662040	4	O
exome	26662040	4	O
sequencing	26662040	4	O
to	26662040	4	O
investigate	26662040	4	O
the	26662040	4	O
molecular	26662040	4	O
basis	26662040	4	O
of	26662040	4	O
a	26662040	4	O
syndromic	26662040	4	O
RP	26662040	4	O
case	26662040	4	O
which	26662040	4	O
cannot	26662040	4	O
be	26662040	4	O
solved	26662040	4	O
by	26662040	4	O
mutations	26662040	4	O
in	26662040	4	O
known	26662040	4	O
disease	26662040	4	O
-	26662040	4	O
causing	26662040	4	O
genes	26662040	4	O
.	26662040	4	O
After	26662040	4	O
applying	26662040	4	O
a	26662040	4	O
series	26662040	4	O
of	26662040	4	O
variant	26662040	4	O
filtering	26662040	4	O
strategies	26662040	4	O
,	26662040	4	O
we	26662040	4	O
identified	26662040	4	O
an	26662040	4	O
apparently	26662040	4	O
homozygous	26662040	4	O
frameshift	26662040	4	O
mutation	26662040	4	O
,	26662040	4	O
c.31	26662040	4	O
delC	26662040	4	O
(	26662040	4	O
p.Q11Rfs*24	26662040	4	O
)	26662040	4	O
in	26662040	4	O
the	26662040	4	O
ADIPOR1	26662040	4	O
gene	26662040	4	O
.	26662040	4	O
The	26662040	4	O
reported	26662040	4	O
phenotypes	26662040	4	O
of	26662040	4	O
Adipor1	26662040	4	O
-	26662040	4	O
null	26662040	4	O
mice	26662040	4	O
contain	26662040	4	O
retinal	26662040	4	O
dystrophy	26662040	4	O
,	26662040	4	O
obesity	26662040	4	O
and	26662040	4	O
behavioral	26662040	4	O
abnormalities	26662040	4	O
,	26662040	4	O
which	26662040	4	O
highly	26662040	4	O
mimic	26662040	4	O
those	26662040	4	O
in	26662040	4	O
the	26662040	4	O
syndromic	26662040	4	O
RP	26662040	4	O
patient	26662040	4	O
.	26662040	4	O
We	26662040	4	O
further	26662040	4	O
confirmed	26662040	4	O
ADIPOR1	26662040	4	O
retina	26662040	4	O
expression	26662040	4	O
by	26662040	4	O
immunohistochemistry	26662040	4	O
.	26662040	4	O
Our	26662040	4	O
results	26662040	4	O
established	26662040	4	O
ADIPOR1	26662040	4	O
as	26662040	4	O
a	26662040	4	O
novel	26662040	4	O
disease	26662040	4	O
-	26662040	4	O
causing	26662040	4	O
gene	26662040	4	O
for	26662040	4	O
syndromic	26662040	4	O
RP	26662040	4	O
and	26662040	4	O
highlight	26662040	4	O
the	26662040	4	O
importance	26662040	4	O
of	26662040	4	O
fatty	26662040	4	O
acid	26662040	4	O
transport	26662040	4	O
in	26662040	4	O
the	26662040	4	O
retina	26662040	4	O
.	26662040	4	O
This	26662040	4	O
article	26662040	4	O
is	26662040	4	O
protected	26662040	4	O
by	26662040	4	O
copyright	26662040	4	O
.	26662040	4	O
All	26662040	4	O
rights	26662040	4	O
reserved	26662040	4	O
.	26662040	4	O

Dysferlinopathy	26671124	4	O
in	26671124	4	O
Iran	26671124	4	O
:	26671124	4	O
Clinical	26671124	4	O
and	26671124	4	O
genetic	26671124	4	O
report	26671124	4	O
.	26671124	4	O
BACKGROUND	26671124	4	O
:	26671124	4	O
Dysferlinopathy	26671124	4	B-Disease
is	26671124	4	O
caused	26671124	4	B-Reg
by	26671124	4	I-Reg
a	26671124	4	O
very	26671124	4	O
wide	26671124	4	O
range	26671124	4	O
of	26671124	4	O
autosomal	26671124	4	O
recessively	26671124	4	O
inherited	26671124	4	O
mutations	26671124	4	B-Var
of	26671124	4	O
the	26671124	4	O
Dysferlin	26671124	4	B-Gene
gene	26671124	4	I-Gene
.	26671124	4	O
It	26671124	4	O
causes	26671124	4	B-Reg
a	26671124	4	O
spectrum	26671124	4	O
of	26671124	4	O
muscle	26671124	4	O
diseases	26671124	4	O
including	26671124	4	O
limb	26671124	4	B-Disease
-	26671124	4	I-Disease
girdle	26671124	4	I-Disease
muscular	26671124	4	I-Disease
dystrophy	26671124	4	I-Disease
(	26671124	4	O
LGMD	26671124	4	O
)	26671124	4	O
2	26671124	4	O
B	26671124	4	O
and	26671124	4	O
Miyoshi	26671124	4	B-Disease
myopathy	26671124	4	I-Disease
(	26671124	4	O
MM	26671124	4	O
)	26671124	4	O
.	26671124	4	O
We	26671124	4	O
describe	26671124	4	O
the	26671124	4	O
clinical	26671124	4	O
course	26671124	4	O
and	26671124	4	O
mutational	26671124	4	O
analyses	26671124	4	O
of	26671124	4	O
15	26671124	4	O
Iranian	26671124	4	O
patients	26671124	4	O
with	26671124	4	O
dysferlinopathy	26671124	4	O
from	26671124	4	O
9	26671124	4	O
different	26671124	4	O
families	26671124	4	O
.	26671124	4	O
METHODS	26671124	4	O
:	26671124	4	O
Genomic	26671124	4	O
DNA	26671124	4	O
was	26671124	4	O
extracted	26671124	4	O
from	26671124	4	O
peripheral	26671124	4	O
blood	26671124	4	O
and	26671124	4	O
55	26671124	4	O
exons	26671124	4	O
and	26671124	4	O
flanking	26671124	4	O
intronic	26671124	4	O
boundaries	26671124	4	O
of	26671124	4	O
the	26671124	4	O
dysferlin	26671124	4	O
gene	26671124	4	O
(	26671124	4	O
DYSF	26671124	4	O
;	26671124	4	O
NM_003494.2	26671124	4	O
)	26671124	4	O
were	26671124	4	O
screened	26671124	4	O
for	26671124	4	O
mutations	26671124	4	O
and	26671124	4	O
analyzed	26671124	4	O
.	26671124	4	O
RESULTS	26671124	4	O
:	26671124	4	O
From	26671124	4	O
15	26671124	4	O
studied	26671124	4	O
patients	26671124	4	O
in	26671124	4	O
9	26671124	4	O
families	26671124	4	O
,	26671124	4	O
5	26671124	4	O
patients	26671124	4	O
were	26671124	4	O
male	26671124	4	O
.	26671124	4	O
Seven	26671124	4	O
families	26671124	4	O
had	26671124	4	O
consanguineous	26671124	4	O
marriage	26671124	4	O
.	26671124	4	O
Median	26671124	4	O
age	26671124	4	O
of	26671124	4	O
onset	26671124	4	O
was	26671124	4	O
16.8	26671124	4	O
;	26671124	4	O
and	26671124	4	O
the	26671124	4	O
median	26671124	4	O
age	26671124	4	O
of	26671124	4	O
diagnosis	26671124	4	O
was	26671124	4	O
26.6	26671124	4	O
.	26671124	4	O
The	26671124	4	O
onset	26671124	4	O
was	26671124	4	O
clearly	26671124	4	O
distal	26671124	4	O
in	26671124	4	O
7	26671124	4	O
patients	26671124	4	O
,	26671124	4	O
and	26671124	4	O
proximal	26671124	4	O
in	26671124	4	O
6	26671124	4	O
patients	26671124	4	O
.	26671124	4	O
Three	26671124	4	O
patients	26671124	4	O
had	26671124	4	O
partial	26671124	4	O
biceps	26671124	4	O
atrophy	26671124	4	O
and	26671124	4	O
13	26671124	4	O
showed	26671124	4	O
prominent	26671124	4	O
calf	26671124	4	O
muscle	26671124	4	O
wasting	26671124	4	O
.	26671124	4	O
Foot	26671124	4	O
plantar	26671124	4	O
flexors	26671124	4	O
,	26671124	4	O
deep	26671124	4	O
finger	26671124	4	O
flexors	26671124	4	O
and	26671124	4	O
hip	26671124	4	O
adductors	26671124	4	O
were	26671124	4	O
predominantly	26671124	4	O
involved	26671124	4	O
.	26671124	4	O
Genetic	26671124	4	O
testing	26671124	4	O
showed	26671124	4	O
homozygous	26671124	4	O
mutation	26671124	4	O
of	26671124	4	O
dysferlin	26671124	4	O
gene	26671124	4	O
in	26671124	4	O
9	26671124	4	O
probands	26671124	4	O
,	26671124	4	O
5	26671124	4	O
of	26671124	4	O
which	26671124	4	O
were	26671124	4	O
not	26671124	4	O
previously	26671124	4	O
reported	26671124	4	O
.	26671124	4	O
CONCLUSION	26671124	4	O
:	26671124	4	O
This	26671124	4	O
work	26671124	4	O
,	26671124	4	O
in	26671124	4	O
fact	26671124	4	O
,	26671124	4	O
may	26671124	4	O
help	26671124	4	O
shed	26671124	4	O
some	26671124	4	O
light	26671124	4	O
on	26671124	4	O
the	26671124	4	O
pattern	26671124	4	O
of	26671124	4	O
this	26671124	4	O
morbidity	26671124	4	O
in	26671124	4	O
Iran	26671124	4	O
,	26671124	4	O
an	26671124	4	O
effort	26671124	4	O
that	26671124	4	O
may	26671124	4	O
have	26671124	4	O
not	26671124	4	O
been	26671124	4	O
attempted	26671124	4	O
so	26671124	4	O
far	26671124	4	O
.	26671124	4	O

Limb	26677118	4	O
-	26677118	4	O
girdle	26677118	4	O
muscular	26677118	4	O
dystrophy	26677118	4	O
type	26677118	4	O
2	26677118	4	O
A	26677118	4	O
in	26677118	4	O
Brazilian	26677118	4	O
children	26677118	4	O
.	26677118	4	O
Calpainopathy	26677118	4	O
is	26677118	4	O
an	26677118	4	O
autosomal	26677118	4	B-Disease
recessive	26677118	4	I-Disease
limb	26677118	4	I-Disease
girdle	26677118	4	I-Disease
muscular	26677118	4	I-Disease
dystrophy	26677118	4	I-Disease
(	26677118	4	O
LGMD2A	26677118	4	O
)	26677118	4	O
caused	26677118	4	B-Reg
by	26677118	4	I-Reg
mutations	26677118	4	B-Var
in	26677118	4	O
CAPN3	26677118	4	B-Gene
gene	26677118	4	O
.	26677118	4	O
Objective	26677118	4	O
To	26677118	4	O
present	26677118	4	O
clinical	26677118	4	O
and	26677118	4	O
histological	26677118	4	O
findings	26677118	4	O
in	26677118	4	O
six	26677118	4	O
children	26677118	4	O
with	26677118	4	O
a	26677118	4	O
molecular	26677118	4	O
diagnosis	26677118	4	O
of	26677118	4	O
LGMD2A	26677118	4	O
and	26677118	4	O
additionally	26677118	4	O
the	26677118	4	O
MRI	26677118	4	O
findings	26677118	4	O
in	26677118	4	O
two	26677118	4	O
of	26677118	4	O
them	26677118	4	O
.	26677118	4	O
Method	26677118	4	O
We	26677118	4	O
retrospectively	26677118	4	O
assessed	26677118	4	O
medical	26677118	4	O
records	26677118	4	O
of	26677118	4	O
6	26677118	4	O
patients	26677118	4	O
with	26677118	4	O
mutation	26677118	4	O
on	26677118	4	O
CAPN3	26677118	4	O
gene	26677118	4	O
.	26677118	4	O
Results	26677118	4	O
All	26677118	4	O
patients	26677118	4	O
were	26677118	4	O
female	26677118	4	O
(	26677118	4	O
three	26677118	4	O
to	26677118	4	O
12	26677118	4	O
years	26677118	4	O
)	26677118	4	O
.	26677118	4	O
The	26677118	4	O
mean	26677118	4	O
of	26677118	4	O
age	26677118	4	O
of	26677118	4	O
disease	26677118	4	O
onset	26677118	4	O
was	26677118	4	O
9	26677118	4	O
years	26677118	4	O
.	26677118	4	O
All	26677118	4	O
of	26677118	4	O
them	26677118	4	O
showed	26677118	4	O
progressive	26677118	4	O
weakness	26677118	4	O
with	26677118	4	O
predominance	26677118	4	O
in	26677118	4	O
lower	26677118	4	O
limbs	26677118	4	O
.	26677118	4	O
Other	26677118	4	O
findings	26677118	4	O
were	26677118	4	O
scapular	26677118	4	O
winging	26677118	4	O
,	26677118	4	O
joint	26677118	4	O
contractures	26677118	4	O
and	26677118	4	O
calf	26677118	4	O
hypertrophy	26677118	4	O
.	26677118	4	O
One	26677118	4	O
female	26677118	4	O
had	26677118	4	O
a	26677118	4	O
more	26677118	4	O
severe	26677118	4	O
phenotype	26677118	4	O
than	26677118	4	O
her	26677118	4	O
dizygotic	26677118	4	O
twin	26677118	4	O
sister	26677118	4	O
that	26677118	4	O
was	26677118	4	O
confirmed	26677118	4	O
by	26677118	4	O
muscle	26677118	4	O
MRI	26677118	4	O
.	26677118	4	O
Muscle	26677118	4	O
biopsies	26677118	4	O
showed	26677118	4	O
a	26677118	4	O
dystrophic	26677118	4	O
pattern	26677118	4	O
in	26677118	4	O
all	26677118	4	O
patients	26677118	4	O
.	26677118	4	O
Conclusion	26677118	4	O
In	26677118	4	O
this	26677118	4	O
cohort	26677118	4	O
of	26677118	4	O
children	26677118	4	O
with	26677118	4	O
LGMD2A	26677118	4	O
,	26677118	4	O
the	26677118	4	O
clinical	26677118	4	O
aspects	26677118	4	O
were	26677118	4	O
similar	26677118	4	O
to	26677118	4	O
adults	26677118	4	O
with	26677118	4	O
the	26677118	4	O
same	26677118	4	O
disorder	26677118	4	O
.	26677118	4	O

Frequency	26690517	4	O
of	26690517	4	O
mutations	26690517	4	O
in	26690517	4	O
Mediterranean	26690517	4	O
fever	26690517	4	O
gene	26690517	4	O
,	26690517	4	O
with	26690517	4	O
gender	26690517	4	O
and	26690517	4	O
genotype	26690517	4	O
-	26690517	4	O
phenotype	26690517	4	O
correlations	26690517	4	O
in	26690517	4	O
a	26690517	4	O
Turkish	26690517	4	O
population	26690517	4	O
.	26690517	4	O
Familial	26690517	4	B-Disease
Mediterranean	26690517	4	I-Disease
fever	26690517	4	I-Disease
(	26690517	4	O
FMF	26690517	4	O
)	26690517	4	O
is	26690517	4	O
the	26690517	4	O
most	26690517	4	O
common	26690517	4	O
hereditary	26690517	4	O
inflammatory	26690517	4	O
periodic	26690517	4	O
disease	26690517	4	O
,	26690517	4	O
characterized	26690517	4	O
by	26690517	4	O
recurrent	26690517	4	O
episodes	26690517	4	O
of	26690517	4	O
fever	26690517	4	O
,	26690517	4	O
abdominal	26690517	4	O
pain	26690517	4	O
,	26690517	4	O
synovitis	26690517	4	O
and	26690517	4	O
pleurisy	26690517	4	O
.	26690517	4	O
The	26690517	4	O
aim	26690517	4	O
of	26690517	4	O
this	26690517	4	O
study	26690517	4	O
was	26690517	4	O
to	26690517	4	O
determine	26690517	4	O
the	26690517	4	O
frequency	26690517	4	O
and	26690517	4	O
distribution	26690517	4	O
of	26690517	4	O
Mediterranean	26690517	4	O
fever	26690517	4	O
(	26690517	4	B-Gene
MEFV	26690517	4	I-Gene
)	26690517	4	I-Gene
gene	26690517	4	O
mutations	26690517	4	B-Var
and	26690517	4	O
to	26690517	4	O
investigate	26690517	4	O
the	26690517	4	O
clinical	26690517	4	O
characteristics	26690517	4	O
and	26690517	4	O
genotype	26690517	4	O
-	26690517	4	O
phenotype	26690517	4	O
correlation	26690517	4	O
in	26690517	4	B-Reg
patients	26690517	4	O
with	26690517	4	O
FMF	26690517	4	B-Disease
in	26690517	4	O
Aydin	26690517	4	O
,	26690517	4	O
a	26690517	4	O
province	26690517	4	O
in	26690517	4	O
western	26690517	4	O
Anatolia	26690517	4	O
,	26690517	4	O
Turkey	26690517	4	O
.	26690517	4	O
Therefore	26690517	4	O
,	26690517	4	O
we	26690517	4	O
retrospectively	26690517	4	O
analysed	26690517	4	O
MEFV	26690517	4	O
gene	26690517	4	O
mutations	26690517	4	O
in	26690517	4	O
383	26690517	4	O
patients	26690517	4	O
with	26690517	4	O
suspected	26690517	4	O
FMF	26690517	4	O
and	26690517	4	O
the	26690517	4	O
clinical	26690517	4	O
features	26690517	4	O
of	26690517	4	O
327	26690517	4	O
among	26690517	4	O
them	26690517	4	O
.	26690517	4	O
The	26690517	4	O
MEFV	26690517	4	O
gene	26690517	4	O
mutations	26690517	4	O
were	26690517	4	O
investigated	26690517	4	O
using	26690517	4	O
the	26690517	4	O
reverse	26690517	4	O
dot	26690517	4	O
-	26690517	4	O
blot	26690517	4	O
hybridization	26690517	4	O
technique	26690517	4	O
.	26690517	4	O
We	26690517	4	O
detected	26690517	4	O
26	26690517	4	O
different	26690517	4	O
genotypes	26690517	4	O
and	26690517	4	O
11	26690517	4	O
different	26690517	4	O
mutations	26690517	4	O
.	26690517	4	O
The	26690517	4	O
most	26690517	4	O
common	26690517	4	O
mutations	26690517	4	O
in	26690517	4	O
our	26690517	4	O
cohort	26690517	4	O
were	26690517	4	O
p.M694V	26690517	4	O
(	26690517	4	O
41.15%	26690517	4	O
)	26690517	4	O
,	26690517	4	O
p.E148Q	26690517	4	O
(	26690517	4	O
20.35%	26690517	4	O
)	26690517	4	O
,	26690517	4	O
p.M680I	26690517	4	O
(	26690517	4	O
G	26690517	4	O
/	26690517	4	O
C	26690517	4	O
)	26690517	4	O
(	26690517	4	O
12.39%	26690517	4	O
)	26690517	4	O
and	26690517	4	O
p.R761H	26690517	4	O
(	26690517	4	O
9.73%	26690517	4	O
)	26690517	4	O
.	26690517	4	O
Abdominal	26690517	4	O
pain	26690517	4	O
(	26690517	4	O
86.2%	26690517	4	O
)	26690517	4	O
,	26690517	4	O
fever	26690517	4	O
(	26690517	4	O
80.7%	26690517	4	O
)	26690517	4	O
,	26690517	4	O
arthralgia	26690517	4	O
(	26690517	4	O
57.2%	26690517	4	O
)	26690517	4	O
,	26690517	4	O
vomiting	26690517	4	O
(	26690517	4	O
36.1%	26690517	4	O
)	26690517	4	O
,	26690517	4	O
arthritis	26690517	4	O
(	26690517	4	O
34.6%	26690517	4	O
)	26690517	4	O
,	26690517	4	O
fatigue	26690517	4	O
(	26690517	4	O
31.5%	26690517	4	O
)	26690517	4	O
,	26690517	4	O
anorexia	26690517	4	O
(	26690517	4	O
22.9%	26690517	4	O
)	26690517	4	O
and	26690517	4	O
chest	26690517	4	O
pain	26690517	4	O
(	26690517	4	O
19.0%	26690517	4	O
)	26690517	4	O
were	26690517	4	O
the	26690517	4	O
most	26690517	4	O
prevalent	26690517	4	O
clinical	26690517	4	O
features	26690517	4	O
in	26690517	4	O
our	26690517	4	O
patients	26690517	4	O
.	26690517	4	O
This	26690517	4	O
is	26690517	4	O
the	26690517	4	O
first	26690517	4	O
study	26690517	4	O
from	26690517	4	O
Aydin	26690517	4	O
in	26690517	4	O
which	26690517	4	O
the	26690517	4	O
distribution	26690517	4	O
of	26690517	4	O
MEFV	26690517	4	B-Gene
gene	26690517	4	O
mutations	26690517	4	B-Var
and	26690517	4	O
clinical	26690517	4	O
features	26690517	4	O
were	26690517	4	O
evaluated	26690517	4	O
in	26690517	4	B-Reg
patients	26690517	4	O
with	26690517	4	O
FMF	26690517	4	B-Disease
.	26690517	4	O
We	26690517	4	O
found	26690517	4	O
that	26690517	4	O
the	26690517	4	O
most	26690517	4	O
common	26690517	4	O
mutation	26690517	4	O
was	26690517	4	O
p.M694V	26690517	4	O
in	26690517	4	O
our	26690517	4	O
region	26690517	4	O
,	26690517	4	O
while	26690517	4	O
the	26690517	4	O
frequency	26690517	4	O
of	26690517	4	O
the	26690517	4	O
p.R761H	26690517	4	O
mutation	26690517	4	O
was	26690517	4	O
higher	26690517	4	O
compared	26690517	4	O
to	26690517	4	O
other	26690517	4	O
regions	26690517	4	O
of	26690517	4	O
Turkey	26690517	4	O
with	26690517	4	O
respect	26690517	4	O
to	26690517	4	O
extracted	26690517	4	O
data	26690517	4	O
from	26690517	4	O
previous	26690517	4	O
similar	26690517	4	O
studies	26690517	4	O
.	26690517	4	O
Presented	26690517	4	O
results	26690517	4	O
supported	26690517	4	O
the	26690517	4	O
clinical	26690517	4	O
findings	26690517	4	O
in	26690517	4	O
the	26690517	4	O
literature	26690517	4	O
that	26690517	4	O
the	26690517	4	O
homozygous	26690517	4	O
p.M694V	26690517	4	O
and	26690517	4	O
compound	26690517	4	O
heterozygous	26690517	4	O
genotype	26690517	4	O
were	26690517	4	O
associated	26690517	4	O
with	26690517	4	O
more	26690517	4	O
severe	26690517	4	O
courses	26690517	4	O
in	26690517	4	O
FMF	26690517	4	O
patients	26690517	4	O
.	26690517	4	O

Delayed	26706855	2	O
hemoglobin	26706855	2	O
switching	26706855	2	O
and	26706855	2	O
perinatal	26706855	2	O
neocytolysis	26706855	2	O
in	26706855	2	O
mice	26706855	2	O
with	26706855	2	O
gain	26706855	2	O
-	26706855	2	O
of	26706855	2	O
-	26706855	2	O
function	26706855	2	O
erythropoietin	26706855	2	O
receptor	26706855	2	O
.	26706855	2	O
Mutations	26706855	2	B-Var
of	26706855	2	O
the	26706855	2	O
truncated	26706855	2	O
cytoplasmic	26706855	2	O
domain	26706855	2	O
of	26706855	2	O
human	26706855	2	O
erythropoietin	26706855	2	O
receptor	26706855	2	O
(	26706855	2	B-Gene
EPOR	26706855	2	I-Gene
)	26706855	2	I-Gene
result	26706855	2	B-Reg
in	26706855	2	I-Reg
gain	26706855	2	B-PosReg
-	26706855	2	I-PosReg
of	26706855	2	I-PosReg
-	26706855	2	I-PosReg
function	26706855	2	I-PosReg
of	26706855	2	O
erythropoietin	26706855	2	O
(	26706855	2	O
EPO	26706855	2	O
)	26706855	2	O
signaling	26706855	2	O
and	26706855	2	O
a	26706855	2	O
dominantly	26706855	2	B-Disease
inherited	26706855	2	I-Disease
polycythemia	26706855	2	I-Disease
,	26706855	2	O
primary	26706855	2	B-Disease
familial	26706855	2	I-Disease
and	26706855	2	I-Disease
congenital	26706855	2	I-Disease
polycythemia	26706855	2	I-Disease
(	26706855	2	O
PFCP	26706855	2	O
)	26706855	2	O
.	26706855	2	O
We	26706855	2	O
interrogated	26706855	2	O
the	26706855	2	O
unexplained	26706855	2	O
transient	26706855	2	O
absence	26706855	2	O
of	26706855	2	O
perinatal	26706855	2	O
polycythemia	26706855	2	O
observed	26706855	2	O
in	26706855	2	O
PFCP	26706855	2	O
patients	26706855	2	O
using	26706855	2	O
an	26706855	2	O
animal	26706855	2	O
model	26706855	2	O
of	26706855	2	O
PFCP	26706855	2	O
to	26706855	2	O
examine	26706855	2	O
its	26706855	2	O
erythropoiesis	26706855	2	O
during	26706855	2	O
embryonic	26706855	2	O
,	26706855	2	O
perinatal	26706855	2	O
,	26706855	2	O
and	26706855	2	O
early	26706855	2	O
postnatal	26706855	2	O
periods	26706855	2	O
.	26706855	2	O
In	26706855	2	O
this	26706855	2	O
model	26706855	2	O
,	26706855	2	O
we	26706855	2	O
replaced	26706855	2	O
the	26706855	2	O
murine	26706855	2	O
EpoR	26706855	2	O
gene	26706855	2	O
(	26706855	2	O
mEpoR	26706855	2	O
)	26706855	2	O
with	26706855	2	O
the	26706855	2	O
wild	26706855	2	O
-	26706855	2	O
type	26706855	2	O
human	26706855	2	O
EPOR	26706855	2	O
(	26706855	2	O
wtHEPOR	26706855	2	O
)	26706855	2	O
or	26706855	2	O
mutant	26706855	2	O
human	26706855	2	O
EPOR	26706855	2	O
gene	26706855	2	O
(	26706855	2	O
mtHEPOR	26706855	2	O
)	26706855	2	O
and	26706855	2	O
previously	26706855	2	O
reported	26706855	2	O
that	26706855	2	O
the	26706855	2	O
gain	26706855	2	O
-	26706855	2	O
of	26706855	2	O
-	26706855	2	O
function	26706855	2	O
mtHEPOR	26706855	2	O
mice	26706855	2	O
become	26706855	2	O
polycythemic	26706855	2	O
at	26706855	2	O
3	26706855	2	O
6	26706855	2	O
weeks	26706855	2	O
of	26706855	2	O
age	26706855	2	O
,	26706855	2	O
but	26706855	2	O
not	26706855	2	O
at	26706855	2	O
birth	26706855	2	O
,	26706855	2	O
similar	26706855	2	O
to	26706855	2	O
the	26706855	2	O
phenotype	26706855	2	O
of	26706855	2	O
PFCP	26706855	2	O
patients	26706855	2	O
.	26706855	2	O
In	26706855	2	O
contrast	26706855	2	O
,	26706855	2	O
wtHEPOR	26706855	2	O
mice	26706855	2	O
had	26706855	2	O
sustained	26706855	2	O
anemia	26706855	2	O
.	26706855	2	O
We	26706855	2	O
report	26706855	2	O
that	26706855	2	O
the	26706855	2	O
mtHEPOR	26706855	2	O
fetuses	26706855	2	O
are	26706855	2	O
polycythemic	26706855	2	O
,	26706855	2	O
but	26706855	2	O
their	26706855	2	O
polycythemia	26706855	2	O
is	26706855	2	O
abrogated	26706855	2	O
in	26706855	2	O
the	26706855	2	O
perinatal	26706855	2	O
period	26706855	2	O
and	26706855	2	O
reappears	26706855	2	O
again	26706855	2	O
at	26706855	2	O
3	26706855	2	O
weeks	26706855	2	O
after	26706855	2	O
birth	26706855	2	O
.	26706855	2	O
mtHEPOR	26706855	2	O
fetuses	26706855	2	O
have	26706855	2	O
a	26706855	2	O
delayed	26706855	2	O
switch	26706855	2	O
from	26706855	2	O
primitive	26706855	2	O
to	26706855	2	O
definitive	26706855	2	O
erythropoiesis	26706855	2	O
,	26706855	2	O
augmented	26706855	2	O
erythropoietin	26706855	2	O
signaling	26706855	2	O
,	26706855	2	O
and	26706855	2	O
prolonged	26706855	2	O
Stat5	26706855	2	O
phosphorylation	26706855	2	O
while	26706855	2	O
the	26706855	2	O
wtHEPOR	26706855	2	O
fetuses	26706855	2	O
are	26706855	2	O
anemic	26706855	2	O
.	26706855	2	O
Our	26706855	2	O
study	26706855	2	O
demonstrates	26706855	2	O
the	26706855	2	O
in	26706855	2	O
vivo	26706855	2	O
effect	26706855	2	O
of	26706855	2	O
excessive	26706855	2	O
EPO	26706855	2	O
/	26706855	2	O
EPOR	26706855	2	O
signaling	26706855	2	O
on	26706855	2	O
developmental	26706855	2	O
erythropoiesis	26706855	2	O
switch	26706855	2	O
and	26706855	2	O
describes	26706855	2	O
that	26706855	2	O
fetal	26706855	2	O
polycythemia	26706855	2	O
in	26706855	2	O
this	26706855	2	O
PFCP	26706855	2	O
model	26706855	2	O
is	26706855	2	O
followed	26706855	2	O
by	26706855	2	O
transient	26706855	2	O
correction	26706855	2	O
of	26706855	2	O
polycythemia	26706855	2	O
in	26706855	2	O
perinatal	26706855	2	O
life	26706855	2	O
associated	26706855	2	O
with	26706855	2	O
low	26706855	2	O
Epo	26706855	2	O
levels	26706855	2	O
and	26706855	2	O
increased	26706855	2	O
exposure	26706855	2	O
of	26706855	2	O
erythrocytes	26706855	2	O
'	26706855	2	O
phosphatidylserine	26706855	2	O
.	26706855	2	O
We	26706855	2	O
suggest	26706855	2	O
that	26706855	2	O
neocytolysis	26706855	2	O
contributes	26706855	2	O
to	26706855	2	O
the	26706855	2	O
observed	26706855	2	O
perinatal	26706855	2	O
correction	26706855	2	O
of	26706855	2	O
polycythemia	26706855	2	O
in	26706855	2	O
mtHEPOR	26706855	2	O
newborns	26706855	2	O
as	26706855	2	O
embryos	26706855	2	O
leaving	26706855	2	O
the	26706855	2	O
hypoxic	26706855	2	O
uterus	26706855	2	O
are	26706855	2	O
exposed	26706855	2	O
to	26706855	2	O
normoxia	26706855	2	O
at	26706855	2	O
birth	26706855	2	O
.	26706855	2	O
KEY	26706855	2	O
MESSAGE	26706855	2	O
:	26706855	2	O
Human	26706855	2	O
gain	26706855	2	O
-	26706855	2	O
of	26706855	2	O
-	26706855	2	O
function	26706855	2	O
EPOR	26706855	2	B-Gene
(	26706855	2	O
mtHEPOR	26706855	2	O
)	26706855	2	O
causes	26706855	2	B-Reg
fetal	26706855	2	B-Disease
polycythemia	26706855	2	I-Disease
in	26706855	2	O
knock	26706855	2	B-Var
-	26706855	2	I-Var
in	26706855	2	I-Var
mice	26706855	2	O
.	26706855	2	O
Wild	26706855	2	O
-	26706855	2	O
type	26706855	2	O
human	26706855	2	O
EPOR	26706855	2	O
causes	26706855	2	O
fetal	26706855	2	O
anemia	26706855	2	O
in	26706855	2	O
knock	26706855	2	O
-	26706855	2	O
in	26706855	2	O
mouse	26706855	2	O
model	26706855	2	O
.	26706855	2	O
mtHEPOR	26706855	2	O
mice	26706855	2	O
have	26706855	2	O
delayed	26706855	2	O
switch	26706855	2	O
from	26706855	2	O
primitive	26706855	2	O
to	26706855	2	O
definitive	26706855	2	O
erythropoiesis	26706855	2	O
.	26706855	2	O
Polycythemia	26706855	2	O
of	26706855	2	O
mtHEPOR	26706855	2	O
mice	26706855	2	O
is	26706855	2	O
transiently	26706855	2	O
corrected	26706855	2	O
in	26706855	2	O
perinatal	26706855	2	O
life	26706855	2	O
.	26706855	2	O
mtHEPOR	26706855	2	O
newborns	26706855	2	O
have	26706855	2	O
low	26706855	2	O
Epo	26706855	2	O
and	26706855	2	O
increased	26706855	2	O
exposure	26706855	2	O
of	26706855	2	O
erythrocytes	26706855	2	O
'	26706855	2	O
phosphatidylserine	26706855	2	O
.	26706855	2	O

Renal	26707870	0	O
Cell	26707870	0	O
Carcinoma	26707870	0	O
Programmed	26707870	0	O
Death	26707870	0	O
-	26707870	0	O
ligand	26707870	0	O
1	26707870	0	O
,	26707870	0	O
a	26707870	0	O
New	26707870	0	O
Direct	26707870	0	O
Target	26707870	0	O
of	26707870	0	O
Hypoxia	26707870	0	O
-	26707870	0	O
inducible	26707870	0	O
Factor-2	26707870	0	O
Alpha	26707870	0	O
,	26707870	0	O
is	26707870	0	O
Regulated	26707870	0	O
by	26707870	0	O
von	26707870	0	O
Hippel	26707870	0	O
-	26707870	0	O
Lindau	26707870	0	O
Gene	26707870	0	O
Mutation	26707870	0	O
Status	26707870	0	O
.	26707870	0	O
BACKGROUND	26707870	0	O
:	26707870	0	O
Clear	26707870	0	O
cell	26707870	0	O
renal	26707870	0	O
cell	26707870	0	O
carcinomas	26707870	0	O
(	26707870	0	O
ccRCC	26707870	0	O
)	26707870	0	O
frequently	26707870	0	O
display	26707870	0	O
a	26707870	0	O
loss	26707870	0	O
of	26707870	0	O
function	26707870	0	O
of	26707870	0	O
the	26707870	0	O
von	26707870	0	O
Hippel	26707870	0	O
-	26707870	0	O
Lindau	26707870	0	O
(	26707870	0	O
VHL	26707870	0	O
)	26707870	0	O
gene	26707870	0	O
.	26707870	0	O
OBJECTIVE	26707870	0	O
:	26707870	0	O
To	26707870	0	O
elucidate	26707870	0	O
the	26707870	0	O
putative	26707870	0	O
relationship	26707870	0	O
between	26707870	0	O
VHL	26707870	0	O
mutation	26707870	0	O
status	26707870	0	O
and	26707870	0	O
immune	26707870	0	O
checkpoint	26707870	0	O
ligand	26707870	0	O
programmed	26707870	0	O
death	26707870	0	O
-	26707870	0	O
ligand	26707870	0	O
1	26707870	0	O
(	26707870	0	O
PD	26707870	0	O
-	26707870	0	O
L1	26707870	0	O
)	26707870	0	O
expression	26707870	0	O
.	26707870	0	O
DESIGN	26707870	0	O
,	26707870	0	O
SETTING	26707870	0	O
,	26707870	0	O
AND	26707870	0	O
PARTICIPANTS	26707870	0	O
:	26707870	0	O
A	26707870	0	O
series	26707870	0	O
of	26707870	0	O
32	26707870	0	O
renal	26707870	0	O
tumors	26707870	0	O
composed	26707870	0	O
of	26707870	0	O
11	26707870	0	O
VHL	26707870	0	O
tumor	26707870	0	O
-	26707870	0	O
associated	26707870	0	O
and	26707870	0	O
21	26707870	0	O
sporadic	26707870	0	O
RCCs	26707870	0	O
were	26707870	0	O
used	26707870	0	O
to	26707870	0	O
evaluate	26707870	0	O
PD	26707870	0	O
-	26707870	0	O
L1	26707870	0	O
expression	26707870	0	O
levels	26707870	0	O
after	26707870	0	O
sequencing	26707870	0	O
of	26707870	0	O
the	26707870	0	O
three	26707870	0	O
exons	26707870	0	O
and	26707870	0	O
exon	26707870	0	O
-	26707870	0	O
intron	26707870	0	O
junctions	26707870	0	O
of	26707870	0	O
the	26707870	0	O
VHL	26707870	0	O
gene	26707870	0	O
.	26707870	0	O
The	26707870	0	O
786	26707870	0	O
-	26707870	0	O
O	26707870	0	O
,	26707870	0	O
A498	26707870	0	O
,	26707870	0	O
and	26707870	0	O
RCC4	26707870	0	O
cell	26707870	0	O
lines	26707870	0	O
were	26707870	0	O
used	26707870	0	O
to	26707870	0	O
investigate	26707870	0	O
the	26707870	0	O
mechanisms	26707870	0	O
of	26707870	0	O
PD	26707870	0	O
-	26707870	0	O
L1	26707870	0	O
regulation	26707870	0	O
.	26707870	0	O
OUTCOME	26707870	0	O
MEASUREMENTS	26707870	0	O
AND	26707870	0	O
STATISTICAL	26707870	0	O
ANALYSIS	26707870	0	O
:	26707870	0	O
Fisher	26707870	0	O
'	26707870	0	O
s	26707870	0	O
exact	26707870	0	O
test	26707870	0	O
was	26707870	0	O
used	26707870	0	O
for	26707870	0	O
VHL	26707870	0	O
mutation	26707870	0	O
and	26707870	0	O
Kruskal	26707870	0	O
-	26707870	0	O
Wallis	26707870	0	O
test	26707870	0	O
for	26707870	0	O
PD	26707870	0	O
-	26707870	0	O
L1	26707870	0	O
expression	26707870	0	O
.	26707870	0	O
If	26707870	0	O
no	26707870	0	O
covariate	26707870	0	O
accounted	26707870	0	O
for	26707870	0	O
the	26707870	0	O
association	26707870	0	O
of	26707870	0	O
VHL	26707870	0	O
and	26707870	0	O
PD	26707870	0	O
-	26707870	0	O
L1	26707870	0	O
,	26707870	0	O
then	26707870	0	O
a	26707870	0	O
Kruskal	26707870	0	O
-	26707870	0	O
Wallis	26707870	0	O
test	26707870	0	O
was	26707870	0	O
used	26707870	0	O
;	26707870	0	O
otherwise	26707870	0	O
Cochran	26707870	0	O
-	26707870	0	O
Mantel	26707870	0	O
-	26707870	0	O
Haenzsel	26707870	0	O
test	26707870	0	O
was	26707870	0	O
used	26707870	0	O
.	26707870	0	O
We	26707870	0	O
also	26707870	0	O
used	26707870	0	O
the	26707870	0	O
Fligner	26707870	0	O
-	26707870	0	O
Policello	26707870	0	O
test	26707870	0	O
to	26707870	0	O
compare	26707870	0	O
two	26707870	0	O
medians	26707870	0	O
when	26707870	0	O
the	26707870	0	O
distributions	26707870	0	O
had	26707870	0	O
different	26707870	0	O
dispersions	26707870	0	O
.	26707870	0	O
RESULTS	26707870	0	O
AND	26707870	0	O
LIMITATIONS	26707870	0	O
:	26707870	0	O
We	26707870	0	O
demonstrated	26707870	0	O
that	26707870	0	O
tumors	26707870	0	O
from	26707870	0	O
ccRCC	26707870	0	O
patients	26707870	0	O
with	26707870	0	O
VHL	26707870	0	B-Gene
biallelic	26707870	0	O
inactivation	26707870	0	B-Var
(	26707870	0	O
ie	26707870	0	O
,	26707870	0	O
loss	26707870	0	O
of	26707870	0	O
function	26707870	0	O
)	26707870	0	O
display	26707870	0	O
a	26707870	0	O
significant	26707870	0	O
increase	26707870	0	B-PosReg
in	26707870	0	O
PD	26707870	0	O
-	26707870	0	O
L1	26707870	0	O
expression	26707870	0	O
compared	26707870	0	O
with	26707870	0	O
ccRCC	26707870	0	O
tumors	26707870	0	O
carrying	26707870	0	O
one	26707870	0	O
VHL	26707870	0	O
wild	26707870	0	O
-	26707870	0	O
type	26707870	0	O
allele	26707870	0	O
.	26707870	0	O
Using	26707870	0	O
the	26707870	0	O
inducible	26707870	0	O
VHL	26707870	0	O
786	26707870	0	O
-	26707870	0	O
O	26707870	0	O
-	26707870	0	O
derived	26707870	0	O
cell	26707870	0	O
lines	26707870	0	O
with	26707870	0	O
varying	26707870	0	O
hypoxia	26707870	0	O
-	26707870	0	O
inducible	26707870	0	O
factor-2	26707870	0	O
alpha	26707870	0	O
(	26707870	0	O
HIF-2	26707870	0	O
α	26707870	0	O
)	26707870	0	O
stabilization	26707870	0	O
levels	26707870	0	O
,	26707870	0	O
we	26707870	0	O
showed	26707870	0	O
that	26707870	0	O
PD	26707870	0	O
-	26707870	0	O
L1	26707870	0	O
expression	26707870	0	O
levels	26707870	0	O
positively	26707870	0	O
correlate	26707870	0	B-Reg
with	26707870	0	O
VHL	26707870	0	B-Gene
mutation	26707870	0	B-Var
and	26707870	0	O
HIF-2	26707870	0	O
α	26707870	0	O
expression	26707870	0	O
.	26707870	0	O
Targeting	26707870	0	O
HIF-2	26707870	0	O
α	26707870	0	O
decreased	26707870	0	O
PD	26707870	0	O
-	26707870	0	O
L1	26707870	0	O
,	26707870	0	O
while	26707870	0	O
HIF-2	26707870	0	O
α	26707870	0	O
overexpression	26707870	0	O
increased	26707870	0	O
PD	26707870	0	O
-	26707870	0	O
L1	26707870	0	O
mRNA	26707870	0	O
and	26707870	0	O
protein	26707870	0	O
levels	26707870	0	O
in	26707870	0	O
ccRCC	26707870	0	O
cells	26707870	0	O
.	26707870	0	O
Interestingly	26707870	0	O
,	26707870	0	O
chromatin	26707870	0	O
immunoprecipitation	26707870	0	O
and	26707870	0	O
luciferase	26707870	0	O
assays	26707870	0	O
revealed	26707870	0	O
a	26707870	0	O
direct	26707870	0	O
binding	26707870	0	O
of	26707870	0	O
HIF-2	26707870	0	O
α	26707870	0	O
to	26707870	0	O
a	26707870	0	O
transcriptionally	26707870	0	O
active	26707870	0	O
hypoxia	26707870	0	O
-	26707870	0	O
response	26707870	0	O
element	26707870	0	O
in	26707870	0	O
the	26707870	0	O
human	26707870	0	O
PD	26707870	0	O
-	26707870	0	O
L1	26707870	0	O
proximal	26707870	0	O
promoter	26707870	0	O
in	26707870	0	O
786	26707870	0	O
-	26707870	0	O
O	26707870	0	O
cells	26707870	0	O
.	26707870	0	O
CONCLUSIONS	26707870	0	O
:	26707870	0	O
Our	26707870	0	O
work	26707870	0	O
provides	26707870	0	O
the	26707870	0	O
first	26707870	0	O
evidence	26707870	0	O
that	26707870	0	O
VHL	26707870	0	B-Gene
mutations	26707870	0	B-Var
positively	26707870	0	O
correlate	26707870	0	B-Reg
with	26707870	0	O
PD	26707870	0	O
-	26707870	0	O
L1	26707870	0	O
expression	26707870	0	O
in	26707870	0	O
ccRCC	26707870	0	O
and	26707870	0	O
may	26707870	0	O
influence	26707870	0	B-Reg
the	26707870	0	O
response	26707870	0	O
to	26707870	0	O
ccRCC	26707870	0	O
anti	26707870	0	O
-	26707870	0	O
PD	26707870	0	O
-	26707870	0	O
L1	26707870	0	O
/	26707870	0	O
PD-1	26707870	0	O
immunotherapy	26707870	0	O
.	26707870	0	O
PATIENT	26707870	0	O
SUMMARY	26707870	0	O
:	26707870	0	O
We	26707870	0	O
investigated	26707870	0	O
the	26707870	0	O
relationship	26707870	0	O
between	26707870	0	O
von	26707870	0	O
Hippel	26707870	0	O
-	26707870	0	O
Lindau	26707870	0	O
mutations	26707870	0	O
and	26707870	0	O
programmed	26707870	0	O
death	26707870	0	O
-	26707870	0	O
ligand	26707870	0	O
1	26707870	0	O
expression	26707870	0	O
.	26707870	0	O
We	26707870	0	O
demonstrated	26707870	0	O
that	26707870	0	O
von	26707870	0	B-Gene
Hippel	26707870	0	I-Gene
-	26707870	0	I-Gene
Lindau	26707870	0	I-Gene
mutation	26707870	0	B-Var
status	26707870	0	O
significantly	26707870	0	O
correlated	26707870	0	B-Reg
with	26707870	0	O
programmed	26707870	0	O
death	26707870	0	O
-	26707870	0	O
ligand	26707870	0	O
1	26707870	0	O
expression	26707870	0	O
in	26707870	0	O
clear	26707870	0	O
cell	26707870	0	O
renal	26707870	0	O
cell	26707870	0	O
carcinomas	26707870	0	O
.	26707870	0	O

Huntington	26742514	4	O
'	26742514	4	O
s	26742514	4	O
Disease	26742514	4	O
:	26742514	4	O
Relationship	26742514	4	O
Between	26742514	4	O
Phenotype	26742514	4	O
and	26742514	4	O
Genotype	26742514	4	O
.	26742514	4	O
Huntington	26742514	4	B-Disease
'	26742514	4	I-Disease
s	26742514	4	I-Disease
disease	26742514	4	I-Disease
(	26742514	4	O
HD	26742514	4	O
)	26742514	4	O
is	26742514	4	O
an	26742514	4	O
autosomal	26742514	4	O
dominant	26742514	4	O
inherited	26742514	4	O
neurodegenerative	26742514	4	O
disease	26742514	4	O
with	26742514	4	O
the	26742514	4	O
typical	26742514	4	O
manifestations	26742514	4	O
of	26742514	4	O
involuntary	26742514	4	O
movements	26742514	4	O
,	26742514	4	O
psychiatric	26742514	4	O
and	26742514	4	O
behavior	26742514	4	O
disorders	26742514	4	O
,	26742514	4	O
and	26742514	4	O
cognitive	26742514	4	O
impairment	26742514	4	O
.	26742514	4	O
It	26742514	4	O
is	26742514	4	O
caused	26742514	4	B-Reg
by	26742514	4	I-Reg
the	26742514	4	O
dynamic	26742514	4	B-Var
mutation	26742514	4	I-Var
in	26742514	4	I-Var
CAG	26742514	4	I-Var
triplet	26742514	4	I-Var
repeat	26742514	4	I-Var
number	26742514	4	I-Var
in	26742514	4	I-Var
exon	26742514	4	I-Var
1	26742514	4	I-Var
of	26742514	4	O
huntingtin	26742514	4	O
(	26742514	4	B-Gene
HTT	26742514	4	I-Gene
)	26742514	4	I-Gene
gene	26742514	4	O
.	26742514	4	O
The	26742514	4	O
symptoms	26742514	4	O
of	26742514	4	O
HD	26742514	4	O
especially	26742514	4	O
the	26742514	4	O
age	26742514	4	O
at	26742514	4	O
onset	26742514	4	O
are	26742514	4	O
related	26742514	4	O
to	26742514	4	O
the	26742514	4	O
genetic	26742514	4	O
characteristics	26742514	4	O
,	26742514	4	O
both	26742514	4	O
the	26742514	4	O
CAG	26742514	4	O
triplet	26742514	4	O
repeat	26742514	4	O
and	26742514	4	O
the	26742514	4	O
modified	26742514	4	O
factors	26742514	4	O
.	26742514	4	O
Here	26742514	4	O
,	26742514	4	O
we	26742514	4	O
reviewed	26742514	4	O
the	26742514	4	O
recent	26742514	4	O
advancement	26742514	4	O
on	26742514	4	O
the	26742514	4	O
genotype	26742514	4	O
-	26742514	4	O
phenotype	26742514	4	O
relationship	26742514	4	O
of	26742514	4	O
HD	26742514	4	O
,	26742514	4	O
mainly	26742514	4	O
focus	26742514	4	O
on	26742514	4	O
the	26742514	4	O
characteristics	26742514	4	O
of	26742514	4	O
different	26742514	4	O
expanded	26742514	4	O
CAG	26742514	4	O
repeat	26742514	4	O
number	26742514	4	O
,	26742514	4	O
genetic	26742514	4	O
modifiers	26742514	4	O
,	26742514	4	O
and	26742514	4	O
CCG	26742514	4	O
repeat	26742514	4	O
number	26742514	4	O
in	26742514	4	O
the	26742514	4	O
3	26742514	4	O
'	26742514	4	O
end	26742514	4	O
of	26742514	4	O
CAG	26742514	4	O
triplet	26742514	4	O
repeat	26742514	4	O
and	26742514	4	O
their	26742514	4	O
effects	26742514	4	O
on	26742514	4	O
the	26742514	4	O
phenotype	26742514	4	O
.	26742514	4	O
We	26742514	4	O
also	26742514	4	O
reviewed	26742514	4	O
the	26742514	4	O
special	26742514	4	O
forms	26742514	4	O
of	26742514	4	O
HD	26742514	4	O
(	26742514	4	O
juvenile	26742514	4	O
HD	26742514	4	O
,	26742514	4	O
atypical	26742514	4	O
onset	26742514	4	O
HD	26742514	4	O
,	26742514	4	O
and	26742514	4	O
homozygous	26742514	4	O
HD	26742514	4	O
)	26742514	4	O
and	26742514	4	O
their	26742514	4	O
phenotype	26742514	4	O
-	26742514	4	O
genotype	26742514	4	O
correlations	26742514	4	O
.	26742514	4	O
The	26742514	4	O
review	26742514	4	O
will	26742514	4	O
aid	26742514	4	O
clinicians	26742514	4	O
to	26742514	4	O
predict	26742514	4	O
the	26742514	4	O
onset	26742514	4	O
age	26742514	4	O
and	26742514	4	O
disease	26742514	4	O
course	26742514	4	O
of	26742514	4	O
HD	26742514	4	O
,	26742514	4	O
give	26742514	4	O
the	26742514	4	O
genetic	26742514	4	O
counseling	26742514	4	O
,	26742514	4	O
and	26742514	4	O
accelerate	26742514	4	O
research	26742514	4	O
into	26742514	4	O
the	26742514	4	O
HD	26742514	4	O
mechanism	26742514	4	O
.	26742514	4	O

Polyamine	26791972	0	O
oxidase	26791972	0	O
5	26791972	0	O
loss	26791972	0	B-NegReg
-	26791972	0	I-NegReg
of	26791972	0	I-NegReg
-	26791972	0	I-NegReg
function	26791972	0	I-NegReg
mutations	26791972	0	B-Var
in	26791972	0	O
Arabidopsis	26791972	0	O
thaliana	26791972	0	O
trigger	26791972	0	B-Reg
metabolic	26791972	0	O
and	26791972	0	O
transcriptional	26791972	0	O
reprogramming	26791972	0	O
and	26791972	0	O
promote	26791972	0	B-PosReg
salt	26791972	0	O
stress	26791972	0	O
tolerance	26791972	0	O
.	26791972	0	O
The	26791972	0	O
family	26791972	0	O
of	26791972	0	O
polyamine	26791972	0	O
oxidases	26791972	0	O
(	26791972	0	O
PAO	26791972	0	O
)	26791972	0	O
in	26791972	0	O
Arabidopsis	26791972	0	O
(	26791972	0	O
AtPAO1-5	26791972	0	O
)	26791972	0	O
mediates	26791972	0	O
polyamine	26791972	0	O
(	26791972	0	O
PA	26791972	0	O
)	26791972	0	O
back	26791972	0	O
-	26791972	0	O
conversion	26791972	0	O
,	26791972	0	O
which	26791972	0	O
reverses	26791972	0	O
the	26791972	0	O
PA	26791972	0	O
biosynthetic	26791972	0	O
pathway	26791972	0	O
from	26791972	0	O
spermine	26791972	0	O
and	26791972	0	O
its	26791972	0	O
structural	26791972	0	O
isomer	26791972	0	O
thermospermine	26791972	0	O
(	26791972	0	O
tSpm	26791972	0	O
)	26791972	0	O
into	26791972	0	O
spermidine	26791972	0	O
and	26791972	0	O
then	26791972	0	O
putrescine	26791972	0	O
.	26791972	0	O
Here	26791972	0	O
,	26791972	0	O
we	26791972	0	O
have	26791972	0	O
studied	26791972	0	O
the	26791972	0	O
involvement	26791972	0	O
of	26791972	0	O
PA	26791972	0	O
back	26791972	0	O
-	26791972	0	O
conversion	26791972	0	O
in	26791972	0	O
Arabidopsis	26791972	0	O
salinity	26791972	0	O
tolerance	26791972	0	O
.	26791972	0	O
AtPAO5	26791972	0	O
is	26791972	0	O
the	26791972	0	O
Arabidopsis	26791972	0	O
PAO	26791972	0	O
gene	26791972	0	O
member	26791972	0	O
most	26791972	0	O
transcriptionally	26791972	0	O
induced	26791972	0	O
by	26791972	0	O
salt	26791972	0	O
stress	26791972	0	O
.	26791972	0	O
Two	26791972	0	O
independent	26791972	0	O
loss	26791972	0	O
-	26791972	0	O
of	26791972	0	O
-	26791972	0	O
function	26791972	0	O
mutants	26791972	0	B-Var
(	26791972	0	O
atpao5-2	26791972	0	O
and	26791972	0	O
atpao5-3	26791972	0	O
)	26791972	0	O
were	26791972	0	O
found	26791972	0	O
to	26791972	0	O
exhibit	26791972	0	O
constitutively	26791972	0	O
higher	26791972	0	B-PosReg
tSpm	26791972	0	O
levels	26791972	0	O
,	26791972	0	O
with	26791972	0	O
associated	26791972	0	O
increased	26791972	0	O
salt	26791972	0	O
tolerance	26791972	0	O
.	26791972	0	O
Using	26791972	0	O
global	26791972	0	O
transcriptional	26791972	0	O
and	26791972	0	O
metabolomic	26791972	0	O
analyses	26791972	0	O
,	26791972	0	O
the	26791972	0	O
underlying	26791972	0	O
mechanisms	26791972	0	O
were	26791972	0	O
studied	26791972	0	O
.	26791972	0	O
Stimulation	26791972	0	B-PosReg
of	26791972	0	O
abscisic	26791972	0	O
acid	26791972	0	O
and	26791972	0	O
jasmonate	26791972	0	O
(	26791972	0	O
JA	26791972	0	O
)	26791972	0	O
biosynthesis	26791972	0	O
and	26791972	0	O
accumulation	26791972	0	O
of	26791972	0	O
important	26791972	0	O
compatible	26791972	0	O
solutes	26791972	0	O
,	26791972	0	O
such	26791972	0	O
as	26791972	0	O
sugars	26791972	0	O
,	26791972	0	O
polyols	26791972	0	O
and	26791972	0	O
proline	26791972	0	O
,	26791972	0	O
as	26791972	0	O
well	26791972	0	O
as	26791972	0	O
TCA	26791972	0	O
cycle	26791972	0	O
intermediates	26791972	0	O
were	26791972	0	O
observed	26791972	0	O
in	26791972	0	O
atpao5	26791972	0	O
mutants	26791972	0	B-Var
under	26791972	0	O
salt	26791972	0	O
stress	26791972	0	O
.	26791972	0	O
Expression	26791972	0	O
analyses	26791972	0	O
indicate	26791972	0	O
that	26791972	0	O
tSpm	26791972	0	O
modulates	26791972	0	O
the	26791972	0	O
transcript	26791972	0	O
levels	26791972	0	O
of	26791972	0	O
several	26791972	0	O
target	26791972	0	O
genes	26791972	0	O
,	26791972	0	O
including	26791972	0	O
many	26791972	0	O
involved	26791972	0	O
in	26791972	0	O
the	26791972	0	O
biosynthesis	26791972	0	O
and	26791972	0	O
signalling	26791972	0	O
of	26791972	0	O
JA	26791972	0	O
,	26791972	0	O
some	26791972	0	O
of	26791972	0	O
which	26791972	0	O
are	26791972	0	O
already	26791972	0	O
known	26791972	0	O
to	26791972	0	O
promote	26791972	0	O
salinity	26791972	0	O
tolerance	26791972	0	O
.	26791972	0	O
Transcriptional	26791972	0	O
modulation	26791972	0	O
by	26791972	0	O
tSpm	26791972	0	O
is	26791972	0	O
isomer	26791972	0	O
-	26791972	0	O
dependent	26791972	0	O
,	26791972	0	O
thus	26791972	0	O
demonstrating	26791972	0	O
the	26791972	0	O
specificity	26791972	0	O
of	26791972	0	O
this	26791972	0	O
response	26791972	0	O
.	26791972	0	O
Overall	26791972	0	O
,	26791972	0	O
we	26791972	0	O
conclude	26791972	0	O
that	26791972	0	O
tSpm	26791972	0	O
triggers	26791972	0	O
metabolic	26791972	0	O
and	26791972	0	O
transcriptional	26791972	0	O
reprogramming	26791972	0	O
that	26791972	0	O
promotes	26791972	0	O
salt	26791972	0	O
stress	26791972	0	O
tolerance	26791972	0	O
in	26791972	0	O
Arabidopsis	26791972	0	O
.	26791972	0	O

Recessive	26940370	1	B-Disease
dystrophic	26940370	1	I-Disease
epidermolysis	26940370	1	I-Disease
bullosa	26940370	1	I-Disease
caused	26940370	1	B-Reg
by	26940370	1	I-Reg
a	26940370	1	O
de	26940370	1	O
novo	26940370	1	O
interstitial	26940370	1	O
deletion	26940370	1	B-NegReg
spanning	26940370	1	O
COL7A1	26940370	1	B-Gene
and	26940370	1	O
a	26940370	1	O
hemizygous	26940370	1	O
splicing	26940370	1	B-Var
mutation	26940370	1	I-Var
in	26940370	1	I-Var
trans	26940370	1	I-Var
.	26940370	1	O
BACKGROUND	26940370	1	O
:	26940370	1	O
Recessive	26940370	1	B-Disease
dystrophic	26940370	1	I-Disease
epidermolysis	26940370	1	I-Disease
bullosa	26940370	1	I-Disease
(	26940370	1	O
RDEB	26940370	1	O
)	26940370	1	O
is	26940370	1	O
a	26940370	1	O
rare	26940370	1	O
heritable	26940370	1	O
blistering	26940370	1	O
skin	26940370	1	O
condition	26940370	1	O
caused	26940370	1	O
by	26940370	1	O
loss	26940370	1	B-NegReg
-	26940370	1	I-NegReg
of	26940370	1	I-NegReg
-	26940370	1	I-NegReg
function	26940370	1	I-NegReg
mutations	26940370	1	B-Var
in	26940370	1	O
the	26940370	1	O
COL7A1	26940370	1	B-Gene
gene	26940370	1	O
.	26940370	1	O
Incongruent	26940370	1	O
gene	26940370	1	O
transmission	26940370	1	O
is	26940370	1	O
occasionally	26940370	1	O
reported	26940370	1	O
in	26940370	1	O
recessive	26940370	1	O
diseases	26940370	1	O
,	26940370	1	O
and	26940370	1	O
its	26940370	1	O
underlying	26940370	1	O
mechanism	26940370	1	O
is	26940370	1	O
often	26940370	1	O
uniparental	26940370	1	O
disomy	26940370	1	O
(	26940370	1	O
UPD	26940370	1	O
)	26940370	1	O
.	26940370	1	O
AIM	26940370	1	O
:	26940370	1	O
To	26940370	1	O
understand	26940370	1	O
the	26940370	1	O
genetic	26940370	1	O
basis	26940370	1	O
of	26940370	1	O
incongruent	26940370	1	O
gene	26940370	1	O
transmission	26940370	1	O
in	26940370	1	O
a	26940370	1	O
Chinese	26940370	1	O
family	26940370	1	O
with	26940370	1	O
RDEB	26940370	1	O
,	26940370	1	O
in	26940370	1	O
which	26940370	1	O
a	26940370	1	O
discrepancy	26940370	1	O
of	26940370	1	O
COL7A1	26940370	1	O
genotyping	26940370	1	O
was	26940370	1	O
encountered	26940370	1	O
during	26940370	1	O
our	26940370	1	O
mutation	26940370	1	O
analysis	26940370	1	O
.	26940370	1	O
METHODS	26940370	1	O
:	26940370	1	O
We	26940370	1	O
used	26940370	1	O
a	26940370	1	O
pCAS2	26940370	1	O
minigene	26940370	1	O
-	26940370	1	O
based	26940370	1	O
in	26940370	1	O
vitro	26940370	1	O
splicing	26940370	1	O
assay	26940370	1	O
to	26940370	1	O
confirm	26940370	1	O
the	26940370	1	O
pathogenicity	26940370	1	O
of	26940370	1	O
the	26940370	1	O
splicing	26940370	1	O
variant	26940370	1	O
we	26940370	1	O
identified	26940370	1	O
in	26940370	1	O
the	26940370	1	O
proband	26940370	1	O
.	26940370	1	O
Next	26940370	1	O
,	26940370	1	O
a	26940370	1	O
combination	26940370	1	O
of	26940370	1	O
genetic	26940370	1	O
tools	26940370	1	O
,	26940370	1	O
including	26940370	1	O
whole	26940370	1	O
-	26940370	1	O
genome	26940370	1	O
SNP	26940370	1	O
array	26940370	1	O
analysis	26940370	1	O
and	26940370	1	O
multiplex	26940370	1	O
ligation	26940370	1	O
-	26940370	1	O
dependent	26940370	1	O
probe	26940370	1	O
amplification	26940370	1	O
copy	26940370	1	O
number	26940370	1	O
analysis	26940370	1	O
,	26940370	1	O
was	26940370	1	O
used	26940370	1	O
to	26940370	1	O
unravel	26940370	1	O
the	26940370	1	O
cause	26940370	1	O
of	26940370	1	O
the	26940370	1	O
discrepancy	26940370	1	O
in	26940370	1	O
the	26940370	1	O
COL7A1	26940370	1	O
genotyping	26940370	1	O
.	26940370	1	O
RESULTS	26940370	1	O
:	26940370	1	O
Sanger	26940370	1	O
sequencing	26940370	1	O
identified	26940370	1	O
a	26940370	1	O
novel	26940370	1	O
,	26940370	1	O
single	26940370	1	O
-	26940370	1	O
peak	26940370	1	O
mutation	26940370	1	O
,	26940370	1	O
c.4980	26940370	1	O
5	26940370	1	O
G	26940370	1	O
>	26940370	1	O
C	26940370	1	O
,	26940370	1	O
in	26940370	1	O
COL7A1	26940370	1	O
in	26940370	1	O
the	26940370	1	O
proband	26940370	1	O
,	26940370	1	O
which	26940370	1	O
was	26940370	1	O
heterozygous	26940370	1	O
in	26940370	1	O
his	26940370	1	O
father	26940370	1	O
and	26940370	1	O
wild	26940370	1	O
type	26940370	1	O
in	26940370	1	O
his	26940370	1	O
mother	26940370	1	O
.	26940370	1	O
In	26940370	1	O
vitro	26940370	1	O
splicing	26940370	1	O
assay	26940370	1	O
showed	26940370	1	O
that	26940370	1	O
c.4980	26940370	1	O
5	26940370	1	O
G	26940370	1	O
>	26940370	1	O
C	26940370	1	O
was	26940370	1	O
pathogenic	26940370	1	O
and	26940370	1	O
led	26940370	1	O
to	26940370	1	O
skipping	26940370	1	O
of	26940370	1	O
COL7A1	26940370	1	O
exon	26940370	1	O
53	26940370	1	O
.	26940370	1	O
SNP	26940370	1	O
array	26940370	1	O
analysis	26940370	1	O
and	26940370	1	O
multiplex	26940370	1	O
ligation	26940370	1	O
-	26940370	1	O
dependent	26940370	1	O
probe	26940370	1	O
amplification	26940370	1	O
of	26940370	1	O
the	26940370	1	O
proband	26940370	1	O
'	26940370	1	O
s	26940370	1	O
DNA	26940370	1	O
revealed	26940370	1	O
a	26940370	1	O
maternally	26940370	1	O
derived	26940370	1	O
,	26940370	1	O
de	26940370	1	O
novo	26940370	1	O
,	26940370	1	O
interstitial	26940370	1	O
deletion	26940370	1	O
on	26940370	1	O
chromosome	26940370	1	O
3	26940370	1	O
p21.31	26940370	1	O
,	26940370	1	O
which	26940370	1	O
removed	26940370	1	O
COL7A1	26940370	1	O
and	26940370	1	O
15	26940370	1	O
flanking	26940370	1	O
genes	26940370	1	O
,	26940370	1	O
excluding	26940370	1	O
the	26940370	1	O
possibility	26940370	1	O
of	26940370	1	O
UPD	26940370	1	O
.	26940370	1	O
CONCLUSION	26940370	1	O
:	26940370	1	O
Our	26940370	1	O
findings	26940370	1	O
favour	26940370	1	O
an	26940370	1	O
exceptionally	26940370	1	O
rare	26940370	1	O
event	26940370	1	O
,	26940370	1	O
namely	26940370	1	O
a	26940370	1	O
de	26940370	1	O
novo	26940370	1	O
COL7A1	26940370	1	O
microdeletion	26940370	1	O
in	26940370	1	O
concurrence	26940370	1	O
with	26940370	1	O
an	26940370	1	O
inherited	26940370	1	O
mutation	26940370	1	O
in	26940370	1	O
trans	26940370	1	O
.	26940370	1	O
This	26940370	1	O
study	26940370	1	O
should	26940370	1	O
aid	26940370	1	O
molecular	26940370	1	O
diagnosis	26940370	1	O
and	26940370	1	O
genetic	26940370	1	O
counselling	26940370	1	O
of	26940370	1	O
RDEB	26940370	1	O
and	26940370	1	O
possibly	26940370	1	O
other	26940370	1	O
recessive	26940370	1	O
diseases	26940370	1	O
in	26940370	1	O
which	26940370	1	O
genotyping	26940370	1	O
discrepancy	26940370	1	O
is	26940370	1	O
encountered	26940370	1	O
.	26940370	1	O

A	26974330	4	O
novel	26974330	4	O
frameshift	26974330	4	O
mutation	26974330	4	O
leading	26974330	4	O
to	26974330	4	O
inherited	26974330	4	O
type	26974330	4	O
I	26974330	4	O
antithrombin	26974330	4	O
deficiency	26974330	4	O
.	26974330	4	O
Inherited	26974330	4	B-Disease
antithrombin	26974330	4	I-Disease
(	26974330	4	I-Disease
AT	26974330	4	I-Disease
)	26974330	4	I-Disease
deficiency	26974330	4	I-Disease
is	26974330	4	O
an	26974330	4	O
autosomal	26974330	4	O
dominant	26974330	4	O
thrombotic	26974330	4	O
disorder	26974330	4	O
.	26974330	4	O
We	26974330	4	O
encountered	26974330	4	O
a	26974330	4	O
case	26974330	4	O
of	26974330	4	O
inherited	26974330	4	O
type	26974330	4	O
I	26974330	4	O
AT	26974330	4	B-Disease
deficiency	26974330	4	I-Disease
and	26974330	4	O
identified	26974330	4	B-Reg
the	26974330	4	O
mutation	26974330	4	O
responsible	26974330	4	O
;	26974330	4	O
a	26974330	4	O
novel	26974330	4	O
5406	26974330	4	B-Var
delA	26974330	4	I-Var
mutation	26974330	4	I-Var
in	26974330	4	O
the	26974330	4	O
SERPINC1	26974330	4	B-Gene
gene	26974330	4	O
appeared	26974330	4	O
to	26974330	4	O
have	26974330	4	O
caused	26974330	4	B-Reg
a	26974330	4	O
frameshift	26974330	4	O
with	26974330	4	O
premature	26974330	4	O
termination	26974330	4	O
at	26974330	4	O
amino	26974330	4	O
acid	26974330	4	O
283	26974330	4	O
.	26974330	4	O
The	26974330	4	O
recombinant	26974330	4	O
AT	26974330	4	O
protein	26974330	4	O
including	26974330	4	O
5406	26974330	4	O
delA	26974330	4	O
was	26974330	4	O
not	26974330	4	O
detected	26974330	4	O
in	26974330	4	O
cell	26974330	4	O
lysates	26974330	4	O
or	26974330	4	O
culture	26974330	4	O
supernatants	26974330	4	O
.	26974330	4	O
These	26974330	4	O
results	26974330	4	O
will	26974330	4	O
contribute	26974330	4	O
to	26974330	4	O
the	26974330	4	O
creation	26974330	4	O
of	26974330	4	O
an	26974330	4	O
accurate	26974330	4	O
database	26974330	4	O
and	26974330	4	O
define	26974330	4	O
the	26974330	4	O
molecular	26974330	4	O
basis	26974330	4	O
for	26974330	4	O
AT	26974330	4	O
deficiency	26974330	4	O
.	26974330	4	O

Increase	26990546	2	O
in	26990546	2	O
NRAS	26990546	2	O
mutant	26990546	2	O
allele	26990546	2	O
percentage	26990546	2	O
during	26990546	2	O
metastatic	26990546	2	O
melanoma	26990546	2	O
progression	26990546	2	O
.	26990546	2	O
One	26990546	2	O
-	26990546	2	O
fifth	26990546	2	O
of	26990546	2	O
cutaneous	26990546	2	B-Disease
melanomas	26990546	2	I-Disease
have	26990546	2	O
dominant	26990546	2	O
gain	26990546	2	B-PosReg
-	26990546	2	I-PosReg
of	26990546	2	I-PosReg
-	26990546	2	I-PosReg
function	26990546	2	I-PosReg
mutations	26990546	2	B-Var
of	26990546	2	O
the	26990546	2	O
NRAS	26990546	2	B-Gene
oncogene	26990546	2	O
.	26990546	2	O
We	26990546	2	O
report	26990546	2	O
the	26990546	2	O
first	26990546	2	O
two	26990546	2	O
cases	26990546	2	O
of	26990546	2	O
increasing	26990546	2	O
NRAS	26990546	2	O
mutant	26990546	2	O
allele	26990546	2	O
frequency	26990546	2	O
in	26990546	2	O
melanoma	26990546	2	O
metastases	26990546	2	O
and	26990546	2	O
show	26990546	2	O
that	26990546	2	O
the	26990546	2	O
chromosomal	26990546	2	O
mechanism	26990546	2	O
of	26990546	2	O
this	26990546	2	O
homozygosity	26990546	2	O
is	26990546	2	O
an	26990546	2	O
increased	26990546	2	O
polysomy	26990546	2	O
of	26990546	2	O
chromosome	26990546	2	O
1	26990546	2	O
.	26990546	2	O
We	26990546	2	O
observed	26990546	2	O
an	26990546	2	O
increase	26990546	2	O
in	26990546	2	O
NRAS	26990546	2	O
mutant	26990546	2	O
allele	26990546	2	O
percentage	26990546	2	O
(	26990546	2	O
NRAS	26990546	2	O
-	26990546	2	O
MA	26990546	2	O
)	26990546	2	O
in	26990546	2	O
the	26990546	2	O
metastatic	26990546	2	O
melanoma	26990546	2	O
progression	26990546	2	O
from	26990546	2	O
2	26990546	2	O
patients	26990546	2	O
with	26990546	2	O
melanomas	26990546	2	O
harbouring	26990546	2	O
a	26990546	2	O
NRAS	26990546	2	O
mutation	26990546	2	O
(	26990546	2	O
p.Q61K	26990546	2	O
in	26990546	2	O
case	26990546	2	O
1	26990546	2	O
and	26990546	2	O
p.Q61R	26990546	2	O
in	26990546	2	O
case	26990546	2	O
2	26990546	2	O
)	26990546	2	O
.	26990546	2	O
In	26990546	2	O
case	26990546	2	O
1	26990546	2	O
,	26990546	2	O
we	26990546	2	O
observed	26990546	2	O
a	26990546	2	O
NRAS	26990546	2	O
-	26990546	2	O
MA	26990546	2	O
increase	26990546	2	O
from	26990546	2	O
18%	26990546	2	O
within	26990546	2	O
the	26990546	2	O
first	26990546	2	O
metastatic	26990546	2	O
node	26990546	2	O
to	26990546	2	O
81%	26990546	2	O
,	26990546	2	O
92%	26990546	2	O
and	26990546	2	O
85%	26990546	2	O
respectively	26990546	2	O
in	26990546	2	O
the	26990546	2	O
three	26990546	2	O
subsequent	26990546	2	O
metastases	26990546	2	O
:	26990546	2	O
lymph	26990546	2	O
node	26990546	2	O
,	26990546	2	O
brain	26990546	2	O
and	26990546	2	O
subcutaneous	26990546	2	O
metastases	26990546	2	O
biopsied	26990546	2	O
1	26990546	2	O
,	26990546	2	O
6	26990546	2	O
and	26990546	2	O
17	26990546	2	O
months	26990546	2	O
,	26990546	2	O
respectively	26990546	2	O
,	26990546	2	O
after	26990546	2	O
the	26990546	2	O
initial	26990546	2	O
lymph	26990546	2	O
node	26990546	2	O
biopsy	26990546	2	O
.	26990546	2	O
In	26990546	2	O
case	26990546	2	O
2	26990546	2	O
,	26990546	2	O
we	26990546	2	O
observed	26990546	2	O
an	26990546	2	O
increase	26990546	2	O
in	26990546	2	O
NRAS	26990546	2	O
-	26990546	2	O
MA	26990546	2	O
from	26990546	2	O
40%	26990546	2	O
within	26990546	2	O
the	26990546	2	O
primary	26990546	2	O
melanoma	26990546	2	O
to	26990546	2	O
63%	26990546	2	O
within	26990546	2	O
the	26990546	2	O
metastatic	26990546	2	O
lymph	26990546	2	O
node	26990546	2	O
.	26990546	2	O
FISH	26990546	2	O
analysis	26990546	2	O
showed	26990546	2	O
the	26990546	2	O
same	26990546	2	O
results	26990546	2	O
in	26990546	2	O
both	26990546	2	O
cases	26990546	2	O
:	26990546	2	O
a	26990546	2	O
frequent	26990546	2	O
polysomy	26990546	2	O
of	26990546	2	O
chromosome	26990546	2	O
1	26990546	2	O
in	26990546	2	O
metastasis	26990546	2	O
samples	26990546	2	O
with	26990546	2	O
NRAS	26990546	2	O
mutant	26990546	2	O
allele	26990546	2	O
percentage	26990546	2	O
>	26990546	2	O
60%	26990546	2	O
,	26990546	2	O
while	26990546	2	O
most	26990546	2	O
cells	26990546	2	O
were	26990546	2	O
disomic	26990546	2	O
in	26990546	2	O
the	26990546	2	O
samples	26990546	2	O
with	26990546	2	O
well	26990546	2	O
-	26990546	2	O
balanced	26990546	2	O
heterozygous	26990546	2	O
mutations	26990546	2	O
.	26990546	2	O
The	26990546	2	O
percentage	26990546	2	O
of	26990546	2	O
NRAS	26990546	2	O
mutant	26990546	2	O
allele	26990546	2	O
may	26990546	2	O
increase	26990546	2	O
during	26990546	2	O
metastatic	26990546	2	O
progression	26990546	2	O
and	26990546	2	O
may	26990546	2	O
be	26990546	2	O
associated	26990546	2	O
with	26990546	2	O
chromosomal	26990546	2	O
instability	26990546	2	O
.	26990546	2	O
Further	26990546	2	O
studies	26990546	2	O
are	26990546	2	O
needed	26990546	2	O
to	26990546	2	O
evaluate	26990546	2	O
the	26990546	2	O
prognostic	26990546	2	O
impact	26990546	2	O
of	26990546	2	O
the	26990546	2	O
NRAS	26990546	2	O
homozygous	26990546	2	O
status	26990546	2	O
and	26990546	2	O
/	26990546	2	O
or	26990546	2	O
polyploidy	26990546	2	O
in	26990546	2	O
metastatic	26990546	2	O
cutaneous	26990546	2	O
melanomas	26990546	2	O
.	26990546	2	O

A	27070432	4	O
Comprehensive	27070432	4	O
Analysis	27070432	4	O
of	27070432	4	O
Choroideremia	27070432	4	O
:	27070432	4	O
From	27070432	4	O
Genetic	27070432	4	O
Characterization	27070432	4	O
to	27070432	4	O
Clinical	27070432	4	O
Practice	27070432	4	O
.	27070432	4	O
Choroideremia	27070432	4	B-Disease
(	27070432	4	O
CHM	27070432	4	O
)	27070432	4	O
is	27070432	4	O
a	27070432	4	O
rare	27070432	4	O
X	27070432	4	O
-	27070432	4	O
linked	27070432	4	O
disease	27070432	4	O
leading	27070432	4	O
to	27070432	4	O
progressive	27070432	4	O
retinal	27070432	4	O
degeneration	27070432	4	O
resulting	27070432	4	O
in	27070432	4	O
blindness	27070432	4	O
.	27070432	4	O
The	27070432	4	O
disorder	27070432	4	O
is	27070432	4	O
caused	27070432	4	B-Reg
by	27070432	4	I-Reg
mutations	27070432	4	B-Var
in	27070432	4	O
the	27070432	4	O
CHM	27070432	4	B-Gene
gene	27070432	4	O
encoding	27070432	4	O
REP-1	27070432	4	O
protein	27070432	4	O
,	27070432	4	O
an	27070432	4	O
essential	27070432	4	O
component	27070432	4	O
of	27070432	4	O
the	27070432	4	O
Rab	27070432	4	O
geranylgeranyltransferase	27070432	4	O
(	27070432	4	O
GGTase	27070432	4	O
)	27070432	4	O
complex	27070432	4	O
.	27070432	4	O
In	27070432	4	O
the	27070432	4	O
present	27070432	4	O
study	27070432	4	O
,	27070432	4	O
we	27070432	4	O
evaluated	27070432	4	O
a	27070432	4	O
multi	27070432	4	O
-	27070432	4	O
technique	27070432	4	O
analysis	27070432	4	O
algorithm	27070432	4	O
to	27070432	4	O
describe	27070432	4	O
the	27070432	4	O
mutational	27070432	4	O
spectrum	27070432	4	O
identified	27070432	4	O
in	27070432	4	O
a	27070432	4	O
large	27070432	4	O
cohort	27070432	4	O
of	27070432	4	O
cases	27070432	4	O
and	27070432	4	O
further	27070432	4	O
correlate	27070432	4	O
CHM	27070432	4	O
variants	27070432	4	O
with	27070432	4	O
phenotypic	27070432	4	O
characteristics	27070432	4	O
and	27070432	4	O
biochemical	27070432	4	O
defects	27070432	4	O
of	27070432	4	O
choroideremia	27070432	4	O
patients	27070432	4	O
.	27070432	4	O
Molecular	27070432	4	O
genetic	27070432	4	O
testing	27070432	4	O
led	27070432	4	O
to	27070432	4	O
the	27070432	4	O
characterization	27070432	4	O
of	27070432	4	O
36	27070432	4	O
out	27070432	4	O
of	27070432	4	O
45	27070432	4	O
unrelated	27070432	4	O
CHM	27070432	4	O
families	27070432	4	O
(	27070432	4	O
80%	27070432	4	O
)	27070432	4	O
,	27070432	4	O
allowing	27070432	4	O
the	27070432	4	O
clinical	27070432	4	O
reclassification	27070432	4	O
of	27070432	4	O
four	27070432	4	O
CHM	27070432	4	O
families	27070432	4	O
.	27070432	4	O
Haplotype	27070432	4	O
reconstruction	27070432	4	O
showed	27070432	4	O
independent	27070432	4	O
origins	27070432	4	O
for	27070432	4	O
the	27070432	4	O
recurrent	27070432	4	O
p.Arg293*	27070432	4	O
and	27070432	4	O
p.Lys178Argfs*5	27070432	4	O
mutations	27070432	4	O
,	27070432	4	O
suggesting	27070432	4	O
the	27070432	4	O
presence	27070432	4	O
of	27070432	4	O
hotspots	27070432	4	O
in	27070432	4	O
CHM	27070432	4	O
,	27070432	4	O
as	27070432	4	O
well	27070432	4	O
as	27070432	4	O
the	27070432	4	O
identification	27070432	4	O
of	27070432	4	O
two	27070432	4	O
different	27070432	4	O
unrelated	27070432	4	O
events	27070432	4	O
involving	27070432	4	O
exon	27070432	4	O
9	27070432	4	O
deletion	27070432	4	O
.	27070432	4	O
No	27070432	4	O
certain	27070432	4	O
genotype	27070432	4	O
-	27070432	4	O
phenotype	27070432	4	O
correlation	27070432	4	O
could	27070432	4	O
be	27070432	4	O
established	27070432	4	O
.	27070432	4	O
Furthermore	27070432	4	O
,	27070432	4	O
all	27070432	4	O
the	27070432	4	O
patients	27070432	4	O
fibroblasts	27070432	4	O
analyzed	27070432	4	O
presented	27070432	4	O
significantly	27070432	4	O
increased	27070432	4	O
levels	27070432	4	O
of	27070432	4	O
unprenylated	27070432	4	O
Rabs	27070432	4	O
proteins	27070432	4	O
compared	27070432	4	O
to	27070432	4	O
control	27070432	4	O
cells	27070432	4	O
;	27070432	4	O
however	27070432	4	O
,	27070432	4	O
this	27070432	4	O
was	27070432	4	O
not	27070432	4	O
related	27070432	4	O
to	27070432	4	O
the	27070432	4	O
genotype	27070432	4	O
.	27070432	4	O
This	27070432	4	O
research	27070432	4	O
demonstrates	27070432	4	O
the	27070432	4	O
major	27070432	4	O
potential	27070432	4	O
of	27070432	4	O
the	27070432	4	O
algorithm	27070432	4	O
proposed	27070432	4	O
for	27070432	4	O
diagnosis	27070432	4	O
.	27070432	4	O
Our	27070432	4	O
data	27070432	4	O
enhance	27070432	4	O
the	27070432	4	O
importance	27070432	4	O
of	27070432	4	O
establish	27070432	4	O
a	27070432	4	O
differential	27070432	4	O
diagnosis	27070432	4	O
with	27070432	4	O
other	27070432	4	O
retinal	27070432	4	O
dystrophies	27070432	4	O
,	27070432	4	O
supporting	27070432	4	O
the	27070432	4	O
idea	27070432	4	O
of	27070432	4	O
an	27070432	4	O
underestimated	27070432	4	O
prevalence	27070432	4	O
of	27070432	4	O
choroideremia	27070432	4	O
.	27070432	4	O
Moreover	27070432	4	O
,	27070432	4	O
they	27070432	4	O
suggested	27070432	4	O
that	27070432	4	O
the	27070432	4	O
severity	27070432	4	O
of	27070432	4	O
the	27070432	4	O
disorder	27070432	4	O
cannot	27070432	4	O
be	27070432	4	O
exclusively	27070432	4	O
explained	27070432	4	O
by	27070432	4	O
the	27070432	4	O
genotype	27070432	4	O
.	27070432	4	O

Four	27095120	4	O
novel	27095120	4	O
ATP2C1	27095120	4	B-Gene
mutations	27095120	4	B-Var
in	27095120	4	O
Chinese	27095120	4	O
patients	27095120	4	O
with	27095120	4	B-Reg
Hailey	27095120	4	B-Disease
-	27095120	4	I-Disease
Hailey	27095120	4	I-Disease
disease	27095120	4	I-Disease
.	27095120	4	O
Hailey	27095120	4	O
-	27095120	4	O
Hailey	27095120	4	O
disease	27095120	4	O
(	27095120	4	O
HHD	27095120	4	O
)	27095120	4	O
is	27095120	4	O
a	27095120	4	O
kind	27095120	4	O
of	27095120	4	O
autosomal	27095120	4	O
dominant	27095120	4	O
dermatosis	27095120	4	O
.	27095120	4	O
The	27095120	4	O
ATP2C1	27095120	4	O
gene	27095120	4	O
has	27095120	4	O
been	27095120	4	O
identified	27095120	4	O
as	27095120	4	O
the	27095120	4	O
pathogenic	27095120	4	O
gene	27095120	4	O
of	27095120	4	O
HHD	27095120	4	O
since	27095120	4	O
2000	27095120	4	O
.	27095120	4	O
In	27095120	4	O
this	27095120	4	O
study	27095120	4	O
,	27095120	4	O
direct	27095120	4	O
DNA	27095120	4	O
sequencing	27095120	4	O
was	27095120	4	O
used	27095120	4	O
to	27095120	4	O
identify	27095120	4	O
ATP2C1	27095120	4	O
gene	27095120	4	O
mutations	27095120	4	O
in	27095120	4	O
four	27095120	4	O
Chinese	27095120	4	O
families	27095120	4	O
and	27095120	4	O
two	27095120	4	O
sporadic	27095120	4	O
cases	27095120	4	O
with	27095120	4	O
HHD	27095120	4	O
.	27095120	4	O
The	27095120	4	O
entire	27095120	4	O
coding	27095120	4	O
and	27095120	4	O
flanking	27095120	4	O
intronic	27095120	4	O
sequences	27095120	4	O
of	27095120	4	O
ATP2C1	27095120	4	O
were	27095120	4	O
screened	27095120	4	O
for	27095120	4	O
mutations	27095120	4	O
and	27095120	4	O
five	27095120	4	O
heterozygous	27095120	4	O
mutations	27095120	4	O
of	27095120	4	O
the	27095120	4	O
ATP2C1	27095120	4	O
gene	27095120	4	O
were	27095120	4	O
detected	27095120	4	O
in	27095120	4	O
the	27095120	4	O
four	27095120	4	O
pedigrees	27095120	4	O
and	27095120	4	O
two	27095120	4	O
sporadic	27095120	4	O
cases	27095120	4	O
with	27095120	4	O
HHD	27095120	4	O
.	27095120	4	O
Four	27095120	4	O
of	27095120	4	O
them	27095120	4	O
were	27095120	4	O
novel	27095120	4	O
,	27095120	4	O
including	27095120	4	O
three	27095120	4	O
frame	27095120	4	O
-	27095120	4	O
shift	27095120	4	O
mutations	27095120	4	O
(	27095120	4	O
c.1330	27095120	4	O
delC	27095120	4	O
,	27095120	4	O
c.888	27095120	4	O
_889insT	27095120	4	O
,	27095120	4	O
c.478	27095120	4	O
_479insA	27095120	4	O
)	27095120	4	O
and	27095120	4	O
one	27095120	4	O
nonsense	27095120	4	O
mutation	27095120	4	O
(	27095120	4	O
c.1720	27095120	4	O
C	27095120	4	O
>	27095120	4	O
T	27095120	4	O
)	27095120	4	O
.	27095120	4	O
These	27095120	4	O
data	27095120	4	O
added	27095120	4	O
new	27095120	4	O
variants	27095120	4	O
to	27095120	4	O
the	27095120	4	O
database	27095120	4	O
of	27095120	4	O
ATP2C1	27095120	4	B-Gene
mutations	27095120	4	B-Var
associated	27095120	4	B-Reg
with	27095120	4	I-Reg
HHD	27095120	4	B-Disease
.	27095120	4	O

Glycogen	27106217	4	O
storage	27106217	4	O
disease	27106217	4	O
type	27106217	4	O
III	27106217	4	O
:	27106217	4	O
diagnosis	27106217	4	O
,	27106217	4	O
genotype	27106217	4	O
,	27106217	4	O
management	27106217	4	O
,	27106217	4	O
clinical	27106217	4	O
course	27106217	4	O
and	27106217	4	O
outcome	27106217	4	O
.	27106217	4	O
Glycogen	27106217	4	B-Disease
storage	27106217	4	I-Disease
disease	27106217	4	I-Disease
type	27106217	4	I-Disease
III	27106217	4	I-Disease
(	27106217	4	O
GSDIII	27106217	4	O
)	27106217	4	O
is	27106217	4	O
a	27106217	4	O
rare	27106217	4	O
disorder	27106217	4	O
of	27106217	4	O
glycogenolysis	27106217	4	O
due	27106217	4	B-Reg
to	27106217	4	I-Reg
AGL	27106217	4	B-Gene
gene	27106217	4	O
mutations	27106217	4	B-Var
,	27106217	4	O
causing	27106217	4	O
glycogen	27106217	4	O
debranching	27106217	4	O
enzyme	27106217	4	O
deficiency	27106217	4	O
and	27106217	4	O
storage	27106217	4	O
of	27106217	4	O
limited	27106217	4	O
dextrin	27106217	4	O
.	27106217	4	O
Patients	27106217	4	O
with	27106217	4	O
GSDIIIa	27106217	4	O
show	27106217	4	O
involvement	27106217	4	O
of	27106217	4	O
liver	27106217	4	O
and	27106217	4	O
cardiac	27106217	4	O
/	27106217	4	O
skeletal	27106217	4	O
muscle	27106217	4	O
,	27106217	4	O
whereas	27106217	4	O
GSDIIIb	27106217	4	O
patients	27106217	4	O
display	27106217	4	O
only	27106217	4	O
liver	27106217	4	O
symptoms	27106217	4	O
and	27106217	4	O
signs	27106217	4	O
.	27106217	4	O
The	27106217	4	O
International	27106217	4	O
Study	27106217	4	O
on	27106217	4	O
Glycogen	27106217	4	O
Storage	27106217	4	O
Disease	27106217	4	O
(	27106217	4	O
ISGSDIII	27106217	4	O
)	27106217	4	O
is	27106217	4	O
a	27106217	4	O
descriptive	27106217	4	O
retrospective	27106217	4	O
,	27106217	4	O
international	27106217	4	O
,	27106217	4	O
multi	27106217	4	O
-	27106217	4	O
centre	27106217	4	O
cohort	27106217	4	O
study	27106217	4	O
of	27106217	4	O
diagnosis	27106217	4	O
,	27106217	4	O
genotype	27106217	4	O
,	27106217	4	O
management	27106217	4	O
,	27106217	4	O
clinical	27106217	4	O
course	27106217	4	O
and	27106217	4	O
outcome	27106217	4	O
of	27106217	4	O
175	27106217	4	O
patients	27106217	4	O
from	27106217	4	O
147	27106217	4	O
families	27106217	4	O
(	27106217	4	O
86	27106217	4	O
GSDIIIa	27106217	4	O
;	27106217	4	O
14	27106217	4	O
GSDIIIb	27106217	4	O
)	27106217	4	O
,	27106217	4	O
with	27106217	4	O
follow	27106217	4	O
-	27106217	4	O
up	27106217	4	O
into	27106217	4	O
adulthood	27106217	4	O
in	27106217	4	O
91	27106217	4	O
patients	27106217	4	O
.	27106217	4	O
In	27106217	4	O
total	27106217	4	O
58	27106217	4	O
AGL	27106217	4	O
mutations	27106217	4	O
(	27106217	4	O
non	27106217	4	O
-	27106217	4	O
missense	27106217	4	O
mutations	27106217	4	O
were	27106217	4	O
overrepresented	27106217	4	O
and	27106217	4	O
21	27106217	4	O
novel	27106217	4	O
mutations	27106217	4	O
were	27106217	4	O
observed	27106217	4	O
)	27106217	4	O
were	27106217	4	O
identified	27106217	4	O
in	27106217	4	O
76	27106217	4	O
families	27106217	4	O
.	27106217	4	O
GSDIII	27106217	4	O
patients	27106217	4	O
first	27106217	4	O
presented	27106217	4	O
before	27106217	4	O
the	27106217	4	O
age	27106217	4	O
of	27106217	4	O
1.5	27106217	4	O
years	27106217	4	O
,	27106217	4	O
hepatomegaly	27106217	4	O
was	27106217	4	O
the	27106217	4	O
most	27106217	4	O
common	27106217	4	O
presenting	27106217	4	O
clinical	27106217	4	O
sign	27106217	4	O
.	27106217	4	O
Dietary	27106217	4	O
management	27106217	4	O
was	27106217	4	O
very	27106217	4	O
diverse	27106217	4	O
and	27106217	4	O
included	27106217	4	O
frequent	27106217	4	O
meals	27106217	4	O
,	27106217	4	O
uncooked	27106217	4	O
cornstarch	27106217	4	O
and	27106217	4	O
continuous	27106217	4	O
gastric	27106217	4	O
drip	27106217	4	O
feeding	27106217	4	O
.	27106217	4	O
Chronic	27106217	4	O
complications	27106217	4	O
involved	27106217	4	O
the	27106217	4	O
liver	27106217	4	O
(	27106217	4	O
hepatic	27106217	4	O
cirrhosis	27106217	4	O
,	27106217	4	O
adenoma	27106217	4	O
(	27106217	4	O
s	27106217	4	O
)	27106217	4	O
,	27106217	4	O
and	27106217	4	O
/	27106217	4	O
or	27106217	4	O
hepatocellular	27106217	4	O
carcinoma	27106217	4	O
in	27106217	4	O
11	27106217	4	O
)	27106217	4	O
,	27106217	4	O
heart	27106217	4	O
(	27106217	4	O
cardiac	27106217	4	O
involvement	27106217	4	O
and	27106217	4	O
cardiomyopathy	27106217	4	O
,	27106217	4	O
in	27106217	4	O
58	27106217	4	O
and	27106217	4	O
15	27106217	4	O
,	27106217	4	O
respectively	27106217	4	O
,	27106217	4	O
generally	27106217	4	O
presenting	27106217	4	O
in	27106217	4	O
early	27106217	4	O
childhood	27106217	4	O
)	27106217	4	O
,	27106217	4	O
and	27106217	4	O
muscle	27106217	4	O
(	27106217	4	O
pain	27106217	4	O
in	27106217	4	O
34	27106217	4	O
)	27106217	4	O
.	27106217	4	O
Type	27106217	4	O
2	27106217	4	O
diabetes	27106217	4	O
mellitus	27106217	4	O
was	27106217	4	O
diagnosed	27106217	4	O
in	27106217	4	O
eight	27106217	4	O
out	27106217	4	O
of	27106217	4	O
91	27106217	4	O
adult	27106217	4	O
patients	27106217	4	O
(	27106217	4	O
9	27106217	4	O
)	27106217	4	O
.	27106217	4	O
In	27106217	4	O
adult	27106217	4	O
patients	27106217	4	O
no	27106217	4	O
significant	27106217	4	O
correlation	27106217	4	O
was	27106217	4	O
detected	27106217	4	O
between	27106217	4	O
(	27106217	4	O
non	27106217	4	O
-	27106217	4	O
)	27106217	4	O
missense	27106217	4	O
AGL	27106217	4	O
genotypes	27106217	4	O
and	27106217	4	O
hepatic	27106217	4	O
,	27106217	4	O
cardiac	27106217	4	O
or	27106217	4	O
muscular	27106217	4	O
complications	27106217	4	O
.	27106217	4	O
This	27106217	4	O
study	27106217	4	O
demonstrates	27106217	4	O
heterogeneity	27106217	4	O
in	27106217	4	O
a	27106217	4	O
large	27106217	4	O
cohort	27106217	4	O
of	27106217	4	O
ageing	27106217	4	O
GSDIII	27106217	4	O
patients	27106217	4	O
.	27106217	4	O
An	27106217	4	O
international	27106217	4	O
GSD	27106217	4	O
patient	27106217	4	O
registry	27106217	4	O
is	27106217	4	O
warranted	27106217	4	O
to	27106217	4	O
prospectively	27106217	4	O
define	27106217	4	O
the	27106217	4	O
clinical	27106217	4	O
course	27106217	4	O
,	27106217	4	O
heterogeneity	27106217	4	O
and	27106217	4	O
the	27106217	4	O
effect	27106217	4	O
of	27106217	4	O
different	27106217	4	O
dietary	27106217	4	O
interventions	27106217	4	O
in	27106217	4	O
patients	27106217	4	O
with	27106217	4	O
GSDIII	27106217	4	O
.	27106217	4	O

Gain	27120018	4	B-PosReg
-	27120018	4	I-PosReg
of	27120018	4	I-PosReg
-	27120018	4	I-PosReg
Function	27120018	4	I-PosReg
Mutations	27120018	4	B-Var
in	27120018	4	O
RARB	27120018	4	B-Gene
Cause	27120018	4	B-Reg
Intellectual	27120018	4	O
Disability	27120018	4	O
with	27120018	4	O
Progressive	27120018	4	O
Motor	27120018	4	O
Impairment	27120018	4	O
.	27120018	4	O
Retinoic	27120018	4	O
acid	27120018	4	O
(	27120018	4	O
RA	27120018	4	O
)	27120018	4	O
signaling	27120018	4	O
plays	27120018	4	O
a	27120018	4	O
key	27120018	4	O
role	27120018	4	O
in	27120018	4	O
the	27120018	4	O
development	27120018	4	O
and	27120018	4	O
function	27120018	4	O
of	27120018	4	O
several	27120018	4	O
systems	27120018	4	O
in	27120018	4	O
mammals	27120018	4	O
.	27120018	4	O
We	27120018	4	O
previously	27120018	4	O
discovered	27120018	4	O
that	27120018	4	O
the	27120018	4	O
de	27120018	4	O
novo	27120018	4	O
mutations	27120018	4	O
c.1159	27120018	4	B-Var
C	27120018	4	I-Var
>	27120018	4	I-Var
T	27120018	4	I-Var
(	27120018	4	O
p.Arg387Cys	27120018	4	O
)	27120018	4	O
and	27120018	4	O
c.1159	27120018	4	B-Var
C	27120018	4	I-Var
>	27120018	4	I-Var
A	27120018	4	I-Var
(	27120018	4	O
p.Arg387Ser	27120018	4	O
)	27120018	4	O
in	27120018	4	O
the	27120018	4	O
RA	27120018	4	O
Receptor	27120018	4	O
Beta	27120018	4	O
(	27120018	4	B-Gene
RARB	27120018	4	I-Gene
)	27120018	4	I-Gene
gene	27120018	4	O
cause	27120018	4	B-Reg
microphthalmia	27120018	4	B-Disease
and	27120018	4	O
diaphragmatic	27120018	4	B-Disease
hernia	27120018	4	I-Disease
.	27120018	4	O
However	27120018	4	O
,	27120018	4	O
the	27120018	4	O
natural	27120018	4	O
history	27120018	4	O
of	27120018	4	O
affected	27120018	4	O
subjects	27120018	4	O
beyond	27120018	4	O
the	27120018	4	O
prenatal	27120018	4	O
or	27120018	4	O
neonatal	27120018	4	O
period	27120018	4	O
was	27120018	4	O
unknown	27120018	4	O
.	27120018	4	O
Here	27120018	4	O
,	27120018	4	O
we	27120018	4	O
describe	27120018	4	O
nine	27120018	4	O
additional	27120018	4	O
subjects	27120018	4	O
with	27120018	4	O
microphthalmia	27120018	4	O
who	27120018	4	O
have	27120018	4	O
de	27120018	4	O
novo	27120018	4	O
mutations	27120018	4	O
in	27120018	4	O
RARB	27120018	4	O
,	27120018	4	O
including	27120018	4	O
the	27120018	4	O
previously	27120018	4	O
described	27120018	4	O
p.Arg387Cys	27120018	4	O
as	27120018	4	O
well	27120018	4	O
as	27120018	4	O
the	27120018	4	O
novel	27120018	4	O
c.887	27120018	4	O
G	27120018	4	O
>	27120018	4	O
C	27120018	4	O
(	27120018	4	O
p.Gly296Ala	27120018	4	O
)	27120018	4	O
and	27120018	4	O
c.638	27120018	4	O
T	27120018	4	O
>	27120018	4	O
C	27120018	4	O
(	27120018	4	O
p.Leu213Pro	27120018	4	O
)	27120018	4	O
.	27120018	4	O
Moreover	27120018	4	O
,	27120018	4	O
we	27120018	4	O
review	27120018	4	O
the	27120018	4	O
information	27120018	4	O
on	27120018	4	O
four	27120018	4	O
previously	27120018	4	O
reported	27120018	4	O
cases	27120018	4	O
.	27120018	4	O
All	27120018	4	O
subjects	27120018	4	O
who	27120018	4	O
survived	27120018	4	O
the	27120018	4	O
neonatal	27120018	4	O
period	27120018	4	O
(	27120018	4	O
n	27120018	4	O
=	27120018	4	O
10	27120018	4	O
)	27120018	4	O
displayed	27120018	4	O
severe	27120018	4	O
global	27120018	4	O
developmental	27120018	4	O
delay	27120018	4	O
with	27120018	4	O
progressive	27120018	4	O
motor	27120018	4	O
impairment	27120018	4	O
due	27120018	4	O
to	27120018	4	O
spasticity	27120018	4	O
and	27120018	4	O
/	27120018	4	O
or	27120018	4	O
dystonia	27120018	4	O
(	27120018	4	O
with	27120018	4	O
or	27120018	4	O
without	27120018	4	O
chorea	27120018	4	O
)	27120018	4	O
.	27120018	4	O
The	27120018	4	O
majority	27120018	4	O
of	27120018	4	O
subjects	27120018	4	O
also	27120018	4	O
showed	27120018	4	O
Chiari	27120018	4	O
type	27120018	4	O
I	27120018	4	O
malformation	27120018	4	O
and	27120018	4	O
severe	27120018	4	O
feeding	27120018	4	O
difficulties	27120018	4	O
.	27120018	4	O
We	27120018	4	O
previously	27120018	4	O
found	27120018	4	O
that	27120018	4	O
p.Arg387Cys	27120018	4	O
and	27120018	4	O
p.Arg387Ser	27120018	4	O
induce	27120018	4	O
a	27120018	4	O
gain	27120018	4	O
-	27120018	4	O
of	27120018	4	O
-	27120018	4	O
function	27120018	4	O
.	27120018	4	O
We	27120018	4	O
show	27120018	4	O
here	27120018	4	O
that	27120018	4	O
the	27120018	4	O
p.Gly296Ala	27120018	4	B-Var
and	27120018	4	O
p.Leu213Pro	27120018	4	B-Var
RARB	27120018	4	B-Gene
mutations	27120018	4	O
further	27120018	4	O
promote	27120018	4	B-PosReg
the	27120018	4	O
RA	27120018	4	O
ligand	27120018	4	O
-	27120018	4	O
induced	27120018	4	O
transcriptional	27120018	4	O
activity	27120018	4	O
by	27120018	4	O
twofold	27120018	4	O
to	27120018	4	O
threefold	27120018	4	O
over	27120018	4	O
the	27120018	4	O
wild	27120018	4	O
-	27120018	4	O
type	27120018	4	O
receptor	27120018	4	O
,	27120018	4	O
also	27120018	4	O
indicating	27120018	4	O
a	27120018	4	O
gain	27120018	4	O
-	27120018	4	O
of	27120018	4	O
-	27120018	4	O
function	27120018	4	O
mechanism	27120018	4	O
.	27120018	4	O
These	27120018	4	O
observations	27120018	4	O
suggest	27120018	4	O
that	27120018	4	O
precise	27120018	4	O
regulation	27120018	4	O
of	27120018	4	O
RA	27120018	4	O
signaling	27120018	4	O
is	27120018	4	O
required	27120018	4	O
for	27120018	4	O
brain	27120018	4	O
development	27120018	4	O
and	27120018	4	O
/	27120018	4	O
or	27120018	4	O
function	27120018	4	O
in	27120018	4	O
humans	27120018	4	O
.	27120018	4	O

Long	27127178	0	O
-	27127178	0	O
term	27127178	0	O
vemurafenib	27127178	0	O
treatment	27127178	0	O
drives	27127178	0	B-Reg
inhibitor	27127178	0	O
resistance	27127178	0	O
through	27127178	0	O
a	27127178	0	O
spontaneous	27127178	0	O
KRAS	27127178	0	B-Gene
G12D	27127178	0	B-Var
mutation	27127178	0	O
in	27127178	0	O
a	27127178	0	O
BRAF	27127178	0	O
V600E	27127178	0	O
papillary	27127178	0	O
thyroid	27127178	0	O
carcinoma	27127178	0	O
model	27127178	0	O
.	27127178	0	O
The	27127178	0	O
BRAF	27127178	0	O
V600E	27127178	0	O
mutation	27127178	0	O
is	27127178	0	O
commonly	27127178	0	O
observed	27127178	0	O
in	27127178	0	O
papillary	27127178	0	O
thyroid	27127178	0	O
cancer	27127178	0	O
(	27127178	0	O
PTC	27127178	0	O
)	27127178	0	O
and	27127178	0	O
predominantly	27127178	0	O
activates	27127178	0	O
the	27127178	0	O
MAPK	27127178	0	O
pathway	27127178	0	O
.	27127178	0	O
Presence	27127178	0	O
of	27127178	0	O
BRAF	27127178	0	O
V600E	27127178	0	O
predicts	27127178	0	O
increasing	27127178	0	O
risk	27127178	0	O
of	27127178	0	O
recurrence	27127178	0	O
and	27127178	0	O
higher	27127178	0	O
mortality	27127178	0	O
rate	27127178	0	O
,	27127178	0	O
and	27127178	0	O
treatment	27127178	0	O
options	27127178	0	O
for	27127178	0	O
such	27127178	0	O
patients	27127178	0	O
are	27127178	0	O
limited	27127178	0	O
.	27127178	0	O
Vemurafenib	27127178	0	O
,	27127178	0	O
a	27127178	0	O
BRAF	27127178	0	O
V600E	27127178	0	O
inhibitor	27127178	0	O
,	27127178	0	O
is	27127178	0	O
initially	27127178	0	O
effective	27127178	0	O
,	27127178	0	O
but	27127178	0	O
cells	27127178	0	O
inevitably	27127178	0	O
develop	27127178	0	O
alternative	27127178	0	O
mechanisms	27127178	0	O
of	27127178	0	O
pathway	27127178	0	O
activation	27127178	0	O
.	27127178	0	O
Mechanisms	27127178	0	O
of	27127178	0	O
primary	27127178	0	O
resistance	27127178	0	O
have	27127178	0	O
been	27127178	0	O
described	27127178	0	O
in	27127178	0	O
short	27127178	0	O
-	27127178	0	O
term	27127178	0	O
cultures	27127178	0	O
of	27127178	0	O
PTC	27127178	0	O
cells	27127178	0	O
;	27127178	0	O
however	27127178	0	O
,	27127178	0	O
mechanisms	27127178	0	O
of	27127178	0	O
acquired	27127178	0	O
resistance	27127178	0	O
have	27127178	0	O
not	27127178	0	O
.	27127178	0	O
In	27127178	0	O
the	27127178	0	O
present	27127178	0	O
study	27127178	0	O
,	27127178	0	O
we	27127178	0	O
investigated	27127178	0	O
possible	27127178	0	O
adaptive	27127178	0	O
mechanisms	27127178	0	O
of	27127178	0	O
BRAF	27127178	0	O
V600E	27127178	0	O
inhibitor	27127178	0	O
resistance	27127178	0	O
in	27127178	0	O
KTC1	27127178	0	O
thyroid	27127178	0	O
cancer	27127178	0	O
cells	27127178	0	O
following	27127178	0	O
long	27127178	0	O
-	27127178	0	O
term	27127178	0	O
vemurafenib	27127178	0	O
exposure	27127178	0	O
.	27127178	0	O
We	27127178	0	O
found	27127178	0	O
that	27127178	0	O
a	27127178	0	O
subpopulation	27127178	0	O
of	27127178	0	O
KTC1	27127178	0	O
cells	27127178	0	O
acquired	27127178	0	O
resistance	27127178	0	O
to	27127178	0	O
vemurafenib	27127178	0	O
following	27127178	0	O
5	27127178	0	O
months	27127178	0	O
of	27127178	0	O
treatment	27127178	0	O
with	27127178	0	O
the	27127178	0	O
inhibitor	27127178	0	O
.	27127178	0	O
Resistance	27127178	0	O
coincided	27127178	0	O
with	27127178	0	O
the	27127178	0	O
spontaneous	27127178	0	O
acquisition	27127178	0	O
of	27127178	0	O
a	27127178	0	O
KRAS	27127178	0	O
G12D	27127178	0	O
activating	27127178	0	O
mutation	27127178	0	O
.	27127178	0	O
Increases	27127178	0	O
in	27127178	0	O
activated	27127178	0	O
AKT	27127178	0	O
,	27127178	0	O
ERK1	27127178	0	O
/	27127178	0	O
2	27127178	0	O
,	27127178	0	O
and	27127178	0	O
EGFR	27127178	0	O
were	27127178	0	O
observed	27127178	0	O
in	27127178	0	O
these	27127178	0	O
cells	27127178	0	O
.	27127178	0	O
In	27127178	0	O
addition	27127178	0	O
,	27127178	0	O
the	27127178	0	O
resistant	27127178	0	O
cells	27127178	0	O
were	27127178	0	O
less	27127178	0	O
sensitive	27127178	0	O
to	27127178	0	O
combinations	27127178	0	O
of	27127178	0	O
vemurafenib	27127178	0	O
and	27127178	0	O
MEK1	27127178	0	O
inhibitor	27127178	0	O
or	27127178	0	O
AKT	27127178	0	O
inhibitor	27127178	0	O
.	27127178	0	O
These	27127178	0	O
results	27127178	0	O
support	27127178	0	O
the	27127178	0	O
KRAS	27127178	0	B-Gene
G12D	27127178	0	B-Var
mutation	27127178	0	O
as	27127178	0	O
a	27127178	0	O
genetic	27127178	0	O
mechanism	27127178	0	O
of	27127178	0	O
spontaneously	27127178	0	O
acquired	27127178	0	B-Reg
secondary	27127178	0	O
BRAF	27127178	0	O
inhibitor	27127178	0	O
resistance	27127178	0	O
in	27127178	0	O
BRAF	27127178	0	O
V600E	27127178	0	O
thyroid	27127178	0	O
cancer	27127178	0	O
cells	27127178	0	O
.	27127178	0	O

Loss	27149098	0	B-NegReg
-	27149098	0	I-NegReg
of	27149098	0	I-NegReg
-	27149098	0	I-NegReg
function	27149098	0	I-NegReg
mutations	27149098	0	B-Var
in	27149098	0	O
the	27149098	0	O
APX1	27149098	0	B-Gene
gene	27149098	0	O
result	27149098	0	O
in	27149098	0	O
enhanced	27149098	0	B-PosReg
selenium	27149098	0	O
tolerance	27149098	0	O
in	27149098	0	O
Arabidopsis	27149098	0	O
thaliana	27149098	0	O
.	27149098	0	O
It	27149098	0	O
is	27149098	0	O
generally	27149098	0	O
recognized	27149098	0	O
that	27149098	0	O
excess	27149098	0	O
selenium	27149098	0	O
(	27149098	0	O
Se	27149098	0	O
)	27149098	0	O
has	27149098	0	O
a	27149098	0	O
negative	27149098	0	O
effect	27149098	0	O
on	27149098	0	O
the	27149098	0	O
growth	27149098	0	O
and	27149098	0	O
development	27149098	0	O
of	27149098	0	O
plants	27149098	0	O
.	27149098	0	O
Numerous	27149098	0	O
studies	27149098	0	O
have	27149098	0	O
identified	27149098	0	O
key	27149098	0	O
genes	27149098	0	O
involved	27149098	0	O
in	27149098	0	O
selenium	27149098	0	O
tolerance	27149098	0	O
in	27149098	0	O
plants	27149098	0	O
;	27149098	0	O
however	27149098	0	O
,	27149098	0	O
our	27149098	0	O
understanding	27149098	0	O
of	27149098	0	O
its	27149098	0	O
molecular	27149098	0	O
mechanisms	27149098	0	O
is	27149098	0	O
far	27149098	0	O
from	27149098	0	O
complete	27149098	0	O
.	27149098	0	O
In	27149098	0	O
this	27149098	0	O
study	27149098	0	O
,	27149098	0	O
we	27149098	0	O
isolated	27149098	0	O
an	27149098	0	O
Arabidopsis	27149098	0	O
selenium	27149098	0	O
-	27149098	0	O
resistant	27149098	0	O
mutant	27149098	0	B-Var
from	27149098	0	O
the	27149098	0	O
mutant	27149098	0	O
XVE	27149098	0	O
pool	27149098	0	O
lines	27149098	0	O
because	27149098	0	O
of	27149098	0	O
its	27149098	0	O
increased	27149098	0	B-PosReg
root	27149098	0	O
growth	27149098	0	O
and	27149098	0	O
fresh	27149098	0	O
weight	27149098	0	O
in	27149098	0	O
Se	27149098	0	O
stress	27149098	0	O
,	27149098	0	O
and	27149098	0	O
cloned	27149098	0	O
the	27149098	0	O
gene	27149098	0	O
,	27149098	0	O
which	27149098	0	O
encodes	27149098	0	O
the	27149098	0	O
cytosolic	27149098	0	O
ascorbate	27149098	0	O
peroxidase	27149098	0	O
(	27149098	0	O
APX1	27149098	0	O
)	27149098	0	O
.	27149098	0	O
Two	27149098	0	O
other	27149098	0	O
APX1	27149098	0	O
gene	27149098	0	O
knockout	27149098	0	O
allelic	27149098	0	O
lines	27149098	0	O
were	27149098	0	O
also	27149098	0	O
selenium	27149098	0	O
resistant	27149098	0	O
,	27149098	0	O
and	27149098	0	O
the	27149098	0	O
APX1	27149098	0	O
-	27149098	0	O
complementary	27149098	0	O
COM1	27149098	0	O
restored	27149098	0	O
the	27149098	0	O
growth	27149098	0	O
state	27149098	0	O
of	27149098	0	O
wild	27149098	0	O
type	27149098	0	O
under	27149098	0	O
Se	27149098	0	O
stress	27149098	0	O
.	27149098	0	O
In	27149098	0	O
addition	27149098	0	O
,	27149098	0	O
these	27149098	0	O
APX1	27149098	0	O
allelic	27149098	0	O
lines	27149098	0	O
accumulated	27149098	0	O
more	27149098	0	O
Se	27149098	0	O
than	27149098	0	O
did	27149098	0	O
wild	27149098	0	O
-	27149098	0	O
type	27149098	0	O
plants	27149098	0	O
when	27149098	0	O
subjected	27149098	0	O
to	27149098	0	O
Se	27149098	0	O
stress	27149098	0	O
.	27149098	0	O
Further	27149098	0	O
analysis	27149098	0	O
revealed	27149098	0	O
that	27149098	0	O
the	27149098	0	O
APX1	27149098	0	O
-	27149098	0	O
mediated	27149098	0	O
Se	27149098	0	O
tolerance	27149098	0	O
was	27149098	0	O
associated	27149098	0	O
,	27149098	0	O
at	27149098	0	O
least	27149098	0	O
in	27149098	0	O
part	27149098	0	O
,	27149098	0	O
with	27149098	0	O
the	27149098	0	O
enhanced	27149098	0	O
activities	27149098	0	O
of	27149098	0	O
antioxidant	27149098	0	O
enzymes	27149098	0	O
catalase	27149098	0	O
,	27149098	0	O
glutathione	27149098	0	O
peroxidase	27149098	0	O
and	27149098	0	O
glutathione	27149098	0	O
reductase	27149098	0	O
.	27149098	0	O
Moreover	27149098	0	O
,	27149098	0	O
enhanced	27149098	0	B-PosReg
Se	27149098	0	O
resistance	27149098	0	O
of	27149098	0	O
the	27149098	0	O
mutants	27149098	0	B-Var
was	27149098	0	O
associated	27149098	0	B-Reg
with	27149098	0	O
glutathione	27149098	0	O
(	27149098	0	O
GSH	27149098	0	O
)	27149098	0	O
,	27149098	0	O
which	27149098	0	O
had	27149098	0	O
the	27149098	0	O
higher	27149098	0	O
expression	27149098	0	O
level	27149098	0	O
of	27149098	0	O
GSH1	27149098	0	O
gene	27149098	0	O
involved	27149098	0	O
in	27149098	0	O
GSH	27149098	0	O
synthesis	27149098	0	O
and	27149098	0	O
consequently	27149098	0	O
increased	27149098	0	O
GSH	27149098	0	O
content	27149098	0	O
.	27149098	0	O
Our	27149098	0	O
results	27149098	0	O
provide	27149098	0	O
genetic	27149098	0	O
evidence	27149098	0	O
indicating	27149098	0	O
that	27149098	0	O
loss	27149098	0	O
-	27149098	0	O
of	27149098	0	O
-	27149098	0	O
function	27149098	0	O
of	27149098	0	O
APX1	27149098	0	O
results	27149098	0	O
in	27149098	0	O
tolerance	27149098	0	O
to	27149098	0	O
Se	27149098	0	O
stress	27149098	0	O
.	27149098	0	O

Coexistence	27173951	4	O
of	27173951	4	O
Mosaic	27173951	4	O
Uniparental	27173951	4	O
Isodisomy	27173951	4	O
and	27173951	4	O
a	27173951	4	O
KCNJ11	27173951	4	O
Mutation	27173951	4	O
Presenting	27173951	4	O
as	27173951	4	O
Diffuse	27173951	4	O
Congenital	27173951	4	O
Hyperinsulinism	27173951	4	O
and	27173951	4	O
Hemihypertrophy	27173951	4	O
.	27173951	4	O
BACKGROUND	27173951	4	O
:	27173951	4	O
Isolated	27173951	4	O
hyperinsulinaemic	27173951	4	B-Disease
hypoglycaemia	27173951	4	I-Disease
(	27173951	4	O
HH	27173951	4	O
)	27173951	4	O
commonly	27173951	4	O
results	27173951	4	B-Reg
from	27173951	4	I-Reg
recessively	27173951	4	B-Var
inherited	27173951	4	I-Var
mutations	27173951	4	I-Var
in	27173951	4	O
the	27173951	4	O
ABCC8	27173951	4	B-Gene
and	27173951	4	O
KCNJ11	27173951	4	B-Gene
genes	27173951	4	O
that	27173951	4	O
are	27173951	4	O
located	27173951	4	O
on	27173951	4	O
chromosome	27173951	4	O
11	27173951	4	O
p15.1	27173951	4	O
.	27173951	4	O
More	27173951	4	O
rarely	27173951	4	O
,	27173951	4	O
HH	27173951	4	O
can	27173951	4	O
feature	27173951	4	O
in	27173951	4	O
patients	27173951	4	O
with	27173951	4	O
Beckwith	27173951	4	O
-	27173951	4	O
Wiedemann	27173951	4	O
syndrome	27173951	4	O
(	27173951	4	O
BWS	27173951	4	O
)	27173951	4	O
,	27173951	4	O
a	27173951	4	O
congenital	27173951	4	O
overgrowth	27173951	4	O
disorder	27173951	4	O
,	27173951	4	O
resulting	27173951	4	O
from	27173951	4	O
defects	27173951	4	O
at	27173951	4	O
a	27173951	4	O
differentially	27173951	4	O
methylated	27173951	4	O
region	27173951	4	O
telomeric	27173951	4	O
to	27173951	4	O
the	27173951	4	O
K	27173951	4	O
-	27173951	4	O
ATP	27173951	4	O
channel	27173951	4	O
genes	27173951	4	O
at	27173951	4	O
chromosome	27173951	4	O
11	27173951	4	O
p15.5	27173951	4	O
.	27173951	4	O
SUBJECT	27173951	4	O
:	27173951	4	O
We	27173951	4	O
undertook	27173951	4	O
genetic	27173951	4	O
testing	27173951	4	O
in	27173951	4	O
a	27173951	4	O
patient	27173951	4	O
with	27173951	4	O
diazoxide	27173951	4	O
-	27173951	4	O
unresponsive	27173951	4	O
HH	27173951	4	O
diagnosed	27173951	4	O
at	27173951	4	O
birth	27173951	4	O
.	27173951	4	O
Physical	27173951	4	O
examination	27173951	4	O
later	27173951	4	O
revealed	27173951	4	O
hemihypertrophy	27173951	4	O
of	27173951	4	O
the	27173951	4	O
right	27173951	4	O
arm	27173951	4	O
,	27173951	4	O
a	27173951	4	O
feature	27173951	4	O
of	27173951	4	O
BWS	27173951	4	O
.	27173951	4	O
RESULTS	27173951	4	O
:	27173951	4	O
We	27173951	4	O
identified	27173951	4	O
a	27173951	4	O
novel	27173951	4	O
mosaic	27173951	4	O
,	27173951	4	O
paternally	27173951	4	O
-	27173951	4	O
inherited	27173951	4	O
KCNJ11	27173951	4	O
mutation	27173951	4	O
(	27173951	4	O
s	27173951	4	O
)	27173951	4	O
in	27173951	4	O
the	27173951	4	O
patient	27173951	4	O
.	27173951	4	O
Further	27173951	4	O
analysis	27173951	4	O
confirmed	27173951	4	O
uniparental	27173951	4	O
disomy	27173951	4	O
(	27173951	4	O
UPD	27173951	4	O
)	27173951	4	O
of	27173951	4	O
chromosome	27173951	4	O
11	27173951	4	O
,	27173951	4	O
which	27173951	4	O
extended	27173951	4	O
across	27173951	4	O
the	27173951	4	O
KCNJ11	27173951	4	O
gene	27173951	4	O
at	27173951	4	O
11	27173951	4	O
p15.1	27173951	4	O
and	27173951	4	O
the	27173951	4	O
BWS	27173951	4	O
locus	27173951	4	O
at	27173951	4	O
11	27173951	4	O
p15.5	27173951	4	O
.	27173951	4	O
CONCLUSION	27173951	4	O
:	27173951	4	O
These	27173951	4	O
results	27173951	4	O
highlight	27173951	4	O
the	27173951	4	O
importance	27173951	4	O
of	27173951	4	O
considering	27173951	4	O
UPD	27173951	4	O
as	27173951	4	O
a	27173951	4	O
mechanism	27173951	4	O
of	27173951	4	O
disease	27173951	4	O
in	27173951	4	O
patients	27173951	4	O
with	27173951	4	O
HH	27173951	4	O
and	27173951	4	O
a	27173951	4	O
paternally	27173951	4	O
inherited	27173951	4	O
K	27173951	4	O
-	27173951	4	O
ATP	27173951	4	O
channel	27173951	4	O
mutation	27173951	4	O
,	27173951	4	O
especially	27173951	4	O
when	27173951	4	O
additional	27173951	4	O
syndromic	27173951	4	O
features	27173951	4	O
are	27173951	4	O
present	27173951	4	O
.	27173951	4	O

Loss	27206675	0	O
of	27206675	0	O
T	27206675	0	O
-	27206675	0	O
cell	27206675	0	O
quiescence	27206675	0	O
by	27206675	0	O
targeting	27206675	0	O
Slfn2	27206675	0	O
prevents	27206675	0	O
the	27206675	0	O
development	27206675	0	O
and	27206675	0	O
progression	27206675	0	O
of	27206675	0	O
T	27206675	0	O
-	27206675	0	O
ALL	27206675	0	O
.	27206675	0	O
T	27206675	0	O
-	27206675	0	O
cell	27206675	0	O
acute	27206675	0	O
lymphoblastic	27206675	0	O
leukemia	27206675	0	O
(	27206675	0	O
T	27206675	0	O
-	27206675	0	O
ALL	27206675	0	O
)	27206675	0	O
is	27206675	0	O
an	27206675	0	O
aggressive	27206675	0	O
malignancy	27206675	0	O
of	27206675	0	O
thymocytes	27206675	0	O
.	27206675	0	O
Despite	27206675	0	O
significant	27206675	0	O
improvement	27206675	0	O
in	27206675	0	O
the	27206675	0	O
treatment	27206675	0	O
of	27206675	0	O
T	27206675	0	O
-	27206675	0	O
ALL	27206675	0	O
,	27206675	0	O
approximately	27206675	0	O
20%	27206675	0	O
of	27206675	0	O
children	27206675	0	O
and	27206675	0	O
most	27206675	0	O
adults	27206675	0	O
undergo	27206675	0	O
relapse	27206675	0	O
.	27206675	0	O
Previous	27206675	0	O
findings	27206675	0	O
demonstrated	27206675	0	O
that	27206675	0	O
loss	27206675	0	B-NegReg
of	27206675	0	O
T	27206675	0	O
-	27206675	0	O
cell	27206675	0	O
quiescence	27206675	0	O
due	27206675	0	O
to	27206675	0	O
a	27206675	0	O
mutation	27206675	0	B-Var
in	27206675	0	O
the	27206675	0	O
Slfn2	27206675	0	B-Gene
gene	27206675	0	O
(	27206675	0	O
elektra	27206675	0	O
)	27206675	0	O
leads	27206675	0	B-Reg
to	27206675	0	I-Reg
acquisition	27206675	0	O
of	27206675	0	O
an	27206675	0	O
aberrant	27206675	0	O
developmental	27206675	0	O
program	27206675	0	O
by	27206675	0	O
which	27206675	0	O
T	27206675	0	O
-	27206675	0	O
cells	27206675	0	O
lose	27206675	0	B-NegReg
their	27206675	0	O
renewal	27206675	0	O
capabilities	27206675	0	O
and	27206675	0	O
undergo	27206675	0	O
apoptosis	27206675	0	O
.	27206675	0	O
Here	27206675	0	O
we	27206675	0	O
show	27206675	0	O
that	27206675	0	O
the	27206675	0	O
elektra	27206675	0	O
mutation	27206675	0	O
in	27206675	0	O
Slfn2	27206675	0	O
completely	27206675	0	O
prevents	27206675	0	O
a	27206675	0	O
severe	27206675	0	O
lymphoproliferative	27206675	0	O
disease	27206675	0	O
caused	27206675	0	O
by	27206675	0	O
overexpression	27206675	0	O
of	27206675	0	O
BCL2	27206675	0	O
in	27206675	0	O
combination	27206675	0	O
with	27206675	0	O
Fas	27206675	0	O
deficiency	27206675	0	O
in	27206675	0	O
mice	27206675	0	O
.	27206675	0	O
Moreover	27206675	0	O
,	27206675	0	O
Slfn2	27206675	0	O
impaired	27206675	0	O
-	27206675	0	O
function	27206675	0	O
protects	27206675	0	O
mice	27206675	0	O
from	27206675	0	O
experimental	27206675	0	O
disease	27206675	0	O
similar	27206675	0	O
to	27206675	0	O
human	27206675	0	O
T	27206675	0	O
-	27206675	0	O
ALL	27206675	0	O
by	27206675	0	O
severely	27206675	0	O
impairing	27206675	0	O
the	27206675	0	O
proliferation	27206675	0	O
potential	27206675	0	O
and	27206675	0	O
survival	27206675	0	O
of	27206675	0	O
leukemic	27206675	0	O
T	27206675	0	O
-	27206675	0	O
cells	27206675	0	O
,	27206675	0	O
partially	27206675	0	O
by	27206675	0	O
activation	27206675	0	O
of	27206675	0	O
the	27206675	0	O
p53	27206675	0	O
tumor	27206675	0	O
suppressor	27206675	0	O
protein	27206675	0	O
.	27206675	0	O
Our	27206675	0	O
study	27206675	0	O
suggest	27206675	0	O
that	27206675	0	O
in	27206675	0	O
certain	27206675	0	O
malignancies	27206675	0	O
,	27206675	0	O
such	27206675	0	O
as	27206675	0	O
T	27206675	0	O
-	27206675	0	O
ALL	27206675	0	O
,	27206675	0	O
a	27206675	0	O
novel	27206675	0	O
therapeutic	27206675	0	O
strategy	27206675	0	O
may	27206675	0	O
be	27206675	0	O
applied	27206675	0	O
by	27206675	0	O
imposing	27206675	0	O
aberrant	27206675	0	O
development	27206675	0	O
of	27206675	0	O
leukemic	27206675	0	O
cells	27206675	0	O
.	27206675	0	O
Furthermore	27206675	0	O
,	27206675	0	O
as	27206675	0	O
the	27206675	0	O
elektra	27206675	0	O
mutation	27206675	0	B-Var
in	27206675	0	O
Slfn2	27206675	0	B-Gene
seems	27206675	0	O
to	27206675	0	O
impair	27206675	0	B-Reg
only	27206675	0	O
T	27206675	0	O
-	27206675	0	O
cells	27206675	0	O
and	27206675	0	O
monocytes	27206675	0	O
,	27206675	0	O
targeting	27206675	0	O
Slfn2	27206675	0	O
is	27206675	0	O
expected	27206675	0	O
to	27206675	0	O
be	27206675	0	O
harmless	27206675	0	O
to	27206675	0	O
other	27206675	0	O
cell	27206675	0	O
types	27206675	0	O
,	27206675	0	O
and	27206675	0	O
thereby	27206675	0	O
could	27206675	0	O
be	27206675	0	O
a	27206675	0	O
promising	27206675	0	O
target	27206675	0	O
for	27206675	0	O
treating	27206675	0	O
malignancies	27206675	0	O
.	27206675	0	O
Together	27206675	0	O
our	27206675	0	O
results	27206675	0	O
demonstrate	27206675	0	O
the	27206675	0	O
potential	27206675	0	O
of	27206675	0	O
targeting	27206675	0	O
Slfn2	27206675	0	O
and	27206675	0	O
its	27206675	0	O
human	27206675	0	O
paralog	27206675	0	O
for	27206675	0	O
T	27206675	0	O
-	27206675	0	O
ALL	27206675	0	O
treatment	27206675	0	O
.	27206675	0	O

Mutational	27225717	4	B-Var
Spectrum	27225717	4	O
of	27225717	4	O
the	27225717	4	O
MEFV	27225717	4	B-Gene
Gene	27225717	4	O
in	27225717	4	O
AA	27225717	4	O
Amyloidosis	27225717	4	O
Associated	27225717	4	B-Reg
With	27225717	4	I-Reg
Familial	27225717	4	B-Disease
Mediterranean	27225717	4	I-Disease
Fever	27225717	4	I-Disease
.	27225717	4	O
INTRODUCTION	27225717	4	O
:	27225717	4	O
Familial	27225717	4	B-Disease
Mediterranean	27225717	4	I-Disease
fever	27225717	4	I-Disease
(	27225717	4	O
FMF	27225717	4	O
)	27225717	4	O
is	27225717	4	O
a	27225717	4	O
recessively	27225717	4	O
inherited	27225717	4	O
disease	27225717	4	O
which	27225717	4	O
is	27225717	4	O
characterized	27225717	4	O
by	27225717	4	O
recurrent	27225717	4	O
episodic	27225717	4	O
fever	27225717	4	O
,	27225717	4	O
abdominal	27225717	4	O
pain	27225717	4	O
,	27225717	4	O
and	27225717	4	O
polyserositis	27225717	4	O
.	27225717	4	O
It	27225717	4	O
is	27225717	4	O
caused	27225717	4	B-Reg
by	27225717	4	I-Reg
mutations	27225717	4	B-Var
in	27225717	4	O
the	27225717	4	O
MEFV	27225717	4	B-Gene
gene	27225717	4	O
,	27225717	4	O
encoding	27225717	4	O
the	27225717	4	O
pyrin	27225717	4	O
protein	27225717	4	O
.	27225717	4	O
The	27225717	4	O
most	27225717	4	O
important	27225717	4	O
complication	27225717	4	O
of	27225717	4	O
FMF	27225717	4	O
is	27225717	4	O
secondary	27225717	4	O
(	27225717	4	O
AA	27225717	4	O
)	27225717	4	O
amyloidosis	27225717	4	O
that	27225717	4	O
leads	27225717	4	O
to	27225717	4	O
kidney	27225717	4	O
failure	27225717	4	O
.	27225717	4	O
This	27225717	4	O
study	27225717	4	O
aimed	27225717	4	O
to	27225717	4	O
identify	27225717	4	O
the	27225717	4	O
frequency	27225717	4	O
and	27225717	4	O
distribution	27225717	4	O
of	27225717	4	O
MEFV	27225717	4	O
mutations	27225717	4	O
in	27225717	4	O
Turkish	27225717	4	O
patients	27225717	4	O
with	27225717	4	O
FMF	27225717	4	O
-	27225717	4	O
associated	27225717	4	O
AA	27225717	4	O
amyloidosis	27225717	4	O
.	27225717	4	O
MATERIALS	27225717	4	O
AND	27225717	4	O
METHODS	27225717	4	O
:	27225717	4	O
A	27225717	4	O
total	27225717	4	O
of	27225717	4	O
57	27225717	4	O
patients	27225717	4	O
with	27225717	4	O
FMF	27225717	4	O
-	27225717	4	O
associated	27225717	4	O
AA	27225717	4	O
amyloidosis	27225717	4	O
and	27225717	4	O
60	27225717	4	O
healthy	27225717	4	O
controls	27225717	4	O
were	27225717	4	O
included	27225717	4	O
in	27225717	4	O
this	27225717	4	O
study	27225717	4	O
.	27225717	4	O
We	27225717	4	O
analyzed	27225717	4	O
the	27225717	4	O
MEFV	27225717	4	O
gene	27225717	4	O
for	27225717	4	O
E148Q	27225717	4	O
,	27225717	4	O
M694V	27225717	4	O
,	27225717	4	O
M680I	27225717	4	O
,	27225717	4	O
and	27225717	4	O
V726A	27225717	4	O
mutations	27225717	4	O
and	27225717	4	O
R202Q	27225717	4	O
variant	27225717	4	O
by	27225717	4	O
polymerase	27225717	4	O
chain	27225717	4	O
reaction	27225717	4	O
and	27225717	4	O
restriction	27225717	4	O
fragment	27225717	4	O
length	27225717	4	O
polymorphism	27225717	4	O
methods	27225717	4	O
.	27225717	4	O
Results	27225717	4	O
.	27225717	4	O
The	27225717	4	O
male	27225717	4	O
-	27225717	4	O
female	27225717	4	O
ratio	27225717	4	O
was	27225717	4	O
0.72	27225717	4	O
.	27225717	4	O
The	27225717	4	O
mean	27225717	4	O
age	27225717	4	O
of	27225717	4	O
the	27225717	4	O
patients	27225717	4	O
was	27225717	4	O
29.8	27225717	4	O
12.8	27225717	4	O
years	27225717	4	O
.	27225717	4	O
Among	27225717	4	O
the	27225717	4	O
patients	27225717	4	O
,	27225717	4	O
the	27225717	4	O
rate	27225717	4	O
of	27225717	4	O
the	27225717	4	O
MEFV	27225717	4	O
mutations	27225717	4	O
was	27225717	4	O
found	27225717	4	O
to	27225717	4	O
be	27225717	4	O
77.2%	27225717	4	O
.	27225717	4	O
The	27225717	4	O
most	27225717	4	O
frequently	27225717	4	O
observed	27225717	4	O
genotype	27225717	4	O
was	27225717	4	O
homozygous	27225717	4	O
M694V	27225717	4	O
mutation	27225717	4	O
,	27225717	4	O
which	27225717	4	O
was	27225717	4	O
present	27225717	4	O
in	27225717	4	O
17	27225717	4	O
patients	27225717	4	O
(	27225717	4	O
29.8%	27225717	4	O
,	27225717	4	O
P	27225717	4	O
<	27225717	4	O
.001	27225717	4	O
)	27225717	4	O
,	27225717	4	O
followed	27225717	4	O
by	27225717	4	O
compound	27225717	4	O
heterozygous	27225717	4	O
M680I	27225717	4	O
/	27225717	4	O
M694V	27225717	4	O
(	27225717	4	O
14.3%	27225717	4	O
,	27225717	4	O
P	27225717	4	O
=	27225717	4	O
.01	27225717	4	O
)	27225717	4	O
.	27225717	4	O
The	27225717	4	O
R202Q	27225717	4	O
allele	27225717	4	O
frequencies	27225717	4	O
were	27225717	4	O
significantly	27225717	4	O
different	27225717	4	O
between	27225717	4	O
patients	27225717	4	O
and	27225717	4	O
control	27225717	4	O
group	27225717	4	O
(	27225717	4	O
P	27225717	4	O
=	27225717	4	O
.02	27225717	4	O
;	27225717	4	O
odds	27225717	4	O
ratio	27225717	4	O
,	27225717	4	O
0.53	27225717	4	O
;	27225717	4	O
95%	27225717	4	O
confidence	27225717	4	O
interval	27225717	4	O
,	27225717	4	O
0.30	27225717	4	O
to	27225717	4	O
0.94	27225717	4	O
)	27225717	4	O
.	27225717	4	O
CONCLUSIONS	27225717	4	O
:	27225717	4	O
In	27225717	4	O
this	27225717	4	O
study	27225717	4	O
,	27225717	4	O
mutation	27225717	4	O
analysis	27225717	4	O
of	27225717	4	O
MEFV	27225717	4	O
gene	27225717	4	O
confirmed	27225717	4	O
that	27225717	4	O
the	27225717	4	O
most	27225717	4	O
frequent	27225717	4	O
mutation	27225717	4	O
was	27225717	4	O
homozygous	27225717	4	O
M694V	27225717	4	O
genotype	27225717	4	O
.	27225717	4	O
R202Q	27225717	4	O
may	27225717	4	O
be	27225717	4	O
important	27225717	4	O
in	27225717	4	O
patients	27225717	4	O
with	27225717	4	O
FMF	27225717	4	O
-	27225717	4	O
associated	27225717	4	O
AA	27225717	4	O
amyloidosis	27225717	4	O
.	27225717	4	O
Thus	27225717	4	O
,	27225717	4	O
it	27225717	4	O
is	27225717	4	O
suggested	27225717	4	O
that	27225717	4	O
investigation	27225717	4	O
of	27225717	4	O
R202Q	27225717	4	O
should	27225717	4	O
be	27225717	4	O
considered	27225717	4	O
as	27225717	4	O
a	27225717	4	O
genetic	27225717	4	O
test	27225717	4	O
for	27225717	4	O
Turkish	27225717	4	O
FMF	27225717	4	O
patients	27225717	4	O
.	27225717	4	O

Oncogenic	27235476	0	O
Mutant	27235476	0	O
p53	27235476	0	O
Gain	27235476	0	O
of	27235476	0	O
Function	27235476	0	O
Nourishes	27235476	0	O
the	27235476	0	O
Vicious	27235476	0	O
Cycle	27235476	0	O
of	27235476	0	O
Tumor	27235476	0	O
Development	27235476	0	O
and	27235476	0	O
Cancer	27235476	0	O
Stem	27235476	0	O
-	27235476	0	O
Cell	27235476	0	O
Formation	27235476	0	O
.	27235476	0	O
More	27235476	0	O
than	27235476	0	O
half	27235476	0	O
of	27235476	0	O
human	27235476	0	O
tumors	27235476	0	O
harbor	27235476	0	O
an	27235476	0	O
inactivated	27235476	0	O
p53	27235476	0	O
tumor	27235476	0	O
-	27235476	0	O
suppressor	27235476	0	O
gene	27235476	0	O
.	27235476	0	O
It	27235476	0	O
is	27235476	0	O
well	27235476	0	O
accepted	27235476	0	O
that	27235476	0	O
mutant	27235476	0	B-Var
p53	27235476	0	B-Gene
shows	27235476	0	O
an	27235476	0	O
oncogenic	27235476	0	O
gain	27235476	0	O
-	27235476	0	O
of	27235476	0	O
-	27235476	0	O
function	27235476	0	O
(	27235476	0	O
GOF	27235476	0	O
)	27235476	0	O
activity	27235476	0	O
that	27235476	0	O
facilitates	27235476	0	B-PosReg
the	27235476	0	O
transformed	27235476	0	O
phenotype	27235476	0	O
of	27235476	0	O
cancer	27235476	0	O
cells	27235476	0	O
.	27235476	0	O
In	27235476	0	O
addition	27235476	0	O
,	27235476	0	O
a	27235476	0	O
growing	27235476	0	O
body	27235476	0	O
of	27235476	0	O
evidence	27235476	0	O
supports	27235476	0	O
the	27235476	0	O
notion	27235476	0	O
that	27235476	0	O
cancer	27235476	0	O
stem	27235476	0	O
cells	27235476	0	O
comprise	27235476	0	O
a	27235476	0	O
seminal	27235476	0	O
constituent	27235476	0	O
in	27235476	0	O
the	27235476	0	O
initiation	27235476	0	O
and	27235476	0	O
progression	27235476	0	O
of	27235476	0	O
cancer	27235476	0	O
development	27235476	0	O
.	27235476	0	O
Here	27235476	0	O
,	27235476	0	O
we	27235476	0	O
elaborate	27235476	0	O
on	27235476	0	O
the	27235476	0	O
mutant	27235476	0	B-Var
p53	27235476	0	B-Gene
oncogenic	27235476	0	O
GOF	27235476	0	B-PosReg
leading	27235476	0	O
toward	27235476	0	O
the	27235476	0	O
acquisition	27235476	0	O
of	27235476	0	O
a	27235476	0	O
transformed	27235476	0	O
phenotype	27235476	0	O
,	27235476	0	O
as	27235476	0	O
well	27235476	0	O
as	27235476	0	O
placing	27235476	0	O
mutant	27235476	0	O
p53	27235476	0	O
as	27235476	0	O
a	27235476	0	O
major	27235476	0	O
component	27235476	0	O
in	27235476	0	O
the	27235476	0	O
establishment	27235476	0	O
of	27235476	0	O
cancer	27235476	0	O
stem	27235476	0	O
cell	27235476	0	O
entity	27235476	0	O
.	27235476	0	O
Therefore	27235476	0	O
,	27235476	0	O
therapy	27235476	0	O
targeted	27235476	0	O
toward	27235476	0	O
cancer	27235476	0	O
stem	27235476	0	O
cells	27235476	0	O
harboring	27235476	0	O
mutant	27235476	0	O
p53	27235476	0	O
is	27235476	0	O
expected	27235476	0	O
to	27235476	0	O
pave	27235476	0	O
the	27235476	0	O
way	27235476	0	O
to	27235476	0	O
eradicate	27235476	0	O
tumor	27235476	0	O
growth	27235476	0	O
and	27235476	0	O
recurrence	27235476	0	O
.	27235476	0	O

N	27241276	0	O
-	27241276	0	O
glycan	27241276	0	O
containing	27241276	0	O
a	27241276	0	O
core	27241276	0	O
α1	27241276	0	O
,	27241276	0	O
3	27241276	0	O
-	27241276	0	O
fucose	27241276	0	O
residue	27241276	0	O
is	27241276	0	O
required	27241276	0	O
for	27241276	0	O
basipetal	27241276	0	O
auxin	27241276	0	O
transport	27241276	0	O
and	27241276	0	O
gravitropic	27241276	0	O
response	27241276	0	O
in	27241276	0	O
rice	27241276	0	O
(	27241276	0	O
Oryza	27241276	0	O
sativa	27241276	0	O
)	27241276	0	O
.	27241276	0	O
In	27241276	0	O
plants	27241276	0	O
,	27241276	0	O
α1	27241276	0	O
,	27241276	0	O
3	27241276	0	O
-	27241276	0	O
fucosyltransferase	27241276	0	O
(	27241276	0	O
FucT	27241276	0	O
)	27241276	0	O
catalyzes	27241276	0	O
the	27241276	0	O
transfer	27241276	0	O
of	27241276	0	O
fucose	27241276	0	O
from	27241276	0	O
GDP	27241276	0	O
-	27241276	0	O
fucose	27241276	0	O
to	27241276	0	O
asparagine	27241276	0	O
-	27241276	0	O
linked	27241276	0	O
GlcNAc	27241276	0	O
of	27241276	0	O
the	27241276	0	O
N	27241276	0	O
-	27241276	0	O
glycan	27241276	0	O
core	27241276	0	O
in	27241276	0	O
the	27241276	0	O
medial	27241276	0	O
Golgi	27241276	0	O
.	27241276	0	O
To	27241276	0	O
explore	27241276	0	O
the	27241276	0	O
physiological	27241276	0	O
significance	27241276	0	O
of	27241276	0	O
this	27241276	0	O
processing	27241276	0	O
,	27241276	0	O
we	27241276	0	O
isolated	27241276	0	O
two	27241276	0	O
Oryza	27241276	0	O
sativa	27241276	0	O
(	27241276	0	O
rice	27241276	0	O
)	27241276	0	O
mutants	27241276	0	O
(	27241276	0	O
fuct-1	27241276	0	O
and	27241276	0	O
fuct-2	27241276	0	O
)	27241276	0	O
with	27241276	0	O
loss	27241276	0	O
of	27241276	0	O
FucT	27241276	0	O
function	27241276	0	O
.	27241276	0	O
Biochemical	27241276	0	O
analyses	27241276	0	O
of	27241276	0	O
the	27241276	0	O
N	27241276	0	O
-	27241276	0	O
glycan	27241276	0	O
structure	27241276	0	O
confirmed	27241276	0	O
that	27241276	0	O
α1	27241276	0	O
,	27241276	0	O
3	27241276	0	O
-	27241276	0	O
fucose	27241276	0	O
is	27241276	0	O
missing	27241276	0	B-Var
from	27241276	0	O
the	27241276	0	O
N	27241276	0	O
-	27241276	0	O
glycans	27241276	0	O
of	27241276	0	O
allelic	27241276	0	O
fuct-1	27241276	0	B-Gene
and	27241276	0	O
fuct-2	27241276	0	B-Gene
.	27241276	0	O
Compared	27241276	0	O
with	27241276	0	O
the	27241276	0	O
wild	27241276	0	O
-	27241276	0	O
type	27241276	0	O
cv	27241276	0	O
Kitaake	27241276	0	O
,	27241276	0	O
fuct-1	27241276	0	O
displayed	27241276	0	O
a	27241276	0	O
larger	27241276	0	B-PosReg
tiller	27241276	0	O
angle	27241276	0	O
,	27241276	0	O
shorter	27241276	0	B-NegReg
internode	27241276	0	O
and	27241276	0	O
panicle	27241276	0	O
lengths	27241276	0	O
,	27241276	0	O
and	27241276	0	O
decreased	27241276	0	B-NegReg
grain	27241276	0	O
filling	27241276	0	O
as	27241276	0	O
well	27241276	0	O
as	27241276	0	O
an	27241276	0	O
increase	27241276	0	B-PosReg
in	27241276	0	O
chalky	27241276	0	O
grains	27241276	0	O
with	27241276	0	O
abnormal	27241276	0	O
shape	27241276	0	O
.	27241276	0	O
The	27241276	0	O
mutant	27241276	0	O
allele	27241276	0	O
fuct-2	27241276	0	O
gave	27241276	0	O
rise	27241276	0	O
to	27241276	0	O
similar	27241276	0	O
developmental	27241276	0	O
abnormalities	27241276	0	O
,	27241276	0	O
although	27241276	0	O
they	27241276	0	O
were	27241276	0	O
milder	27241276	0	O
than	27241276	0	O
those	27241276	0	O
of	27241276	0	O
fuct-1	27241276	0	O
.	27241276	0	O
Restoration	27241276	0	O
of	27241276	0	O
a	27241276	0	O
normal	27241276	0	O
tiller	27241276	0	O
angle	27241276	0	O
in	27241276	0	O
fuct-1	27241276	0	O
by	27241276	0	O
complementation	27241276	0	O
demonstrated	27241276	0	O
that	27241276	0	O
the	27241276	0	O
phenotype	27241276	0	O
is	27241276	0	O
caused	27241276	0	O
by	27241276	0	O
the	27241276	0	O
loss	27241276	0	O
of	27241276	0	O
FucT	27241276	0	O
function	27241276	0	O
.	27241276	0	O
Both	27241276	0	O
fuct-1	27241276	0	O
and	27241276	0	O
fuct-2	27241276	0	O
plants	27241276	0	O
exhibited	27241276	0	O
reduced	27241276	0	O
gravitropic	27241276	0	O
responses	27241276	0	O
.	27241276	0	O
Expression	27241276	0	O
of	27241276	0	O
the	27241276	0	O
genes	27241276	0	O
involved	27241276	0	O
in	27241276	0	O
tiller	27241276	0	O
and	27241276	0	O
leaf	27241276	0	O
angle	27241276	0	O
control	27241276	0	O
was	27241276	0	O
also	27241276	0	O
affected	27241276	0	O
in	27241276	0	O
the	27241276	0	O
mutants	27241276	0	O
.	27241276	0	O
We	27241276	0	O
demonstrate	27241276	0	O
that	27241276	0	O
reduced	27241276	0	O
basipetal	27241276	0	O
auxin	27241276	0	O
transport	27241276	0	O
and	27241276	0	O
low	27241276	0	O
auxin	27241276	0	O
accumulation	27241276	0	O
at	27241276	0	O
the	27241276	0	O
base	27241276	0	O
of	27241276	0	O
the	27241276	0	O
shoot	27241276	0	O
in	27241276	0	O
fuct-1	27241276	0	O
account	27241276	0	O
for	27241276	0	O
both	27241276	0	O
the	27241276	0	O
reduced	27241276	0	O
gravitropic	27241276	0	O
response	27241276	0	O
and	27241276	0	O
the	27241276	0	O
increased	27241276	0	O
tiller	27241276	0	O
angle	27241276	0	O
.	27241276	0	O

Hajdu	27241678	2	O
-	27241678	2	O
Cheney	27241678	2	O
Syndrome	27241678	2	O
,	27241678	2	O
a	27241678	2	O
Disease	27241678	2	O
Associated	27241678	2	O
with	27241678	2	O
NOTCH2	27241678	2	O
Mutations	27241678	2	O
.	27241678	2	O
Notch	27241678	2	O
plays	27241678	2	O
an	27241678	2	O
important	27241678	2	O
function	27241678	2	O
in	27241678	2	O
skeletal	27241678	2	O
homeostasis	27241678	2	O
,	27241678	2	O
osteoblastogenesis	27241678	2	O
,	27241678	2	O
and	27241678	2	O
osteoclastogenesis	27241678	2	O
.	27241678	2	O
Hajdu	27241678	2	B-Disease
-	27241678	2	I-Disease
Cheney	27241678	2	I-Disease
syndrome	27241678	2	I-Disease
(	27241678	2	O
HCS	27241678	2	O
)	27241678	2	O
is	27241678	2	O
a	27241678	2	O
rare	27241678	2	O
disease	27241678	2	O
associated	27241678	2	O
with	27241678	2	O
mutations	27241678	2	B-Var
in	27241678	2	O
NOTCH2	27241678	2	B-Gene
leading	27241678	2	B-Reg
to	27241678	2	I-Reg
the	27241678	2	O
translation	27241678	2	O
of	27241678	2	O
a	27241678	2	O
truncated	27241678	2	O
NOTCH2	27241678	2	B-Gene
stable	27241678	2	O
protein	27241678	2	O
.	27241678	2	O
As	27241678	2	O
a	27241678	2	O
consequence	27241678	2	O
,	27241678	2	O
a	27241678	2	O
gain	27241678	2	O
-	27241678	2	O
of	27241678	2	O
-	27241678	2	O
NOTCH2	27241678	2	O
function	27241678	2	O
is	27241678	2	O
manifested	27241678	2	O
.	27241678	2	O
HCS	27241678	2	O
is	27241678	2	O
inherited	27241678	2	O
as	27241678	2	O
an	27241678	2	O
autosomal	27241678	2	O
dominant	27241678	2	O
disease	27241678	2	O
although	27241678	2	O
sporadic	27241678	2	O
cases	27241678	2	O
exist	27241678	2	O
.	27241678	2	O
HCS	27241678	2	O
is	27241678	2	O
characterized	27241678	2	O
by	27241678	2	O
craniofacial	27241678	2	O
developmental	27241678	2	O
defects	27241678	2	O
,	27241678	2	O
including	27241678	2	O
platybasia	27241678	2	O
and	27241678	2	O
wormian	27241678	2	O
bones	27241678	2	O
,	27241678	2	O
osteoporosis	27241678	2	O
with	27241678	2	O
fractures	27241678	2	O
,	27241678	2	O
and	27241678	2	O
acro	27241678	2	O
-	27241678	2	O
osteolysis	27241678	2	O
.	27241678	2	O
Subjects	27241678	2	O
may	27241678	2	O
suffer	27241678	2	O
severe	27241678	2	O
neurological	27241678	2	O
complications	27241678	2	O
,	27241678	2	O
and	27241678	2	O
HCS	27241678	2	O
presents	27241678	2	O
with	27241678	2	O
cardiovascular	27241678	2	O
defects	27241678	2	O
and	27241678	2	O
polycystic	27241678	2	O
kidneys	27241678	2	O
.	27241678	2	O
An	27241678	2	O
experimental	27241678	2	O
mouse	27241678	2	O
model	27241678	2	O
harboring	27241678	2	O
a	27241678	2	O
HCSNotch2	27241678	2	O
mutation	27241678	2	O
exhibits	27241678	2	O
osteopenia	27241678	2	O
secondary	27241678	2	O
to	27241678	2	O
enhanced	27241678	2	O
bone	27241678	2	O
resorption	27241678	2	O
suggesting	27241678	2	O
this	27241678	2	O
as	27241678	2	O
a	27241678	2	O
possible	27241678	2	O
mechanism	27241678	2	O
for	27241678	2	O
the	27241678	2	O
skeletal	27241678	2	O
disease	27241678	2	O
.	27241678	2	O
If	27241678	2	O
the	27241678	2	O
same	27241678	2	O
mechanisms	27241678	2	O
were	27241678	2	O
operational	27241678	2	O
in	27241678	2	O
humans	27241678	2	O
,	27241678	2	O
anti	27241678	2	O
-	27241678	2	O
resorptive	27241678	2	O
therapy	27241678	2	O
could	27241678	2	O
correct	27241678	2	O
the	27241678	2	O
bone	27241678	2	O
loss	27241678	2	O
,	27241678	2	O
but	27241678	2	O
not	27241678	2	O
necessarily	27241678	2	O
the	27241678	2	O
acro	27241678	2	O
-	27241678	2	O
osteolysis	27241678	2	O
.	27241678	2	O
In	27241678	2	O
conclusion	27241678	2	O
,	27241678	2	O
HCS	27241678	2	O
is	27241678	2	O
a	27241678	2	O
devastating	27241678	2	O
disease	27241678	2	O
associated	27241678	2	O
with	27241678	2	O
a	27241678	2	O
gain	27241678	2	O
-	27241678	2	O
of	27241678	2	O
-	27241678	2	O
NOTCH2	27241678	2	O
function	27241678	2	O
resulting	27241678	2	O
in	27241678	2	O
diverse	27241678	2	O
clinical	27241678	2	O
manifestations	27241678	2	O
.	27241678	2	O

Phenotypes	27265460	4	O
and	27265460	4	O
Genotypes	27265460	4	O
in	27265460	4	O
Five	27265460	4	O
Children	27265460	4	O
with	27265460	4	O
Congenital	27265460	4	O
Insensitivity	27265460	4	O
to	27265460	4	O
Pain	27265460	4	O
with	27265460	4	O
Anhidrosis	27265460	4	O
.	27265460	4	O
BACKGROUND	27265460	4	O
:	27265460	4	O
Congenital	27265460	4	B-Disease
insensitivity	27265460	4	I-Disease
to	27265460	4	I-Disease
pain	27265460	4	I-Disease
with	27265460	4	I-Disease
anhidrosis	27265460	4	I-Disease
is	27265460	4	O
an	27265460	4	O
extremely	27265460	4	O
rare	27265460	4	O
hereditary	27265460	4	O
disorder	27265460	4	O
linked	27265460	4	B-Reg
to	27265460	4	I-Reg
variants	27265460	4	B-Var
in	27265460	4	O
NTRK1	27265460	4	B-Gene
.	27265460	4	O
Our	27265460	4	O
goal	27265460	4	O
was	27265460	4	O
to	27265460	4	O
characterize	27265460	4	O
the	27265460	4	O
clinical	27265460	4	O
features	27265460	4	O
and	27265460	4	O
the	27265460	4	O
genetic	27265460	4	O
basis	27265460	4	O
of	27265460	4	O
the	27265460	4	O
disorder	27265460	4	O
in	27265460	4	O
Chinese	27265460	4	O
patients	27265460	4	O
.	27265460	4	O
METHODS	27265460	4	O
:	27265460	4	O
Patients	27265460	4	O
were	27265460	4	O
enrolled	27265460	4	O
via	27265460	4	O
social	27265460	4	O
networking	27265460	4	O
.	27265460	4	O
Clinical	27265460	4	O
features	27265460	4	O
were	27265460	4	O
investigated	27265460	4	O
by	27265460	4	O
interview	27265460	4	O
,	27265460	4	O
chart	27265460	4	O
review	27265460	4	O
,	27265460	4	O
and	27265460	4	O
physical	27265460	4	O
examination	27265460	4	O
.	27265460	4	O
DNA	27265460	4	O
was	27265460	4	O
extracted	27265460	4	O
from	27265460	4	O
peripheral	27265460	4	O
blood	27265460	4	O
to	27265460	4	O
genotype	27265460	4	O
NTRK1	27265460	4	O
in	27265460	4	O
patients	27265460	4	O
and	27265460	4	O
their	27265460	4	O
parents	27265460	4	O
.	27265460	4	O
Variants	27265460	4	O
identified	27265460	4	O
were	27265460	4	O
checked	27265460	4	O
against	27265460	4	O
a	27265460	4	O
control	27265460	4	O
cohort	27265460	4	O
by	27265460	4	O
high	27265460	4	O
-	27265460	4	O
throughput	27265460	4	O
sequencing	27265460	4	O
,	27265460	4	O
and	27265460	4	O
the	27265460	4	O
effects	27265460	4	O
of	27265460	4	O
these	27265460	4	O
variants	27265460	4	O
were	27265460	4	O
assessed	27265460	4	O
in	27265460	4	O
silico	27265460	4	O
.	27265460	4	O
RESULTS	27265460	4	O
:	27265460	4	O
Clinical	27265460	4	O
features	27265460	4	O
in	27265460	4	O
five	27265460	4	O
patients	27265460	4	O
were	27265460	4	O
cataloged	27265460	4	O
,	27265460	4	O
and	27265460	4	O
six	27265460	4	O
loss	27265460	4	O
-	27265460	4	O
of	27265460	4	O
-	27265460	4	O
function	27265460	4	O
NTRK1	27265460	4	O
variants	27265460	4	O
were	27265460	4	O
identified	27265460	4	O
,	27265460	4	O
including	27265460	4	O
a	27265460	4	O
frameshift	27265460	4	O
variant	27265460	4	O
c.963	27265460	4	O
delG	27265460	4	O
,	27265460	4	O
a	27265460	4	O
nonsense	27265460	4	O
variant	27265460	4	O
c.1804	27265460	4	O
C	27265460	4	O
>	27265460	4	O
T	27265460	4	O
,	27265460	4	O
an	27265460	4	O
intron	27265460	4	O
variant	27265460	4	O
c.851	27265460	4	O
-	27265460	4	O
33	27265460	4	O
T	27265460	4	O
>	27265460	4	O
A	27265460	4	O
,	27265460	4	O
and	27265460	4	O
three	27265460	4	O
missense	27265460	4	O
variants	27265460	4	O
c.1802	27265460	4	O
T	27265460	4	O
>	27265460	4	O
G	27265460	4	O
,	27265460	4	O
c.2074	27265460	4	O
C	27265460	4	O
>	27265460	4	O
T	27265460	4	O
,	27265460	4	O
and	27265460	4	O
c.2311	27265460	4	O
C	27265460	4	O
>	27265460	4	O
T.	27265460	4	O
CONCLUSIONS	27265460	4	O
:	27265460	4	O
The	27265460	4	O
results	27265460	4	O
expand	27265460	4	O
the	27265460	4	O
spectrum	27265460	4	O
of	27265460	4	O
clinical	27265460	4	O
and	27265460	4	O
genetic	27265460	4	O
features	27265460	4	O
of	27265460	4	O
congenital	27265460	4	O
insensitivity	27265460	4	O
to	27265460	4	O
pain	27265460	4	O
with	27265460	4	O
anhidrosis	27265460	4	O
and	27265460	4	O
will	27265460	4	O
help	27265460	4	O
facilitate	27265460	4	O
analysis	27265460	4	O
of	27265460	4	O
genotype	27265460	4	O
-	27265460	4	O
phenotype	27265460	4	O
association	27265460	4	O
in	27265460	4	O
the	27265460	4	O
future	27265460	4	O
.	27265460	4	O

The	27270313	0	O
impact	27270313	0	O
of	27270313	0	O
intermittent	27270313	0	O
versus	27270313	0	O
continuous	27270313	0	O
exposure	27270313	0	O
to	27270313	0	O
EGFR	27270313	0	O
tyrosine	27270313	0	O
kinase	27270313	0	O
inhibitor	27270313	0	O
on	27270313	0	O
selection	27270313	0	O
of	27270313	0	O
EGFR	27270313	0	O
T790M	27270313	0	O
-	27270313	0	O
mutant	27270313	0	O
drug	27270313	0	O
-	27270313	0	O
resistant	27270313	0	O
clones	27270313	0	O
in	27270313	0	O
a	27270313	0	O
lung	27270313	0	O
cancer	27270313	0	O
cell	27270313	0	O
line	27270313	0	O
carrying	27270313	0	O
activating	27270313	0	O
EGFR	27270313	0	O
mutation	27270313	0	O
.	27270313	0	O
Drug	27270313	0	O
-	27270313	0	O
resistant	27270313	0	O
cell	27270313	0	O
lines	27270313	0	O
are	27270313	0	O
essential	27270313	0	O
tools	27270313	0	O
for	27270313	0	O
investigating	27270313	0	O
the	27270313	0	O
mechanisms	27270313	0	O
of	27270313	0	O
resistance	27270313	0	O
to	27270313	0	O
molecular	27270313	0	O
-	27270313	0	O
targeted	27270313	0	O
anti	27270313	0	O
-	27270313	0	O
cancer	27270313	0	O
drugs	27270313	0	O
.	27270313	0	O
However	27270313	0	O
,	27270313	0	O
little	27270313	0	O
is	27270313	0	O
known	27270313	0	O
about	27270313	0	O
how	27270313	0	O
to	27270313	0	O
establish	27270313	0	O
clinically	27270313	0	O
relevant	27270313	0	O
drug	27270313	0	O
-	27270313	0	O
resistant	27270313	0	O
cell	27270313	0	O
lines	27270313	0	O
.	27270313	0	O
Our	27270313	0	O
study	27270313	0	O
examined	27270313	0	O
the	27270313	0	O
impact	27270313	0	O
of	27270313	0	O
a	27270313	0	O
drug	27270313	0	O
-	27270313	0	O
free	27270313	0	O
period	27270313	0	O
on	27270313	0	O
the	27270313	0	O
establishment	27270313	0	O
of	27270313	0	O
a	27270313	0	O
cell	27270313	0	O
line	27270313	0	O
with	27270313	0	O
clinically	27270313	0	O
relevant	27270313	0	O
resistance	27270313	0	O
to	27270313	0	O
molecular	27270313	0	O
-	27270313	0	O
targeted	27270313	0	O
drugs	27270313	0	O
.	27270313	0	O
We	27270313	0	O
used	27270313	0	O
PC9	27270313	0	O
cells	27270313	0	O
,	27270313	0	O
a	27270313	0	O
lung	27270313	0	O
cancer	27270313	0	O
cell	27270313	0	O
line	27270313	0	O
carrying	27270313	0	O
EGFR	27270313	0	O
mutation	27270313	0	O
,	27270313	0	O
because	27270313	0	O
this	27270313	0	O
is	27270313	0	O
a	27270313	0	O
validated	27270313	0	O
target	27270313	0	O
for	27270313	0	O
EGFR	27270313	0	O
tyrosine	27270313	0	O
kinase	27270313	0	O
inhibitors	27270313	0	O
(	27270313	0	O
TKI	27270313	0	O
)	27270313	0	O
.	27270313	0	O
PC9	27270313	0	O
cells	27270313	0	O
were	27270313	0	O
intermittently	27270313	0	O
or	27270313	0	O
continuously	27270313	0	O
exposed	27270313	0	O
to	27270313	0	O
increasing	27270313	0	O
concentrations	27270313	0	O
of	27270313	0	O
gefitinib	27270313	0	O
(	27270313	0	O
0.01	27270313	0	O
μM	27270313	0	O
to	27270313	0	O
1.0	27270313	0	O
μM	27270313	0	O
)	27270313	0	O
and	27270313	0	O
the	27270313	0	O
emergence	27270313	0	O
of	27270313	0	O
the	27270313	0	O
most	27270313	0	O
common	27270313	0	O
acquired	27270313	0	O
resistance	27270313	0	O
mutation	27270313	0	O
in	27270313	0	O
EGFR	27270313	0	O
,	27270313	0	O
T790M	27270313	0	O
,	27270313	0	O
was	27270313	0	O
determined	27270313	0	O
.	27270313	0	O
T790M	27270313	0	O
was	27270313	0	O
detected	27270313	0	O
at	27270313	0	O
a	27270313	0	O
25	27270313	0	O
-	27270313	0	O
fold	27270313	0	O
lower	27270313	0	O
drug	27270313	0	O
concentration	27270313	0	O
in	27270313	0	O
cells	27270313	0	O
continuously	27270313	0	O
exposed	27270313	0	O
to	27270313	0	O
gefitinib	27270313	0	O
(	27270313	0	O
PC9	27270313	0	O
/	27270313	0	O
GRc	27270313	0	O
)	27270313	0	O
than	27270313	0	O
in	27270313	0	O
cells	27270313	0	O
intermittently	27270313	0	O
exposed	27270313	0	O
to	27270313	0	O
gefitinib	27270313	0	O
(	27270313	0	O
PC9	27270313	0	O
/	27270313	0	O
GRi	27270313	0	O
)	27270313	0	O
(	27270313	0	O
0.04	27270313	0	O
μM	27270313	0	O
vs	27270313	0	O
1.0	27270313	0	O
μM	27270313	0	O
,	27270313	0	O
respectively	27270313	0	O
)	27270313	0	O
.	27270313	0	O
The	27270313	0	O
mutation	27270313	0	B-Var
frequencies	27270313	0	O
at	27270313	0	O
those	27270313	0	O
drug	27270313	0	O
concentrations	27270313	0	O
were	27270313	0	O
19.8%	27270313	0	O
and	27270313	0	O
8.0%	27270313	0	O
in	27270313	0	O
PC9	27270313	0	O
/	27270313	0	O
GRc	27270313	0	O
and	27270313	0	O
PC9	27270313	0	O
/	27270313	0	O
GRi	27270313	0	O
cells	27270313	0	O
,	27270313	0	O
respectively	27270313	0	O
.	27270313	0	O
After	27270313	0	O
drug	27270313	0	O
-	27270313	0	O
free	27270313	0	O
culture	27270313	0	O
for	27270313	0	O
8	27270313	0	O
weeks	27270313	0	O
,	27270313	0	O
resistance	27270313	0	O
to	27270313	0	O
gefitinib	27270313	0	O
decreased	27270313	0	B-NegReg
in	27270313	0	O
the	27270313	0	O
PC9	27270313	0	O
/	27270313	0	O
GRi	27270313	0	O
cells	27270313	0	O
but	27270313	0	O
not	27270313	0	O
in	27270313	0	O
the	27270313	0	O
PC9	27270313	0	O
/	27270313	0	O
GRc	27270313	0	O
cells	27270313	0	O
.	27270313	0	O
In	27270313	0	O
the	27270313	0	O
PC9	27270313	0	O
/	27270313	0	O
GRc	27270313	0	O
cells	27270313	0	O
,	27270313	0	O
the	27270313	0	O
frequency	27270313	0	O
of	27270313	0	O
the	27270313	0	O
T790M	27270313	0	O
mutation	27270313	0	O
was	27270313	0	O
consistently	27270313	0	O
about	27270313	0	O
20%	27270313	0	O
from	27270313	0	O
0.04	27270313	0	O
μM	27270313	0	O
to	27270313	0	O
1.0	27270313	0	O
μM	27270313	0	O
of	27270313	0	O
gefitinib	27270313	0	O
.	27270313	0	O
In	27270313	0	O
the	27270313	0	O
PC9	27270313	0	O
/	27270313	0	O
GRc	27270313	0	O
cells	27270313	0	O
,	27270313	0	O
the	27270313	0	O
T790M	27270313	0	O
mutation	27270313	0	O
was	27270313	0	O
detected	27270313	0	O
in	27270313	0	O
all	27270313	0	O
single	27270313	0	O
-	27270313	0	O
cell	27270313	0	O
clones	27270313	0	O
,	27270313	0	O
at	27270313	0	O
frequencies	27270313	0	O
ranging	27270313	0	O
from	27270313	0	O
7.0%	27270313	0	O
to	27270313	0	O
37.0%	27270313	0	O
,	27270313	0	O
with	27270313	0	O
a	27270313	0	O
median	27270313	0	O
of	27270313	0	O
19.5%	27270313	0	O
(	27270313	0	O
95%	27270313	0	O
confidence	27270313	0	O
interval	27270313	0	O
,	27270313	0	O
17.3%	27270313	0	O
-	27270313	0	O
20.9%	27270313	0	O
)	27270313	0	O
.	27270313	0	O
In	27270313	0	O
conclusion	27270313	0	O
,	27270313	0	O
compared	27270313	0	O
with	27270313	0	O
intermittent	27270313	0	O
drug	27270313	0	O
exposure	27270313	0	O
,	27270313	0	O
continuous	27270313	0	O
exposure	27270313	0	O
might	27270313	0	O
select	27270313	0	O
better	27270313	0	O
minor	27270313	0	O
drug	27270313	0	O
-	27270313	0	O
resistant	27270313	0	O
clones	27270313	0	O
when	27270313	0	O
creating	27270313	0	O
cell	27270313	0	O
lines	27270313	0	O
resistant	27270313	0	O
to	27270313	0	O
molecular	27270313	0	O
-	27270313	0	O
targeted	27270313	0	O
drugs	27270313	0	O
.	27270313	0	O

Identification	27292088	4	O
of	27292088	4	O
mutations	27292088	4	B-Var
in	27292088	4	O
the	27292088	4	O
F8	27292088	4	B-Gene
and	27292088	4	O
F9	27292088	4	B-Gene
gene	27292088	4	O
in	27292088	4	O
families	27292088	4	O
with	27292088	4	B-Reg
haemophilia	27292088	4	B-Disease
using	27292088	4	O
targeted	27292088	4	O
high	27292088	4	O
-	27292088	4	O
throughput	27292088	4	O
sequencing	27292088	4	O
.	27292088	4	O
INTRODUCTION	27292088	4	O
:	27292088	4	O
At	27292088	4	O
present	27292088	4	O
,	27292088	4	O
many	27292088	4	O
methods	27292088	4	O
are	27292088	4	O
available	27292088	4	O
for	27292088	4	O
the	27292088	4	O
genetic	27292088	4	O
diagnosis	27292088	4	O
of	27292088	4	O
haemophilia	27292088	4	O
,	27292088	4	O
including	27292088	4	O
indirect	27292088	4	O
linkage	27292088	4	O
analysis	27292088	4	O
,	27292088	4	O
direct	27292088	4	O
sequencing	27292088	4	O
.	27292088	4	O
However	27292088	4	O
,	27292088	4	O
these	27292088	4	O
methods	27292088	4	O
are	27292088	4	O
time	27292088	4	O
-	27292088	4	O
consuming	27292088	4	O
,	27292088	4	O
labourious	27292088	4	O
,	27292088	4	O
and	27292088	4	O
limited	27292088	4	O
in	27292088	4	O
their	27292088	4	O
application	27292088	4	O
.	27292088	4	O
Therefore	27292088	4	O
,	27292088	4	O
the	27292088	4	O
development	27292088	4	O
of	27292088	4	O
new	27292088	4	O
,	27292088	4	O
more	27292088	4	O
effective	27292088	4	O
techniques	27292088	4	O
is	27292088	4	O
necessary	27292088	4	O
.	27292088	4	O
AIM	27292088	4	O
:	27292088	4	O
To	27292088	4	O
detect	27292088	4	O
the	27292088	4	O
F8	27292088	4	B-Gene
and	27292088	4	O
F9	27292088	4	B-Gene
gene	27292088	4	O
mutations	27292088	4	B-Var
in	27292088	4	O
patients	27292088	4	O
with	27292088	4	B-Reg
haemophilia	27292088	4	B-Disease
and	27292088	4	O
their	27292088	4	O
female	27292088	4	O
relatives	27292088	4	O
in	27292088	4	O
29	27292088	4	O
haemophilia	27292088	4	O
A	27292088	4	O
(	27292088	4	O
HA	27292088	4	O
)	27292088	4	O
and	27292088	4	O
11	27292088	4	O
haemophilia	27292088	4	O
B	27292088	4	O
(	27292088	4	O
HB	27292088	4	O
)	27292088	4	O
families	27292088	4	O
.	27292088	4	O
METHODS	27292088	4	O
:	27292088	4	O
FVIII	27292088	4	O
:	27292088	4	O
C	27292088	4	O
and	27292088	4	O
FIX	27292088	4	O
:	27292088	4	O
C	27292088	4	O
were	27292088	4	O
analyzed	27292088	4	O
using	27292088	4	O
one	27292088	4	O
-	27292088	4	O
stage	27292088	4	O
method	27292088	4	O
,	27292088	4	O
and	27292088	4	O
factor	27292088	4	O
VIII	27292088	4	O
and	27292088	4	O
factor	27292088	4	O
IX	27292088	4	O
inhibitors	27292088	4	O
were	27292088	4	O
tested	27292088	4	O
using	27292088	4	O
the	27292088	4	O
Bethesda	27292088	4	O
method	27292088	4	O
.	27292088	4	O
Intron	27292088	4	O
22	27292088	4	O
and	27292088	4	O
one	27292088	4	O
inversions	27292088	4	O
were	27292088	4	O
identified	27292088	4	O
using	27292088	4	O
long	27292088	4	O
-	27292088	4	O
distance	27292088	4	O
polymerase	27292088	4	O
chain	27292088	4	O
reaction	27292088	4	O
(	27292088	4	O
PCR	27292088	4	O
)	27292088	4	O
and	27292088	4	O
standard	27292088	4	O
PCR	27292088	4	O
.	27292088	4	O
Non	27292088	4	O
-	27292088	4	O
inversion	27292088	4	O
mutations	27292088	4	O
of	27292088	4	O
the	27292088	4	O
F8	27292088	4	O
and	27292088	4	O
F9	27292088	4	O
gene	27292088	4	O
were	27292088	4	O
identified	27292088	4	O
by	27292088	4	O
targeted	27292088	4	O
high	27292088	4	O
-	27292088	4	O
throughput	27292088	4	O
sequencing	27292088	4	O
.	27292088	4	O
All	27292088	4	O
mutations	27292088	4	O
were	27292088	4	O
verified	27292088	4	O
by	27292088	4	O
Sanger	27292088	4	O
sequencing	27292088	4	O
.	27292088	4	O
RESULTS	27292088	4	O
:	27292088	4	O
Intron	27292088	4	O
22	27292088	4	O
inversion	27292088	4	O
was	27292088	4	O
detected	27292088	4	O
in	27292088	4	O
eight	27292088	4	O
HA	27292088	4	O
families	27292088	4	O
and	27292088	4	O
intron	27292088	4	O
one	27292088	4	O
inversion	27292088	4	O
was	27292088	4	O
detected	27292088	4	O
in	27292088	4	O
one	27292088	4	O
HA	27292088	4	O
family	27292088	4	O
.	27292088	4	O
Apart	27292088	4	O
from	27292088	4	O
the	27292088	4	O
inversion	27292088	4	O
mutations	27292088	4	O
,	27292088	4	O
20	27292088	4	O
mutations	27292088	4	O
were	27292088	4	O
identified	27292088	4	O
in	27292088	4	O
HA	27292088	4	O
families	27292088	4	O
,	27292088	4	O
including	27292088	4	O
17	27292088	4	O
previously	27292088	4	O
reported	27292088	4	O
and	27292088	4	O
three	27292088	4	O
novel	27292088	4	O
mutations	27292088	4	O
:	27292088	4	O
c.5724	27292088	4	O
G	27292088	4	O
>	27292088	4	O
A	27292088	4	O
(	27292088	4	O
p.Trp1908*	27292088	4	O
)	27292088	4	O
,	27292088	4	O
c.6116	27292088	4	O
-	27292088	4	O
1	27292088	4	O
_6120delGAGTGTinsTCC	27292088	4	O
(	27292088	4	O
p.Lys2039Ilefs*13	27292088	4	O
)	27292088	4	O
,	27292088	4	O
and	27292088	4	O
c.5220	27292088	4	O
-	27292088	4	O
2	27292088	4	O
A	27292088	4	O
>	27292088	4	O
C.	27292088	4	O
We	27292088	4	O
found	27292088	4	O
a	27292088	4	O
complex	27292088	4	O
rearrangement	27292088	4	O
in	27292088	4	O
HA	27292088	4	O
:	27292088	4	O
intron	27292088	4	O
one	27292088	4	O
inversion	27292088	4	O
concomitant	27292088	4	O
with	27292088	4	O
exon	27292088	4	O
one	27292088	4	O
deletion	27292088	4	O
.	27292088	4	O
In	27292088	4	O
HB	27292088	4	O
,	27292088	4	O
eight	27292088	4	O
recurrent	27292088	4	O
mutations	27292088	4	O
were	27292088	4	O
detected	27292088	4	O
,	27292088	4	O
including	27292088	4	O
six	27292088	4	O
missense	27292088	4	O
mutations	27292088	4	O
and	27292088	4	O
two	27292088	4	O
nonsense	27292088	4	O
mutations	27292088	4	O
.	27292088	4	O
CONCLUSION	27292088	4	O
:	27292088	4	O
Targeted	27292088	4	O
high	27292088	4	O
-	27292088	4	O
throughput	27292088	4	O
sequencing	27292088	4	O
is	27292088	4	O
an	27292088	4	O
effective	27292088	4	O
technique	27292088	4	O
to	27292088	4	O
detect	27292088	4	O
the	27292088	4	O
F8	27292088	4	O
and	27292088	4	O
F9	27292088	4	O
gene	27292088	4	O
mutations	27292088	4	O
,	27292088	4	O
especially	27292088	4	O
for	27292088	4	O
the	27292088	4	O
discovery	27292088	4	O
of	27292088	4	O
novel	27292088	4	O
mutations	27292088	4	O
.	27292088	4	O
The	27292088	4	O
method	27292088	4	O
is	27292088	4	O
highly	27292088	4	O
accurate	27292088	4	O
,	27292088	4	O
time	27292088	4	O
-	27292088	4	O
saving	27292088	4	O
and	27292088	4	O
shows	27292088	4	O
great	27292088	4	O
advantage	27292088	4	O
in	27292088	4	O
uncovering	27292088	4	O
large	27292088	4	O
deletion	27292088	4	O
mutations	27292088	4	O
and	27292088	4	O
also	27292088	4	O
in	27292088	4	O
distinguishing	27292088	4	O
the	27292088	4	O
wild	27292088	4	O
-	27292088	4	O
type	27292088	4	O
genotype	27292088	4	O
and	27292088	4	O
heterozygous	27292088	4	O
large	27292088	4	O
deletions	27292088	4	O
.	27292088	4	O

Loss	27307693	4	B-NegReg
of	27307693	4	I-NegReg
function	27307693	4	I-NegReg
mutations	27307693	4	B-Var
in	27307693	4	O
RP1	27307693	4	B-Gene
are	27307693	4	O
responsible	27307693	4	O
for	27307693	4	O
retinitis	27307693	4	B-Disease
pigmentosa	27307693	4	I-Disease
in	27307693	4	O
consanguineous	27307693	4	O
familial	27307693	4	O
cases	27307693	4	O
.	27307693	4	O
PURPOSE	27307693	4	O
:	27307693	4	O
This	27307693	4	O
study	27307693	4	O
was	27307693	4	O
undertaken	27307693	4	O
to	27307693	4	O
identify	27307693	4	O
causal	27307693	4	O
mutations	27307693	4	O
responsible	27307693	4	O
for	27307693	4	O
autosomal	27307693	4	O
recessive	27307693	4	O
retinitis	27307693	4	O
pigmentosa	27307693	4	O
(	27307693	4	O
arRP	27307693	4	O
)	27307693	4	O
in	27307693	4	O
consanguineous	27307693	4	O
families	27307693	4	O
.	27307693	4	O
METHODS	27307693	4	O
:	27307693	4	O
Large	27307693	4	O
consanguineous	27307693	4	O
families	27307693	4	O
were	27307693	4	O
ascertained	27307693	4	O
from	27307693	4	O
the	27307693	4	O
Punjab	27307693	4	O
province	27307693	4	O
of	27307693	4	O
Pakistan	27307693	4	O
.	27307693	4	O
An	27307693	4	O
ophthalmic	27307693	4	O
examination	27307693	4	O
consisting	27307693	4	O
of	27307693	4	O
a	27307693	4	O
fundus	27307693	4	O
evaluation	27307693	4	O
and	27307693	4	O
electroretinography	27307693	4	O
(	27307693	4	O
ERG	27307693	4	O
)	27307693	4	O
was	27307693	4	O
completed	27307693	4	O
,	27307693	4	O
and	27307693	4	O
small	27307693	4	O
aliquots	27307693	4	O
of	27307693	4	O
blood	27307693	4	O
were	27307693	4	O
collected	27307693	4	O
from	27307693	4	O
all	27307693	4	O
participating	27307693	4	O
individuals	27307693	4	O
.	27307693	4	O
Genomic	27307693	4	O
DNA	27307693	4	O
was	27307693	4	O
extracted	27307693	4	O
from	27307693	4	O
white	27307693	4	O
blood	27307693	4	O
cells	27307693	4	O
,	27307693	4	O
and	27307693	4	O
a	27307693	4	O
genome	27307693	4	O
-	27307693	4	O
wide	27307693	4	O
linkage	27307693	4	O
or	27307693	4	O
a	27307693	4	O
locus	27307693	4	O
-	27307693	4	O
specific	27307693	4	O
exclusion	27307693	4	O
analysis	27307693	4	O
was	27307693	4	O
completed	27307693	4	O
with	27307693	4	O
polymorphic	27307693	4	O
short	27307693	4	O
tandem	27307693	4	O
repeats	27307693	4	O
(	27307693	4	O
STRs	27307693	4	O
)	27307693	4	O
.	27307693	4	O
Two	27307693	4	O
-	27307693	4	O
point	27307693	4	O
logarithm	27307693	4	O
of	27307693	4	O
odds	27307693	4	O
(	27307693	4	O
LOD	27307693	4	O
)	27307693	4	O
scores	27307693	4	O
were	27307693	4	O
calculated	27307693	4	O
,	27307693	4	O
and	27307693	4	O
all	27307693	4	O
coding	27307693	4	O
exons	27307693	4	O
and	27307693	4	O
exon	27307693	4	O
-	27307693	4	O
intron	27307693	4	O
boundaries	27307693	4	O
of	27307693	4	O
RP1	27307693	4	O
were	27307693	4	O
sequenced	27307693	4	O
to	27307693	4	O
identify	27307693	4	O
the	27307693	4	O
causal	27307693	4	O
mutation	27307693	4	O
.	27307693	4	O
RESULTS	27307693	4	O
:	27307693	4	O
The	27307693	4	O
ophthalmic	27307693	4	O
examination	27307693	4	O
showed	27307693	4	O
that	27307693	4	O
affected	27307693	4	O
individuals	27307693	4	O
in	27307693	4	O
all	27307693	4	O
families	27307693	4	O
manifest	27307693	4	O
cardinal	27307693	4	O
symptoms	27307693	4	O
of	27307693	4	O
RP	27307693	4	O
.	27307693	4	O
Genome	27307693	4	O
-	27307693	4	O
wide	27307693	4	O
scans	27307693	4	O
localized	27307693	4	O
the	27307693	4	O
disease	27307693	4	O
phenotype	27307693	4	O
to	27307693	4	O
chromosome	27307693	4	O
8	27307693	4	O
q	27307693	4	O
,	27307693	4	O
a	27307693	4	O
region	27307693	4	O
harboring	27307693	4	O
RP1	27307693	4	O
,	27307693	4	O
a	27307693	4	O
gene	27307693	4	O
previously	27307693	4	O
implicated	27307693	4	O
in	27307693	4	O
the	27307693	4	O
pathogenesis	27307693	4	O
of	27307693	4	O
RP	27307693	4	O
.	27307693	4	O
Sanger	27307693	4	O
sequencing	27307693	4	O
identified	27307693	4	O
a	27307693	4	O
homozygous	27307693	4	O
single	27307693	4	O
base	27307693	4	O
deletion	27307693	4	O
in	27307693	4	O
exon	27307693	4	O
4	27307693	4	O
:	27307693	4	O
c.3697	27307693	4	O
delT	27307693	4	O
(	27307693	4	O
p.S1233Pfs22*	27307693	4	O
)	27307693	4	O
,	27307693	4	O
a	27307693	4	O
single	27307693	4	O
base	27307693	4	O
substitution	27307693	4	O
in	27307693	4	O
intron	27307693	4	O
3	27307693	4	O
:	27307693	4	O
c.787	27307693	4	O
1	27307693	4	O
G	27307693	4	O
>	27307693	4	O
A	27307693	4	O
(	27307693	4	O
p.I263Nfs8*	27307693	4	O
)	27307693	4	O
,	27307693	4	O
a	27307693	4	O
2	27307693	4	O
bp	27307693	4	O
duplication	27307693	4	O
in	27307693	4	O
exon	27307693	4	O
2	27307693	4	O
:	27307693	4	O
c.551	27307693	4	O
_552dupTA	27307693	4	O
(	27307693	4	O
p.Q185Yfs4*	27307693	4	O
)	27307693	4	O
and	27307693	4	O
an	27307693	4	O
11	27307693	4	O
,	27307693	4	O
117	27307693	4	O
bp	27307693	4	O
deletion	27307693	4	O
that	27307693	4	O
removes	27307693	4	O
all	27307693	4	O
three	27307693	4	O
coding	27307693	4	O
exons	27307693	4	O
of	27307693	4	O
RP1	27307693	4	O
.	27307693	4	O
These	27307693	4	O
variations	27307693	4	O
segregated	27307693	4	O
with	27307693	4	O
the	27307693	4	O
disease	27307693	4	O
phenotype	27307693	4	O
within	27307693	4	O
the	27307693	4	O
respective	27307693	4	O
families	27307693	4	O
and	27307693	4	O
were	27307693	4	O
not	27307693	4	O
present	27307693	4	O
in	27307693	4	O
ethnically	27307693	4	O
matched	27307693	4	O
control	27307693	4	O
samples	27307693	4	O
.	27307693	4	O
CONCLUSIONS	27307693	4	O
:	27307693	4	O
These	27307693	4	O
results	27307693	4	O
strongly	27307693	4	O
suggest	27307693	4	O
that	27307693	4	O
these	27307693	4	O
mutations	27307693	4	O
in	27307693	4	O
RP1	27307693	4	O
are	27307693	4	O
responsible	27307693	4	O
for	27307693	4	O
the	27307693	4	O
retinal	27307693	4	O
phenotype	27307693	4	O
in	27307693	4	O
affected	27307693	4	O
individuals	27307693	4	O
of	27307693	4	O
all	27307693	4	O
four	27307693	4	O
consanguineous	27307693	4	O
families	27307693	4	O
.	27307693	4	O

Ectrodactyly	27323706	1	B-Disease
and	27323706	1	I-Disease
Lethal	27323706	1	I-Disease
Pulmonary	27323706	1	I-Disease
Acinar	27323706	1	I-Disease
Dysplasia	27323706	1	I-Disease
Associated	27323706	1	B-Reg
with	27323706	1	O
Homozygous	27323706	1	O
FGFR2	27323706	1	B-Gene
Mutations	27323706	1	B-Var
Identified	27323706	1	O
by	27323706	1	O
Exome	27323706	1	O
Sequencing	27323706	1	O
.	27323706	1	O
Ectrodactyly	27323706	1	O
/	27323706	1	O
split	27323706	1	O
hand	27323706	1	O
-	27323706	1	O
foot	27323706	1	O
malformation	27323706	1	O
is	27323706	1	O
genetically	27323706	1	O
heterogeneous	27323706	1	O
with	27323706	1	O
more	27323706	1	O
than	27323706	1	O
100	27323706	1	O
syndromic	27323706	1	O
associations	27323706	1	O
.	27323706	1	O
Acinar	27323706	1	O
dysplasia	27323706	1	O
is	27323706	1	O
a	27323706	1	O
rare	27323706	1	O
congenital	27323706	1	O
lung	27323706	1	O
lesion	27323706	1	O
of	27323706	1	O
unknown	27323706	1	O
etiology	27323706	1	O
,	27323706	1	O
which	27323706	1	O
is	27323706	1	O
frequently	27323706	1	O
lethal	27323706	1	O
postnatally	27323706	1	O
.	27323706	1	O
To	27323706	1	O
date	27323706	1	O
,	27323706	1	O
there	27323706	1	O
have	27323706	1	O
been	27323706	1	O
no	27323706	1	O
reports	27323706	1	O
of	27323706	1	O
combinations	27323706	1	O
of	27323706	1	O
these	27323706	1	O
two	27323706	1	O
phenotypes	27323706	1	O
.	27323706	1	O
Here	27323706	1	O
,	27323706	1	O
we	27323706	1	O
present	27323706	1	O
an	27323706	1	O
infant	27323706	1	O
from	27323706	1	O
a	27323706	1	O
consanguineous	27323706	1	O
union	27323706	1	O
with	27323706	1	O
both	27323706	1	O
ectrodactyly	27323706	1	O
and	27323706	1	O
autopsy	27323706	1	O
confirmed	27323706	1	O
acinar	27323706	1	O
dysplasia	27323706	1	O
.	27323706	1	O
SNP	27323706	1	O
array	27323706	1	O
and	27323706	1	O
whole	27323706	1	O
-	27323706	1	O
exome	27323706	1	O
sequencing	27323706	1	O
analyses	27323706	1	O
of	27323706	1	O
the	27323706	1	O
affected	27323706	1	O
infant	27323706	1	O
identified	27323706	1	O
a	27323706	1	O
novel	27323706	1	O
homozygous	27323706	1	O
Fibroblast	27323706	1	O
Growth	27323706	1	O
Factor	27323706	1	O
Receptor	27323706	1	O
2	27323706	1	O
(	27323706	1	O
FGFR2	27323706	1	O
)	27323706	1	O
missense	27323706	1	O
mutation	27323706	1	O
(	27323706	1	O
p.R255Q	27323706	1	O
)	27323706	1	O
in	27323706	1	O
the	27323706	1	O
IgIII	27323706	1	O
domain	27323706	1	O
(	27323706	1	O
D3	27323706	1	O
)	27323706	1	O
.	27323706	1	O
Expression	27323706	1	O
studies	27323706	1	O
of	27323706	1	O
Fgfr2	27323706	1	O
in	27323706	1	O
development	27323706	1	O
show	27323706	1	O
localization	27323706	1	O
to	27323706	1	O
the	27323706	1	O
affected	27323706	1	O
limbs	27323706	1	O
and	27323706	1	O
organs	27323706	1	O
.	27323706	1	O
Molecular	27323706	1	O
modeling	27323706	1	O
and	27323706	1	O
genetic	27323706	1	O
and	27323706	1	O
functional	27323706	1	O
assays	27323706	1	O
support	27323706	1	O
that	27323706	1	O
this	27323706	1	O
mutation	27323706	1	O
is	27323706	1	O
at	27323706	1	O
least	27323706	1	O
a	27323706	1	O
partial	27323706	1	O
loss	27323706	1	B-NegReg
-	27323706	1	I-NegReg
of	27323706	1	I-NegReg
-	27323706	1	I-NegReg
function	27323706	1	I-NegReg
mutation	27323706	1	B-Var
,	27323706	1	O
and	27323706	1	O
contributes	27323706	1	O
to	27323706	1	O
ectrodactyly	27323706	1	B-Disease
and	27323706	1	I-Disease
acinar	27323706	1	I-Disease
dysplasia	27323706	1	I-Disease
only	27323706	1	O
in	27323706	1	O
homozygosity	27323706	1	O
,	27323706	1	O
unlike	27323706	1	O
previously	27323706	1	O
reported	27323706	1	O
heterozygous	27323706	1	O
activating	27323706	1	O
FGFR2	27323706	1	B-Gene
mutations	27323706	1	B-Var
that	27323706	1	O
cause	27323706	1	B-Reg
Crouzon	27323706	1	B-Disease
,	27323706	1	O
Apert	27323706	1	B-Disease
,	27323706	1	O
and	27323706	1	O
Pfeiffer	27323706	1	B-Disease
syndromes	27323706	1	I-Disease
.	27323706	1	O
This	27323706	1	O
is	27323706	1	O
the	27323706	1	O
first	27323706	1	O
report	27323706	1	O
of	27323706	1	O
mutations	27323706	1	O
in	27323706	1	O
a	27323706	1	O
human	27323706	1	O
disease	27323706	1	O
with	27323706	1	O
ectrodactyly	27323706	1	O
with	27323706	1	O
pulmonary	27323706	1	O
acinar	27323706	1	O
dysplasia	27323706	1	O
and	27323706	1	O
,	27323706	1	O
as	27323706	1	O
such	27323706	1	O
,	27323706	1	O
homozygous	27323706	1	O
loss	27323706	1	O
-	27323706	1	O
of	27323706	1	O
-	27323706	1	O
function	27323706	1	O
FGFR2	27323706	1	O
mutations	27323706	1	O
represent	27323706	1	O
a	27323706	1	O
unique	27323706	1	O
syndrome	27323706	1	O
.	27323706	1	O

X	27376611	1	B-Disease
-	27376611	1	I-Disease
linked	27376611	1	I-Disease
Congenital	27376611	1	I-Disease
Adrenal	27376611	1	I-Disease
Hypoplasia	27376611	1	I-Disease
with	27376611	1	B-Reg
a	27376611	1	O
Novel	27376611	1	O
NR0B1	27376611	1	B-Gene
/	27376611	1	I-Gene
DAX	27376611	1	I-Gene
Gene	27376611	1	O
Mutation	27376611	1	B-Var
.	27376611	1	O
BACKGROUND	27376611	1	O
:	27376611	1	O
The	27376611	1	O
etiology	27376611	1	O
of	27376611	1	O
primary	27376611	1	O
adrenal	27376611	1	O
insufficiency	27376611	1	O
has	27376611	1	O
implications	27376611	1	O
for	27376611	1	O
further	27376611	1	O
management	27376611	1	O
of	27376611	1	O
the	27376611	1	O
condition	27376611	1	O
.	27376611	1	O
CASE	27376611	1	O
CHARACTERISTICS	27376611	1	O
:	27376611	1	O
A	27376611	1	O
5	27376611	1	O
-	27376611	1	O
year	27376611	1	O
-	27376611	1	O
old	27376611	1	O
boy	27376611	1	O
presented	27376611	1	O
in	27376611	1	O
adrenal	27376611	1	O
crisis	27376611	1	O
with	27376611	1	O
glucocorticoid	27376611	1	O
and	27376611	1	O
mineralocorticoid	27376611	1	O
deficiency	27376611	1	O
.	27376611	1	O
OBSERVATION	27376611	1	O
:	27376611	1	O
Investigations	27376611	1	O
confirmed	27376611	1	O
primary	27376611	1	O
adrenal	27376611	1	O
insufficiency	27376611	1	B-NegReg
and	27376611	1	O
ruled	27376611	1	O
out	27376611	1	O
the	27376611	1	O
common	27376611	1	O
etiologies	27376611	1	O
.	27376611	1	O
Genetic	27376611	1	O
testing	27376611	1	O
identified	27376611	1	O
a	27376611	1	O
novel	27376611	1	O
NR0B1	27376611	1	B-Gene
/	27376611	1	I-Gene
DAX	27376611	1	I-Gene
gene	27376611	1	O
mutation	27376611	1	B-Var
.	27376611	1	O
MESSAGE	27376611	1	O
:	27376611	1	O
A	27376611	1	O
genetic	27376611	1	O
diagnosis	27376611	1	O
in	27376611	1	O
children	27376611	1	O
with	27376611	1	O
primary	27376611	1	O
adrenal	27376611	1	O
insufficiency	27376611	1	O
is	27376611	1	O
useful	27376611	1	O
to	27376611	1	O
provide	27376611	1	O
genetic	27376611	1	O
counselling	27376611	1	O
.	27376611	1	O

Severe	27379765	2	O
Early	27379765	2	B-Disease
-	27379765	2	I-Disease
Onset	27379765	2	I-Disease
Combined	27379765	2	I-Disease
Immunodeficiency	27379765	2	I-Disease
due	27379765	2	O
to	27379765	2	O
Heterozygous	27379765	2	O
Gain	27379765	2	B-PosReg
-	27379765	2	I-PosReg
of	27379765	2	I-PosReg
-	27379765	2	I-PosReg
Function	27379765	2	I-PosReg
Mutations	27379765	2	B-Var
in	27379765	2	O
STAT1	27379765	2	B-Gene
.	27379765	2	O
PURPOSE	27379765	2	O
:	27379765	2	O
Loss	27379765	2	O
and	27379765	2	O
gain	27379765	2	O
-	27379765	2	O
of	27379765	2	O
-	27379765	2	O
function	27379765	2	O
(	27379765	2	O
GOF	27379765	2	O
)	27379765	2	O
mutations	27379765	2	O
in	27379765	2	O
human	27379765	2	O
signal	27379765	2	O
transducer	27379765	2	O
and	27379765	2	O
activator	27379765	2	O
of	27379765	2	O
transcription	27379765	2	O
1	27379765	2	O
(	27379765	2	O
STAT1	27379765	2	O
)	27379765	2	O
lead	27379765	2	O
to	27379765	2	O
distinct	27379765	2	O
phenotypes	27379765	2	O
.	27379765	2	O
Although	27379765	2	O
recurrent	27379765	2	O
infections	27379765	2	O
are	27379765	2	O
common	27379765	2	O
to	27379765	2	O
both	27379765	2	O
types	27379765	2	O
of	27379765	2	O
STAT1	27379765	2	O
mutations	27379765	2	O
,	27379765	2	O
GOF	27379765	2	B-PosReg
mutations	27379765	2	B-Var
are	27379765	2	O
distinguished	27379765	2	O
by	27379765	2	O
chronic	27379765	2	B-Disease
mucocutaneous	27379765	2	I-Disease
candidiasis	27379765	2	I-Disease
and	27379765	2	O
autoimmunity	27379765	2	B-Disease
.	27379765	2	O
However	27379765	2	O
,	27379765	2	O
the	27379765	2	O
clinical	27379765	2	O
spectra	27379765	2	O
of	27379765	2	O
STAT1	27379765	2	O
GOF	27379765	2	O
mutations	27379765	2	O
continue	27379765	2	O
to	27379765	2	O
expand	27379765	2	O
.	27379765	2	O
We	27379765	2	O
here	27379765	2	O
describe	27379765	2	O
two	27379765	2	O
patients	27379765	2	O
with	27379765	2	O
STAT1	27379765	2	B-Gene
GOF	27379765	2	B-PosReg
mutations	27379765	2	B-Var
presenting	27379765	2	O
early	27379765	2	O
in	27379765	2	O
life	27379765	2	O
with	27379765	2	O
combined	27379765	2	B-Disease
immunodeficiency	27379765	2	I-Disease
(	27379765	2	O
CID	27379765	2	O
)	27379765	2	O
.	27379765	2	O
METHODS	27379765	2	O
:	27379765	2	O
Clinical	27379765	2	O
data	27379765	2	O
and	27379765	2	O
laboratory	27379765	2	O
findings	27379765	2	O
including	27379765	2	O
immunophenotyping	27379765	2	O
,	27379765	2	O
level	27379765	2	O
of	27379765	2	O
interferon	27379765	2	O
(	27379765	2	O
IFN	27379765	2	O
)	27379765	2	O
-	27379765	2	O
γ	27379765	2	O
/	27379765	2	O
IL-17	27379765	2	O
(	27379765	2	O
)	27379765	2	O
T	27379765	2	O
cells	27379765	2	O
,	27379765	2	O
interferon	27379765	2	O
-	27379765	2	O
induced	27379765	2	O
STAT1	27379765	2	O
phosphorylation	27379765	2	O
,	27379765	2	O
and	27379765	2	O
JAK	27379765	2	O
inhibitor	27379765	2	O
assays	27379765	2	O
were	27379765	2	O
evaluated	27379765	2	O
.	27379765	2	O
Sequencing	27379765	2	O
of	27379765	2	O
STAT1	27379765	2	O
gene	27379765	2	O
was	27379765	2	O
performed	27379765	2	O
by	27379765	2	O
Sanger	27379765	2	O
sequencer	27379765	2	O
.	27379765	2	O
RESULTS	27379765	2	O
:	27379765	2	O
Patient	27379765	2	O
1	27379765	2	O
(	27379765	2	O
P1	27379765	2	O
)	27379765	2	O
had	27379765	2	O
persistent	27379765	2	O
oral	27379765	2	O
candidiasis	27379765	2	O
and	27379765	2	O
cytomegalovirus	27379765	2	O
(	27379765	2	O
CMV	27379765	2	O
)	27379765	2	O
infection	27379765	2	O
since	27379765	2	O
2	27379765	2	O
months	27379765	2	O
of	27379765	2	O
age	27379765	2	O
and	27379765	2	O
later	27379765	2	O
developed	27379765	2	O
cavitary	27379765	2	O
lung	27379765	2	O
lesions	27379765	2	O
due	27379765	2	O
to	27379765	2	O
Mycobacterium	27379765	2	O
tuberculosis	27379765	2	O
.	27379765	2	O
Patient	27379765	2	O
2	27379765	2	O
(	27379765	2	O
P2	27379765	2	O
)	27379765	2	O
presented	27379765	2	O
with	27379765	2	O
oral	27379765	2	O
candidiasis	27379765	2	O
and	27379765	2	O
recurrent	27379765	2	O
pneumonia	27379765	2	O
at	27379765	2	O
4	27379765	2	O
months	27379765	2	O
of	27379765	2	O
age	27379765	2	O
and	27379765	2	O
subsequently	27379765	2	O
developed	27379765	2	O
CMV	27379765	2	O
pneumonitis	27379765	2	O
.	27379765	2	O
Both	27379765	2	O
patients	27379765	2	O
suffered	27379765	2	O
heterozygous	27379765	2	O
missense	27379765	2	B-Var
mutations	27379765	2	I-Var
in	27379765	2	O
STAT1	27379765	2	B-Gene
,	27379765	2	O
leading	27379765	2	B-Reg
to	27379765	2	I-Reg
deleterious	27379765	2	O
amino	27379765	2	O
acid	27379765	2	O
substitutions	27379765	2	B-Var
in	27379765	2	O
the	27379765	2	O
DNA	27379765	2	O
binding	27379765	2	O
domain	27379765	2	O
(	27379765	2	O
P1	27379765	2	O
:	27379765	2	O
c.1154	27379765	2	B-Var
C	27379765	2	I-Var
>	27379765	2	I-Var
T	27379765	2	I-Var
;	27379765	2	I-Var
p.T385M	27379765	2	B-Var
;	27379765	2	I-Var
P2	27379765	2	O
.	27379765	2	O
c.971	27379765	2	B-Var
G	27379765	2	I-Var
>	27379765	2	I-Var
T	27379765	2	I-Var
;	27379765	2	I-Var
p.C324F	27379765	2	B-Var
)	27379765	2	I-Var
.	27379765	2	O
Circulating	27379765	2	O
CD4	27379765	2	O
(	27379765	2	O
)	27379765	2	O
T	27379765	2	O
cells	27379765	2	O
of	27379765	2	O
both	27379765	2	O
patients	27379765	2	O
exhibited	27379765	2	O
increased	27379765	2	B-PosReg
interferon	27379765	2	O
-	27379765	2	O
γ	27379765	2	O
and	27379765	2	O
decreased	27379765	2	B-NegReg
IL-17	27379765	2	O
expression	27379765	2	O
as	27379765	2	O
compared	27379765	2	O
to	27379765	2	O
controls	27379765	2	O
.	27379765	2	O
They	27379765	2	O
also	27379765	2	O
exhibited	27379765	2	O
increased	27379765	2	B-PosReg
IFN	27379765	2	O
-	27379765	2	O
β	27379765	2	O
and	27379765	2	O
-	27379765	2	O
γ	27379765	2	O
-	27379765	2	O
induced	27379765	2	O
STAT1	27379765	2	O
phosphorylation	27379765	2	O
that	27379765	2	O
was	27379765	2	O
reversed	27379765	2	O
upon	27379765	2	O
treatment	27379765	2	O
with	27379765	2	O
the	27379765	2	O
JAK	27379765	2	O
kinase	27379765	2	O
inhibitor	27379765	2	O
ruxolitinib	27379765	2	O
.	27379765	2	O
CONCLUSION	27379765	2	O
:	27379765	2	O
STAT1	27379765	2	O
GOF	27379765	2	O
mutations	27379765	2	O
may	27379765	2	O
present	27379765	2	O
early	27379765	2	O
in	27379765	2	O
life	27379765	2	O
with	27379765	2	O
CID	27379765	2	O
,	27379765	2	O
consistent	27379765	2	O
with	27379765	2	O
the	27379765	2	O
clinical	27379765	2	O
heterogeneity	27379765	2	O
of	27379765	2	O
the	27379765	2	O
disease	27379765	2	O
.	27379765	2	O
JAK	27379765	2	O
kinase	27379765	2	O
inhibitors	27379765	2	O
may	27379765	2	O
potentially	27379765	2	O
be	27379765	2	O
useful	27379765	2	O
in	27379765	2	O
some	27379765	2	O
patients	27379765	2	O
as	27379765	2	O
adjunct	27379765	2	O
therapy	27379765	2	O
pending	27379765	2	O
definitive	27379765	2	O
treatment	27379765	2	O
with	27379765	2	O
bone	27379765	2	O
marrow	27379765	2	O
transplantation	27379765	2	O
.	27379765	2	O

Directed	27432949	0	O
evolution	27432949	0	O
of	27432949	0	O
a	27432949	0	O
sphingomyelin	27432949	0	O
flippase	27432949	0	O
reveals	27432949	0	O
mechanism	27432949	0	O
of	27432949	0	O
substrate	27432949	0	O
backbone	27432949	0	O
discrimination	27432949	0	O
by	27432949	0	O
a	27432949	0	O
P4	27432949	0	O
-	27432949	0	O
ATPase	27432949	0	O
.	27432949	0	O
Phospholipid	27432949	0	O
flippases	27432949	0	O
in	27432949	0	O
the	27432949	0	O
type	27432949	0	O
IV	27432949	0	O
P	27432949	0	O
-	27432949	0	O
type	27432949	0	O
ATPase	27432949	0	O
(	27432949	0	O
P4	27432949	0	O
-	27432949	0	O
ATPases	27432949	0	O
)	27432949	0	O
family	27432949	0	O
establish	27432949	0	O
membrane	27432949	0	O
asymmetry	27432949	0	O
and	27432949	0	O
play	27432949	0	O
critical	27432949	0	O
roles	27432949	0	O
in	27432949	0	O
vesicular	27432949	0	O
transport	27432949	0	O
,	27432949	0	O
cell	27432949	0	O
polarity	27432949	0	O
,	27432949	0	O
signal	27432949	0	O
transduction	27432949	0	O
,	27432949	0	O
and	27432949	0	O
neurologic	27432949	0	O
development	27432949	0	O
.	27432949	0	O
All	27432949	0	O
characterized	27432949	0	O
P4	27432949	0	O
-	27432949	0	O
ATPases	27432949	0	O
flip	27432949	0	O
glycerophospholipids	27432949	0	O
across	27432949	0	O
the	27432949	0	O
bilayer	27432949	0	O
to	27432949	0	O
the	27432949	0	O
cytosolic	27432949	0	O
leaflet	27432949	0	O
of	27432949	0	O
the	27432949	0	O
membrane	27432949	0	O
,	27432949	0	O
but	27432949	0	O
how	27432949	0	O
these	27432949	0	O
enzymes	27432949	0	O
distinguish	27432949	0	O
glycerophospholipids	27432949	0	O
from	27432949	0	O
sphingolipids	27432949	0	O
is	27432949	0	O
not	27432949	0	O
known	27432949	0	O
.	27432949	0	O
We	27432949	0	O
used	27432949	0	O
a	27432949	0	O
directed	27432949	0	O
evolution	27432949	0	O
approach	27432949	0	O
to	27432949	0	O
examine	27432949	0	O
the	27432949	0	O
molecular	27432949	0	O
mechanisms	27432949	0	O
through	27432949	0	O
which	27432949	0	O
P4	27432949	0	O
-	27432949	0	O
ATPases	27432949	0	O
discriminate	27432949	0	O
substrate	27432949	0	O
backbone	27432949	0	O
.	27432949	0	O
A	27432949	0	O
mutagenesis	27432949	0	O
screen	27432949	0	O
in	27432949	0	O
the	27432949	0	O
yeast	27432949	0	O
Saccharomyces	27432949	0	O
cerevisiae	27432949	0	O
has	27432949	0	O
identified	27432949	0	O
several	27432949	0	O
gain	27432949	0	B-PosReg
-	27432949	0	I-PosReg
of	27432949	0	I-PosReg
-	27432949	0	I-PosReg
function	27432949	0	I-PosReg
mutations	27432949	0	B-Var
in	27432949	0	O
the	27432949	0	O
P4	27432949	0	O
-	27432949	0	O
ATPase	27432949	0	O
Dnf1	27432949	0	O
that	27432949	0	O
facilitate	27432949	0	B-PosReg
the	27432949	0	O
transport	27432949	0	O
of	27432949	0	O
a	27432949	0	O
novel	27432949	0	O
lipid	27432949	0	O
substrate	27432949	0	O
,	27432949	0	O
sphingomyelin	27432949	0	O
.	27432949	0	O
We	27432949	0	O
found	27432949	0	O
that	27432949	0	O
a	27432949	0	O
highly	27432949	0	O
conserved	27432949	0	O
asparagine	27432949	0	O
(	27432949	0	O
N220	27432949	0	O
)	27432949	0	O
in	27432949	0	O
the	27432949	0	O
first	27432949	0	O
transmembrane	27432949	0	O
segment	27432949	0	O
is	27432949	0	O
a	27432949	0	O
key	27432949	0	O
enforcer	27432949	0	O
of	27432949	0	O
glycerophospholipid	27432949	0	O
selection	27432949	0	O
,	27432949	0	O
and	27432949	0	O
specific	27432949	0	O
substitutions	27432949	0	O
at	27432949	0	O
this	27432949	0	O
site	27432949	0	O
allow	27432949	0	O
transport	27432949	0	O
of	27432949	0	O
sphingomyelin	27432949	0	O
.	27432949	0	O

Loss	27432961	1	B-NegReg
of	27432961	1	I-NegReg
function	27432961	1	I-NegReg
mutation	27432961	1	B-Var
in	27432961	1	O
LOX	27432961	1	B-Gene
causes	27432961	1	O
thoracic	27432961	1	B-Disease
aortic	27432961	1	I-Disease
aneurysm	27432961	1	I-Disease
and	27432961	1	I-Disease
dissection	27432961	1	I-Disease
in	27432961	1	O
humans	27432961	1	O
.	27432961	1	O
Thoracic	27432961	1	O
aortic	27432961	1	O
aneurysms	27432961	1	O
and	27432961	1	O
dissections	27432961	1	O
(	27432961	1	O
TAAD	27432961	1	O
)	27432961	1	O
represent	27432961	1	O
a	27432961	1	O
substantial	27432961	1	O
cause	27432961	1	O
of	27432961	1	O
morbidity	27432961	1	O
and	27432961	1	O
mortality	27432961	1	O
worldwide	27432961	1	O
.	27432961	1	O
Many	27432961	1	O
individuals	27432961	1	O
presenting	27432961	1	O
with	27432961	1	O
an	27432961	1	O
inherited	27432961	1	O
form	27432961	1	O
of	27432961	1	O
TAAD	27432961	1	O
do	27432961	1	O
not	27432961	1	O
have	27432961	1	O
causal	27432961	1	O
mutations	27432961	1	O
in	27432961	1	O
the	27432961	1	O
set	27432961	1	O
of	27432961	1	O
genes	27432961	1	O
known	27432961	1	O
to	27432961	1	O
underlie	27432961	1	O
disease	27432961	1	O
.	27432961	1	O
Using	27432961	1	O
whole	27432961	1	O
-	27432961	1	O
genome	27432961	1	O
sequencing	27432961	1	O
in	27432961	1	O
two	27432961	1	O
first	27432961	1	O
cousins	27432961	1	O
with	27432961	1	O
TAAD	27432961	1	O
,	27432961	1	O
we	27432961	1	O
identified	27432961	1	O
a	27432961	1	O
missense	27432961	1	O
mutation	27432961	1	O
in	27432961	1	O
the	27432961	1	O
lysyl	27432961	1	O
oxidase	27432961	1	O
(	27432961	1	B-Gene
LOX	27432961	1	I-Gene
)	27432961	1	I-Gene
gene	27432961	1	O
(	27432961	1	B-Var
c.893	27432961	1	I-Var
T	27432961	1	I-Var
-	27432961	1	I-Var
G	27432961	1	I-Var
encoding	27432961	1	O
p.Met298Arg	27432961	1	B-Var
)	27432961	1	I-Var
that	27432961	1	O
cosegregated	27432961	1	O
with	27432961	1	O
disease	27432961	1	O
in	27432961	1	O
the	27432961	1	O
family	27432961	1	O
.	27432961	1	O
Using	27432961	1	O
clustered	27432961	1	O
regularly	27432961	1	O
interspaced	27432961	1	O
short	27432961	1	O
palindromic	27432961	1	O
repeats	27432961	1	O
(	27432961	1	O
CRISPR	27432961	1	O
)	27432961	1	O
/	27432961	1	O
clustered	27432961	1	O
regularly	27432961	1	O
interspaced	27432961	1	O
short	27432961	1	O
palindromic	27432961	1	O
repeats	27432961	1	O
-	27432961	1	O
associated	27432961	1	O
protein-9	27432961	1	O
nuclease	27432961	1	O
(	27432961	1	O
Cas9	27432961	1	O
)	27432961	1	O
genome	27432961	1	O
engineering	27432961	1	O
tools	27432961	1	O
,	27432961	1	O
we	27432961	1	O
introduced	27432961	1	O
the	27432961	1	O
human	27432961	1	O
mutation	27432961	1	O
into	27432961	1	O
the	27432961	1	O
homologous	27432961	1	O
position	27432961	1	O
in	27432961	1	O
the	27432961	1	O
mouse	27432961	1	O
genome	27432961	1	O
,	27432961	1	O
creating	27432961	1	O
mice	27432961	1	O
that	27432961	1	O
were	27432961	1	O
heterozygous	27432961	1	O
and	27432961	1	O
homozygous	27432961	1	O
for	27432961	1	O
the	27432961	1	O
human	27432961	1	O
allele	27432961	1	O
.	27432961	1	O
Mutant	27432961	1	O
mice	27432961	1	O
that	27432961	1	O
were	27432961	1	O
heterozygous	27432961	1	O
for	27432961	1	O
the	27432961	1	O
human	27432961	1	O
allele	27432961	1	O
displayed	27432961	1	O
disorganized	27432961	1	O
ultrastructural	27432961	1	O
properties	27432961	1	O
of	27432961	1	O
the	27432961	1	O
aortic	27432961	1	O
wall	27432961	1	O
characterized	27432961	1	O
by	27432961	1	O
fragmented	27432961	1	O
elastic	27432961	1	O
lamellae	27432961	1	O
,	27432961	1	O
whereas	27432961	1	O
mice	27432961	1	O
homozygous	27432961	1	O
for	27432961	1	O
the	27432961	1	O
human	27432961	1	O
allele	27432961	1	O
died	27432961	1	O
shortly	27432961	1	O
after	27432961	1	O
parturition	27432961	1	O
from	27432961	1	O
ascending	27432961	1	O
aortic	27432961	1	O
aneurysm	27432961	1	O
and	27432961	1	O
spontaneous	27432961	1	O
hemorrhage	27432961	1	O
.	27432961	1	O
These	27432961	1	O
data	27432961	1	O
suggest	27432961	1	O
that	27432961	1	O
a	27432961	1	O
missense	27432961	1	B-Var
mutation	27432961	1	I-Var
in	27432961	1	O
LOX	27432961	1	B-Gene
is	27432961	1	O
associated	27432961	1	B-Reg
with	27432961	1	O
aortic	27432961	1	B-Disease
disease	27432961	1	I-Disease
in	27432961	1	O
humans	27432961	1	O
,	27432961	1	O
likely	27432961	1	O
through	27432961	1	O
insufficient	27432961	1	B-NegReg
cross	27432961	1	O
-	27432961	1	O
linking	27432961	1	O
of	27432961	1	O
elastin	27432961	1	O
and	27432961	1	O
collagen	27432961	1	O
in	27432961	1	O
the	27432961	1	O
aortic	27432961	1	O
wall	27432961	1	O
.	27432961	1	O
Mutation	27432961	1	B-Var
carriers	27432961	1	O
may	27432961	1	O
be	27432961	1	O
predisposed	27432961	1	B-Reg
to	27432961	1	O
vascular	27432961	1	B-Disease
diseases	27432961	1	I-Disease
because	27432961	1	O
of	27432961	1	O
weakened	27432961	1	B-NegReg
vessel	27432961	1	O
walls	27432961	1	O
under	27432961	1	O
stress	27432961	1	O
conditions	27432961	1	O
.	27432961	1	O
LOX	27432961	1	O
sequencing	27432961	1	O
for	27432961	1	O
clinical	27432961	1	O
TAAD	27432961	1	O
may	27432961	1	O
identify	27432961	1	O
additional	27432961	1	O
mutation	27432961	1	O
carriers	27432961	1	O
in	27432961	1	O
the	27432961	1	O
future	27432961	1	O
.	27432961	1	O
Additional	27432961	1	O
studies	27432961	1	O
using	27432961	1	O
our	27432961	1	O
mouse	27432961	1	O
model	27432961	1	O
of	27432961	1	O
LOX	27432961	1	O
-	27432961	1	O
associated	27432961	1	O
TAAD	27432961	1	O
have	27432961	1	O
the	27432961	1	O
potential	27432961	1	O
to	27432961	1	O
clarify	27432961	1	O
the	27432961	1	O
mechanism	27432961	1	O
of	27432961	1	O
disease	27432961	1	O
and	27432961	1	O
identify	27432961	1	O
novel	27432961	1	O
therapeutics	27432961	1	O
specific	27432961	1	O
to	27432961	1	O
this	27432961	1	O
genetic	27432961	1	O
cause	27432961	1	O
.	27432961	1	O

Fanconi	27487919	4	O
-	27487919	4	O
Bickel	27487919	4	O
syndrome	27487919	4	O
in	27487919	4	O
two	27487919	4	O
Palestinian	27487919	4	O
children	27487919	4	O
:	27487919	4	O
marked	27487919	4	O
phenotypic	27487919	4	O
variability	27487919	4	O
with	27487919	4	O
identical	27487919	4	O
mutation	27487919	4	O
.	27487919	4	O
BACKGROUND	27487919	4	O
:	27487919	4	O
Fanconi	27487919	4	B-Disease
-	27487919	4	I-Disease
Bickel	27487919	4	I-Disease
syndrome	27487919	4	I-Disease
(	27487919	4	O
FBS	27487919	4	O
,	27487919	4	O
OMIM	27487919	4	O
227810	27487919	4	O
)	27487919	4	O
is	27487919	4	O
a	27487919	4	O
rare	27487919	4	O
autosomal	27487919	4	O
recessive	27487919	4	O
disease	27487919	4	O
caused	27487919	4	B-Reg
by	27487919	4	I-Reg
a	27487919	4	O
deficiency	27487919	4	B-Var
of	27487919	4	O
glucose	27487919	4	O
transporter	27487919	4	O
2	27487919	4	O
(	27487919	4	B-Gene
GLUT2	27487919	4	I-Gene
)	27487919	4	I-Gene
,	27487919	4	O
a	27487919	4	O
member	27487919	4	O
of	27487919	4	O
the	27487919	4	O
facilitative	27487919	4	O
glucose	27487919	4	O
transporter	27487919	4	O
family	27487919	4	O
(	27487919	4	O
Santer	27487919	4	O
et	27487919	4	O
al	27487919	4	O
.	27487919	4	O
J	27487919	4	O
Inherit	27487919	4	O
Metab	27487919	4	O
Dis	27487919	4	O
21	27487919	4	O
:	27487919	4	O
191	27487919	4	O
-	27487919	4	O
194	27487919	4	O
,	27487919	4	O
1998	27487919	4	O
)	27487919	4	O
.	27487919	4	O
The	27487919	4	O
typical	27487919	4	O
clinical	27487919	4	O
picture	27487919	4	O
is	27487919	4	O
characterized	27487919	4	O
by	27487919	4	O
hepatorenal	27487919	4	O
glycogen	27487919	4	O
accumulation	27487919	4	O
resulting	27487919	4	O
in	27487919	4	O
hepato	27487919	4	O
-	27487919	4	O
and	27487919	4	O
nephromegaly	27487919	4	O
,	27487919	4	O
impaired	27487919	4	O
utilization	27487919	4	O
of	27487919	4	O
glucose	27487919	4	O
and	27487919	4	O
galactose	27487919	4	O
,	27487919	4	O
proximal	27487919	4	O
renal	27487919	4	O
tubular	27487919	4	O
dysfunction	27487919	4	O
,	27487919	4	O
rickets	27487919	4	O
and	27487919	4	O
severe	27487919	4	O
short	27487919	4	O
stature	27487919	4	O
.	27487919	4	O
CASE	27487919	4	O
PRESENTATION	27487919	4	O
:	27487919	4	O
We	27487919	4	O
report	27487919	4	O
2	27487919	4	O
Palestinian	27487919	4	O
patients	27487919	4	O
from	27487919	4	O
2	27487919	4	O
families	27487919	4	O
who	27487919	4	O
were	27487919	4	O
homozygous	27487919	4	O
for	27487919	4	O
the	27487919	4	O
mutation	27487919	4	O
p.R301X	27487919	4	O
(	27487919	4	O
C	27487919	4	O
>	27487919	4	O
T	27487919	4	O
)	27487919	4	O
in	27487919	4	O
exon	27487919	4	O
7	27487919	4	O
of	27487919	4	O
GLUT2	27487919	4	O
gene	27487919	4	O
.	27487919	4	O
Patient	27487919	4	O
1	27487919	4	O
showed	27487919	4	O
clinical	27487919	4	O
and	27487919	4	O
laboratory	27487919	4	O
improvement	27487919	4	O
with	27487919	4	O
age	27487919	4	O
characterized	27487919	4	O
by	27487919	4	O
normal	27487919	4	O
growth	27487919	4	O
and	27487919	4	O
resolution	27487919	4	O
of	27487919	4	O
rickets	27487919	4	O
.	27487919	4	O
Patient	27487919	4	O
2	27487919	4	O
had	27487919	4	O
severe	27487919	4	O
phenotype	27487919	4	O
characterized	27487919	4	O
by	27487919	4	O
progressive	27487919	4	O
weight	27487919	4	O
loss	27487919	4	O
,	27487919	4	O
persistent	27487919	4	O
metabolic	27487919	4	O
acidosis	27487919	4	O
,	27487919	4	O
marked	27487919	4	O
polyuria	27487919	4	O
and	27487919	4	O
clinical	27487919	4	O
and	27487919	4	O
laboratory	27487919	4	O
findings	27487919	4	O
of	27487919	4	O
rickets	27487919	4	O
progressing	27487919	4	O
to	27487919	4	O
death	27487919	4	O
at	27487919	4	O
age	27487919	4	O
10	27487919	4	O
months	27487919	4	O
.	27487919	4	O
CONCLUSION	27487919	4	O
:	27487919	4	O
This	27487919	4	O
report	27487919	4	O
further	27487919	4	O
expands	27487919	4	O
the	27487919	4	O
clinical	27487919	4	O
spectrum	27487919	4	O
of	27487919	4	O
FBS	27487919	4	O
even	27487919	4	O
with	27487919	4	O
identical	27487919	4	O
mutations	27487919	4	O
.	27487919	4	O
Other	27487919	4	O
yet	27487919	4	O
unknown	27487919	4	O
genetic	27487919	4	O
,	27487919	4	O
environmental	27487919	4	O
or	27487919	4	O
stochastic	27487919	4	O
factors	27487919	4	O
may	27487919	4	O
be	27487919	4	O
responsible	27487919	4	O
for	27487919	4	O
phenotypic	27487919	4	O
variability	27487919	4	O
.	27487919	4	O

Gli2	27585885	1	O
gene	27585885	1	O
-	27585885	1	O
environment	27585885	1	O
interactions	27585885	1	O
contribute	27585885	1	O
to	27585885	1	O
the	27585885	1	O
etiological	27585885	1	O
complexity	27585885	1	O
of	27585885	1	O
holoprosencephaly	27585885	1	O
:	27585885	1	O
evidence	27585885	1	O
from	27585885	1	O
a	27585885	1	O
mouse	27585885	1	O
model	27585885	1	O
.	27585885	1	O
Holoprosencephaly	27585885	1	B-Disease
(	27585885	1	O
HPE	27585885	1	O
)	27585885	1	O
is	27585885	1	O
a	27585885	1	O
common	27585885	1	O
and	27585885	1	O
severe	27585885	1	O
human	27585885	1	O
developmental	27585885	1	O
abnormality	27585885	1	O
marked	27585885	1	O
by	27585885	1	O
malformations	27585885	1	O
of	27585885	1	O
the	27585885	1	O
forebrain	27585885	1	O
and	27585885	1	O
face	27585885	1	O
.	27585885	1	O
Although	27585885	1	O
several	27585885	1	O
genetic	27585885	1	O
mutations	27585885	1	O
have	27585885	1	O
been	27585885	1	O
linked	27585885	1	O
to	27585885	1	O
HPE	27585885	1	O
,	27585885	1	O
phenotypic	27585885	1	O
outcomes	27585885	1	O
range	27585885	1	O
dramatically	27585885	1	O
,	27585885	1	O
and	27585885	1	O
most	27585885	1	O
cases	27585885	1	O
cannot	27585885	1	O
be	27585885	1	O
attributed	27585885	1	O
to	27585885	1	O
a	27585885	1	O
specific	27585885	1	O
cause	27585885	1	O
.	27585885	1	O
Gene	27585885	1	O
-	27585885	1	O
environment	27585885	1	O
interaction	27585885	1	O
has	27585885	1	O
been	27585885	1	O
invoked	27585885	1	O
as	27585885	1	O
a	27585885	1	O
premise	27585885	1	O
to	27585885	1	O
explain	27585885	1	O
the	27585885	1	O
etiological	27585885	1	O
complexity	27585885	1	O
of	27585885	1	O
HPE	27585885	1	O
,	27585885	1	O
but	27585885	1	O
identification	27585885	1	O
of	27585885	1	O
interacting	27585885	1	O
factors	27585885	1	O
has	27585885	1	O
been	27585885	1	O
extremely	27585885	1	O
limited	27585885	1	O
.	27585885	1	O
Here	27585885	1	O
,	27585885	1	O
we	27585885	1	O
demonstrate	27585885	1	O
that	27585885	1	O
mutations	27585885	1	B-Var
in	27585885	1	O
Gli2	27585885	1	B-Gene
,	27585885	1	O
which	27585885	1	O
encodes	27585885	1	O
a	27585885	1	O
Hedgehog	27585885	1	O
pathway	27585885	1	O
transcription	27585885	1	O
factor	27585885	1	O
,	27585885	1	O
can	27585885	1	O
cause	27585885	1	B-Reg
or	27585885	1	O
predispose	27585885	1	O
to	27585885	1	O
HPE	27585885	1	B-Disease
depending	27585885	1	O
upon	27585885	1	O
gene	27585885	1	O
dosage	27585885	1	O
.	27585885	1	O
On	27585885	1	O
the	27585885	1	O
C57BL	27585885	1	O
/	27585885	1	O
6	27585885	1	O
J	27585885	1	O
background	27585885	1	O
,	27585885	1	O
homozygous	27585885	1	B-Var
GLI2	27585885	1	B-Gene
loss	27585885	1	B-NegReg
of	27585885	1	I-NegReg
function	27585885	1	I-NegReg
results	27585885	1	O
in	27585885	1	O
the	27585885	1	O
characteristic	27585885	1	O
brain	27585885	1	O
and	27585885	1	O
facial	27585885	1	O
features	27585885	1	O
seen	27585885	1	O
in	27585885	1	O
severe	27585885	1	O
human	27585885	1	O
HPE	27585885	1	B-Disease
,	27585885	1	O
including	27585885	1	O
midfacial	27585885	1	O
hypoplasia	27585885	1	O
,	27585885	1	O
hypotelorism	27585885	1	O
and	27585885	1	O
medial	27585885	1	O
forebrain	27585885	1	O
deficiency	27585885	1	O
with	27585885	1	O
loss	27585885	1	O
of	27585885	1	O
ventral	27585885	1	O
neurospecification	27585885	1	O
.	27585885	1	O
Although	27585885	1	O
normally	27585885	1	O
indistinguishable	27585885	1	O
from	27585885	1	O
wild	27585885	1	O
-	27585885	1	O
type	27585885	1	O
littermates	27585885	1	O
,	27585885	1	O
we	27585885	1	O
demonstrate	27585885	1	O
that	27585885	1	O
mice	27585885	1	O
with	27585885	1	O
single	27585885	1	O
-	27585885	1	O
allele	27585885	1	O
Gli2	27585885	1	O
mutations	27585885	1	O
exhibit	27585885	1	O
increased	27585885	1	O
penetrance	27585885	1	O
and	27585885	1	O
severity	27585885	1	O
of	27585885	1	O
HPE	27585885	1	O
in	27585885	1	O
response	27585885	1	O
to	27585885	1	O
low	27585885	1	O
-	27585885	1	O
dose	27585885	1	O
teratogen	27585885	1	O
exposure	27585885	1	O
.	27585885	1	O
This	27585885	1	O
genetic	27585885	1	O
predisposition	27585885	1	O
is	27585885	1	O
associated	27585885	1	O
with	27585885	1	O
a	27585885	1	O
Gli2	27585885	1	O
dosage	27585885	1	O
-	27585885	1	O
dependent	27585885	1	O
attenuation	27585885	1	O
of	27585885	1	O
Hedgehog	27585885	1	O
ligand	27585885	1	O
responsiveness	27585885	1	O
at	27585885	1	O
the	27585885	1	O
cellular	27585885	1	O
level	27585885	1	O
.	27585885	1	O
In	27585885	1	O
addition	27585885	1	O
to	27585885	1	O
revealing	27585885	1	O
a	27585885	1	O
causative	27585885	1	O
role	27585885	1	O
for	27585885	1	O
GLI2	27585885	1	O
in	27585885	1	O
HPE	27585885	1	O
genesis	27585885	1	O
,	27585885	1	O
these	27585885	1	O
studies	27585885	1	O
demonstrate	27585885	1	O
a	27585885	1	O
mechanism	27585885	1	O
by	27585885	1	O
which	27585885	1	O
normally	27585885	1	O
silent	27585885	1	O
genetic	27585885	1	O
and	27585885	1	O
environmental	27585885	1	O
factors	27585885	1	O
can	27585885	1	O
interact	27585885	1	O
to	27585885	1	O
produce	27585885	1	O
severe	27585885	1	O
outcomes	27585885	1	O
.	27585885	1	O
Taken	27585885	1	O
together	27585885	1	O
,	27585885	1	O
these	27585885	1	O
findings	27585885	1	O
provide	27585885	1	O
a	27585885	1	O
framework	27585885	1	O
for	27585885	1	O
the	27585885	1	O
understanding	27585885	1	O
of	27585885	1	O
the	27585885	1	O
extreme	27585885	1	O
phenotypic	27585885	1	O
variability	27585885	1	O
observed	27585885	1	O
in	27585885	1	O
humans	27585885	1	O
carrying	27585885	1	O
GLI2	27585885	1	O
mutations	27585885	1	O
and	27585885	1	O
a	27585885	1	O
paradigm	27585885	1	O
for	27585885	1	O
reducing	27585885	1	O
the	27585885	1	O
incidence	27585885	1	O
of	27585885	1	O
this	27585885	1	O
morbid	27585885	1	O
birth	27585885	1	O
defect	27585885	1	O
.	27585885	1	O

Identification	27604558	4	O
of	27604558	4	O
15	27604558	4	O
novel	27604558	4	O
partial	27604558	4	O
SHOX	27604558	4	O
deletions	27604558	4	O
and	27604558	4	O
13	27604558	4	O
partial	27604558	4	O
duplications	27604558	4	O
,	27604558	4	O
and	27604558	4	O
a	27604558	4	O
review	27604558	4	O
of	27604558	4	O
the	27604558	4	O
literature	27604558	4	O
reveals	27604558	4	O
intron	27604558	4	O
3	27604558	4	O
to	27604558	4	O
be	27604558	4	O
a	27604558	4	O
hotspot	27604558	4	O
region	27604558	4	O
.	27604558	4	O
Short	27604558	4	O
stature	27604558	4	O
homeobox	27604558	4	O
gene	27604558	4	O
(	27604558	4	O
SHOX	27604558	4	O
)	27604558	4	O
is	27604558	4	O
located	27604558	4	O
in	27604558	4	O
the	27604558	4	O
pseudoautosomal	27604558	4	O
region	27604558	4	O
1	27604558	4	O
of	27604558	4	O
the	27604558	4	O
sex	27604558	4	O
chromosomes	27604558	4	O
.	27604558	4	O
It	27604558	4	O
encodes	27604558	4	O
a	27604558	4	O
transcription	27604558	4	O
factor	27604558	4	O
implicated	27604558	4	O
in	27604558	4	O
the	27604558	4	O
skeletal	27604558	4	O
growth	27604558	4	O
.	27604558	4	O
Point	27604558	4	B-Var
mutations	27604558	4	I-Var
,	27604558	4	O
deletions	27604558	4	B-Var
or	27604558	4	O
duplications	27604558	4	B-Var
of	27604558	4	O
SHOX	27604558	4	B-Gene
or	27604558	4	O
its	27604558	4	O
transcriptional	27604558	4	O
regulatory	27604558	4	O
elements	27604558	4	O
are	27604558	4	O
associated	27604558	4	B-Reg
with	27604558	4	O
two	27604558	4	O
skeletal	27604558	4	O
dysplasias	27604558	4	O
,	27604558	4	O
Léri	27604558	4	B-Disease
-	27604558	4	I-Disease
Weill	27604558	4	I-Disease
dyschondrosteosis	27604558	4	I-Disease
(	27604558	4	O
LWD	27604558	4	O
)	27604558	4	O
and	27604558	4	O
Langer	27604558	4	B-Disease
mesomelic	27604558	4	I-Disease
dysplasia	27604558	4	I-Disease
(	27604558	4	O
LMD	27604558	4	O
)	27604558	4	O
,	27604558	4	O
as	27604558	4	O
well	27604558	4	O
as	27604558	4	O
in	27604558	4	O
a	27604558	4	O
small	27604558	4	O
proportion	27604558	4	O
of	27604558	4	O
idiopathic	27604558	4	B-Disease
short	27604558	4	I-Disease
stature	27604558	4	I-Disease
(	27604558	4	O
ISS	27604558	4	O
)	27604558	4	O
individuals	27604558	4	O
.	27604558	4	O
We	27604558	4	O
have	27604558	4	O
identified	27604558	4	O
a	27604558	4	O
total	27604558	4	O
of	27604558	4	O
15	27604558	4	O
partial	27604558	4	O
SHOX	27604558	4	O
deletions	27604558	4	O
and	27604558	4	O
13	27604558	4	O
partial	27604558	4	O
SHOX	27604558	4	O
duplications	27604558	4	O
in	27604558	4	O
LWD	27604558	4	O
,	27604558	4	O
LMD	27604558	4	O
and	27604558	4	O
ISS	27604558	4	O
patients	27604558	4	O
referred	27604558	4	O
for	27604558	4	O
routine	27604558	4	O
SHOX	27604558	4	O
diagnostics	27604558	4	O
during	27604558	4	O
a	27604558	4	O
10	27604558	4	O
year	27604558	4	O
period	27604558	4	O
(	27604558	4	O
2004	27604558	4	O
-	27604558	4	O
2014	27604558	4	O
)	27604558	4	O
.	27604558	4	O
Subsequently	27604558	4	O
,	27604558	4	O
we	27604558	4	O
characterized	27604558	4	O
these	27604558	4	O
alterations	27604558	4	O
using	27604558	4	O
MLPA	27604558	4	O
(	27604558	4	O
multiplex	27604558	4	O
ligation	27604558	4	O
-	27604558	4	O
dependent	27604558	4	O
probe	27604558	4	O
amplification	27604558	4	O
assay	27604558	4	O
)	27604558	4	O
,	27604558	4	O
fine	27604558	4	O
-	27604558	4	O
tiling	27604558	4	O
array	27604558	4	O
CGH	27604558	4	O
(	27604558	4	O
comparative	27604558	4	O
genomic	27604558	4	O
hybridation	27604558	4	O
)	27604558	4	O
and	27604558	4	O
breakpoint	27604558	4	O
PCR	27604558	4	O
.	27604558	4	O
Nearly	27604558	4	O
half	27604558	4	O
of	27604558	4	O
the	27604558	4	O
alterations	27604558	4	O
have	27604558	4	O
a	27604558	4	O
distal	27604558	4	O
or	27604558	4	O
proximal	27604558	4	O
breakpoint	27604558	4	O
in	27604558	4	O
intron	27604558	4	O
3	27604558	4	O
.	27604558	4	O
Evaluation	27604558	4	O
of	27604558	4	O
our	27604558	4	O
data	27604558	4	O
and	27604558	4	O
that	27604558	4	O
in	27604558	4	O
the	27604558	4	O
literature	27604558	4	O
reveals	27604558	4	O
that	27604558	4	O
although	27604558	4	O
partial	27604558	4	O
deletions	27604558	4	O
and	27604558	4	O
duplications	27604558	4	O
only	27604558	4	O
account	27604558	4	O
for	27604558	4	O
a	27604558	4	O
small	27604558	4	O
fraction	27604558	4	O
of	27604558	4	O
SHOX	27604558	4	O
alterations	27604558	4	O
,	27604558	4	O
intron	27604558	4	O
3	27604558	4	O
appears	27604558	4	O
to	27604558	4	O
be	27604558	4	O
a	27604558	4	O
breakpoint	27604558	4	O
hotspot	27604558	4	O
,	27604558	4	O
with	27604558	4	O
alterations	27604558	4	O
arising	27604558	4	O
by	27604558	4	O
non	27604558	4	O
-	27604558	4	O
allelic	27604558	4	O
homologous	27604558	4	O
recombination	27604558	4	O
,	27604558	4	O
non	27604558	4	O
-	27604558	4	O
homologous	27604558	4	O
end	27604558	4	O
joining	27604558	4	O
or	27604558	4	O
other	27604558	4	O
complex	27604558	4	O
mechanisms	27604558	4	O
.	27604558	4	O

VHL	27617348	4	O
Germline	27617348	4	O
Mutations	27617348	4	O
in	27617348	4	O
Argentinian	27617348	4	O
Patients	27617348	4	O
with	27617348	4	O
Clinical	27617348	4	O
Diagnoses	27617348	4	O
or	27617348	4	O
Single	27617348	4	O
Typical	27617348	4	O
Manifestations	27617348	4	O
of	27617348	4	O
Type	27617348	4	O
1	27617348	4	O
von	27617348	4	O
Hippel	27617348	4	O
-	27617348	4	O
Lindau	27617348	4	O
Disease	27617348	4	O
.	27617348	4	O
AIMS	27617348	4	O
:	27617348	4	O
von	27617348	4	B-Disease
Hippel	27617348	4	I-Disease
-	27617348	4	I-Disease
Lindau	27617348	4	I-Disease
(	27617348	4	O
VHL	27617348	4	O
)	27617348	4	O
disease	27617348	4	O
is	27617348	4	O
caused	27617348	4	B-Reg
by	27617348	4	I-Reg
mutations	27617348	4	B-Var
in	27617348	4	O
the	27617348	4	O
VHL	27617348	4	B-Gene
tumor	27617348	4	O
suppressor	27617348	4	O
gene	27617348	4	O
.	27617348	4	O
As	27617348	4	O
tumors	27617348	4	O
that	27617348	4	O
develop	27617348	4	O
in	27617348	4	O
the	27617348	4	O
context	27617348	4	O
of	27617348	4	O
VHL	27617348	4	O
also	27617348	4	O
occur	27617348	4	O
in	27617348	4	O
a	27617348	4	O
sporadic	27617348	4	O
context	27617348	4	O
,	27617348	4	O
the	27617348	4	O
frequency	27617348	4	O
of	27617348	4	O
this	27617348	4	O
syndrome	27617348	4	O
may	27617348	4	O
be	27617348	4	O
underestimated	27617348	4	O
.	27617348	4	O
Our	27617348	4	O
aim	27617348	4	O
was	27617348	4	O
to	27617348	4	O
identify	27617348	4	O
VHL	27617348	4	O
gene	27617348	4	O
mutations	27617348	4	O
in	27617348	4	O
Argentinian	27617348	4	O
patients	27617348	4	O
who	27617348	4	O
fulfilled	27617348	4	O
the	27617348	4	O
clinical	27617348	4	O
criteria	27617348	4	O
for	27617348	4	O
type	27617348	4	O
1	27617348	4	O
VHL	27617348	4	O
disease	27617348	4	O
and	27617348	4	O
in	27617348	4	O
patients	27617348	4	O
with	27617348	4	O
VHL	27617348	4	O
-	27617348	4	O
associated	27617348	4	O
manifestations	27617348	4	O
that	27617348	4	O
did	27617348	4	O
not	27617348	4	O
meet	27617348	4	O
these	27617348	4	O
criteria	27617348	4	O
.	27617348	4	O
METHODS	27617348	4	O
:	27617348	4	O
We	27617348	4	O
performed	27617348	4	O
a	27617348	4	O
retrospective	27617348	4	O
cohort	27617348	4	O
study	27617348	4	O
,	27617348	4	O
including	27617348	4	O
patients	27617348	4	O
who	27617348	4	O
met	27617348	4	O
current	27617348	4	O
diagnostic	27617348	4	O
criteria	27617348	4	O
for	27617348	4	O
type	27617348	4	O
1	27617348	4	O
VHL	27617348	4	O
(	27617348	4	O
Group	27617348	4	O
1	27617348	4	O
,	27617348	4	O
n	27617348	4	O
=	27617348	4	O
19	27617348	4	O
)	27617348	4	O
and	27617348	4	O
patients	27617348	4	O
with	27617348	4	O
VHL	27617348	4	O
-	27617348	4	O
associated	27617348	4	O
manifestations	27617348	4	O
that	27617348	4	O
did	27617348	4	O
not	27617348	4	O
meet	27617348	4	O
these	27617348	4	O
criteria	27617348	4	O
(	27617348	4	O
Group	27617348	4	O
2	27617348	4	O
,	27617348	4	O
n	27617348	4	O
=	27617348	4	O
21	27617348	4	O
)	27617348	4	O
.	27617348	4	O
Genomic	27617348	4	O
DNA	27617348	4	O
was	27617348	4	O
extracted	27617348	4	O
from	27617348	4	O
peripheral	27617348	4	O
blood	27617348	4	O
leukocytes	27617348	4	O
.	27617348	4	O
Mutation	27617348	4	O
analysis	27617348	4	O
involved	27617348	4	O
DNA	27617348	4	O
sequencing	27617348	4	O
,	27617348	4	O
while	27617348	4	O
large	27617348	4	O
deletions	27617348	4	O
were	27617348	4	O
determined	27617348	4	O
by	27617348	4	O
universal	27617348	4	O
primer	27617348	4	O
quantitative	27617348	4	O
fluorescent	27617348	4	O
multiplex	27617348	4	O
polymerase	27617348	4	O
chain	27617348	4	O
reaction	27617348	4	O
(	27617348	4	O
UPQFM	27617348	4	O
-	27617348	4	O
PCR	27617348	4	O
)	27617348	4	O
and	27617348	4	O
multiplex	27617348	4	O
ligation	27617348	4	O
-	27617348	4	O
dependent	27617348	4	O
probe	27617348	4	O
amplification	27617348	4	O
(	27617348	4	O
MLPA	27617348	4	O
)	27617348	4	O
analysis	27617348	4	O
.	27617348	4	O
RESULTS	27617348	4	O
:	27617348	4	O
VHL	27617348	4	O
mutations	27617348	4	O
were	27617348	4	O
detected	27617348	4	O
in	27617348	4	O
16	27617348	4	O
/	27617348	4	O
19	27617348	4	O
(	27617348	4	O
84.2%	27617348	4	O
)	27617348	4	O
patients	27617348	4	O
in	27617348	4	O
Group	27617348	4	O
1	27617348	4	O
and	27617348	4	O
included	27617348	4	O
:	27617348	4	O
gross	27617348	4	O
deletions	27617348	4	O
(	27617348	4	O
4	27617348	4	O
/	27617348	4	O
16	27617348	4	O
)	27617348	4	O
;	27617348	4	O
nonsense	27617348	4	O
mutations	27617348	4	O
(	27617348	4	O
6	27617348	4	O
/	27617348	4	O
16	27617348	4	O
)	27617348	4	O
;	27617348	4	O
frameshift	27617348	4	O
mutations	27617348	4	O
(	27617348	4	O
4	27617348	4	O
/	27617348	4	O
16	27617348	4	O
)	27617348	4	O
;	27617348	4	O
missense	27617348	4	O
mutations	27617348	4	O
(	27617348	4	O
1	27617348	4	O
/	27617348	4	O
16	27617348	4	O
)	27617348	4	O
;	27617348	4	O
and	27617348	4	O
splicing	27617348	4	O
mutations	27617348	4	O
(	27617348	4	O
1	27617348	4	O
/	27617348	4	O
16	27617348	4	O
)	27617348	4	O
.	27617348	4	O
Three	27617348	4	O
of	27617348	4	O
these	27617348	4	O
mutations	27617348	4	O
were	27617348	4	O
novel	27617348	4	O
.	27617348	4	O
No	27617348	4	O
alterations	27617348	4	O
were	27617348	4	O
found	27617348	4	O
in	27617348	4	O
3	27617348	4	O
of	27617348	4	O
19	27617348	4	O
VHL	27617348	4	O
patients	27617348	4	O
.	27617348	4	O
In	27617348	4	O
Group	27617348	4	O
2	27617348	4	O
,	27617348	4	O
one	27617348	4	O
nonsense	27617348	4	O
VHL	27617348	4	O
mutation	27617348	4	O
was	27617348	4	O
detected	27617348	4	O
in	27617348	4	O
a	27617348	4	O
young	27617348	4	O
patient	27617348	4	O
with	27617348	4	O
a	27617348	4	O
solitary	27617348	4	O
central	27617348	4	O
nervous	27617348	4	O
system	27617348	4	O
hemangioblastoma	27617348	4	O
without	27617348	4	O
familial	27617348	4	O
history	27617348	4	O
.	27617348	4	O
A	27617348	4	O
study	27617348	4	O
of	27617348	4	O
30	27617348	4	O
first	27617348	4	O
-	27617348	4	O
degree	27617348	4	O
relatives	27617348	4	O
revealed	27617348	4	O
four	27617348	4	O
carriers	27617348	4	O
with	27617348	4	O
VHL	27617348	4	O
mutations	27617348	4	O
.	27617348	4	O
CONCLUSIONS	27617348	4	O
:	27617348	4	O
We	27617348	4	O
found	27617348	4	O
three	27617348	4	O
novel	27617348	4	O
mutations	27617348	4	O
in	27617348	4	O
the	27617348	4	O
VHL	27617348	4	O
gene	27617348	4	O
in	27617348	4	O
our	27617348	4	O
population	27617348	4	O
.	27617348	4	O
Our	27617348	4	O
results	27617348	4	O
emphasize	27617348	4	O
the	27617348	4	O
importance	27617348	4	O
of	27617348	4	O
a	27617348	4	O
complete	27617348	4	O
genetic	27617348	4	O
study	27617348	4	O
of	27617348	4	O
VHL	27617348	4	O
to	27617348	4	O
confirm	27617348	4	O
type	27617348	4	O
1	27617348	4	O
VHL	27617348	4	O
disease	27617348	4	O
,	27617348	4	O
not	27617348	4	O
only	27617348	4	O
in	27617348	4	O
patients	27617348	4	O
with	27617348	4	O
clinical	27617348	4	O
diagnostic	27617348	4	O
criteria	27617348	4	O
but	27617348	4	O
also	27617348	4	O
in	27617348	4	O
those	27617348	4	O
presenting	27617348	4	O
a	27617348	4	O
single	27617348	4	O
typical	27617348	4	O
manifestation	27617348	4	O
.	27617348	4	O

Dysferlin	27647186	4	O
Gene	27647186	4	O
Mutation	27647186	4	O
Spectrum	27647186	4	O
in	27647186	4	O
a	27647186	4	O
Large	27647186	4	O
Cohort	27647186	4	O
of	27647186	4	O
Chinese	27647186	4	O
Patients	27647186	4	O
with	27647186	4	O
Dysferlinopathy	27647186	4	O
.	27647186	4	O
BACKGROUND	27647186	4	O
:	27647186	4	O
Dysferlinopathy	27647186	4	B-Disease
is	27647186	4	O
caused	27647186	4	B-Reg
by	27647186	4	I-Reg
mutations	27647186	4	B-Var
in	27647186	4	O
the	27647186	4	O
dysferlin	27647186	4	O
(	27647186	4	B-Gene
DYSF	27647186	4	I-Gene
)	27647186	4	I-Gene
gene	27647186	4	O
.	27647186	4	O
Here	27647186	4	O
,	27647186	4	O
we	27647186	4	O
described	27647186	4	O
the	27647186	4	O
genetic	27647186	4	O
features	27647186	4	O
of	27647186	4	O
a	27647186	4	O
large	27647186	4	O
cohort	27647186	4	O
of	27647186	4	O
Chinese	27647186	4	O
patients	27647186	4	O
with	27647186	4	O
this	27647186	4	O
disease	27647186	4	O
.	27647186	4	O
METHODS	27647186	4	O
:	27647186	4	O
Eighty	27647186	4	O
-	27647186	4	O
nine	27647186	4	O
index	27647186	4	O
patients	27647186	4	O
were	27647186	4	O
included	27647186	4	O
in	27647186	4	O
the	27647186	4	O
study	27647186	4	O
.	27647186	4	O
DYSF	27647186	4	O
gene	27647186	4	O
analysis	27647186	4	O
was	27647186	4	O
performed	27647186	4	O
by	27647186	4	O
Sanger	27647186	4	O
sequencing	27647186	4	O
in	27647186	4	O
41	27647186	4	O
patients	27647186	4	O
and	27647186	4	O
targeted	27647186	4	O
next	27647186	4	O
generation	27647186	4	O
sequencing	27647186	4	O
(	27647186	4	O
NGS	27647186	4	O
)	27647186	4	O
in	27647186	4	O
48	27647186	4	O
patients	27647186	4	O
.	27647186	4	O
Multiplex	27647186	4	O
ligation	27647186	4	O
-	27647186	4	O
dependent	27647186	4	O
probe	27647186	4	O
amplification	27647186	4	O
(	27647186	4	O
MLPA	27647186	4	O
)	27647186	4	O
was	27647186	4	O
performed	27647186	4	O
to	27647186	4	O
detect	27647186	4	O
exon	27647186	4	O
duplication	27647186	4	O
/	27647186	4	O
deletion	27647186	4	O
in	27647186	4	O
patients	27647186	4	O
with	27647186	4	O
only	27647186	4	O
one	27647186	4	O
pathogenic	27647186	4	O
mutation	27647186	4	O
.	27647186	4	O
RESULTS	27647186	4	O
:	27647186	4	O
Among	27647186	4	O
the	27647186	4	O
89	27647186	4	O
index	27647186	4	O
patients	27647186	4	O
,	27647186	4	O
79	27647186	4	O
patients	27647186	4	O
were	27647186	4	O
demonstrated	27647186	4	O
to	27647186	4	O
carry	27647186	4	O
two	27647186	4	O
disease	27647186	4	O
-	27647186	4	O
causing	27647186	4	O
(	27647186	4	O
73	27647186	4	O
cases	27647186	4	O
)	27647186	4	O
or	27647186	4	O
possibly	27647186	4	O
disease	27647186	4	O
-	27647186	4	O
causing	27647186	4	O
mutations	27647186	4	O
(	27647186	4	O
6	27647186	4	O
cases	27647186	4	O
)	27647186	4	O
,	27647186	4	O
including	27647186	4	O
26	27647186	4	O
patients	27647186	4	O
with	27647186	4	O
homozygous	27647186	4	O
mutations	27647186	4	O
.	27647186	4	O
We	27647186	4	O
identified	27647186	4	O
105	27647186	4	O
different	27647186	4	O
mutations	27647186	4	O
,	27647186	4	O
including	27647186	4	O
59	27647186	4	O
novel	27647186	4	O
ones	27647186	4	O
.	27647186	4	O
Notably	27647186	4	O
,	27647186	4	O
in	27647186	4	O
13	27647186	4	O
patients	27647186	4	O
in	27647186	4	O
whom	27647186	4	O
only	27647186	4	O
one	27647186	4	O
pathogenic	27647186	4	O
mutation	27647186	4	O
was	27647186	4	O
initially	27647186	4	O
found	27647186	4	O
by	27647186	4	O
Sanger	27647186	4	O
sequencing	27647186	4	O
or	27647186	4	O
NGS	27647186	4	O
,	27647186	4	O
3	27647186	4	O
were	27647186	4	O
further	27647186	4	O
identified	27647186	4	O
to	27647186	4	O
carry	27647186	4	O
exon	27647186	4	O
deletions	27647186	4	O
by	27647186	4	O
MLPA	27647186	4	O
.	27647186	4	O
The	27647186	4	O
mutations	27647186	4	O
identified	27647186	4	O
in	27647186	4	O
this	27647186	4	O
study	27647186	4	O
appeared	27647186	4	O
to	27647186	4	O
cluster	27647186	4	O
in	27647186	4	O
the	27647186	4	O
N	27647186	4	O
-	27647186	4	O
terminal	27647186	4	O
region	27647186	4	O
.	27647186	4	O
Mutation	27647186	4	O
types	27647186	4	O
included	27647186	4	O
missense	27647186	4	O
mutations	27647186	4	O
(	27647186	4	O
30.06%	27647186	4	O
)	27647186	4	O
,	27647186	4	O
nonsense	27647186	4	O
mutations	27647186	4	O
(	27647186	4	O
17.18%	27647186	4	O
)	27647186	4	O
,	27647186	4	O
frameshift	27647186	4	O
mutations	27647186	4	O
(	27647186	4	O
30.67%	27647186	4	O
)	27647186	4	O
,	27647186	4	O
in	27647186	4	O
-	27647186	4	O
frame	27647186	4	O
deletions	27647186	4	O
(	27647186	4	O
2.45%	27647186	4	O
)	27647186	4	O
,	27647186	4	O
intronic	27647186	4	O
mutations	27647186	4	O
(	27647186	4	O
17.79%	27647186	4	O
)	27647186	4	O
,	27647186	4	O
and	27647186	4	O
exonic	27647186	4	O
rearrangement	27647186	4	O
(	27647186	4	O
1.84%	27647186	4	O
)	27647186	4	O
.	27647186	4	O
No	27647186	4	O
genotype	27647186	4	O
-	27647186	4	O
phenotype	27647186	4	O
correlation	27647186	4	O
was	27647186	4	O
identified	27647186	4	O
.	27647186	4	O
CONCLUSIONS	27647186	4	O
:	27647186	4	O
DYSF	27647186	4	O
mutations	27647186	4	O
in	27647186	4	O
Chinese	27647186	4	O
patients	27647186	4	O
clustered	27647186	4	O
in	27647186	4	O
the	27647186	4	O
N	27647186	4	O
-	27647186	4	O
terminal	27647186	4	O
region	27647186	4	O
of	27647186	4	O
the	27647186	4	O
gene	27647186	4	O
.	27647186	4	O
Exonic	27647186	4	O
rearrangements	27647186	4	O
were	27647186	4	O
found	27647186	4	O
in	27647186	4	O
23%	27647186	4	O
of	27647186	4	O
patients	27647186	4	O
with	27647186	4	O
only	27647186	4	O
one	27647186	4	O
pathogenic	27647186	4	O
mutation	27647186	4	O
identified	27647186	4	O
by	27647186	4	O
Sanger	27647186	4	O
sequencing	27647186	4	O
or	27647186	4	O
NGS	27647186	4	O
.	27647186	4	O
The	27647186	4	O
novel	27647186	4	O
mutations	27647186	4	O
found	27647186	4	O
in	27647186	4	O
this	27647186	4	O
study	27647186	4	O
greatly	27647186	4	O
expanded	27647186	4	O
the	27647186	4	O
mutational	27647186	4	O
spectrum	27647186	4	O
of	27647186	4	O
dysferlinopathy	27647186	4	O
.	27647186	4	O

Whole	27647909	0	O
-	27647909	0	O
exome	27647909	0	O
sequencing	27647909	0	O
identifies	27647909	0	O
multiple	27647909	0	O
loss	27647909	0	O
-	27647909	0	O
of	27647909	0	O
-	27647909	0	O
function	27647909	0	O
mutations	27647909	0	O
of	27647909	0	O
NF	27647909	0	O
-	27647909	0	O
κB	27647909	0	O
pathway	27647909	0	O
regulators	27647909	0	O
in	27647909	0	O
nasopharyngeal	27647909	0	O
carcinoma	27647909	0	O
.	27647909	0	O
Nasopharyngeal	27647909	0	O
carcinoma	27647909	0	O
(	27647909	0	O
NPC	27647909	0	O
)	27647909	0	O
is	27647909	0	O
an	27647909	0	O
epithelial	27647909	0	O
malignancy	27647909	0	O
with	27647909	0	O
a	27647909	0	O
unique	27647909	0	O
geographical	27647909	0	O
distribution	27647909	0	O
.	27647909	0	O
The	27647909	0	O
genomic	27647909	0	O
abnormalities	27647909	0	O
leading	27647909	0	O
to	27647909	0	O
NPC	27647909	0	O
pathogenesis	27647909	0	O
remain	27647909	0	O
unclear	27647909	0	O
.	27647909	0	O
In	27647909	0	O
total	27647909	0	O
,	27647909	0	O
135	27647909	0	O
NPC	27647909	0	O
tumors	27647909	0	O
were	27647909	0	O
examined	27647909	0	O
to	27647909	0	O
characterize	27647909	0	O
the	27647909	0	O
mutational	27647909	0	O
landscape	27647909	0	O
using	27647909	0	O
whole	27647909	0	O
-	27647909	0	O
exome	27647909	0	O
sequencing	27647909	0	O
and	27647909	0	O
targeted	27647909	0	O
resequencing	27647909	0	O
.	27647909	0	O
An	27647909	0	O
APOBEC	27647909	0	O
cytidine	27647909	0	O
deaminase	27647909	0	O
mutagenesis	27647909	0	O
signature	27647909	0	O
was	27647909	0	O
revealed	27647909	0	O
in	27647909	0	O
the	27647909	0	O
somatic	27647909	0	O
mutations	27647909	0	O
.	27647909	0	O
Noticeably	27647909	0	O
,	27647909	0	O
multiple	27647909	0	O
loss	27647909	0	O
-	27647909	0	O
of	27647909	0	O
-	27647909	0	O
function	27647909	0	O
mutations	27647909	0	O
were	27647909	0	O
identified	27647909	0	O
in	27647909	0	O
several	27647909	0	O
NF	27647909	0	O
-	27647909	0	O
κB	27647909	0	O
signaling	27647909	0	O
negative	27647909	0	O
regulators	27647909	0	O
NFKBIA	27647909	0	O
,	27647909	0	O
CYLD	27647909	0	O
,	27647909	0	O
and	27647909	0	O
TNFAIP3	27647909	0	O
Functional	27647909	0	O
studies	27647909	0	O
confirmed	27647909	0	O
that	27647909	0	O
inhibition	27647909	0	O
of	27647909	0	O
NFKBIA	27647909	0	O
had	27647909	0	O
a	27647909	0	O
significant	27647909	0	O
impact	27647909	0	O
on	27647909	0	O
NF	27647909	0	O
-	27647909	0	O
κB	27647909	0	O
activity	27647909	0	O
and	27647909	0	O
NPC	27647909	0	O
cell	27647909	0	O
growth	27647909	0	O
.	27647909	0	O
The	27647909	0	O
identified	27647909	0	O
loss	27647909	0	B-NegReg
-	27647909	0	I-NegReg
of	27647909	0	I-NegReg
-	27647909	0	I-NegReg
function	27647909	0	I-NegReg
mutations	27647909	0	B-Var
in	27647909	0	O
NFKBIA	27647909	0	B-Gene
leading	27647909	0	O
to	27647909	0	O
protein	27647909	0	O
truncation	27647909	0	O
contributed	27647909	0	O
to	27647909	0	O
the	27647909	0	O
altered	27647909	0	B-Reg
NF	27647909	0	O
-	27647909	0	O
κB	27647909	0	O
activity	27647909	0	O
,	27647909	0	O
which	27647909	0	O
is	27647909	0	O
critical	27647909	0	O
for	27647909	0	O
NPC	27647909	0	O
tumorigenesis	27647909	0	O
.	27647909	0	O
In	27647909	0	O
addition	27647909	0	O
,	27647909	0	O
somatic	27647909	0	O
mutations	27647909	0	O
were	27647909	0	O
found	27647909	0	O
in	27647909	0	O
several	27647909	0	O
cancer	27647909	0	O
-	27647909	0	O
relevant	27647909	0	O
pathways	27647909	0	O
,	27647909	0	O
including	27647909	0	O
cell	27647909	0	O
cycle	27647909	0	O
-	27647909	0	O
phase	27647909	0	O
transition	27647909	0	O
,	27647909	0	O
cell	27647909	0	O
death	27647909	0	O
,	27647909	0	O
EBV	27647909	0	O
infection	27647909	0	O
,	27647909	0	O
and	27647909	0	O
viral	27647909	0	O
carcinogenesis	27647909	0	O
.	27647909	0	O
These	27647909	0	O
data	27647909	0	O
provide	27647909	0	O
an	27647909	0	O
enhanced	27647909	0	O
road	27647909	0	O
map	27647909	0	O
for	27647909	0	O
understanding	27647909	0	O
the	27647909	0	O
molecular	27647909	0	O
basis	27647909	0	O
underlying	27647909	0	O
NPC	27647909	0	O
.	27647909	0	O

ACOX2	27647924	0	O
deficiency	27647924	0	O
:	27647924	0	O
A	27647924	0	O
disorder	27647924	0	O
of	27647924	0	O
bile	27647924	0	O
acid	27647924	0	O
synthesis	27647924	0	O
with	27647924	0	O
transaminase	27647924	0	O
elevation	27647924	0	O
,	27647924	0	O
liver	27647924	0	O
fibrosis	27647924	0	O
,	27647924	0	O
ataxia	27647924	0	O
,	27647924	0	O
and	27647924	0	O
cognitive	27647924	0	O
impairment	27647924	0	O
.	27647924	0	O
Acyl	27647924	0	O
CoA	27647924	0	O
Oxidase	27647924	0	O
2	27647924	0	O
(	27647924	0	O
ACOX2	27647924	0	O
)	27647924	0	O
encodes	27647924	0	O
branched	27647924	0	O
-	27647924	0	O
chain	27647924	0	O
acyl	27647924	0	O
-	27647924	0	O
CoA	27647924	0	O
oxidase	27647924	0	O
,	27647924	0	O
a	27647924	0	O
peroxisomal	27647924	0	O
enzyme	27647924	0	O
believed	27647924	0	O
to	27647924	0	O
be	27647924	0	O
involved	27647924	0	O
in	27647924	0	O
the	27647924	0	O
metabolism	27647924	0	O
of	27647924	0	O
branched	27647924	0	O
-	27647924	0	O
chain	27647924	0	O
fatty	27647924	0	O
acids	27647924	0	O
and	27647924	0	O
bile	27647924	0	O
acid	27647924	0	O
intermediates	27647924	0	O
.	27647924	0	O
Deficiency	27647924	0	O
of	27647924	0	O
this	27647924	0	O
enzyme	27647924	0	O
has	27647924	0	O
not	27647924	0	O
been	27647924	0	O
described	27647924	0	O
previously	27647924	0	O
.	27647924	0	O
We	27647924	0	O
report	27647924	0	O
an	27647924	0	O
8	27647924	0	O
-	27647924	0	O
y	27647924	0	O
-	27647924	0	O
old	27647924	0	O
male	27647924	0	O
with	27647924	0	O
intermittently	27647924	0	O
elevated	27647924	0	O
transaminase	27647924	0	O
levels	27647924	0	O
,	27647924	0	O
liver	27647924	0	O
fibrosis	27647924	0	O
,	27647924	0	O
mild	27647924	0	O
ataxia	27647924	0	O
,	27647924	0	O
and	27647924	0	O
cognitive	27647924	0	O
impairment	27647924	0	O
.	27647924	0	O
Exome	27647924	0	O
sequencing	27647924	0	O
revealed	27647924	0	O
a	27647924	0	O
previously	27647924	0	O
unidentified	27647924	0	O
homozygous	27647924	0	O
premature	27647924	0	O
termination	27647924	0	O
mutation	27647924	0	O
(	27647924	0	B-Var
p.Y69*	27647924	0	I-Var
)	27647924	0	I-Var
in	27647924	0	O
ACOX2	27647924	0	B-Gene
Immunohistochemistry	27647924	0	O
confirmed	27647924	0	O
the	27647924	0	O
absence	27647924	0	B-NegReg
of	27647924	0	O
ACOX2	27647924	0	B-Gene
expression	27647924	0	O
in	27647924	0	O
the	27647924	0	O
patient	27647924	0	O
'	27647924	0	O
s	27647924	0	O
liver	27647924	0	O
,	27647924	0	O
and	27647924	0	O
biochemical	27647924	0	O
analysis	27647924	0	O
showed	27647924	0	O
marked	27647924	0	O
elevation	27647924	0	B-PosReg
of	27647924	0	O
intermediate	27647924	0	O
bile	27647924	0	O
acids	27647924	0	O
upstream	27647924	0	O
of	27647924	0	O
ACOX2	27647924	0	O
.	27647924	0	O
These	27647924	0	O
findings	27647924	0	O
define	27647924	0	O
a	27647924	0	O
potentially	27647924	0	O
treatable	27647924	0	O
inborn	27647924	0	O
error	27647924	0	O
of	27647924	0	O
bile	27647924	0	O
acid	27647924	0	O
biosynthesis	27647924	0	O
caused	27647924	0	O
by	27647924	0	O
ACOX2	27647924	0	O
deficiency	27647924	0	O
.	27647924	0	O

Prevalence	27654141	0	O
and	27654141	0	O
phenotypic	27654141	0	O
characterization	27654141	0	O
of	27654141	0	O
MC4R	27654141	0	O
variants	27654141	0	O
in	27654141	0	O
a	27654141	0	O
large	27654141	0	O
pediatric	27654141	0	O
cohort	27654141	0	O
.	27654141	0	O
OBJECTIVE	27654141	0	O
:	27654141	0	O
We	27654141	0	O
aimed	27654141	0	O
to	27654141	0	O
determine	27654141	0	O
the	27654141	0	O
prevalence	27654141	0	O
of	27654141	0	O
melanocortin-4	27654141	0	O
receptor	27654141	0	O
(	27654141	0	O
MC4R	27654141	0	O
)	27654141	0	O
variants	27654141	0	O
in	27654141	0	O
a	27654141	0	O
large	27654141	0	O
German	27654141	0	O
cohort	27654141	0	O
of	27654141	0	O
children	27654141	0	O
with	27654141	0	O
obesity	27654141	0	O
in	27654141	0	O
a	27654141	0	O
pediatric	27654141	0	O
outpatient	27654141	0	O
clinic	27654141	0	O
and	27654141	0	O
to	27654141	0	O
ascertain	27654141	0	O
whether	27654141	0	O
there	27654141	0	O
is	27654141	0	O
a	27654141	0	O
specific	27654141	0	O
phenotype	27654141	0	O
associated	27654141	0	O
with	27654141	0	O
loss	27654141	0	O
-	27654141	0	O
of	27654141	0	O
-	27654141	0	O
function	27654141	0	O
variants	27654141	0	O
as	27654141	0	O
previously	27654141	0	O
reported	27654141	0	O
.	27654141	0	O
STUDY	27654141	0	O
DESIGN	27654141	0	O
:	27654141	0	O
Eight	27654141	0	O
hundred	27654141	0	O
and	27654141	0	O
ninety	27654141	0	O
-	27654141	0	O
nine	27654141	0	O
patients	27654141	0	O
from	27654141	0	O
our	27654141	0	O
pediatric	27654141	0	O
obesity	27654141	0	O
clinic	27654141	0	O
were	27654141	0	O
screened	27654141	0	O
for	27654141	0	O
MC4R	27654141	0	O
variants	27654141	0	O
by	27654141	0	O
DNA	27654141	0	O
sequencing	27654141	0	O
after	27654141	0	O
PCR	27654141	0	O
amplification	27654141	0	O
.	27654141	0	O
Retrospective	27654141	0	O
statistical	27654141	0	O
analysis	27654141	0	O
of	27654141	0	O
anthropometric	27654141	0	O
and	27654141	0	O
metabolic	27654141	0	O
characteristics	27654141	0	O
was	27654141	0	O
performed	27654141	0	O
,	27654141	0	O
comparing	27654141	0	O
patients	27654141	0	O
with	27654141	0	O
and	27654141	0	O
without	27654141	0	O
MC4R	27654141	0	O
variants	27654141	0	O
across	27654141	0	O
the	27654141	0	O
entire	27654141	0	O
cohort	27654141	0	O
(	27654141	0	O
n	27654141	0	O
=	27654141	0	O
586	27654141	0	O
)	27654141	0	O
as	27654141	0	O
well	27654141	0	O
as	27654141	0	O
in	27654141	0	O
case	27654141	0	O
-	27654141	0	O
control	27654141	0	O
analysis	27654141	0	O
using	27654141	0	O
patients	27654141	0	O
with	27654141	0	O
common	27654141	0	O
sequence	27654141	0	O
MC4R	27654141	0	O
individually	27654141	0	O
matched	27654141	0	O
for	27654141	0	O
age	27654141	0	O
,	27654141	0	O
sex	27654141	0	O
and	27654141	0	O
body	27654141	0	O
mass	27654141	0	O
index	27654141	0	O
standard	27654141	0	O
deviation	27654141	0	O
score	27654141	0	O
(	27654141	0	O
SDS	27654141	0	O
)	27654141	0	O
(	27654141	0	O
n	27654141	0	O
=	27654141	0	O
11	27654141	0	O
case	27654141	0	O
-	27654141	0	O
control	27654141	0	O
pairs	27654141	0	O
)	27654141	0	O
.	27654141	0	O
RESULTS	27654141	0	O
:	27654141	0	O
We	27654141	0	O
identified	27654141	0	O
heterozygous	27654141	0	O
variants	27654141	0	O
within	27654141	0	O
the	27654141	0	O
coding	27654141	0	O
region	27654141	0	O
of	27654141	0	O
the	27654141	0	O
MC4R	27654141	0	B-Gene
gene	27654141	0	O
in	27654141	0	O
n	27654141	0	O
=	27654141	0	O
22	27654141	0	O
(	27654141	0	O
2.45%	27654141	0	O
)	27654141	0	O
patients	27654141	0	O
.	27654141	0	O
Fourteen	27654141	0	O
(	27654141	0	O
1.56%	27654141	0	O
)	27654141	0	O
had	27654141	0	O
a	27654141	0	O
variant	27654141	0	B-Var
that	27654141	0	O
impaired	27654141	0	B-NegReg
receptor	27654141	0	O
function	27654141	0	O
.	27654141	0	O
One	27654141	0	O
new	27654141	0	O
frameshift	27654141	0	O
(	27654141	0	O
p.F152Sfs	27654141	0	O
)	27654141	0	O
,	27654141	0	O
an	27654141	0	O
yet	27654141	0	O
unpublished	27654141	0	O
nonsense	27654141	0	O
mutation	27654141	0	O
(	27654141	0	O
p.Q156X	27654141	0	O
)	27654141	0	O
and	27654141	0	O
one	27654141	0	O
nonsynonymous	27654141	0	O
variation	27654141	0	O
(	27654141	0	O
p.V65E	27654141	0	O
)	27654141	0	O
described	27654141	0	O
in	27654141	0	O
the	27654141	0	O
Mouse	27654141	0	O
Genome	27654141	0	O
Database	27654141	0	O
were	27654141	0	O
detected	27654141	0	O
.	27654141	0	O
Across	27654141	0	O
the	27654141	0	O
whole	27654141	0	O
cohort	27654141	0	O
,	27654141	0	O
at	27654141	0	O
all	27654141	0	O
ages	27654141	0	O
,	27654141	0	O
mean	27654141	0	O
height	27654141	0	O
SDS	27654141	0	O
in	27654141	0	O
subjects	27654141	0	O
with	27654141	0	O
impaired	27654141	0	O
receptor	27654141	0	O
function	27654141	0	O
was	27654141	0	O
higher	27654141	0	O
than	27654141	0	O
in	27654141	0	O
patients	27654141	0	O
with	27654141	0	O
common	27654141	0	O
sequence	27654141	0	O
MC4R	27654141	0	O
.	27654141	0	O
In	27654141	0	O
matched	27654141	0	O
individuals	27654141	0	O
,	27654141	0	O
this	27654141	0	O
trend	27654141	0	O
persisted	27654141	0	O
(	27654141	0	O
8	27654141	0	O
of	27654141	0	O
the	27654141	0	O
11	27654141	0	O
pairs	27654141	0	O
)	27654141	0	O
within	27654141	0	O
the	27654141	0	O
case	27654141	0	O
-	27654141	0	O
control	27654141	0	O
setting	27654141	0	O
.	27654141	0	O
No	27654141	0	O
differences	27654141	0	O
were	27654141	0	O
found	27654141	0	O
regarding	27654141	0	O
metabolic	27654141	0	O
characteristics	27654141	0	O
.	27654141	0	O
CONCLUSIONS	27654141	0	O
:	27654141	0	O
The	27654141	0	O
observed	27654141	0	O
prevalence	27654141	0	O
of	27654141	0	O
mutations	27654141	0	O
causing	27654141	0	O
impaired	27654141	0	O
receptor	27654141	0	O
function	27654141	0	O
in	27654141	0	O
this	27654141	0	O
large	27654141	0	O
cohort	27654141	0	O
is	27654141	0	O
comparable	27654141	0	O
to	27654141	0	O
other	27654141	0	O
pediatric	27654141	0	O
cohorts	27654141	0	O
.	27654141	0	O
MC4R	27654141	0	O
deficiency	27654141	0	O
tends	27654141	0	O
to	27654141	0	O
lead	27654141	0	O
to	27654141	0	O
a	27654141	0	O
taller	27654141	0	O
stature	27654141	0	O
,	27654141	0	O
confirming	27654141	0	O
previous	27654141	0	O
clinical	27654141	0	O
reports	27654141	0	O
.	27654141	0	O
The	27654141	0	O
association	27654141	0	O
of	27654141	0	O
MC4R	27654141	0	O
mutations	27654141	0	O
with	27654141	0	O
a	27654141	0	O
distinct	27654141	0	O
phenotype	27654141	0	O
concerning	27654141	0	O
metabolic	27654141	0	O
characteristics	27654141	0	O
remains	27654141	0	O
questionable	27654141	0	O
.	27654141	0	O

Novel	27663151	4	O
MBTPS2	27663151	4	B-Gene
missense	27663151	4	B-Var
mutation	27663151	4	I-Var
causes	27663151	4	B-Reg
a	27663151	4	O
keratosis	27663151	4	B-Disease
follicularis	27663151	4	I-Disease
spinulosa	27663151	4	I-Disease
decalvans	27663151	4	I-Disease
phenotype	27663151	4	O
:	27663151	4	O
mutation	27663151	4	O
update	27663151	4	O
and	27663151	4	O
review	27663151	4	O
of	27663151	4	O
the	27663151	4	O
literature	27663151	4	O
.	27663151	4	O
Keratosis	27663151	4	B-Disease
follicularis	27663151	4	I-Disease
spinulosa	27663151	4	I-Disease
decalvans	27663151	4	I-Disease
(	27663151	4	O
KFSD	27663151	4	O
)	27663151	4	O
is	27663151	4	O
an	27663151	4	O
X	27663151	4	O
-	27663151	4	O
linked	27663151	4	O
condition	27663151	4	O
characterized	27663151	4	O
by	27663151	4	O
keratotic	27663151	4	O
follicular	27663151	4	O
papules	27663151	4	O
and	27663151	4	O
progressive	27663151	4	O
alopecia	27663151	4	O
,	27663151	4	O
which	27663151	4	O
is	27663151	4	O
caused	27663151	4	B-Reg
by	27663151	4	I-Reg
mutations	27663151	4	B-Var
in	27663151	4	O
the	27663151	4	O
MBTPS2	27663151	4	B-Gene
gene	27663151	4	O
.	27663151	4	O
We	27663151	4	O
carried	27663151	4	O
out	27663151	4	O
a	27663151	4	O
genetic	27663151	4	O
study	27663151	4	O
on	27663151	4	O
a	27663151	4	O
child	27663151	4	O
who	27663151	4	O
was	27663151	4	O
suspected	27663151	4	O
clinically	27663151	4	O
to	27663151	4	O
have	27663151	4	O
KFSD	27663151	4	O
.	27663151	4	O
Sanger	27663151	4	O
sequencing	27663151	4	O
was	27663151	4	O
performed	27663151	4	O
to	27663151	4	O
detect	27663151	4	O
mutations	27663151	4	O
in	27663151	4	O
the	27663151	4	O
entire	27663151	4	O
coding	27663151	4	O
region	27663151	4	O
of	27663151	4	O
MBTPS2	27663151	4	O
.	27663151	4	O
A	27663151	4	O
novel	27663151	4	O
missense	27663151	4	O
mutation	27663151	4	O
(	27663151	4	B-Var
c.599	27663151	4	I-Var
C	27663151	4	I-Var
>	27663151	4	I-Var
T	27663151	4	I-Var
)	27663151	4	I-Var
was	27663151	4	O
identified	27663151	4	O
in	27663151	4	O
the	27663151	4	O
patient	27663151	4	O
,	27663151	4	O
confirming	27663151	4	B-Reg
a	27663151	4	O
diagnosis	27663151	4	O
of	27663151	4	O
KFSD	27663151	4	B-Disease
.	27663151	4	O
We	27663151	4	O
reviewed	27663151	4	O
related	27663151	4	O
cases	27663151	4	O
with	27663151	4	O
MBTPS2	27663151	4	O
mutations	27663151	4	O
for	27663151	4	O
evidence	27663151	4	O
of	27663151	4	O
genotype	27663151	4	O
-	27663151	4	O
phenotype	27663151	4	O
correlations	27663151	4	O
.	27663151	4	O

Temperature	27699788	0	O
-	27699788	0	O
dependent	27699788	0	O
autoimmunity	27699788	0	O
mediated	27699788	0	O
by	27699788	0	O
chs1	27699788	0	O
requires	27699788	0	O
its	27699788	0	O
neighboring	27699788	0	O
TNL	27699788	0	O
gene	27699788	0	O
SOC3	27699788	0	O
.	27699788	0	O
Toll	27699788	0	O
/	27699788	0	O
interleukin	27699788	0	O
receptor	27699788	0	O
(	27699788	0	O
TIR	27699788	0	O
)	27699788	0	O
-	27699788	0	O
nucleotide	27699788	0	O
binding	27699788	0	O
site	27699788	0	O
(	27699788	0	O
NB	27699788	0	O
)	27699788	0	O
-	27699788	0	O
type	27699788	0	O
(	27699788	0	O
TN	27699788	0	O
)	27699788	0	O
proteins	27699788	0	O
are	27699788	0	O
encoded	27699788	0	O
by	27699788	0	O
a	27699788	0	O
family	27699788	0	O
of	27699788	0	O
21	27699788	0	O
genes	27699788	0	O
in	27699788	0	O
the	27699788	0	O
Arabidopsis	27699788	0	O
genome	27699788	0	O
.	27699788	0	O
Previous	27699788	0	O
studies	27699788	0	O
have	27699788	0	O
shown	27699788	0	O
that	27699788	0	O
a	27699788	0	O
mutation	27699788	0	O
in	27699788	0	O
the	27699788	0	O
TN	27699788	0	O
gene	27699788	0	O
CHS1	27699788	0	O
activates	27699788	0	O
the	27699788	0	O
activation	27699788	0	O
of	27699788	0	O
defense	27699788	0	O
responses	27699788	0	O
at	27699788	0	O
low	27699788	0	O
temperatures	27699788	0	O
.	27699788	0	O
However	27699788	0	O
,	27699788	0	O
the	27699788	0	O
underlying	27699788	0	O
molecular	27699788	0	O
mechanism	27699788	0	O
remains	27699788	0	O
unknown	27699788	0	O
.	27699788	0	O
To	27699788	0	O
genetically	27699788	0	O
dissect	27699788	0	O
chs1	27699788	0	O
-	27699788	0	O
mediated	27699788	0	O
signaling	27699788	0	O
,	27699788	0	O
we	27699788	0	O
isolated	27699788	0	O
genetic	27699788	0	O
suppressors	27699788	0	O
of	27699788	0	O
chs1-2	27699788	0	O
(	27699788	0	O
soc	27699788	0	O
)	27699788	0	O
.	27699788	0	O
Several	27699788	0	O
independent	27699788	0	O
soc	27699788	0	O
mutants	27699788	0	O
carried	27699788	0	O
mutations	27699788	0	O
in	27699788	0	O
the	27699788	0	O
same	27699788	0	O
TIR	27699788	0	O
-	27699788	0	O
NB	27699788	0	O
-	27699788	0	O
leucine	27699788	0	O
-	27699788	0	O
rich	27699788	0	O
repeat	27699788	0	O
(	27699788	0	O
LRR	27699788	0	O
)	27699788	0	O
(	27699788	0	O
TNL	27699788	0	O
)	27699788	0	O
-	27699788	0	O
encoding	27699788	0	O
gene	27699788	0	O
SOC3	27699788	0	O
,	27699788	0	O
which	27699788	0	O
is	27699788	0	O
adjacent	27699788	0	O
to	27699788	0	O
CHS1	27699788	0	O
on	27699788	0	O
chromosome	27699788	0	O
1	27699788	0	O
.	27699788	0	O
Expression	27699788	0	O
of	27699788	0	O
SOC3	27699788	0	B-Gene
was	27699788	0	O
upregulated	27699788	0	B-PosReg
in	27699788	0	O
the	27699788	0	O
chs1-2	27699788	0	B-Gene
mutant	27699788	0	B-Var
.	27699788	0	O
Mutations	27699788	0	O
in	27699788	0	O
six	27699788	0	O
soc3	27699788	0	O
alleles	27699788	0	O
and	27699788	0	O
downregulation	27699788	0	O
of	27699788	0	O
SOC3	27699788	0	O
by	27699788	0	O
an	27699788	0	O
artificial	27699788	0	O
microRNA	27699788	0	O
construct	27699788	0	O
fully	27699788	0	O
rescued	27699788	0	O
the	27699788	0	O
chilling	27699788	0	O
sensitivity	27699788	0	O
and	27699788	0	O
defense	27699788	0	O
defects	27699788	0	O
of	27699788	0	O
chs1-2	27699788	0	O
.	27699788	0	O
Biochemical	27699788	0	O
studies	27699788	0	O
showed	27699788	0	O
that	27699788	0	O
CHS1	27699788	0	O
interacted	27699788	0	O
with	27699788	0	O
the	27699788	0	O
NB	27699788	0	O
and	27699788	0	O
LRR	27699788	0	O
domains	27699788	0	O
of	27699788	0	O
SOC3	27699788	0	O
;	27699788	0	O
however	27699788	0	O
,	27699788	0	O
mutated	27699788	0	O
chs1	27699788	0	O
interacted	27699788	0	O
with	27699788	0	O
the	27699788	0	O
TIR	27699788	0	O
,	27699788	0	O
NB	27699788	0	O
and	27699788	0	O
LRR	27699788	0	O
domains	27699788	0	O
of	27699788	0	O
SOC3	27699788	0	O
in	27699788	0	O
vitro	27699788	0	O
and	27699788	0	O
in	27699788	0	O
vivo	27699788	0	O
.	27699788	0	O
This	27699788	0	O
study	27699788	0	O
reveals	27699788	0	O
that	27699788	0	O
the	27699788	0	O
TN	27699788	0	O
protein	27699788	0	O
CHS1	27699788	0	O
interacts	27699788	0	O
with	27699788	0	O
the	27699788	0	O
TNL	27699788	0	O
protein	27699788	0	O
SOC3	27699788	0	O
to	27699788	0	O
modulate	27699788	0	O
temperature	27699788	0	O
-	27699788	0	O
dependent	27699788	0	O
autoimmunity	27699788	0	O
.	27699788	0	O

INPPL1	27708270	4	B-Gene
gene	27708270	4	O
mutations	27708270	4	B-Var
in	27708270	4	B-Reg
opsismodysplasia	27708270	4	B-Disease
.	27708270	4	O
The	27708270	4	O
INPPL1	27708270	4	O
(	27708270	4	O
inositol	27708270	4	O
polyphosphate	27708270	4	O
phosphatase	27708270	4	O
-	27708270	4	O
like	27708270	4	O
1	27708270	4	O
)	27708270	4	O
gene	27708270	4	O
encodes	27708270	4	O
the	27708270	4	O
inositol	27708270	4	O
phosphatase	27708270	4	O
,	27708270	4	O
SHIP2	27708270	4	O
(	27708270	4	O
for	27708270	4	O
src	27708270	4	O
homology	27708270	4	O
2	27708270	4	O
domain	27708270	4	O
-	27708270	4	O
containing	27708270	4	O
inositol	27708270	4	O
phosphatase	27708270	4	O
2	27708270	4	O
)	27708270	4	O
.	27708270	4	O
SHIP2	27708270	4	O
functions	27708270	4	O
to	27708270	4	O
dephosphorylate	27708270	4	O
,	27708270	4	O
and	27708270	4	O
negatively	27708270	4	O
regulate	27708270	4	O
,	27708270	4	O
the	27708270	4	O
lipid	27708270	4	O
second	27708270	4	O
messenger	27708270	4	O
phosphatidylinositol	27708270	4	O
(	27708270	4	O
3	27708270	4	O
,	27708270	4	O
4	27708270	4	O
,	27708270	4	O
5	27708270	4	O
)	27708270	4	O
P3	27708270	4	O
.	27708270	4	O
SHIP2	27708270	4	O
has	27708270	4	O
been	27708270	4	O
well	27708270	4	O
studied	27708270	4	O
in	27708270	4	O
the	27708270	4	O
area	27708270	4	O
of	27708270	4	O
insulin	27708270	4	O
resistance	27708270	4	O
and	27708270	4	O
obesity	27708270	4	O
but	27708270	4	O
has	27708270	4	O
roles	27708270	4	O
in	27708270	4	O
cancer	27708270	4	O
and	27708270	4	O
other	27708270	4	O
disorders	27708270	4	O
.	27708270	4	O
Recently	27708270	4	O
,	27708270	4	O
it	27708270	4	O
was	27708270	4	O
reported	27708270	4	O
that	27708270	4	O
mutations	27708270	4	B-Var
in	27708270	4	O
INPPL1	27708270	4	B-Gene
cause	27708270	4	B-Reg
opsismodysplasia	27708270	4	B-Disease
,	27708270	4	O
a	27708270	4	O
rare	27708270	4	O
,	27708270	4	O
autosomal	27708270	4	O
recessive	27708270	4	O
severe	27708270	4	O
skeletal	27708270	4	O
dysplasia	27708270	4	O
.	27708270	4	O
This	27708270	4	O
review	27708270	4	O
focuses	27708270	4	O
on	27708270	4	O
the	27708270	4	O
mutations	27708270	4	O
associated	27708270	4	O
with	27708270	4	O
opsismodysplasia	27708270	4	O
and	27708270	4	O
explores	27708270	4	O
the	27708270	4	O
role	27708270	4	O
of	27708270	4	O
INPPL1	27708270	4	O
/	27708270	4	O
SHIP2	27708270	4	O
in	27708270	4	O
skeletal	27708270	4	O
development	27708270	4	O
.	27708270	4	O

Genetic	27734835	4	O
screening	27734835	4	O
of	27734835	4	O
the	27734835	4	O
FLCN	27734835	4	O
gene	27734835	4	O
identify	27734835	4	O
six	27734835	4	O
novel	27734835	4	O
variants	27734835	4	O
and	27734835	4	O
a	27734835	4	O
Danish	27734835	4	O
founder	27734835	4	O
mutation	27734835	4	O
.	27734835	4	O
Pathogenic	27734835	4	O
germline	27734835	4	O
mutations	27734835	4	B-Var
in	27734835	4	O
the	27734835	4	O
folliculin	27734835	4	O
(	27734835	4	B-Gene
FLCN	27734835	4	I-Gene
)	27734835	4	I-Gene
tumor	27734835	4	O
suppressor	27734835	4	O
gene	27734835	4	O
predispose	27734835	4	O
to	27734835	4	B-Reg
Birt	27734835	4	B-Disease
-	27734835	4	I-Disease
Hogg	27734835	4	I-Disease
-	27734835	4	I-Disease
Dubé	27734835	4	I-Disease
(	27734835	4	O
BHD	27734835	4	O
)	27734835	4	O
syndrome	27734835	4	O
,	27734835	4	O
a	27734835	4	O
rare	27734835	4	O
disease	27734835	4	O
characterized	27734835	4	O
by	27734835	4	O
the	27734835	4	O
development	27734835	4	O
of	27734835	4	O
cutaneous	27734835	4	O
hamartomas	27734835	4	O
(	27734835	4	O
fibrofolliculomas	27734835	4	O
)	27734835	4	O
,	27734835	4	O
multiple	27734835	4	O
lung	27734835	4	O
cysts	27734835	4	O
,	27734835	4	O
spontaneous	27734835	4	O
pneumothoraces	27734835	4	O
and	27734835	4	O
renal	27734835	4	O
cell	27734835	4	O
cancer	27734835	4	O
.	27734835	4	O
In	27734835	4	O
this	27734835	4	O
study	27734835	4	O
,	27734835	4	O
we	27734835	4	O
report	27734835	4	O
the	27734835	4	O
identification	27734835	4	O
of	27734835	4	O
13	27734835	4	O
variants	27734835	4	O
and	27734835	4	O
three	27734835	4	O
polymorphisms	27734835	4	O
in	27734835	4	O
the	27734835	4	O
FLCN	27734835	4	O
gene	27734835	4	O
in	27734835	4	O
143	27734835	4	O
Danish	27734835	4	O
patients	27734835	4	O
or	27734835	4	O
families	27734835	4	O
with	27734835	4	O
suspected	27734835	4	O
BHD	27734835	4	O
syndrome	27734835	4	O
.	27734835	4	O
Functional	27734835	4	O
mini	27734835	4	O
-	27734835	4	O
gene	27734835	4	O
splicing	27734835	4	O
analysis	27734835	4	O
revealed	27734835	4	O
that	27734835	4	O
two	27734835	4	O
intronic	27734835	4	O
variants	27734835	4	O
(	27734835	4	O
c.1062	27734835	4	O
2	27734835	4	O
T	27734835	4	O
>	27734835	4	O
G	27734835	4	O
and	27734835	4	O
c.1177	27734835	4	O
-	27734835	4	O
5	27734835	4	O
_1177-3	27734835	4	O
del	27734835	4	O
)	27734835	4	O
introduced	27734835	4	O
splicing	27734835	4	O
aberrations	27734835	4	O
.	27734835	4	O
Eleven	27734835	4	O
families	27734835	4	O
exhibited	27734835	4	O
the	27734835	4	O
c.1062	27734835	4	O
2	27734835	4	O
T	27734835	4	O
>	27734835	4	O
G	27734835	4	O
mutation	27734835	4	O
.	27734835	4	O
Combined	27734835	4	O
single	27734835	4	O
nucleotide	27734835	4	O
polymorphism	27734835	4	O
array	27734835	4	O
-	27734835	4	O
haplotype	27734835	4	O
analysis	27734835	4	O
showed	27734835	4	O
that	27734835	4	O
these	27734835	4	O
families	27734835	4	O
share	27734835	4	O
a	27734835	4	O
3	27734835	4	O
-	27734835	4	O
Mb	27734835	4	O
genomic	27734835	4	O
fragment	27734835	4	O
containing	27734835	4	O
the	27734835	4	O
FLCN	27734835	4	O
gene	27734835	4	O
,	27734835	4	O
revealing	27734835	4	O
that	27734835	4	O
the	27734835	4	O
c.1062	27734835	4	O
2	27734835	4	O
T	27734835	4	O
>	27734835	4	O
G	27734835	4	O
mutation	27734835	4	O
is	27734835	4	O
a	27734835	4	O
Danish	27734835	4	O
founder	27734835	4	O
mutation	27734835	4	O
.	27734835	4	O
On	27734835	4	O
the	27734835	4	O
basis	27734835	4	O
of	27734835	4	O
in	27734835	4	O
silico	27734835	4	O
prediction	27734835	4	O
and	27734835	4	O
functional	27734835	4	O
splicing	27734835	4	O
assays	27734835	4	O
,	27734835	4	O
we	27734835	4	O
classify	27734835	4	O
the	27734835	4	O
16	27734835	4	O
identified	27734835	4	O
variants	27734835	4	O
in	27734835	4	O
the	27734835	4	O
FLCN	27734835	4	O
gene	27734835	4	O
as	27734835	4	O
follows	27734835	4	O
:	27734835	4	O
nine	27734835	4	O
as	27734835	4	O
pathogenic	27734835	4	O
,	27734835	4	O
one	27734835	4	O
as	27734835	4	O
likely	27734835	4	O
pathogenic	27734835	4	O
,	27734835	4	O
three	27734835	4	O
as	27734835	4	O
likely	27734835	4	O
benign	27734835	4	O
and	27734835	4	O
three	27734835	4	O
as	27734835	4	O
polymorphisms	27734835	4	O
.	27734835	4	O
In	27734835	4	O
conclusion	27734835	4	O
,	27734835	4	O
the	27734835	4	O
study	27734835	4	O
describes	27734835	4	O
the	27734835	4	O
FLCN	27734835	4	O
mutation	27734835	4	O
spectrum	27734835	4	O
in	27734835	4	O
Danish	27734835	4	O
BHD	27734835	4	O
patients	27734835	4	O
,	27734835	4	O
and	27734835	4	O
contributes	27734835	4	O
to	27734835	4	O
a	27734835	4	O
better	27734835	4	O
understanding	27734835	4	O
of	27734835	4	O
BHD	27734835	4	O
syndrome	27734835	4	O
and	27734835	4	O
management	27734835	4	O
of	27734835	4	O
BHD	27734835	4	O
patients	27734835	4	O
.	27734835	4	O

Structural	27747153	4	O
brain	27747153	4	O
abnormalities	27747153	4	O
in	27747153	4	O
a	27747153	4	O
single	27747153	4	O
gene	27747153	4	O
disorder	27747153	4	O
associated	27747153	4	O
with	27747153	4	O
epilepsy	27747153	4	O
,	27747153	4	O
language	27747153	4	O
impairment	27747153	4	O
and	27747153	4	O
intellectual	27747153	4	O
disability	27747153	4	O
.	27747153	4	O
Childhood	27747153	4	O
speech	27747153	4	O
and	27747153	4	O
language	27747153	4	O
deficits	27747153	4	O
are	27747153	4	O
highly	27747153	4	O
prevalent	27747153	4	O
and	27747153	4	O
are	27747153	4	O
a	27747153	4	O
common	27747153	4	O
feature	27747153	4	O
of	27747153	4	O
neurodevelopmental	27747153	4	O
disorders	27747153	4	O
.	27747153	4	O
However	27747153	4	O
,	27747153	4	O
it	27747153	4	O
is	27747153	4	O
difficult	27747153	4	O
to	27747153	4	O
investigate	27747153	4	O
the	27747153	4	O
underlying	27747153	4	O
causal	27747153	4	O
pathways	27747153	4	O
because	27747153	4	O
many	27747153	4	O
diagnostic	27747153	4	O
groups	27747153	4	O
have	27747153	4	O
a	27747153	4	O
heterogeneous	27747153	4	O
aetiology	27747153	4	O
.	27747153	4	O
Studying	27747153	4	O
disorders	27747153	4	O
with	27747153	4	O
a	27747153	4	O
shared	27747153	4	O
genetic	27747153	4	O
cause	27747153	4	O
and	27747153	4	O
shared	27747153	4	O
cognitive	27747153	4	O
deficits	27747153	4	O
can	27747153	4	O
provide	27747153	4	O
crucial	27747153	4	O
insight	27747153	4	O
into	27747153	4	O
the	27747153	4	O
cellular	27747153	4	O
mechanisms	27747153	4	O
and	27747153	4	O
neural	27747153	4	O
systems	27747153	4	O
that	27747153	4	O
give	27747153	4	O
rise	27747153	4	O
to	27747153	4	O
those	27747153	4	O
impairments	27747153	4	O
.	27747153	4	O
The	27747153	4	O
current	27747153	4	O
study	27747153	4	O
investigated	27747153	4	O
structural	27747153	4	O
brain	27747153	4	O
differences	27747153	4	O
of	27747153	4	O
individuals	27747153	4	O
with	27747153	4	O
mutations	27747153	4	B-Var
in	27747153	4	O
ZDHHC9	27747153	4	B-Gene
,	27747153	4	O
which	27747153	4	O
is	27747153	4	O
associated	27747153	4	B-Reg
with	27747153	4	I-Reg
a	27747153	4	O
specific	27747153	4	O
neurodevelopmental	27747153	4	O
phenotype	27747153	4	O
including	27747153	4	O
prominent	27747153	4	O
speech	27747153	4	B-Disease
and	27747153	4	I-Disease
language	27747153	4	I-Disease
impairments	27747153	4	I-Disease
and	27747153	4	O
intellectual	27747153	4	B-Disease
disability	27747153	4	I-Disease
.	27747153	4	O
We	27747153	4	O
used	27747153	4	O
multiple	27747153	4	O
structural	27747153	4	O
neuroimaging	27747153	4	O
methods	27747153	4	O
to	27747153	4	O
characterise	27747153	4	O
neuroanatomy	27747153	4	O
in	27747153	4	O
this	27747153	4	O
group	27747153	4	O
,	27747153	4	O
and	27747153	4	O
observed	27747153	4	O
bilateral	27747153	4	O
reductions	27747153	4	O
in	27747153	4	O
cortical	27747153	4	O
thickness	27747153	4	O
in	27747153	4	O
areas	27747153	4	O
surrounding	27747153	4	O
the	27747153	4	O
temporo	27747153	4	O
-	27747153	4	O
parietal	27747153	4	O
junction	27747153	4	O
,	27747153	4	O
parietal	27747153	4	O
lobule	27747153	4	O
,	27747153	4	O
and	27747153	4	O
inferior	27747153	4	O
frontal	27747153	4	O
lobe	27747153	4	O
,	27747153	4	O
and	27747153	4	O
decreased	27747153	4	O
microstructural	27747153	4	O
integrity	27747153	4	O
of	27747153	4	O
cortical	27747153	4	O
,	27747153	4	O
subcortical	27747153	4	O
-	27747153	4	O
cortical	27747153	4	O
,	27747153	4	O
and	27747153	4	O
interhemispheric	27747153	4	O
white	27747153	4	O
matter	27747153	4	O
projections	27747153	4	O
.	27747153	4	O
These	27747153	4	O
findings	27747153	4	O
are	27747153	4	O
compared	27747153	4	O
to	27747153	4	O
reports	27747153	4	O
for	27747153	4	O
other	27747153	4	O
genetic	27747153	4	O
groups	27747153	4	O
and	27747153	4	O
genetically	27747153	4	O
heterogeneous	27747153	4	O
disorders	27747153	4	O
with	27747153	4	O
a	27747153	4	O
similar	27747153	4	O
presentation	27747153	4	O
.	27747153	4	O
Overlap	27747153	4	O
in	27747153	4	O
the	27747153	4	O
neuroanatomical	27747153	4	O
phenotype	27747153	4	O
suggests	27747153	4	O
a	27747153	4	O
common	27747153	4	O
pathway	27747153	4	O
that	27747153	4	O
particularly	27747153	4	O
affects	27747153	4	O
the	27747153	4	O
development	27747153	4	O
of	27747153	4	O
temporo	27747153	4	O
-	27747153	4	O
parietal	27747153	4	O
and	27747153	4	O
inferior	27747153	4	O
frontal	27747153	4	O
areas	27747153	4	O
,	27747153	4	O
and	27747153	4	O
their	27747153	4	O
connections	27747153	4	O
.	27747153	4	O

Pharmacological	27774737	1	O
Chaperoning	27774737	1	O
:	27774737	1	O
A	27774737	1	O
Potential	27774737	1	O
Treatment	27774737	1	O
for	27774737	1	O
PMM2	27774737	1	O
-	27774737	1	O
CDG	27774737	1	O
.	27774737	1	O
The	27774737	1	O
congenital	27774737	1	B-Disease
disorder	27774737	1	I-Disease
of	27774737	1	I-Disease
glycosylation	27774737	1	I-Disease
(	27774737	1	I-Disease
CDG	27774737	1	I-Disease
)	27774737	1	I-Disease
due	27774737	1	I-Disease
to	27774737	1	I-Disease
phosphomannomutase	27774737	1	I-Disease
2	27774737	1	I-Disease
deficiency	27774737	1	I-Disease
(	27774737	1	O
PMM2	27774737	1	O
-	27774737	1	O
CDG	27774737	1	O
)	27774737	1	O
,	27774737	1	O
the	27774737	1	O
most	27774737	1	O
common	27774737	1	O
N	27774737	1	O
-	27774737	1	O
glycosylation	27774737	1	O
disorder	27774737	1	O
,	27774737	1	O
is	27774737	1	O
a	27774737	1	O
multisystem	27774737	1	O
disease	27774737	1	O
for	27774737	1	O
which	27774737	1	O
no	27774737	1	O
effective	27774737	1	O
treatment	27774737	1	O
is	27774737	1	O
available	27774737	1	O
.	27774737	1	O
The	27774737	1	O
recent	27774737	1	O
functional	27774737	1	O
characterization	27774737	1	O
of	27774737	1	O
disease	27774737	1	O
-	27774737	1	O
causing	27774737	1	O
mutations	27774737	1	O
described	27774737	1	O
in	27774737	1	O
patients	27774737	1	O
with	27774737	1	O
PMM2	27774737	1	B-Disease
-	27774737	1	I-Disease
CDG	27774737	1	I-Disease
led	27774737	1	O
to	27774737	1	O
the	27774737	1	O
idea	27774737	1	O
of	27774737	1	O
a	27774737	1	O
therapeutic	27774737	1	O
strategy	27774737	1	O
involving	27774737	1	O
pharmacological	27774737	1	O
chaperones	27774737	1	O
(	27774737	1	O
PC	27774737	1	O
)	27774737	1	O
to	27774737	1	O
rescue	27774737	1	O
PMM2	27774737	1	B-Gene
loss	27774737	1	B-NegReg
-	27774737	1	I-NegReg
of	27774737	1	I-NegReg
-	27774737	1	I-NegReg
function	27774737	1	I-NegReg
mutations	27774737	1	B-Var
.	27774737	1	O
The	27774737	1	O
present	27774737	1	O
work	27774737	1	O
describes	27774737	1	O
the	27774737	1	O
high	27774737	1	O
-	27774737	1	O
throughput	27774737	1	O
screening	27774737	1	O
,	27774737	1	O
by	27774737	1	O
differential	27774737	1	O
scanning	27774737	1	O
fluorimetry	27774737	1	O
,	27774737	1	O
of	27774737	1	O
10	27774737	1	O
,	27774737	1	O
000	27774737	1	O
low	27774737	1	O
-	27774737	1	O
molecular	27774737	1	O
-	27774737	1	O
weight	27774737	1	O
compounds	27774737	1	O
from	27774737	1	O
a	27774737	1	O
commercial	27774737	1	O
library	27774737	1	O
,	27774737	1	O
to	27774737	1	O
search	27774737	1	O
for	27774737	1	O
possible	27774737	1	O
PCs	27774737	1	O
for	27774737	1	O
the	27774737	1	O
enzyme	27774737	1	O
PMM2	27774737	1	O
.	27774737	1	O
This	27774737	1	O
exercise	27774737	1	O
identified	27774737	1	O
eight	27774737	1	O
compounds	27774737	1	O
that	27774737	1	O
increased	27774737	1	O
the	27774737	1	O
thermal	27774737	1	O
stability	27774737	1	O
of	27774737	1	O
PMM2	27774737	1	O
.	27774737	1	O
Of	27774737	1	O
these	27774737	1	O
,	27774737	1	O
four	27774737	1	O
compounds	27774737	1	O
functioned	27774737	1	O
as	27774737	1	O
potential	27774737	1	O
PCs	27774737	1	O
that	27774737	1	O
significantly	27774737	1	O
increased	27774737	1	O
the	27774737	1	O
stability	27774737	1	O
of	27774737	1	O
several	27774737	1	O
destabilizing	27774737	1	O
and	27774737	1	O
oligomerization	27774737	1	O
mutants	27774737	1	O
and	27774737	1	O
also	27774737	1	O
increased	27774737	1	O
PMM	27774737	1	O
activity	27774737	1	O
in	27774737	1	O
a	27774737	1	O
disease	27774737	1	O
model	27774737	1	O
of	27774737	1	O
cells	27774737	1	O
overexpressing	27774737	1	O
PMM2	27774737	1	O
mutations	27774737	1	O
.	27774737	1	O
Structural	27774737	1	O
analysis	27774737	1	O
revealed	27774737	1	O
one	27774737	1	O
of	27774737	1	O
these	27774737	1	O
compounds	27774737	1	O
to	27774737	1	O
provide	27774737	1	O
an	27774737	1	O
excellent	27774737	1	O
starting	27774737	1	O
point	27774737	1	O
for	27774737	1	O
chemical	27774737	1	O
optimization	27774737	1	O
since	27774737	1	O
it	27774737	1	O
passed	27774737	1	O
tests	27774737	1	O
based	27774737	1	O
on	27774737	1	O
a	27774737	1	O
number	27774737	1	O
of	27774737	1	O
pharmacochemical	27774737	1	O
quality	27774737	1	O
filters	27774737	1	O
.	27774737	1	O
The	27774737	1	O
present	27774737	1	O
results	27774737	1	O
provide	27774737	1	O
the	27774737	1	O
first	27774737	1	O
proof	27774737	1	O
-	27774737	1	O
of	27774737	1	O
-	27774737	1	O
concept	27774737	1	O
of	27774737	1	O
a	27774737	1	O
possible	27774737	1	O
treatment	27774737	1	O
for	27774737	1	O
PMM2	27774737	1	O
-	27774737	1	O
CDG	27774737	1	O
and	27774737	1	O
describe	27774737	1	O
a	27774737	1	O
promising	27774737	1	O
chemical	27774737	1	O
structure	27774737	1	O
as	27774737	1	O
a	27774737	1	O
starting	27774737	1	O
point	27774737	1	O
for	27774737	1	O
the	27774737	1	O
development	27774737	1	O
of	27774737	1	O
new	27774737	1	O
therapeutic	27774737	1	O
agents	27774737	1	O
for	27774737	1	O
this	27774737	1	O
severe	27774737	1	O
orphan	27774737	1	O
disease	27774737	1	O
.	27774737	1	O

Subtypes	27863268	4	O
of	27863268	4	O
SERPINC1	27863268	4	O
mutations	27863268	4	O
and	27863268	4	O
the	27863268	4	O
thrombotic	27863268	4	O
phenotype	27863268	4	O
of	27863268	4	O
inherited	27863268	4	O
antithrombin	27863268	4	O
deficient	27863268	4	O
individuals	27863268	4	O
in	27863268	4	O
Chinese	27863268	4	O
Han	27863268	4	O
population	27863268	4	O
.	27863268	4	O
Inherited	27863268	4	B-Disease
antithrombin	27863268	4	I-Disease
(	27863268	4	I-Disease
AT	27863268	4	I-Disease
)	27863268	4	I-Disease
deficiency	27863268	4	I-Disease
is	27863268	4	O
a	27863268	4	O
rare	27863268	4	O
autosomal	27863268	4	O
disease	27863268	4	O
that	27863268	4	O
could	27863268	4	O
increase	27863268	4	O
the	27863268	4	O
risk	27863268	4	O
of	27863268	4	O
venous	27863268	4	O
thromboembolism	27863268	4	O
(	27863268	4	O
VTE	27863268	4	O
)	27863268	4	O
and	27863268	4	O
usually	27863268	4	O
caused	27863268	4	B-Reg
by	27863268	4	I-Reg
mutations	27863268	4	B-Var
of	27863268	4	O
SERPINC1	27863268	4	B-Gene
.	27863268	4	O
Although	27863268	4	O
a	27863268	4	O
number	27863268	4	O
of	27863268	4	O
mutations	27863268	4	O
of	27863268	4	O
SERPINC1	27863268	4	O
have	27863268	4	O
been	27863268	4	O
reported	27863268	4	O
in	27863268	4	O
Chinese	27863268	4	O
Han	27863268	4	O
population	27863268	4	O
,	27863268	4	O
the	27863268	4	O
impact	27863268	4	O
of	27863268	4	O
different	27863268	4	O
subtypes	27863268	4	O
of	27863268	4	O
these	27863268	4	O
mutations	27863268	4	O
on	27863268	4	O
the	27863268	4	O
thrombotic	27863268	4	O
phenotype	27863268	4	O
is	27863268	4	O
still	27863268	4	O
unknown	27863268	4	O
.	27863268	4	O
Here	27863268	4	O
,	27863268	4	O
we	27863268	4	O
performed	27863268	4	O
a	27863268	4	O
retrospective	27863268	4	O
cohort	27863268	4	O
study	27863268	4	O
including	27863268	4	O
169	27863268	4	O
AT	27863268	4	O
patients	27863268	4	O
from	27863268	4	O
63	27863268	4	O
families	27863268	4	O
to	27863268	4	O
compare	27863268	4	O
the	27863268	4	O
clinical	27863268	4	O
features	27863268	4	O
between	27863268	4	O
null	27863268	4	O
mutation	27863268	4	O
carriers	27863268	4	O
and	27863268	4	O
missense	27863268	4	O
mutation	27863268	4	O
carriers	27863268	4	O
.	27863268	4	O
We	27863268	4	O
found	27863268	4	O
that	27863268	4	O
patients	27863268	4	O
carrying	27863268	4	O
null	27863268	4	O
mutations	27863268	4	O
have	27863268	4	O
a	27863268	4	O
higher	27863268	4	O
risk	27863268	4	O
of	27863268	4	O
VTE	27863268	4	O
(	27863268	4	O
HR	27863268	4	O
2.29	27863268	4	O
,	27863268	4	O
95%	27863268	4	O
CI	27863268	4	O
1.16	27863268	4	O
-	27863268	4	O
4.69	27863268	4	O
,	27863268	4	O
P	27863268	4	O
=	27863268	4	O
0.02	27863268	4	O
adjusted	27863268	4	O
for	27863268	4	O
sex	27863268	4	O
and	27863268	4	O
VTE	27863268	4	O
family	27863268	4	O
history	27863268	4	O
)	27863268	4	O
and	27863268	4	O
earlier	27863268	4	O
median	27863268	4	O
onset	27863268	4	O
age	27863268	4	O
of	27863268	4	O
VTE	27863268	4	O
(	27863268	4	O
27	27863268	4	O
vs.32	27863268	4	O
years	27863268	4	O
,	27863268	4	O
P	27863268	4	O
=	27863268	4	O
0.045	27863268	4	O
)	27863268	4	O
as	27863268	4	O
well	27863268	4	O
as	27863268	4	O
lower	27863268	4	O
AT	27863268	4	O
activities	27863268	4	O
(	27863268	4	O
47.6	27863268	4	O
1.0%	27863268	4	O
vs.59	27863268	4	O
.1	27863268	4	O
2.3%	27863268	4	O
,	27863268	4	O
P	27863268	4	O
<	27863268	4	O
0.001	27863268	4	O
)	27863268	4	O
than	27863268	4	O
those	27863268	4	O
with	27863268	4	O
missense	27863268	4	O
mutations	27863268	4	O
.	27863268	4	O
We	27863268	4	O
also	27863268	4	O
observed	27863268	4	O
that	27863268	4	O
thrombus	27863268	4	O
location	27863268	4	O
sites	27863268	4	O
showed	27863268	4	O
no	27863268	4	O
difference	27863268	4	O
between	27863268	4	O
null	27863268	4	O
mutation	27863268	4	O
carriers	27863268	4	O
and	27863268	4	O
missense	27863268	4	O
mutation	27863268	4	O
carriers	27863268	4	O
,	27863268	4	O
gene	27863268	4	O
locations	27863268	4	O
of	27863268	4	O
the	27863268	4	O
mutations	27863268	4	O
did	27863268	4	O
not	27863268	4	O
relate	27863268	4	O
with	27863268	4	O
the	27863268	4	O
incidence	27863268	4	O
rate	27863268	4	O
of	27863268	4	O
VTE	27863268	4	O
.	27863268	4	O
This	27863268	4	O
study	27863268	4	O
demonstrated	27863268	4	O
that	27863268	4	O
different	27863268	4	O
types	27863268	4	O
of	27863268	4	O
SERPINC1	27863268	4	O
mutations	27863268	4	O
may	27863268	4	O
play	27863268	4	O
different	27863268	4	O
roles	27863268	4	O
in	27863268	4	O
the	27863268	4	O
development	27863268	4	O
of	27863268	4	O
VTE	27863268	4	O
and	27863268	4	O
should	27863268	4	O
be	27863268	4	O
considered	27863268	4	O
in	27863268	4	O
the	27863268	4	O
prevention	27863268	4	O
of	27863268	4	O
VTE	27863268	4	O
.	27863268	4	O

Loss	27874073	0	B-NegReg
-	27874073	0	I-NegReg
of	27874073	0	I-NegReg
-	27874073	0	I-NegReg
function	27874073	0	I-NegReg
of	27874073	0	O
an	27874073	0	O
Arabidopsis	27874073	0	O
NADPH	27874073	0	O
pyrophosphohydrolase	27874073	0	O
,	27874073	0	O
AtNUDX19	27874073	0	O
,	27874073	0	O
impacts	27874073	0	B-Reg
on	27874073	0	O
the	27874073	0	O
pyridine	27874073	0	O
nucleotides	27874073	0	O
status	27874073	0	O
and	27874073	0	O
confers	27874073	0	B-PosReg
photooxidative	27874073	0	O
stress	27874073	0	O
tolerance	27874073	0	O
.	27874073	0	O
The	27874073	0	O
levels	27874073	0	O
and	27874073	0	O
redox	27874073	0	O
states	27874073	0	O
of	27874073	0	O
pyridine	27874073	0	O
nucleotides	27874073	0	O
,	27874073	0	O
such	27874073	0	O
as	27874073	0	O
NADP	27874073	0	O
(	27874073	0	O
H	27874073	0	O
)	27874073	0	O
,	27874073	0	O
regulate	27874073	0	O
the	27874073	0	O
cellular	27874073	0	O
redox	27874073	0	O
homeostasis	27874073	0	O
,	27874073	0	O
which	27874073	0	O
is	27874073	0	O
crucial	27874073	0	O
for	27874073	0	O
photooxidative	27874073	0	O
stress	27874073	0	O
response	27874073	0	O
in	27874073	0	O
plants	27874073	0	O
.	27874073	0	O
However	27874073	0	O
,	27874073	0	O
how	27874073	0	O
they	27874073	0	O
are	27874073	0	O
controlled	27874073	0	O
is	27874073	0	O
poorly	27874073	0	O
understood	27874073	0	O
.	27874073	0	O
An	27874073	0	O
Arabidopsis	27874073	0	O
Nudix	27874073	0	O
hydrolase	27874073	0	O
,	27874073	0	O
AtNUDX19	27874073	0	O
,	27874073	0	O
was	27874073	0	O
previously	27874073	0	O
identified	27874073	0	O
to	27874073	0	O
have	27874073	0	O
NADPH	27874073	0	O
hydrolytic	27874073	0	O
activity	27874073	0	O
in	27874073	0	O
vitro	27874073	0	O
,	27874073	0	O
suggesting	27874073	0	O
this	27874073	0	O
enzyme	27874073	0	O
to	27874073	0	O
be	27874073	0	O
a	27874073	0	O
regulator	27874073	0	O
of	27874073	0	O
the	27874073	0	O
NADPH	27874073	0	O
status	27874073	0	O
.	27874073	0	O
We	27874073	0	O
herein	27874073	0	O
examined	27874073	0	O
the	27874073	0	O
physiological	27874073	0	O
role	27874073	0	O
of	27874073	0	O
AtNUDX19	27874073	0	B-Gene
using	27874073	0	O
its	27874073	0	O
loss	27874073	0	B-NegReg
-	27874073	0	I-NegReg
of	27874073	0	I-NegReg
-	27874073	0	I-NegReg
function	27874073	0	I-NegReg
mutants	27874073	0	B-Var
.	27874073	0	O
NADPH	27874073	0	O
levels	27874073	0	O
were	27874073	0	O
increased	27874073	0	B-PosReg
in	27874073	0	O
nudx19	27874073	0	B-Gene
mutants	27874073	0	B-Var
under	27874073	0	O
both	27874073	0	O
normal	27874073	0	O
and	27874073	0	O
high	27874073	0	O
light	27874073	0	O
conditions	27874073	0	O
,	27874073	0	O
while	27874073	0	O
NADP	27874073	0	O
(	27874073	0	O
)	27874073	0	O
and	27874073	0	O
NAD	27874073	0	O
(	27874073	0	O
)	27874073	0	O
levels	27874073	0	O
were	27874073	0	O
decreased	27874073	0	B-PosReg
.	27874073	0	O
Despite	27874073	0	O
the	27874073	0	O
high	27874073	0	O
redox	27874073	0	O
states	27874073	0	O
of	27874073	0	O
NADP	27874073	0	O
(	27874073	0	O
H	27874073	0	O
)	27874073	0	O
,	27874073	0	O
nudx19	27874073	0	O
mutants	27874073	0	O
exhibited	27874073	0	O
high	27874073	0	O
tolerance	27874073	0	O
to	27874073	0	O
moderate	27874073	0	O
light	27874073	0	O
-	27874073	0	O
or	27874073	0	O
methylviologen	27874073	0	O
-	27874073	0	O
induced	27874073	0	O
photooxidative	27874073	0	O
stresses	27874073	0	O
.	27874073	0	O
This	27874073	0	O
tolerance	27874073	0	O
might	27874073	0	O
be	27874073	0	O
partially	27874073	0	O
attributed	27874073	0	O
to	27874073	0	O
the	27874073	0	O
activation	27874073	0	O
of	27874073	0	O
either	27874073	0	O
or	27874073	0	O
both	27874073	0	O
photosynthesis	27874073	0	O
and	27874073	0	O
the	27874073	0	O
antioxidant	27874073	0	O
system	27874073	0	O
.	27874073	0	O
Furthermore	27874073	0	O
,	27874073	0	O
a	27874073	0	O
microarray	27874073	0	O
analysis	27874073	0	O
suggested	27874073	0	O
the	27874073	0	O
role	27874073	0	O
of	27874073	0	O
ANUDX19	27874073	0	O
in	27874073	0	O
regulation	27874073	0	O
of	27874073	0	O
the	27874073	0	O
salicylic	27874073	0	O
acid	27874073	0	O
(	27874073	0	O
SA	27874073	0	O
)	27874073	0	O
response	27874073	0	O
in	27874073	0	O
a	27874073	0	O
negative	27874073	0	O
manner	27874073	0	O
.	27874073	0	O
Indeed	27874073	0	O
,	27874073	0	O
nudx19	27874073	0	O
mutants	27874073	0	O
accumulated	27874073	0	O
SA	27874073	0	O
and	27874073	0	O
showed	27874073	0	O
high	27874073	0	O
sensitivity	27874073	0	O
to	27874073	0	O
the	27874073	0	O
hormone	27874073	0	O
.	27874073	0	O
Our	27874073	0	O
findings	27874073	0	O
demonstrate	27874073	0	O
that	27874073	0	O
ANUDX19	27874073	0	O
acts	27874073	0	O
as	27874073	0	O
an	27874073	0	O
NADPH	27874073	0	O
pyrophosphohydrolase	27874073	0	O
to	27874073	0	O
modulate	27874073	0	O
cellular	27874073	0	O
levels	27874073	0	O
and	27874073	0	O
redox	27874073	0	O
states	27874073	0	O
of	27874073	0	O
pyridine	27874073	0	O
nucleotides	27874073	0	O
and	27874073	0	O
fine	27874073	0	O
-	27874073	0	O
tunes	27874073	0	O
photooxidative	27874073	0	O
stress	27874073	0	O
response	27874073	0	O
through	27874073	0	O
the	27874073	0	O
regulation	27874073	0	O
of	27874073	0	O
photosynthesis	27874073	0	O
,	27874073	0	O
antioxidant	27874073	0	O
system	27874073	0	O
,	27874073	0	O
and	27874073	0	O
possibly	27874073	0	O
hormonal	27874073	0	O
signaling	27874073	0	O
.	27874073	0	O

Compound	27878139	1	O
heterozygous	27878139	1	O
LDLR	27878139	1	O
variant	27878139	1	O
in	27878139	1	O
severely	27878139	1	O
affected	27878139	1	O
familial	27878139	1	O
hypercholesterolemia	27878139	1	O
patient	27878139	1	O
.	27878139	1	O
Familial	27878139	1	B-Disease
hypercholesterolemia	27878139	1	I-Disease
(	27878139	1	O
FH	27878139	1	O
)	27878139	1	O
is	27878139	1	O
most	27878139	1	O
commonly	27878139	1	O
caused	27878139	1	B-Reg
by	27878139	1	I-Reg
mutations	27878139	1	B-Var
in	27878139	1	O
the	27878139	1	O
LDL	27878139	1	O
receptor	27878139	1	O
(	27878139	1	B-Gene
LDLR	27878139	1	I-Gene
)	27878139	1	I-Gene
,	27878139	1	O
which	27878139	1	O
is	27878139	1	O
responsible	27878139	1	O
for	27878139	1	O
hepatic	27878139	1	O
clearance	27878139	1	O
of	27878139	1	O
LDL	27878139	1	O
from	27878139	1	O
the	27878139	1	O
blood	27878139	1	O
circulation	27878139	1	O
.	27878139	1	O
We	27878139	1	O
described	27878139	1	O
a	27878139	1	O
severely	27878139	1	O
affected	27878139	1	O
FH	27878139	1	O
proband	27878139	1	O
and	27878139	1	O
their	27878139	1	O
first	27878139	1	O
-	27878139	1	O
degree	27878139	1	O
blood	27878139	1	O
relatives	27878139	1	O
;	27878139	1	O
the	27878139	1	O
proband	27878139	1	O
was	27878139	1	O
resistant	27878139	1	O
to	27878139	1	O
statin	27878139	1	O
therapy	27878139	1	O
and	27878139	1	O
was	27878139	1	O
managed	27878139	1	O
on	27878139	1	O
an	27878139	1	O
LDL	27878139	1	O
apheresis	27878139	1	O
program	27878139	1	O
.	27878139	1	O
In	27878139	1	O
order	27878139	1	O
to	27878139	1	O
find	27878139	1	O
the	27878139	1	O
causative	27878139	1	O
genetic	27878139	1	O
variant	27878139	1	O
in	27878139	1	O
this	27878139	1	O
family	27878139	1	O
,	27878139	1	O
direct	27878139	1	O
exon	27878139	1	O
sequencing	27878139	1	O
of	27878139	1	O
the	27878139	1	O
LDLR	27878139	1	O
,	27878139	1	O
APOB	27878139	1	O
and	27878139	1	O
PCSK9	27878139	1	O
genes	27878139	1	O
was	27878139	1	O
performed	27878139	1	O
.	27878139	1	O
We	27878139	1	O
identified	27878139	1	O
a	27878139	1	O
compound	27878139	1	O
heterozygous	27878139	1	O
mutation	27878139	1	O
in	27878139	1	O
the	27878139	1	O
proband	27878139	1	O
with	27878139	1	O
missense	27878139	1	O
p.(W577C)	27878139	1	O
and	27878139	1	O
frameshift	27878139	1	O
p.(G676Afs33)	27878139	1	O
variants	27878139	1	O
at	27878139	1	O
exons	27878139	1	O
12	27878139	1	O
and	27878139	1	O
14	27878139	1	O
of	27878139	1	O
the	27878139	1	O
LDLR	27878139	1	O
gene	27878139	1	O
respectively	27878139	1	O
.	27878139	1	O
DNA	27878139	1	O
sequencing	27878139	1	O
of	27878139	1	O
LDLR	27878139	1	O
gene	27878139	1	O
from	27878139	1	O
the	27878139	1	O
parents	27878139	1	O
demonstrated	27878139	1	O
that	27878139	1	O
the	27878139	1	O
missense	27878139	1	O
variant	27878139	1	O
was	27878139	1	O
inherited	27878139	1	O
from	27878139	1	O
the	27878139	1	O
mother	27878139	1	O
and	27878139	1	O
frameshift	27878139	1	O
variant	27878139	1	O
was	27878139	1	O
inherited	27878139	1	O
from	27878139	1	O
the	27878139	1	O
father	27878139	1	O
.	27878139	1	O
The	27878139	1	O
frameshift	27878139	1	B-Var
variant	27878139	1	I-Var
resulted	27878139	1	O
in	27878139	1	O
a	27878139	1	O
stop	27878139	1	O
signal	27878139	1	O
33	27878139	1	O
codons	27878139	1	O
downstream	27878139	1	O
of	27878139	1	O
the	27878139	1	O
deletion	27878139	1	B-NegReg
,	27878139	1	O
which	27878139	1	O
most	27878139	1	O
likely	27878139	1	O
led	27878139	1	O
to	27878139	1	O
a	27878139	1	O
truncated	27878139	1	O
protein	27878139	1	O
that	27878139	1	O
lacks	27878139	1	B-NegReg
important	27878139	1	O
functional	27878139	1	O
domains	27878139	1	O
,	27878139	1	O
including	27878139	1	O
the	27878139	1	O
trans	27878139	1	O
-	27878139	1	O
membrane	27878139	1	O
domain	27878139	1	O
and	27878139	1	O
the	27878139	1	O
cytoplasmic	27878139	1	O
tail	27878139	1	O
domain	27878139	1	O
.	27878139	1	O
The	27878139	1	O
missense	27878139	1	O
variant	27878139	1	O
is	27878139	1	O
also	27878139	1	O
predicted	27878139	1	O
to	27878139	1	O
be	27878139	1	O
likely	27878139	1	O
pathogenic	27878139	1	O
and	27878139	1	O
affect	27878139	1	O
EGF	27878139	1	O
-	27878139	1	O
precursor	27878139	1	O
homology	27878139	1	O
domain	27878139	1	O
of	27878139	1	O
the	27878139	1	O
LDLR	27878139	1	O
protein	27878139	1	O
.	27878139	1	O
The	27878139	1	O
segregation	27878139	1	O
pattern	27878139	1	O
of	27878139	1	O
the	27878139	1	O
variants	27878139	1	O
was	27878139	1	O
consistent	27878139	1	O
with	27878139	1	O
the	27878139	1	O
lipid	27878139	1	O
profile	27878139	1	O
,	27878139	1	O
suggesting	27878139	1	O
a	27878139	1	O
more	27878139	1	O
severe	27878139	1	O
FH	27878139	1	O
phenotype	27878139	1	O
when	27878139	1	O
the	27878139	1	O
variants	27878139	1	O
are	27878139	1	O
in	27878139	1	O
the	27878139	1	O
compound	27878139	1	O
heterozygous	27878139	1	O
state	27878139	1	O
.	27878139	1	O
The	27878139	1	O
finding	27878139	1	O
of	27878139	1	O
a	27878139	1	O
compound	27878139	1	O
heterozygous	27878139	1	O
mutation	27878139	1	O
causing	27878139	1	O
severe	27878139	1	O
FH	27878139	1	O
phenotype	27878139	1	O
is	27878139	1	O
important	27878139	1	O
for	27878139	1	O
the	27878139	1	O
genotype	27878139	1	O
-	27878139	1	O
phenotype	27878139	1	O
correlation	27878139	1	O
and	27878139	1	O
also	27878139	1	O
enlarges	27878139	1	O
the	27878139	1	O
spectrum	27878139	1	O
of	27878139	1	O
FH	27878139	1	O
-	27878139	1	O
causative	27878139	1	O
LDLR	27878139	1	O
variants	27878139	1	O
in	27878139	1	O
the	27878139	1	O
Arab	27878139	1	O
population	27878139	1	O
,	27878139	1	O
including	27878139	1	O
the	27878139	1	O
Saudi	27878139	1	O
population	27878139	1	O
.	27878139	1	O

Activity	27882351	0	O
of	27882351	0	O
NaV1.2	27882351	0	O
promotes	27882351	0	O
neurodegeneration	27882351	0	O
in	27882351	0	O
an	27882351	0	O
animal	27882351	0	O
model	27882351	0	O
of	27882351	0	O
multiple	27882351	0	O
sclerosis	27882351	0	O
.	27882351	0	O
Counteracting	27882351	0	O
the	27882351	0	O
progressive	27882351	0	O
neurological	27882351	0	O
disability	27882351	0	O
caused	27882351	0	O
by	27882351	0	O
neuronal	27882351	0	O
and	27882351	0	O
axonal	27882351	0	O
loss	27882351	0	O
is	27882351	0	O
the	27882351	0	O
major	27882351	0	O
unmet	27882351	0	O
clinical	27882351	0	O
need	27882351	0	O
in	27882351	0	O
multiple	27882351	0	O
sclerosis	27882351	0	O
therapy	27882351	0	O
.	27882351	0	O
However	27882351	0	O
,	27882351	0	O
the	27882351	0	O
mechanisms	27882351	0	O
underlying	27882351	0	O
irreversible	27882351	0	O
neuroaxonal	27882351	0	O
degeneration	27882351	0	O
in	27882351	0	O
multiple	27882351	0	O
sclerosis	27882351	0	O
and	27882351	0	O
its	27882351	0	O
animal	27882351	0	O
model	27882351	0	O
experimental	27882351	0	O
autoimmune	27882351	0	O
encephalomyelitis	27882351	0	O
(	27882351	0	O
EAE	27882351	0	O
)	27882351	0	O
are	27882351	0	O
not	27882351	0	O
well	27882351	0	O
understood	27882351	0	O
.	27882351	0	O
A	27882351	0	O
long	27882351	0	O
-	27882351	0	O
standing	27882351	0	O
hypothesis	27882351	0	O
holds	27882351	0	O
that	27882351	0	O
the	27882351	0	O
distribution	27882351	0	O
of	27882351	0	O
voltage	27882351	0	O
-	27882351	0	O
gated	27882351	0	O
sodium	27882351	0	O
channels	27882351	0	O
along	27882351	0	O
demyelinated	27882351	0	O
axons	27882351	0	O
contributes	27882351	0	O
to	27882351	0	O
neurodegeneration	27882351	0	O
by	27882351	0	O
increasing	27882351	0	O
neuroaxonal	27882351	0	O
sodium	27882351	0	O
influx	27882351	0	O
and	27882351	0	O
energy	27882351	0	O
demand	27882351	0	O
during	27882351	0	O
CNS	27882351	0	O
inflammation	27882351	0	O
.	27882351	0	O
Here	27882351	0	O
,	27882351	0	O
we	27882351	0	O
tested	27882351	0	O
this	27882351	0	O
hypothesis	27882351	0	O
in	27882351	0	O
vivo	27882351	0	O
by	27882351	0	O
inserting	27882351	0	O
a	27882351	0	O
human	27882351	0	O
gain	27882351	0	B-PosReg
-	27882351	0	I-PosReg
of	27882351	0	I-PosReg
-	27882351	0	I-PosReg
function	27882351	0	I-PosReg
mutation	27882351	0	B-Var
in	27882351	0	O
the	27882351	0	O
mouse	27882351	0	O
NaV1.2	27882351	0	O
-	27882351	0	O
encoding	27882351	0	O
gene	27882351	0	O
Scn2a	27882351	0	B-Gene
that	27882351	0	O
is	27882351	0	O
known	27882351	0	O
to	27882351	0	O
increase	27882351	0	O
NaV1.2	27882351	0	O
-	27882351	0	O
mediated	27882351	0	O
persistent	27882351	0	O
sodium	27882351	0	O
currents	27882351	0	O
.	27882351	0	O
In	27882351	0	O
mutant	27882351	0	O
mice	27882351	0	O
,	27882351	0	O
CNS	27882351	0	O
inflammation	27882351	0	O
during	27882351	0	O
EAE	27882351	0	O
leads	27882351	0	O
to	27882351	0	O
elevated	27882351	0	B-PosReg
neuroaxonal	27882351	0	O
degeneration	27882351	0	O
and	27882351	0	O
increased	27882351	0	B-PosReg
disability	27882351	0	O
and	27882351	0	O
lethality	27882351	0	O
compared	27882351	0	O
with	27882351	0	O
wild	27882351	0	O
-	27882351	0	O
type	27882351	0	O
littermate	27882351	0	O
controls	27882351	0	O
.	27882351	0	O
Importantly	27882351	0	O
,	27882351	0	O
immune	27882351	0	O
cell	27882351	0	O
infiltrates	27882351	0	O
were	27882351	0	O
not	27882351	0	O
different	27882351	0	O
between	27882351	0	O
mutant	27882351	0	O
EAE	27882351	0	O
mice	27882351	0	O
and	27882351	0	O
wild	27882351	0	O
-	27882351	0	O
type	27882351	0	O
EAE	27882351	0	O
mice	27882351	0	O
.	27882351	0	O
Thus	27882351	0	O
,	27882351	0	O
this	27882351	0	O
study	27882351	0	O
shows	27882351	0	O
that	27882351	0	O
increased	27882351	0	O
neuronal	27882351	0	O
NaV1.2	27882351	0	O
activity	27882351	0	O
exacerbates	27882351	0	O
inflammation	27882351	0	O
-	27882351	0	O
induced	27882351	0	O
neurodegeneration	27882351	0	O
irrespective	27882351	0	O
of	27882351	0	O
immune	27882351	0	O
cell	27882351	0	O
alterations	27882351	0	O
and	27882351	0	O
identifies	27882351	0	O
NaV1.2	27882351	0	O
as	27882351	0	O
a	27882351	0	O
promising	27882351	0	O
neuroprotective	27882351	0	O
drug	27882351	0	O
target	27882351	0	O
in	27882351	0	O
multiple	27882351	0	O
sclerosis	27882351	0	O
.	27882351	0	O

Exome	27900366	2	O
sequencing	27900366	2	O
reveals	27900366	2	O
germline	27900366	2	O
gain	27900366	2	B-PosReg
-	27900366	2	I-PosReg
of	27900366	2	I-PosReg
-	27900366	2	I-PosReg
function	27900366	2	I-PosReg
EGFR	27900366	2	B-Gene
mutation	27900366	2	B-Var
in	27900366	2	O
an	27900366	2	O
adult	27900366	2	O
with	27900366	2	O
Lhermitte	27900366	2	B-Disease
-	27900366	2	I-Disease
Duclos	27900366	2	I-Disease
disease	27900366	2	I-Disease
.	27900366	2	O
Lhermitte	27900366	2	B-Disease
-	27900366	2	I-Disease
Duclos	27900366	2	I-Disease
disease	27900366	2	I-Disease
(	27900366	2	O
LDD	27900366	2	O
)	27900366	2	O
is	27900366	2	O
a	27900366	2	O
rare	27900366	2	O
cerebellar	27900366	2	O
disorder	27900366	2	O
believed	27900366	2	O
to	27900366	2	O
be	27900366	2	O
pathognomonic	27900366	2	O
for	27900366	2	O
Cowden	27900366	2	O
syndrome	27900366	2	O
.	27900366	2	O
Presently	27900366	2	O
,	27900366	2	O
the	27900366	2	O
only	27900366	2	O
known	27900366	2	O
etiology	27900366	2	B-Reg
is	27900366	2	O
germline	27900366	2	O
PTEN	27900366	2	B-Gene
mutation	27900366	2	B-Var
.	27900366	2	O
We	27900366	2	O
report	27900366	2	O
a	27900366	2	O
41	27900366	2	O
-	27900366	2	O
yr	27900366	2	O
-	27900366	2	O
old	27900366	2	O
white	27900366	2	O
female	27900366	2	O
diagnosed	27900366	2	O
with	27900366	2	O
LDD	27900366	2	O
and	27900366	2	O
wild	27900366	2	O
-	27900366	2	O
type	27900366	2	O
for	27900366	2	O
PTEN	27900366	2	O
.	27900366	2	O
Exome	27900366	2	O
sequencing	27900366	2	O
revealed	27900366	2	O
a	27900366	2	O
germline	27900366	2	O
heterozygous	27900366	2	O
EGFR	27900366	2	B-Gene
mutation	27900366	2	B-Var
that	27900366	2	O
breaks	27900366	2	B-NegReg
a	27900366	2	O
disulfide	27900366	2	O
bond	27900366	2	O
in	27900366	2	O
the	27900366	2	O
receptor	27900366	2	O
'	27900366	2	O
s	27900366	2	O
extracellular	27900366	2	O
domain	27900366	2	O
,	27900366	2	O
resulting	27900366	2	O
in	27900366	2	O
constitutive	27900366	2	O
activation	27900366	2	B-PosReg
.	27900366	2	O
Functional	27900366	2	O
studies	27900366	2	O
demonstrate	27900366	2	O
activation	27900366	2	B-PosReg
of	27900366	2	O
ERK	27900366	2	O
/	27900366	2	O
AKT	27900366	2	O
signaling	27900366	2	O
pathways	27900366	2	O
,	27900366	2	O
mimicking	27900366	2	O
PTEN	27900366	2	B-Gene
loss	27900366	2	B-NegReg
-	27900366	2	I-NegReg
of	27900366	2	I-NegReg
-	27900366	2	I-NegReg
function	27900366	2	I-NegReg
downstream	27900366	2	O
effects	27900366	2	O
.	27900366	2	O
The	27900366	2	O
identification	27900366	2	O
of	27900366	2	O
EGFR	27900366	2	O
as	27900366	2	O
a	27900366	2	O
candidate	27900366	2	O
LDD	27900366	2	O
susceptibility	27900366	2	O
gene	27900366	2	O
contributes	27900366	2	O
to	27900366	2	O
advancement	27900366	2	O
of	27900366	2	O
molecular	27900366	2	O
diagnosis	27900366	2	O
and	27900366	2	O
targeted	27900366	2	O
therapy	27900366	2	O
for	27900366	2	O
this	27900366	2	O
rare	27900366	2	O
condition	27900366	2	O
with	27900366	2	O
limited	27900366	2	O
treatment	27900366	2	O
options	27900366	2	O
.	27900366	2	O

GBA2	28052128	3	B-Gene
Mutations	28052128	3	B-Var
Cause	28052128	3	B-Reg
a	28052128	3	O
Marinesco	28052128	3	B-Disease
-	28052128	3	I-Disease
Sjögren	28052128	3	I-Disease
-	28052128	3	I-Disease
Like	28052128	3	I-Disease
Syndrome	28052128	3	I-Disease
:	28052128	3	I-Disease
Genetic	28052128	3	O
and	28052128	3	O
Biochemical	28052128	3	O
Studies	28052128	3	O
.	28052128	3	O
BACKGROUND	28052128	3	O
:	28052128	3	O
With	28052128	3	O
the	28052128	3	O
advent	28052128	3	O
new	28052128	3	O
sequencing	28052128	3	O
technologies	28052128	3	O
,	28052128	3	O
we	28052128	3	O
now	28052128	3	O
have	28052128	3	O
the	28052128	3	O
tools	28052128	3	O
to	28052128	3	O
understand	28052128	3	O
the	28052128	3	O
phenotypic	28052128	3	O
diversity	28052128	3	O
and	28052128	3	O
the	28052128	3	O
common	28052128	3	O
occurrence	28052128	3	O
of	28052128	3	O
phenocopies	28052128	3	O
.	28052128	3	O
We	28052128	3	O
used	28052128	3	O
these	28052128	3	O
techniques	28052128	3	O
to	28052128	3	O
investigate	28052128	3	O
two	28052128	3	O
Norwegian	28052128	3	O
families	28052128	3	O
with	28052128	3	O
an	28052128	3	O
autosomal	28052128	3	O
recessive	28052128	3	O
cerebellar	28052128	3	O
ataxia	28052128	3	O
with	28052128	3	O
cataracts	28052128	3	O
and	28052128	3	O
mental	28052128	3	O
retardation	28052128	3	O
.	28052128	3	O
METHODS	28052128	3	O
AND	28052128	3	O
RESULTS	28052128	3	O
:	28052128	3	O
Single	28052128	3	O
nucleotide	28052128	3	O
polymorphism	28052128	3	O
(	28052128	3	O
SNP	28052128	3	O
)	28052128	3	O
chip	28052128	3	O
analysis	28052128	3	O
followed	28052128	3	O
by	28052128	3	O
Exome	28052128	3	O
sequencing	28052128	3	O
identified	28052128	3	O
a	28052128	3	O
2	28052128	3	O
bp	28052128	3	O
homozygous	28052128	3	O
deletion	28052128	3	O
in	28052128	3	O
GBA2	28052128	3	O
in	28052128	3	O
both	28052128	3	O
families	28052128	3	O
,	28052128	3	O
c.1528	28052128	3	B-Var
_1529del	28052128	3	I-Var
[	28052128	3	O
p.Met510Valfs*17	28052128	3	O
]	28052128	3	O
.	28052128	3	O
Furthermore	28052128	3	O
,	28052128	3	O
we	28052128	3	O
report	28052128	3	O
the	28052128	3	O
biochemical	28052128	3	O
characterization	28052128	3	O
of	28052128	3	O
GBA2	28052128	3	O
in	28052128	3	O
these	28052128	3	O
patients	28052128	3	O
.	28052128	3	O
Our	28052128	3	O
studies	28052128	3	O
show	28052128	3	O
that	28052128	3	O
a	28052128	3	O
reduced	28052128	3	B-NegReg
activity	28052128	3	O
of	28052128	3	O
GBA2	28052128	3	B-Gene
is	28052128	3	O
sufficient	28052128	3	O
to	28052128	3	O
elevate	28052128	3	B-PosReg
the	28052128	3	O
levels	28052128	3	O
of	28052128	3	O
glucosylceramide	28052128	3	O
to	28052128	3	O
similar	28052128	3	O
levels	28052128	3	O
as	28052128	3	O
seen	28052128	3	O
in	28052128	3	O
Gaucher	28052128	3	O
disease	28052128	3	O
.	28052128	3	O
Furthermore	28052128	3	O
,	28052128	3	O
leucocytes	28052128	3	O
seem	28052128	3	O
to	28052128	3	O
be	28052128	3	O
the	28052128	3	O
proper	28052128	3	O
enzyme	28052128	3	O
source	28052128	3	O
for	28052128	3	O
in	28052128	3	O
vitro	28052128	3	O
analysis	28052128	3	O
of	28052128	3	O
GBA2	28052128	3	O
activity	28052128	3	O
.	28052128	3	O
CONCLUSIONS	28052128	3	O
:	28052128	3	O
We	28052128	3	O
report	28052128	3	O
GBA2	28052128	3	B-Gene
mutations	28052128	3	B-Var
causing	28052128	3	B-Reg
a	28052128	3	O
Marinesco	28052128	3	B-Disease
-	28052128	3	I-Disease
Sjögren	28052128	3	I-Disease
-	28052128	3	I-Disease
like	28052128	3	I-Disease
syndrome	28052128	3	I-Disease
in	28052128	3	O
two	28052128	3	O
Norwegian	28052128	3	O
families	28052128	3	O
.	28052128	3	O
One	28052128	3	O
of	28052128	3	O
the	28052128	3	O
families	28052128	3	O
was	28052128	3	O
originally	28052128	3	O
diagnosed	28052128	3	O
with	28052128	3	O
Marinesco	28052128	3	O
-	28052128	3	O
Sjögren	28052128	3	O
syndrome	28052128	3	O
based	28052128	3	O
on	28052128	3	O
an	28052128	3	O
autosomal	28052128	3	O
recessive	28052128	3	O
cerebellar	28052128	3	O
ataxia	28052128	3	O
with	28052128	3	O
cataracts	28052128	3	O
and	28052128	3	O
mental	28052128	3	O
retardation	28052128	3	O
.	28052128	3	O
Our	28052128	3	O
findings	28052128	3	O
highlight	28052128	3	O
the	28052128	3	O
phenotypic	28052128	3	O
variability	28052128	3	O
associated	28052128	3	O
with	28052128	3	O
GBA2	28052128	3	O
mutations	28052128	3	O
,	28052128	3	O
and	28052128	3	O
suggest	28052128	3	O
that	28052128	3	O
patients	28052128	3	O
with	28052128	3	O
Marinesco	28052128	3	O
-	28052128	3	O
Sjögren	28052128	3	O
-	28052128	3	O
like	28052128	3	O
syndromes	28052128	3	O
should	28052128	3	O
be	28052128	3	O
tested	28052128	3	O
for	28052128	3	O
mutations	28052128	3	O
in	28052128	3	O
this	28052128	3	O
gene	28052128	3	O
.	28052128	3	O

Compound	28054739	1	O
Heterozygosity	28054739	1	O
for	28054739	1	O
Null	28054739	1	B-Var
Mutations	28054739	1	I-Var
and	28054739	1	O
a	28054739	1	O
Common	28054739	1	O
Hypomorphic	28054739	1	O
Risk	28054739	1	O
Haplotype	28054739	1	O
in	28054739	1	O
TBX6	28054739	1	B-Gene
Causes	28054739	1	B-Reg
Congenital	28054739	1	B-Disease
Scoliosis	28054739	1	I-Disease
.	28054739	1	O
Congenital	28054739	1	O
scoliosis	28054739	1	O
(	28054739	1	O
CS	28054739	1	O
)	28054739	1	O
occurs	28054739	1	O
as	28054739	1	O
a	28054739	1	O
result	28054739	1	O
of	28054739	1	O
vertebral	28054739	1	O
malformations	28054739	1	O
and	28054739	1	O
has	28054739	1	O
an	28054739	1	O
incidence	28054739	1	O
of	28054739	1	O
0.5	28054739	1	O
-	28054739	1	O
1	28054739	1	O
/	28054739	1	O
1	28054739	1	O
,	28054739	1	O
000	28054739	1	O
births	28054739	1	O
.	28054739	1	O
Recently	28054739	1	O
,	28054739	1	O
TBX6	28054739	1	O
on	28054739	1	O
chromosome	28054739	1	O
16	28054739	1	O
p11.2	28054739	1	O
was	28054739	1	O
reported	28054739	1	O
as	28054739	1	O
a	28054739	1	O
disease	28054739	1	O
gene	28054739	1	O
for	28054739	1	O
CS	28054739	1	O
;	28054739	1	O
about	28054739	1	O
10%	28054739	1	O
of	28054739	1	O
Chinese	28054739	1	O
CS	28054739	1	O
patients	28054739	1	O
were	28054739	1	O
compound	28054739	1	O
heterozygotes	28054739	1	O
for	28054739	1	O
rare	28054739	1	O
null	28054739	1	O
mutations	28054739	1	O
and	28054739	1	O
a	28054739	1	O
common	28054739	1	O
haplotype	28054739	1	O
defined	28054739	1	O
by	28054739	1	O
three	28054739	1	O
SNPs	28054739	1	O
in	28054739	1	O
TBX6	28054739	1	O
.	28054739	1	O
All	28054739	1	O
patients	28054739	1	O
had	28054739	1	O
hemivertebrae	28054739	1	O
.	28054739	1	O
We	28054739	1	O
recruited	28054739	1	O
94	28054739	1	O
Japanese	28054739	1	O
CS	28054739	1	O
patients	28054739	1	O
,	28054739	1	O
investigated	28054739	1	O
the	28054739	1	O
TBX6	28054739	1	O
locus	28054739	1	O
for	28054739	1	O
both	28054739	1	O
mutations	28054739	1	O
and	28054739	1	O
the	28054739	1	O
risk	28054739	1	O
haplotype	28054739	1	O
,	28054739	1	O
examined	28054739	1	O
transcriptional	28054739	1	O
activities	28054739	1	O
of	28054739	1	O
mutant	28054739	1	O
TBX6	28054739	1	O
in	28054739	1	O
vitro	28054739	1	O
,	28054739	1	O
and	28054739	1	O
evaluated	28054739	1	O
clinical	28054739	1	O
and	28054739	1	O
radiographic	28054739	1	O
features	28054739	1	O
.	28054739	1	O
We	28054739	1	O
identified	28054739	1	O
TBX6	28054739	1	O
null	28054739	1	O
mutations	28054739	1	O
in	28054739	1	O
nine	28054739	1	O
patients	28054739	1	O
,	28054739	1	O
including	28054739	1	O
a	28054739	1	O
missense	28054739	1	O
mutation	28054739	1	O
that	28054739	1	O
had	28054739	1	O
a	28054739	1	O
loss	28054739	1	O
of	28054739	1	O
function	28054739	1	O
in	28054739	1	O
vitro	28054739	1	O
.	28054739	1	O
All	28054739	1	O
had	28054739	1	O
the	28054739	1	O
risk	28054739	1	O
haplotype	28054739	1	O
in	28054739	1	O
the	28054739	1	O
opposite	28054739	1	O
allele	28054739	1	O
.	28054739	1	O
One	28054739	1	O
of	28054739	1	O
the	28054739	1	O
mutations	28054739	1	O
showed	28054739	1	O
dominant	28054739	1	O
negative	28054739	1	O
effect	28054739	1	O
.	28054739	1	O
Although	28054739	1	O
all	28054739	1	O
Chinese	28054739	1	O
patients	28054739	1	O
had	28054739	1	O
one	28054739	1	O
or	28054739	1	O
more	28054739	1	O
hemivertebrae	28054739	1	O
,	28054739	1	O
two	28054739	1	O
Japanese	28054739	1	O
patients	28054739	1	O
did	28054739	1	O
not	28054739	1	O
have	28054739	1	O
hemivertebra	28054739	1	O
.	28054739	1	O
The	28054739	1	O
compound	28054739	1	O
heterozygosity	28054739	1	O
of	28054739	1	O
null	28054739	1	O
mutations	28054739	1	O
and	28054739	1	O
the	28054739	1	O
common	28054739	1	O
risk	28054739	1	O
haplotype	28054739	1	O
in	28054739	1	O
TBX6	28054739	1	O
also	28054739	1	O
causes	28054739	1	O
CS	28054739	1	O
in	28054739	1	O
Japanese	28054739	1	O
patients	28054739	1	O
with	28054739	1	O
similar	28054739	1	O
incidence	28054739	1	O
.	28054739	1	O
Hemivertebra	28054739	1	O
was	28054739	1	O
not	28054739	1	O
a	28054739	1	O
specific	28054739	1	O
type	28054739	1	O
of	28054739	1	O
spinal	28054739	1	O
malformation	28054739	1	O
in	28054739	1	O
TBX6	28054739	1	O
-	28054739	1	O
associated	28054739	1	O
CS	28054739	1	O
(	28054739	1	O
TACS	28054739	1	O
)	28054739	1	O
.	28054739	1	O
A	28054739	1	O
heterozygous	28054739	1	O
TBX6	28054739	1	B-Gene
loss	28054739	1	B-NegReg
-	28054739	1	I-NegReg
of	28054739	1	I-NegReg
-	28054739	1	I-NegReg
function	28054739	1	I-NegReg
mutation	28054739	1	B-Var
has	28054739	1	O
been	28054739	1	O
reported	28054739	1	O
in	28054739	1	O
a	28054739	1	O
family	28054739	1	O
with	28054739	1	O
autosomal	28054739	1	B-Disease
-	28054739	1	I-Disease
dominant	28054739	1	I-Disease
spondylocostal	28054739	1	I-Disease
dysostosis	28054739	1	I-Disease
,	28054739	1	O
but	28054739	1	O
it	28054739	1	O
may	28054739	1	O
represent	28054739	1	O
a	28054739	1	O
spectrum	28054739	1	O
of	28054739	1	O
the	28054739	1	O
same	28054739	1	O
disease	28054739	1	O
with	28054739	1	O
TACS	28054739	1	O
.	28054739	1	O

Aspartylglucosaminuria	28063748	4	B-Disease
caused	28063748	4	B-Reg
by	28063748	4	I-Reg
a	28063748	4	O
novel	28063748	4	O
homozygous	28063748	4	O
mutation	28063748	4	B-Var
in	28063748	4	O
the	28063748	4	O
AGA	28063748	4	B-Gene
gene	28063748	4	O
was	28063748	4	O
identified	28063748	4	O
by	28063748	4	O
an	28063748	4	O
exome	28063748	4	O
-	28063748	4	O
first	28063748	4	O
approach	28063748	4	O
in	28063748	4	O
a	28063748	4	O
patient	28063748	4	O
from	28063748	4	O
Japan	28063748	4	O
.	28063748	4	O
BACKGROUND	28063748	4	O
:	28063748	4	O
Aspartylglucosaminuria	28063748	4	O
(	28063748	4	O
AGU	28063748	4	O
)	28063748	4	O
is	28063748	4	O
an	28063748	4	O
autosomal	28063748	4	O
recessive	28063748	4	O
lysosomal	28063748	4	O
storage	28063748	4	O
disorder	28063748	4	O
caused	28063748	4	O
by	28063748	4	O
a	28063748	4	O
deficiency	28063748	4	O
of	28063748	4	O
the	28063748	4	O
lysosomal	28063748	4	O
enzyme	28063748	4	O
,	28063748	4	O
aspartylglucosaminidase	28063748	4	O
(	28063748	4	O
AGA	28063748	4	O
)	28063748	4	O
.	28063748	4	O
This	28063748	4	O
disorder	28063748	4	O
is	28063748	4	O
rare	28063748	4	O
in	28063748	4	O
the	28063748	4	O
general	28063748	4	O
population	28063748	4	O
except	28063748	4	O
in	28063748	4	O
Finland	28063748	4	O
.	28063748	4	O
Since	28063748	4	O
the	28063748	4	O
most	28063748	4	O
characteristic	28063748	4	O
feature	28063748	4	O
of	28063748	4	O
this	28063748	4	O
disorder	28063748	4	O
is	28063748	4	O
a	28063748	4	O
progressive	28063748	4	O
developmental	28063748	4	O
regression	28063748	4	O
,	28063748	4	O
patients	28063748	4	O
often	28063748	4	O
show	28063748	4	O
no	28063748	4	O
specific	28063748	4	O
symptoms	28063748	4	O
in	28063748	4	O
the	28063748	4	O
initial	28063748	4	O
stages	28063748	4	O
,	28063748	4	O
and	28063748	4	O
thus	28063748	4	O
early	28063748	4	O
diagnosis	28063748	4	O
is	28063748	4	O
often	28063748	4	O
challenging	28063748	4	O
.	28063748	4	O
CASE	28063748	4	O
REPORT	28063748	4	O
:	28063748	4	O
We	28063748	4	O
encountered	28063748	4	O
a	28063748	4	O
16	28063748	4	O
-	28063748	4	O
year	28063748	4	O
-	28063748	4	O
old	28063748	4	O
boy	28063748	4	O
who	28063748	4	O
began	28063748	4	O
to	28063748	4	O
show	28063748	4	O
difficulties	28063748	4	O
in	28063748	4	O
his	28063748	4	O
speech	28063748	4	O
at	28063748	4	O
the	28063748	4	O
age	28063748	4	O
of	28063748	4	O
6	28063748	4	O
years	28063748	4	O
.	28063748	4	O
Due	28063748	4	O
to	28063748	4	O
a	28063748	4	O
mild	28063748	4	O
regression	28063748	4	O
in	28063748	4	O
his	28063748	4	O
development	28063748	4	O
,	28063748	4	O
he	28063748	4	O
gradually	28063748	4	O
lost	28063748	4	O
common	28063748	4	O
daily	28063748	4	O
abilities	28063748	4	O
.	28063748	4	O
His	28063748	4	O
diagnosis	28063748	4	O
was	28063748	4	O
first	28063748	4	O
obtained	28063748	4	O
through	28063748	4	O
exome	28063748	4	O
sequencing	28063748	4	O
that	28063748	4	O
identified	28063748	4	O
a	28063748	4	O
novel	28063748	4	O
homozygous	28063748	4	O
mutation	28063748	4	O
in	28063748	4	O
the	28063748	4	O
AGA	28063748	4	O
gene	28063748	4	O
.	28063748	4	O
This	28063748	4	O
result	28063748	4	O
was	28063748	4	O
reasonable	28063748	4	O
because	28063748	4	O
of	28063748	4	O
parental	28063748	4	O
consanguinity	28063748	4	O
.	28063748	4	O
Reduced	28063748	4	O
enzymatic	28063748	4	O
activity	28063748	4	O
of	28063748	4	O
AGA	28063748	4	O
was	28063748	4	O
then	28063748	4	O
confirmed	28063748	4	O
.	28063748	4	O
His	28063748	4	O
urine	28063748	4	O
was	28063748	4	O
retrospectively	28063748	4	O
screened	28063748	4	O
by	28063748	4	O
matrix	28063748	4	O
-	28063748	4	O
assisted	28063748	4	O
laser	28063748	4	O
desorption	28063748	4	O
/	28063748	4	O
ionization	28063748	4	O
time	28063748	4	O
-	28063748	4	O
of	28063748	4	O
-	28063748	4	O
flight	28063748	4	O
mass	28063748	4	O
spectrometry	28063748	4	O
(	28063748	4	O
MALDI	28063748	4	O
-	28063748	4	O
TOF	28063748	4	O
-	28063748	4	O
MS	28063748	4	O
)	28063748	4	O
and	28063748	4	O
a	28063748	4	O
specific	28063748	4	O
pattern	28063748	4	O
of	28063748	4	O
abnormal	28063748	4	O
metabolites	28063748	4	O
was	28063748	4	O
identified	28063748	4	O
.	28063748	4	O
CONCLUSIONS	28063748	4	O
:	28063748	4	O
Because	28063748	4	O
both	28063748	4	O
exome	28063748	4	O
sequencing	28063748	4	O
and	28063748	4	O
MALDI	28063748	4	O
-	28063748	4	O
TOF	28063748	4	O
-	28063748	4	O
MS	28063748	4	O
screening	28063748	4	O
are	28063748	4	O
adaptable	28063748	4	O
and	28063748	4	O
comprehensive	28063748	4	O
,	28063748	4	O
future	28063748	4	O
combinatory	28063748	4	O
use	28063748	4	O
of	28063748	4	O
these	28063748	4	O
methods	28063748	4	O
would	28063748	4	O
be	28063748	4	O
useful	28063748	4	O
for	28063748	4	O
diagnosis	28063748	4	O
of	28063748	4	O
rare	28063748	4	O
inborn	28063748	4	O
errors	28063748	4	O
of	28063748	4	O
metabolism	28063748	4	O
such	28063748	4	O
as	28063748	4	O
AGU	28063748	4	O
.	28063748	4	O

WT1	28081536	1	O
Haploinsufficiency	28081536	1	O
Supports	28081536	1	O
Milder	28081536	1	O
Renal	28081536	1	O
Manifestation	28081536	1	O
in	28081536	1	O
Two	28081536	1	O
Patients	28081536	1	O
with	28081536	1	O
Denys	28081536	1	O
-	28081536	1	O
Drash	28081536	1	O
Syndrome	28081536	1	O
.	28081536	1	O
Denys	28081536	1	B-Disease
-	28081536	1	I-Disease
Drash	28081536	1	I-Disease
syndrome	28081536	1	I-Disease
(	28081536	1	O
DDS	28081536	1	O
)	28081536	1	O
is	28081536	1	O
characterized	28081536	1	O
by	28081536	1	O
nephropathy	28081536	1	O
,	28081536	1	O
genital	28081536	1	O
abnormalities	28081536	1	O
,	28081536	1	O
and	28081536	1	O
predisposition	28081536	1	O
to	28081536	1	O
Wilms	28081536	1	O
'	28081536	1	O
tumor	28081536	1	O
.	28081536	1	O
DDS	28081536	1	O
patients	28081536	1	O
usually	28081536	1	O
present	28081536	1	B-Reg
heterozygous	28081536	1	O
de	28081536	1	O
novo	28081536	1	O
germline	28081536	1	O
WT1	28081536	1	B-Gene
mutations	28081536	1	B-Var
.	28081536	1	O
The	28081536	1	O
WT1	28081536	1	O
gene	28081536	1	O
comprises	28081536	1	O
10	28081536	1	O
exons	28081536	1	O
encoding	28081536	1	O
the	28081536	1	O
N	28081536	1	O
-	28081536	1	O
terminal	28081536	1	O
transactivation	28081536	1	O
and	28081536	1	O
the	28081536	1	O
C	28081536	1	O
-	28081536	1	O
terminal	28081536	1	O
DNA	28081536	1	O
-	28081536	1	O
binding	28081536	1	O
regions	28081536	1	O
.	28081536	1	O
Two	28081536	1	O
unrelated	28081536	1	O
patients	28081536	1	O
with	28081536	1	O
genital	28081536	1	O
ambiguity	28081536	1	O
and	28081536	1	O
Wilms	28081536	1	O
'	28081536	1	O
tumor	28081536	1	O
were	28081536	1	O
analyzed	28081536	1	O
by	28081536	1	O
sequencing	28081536	1	O
of	28081536	1	O
the	28081536	1	O
WT1	28081536	1	O
gene	28081536	1	O
,	28081536	1	O
and	28081536	1	O
3	28081536	1	O
mutations	28081536	1	O
in	28081536	1	O
exon	28081536	1	O
1	28081536	1	O
were	28081536	1	O
identified	28081536	1	O
of	28081536	1	O
which	28081536	1	O
2	28081536	1	O
are	28081536	1	O
novel	28081536	1	O
.	28081536	1	O
Patient	28081536	1	O
1	28081536	1	O
carried	28081536	1	O
a	28081536	1	O
c.555	28081536	1	B-Var
delC	28081536	1	I-Var
mutation	28081536	1	O
that	28081536	1	O
causes	28081536	1	B-Reg
a	28081536	1	O
frameshift	28081536	1	B-Var
and	28081536	1	O
a	28081536	1	O
premature	28081536	1	O
stop	28081536	1	O
codon	28081536	1	O
.	28081536	1	O
Patient	28081536	1	O
2	28081536	1	O
carried	28081536	1	O
both	28081536	1	O
c.421	28081536	1	B-Var
A	28081536	1	I-Var
>	28081536	1	I-Var
C	28081536	1	I-Var
and	28081536	1	O
c.424	28081536	1	B-Var
C	28081536	1	I-Var
>	28081536	1	I-Var
T	28081536	1	I-Var
aberrations	28081536	1	O
that	28081536	1	O
lead	28081536	1	B-Reg
to	28081536	1	I-Reg
the	28081536	1	O
missense	28081536	1	O
p.Lys141Gln	28081536	1	B-Var
and	28081536	1	O
the	28081536	1	O
nonsense	28081536	1	O
p.Lys142*	28081536	1	B-Var
mutation	28081536	1	O
,	28081536	1	O
respectively	28081536	1	O
.	28081536	1	O
As	28081536	1	O
both	28081536	1	O
patients	28081536	1	O
were	28081536	1	O
heterozygous	28081536	1	O
for	28081536	1	O
the	28081536	1	O
mutations	28081536	1	O
,	28081536	1	O
we	28081536	1	O
tested	28081536	1	O
their	28081536	1	O
parents	28081536	1	O
who	28081536	1	O
did	28081536	1	O
not	28081536	1	O
carry	28081536	1	O
any	28081536	1	O
mutation	28081536	1	O
.	28081536	1	O
Therefore	28081536	1	O
,	28081536	1	O
the	28081536	1	O
3	28081536	1	O
WT1	28081536	1	O
mutations	28081536	1	O
occurred	28081536	1	O
de	28081536	1	O
novo	28081536	1	O
in	28081536	1	O
both	28081536	1	O
patients	28081536	1	O
.	28081536	1	O
Heterozygous	28081536	1	O
mutations	28081536	1	B-Var
result	28081536	1	O
in	28081536	1	O
WT1	28081536	1	B-Gene
haploinsufficiency	28081536	1	O
as	28081536	1	O
they	28081536	1	O
impair	28081536	1	B-NegReg
protein	28081536	1	O
production	28081536	1	O
.	28081536	1	O
They	28081536	1	O
are	28081536	1	O
associated	28081536	1	O
with	28081536	1	O
a	28081536	1	O
milder	28081536	1	O
DDS	28081536	1	O
phenotype	28081536	1	O
as	28081536	1	O
observed	28081536	1	O
in	28081536	1	O
the	28081536	1	O
patients	28081536	1	O
studied	28081536	1	O
here	28081536	1	O
.	28081536	1	O

Delineating	28100473	1	O
the	28100473	1	O
phenotypic	28100473	1	O
spectrum	28100473	1	O
of	28100473	1	O
Bainbridge	28100473	1	B-Disease
-	28100473	1	I-Disease
Ropers	28100473	1	I-Disease
syndrome	28100473	1	I-Disease
:	28100473	1	I-Disease
12	28100473	1	O
new	28100473	1	O
patients	28100473	1	O
with	28100473	1	O
de	28100473	1	O
novo	28100473	1	O
,	28100473	1	O
heterozygous	28100473	1	O
,	28100473	1	O
loss	28100473	1	B-NegReg
-	28100473	1	I-NegReg
of	28100473	1	I-NegReg
-	28100473	1	I-NegReg
function	28100473	1	I-NegReg
mutations	28100473	1	B-Var
in	28100473	1	O
ASXL3	28100473	1	B-Gene
and	28100473	1	O
review	28100473	1	O
of	28100473	1	O
published	28100473	1	O
literature	28100473	1	O
.	28100473	1	O
BACKGROUND	28100473	1	O
:	28100473	1	O
Bainbridge	28100473	1	B-Disease
-	28100473	1	I-Disease
Ropers	28100473	1	I-Disease
syndrome	28100473	1	I-Disease
(	28100473	1	O
BRPS	28100473	1	O
)	28100473	1	O
is	28100473	1	O
a	28100473	1	O
recently	28100473	1	O
described	28100473	1	O
developmental	28100473	1	O
disorder	28100473	1	O
caused	28100473	1	B-Reg
by	28100473	1	I-Reg
de	28100473	1	O
novo	28100473	1	O
truncating	28100473	1	B-Var
mutations	28100473	1	I-Var
in	28100473	1	O
the	28100473	1	O
additional	28100473	1	O
sex	28100473	1	O
combs	28100473	1	O
like	28100473	1	O
3	28100473	1	O
(	28100473	1	B-Gene
ASXL3	28100473	1	I-Gene
)	28100473	1	I-Gene
gene	28100473	1	O
.	28100473	1	O
To	28100473	1	O
date	28100473	1	O
,	28100473	1	O
there	28100473	1	O
have	28100473	1	O
been	28100473	1	O
fewer	28100473	1	O
than	28100473	1	O
10	28100473	1	O
reported	28100473	1	O
patients	28100473	1	O
.	28100473	1	O
OBJECTIVES	28100473	1	O
:	28100473	1	O
Here	28100473	1	O
,	28100473	1	O
we	28100473	1	O
delineate	28100473	1	O
the	28100473	1	O
BRPS	28100473	1	O
phenotype	28100473	1	O
further	28100473	1	O
by	28100473	1	O
describing	28100473	1	O
a	28100473	1	O
series	28100473	1	O
of	28100473	1	O
12	28100473	1	O
previously	28100473	1	O
unreported	28100473	1	O
patients	28100473	1	O
identified	28100473	1	O
by	28100473	1	O
the	28100473	1	O
Deciphering	28100473	1	O
Developmental	28100473	1	O
Disorders	28100473	1	O
study	28100473	1	O
.	28100473	1	O
METHODS	28100473	1	O
:	28100473	1	O
Trio	28100473	1	O
-	28100473	1	O
based	28100473	1	O
exome	28100473	1	O
sequencing	28100473	1	O
was	28100473	1	O
performed	28100473	1	O
on	28100473	1	O
all	28100473	1	O
12	28100473	1	O
patients	28100473	1	O
included	28100473	1	O
in	28100473	1	O
this	28100473	1	O
study	28100473	1	O
,	28100473	1	O
which	28100473	1	O
found	28100473	1	O
a	28100473	1	O
de	28100473	1	O
novo	28100473	1	O
truncating	28100473	1	O
mutation	28100473	1	O
in	28100473	1	O
ASXL3	28100473	1	O
.	28100473	1	O
Detailed	28100473	1	O
phenotypic	28100473	1	O
information	28100473	1	O
and	28100473	1	O
patient	28100473	1	O
images	28100473	1	O
were	28100473	1	O
collected	28100473	1	O
and	28100473	1	O
summarised	28100473	1	O
as	28100473	1	O
part	28100473	1	O
of	28100473	1	O
this	28100473	1	O
study	28100473	1	O
.	28100473	1	O
RESULTS	28100473	1	O
:	28100473	1	O
By	28100473	1	O
obtaining	28100473	1	O
genotype	28100473	1	O
:	28100473	1	O
phenotype	28100473	1	O
data	28100473	1	O
,	28100473	1	O
we	28100473	1	O
have	28100473	1	O
been	28100473	1	O
able	28100473	1	O
to	28100473	1	O
demonstrate	28100473	1	O
a	28100473	1	O
second	28100473	1	O
mutation	28100473	1	O
cluster	28100473	1	O
region	28100473	1	O
within	28100473	1	O
ASXL3	28100473	1	O
.	28100473	1	O
This	28100473	1	O
report	28100473	1	O
expands	28100473	1	O
the	28100473	1	O
phenotype	28100473	1	O
of	28100473	1	O
older	28100473	1	O
patients	28100473	1	O
with	28100473	1	O
BRPS	28100473	1	O
;	28100473	1	O
common	28100473	1	O
emerging	28100473	1	O
features	28100473	1	O
include	28100473	1	O
severe	28100473	1	O
intellectual	28100473	1	O
disability	28100473	1	O
(	28100473	1	O
11	28100473	1	O
/	28100473	1	O
12	28100473	1	O
)	28100473	1	O
,	28100473	1	O
poor	28100473	1	O
/	28100473	1	O
absent	28100473	1	O
speech	28100473	1	O
(	28100473	1	O
12	28100473	1	O
/	28100473	1	O
12	28100473	1	O
)	28100473	1	O
,	28100473	1	O
autistic	28100473	1	O
traits	28100473	1	O
(	28100473	1	O
9	28100473	1	O
/	28100473	1	O
12	28100473	1	O
)	28100473	1	O
,	28100473	1	O
distinct	28100473	1	O
face	28100473	1	O
(	28100473	1	O
arched	28100473	1	O
eyebrows	28100473	1	O
,	28100473	1	O
prominent	28100473	1	O
forehead	28100473	1	O
,	28100473	1	O
high	28100473	1	O
-	28100473	1	O
arched	28100473	1	O
palate	28100473	1	O
,	28100473	1	O
hypertelorism	28100473	1	O
and	28100473	1	O
downslanting	28100473	1	O
palpebral	28100473	1	O
fissures	28100473	1	O
)	28100473	1	O
,	28100473	1	O
(	28100473	1	O
9	28100473	1	O
/	28100473	1	O
12	28100473	1	O
)	28100473	1	O
,	28100473	1	O
hypotonia	28100473	1	O
(	28100473	1	O
11	28100473	1	O
/	28100473	1	O
12	28100473	1	O
)	28100473	1	O
and	28100473	1	O
significant	28100473	1	O
feeding	28100473	1	O
difficulties	28100473	1	O
(	28100473	1	O
9	28100473	1	O
/	28100473	1	O
12	28100473	1	O
)	28100473	1	O
when	28100473	1	O
young	28100473	1	O
.	28100473	1	O
DISCUSSION	28100473	1	O
:	28100473	1	O
Similarities	28100473	1	O
in	28100473	1	O
the	28100473	1	O
patients	28100473	1	O
reported	28100473	1	O
previously	28100473	1	O
in	28100473	1	O
comparison	28100473	1	O
with	28100473	1	O
this	28100473	1	O
cohort	28100473	1	O
included	28100473	1	O
their	28100473	1	O
distinctive	28100473	1	O
craniofacial	28100473	1	O
features	28100473	1	O
,	28100473	1	O
feeding	28100473	1	O
problems	28100473	1	O
,	28100473	1	O
absent	28100473	1	O
/	28100473	1	O
limited	28100473	1	O
speech	28100473	1	O
and	28100473	1	O
intellectual	28100473	1	O
disability	28100473	1	O
.	28100473	1	O
Shared	28100473	1	O
behavioural	28100473	1	O
phenotypes	28100473	1	O
include	28100473	1	O
autistic	28100473	1	O
traits	28100473	1	O
,	28100473	1	O
hand	28100473	1	O
-	28100473	1	O
flapping	28100473	1	O
,	28100473	1	O
rocking	28100473	1	O
,	28100473	1	O
aggressive	28100473	1	O
behaviour	28100473	1	O
and	28100473	1	O
sleep	28100473	1	O
disturbance	28100473	1	O
.	28100473	1	O
CONCLUSIONS	28100473	1	O
:	28100473	1	O
This	28100473	1	O
series	28100473	1	O
expands	28100473	1	O
the	28100473	1	O
phenotypic	28100473	1	O
spectrum	28100473	1	O
of	28100473	1	O
this	28100473	1	O
severe	28100473	1	O
disorder	28100473	1	O
and	28100473	1	O
highlights	28100473	1	O
its	28100473	1	O
surprisingly	28100473	1	O
high	28100473	1	O
frequency	28100473	1	O
.	28100473	1	O
With	28100473	1	O
the	28100473	1	O
advent	28100473	1	O
of	28100473	1	O
advanced	28100473	1	O
genomic	28100473	1	O
screening	28100473	1	O
,	28100473	1	O
we	28100473	1	O
are	28100473	1	O
likely	28100473	1	O
to	28100473	1	O
identify	28100473	1	O
more	28100473	1	O
variants	28100473	1	O
in	28100473	1	O
this	28100473	1	O
gene	28100473	1	O
presenting	28100473	1	O
with	28100473	1	O
a	28100473	1	O
variable	28100473	1	O
phenotype	28100473	1	O
,	28100473	1	O
which	28100473	1	O
this	28100473	1	O
study	28100473	1	O
will	28100473	1	O
explore	28100473	1	O
.	28100473	1	O

Rhomboid	28128203	2	O
family	28128203	2	O
member	28128203	2	O
2	28128203	2	O
regulates	28128203	2	O
cytoskeletal	28128203	2	O
stress	28128203	2	O
-	28128203	2	O
associated	28128203	2	O
Keratin	28128203	2	O
16	28128203	2	O
.	28128203	2	O
Keratin	28128203	2	O
16	28128203	2	O
(	28128203	2	O
K16	28128203	2	O
)	28128203	2	O
is	28128203	2	O
a	28128203	2	O
cytoskeletal	28128203	2	O
scaffolding	28128203	2	O
protein	28128203	2	O
highly	28128203	2	O
expressed	28128203	2	O
at	28128203	2	O
pressure	28128203	2	O
-	28128203	2	O
bearing	28128203	2	O
sites	28128203	2	O
of	28128203	2	O
the	28128203	2	O
mammalian	28128203	2	O
footpad	28128203	2	O
.	28128203	2	O
It	28128203	2	O
can	28128203	2	O
be	28128203	2	O
induced	28128203	2	O
in	28128203	2	O
hyperproliferative	28128203	2	O
states	28128203	2	O
such	28128203	2	O
as	28128203	2	O
wound	28128203	2	O
healing	28128203	2	O
,	28128203	2	O
inflammation	28128203	2	O
and	28128203	2	O
cancer	28128203	2	O
.	28128203	2	O
Here	28128203	2	O
we	28128203	2	O
show	28128203	2	O
that	28128203	2	O
the	28128203	2	O
inactive	28128203	2	O
rhomboid	28128203	2	O
protease	28128203	2	O
RHBDF2	28128203	2	O
(	28128203	2	O
iRHOM2	28128203	2	O
)	28128203	2	O
regulates	28128203	2	O
thickening	28128203	2	O
of	28128203	2	O
the	28128203	2	O
footpad	28128203	2	O
epidermis	28128203	2	O
through	28128203	2	O
its	28128203	2	O
interaction	28128203	2	O
with	28128203	2	O
K16	28128203	2	O
.	28128203	2	O
K16	28128203	2	O
expression	28128203	2	O
is	28128203	2	O
absent	28128203	2	O
in	28128203	2	O
the	28128203	2	O
thinned	28128203	2	O
footpads	28128203	2	O
of	28128203	2	O
irhom2	28128203	2	O
(	28128203	2	O
-	28128203	2	O
/	28128203	2	O
-	28128203	2	O
)	28128203	2	O
mice	28128203	2	O
compared	28128203	2	O
with	28128203	2	O
irhom2	28128203	2	O
(	28128203	2	O
/	28128203	2	O
)	28128203	2	O
mice	28128203	2	O
,	28128203	2	O
due	28128203	2	O
to	28128203	2	O
reduced	28128203	2	O
keratinocyte	28128203	2	O
proliferation	28128203	2	O
.	28128203	2	O
Gain	28128203	2	B-PosReg
-	28128203	2	I-PosReg
of	28128203	2	I-PosReg
-	28128203	2	I-PosReg
function	28128203	2	I-PosReg
mutations	28128203	2	B-Var
in	28128203	2	O
iRHOM2	28128203	2	B-Gene
underlie	28128203	2	O
Tylosis	28128203	2	B-Disease
with	28128203	2	I-Disease
oesophageal	28128203	2	I-Disease
cancer	28128203	2	I-Disease
(	28128203	2	O
TOC	28128203	2	O
)	28128203	2	O
,	28128203	2	O
characterized	28128203	2	O
by	28128203	2	O
palmoplantar	28128203	2	O
thickening	28128203	2	O
,	28128203	2	O
upregulate	28128203	2	B-PosReg
K16	28128203	2	O
with	28128203	2	O
robust	28128203	2	O
downregulation	28128203	2	B-NegReg
of	28128203	2	O
its	28128203	2	O
type	28128203	2	O
II	28128203	2	O
keratin	28128203	2	O
binding	28128203	2	O
partner	28128203	2	O
,	28128203	2	O
K6	28128203	2	O
.	28128203	2	O
By	28128203	2	O
orchestrating	28128203	2	O
the	28128203	2	O
remodelling	28128203	2	O
and	28128203	2	O
turnover	28128203	2	O
of	28128203	2	O
K16	28128203	2	O
,	28128203	2	O
and	28128203	2	O
uncoupling	28128203	2	O
it	28128203	2	O
from	28128203	2	O
K6	28128203	2	O
,	28128203	2	O
iRHOM2	28128203	2	O
regulates	28128203	2	O
the	28128203	2	O
epithelial	28128203	2	O
response	28128203	2	O
to	28128203	2	O
physical	28128203	2	O
stress	28128203	2	O
.	28128203	2	O
These	28128203	2	O
findings	28128203	2	O
contribute	28128203	2	O
to	28128203	2	O
our	28128203	2	O
understanding	28128203	2	O
of	28128203	2	O
the	28128203	2	O
molecular	28128203	2	O
mechanisms	28128203	2	O
underlying	28128203	2	O
hyperproliferation	28128203	2	O
of	28128203	2	O
the	28128203	2	O
palmoplantar	28128203	2	O
epidermis	28128203	2	O
in	28128203	2	O
both	28128203	2	O
physiological	28128203	2	O
and	28128203	2	O
disease	28128203	2	O
states	28128203	2	O
,	28128203	2	O
and	28128203	2	O
how	28128203	2	O
this	28128203	2	O
'	28128203	2	O
stress	28128203	2	O
'	28128203	2	O
keratin	28128203	2	O
is	28128203	2	O
regulated	28128203	2	O
.	28128203	2	O

Loss	28150888	0	B-NegReg
-	28150888	0	I-NegReg
of	28150888	0	I-NegReg
-	28150888	0	I-NegReg
function	28150888	0	I-NegReg
mutation	28150888	0	B-Var
of	28150888	0	O
the	28150888	0	O
calcium	28150888	0	O
sensor	28150888	0	O
CBL1	28150888	0	O
increases	28150888	0	B-PosReg
aluminum	28150888	0	O
sensitivity	28150888	0	O
in	28150888	0	O
Arabidopsis	28150888	0	O
.	28150888	0	O
Despite	28150888	0	O
the	28150888	0	O
physiological	28150888	0	O
importance	28150888	0	O
of	28150888	0	O
aluminum	28150888	0	O
(	28150888	0	O
Al	28150888	0	O
)	28150888	0	O
phytotoxicity	28150888	0	O
for	28150888	0	O
plants	28150888	0	O
,	28150888	0	O
it	28150888	0	O
remained	28150888	0	O
unknown	28150888	0	O
if	28150888	0	O
,	28150888	0	O
and	28150888	0	O
how	28150888	0	O
,	28150888	0	O
calcineurin	28150888	0	O
B	28150888	0	O
-	28150888	0	O
like	28150888	0	O
calcium	28150888	0	O
sensors	28150888	0	O
(	28150888	0	O
CBLs	28150888	0	O
)	28150888	0	O
and	28150888	0	O
CBL	28150888	0	O
-	28150888	0	O
interacting	28150888	0	O
protein	28150888	0	O
kinases	28150888	0	O
(	28150888	0	O
CIPKs	28150888	0	O
)	28150888	0	O
are	28150888	0	O
involved	28150888	0	O
in	28150888	0	O
Al	28150888	0	O
resistance	28150888	0	O
.	28150888	0	O
We	28150888	0	O
performed	28150888	0	O
a	28150888	0	O
comparative	28150888	0	O
physiological	28150888	0	O
and	28150888	0	O
whole	28150888	0	O
transcriptome	28150888	0	O
investigation	28150888	0	O
of	28150888	0	O
an	28150888	0	O
Arabidopsis	28150888	0	O
CBL1	28150888	0	B-Gene
mutant	28150888	0	B-Var
(	28150888	0	O
cbl1	28150888	0	O
)	28150888	0	O
and	28150888	0	O
the	28150888	0	O
wild	28150888	0	O
-	28150888	0	O
type	28150888	0	O
(	28150888	0	O
WT	28150888	0	O
)	28150888	0	O
.	28150888	0	O
cbl1	28150888	0	O
plants	28150888	0	O
exudated	28150888	0	O
less	28150888	0	B-NegReg
Al	28150888	0	O
-	28150888	0	O
chelating	28150888	0	O
malate	28150888	0	O
,	28150888	0	O
accumulated	28150888	0	O
more	28150888	0	B-PosReg
Al	28150888	0	O
,	28150888	0	O
and	28150888	0	O
displayed	28150888	0	O
a	28150888	0	O
severe	28150888	0	O
root	28150888	0	O
growth	28150888	0	O
reduction	28150888	0	B-NegReg
in	28150888	0	O
response	28150888	0	O
to	28150888	0	O
Al	28150888	0	O
.	28150888	0	O
Genes	28150888	0	O
involved	28150888	0	O
in	28150888	0	O
metabolism	28150888	0	O
,	28150888	0	O
transport	28150888	0	O
,	28150888	0	O
cell	28150888	0	O
wall	28150888	0	O
modification	28150888	0	O
,	28150888	0	O
transcription	28150888	0	O
and	28150888	0	O
oxidative	28150888	0	O
stress	28150888	0	O
were	28150888	0	O
differentially	28150888	0	O
regulated	28150888	0	O
between	28150888	0	O
the	28150888	0	O
two	28150888	0	O
lines	28150888	0	O
,	28150888	0	O
under	28150888	0	O
both	28150888	0	O
control	28150888	0	O
and	28150888	0	O
Al	28150888	0	O
stress	28150888	0	O
treatments	28150888	0	O
.	28150888	0	O
Exposure	28150888	0	O
to	28150888	0	O
Al	28150888	0	O
resulted	28150888	0	O
in	28150888	0	O
up	28150888	0	O
-	28150888	0	O
regulation	28150888	0	O
of	28150888	0	O
a	28150888	0	O
large	28150888	0	O
set	28150888	0	O
of	28150888	0	O
genes	28150888	0	O
only	28150888	0	O
in	28150888	0	O
WT	28150888	0	O
and	28150888	0	O
not	28150888	0	O
cbl1	28150888	0	O
shoots	28150888	0	O
,	28150888	0	O
while	28150888	0	O
a	28150888	0	O
different	28150888	0	O
set	28150888	0	O
of	28150888	0	O
genes	28150888	0	O
were	28150888	0	O
down	28150888	0	O
-	28150888	0	O
regulated	28150888	0	O
in	28150888	0	O
cbl1	28150888	0	O
but	28150888	0	O
not	28150888	0	O
in	28150888	0	O
WT	28150888	0	O
roots	28150888	0	O
.	28150888	0	O
These	28150888	0	O
differences	28150888	0	O
allowed	28150888	0	O
us	28150888	0	O
,	28150888	0	O
for	28150888	0	O
the	28150888	0	O
first	28150888	0	O
time	28150888	0	O
,	28150888	0	O
to	28150888	0	O
define	28150888	0	O
a	28150888	0	O
calcium	28150888	0	O
-	28150888	0	O
regulated	28150888	0	O
/	28150888	0	O
dependent	28150888	0	O
transcriptomic	28150888	0	O
network	28150888	0	O
for	28150888	0	O
Al	28150888	0	O
stress	28150888	0	O
responses	28150888	0	O
.	28150888	0	O
Our	28150888	0	O
analyses	28150888	0	O
reveal	28150888	0	O
not	28150888	0	O
only	28150888	0	O
the	28150888	0	O
fundamental	28150888	0	O
role	28150888	0	O
of	28150888	0	O
CBL1	28150888	0	O
in	28150888	0	O
the	28150888	0	O
adjustment	28150888	0	O
of	28150888	0	O
central	28150888	0	O
transcriptomic	28150888	0	O
networks	28150888	0	O
involved	28150888	0	O
in	28150888	0	O
maintaining	28150888	0	O
adequate	28150888	0	O
physiological	28150888	0	O
homeostasis	28150888	0	O
processes	28150888	0	O
,	28150888	0	O
but	28150888	0	O
also	28150888	0	O
that	28150888	0	O
a	28150888	0	O
high	28150888	0	O
shoot	28150888	0	O
-	28150888	0	O
root	28150888	0	O
dynamics	28150888	0	O
is	28150888	0	O
required	28150888	0	O
for	28150888	0	O
the	28150888	0	O
proper	28150888	0	O
deployment	28150888	0	O
of	28150888	0	O
Al	28150888	0	O
resistance	28150888	0	O
responses	28150888	0	O
in	28150888	0	O
the	28150888	0	O
root	28150888	0	O
.	28150888	0	O

Clinical	28151491	1	O
and	28151491	1	O
molecular	28151491	1	O
consequences	28151491	1	O
of	28151491	1	O
disease	28151491	1	O
-	28151491	1	O
associated	28151491	1	O
de	28151491	1	O
novo	28151491	1	O
mutations	28151491	1	O
in	28151491	1	O
SATB2	28151491	1	O
.	28151491	1	O
PURPOSE	28151491	1	O
:	28151491	1	O
To	28151491	1	O
characterize	28151491	1	O
features	28151491	1	O
associated	28151491	1	O
with	28151491	1	O
de	28151491	1	O
novo	28151491	1	O
mutations	28151491	1	O
affecting	28151491	1	O
SATB2	28151491	1	O
function	28151491	1	O
in	28151491	1	O
individuals	28151491	1	O
ascertained	28151491	1	O
on	28151491	1	O
the	28151491	1	O
basis	28151491	1	O
of	28151491	1	O
intellectual	28151491	1	O
disability	28151491	1	O
.	28151491	1	O
METHODS	28151491	1	O
:	28151491	1	O
Twenty	28151491	1	O
previously	28151491	1	O
unreported	28151491	1	O
individuals	28151491	1	O
with	28151491	1	O
19	28151491	1	O
different	28151491	1	O
SATB2	28151491	1	O
mutations	28151491	1	O
(	28151491	1	O
11	28151491	1	O
loss	28151491	1	O
-	28151491	1	O
of	28151491	1	O
-	28151491	1	O
function	28151491	1	O
and	28151491	1	O
8	28151491	1	O
missense	28151491	1	O
variants	28151491	1	O
)	28151491	1	O
were	28151491	1	O
studied	28151491	1	O
.	28151491	1	O
Fibroblasts	28151491	1	O
were	28151491	1	O
used	28151491	1	O
to	28151491	1	O
measure	28151491	1	O
mutant	28151491	1	O
protein	28151491	1	O
production	28151491	1	O
.	28151491	1	O
Subcellular	28151491	1	O
localization	28151491	1	O
and	28151491	1	O
mobility	28151491	1	O
of	28151491	1	O
wild	28151491	1	O
-	28151491	1	O
type	28151491	1	O
and	28151491	1	O
mutant	28151491	1	O
SATB2	28151491	1	O
were	28151491	1	O
assessed	28151491	1	O
using	28151491	1	O
fluorescently	28151491	1	O
tagged	28151491	1	O
protein	28151491	1	O
.	28151491	1	O
RESULTS	28151491	1	O
:	28151491	1	O
Recurrent	28151491	1	O
clinical	28151491	1	O
features	28151491	1	O
included	28151491	1	O
neurodevelopmental	28151491	1	O
impairment	28151491	1	O
(	28151491	1	O
19	28151491	1	O
/	28151491	1	O
19	28151491	1	O
)	28151491	1	O
,	28151491	1	O
absent	28151491	1	O
/	28151491	1	O
near	28151491	1	O
absent	28151491	1	O
speech	28151491	1	O
(	28151491	1	O
16	28151491	1	O
/	28151491	1	O
19	28151491	1	O
)	28151491	1	O
,	28151491	1	O
normal	28151491	1	O
somatic	28151491	1	O
growth	28151491	1	O
(	28151491	1	O
17	28151491	1	O
/	28151491	1	O
19	28151491	1	O
)	28151491	1	O
,	28151491	1	O
cleft	28151491	1	O
palate	28151491	1	O
(	28151491	1	O
9	28151491	1	O
/	28151491	1	O
19	28151491	1	O
)	28151491	1	O
,	28151491	1	O
drooling	28151491	1	O
(	28151491	1	O
12	28151491	1	O
/	28151491	1	O
19	28151491	1	O
)	28151491	1	O
,	28151491	1	O
and	28151491	1	O
dental	28151491	1	O
anomalies	28151491	1	O
(	28151491	1	O
8	28151491	1	O
/	28151491	1	O
19	28151491	1	O
)	28151491	1	O
.	28151491	1	O
Six	28151491	1	O
of	28151491	1	O
eight	28151491	1	O
missense	28151491	1	O
variants	28151491	1	O
clustered	28151491	1	O
in	28151491	1	O
the	28151491	1	O
first	28151491	1	O
CUT	28151491	1	O
domain	28151491	1	O
.	28151491	1	O
Sibling	28151491	1	O
recurrence	28151491	1	O
due	28151491	1	O
to	28151491	1	O
gonadal	28151491	1	O
mosaicism	28151491	1	O
was	28151491	1	O
seen	28151491	1	O
in	28151491	1	O
one	28151491	1	O
family	28151491	1	O
.	28151491	1	O
A	28151491	1	O
nonsense	28151491	1	B-Var
mutation	28151491	1	I-Var
in	28151491	1	I-Var
the	28151491	1	I-Var
last	28151491	1	I-Var
exon	28151491	1	I-Var
resulted	28151491	1	B-Reg
in	28151491	1	I-Reg
production	28151491	1	O
of	28151491	1	O
a	28151491	1	O
truncated	28151491	1	O
protein	28151491	1	O
retaining	28151491	1	O
all	28151491	1	O
three	28151491	1	O
DNA	28151491	1	O
-	28151491	1	O
binding	28151491	1	O
domains	28151491	1	O
.	28151491	1	O
SATB2	28151491	1	B-Gene
nuclear	28151491	1	O
mobility	28151491	1	O
was	28151491	1	O
mutation	28151491	1	O
-	28151491	1	O
dependent	28151491	1	O
;	28151491	1	O
p.Arg389Cys	28151491	1	B-Var
in	28151491	1	I-Var
CUT1	28151491	1	I-Var
increased	28151491	1	B-PosReg
mobility	28151491	1	O
and	28151491	1	O
both	28151491	1	O
p.Gly515Ser	28151491	1	B-Var
in	28151491	1	I-Var
CUT2	28151491	1	I-Var
and	28151491	1	O
p.Gln566Lys	28151491	1	B-Var
between	28151491	1	I-Var
CUT2	28151491	1	I-Var
and	28151491	1	I-Var
HOX	28151491	1	I-Var
reduced	28151491	1	B-NegReg
mobility	28151491	1	O
.	28151491	1	O
The	28151491	1	O
clinical	28151491	1	O
features	28151491	1	O
in	28151491	1	O
individuals	28151491	1	O
with	28151491	1	O
missense	28151491	1	O
variants	28151491	1	O
were	28151491	1	O
indistinguishable	28151491	1	O
from	28151491	1	O
those	28151491	1	O
with	28151491	1	O
loss	28151491	1	O
of	28151491	1	O
function	28151491	1	O
.	28151491	1	O
CONCLUSION	28151491	1	O
:	28151491	1	O
SATB2	28151491	1	B-Gene
haploinsufficiency	28151491	1	B-Var
is	28151491	1	O
a	28151491	1	O
common	28151491	1	O
cause	28151491	1	B-Reg
of	28151491	1	O
syndromic	28151491	1	B-Disease
intellectual	28151491	1	I-Disease
disability	28151491	1	I-Disease
.	28151491	1	O
When	28151491	1	O
mutant	28151491	1	B-Var
SATB2	28151491	1	B-Gene
protein	28151491	1	O
is	28151491	1	O
produced	28151491	1	O
,	28151491	1	O
the	28151491	1	O
protein	28151491	1	O
appears	28151491	1	O
functionally	28151491	1	O
inactive	28151491	1	B-NegReg
with	28151491	1	O
a	28151491	1	O
disrupted	28151491	1	O
pattern	28151491	1	O
of	28151491	1	O
chromatin	28151491	1	O
or	28151491	1	O
matrix	28151491	1	O
association	28151491	1	O
.	28151491	1	O
Genet	28151491	1	O
Med	28151491	1	O
advance	28151491	1	O
online	28151491	1	O
publication	28151491	1	O
02	28151491	1	O
February	28151491	1	O
2017	28151491	1	O
.	28151491	1	O

Complexity	28157721	3	O
of	28157721	3	O
mechanisms	28157721	3	O
among	28157721	3	O
human	28157721	3	O
proprotein	28157721	3	O
convertase	28157721	3	O
subtilisin	28157721	3	O
-	28157721	3	O
kexin	28157721	3	O
type	28157721	3	O
9	28157721	3	O
variants	28157721	3	O
.	28157721	3	O
PURPOSE	28157721	3	O
OF	28157721	3	O
REVIEW	28157721	3	O
:	28157721	3	O
There	28157721	3	O
are	28157721	3	O
many	28157721	3	O
reports	28157721	3	O
of	28157721	3	O
human	28157721	3	O
variants	28157721	3	B-Var
in	28157721	3	O
proprotein	28157721	3	O
convertase	28157721	3	O
subtilisin	28157721	3	O
-	28157721	3	O
kexin	28157721	3	O
type	28157721	3	O
9	28157721	3	O
(	28157721	3	B-Gene
PCSK9	28157721	3	I-Gene
)	28157721	3	I-Gene
that	28157721	3	O
are	28157721	3	O
either	28157721	3	O
gain	28157721	3	B-PosReg
-	28157721	3	I-PosReg
of	28157721	3	I-PosReg
-	28157721	3	I-PosReg
function	28157721	3	I-PosReg
(	28157721	3	O
GOF	28157721	3	O
)	28157721	3	O
or	28157721	3	O
loss	28157721	3	B-NegReg
-	28157721	3	I-NegReg
of	28157721	3	I-NegReg
-	28157721	3	I-NegReg
function	28157721	3	I-NegReg
(	28157721	3	O
LOF	28157721	3	O
)	28157721	3	O
,	28157721	3	O
with	28157721	3	O
downstream	28157721	3	O
effects	28157721	3	B-Reg
on	28157721	3	O
LDL	28157721	3	B-Disease
cholesterol	28157721	3	I-Disease
and	28157721	3	O
cardiovascular	28157721	3	B-Disease
disease	28157721	3	I-Disease
(	28157721	3	O
CVD	28157721	3	O
)	28157721	3	O
risk	28157721	3	O
.	28157721	3	O
However	28157721	3	O
,	28157721	3	O
data	28157721	3	O
on	28157721	3	O
particular	28157721	3	O
mechanisms	28157721	3	O
have	28157721	3	O
only	28157721	3	O
been	28157721	3	O
minimally	28157721	3	O
curated	28157721	3	O
.	28157721	3	O
RECENT	28157721	3	O
FINDINGS	28157721	3	O
:	28157721	3	O
GOF	28157721	3	B-PosReg
variants	28157721	3	B-Var
are	28157721	3	O
individually	28157721	3	O
ultrarare	28157721	3	O
,	28157721	3	O
affect	28157721	3	B-Reg
all	28157721	3	O
domains	28157721	3	O
of	28157721	3	O
the	28157721	3	O
protein	28157721	3	O
,	28157721	3	O
act	28157721	3	O
to	28157721	3	O
reduce	28157721	3	B-NegReg
LDL	28157721	3	O
receptor	28157721	3	O
expression	28157721	3	O
through	28157721	3	O
several	28157721	3	O
mechanisms	28157721	3	O
,	28157721	3	O
are	28157721	3	O
a	28157721	3	O
minor	28157721	3	O
cause	28157721	3	B-Reg
of	28157721	3	O
familial	28157721	3	B-Disease
hypercholesterolemia	28157721	3	I-Disease
,	28157721	3	O
have	28157721	3	O
been	28157721	3	O
reported	28157721	3	O
mainly	28157721	3	O
within	28157721	3	O
families	28157721	3	O
,	28157721	3	O
have	28157721	3	O
variable	28157721	3	O
LDL	28157721	3	O
cholesterol	28157721	3	O
-	28157721	3	O
raising	28157721	3	O
effects	28157721	3	O
,	28157721	3	O
and	28157721	3	O
are	28157721	3	O
associated	28157721	3	O
with	28157721	3	O
increased	28157721	3	O
CVD	28157721	3	O
risk	28157721	3	O
mainly	28157721	3	O
through	28157721	3	O
observational	28157721	3	O
studies	28157721	3	O
in	28157721	3	O
families	28157721	3	O
and	28157721	3	O
small	28157721	3	O
cohorts	28157721	3	O
.	28157721	3	O
In	28157721	3	O
contrast	28157721	3	O
,	28157721	3	O
LOF	28157721	3	B-NegReg
variants	28157721	3	B-Var
can	28157721	3	O
be	28157721	3	O
either	28157721	3	O
ultrarare	28157721	3	O
mutations	28157721	3	O
or	28157721	3	O
relatively	28157721	3	O
more	28157721	3	O
common	28157721	3	O
polymorphisms	28157721	3	O
seen	28157721	3	O
in	28157721	3	O
populations	28157721	3	O
,	28157721	3	O
affect	28157721	3	B-Reg
all	28157721	3	O
domains	28157721	3	O
of	28157721	3	O
the	28157721	3	O
protein	28157721	3	O
,	28157721	3	O
act	28157721	3	O
to	28157721	3	O
increase	28157721	3	B-PosReg
LDL	28157721	3	O
receptor	28157721	3	O
expression	28157721	3	O
through	28157721	3	O
several	28157721	3	O
mechanisms	28157721	3	O
,	28157721	3	O
have	28157721	3	O
variable	28157721	3	O
LDL	28157721	3	O
cholesterol	28157721	3	B-NegReg
-	28157721	3	I-NegReg
lowering	28157721	3	I-NegReg
effects	28157721	3	O
,	28157721	3	O
and	28157721	3	O
have	28157721	3	O
been	28157721	3	O
associated	28157721	3	O
with	28157721	3	O
decreased	28157721	3	B-NegReg
CVD	28157721	3	B-Disease
risk	28157721	3	O
mainly	28157721	3	O
through	28157721	3	O
Mendelian	28157721	3	O
randomization	28157721	3	O
studies	28157721	3	O
in	28157721	3	O
epidemiologic	28157721	3	O
populations	28157721	3	O
.	28157721	3	O
SUMMARY	28157721	3	O
:	28157721	3	O
There	28157721	3	O
is	28157721	3	O
considerable	28157721	3	O
complexity	28157721	3	O
underlying	28157721	3	O
the	28157721	3	O
clinical	28157721	3	O
concept	28157721	3	O
of	28157721	3	O
both	28157721	3	O
LOF	28157721	3	O
and	28157721	3	O
GOF	28157721	3	O
variants	28157721	3	O
of	28157721	3	O
PCSK9	28157721	3	O
.	28157721	3	O
But	28157721	3	O
despite	28157721	3	O
the	28157721	3	O
underlying	28157721	3	O
mechanistic	28157721	3	O
heterogeneity	28157721	3	O
,	28157721	3	O
altered	28157721	3	O
PCSK9	28157721	3	O
secretion	28157721	3	O
or	28157721	3	O
function	28157721	3	O
is	28157721	3	O
ultimately	28157721	3	O
correlated	28157721	3	O
with	28157721	3	O
plasma	28157721	3	O
LDL	28157721	3	O
cholesterol	28157721	3	O
level	28157721	3	O
,	28157721	3	O
which	28157721	3	O
is	28157721	3	O
also	28157721	3	O
the	28157721	3	O
driver	28157721	3	O
of	28157721	3	O
CVD	28157721	3	O
outcomes	28157721	3	O
.	28157721	3	O

Loss	28163187	0	B-Var
of	28163187	0	O
Ssq1	28163187	0	B-Gene
leads	28163187	0	B-Reg
to	28163187	0	O
mitochondrial	28163187	0	O
dysfunction	28163187	0	O
,	28163187	0	O
activation	28163187	0	O
of	28163187	0	O
autophagy	28163187	0	O
and	28163187	0	O
cell	28163187	0	O
cycle	28163187	0	O
arrest	28163187	0	O
due	28163187	0	O
to	28163187	0	O
iron	28163187	0	O
overload	28163187	0	B-PosReg
triggered	28163187	0	O
by	28163187	0	O
mitochondrial	28163187	0	O
iron	28163187	0	O
-	28163187	0	O
sulfur	28163187	0	O
cluster	28163187	0	O
assembly	28163187	0	O
defects	28163187	0	B-NegReg
in	28163187	0	O
Candida	28163187	0	O
albicans	28163187	0	O
.	28163187	0	O
Iron	28163187	0	O
-	28163187	0	O
sulfur	28163187	0	O
clusters	28163187	0	O
perform	28163187	0	O
essential	28163187	0	O
functions	28163187	0	O
in	28163187	0	O
enzymatic	28163187	0	O
catalysis	28163187	0	O
and	28163187	0	O
homeostatic	28163187	0	O
regulation	28163187	0	O
.	28163187	0	O
Here	28163187	0	O
we	28163187	0	O
for	28163187	0	O
the	28163187	0	O
first	28163187	0	O
time	28163187	0	O
identified	28163187	0	O
Ssq1	28163187	0	O
as	28163187	0	O
an	28163187	0	O
essential	28163187	0	O
component	28163187	0	O
for	28163187	0	O
iron	28163187	0	O
-	28163187	0	O
sulfur	28163187	0	O
cluster	28163187	0	O
assembly	28163187	0	O
in	28163187	0	O
Candida	28163187	0	O
albicans	28163187	0	O
.	28163187	0	O
Ssq1	28163187	0	O
played	28163187	0	O
an	28163187	0	O
important	28163187	0	O
role	28163187	0	O
in	28163187	0	O
cell	28163187	0	O
growth	28163187	0	O
.	28163187	0	O
Shutting	28163187	0	O
off	28163187	0	O
SSQ1	28163187	0	O
led	28163187	0	O
to	28163187	0	O
accumulation	28163187	0	O
of	28163187	0	O
intracellular	28163187	0	O
iron	28163187	0	O
,	28163187	0	O
especially	28163187	0	O
in	28163187	0	O
mitochondria	28163187	0	O
,	28163187	0	O
and	28163187	0	O
disorder	28163187	0	O
of	28163187	0	O
intracellular	28163187	0	O
iron	28163187	0	O
regulation	28163187	0	O
.	28163187	0	O
In	28163187	0	O
tetO	28163187	0	O
-	28163187	0	O
SSQ1	28163187	0	O
,	28163187	0	O
iron	28163187	0	O
overloading	28163187	0	O
triggered	28163187	0	O
the	28163187	0	O
oxidative	28163187	0	O
damage	28163187	0	O
of	28163187	0	O
mitochondrial	28163187	0	O
function	28163187	0	O
.	28163187	0	O
Surprisingly	28163187	0	O
,	28163187	0	O
disruption	28163187	0	O
of	28163187	0	O
SSQ1	28163187	0	O
activated	28163187	0	O
autophagic	28163187	0	O
pathway	28163187	0	O
.	28163187	0	O
The	28163187	0	O
mitochondrial	28163187	0	O
dysfunction	28163187	0	O
was	28163187	0	O
further	28163187	0	O
aggravated	28163187	0	B-NegReg
when	28163187	0	O
CCZ1	28163187	0	B-Gene
(	28163187	0	O
which	28163187	0	O
is	28163187	0	O
essential	28163187	0	O
for	28163187	0	O
autophagy	28163187	0	O
)	28163187	0	O
and	28163187	0	O
SSQ1	28163187	0	B-Gene
was	28163187	0	O
simultaneously	28163187	0	O
deleted	28163187	0	B-Var
,	28163187	0	O
suggesting	28163187	0	O
that	28163187	0	O
autophagy	28163187	0	O
played	28163187	0	O
a	28163187	0	O
critical	28163187	0	O
role	28163187	0	O
in	28163187	0	O
maintenance	28163187	0	O
of	28163187	0	O
mitochondrial	28163187	0	O
function	28163187	0	O
in	28163187	0	O
tetO	28163187	0	O
-	28163187	0	O
SSQ1	28163187	0	O
.	28163187	0	O
In	28163187	0	O
addition	28163187	0	O
,	28163187	0	O
double	28163187	0	O
deletion	28163187	0	B-Var
of	28163187	0	O
SSQ1	28163187	0	B-Gene
and	28163187	0	O
CCZ1	28163187	0	B-Gene
further	28163187	0	O
elevated	28163187	0	B-PosReg
cellular	28163187	0	O
iron	28163187	0	O
levels	28163187	0	O
in	28163187	0	O
comparison	28163187	0	O
with	28163187	0	O
tetO	28163187	0	O
-	28163187	0	O
SSQ1	28163187	0	O
,	28163187	0	O
indicating	28163187	0	O
that	28163187	0	O
autophagy	28163187	0	O
participated	28163187	0	O
in	28163187	0	O
maintenance	28163187	0	O
of	28163187	0	O
iron	28163187	0	O
homeostasis	28163187	0	O
.	28163187	0	O
Furthermore	28163187	0	O
,	28163187	0	O
we	28163187	0	O
found	28163187	0	O
that	28163187	0	O
loss	28163187	0	B-Var
of	28163187	0	O
SSQ1	28163187	0	B-Gene
led	28163187	0	O
to	28163187	0	O
increasing	28163187	0	B-PosReg
protein	28163187	0	O
expression	28163187	0	O
of	28163187	0	O
Rnr1	28163187	0	B-Gene
and	28163187	0	O
redistribution	28163187	0	O
of	28163187	0	O
Rnr2	28163187	0	B-Gene
from	28163187	0	O
the	28163187	0	O
nucleus	28163187	0	O
to	28163187	0	O
cytoplasm	28163187	0	O
,	28163187	0	O
and	28163187	0	O
further	28163187	0	O
resulted	28163187	0	B-Reg
in	28163187	0	O
cell	28163187	0	O
cycle	28163187	0	O
arrest	28163187	0	O
.	28163187	0	O
The	28163187	0	O
results	28163187	0	O
implied	28163187	0	O
that	28163187	0	O
cell	28163187	0	O
cycle	28163187	0	O
arrest	28163187	0	O
was	28163187	0	O
caused	28163187	0	O
by	28163187	0	O
activating	28163187	0	O
the	28163187	0	O
checkpoint	28163187	0	O
pathway	28163187	0	O
because	28163187	0	O
of	28163187	0	O
impairing	28163187	0	O
the	28163187	0	O
iron	28163187	0	O
-	28163187	0	O
sulfur	28163187	0	O
cluster	28163187	0	O
assembly	28163187	0	O
in	28163187	0	O
tetO	28163187	0	O
-	28163187	0	O
SSQ1	28163187	0	O
.	28163187	0	O
Shutting	28163187	0	O
off	28163187	0	O
SSQ1	28163187	0	O
led	28163187	0	O
to	28163187	0	O
a	28163187	0	O
significant	28163187	0	O
defect	28163187	0	O
in	28163187	0	O
filamentous	28163187	0	O
development	28163187	0	O
.	28163187	0	O
Interestingly	28163187	0	O
,	28163187	0	O
the	28163187	0	O
tetO	28163187	0	O
-	28163187	0	O
SSQ1ccz1Δ	28163187	0	O
/	28163187	0	O
Δ	28163187	0	O
growth	28163187	0	O
was	28163187	0	O
inhibited	28163187	0	O
on	28163187	0	O
hyphae	28163187	0	O
-	28163187	0	O
inducing	28163187	0	O
solid	28163187	0	O
media	28163187	0	O
.	28163187	0	O
Both	28163187	0	O
tetO	28163187	0	O
-	28163187	0	O
SSQ1	28163187	0	O
and	28163187	0	O
tetO	28163187	0	O
-	28163187	0	O
SSQ1ccz1Δ	28163187	0	O
/	28163187	0	O
Δ	28163187	0	O
exhibited	28163187	0	O
extremely	28163187	0	O
attenuated	28163187	0	O
virulence	28163187	0	O
,	28163187	0	O
indicating	28163187	0	O
that	28163187	0	O
Ssq1	28163187	0	O
might	28163187	0	O
provide	28163187	0	O
a	28163187	0	O
promising	28163187	0	O
target	28163187	0	O
for	28163187	0	O
antifungal	28163187	0	O
drugs	28163187	0	O
development	28163187	0	O
.	28163187	0	O
In	28163187	0	O
summary	28163187	0	O
,	28163187	0	O
our	28163187	0	O
findings	28163187	0	O
provide	28163187	0	O
new	28163187	0	O
insights	28163187	0	O
into	28163187	0	O
the	28163187	0	O
understanding	28163187	0	O
of	28163187	0	O
iron	28163187	0	O
-	28163187	0	O
sulfur	28163187	0	O
cluster	28163187	0	O
assembly	28163187	0	O
-	28163187	0	O
related	28163187	0	O
gene	28163187	0	O
in	28163187	0	O
C.	28163187	0	O
albicans	28163187	0	O
.	28163187	0	O

Towards	28167616	0	O
trans	28167616	0	O
-	28167616	0	O
diagnostic	28167616	0	O
mechanisms	28167616	0	O
in	28167616	0	O
psychiatry	28167616	0	O
:	28167616	0	O
neurobehavioral	28167616	0	O
profile	28167616	0	O
of	28167616	0	O
rats	28167616	0	O
with	28167616	0	O
a	28167616	0	O
loss	28167616	0	O
-	28167616	0	O
of	28167616	0	O
-	28167616	0	O
function	28167616	0	O
point	28167616	0	O
mutation	28167616	0	O
in	28167616	0	O
the	28167616	0	O
dopamine	28167616	0	O
transporter	28167616	0	O
gene	28167616	0	O
.	28167616	0	O
The	28167616	0	O
research	28167616	0	O
domain	28167616	0	O
criteria	28167616	0	O
(	28167616	0	O
RDoC	28167616	0	O
)	28167616	0	O
matrix	28167616	0	O
has	28167616	0	O
been	28167616	0	O
developed	28167616	0	O
to	28167616	0	O
reorient	28167616	0	O
psychiatric	28167616	0	O
research	28167616	0	O
towards	28167616	0	O
measurable	28167616	0	O
behavioral	28167616	0	O
dimensions	28167616	0	O
and	28167616	0	O
underlying	28167616	0	O
mechanisms	28167616	0	O
.	28167616	0	O
Here	28167616	0	O
,	28167616	0	O
we	28167616	0	O
used	28167616	0	O
a	28167616	0	O
new	28167616	0	O
genetic	28167616	0	O
rat	28167616	0	O
model	28167616	0	O
with	28167616	0	O
a	28167616	0	O
loss	28167616	0	O
-	28167616	0	O
of	28167616	0	O
-	28167616	0	O
function	28167616	0	O
point	28167616	0	O
mutation	28167616	0	O
in	28167616	0	O
the	28167616	0	O
dopamine	28167616	0	O
transporter	28167616	0	O
(	28167616	0	O
DAT	28167616	0	O
)	28167616	0	O
gene	28167616	0	O
(	28167616	0	O
Slc6a3_N157K	28167616	0	O
)	28167616	0	O
to	28167616	0	O
systematically	28167616	0	O
study	28167616	0	O
the	28167616	0	O
RDoC	28167616	0	O
matrix	28167616	0	O
.	28167616	0	O
First	28167616	0	O
,	28167616	0	O
we	28167616	0	O
examined	28167616	0	O
the	28167616	0	O
impact	28167616	0	O
of	28167616	0	O
the	28167616	0	O
Slc6a3_N157K	28167616	0	O
mutation	28167616	0	O
on	28167616	0	O
monoaminergic	28167616	0	O
signaling	28167616	0	O
.	28167616	0	O
We	28167616	0	O
then	28167616	0	O
performed	28167616	0	O
behavioral	28167616	0	O
tests	28167616	0	O
representing	28167616	0	O
each	28167616	0	O
of	28167616	0	O
the	28167616	0	O
five	28167616	0	O
RDoC	28167616	0	O
domains	28167616	0	O
:	28167616	0	O
negative	28167616	0	O
and	28167616	0	O
positive	28167616	0	O
valence	28167616	0	O
systems	28167616	0	O
,	28167616	0	O
cognitive	28167616	0	O
,	28167616	0	O
social	28167616	0	O
and	28167616	0	O
arousal	28167616	0	O
/	28167616	0	O
regulatory	28167616	0	O
systems	28167616	0	O
.	28167616	0	O
The	28167616	0	O
use	28167616	0	O
of	28167616	0	O
RDoC	28167616	0	O
may	28167616	0	O
be	28167616	0	O
particularly	28167616	0	O
helpful	28167616	0	O
for	28167616	0	O
drug	28167616	0	O
development	28167616	0	O
.	28167616	0	O
We	28167616	0	O
studied	28167616	0	O
the	28167616	0	O
effects	28167616	0	O
of	28167616	0	O
a	28167616	0	O
novel	28167616	0	O
pharmacological	28167616	0	O
approach	28167616	0	O
metabotropic	28167616	0	O
glutamate	28167616	0	O
receptor	28167616	0	O
mGluR2	28167616	0	O
/	28167616	0	O
3	28167616	0	O
antagonism	28167616	0	O
,	28167616	0	O
in	28167616	0	O
DAT	28167616	0	O
mutants	28167616	0	O
in	28167616	0	O
a	28167616	0	O
comparative	28167616	0	O
way	28167616	0	O
with	28167616	0	O
standard	28167616	0	O
medications	28167616	0	O
.	28167616	0	O
Loss	28167616	0	B-NegReg
of	28167616	0	O
DAT	28167616	0	B-Gene
functionality	28167616	0	O
in	28167616	0	O
mutant	28167616	0	B-Var
rats	28167616	0	O
not	28167616	0	O
only	28167616	0	O
elevated	28167616	0	B-PosReg
subcortical	28167616	0	O
extracellular	28167616	0	O
dopamine	28167616	0	O
concentration	28167616	0	O
but	28167616	0	O
also	28167616	0	O
altered	28167616	0	B-Reg
the	28167616	0	O
balance	28167616	0	O
of	28167616	0	O
monoaminergic	28167616	0	O
transmission	28167616	0	O
.	28167616	0	O
DAT	28167616	0	O
mutant	28167616	0	O
rats	28167616	0	O
showed	28167616	0	O
deficits	28167616	0	O
in	28167616	0	O
all	28167616	0	O
five	28167616	0	O
RDoC	28167616	0	O
domains	28167616	0	O
.	28167616	0	O
Thus	28167616	0	O
,	28167616	0	O
mutant	28167616	0	O
rats	28167616	0	O
failed	28167616	0	O
to	28167616	0	O
show	28167616	0	O
conditioned	28167616	0	O
fear	28167616	0	O
responses	28167616	0	O
,	28167616	0	O
were	28167616	0	O
anhedonic	28167616	0	O
,	28167616	0	O
were	28167616	0	O
unable	28167616	0	O
to	28167616	0	O
learn	28167616	0	O
stimulus	28167616	0	O
-	28167616	0	O
reward	28167616	0	O
associations	28167616	0	O
,	28167616	0	O
showed	28167616	0	O
impaired	28167616	0	O
cognition	28167616	0	O
and	28167616	0	O
social	28167616	0	O
behavior	28167616	0	O
,	28167616	0	O
and	28167616	0	O
were	28167616	0	O
hyperactive	28167616	0	O
.	28167616	0	O
Hyperactivity	28167616	0	O
in	28167616	0	O
mutant	28167616	0	O
rats	28167616	0	O
was	28167616	0	O
reduced	28167616	0	O
by	28167616	0	O
amphetamine	28167616	0	O
and	28167616	0	O
atomoxetine	28167616	0	O
,	28167616	0	O
which	28167616	0	O
are	28167616	0	O
well	28167616	0	O
-	28167616	0	O
established	28167616	0	O
medications	28167616	0	O
to	28167616	0	O
reduce	28167616	0	O
hyperactivity	28167616	0	O
in	28167616	0	O
humans	28167616	0	O
.	28167616	0	O
The	28167616	0	O
mGluR2	28167616	0	O
/	28167616	0	O
3	28167616	0	O
antagonist	28167616	0	O
LY341495	28167616	0	O
also	28167616	0	O
normalized	28167616	0	O
hyperactivity	28167616	0	O
in	28167616	0	O
DAT	28167616	0	O
mutant	28167616	0	O
rats	28167616	0	O
without	28167616	0	O
affecting	28167616	0	O
extracellular	28167616	0	O
dopamine	28167616	0	O
levels	28167616	0	O
.	28167616	0	O
We	28167616	0	O
systematically	28167616	0	O
characterized	28167616	0	O
an	28167616	0	O
altered	28167616	0	O
dopamine	28167616	0	O
system	28167616	0	O
within	28167616	0	O
the	28167616	0	O
context	28167616	0	O
of	28167616	0	O
the	28167616	0	O
RDoC	28167616	0	O
matrix	28167616	0	O
and	28167616	0	O
studied	28167616	0	O
mGluR2	28167616	0	O
/	28167616	0	O
3	28167616	0	O
antagonism	28167616	0	O
as	28167616	0	O
a	28167616	0	O
new	28167616	0	O
pharmacological	28167616	0	O
strategy	28167616	0	O
to	28167616	0	O
treat	28167616	0	O
mental	28167616	0	O
disorders	28167616	0	O
with	28167616	0	O
underlying	28167616	0	O
subcortical	28167616	0	O
dopaminergic	28167616	0	O
hyperactivity	28167616	0	O
.	28167616	0	O

Identification	28183324	4	O
of	28183324	4	O
TAZ	28183324	4	B-Gene
mutations	28183324	4	B-Var
in	28183324	4	O
pediatric	28183324	4	O
patients	28183324	4	O
with	28183324	4	B-Reg
cardiomyopathy	28183324	4	B-Disease
by	28183324	4	O
targeted	28183324	4	O
next	28183324	4	O
-	28183324	4	O
generation	28183324	4	O
sequencing	28183324	4	O
in	28183324	4	O
a	28183324	4	O
Chinese	28183324	4	O
cohort	28183324	4	O
.	28183324	4	O
BACKGROUND	28183324	4	O
:	28183324	4	O
Barth	28183324	4	O
syndrome	28183324	4	O
(	28183324	4	O
BTHS	28183324	4	O
)	28183324	4	O
is	28183324	4	O
a	28183324	4	O
rare	28183324	4	O
X	28183324	4	O
-	28183324	4	O
linked	28183324	4	O
recessive	28183324	4	O
disease	28183324	4	O
characterized	28183324	4	O
by	28183324	4	O
cardiomyopathy	28183324	4	O
,	28183324	4	O
neutropenia	28183324	4	O
,	28183324	4	O
skeletal	28183324	4	O
myopathy	28183324	4	O
and	28183324	4	O
growth	28183324	4	O
delay	28183324	4	O
.	28183324	4	O
Early	28183324	4	O
diagnosis	28183324	4	O
and	28183324	4	O
appropriate	28183324	4	O
treatment	28183324	4	O
may	28183324	4	O
improve	28183324	4	O
the	28183324	4	O
prognosis	28183324	4	O
of	28183324	4	O
this	28183324	4	O
disease	28183324	4	O
.	28183324	4	O
The	28183324	4	O
purpose	28183324	4	O
of	28183324	4	O
this	28183324	4	O
study	28183324	4	O
is	28183324	4	O
to	28183324	4	O
determine	28183324	4	O
the	28183324	4	O
role	28183324	4	O
of	28183324	4	O
targeted	28183324	4	O
next	28183324	4	O
-	28183324	4	O
generation	28183324	4	O
sequencing	28183324	4	O
(	28183324	4	O
NGS	28183324	4	O
)	28183324	4	O
in	28183324	4	O
the	28183324	4	O
early	28183324	4	O
diagnosis	28183324	4	O
of	28183324	4	O
BTHS	28183324	4	O
in	28183324	4	O
children	28183324	4	O
with	28183324	4	O
cardiomyopathy	28183324	4	O
.	28183324	4	O
METHODS	28183324	4	O
:	28183324	4	O
During	28183324	4	O
the	28183324	4	O
period	28183324	4	O
between	28183324	4	O
2012	28183324	4	O
and	28183324	4	O
2015	28183324	4	O
,	28183324	4	O
a	28183324	4	O
gene	28183324	4	O
panel	28183324	4	O
-	28183324	4	O
based	28183324	4	O
NGS	28183324	4	O
approach	28183324	4	O
was	28183324	4	O
used	28183324	4	O
to	28183324	4	O
search	28183324	4	O
for	28183324	4	O
potentially	28183324	4	O
disease	28183324	4	O
-	28183324	4	O
causing	28183324	4	O
genetic	28183324	4	O
variants	28183324	4	O
in	28183324	4	O
all	28183324	4	O
patients	28183324	4	O
referred	28183324	4	O
to	28183324	4	O
our	28183324	4	O
institution	28183324	4	O
with	28183324	4	O
a	28183324	4	O
clinical	28183324	4	O
diagnosis	28183324	4	O
of	28183324	4	O
primary	28183324	4	O
cardiomyopathy	28183324	4	O
.	28183324	4	O
NGS	28183324	4	O
was	28183324	4	O
performed	28183324	4	O
using	28183324	4	O
the	28183324	4	O
Illumina	28183324	4	O
sequencing	28183324	4	O
system	28183324	4	O
.	28183324	4	O
RESULTS	28183324	4	O
:	28183324	4	O
A	28183324	4	O
total	28183324	4	O
of	28183324	4	O
180	28183324	4	O
Chinese	28183324	4	O
pediatric	28183324	4	O
patients	28183324	4	O
(	28183324	4	O
114	28183324	4	O
males	28183324	4	O
and	28183324	4	O
66	28183324	4	O
females	28183324	4	O
)	28183324	4	O
diagnosed	28183324	4	O
with	28183324	4	O
primary	28183324	4	O
cardiomyopathy	28183324	4	O
were	28183324	4	O
enrolled	28183324	4	O
in	28183324	4	O
this	28183324	4	O
study	28183324	4	O
.	28183324	4	O
TAZ	28183324	4	O
mutations	28183324	4	O
were	28183324	4	O
identified	28183324	4	O
in	28183324	4	O
four	28183324	4	O
of	28183324	4	O
the	28183324	4	O
male	28183324	4	O
index	28183324	4	O
patients	28183324	4	O
,	28183324	4	O
including	28183324	4	O
two	28183324	4	O
novel	28183324	4	O
mutations	28183324	4	O
(	28183324	4	O
c.527	28183324	4	O
A	28183324	4	O
>	28183324	4	O
G	28183324	4	O
,	28183324	4	O
p.H176R	28183324	4	O
and	28183324	4	O
c.134	28183324	4	O
_136delinsCC	28183324	4	O
,	28183324	4	O
p.H45PfsX38	28183324	4	O
)	28183324	4	O
.	28183324	4	O
All	28183324	4	O
four	28183324	4	O
probands	28183324	4	O
and	28183324	4	O
two	28183324	4	O
additional	28183324	4	O
affected	28183324	4	O
male	28183324	4	O
family	28183324	4	O
members	28183324	4	O
were	28183324	4	O
born	28183324	4	O
at	28183324	4	O
full	28183324	4	O
term	28183324	4	O
with	28183324	4	O
a	28183324	4	O
median	28183324	4	O
birth	28183324	4	O
weight	28183324	4	O
of	28183324	4	O
2350	28183324	4	O
g	28183324	4	O
(	28183324	4	O
range	28183324	4	O
,	28183324	4	O
2000	28183324	4	O
-	28183324	4	O
2850	28183324	4	O
g	28183324	4	O
)	28183324	4	O
.	28183324	4	O
The	28183324	4	O
median	28183324	4	O
age	28183324	4	O
at	28183324	4	O
diagnosis	28183324	4	O
of	28183324	4	O
cardiomyopathy	28183324	4	O
was	28183324	4	O
3.0	28183324	4	O
months	28183324	4	O
(	28183324	4	O
range	28183324	4	O
,	28183324	4	O
1.0	28183324	4	O
-	28183324	4	O
20.0	28183324	4	O
months	28183324	4	O
)	28183324	4	O
.	28183324	4	O
The	28183324	4	O
baseline	28183324	4	O
echocardiography	28183324	4	O
revealed	28183324	4	O
prominent	28183324	4	O
dilation	28183324	4	O
and	28183324	4	O
trabeculations	28183324	4	O
of	28183324	4	O
the	28183324	4	O
left	28183324	4	O
ventricle	28183324	4	O
with	28183324	4	O
impaired	28183324	4	O
systolic	28183324	4	O
function	28183324	4	O
in	28183324	4	O
the	28183324	4	O
six	28183324	4	O
patients	28183324	4	O
,	28183324	4	O
four	28183324	4	O
of	28183324	4	O
which	28183324	4	O
fulfilled	28183324	4	O
the	28183324	4	O
diagnostic	28183324	4	O
criteria	28183324	4	O
of	28183324	4	O
left	28183324	4	O
ventricular	28183324	4	O
noncompaction	28183324	4	O
.	28183324	4	O
Other	28183324	4	O
aspects	28183324	4	O
of	28183324	4	O
their	28183324	4	O
clinical	28183324	4	O
presentations	28183324	4	O
included	28183324	4	O
hypotonia	28183324	4	O
(	28183324	4	O
6	28183324	4	O
/	28183324	4	O
6	28183324	4	O
)	28183324	4	O
,	28183324	4	O
growth	28183324	4	O
delay	28183324	4	O
(	28183324	4	O
6	28183324	4	O
/	28183324	4	O
6	28183324	4	O
)	28183324	4	O
,	28183324	4	O
neutropenia	28183324	4	O
(	28183324	4	O
3	28183324	4	O
/	28183324	4	O
6	28183324	4	O
)	28183324	4	O
and	28183324	4	O
3	28183324	4	O
-	28183324	4	O
methylglutaconic	28183324	4	O
aciduria	28183324	4	O
(	28183324	4	O
4	28183324	4	O
/	28183324	4	O
5	28183324	4	O
)	28183324	4	O
.	28183324	4	O
Five	28183324	4	O
patients	28183324	4	O
died	28183324	4	O
at	28183324	4	O
a	28183324	4	O
median	28183324	4	O
age	28183324	4	O
of	28183324	4	O
7.5	28183324	4	O
months	28183324	4	O
(	28183324	4	O
range	28183324	4	O
,	28183324	4	O
7.0	28183324	4	O
-	28183324	4	O
12.0	28183324	4	O
months	28183324	4	O
)	28183324	4	O
.	28183324	4	O
The	28183324	4	O
cause	28183324	4	O
of	28183324	4	O
death	28183324	4	O
was	28183324	4	O
heart	28183324	4	O
failure	28183324	4	O
associated	28183324	4	O
with	28183324	4	O
infection	28183324	4	O
in	28183324	4	O
three	28183324	4	O
patients	28183324	4	O
and	28183324	4	O
cardiac	28183324	4	O
arrhythmia	28183324	4	O
in	28183324	4	O
two	28183324	4	O
patients	28183324	4	O
.	28183324	4	O
The	28183324	4	O
remaining	28183324	4	O
one	28183324	4	O
patient	28183324	4	O
survived	28183324	4	O
beyond	28183324	4	O
infancy	28183324	4	O
but	28183324	4	O
had	28183324	4	O
fallen	28183324	4	O
into	28183324	4	O
a	28183324	4	O
persistent	28183324	4	O
vegetative	28183324	4	O
state	28183324	4	O
after	28183324	4	O
suffering	28183324	4	O
from	28183324	4	O
cardiac	28183324	4	O
arrest	28183324	4	O
.	28183324	4	O
CONCLUSIONS	28183324	4	O
:	28183324	4	O
This	28183324	4	O
is	28183324	4	O
the	28183324	4	O
first	28183324	4	O
report	28183324	4	O
of	28183324	4	O
systematic	28183324	4	O
mutation	28183324	4	O
screening	28183324	4	O
of	28183324	4	O
TAZ	28183324	4	O
in	28183324	4	O
a	28183324	4	O
large	28183324	4	O
cohort	28183324	4	O
of	28183324	4	O
pediatric	28183324	4	O
patients	28183324	4	O
with	28183324	4	O
primary	28183324	4	O
cardiomyopathy	28183324	4	O
using	28183324	4	O
the	28183324	4	O
NGS	28183324	4	O
approach	28183324	4	O
.	28183324	4	O
TAZ	28183324	4	O
mutations	28183324	4	O
were	28183324	4	O
found	28183324	4	O
in	28183324	4	O
4	28183324	4	O
/	28183324	4	O
114	28183324	4	O
(	28183324	4	O
3.5%	28183324	4	O
)	28183324	4	O
male	28183324	4	O
patients	28183324	4	O
with	28183324	4	O
primary	28183324	4	O
cardiomyopathy	28183324	4	O
.	28183324	4	O
Our	28183324	4	O
findings	28183324	4	O
indicate	28183324	4	O
that	28183324	4	O
the	28183324	4	O
inclusion	28183324	4	O
of	28183324	4	O
TAZ	28183324	4	O
gene	28183324	4	O
testing	28183324	4	O
in	28183324	4	O
cardiomyopathy	28183324	4	O
genetic	28183324	4	O
testing	28183324	4	O
panels	28183324	4	O
may	28183324	4	O
contribute	28183324	4	O
to	28183324	4	O
the	28183324	4	O
early	28183324	4	O
diagnosis	28183324	4	O
of	28183324	4	O
BTHS	28183324	4	O
.	28183324	4	O

Mutations	28191891	1	B-Var
in	28191891	1	O
DONSON	28191891	1	B-Gene
disrupt	28191891	1	B-NegReg
replication	28191891	1	O
fork	28191891	1	O
stability	28191891	1	O
and	28191891	1	O
cause	28191891	1	B-Reg
microcephalic	28191891	1	B-Disease
dwarfism	28191891	1	I-Disease
.	28191891	1	O
To	28191891	1	O
ensure	28191891	1	O
efficient	28191891	1	O
genome	28191891	1	O
duplication	28191891	1	O
,	28191891	1	O
cells	28191891	1	O
have	28191891	1	O
evolved	28191891	1	O
numerous	28191891	1	O
factors	28191891	1	O
that	28191891	1	O
promote	28191891	1	O
unperturbed	28191891	1	O
DNA	28191891	1	O
replication	28191891	1	O
and	28191891	1	O
protect	28191891	1	O
,	28191891	1	O
repair	28191891	1	O
and	28191891	1	O
restart	28191891	1	O
damaged	28191891	1	O
forks	28191891	1	O
.	28191891	1	O
Here	28191891	1	O
we	28191891	1	O
identify	28191891	1	O
downstream	28191891	1	O
neighbor	28191891	1	O
of	28191891	1	O
SON	28191891	1	O
(	28191891	1	O
DONSON	28191891	1	O
)	28191891	1	O
as	28191891	1	O
a	28191891	1	O
novel	28191891	1	O
fork	28191891	1	O
protection	28191891	1	O
factor	28191891	1	O
and	28191891	1	O
report	28191891	1	O
biallelic	28191891	1	O
DONSON	28191891	1	O
mutations	28191891	1	O
in	28191891	1	O
29	28191891	1	O
individuals	28191891	1	O
with	28191891	1	O
microcephalic	28191891	1	O
dwarfism	28191891	1	O
.	28191891	1	O
We	28191891	1	O
demonstrate	28191891	1	O
that	28191891	1	O
DONSON	28191891	1	O
is	28191891	1	O
a	28191891	1	O
replisome	28191891	1	O
component	28191891	1	O
that	28191891	1	O
stabilizes	28191891	1	O
forks	28191891	1	O
during	28191891	1	O
genome	28191891	1	O
replication	28191891	1	O
.	28191891	1	O
Loss	28191891	1	B-Var
of	28191891	1	O
DONSON	28191891	1	B-Gene
leads	28191891	1	B-Reg
to	28191891	1	I-Reg
severe	28191891	1	O
replication	28191891	1	O
-	28191891	1	O
associated	28191891	1	O
DNA	28191891	1	O
damage	28191891	1	O
arising	28191891	1	O
from	28191891	1	O
nucleolytic	28191891	1	O
cleavage	28191891	1	O
of	28191891	1	O
stalled	28191891	1	O
replication	28191891	1	O
forks	28191891	1	O
.	28191891	1	O
Furthermore	28191891	1	O
,	28191891	1	O
ATM	28191891	1	O
-	28191891	1	O
and	28191891	1	O
Rad3	28191891	1	O
-	28191891	1	O
related	28191891	1	O
(	28191891	1	O
ATR	28191891	1	O
)	28191891	1	O
-	28191891	1	O
dependent	28191891	1	O
signaling	28191891	1	O
in	28191891	1	O
response	28191891	1	O
to	28191891	1	O
replication	28191891	1	O
stress	28191891	1	O
is	28191891	1	O
impaired	28191891	1	B-NegReg
in	28191891	1	O
DONSON	28191891	1	B-Var
-	28191891	1	I-Var
deficient	28191891	1	I-Var
cells	28191891	1	O
,	28191891	1	O
resulting	28191891	1	O
in	28191891	1	O
decreased	28191891	1	B-NegReg
checkpoint	28191891	1	O
activity	28191891	1	O
and	28191891	1	O
the	28191891	1	O
potentiation	28191891	1	B-PosReg
of	28191891	1	O
chromosomal	28191891	1	O
instability	28191891	1	O
.	28191891	1	O
Hypomorphic	28191891	1	B-Var
mutations	28191891	1	I-Var
in	28191891	1	O
DONSON	28191891	1	B-Gene
substantially	28191891	1	O
reduce	28191891	1	B-NegReg
DONSON	28191891	1	B-Gene
protein	28191891	1	O
levels	28191891	1	O
and	28191891	1	O
impair	28191891	1	B-NegReg
fork	28191891	1	O
stability	28191891	1	O
in	28191891	1	O
cells	28191891	1	O
from	28191891	1	O
patients	28191891	1	O
,	28191891	1	O
consistent	28191891	1	O
with	28191891	1	O
defective	28191891	1	O
DNA	28191891	1	O
replication	28191891	1	O
underlying	28191891	1	O
the	28191891	1	O
disease	28191891	1	O
phenotype	28191891	1	O
.	28191891	1	O
In	28191891	1	O
summary	28191891	1	O
,	28191891	1	O
we	28191891	1	O
have	28191891	1	O
identified	28191891	1	O
mutations	28191891	1	B-Var
in	28191891	1	O
DONSON	28191891	1	B-Gene
as	28191891	1	O
a	28191891	1	O
common	28191891	1	O
cause	28191891	1	B-Reg
of	28191891	1	O
microcephalic	28191891	1	B-Disease
dwarfism	28191891	1	I-Disease
and	28191891	1	O
established	28191891	1	O
DONSON	28191891	1	O
as	28191891	1	O
a	28191891	1	O
critical	28191891	1	O
replication	28191891	1	O
fork	28191891	1	O
protein	28191891	1	O
required	28191891	1	O
for	28191891	1	O
mammalian	28191891	1	O
DNA	28191891	1	O
replication	28191891	1	O
and	28191891	1	O
genome	28191891	1	O
stability	28191891	1	O
.	28191891	1	O

Phenotypic	28211240	4	O
spectrum	28211240	4	O
of	28211240	4	O
Charcot	28211240	4	B-Disease
-	28211240	4	I-Disease
Marie	28211240	4	I-Disease
-	28211240	4	I-Disease
Tooth	28211240	4	I-Disease
disease	28211240	4	O
due	28211240	4	B-Reg
to	28211240	4	I-Reg
LITAF	28211240	4	B-Gene
/	28211240	4	I-Gene
SIMPLE	28211240	4	I-Gene
mutations	28211240	4	B-Var
:	28211240	4	I-Var
a	28211240	4	O
study	28211240	4	O
of	28211240	4	O
18	28211240	4	O
patients	28211240	4	O
.	28211240	4	O
BACKGROUND	28211240	4	O
AND	28211240	4	O
PURPOSE	28211240	4	O
:	28211240	4	O
Charcot	28211240	4	B-Disease
-	28211240	4	I-Disease
Marie	28211240	4	I-Disease
-	28211240	4	I-Disease
Tooth	28211240	4	I-Disease
(	28211240	4	O
CMT	28211240	4	O
)	28211240	4	O
1	28211240	4	O
C	28211240	4	O
due	28211240	4	B-Reg
to	28211240	4	I-Reg
mutations	28211240	4	B-Var
in	28211240	4	O
LITAF	28211240	4	B-Gene
/	28211240	4	I-Gene
SIMPLE	28211240	4	I-Gene
is	28211240	4	O
a	28211240	4	O
rare	28211240	4	O
subtype	28211240	4	O
amongst	28211240	4	O
the	28211240	4	O
autosomal	28211240	4	O
dominant	28211240	4	O
demyelinating	28211240	4	O
forms	28211240	4	O
of	28211240	4	O
CMT	28211240	4	O
.	28211240	4	O
Our	28211240	4	O
objective	28211240	4	O
was	28211240	4	O
to	28211240	4	O
report	28211240	4	O
the	28211240	4	O
clinical	28211240	4	O
and	28211240	4	O
electrophysiological	28211240	4	O
characteristics	28211240	4	O
of	28211240	4	O
18	28211240	4	O
CMT1C	28211240	4	O
patients	28211240	4	O
and	28211240	4	O
compare	28211240	4	O
them	28211240	4	O
to	28211240	4	O
20	28211240	4	O
patients	28211240	4	O
with	28211240	4	O
PMP22	28211240	4	O
mutations	28211240	4	O
:	28211240	4	O
10	28211240	4	O
CMT1A	28211240	4	O
patients	28211240	4	O
and	28211240	4	O
10	28211240	4	O
patients	28211240	4	O
with	28211240	4	O
hereditary	28211240	4	O
neuropathy	28211240	4	O
with	28211240	4	O
liability	28211240	4	O
to	28211240	4	O
pressure	28211240	4	O
palsies	28211240	4	O
(	28211240	4	O
HNPP	28211240	4	O
)	28211240	4	O
.	28211240	4	O
METHODS	28211240	4	O
:	28211240	4	O
Charcot	28211240	4	O
-	28211240	4	O
Marie	28211240	4	O
-	28211240	4	O
Tooth	28211240	4	O
1	28211240	4	O
C	28211240	4	O
patients	28211240	4	O
were	28211240	4	O
followed	28211240	4	O
-	28211240	4	O
up	28211240	4	O
in	28211240	4	O
referral	28211240	4	O
centres	28211240	4	O
for	28211240	4	O
neuromuscular	28211240	4	O
diseases	28211240	4	O
or	28211240	4	O
were	28211240	4	O
identified	28211240	4	O
by	28211240	4	O
familial	28211240	4	O
survey	28211240	4	O
.	28211240	4	O
All	28211240	4	O
CMT1A	28211240	4	O
and	28211240	4	O
HNPP	28211240	4	O
patients	28211240	4	O
were	28211240	4	O
recruited	28211240	4	O
at	28211240	4	O
the	28211240	4	O
referral	28211240	4	O
centre	28211240	4	O
for	28211240	4	O
neuromuscular	28211240	4	O
diseases	28211240	4	O
of	28211240	4	O
Pitié	28211240	4	O
-	28211240	4	O
Salpêtrière	28211240	4	O
Hospital	28211240	4	O
.	28211240	4	O
RESULTS	28211240	4	O
:	28211240	4	O
Two	28211240	4	O
phenotypes	28211240	4	O
were	28211240	4	O
identified	28211240	4	O
amongst	28211240	4	O
18	28211240	4	O
CMT1C	28211240	4	O
patients	28211240	4	O
:	28211240	4	O
the	28211240	4	O
classical	28211240	4	O
CMT	28211240	4	O
form	28211240	4	O
(	28211240	4	O
'	28211240	4	O
CMT	28211240	4	O
-	28211240	4	O
like	28211240	4	O
'	28211240	4	O
,	28211240	4	O
11	28211240	4	O
cases	28211240	4	O
)	28211240	4	O
and	28211240	4	O
a	28211240	4	O
predominantly	28211240	4	O
sensory	28211240	4	O
form	28211240	4	O
(	28211240	4	O
'	28211240	4	O
sensory	28211240	4	O
form	28211240	4	O
'	28211240	4	O
,	28211240	4	O
seven	28211240	4	O
cases	28211240	4	O
)	28211240	4	O
.	28211240	4	O
The	28211240	4	O
mean	28211240	4	O
CMT	28211240	4	O
neuropathy	28211240	4	O
score	28211240	4	O
was	28211240	4	O
4.45	28211240	4	O
in	28211240	4	O
CMT1C	28211240	4	O
patients	28211240	4	O
.	28211240	4	O
Motor	28211240	4	O
nerve	28211240	4	O
conduction	28211240	4	O
velocities	28211240	4	O
in	28211240	4	O
the	28211240	4	O
upper	28211240	4	O
limbs	28211240	4	O
were	28211240	4	O
significantly	28211240	4	O
more	28211240	4	O
reduced	28211240	4	O
in	28211240	4	O
CMT1A	28211240	4	O
than	28211240	4	O
in	28211240	4	O
CMT1C	28211240	4	O
patients	28211240	4	O
.	28211240	4	O
On	28211240	4	O
the	28211240	4	O
other	28211240	4	O
hand	28211240	4	O
,	28211240	4	O
the	28211240	4	O
motor	28211240	4	O
nerve	28211240	4	O
conduction	28211240	4	O
velocity	28211240	4	O
of	28211240	4	O
the	28211240	4	O
median	28211240	4	O
nerve	28211240	4	O
was	28211240	4	O
significantly	28211240	4	O
lower	28211240	4	O
in	28211240	4	O
CMT1C	28211240	4	O
compared	28211240	4	O
to	28211240	4	O
the	28211240	4	O
HNPP	28211240	4	O
group	28211240	4	O
.	28211240	4	O
Distal	28211240	4	O
motor	28211240	4	O
latency	28211240	4	O
was	28211240	4	O
significantly	28211240	4	O
more	28211240	4	O
prolonged	28211240	4	O
in	28211240	4	O
CMT1A	28211240	4	O
patients	28211240	4	O
compared	28211240	4	O
to	28211240	4	O
the	28211240	4	O
CMT1C	28211240	4	O
and	28211240	4	O
HNPP	28211240	4	O
groups	28211240	4	O
,	28211240	4	O
the	28211240	4	O
latter	28211240	4	O
two	28211240	4	O
groups	28211240	4	O
having	28211240	4	O
similar	28211240	4	O
distal	28211240	4	O
motor	28211240	4	O
latency	28211240	4	O
values	28211240	4	O
.	28211240	4	O
Molecular	28211240	4	O
analysis	28211240	4	O
revealed	28211240	4	O
five	28211240	4	O
new	28211240	4	O
LITAF	28211240	4	O
/	28211240	4	O
SIMPLE	28211240	4	O
mutations	28211240	4	O
(	28211240	4	O
Ala111Thr	28211240	4	O
,	28211240	4	O
Gly112Ala	28211240	4	O
,	28211240	4	O
Trp116Arg	28211240	4	O
,	28211240	4	O
Pro135Leu	28211240	4	O
,	28211240	4	O
Arg160Cys	28211240	4	O
)	28211240	4	O
.	28211240	4	O
CONCLUSIONS	28211240	4	O
:	28211240	4	O
Our	28211240	4	O
study	28211240	4	O
delineates	28211240	4	O
CMT1C	28211240	4	O
as	28211240	4	O
mostly	28211240	4	O
a	28211240	4	O
mild	28211240	4	O
form	28211240	4	O
of	28211240	4	O
neuropathy	28211240	4	O
,	28211240	4	O
and	28211240	4	O
gives	28211240	4	O
clinical	28211240	4	O
and	28211240	4	O
electrophysiological	28211240	4	O
clues	28211240	4	O
differentiating	28211240	4	O
CMT1C	28211240	4	O
from	28211240	4	O
CMT1A	28211240	4	O
and	28211240	4	O
HNPP	28211240	4	O
.	28211240	4	O
Delineating	28211240	4	O
phenotypes	28211240	4	O
in	28211240	4	O
CMT	28211240	4	O
subtypes	28211240	4	O
is	28211240	4	O
important	28211240	4	O
to	28211240	4	O
orient	28211240	4	O
molecular	28211240	4	O
diagnosis	28211240	4	O
and	28211240	4	O
to	28211240	4	O
help	28211240	4	O
to	28211240	4	O
interpret	28211240	4	O
complex	28211240	4	O
molecular	28211240	4	O
findings	28211240	4	O
.	28211240	4	O

N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
Regulation	28240364	0	O
of	28240364	0	O
Bone	28240364	0	O
Growth	28240364	0	O
and	28240364	0	O
Homeostasis	28240364	0	O
Is	28240364	0	O
Osteolineage	28240364	0	O
Stage	28240364	0	O
-	28240364	0	O
Specific	28240364	0	O
.	28240364	0	O
N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
inhibits	28240364	0	O
osteogenic	28240364	0	O
cell	28240364	0	O
differentiation	28240364	0	O
and	28240364	0	O
canonical	28240364	0	O
Wnt	28240364	0	O
/	28240364	0	O
β	28240364	0	O
-	28240364	0	O
catenin	28240364	0	O
signaling	28240364	0	O
in	28240364	0	O
vitro	28240364	0	O
.	28240364	0	O
However	28240364	0	O
,	28240364	0	O
in	28240364	0	O
vivo	28240364	0	O
both	28240364	0	O
conditional	28240364	0	O
Cdh2	28240364	0	O
ablation	28240364	0	O
and	28240364	0	O
overexpression	28240364	0	O
in	28240364	0	O
osteoblasts	28240364	0	O
lead	28240364	0	O
to	28240364	0	O
low	28240364	0	O
bone	28240364	0	O
mass	28240364	0	O
.	28240364	0	O
We	28240364	0	O
tested	28240364	0	O
the	28240364	0	O
hypothesis	28240364	0	O
that	28240364	0	O
N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
has	28240364	0	O
different	28240364	0	O
effects	28240364	0	O
on	28240364	0	O
osteolineage	28240364	0	O
cells	28240364	0	O
depending	28240364	0	O
upon	28240364	0	O
their	28240364	0	O
differentiation	28240364	0	O
stage	28240364	0	O
.	28240364	0	O
Embryonic	28240364	0	O
conditional	28240364	0	O
osteolineage	28240364	0	O
Cdh2	28240364	0	B-Gene
deletion	28240364	0	B-Var
in	28240364	0	O
mice	28240364	0	O
results	28240364	0	O
in	28240364	0	O
defective	28240364	0	B-NegReg
growth	28240364	0	O
,	28240364	0	O
low	28240364	0	B-NegReg
bone	28240364	0	O
mass	28240364	0	O
,	28240364	0	O
and	28240364	0	O
reduced	28240364	0	B-NegReg
osteoprogenitor	28240364	0	O
number	28240364	0	O
.	28240364	0	O
These	28240364	0	O
abnormalities	28240364	0	O
are	28240364	0	O
prevented	28240364	0	O
by	28240364	0	O
delaying	28240364	0	O
Cdh2	28240364	0	O
ablation	28240364	0	O
until	28240364	0	O
1	28240364	0	O
month	28240364	0	O
of	28240364	0	O
age	28240364	0	O
,	28240364	0	O
thus	28240364	0	O
targeting	28240364	0	O
only	28240364	0	O
committed	28240364	0	O
and	28240364	0	O
mature	28240364	0	O
osteoblasts	28240364	0	O
,	28240364	0	O
suggesting	28240364	0	O
they	28240364	0	O
are	28240364	0	O
the	28240364	0	O
consequence	28240364	0	O
of	28240364	0	O
N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
deficiency	28240364	0	O
in	28240364	0	O
osteoprogenitors	28240364	0	O
.	28240364	0	O
Indeed	28240364	0	O
,	28240364	0	O
diaphyseal	28240364	0	O
trabecularization	28240364	0	O
actually	28240364	0	O
increases	28240364	0	O
when	28240364	0	O
Cdh2	28240364	0	O
is	28240364	0	O
ablated	28240364	0	O
postnatally	28240364	0	O
.	28240364	0	O
The	28240364	0	O
sclerostin	28240364	0	O
-	28240364	0	O
insensitive	28240364	0	O
Lrp5	28240364	0	O
(	28240364	0	O
A214V	28240364	0	O
)	28240364	0	O
mutant	28240364	0	O
,	28240364	0	O
associated	28240364	0	O
with	28240364	0	O
high	28240364	0	O
bone	28240364	0	O
mass	28240364	0	O
,	28240364	0	O
does	28240364	0	O
not	28240364	0	O
rescue	28240364	0	O
the	28240364	0	O
growth	28240364	0	O
defect	28240364	0	O
,	28240364	0	O
but	28240364	0	O
it	28240364	0	O
overrides	28240364	0	O
the	28240364	0	O
low	28240364	0	O
bone	28240364	0	O
mass	28240364	0	O
of	28240364	0	O
embryonically	28240364	0	O
Cdh2	28240364	0	O
-	28240364	0	O
deleted	28240364	0	O
mice	28240364	0	O
,	28240364	0	O
suggesting	28240364	0	O
N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
interacts	28240364	0	O
with	28240364	0	O
Wnt	28240364	0	O
signaling	28240364	0	O
to	28240364	0	O
control	28240364	0	O
bone	28240364	0	O
mass	28240364	0	O
.	28240364	0	O
Finally	28240364	0	O
,	28240364	0	O
bone	28240364	0	O
accrual	28240364	0	O
and	28240364	0	O
β	28240364	0	O
-	28240364	0	O
catenin	28240364	0	O
accumulation	28240364	0	O
after	28240364	0	O
administration	28240364	0	O
of	28240364	0	O
an	28240364	0	O
anti	28240364	0	O
-	28240364	0	O
Dkk1	28240364	0	O
antibody	28240364	0	O
are	28240364	0	O
enhanced	28240364	0	O
in	28240364	0	O
N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
-	28240364	0	O
deficient	28240364	0	O
mice	28240364	0	O
.	28240364	0	O
Thus	28240364	0	O
,	28240364	0	O
although	28240364	0	O
lack	28240364	0	O
of	28240364	0	O
N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
in	28240364	0	O
embryonic	28240364	0	O
and	28240364	0	O
perinatal	28240364	0	O
age	28240364	0	O
is	28240364	0	O
detrimental	28240364	0	O
to	28240364	0	O
bone	28240364	0	O
growth	28240364	0	O
and	28240364	0	O
bone	28240364	0	O
accrual	28240364	0	O
,	28240364	0	O
in	28240364	0	O
adult	28240364	0	O
mice	28240364	0	O
loss	28240364	0	O
of	28240364	0	O
N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
in	28240364	0	O
osteolineage	28240364	0	O
cells	28240364	0	O
favors	28240364	0	O
bone	28240364	0	O
formation	28240364	0	O
.	28240364	0	O
Hence	28240364	0	O
,	28240364	0	O
N	28240364	0	O
-	28240364	0	O
cadherin	28240364	0	O
inhibition	28240364	0	O
may	28240364	0	O
widen	28240364	0	O
the	28240364	0	O
therapeutic	28240364	0	O
window	28240364	0	O
of	28240364	0	O
osteoanabolic	28240364	0	O
agents	28240364	0	O
.	28240364	0	O
2017	28240364	0	O
American	28240364	0	O
Society	28240364	0	O
for	28240364	0	O
Bone	28240364	0	O
and	28240364	0	O
Mineral	28240364	0	O
Research	28240364	0	O
.	28240364	0	O

ATR	28273450	1	B-Gene
Mutations	28273450	1	B-Var
Promote	28273450	1	B-PosReg
the	28273450	1	O
Growth	28273450	1	O
of	28273450	1	O
Melanoma	28273450	1	B-Disease
Tumors	28273450	1	I-Disease
by	28273450	1	O
Modulating	28273450	1	O
the	28273450	1	O
Immune	28273450	1	O
Microenvironment	28273450	1	O
.	28273450	1	O
Melanomas	28273450	1	O
accumulate	28273450	1	O
a	28273450	1	O
high	28273450	1	O
burden	28273450	1	O
of	28273450	1	O
mutations	28273450	1	B-Var
that	28273450	1	O
could	28273450	1	O
potentially	28273450	1	O
generate	28273450	1	B-Reg
neoantigens	28273450	1	O
,	28273450	1	O
yet	28273450	1	O
somehow	28273450	1	O
suppress	28273450	1	B-NegReg
the	28273450	1	O
immune	28273450	1	O
response	28273450	1	O
to	28273450	1	O
facilitate	28273450	1	O
continued	28273450	1	O
growth	28273450	1	O
.	28273450	1	O
In	28273450	1	O
this	28273450	1	O
study	28273450	1	O
,	28273450	1	O
we	28273450	1	O
identify	28273450	1	O
a	28273450	1	O
subset	28273450	1	O
of	28273450	1	O
human	28273450	1	O
melanomas	28273450	1	O
that	28273450	1	O
have	28273450	1	O
loss	28273450	1	O
-	28273450	1	O
of	28273450	1	O
-	28273450	1	O
function	28273450	1	O
mutations	28273450	1	O
in	28273450	1	O
ATR	28273450	1	O
,	28273450	1	O
a	28273450	1	O
kinase	28273450	1	O
that	28273450	1	O
recognizes	28273450	1	O
and	28273450	1	O
repairs	28273450	1	O
UV	28273450	1	O
-	28273450	1	O
induced	28273450	1	O
DNA	28273450	1	O
damage	28273450	1	O
and	28273450	1	O
is	28273450	1	O
required	28273450	1	O
for	28273450	1	O
cellular	28273450	1	O
proliferation	28273450	1	O
.	28273450	1	O
ATR	28273450	1	B-Gene
mutant	28273450	1	B-Var
tumors	28273450	1	O
exhibit	28273450	1	O
both	28273450	1	O
the	28273450	1	O
accumulation	28273450	1	O
of	28273450	1	O
multiple	28273450	1	O
mutations	28273450	1	O
and	28273450	1	O
the	28273450	1	O
altered	28273450	1	O
expression	28273450	1	O
of	28273450	1	O
inflammatory	28273450	1	O
genes	28273450	1	O
,	28273450	1	O
resulting	28273450	1	O
in	28273450	1	O
decreased	28273450	1	B-NegReg
T	28273450	1	O
cell	28273450	1	O
recruitment	28273450	1	O
and	28273450	1	O
increased	28273450	1	B-PosReg
recruitment	28273450	1	O
of	28273450	1	O
macrophages	28273450	1	O
known	28273450	1	O
to	28273450	1	O
spur	28273450	1	O
tumor	28273450	1	O
invasion	28273450	1	O
.	28273450	1	O
Taken	28273450	1	O
together	28273450	1	O
,	28273450	1	O
these	28273450	1	O
studies	28273450	1	O
identify	28273450	1	O
a	28273450	1	O
mechanism	28273450	1	O
by	28273450	1	O
which	28273450	1	O
melanoma	28273450	1	O
cells	28273450	1	O
modulate	28273450	1	O
the	28273450	1	O
immune	28273450	1	O
microenvironment	28273450	1	O
to	28273450	1	O
promote	28273450	1	O
continued	28273450	1	O
growth	28273450	1	O
.	28273450	1	O

Regulation	28277116	0	O
of	28277116	0	O
endometrial	28277116	0	O
cell	28277116	0	O
proliferation	28277116	0	O
by	28277116	0	O
estrogen	28277116	0	O
-	28277116	0	O
induced	28277116	0	O
BDNF	28277116	0	O
signaling	28277116	0	O
pathway	28277116	0	O
.	28277116	0	O
Brain	28277116	0	O
-	28277116	0	O
derived	28277116	0	O
neurotrophic	28277116	0	O
factor	28277116	0	O
(	28277116	0	O
BDNF	28277116	0	O
)	28277116	0	O
is	28277116	0	O
a	28277116	0	O
member	28277116	0	O
of	28277116	0	O
the	28277116	0	O
neurotrophin	28277116	0	O
growth	28277116	0	O
factors	28277116	0	O
family	28277116	0	O
.	28277116	0	O
Recent	28277116	0	O
studies	28277116	0	O
indicated	28277116	0	O
that	28277116	0	O
the	28277116	0	O
level	28277116	0	O
of	28277116	0	O
BDNF	28277116	0	O
in	28277116	0	O
follicular	28277116	0	O
fluid	28277116	0	O
is	28277116	0	O
a	28277116	0	O
marker	28277116	0	O
for	28277116	0	O
oocyte	28277116	0	O
quality	28277116	0	O
and	28277116	0	O
infertility	28277116	0	O
.	28277116	0	O
Here	28277116	0	O
,	28277116	0	O
we	28277116	0	O
intend	28277116	0	O
to	28277116	0	O
further	28277116	0	O
investigate	28277116	0	O
the	28277116	0	O
function	28277116	0	O
of	28277116	0	O
BDNF	28277116	0	O
and	28277116	0	O
its	28277116	0	O
signaling	28277116	0	O
pathway	28277116	0	O
in	28277116	0	O
the	28277116	0	O
regulation	28277116	0	O
of	28277116	0	O
endometrial	28277116	0	O
cells	28277116	0	O
proliferation	28277116	0	O
.	28277116	0	O
We	28277116	0	O
found	28277116	0	O
that	28277116	0	O
BDNF	28277116	0	O
is	28277116	0	O
a	28277116	0	O
critical	28277116	0	O
growth	28277116	0	O
factor	28277116	0	O
in	28277116	0	O
endometrial	28277116	0	O
cells	28277116	0	O
.	28277116	0	O
Activation	28277116	0	O
of	28277116	0	O
signal	28277116	0	O
transducer	28277116	0	O
and	28277116	0	O
activator	28277116	0	O
of	28277116	0	O
transcription	28277116	0	O
3	28277116	0	O
signaling	28277116	0	O
pathway	28277116	0	O
is	28277116	0	O
required	28277116	0	O
for	28277116	0	O
BNDF	28277116	0	O
-	28277116	0	O
regulated	28277116	0	O
endometrial	28277116	0	O
cell	28277116	0	O
proliferation	28277116	0	O
.	28277116	0	O
Furthermore	28277116	0	O
,	28277116	0	O
BDNF	28277116	0	O
is	28277116	0	O
an	28277116	0	O
effector	28277116	0	O
of	28277116	0	O
estrogen	28277116	0	O
in	28277116	0	O
endometrial	28277116	0	O
cells	28277116	0	O
.	28277116	0	O
Finally	28277116	0	O
,	28277116	0	O
we	28277116	0	O
investigated	28277116	0	O
the	28277116	0	O
different	28277116	0	O
role	28277116	0	O
of	28277116	0	O
Val66Met	28277116	0	O
,	28277116	0	O
a	28277116	0	O
single	28277116	0	O
-	28277116	0	O
nucleotide	28277116	0	O
polymorphism	28277116	0	O
of	28277116	0	O
the	28277116	0	O
BDNF	28277116	0	O
gene	28277116	0	O
,	28277116	0	O
in	28277116	0	O
regulating	28277116	0	O
endometrial	28277116	0	O
cells	28277116	0	O
proliferation	28277116	0	O
.	28277116	0	O
The	28277116	0	O
results	28277116	0	O
showed	28277116	0	O
that	28277116	0	O
BDNF	28277116	0	B-Gene
(	28277116	0	I-Gene
V66M	28277116	0	I-Gene
)	28277116	0	I-Gene
polymorphism	28277116	0	B-Var
is	28277116	0	O
a	28277116	0	O
loss	28277116	0	B-NegReg
-	28277116	0	I-NegReg
of	28277116	0	I-NegReg
-	28277116	0	I-NegReg
function	28277116	0	I-NegReg
polymorphism	28277116	0	B-Var
in	28277116	0	O
the	28277116	0	O
regulation	28277116	0	O
of	28277116	0	O
endometrial	28277116	0	O
cells	28277116	0	O
growth	28277116	0	O
.	28277116	0	O
Given	28277116	0	O
the	28277116	0	O
correlation	28277116	0	O
between	28277116	0	O
endometriosis	28277116	0	O
and	28277116	0	O
infertility	28277116	0	O
,	28277116	0	O
it	28277116	0	O
is	28277116	0	O
important	28277116	0	O
to	28277116	0	O
understand	28277116	0	O
the	28277116	0	O
role	28277116	0	O
of	28277116	0	O
BDNF	28277116	0	O
in	28277116	0	O
regulating	28277116	0	O
endometrial	28277116	0	O
cells	28277116	0	O
proliferation	28277116	0	O
and	28277116	0	O
to	28277116	0	O
develop	28277116	0	O
new	28277116	0	O
therapeutic	28277116	0	O
strategies	28277116	0	O
for	28277116	0	O
the	28277116	0	O
treatment	28277116	0	O
of	28277116	0	O
endometriosis	28277116	0	O
-	28277116	0	O
related	28277116	0	O
infertility	28277116	0	O
.	28277116	0	O

Impact	28283687	0	O
of	28283687	0	O
gain	28283687	0	B-PosReg
-	28283687	0	I-PosReg
of	28283687	0	I-PosReg
-	28283687	0	I-PosReg
function	28283687	0	I-PosReg
mutations	28283687	0	B-Var
in	28283687	0	O
the	28283687	0	O
low	28283687	0	O
-	28283687	0	O
density	28283687	0	O
lipoprotein	28283687	0	O
receptor	28283687	0	O
-	28283687	0	O
related	28283687	0	O
protein	28283687	0	O
5	28283687	0	O
(	28283687	0	B-Gene
LRP5	28283687	0	I-Gene
)	28283687	0	I-Gene
on	28283687	0	O
glucose	28283687	0	O
and	28283687	0	O
lipid	28283687	0	O
homeostasis	28283687	0	O
.	28283687	0	O
LRP5	28283687	0	B-Gene
loss	28283687	0	B-NegReg
-	28283687	0	I-NegReg
of	28283687	0	I-NegReg
-	28283687	0	I-NegReg
function	28283687	0	I-NegReg
mutations	28283687	0	B-Var
have	28283687	0	O
been	28283687	0	O
shown	28283687	0	O
to	28283687	0	O
cause	28283687	0	O
profound	28283687	0	O
osteoporosis	28283687	0	O
and	28283687	0	O
have	28283687	0	O
been	28283687	0	O
associated	28283687	0	O
with	28283687	0	O
impaired	28283687	0	O
insulin	28283687	0	O
sensitivity	28283687	0	O
and	28283687	0	O
dysregulated	28283687	0	O
lipid	28283687	0	O
metabolism	28283687	0	O
.	28283687	0	O
We	28283687	0	O
hypothesized	28283687	0	O
that	28283687	0	O
gain	28283687	0	O
-	28283687	0	O
of	28283687	0	O
-	28283687	0	O
function	28283687	0	O
mutations	28283687	0	O
in	28283687	0	O
LRP5	28283687	0	O
would	28283687	0	O
also	28283687	0	O
affect	28283687	0	O
these	28283687	0	O
parameters	28283687	0	O
.	28283687	0	O
We	28283687	0	O
therefore	28283687	0	O
studied	28283687	0	O
individuals	28283687	0	O
with	28283687	0	O
LRP5	28283687	0	B-Gene
gain	28283687	0	B-PosReg
-	28283687	0	I-PosReg
of	28283687	0	I-PosReg
-	28283687	0	I-PosReg
function	28283687	0	I-PosReg
mutations	28283687	0	B-Var
exhibiting	28283687	0	O
high	28283687	0	O
bone	28283687	0	O
mass	28283687	0	O
(	28283687	0	O
HBM	28283687	0	O
)	28283687	0	O
phenotypes	28283687	0	O
and	28283687	0	O
found	28283687	0	O
that	28283687	0	O
while	28283687	0	O
there	28283687	0	O
was	28283687	0	O
no	28283687	0	O
detected	28283687	0	O
change	28283687	0	O
in	28283687	0	O
insulin	28283687	0	O
sensitivity	28283687	0	O
,	28283687	0	O
there	28283687	0	O
was	28283687	0	O
a	28283687	0	O
significant	28283687	0	O
reduction	28283687	0	B-NegReg
in	28283687	0	O
serum	28283687	0	O
LDL	28283687	0	O
.	28283687	0	O
INTRODUCTION	28283687	0	O
:	28283687	0	O
Wnt	28283687	0	O
signaling	28283687	0	O
through	28283687	0	O
LRP5	28283687	0	O
represents	28283687	0	O
a	28283687	0	O
newly	28283687	0	O
appreciated	28283687	0	O
metabolic	28283687	0	O
pathway	28283687	0	O
,	28283687	0	O
which	28283687	0	O
potentially	28283687	0	O
represents	28283687	0	O
a	28283687	0	O
target	28283687	0	O
for	28283687	0	O
drug	28283687	0	O
discovery	28283687	0	O
in	28283687	0	O
type	28283687	0	O
2	28283687	0	O
diabetes	28283687	0	O
and	28283687	0	O
hyperlipidemia	28283687	0	O
.	28283687	0	O
Studies	28283687	0	O
in	28283687	0	O
animal	28283687	0	O
models	28283687	0	O
suggest	28283687	0	O
a	28283687	0	O
physiologic	28283687	0	O
link	28283687	0	O
between	28283687	0	O
LRP5	28283687	0	O
and	28283687	0	O
glucose	28283687	0	O
and	28283687	0	O
lipid	28283687	0	O
homeostasis	28283687	0	O
;	28283687	0	O
however	28283687	0	O
,	28283687	0	O
whether	28283687	0	O
it	28283687	0	O
plays	28283687	0	O
a	28283687	0	O
similar	28283687	0	O
role	28283687	0	O
in	28283687	0	O
humans	28283687	0	O
is	28283687	0	O
unclear	28283687	0	O
.	28283687	0	O
As	28283687	0	O
current	28283687	0	O
literature	28283687	0	O
links	28283687	0	O
loss	28283687	0	O
-	28283687	0	O
of	28283687	0	O
-	28283687	0	O
function	28283687	0	O
LRP5	28283687	0	O
to	28283687	0	O
impaired	28283687	0	O
glucose	28283687	0	O
and	28283687	0	O
lipid	28283687	0	O
metabolism	28283687	0	O
,	28283687	0	O
we	28283687	0	O
hypothesized	28283687	0	O
that	28283687	0	O
individuals	28283687	0	O
with	28283687	0	O
an	28283687	0	O
HBM	28283687	0	O
-	28283687	0	O
causing	28283687	0	O
mutation	28283687	0	O
in	28283687	0	O
LRP5	28283687	0	O
would	28283687	0	O
exhibit	28283687	0	O
improved	28283687	0	O
glucose	28283687	0	O
and	28283687	0	O
lipid	28283687	0	O
homeostasis	28283687	0	O
.	28283687	0	O
Since	28283687	0	O
studies	28283687	0	O
in	28283687	0	O
animal	28283687	0	O
models	28283687	0	O
have	28283687	0	O
suggested	28283687	0	O
that	28283687	0	O
Wnt	28283687	0	O
signaling	28283687	0	O
augments	28283687	0	O
insulin	28283687	0	O
secretion	28283687	0	O
,	28283687	0	O
we	28283687	0	O
also	28283687	0	O
examined	28283687	0	O
the	28283687	0	O
effect	28283687	0	O
of	28283687	0	O
Wnt	28283687	0	O
signaling	28283687	0	O
on	28283687	0	O
glucose	28283687	0	O
-	28283687	0	O
stimulated	28283687	0	O
insulin	28283687	0	O
secretion	28283687	0	O
on	28283687	0	O
human	28283687	0	O
pancreatic	28283687	0	O
islets	28283687	0	O
.	28283687	0	O
METHODS	28283687	0	O
:	28283687	0	O
This	28283687	0	O
was	28283687	0	O
a	28283687	0	O
matched	28283687	0	O
case	28283687	0	O
-	28283687	0	O
control	28283687	0	O
study	28283687	0	O
.	28283687	0	O
We	28283687	0	O
used	28283687	0	O
several	28283687	0	O
methods	28283687	0	O
to	28283687	0	O
assess	28283687	0	O
glucose	28283687	0	O
and	28283687	0	O
lipid	28283687	0	O
metabolism	28283687	0	O
in	28283687	0	O
11	28283687	0	O
individuals	28283687	0	O
with	28283687	0	O
HBM	28283687	0	O
-	28283687	0	O
causing	28283687	0	O
mutations	28283687	0	O
in	28283687	0	O
LRP5	28283687	0	O
.	28283687	0	O
Affected	28283687	0	O
study	28283687	0	O
participants	28283687	0	O
were	28283687	0	O
recruited	28283687	0	O
from	28283687	0	O
previously	28283687	0	O
identified	28283687	0	O
kindreds	28283687	0	O
with	28283687	0	O
HBM	28283687	0	O
-	28283687	0	O
causing	28283687	0	O
LRP5	28283687	0	O
mutations	28283687	0	O
and	28283687	0	O
included	28283687	0	O
9	28283687	0	O
males	28283687	0	O
and	28283687	0	O
2	28283687	0	O
females	28283687	0	O
.	28283687	0	O
Two	28283687	0	O
subjects	28283687	0	O
that	28283687	0	O
were	28283687	0	O
being	28283687	0	O
treated	28283687	0	O
with	28283687	0	O
insulin	28283687	0	O
for	28283687	0	O
type	28283687	0	O
2	28283687	0	O
diabetes	28283687	0	O
were	28283687	0	O
excluded	28283687	0	O
from	28283687	0	O
our	28283687	0	O
analysis	28283687	0	O
,	28283687	0	O
as	28283687	0	O
this	28283687	0	O
would	28283687	0	O
have	28283687	0	O
obscured	28283687	0	O
our	28283687	0	O
ability	28283687	0	O
to	28283687	0	O
determine	28283687	0	O
the	28283687	0	O
impact	28283687	0	O
of	28283687	0	O
gain	28283687	0	O
-	28283687	0	O
of	28283687	0	O
-	28283687	0	O
function	28283687	0	O
LRP5	28283687	0	O
mutations	28283687	0	O
on	28283687	0	O
glucose	28283687	0	O
metabolism	28283687	0	O
.	28283687	0	O
The	28283687	0	O
mean	28283687	0	O
age	28283687	0	O
of	28283687	0	O
the	28283687	0	O
evaluated	28283687	0	O
study	28283687	0	O
subjects	28283687	0	O
was	28283687	0	O
55	28283687	0	O
7	28283687	0	O
with	28283687	0	O
a	28283687	0	O
mean	28283687	0	O
BMI	28283687	0	O
of	28283687	0	O
27.2	28283687	0	O
2.0	28283687	0	O
.	28283687	0	O
Control	28283687	0	O
subjects	28283687	0	O
were	28283687	0	O
matched	28283687	0	O
and	28283687	0	O
recruited	28283687	0	O
from	28283687	0	O
the	28283687	0	O
general	28283687	0	O
community	28283687	0	O
at	28283687	0	O
an	28283687	0	O
equivalent	28283687	0	O
ratio	28283687	0	O
,	28283687	0	O
with	28283687	0	O
18	28283687	0	O
males	28283687	0	O
and	28283687	0	O
4	28283687	0	O
females	28283687	0	O
(	28283687	0	O
mean	28283687	0	O
age	28283687	0	O
56	28283687	0	O
4	28283687	0	O
;	28283687	0	O
mean	28283687	0	O
BMI	28283687	0	O
27.2	28283687	0	O
1.0	28283687	0	O
)	28283687	0	O
.	28283687	0	O
Study	28283687	0	O
testing	28283687	0	O
was	28283687	0	O
conducted	28283687	0	O
at	28283687	0	O
an	28283687	0	O
academic	28283687	0	O
medical	28283687	0	O
center	28283687	0	O
.	28283687	0	O
RESULTS	28283687	0	O
:	28283687	0	O
There	28283687	0	O
were	28283687	0	O
no	28283687	0	O
statistically	28283687	0	O
significant	28283687	0	O
differences	28283687	0	O
between	28283687	0	O
affected	28283687	0	O
and	28283687	0	O
matched	28283687	0	O
control	28283687	0	O
populations	28283687	0	O
for	28283687	0	O
HbA1c	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.06	28283687	0	O
)	28283687	0	O
,	28283687	0	O
eAG	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.06	28283687	0	O
)	28283687	0	O
,	28283687	0	O
insulin	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.82	28283687	0	O
)	28283687	0	O
,	28283687	0	O
HOMA	28283687	0	O
-	28283687	0	O
B	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.34	28283687	0	O
)	28283687	0	O
,	28283687	0	O
or	28283687	0	O
HOMA	28283687	0	O
-	28283687	0	O
IR	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.66	28283687	0	O
)	28283687	0	O
.	28283687	0	O
The	28283687	0	O
mean	28283687	0	O
Insulin	28283687	0	O
Sensitivity	28283687	0	O
Index	28283687	0	O
(	28283687	0	O
ISI	28283687	0	O
)	28283687	0	O
was	28283687	0	O
also	28283687	0	O
similar	28283687	0	O
between	28283687	0	O
control	28283687	0	O
and	28283687	0	O
affected	28283687	0	O
individuals	28283687	0	O
.	28283687	0	O
Total	28283687	0	O
cholesterol	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.43	28283687	0	O
)	28283687	0	O
,	28283687	0	O
triglycerides	28283687	0	O
(	28283687	0	O
TG	28283687	0	O
)	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.56	28283687	0	O
)	28283687	0	O
,	28283687	0	O
and	28283687	0	O
HDL	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.32	28283687	0	O
)	28283687	0	O
were	28283687	0	O
not	28283687	0	O
different	28283687	0	O
between	28283687	0	O
the	28283687	0	O
same	28283687	0	O
two	28283687	0	O
groups	28283687	0	O
.	28283687	0	O
In	28283687	0	O
a	28283687	0	O
small	28283687	0	O
subset	28283687	0	O
of	28283687	0	O
studied	28283687	0	O
subjects	28283687	0	O
,	28283687	0	O
intramyocellular	28283687	0	O
and	28283687	0	O
hepatic	28283687	0	O
lipid	28283687	0	O
content	28283687	0	O
were	28283687	0	O
similar	28283687	0	O
in	28283687	0	O
the	28283687	0	O
affected	28283687	0	O
individuals	28283687	0	O
and	28283687	0	O
controls	28283687	0	O
when	28283687	0	O
quantified	28283687	0	O
by	28283687	0	O
proton	28283687	0	O
magnetic	28283687	0	O
resonance	28283687	0	O
spectroscopy	28283687	0	O
(	28283687	0	O
MRS	28283687	0	O
)	28283687	0	O
.	28283687	0	O
However	28283687	0	O
,	28283687	0	O
the	28283687	0	O
mean	28283687	0	O
value	28283687	0	O
for	28283687	0	O
serum	28283687	0	O
LDL	28283687	0	O
was	28283687	0	O
significantly	28283687	0	O
lower	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.04	28283687	0	O
)	28283687	0	O
in	28283687	0	O
affected	28283687	0	O
individuals	28283687	0	O
.	28283687	0	O
In	28283687	0	O
primary	28283687	0	O
human	28283687	0	O
islets	28283687	0	O
,	28283687	0	O
there	28283687	0	O
were	28283687	0	O
no	28283687	0	O
differences	28283687	0	O
between	28283687	0	O
control	28283687	0	O
and	28283687	0	O
Wnt	28283687	0	O
treatment	28283687	0	O
groups	28283687	0	O
for	28283687	0	O
insulin	28283687	0	O
secretion	28283687	0	O
measured	28283687	0	O
as	28283687	0	O
area	28283687	0	O
under	28283687	0	O
the	28283687	0	O
curve	28283687	0	O
(	28283687	0	O
AUC	28283687	0	O
)	28283687	0	O
for	28283687	0	O
first	28283687	0	O
phase	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.17	28283687	0	O
)	28283687	0	O
or	28283687	0	O
second	28283687	0	O
phase	28283687	0	O
(	28283687	0	O
p	28283687	0	O
=	28283687	0	O
0.33	28283687	0	O
)	28283687	0	O
insulin	28283687	0	O
secretion	28283687	0	O
.	28283687	0	O
CONCLUSIONS	28283687	0	O
:	28283687	0	O
Although	28283687	0	O
our	28283687	0	O
sample	28283687	0	O
size	28283687	0	O
was	28283687	0	O
small	28283687	0	O
,	28283687	0	O
our	28283687	0	O
data	28283687	0	O
do	28283687	0	O
not	28283687	0	O
support	28283687	0	O
the	28283687	0	O
hypothesis	28283687	0	O
that	28283687	0	O
HBM	28283687	0	O
-	28283687	0	O
causing	28283687	0	O
LRP5	28283687	0	O
mutations	28283687	0	O
,	28283687	0	O
associated	28283687	0	O
with	28283687	0	O
increased	28283687	0	O
Wnt	28283687	0	O
signaling	28283687	0	O
,	28283687	0	O
improve	28283687	0	O
glucose	28283687	0	O
metabolism	28283687	0	O
in	28283687	0	O
humans	28283687	0	O
.	28283687	0	O
However	28283687	0	O
,	28283687	0	O
it	28283687	0	O
does	28283687	0	O
appear	28283687	0	O
that	28283687	0	O
LRP5	28283687	0	B-Gene
variants	28283687	0	B-Var
may	28283687	0	O
affect	28283687	0	B-Reg
LDL	28283687	0	O
metabolism	28283687	0	O
,	28283687	0	O
a	28283687	0	O
major	28283687	0	O
risk	28283687	0	O
factor	28283687	0	O
for	28283687	0	O
coronary	28283687	0	O
artery	28283687	0	O
disease	28283687	0	O
.	28283687	0	O
The	28283687	0	O
molecular	28283687	0	O
mechanisms	28283687	0	O
underpinning	28283687	0	O
this	28283687	0	O
effect	28283687	0	O
warrant	28283687	0	O
further	28283687	0	O
study	28283687	0	O
.	28283687	0	O

A	28297138	4	O
Novel	28297138	4	O
Homozygous	28297138	4	O
Missense	28297138	4	O
Mutation	28297138	4	B-Var
in	28297138	4	O
HOXC13	28297138	4	B-Gene
Leads	28297138	4	B-Reg
to	28297138	4	I-Reg
Autosomal	28297138	4	O
Recessive	28297138	4	O
Pure	28297138	4	B-Disease
Hair	28297138	4	I-Disease
and	28297138	4	I-Disease
Nail	28297138	4	I-Disease
Ectodermal	28297138	4	I-Disease
Dysplasia	28297138	4	I-Disease
.	28297138	4	O
Pure	28297138	4	O
hair	28297138	4	O
and	28297138	4	O
nail	28297138	4	O
ectodermal	28297138	4	O
dysplasia	28297138	4	O
(	28297138	4	O
PHNED	28297138	4	O
)	28297138	4	O
is	28297138	4	O
a	28297138	4	O
rare	28297138	4	O
disorder	28297138	4	O
that	28297138	4	O
presents	28297138	4	O
with	28297138	4	O
hypotrichosis	28297138	4	O
and	28297138	4	O
nail	28297138	4	O
dystrophy	28297138	4	O
while	28297138	4	O
sparing	28297138	4	O
other	28297138	4	O
ectodermal	28297138	4	O
structures	28297138	4	O
such	28297138	4	O
as	28297138	4	O
teeth	28297138	4	O
and	28297138	4	O
sweat	28297138	4	O
glands	28297138	4	O
.	28297138	4	O
We	28297138	4	O
describe	28297138	4	O
a	28297138	4	O
homozygous	28297138	4	O
novel	28297138	4	O
missense	28297138	4	O
mutation	28297138	4	B-Var
in	28297138	4	O
the	28297138	4	O
HOXC13	28297138	4	B-Gene
gene	28297138	4	O
that	28297138	4	O
resulted	28297138	4	B-Reg
in	28297138	4	I-Reg
autosomal	28297138	4	O
recessive	28297138	4	O
PHNED	28297138	4	B-Disease
in	28297138	4	O
a	28297138	4	O
Hispanic	28297138	4	O
child	28297138	4	O
.	28297138	4	O
The	28297138	4	O
mutation	28297138	4	O
c.812	28297138	4	O
A	28297138	4	O
>	28297138	4	O
G	28297138	4	O
(	28297138	4	O
p.Gln271Arg	28297138	4	O
)	28297138	4	O
is	28297138	4	O
located	28297138	4	O
within	28297138	4	O
the	28297138	4	O
DNA	28297138	4	O
-	28297138	4	O
binding	28297138	4	O
domain	28297138	4	O
of	28297138	4	O
the	28297138	4	O
HOXC13	28297138	4	O
gene	28297138	4	O
,	28297138	4	O
cosegregates	28297138	4	O
within	28297138	4	O
the	28297138	4	O
family	28297138	4	O
,	28297138	4	O
and	28297138	4	O
is	28297138	4	O
predicted	28297138	4	O
to	28297138	4	O
be	28297138	4	O
maximally	28297138	4	O
damaging	28297138	4	O
.	28297138	4	O
This	28297138	4	O
is	28297138	4	O
the	28297138	4	O
first	28297138	4	O
reported	28297138	4	O
case	28297138	4	O
of	28297138	4	O
a	28297138	4	O
missense	28297138	4	O
HOXC13	28297138	4	B-Gene
mutation	28297138	4	B-Var
resulting	28297138	4	B-Reg
in	28297138	4	I-Reg
PHNED	28297138	4	B-Disease
and	28297138	4	O
the	28297138	4	O
first	28297138	4	O
reported	28297138	4	O
case	28297138	4	O
of	28297138	4	O
PHNED	28297138	4	O
identified	28297138	4	O
in	28297138	4	O
a	28297138	4	O
North	28297138	4	O
American	28297138	4	O
family	28297138	4	O
.	28297138	4	O
Our	28297138	4	O
findings	28297138	4	O
illustrate	28297138	4	O
the	28297138	4	O
critical	28297138	4	O
role	28297138	4	O
of	28297138	4	O
HOXC13	28297138	4	O
in	28297138	4	O
human	28297138	4	O
hair	28297138	4	O
and	28297138	4	O
nail	28297138	4	O
development	28297138	4	O
.	28297138	4	O

The	28314794	0	O
Microtubule	28314794	0	O
-	28314794	0	O
Associated	28314794	0	O
Protein	28314794	0	O
MAP18	28314794	0	O
Affects	28314794	0	O
ROP2	28314794	0	O
GTPase	28314794	0	O
Activity	28314794	0	O
during	28314794	0	O
Root	28314794	0	O
Hair	28314794	0	O
Growth	28314794	0	O
.	28314794	0	O
Establishment	28314794	0	O
and	28314794	0	O
maintenance	28314794	0	O
of	28314794	0	O
the	28314794	0	O
polar	28314794	0	O
site	28314794	0	O
are	28314794	0	O
important	28314794	0	O
for	28314794	0	O
root	28314794	0	O
hair	28314794	0	O
tip	28314794	0	O
growth	28314794	0	O
.	28314794	0	O
We	28314794	0	O
previously	28314794	0	O
reported	28314794	0	O
that	28314794	0	O
Arabidopsis	28314794	0	O
(	28314794	0	O
Arabidopsis	28314794	0	O
thaliana	28314794	0	O
)	28314794	0	O
MICROTUBULE	28314794	0	O
-	28314794	0	O
ASSOCIATED	28314794	0	O
PROTEIN18	28314794	0	O
(	28314794	0	O
MAP18	28314794	0	O
)	28314794	0	O
functions	28314794	0	O
in	28314794	0	O
controlling	28314794	0	O
the	28314794	0	O
direction	28314794	0	O
of	28314794	0	O
pollen	28314794	0	O
tube	28314794	0	O
growth	28314794	0	O
and	28314794	0	O
root	28314794	0	O
hair	28314794	0	O
elongation	28314794	0	O
.	28314794	0	O
Additionally	28314794	0	O
,	28314794	0	O
the	28314794	0	O
Rop	28314794	0	O
GTPase	28314794	0	O
ROP2	28314794	0	O
was	28314794	0	O
reported	28314794	0	O
as	28314794	0	O
a	28314794	0	O
positive	28314794	0	O
regulator	28314794	0	O
of	28314794	0	O
both	28314794	0	O
root	28314794	0	O
hair	28314794	0	O
initiation	28314794	0	O
and	28314794	0	O
tip	28314794	0	O
growth	28314794	0	O
in	28314794	0	O
Arabidopsis	28314794	0	O
.	28314794	0	O
Both	28314794	0	O
loss	28314794	0	B-NegReg
of	28314794	0	I-NegReg
function	28314794	0	I-NegReg
of	28314794	0	O
ROP2	28314794	0	B-Gene
and	28314794	0	O
knockdown	28314794	0	B-Var
of	28314794	0	O
MAP18	28314794	0	B-Gene
lead	28314794	0	O
to	28314794	0	O
a	28314794	0	O
decrease	28314794	0	B-NegReg
in	28314794	0	O
root	28314794	0	O
hair	28314794	0	O
length	28314794	0	O
,	28314794	0	O
whereas	28314794	0	O
overexpression	28314794	0	O
of	28314794	0	O
either	28314794	0	O
MAP18	28314794	0	O
or	28314794	0	O
ROP2	28314794	0	O
causes	28314794	0	O
multiple	28314794	0	O
tips	28314794	0	O
or	28314794	0	O
a	28314794	0	O
branching	28314794	0	O
hair	28314794	0	O
phenotype	28314794	0	O
.	28314794	0	O
However	28314794	0	O
,	28314794	0	O
it	28314794	0	O
is	28314794	0	O
unclear	28314794	0	O
whether	28314794	0	O
MAP18	28314794	0	O
and	28314794	0	O
ROP2	28314794	0	O
coordinately	28314794	0	O
regulate	28314794	0	O
root	28314794	0	O
hair	28314794	0	O
growth	28314794	0	O
.	28314794	0	O
In	28314794	0	O
this	28314794	0	O
study	28314794	0	O
,	28314794	0	O
we	28314794	0	O
demonstrate	28314794	0	O
that	28314794	0	O
MAP18	28314794	0	O
and	28314794	0	O
ROP2	28314794	0	O
interact	28314794	0	O
genetically	28314794	0	O
and	28314794	0	O
functionally	28314794	0	O
.	28314794	0	O
MAP18	28314794	0	O
interacts	28314794	0	O
physically	28314794	0	O
with	28314794	0	O
ROP2	28314794	0	O
in	28314794	0	O
vitro	28314794	0	O
and	28314794	0	O
in	28314794	0	O
vivo	28314794	0	O
and	28314794	0	O
preferentially	28314794	0	O
binds	28314794	0	O
to	28314794	0	O
the	28314794	0	O
inactive	28314794	0	O
form	28314794	0	O
of	28314794	0	O
the	28314794	0	O
ROP2	28314794	0	O
protein	28314794	0	O
.	28314794	0	O
MAP18	28314794	0	O
promotes	28314794	0	O
ROP2	28314794	0	O
activity	28314794	0	O
during	28314794	0	O
root	28314794	0	O
hair	28314794	0	O
tip	28314794	0	O
growth	28314794	0	O
.	28314794	0	O
Further	28314794	0	O
investigation	28314794	0	O
revealed	28314794	0	O
that	28314794	0	O
MAP18	28314794	0	O
competes	28314794	0	O
with	28314794	0	O
RhoGTPase	28314794	0	O
GDP	28314794	0	O
DISSOCIATION	28314794	0	O
INHIBITOR1	28314794	0	O
/	28314794	0	O
SUPERCENTIPEDE1	28314794	0	O
for	28314794	0	O
binding	28314794	0	O
to	28314794	0	O
ROP2	28314794	0	O
,	28314794	0	O
in	28314794	0	O
turn	28314794	0	O
affecting	28314794	0	O
the	28314794	0	O
localization	28314794	0	O
of	28314794	0	O
active	28314794	0	O
ROP2	28314794	0	O
in	28314794	0	O
the	28314794	0	O
plasma	28314794	0	O
membrane	28314794	0	O
of	28314794	0	O
the	28314794	0	O
root	28314794	0	O
hair	28314794	0	O
tip	28314794	0	O
.	28314794	0	O
These	28314794	0	O
results	28314794	0	O
reveal	28314794	0	O
a	28314794	0	O
novel	28314794	0	O
function	28314794	0	O
of	28314794	0	O
MAP18	28314794	0	O
in	28314794	0	O
the	28314794	0	O
regulation	28314794	0	O
of	28314794	0	O
ROP2	28314794	0	O
activation	28314794	0	O
during	28314794	0	O
root	28314794	0	O
hair	28314794	0	O
growth	28314794	0	O
.	28314794	0	O

SERPINC1	28317092	4	B-Gene
gene	28317092	4	O
mutations	28317092	4	B-Var
in	28317092	4	B-Reg
antithrombin	28317092	4	B-Disease
deficiency	28317092	4	I-Disease
.	28317092	4	O
Existing	28317092	4	O
evidence	28317092	4	O
suggests	28317092	4	O
that	28317092	4	O
in	28317092	4	O
most	28317092	4	O
cases	28317092	4	O
antithrombin	28317092	4	B-Disease
deficiency	28317092	4	I-Disease
can	28317092	4	O
be	28317092	4	O
explained	28317092	4	B-Reg
by	28317092	4	I-Reg
mutations	28317092	4	B-Var
in	28317092	4	O
its	28317092	4	O
gene	28317092	4	O
,	28317092	4	O
SERPINC1	28317092	4	B-Gene
.	28317092	4	O
We	28317092	4	O
investigated	28317092	4	O
the	28317092	4	O
molecular	28317092	4	O
background	28317092	4	O
of	28317092	4	O
antithrombin	28317092	4	O
deficiency	28317092	4	O
in	28317092	4	O
a	28317092	4	O
single	28317092	4	O
centre	28317092	4	O
family	28317092	4	O
cohort	28317092	4	O
study	28317092	4	O
.	28317092	4	O
We	28317092	4	O
included	28317092	4	O
a	28317092	4	O
total	28317092	4	O
of	28317092	4	O
21	28317092	4	O
families	28317092	4	O
comprising	28317092	4	O
15	28317092	4	O
original	28317092	4	O
probands	28317092	4	O
and	28317092	4	O
sixty	28317092	4	O
-	28317092	4	O
six	28317092	4	O
relatives	28317092	4	O
,	28317092	4	O
6	28317092	4	O
of	28317092	4	O
who	28317092	4	O
were	28317092	4	O
surrogate	28317092	4	O
probands	28317092	4	O
for	28317092	4	O
the	28317092	4	O
genetic	28317092	4	O
analysis	28317092	4	O
.	28317092	4	O
Antithrombin	28317092	4	O
activity	28317092	4	O
and	28317092	4	O
antigen	28317092	4	O
levels	28317092	4	O
were	28317092	4	O
measured	28317092	4	O
.	28317092	4	O
The	28317092	4	O
heparin	28317092	4	O
-	28317092	4	O
antithrombin	28317092	4	O
binding	28317092	4	O
ratio	28317092	4	O
assay	28317092	4	O
was	28317092	4	O
used	28317092	4	O
to	28317092	4	O
distinguish	28317092	4	O
between	28317092	4	O
the	28317092	4	O
different	28317092	4	O
subtypes	28317092	4	O
of	28317092	4	O
type	28317092	4	O
II	28317092	4	O
antithrombin	28317092	4	O
deficiency	28317092	4	O
.	28317092	4	O
SERPINC1	28317092	4	O
mutations	28317092	4	O
were	28317092	4	O
detected	28317092	4	O
by	28317092	4	O
direct	28317092	4	O
sequencing	28317092	4	O
of	28317092	4	O
all	28317092	4	O
7	28317092	4	O
exons	28317092	4	O
and	28317092	4	O
regulatory	28317092	4	O
regions	28317092	4	O
,	28317092	4	O
and	28317092	4	O
multiplex	28317092	4	O
ligation	28317092	4	O
-	28317092	4	O
dependent	28317092	4	O
probe	28317092	4	O
amplification	28317092	4	O
.	28317092	4	O
Eighty	28317092	4	O
-	28317092	4	O
six	28317092	4	O
per	28317092	4	O
cent	28317092	4	O
of	28317092	4	O
the	28317092	4	O
families	28317092	4	O
had	28317092	4	O
a	28317092	4	O
detrimental	28317092	4	O
SERPINC1	28317092	4	O
gene	28317092	4	O
mutation	28317092	4	O
that	28317092	4	O
segregated	28317092	4	O
in	28317092	4	O
the	28317092	4	O
family	28317092	4	O
.	28317092	4	O
We	28317092	4	O
detected	28317092	4	O
13	28317092	4	O
different	28317092	4	O
SERPINC1	28317092	4	O
gene	28317092	4	O
mutations	28317092	4	O
of	28317092	4	O
which	28317092	4	O
5	28317092	4	O
were	28317092	4	O
novel	28317092	4	O
.	28317092	4	O
Among	28317092	4	O
all	28317092	4	O
these	28317092	4	O
mutations	28317092	4	O
,	28317092	4	O
44%	28317092	4	O
was	28317092	4	O
associated	28317092	4	O
with	28317092	4	O
type	28317092	4	O
I	28317092	4	O
deficiency	28317092	4	O
,	28317092	4	O
whereas	28317092	4	O
the	28317092	4	O
remainder	28317092	4	O
was	28317092	4	O
associated	28317092	4	O
with	28317092	4	O
type	28317092	4	O
II	28317092	4	O
heparin	28317092	4	O
binding	28317092	4	O
site	28317092	4	O
(	28317092	4	O
11%	28317092	4	O
)	28317092	4	O
,	28317092	4	O
type	28317092	4	O
II	28317092	4	O
pleiotropic	28317092	4	O
effect	28317092	4	O
(	28317092	4	O
33%	28317092	4	O
)	28317092	4	O
,	28317092	4	O
type	28317092	4	O
II	28317092	4	O
reactive	28317092	4	O
site	28317092	4	O
(	28317092	4	O
6%	28317092	4	O
)	28317092	4	O
or	28317092	4	O
had	28317092	4	O
the	28317092	4	O
antithrombin	28317092	4	O
Cambridge	28317092	4	O
II	28317092	4	O
mutation	28317092	4	O
(	28317092	4	O
6%	28317092	4	O
)	28317092	4	O
.	28317092	4	O
The	28317092	4	O
current	28317092	4	O
study	28317092	4	O
reports	28317092	4	O
several	28317092	4	O
novel	28317092	4	O
SERPINC1	28317092	4	O
mutations	28317092	4	O
,	28317092	4	O
thereby	28317092	4	O
adding	28317092	4	O
to	28317092	4	O
our	28317092	4	O
knowledge	28317092	4	O
of	28317092	4	O
the	28317092	4	O
molecular	28317092	4	O
background	28317092	4	O
of	28317092	4	O
antithrombin	28317092	4	O
deficiency	28317092	4	O
.	28317092	4	O
Finally	28317092	4	O
,	28317092	4	O
our	28317092	4	O
results	28317092	4	O
point	28317092	4	O
out	28317092	4	O
the	28317092	4	O
importance	28317092	4	O
of	28317092	4	O
future	28317092	4	O
research	28317092	4	O
outside	28317092	4	O
the	28317092	4	O
conventional	28317092	4	O
SERPINC1	28317092	4	O
gene	28317092	4	O
approach	28317092	4	O
.	28317092	4	O

A	28322269	0	O
Ras	28322269	0	O
GTPase	28322269	0	O
associated	28322269	0	O
protein	28322269	0	O
is	28322269	0	O
involved	28322269	0	O
in	28322269	0	O
the	28322269	0	O
phototropic	28322269	0	O
and	28322269	0	O
circadian	28322269	0	O
photobiology	28322269	0	O
responses	28322269	0	O
in	28322269	0	O
fungi	28322269	0	O
.	28322269	0	O
Light	28322269	0	O
is	28322269	0	O
an	28322269	0	O
environmental	28322269	0	O
signal	28322269	0	O
perceived	28322269	0	O
by	28322269	0	O
most	28322269	0	O
eukaryotic	28322269	0	O
organisms	28322269	0	O
and	28322269	0	O
that	28322269	0	O
can	28322269	0	O
have	28322269	0	O
major	28322269	0	O
impacts	28322269	0	O
on	28322269	0	O
their	28322269	0	O
growth	28322269	0	O
and	28322269	0	O
development	28322269	0	O
.	28322269	0	O
The	28322269	0	O
MadC	28322269	0	O
protein	28322269	0	O
in	28322269	0	O
the	28322269	0	O
fungus	28322269	0	O
Phycomyces	28322269	0	O
blakesleeanus	28322269	0	O
(	28322269	0	O
Mucoromycotina	28322269	0	O
)	28322269	0	O
has	28322269	0	O
been	28322269	0	O
postulated	28322269	0	O
to	28322269	0	O
form	28322269	0	O
part	28322269	0	O
of	28322269	0	O
the	28322269	0	O
photosensory	28322269	0	O
input	28322269	0	O
for	28322269	0	O
phototropism	28322269	0	O
of	28322269	0	O
the	28322269	0	O
fruiting	28322269	0	O
body	28322269	0	O
sporangiophores	28322269	0	O
,	28322269	0	O
but	28322269	0	O
the	28322269	0	O
madC	28322269	0	O
gene	28322269	0	O
has	28322269	0	O
remained	28322269	0	O
unidentified	28322269	0	O
since	28322269	0	O
the	28322269	0	O
1960	28322269	0	O
s	28322269	0	O
when	28322269	0	O
madC	28322269	0	O
mutants	28322269	0	O
were	28322269	0	O
first	28322269	0	O
isolated	28322269	0	O
.	28322269	0	O
In	28322269	0	O
this	28322269	0	O
study	28322269	0	O
the	28322269	0	O
madC	28322269	0	O
gene	28322269	0	O
was	28322269	0	O
identified	28322269	0	O
by	28322269	0	O
positional	28322269	0	O
cloning	28322269	0	O
.	28322269	0	O
All	28322269	0	O
madC	28322269	0	O
mutant	28322269	0	O
strains	28322269	0	O
contain	28322269	0	O
loss	28322269	0	O
-	28322269	0	O
of	28322269	0	O
-	28322269	0	O
function	28322269	0	O
point	28322269	0	O
mutations	28322269	0	O
within	28322269	0	O
a	28322269	0	O
gene	28322269	0	O
predicted	28322269	0	O
to	28322269	0	O
encode	28322269	0	O
a	28322269	0	O
GTPase	28322269	0	O
activating	28322269	0	O
protein	28322269	0	O
(	28322269	0	O
GAP	28322269	0	O
)	28322269	0	O
for	28322269	0	O
Ras	28322269	0	O
.	28322269	0	O
The	28322269	0	O
madC	28322269	0	O
gene	28322269	0	O
complements	28322269	0	O
the	28322269	0	O
Saccharomyces	28322269	0	O
cerevisiae	28322269	0	O
Ras	28322269	0	O
-	28322269	0	O
GAP	28322269	0	O
ira1	28322269	0	O
mutant	28322269	0	O
and	28322269	0	O
the	28322269	0	O
encoded	28322269	0	O
MadC	28322269	0	O
protein	28322269	0	O
interacts	28322269	0	O
with	28322269	0	O
P.	28322269	0	O
blakesleeanus	28322269	0	O
Ras	28322269	0	O
homologs	28322269	0	O
in	28322269	0	O
yeast	28322269	0	O
two	28322269	0	O
-	28322269	0	O
hybrid	28322269	0	O
assays	28322269	0	O
,	28322269	0	O
indicating	28322269	0	O
that	28322269	0	O
MadC	28322269	0	O
is	28322269	0	O
a	28322269	0	O
regulator	28322269	0	O
of	28322269	0	O
Ras	28322269	0	O
signaling	28322269	0	O
.	28322269	0	O
Deletion	28322269	0	B-Var
of	28322269	0	O
the	28322269	0	O
homolog	28322269	0	O
in	28322269	0	O
the	28322269	0	O
filamentous	28322269	0	O
ascomycete	28322269	0	O
Neurospora	28322269	0	O
crassa	28322269	0	O
affects	28322269	0	B-Reg
the	28322269	0	O
circadian	28322269	0	O
clock	28322269	0	O
output	28322269	0	O
,	28322269	0	O
yielding	28322269	0	B-Reg
a	28322269	0	O
pattern	28322269	0	O
of	28322269	0	O
asexual	28322269	0	O
conidiation	28322269	0	O
similar	28322269	0	O
to	28322269	0	O
a	28322269	0	O
ras-1	28322269	0	O
mutant	28322269	0	O
that	28322269	0	O
is	28322269	0	O
used	28322269	0	O
in	28322269	0	O
circadian	28322269	0	O
studies	28322269	0	O
in	28322269	0	O
N.	28322269	0	O
crassa	28322269	0	O
.	28322269	0	O
Thus	28322269	0	O
,	28322269	0	O
MadC	28322269	0	O
is	28322269	0	O
unlikely	28322269	0	O
to	28322269	0	O
be	28322269	0	O
a	28322269	0	O
photosensor	28322269	0	O
,	28322269	0	O
yet	28322269	0	O
is	28322269	0	O
a	28322269	0	O
fundamental	28322269	0	O
link	28322269	0	O
in	28322269	0	O
the	28322269	0	O
photoresponses	28322269	0	O
from	28322269	0	O
blue	28322269	0	O
light	28322269	0	O
perceived	28322269	0	O
by	28322269	0	O
the	28322269	0	O
conserved	28322269	0	O
White	28322269	0	O
Collar	28322269	0	O
complex	28322269	0	O
with	28322269	0	O
Ras	28322269	0	O
signaling	28322269	0	O
in	28322269	0	O
two	28322269	0	O
distantly	28322269	0	O
-	28322269	0	O
related	28322269	0	O
filamentous	28322269	0	O
fungal	28322269	0	O
species	28322269	0	O
.	28322269	0	O

Paradoxical	28338294	0	O
gain	28338294	0	O
-	28338294	0	O
of	28338294	0	O
-	28338294	0	O
function	28338294	0	O
mutant	28338294	0	O
of	28338294	0	O
the	28338294	0	O
G	28338294	0	O
-	28338294	0	O
protein	28338294	0	O
-	28338294	0	O
coupled	28338294	0	O
receptor	28338294	0	O
PROKR2	28338294	0	O
promotes	28338294	0	O
early	28338294	0	O
puberty	28338294	0	O
.	28338294	0	O
The	28338294	0	O
human	28338294	0	O
genome	28338294	0	O
encodes	28338294	0	O
750	28338294	0	O
G	28338294	0	O
-	28338294	0	O
protein	28338294	0	O
-	28338294	0	O
coupled	28338294	0	O
receptors	28338294	0	O
(	28338294	0	O
GPCRs	28338294	0	O
)	28338294	0	O
,	28338294	0	O
including	28338294	0	O
prokineticin	28338294	0	O
receptor	28338294	0	O
2	28338294	0	O
(	28338294	0	O
PROKR2	28338294	0	O
)	28338294	0	O
involved	28338294	0	O
in	28338294	0	O
the	28338294	0	O
regulation	28338294	0	O
of	28338294	0	O
sexual	28338294	0	O
maturation	28338294	0	O
.	28338294	0	O
Previously	28338294	0	O
reported	28338294	0	O
pathogenic	28338294	0	O
gain	28338294	0	O
-	28338294	0	O
of	28338294	0	O
-	28338294	0	O
function	28338294	0	O
mutations	28338294	0	O
of	28338294	0	O
GPCR	28338294	0	O
genes	28338294	0	O
invariably	28338294	0	O
encoded	28338294	0	O
aberrant	28338294	0	O
receptors	28338294	0	O
with	28338294	0	O
excessive	28338294	0	O
signal	28338294	0	O
transduction	28338294	0	O
activity	28338294	0	O
.	28338294	0	O
Although	28338294	0	O
in	28338294	0	O
vitro	28338294	0	O
assays	28338294	0	O
demonstrated	28338294	0	O
that	28338294	0	O
an	28338294	0	O
artificially	28338294	0	O
created	28338294	0	O
inactive	28338294	0	O
mutant	28338294	0	O
of	28338294	0	O
PROKR2	28338294	0	O
exerted	28338294	0	O
paradoxical	28338294	0	O
gain	28338294	0	O
-	28338294	0	O
of	28338294	0	O
-	28338294	0	O
function	28338294	0	O
effects	28338294	0	O
when	28338294	0	O
co	28338294	0	O
-	28338294	0	O
transfected	28338294	0	O
with	28338294	0	O
wild	28338294	0	O
-	28338294	0	O
type	28338294	0	O
proteins	28338294	0	O
,	28338294	0	O
such	28338294	0	O
a	28338294	0	O
phenomenon	28338294	0	O
has	28338294	0	O
not	28338294	0	O
been	28338294	0	O
observed	28338294	0	O
in	28338294	0	O
vivo	28338294	0	O
.	28338294	0	O
Here	28338294	0	O
,	28338294	0	O
we	28338294	0	O
report	28338294	0	O
a	28338294	0	O
heterozygous	28338294	0	O
frameshift	28338294	0	O
mutation	28338294	0	O
of	28338294	0	O
PROKR2	28338294	0	O
identified	28338294	0	O
in	28338294	0	O
a	28338294	0	O
3.5	28338294	0	O
-	28338294	0	O
year	28338294	0	O
-	28338294	0	O
old	28338294	0	O
girl	28338294	0	O
with	28338294	0	O
central	28338294	0	O
precocious	28338294	0	O
puberty	28338294	0	O
.	28338294	0	O
The	28338294	0	O
mutant	28338294	0	B-Var
mRNA	28338294	0	O
escaped	28338294	0	B-NegReg
nonsense	28338294	0	O
-	28338294	0	O
mediated	28338294	0	O
decay	28338294	0	O
and	28338294	0	O
generated	28338294	0	O
a	28338294	0	O
GPCR	28338294	0	O
lacking	28338294	0	B-NegReg
two	28338294	0	O
transmembrane	28338294	0	O
domains	28338294	0	O
and	28338294	0	O
the	28338294	0	O
carboxyl	28338294	0	O
-	28338294	0	O
terminal	28338294	0	O
tail	28338294	0	O
.	28338294	0	O
The	28338294	0	O
mutant	28338294	0	O
protein	28338294	0	O
had	28338294	0	O
no	28338294	0	O
in	28338294	0	O
vitro	28338294	0	O
signal	28338294	0	O
transduction	28338294	0	O
activity	28338294	0	O
;	28338294	0	O
however	28338294	0	O
,	28338294	0	O
cells	28338294	0	O
co	28338294	0	O
-	28338294	0	O
expressing	28338294	0	O
the	28338294	0	O
mutant	28338294	0	O
and	28338294	0	O
wild	28338294	0	O
-	28338294	0	O
type	28338294	0	O
PROKR2	28338294	0	O
exhibited	28338294	0	O
markedly	28338294	0	O
exaggerated	28338294	0	O
ligand	28338294	0	O
-	28338294	0	O
induced	28338294	0	O
Ca	28338294	0	O
(	28338294	0	O
2	28338294	0	O
)	28338294	0	O
responses	28338294	0	O
.	28338294	0	O
The	28338294	0	O
results	28338294	0	O
indicate	28338294	0	O
that	28338294	0	O
certain	28338294	0	O
inactive	28338294	0	O
PROKR2	28338294	0	B-Gene
mutants	28338294	0	B-Var
can	28338294	0	O
cause	28338294	0	O
early	28338294	0	O
puberty	28338294	0	O
by	28338294	0	O
enhancing	28338294	0	B-PosReg
the	28338294	0	O
functional	28338294	0	O
property	28338294	0	O
of	28338294	0	O
coexisting	28338294	0	O
wild	28338294	0	O
-	28338294	0	O
type	28338294	0	O
proteins	28338294	0	O
.	28338294	0	O
Considering	28338294	0	O
the	28338294	0	O
structural	28338294	0	O
similarity	28338294	0	O
among	28338294	0	O
GPCRs	28338294	0	O
,	28338294	0	O
this	28338294	0	O
paradoxical	28338294	0	O
gain	28338294	0	O
-	28338294	0	O
of	28338294	0	O
-	28338294	0	O
function	28338294	0	O
mechanism	28338294	0	O
may	28338294	0	O
underlie	28338294	0	O
various	28338294	0	O
human	28338294	0	O
disorders	28338294	0	O
.	28338294	0	O

The	28339550	0	O
Tension	28339550	0	O
-	28339550	0	O
sensitive	28339550	0	O
Ion	28339550	0	O
Transport	28339550	0	O
Activity	28339550	0	O
of	28339550	0	O
MSL8	28339550	0	O
is	28339550	0	O
Critical	28339550	0	O
for	28339550	0	O
its	28339550	0	O
Function	28339550	0	O
in	28339550	0	O
Pollen	28339550	0	O
Hydration	28339550	0	O
and	28339550	0	O
Germination	28339550	0	O
.	28339550	0	O
All	28339550	0	O
cells	28339550	0	O
respond	28339550	0	O
to	28339550	0	O
osmotic	28339550	0	O
challenges	28339550	0	O
,	28339550	0	O
including	28339550	0	O
those	28339550	0	O
imposed	28339550	0	O
during	28339550	0	O
normal	28339550	0	O
growth	28339550	0	O
and	28339550	0	O
development	28339550	0	O
.	28339550	0	O
Mechanosensitive	28339550	0	O
(	28339550	0	O
MS	28339550	0	O
)	28339550	0	O
ion	28339550	0	O
channels	28339550	0	O
provide	28339550	0	O
a	28339550	0	O
conserved	28339550	0	O
mechanism	28339550	0	O
for	28339550	0	O
regulating	28339550	0	O
osmotic	28339550	0	O
forces	28339550	0	O
by	28339550	0	O
conducting	28339550	0	O
ions	28339550	0	O
in	28339550	0	O
response	28339550	0	O
to	28339550	0	O
increased	28339550	0	O
membrane	28339550	0	O
tension	28339550	0	O
.	28339550	0	O
We	28339550	0	O
previously	28339550	0	O
demonstrated	28339550	0	O
that	28339550	0	O
the	28339550	0	O
MS	28339550	0	O
ion	28339550	0	O
channel	28339550	0	O
MscS	28339550	0	O
-	28339550	0	O
Like	28339550	0	O
8	28339550	0	O
(	28339550	0	O
MSL8	28339550	0	O
)	28339550	0	O
is	28339550	0	O
required	28339550	0	O
for	28339550	0	O
pollen	28339550	0	O
to	28339550	0	O
survive	28339550	0	O
multiple	28339550	0	O
osmotic	28339550	0	O
challenges	28339550	0	O
that	28339550	0	O
occur	28339550	0	O
during	28339550	0	O
the	28339550	0	O
normal	28339550	0	O
process	28339550	0	O
of	28339550	0	O
fertilization	28339550	0	O
,	28339550	0	O
and	28339550	0	O
that	28339550	0	O
it	28339550	0	O
can	28339550	0	O
inhibit	28339550	0	O
pollen	28339550	0	O
germination	28339550	0	O
.	28339550	0	O
However	28339550	0	O
,	28339550	0	O
it	28339550	0	O
remained	28339550	0	O
unclear	28339550	0	O
whether	28339550	0	O
these	28339550	0	O
physiological	28339550	0	O
functions	28339550	0	O
required	28339550	0	O
ion	28339550	0	O
flux	28339550	0	O
through	28339550	0	O
a	28339550	0	O
mechanically	28339550	0	O
gated	28339550	0	O
channel	28339550	0	O
provided	28339550	0	O
by	28339550	0	O
MSL8	28339550	0	O
.	28339550	0	O
We	28339550	0	O
introduced	28339550	0	O
two	28339550	0	O
point	28339550	0	O
mutations	28339550	0	B-Var
into	28339550	0	O
the	28339550	0	O
predicted	28339550	0	O
pore	28339550	0	O
-	28339550	0	O
lining	28339550	0	O
domain	28339550	0	O
of	28339550	0	O
MSL8	28339550	0	B-Gene
that	28339550	0	O
disrupted	28339550	0	B-NegReg
normal	28339550	0	O
channel	28339550	0	O
function	28339550	0	O
in	28339550	0	O
different	28339550	0	O
ways	28339550	0	O
.	28339550	0	O
The	28339550	0	O
Ile711Ser	28339550	0	B-Var
mutation	28339550	0	I-Var
increased	28339550	0	B-PosReg
the	28339550	0	O
tension	28339550	0	O
threshold	28339550	0	O
of	28339550	0	O
the	28339550	0	O
MSL8	28339550	0	B-Gene
channel	28339550	0	O
while	28339550	0	O
leaving	28339550	0	B-Reg
conductance	28339550	0	O
unchanged	28339550	0	O
,	28339550	0	O
and	28339550	0	O
the	28339550	0	O
Phe720Leu	28339550	0	B-Var
mutation	28339550	0	I-Var
severely	28339550	0	O
disrupted	28339550	0	B-NegReg
the	28339550	0	O
MSL8	28339550	0	B-Gene
channel	28339550	0	O
.	28339550	0	O
Both	28339550	0	O
of	28339550	0	O
these	28339550	0	O
mutations	28339550	0	B-Var
impaired	28339550	0	B-NegReg
the	28339550	0	O
ability	28339550	0	O
of	28339550	0	O
MSL8	28339550	0	O
to	28339550	0	O
preserve	28339550	0	O
pollen	28339550	0	O
viability	28339550	0	O
during	28339550	0	O
hydration	28339550	0	O
and	28339550	0	O
to	28339550	0	O
maintain	28339550	0	B-Reg
the	28339550	0	O
integrity	28339550	0	O
of	28339550	0	O
the	28339550	0	O
pollen	28339550	0	O
tube	28339550	0	O
when	28339550	0	O
expressed	28339550	0	O
at	28339550	0	O
endogenous	28339550	0	O
levels	28339550	0	O
.	28339550	0	O
When	28339550	0	O
overexpressed	28339550	0	O
in	28339550	0	O
an	28339550	0	O
msl8-4	28339550	0	O
null	28339550	0	O
background	28339550	0	O
,	28339550	0	O
MSL8I711S	28339550	0	O
could	28339550	0	O
partially	28339550	0	O
rescue	28339550	0	O
loss	28339550	0	O
-	28339550	0	O
of	28339550	0	O
-	28339550	0	O
function	28339550	0	O
phenotypes	28339550	0	O
,	28339550	0	O
while	28339550	0	O
MSL8F720L	28339550	0	O
could	28339550	0	O
not	28339550	0	O
.	28339550	0	O
When	28339550	0	O
overexpressed	28339550	0	O
in	28339550	0	O
the	28339550	0	O
wild	28339550	0	O
-	28339550	0	O
type	28339550	0	O
Ler	28339550	0	O
background	28339550	0	O
,	28339550	0	O
MSL8I711S	28339550	0	O
suppressed	28339550	0	O
pollen	28339550	0	O
germination	28339550	0	O
,	28339550	0	O
similar	28339550	0	O
to	28339550	0	O
wild	28339550	0	O
-	28339550	0	O
type	28339550	0	O
MSL8	28339550	0	O
.	28339550	0	O
In	28339550	0	O
contrast	28339550	0	O
,	28339550	0	O
MSL8F720L	28339550	0	O
failed	28339550	0	O
to	28339550	0	O
suppress	28339550	0	O
pollen	28339550	0	O
germination	28339550	0	O
and	28339550	0	O
increased	28339550	0	O
pollen	28339550	0	O
bursting	28339550	0	O
,	28339550	0	O
thereby	28339550	0	O
phenocopying	28339550	0	O
the	28339550	0	O
msl8-4	28339550	0	O
mutant	28339550	0	O
.	28339550	0	O
Thus	28339550	0	O
,	28339550	0	O
an	28339550	0	O
intact	28339550	0	O
MSL8	28339550	0	O
channel	28339550	0	O
is	28339550	0	O
required	28339550	0	O
for	28339550	0	O
normal	28339550	0	O
pollen	28339550	0	O
function	28339550	0	O
during	28339550	0	O
hydration	28339550	0	O
and	28339550	0	O
germination	28339550	0	O
.	28339550	0	O
These	28339550	0	O
data	28339550	0	O
establish	28339550	0	O
MSL8	28339550	0	O
as	28339550	0	O
the	28339550	0	O
first	28339550	0	O
plant	28339550	0	O
MS	28339550	0	O
channel	28339550	0	O
to	28339550	0	O
fulfill	28339550	0	O
previously	28339550	0	O
established	28339550	0	O
criteria	28339550	0	O
for	28339550	0	O
assignment	28339550	0	O
as	28339550	0	O
a	28339550	0	O
mechanotransducer	28339550	0	O
.	28339550	0	O

RACK1	28343944	0	O
cooperates	28343944	0	O
with	28343944	0	O
NRAS	28343944	0	O
(	28343944	0	O
Q61K	28343944	0	O
)	28343944	0	O
to	28343944	0	O
promote	28343944	0	O
melanoma	28343944	0	O
in	28343944	0	O
vivo	28343944	0	O
.	28343944	0	O
Melanoma	28343944	0	O
is	28343944	0	O
the	28343944	0	O
deadliest	28343944	0	O
skin	28343944	0	O
cancer	28343944	0	O
.	28343944	0	O
RACK1	28343944	0	O
(	28343944	0	O
Receptor	28343944	0	O
for	28343944	0	O
activated	28343944	0	O
protein	28343944	0	O
kinase	28343944	0	O
C	28343944	0	O
)	28343944	0	O
protein	28343944	0	O
was	28343944	0	O
proposed	28343944	0	O
as	28343944	0	O
a	28343944	0	O
biological	28343944	0	O
marker	28343944	0	O
of	28343944	0	O
melanoma	28343944	0	O
in	28343944	0	O
human	28343944	0	O
and	28343944	0	O
domestic	28343944	0	O
animal	28343944	0	O
species	28343944	0	O
harboring	28343944	0	O
spontaneous	28343944	0	O
melanomas	28343944	0	O
.	28343944	0	O
As	28343944	0	O
a	28343944	0	O
scaffold	28343944	0	O
protein	28343944	0	O
,	28343944	0	O
RACK1	28343944	0	O
is	28343944	0	O
able	28343944	0	O
to	28343944	0	O
coordinate	28343944	0	O
the	28343944	0	O
interaction	28343944	0	O
of	28343944	0	O
key	28343944	0	O
signaling	28343944	0	O
molecules	28343944	0	O
implicated	28343944	0	O
in	28343944	0	O
both	28343944	0	O
physiological	28343944	0	O
cellular	28343944	0	O
functions	28343944	0	O
and	28343944	0	O
tumorigenesis	28343944	0	O
.	28343944	0	O
A	28343944	0	O
role	28343944	0	O
for	28343944	0	O
RACK1	28343944	0	O
in	28343944	0	O
rewiring	28343944	0	O
ERK	28343944	0	O
and	28343944	0	O
JNK	28343944	0	O
signaling	28343944	0	O
pathways	28343944	0	O
in	28343944	0	O
melanoma	28343944	0	O
cell	28343944	0	O
lines	28343944	0	O
had	28343944	0	O
been	28343944	0	O
proposed	28343944	0	O
.	28343944	0	O
Here	28343944	0	O
,	28343944	0	O
we	28343944	0	O
used	28343944	0	O
a	28343944	0	O
genetic	28343944	0	O
approach	28343944	0	O
to	28343944	0	O
test	28343944	0	O
this	28343944	0	O
hypothesis	28343944	0	O
in	28343944	0	O
vivo	28343944	0	O
in	28343944	0	O
the	28343944	0	O
mouse	28343944	0	O
.	28343944	0	O
We	28343944	0	O
show	28343944	0	O
that	28343944	0	O
Rack1	28343944	0	B-Gene
knock	28343944	0	B-Var
-	28343944	0	I-Var
down	28343944	0	I-Var
in	28343944	0	O
the	28343944	0	O
mouse	28343944	0	O
melanoma	28343944	0	O
cell	28343944	0	O
line	28343944	0	O
B16	28343944	0	O
reduces	28343944	0	B-NegReg
invasiveness	28343944	0	O
and	28343944	0	O
induces	28343944	0	B-Reg
cell	28343944	0	O
differentiation	28343944	0	O
.	28343944	0	O
We	28343944	0	O
have	28343944	0	O
developed	28343944	0	O
the	28343944	0	O
first	28343944	0	O
mouse	28343944	0	O
model	28343944	0	O
for	28343944	0	O
RACK1	28343944	0	O
gain	28343944	0	O
of	28343944	0	O
function	28343944	0	O
,	28343944	0	O
Tyr	28343944	0	O
:	28343944	0	O
:	28343944	0	O
Rack1	28343944	0	O
-	28343944	0	O
HA	28343944	0	O
transgenic	28343944	0	O
mice	28343944	0	O
,	28343944	0	O
targeting	28343944	0	O
RACK1	28343944	0	O
to	28343944	0	O
melanocytes	28343944	0	O
in	28343944	0	O
vivo	28343944	0	O
.	28343944	0	O
RACK1	28343944	0	O
overexpression	28343944	0	O
was	28343944	0	O
not	28343944	0	O
sufficient	28343944	0	O
to	28343944	0	O
initiate	28343944	0	O
melanomas	28343944	0	O
despite	28343944	0	O
activated	28343944	0	O
ERK	28343944	0	O
and	28343944	0	O
AKT	28343944	0	O
.	28343944	0	O
However	28343944	0	O
,	28343944	0	O
in	28343944	0	O
a	28343944	0	O
context	28343944	0	O
of	28343944	0	O
melanoma	28343944	0	O
predisposition	28343944	0	O
,	28343944	0	O
RACK1	28343944	0	O
overexpression	28343944	0	O
reduced	28343944	0	O
latency	28343944	0	O
and	28343944	0	O
increased	28343944	0	O
incidence	28343944	0	O
and	28343944	0	O
metastatic	28343944	0	O
rate	28343944	0	O
.	28343944	0	O
In	28343944	0	O
primary	28343944	0	O
melanoma	28343944	0	O
cells	28343944	0	O
from	28343944	0	O
Tyr	28343944	0	O
:	28343944	0	O
:	28343944	0	O
Rack1	28343944	0	O
-	28343944	0	O
HA	28343944	0	O
,	28343944	0	O
Tyr	28343944	0	O
:	28343944	0	O
:	28343944	0	O
NRas	28343944	0	O
(	28343944	0	O
Q61K	28343944	0	O
)	28343944	0	O
mice	28343944	0	O
,	28343944	0	O
activated	28343944	0	O
JNK	28343944	0	O
(	28343944	0	O
c	28343944	0	O
-	28343944	0	O
Jun	28343944	0	O
N	28343944	0	O
-	28343944	0	O
terminal	28343944	0	O
kinase	28343944	0	O
)	28343944	0	O
and	28343944	0	O
activated	28343944	0	O
STAT3	28343944	0	O
(	28343944	0	O
signal	28343944	0	O
transducer	28343944	0	O
and	28343944	0	O
activator	28343944	0	O
of	28343944	0	O
transcription	28343944	0	O
3	28343944	0	O
)	28343944	0	O
acted	28343944	0	O
as	28343944	0	O
RACK1	28343944	0	O
oncogenic	28343944	0	O
partners	28343944	0	O
in	28343944	0	O
tumoral	28343944	0	O
progression	28343944	0	O
.	28343944	0	O
A	28343944	0	O
sequential	28343944	0	O
and	28343944	0	O
coordinated	28343944	0	O
activation	28343944	0	O
of	28343944	0	O
ERK	28343944	0	O
,	28343944	0	O
JNK	28343944	0	O
and	28343944	0	O
STAT3	28343944	0	O
with	28343944	0	O
RACK1	28343944	0	O
is	28343944	0	O
shown	28343944	0	O
to	28343944	0	O
accelerate	28343944	0	O
aggressive	28343944	0	O
melanoma	28343944	0	O
development	28343944	0	O
in	28343944	0	O
vivo	28343944	0	O
.	28343944	0	O

Identification	28373485	1	O
and	28373485	1	O
characterization	28373485	1	O
of	28373485	1	O
a	28373485	1	O
novel	28373485	1	O
DGAT1	28373485	1	O
missense	28373485	1	O
mutation	28373485	1	O
associated	28373485	1	O
with	28373485	1	O
congenital	28373485	1	O
diarrhea	28373485	1	O
.	28373485	1	O
Acyl	28373485	1	O
-	28373485	1	O
CoA	28373485	1	O
:	28373485	1	O
diacylglycerol	28373485	1	O
acyltransferase	28373485	1	O
(	28373485	1	O
DGAT	28373485	1	O
)	28373485	1	O
1	28373485	1	O
and	28373485	1	O
DGAT2	28373485	1	O
catalyze	28373485	1	O
triglyceride	28373485	1	O
(	28373485	1	O
TG	28373485	1	O
)	28373485	1	O
biosynthesis	28373485	1	O
in	28373485	1	O
humans	28373485	1	O
.	28373485	1	O
Biallelic	28373485	1	O
loss	28373485	1	B-NegReg
-	28373485	1	I-NegReg
of	28373485	1	I-NegReg
-	28373485	1	I-NegReg
function	28373485	1	I-NegReg
mutations	28373485	1	B-Var
in	28373485	1	O
human	28373485	1	O
DGAT1	28373485	1	B-Gene
result	28373485	1	O
in	28373485	1	O
severe	28373485	1	O
congenital	28373485	1	B-Disease
diarrhea	28373485	1	I-Disease
and	28373485	1	O
protein	28373485	1	B-Disease
-	28373485	1	I-Disease
losing	28373485	1	I-Disease
enteropathy	28373485	1	I-Disease
.	28373485	1	O
Additionally	28373485	1	O
,	28373485	1	O
pharmacologic	28373485	1	O
inhibition	28373485	1	O
of	28373485	1	O
DGAT1	28373485	1	O
led	28373485	1	O
to	28373485	1	O
dose	28373485	1	O
-	28373485	1	O
related	28373485	1	O
diarrhea	28373485	1	O
in	28373485	1	O
human	28373485	1	O
clinical	28373485	1	O
trials	28373485	1	O
.	28373485	1	O
Here	28373485	1	O
we	28373485	1	O
identify	28373485	1	O
a	28373485	1	O
previously	28373485	1	O
unknown	28373485	1	O
DGAT1	28373485	1	O
mutation	28373485	1	O
in	28373485	1	O
identical	28373485	1	O
twins	28373485	1	O
of	28373485	1	O
South	28373485	1	O
Asian	28373485	1	O
descent	28373485	1	O
.	28373485	1	O
These	28373485	1	O
male	28373485	1	O
patients	28373485	1	O
developed	28373485	1	O
watery	28373485	1	O
diarrhea	28373485	1	O
shortly	28373485	1	O
after	28373485	1	O
birth	28373485	1	O
,	28373485	1	O
with	28373485	1	O
protein	28373485	1	O
-	28373485	1	O
losing	28373485	1	O
enteropathy	28373485	1	O
and	28373485	1	O
failure	28373485	1	O
to	28373485	1	O
thrive	28373485	1	O
.	28373485	1	O
Exome	28373485	1	O
sequencing	28373485	1	O
revealed	28373485	1	O
a	28373485	1	O
homozygous	28373485	1	O
recessive	28373485	1	O
mutation	28373485	1	O
in	28373485	1	O
DGAT1	28373485	1	O
,	28373485	1	O
c.314	28373485	1	O
T	28373485	1	O
>	28373485	1	O
C	28373485	1	O
,	28373485	1	O
p.L105P	28373485	1	O
.	28373485	1	O
We	28373485	1	O
show	28373485	1	O
here	28373485	1	O
that	28373485	1	O
the	28373485	1	O
p.L105P	28373485	1	B-Var
DGAT1	28373485	1	B-Gene
enzyme	28373485	1	O
produced	28373485	1	O
from	28373485	1	O
the	28373485	1	O
mutant	28373485	1	B-Var
allele	28373485	1	O
is	28373485	1	O
less	28373485	1	B-NegReg
abundant	28373485	1	O
,	28373485	1	O
resulting	28373485	1	O
in	28373485	1	O
partial	28373485	1	O
loss	28373485	1	B-NegReg
of	28373485	1	O
TG	28373485	1	O
synthesis	28373485	1	O
activity	28373485	1	O
and	28373485	1	O
decreased	28373485	1	B-NegReg
formation	28373485	1	O
of	28373485	1	O
lipid	28373485	1	O
droplets	28373485	1	O
in	28373485	1	O
patient	28373485	1	O
-	28373485	1	O
derived	28373485	1	O
primary	28373485	1	O
dermal	28373485	1	O
fibroblasts	28373485	1	O
.	28373485	1	O
Thus	28373485	1	O
,	28373485	1	O
in	28373485	1	O
contrast	28373485	1	O
with	28373485	1	O
complete	28373485	1	O
loss	28373485	1	O
-	28373485	1	O
of	28373485	1	O
-	28373485	1	O
function	28373485	1	O
alleles	28373485	1	O
of	28373485	1	O
DGAT1	28373485	1	O
,	28373485	1	O
the	28373485	1	O
p.L105P	28373485	1	B-Var
missense	28373485	1	I-Var
allele	28373485	1	O
partially	28373485	1	O
reduces	28373485	1	B-NegReg
TG	28373485	1	O
synthesis	28373485	1	O
activity	28373485	1	O
and	28373485	1	O
causes	28373485	1	B-Reg
a	28373485	1	O
less	28373485	1	O
severe	28373485	1	O
clinical	28373485	1	O
phenotype	28373485	1	O
.	28373485	1	O
Our	28373485	1	O
findings	28373485	1	O
add	28373485	1	O
to	28373485	1	O
the	28373485	1	O
growing	28373485	1	O
recognition	28373485	1	O
of	28373485	1	O
DGAT1	28373485	1	B-Gene
deficiency	28373485	1	B-Var
as	28373485	1	O
a	28373485	1	O
cause	28373485	1	B-Reg
of	28373485	1	O
congenital	28373485	1	B-Disease
diarrhea	28373485	1	I-Disease
with	28373485	1	O
protein	28373485	1	B-Disease
-	28373485	1	I-Disease
losing	28373485	1	I-Disease
enteropathy	28373485	1	I-Disease
and	28373485	1	O
indicate	28373485	1	O
that	28373485	1	O
DGAT1	28373485	1	B-Gene
mutations	28373485	1	B-Var
result	28373485	1	B-Reg
in	28373485	1	I-Reg
a	28373485	1	O
spectrum	28373485	1	B-Disease
of	28373485	1	I-Disease
diseases	28373485	1	I-Disease
.	28373485	1	O

Control	28389584	1	O
of	28389584	1	O
Kir	28389584	1	O
channel	28389584	1	O
gating	28389584	1	O
by	28389584	1	O
cytoplasmic	28389584	1	O
domain	28389584	1	O
interface	28389584	1	O
interactions	28389584	1	O
.	28389584	1	O
Inward	28389584	1	O
rectifier	28389584	1	O
potassium	28389584	1	O
(	28389584	1	O
Kir	28389584	1	O
)	28389584	1	O
channels	28389584	1	O
are	28389584	1	O
expressed	28389584	1	O
in	28389584	1	O
almost	28389584	1	O
all	28389584	1	O
mammalian	28389584	1	O
tissues	28389584	1	O
and	28389584	1	O
play	28389584	1	O
critical	28389584	1	O
roles	28389584	1	O
in	28389584	1	O
the	28389584	1	O
control	28389584	1	O
of	28389584	1	O
excitability	28389584	1	O
.	28389584	1	O
Pancreatic	28389584	1	O
ATP	28389584	1	O
-	28389584	1	O
sensitive	28389584	1	O
K	28389584	1	O
(	28389584	1	O
KATP	28389584	1	O
)	28389584	1	O
channels	28389584	1	O
are	28389584	1	O
key	28389584	1	O
regulators	28389584	1	O
of	28389584	1	O
insulin	28389584	1	O
secretion	28389584	1	O
and	28389584	1	O
comprise	28389584	1	O
Kir6.2	28389584	1	O
subunits	28389584	1	O
coupled	28389584	1	O
to	28389584	1	O
sulfonylurea	28389584	1	O
receptors	28389584	1	O
.	28389584	1	O
Because	28389584	1	O
these	28389584	1	O
channels	28389584	1	O
are	28389584	1	O
reversibly	28389584	1	O
inhibited	28389584	1	O
by	28389584	1	O
cytoplasmic	28389584	1	O
ATP	28389584	1	O
,	28389584	1	O
they	28389584	1	O
link	28389584	1	O
cellular	28389584	1	O
metabolism	28389584	1	O
with	28389584	1	O
membrane	28389584	1	O
excitability	28389584	1	O
.	28389584	1	O
Loss	28389584	1	B-NegReg
-	28389584	1	I-NegReg
of	28389584	1	I-NegReg
-	28389584	1	I-NegReg
function	28389584	1	I-NegReg
mutations	28389584	1	B-Var
in	28389584	1	O
the	28389584	1	O
pore	28389584	1	O
-	28389584	1	O
forming	28389584	1	O
Kir6.2	28389584	1	B-Gene
subunit	28389584	1	O
cause	28389584	1	O
congenital	28389584	1	B-Disease
hyperinsulinism	28389584	1	I-Disease
as	28389584	1	O
a	28389584	1	O
result	28389584	1	O
of	28389584	1	O
diminished	28389584	1	B-NegReg
channel	28389584	1	O
activity	28389584	1	O
.	28389584	1	O
Here	28389584	1	O
,	28389584	1	O
we	28389584	1	O
show	28389584	1	O
that	28389584	1	O
several	28389584	1	O
disease	28389584	1	O
mutations	28389584	1	B-Var
,	28389584	1	O
which	28389584	1	O
disrupt	28389584	1	B-NegReg
intersubunit	28389584	1	O
salt	28389584	1	O
bridges	28389584	1	O
at	28389584	1	O
the	28389584	1	O
interface	28389584	1	O
of	28389584	1	O
the	28389584	1	O
cytoplasmic	28389584	1	O
domains	28389584	1	O
(	28389584	1	O
CD	28389584	1	O
-	28389584	1	O
I	28389584	1	O
)	28389584	1	O
of	28389584	1	O
adjacent	28389584	1	O
subunits	28389584	1	O
,	28389584	1	O
induce	28389584	1	O
loss	28389584	1	B-NegReg
of	28389584	1	O
channel	28389584	1	O
activity	28389584	1	O
via	28389584	1	O
a	28389584	1	O
novel	28389584	1	O
channel	28389584	1	O
behavior	28389584	1	O
:	28389584	1	O
after	28389584	1	O
ATP	28389584	1	O
removal	28389584	1	O
,	28389584	1	O
channels	28389584	1	O
open	28389584	1	O
but	28389584	1	O
then	28389584	1	O
rapidly	28389584	1	O
inactivate	28389584	1	O
.	28389584	1	O
Re	28389584	1	O
-	28389584	1	O
exposure	28389584	1	O
to	28389584	1	O
inhibitory	28389584	1	O
ATP	28389584	1	O
causes	28389584	1	O
recovery	28389584	1	O
from	28389584	1	O
this	28389584	1	O
inactivation	28389584	1	O
.	28389584	1	O
Inactivation	28389584	1	O
can	28389584	1	O
be	28389584	1	O
abolished	28389584	1	O
by	28389584	1	O
application	28389584	1	O
of	28389584	1	O
phosphatidylinositol-4	28389584	1	O
,	28389584	1	O
5	28389584	1	O
-	28389584	1	O
bisphosphate	28389584	1	O
(	28389584	1	O
PIP2	28389584	1	O
)	28389584	1	O
to	28389584	1	O
the	28389584	1	O
cytoplasmic	28389584	1	O
face	28389584	1	O
of	28389584	1	O
the	28389584	1	O
membrane	28389584	1	O
,	28389584	1	O
an	28389584	1	O
effect	28389584	1	O
that	28389584	1	O
can	28389584	1	O
be	28389584	1	O
explained	28389584	1	O
by	28389584	1	O
a	28389584	1	O
simple	28389584	1	O
kinetic	28389584	1	O
model	28389584	1	O
in	28389584	1	O
which	28389584	1	O
PIP2	28389584	1	O
binding	28389584	1	O
competes	28389584	1	O
with	28389584	1	O
the	28389584	1	O
inactivation	28389584	1	O
process	28389584	1	O
.	28389584	1	O
Kir2.1	28389584	1	O
channels	28389584	1	O
contain	28389584	1	O
homologous	28389584	1	O
salt	28389584	1	O
bridges	28389584	1	O
,	28389584	1	O
and	28389584	1	O
we	28389584	1	O
find	28389584	1	O
that	28389584	1	O
mutations	28389584	1	O
that	28389584	1	O
disrupt	28389584	1	O
CD	28389584	1	O
-	28389584	1	O
I	28389584	1	O
interactions	28389584	1	O
in	28389584	1	O
Kir2.1	28389584	1	O
also	28389584	1	O
reduce	28389584	1	O
channel	28389584	1	O
activity	28389584	1	O
and	28389584	1	O
PIP2	28389584	1	O
sensitivity	28389584	1	O
.	28389584	1	O
Kir2.1	28389584	1	O
channels	28389584	1	O
also	28389584	1	O
contain	28389584	1	O
an	28389584	1	O
additional	28389584	1	O
CD	28389584	1	O
-	28389584	1	O
I	28389584	1	O
salt	28389584	1	O
bridge	28389584	1	O
that	28389584	1	O
is	28389584	1	O
not	28389584	1	O
present	28389584	1	O
in	28389584	1	O
Kir6.2	28389584	1	O
channels	28389584	1	O
.	28389584	1	O
Introduction	28389584	1	O
of	28389584	1	O
this	28389584	1	O
salt	28389584	1	O
bridge	28389584	1	O
into	28389584	1	O
Kir6.2	28389584	1	O
partially	28389584	1	O
rescues	28389584	1	O
inactivating	28389584	1	O
mutants	28389584	1	O
from	28389584	1	O
the	28389584	1	O
phenotype	28389584	1	O
.	28389584	1	O
These	28389584	1	O
results	28389584	1	O
indicate	28389584	1	O
that	28389584	1	O
the	28389584	1	O
stability	28389584	1	O
of	28389584	1	O
the	28389584	1	O
intersubunit	28389584	1	O
CD	28389584	1	O
-	28389584	1	O
I	28389584	1	O
is	28389584	1	O
a	28389584	1	O
major	28389584	1	O
determinant	28389584	1	O
of	28389584	1	O
the	28389584	1	O
inactivation	28389584	1	O
process	28389584	1	O
in	28389584	1	O
Kir6.2	28389584	1	O
and	28389584	1	O
may	28389584	1	O
control	28389584	1	O
gating	28389584	1	O
in	28389584	1	O
other	28389584	1	O
Kir	28389584	1	O
channels	28389584	1	O
.	28389584	1	O

Patient	28390992	4	O
-	28390992	4	O
specific	28390992	4	O
induced	28390992	4	O
pluripotent	28390992	4	O
stem	28390992	4	O
cells	28390992	4	O
to	28390992	4	O
evaluate	28390992	4	O
the	28390992	4	O
pathophysiology	28390992	4	O
of	28390992	4	O
TRNT1	28390992	4	O
-	28390992	4	O
associated	28390992	4	O
Retinitis	28390992	4	O
pigmentosa	28390992	4	O
.	28390992	4	O
Retinitis	28390992	4	B-Disease
pigmentosa	28390992	4	I-Disease
(	28390992	4	O
RP	28390992	4	O
)	28390992	4	O
is	28390992	4	O
a	28390992	4	O
heterogeneous	28390992	4	O
group	28390992	4	O
of	28390992	4	O
monogenic	28390992	4	O
disorders	28390992	4	O
characterized	28390992	4	O
by	28390992	4	O
progressive	28390992	4	O
death	28390992	4	O
of	28390992	4	O
the	28390992	4	O
light	28390992	4	O
-	28390992	4	O
sensing	28390992	4	O
photoreceptor	28390992	4	O
cells	28390992	4	O
of	28390992	4	O
the	28390992	4	O
outer	28390992	4	O
neural	28390992	4	O
retina	28390992	4	O
.	28390992	4	O
We	28390992	4	O
recently	28390992	4	O
identified	28390992	4	O
novel	28390992	4	O
hypomorphic	28390992	4	O
mutations	28390992	4	B-Var
in	28390992	4	O
the	28390992	4	O
tRNA	28390992	4	O
Nucleotidyl	28390992	4	O
Transferase	28390992	4	O
,	28390992	4	O
CCA	28390992	4	O
-	28390992	4	O
Adding	28390992	4	O
1	28390992	4	O
(	28390992	4	B-Gene
TRNT1	28390992	4	I-Gene
)	28390992	4	I-Gene
gene	28390992	4	O
that	28390992	4	O
cause	28390992	4	B-Reg
early	28390992	4	O
-	28390992	4	O
onset	28390992	4	O
RP	28390992	4	B-Disease
.	28390992	4	O
To	28390992	4	O
model	28390992	4	O
this	28390992	4	O
disease	28390992	4	O
in	28390992	4	O
vitro	28390992	4	O
,	28390992	4	O
we	28390992	4	O
generated	28390992	4	O
patient	28390992	4	O
-	28390992	4	O
specific	28390992	4	O
iPSCs	28390992	4	O
and	28390992	4	O
iPSC	28390992	4	O
-	28390992	4	O
derived	28390992	4	O
retinal	28390992	4	O
organoids	28390992	4	O
from	28390992	4	O
dermal	28390992	4	O
fibroblasts	28390992	4	O
of	28390992	4	O
patients	28390992	4	O
with	28390992	4	O
molecularly	28390992	4	O
confirmed	28390992	4	O
TRNT1	28390992	4	O
-	28390992	4	O
associated	28390992	4	O
RP	28390992	4	O
.	28390992	4	O
Pluripotency	28390992	4	O
was	28390992	4	O
confirmed	28390992	4	O
using	28390992	4	O
rt	28390992	4	O
-	28390992	4	O
PCR	28390992	4	O
,	28390992	4	O
immunocytochemistry	28390992	4	O
,	28390992	4	O
and	28390992	4	O
a	28390992	4	O
TaqMan	28390992	4	O
Scorecard	28390992	4	O
Assay	28390992	4	O
.	28390992	4	O
Mutations	28390992	4	B-Var
in	28390992	4	O
TRNT1	28390992	4	B-Gene
caused	28390992	4	O
reduced	28390992	4	B-NegReg
levels	28390992	4	O
of	28390992	4	O
full	28390992	4	O
-	28390992	4	O
length	28390992	4	O
TRNT1	28390992	4	B-Gene
protein	28390992	4	O
and	28390992	4	O
expression	28390992	4	O
of	28390992	4	O
a	28390992	4	O
truncated	28390992	4	O
smaller	28390992	4	O
protein	28390992	4	O
in	28390992	4	O
both	28390992	4	O
patient	28390992	4	O
-	28390992	4	O
specific	28390992	4	O
iPSCs	28390992	4	O
and	28390992	4	O
iPSC	28390992	4	O
-	28390992	4	O
derived	28390992	4	O
retinal	28390992	4	O
organoids	28390992	4	O
.	28390992	4	O
Patient	28390992	4	O
-	28390992	4	O
specific	28390992	4	O
iPSCs	28390992	4	O
and	28390992	4	O
iPSC	28390992	4	O
-	28390992	4	O
derived	28390992	4	O
retinal	28390992	4	O
organoids	28390992	4	O
exhibited	28390992	4	O
a	28390992	4	O
deficit	28390992	4	O
in	28390992	4	O
autophagy	28390992	4	O
,	28390992	4	O
as	28390992	4	O
evidenced	28390992	4	O
by	28390992	4	O
aberrant	28390992	4	O
accumulation	28390992	4	O
of	28390992	4	O
LC3	28390992	4	O
-	28390992	4	O
II	28390992	4	O
and	28390992	4	O
elevated	28390992	4	O
levels	28390992	4	O
of	28390992	4	O
oxidative	28390992	4	O
stress	28390992	4	O
.	28390992	4	O
Autologous	28390992	4	O
stem	28390992	4	O
cell	28390992	4	O
-	28390992	4	O
based	28390992	4	O
disease	28390992	4	O
modeling	28390992	4	O
will	28390992	4	O
provide	28390992	4	O
a	28390992	4	O
platform	28390992	4	O
for	28390992	4	O
testing	28390992	4	O
multiple	28390992	4	O
avenues	28390992	4	O
of	28390992	4	O
treatment	28390992	4	O
in	28390992	4	O
patients	28390992	4	O
suffering	28390992	4	O
from	28390992	4	O
TRNT1	28390992	4	O
-	28390992	4	O
associated	28390992	4	O
RP	28390992	4	O
.	28390992	4	O

Gain	28423230	2	B-Var
-	28423230	2	I-Var
of	28423230	2	I-Var
-	28423230	2	I-Var
function	28423230	2	I-Var
p53	28423230	2	B-Gene
activates	28423230	2	B-PosReg
multiple	28423230	2	O
signaling	28423230	2	O
pathways	28423230	2	O
to	28423230	2	O
induce	28423230	2	B-PosReg
oncogenicity	28423230	2	O
in	28423230	2	O
lung	28423230	2	B-Disease
cancer	28423230	2	I-Disease
cells	28423230	2	O
.	28423230	2	O
Gain	28423230	2	B-PosReg
-	28423230	2	I-PosReg
of	28423230	2	I-PosReg
-	28423230	2	I-PosReg
function	28423230	2	I-PosReg
(	28423230	2	O
GOF	28423230	2	O
)	28423230	2	O
mutants	28423230	2	B-Var
of	28423230	2	O
p53	28423230	2	B-Gene
upregulate	28423230	2	B-PosReg
genes	28423230	2	B-Gene
implicated	28423230	2	B-Reg
in	28423230	2	O
cell	28423230	2	O
proliferation	28423230	2	O
and	28423230	2	O
oncogenesis	28423230	2	O
.	28423230	2	O
Here	28423230	2	O
,	28423230	2	O
we	28423230	2	O
report	28423230	2	O
that	28423230	2	O
GOF	28423230	2	B-Var
p53	28423230	2	B-Gene
induces	28423230	2	O
tumorigenicity	28423230	2	O
through	28423230	2	O
simultaneous	28423230	2	O
activation	28423230	2	B-PosReg
of	28423230	2	O
key	28423230	2	O
oncogenic	28423230	2	O
pathways	28423230	2	O
including	28423230	2	O
those	28423230	2	O
controlling	28423230	2	O
putative	28423230	2	O
tumor	28423230	2	O
-	28423230	2	O
initiating	28423230	2	O
cell	28423230	2	O
functions	28423230	2	O
.	28423230	2	O
We	28423230	2	O
determined	28423230	2	O
that	28423230	2	O
in	28423230	2	O
cells	28423230	2	O
expressing	28423230	2	O
p53	28423230	2	B-Var
-	28423230	2	I-Var
R273H	28423230	2	I-Var
,	28423230	2	O
GOF	28423230	2	O
p53	28423230	2	O
simultaneously	28423230	2	O
upregulates	28423230	2	B-PosReg
genes	28423230	2	O
from	28423230	2	O
multiple	28423230	2	O
signaling	28423230	2	O
pathways	28423230	2	O
by	28423230	2	O
recognizing	28423230	2	O
promoters	28423230	2	O
containing	28423230	2	O
distinct	28423230	2	O
transcription	28423230	2	O
factor	28423230	2	O
(	28423230	2	O
TF	28423230	2	O
)	28423230	2	O
binding	28423230	2	O
sites	28423230	2	O
.	28423230	2	O
Our	28423230	2	O
analytical	28423230	2	O
data	28423230	2	O
support	28423230	2	O
a	28423230	2	O
model	28423230	2	O
in	28423230	2	O
which	28423230	2	O
GOF	28423230	2	B-Var
p53	28423230	2	B-Gene
complexes	28423230	2	O
with	28423230	2	O
two	28423230	2	O
TFs	28423230	2	O
on	28423230	2	O
the	28423230	2	O
promoter	28423230	2	O
-	28423230	2	O
a	28423230	2	O
mediator	28423230	2	O
protein	28423230	2	O
,	28423230	2	O
Med17	28423230	2	O
,	28423230	2	O
and	28423230	2	O
a	28423230	2	O
histone	28423230	2	O
acetyl	28423230	2	O
transferase	28423230	2	O
,	28423230	2	O
activating	28423230	2	B-PosReg
histone	28423230	2	O
acetylation	28423230	2	O
-	28423230	2	O
and	28423230	2	O
enhances	28423230	2	B-PosReg
gene	28423230	2	O
expression	28423230	2	O
to	28423230	2	O
signal	28423230	2	O
cell	28423230	2	O
proliferation	28423230	2	O
and	28423230	2	O
oncogenesis	28423230	2	O
.	28423230	2	O
Thus	28423230	2	O
,	28423230	2	O
therapeutic	28423230	2	O
inhibition	28423230	2	O
of	28423230	2	O
one	28423230	2	O
GOF	28423230	2	O
p53	28423230	2	O
-	28423230	2	O
induced	28423230	2	O
pathway	28423230	2	O
would	28423230	2	O
be	28423230	2	O
insufficient	28423230	2	O
to	28423230	2	O
prevent	28423230	2	O
tumor	28423230	2	O
growth	28423230	2	O
as	28423230	2	O
the	28423230	2	O
oncoprotein	28423230	2	O
activates	28423230	2	O
a	28423230	2	O
multitude	28423230	2	O
of	28423230	2	O
parallel	28423230	2	O
pathways	28423230	2	O
.	28423230	2	O
This	28423230	2	O
discovery	28423230	2	O
suggests	28423230	2	O
enormous	28423230	2	O
selection	28423230	2	O
advantage	28423230	2	O
for	28423230	2	O
cancer	28423230	2	O
cells	28423230	2	O
with	28423230	2	O
GOF	28423230	2	O
p53	28423230	2	O
to	28423230	2	O
induce	28423230	2	O
oncogenic	28423230	2	O
growth	28423230	2	O
,	28423230	2	O
highlighting	28423230	2	O
the	28423230	2	O
problems	28423230	2	O
of	28423230	2	O
cancer	28423230	2	O
therapy	28423230	2	O
.	28423230	2	O

Hand	28425595	1	O
eczema	28425595	1	O
,	28425595	1	O
atopic	28425595	1	O
dermatitis	28425595	1	O
and	28425595	1	O
filaggrin	28425595	1	O
mutations	28425595	1	O
in	28425595	1	O
adult	28425595	1	O
Danes	28425595	1	O
:	28425595	1	O
a	28425595	1	O
registry	28425595	1	O
-	28425595	1	O
based	28425595	1	O
study	28425595	1	O
assessing	28425595	1	O
risk	28425595	1	O
of	28425595	1	O
disability	28425595	1	O
pension	28425595	1	O
.	28425595	1	O
BACKGROUND	28425595	1	O
:	28425595	1	O
Atopic	28425595	1	O
dermatitis	28425595	1	O
and	28425595	1	O
hand	28425595	1	O
eczema	28425595	1	O
often	28425595	1	O
impair	28425595	1	O
the	28425595	1	O
ability	28425595	1	O
of	28425595	1	O
people	28425595	1	O
to	28425595	1	O
work	28425595	1	O
.	28425595	1	O
Only	28425595	1	O
a	28425595	1	O
few	28425595	1	O
studies	28425595	1	O
have	28425595	1	O
investigated	28425595	1	O
whether	28425595	1	O
individuals	28425595	1	O
with	28425595	1	O
loss	28425595	1	B-NegReg
-	28425595	1	I-NegReg
of	28425595	1	I-NegReg
-	28425595	1	I-NegReg
function	28425595	1	I-NegReg
filaggrin	28425595	1	O
gene	28425595	1	O
(	28425595	1	B-Gene
FLG	28425595	1	I-Gene
)	28425595	1	I-Gene
mutations	28425595	1	B-Var
,	28425595	1	O
who	28425595	1	O
often	28425595	1	O
have	28425595	1	O
severe	28425595	1	O
and	28425595	1	O
early	28425595	1	O
onset	28425595	1	O
of	28425595	1	O
dermatitis	28425595	1	B-Disease
,	28425595	1	O
experience	28425595	1	O
occupational	28425595	1	O
consequences	28425595	1	O
.	28425595	1	O
OBJECTIVE	28425595	1	O
:	28425595	1	O
To	28425595	1	O
investigate	28425595	1	O
the	28425595	1	O
personal	28425595	1	O
consequences	28425595	1	O
of	28425595	1	O
having	28425595	1	O
atopic	28425595	1	O
dermatitis	28425595	1	O
and	28425595	1	O
/	28425595	1	O
or	28425595	1	O
hand	28425595	1	O
eczema	28425595	1	O
and	28425595	1	O
FLG	28425595	1	O
mutations	28425595	1	O
.	28425595	1	O
METHOD	28425595	1	O
:	28425595	1	O
Adult	28425595	1	O
Danes	28425595	1	O
from	28425595	1	O
the	28425595	1	O
general	28425595	1	O
population	28425595	1	O
(	28425595	1	O
n	28425595	1	O
=	28425595	1	O
3247	28425595	1	O
)	28425595	1	O
and	28425595	1	O
patients	28425595	1	O
with	28425595	1	O
atopic	28425595	1	O
dermatitis	28425595	1	O
and	28425595	1	O
/	28425595	1	O
or	28425595	1	O
hand	28425595	1	O
eczema	28425595	1	O
(	28425595	1	O
n	28425595	1	O
=	28425595	1	O
496	28425595	1	O
)	28425595	1	O
were	28425595	1	O
genotyped	28425595	1	O
for	28425595	1	O
common	28425595	1	O
FLG	28425595	1	O
mutations	28425595	1	O
,	28425595	1	O
and	28425595	1	O
completed	28425595	1	O
a	28425595	1	O
questionnaire	28425595	1	O
about	28425595	1	O
skin	28425595	1	O
symptoms	28425595	1	O
and	28425595	1	O
hand	28425595	1	O
eczema	28425595	1	O
.	28425595	1	O
Socioeconomic	28425595	1	O
variables	28425595	1	O
,	28425595	1	O
including	28425595	1	O
disability	28425595	1	O
pension	28425595	1	O
,	28425595	1	O
and	28425595	1	O
information	28425595	1	O
on	28425595	1	O
work	28425595	1	O
in	28425595	1	O
risk	28425595	1	O
occupations	28425595	1	O
were	28425595	1	O
retrieved	28425595	1	O
from	28425595	1	O
national	28425595	1	O
registries	28425595	1	O
.	28425595	1	O
The	28425595	1	O
reasons	28425595	1	O
for	28425595	1	O
granting	28425595	1	O
disability	28425595	1	O
pension	28425595	1	O
were	28425595	1	O
unknown	28425595	1	O
.	28425595	1	O
RESULTS	28425595	1	O
:	28425595	1	O
Disability	28425595	1	O
pension	28425595	1	O
was	28425595	1	O
associated	28425595	1	O
with	28425595	1	O
hand	28425595	1	O
eczema	28425595	1	O
in	28425595	1	O
the	28425595	1	O
general	28425595	1	O
population	28425595	1	O
,	28425595	1	O
especially	28425595	1	O
among	28425595	1	O
individuals	28425595	1	O
with	28425595	1	O
a	28425595	1	O
history	28425595	1	O
of	28425595	1	O
atopic	28425595	1	O
dermatitis	28425595	1	O
.	28425595	1	O
Moreover	28425595	1	O
,	28425595	1	O
self	28425595	1	O
-	28425595	1	O
reported	28425595	1	O
hand	28425595	1	O
eczema	28425595	1	O
and	28425595	1	O
atopic	28425595	1	O
dermatitis	28425595	1	O
were	28425595	1	O
associated	28425595	1	O
with	28425595	1	O
particularly	28425595	1	O
high	28425595	1	O
risk	28425595	1	O
of	28425595	1	O
disability	28425595	1	O
pension	28425595	1	O
among	28425595	1	O
FLG	28425595	1	O
mutation	28425595	1	O
carriers	28425595	1	O
[	28425595	1	O
odds	28425595	1	O
ratio	28425595	1	O
(	28425595	1	O
OR	28425595	1	O
)	28425595	1	O
4.02	28425595	1	O
and	28425595	1	O
95%	28425595	1	O
confidence	28425595	1	O
interval	28425595	1	O
(	28425595	1	O
CI	28425595	1	O
)	28425595	1	O
:	28425595	1	O
1.15	28425595	1	O
-	28425595	1	O
14.11	28425595	1	O
;	28425595	1	O
and	28425595	1	O
OR	28425595	1	O
6.01	28425595	1	O
and	28425595	1	O
95%	28425595	1	O
CI	28425595	1	O
:	28425595	1	O
2.37	28425595	1	O
-	28425595	1	O
15.34	28425595	1	O
,	28425595	1	O
respectively	28425595	1	O
]	28425595	1	O
.	28425595	1	O
Furthermore	28425595	1	O
,	28425595	1	O
60%	28425595	1	O
of	28425595	1	O
the	28425595	1	O
FLG	28425595	1	O
mutation	28425595	1	O
carriers	28425595	1	O
with	28425595	1	O
atopic	28425595	1	O
dermatitis	28425595	1	O
who	28425595	1	O
developed	28425595	1	O
hand	28425595	1	O
eczema	28425595	1	O
had	28425595	1	O
experienced	28425595	1	O
symptoms	28425595	1	O
before	28425595	1	O
adulthood	28425595	1	O
.	28425595	1	O
CONCLUSION	28425595	1	O
:	28425595	1	O
In	28425595	1	O
the	28425595	1	O
general	28425595	1	O
population	28425595	1	O
,	28425595	1	O
self	28425595	1	O
-	28425595	1	O
reported	28425595	1	O
hand	28425595	1	O
eczema	28425595	1	O
and	28425595	1	O
atopic	28425595	1	O
dermatitis	28425595	1	O
,	28425595	1	O
particularly	28425595	1	O
in	28425595	1	O
individuals	28425595	1	O
with	28425595	1	O
a	28425595	1	O
genetically	28425595	1	O
impaired	28425595	1	O
skin	28425595	1	O
barrier	28425595	1	O
,	28425595	1	O
were	28425595	1	O
associated	28425595	1	O
with	28425595	1	O
disability	28425595	1	O
pension	28425595	1	O
,	28425595	1	O
suggesting	28425595	1	O
that	28425595	1	O
FLG	28425595	1	B-Gene
mutations	28425595	1	B-Var
carriers	28425595	1	B-Reg
with	28425595	1	I-Reg
a	28425595	1	O
history	28425595	1	O
of	28425595	1	O
atopic	28425595	1	B-Disease
dermatitis	28425595	1	I-Disease
and	28425595	1	O
hand	28425595	1	B-Disease
eczema	28425595	1	I-Disease
could	28425595	1	O
benefit	28425595	1	O
from	28425595	1	O
early	28425595	1	O
attention	28425595	1	O
with	28425595	1	O
respect	28425595	1	O
to	28425595	1	O
choice	28425595	1	O
of	28425595	1	O
occupation	28425595	1	O
.	28425595	1	O

Short	28464429	0	O
hairpin	28464429	0	O
RNA	28464429	0	O
is	28464429	0	O
more	28464429	0	O
effective	28464429	0	O
than	28464429	0	O
long	28464429	0	O
hairpin	28464429	0	O
RNA	28464429	0	O
in	28464429	0	O
eliciting	28464429	0	O
pointed	28464429	0	O
loss	28464429	0	O
-	28464429	0	O
of	28464429	0	O
-	28464429	0	O
function	28464429	0	O
phenotypes	28464429	0	O
in	28464429	0	O
Drosophila	28464429	0	O
.	28464429	0	O
Pointed	28464429	0	O
(	28464429	0	O
Pnt	28464429	0	O
)	28464429	0	O
is	28464429	0	O
a	28464429	0	O
transcriptional	28464429	0	O
activator	28464429	0	O
that	28464429	0	O
functions	28464429	0	O
downstream	28464429	0	O
of	28464429	0	O
the	28464429	0	O
highly	28464429	0	O
conserved	28464429	0	O
Receptor	28464429	0	O
Tyrosine	28464429	0	O
Kinase	28464429	0	O
(	28464429	0	O
RTK	28464429	0	O
)	28464429	0	O
signaling	28464429	0	O
pathway	28464429	0	O
.	28464429	0	O
Pnt	28464429	0	O
is	28464429	0	O
an	28464429	0	O
ETS	28464429	0	O
family	28464429	0	O
transcription	28464429	0	O
factor	28464429	0	O
and	28464429	0	O
encodes	28464429	0	O
for	28464429	0	O
two	28464429	0	O
proteins	28464429	0	O
,	28464429	0	O
PntP1	28464429	0	O
and	28464429	0	O
PntP2	28464429	0	O
.	28464429	0	O
However	28464429	0	O
,	28464429	0	O
while	28464429	0	O
PntP1	28464429	0	O
is	28464429	0	O
constitutively	28464429	0	O
active	28464429	0	O
,	28464429	0	O
PntP2	28464429	0	O
is	28464429	0	O
only	28464429	0	O
active	28464429	0	O
after	28464429	0	O
being	28464429	0	O
phosphorylated	28464429	0	O
by	28464429	0	O
MAPK	28464429	0	O
in	28464429	0	O
the	28464429	0	O
RTK	28464429	0	O
pathway	28464429	0	O
.	28464429	0	O
As	28464429	0	O
mutations	28464429	0	B-Var
in	28464429	0	O
pnt	28464429	0	B-Gene
perturb	28464429	0	B-Reg
the	28464429	0	O
development	28464429	0	O
of	28464429	0	O
several	28464429	0	O
tissues	28464429	0	O
,	28464429	0	O
we	28464429	0	O
wanted	28464429	0	O
to	28464429	0	O
examine	28464429	0	O
the	28464429	0	O
effect	28464429	0	O
and	28464429	0	O
efficacy	28464429	0	O
of	28464429	0	O
using	28464429	0	O
RNAi	28464429	0	O
to	28464429	0	O
target	28464429	0	O
Pnt	28464429	0	O
.	28464429	0	O
We	28464429	0	O
have	28464429	0	O
expressed	28464429	0	O
pnt	28464429	0	O
RNAi	28464429	0	O
in	28464429	0	O
the	28464429	0	O
eyes	28464429	0	O
,	28464429	0	O
oocyte	28464429	0	O
,	28464429	0	O
and	28464429	0	O
heart	28464429	0	O
cells	28464429	0	O
using	28464429	0	O
three	28464429	0	O
different	28464429	0	O
RNAi	28464429	0	O
lines	28464429	0	O
:	28464429	0	O
Valium20	28464429	0	O
,	28464429	0	O
Valium10	28464429	0	O
,	28464429	0	O
and	28464429	0	O
VDRC	28464429	0	O
.	28464429	0	O
Valium20	28464429	0	O
is	28464429	0	O
distinct	28464429	0	O
since	28464429	0	O
it	28464429	0	O
generates	28464429	0	O
a	28464429	0	O
short	28464429	0	O
hairpin	28464429	0	O
RNA	28464429	0	O
(	28464429	0	O
shRNA	28464429	0	O
)	28464429	0	O
,	28464429	0	O
while	28464429	0	O
Valium10	28464429	0	O
and	28464429	0	O
VDRC	28464429	0	O
produce	28464429	0	O
long	28464429	0	O
hairpin	28464429	0	O
dsRNA	28464429	0	O
.	28464429	0	O
We	28464429	0	O
found	28464429	0	O
that	28464429	0	O
for	28464429	0	O
each	28464429	0	O
tissue	28464429	0	O
examined	28464429	0	O
Valium20	28464429	0	O
exhibited	28464429	0	O
the	28464429	0	O
strongest	28464429	0	O
phenotype	28464429	0	O
while	28464429	0	O
the	28464429	0	O
Valium10	28464429	0	O
and	28464429	0	O
VDRC	28464429	0	O
lines	28464429	0	O
produced	28464429	0	O
varying	28464429	0	O
levels	28464429	0	O
of	28464429	0	O
severity	28464429	0	O
and	28464429	0	O
that	28464429	0	O
the	28464429	0	O
long	28464429	0	O
hairpin	28464429	0	O
RNA	28464429	0	O
produced	28464429	0	O
by	28464429	0	O
the	28464429	0	O
Valium10	28464429	0	O
and	28464429	0	O
VDRC	28464429	0	O
lines	28464429	0	O
are	28464429	0	O
unable	28464429	0	O
to	28464429	0	O
effectively	28464429	0	O
knockdown	28464429	0	O
pnt	28464429	0	O
in	28464429	0	O
embryonic	28464429	0	O
tissues	28464429	0	O
.	28464429	0	O

New	28472301	2	O
gain	28472301	2	B-PosReg
-	28472301	2	I-PosReg
of	28472301	2	I-PosReg
-	28472301	2	I-PosReg
function	28472301	2	I-PosReg
mutation	28472301	2	B-Var
shows	28472301	2	O
CACNA1D	28472301	2	B-Gene
as	28472301	2	O
recurrently	28472301	2	O
mutated	28472301	2	O
gene	28472301	2	O
in	28472301	2	O
autism	28472301	2	B-Disease
spectrum	28472301	2	I-Disease
disorders	28472301	2	I-Disease
and	28472301	2	O
epilepsy	28472301	2	B-Disease
.	28472301	2	O
CACNA1D	28472301	2	O
encodes	28472301	2	O
the	28472301	2	O
pore	28472301	2	O
-	28472301	2	O
forming	28472301	2	O
α1	28472301	2	O
-	28472301	2	O
subunit	28472301	2	O
of	28472301	2	O
Cav1.3	28472301	2	O
,	28472301	2	O
an	28472301	2	O
L	28472301	2	O
-	28472301	2	O
type	28472301	2	O
voltage	28472301	2	O
-	28472301	2	O
gated	28472301	2	O
Ca2	28472301	2	O
-	28472301	2	O
channel	28472301	2	O
.	28472301	2	O
Despite	28472301	2	O
the	28472301	2	O
recent	28472301	2	O
discovery	28472301	2	O
of	28472301	2	O
two	28472301	2	O
de	28472301	2	O
novo	28472301	2	O
missense	28472301	2	O
gain	28472301	2	O
-	28472301	2	O
of	28472301	2	O
-	28472301	2	O
function	28472301	2	O
mutations	28472301	2	O
in	28472301	2	O
Cav1.3	28472301	2	O
in	28472301	2	O
two	28472301	2	O
individuals	28472301	2	O
with	28472301	2	O
autism	28472301	2	O
spectrum	28472301	2	O
disorder	28472301	2	O
(	28472301	2	O
ASD	28472301	2	O
)	28472301	2	O
and	28472301	2	O
intellectual	28472301	2	O
disability	28472301	2	O
CACNA1D	28472301	2	O
has	28472301	2	O
not	28472301	2	O
been	28472301	2	O
considered	28472301	2	O
a	28472301	2	O
prominent	28472301	2	O
ASD	28472301	2	O
-	28472301	2	O
risk	28472301	2	O
gene	28472301	2	O
in	28472301	2	O
large	28472301	2	O
scale	28472301	2	O
genetic	28472301	2	O
analyses	28472301	2	O
,	28472301	2	O
since	28472301	2	O
such	28472301	2	O
studies	28472301	2	O
primarly	28472301	2	O
focus	28472301	2	O
on	28472301	2	O
likely	28472301	2	O
-	28472301	2	O
disruptive	28472301	2	O
genetic	28472301	2	O
variants	28472301	2	O
.	28472301	2	O
Here	28472301	2	O
we	28472301	2	O
report	28472301	2	O
the	28472301	2	O
discovery	28472301	2	O
and	28472301	2	O
characterization	28472301	2	O
of	28472301	2	O
a	28472301	2	O
third	28472301	2	O
de	28472301	2	O
novo	28472301	2	O
missense	28472301	2	O
mutation	28472301	2	O
in	28472301	2	O
CACNA1D	28472301	2	O
(	28472301	2	O
V401L	28472301	2	O
)	28472301	2	O
in	28472301	2	O
a	28472301	2	O
patient	28472301	2	O
with	28472301	2	O
ASD	28472301	2	O
and	28472301	2	O
epilepsy	28472301	2	O
.	28472301	2	O
For	28472301	2	O
the	28472301	2	O
functional	28472301	2	O
characterization	28472301	2	O
we	28472301	2	O
introduced	28472301	2	O
mutation	28472301	2	O
V401L	28472301	2	O
into	28472301	2	O
two	28472301	2	O
major	28472301	2	O
C	28472301	2	O
-	28472301	2	O
terminal	28472301	2	O
long	28472301	2	O
and	28472301	2	O
short	28472301	2	O
Cav1.3	28472301	2	O
splice	28472301	2	O
variants	28472301	2	O
,	28472301	2	O
expressed	28472301	2	O
wild	28472301	2	O
-	28472301	2	O
type	28472301	2	O
or	28472301	2	O
mutant	28472301	2	O
channel	28472301	2	O
complexes	28472301	2	O
in	28472301	2	O
tsA-201	28472301	2	O
cells	28472301	2	O
and	28472301	2	O
performed	28472301	2	O
whole	28472301	2	O
-	28472301	2	O
cell	28472301	2	O
patch	28472301	2	O
-	28472301	2	O
clamp	28472301	2	O
recordings	28472301	2	O
.	28472301	2	O
Mutation	28472301	2	O
V401L	28472301	2	B-Var
,	28472301	2	O
localized	28472301	2	O
within	28472301	2	O
the	28472301	2	O
channel	28472301	2	O
'	28472301	2	O
s	28472301	2	O
activation	28472301	2	O
gate	28472301	2	O
,	28472301	2	O
significantly	28472301	2	O
enhanced	28472301	2	B-PosReg
current	28472301	2	O
densities	28472301	2	O
,	28472301	2	O
shifted	28472301	2	O
voltage	28472301	2	O
dependence	28472301	2	O
of	28472301	2	O
activation	28472301	2	O
and	28472301	2	O
inactivation	28472301	2	O
to	28472301	2	O
more	28472301	2	O
negative	28472301	2	O
voltages	28472301	2	O
and	28472301	2	O
reduced	28472301	2	O
channel	28472301	2	O
inactivation	28472301	2	O
in	28472301	2	O
both	28472301	2	O
Cav1.3	28472301	2	O
splice	28472301	2	O
variants	28472301	2	O
.	28472301	2	O
Altogether	28472301	2	O
these	28472301	2	O
gating	28472301	2	O
changes	28472301	2	B-Var
are	28472301	2	O
expected	28472301	2	O
to	28472301	2	O
result	28472301	2	O
in	28472301	2	O
enhanced	28472301	2	B-PosReg
Ca2	28472301	2	O
-	28472301	2	O
influx	28472301	2	O
through	28472301	2	O
the	28472301	2	O
channel	28472301	2	O
,	28472301	2	O
thus	28472301	2	O
representing	28472301	2	O
a	28472301	2	O
strong	28472301	2	O
gain	28472301	2	O
-	28472301	2	O
of	28472301	2	O
-	28472301	2	O
function	28472301	2	O
phenotype	28472301	2	O
.	28472301	2	O
Additionally	28472301	2	O
,	28472301	2	O
we	28472301	2	O
also	28472301	2	O
found	28472301	2	O
that	28472301	2	O
mutant	28472301	2	O
channels	28472301	2	O
retained	28472301	2	O
full	28472301	2	O
sensitivity	28472301	2	O
towards	28472301	2	O
the	28472301	2	O
clinically	28472301	2	O
available	28472301	2	O
Ca2	28472301	2	O
-	28472301	2	O
channel	28472301	2	O
blocker	28472301	2	O
isradipine	28472301	2	O
.	28472301	2	O
Our	28472301	2	O
findings	28472301	2	O
strengthen	28472301	2	O
the	28472301	2	O
evidence	28472301	2	O
for	28472301	2	O
CACNA1D	28472301	2	O
as	28472301	2	O
a	28472301	2	O
novel	28472301	2	O
candidate	28472301	2	O
autism	28472301	2	O
risk	28472301	2	O
gene	28472301	2	O
and	28472301	2	O
encourage	28472301	2	O
experimental	28472301	2	O
therapy	28472301	2	O
with	28472301	2	O
available	28472301	2	O
channel	28472301	2	O
-	28472301	2	O
blockers	28472301	2	O
for	28472301	2	O
this	28472301	2	O
mutation	28472301	2	O
.	28472301	2	O
The	28472301	2	O
additional	28472301	2	O
presence	28472301	2	O
of	28472301	2	O
seizures	28472301	2	O
and	28472301	2	O
neurological	28472301	2	O
abnormalities	28472301	2	O
in	28472301	2	O
our	28472301	2	O
patient	28472301	2	O
define	28472301	2	O
a	28472301	2	O
novel	28472301	2	O
phenotype	28472301	2	O
partially	28472301	2	O
overlapping	28472301	2	O
with	28472301	2	O
symptoms	28472301	2	O
in	28472301	2	O
two	28472301	2	O
individuals	28472301	2	O
with	28472301	2	O
PASNA	28472301	2	O
(	28472301	2	O
congential	28472301	2	O
primary	28472301	2	O
aldosteronism	28472301	2	O
,	28472301	2	O
seizures	28472301	2	O
and	28472301	2	O
neurological	28472301	2	O
abnormalities	28472301	2	O
)	28472301	2	O
caused	28472301	2	O
by	28472301	2	O
similar	28472301	2	O
Cav1.3	28472301	2	O
gain	28472301	2	O
-	28472301	2	O
of	28472301	2	O
-	28472301	2	O
function	28472301	2	O
mutations	28472301	2	O
.	28472301	2	O

ATM	28477109	1	O
Gene	28477109	1	O
Mutation	28477109	1	O
Detection	28477109	1	O
Techniques	28477109	1	O
and	28477109	1	O
Functional	28477109	1	O
Analysis	28477109	1	O
.	28477109	1	O
Ataxia	28477109	1	B-Disease
Telangiectasia	28477109	1	I-Disease
(	28477109	1	O
A	28477109	1	O
-	28477109	1	O
T	28477109	1	O
)	28477109	1	O
is	28477109	1	O
caused	28477109	1	O
by	28477109	1	O
biallelic	28477109	1	O
inactivation	28477109	1	B-NegReg
of	28477109	1	O
the	28477109	1	O
Ataxia	28477109	1	O
Telangiectasia	28477109	1	O
Mutated	28477109	1	O
(	28477109	1	B-Gene
ATM	28477109	1	I-Gene
)	28477109	1	I-Gene
gene	28477109	1	O
,	28477109	1	O
due	28477109	1	O
to	28477109	1	O
nonsense	28477109	1	B-Var
or	28477109	1	I-Var
missense	28477109	1	I-Var
mutations	28477109	1	I-Var
,	28477109	1	O
small	28477109	1	O
insertions	28477109	1	O
/	28477109	1	O
deletions	28477109	1	O
(	28477109	1	B-Var
indels	28477109	1	I-Var
)	28477109	1	I-Var
,	28477109	1	O
splicing	28477109	1	B-Var
alterations	28477109	1	I-Var
,	28477109	1	O
and	28477109	1	O
large	28477109	1	B-Var
genomic	28477109	1	I-Var
rearrangements	28477109	1	I-Var
.	28477109	1	O
After	28477109	1	O
establishing	28477109	1	O
A	28477109	1	O
-	28477109	1	O
T	28477109	1	O
clinical	28477109	1	O
diagnosis	28477109	1	O
,	28477109	1	O
a	28477109	1	O
molecular	28477109	1	O
confirmation	28477109	1	O
is	28477109	1	O
needed	28477109	1	O
,	28477109	1	O
based	28477109	1	O
on	28477109	1	O
the	28477109	1	O
detection	28477109	1	O
of	28477109	1	O
one	28477109	1	O
of	28477109	1	O
these	28477109	1	O
loss	28477109	1	O
-	28477109	1	O
of	28477109	1	O
-	28477109	1	O
function	28477109	1	O
mutations	28477109	1	O
in	28477109	1	O
at	28477109	1	O
least	28477109	1	O
one	28477109	1	O
allele	28477109	1	O
.	28477109	1	O
In	28477109	1	O
most	28477109	1	O
cases	28477109	1	O
,	28477109	1	O
the	28477109	1	O
pathogenicity	28477109	1	O
of	28477109	1	O
the	28477109	1	O
detected	28477109	1	O
mutations	28477109	1	O
is	28477109	1	O
sufficient	28477109	1	O
to	28477109	1	O
make	28477109	1	O
a	28477109	1	O
definitive	28477109	1	O
diagnosis	28477109	1	O
.	28477109	1	O
More	28477109	1	O
rarely	28477109	1	O
,	28477109	1	O
mutations	28477109	1	O
of	28477109	1	O
unknown	28477109	1	O
consequences	28477109	1	O
are	28477109	1	O
identified	28477109	1	O
and	28477109	1	O
direct	28477109	1	O
biological	28477109	1	O
analyses	28477109	1	O
are	28477109	1	O
required	28477109	1	O
to	28477109	1	O
establish	28477109	1	O
their	28477109	1	O
pathogenic	28477109	1	O
characters	28477109	1	O
.	28477109	1	O
In	28477109	1	O
such	28477109	1	O
cases	28477109	1	O
,	28477109	1	O
complementary	28477109	1	O
analyses	28477109	1	O
of	28477109	1	O
ATM	28477109	1	O
expression	28477109	1	O
,	28477109	1	O
localization	28477109	1	O
,	28477109	1	O
and	28477109	1	O
activity	28477109	1	O
allow	28477109	1	O
fine	28477109	1	O
characterization	28477109	1	O
of	28477109	1	O
these	28477109	1	O
mutations	28477109	1	O
and	28477109	1	O
facilitate	28477109	1	O
A	28477109	1	O
-	28477109	1	O
T	28477109	1	O
diagnosis	28477109	1	O
.	28477109	1	O
Here	28477109	1	O
,	28477109	1	O
we	28477109	1	O
present	28477109	1	O
genetic	28477109	1	O
and	28477109	1	O
biochemical	28477109	1	O
protocols	28477109	1	O
currently	28477109	1	O
used	28477109	1	O
in	28477109	1	O
the	28477109	1	O
laboratory	28477109	1	O
that	28477109	1	O
have	28477109	1	O
proven	28477109	1	O
to	28477109	1	O
be	28477109	1	O
highly	28477109	1	O
accurate	28477109	1	O
,	28477109	1	O
reproducible	28477109	1	O
,	28477109	1	O
and	28477109	1	O
quantitative	28477109	1	O
.	28477109	1	O
We	28477109	1	O
also	28477109	1	O
provide	28477109	1	O
additional	28477109	1	O
discussion	28477109	1	O
on	28477109	1	O
the	28477109	1	O
critical	28477109	1	O
points	28477109	1	O
of	28477109	1	O
the	28477109	1	O
techniques	28477109	1	O
presented	28477109	1	O
here	28477109	1	O
.	28477109	1	O

Proteomic	28479159	2	O
analysis	28479159	2	O
of	28479159	2	O
filaggrin	28479159	2	O
deficiency	28479159	2	O
identifies	28479159	2	O
molecular	28479159	2	O
signatures	28479159	2	O
characteristic	28479159	2	O
of	28479159	2	O
atopic	28479159	2	O
eczema	28479159	2	O
.	28479159	2	O
BACKGROUND	28479159	2	O
:	28479159	2	O
Atopic	28479159	2	B-Disease
eczema	28479159	2	I-Disease
(	28479159	2	O
AE	28479159	2	O
)	28479159	2	O
is	28479159	2	O
characterized	28479159	2	O
by	28479159	2	O
skin	28479159	2	O
barrier	28479159	2	O
and	28479159	2	O
immune	28479159	2	O
dysfunction	28479159	2	O
.	28479159	2	O
Null	28479159	2	B-Var
mutations	28479159	2	I-Var
in	28479159	2	O
filaggrin	28479159	2	O
(	28479159	2	B-Gene
FLG	28479159	2	I-Gene
)	28479159	2	I-Gene
,	28479159	2	O
a	28479159	2	O
key	28479159	2	O
epidermal	28479159	2	O
barrier	28479159	2	O
protein	28479159	2	O
,	28479159	2	O
strongly	28479159	2	O
predispose	28479159	2	B-Reg
to	28479159	2	O
AE	28479159	2	B-Disease
;	28479159	2	I-Disease
however	28479159	2	O
,	28479159	2	O
the	28479159	2	O
precise	28479159	2	O
role	28479159	2	O
of	28479159	2	O
FLG	28479159	2	O
deficiency	28479159	2	O
in	28479159	2	O
AE	28479159	2	O
pathogenesis	28479159	2	O
remains	28479159	2	O
incompletely	28479159	2	O
understood	28479159	2	O
.	28479159	2	O
OBJECTIVES	28479159	2	O
:	28479159	2	O
We	28479159	2	O
sought	28479159	2	O
to	28479159	2	O
identify	28479159	2	O
global	28479159	2	O
proteomic	28479159	2	O
changes	28479159	2	O
downstream	28479159	2	O
of	28479159	2	O
FLG	28479159	2	O
deficiency	28479159	2	O
in	28479159	2	O
human	28479159	2	O
epidermal	28479159	2	O
living	28479159	2	O
skin	28479159	2	O
-	28479159	2	O
equivalent	28479159	2	O
(	28479159	2	O
LSE	28479159	2	O
)	28479159	2	O
models	28479159	2	O
and	28479159	2	O
validate	28479159	2	O
findings	28479159	2	O
in	28479159	2	O
skin	28479159	2	O
of	28479159	2	O
patients	28479159	2	O
with	28479159	2	O
AE	28479159	2	O
.	28479159	2	O
METHODS	28479159	2	O
:	28479159	2	O
Differentially	28479159	2	O
expressed	28479159	2	O
proteins	28479159	2	O
from	28479159	2	O
paired	28479159	2	O
control	28479159	2	O
(	28479159	2	O
nontargeting	28479159	2	O
control	28479159	2	O
short	28479159	2	O
hairpin	28479159	2	O
RNA	28479159	2	O
[	28479159	2	O
shNT	28479159	2	O
]	28479159	2	O
)	28479159	2	O
and	28479159	2	O
FLG	28479159	2	O
knockdown	28479159	2	O
(	28479159	2	O
FLG	28479159	2	O
knockdown	28479159	2	O
short	28479159	2	O
hairpin	28479159	2	O
RNA	28479159	2	O
[	28479159	2	O
shFLG	28479159	2	O
]	28479159	2	O
)	28479159	2	O
LSEs	28479159	2	O
were	28479159	2	O
identified	28479159	2	O
by	28479159	2	O
means	28479159	2	O
of	28479159	2	O
proteomic	28479159	2	O
analysis	28479159	2	O
(	28479159	2	O
liquid	28479159	2	O
chromatography	28479159	2	O
-	28479159	2	O
mass	28479159	2	O
spectrometry	28479159	2	O
)	28479159	2	O
and	28479159	2	O
Ingenuity	28479159	2	O
Pathway	28479159	2	O
Analysis	28479159	2	O
.	28479159	2	O
Expression	28479159	2	O
of	28479159	2	O
key	28479159	2	O
targets	28479159	2	O
was	28479159	2	O
validated	28479159	2	O
in	28479159	2	O
independent	28479159	2	O
LSE	28479159	2	O
samples	28479159	2	O
(	28479159	2	O
quantitative	28479159	2	O
RT	28479159	2	O
-	28479159	2	O
PCR	28479159	2	O
and	28479159	2	O
Western	28479159	2	O
blotting	28479159	2	O
)	28479159	2	O
and	28479159	2	O
in	28479159	2	O
normal	28479159	2	O
and	28479159	2	O
AE	28479159	2	O
skin	28479159	2	O
biopsy	28479159	2	O
specimens	28479159	2	O
(	28479159	2	O
immunofluorescence	28479159	2	O
)	28479159	2	O
.	28479159	2	O
RESULTS	28479159	2	O
:	28479159	2	O
Proteomic	28479159	2	O
analysis	28479159	2	O
identified	28479159	2	O
17	28479159	2	O
(	28479159	2	O
P	28479159	2	O
.05	28479159	2	O
)	28479159	2	O
differentially	28479159	2	O
expressed	28479159	2	O
proteins	28479159	2	O
after	28479159	2	O
FLG	28479159	2	O
knockdown	28479159	2	O
,	28479159	2	O
including	28479159	2	O
kallikrein-7	28479159	2	O
(	28479159	2	O
KLK7	28479159	2	O
;	28479159	2	O
2.2	28479159	2	O
-	28479159	2	O
fold	28479159	2	O
)	28479159	2	O
,	28479159	2	O
cyclophilin	28479159	2	O
A	28479159	2	O
(	28479159	2	O
PPIA	28479159	2	O
;	28479159	2	O
0.9	28479159	2	O
-	28479159	2	O
fold	28479159	2	O
)	28479159	2	O
,	28479159	2	O
and	28479159	2	O
cofilin-1	28479159	2	O
(	28479159	2	O
CFL1	28479159	2	O
,	28479159	2	O
1.3	28479159	2	O
-	28479159	2	O
fold	28479159	2	O
)	28479159	2	O
.	28479159	2	O
Differential	28479159	2	O
protein	28479159	2	O
expression	28479159	2	O
was	28479159	2	O
confirmed	28479159	2	O
in	28479159	2	O
shNT	28479159	2	O
/	28479159	2	O
shFLG	28479159	2	O
LSEs	28479159	2	O
;	28479159	2	O
however	28479159	2	O
,	28479159	2	O
only	28479159	2	O
KLK7	28479159	2	O
was	28479159	2	O
transcriptionally	28479159	2	O
dysregulated	28479159	2	O
.	28479159	2	O
Molecular	28479159	2	O
pathways	28479159	2	O
overrepresented	28479159	2	B-PosReg
after	28479159	2	O
FLG	28479159	2	B-Gene
knockdown	28479159	2	B-Var
included	28479159	2	O
inflammation	28479159	2	O
,	28479159	2	O
protease	28479159	2	O
activity	28479159	2	O
,	28479159	2	O
cell	28479159	2	O
structure	28479159	2	O
,	28479159	2	O
and	28479159	2	O
stress	28479159	2	O
.	28479159	2	O
Furthermore	28479159	2	O
,	28479159	2	O
KLK7	28479159	2	O
(	28479159	2	O
1.8	28479159	2	O
-	28479159	2	O
fold	28479159	2	O
)	28479159	2	O
and	28479159	2	O
PPIA	28479159	2	O
(	28479159	2	O
0.65	28479159	2	O
-	28479159	2	O
fold	28479159	2	O
)	28479159	2	O
proteins	28479159	2	O
were	28479159	2	O
differentially	28479159	2	O
expressed	28479159	2	O
in	28479159	2	O
lesional	28479159	2	O
biopsy	28479159	2	O
specimens	28479159	2	O
from	28479159	2	O
patients	28479159	2	O
with	28479159	2	O
AE	28479159	2	O
relative	28479159	2	O
to	28479159	2	O
normal	28479159	2	O
skin	28479159	2	O
.	28479159	2	O
CONCLUSIONS	28479159	2	O
:	28479159	2	O
For	28479159	2	O
the	28479159	2	O
first	28479159	2	O
time	28479159	2	O
,	28479159	2	O
we	28479159	2	O
show	28479159	2	O
that	28479159	2	O
loss	28479159	2	B-Var
of	28479159	2	O
FLG	28479159	2	B-Gene
in	28479159	2	O
the	28479159	2	O
absence	28479159	2	O
of	28479159	2	O
inflammation	28479159	2	O
is	28479159	2	O
sufficient	28479159	2	O
to	28479159	2	O
alter	28479159	2	B-Reg
the	28479159	2	O
expression	28479159	2	O
level	28479159	2	O
of	28479159	2	O
proteins	28479159	2	O
relevant	28479159	2	O
to	28479159	2	O
the	28479159	2	O
pathogenesis	28479159	2	O
of	28479159	2	O
AE	28479159	2	O
.	28479159	2	O
These	28479159	2	O
include	28479159	2	O
proteins	28479159	2	O
regulating	28479159	2	O
inflammatory	28479159	2	O
,	28479159	2	O
proteolytic	28479159	2	O
,	28479159	2	O
and	28479159	2	O
cytoskeletal	28479159	2	O
functions	28479159	2	O
.	28479159	2	O
We	28479159	2	O
identify	28479159	2	O
PPIA	28479159	2	O
as	28479159	2	O
a	28479159	2	O
novel	28479159	2	O
protein	28479159	2	O
with	28479159	2	O
levels	28479159	2	O
that	28479159	2	O
are	28479159	2	O
decreased	28479159	2	O
in	28479159	2	O
clinically	28479159	2	O
active	28479159	2	O
AE	28479159	2	O
skin	28479159	2	O
and	28479159	2	O
show	28479159	2	O
that	28479159	2	O
the	28479159	2	O
characteristic	28479159	2	O
upregulation	28479159	2	O
of	28479159	2	O
KLK7	28479159	2	O
expression	28479159	2	O
in	28479159	2	O
patients	28479159	2	O
with	28479159	2	O
AE	28479159	2	O
occurs	28479159	2	O
downstream	28479159	2	O
of	28479159	2	O
FLG	28479159	2	O
loss	28479159	2	O
.	28479159	2	O
Importantly	28479159	2	O
,	28479159	2	O
we	28479159	2	O
highlight	28479159	2	O
disconnect	28479159	2	O
between	28479159	2	O
the	28479159	2	O
epidermal	28479159	2	O
proteome	28479159	2	O
and	28479159	2	O
transcriptome	28479159	2	O
,	28479159	2	O
emphasizing	28479159	2	O
the	28479159	2	O
utility	28479159	2	O
of	28479159	2	O
global	28479159	2	O
proteomic	28479159	2	O
studies	28479159	2	O
.	28479159	2	O

TREM2	28483841	1	O
deficiency	28483841	1	O
impairs	28483841	1	O
chemotaxis	28483841	1	O
and	28483841	1	O
microglial	28483841	1	O
responses	28483841	1	O
to	28483841	1	O
neuronal	28483841	1	O
injury	28483841	1	O
.	28483841	1	O
Sequence	28483841	1	O
variations	28483841	1	B-Var
in	28483841	1	O
the	28483841	1	O
triggering	28483841	1	O
receptor	28483841	1	O
expressed	28483841	1	O
on	28483841	1	O
myeloid	28483841	1	O
cells	28483841	1	O
2	28483841	1	O
(	28483841	1	B-Gene
TREM2	28483841	1	I-Gene
)	28483841	1	I-Gene
have	28483841	1	O
been	28483841	1	O
linked	28483841	1	B-Reg
to	28483841	1	I-Reg
an	28483841	1	O
increased	28483841	1	O
risk	28483841	1	O
for	28483841	1	O
neurodegenerative	28483841	1	O
disorders	28483841	1	O
such	28483841	1	O
as	28483841	1	O
Alzheimer	28483841	1	B-Disease
'	28483841	1	I-Disease
s	28483841	1	I-Disease
disease	28483841	1	I-Disease
and	28483841	1	O
frontotemporal	28483841	1	B-Disease
lobar	28483841	1	I-Disease
degeneration	28483841	1	I-Disease
.	28483841	1	O
In	28483841	1	O
the	28483841	1	O
brain	28483841	1	O
,	28483841	1	O
TREM2	28483841	1	O
is	28483841	1	O
predominantly	28483841	1	O
expressed	28483841	1	O
in	28483841	1	O
microglia	28483841	1	O
.	28483841	1	O
Several	28483841	1	O
disease	28483841	1	O
-	28483841	1	O
associated	28483841	1	O
TREM2	28483841	1	B-Gene
variants	28483841	1	B-Var
result	28483841	1	O
in	28483841	1	O
a	28483841	1	O
loss	28483841	1	O
of	28483841	1	O
function	28483841	1	O
by	28483841	1	O
reducing	28483841	1	B-NegReg
microglial	28483841	1	O
phagocytosis	28483841	1	O
,	28483841	1	O
impairing	28483841	1	B-NegReg
lipid	28483841	1	O
sensing	28483841	1	O
,	28483841	1	O
preventing	28483841	1	B-NegReg
binding	28483841	1	O
of	28483841	1	O
lipoproteins	28483841	1	O
and	28483841	1	O
affecting	28483841	1	B-Reg
shielding	28483841	1	O
of	28483841	1	O
amyloid	28483841	1	O
plaques	28483841	1	O
.	28483841	1	O
We	28483841	1	O
here	28483841	1	O
investigate	28483841	1	O
the	28483841	1	O
consequences	28483841	1	O
of	28483841	1	O
TREM2	28483841	1	O
loss	28483841	1	O
of	28483841	1	O
function	28483841	1	O
on	28483841	1	O
the	28483841	1	O
microglia	28483841	1	O
transcriptome	28483841	1	O
.	28483841	1	O
Among	28483841	1	O
the	28483841	1	O
differentially	28483841	1	O
expressed	28483841	1	O
messenger	28483841	1	O
RNAs	28483841	1	O
in	28483841	1	O
wild	28483841	1	O
-	28483841	1	O
type	28483841	1	O
and	28483841	1	O
Trem2	28483841	1	O
(	28483841	1	O
-	28483841	1	O
/	28483841	1	O
-	28483841	1	O
)	28483841	1	O
microglia	28483841	1	O
,	28483841	1	O
gene	28483841	1	O
clusters	28483841	1	O
are	28483841	1	O
identified	28483841	1	O
which	28483841	1	O
represent	28483841	1	O
gene	28483841	1	O
functions	28483841	1	O
in	28483841	1	O
chemotaxis	28483841	1	O
,	28483841	1	O
migration	28483841	1	O
and	28483841	1	O
mobility	28483841	1	O
.	28483841	1	O
Functional	28483841	1	O
analyses	28483841	1	O
confirm	28483841	1	O
that	28483841	1	O
loss	28483841	1	B-Var
of	28483841	1	O
TREM2	28483841	1	B-Gene
impairs	28483841	1	B-NegReg
appropriate	28483841	1	O
microglial	28483841	1	O
responses	28483841	1	O
to	28483841	1	O
injury	28483841	1	O
and	28483841	1	O
signals	28483841	1	O
that	28483841	1	O
normally	28483841	1	O
evoke	28483841	1	O
chemotaxis	28483841	1	O
on	28483841	1	O
multiple	28483841	1	O
levels	28483841	1	O
.	28483841	1	O
In	28483841	1	O
an	28483841	1	O
ex	28483841	1	O
vivo	28483841	1	O
organotypic	28483841	1	O
brain	28483841	1	O
slice	28483841	1	O
assay	28483841	1	O
,	28483841	1	O
absence	28483841	1	O
of	28483841	1	O
TREM2	28483841	1	O
reduces	28483841	1	O
the	28483841	1	O
distance	28483841	1	O
migrated	28483841	1	O
by	28483841	1	O
microglia	28483841	1	O
.	28483841	1	O
Moreover	28483841	1	O
,	28483841	1	O
migration	28483841	1	O
towards	28483841	1	O
defined	28483841	1	O
chemo	28483841	1	O
-	28483841	1	O
attractants	28483841	1	O
is	28483841	1	O
reduced	28483841	1	O
upon	28483841	1	O
ablation	28483841	1	O
of	28483841	1	O
TREM2	28483841	1	O
and	28483841	1	O
can	28483841	1	O
be	28483841	1	O
rescued	28483841	1	O
by	28483841	1	O
TREM2	28483841	1	O
re	28483841	1	O
-	28483841	1	O
expression	28483841	1	O
.	28483841	1	O
In	28483841	1	O
vivo	28483841	1	O
,	28483841	1	O
microglia	28483841	1	O
lacking	28483841	1	O
TREM2	28483841	1	O
migrate	28483841	1	O
less	28483841	1	O
towards	28483841	1	O
injected	28483841	1	O
apoptotic	28483841	1	O
neurons	28483841	1	O
,	28483841	1	O
and	28483841	1	O
outgrowth	28483841	1	O
of	28483841	1	O
microglial	28483841	1	O
processes	28483841	1	O
towards	28483841	1	O
sites	28483841	1	O
of	28483841	1	O
laser	28483841	1	O
-	28483841	1	O
induced	28483841	1	O
focal	28483841	1	O
CNS	28483841	1	O
damage	28483841	1	O
in	28483841	1	O
the	28483841	1	O
somatosensory	28483841	1	O
cortex	28483841	1	O
is	28483841	1	O
slowed	28483841	1	O
.	28483841	1	O
The	28483841	1	O
apparent	28483841	1	O
lack	28483841	1	O
of	28483841	1	O
chemotactic	28483841	1	O
stimulation	28483841	1	O
upon	28483841	1	O
depletion	28483841	1	O
of	28483841	1	O
TREM2	28483841	1	O
is	28483841	1	O
consistent	28483841	1	O
with	28483841	1	O
a	28483841	1	O
stable	28483841	1	O
expression	28483841	1	O
profile	28483841	1	O
of	28483841	1	O
genes	28483841	1	O
characterizing	28483841	1	O
the	28483841	1	O
homoeostatic	28483841	1	O
signature	28483841	1	O
of	28483841	1	O
microglia	28483841	1	O
.	28483841	1	O

Novel	28488085	1	O
loss	28488085	1	B-NegReg
of	28488085	1	I-NegReg
function	28488085	1	I-NegReg
mutation	28488085	1	B-Var
in	28488085	1	O
KRIT1	28488085	1	B-Gene
/	28488085	1	I-Gene
CCM1	28488085	1	I-Gene
is	28488085	1	O
associated	28488085	1	B-Reg
with	28488085	1	I-Reg
distinctly	28488085	1	O
progressive	28488085	1	O
cerebral	28488085	1	B-Disease
and	28488085	1	I-Disease
spinal	28488085	1	I-Disease
cavernous	28488085	1	I-Disease
malformations	28488085	1	I-Disease
after	28488085	1	O
radiochemotherapy	28488085	1	O
for	28488085	1	O
intracranial	28488085	1	O
malignant	28488085	1	O
germ	28488085	1	O
cell	28488085	1	O
tumor	28488085	1	O
.	28488085	1	O
PURPOSE	28488085	1	O
:	28488085	1	O
Cerebrospinal	28488085	1	B-Disease
cavernous	28488085	1	I-Disease
malformations	28488085	1	I-Disease
(	28488085	1	O
CCMs	28488085	1	O
)	28488085	1	O
are	28488085	1	O
vascular	28488085	1	O
lesions	28488085	1	O
characterized	28488085	1	O
by	28488085	1	O
dilated	28488085	1	O
and	28488085	1	O
leaky	28488085	1	O
capillary	28488085	1	O
caverns	28488085	1	O
.	28488085	1	O
CCMs	28488085	1	O
can	28488085	1	O
cause	28488085	1	O
seizures	28488085	1	O
,	28488085	1	O
focal	28488085	1	O
neurological	28488085	1	O
deficits	28488085	1	O
or	28488085	1	O
acute	28488085	1	O
intracranial	28488085	1	O
hemorrhage	28488085	1	O
;	28488085	1	O
however	28488085	1	O
,	28488085	1	O
most	28488085	1	O
patients	28488085	1	O
are	28488085	1	O
asymptomatic	28488085	1	O
.	28488085	1	O
CCMs	28488085	1	O
occur	28488085	1	O
either	28488085	1	O
sporadically	28488085	1	O
or	28488085	1	O
as	28488085	1	O
a	28488085	1	O
familial	28488085	1	O
autosomal	28488085	1	O
-	28488085	1	O
dominant	28488085	1	O
disorder	28488085	1	O
.	28488085	1	O
We	28488085	1	O
present	28488085	1	O
a	28488085	1	O
clinical	28488085	1	O
and	28488085	1	O
molecular	28488085	1	O
study	28488085	1	O
of	28488085	1	O
a	28488085	1	O
patient	28488085	1	O
with	28488085	1	O
distinctive	28488085	1	O
cerebral	28488085	1	O
and	28488085	1	O
spinal	28488085	1	O
cavernous	28488085	1	O
malformations	28488085	1	O
following	28488085	1	O
radiochemotherapy	28488085	1	O
for	28488085	1	O
a	28488085	1	O
malignant	28488085	1	O
brain	28488085	1	O
tumor	28488085	1	O
.	28488085	1	O
METHODS	28488085	1	O
:	28488085	1	O
The	28488085	1	O
patient	28488085	1	O
had	28488085	1	O
multiple	28488085	1	O
magnet	28488085	1	O
resonance	28488085	1	O
imaging	28488085	1	O
(	28488085	1	O
MRI	28488085	1	O
)	28488085	1	O
examinations	28488085	1	O
of	28488085	1	O
his	28488085	1	O
brain	28488085	1	O
and	28488085	1	O
spine	28488085	1	O
following	28488085	1	O
radiochemotherapy	28488085	1	O
for	28488085	1	O
a	28488085	1	O
primary	28488085	1	O
intracranial	28488085	1	O
germ	28488085	1	O
cell	28488085	1	O
tumor	28488085	1	O
(	28488085	1	O
GCT	28488085	1	O
)	28488085	1	O
,	28488085	1	O
as	28488085	1	O
part	28488085	1	O
of	28488085	1	O
his	28488085	1	O
oncologic	28488085	1	O
follow	28488085	1	O
-	28488085	1	O
up	28488085	1	O
.	28488085	1	O
The	28488085	1	O
MRI	28488085	1	O
sequences	28488085	1	O
included	28488085	1	O
susceptibility	28488085	1	O
-	28488085	1	O
weighted	28488085	1	O
imaging	28488085	1	O
(	28488085	1	O
SWI	28488085	1	O
)	28488085	1	O
.	28488085	1	O
The	28488085	1	O
coding	28488085	1	O
exons	28488085	1	O
and	28488085	1	O
their	28488085	1	O
flanking	28488085	1	O
intronic	28488085	1	O
regions	28488085	1	O
of	28488085	1	O
KRIT1	28488085	1	O
/	28488085	1	O
CCM1	28488085	1	O
gene	28488085	1	O
were	28488085	1	O
analyzed	28488085	1	O
for	28488085	1	O
mutations	28488085	1	O
by	28488085	1	O
polymerase	28488085	1	O
chain	28488085	1	O
reaction	28488085	1	O
(	28488085	1	O
PCR	28488085	1	O
)	28488085	1	O
and	28488085	1	O
direct	28488085	1	O
sequencing	28488085	1	O
.	28488085	1	O
RESULTS	28488085	1	O
:	28488085	1	O
MRI	28488085	1	O
revealed	28488085	1	O
numerous	28488085	1	O
cerebral	28488085	1	O
and	28488085	1	O
spinal	28488085	1	O
microhemorrhages	28488085	1	O
and	28488085	1	O
pronounced	28488085	1	O
cavernous	28488085	1	O
malformations	28488085	1	O
that	28488085	1	O
progressed	28488085	1	O
with	28488085	1	O
subsequent	28488085	1	O
follow	28488085	1	O
-	28488085	1	O
up	28488085	1	O
imaging	28488085	1	O
.	28488085	1	O
Genetic	28488085	1	O
analysis	28488085	1	O
demonstrated	28488085	1	O
a	28488085	1	O
novel	28488085	1	O
heterozygous	28488085	1	O
KRIT1	28488085	1	B-Gene
/	28488085	1	I-Gene
CCM1	28488085	1	I-Gene
two	28488085	1	O
base	28488085	1	O
pair	28488085	1	O
deletion	28488085	1	O
(	28488085	1	B-Var
c.1535	28488085	1	I-Var
_1536delTG	28488085	1	I-Var
)	28488085	1	I-Var
in	28488085	1	O
exon	28488085	1	O
14	28488085	1	O
.	28488085	1	O
This	28488085	1	O
deletion	28488085	1	O
leads	28488085	1	B-Reg
to	28488085	1	I-Reg
a	28488085	1	O
frameshift	28488085	1	B-Var
with	28488085	1	O
a	28488085	1	O
premature	28488085	1	O
stop	28488085	1	O
codon	28488085	1	O
at	28488085	1	O
nucleotide	28488085	1	O
position	28488085	1	O
1553	28488085	1	O
and	28488085	1	O
a	28488085	1	O
highly	28488085	1	O
likely	28488085	1	O
loss	28488085	1	B-NegReg
of	28488085	1	I-NegReg
function	28488085	1	I-NegReg
of	28488085	1	O
the	28488085	1	O
KRIT1	28488085	1	O
protein	28488085	1	O
.	28488085	1	O
CONCLUSION	28488085	1	O
:	28488085	1	O
We	28488085	1	O
describe	28488085	1	O
a	28488085	1	O
patient	28488085	1	O
with	28488085	1	O
a	28488085	1	O
novel	28488085	1	O
heterozygous	28488085	1	O
germ	28488085	1	O
line	28488085	1	O
loss	28488085	1	B-NegReg
of	28488085	1	I-NegReg
function	28488085	1	I-NegReg
mutation	28488085	1	B-Var
in	28488085	1	O
KRIT1	28488085	1	B-Gene
,	28488085	1	O
which	28488085	1	O
is	28488085	1	O
associated	28488085	1	B-Reg
with	28488085	1	I-Reg
rapid	28488085	1	O
-	28488085	1	O
onset	28488085	1	O
and	28488085	1	O
highly	28488085	1	O
progressive	28488085	1	O
CCMs	28488085	1	B-Disease
after	28488085	1	O
radiochemotherapy	28488085	1	O
for	28488085	1	O
a	28488085	1	O
malignant	28488085	1	O
brain	28488085	1	O
tumor	28488085	1	O
.	28488085	1	O

Loss	28512217	1	B-Var
of	28512217	1	O
the	28512217	1	O
homologous	28512217	1	O
recombination	28512217	1	O
gene	28512217	1	O
rad51	28512217	1	B-Gene
leads	28512217	1	B-Reg
to	28512217	1	O
Fanconi	28512217	1	B-Disease
anemia	28512217	1	I-Disease
-	28512217	1	I-Disease
like	28512217	1	I-Disease
symptoms	28512217	1	I-Disease
in	28512217	1	O
zebrafish	28512217	1	O
.	28512217	1	O
RAD51	28512217	1	O
is	28512217	1	O
an	28512217	1	O
indispensable	28512217	1	O
homologous	28512217	1	O
recombination	28512217	1	O
protein	28512217	1	O
,	28512217	1	O
necessary	28512217	1	O
for	28512217	1	O
strand	28512217	1	O
invasion	28512217	1	O
and	28512217	1	O
crossing	28512217	1	O
over	28512217	1	O
.	28512217	1	O
It	28512217	1	O
has	28512217	1	O
recently	28512217	1	O
been	28512217	1	O
designated	28512217	1	O
as	28512217	1	O
a	28512217	1	O
Fanconi	28512217	1	B-Disease
anemia	28512217	1	I-Disease
(	28512217	1	O
FA	28512217	1	O
)	28512217	1	O
gene	28512217	1	O
,	28512217	1	O
following	28512217	1	O
the	28512217	1	O
discovery	28512217	1	O
of	28512217	1	O
two	28512217	1	O
patients	28512217	1	O
carrying	28512217	1	O
dominant	28512217	1	O
-	28512217	1	O
negative	28512217	1	O
mutations	28512217	1	O
.	28512217	1	O
FA	28512217	1	O
is	28512217	1	O
a	28512217	1	O
hereditary	28512217	1	O
DNA	28512217	1	O
-	28512217	1	O
repair	28512217	1	O
disorder	28512217	1	O
characterized	28512217	1	O
by	28512217	1	O
various	28512217	1	O
congenital	28512217	1	O
abnormalities	28512217	1	O
,	28512217	1	O
progressive	28512217	1	O
bone	28512217	1	O
marrow	28512217	1	O
failure	28512217	1	O
,	28512217	1	O
and	28512217	1	O
cancer	28512217	1	O
predisposition	28512217	1	O
.	28512217	1	O
In	28512217	1	O
this	28512217	1	O
report	28512217	1	O
,	28512217	1	O
we	28512217	1	O
describe	28512217	1	O
a	28512217	1	O
viable	28512217	1	O
vertebrate	28512217	1	O
model	28512217	1	O
of	28512217	1	O
RAD51	28512217	1	O
loss	28512217	1	O
.	28512217	1	O
Zebrafish	28512217	1	O
rad51	28512217	1	B-Gene
loss	28512217	1	B-NegReg
-	28512217	1	I-NegReg
of	28512217	1	I-NegReg
-	28512217	1	I-NegReg
function	28512217	1	I-NegReg
mutants	28512217	1	B-Var
developed	28512217	1	O
key	28512217	1	O
features	28512217	1	O
of	28512217	1	O
FA	28512217	1	B-Disease
,	28512217	1	O
including	28512217	1	O
hypocellular	28512217	1	O
kidney	28512217	1	O
marrow	28512217	1	O
,	28512217	1	O
sensitivity	28512217	1	O
to	28512217	1	O
cross	28512217	1	O
-	28512217	1	O
linking	28512217	1	O
agents	28512217	1	O
,	28512217	1	O
and	28512217	1	O
decreased	28512217	1	O
size	28512217	1	O
.	28512217	1	O
We	28512217	1	O
show	28512217	1	O
that	28512217	1	O
some	28512217	1	O
of	28512217	1	O
these	28512217	1	O
symptoms	28512217	1	O
stem	28512217	1	O
from	28512217	1	O
both	28512217	1	O
decreased	28512217	1	O
proliferation	28512217	1	O
and	28512217	1	O
increased	28512217	1	O
apoptosis	28512217	1	O
of	28512217	1	O
embryonic	28512217	1	O
hematopoietic	28512217	1	O
stem	28512217	1	O
and	28512217	1	O
progenitor	28512217	1	O
cells	28512217	1	O
.	28512217	1	O
Comutation	28512217	1	O
of	28512217	1	O
p53	28512217	1	O
was	28512217	1	O
able	28512217	1	O
to	28512217	1	O
rescue	28512217	1	O
the	28512217	1	O
hematopoietic	28512217	1	O
defects	28512217	1	O
seen	28512217	1	O
in	28512217	1	O
the	28512217	1	O
single	28512217	1	O
mutants	28512217	1	O
,	28512217	1	O
but	28512217	1	O
led	28512217	1	O
to	28512217	1	O
tumor	28512217	1	O
development	28512217	1	O
.	28512217	1	O
We	28512217	1	O
further	28512217	1	O
demonstrate	28512217	1	O
that	28512217	1	O
prolonged	28512217	1	O
inflammatory	28512217	1	O
stress	28512217	1	O
can	28512217	1	O
exacerbate	28512217	1	O
the	28512217	1	O
hematological	28512217	1	O
impairment	28512217	1	O
,	28512217	1	O
leading	28512217	1	O
to	28512217	1	O
an	28512217	1	O
additional	28512217	1	O
decrease	28512217	1	O
in	28512217	1	O
kidney	28512217	1	O
marrow	28512217	1	O
cell	28512217	1	O
numbers	28512217	1	O
.	28512217	1	O
These	28512217	1	O
findings	28512217	1	O
strengthen	28512217	1	O
the	28512217	1	O
assignment	28512217	1	O
of	28512217	1	O
RAD51	28512217	1	O
as	28512217	1	O
a	28512217	1	O
Fanconi	28512217	1	O
gene	28512217	1	O
and	28512217	1	O
provide	28512217	1	O
more	28512217	1	O
evidence	28512217	1	O
for	28512217	1	O
the	28512217	1	O
notion	28512217	1	O
that	28512217	1	O
aberrant	28512217	1	O
p53	28512217	1	O
signaling	28512217	1	O
during	28512217	1	O
embryogenesis	28512217	1	O
leads	28512217	1	O
to	28512217	1	O
the	28512217	1	O
hematological	28512217	1	O
defects	28512217	1	O
seen	28512217	1	O
later	28512217	1	O
in	28512217	1	O
life	28512217	1	O
in	28512217	1	O
FA	28512217	1	O
.	28512217	1	O
Further	28512217	1	O
research	28512217	1	O
on	28512217	1	O
this	28512217	1	O
zebrafish	28512217	1	O
FA	28512217	1	O
model	28512217	1	O
will	28512217	1	O
lead	28512217	1	O
to	28512217	1	O
a	28512217	1	O
deeper	28512217	1	O
understanding	28512217	1	O
of	28512217	1	O
the	28512217	1	O
molecular	28512217	1	O
basis	28512217	1	O
of	28512217	1	O
bone	28512217	1	O
marrow	28512217	1	O
failure	28512217	1	O
in	28512217	1	O
FA	28512217	1	O
and	28512217	1	O
the	28512217	1	O
cellular	28512217	1	O
role	28512217	1	O
of	28512217	1	O
RAD51	28512217	1	O
.	28512217	1	O

Exposure	28525834	0	O
to	28525834	0	O
phenols	28525834	0	O
,	28525834	0	O
parabens	28525834	0	O
and	28525834	0	O
UV	28525834	0	O
filters	28525834	0	O
:	28525834	0	O
Associations	28525834	0	O
with	28525834	0	O
loss	28525834	0	O
-	28525834	0	O
of	28525834	0	O
-	28525834	0	O
function	28525834	0	O
mutations	28525834	0	O
in	28525834	0	O
the	28525834	0	O
filaggrin	28525834	0	O
gene	28525834	0	O
in	28525834	0	O
men	28525834	0	O
from	28525834	0	O
the	28525834	0	O
general	28525834	0	O
population	28525834	0	O
.	28525834	0	O
BACKGROUND	28525834	0	O
:	28525834	0	O
Filaggrin	28525834	0	O
is	28525834	0	O
an	28525834	0	O
epidermal	28525834	0	O
protein	28525834	0	O
that	28525834	0	O
is	28525834	0	O
important	28525834	0	O
for	28525834	0	O
normal	28525834	0	O
skin	28525834	0	O
barrier	28525834	0	O
functions	28525834	0	O
.	28525834	0	O
Up	28525834	0	O
to	28525834	0	O
10%	28525834	0	O
of	28525834	0	O
Europeans	28525834	0	O
and	28525834	0	O
Asians	28525834	0	O
carry	28525834	0	O
filaggrin	28525834	0	O
gene	28525834	0	O
(	28525834	0	B-Gene
FLG	28525834	0	I-Gene
)	28525834	0	I-Gene
loss	28525834	0	B-NegReg
-	28525834	0	I-NegReg
of	28525834	0	I-NegReg
function	28525834	0	I-NegReg
mutations	28525834	0	B-Var
that	28525834	0	O
appear	28525834	0	O
to	28525834	0	O
facilitate	28525834	0	B-PosReg
trans	28525834	0	O
-	28525834	0	O
epidermal	28525834	0	O
penetration	28525834	0	O
of	28525834	0	O
certain	28525834	0	O
chemicals	28525834	0	O
.	28525834	0	O
We	28525834	0	O
previously	28525834	0	O
showed	28525834	0	O
that	28525834	0	O
mutation	28525834	0	O
carriers	28525834	0	O
have	28525834	0	O
higher	28525834	0	O
internal	28525834	0	O
exposure	28525834	0	O
to	28525834	0	O
certain	28525834	0	O
phthalates	28525834	0	O
,	28525834	0	O
compared	28525834	0	O
to	28525834	0	O
controls	28525834	0	O
,	28525834	0	O
and	28525834	0	O
hypothesized	28525834	0	O
that	28525834	0	O
they	28525834	0	O
could	28525834	0	O
have	28525834	0	O
increased	28525834	0	O
trans	28525834	0	O
-	28525834	0	O
epidermal	28525834	0	O
penetration	28525834	0	O
of	28525834	0	O
other	28525834	0	O
chemicals	28525834	0	O
.	28525834	0	O
OBJECTIVES	28525834	0	O
:	28525834	0	O
We	28525834	0	O
investigated	28525834	0	O
exposure	28525834	0	O
to	28525834	0	O
non	28525834	0	O
-	28525834	0	O
persistent	28525834	0	O
chemicals	28525834	0	O
in	28525834	0	O
young	28525834	0	O
Danish	28525834	0	O
men	28525834	0	O
with	28525834	0	O
and	28525834	0	O
without	28525834	0	O
FLG	28525834	0	O
mutations	28525834	0	O
.	28525834	0	O
METHODS	28525834	0	O
:	28525834	0	O
Concentrations	28525834	0	O
of	28525834	0	O
eight	28525834	0	O
simple	28525834	0	O
phenols	28525834	0	O
,	28525834	0	O
six	28525834	0	O
parabens	28525834	0	O
and	28525834	0	O
nine	28525834	0	O
UV	28525834	0	O
filters	28525834	0	O
were	28525834	0	O
analysed	28525834	0	O
in	28525834	0	O
urine	28525834	0	O
from	28525834	0	O
65	28525834	0	O
FLG	28525834	0	O
loss	28525834	0	O
-	28525834	0	O
of	28525834	0	O
-	28525834	0	O
function	28525834	0	O
mutation	28525834	0	O
carriers	28525834	0	O
and	28525834	0	O
130	28525834	0	O
non	28525834	0	O
-	28525834	0	O
carriers	28525834	0	O
(	28525834	0	O
controls	28525834	0	O
)	28525834	0	O
.	28525834	0	O
Regression	28525834	0	O
analyses	28525834	0	O
,	28525834	0	O
controlling	28525834	0	O
for	28525834	0	O
urinary	28525834	0	O
dilution	28525834	0	O
and	28525834	0	O
confounders	28525834	0	O
,	28525834	0	O
were	28525834	0	O
performed	28525834	0	O
to	28525834	0	O
estimate	28525834	0	O
associations	28525834	0	O
between	28525834	0	O
FLG	28525834	0	O
mutation	28525834	0	O
status	28525834	0	O
and	28525834	0	O
chemical	28525834	0	O
concentrations	28525834	0	O
in	28525834	0	O
urine	28525834	0	O
.	28525834	0	O
RESULTS	28525834	0	O
:	28525834	0	O
FLG	28525834	0	O
mutation	28525834	0	O
carriers	28525834	0	O
had	28525834	0	O
80%	28525834	0	O
(	28525834	0	O
13	28525834	0	O
-	28525834	0	O
180%	28525834	0	O
)	28525834	0	O
higher	28525834	0	O
urinary	28525834	0	O
concentrations	28525834	0	O
of	28525834	0	O
methyl	28525834	0	O
paraben	28525834	0	O
(	28525834	0	O
MeP	28525834	0	O
)	28525834	0	O
and	28525834	0	O
91%	28525834	0	O
(	28525834	0	O
13	28525834	0	O
-	28525834	0	O
219%	28525834	0	O
)	28525834	0	O
higher	28525834	0	O
concentrations	28525834	0	O
of	28525834	0	O
n	28525834	0	O
-	28525834	0	O
propyl	28525834	0	O
paraben	28525834	0	O
(	28525834	0	O
n	28525834	0	O
-	28525834	0	O
PrP	28525834	0	O
)	28525834	0	O
than	28525834	0	O
controls	28525834	0	O
.	28525834	0	O
For	28525834	0	O
13	28525834	0	O
compounds	28525834	0	O
,	28525834	0	O
levels	28525834	0	O
were	28525834	0	O
higher	28525834	0	O
in	28525834	0	O
FLG	28525834	0	O
mutation	28525834	0	O
carriers	28525834	0	O
,	28525834	0	O
although	28525834	0	O
differences	28525834	0	O
were	28525834	0	O
only	28525834	0	O
statistically	28525834	0	O
significant	28525834	0	O
for	28525834	0	O
MeP	28525834	0	O
and	28525834	0	O
n	28525834	0	O
-	28525834	0	O
PrP	28525834	0	O
.	28525834	0	O
Combined	28525834	0	O
statistical	28525834	0	O
analysis	28525834	0	O
of	28525834	0	O
concentrations	28525834	0	O
of	28525834	0	O
all	28525834	0	O
the	28525834	0	O
18	28525834	0	O
compounds	28525834	0	O
that	28525834	0	O
were	28525834	0	O
detectable	28525834	0	O
in	28525834	0	O
>	28525834	0	O
10%	28525834	0	O
of	28525834	0	O
subjects	28525834	0	O
,	28525834	0	O
suggested	28525834	0	O
that	28525834	0	O
concentrations	28525834	0	O
were	28525834	0	O
generally	28525834	0	O
higher	28525834	0	O
in	28525834	0	O
mutation	28525834	0	O
carriers	28525834	0	O
(	28525834	0	O
p	28525834	0	O
=	28525834	0	O
0.03	28525834	0	O
)	28525834	0	O
.	28525834	0	O
CONCLUSION	28525834	0	O
:	28525834	0	O
FLG	28525834	0	O
loss	28525834	0	O
-	28525834	0	O
of	28525834	0	O
-	28525834	0	O
function	28525834	0	O
mutation	28525834	0	O
carriers	28525834	0	O
have	28525834	0	O
a	28525834	0	O
higher	28525834	0	O
internal	28525834	0	O
exposure	28525834	0	O
to	28525834	0	O
some	28525834	0	O
non	28525834	0	O
-	28525834	0	O
persistent	28525834	0	O
chemicals	28525834	0	O
,	28525834	0	O
independently	28525834	0	O
of	28525834	0	O
atopic	28525834	0	O
dermatitis	28525834	0	O
.	28525834	0	O
This	28525834	0	O
may	28525834	0	O
be	28525834	0	O
due	28525834	0	O
to	28525834	0	O
increased	28525834	0	O
trans	28525834	0	O
-	28525834	0	O
epidermal	28525834	0	O
absorption	28525834	0	O
and	28525834	0	O
/	28525834	0	O
or	28525834	0	O
higher	28525834	0	O
exposure	28525834	0	O
,	28525834	0	O
and	28525834	0	O
mutation	28525834	0	O
carriers	28525834	0	O
may	28525834	0	O
constitute	28525834	0	O
a	28525834	0	O
group	28525834	0	O
susceptible	28525834	0	O
to	28525834	0	O
increased	28525834	0	O
absorption	28525834	0	O
of	28525834	0	O
chemicals	28525834	0	O
and	28525834	0	O
topical	28525834	0	O
medication	28525834	0	O
.	28525834	0	O

GRIN2B	28533163	2	O
gain	28533163	2	O
of	28533163	2	O
function	28533163	2	O
mutations	28533163	2	O
are	28533163	2	O
sensitive	28533163	2	O
to	28533163	2	O
radiprodil	28533163	2	O
,	28533163	2	O
a	28533163	2	O
negative	28533163	2	O
allosteric	28533163	2	O
modulator	28533163	2	O
of	28533163	2	O
GluN2B	28533163	2	O
-	28533163	2	O
containing	28533163	2	O
NMDA	28533163	2	O
receptors	28533163	2	O
.	28533163	2	O
De	28533163	2	O
novo	28533163	2	O
gain	28533163	2	B-PosReg
of	28533163	2	I-PosReg
function	28533163	2	I-PosReg
mutations	28533163	2	B-Var
in	28533163	2	O
GRIN2B	28533163	2	B-Gene
encoding	28533163	2	O
the	28533163	2	O
GluN2B	28533163	2	O
subunit	28533163	2	O
of	28533163	2	O
the	28533163	2	O
N	28533163	2	O
-	28533163	2	O
methyl	28533163	2	O
-	28533163	2	O
d	28533163	2	O
-	28533163	2	O
aspartate	28533163	2	O
(	28533163	2	O
NMDA	28533163	2	O
)	28533163	2	O
receptor	28533163	2	O
have	28533163	2	O
been	28533163	2	O
linked	28533163	2	O
with	28533163	2	O
epileptic	28533163	2	B-Disease
encephalopathies	28533163	2	I-Disease
,	28533163	2	O
including	28533163	2	O
infantile	28533163	2	B-Disease
spasms	28533163	2	I-Disease
.	28533163	2	O
We	28533163	2	O
investigated	28533163	2	O
the	28533163	2	O
effects	28533163	2	O
of	28533163	2	O
radiprodil	28533163	2	O
,	28533163	2	O
a	28533163	2	O
selective	28533163	2	O
GluN2B	28533163	2	O
negative	28533163	2	O
allosteric	28533163	2	O
modulator	28533163	2	O
and	28533163	2	O
other	28533163	2	O
non	28533163	2	O
-	28533163	2	O
selective	28533163	2	O
NMDA	28533163	2	O
receptor	28533163	2	O
inhibitors	28533163	2	O
on	28533163	2	O
glutamate	28533163	2	O
currents	28533163	2	O
mediated	28533163	2	O
by	28533163	2	O
NMDA	28533163	2	O
receptors	28533163	2	O
containing	28533163	2	O
mutated	28533163	2	O
GluN2B	28533163	2	O
subunits	28533163	2	O
.	28533163	2	O
The	28533163	2	O
experiments	28533163	2	O
were	28533163	2	O
performed	28533163	2	O
in	28533163	2	O
Xenopus	28533163	2	O
oocytes	28533163	2	O
co	28533163	2	O
-	28533163	2	O
injected	28533163	2	O
with	28533163	2	O
the	28533163	2	O
following	28533163	2	O
human	28533163	2	O
mRNAs	28533163	2	O
:	28533163	2	O
GRIN1	28533163	2	O
/	28533163	2	O
GRIN2B	28533163	2	O
,	28533163	2	O
GRIN1	28533163	2	O
/	28533163	2	O
GRIN2B	28533163	2	O
-	28533163	2	O
R540H	28533163	2	O
,	28533163	2	O
GRIN1	28533163	2	O
/	28533163	2	O
GRIN2B	28533163	2	O
-	28533163	2	O
N615I	28533163	2	O
and	28533163	2	O
GRIN1	28533163	2	O
/	28533163	2	O
GRIN2B	28533163	2	O
-	28533163	2	O
V618G	28533163	2	O
.	28533163	2	O
Glutamate	28533163	2	O
displayed	28533163	2	O
slightly	28533163	2	O
increased	28533163	2	O
potency	28533163	2	O
in	28533163	2	O
the	28533163	2	O
R540H	28533163	2	O
variant	28533163	2	O
,	28533163	2	O
but	28533163	2	O
not	28533163	2	O
in	28533163	2	O
N615I	28533163	2	O
and	28533163	2	O
V618G	28533163	2	O
variants	28533163	2	O
.	28533163	2	O
However	28533163	2	O
,	28533163	2	O
the	28533163	2	O
inhibition	28533163	2	O
by	28533163	2	O
Mg	28533163	2	O
(	28533163	2	O
2	28533163	2	O
)	28533163	2	O
was	28533163	2	O
completely	28533163	2	O
abolished	28533163	2	O
in	28533163	2	O
N615I	28533163	2	O
and	28533163	2	O
V618G	28533163	2	O
variants	28533163	2	O
.	28533163	2	O
In	28533163	2	O
fact	28533163	2	O
,	28533163	2	O
Mg	28533163	2	O
(	28533163	2	O
2	28533163	2	O
)	28533163	2	O
enhanced	28533163	2	O
glutamate	28533163	2	O
responses	28533163	2	O
in	28533163	2	O
those	28533163	2	O
variants	28533163	2	O
.	28533163	2	O
The	28533163	2	O
potency	28533163	2	O
of	28533163	2	O
radiprodil	28533163	2	O
to	28533163	2	O
block	28533163	2	O
glutamate	28533163	2	O
-	28533163	2	O
evoked	28533163	2	O
currents	28533163	2	O
was	28533163	2	O
not	28533163	2	O
affected	28533163	2	O
in	28533163	2	O
any	28533163	2	O
of	28533163	2	O
the	28533163	2	O
variants	28533163	2	O
,	28533163	2	O
while	28533163	2	O
the	28533163	2	O
effects	28533163	2	O
by	28533163	2	O
non	28533163	2	O
-	28533163	2	O
selective	28533163	2	O
NMDA	28533163	2	O
inhibitors	28533163	2	O
were	28533163	2	O
greatly	28533163	2	O
reduced	28533163	2	O
in	28533163	2	O
some	28533163	2	O
of	28533163	2	O
the	28533163	2	O
variants	28533163	2	O
.	28533163	2	O
Additionally	28533163	2	O
,	28533163	2	O
in	28533163	2	O
the	28533163	2	O
Mg	28533163	2	O
(	28533163	2	O
2	28533163	2	O
)	28533163	2	O
insensitive	28533163	2	O
variants	28533163	2	O
,	28533163	2	O
radiprodil	28533163	2	O
blocked	28533163	2	O
glutamate	28533163	2	O
-	28533163	2	O
activated	28533163	2	O
currents	28533163	2	O
with	28533163	2	O
the	28533163	2	O
same	28533163	2	O
potency	28533163	2	O
as	28533163	2	O
in	28533163	2	O
the	28533163	2	O
absence	28533163	2	O
of	28533163	2	O
Mg	28533163	2	O
(	28533163	2	O
2	28533163	2	O
)	28533163	2	O
.	28533163	2	O
The	28533163	2	O
gain	28533163	2	O
of	28533163	2	O
function	28533163	2	O
observed	28533163	2	O
in	28533163	2	O
the	28533163	2	O
reported	28533163	2	O
GRIN2B	28533163	2	O
variants	28533163	2	O
could	28533163	2	O
be	28533163	2	O
a	28533163	2	O
key	28533163	2	O
pathophysiological	28533163	2	O
factor	28533163	2	O
leading	28533163	2	O
to	28533163	2	O
neuronal	28533163	2	O
hyper	28533163	2	O
-	28533163	2	O
excitability	28533163	2	O
in	28533163	2	O
epileptic	28533163	2	O
encephalopathies	28533163	2	O
.	28533163	2	O
The	28533163	2	O
GluN2B	28533163	2	O
-	28533163	2	O
selective	28533163	2	O
inhibitor	28533163	2	O
radiprodil	28533163	2	O
fully	28533163	2	O
retained	28533163	2	O
its	28533163	2	O
pharmacological	28533163	2	O
profile	28533163	2	O
under	28533163	2	O
these	28533163	2	O
conditions	28533163	2	O
,	28533163	2	O
while	28533163	2	O
other	28533163	2	O
non	28533163	2	O
-	28533163	2	O
selective	28533163	2	O
NMDA	28533163	2	O
receptor	28533163	2	O
antagonists	28533163	2	O
lost	28533163	2	O
their	28533163	2	O
potency	28533163	2	O
.	28533163	2	O
Consequently	28533163	2	O
,	28533163	2	O
our	28533163	2	O
data	28533163	2	O
suggest	28533163	2	O
that	28533163	2	O
radiprodil	28533163	2	O
may	28533163	2	O
be	28533163	2	O
a	28533163	2	O
valuable	28533163	2	O
therapeutic	28533163	2	O
option	28533163	2	O
for	28533163	2	O
treatment	28533163	2	O
of	28533163	2	O
pediatric	28533163	2	O
epileptic	28533163	2	O
encephalopathies	28533163	2	O
associated	28533163	2	O
with	28533163	2	O
GRIN2B	28533163	2	O
mutations	28533163	2	O
.	28533163	2	O

Severe	28548960	1	O
hypertriglyceridemia	28548960	1	B-Disease
due	28548960	1	O
to	28548960	1	O
two	28548960	1	O
novel	28548960	1	O
loss	28548960	1	B-NegReg
-	28548960	1	I-NegReg
of	28548960	1	I-NegReg
-	28548960	1	I-NegReg
function	28548960	1	I-NegReg
lipoprotein	28548960	1	O
lipase	28548960	1	O
gene	28548960	1	O
mutations	28548960	1	O
(	28548960	1	B-Var
C310R	28548960	1	I-Var
/	28548960	1	I-Var
E396V	28548960	1	I-Var
)	28548960	1	I-Var
in	28548960	1	O
a	28548960	1	O
Chinese	28548960	1	O
family	28548960	1	O
associated	28548960	1	B-Reg
with	28548960	1	I-Reg
recurrent	28548960	1	B-Disease
acute	28548960	1	I-Disease
pancreatitis	28548960	1	I-Disease
.	28548960	1	O
Lipoprotein	28548960	1	O
lipase	28548960	1	O
(	28548960	1	O
LPL	28548960	1	O
)	28548960	1	O
is	28548960	1	O
widely	28548960	1	O
expressed	28548960	1	O
in	28548960	1	O
skeletal	28548960	1	O
muscles	28548960	1	O
,	28548960	1	O
cardiac	28548960	1	O
muscles	28548960	1	O
as	28548960	1	O
well	28548960	1	O
as	28548960	1	O
adipose	28548960	1	O
tissue	28548960	1	O
and	28548960	1	O
involved	28548960	1	O
in	28548960	1	O
the	28548960	1	O
catabolism	28548960	1	O
of	28548960	1	O
triglyceride	28548960	1	O
.	28548960	1	O
Herein	28548960	1	O
we	28548960	1	O
have	28548960	1	O
systematically	28548960	1	O
characterized	28548960	1	O
two	28548960	1	O
novel	28548960	1	O
loss	28548960	1	O
-	28548960	1	O
of	28548960	1	O
-	28548960	1	O
function	28548960	1	O
mutations	28548960	1	O
in	28548960	1	O
LPL	28548960	1	O
from	28548960	1	O
a	28548960	1	O
Chinese	28548960	1	O
family	28548960	1	O
in	28548960	1	O
which	28548960	1	O
afflicted	28548960	1	O
members	28548960	1	O
were	28548960	1	O
manifested	28548960	1	O
by	28548960	1	O
severe	28548960	1	O
hypertriglyceridemia	28548960	1	O
and	28548960	1	O
recurrent	28548960	1	O
pancreatitis	28548960	1	O
.	28548960	1	O
DNA	28548960	1	O
sequencing	28548960	1	O
revealed	28548960	1	O
that	28548960	1	O
the	28548960	1	O
proband	28548960	1	O
was	28548960	1	O
a	28548960	1	O
heterozygote	28548960	1	O
carrying	28548960	1	O
a	28548960	1	O
novel	28548960	1	O
c.	28548960	1	O
T928C	28548960	1	O
(	28548960	1	O
p.C310R	28548960	1	O
)	28548960	1	O
mutation	28548960	1	O
in	28548960	1	O
exon	28548960	1	O
6	28548960	1	O
of	28548960	1	O
the	28548960	1	O
LPL	28548960	1	O
gene	28548960	1	O
.	28548960	1	O
Another	28548960	1	O
member	28548960	1	O
of	28548960	1	O
the	28548960	1	O
family	28548960	1	O
was	28548960	1	O
detected	28548960	1	O
to	28548960	1	O
be	28548960	1	O
a	28548960	1	O
compound	28548960	1	O
heterozygote	28548960	1	O
who	28548960	1	O
along	28548960	1	O
with	28548960	1	O
the	28548960	1	O
c.	28548960	1	O
T928C	28548960	1	O
mutation	28548960	1	O
also	28548960	1	O
carried	28548960	1	O
a	28548960	1	O
novel	28548960	1	O
missense	28548960	1	O
mutation	28548960	1	O
c.	28548960	1	O
A1187T	28548960	1	O
(	28548960	1	O
p.E396V	28548960	1	O
)	28548960	1	O
in	28548960	1	O
exon	28548960	1	O
8	28548960	1	O
of	28548960	1	O
the	28548960	1	O
LPL	28548960	1	O
gene	28548960	1	O
.	28548960	1	O
Furthermore	28548960	1	O
,	28548960	1	O
COS-1	28548960	1	O
cells	28548960	1	O
were	28548960	1	O
transfected	28548960	1	O
with	28548960	1	O
lentiviruses	28548960	1	O
containing	28548960	1	O
the	28548960	1	O
mutant	28548960	1	O
LPL	28548960	1	O
genes	28548960	1	O
.	28548960	1	O
While	28548960	1	O
C310R	28548960	1	B-Var
markedly	28548960	1	O
reduced	28548960	1	B-NegReg
the	28548960	1	O
overall	28548960	1	O
LPL	28548960	1	O
protein	28548960	1	O
level	28548960	1	O
,	28548960	1	O
COS-1	28548960	1	O
cells	28548960	1	O
carrying	28548960	1	O
E396V	28548960	1	O
or	28548960	1	O
double	28548960	1	O
mutations	28548960	1	O
contained	28548960	1	O
similar	28548960	1	O
overall	28548960	1	O
LPL	28548960	1	O
protein	28548960	1	O
levels	28548960	1	O
to	28548960	1	O
the	28548960	1	O
wild	28548960	1	O
-	28548960	1	O
type	28548960	1	O
.	28548960	1	O
The	28548960	1	O
specific	28548960	1	O
activity	28548960	1	O
of	28548960	1	O
the	28548960	1	O
LPL	28548960	1	O
mutants	28548960	1	O
remained	28548960	1	O
at	28548960	1	O
comparable	28548960	1	O
magnitude	28548960	1	O
to	28548960	1	O
the	28548960	1	O
wild	28548960	1	O
-	28548960	1	O
type	28548960	1	O
.	28548960	1	O
However	28548960	1	O
,	28548960	1	O
few	28548960	1	O
LPL	28548960	1	O
were	28548960	1	O
detected	28548960	1	O
in	28548960	1	O
the	28548960	1	O
culture	28548960	1	O
medium	28548960	1	O
for	28548960	1	O
the	28548960	1	O
mutants	28548960	1	O
,	28548960	1	O
suggesting	28548960	1	O
that	28548960	1	O
both	28548960	1	O
mutations	28548960	1	B-Var
caused	28548960	1	B-Reg
aberrant	28548960	1	O
triglyceride	28548960	1	O
catabolism	28548960	1	O
.	28548960	1	O
More	28548960	1	O
specifically	28548960	1	O
,	28548960	1	O
E396V	28548960	1	B-Var
and	28548960	1	O
double	28548960	1	B-Var
mutations	28548960	1	I-Var
dampened	28548960	1	B-NegReg
the	28548960	1	O
transport	28548960	1	O
of	28548960	1	O
LPL	28548960	1	O
to	28548960	1	O
the	28548960	1	O
cell	28548960	1	O
surface	28548960	1	O
,	28548960	1	O
while	28548960	1	O
for	28548960	1	O
the	28548960	1	O
C310R	28548960	1	B-Var
mutation	28548960	1	O
,	28548960	1	O
reducing	28548960	1	B-NegReg
LPL	28548960	1	O
protein	28548960	1	O
level	28548960	1	O
might	28548960	1	O
be	28548960	1	O
involved	28548960	1	O
.	28548960	1	O
By	28548960	1	O
characterizing	28548960	1	O
these	28548960	1	O
two	28548960	1	O
novel	28548960	1	O
LPL	28548960	1	O
mutations	28548960	1	O
,	28548960	1	O
this	28548960	1	O
study	28548960	1	O
has	28548960	1	O
expanded	28548960	1	O
our	28548960	1	O
understanding	28548960	1	O
on	28548960	1	O
the	28548960	1	O
pathogenesis	28548960	1	O
of	28548960	1	O
familial	28548960	1	O
hypertriglyceridemia	28548960	1	O
(	28548960	1	O
FHTG	28548960	1	O
)	28548960	1	O
.	28548960	1	O

Truncating	28572275	1	O
mutations	28572275	1	O
in	28572275	1	O
SPAST	28572275	1	O
patients	28572275	1	O
are	28572275	1	O
associated	28572275	1	O
with	28572275	1	O
a	28572275	1	O
high	28572275	1	O
rate	28572275	1	O
of	28572275	1	O
psychiatric	28572275	1	O
comorbidities	28572275	1	O
in	28572275	1	O
hereditary	28572275	1	O
spastic	28572275	1	O
paraplegia	28572275	1	O
.	28572275	1	O
BACKGROUND	28572275	1	O
:	28572275	1	O
The	28572275	1	O
hereditary	28572275	1	B-Disease
spastic	28572275	1	I-Disease
paraplegias	28572275	1	I-Disease
(	28572275	1	O
HSPs	28572275	1	O
)	28572275	1	O
are	28572275	1	O
a	28572275	1	O
rare	28572275	1	O
and	28572275	1	O
heterogeneous	28572275	1	O
group	28572275	1	O
of	28572275	1	O
neurodegenerative	28572275	1	O
disorders	28572275	1	O
that	28572275	1	O
are	28572275	1	O
clinically	28572275	1	O
characterised	28572275	1	O
by	28572275	1	O
progressive	28572275	1	O
lower	28572275	1	O
limb	28572275	1	O
spasticity	28572275	1	O
.	28572275	1	O
They	28572275	1	O
are	28572275	1	O
classified	28572275	1	O
as	28572275	1	O
either	28572275	1	O
'	28572275	1	O
pure	28572275	1	O
'	28572275	1	O
or	28572275	1	O
'	28572275	1	O
complex	28572275	1	O
'	28572275	1	O
where	28572275	1	O
spastic	28572275	1	O
paraplegia	28572275	1	O
is	28572275	1	O
complicated	28572275	1	O
with	28572275	1	O
additional	28572275	1	O
neurological	28572275	1	O
features	28572275	1	O
.	28572275	1	O
Mutations	28572275	1	B-Var
in	28572275	1	O
the	28572275	1	O
spastin	28572275	1	O
gene	28572275	1	O
(	28572275	1	B-Gene
SPAST	28572275	1	I-Gene
)	28572275	1	I-Gene
are	28572275	1	O
the	28572275	1	O
most	28572275	1	O
common	28572275	1	O
cause	28572275	1	B-Reg
of	28572275	1	O
HSP	28572275	1	B-Disease
and	28572275	1	O
typically	28572275	1	O
present	28572275	1	O
with	28572275	1	O
a	28572275	1	O
pure	28572275	1	O
form	28572275	1	O
.	28572275	1	O
METHODS	28572275	1	O
:	28572275	1	O
We	28572275	1	O
assessed	28572275	1	O
in	28572275	1	O
detail	28572275	1	O
the	28572275	1	O
phenotypic	28572275	1	O
and	28572275	1	O
genetic	28572275	1	O
spectrum	28572275	1	O
of	28572275	1	O
SPAST	28572275	1	O
-	28572275	1	O
related	28572275	1	O
HSP	28572275	1	O
focused	28572275	1	O
on	28572275	1	O
118	28572275	1	O
patients	28572275	1	O
carrying	28572275	1	O
SPAST	28572275	1	O
mutations	28572275	1	O
.	28572275	1	O
RESULTS	28572275	1	O
:	28572275	1	O
This	28572275	1	O
study	28572275	1	O
,	28572275	1	O
one	28572275	1	O
of	28572275	1	O
the	28572275	1	O
largest	28572275	1	O
cohorts	28572275	1	O
of	28572275	1	O
genetically	28572275	1	O
confirmed	28572275	1	O
spastin	28572275	1	O
patients	28572275	1	O
to	28572275	1	O
date	28572275	1	O
,	28572275	1	O
contributes	28572275	1	O
with	28572275	1	O
the	28572275	1	O
discovery	28572275	1	O
of	28572275	1	O
a	28572275	1	O
significant	28572275	1	O
number	28572275	1	O
of	28572275	1	O
novel	28572275	1	O
SPAST	28572275	1	O
mutations	28572275	1	O
.	28572275	1	O
Our	28572275	1	O
data	28572275	1	O
reveal	28572275	1	O
a	28572275	1	O
high	28572275	1	O
rate	28572275	1	O
of	28572275	1	O
complex	28572275	1	O
cases	28572275	1	O
(	28572275	1	O
25%	28572275	1	O
)	28572275	1	O
,	28572275	1	O
with	28572275	1	O
psychiatric	28572275	1	O
disorders	28572275	1	O
among	28572275	1	O
the	28572275	1	O
most	28572275	1	O
common	28572275	1	O
comorbidity	28572275	1	O
(	28572275	1	O
10%	28572275	1	O
of	28572275	1	O
all	28572275	1	O
SPASTpatients	28572275	1	O
)	28572275	1	O
.	28572275	1	O
Further	28572275	1	O
,	28572275	1	O
we	28572275	1	O
identify	28572275	1	O
a	28572275	1	O
genotype	28572275	1	O
-	28572275	1	O
phenotype	28572275	1	O
correlation	28572275	1	O
between	28572275	1	O
patients	28572275	1	O
carrying	28572275	1	O
loss	28572275	1	B-NegReg
-	28572275	1	I-NegReg
of	28572275	1	I-NegReg
-	28572275	1	I-NegReg
function	28572275	1	I-NegReg
mutations	28572275	1	B-Var
in	28572275	1	O
SPAST	28572275	1	B-Gene
and	28572275	1	O
the	28572275	1	O
presence	28572275	1	O
of	28572275	1	O
psychiatric	28572275	1	B-Disease
disorders	28572275	1	I-Disease
.	28572275	1	O

WNT10A	28589954	1	B-Gene
mutation	28589954	1	B-Var
causes	28589954	1	B-Reg
ectodermal	28589954	1	B-Disease
dysplasia	28589954	1	I-Disease
by	28589954	1	O
impairing	28589954	1	B-NegReg
progenitor	28589954	1	O
cell	28589954	1	O
proliferation	28589954	1	O
and	28589954	1	O
KLF4	28589954	1	O
-	28589954	1	O
mediated	28589954	1	O
differentiation	28589954	1	O
.	28589954	1	O
Human	28589954	1	O
WNT10A	28589954	1	O
mutations	28589954	1	O
are	28589954	1	O
associated	28589954	1	O
with	28589954	1	O
developmental	28589954	1	O
tooth	28589954	1	O
abnormalities	28589954	1	O
and	28589954	1	O
adolescent	28589954	1	O
onset	28589954	1	O
of	28589954	1	O
a	28589954	1	O
broad	28589954	1	O
range	28589954	1	O
of	28589954	1	O
ectodermal	28589954	1	O
defects	28589954	1	O
.	28589954	1	O
Here	28589954	1	O
we	28589954	1	O
show	28589954	1	O
that	28589954	1	O
β	28589954	1	O
-	28589954	1	O
catenin	28589954	1	O
pathway	28589954	1	O
activity	28589954	1	O
and	28589954	1	O
adult	28589954	1	O
epithelial	28589954	1	O
progenitor	28589954	1	O
proliferation	28589954	1	O
are	28589954	1	O
reduced	28589954	1	O
in	28589954	1	O
the	28589954	1	O
absence	28589954	1	O
of	28589954	1	O
WNT10A	28589954	1	O
,	28589954	1	O
and	28589954	1	O
identify	28589954	1	O
Wnt	28589954	1	O
-	28589954	1	O
active	28589954	1	O
self	28589954	1	O
-	28589954	1	O
renewing	28589954	1	O
stem	28589954	1	O
cells	28589954	1	O
in	28589954	1	O
affected	28589954	1	O
tissues	28589954	1	O
including	28589954	1	O
hair	28589954	1	O
follicles	28589954	1	O
,	28589954	1	O
sebaceous	28589954	1	O
glands	28589954	1	O
,	28589954	1	O
taste	28589954	1	O
buds	28589954	1	O
,	28589954	1	O
nails	28589954	1	O
and	28589954	1	O
sweat	28589954	1	O
ducts	28589954	1	O
.	28589954	1	O
Human	28589954	1	O
and	28589954	1	O
mouse	28589954	1	O
WNT10A	28589954	1	O
mutant	28589954	1	O
palmoplantar	28589954	1	O
and	28589954	1	O
tongue	28589954	1	O
epithelia	28589954	1	O
also	28589954	1	O
display	28589954	1	O
specific	28589954	1	O
differentiation	28589954	1	O
defects	28589954	1	O
that	28589954	1	O
are	28589954	1	O
mimicked	28589954	1	O
by	28589954	1	O
loss	28589954	1	O
of	28589954	1	O
the	28589954	1	O
transcription	28589954	1	O
factor	28589954	1	O
KLF4	28589954	1	O
.	28589954	1	O
We	28589954	1	O
find	28589954	1	O
that	28589954	1	O
β	28589954	1	O
-	28589954	1	O
catenin	28589954	1	O
interacts	28589954	1	O
directly	28589954	1	O
with	28589954	1	O
region	28589954	1	O
-	28589954	1	O
specific	28589954	1	O
LEF	28589954	1	O
/	28589954	1	O
TCF	28589954	1	O
factors	28589954	1	O
,	28589954	1	O
and	28589954	1	O
with	28589954	1	O
KLF4	28589954	1	O
in	28589954	1	O
differentiating	28589954	1	O
,	28589954	1	O
but	28589954	1	O
not	28589954	1	O
proliferating	28589954	1	O
,	28589954	1	O
cells	28589954	1	O
to	28589954	1	O
promote	28589954	1	O
expression	28589954	1	O
of	28589954	1	O
specialized	28589954	1	O
keratins	28589954	1	O
required	28589954	1	O
for	28589954	1	O
normal	28589954	1	O
tissue	28589954	1	O
structure	28589954	1	O
and	28589954	1	O
integrity	28589954	1	O
.	28589954	1	O
Our	28589954	1	O
data	28589954	1	O
identify	28589954	1	O
WNT10A	28589954	1	O
as	28589954	1	O
a	28589954	1	O
critical	28589954	1	O
ligand	28589954	1	O
controlling	28589954	1	O
adult	28589954	1	O
epithelial	28589954	1	O
proliferation	28589954	1	O
and	28589954	1	O
region	28589954	1	O
-	28589954	1	O
specific	28589954	1	O
differentiation	28589954	1	O
,	28589954	1	O
and	28589954	1	O
suggest	28589954	1	O
downstream	28589954	1	O
β	28589954	1	O
-	28589954	1	O
catenin	28589954	1	O
pathway	28589954	1	O
activation	28589954	1	O
as	28589954	1	O
a	28589954	1	O
potential	28589954	1	O
approach	28589954	1	O
to	28589954	1	O
ameliorate	28589954	1	O
regenerative	28589954	1	O
defects	28589954	1	O
in	28589954	1	O
WNT10A	28589954	1	O
patients	28589954	1	O
.	28589954	1	O

R202Q	28590056	4	B-Var
/	28590056	4	I-Var
M694V	28590056	4	I-Var
as	28590056	4	O
novel	28590056	4	O
MEFV	28590056	4	B-Gene
gene	28590056	4	O
mutations	28590056	4	O
in	28590056	4	B-Reg
chronic	28590056	4	B-Disease
periodontitis	28590056	4	I-Disease
and	28590056	4	O
familial	28590056	4	B-Disease
Mediterranean	28590056	4	I-Disease
fever	28590056	4	I-Disease
.	28590056	4	O
BACKGROUND	28590056	4	O
AND	28590056	4	O
OBJECTIVE	28590056	4	O
:	28590056	4	O
Familial	28590056	4	O
Mediterranean	28590056	4	O
fever	28590056	4	O
(	28590056	4	O
FMF	28590056	4	O
)	28590056	4	O
and	28590056	4	O
chronic	28590056	4	O
periodontitis	28590056	4	O
are	28590056	4	O
inflammatory	28590056	4	O
diseases	28590056	4	O
leading	28590056	4	O
to	28590056	4	O
an	28590056	4	O
increase	28590056	4	O
in	28590056	4	O
the	28590056	4	O
number	28590056	4	O
of	28590056	4	O
inflammasomes	28590056	4	O
.	28590056	4	O
To	28590056	4	O
date	28590056	4	O
,	28590056	4	O
no	28590056	4	O
published	28590056	4	O
studies	28590056	4	O
have	28590056	4	O
reported	28590056	4	O
on	28590056	4	O
mutations	28590056	4	O
in	28590056	4	O
the	28590056	4	O
Mediterranean	28590056	4	O
fever	28590056	4	O
(	28590056	4	O
MEFV	28590056	4	O
)	28590056	4	O
gene	28590056	4	O
in	28590056	4	O
patients	28590056	4	O
with	28590056	4	O
chronic	28590056	4	O
periodontitis	28590056	4	O
,	28590056	4	O
although	28590056	4	O
the	28590056	4	O
roles	28590056	4	B-Reg
of	28590056	4	O
MEFV	28590056	4	B-Gene
gene	28590056	4	O
mutations	28590056	4	B-Var
in	28590056	4	O
FMF	28590056	4	B-Disease
and	28590056	4	O
FMF	28590056	4	B-Disease
-	28590056	4	I-Disease
associated	28590056	4	I-Disease
amyloidosis	28590056	4	I-Disease
(	28590056	4	O
FMF	28590056	4	O
-	28590056	4	O
A	28590056	4	O
)	28590056	4	O
are	28590056	4	O
well	28590056	4	O
known	28590056	4	O
.	28590056	4	O
Therefore	28590056	4	O
,	28590056	4	O
the	28590056	4	O
aim	28590056	4	O
of	28590056	4	O
this	28590056	4	O
study	28590056	4	O
was	28590056	4	O
to	28590056	4	O
evaluate	28590056	4	O
the	28590056	4	O
frequencies	28590056	4	O
of	28590056	4	O
MEFV	28590056	4	O
gene	28590056	4	O
mutations	28590056	4	O
and	28590056	4	O
serum	28590056	4	O
amyloid	28590056	4	O
A	28590056	4	O
(	28590056	4	O
SAA	28590056	4	O
)	28590056	4	O
and	28590056	4	O
high	28590056	4	O
-	28590056	4	O
sensitivity	28590056	4	O
C	28590056	4	O
-	28590056	4	O
reactive	28590056	4	O
protein	28590056	4	O
(	28590056	4	O
hs	28590056	4	O
-	28590056	4	O
CRP	28590056	4	O
)	28590056	4	O
levels	28590056	4	O
in	28590056	4	O
patients	28590056	4	O
with	28590056	4	O
chronic	28590056	4	O
periodontitis	28590056	4	O
,	28590056	4	O
FMF	28590056	4	O
and	28590056	4	O
FMF	28590056	4	O
-	28590056	4	O
A.	28590056	4	O
MATERIAL	28590056	4	O
AND	28590056	4	O
METHODS	28590056	4	O
:	28590056	4	O
The	28590056	4	O
study	28590056	4	O
population	28590056	4	O
included	28590056	4	O
122	28590056	4	O
patients	28590056	4	O
with	28590056	4	O
FMF	28590056	4	O
and	28590056	4	O
128	28590056	4	O
subjects	28590056	4	O
who	28590056	4	O
were	28590056	4	O
systemically	28590056	4	O
healthy	28590056	4	O
.	28590056	4	O
Clinical	28590056	4	O
periodontal	28590056	4	O
parameters	28590056	4	O
,	28590056	4	O
including	28590056	4	O
the	28590056	4	O
plaque	28590056	4	O
index	28590056	4	O
,	28590056	4	O
gingival	28590056	4	O
index	28590056	4	O
,	28590056	4	O
probing	28590056	4	O
pocket	28590056	4	O
depth	28590056	4	O
,	28590056	4	O
clinical	28590056	4	O
attachment	28590056	4	O
level	28590056	4	O
and	28590056	4	O
percentage	28590056	4	O
of	28590056	4	O
bleeding	28590056	4	O
on	28590056	4	O
probing	28590056	4	O
were	28590056	4	O
recorded	28590056	4	O
.	28590056	4	O
Blood	28590056	4	O
samples	28590056	4	O
were	28590056	4	O
obtained	28590056	4	O
from	28590056	4	O
patients	28590056	4	O
with	28590056	4	O
FMF	28590056	4	O
and	28590056	4	O
systemically	28590056	4	O
healthy	28590056	4	O
controls	28590056	4	O
,	28590056	4	O
and	28590056	4	O
all	28590056	4	O
mutations	28590056	4	O
located	28590056	4	O
on	28590056	4	O
exons	28590056	4	O
2	28590056	4	O
and	28590056	4	O
10	28590056	4	O
of	28590056	4	O
the	28590056	4	O
MEFV	28590056	4	O
gene	28590056	4	O
were	28590056	4	O
analyzed	28590056	4	O
by	28590056	4	O
DNA	28590056	4	O
Sanger	28590056	4	O
Sequencing	28590056	4	O
,	28590056	4	O
which	28590056	4	O
is	28590056	4	O
the	28590056	4	O
gold	28590056	4	O
standard	28590056	4	O
.	28590056	4	O
SAA	28590056	4	O
and	28590056	4	O
high	28590056	4	O
-	28590056	4	O
sensitive	28590056	4	O
CRP	28590056	4	O
levels	28590056	4	O
were	28590056	4	O
also	28590056	4	O
assessed	28590056	4	O
.	28590056	4	O
RESULTS	28590056	4	O
:	28590056	4	O
Mean	28590056	4	O
gingival	28590056	4	O
index	28590056	4	O
,	28590056	4	O
percentage	28590056	4	O
of	28590056	4	O
bleeding	28590056	4	O
on	28590056	4	O
probing	28590056	4	O
,	28590056	4	O
probing	28590056	4	O
pocket	28590056	4	O
depth	28590056	4	O
and	28590056	4	O
clinical	28590056	4	O
attachment	28590056	4	O
level	28590056	4	O
,	28590056	4	O
and	28590056	4	O
the	28590056	4	O
levels	28590056	4	O
of	28590056	4	O
SAA	28590056	4	O
and	28590056	4	O
hs	28590056	4	O
-	28590056	4	O
CRP	28590056	4	O
were	28590056	4	O
higher	28590056	4	O
in	28590056	4	O
the	28590056	4	O
FMF	28590056	4	O
-	28590056	4	O
A	28590056	4	O
group	28590056	4	O
than	28590056	4	O
those	28590056	4	O
in	28590056	4	O
the	28590056	4	O
FMF	28590056	4	O
and	28590056	4	O
control	28590056	4	O
groups	28590056	4	O
.	28590056	4	O
The	28590056	4	O
two	28590056	4	O
most	28590056	4	O
relevant	28590056	4	O
mutations	28590056	4	O
in	28590056	4	O
patients	28590056	4	O
with	28590056	4	O
FMF	28590056	4	O
were	28590056	4	O
heterozygous	28590056	4	O
M694V	28590056	4	O
(	28590056	4	O
46.2%	28590056	4	O
)	28590056	4	O
,	28590056	4	O
and	28590056	4	O
heterozygous	28590056	4	O
R202Q	28590056	4	O
(	28590056	4	O
32.7%	28590056	4	O
)	28590056	4	O
.	28590056	4	O
The	28590056	4	O
frequencies	28590056	4	O
of	28590056	4	O
the	28590056	4	O
homozygous	28590056	4	O
M694V	28590056	4	O
and	28590056	4	O
R202Q	28590056	4	O
mutations	28590056	4	O
in	28590056	4	O
the	28590056	4	O
FMF	28590056	4	O
-	28590056	4	O
A	28590056	4	O
group	28590056	4	O
were	28590056	4	O
53.8%	28590056	4	O
and	28590056	4	O
46.1%	28590056	4	O
,	28590056	4	O
respectively	28590056	4	O
.	28590056	4	O
The	28590056	4	O
complex	28590056	4	O
R202Q	28590056	4	O
/	28590056	4	O
M694V	28590056	4	O
homozygous	28590056	4	O
state	28590056	4	O
led	28590056	4	O
to	28590056	4	O
an	28590056	4	O
increased	28590056	4	O
risk	28590056	4	O
of	28590056	4	O
chronic	28590056	4	O
periodontitis	28590056	4	O
(	28590056	4	O
odds	28590056	4	O
ratio	28590056	4	O
:	28590056	4	O
3.6	28590056	4	O
)	28590056	4	O
,	28590056	4	O
and	28590056	4	O
FMF	28590056	4	O
-	28590056	4	O
A	28590056	4	O
(	28590056	4	O
odds	28590056	4	O
ratio	28590056	4	O
:	28590056	4	O
7.6	28590056	4	O
)	28590056	4	O
.	28590056	4	O
CONCLUSION	28590056	4	O
:	28590056	4	O
This	28590056	4	O
is	28590056	4	O
the	28590056	4	O
first	28590056	4	O
study	28590056	4	O
to	28590056	4	O
report	28590056	4	O
the	28590056	4	O
R202Q	28590056	4	O
mutation	28590056	4	O
in	28590056	4	O
patients	28590056	4	O
with	28590056	4	O
periodontitis	28590056	4	O
.	28590056	4	O
Furthermore	28590056	4	O
,	28590056	4	O
the	28590056	4	O
MEFV	28590056	4	O
gene	28590056	4	O
-	28590056	4	O
mediated	28590056	4	O
inflammatory	28590056	4	O
pathway	28590056	4	O
increased	28590056	4	O
serum	28590056	4	O
acute	28590056	4	O
phase	28590056	4	O
reactants	28590056	4	O
,	28590056	4	O
and	28590056	4	O
the	28590056	4	O
changes	28590056	4	O
in	28590056	4	O
the	28590056	4	O
R202Q	28590056	4	B-Var
and	28590056	4	O
M694V	28590056	4	B-Var
could	28590056	4	O
play	28590056	4	B-Reg
a	28590056	4	I-Reg
role	28590056	4	I-Reg
in	28590056	4	O
inflammatory	28590056	4	B-Disease
-	28590056	4	I-Disease
genetic	28590056	4	I-Disease
diseases	28590056	4	I-Disease
,	28590056	4	O
such	28590056	4	O
as	28590056	4	O
FMF	28590056	4	O
,	28590056	4	O
FMF	28590056	4	O
-	28590056	4	O
associated	28590056	4	O
amyloidosis	28590056	4	O
and	28590056	4	O
chronic	28590056	4	O
periodontitis	28590056	4	O
.	28590056	4	O

Loss	28592524	1	B-Var
of	28592524	1	I-Var
function	28592524	1	I-Var
in	28592524	1	O
ROBO1	28592524	1	B-Gene
is	28592524	1	O
associated	28592524	1	B-Reg
with	28592524	1	O
tetralogy	28592524	1	B-Disease
of	28592524	1	I-Disease
Fallot	28592524	1	I-Disease
and	28592524	1	O
septal	28592524	1	B-Disease
defects	28592524	1	I-Disease
.	28592524	1	O
BACKGROUND	28592524	1	O
:	28592524	1	O
Congenital	28592524	1	O
heart	28592524	1	O
disease	28592524	1	O
(	28592524	1	O
CHD	28592524	1	O
)	28592524	1	O
is	28592524	1	O
a	28592524	1	O
common	28592524	1	O
birth	28592524	1	O
defect	28592524	1	O
affecting	28592524	1	O
approximately	28592524	1	O
1%	28592524	1	O
of	28592524	1	O
newborns	28592524	1	O
.	28592524	1	O
Great	28592524	1	O
progress	28592524	1	O
has	28592524	1	O
been	28592524	1	O
made	28592524	1	O
in	28592524	1	O
elucidating	28592524	1	O
the	28592524	1	O
genetic	28592524	1	O
aetiology	28592524	1	O
of	28592524	1	O
CHD	28592524	1	O
with	28592524	1	O
advances	28592524	1	O
in	28592524	1	O
genomic	28592524	1	O
technology	28592524	1	O
,	28592524	1	O
which	28592524	1	O
we	28592524	1	O
leveraged	28592524	1	O
in	28592524	1	O
recovering	28592524	1	O
a	28592524	1	O
new	28592524	1	O
pathway	28592524	1	O
affecting	28592524	1	O
heart	28592524	1	O
development	28592524	1	O
in	28592524	1	O
humans	28592524	1	O
previously	28592524	1	O
known	28592524	1	O
to	28592524	1	O
affect	28592524	1	O
heart	28592524	1	O
development	28592524	1	O
in	28592524	1	O
an	28592524	1	O
animal	28592524	1	O
model	28592524	1	O
.	28592524	1	O
METHODS	28592524	1	O
:	28592524	1	O
Four	28592524	1	O
hundred	28592524	1	O
and	28592524	1	O
sixteen	28592524	1	O
individuals	28592524	1	O
from	28592524	1	O
Thailand	28592524	1	O
and	28592524	1	O
the	28592524	1	O
USA	28592524	1	O
diagnosed	28592524	1	O
with	28592524	1	O
CHD	28592524	1	O
and	28592524	1	O
/	28592524	1	O
or	28592524	1	O
congenital	28592524	1	O
diaphragmatic	28592524	1	O
hernia	28592524	1	O
were	28592524	1	O
evaluated	28592524	1	O
with	28592524	1	O
chromosomal	28592524	1	O
microarray	28592524	1	O
and	28592524	1	O
whole	28592524	1	O
exome	28592524	1	O
sequencing	28592524	1	O
.	28592524	1	O
The	28592524	1	O
DECIPHER	28592524	1	O
Consortium	28592524	1	O
and	28592524	1	O
medical	28592524	1	O
literature	28592524	1	O
were	28592524	1	O
searched	28592524	1	O
for	28592524	1	O
additional	28592524	1	O
patients	28592524	1	O
.	28592524	1	O
Murine	28592524	1	O
hearts	28592524	1	O
from	28592524	1	O
ENU	28592524	1	O
-	28592524	1	O
induced	28592524	1	O
mouse	28592524	1	O
mutants	28592524	1	O
and	28592524	1	O
transgenic	28592524	1	O
mice	28592524	1	O
were	28592524	1	O
evaluated	28592524	1	O
using	28592524	1	O
both	28592524	1	O
episcopic	28592524	1	O
confocal	28592524	1	O
histopathology	28592524	1	O
and	28592524	1	O
troponin	28592524	1	O
I	28592524	1	O
stained	28592524	1	O
sections	28592524	1	O
.	28592524	1	O
RESULTS	28592524	1	O
:	28592524	1	O
Loss	28592524	1	O
of	28592524	1	O
function	28592524	1	O
ROBO1	28592524	1	O
variants	28592524	1	O
were	28592524	1	O
identified	28592524	1	O
in	28592524	1	O
three	28592524	1	O
families	28592524	1	O
;	28592524	1	O
each	28592524	1	O
proband	28592524	1	O
had	28592524	1	O
a	28592524	1	O
ventricular	28592524	1	O
septal	28592524	1	O
defect	28592524	1	O
,	28592524	1	O
and	28592524	1	O
one	28592524	1	O
proband	28592524	1	O
had	28592524	1	O
tetralogy	28592524	1	O
of	28592524	1	O
Fallot	28592524	1	O
.	28592524	1	O
Additionally	28592524	1	O
,	28592524	1	O
a	28592524	1	O
microdeletion	28592524	1	O
in	28592524	1	O
an	28592524	1	O
individual	28592524	1	O
with	28592524	1	O
CHD	28592524	1	O
was	28592524	1	O
found	28592524	1	O
in	28592524	1	O
the	28592524	1	O
medical	28592524	1	O
literature	28592524	1	O
.	28592524	1	O
Mouse	28592524	1	O
models	28592524	1	O
showed	28592524	1	O
perturbation	28592524	1	O
of	28592524	1	O
the	28592524	1	O
Slit	28592524	1	O
-	28592524	1	O
Robo	28592524	1	O
signalling	28592524	1	O
pathway	28592524	1	O
,	28592524	1	O
causing	28592524	1	O
septation	28592524	1	O
and	28592524	1	O
outflow	28592524	1	O
tract	28592524	1	O
defects	28592524	1	O
and	28592524	1	O
craniofacial	28592524	1	O
anomalies	28592524	1	O
.	28592524	1	O
Two	28592524	1	O
probands	28592524	1	O
had	28592524	1	O
variable	28592524	1	O
facial	28592524	1	O
features	28592524	1	O
consistent	28592524	1	O
with	28592524	1	O
the	28592524	1	O
mouse	28592524	1	O
model	28592524	1	O
.	28592524	1	O
CONCLUSION	28592524	1	O
:	28592524	1	O
Our	28592524	1	O
findings	28592524	1	O
identify	28592524	1	O
Slit	28592524	1	O
-	28592524	1	O
Robo	28592524	1	O
as	28592524	1	O
a	28592524	1	O
significant	28592524	1	O
pathway	28592524	1	O
in	28592524	1	O
human	28592524	1	O
heart	28592524	1	O
development	28592524	1	O
and	28592524	1	O
CHD	28592524	1	O
.	28592524	1	O

Human	28597146	2	O
IκBα	28597146	2	O
Gain	28597146	2	O
of	28597146	2	O
Function	28597146	2	O
:	28597146	2	O
a	28597146	2	O
Severe	28597146	2	O
and	28597146	2	O
Syndromic	28597146	2	O
Immunodeficiency	28597146	2	O
.	28597146	2	O
Germline	28597146	2	O
heterozygous	28597146	2	O
gain	28597146	2	B-PosReg
-	28597146	2	I-PosReg
of	28597146	2	I-PosReg
-	28597146	2	I-PosReg
function	28597146	2	I-PosReg
(	28597146	2	O
GOF	28597146	2	O
)	28597146	2	O
mutations	28597146	2	B-Var
of	28597146	2	O
NFKBIA	28597146	2	B-Gene
,	28597146	2	O
encoding	28597146	2	O
IκBα	28597146	2	O
,	28597146	2	O
cause	28597146	2	O
an	28597146	2	O
autosomal	28597146	2	O
dominant	28597146	2	O
(	28597146	2	O
AD	28597146	2	O
)	28597146	2	O
form	28597146	2	O
of	28597146	2	O
anhidrotic	28597146	2	B-Disease
ectodermal	28597146	2	I-Disease
dysplasia	28597146	2	I-Disease
with	28597146	2	I-Disease
immunodeficiency	28597146	2	I-Disease
(	28597146	2	O
EDA	28597146	2	O
-	28597146	2	O
ID	28597146	2	O
)	28597146	2	O
.	28597146	2	O
Fourteen	28597146	2	O
unrelated	28597146	2	O
patients	28597146	2	O
have	28597146	2	O
been	28597146	2	O
reported	28597146	2	O
since	28597146	2	O
the	28597146	2	O
identification	28597146	2	O
of	28597146	2	O
the	28597146	2	O
first	28597146	2	O
case	28597146	2	O
in	28597146	2	O
2003	28597146	2	O
.	28597146	2	O
All	28597146	2	O
mutations	28597146	2	B-Var
enhanced	28597146	2	B-PosReg
the	28597146	2	O
inhibitory	28597146	2	O
activity	28597146	2	O
of	28597146	2	O
IκBα	28597146	2	O
,	28597146	2	O
by	28597146	2	O
preventing	28597146	2	B-NegReg
its	28597146	2	O
phosphorylation	28597146	2	O
on	28597146	2	O
serine	28597146	2	O
32	28597146	2	O
or	28597146	2	O
36	28597146	2	O
and	28597146	2	O
its	28597146	2	O
subsequent	28597146	2	O
degradation	28597146	2	O
.	28597146	2	O
The	28597146	2	O
mutation	28597146	2	O
certainly	28597146	2	O
or	28597146	2	O
probably	28597146	2	O
occurred	28597146	2	O
de	28597146	2	O
novo	28597146	2	O
in	28597146	2	O
13	28597146	2	O
patients	28597146	2	O
,	28597146	2	O
whereas	28597146	2	O
it	28597146	2	O
was	28597146	2	O
inherited	28597146	2	O
from	28597146	2	O
a	28597146	2	O
parent	28597146	2	O
with	28597146	2	O
somatic	28597146	2	O
mosaicism	28597146	2	O
in	28597146	2	O
one	28597146	2	O
patient	28597146	2	O
.	28597146	2	O
Eleven	28597146	2	O
mutations	28597146	2	O
,	28597146	2	O
belonging	28597146	2	O
to	28597146	2	O
two	28597146	2	O
groups	28597146	2	O
,	28597146	2	O
were	28597146	2	O
identified	28597146	2	O
:	28597146	2	O
(	28597146	2	O
i	28597146	2	O
)	28597146	2	O
missense	28597146	2	O
mutations	28597146	2	O
affecting	28597146	2	O
S32	28597146	2	O
,	28597146	2	O
S36	28597146	2	O
,	28597146	2	O
or	28597146	2	O
neighboring	28597146	2	O
residues	28597146	2	O
(	28597146	2	O
8	28597146	2	O
mutations	28597146	2	O
,	28597146	2	O
11	28597146	2	O
patients	28597146	2	O
)	28597146	2	O
and	28597146	2	O
(	28597146	2	O
ii	28597146	2	O
)	28597146	2	O
nonsense	28597146	2	O
mutations	28597146	2	O
upstream	28597146	2	O
from	28597146	2	O
S32	28597146	2	O
associated	28597146	2	O
with	28597146	2	O
the	28597146	2	O
reinitiation	28597146	2	O
of	28597146	2	O
translation	28597146	2	O
downstream	28597146	2	O
from	28597146	2	O
S36	28597146	2	O
(	28597146	2	O
3	28597146	2	O
mutations	28597146	2	O
,	28597146	2	O
3	28597146	2	O
patients	28597146	2	O
)	28597146	2	O
.	28597146	2	O
Thirteen	28597146	2	O
patients	28597146	2	O
had	28597146	2	O
developmental	28597146	2	O
features	28597146	2	O
of	28597146	2	O
EDA	28597146	2	O
,	28597146	2	O
the	28597146	2	O
severity	28597146	2	O
and	28597146	2	O
nature	28597146	2	O
of	28597146	2	O
which	28597146	2	O
differed	28597146	2	O
between	28597146	2	O
cases	28597146	2	O
.	28597146	2	O
All	28597146	2	O
patient	28597146	2	O
cells	28597146	2	O
tested	28597146	2	O
displayed	28597146	2	O
impaired	28597146	2	O
NF	28597146	2	O
-	28597146	2	O
κB	28597146	2	O
-	28597146	2	O
mediated	28597146	2	O
responses	28597146	2	O
to	28597146	2	O
the	28597146	2	O
stimulation	28597146	2	O
of	28597146	2	O
various	28597146	2	O
surface	28597146	2	O
receptors	28597146	2	O
involved	28597146	2	O
in	28597146	2	O
cell	28597146	2	O
-	28597146	2	O
intrinsic	28597146	2	O
(	28597146	2	O
fibroblasts	28597146	2	O
)	28597146	2	O
,	28597146	2	O
innate	28597146	2	O
(	28597146	2	O
monocytes	28597146	2	O
)	28597146	2	O
,	28597146	2	O
and	28597146	2	O
adaptive	28597146	2	O
(	28597146	2	O
B	28597146	2	O
and	28597146	2	O
T	28597146	2	O
cells	28597146	2	O
)	28597146	2	O
immunity	28597146	2	O
,	28597146	2	O
including	28597146	2	O
TLRs	28597146	2	O
,	28597146	2	O
IL-1	28597146	2	O
Rs	28597146	2	O
,	28597146	2	O
TNFRs	28597146	2	O
,	28597146	2	O
TCR	28597146	2	O
,	28597146	2	O
and	28597146	2	O
BCR	28597146	2	O
.	28597146	2	O
All	28597146	2	O
patients	28597146	2	O
had	28597146	2	O
profound	28597146	2	O
B	28597146	2	O
-	28597146	2	O
cell	28597146	2	O
deficiency	28597146	2	O
.	28597146	2	O
Specific	28597146	2	O
immunological	28597146	2	O
features	28597146	2	O
,	28597146	2	O
found	28597146	2	O
in	28597146	2	O
some	28597146	2	O
,	28597146	2	O
but	28597146	2	O
not	28597146	2	O
all	28597146	2	O
patients	28597146	2	O
,	28597146	2	O
included	28597146	2	O
a	28597146	2	O
lack	28597146	2	O
of	28597146	2	O
peripheral	28597146	2	O
lymph	28597146	2	O
nodes	28597146	2	O
,	28597146	2	O
lymphocytosis	28597146	2	O
,	28597146	2	O
dysfunctional	28597146	2	O
α	28597146	2	O
/	28597146	2	O
β	28597146	2	O
T	28597146	2	O
cells	28597146	2	O
,	28597146	2	O
and	28597146	2	O
a	28597146	2	O
lack	28597146	2	O
of	28597146	2	O
circulating	28597146	2	O
γ	28597146	2	O
/	28597146	2	O
δ	28597146	2	O
T	28597146	2	O
cells	28597146	2	O
.	28597146	2	O
The	28597146	2	O
patients	28597146	2	O
had	28597146	2	O
various	28597146	2	O
pyogenic	28597146	2	O
,	28597146	2	O
mycobacterial	28597146	2	O
,	28597146	2	O
fungal	28597146	2	O
,	28597146	2	O
and	28597146	2	O
viral	28597146	2	O
severe	28597146	2	O
infections	28597146	2	O
.	28597146	2	O
Patients	28597146	2	O
with	28597146	2	O
a	28597146	2	O
missense	28597146	2	O
mutation	28597146	2	O
tended	28597146	2	O
to	28597146	2	O
display	28597146	2	O
more	28597146	2	O
severe	28597146	2	O
phenotypes	28597146	2	O
,	28597146	2	O
probably	28597146	2	O
due	28597146	2	O
to	28597146	2	O
higher	28597146	2	O
levels	28597146	2	O
of	28597146	2	O
GOF	28597146	2	O
proteins	28597146	2	O
.	28597146	2	O
In	28597146	2	O
the	28597146	2	O
absence	28597146	2	O
of	28597146	2	O
hematopoietic	28597146	2	O
stem	28597146	2	O
cell	28597146	2	O
transplantation	28597146	2	O
(	28597146	2	O
HSCT	28597146	2	O
)	28597146	2	O
,	28597146	2	O
this	28597146	2	O
condition	28597146	2	O
cause	28597146	2	O
death	28597146	2	O
before	28597146	2	O
the	28597146	2	O
age	28597146	2	O
of	28597146	2	O
1	28597146	2	O
year	28597146	2	O
(	28597146	2	O
one	28597146	2	O
child	28597146	2	O
)	28597146	2	O
.	28597146	2	O
Two	28597146	2	O
survivors	28597146	2	O
have	28597146	2	O
been	28597146	2	O
on	28597146	2	O
prophylaxis	28597146	2	O
(	28597146	2	O
at	28597146	2	O
9	28597146	2	O
and	28597146	2	O
22	28597146	2	O
years	28597146	2	O
)	28597146	2	O
.	28597146	2	O
Six	28597146	2	O
children	28597146	2	O
died	28597146	2	O
after	28597146	2	O
HSCT	28597146	2	O
.	28597146	2	O
Five	28597146	2	O
survived	28597146	2	O
,	28597146	2	O
four	28597146	2	O
of	28597146	2	O
whom	28597146	2	O
have	28597146	2	O
been	28597146	2	O
on	28597146	2	O
prophylaxis	28597146	2	O
(	28597146	2	O
3	28597146	2	O
to	28597146	2	O
21	28597146	2	O
years	28597146	2	O
post	28597146	2	O
HSCT	28597146	2	O
)	28597146	2	O
,	28597146	2	O
whereas	28597146	2	O
one	28597146	2	O
has	28597146	2	O
been	28597146	2	O
well	28597146	2	O
with	28597146	2	O
no	28597146	2	O
prophylaxis	28597146	2	O
.	28597146	2	O
Heterozygous	28597146	2	O
GOF	28597146	2	O
mutations	28597146	2	O
in	28597146	2	O
IκBα	28597146	2	O
underlie	28597146	2	O
a	28597146	2	O
severe	28597146	2	O
and	28597146	2	O
syndromic	28597146	2	O
immunodeficiency	28597146	2	O
,	28597146	2	O
the	28597146	2	O
interindividual	28597146	2	O
variability	28597146	2	O
of	28597146	2	O
which	28597146	2	O
might	28597146	2	O
partly	28597146	2	O
be	28597146	2	O
ascribed	28597146	2	O
to	28597146	2	O
the	28597146	2	O
dichotomy	28597146	2	O
of	28597146	2	O
missense	28597146	2	O
and	28597146	2	O
nonsense	28597146	2	O
mutations	28597146	2	O
,	28597146	2	O
and	28597146	2	O
the	28597146	2	O
hematopoietic	28597146	2	O
component	28597146	2	O
of	28597146	2	O
which	28597146	2	O
can	28597146	2	O
be	28597146	2	O
rescued	28597146	2	O
by	28597146	2	O
HSCT	28597146	2	O
.	28597146	2	O

ARX	28627419	0	B-Gene
polyalanine	28627419	0	B-Var
expansion	28627419	0	I-Var
mutations	28627419	0	I-Var
lead	28627419	0	B-Reg
to	28627419	0	I-Reg
migration	28627419	0	O
impediment	28627419	0	O
in	28627419	0	O
the	28627419	0	O
rostral	28627419	0	O
cortex	28627419	0	O
coupled	28627419	0	O
with	28627419	0	O
a	28627419	0	O
developmental	28627419	0	O
deficit	28627419	0	O
of	28627419	0	O
calbindin	28627419	0	O
-	28627419	0	O
positive	28627419	0	O
cortical	28627419	0	O
GABAergic	28627419	0	O
interneurons	28627419	0	O
.	28627419	0	O
The	28627419	0	O
Aristaless	28627419	0	O
-	28627419	0	O
related	28627419	0	O
homeobox	28627419	0	O
gene	28627419	0	O
(	28627419	0	O
ARX	28627419	0	O
)	28627419	0	O
is	28627419	0	O
indispensable	28627419	0	O
for	28627419	0	O
interneuron	28627419	0	O
development	28627419	0	O
.	28627419	0	O
Patients	28627419	0	O
with	28627419	0	O
ARX	28627419	0	O
polyalanine	28627419	0	O
expansion	28627419	0	O
mutations	28627419	0	O
of	28627419	0	O
the	28627419	0	O
first	28627419	0	O
two	28627419	0	O
tracts	28627419	0	O
(	28627419	0	O
namely	28627419	0	O
PA1	28627419	0	O
and	28627419	0	O
PA2	28627419	0	O
)	28627419	0	O
suffer	28627419	0	O
from	28627419	0	O
intellectual	28627419	0	O
disability	28627419	0	O
of	28627419	0	O
varying	28627419	0	O
severity	28627419	0	O
,	28627419	0	O
with	28627419	0	O
seizures	28627419	0	O
a	28627419	0	O
frequent	28627419	0	O
comorbidity	28627419	0	O
.	28627419	0	O
The	28627419	0	O
impact	28627419	0	O
of	28627419	0	O
PA1	28627419	0	O
and	28627419	0	O
PA2	28627419	0	O
mutations	28627419	0	O
on	28627419	0	O
the	28627419	0	O
brain	28627419	0	O
development	28627419	0	O
is	28627419	0	O
unknown	28627419	0	O
,	28627419	0	O
hindering	28627419	0	O
the	28627419	0	O
search	28627419	0	O
for	28627419	0	O
therapeutic	28627419	0	O
interventions	28627419	0	O
.	28627419	0	O
Here	28627419	0	O
,	28627419	0	O
we	28627419	0	O
characterized	28627419	0	O
the	28627419	0	O
disturbances	28627419	0	O
to	28627419	0	O
cortical	28627419	0	O
interneuron	28627419	0	O
development	28627419	0	O
in	28627419	0	O
mice	28627419	0	O
modeling	28627419	0	O
the	28627419	0	O
two	28627419	0	O
most	28627419	0	O
common	28627419	0	O
ARX	28627419	0	O
polyalanine	28627419	0	O
expansion	28627419	0	O
mutations	28627419	0	O
in	28627419	0	O
human	28627419	0	O
.	28627419	0	O
We	28627419	0	O
found	28627419	0	O
a	28627419	0	O
consistent	28627419	0	O
40	28627419	0	O
-	28627419	0	O
50%	28627419	0	O
reduction	28627419	0	O
of	28627419	0	O
calbindin	28627419	0	O
-	28627419	0	O
positive	28627419	0	O
interneurons	28627419	0	O
,	28627419	0	O
but	28627419	0	O
not	28627419	0	O
Stt	28627419	0	O
or	28627419	0	O
Cr	28627419	0	O
interneurons	28627419	0	O
,	28627419	0	O
within	28627419	0	O
the	28627419	0	O
cortex	28627419	0	O
of	28627419	0	O
newborn	28627419	0	O
hemizygous	28627419	0	O
mice	28627419	0	O
(	28627419	0	O
p	28627419	0	O
=	28627419	0	O
0.024	28627419	0	O
)	28627419	0	O
for	28627419	0	O
both	28627419	0	O
mutant	28627419	0	O
strains	28627419	0	O
compared	28627419	0	O
to	28627419	0	O
wildtype	28627419	0	O
(	28627419	0	O
p	28627419	0	O
=	28627419	0	O
0.011	28627419	0	O
)	28627419	0	O
.	28627419	0	O
We	28627419	0	O
demonstrate	28627419	0	O
that	28627419	0	O
this	28627419	0	O
was	28627419	0	O
a	28627419	0	O
consequence	28627419	0	O
of	28627419	0	O
calbindin	28627419	0	O
precursor	28627419	0	O
cells	28627419	0	O
being	28627419	0	O
arrested	28627419	0	O
or	28627419	0	O
delayed	28627419	0	O
at	28627419	0	O
the	28627419	0	O
ventral	28627419	0	O
subpallium	28627419	0	O
en	28627419	0	O
route	28627419	0	O
of	28627419	0	O
tangential	28627419	0	O
migration	28627419	0	O
.	28627419	0	O
Ex	28627419	0	O
-	28627419	0	O
vivo	28627419	0	O
assay	28627419	0	O
validated	28627419	0	O
this	28627419	0	O
migration	28627419	0	O
deficit	28627419	0	O
in	28627419	0	O
PA1	28627419	0	O
cells	28627419	0	O
(	28627419	0	O
p	28627419	0	O
=	28627419	0	O
0.0002	28627419	0	O
)	28627419	0	O
suggesting	28627419	0	O
that	28627419	0	O
the	28627419	0	O
defect	28627419	0	O
is	28627419	0	O
contributed	28627419	0	O
by	28627419	0	O
intrinsic	28627419	0	O
loss	28627419	0	O
of	28627419	0	O
Arx	28627419	0	O
function	28627419	0	O
within	28627419	0	O
migrating	28627419	0	O
cells	28627419	0	O
.	28627419	0	O
Both	28627419	0	O
humans	28627419	0	O
and	28627419	0	O
mice	28627419	0	O
with	28627419	0	O
PA1	28627419	0	O
mutations	28627419	0	O
present	28627419	0	O
with	28627419	0	O
severe	28627419	0	O
clinical	28627419	0	O
features	28627419	0	O
,	28627419	0	O
including	28627419	0	O
intellectual	28627419	0	O
disability	28627419	0	O
and	28627419	0	O
infantile	28627419	0	O
spasms	28627419	0	O
.	28627419	0	O
Our	28627419	0	O
data	28627419	0	O
further	28627419	0	O
demonstrated	28627419	0	O
the	28627419	0	O
pathogenic	28627419	0	O
mechanism	28627419	0	O
was	28627419	0	O
robustly	28627419	0	O
shared	28627419	0	O
between	28627419	0	O
PA1	28627419	0	O
and	28627419	0	O
PA2	28627419	0	O
mutations	28627419	0	O
,	28627419	0	O
as	28627419	0	O
previously	28627419	0	O
reported	28627419	0	O
including	28627419	0	O
Arx	28627419	0	O
protein	28627419	0	O
reduction	28627419	0	O
and	28627419	0	O
overlapping	28627419	0	O
transcriptome	28627419	0	O
profiles	28627419	0	O
within	28627419	0	O
the	28627419	0	O
developing	28627419	0	O
mouse	28627419	0	O
brains	28627419	0	O
.	28627419	0	O
Data	28627419	0	O
from	28627419	0	O
our	28627419	0	O
study	28627419	0	O
demonstrated	28627419	0	O
that	28627419	0	O
cortical	28627419	0	O
calbindin	28627419	0	O
interneuron	28627419	0	O
development	28627419	0	O
and	28627419	0	O
migration	28627419	0	O
is	28627419	0	O
negatively	28627419	0	B-NegReg
affected	28627419	0	O
by	28627419	0	O
ARX	28627419	0	B-Gene
polyalanine	28627419	0	B-Var
expansion	28627419	0	I-Var
mutations	28627419	0	I-Var
.	28627419	0	O
Understanding	28627419	0	O
the	28627419	0	O
cellular	28627419	0	O
pathogenesis	28627419	0	O
contributing	28627419	0	O
to	28627419	0	O
disease	28627419	0	O
manifestation	28627419	0	O
is	28627419	0	O
necessary	28627419	0	O
to	28627419	0	O
screen	28627419	0	O
efficacy	28627419	0	O
of	28627419	0	O
potential	28627419	0	O
therapeutic	28627419	0	O
interventions	28627419	0	O
.	28627419	0	O

Linking	28640966	1	O
the	28640966	1	O
degree	28640966	1	O
of	28640966	1	O
virilization	28640966	1	O
in	28640966	1	O
females	28640966	1	O
with	28640966	1	O
congenital	28640966	1	O
adrenal	28640966	1	O
hyperplasia	28640966	1	O
to	28640966	1	O
genotype	28640966	1	O
.	28640966	1	O
Mutations	28640966	1	B-Var
of	28640966	1	O
CYP21A2	28640966	1	B-Gene
variably	28640966	1	O
decrease	28640966	1	B-NegReg
21	28640966	1	O
-	28640966	1	O
hydroxylase	28640966	1	O
activity	28640966	1	O
and	28640966	1	O
result	28640966	1	B-Reg
in	28640966	1	I-Reg
a	28640966	1	O
spectrum	28640966	1	O
of	28640966	1	O
disease	28640966	1	O
expressions	28640966	1	O
in	28640966	1	O
patients	28640966	1	O
with	28640966	1	O
congenital	28640966	1	B-Disease
adrenal	28640966	1	I-Disease
hyperplasia	28640966	1	I-Disease
(	28640966	1	O
CAH	28640966	1	O
)	28640966	1	O
.	28640966	1	O
We	28640966	1	O
examined	28640966	1	O
the	28640966	1	O
association	28640966	1	O
between	28640966	1	O
CYP21A2	28640966	1	O
mutations	28640966	1	O
and	28640966	1	O
virilization	28640966	1	O
(	28640966	1	O
Prader	28640966	1	O
score	28640966	1	O
)	28640966	1	O
in	28640966	1	O
females	28640966	1	O
with	28640966	1	O
CAH	28640966	1	O
.	28640966	1	O
The	28640966	1	O
study	28640966	1	O
population	28640966	1	O
included	28640966	1	O
187	28640966	1	O
CAH	28640966	1	B-Disease
females	28640966	1	O
with	28640966	1	B-Reg
fully	28640966	1	O
characterized	28640966	1	O
CYP21A2	28640966	1	B-Gene
mutations	28640966	1	B-Var
.	28640966	1	O
One	28640966	1	O
hundred	28640966	1	O
fifty	28640966	1	O
-	28640966	1	O
eight	28640966	1	O
patients	28640966	1	O
were	28640966	1	O
sorted	28640966	1	O
into	28640966	1	O
groups	28640966	1	O
by	28640966	1	O
expected	28640966	1	O
enzyme	28640966	1	O
activity	28640966	1	O
(	28640966	1	O
percent	28640966	1	O
of	28640966	1	O
normal	28640966	1	O
activity	28640966	1	O
)	28640966	1	O
of	28640966	1	O
the	28640966	1	O
less	28640966	1	O
severely	28640966	1	O
affected	28640966	1	O
allele	28640966	1	O
:	28640966	1	O
(	28640966	1	O
A	28640966	1	O
)	28640966	1	O
null	28640966	1	O
,	28640966	1	O
0%	28640966	1	O
;	28640966	1	O
(	28640966	1	O
B	28640966	1	O
)	28640966	1	O
I2G	28640966	1	O
,	28640966	1	O
1%	28640966	1	O
;	28640966	1	O
(	28640966	1	O
C	28640966	1	O
)	28640966	1	O
I172N	28640966	1	O
,	28640966	1	O
2%	28640966	1	O
;	28640966	1	O
and	28640966	1	O
(	28640966	1	O
D	28640966	1	O
)	28640966	1	O
V281L	28640966	1	O
,	28640966	1	O
>	28640966	1	O
2%	28640966	1	O
.	28640966	1	O
We	28640966	1	O
observed	28640966	1	O
an	28640966	1	O
inverse	28640966	1	O
relationship	28640966	1	O
between	28640966	1	O
virilization	28640966	1	O
and	28640966	1	O
residual	28640966	1	O
enzyme	28640966	1	O
activity	28640966	1	O
(	28640966	1	O
P	28640966	1	O
<	28640966	1	O
0.001	28640966	1	O
)	28640966	1	O
.	28640966	1	O
Subjects	28640966	1	O
in	28640966	1	O
group	28640966	1	O
A	28640966	1	O
or	28640966	1	O
B	28640966	1	O
had	28640966	1	O
a	28640966	1	O
significantly	28640966	1	O
higher	28640966	1	O
likelihood	28640966	1	O
(	28640966	1	O
unadjusted	28640966	1	O
odds	28640966	1	O
ratio	28640966	1	O
:	28640966	1	O
16	28640966	1	O
;	28640966	1	O
P	28640966	1	O
<	28640966	1	O
0.001	28640966	1	O
)	28640966	1	O
of	28640966	1	O
developing	28640966	1	O
severe	28640966	1	O
virilization	28640966	1	O
compared	28640966	1	O
with	28640966	1	O
those	28640966	1	O
in	28640966	1	O
group	28640966	1	O
C.	28640966	1	O
Surprisingly	28640966	1	O
,	28640966	1	O
24%	28640966	1	O
of	28640966	1	O
group	28640966	1	O
D	28640966	1	O
patients	28640966	1	O
,	28640966	1	O
whose	28640966	1	O
mutation	28640966	1	O
is	28640966	1	O
usually	28640966	1	O
associated	28640966	1	O
with	28640966	1	O
nonclassical	28640966	1	O
(	28640966	1	O
NC	28640966	1	O
)	28640966	1	O
CAH	28640966	1	O
,	28640966	1	O
had	28640966	1	O
severe	28640966	1	O
virilization	28640966	1	O
.	28640966	1	O
Among	28640966	1	O
subjects	28640966	1	O
with	28640966	1	O
the	28640966	1	O
NC	28640966	1	O
P30L	28640966	1	O
mutation	28640966	1	O
,	28640966	1	O
66%	28640966	1	O
expressed	28640966	1	O
unexpected	28640966	1	O
virilization	28640966	1	O
.	28640966	1	O
Virilization	28640966	1	O
,	28640966	1	O
usually	28640966	1	O
leading	28640966	1	O
to	28640966	1	O
extensive	28640966	1	O
reconstructive	28640966	1	O
surgery	28640966	1	O
,	28640966	1	O
is	28640966	1	O
highly	28640966	1	O
likely	28640966	1	O
in	28640966	1	O
patients	28640966	1	O
with	28640966	1	O
null	28640966	1	O
or	28640966	1	O
I2G	28640966	1	O
mutations	28640966	1	O
;	28640966	1	O
however	28640966	1	O
,	28640966	1	O
NC	28640966	1	O
mutations	28640966	1	O
(	28640966	1	O
P30L	28640966	1	O
/	28640966	1	O
V281L	28640966	1	O
)	28640966	1	O
may	28640966	1	O
also	28640966	1	O
lead	28640966	1	O
to	28640966	1	O
unexpected	28640966	1	O
virilization	28640966	1	O
.	28640966	1	O
These	28640966	1	O
findings	28640966	1	O
have	28640966	1	O
implications	28640966	1	O
for	28640966	1	O
prenatal	28640966	1	O
counseling	28640966	1	O
and	28640966	1	O
highlight	28640966	1	O
the	28640966	1	O
need	28640966	1	O
for	28640966	1	O
additional	28640966	1	O
investigations	28640966	1	O
into	28640966	1	O
other	28640966	1	O
factors	28640966	1	O
that	28640966	1	O
influence	28640966	1	O
virilization	28640966	1	O
in	28640966	1	O
CAH	28640966	1	O
.	28640966	1	O

Inducible	28650109	2	O
activation	28650109	2	O
of	28650109	2	O
FGFR2	28650109	2	O
in	28650109	2	O
adult	28650109	2	O
mice	28650109	2	O
promotes	28650109	2	O
bone	28650109	2	O
formation	28650109	2	O
after	28650109	2	O
bone	28650109	2	O
marrow	28650109	2	O
ablation	28650109	2	O
.	28650109	2	O
Apert	28650109	2	B-Disease
syndrome	28650109	2	I-Disease
is	28650109	2	O
one	28650109	2	O
of	28650109	2	O
the	28650109	2	O
most	28650109	2	O
severe	28650109	2	O
craniosynostoses	28650109	2	O
,	28650109	2	O
resulting	28650109	2	O
from	28650109	2	O
gain	28650109	2	B-PosReg
-	28650109	2	I-PosReg
of	28650109	2	I-PosReg
-	28650109	2	I-PosReg
function	28650109	2	I-PosReg
mutations	28650109	2	B-Var
in	28650109	2	O
fibroblast	28650109	2	O
growth	28650109	2	O
factor	28650109	2	O
receptor	28650109	2	O
2	28650109	2	O
(	28650109	2	B-Gene
FGFR2	28650109	2	I-Gene
)	28650109	2	I-Gene
.	28650109	2	O
Previous	28650109	2	O
studies	28650109	2	O
have	28650109	2	O
shown	28650109	2	O
that	28650109	2	O
gain	28650109	2	O
-	28650109	2	O
of	28650109	2	O
-	28650109	2	O
function	28650109	2	O
mutations	28650109	2	O
of	28650109	2	O
FGFR2	28650109	2	O
(	28650109	2	O
S252W	28650109	2	O
or	28650109	2	O
P253R	28650109	2	O
)	28650109	2	O
cause	28650109	2	O
skull	28650109	2	O
malformation	28650109	2	O
of	28650109	2	O
human	28650109	2	O
Apert	28650109	2	O
syndrome	28650109	2	O
by	28650109	2	O
affecting	28650109	2	O
both	28650109	2	O
chondrogenesis	28650109	2	O
and	28650109	2	O
osteogenesis	28650109	2	O
,	28650109	2	O
underscoring	28650109	2	O
the	28650109	2	O
key	28650109	2	O
role	28650109	2	O
of	28650109	2	O
FGFR2	28650109	2	O
in	28650109	2	O
bone	28650109	2	O
development	28650109	2	O
.	28650109	2	O
However	28650109	2	O
,	28650109	2	O
the	28650109	2	O
effects	28650109	2	O
of	28650109	2	O
FGFR2	28650109	2	O
on	28650109	2	O
bone	28650109	2	O
formation	28650109	2	O
at	28650109	2	O
the	28650109	2	O
adult	28650109	2	O
stage	28650109	2	O
have	28650109	2	O
not	28650109	2	O
been	28650109	2	O
fully	28650109	2	O
investigated	28650109	2	O
.	28650109	2	O
To	28650109	2	O
investigate	28650109	2	O
the	28650109	2	O
role	28650109	2	O
of	28650109	2	O
FGFR2	28650109	2	O
in	28650109	2	O
bone	28650109	2	O
formation	28650109	2	O
,	28650109	2	O
we	28650109	2	O
generated	28650109	2	O
mice	28650109	2	O
with	28650109	2	O
tamoxifen	28650109	2	O
-	28650109	2	O
inducible	28650109	2	O
expression	28650109	2	O
of	28650109	2	O
mutant	28650109	2	O
FGFR2	28650109	2	O
(	28650109	2	O
P253R	28650109	2	O
)	28650109	2	O
at	28650109	2	O
the	28650109	2	O
adult	28650109	2	O
stage	28650109	2	O
.	28650109	2	O
Mechanical	28650109	2	O
bone	28650109	2	O
marrow	28650109	2	O
ablation	28650109	2	O
(	28650109	2	O
BMX	28650109	2	O
)	28650109	2	O
was	28650109	2	O
performed	28650109	2	O
in	28650109	2	O
both	28650109	2	O
wild	28650109	2	O
-	28650109	2	O
type	28650109	2	O
and	28650109	2	O
Fgfr2	28650109	2	B-Gene
mutant	28650109	2	B-Var
(	28650109	2	O
MT	28650109	2	O
)	28650109	2	O
mice	28650109	2	O
.	28650109	2	O
Changes	28650109	2	O
in	28650109	2	O
newly	28650109	2	O
formed	28650109	2	O
trabecular	28650109	2	O
bone	28650109	2	O
were	28650109	2	O
assessed	28650109	2	O
by	28650109	2	O
micro	28650109	2	O
-	28650109	2	O
computed	28650109	2	O
tomography	28650109	2	O
and	28650109	2	O
bone	28650109	2	O
histomorphometry	28650109	2	O
.	28650109	2	O
We	28650109	2	O
found	28650109	2	O
that	28650109	2	O
MT	28650109	2	O
mice	28650109	2	O
exhibited	28650109	2	O
increased	28650109	2	B-PosReg
trabecular	28650109	2	O
bone	28650109	2	O
formation	28650109	2	O
and	28650109	2	O
decreased	28650109	2	B-NegReg
bone	28650109	2	O
resorption	28650109	2	O
after	28650109	2	O
BMX	28650109	2	O
accompanied	28650109	2	O
with	28650109	2	O
a	28650109	2	O
remarkable	28650109	2	O
increase	28650109	2	B-PosReg
in	28650109	2	O
bone	28650109	2	O
marrow	28650109	2	O
stromal	28650109	2	O
cell	28650109	2	O
recruitment	28650109	2	O
and	28650109	2	O
proliferation	28650109	2	O
,	28650109	2	O
osteoblast	28650109	2	O
proliferation	28650109	2	O
and	28650109	2	O
differentiation	28650109	2	O
,	28650109	2	O
and	28650109	2	O
enhanced	28650109	2	B-PosReg
Wnt	28650109	2	O
/	28650109	2	O
?	28650109	2	O
-	28650109	2	O
catenin	28650109	2	O
activity	28650109	2	O
.	28650109	2	O
Furthermore	28650109	2	O
,	28650109	2	O
pharmacologically	28650109	2	O
inhibiting	28650109	2	O
Wnt	28650109	2	O
/	28650109	2	O
β	28650109	2	O
-	28650109	2	O
catenin	28650109	2	O
signaling	28650109	2	O
can	28650109	2	O
partially	28650109	2	O
reverse	28650109	2	O
the	28650109	2	O
increased	28650109	2	O
trabecular	28650109	2	O
bone	28650109	2	O
formation	28650109	2	O
and	28650109	2	O
decreased	28650109	2	O
bone	28650109	2	O
resorption	28650109	2	O
in	28650109	2	O
MT	28650109	2	O
mice	28650109	2	O
after	28650109	2	O
BMX	28650109	2	O
.	28650109	2	O
Our	28650109	2	O
data	28650109	2	O
demonstrate	28650109	2	O
that	28650109	2	O
gain	28650109	2	B-PosReg
-	28650109	2	I-PosReg
of	28650109	2	I-PosReg
-	28650109	2	I-PosReg
function	28650109	2	I-PosReg
mutation	28650109	2	B-Var
in	28650109	2	O
FGFR2	28650109	2	B-Gene
exerts	28650109	2	O
a	28650109	2	O
Wnt	28650109	2	O
/	28650109	2	O
β	28650109	2	O
-	28650109	2	O
catenin	28650109	2	O
-	28650109	2	O
dependent	28650109	2	O
anabolic	28650109	2	O
effect	28650109	2	O
on	28650109	2	O
trabecular	28650109	2	O
bone	28650109	2	O
by	28650109	2	O
promoting	28650109	2	B-PosReg
bone	28650109	2	O
formation	28650109	2	O
and	28650109	2	O
inhibiting	28650109	2	B-NegReg
bone	28650109	2	O
resorption	28650109	2	O
at	28650109	2	O
the	28650109	2	O
adult	28650109	2	O
stage	28650109	2	O
.	28650109	2	O
This	28650109	2	O
article	28650109	2	O
is	28650109	2	O
protected	28650109	2	O
by	28650109	2	O
copyright	28650109	2	O
.	28650109	2	O
All	28650109	2	O
rights	28650109	2	O
reserved	28650109	2	O
.	28650109	2	O

Early	28659290	1	B-Disease
-	28659290	1	I-Disease
onset	28659290	1	I-Disease
autoimmune	28659290	1	I-Disease
disease	28659290	1	I-Disease
due	28659290	1	O
to	28659290	1	O
a	28659290	1	O
heterozygous	28659290	1	O
loss	28659290	1	B-NegReg
-	28659290	1	I-NegReg
of	28659290	1	I-NegReg
-	28659290	1	I-NegReg
function	28659290	1	I-NegReg
mutation	28659290	1	B-Var
in	28659290	1	O
TNFAIP3	28659290	1	B-Gene
(	28659290	1	O
A20	28659290	1	O
)	28659290	1	O
.	28659290	1	O

The	28662729	0	O
moving	28662729	0	O
junction	28662729	0	O
protein	28662729	0	O
RON4	28662729	0	O
,	28662729	0	O
although	28662729	0	O
not	28662729	0	O
critical	28662729	0	O
,	28662729	0	O
facilitates	28662729	0	O
host	28662729	0	O
cell	28662729	0	O
invasion	28662729	0	O
and	28662729	0	O
stabilizes	28662729	0	O
MJ	28662729	0	O
members	28662729	0	O
.	28662729	0	O
Toxoplasma	28662729	0	O
gondii	28662729	0	O
is	28662729	0	O
an	28662729	0	O
obligate	28662729	0	O
intracellular	28662729	0	O
parasite	28662729	0	O
of	28662729	0	O
phylum	28662729	0	O
Apicomplexa	28662729	0	O
.	28662729	0	O
To	28662729	0	O
facilitate	28662729	0	O
high	28662729	0	O
-	28662729	0	O
efficiency	28662729	0	O
invasion	28662729	0	O
of	28662729	0	O
host	28662729	0	O
cells	28662729	0	O
,	28662729	0	O
T.	28662729	0	O
gondii	28662729	0	O
secretes	28662729	0	O
various	28662729	0	O
proteins	28662729	0	O
related	28662729	0	O
to	28662729	0	O
the	28662729	0	O
moving	28662729	0	O
junction	28662729	0	O
(	28662729	0	O
MJ	28662729	0	O
)	28662729	0	O
complex	28662729	0	O
from	28662729	0	O
rhoptries	28662729	0	O
and	28662729	0	O
micronemes	28662729	0	O
into	28662729	0	O
the	28662729	0	O
interface	28662729	0	O
between	28662729	0	O
the	28662729	0	O
parasite	28662729	0	O
and	28662729	0	O
host	28662729	0	O
.	28662729	0	O
AMA1	28662729	0	O
/	28662729	0	O
RON2	28662729	0	O
/	28662729	0	O
4	28662729	0	O
/	28662729	0	O
5	28662729	0	O
/	28662729	0	O
8	28662729	0	O
is	28662729	0	O
an	28662729	0	O
important	28662729	0	O
MJ	28662729	0	O
complex	28662729	0	O
,	28662729	0	O
but	28662729	0	O
its	28662729	0	O
mechanism	28662729	0	O
of	28662729	0	O
assembly	28662729	0	O
remains	28662729	0	O
unclear	28662729	0	O
.	28662729	0	O
In	28662729	0	O
this	28662729	0	O
study	28662729	0	O
,	28662729	0	O
we	28662729	0	O
used	28662729	0	O
the	28662729	0	O
CRISPR	28662729	0	O
-	28662729	0	O
Cas9	28662729	0	O
system	28662729	0	O
to	28662729	0	O
generate	28662729	0	O
a	28662729	0	O
derivative	28662729	0	O
of	28662729	0	O
T.	28662729	0	O
gondii	28662729	0	O
strain	28662729	0	O
RH	28662729	0	O
with	28662729	0	O
a	28662729	0	O
null	28662729	0	B-Var
mutation	28662729	0	I-Var
in	28662729	0	O
TgRON4	28662729	0	B-Gene
,	28662729	0	O
thought	28662729	0	O
to	28662729	0	O
be	28662729	0	O
an	28662729	0	O
essential	28662729	0	O
MJ	28662729	0	O
component	28662729	0	O
.	28662729	0	O
Deficiency	28662729	0	B-NegReg
of	28662729	0	O
TgRON4	28662729	0	O
moderately	28662729	0	O
decreased	28662729	0	B-NegReg
invasion	28662729	0	O
ability	28662729	0	O
relative	28662729	0	O
to	28662729	0	O
that	28662729	0	O
of	28662729	0	O
the	28662729	0	O
wild	28662729	0	O
-	28662729	0	O
type	28662729	0	O
parasite	28662729	0	O
.	28662729	0	O
In	28662729	0	O
addition	28662729	0	O
,	28662729	0	O
expression	28662729	0	O
of	28662729	0	O
the	28662729	0	O
endogenous	28662729	0	O
N	28662729	0	O
-	28662729	0	O
terminal	28662729	0	O
fragment	28662729	0	O
of	28662729	0	O
RON5	28662729	0	O
decreased	28662729	0	B-NegReg
in	28662729	0	O
the	28662729	0	O
mutant	28662729	0	B-Var
.	28662729	0	O
Together	28662729	0	O
,	28662729	0	O
the	28662729	0	O
results	28662729	0	O
improve	28662729	0	O
our	28662729	0	O
understanding	28662729	0	O
of	28662729	0	O
the	28662729	0	O
assembly	28662729	0	O
mechanism	28662729	0	O
of	28662729	0	O
the	28662729	0	O
MJ	28662729	0	O
complex	28662729	0	O
of	28662729	0	O
T.	28662729	0	O
gondii	28662729	0	O
and	28662729	0	O
raise	28662729	0	O
the	28662729	0	O
possibility	28662729	0	O
of	28662729	0	O
developing	28662729	0	O
new	28662729	0	O
therapeutic	28662729	0	O
drugs	28662729	0	O
that	28662729	0	O
target	28662729	0	O
this	28662729	0	O
complex	28662729	0	O
.	28662729	0	O

Natural	28667273	0	O
and	28667273	0	O
induced	28667273	0	O
loss	28667273	0	B-NegReg
of	28667273	0	I-NegReg
function	28667273	0	I-NegReg
mutations	28667273	0	B-Var
in	28667273	0	O
SlMBP21	28667273	0	B-Gene
MADS	28667273	0	O
-	28667273	0	O
box	28667273	0	O
gene	28667273	0	O
led	28667273	0	O
to	28667273	0	O
jointless-2	28667273	0	O
phenotype	28667273	0	O
in	28667273	0	O
tomato	28667273	0	O
.	28667273	0	O
Abscission	28667273	0	O
is	28667273	0	O
the	28667273	0	O
mechanism	28667273	0	O
by	28667273	0	O
which	28667273	0	O
plants	28667273	0	O
disconnect	28667273	0	O
unfertilized	28667273	0	O
flowers	28667273	0	O
,	28667273	0	O
ripe	28667273	0	O
fruits	28667273	0	O
,	28667273	0	O
senescent	28667273	0	O
or	28667273	0	O
diseased	28667273	0	O
organs	28667273	0	O
from	28667273	0	O
the	28667273	0	O
plant	28667273	0	O
.	28667273	0	O
In	28667273	0	O
tomato	28667273	0	O
,	28667273	0	O
pedicel	28667273	0	O
abscission	28667273	0	O
is	28667273	0	O
an	28667273	0	O
important	28667273	0	O
agronomic	28667273	0	O
factor	28667273	0	O
that	28667273	0	O
controls	28667273	0	O
yield	28667273	0	O
and	28667273	0	O
post	28667273	0	O
-	28667273	0	O
harvest	28667273	0	O
fruit	28667273	0	O
quality	28667273	0	O
.	28667273	0	O
Two	28667273	0	O
non	28667273	0	O
-	28667273	0	O
allelic	28667273	0	O
mutations	28667273	0	O
,	28667273	0	O
jointless	28667273	0	O
(	28667273	0	O
j	28667273	0	O
)	28667273	0	O
and	28667273	0	O
jointless-2	28667273	0	O
(	28667273	0	O
j-2	28667273	0	O
)	28667273	0	O
,	28667273	0	O
controlling	28667273	0	O
pedicel	28667273	0	O
abscission	28667273	0	O
zone	28667273	0	O
formation	28667273	0	O
have	28667273	0	O
been	28667273	0	O
documented	28667273	0	O
but	28667273	0	O
only	28667273	0	O
j-2	28667273	0	O
has	28667273	0	O
been	28667273	0	O
extensively	28667273	0	O
used	28667273	0	O
in	28667273	0	O
breeding	28667273	0	O
.	28667273	0	O
J	28667273	0	O
was	28667273	0	O
shown	28667273	0	O
to	28667273	0	O
encode	28667273	0	O
a	28667273	0	O
MADS	28667273	0	O
-	28667273	0	O
box	28667273	0	O
protein	28667273	0	O
.	28667273	0	O
Using	28667273	0	O
a	28667273	0	O
combination	28667273	0	O
of	28667273	0	O
physical	28667273	0	O
mapping	28667273	0	O
and	28667273	0	O
gene	28667273	0	O
expression	28667273	0	O
analysis	28667273	0	O
we	28667273	0	O
identified	28667273	0	O
a	28667273	0	O
positional	28667273	0	O
candidate	28667273	0	O
,	28667273	0	O
Solyc12g038510	28667273	0	O
,	28667273	0	O
associated	28667273	0	O
with	28667273	0	O
j-2	28667273	0	O
phenotype	28667273	0	O
.	28667273	0	O
Targeted	28667273	0	O
knockout	28667273	0	O
of	28667273	0	O
Solyc12g038510	28667273	0	O
,	28667273	0	O
using	28667273	0	O
CRISPR	28667273	0	O
/	28667273	0	O
Cas9	28667273	0	O
system	28667273	0	O
,	28667273	0	O
validated	28667273	0	O
our	28667273	0	O
hypothesis	28667273	0	O
.	28667273	0	O
Solyc12g038510	28667273	0	O
encodes	28667273	0	O
the	28667273	0	O
MADS	28667273	0	O
-	28667273	0	O
box	28667273	0	O
protein	28667273	0	O
SlMBP21	28667273	0	O
.	28667273	0	O
Molecular	28667273	0	O
analysis	28667273	0	O
of	28667273	0	O
j-2	28667273	0	O
natural	28667273	0	O
variation	28667273	0	O
revealed	28667273	0	O
two	28667273	0	O
independent	28667273	0	O
loss	28667273	0	O
-	28667273	0	O
of	28667273	0	O
-	28667273	0	O
function	28667273	0	O
mutants	28667273	0	O
.	28667273	0	O
The	28667273	0	O
first	28667273	0	O
results	28667273	0	O
of	28667273	0	O
an	28667273	0	O
insertion	28667273	0	O
of	28667273	0	O
a	28667273	0	O
Rider	28667273	0	O
retrotransposable	28667273	0	O
element	28667273	0	O
.	28667273	0	O
The	28667273	0	O
second	28667273	0	O
results	28667273	0	O
of	28667273	0	O
a	28667273	0	O
stop	28667273	0	O
codon	28667273	0	O
mutation	28667273	0	O
that	28667273	0	O
leads	28667273	0	O
to	28667273	0	O
a	28667273	0	O
truncated	28667273	0	O
protein	28667273	0	O
form	28667273	0	O
.	28667273	0	O
To	28667273	0	O
bring	28667273	0	O
new	28667273	0	O
insights	28667273	0	O
into	28667273	0	O
the	28667273	0	O
role	28667273	0	O
of	28667273	0	O
J	28667273	0	O
and	28667273	0	O
J-2	28667273	0	O
in	28667273	0	O
abscission	28667273	0	O
zone	28667273	0	O
formation	28667273	0	O
,	28667273	0	O
we	28667273	0	O
phenotyped	28667273	0	O
the	28667273	0	O
single	28667273	0	O
and	28667273	0	O
the	28667273	0	O
double	28667273	0	O
mutants	28667273	0	O
and	28667273	0	O
the	28667273	0	O
engineered	28667273	0	O
alleles	28667273	0	O
.	28667273	0	O
We	28667273	0	O
showed	28667273	0	O
that	28667273	0	O
J	28667273	0	O
is	28667273	0	O
epistatic	28667273	0	O
to	28667273	0	O
J-2	28667273	0	O
and	28667273	0	O
that	28667273	0	O
the	28667273	0	O
branched	28667273	0	O
inflorescences	28667273	0	O
and	28667273	0	O
the	28667273	0	O
leafy	28667273	0	O
sepals	28667273	0	O
observed	28667273	0	O
in	28667273	0	O
accessions	28667273	0	O
harboring	28667273	0	O
j-2	28667273	0	O
alleles	28667273	0	O
are	28667273	0	O
likely	28667273	0	O
the	28667273	0	O
consequences	28667273	0	O
of	28667273	0	O
linkage	28667273	0	O
drags	28667273	0	O
.	28667273	0	O

Nephron	28683731	0	O
development	28683731	0	O
and	28683731	0	O
extrarenal	28683731	0	O
features	28683731	0	O
in	28683731	0	O
a	28683731	0	O
child	28683731	0	O
with	28683731	0	O
congenital	28683731	0	O
nephrotic	28683731	0	O
syndrome	28683731	0	O
caused	28683731	0	B-Reg
by	28683731	0	I-Reg
null	28683731	0	O
LAMB2	28683731	0	B-Gene
mutations	28683731	0	B-Var
.	28683731	0	O
BACKGROUND	28683731	0	O
:	28683731	0	O
Congenital	28683731	0	O
nephrotic	28683731	0	O
syndrome	28683731	0	O
(	28683731	0	O
CNS	28683731	0	O
)	28683731	0	O
is	28683731	0	O
a	28683731	0	O
rare	28683731	0	O
disorder	28683731	0	O
caused	28683731	0	O
by	28683731	0	O
various	28683731	0	O
structural	28683731	0	O
and	28683731	0	O
developmental	28683731	0	O
defects	28683731	0	O
of	28683731	0	O
glomeruli	28683731	0	O
.	28683731	0	O
It	28683731	0	O
occurs	28683731	0	O
typically	28683731	0	O
as	28683731	0	O
an	28683731	0	O
isolated	28683731	0	O
kidney	28683731	0	O
disorder	28683731	0	O
but	28683731	0	O
associates	28683731	0	O
sometimes	28683731	0	O
with	28683731	0	O
other	28683731	0	O
systemic	28683731	0	O
,	28683731	0	O
extrarenal	28683731	0	O
manifestations	28683731	0	O
.	28683731	0	O
CASE	28683731	0	O
PRESENTATIONS	28683731	0	O
:	28683731	0	O
An	28683731	0	O
infant	28683731	0	O
presented	28683731	0	O
with	28683731	0	O
severe	28683731	0	O
CNS	28683731	0	O
,	28683731	0	O
which	28683731	0	O
progressed	28683731	0	O
rapidly	28683731	0	O
to	28683731	0	O
renal	28683731	0	O
failure	28683731	0	O
at	28683731	0	O
age	28683731	0	O
of	28683731	0	O
3	28683731	0	O
months	28683731	0	O
and	28683731	0	O
death	28683731	0	O
at	28683731	0	O
27	28683731	0	O
months	28683731	0	O
.	28683731	0	O
The	28683731	0	O
clinical	28683731	0	O
phenotypes	28683731	0	O
and	28683731	0	O
genetic	28683731	0	O
causes	28683731	0	O
were	28683731	0	O
studied	28683731	0	O
,	28683731	0	O
including	28683731	0	O
the	28683731	0	O
renal	28683731	0	O
pathology	28683731	0	O
at	28683731	0	O
autopsy	28683731	0	O
.	28683731	0	O
Besides	28683731	0	O
the	28683731	0	O
CNS	28683731	0	O
,	28683731	0	O
the	28683731	0	O
affected	28683731	0	O
child	28683731	0	O
had	28683731	0	O
remarkable	28683731	0	O
right	28683731	0	O
-	28683731	0	O
side	28683731	0	O
predominant	28683731	0	O
eye	28683731	0	O
-	28683731	0	O
ball	28683731	0	O
hypoplasia	28683731	0	O
with	28683731	0	O
bilateral	28683731	0	O
anterior	28683731	0	O
chamber	28683731	0	O
dysgenesis	28683731	0	O
(	28683731	0	O
microcoria	28683731	0	O
)	28683731	0	O
.	28683731	0	O
Brain	28683731	0	O
MRI	28683731	0	O
revealed	28683731	0	O
grossly	28683731	0	O
normal	28683731	0	O
development	28683731	0	O
in	28683731	0	O
the	28683731	0	O
cerebrum	28683731	0	O
,	28683731	0	O
cerebellum	28683731	0	O
,	28683731	0	O
and	28683731	0	O
brain	28683731	0	O
stem	28683731	0	O
.	28683731	0	O
Auditory	28683731	0	O
brainstem	28683731	0	O
responses	28683731	0	O
were	28683731	0	O
bilaterally	28683731	0	O
blunted	28683731	0	O
,	28683731	0	O
suggesting	28683731	0	O
a	28683731	0	O
defective	28683731	0	O
auditory	28683731	0	O
system	28683731	0	O
.	28683731	0	O
At	28683731	0	O
autopsy	28683731	0	O
,	28683731	0	O
both	28683731	0	O
kidneys	28683731	0	O
were	28683731	0	O
mildly	28683731	0	O
atrophied	28683731	0	O
with	28683731	0	O
persistent	28683731	0	O
fetal	28683731	0	O
lobulation	28683731	0	O
.	28683731	0	O
Microscopic	28683731	0	O
examination	28683731	0	O
showed	28683731	0	O
a	28683731	0	O
diffuse	28683731	0	O
global	28683731	0	O
sclerosis	28683731	0	O
.	28683731	0	O
However	28683731	0	O
,	28683731	0	O
despite	28683731	0	O
of	28683731	0	O
the	28683731	0	O
smaller	28683731	0	O
size	28683731	0	O
of	28683731	0	O
glomeruli	28683731	0	O
,	28683731	0	O
the	28683731	0	O
nephron	28683731	0	O
number	28683731	0	O
remained	28683731	0	O
similar	28683731	0	O
to	28683731	0	O
that	28683731	0	O
of	28683731	0	O
the	28683731	0	O
age	28683731	0	O
-	28683731	0	O
matched	28683731	0	O
control	28683731	0	O
.	28683731	0	O
Whole	28683731	0	O
-	28683731	0	O
exome	28683731	0	O
sequencing	28683731	0	O
revealed	28683731	0	O
that	28683731	0	O
the	28683731	0	O
affected	28683731	0	O
child	28683731	0	O
was	28683731	0	O
compound	28683731	0	O
heterozygous	28683731	0	O
for	28683731	0	O
novel	28683731	0	O
truncating	28683731	0	O
LAMB2	28683731	0	O
mutations	28683731	0	O
:	28683731	0	O
a	28683731	0	O
4	28683731	0	O
-	28683731	0	O
bp	28683731	0	O
insertion	28683731	0	O
(	28683731	0	O
p.Gly1693Alafs*8	28683731	0	O
)	28683731	0	O
and	28683731	0	O
a	28683731	0	O
splicing	28683731	0	O
donor	28683731	0	O
-	28683731	0	O
site	28683731	0	O
substitution	28683731	0	O
(	28683731	0	O
c.1225	28683731	0	O
1	28683731	0	O
G	28683731	0	O
>	28683731	0	O
A	28683731	0	O
)	28683731	0	O
,	28683731	0	O
presumably	28683731	0	O
deleting	28683731	0	O
the	28683731	0	O
coiled	28683731	0	O
-	28683731	0	O
coil	28683731	0	O
domains	28683731	0	O
that	28683731	0	O
form	28683731	0	O
the	28683731	0	O
laminin	28683731	0	O
5	28683731	0	O
-	28683731	0	O
2	28683731	0	O
-	28683731	0	O
1	28683731	0	O
heterotrimer	28683731	0	O
complex	28683731	0	O
.	28683731	0	O
CONCLUSIONS	28683731	0	O
:	28683731	0	O
Our	28683731	0	O
case	28683731	0	O
represents	28683731	0	O
a	28683731	0	O
variation	28683731	0	O
of	28683731	0	O
Pierson	28683731	0	O
syndrome	28683731	0	O
that	28683731	0	O
accompanies	28683731	0	O
CNS	28683731	0	O
with	28683731	0	O
unilateral	28683731	0	O
ocular	28683731	0	O
hypoplasia	28683731	0	O
.	28683731	0	O
The	28683731	0	O
average	28683731	0	O
number	28683731	0	O
but	28683731	0	O
smaller	28683731	0	O
glomeruli	28683731	0	O
could	28683731	0	O
reflect	28683731	0	O
either	28683731	0	O
mal	28683731	0	O
-	28683731	0	O
development	28683731	0	O
or	28683731	0	O
glomerulosclerosis	28683731	0	O
.	28683731	0	O
Heterogeneous	28683731	0	O
clinical	28683731	0	O
expression	28683731	0	O
of	28683731	0	O
LAMB2	28683731	0	O
defects	28683731	0	O
may	28683731	0	O
associate	28683731	0	O
with	28683731	0	O
the	28683731	0	O
difference	28683731	0	O
in	28683731	0	O
fetal	28683731	0	O
β1	28683731	0	O
subtype	28683731	0	O
compensation	28683731	0	O
among	28683731	0	O
affected	28683731	0	O
tissues	28683731	0	O
.	28683731	0	O
Further	28683731	0	O
study	28683731	0	O
is	28683731	0	O
necessary	28683731	0	O
to	28683731	0	O
evaluate	28683731	0	O
incidence	28683731	0	O
and	28683731	0	O
features	28683731	0	O
of	28683731	0	O
auditory	28683731	0	O
defect	28683731	0	O
under	28683731	0	O
LAMB2	28683731	0	O
deficiency	28683731	0	O
.	28683731	0	O

Exome	28697784	1	O
sequencing	28697784	1	O
reveals	28697784	1	O
independent	28697784	1	O
SGCD	28697784	1	B-Gene
deletions	28697784	1	B-Var
causing	28697784	1	B-Reg
limb	28697784	1	B-Disease
girdle	28697784	1	I-Disease
muscular	28697784	1	I-Disease
dystrophy	28697784	1	I-Disease
in	28697784	1	O
Boston	28697784	1	O
terriers	28697784	1	O
.	28697784	1	O
BACKGROUND	28697784	1	O
:	28697784	1	O
Limb	28697784	1	O
-	28697784	1	O
girdle	28697784	1	O
muscular	28697784	1	O
dystrophies	28697784	1	O
(	28697784	1	O
LGMDs	28697784	1	O
)	28697784	1	O
are	28697784	1	O
a	28697784	1	O
heterogeneous	28697784	1	O
group	28697784	1	O
of	28697784	1	O
inherited	28697784	1	O
autosomal	28697784	1	O
myopathies	28697784	1	O
that	28697784	1	O
preferentially	28697784	1	O
affect	28697784	1	O
voluntary	28697784	1	O
muscles	28697784	1	O
of	28697784	1	O
the	28697784	1	O
shoulders	28697784	1	O
and	28697784	1	O
hips	28697784	1	O
.	28697784	1	O
LGMD	28697784	1	O
has	28697784	1	O
been	28697784	1	O
clinically	28697784	1	O
described	28697784	1	O
in	28697784	1	O
several	28697784	1	O
breeds	28697784	1	O
of	28697784	1	O
dogs	28697784	1	O
,	28697784	1	O
but	28697784	1	O
the	28697784	1	O
responsible	28697784	1	O
mutations	28697784	1	O
are	28697784	1	O
unknown	28697784	1	O
.	28697784	1	O
The	28697784	1	O
clinical	28697784	1	O
presentation	28697784	1	O
in	28697784	1	O
dogs	28697784	1	O
is	28697784	1	O
characterized	28697784	1	O
by	28697784	1	O
marked	28697784	1	O
muscle	28697784	1	O
weakness	28697784	1	O
and	28697784	1	O
atrophy	28697784	1	O
in	28697784	1	O
the	28697784	1	O
shoulder	28697784	1	O
and	28697784	1	O
hips	28697784	1	O
during	28697784	1	O
puppyhood	28697784	1	O
.	28697784	1	O
METHODS	28697784	1	O
:	28697784	1	O
Following	28697784	1	O
clinical	28697784	1	O
evaluation	28697784	1	O
,	28697784	1	O
the	28697784	1	O
identification	28697784	1	O
of	28697784	1	O
the	28697784	1	O
dystrophic	28697784	1	O
histological	28697784	1	O
phenotype	28697784	1	O
on	28697784	1	O
muscle	28697784	1	O
histology	28697784	1	O
,	28697784	1	O
and	28697784	1	O
demonstration	28697784	1	O
of	28697784	1	O
the	28697784	1	O
absence	28697784	1	O
of	28697784	1	O
sarcoglycan	28697784	1	O
-	28697784	1	O
sarcospan	28697784	1	O
complex	28697784	1	O
by	28697784	1	O
immunostaining	28697784	1	O
,	28697784	1	O
whole	28697784	1	O
exome	28697784	1	O
sequencing	28697784	1	O
was	28697784	1	O
performed	28697784	1	O
on	28697784	1	O
five	28697784	1	O
Boston	28697784	1	O
terriers	28697784	1	O
:	28697784	1	O
one	28697784	1	O
affected	28697784	1	O
dog	28697784	1	O
and	28697784	1	O
its	28697784	1	O
three	28697784	1	O
family	28697784	1	O
members	28697784	1	O
and	28697784	1	O
one	28697784	1	O
unrelated	28697784	1	O
affected	28697784	1	O
dog	28697784	1	O
.	28697784	1	O
RESULTS	28697784	1	O
:	28697784	1	O
Within	28697784	1	O
sarcoglycan	28697784	1	O
-	28697784	1	O
δ	28697784	1	O
(	28697784	1	B-Gene
SGCD	28697784	1	I-Gene
)	28697784	1	I-Gene
,	28697784	1	O
a	28697784	1	O
two	28697784	1	O
base	28697784	1	O
pair	28697784	1	O
deletion	28697784	1	O
segregating	28697784	1	O
with	28697784	1	O
LGMD	28697784	1	O
in	28697784	1	O
the	28697784	1	O
family	28697784	1	O
was	28697784	1	O
discovered	28697784	1	O
,	28697784	1	O
and	28697784	1	O
a	28697784	1	O
deletion	28697784	1	O
encompassing	28697784	1	O
exons	28697784	1	O
7	28697784	1	O
and	28697784	1	O
8	28697784	1	O
was	28697784	1	O
found	28697784	1	O
in	28697784	1	O
the	28697784	1	O
unrelated	28697784	1	O
dog	28697784	1	O
.	28697784	1	O
Both	28697784	1	O
mutations	28697784	1	B-Var
are	28697784	1	O
predicted	28697784	1	O
to	28697784	1	O
cause	28697784	1	O
an	28697784	1	O
absence	28697784	1	B-NegReg
of	28697784	1	O
SGCD	28697784	1	B-Gene
protein	28697784	1	O
,	28697784	1	O
confirmed	28697784	1	O
by	28697784	1	O
immunohistochemistry	28697784	1	O
.	28697784	1	O
The	28697784	1	O
mutations	28697784	1	O
are	28697784	1	O
private	28697784	1	O
to	28697784	1	O
each	28697784	1	O
family	28697784	1	O
.	28697784	1	O
CONCLUSIONS	28697784	1	O
:	28697784	1	O
Here	28697784	1	O
,	28697784	1	O
we	28697784	1	O
describe	28697784	1	O
the	28697784	1	O
first	28697784	1	O
cases	28697784	1	O
of	28697784	1	O
canine	28697784	1	O
LGMD	28697784	1	O
characterized	28697784	1	O
at	28697784	1	O
the	28697784	1	O
molecular	28697784	1	O
level	28697784	1	O
with	28697784	1	O
the	28697784	1	O
classification	28697784	1	O
of	28697784	1	O
LGMD2F	28697784	1	O
.	28697784	1	O

Calcium	28701352	0	O
pumps	28701352	0	O
and	28701352	0	O
interacting	28701352	0	O
BON1	28701352	0	O
protein	28701352	0	O
modulate	28701352	0	O
calcium	28701352	0	O
signature	28701352	0	O
,	28701352	0	O
stomatal	28701352	0	O
closure	28701352	0	O
,	28701352	0	O
and	28701352	0	O
plant	28701352	0	O
immunity	28701352	0	O
.	28701352	0	O
Calcium	28701352	0	O
signaling	28701352	0	O
is	28701352	0	O
essential	28701352	0	O
for	28701352	0	O
environmental	28701352	0	O
responses	28701352	0	O
including	28701352	0	O
immune	28701352	0	O
responses	28701352	0	O
.	28701352	0	O
Here	28701352	0	O
we	28701352	0	O
provide	28701352	0	O
evidence	28701352	0	O
that	28701352	0	O
the	28701352	0	O
evolutionarily	28701352	0	O
conserved	28701352	0	O
protein	28701352	0	O
BONZAI1	28701352	0	O
(	28701352	0	O
BON1	28701352	0	O
)	28701352	0	O
functions	28701352	0	O
together	28701352	0	O
with	28701352	0	O
autoinhibited	28701352	0	O
calcium	28701352	0	O
ATPase	28701352	0	O
10	28701352	0	O
(	28701352	0	O
ACA10	28701352	0	O
)	28701352	0	O
and	28701352	0	O
ACA8	28701352	0	O
to	28701352	0	O
regulate	28701352	0	O
calcium	28701352	0	O
signals	28701352	0	O
in	28701352	0	O
Arabidopsis	28701352	0	O
.	28701352	0	O
BON1	28701352	0	O
is	28701352	0	O
a	28701352	0	O
plasma	28701352	0	O
membrane	28701352	0	O
localized	28701352	0	O
protein	28701352	0	O
that	28701352	0	O
negatively	28701352	0	O
regulates	28701352	0	O
the	28701352	0	O
expression	28701352	0	O
of	28701352	0	O
immune	28701352	0	O
receptor	28701352	0	O
genes	28701352	0	O
and	28701352	0	O
positively	28701352	0	O
regulates	28701352	0	O
stomatal	28701352	0	O
closure	28701352	0	O
.	28701352	0	O
We	28701352	0	O
found	28701352	0	O
that	28701352	0	O
BON1	28701352	0	O
interacts	28701352	0	O
with	28701352	0	O
the	28701352	0	O
autoinhibitory	28701352	0	O
domains	28701352	0	O
of	28701352	0	O
ACA10	28701352	0	O
and	28701352	0	O
ACA8	28701352	0	O
,	28701352	0	O
and	28701352	0	O
the	28701352	0	O
aca10	28701352	0	B-Gene
loss	28701352	0	B-NegReg
of	28701352	0	I-NegReg
function	28701352	0	I-NegReg
(	28701352	0	O
LOF	28701352	0	O
)	28701352	0	O
mutants	28701352	0	B-Var
have	28701352	0	O
an	28701352	0	O
autoimmune	28701352	0	O
phenotype	28701352	0	O
similar	28701352	0	O
to	28701352	0	O
that	28701352	0	O
of	28701352	0	O
the	28701352	0	O
bon1	28701352	0	B-Gene
LOF	28701352	0	B-NegReg
mutants	28701352	0	B-Var
.	28701352	0	O
Genetic	28701352	0	O
evidences	28701352	0	O
indicate	28701352	0	O
that	28701352	0	O
BON1	28701352	0	O
positively	28701352	0	O
regulates	28701352	0	O
the	28701352	0	O
activities	28701352	0	O
of	28701352	0	O
ACA10	28701352	0	O
and	28701352	0	O
ACA8	28701352	0	O
.	28701352	0	O
Consistent	28701352	0	O
with	28701352	0	O
this	28701352	0	O
idea	28701352	0	O
,	28701352	0	O
the	28701352	0	O
steady	28701352	0	O
level	28701352	0	O
of	28701352	0	O
calcium	28701352	0	O
concentration	28701352	0	O
is	28701352	0	O
increased	28701352	0	B-PosReg
in	28701352	0	O
both	28701352	0	O
aca10	28701352	0	B-Gene
and	28701352	0	O
bon1	28701352	0	B-Gene
mutants	28701352	0	B-Var
.	28701352	0	O
Most	28701352	0	O
strikingly	28701352	0	O
,	28701352	0	O
cytosolic	28701352	0	O
calcium	28701352	0	O
oscillation	28701352	0	O
imposed	28701352	0	O
by	28701352	0	O
external	28701352	0	O
calcium	28701352	0	O
treatment	28701352	0	O
was	28701352	0	O
altered	28701352	0	O
in	28701352	0	O
aca10	28701352	0	O
,	28701352	0	O
aca8	28701352	0	O
,	28701352	0	O
and	28701352	0	O
bon1	28701352	0	O
mutants	28701352	0	O
in	28701352	0	O
guard	28701352	0	O
cells	28701352	0	O
.	28701352	0	O
In	28701352	0	O
addition	28701352	0	O
,	28701352	0	O
calcium	28701352	0	O
and	28701352	0	O
pathogen	28701352	0	O
induced	28701352	0	O
stomatal	28701352	0	O
closure	28701352	0	O
was	28701352	0	O
compromised	28701352	0	B-NegReg
in	28701352	0	O
the	28701352	0	O
aca10	28701352	0	B-Gene
and	28701352	0	O
bon1	28701352	0	B-Gene
mutants	28701352	0	B-Var
.	28701352	0	O
Taken	28701352	0	O
together	28701352	0	O
,	28701352	0	O
this	28701352	0	O
study	28701352	0	O
indicates	28701352	0	O
that	28701352	0	O
ACA10	28701352	0	O
/	28701352	0	O
8	28701352	0	O
and	28701352	0	O
BON1	28701352	0	O
physically	28701352	0	O
interact	28701352	0	O
on	28701352	0	O
plasma	28701352	0	O
membrane	28701352	0	O
and	28701352	0	O
function	28701352	0	O
in	28701352	0	O
the	28701352	0	O
generation	28701352	0	O
of	28701352	0	O
cytosol	28701352	0	O
calcium	28701352	0	O
signatures	28701352	0	O
that	28701352	0	O
are	28701352	0	O
critical	28701352	0	O
for	28701352	0	O
stomatal	28701352	0	O
movement	28701352	0	O
and	28701352	0	O
impact	28701352	0	O
plant	28701352	0	O
immunity	28701352	0	O
.	28701352	0	O

A	28711549	1	O
case	28711549	1	O
of	28711549	1	O
hypocholesterolemia	28711549	1	B-Disease
and	28711549	1	O
steatosis	28711549	1	B-Disease
in	28711549	1	O
a	28711549	1	O
carrier	28711549	1	O
of	28711549	1	O
a	28711549	1	O
PCSK9	28711549	1	B-Gene
loss	28711549	1	B-NegReg
-	28711549	1	I-NegReg
of	28711549	1	I-NegReg
-	28711549	1	I-NegReg
function	28711549	1	I-NegReg
mutation	28711549	1	B-Var
and	28711549	1	O
polymorphisms	28711549	1	O
predisposing	28711549	1	O
to	28711549	1	O
nonalcoholic	28711549	1	O
fatty	28711549	1	O
liver	28711549	1	O
disease	28711549	1	O
.	28711549	1	O
We	28711549	1	O
report	28711549	1	O
a	28711549	1	O
new	28711549	1	O
case	28711549	1	O
of	28711549	1	O
hypobetalipoproteinemia	28711549	1	O
in	28711549	1	O
a	28711549	1	O
44	28711549	1	O
-	28711549	1	O
year	28711549	1	O
-	28711549	1	O
old	28711549	1	O
man	28711549	1	O
of	28711549	1	O
Peruvian	28711549	1	O
origin	28711549	1	O
exhibiting	28711549	1	O
a	28711549	1	O
heterozygous	28711549	1	O
PCSK9	28711549	1	O
missense	28711549	1	O
mutation	28711549	1	O
(	28711549	1	B-Var
c.946	28711549	1	I-Var
G	28711549	1	I-Var
>	28711549	1	I-Var
T	28711549	1	I-Var
,	28711549	1	O
p.Gly316Cys	28711549	1	O
)	28711549	1	O
.	28711549	1	O
In	28711549	1	O
vitro	28711549	1	O
functional	28711549	1	O
studies	28711549	1	O
demonstrated	28711549	1	O
that	28711549	1	O
this	28711549	1	O
mutation	28711549	1	O
leads	28711549	1	O
to	28711549	1	O
a	28711549	1	O
loss	28711549	1	O
of	28711549	1	B-NegReg
function	28711549	1	I-NegReg
of	28711549	1	I-NegReg
PCSK9	28711549	1	O
on	28711549	1	B-Gene
low	28711549	1	O
-	28711549	1	O
density	28711549	1	O
lipoprotein	28711549	1	O
receptor	28711549	1	O
degradation	28711549	1	O
.	28711549	1	O
This	28711549	1	O
patient	28711549	1	O
exhibited	28711549	1	O
liver	28711549	1	O
steatosis	28711549	1	O
;	28711549	1	O
he	28711549	1	O
was	28711549	1	O
neither	28711549	1	O
diabetic	28711549	1	O
,	28711549	1	O
nor	28711549	1	O
obese	28711549	1	O
or	28711549	1	O
alcoholic	28711549	1	O
,	28711549	1	O
but	28711549	1	O
is	28711549	1	O
a	28711549	1	O
carrier	28711549	1	O
of	28711549	1	O
2	28711549	1	O
polymorphisms	28711549	1	O
,	28711549	1	O
p.Ile148Met	28711549	1	O
(	28711549	1	O
rs738409	28711549	1	O
)	28711549	1	O
and	28711549	1	O
p.Glu167Lys	28711549	1	O
(	28711549	1	O
rs58542926	28711549	1	O
)	28711549	1	O
on	28711549	1	O
PNPLA3	28711549	1	O
and	28711549	1	O
TM6SF2	28711549	1	O
gene	28711549	1	O
,	28711549	1	O
respectively	28711549	1	O
,	28711549	1	O
previously	28711549	1	O
shown	28711549	1	O
to	28711549	1	O
be	28711549	1	O
associated	28711549	1	O
with	28711549	1	O
nonalcoholic	28711549	1	O
steatosis	28711549	1	O
and	28711549	1	O
fibrosis	28711549	1	O
evolution	28711549	1	O
.	28711549	1	O
These	28711549	1	O
data	28711549	1	O
suggested	28711549	1	O
that	28711549	1	O
if	28711549	1	O
a	28711549	1	O
resistance	28711549	1	O
to	28711549	1	O
hepatic	28711549	1	O
steatosis	28711549	1	O
mediated	28711549	1	O
by	28711549	1	O
the	28711549	1	O
PCSK9	28711549	1	O
deficiency	28711549	1	O
exists	28711549	1	O
,	28711549	1	O
as	28711549	1	O
demonstrated	28711549	1	O
in	28711549	1	O
mice	28711549	1	O
,	28711549	1	O
it	28711549	1	O
is	28711549	1	O
not	28711549	1	O
sufficient	28711549	1	O
to	28711549	1	O
prevent	28711549	1	O
hepatic	28711549	1	O
fatty	28711549	1	O
accumulation	28711549	1	O
in	28711549	1	O
the	28711549	1	O
case	28711549	1	O
of	28711549	1	O
genetic	28711549	1	O
factors	28711549	1	O
predisposing	28711549	1	O
to	28711549	1	O
nonalcoholic	28711549	1	O
fatty	28711549	1	O
liver	28711549	1	O
disease	28711549	1	O
.	28711549	1	O

Ovarian	28711606	0	O
aromatase	28711606	0	O
loss	28711606	0	B-NegReg
-	28711606	0	I-NegReg
of	28711606	0	I-NegReg
-	28711606	0	I-NegReg
function	28711606	0	I-NegReg
mutant	28711606	0	B-Var
medaka	28711606	0	O
undergo	28711606	0	B-Reg
ovary	28711606	0	O
degeneration	28711606	0	O
and	28711606	0	O
partial	28711606	0	O
female	28711606	0	O
-	28711606	0	O
to	28711606	0	O
-	28711606	0	O
male	28711606	0	O
sex	28711606	0	O
reversal	28711606	0	O
after	28711606	0	O
puberty	28711606	0	O
.	28711606	0	O
Although	28711606	0	O
estrogens	28711606	0	O
have	28711606	0	O
been	28711606	0	O
generally	28711606	0	O
considered	28711606	0	O
to	28711606	0	O
play	28711606	0	O
a	28711606	0	O
critical	28711606	0	O
role	28711606	0	O
in	28711606	0	O
ovarian	28711606	0	O
differentiation	28711606	0	O
in	28711606	0	O
non	28711606	0	O
-	28711606	0	O
mammalian	28711606	0	O
vertebrates	28711606	0	O
,	28711606	0	O
the	28711606	0	O
specific	28711606	0	O
functions	28711606	0	O
of	28711606	0	O
estrogens	28711606	0	O
during	28711606	0	O
ovarian	28711606	0	O
differentiation	28711606	0	O
remain	28711606	0	O
unclear	28711606	0	O
.	28711606	0	O
We	28711606	0	O
isolated	28711606	0	O
two	28711606	0	O
mutants	28711606	0	B-Var
with	28711606	0	B-Reg
premature	28711606	0	O
stops	28711606	0	O
in	28711606	0	O
the	28711606	0	O
ovarian	28711606	0	O
aromatase	28711606	0	O
(	28711606	0	B-Gene
cyp19a1	28711606	0	I-Gene
)	28711606	0	I-Gene
gene	28711606	0	O
from	28711606	0	O
an	28711606	0	O
N	28711606	0	O
-	28711606	0	O
ethyl	28711606	0	O
-	28711606	0	O
N	28711606	0	O
-	28711606	0	O
nitrosourea	28711606	0	O
-	28711606	0	O
based	28711606	0	O
gene	28711606	0	O
-	28711606	0	O
driven	28711606	0	O
mutagenesis	28711606	0	O
library	28711606	0	O
of	28711606	0	O
the	28711606	0	O
medaka	28711606	0	O
,	28711606	0	O
Oryzias	28711606	0	O
latipes	28711606	0	O
.	28711606	0	O
In	28711606	0	O
XX	28711606	0	O
mutants	28711606	0	B-Var
,	28711606	0	O
gonads	28711606	0	O
first	28711606	0	O
differentiated	28711606	0	O
into	28711606	0	O
normal	28711606	0	O
ovaries	28711606	0	O
containing	28711606	0	O
many	28711606	0	O
ovarian	28711606	0	O
follicles	28711606	0	O
that	28711606	0	O
failed	28711606	0	B-NegReg
to	28711606	0	O
accumulate	28711606	0	O
yolk	28711606	0	O
.	28711606	0	O
Subsequently	28711606	0	O
,	28711606	0	O
ovarian	28711606	0	O
tissues	28711606	0	O
underwent	28711606	0	O
extensive	28711606	0	O
degeneration	28711606	0	O
,	28711606	0	O
followed	28711606	0	O
by	28711606	0	O
the	28711606	0	O
appearance	28711606	0	O
of	28711606	0	O
testicular	28711606	0	O
tissues	28711606	0	O
on	28711606	0	O
the	28711606	0	O
dorsal	28711606	0	O
side	28711606	0	O
of	28711606	0	O
ovaries	28711606	0	O
.	28711606	0	O
In	28711606	0	O
the	28711606	0	O
newly	28711606	0	O
formed	28711606	0	O
testicular	28711606	0	O
tissue	28711606	0	O
,	28711606	0	O
strong	28711606	0	O
expression	28711606	0	O
of	28711606	0	O
gsdf	28711606	0	O
was	28711606	0	O
detected	28711606	0	O
in	28711606	0	O
sox9a2	28711606	0	O
-	28711606	0	O
positive	28711606	0	O
somatic	28711606	0	O
cells	28711606	0	O
surrounding	28711606	0	O
germline	28711606	0	O
stem	28711606	0	O
cells	28711606	0	O
suggesting	28711606	0	O
that	28711606	0	O
gsdf	28711606	0	O
plays	28711606	0	O
an	28711606	0	O
important	28711606	0	O
role	28711606	0	O
in	28711606	0	O
testicular	28711606	0	O
differentiation	28711606	0	O
during	28711606	0	O
estrogen	28711606	0	O
-	28711606	0	O
depleted	28711606	0	O
female	28711606	0	O
-	28711606	0	O
to	28711606	0	O
-	28711606	0	O
male	28711606	0	O
sex	28711606	0	O
reversal	28711606	0	O
.	28711606	0	O
We	28711606	0	O
conclude	28711606	0	O
that	28711606	0	O
endogenous	28711606	0	O
estrogens	28711606	0	O
synthesized	28711606	0	O
after	28711606	0	O
fertilization	28711606	0	O
are	28711606	0	O
not	28711606	0	O
essential	28711606	0	O
for	28711606	0	O
early	28711606	0	O
ovarian	28711606	0	O
differentiation	28711606	0	O
but	28711606	0	O
are	28711606	0	O
critical	28711606	0	O
for	28711606	0	O
the	28711606	0	O
maintenance	28711606	0	O
of	28711606	0	O
adult	28711606	0	O
ovaries	28711606	0	O
.	28711606	0	O

In	28723893	0	O
vivo	28723893	0	O
CRISPR	28723893	0	O
screening	28723893	0	O
identifies	28723893	0	O
Ptpn2	28723893	0	O
as	28723893	0	O
a	28723893	0	O
cancer	28723893	0	O
immunotherapy	28723893	0	O
target	28723893	0	O
.	28723893	0	O
Immunotherapy	28723893	0	O
with	28723893	0	O
PD-1	28723893	0	O
checkpoint	28723893	0	O
blockade	28723893	0	O
is	28723893	0	O
effective	28723893	0	O
in	28723893	0	O
only	28723893	0	O
a	28723893	0	O
minority	28723893	0	O
of	28723893	0	O
patients	28723893	0	O
with	28723893	0	O
cancer	28723893	0	O
,	28723893	0	O
suggesting	28723893	0	O
that	28723893	0	O
additional	28723893	0	O
treatment	28723893	0	O
strategies	28723893	0	O
are	28723893	0	O
needed	28723893	0	O
.	28723893	0	O
Here	28723893	0	O
we	28723893	0	O
use	28723893	0	O
a	28723893	0	O
pooled	28723893	0	O
in	28723893	0	O
vivo	28723893	0	O
genetic	28723893	0	O
screening	28723893	0	O
approach	28723893	0	O
using	28723893	0	O
CRISPR	28723893	0	O
-	28723893	0	O
Cas9	28723893	0	O
genome	28723893	0	O
editing	28723893	0	O
in	28723893	0	O
transplantable	28723893	0	O
tumours	28723893	0	O
in	28723893	0	O
mice	28723893	0	O
treated	28723893	0	O
with	28723893	0	O
immunotherapy	28723893	0	O
to	28723893	0	O
discover	28723893	0	O
previously	28723893	0	O
undescribed	28723893	0	O
immunotherapy	28723893	0	O
targets	28723893	0	O
.	28723893	0	O
We	28723893	0	O
tested	28723893	0	O
2	28723893	0	O
,	28723893	0	O
368	28723893	0	O
genes	28723893	0	O
expressed	28723893	0	O
by	28723893	0	O
melanoma	28723893	0	O
cells	28723893	0	O
to	28723893	0	O
identify	28723893	0	O
those	28723893	0	O
that	28723893	0	O
synergize	28723893	0	O
with	28723893	0	O
or	28723893	0	O
cause	28723893	0	O
resistance	28723893	0	O
to	28723893	0	O
checkpoint	28723893	0	O
blockade	28723893	0	O
.	28723893	0	O
We	28723893	0	O
recovered	28723893	0	O
the	28723893	0	O
known	28723893	0	O
immune	28723893	0	O
evasion	28723893	0	O
molecules	28723893	0	O
PD	28723893	0	O
-	28723893	0	O
L1	28723893	0	O
and	28723893	0	O
CD47	28723893	0	O
,	28723893	0	O
and	28723893	0	O
confirmed	28723893	0	O
that	28723893	0	O
defects	28723893	0	O
in	28723893	0	O
interferon	28723893	0	O
-	28723893	0	O
γ	28723893	0	O
signalling	28723893	0	O
caused	28723893	0	O
resistance	28723893	0	O
to	28723893	0	O
immunotherapy	28723893	0	O
.	28723893	0	O
Tumours	28723893	0	O
were	28723893	0	O
sensitized	28723893	0	O
to	28723893	0	O
immunotherapy	28723893	0	O
by	28723893	0	O
deletion	28723893	0	O
of	28723893	0	O
genes	28723893	0	O
involved	28723893	0	O
in	28723893	0	O
several	28723893	0	O
diverse	28723893	0	O
pathways	28723893	0	O
,	28723893	0	O
including	28723893	0	O
NF	28723893	0	O
-	28723893	0	O
κB	28723893	0	O
signalling	28723893	0	O
,	28723893	0	O
antigen	28723893	0	O
presentation	28723893	0	O
and	28723893	0	O
the	28723893	0	O
unfolded	28723893	0	O
protein	28723893	0	O
response	28723893	0	O
.	28723893	0	O
In	28723893	0	O
addition	28723893	0	O
,	28723893	0	O
deletion	28723893	0	B-Var
of	28723893	0	O
the	28723893	0	O
protein	28723893	0	O
tyrosine	28723893	0	O
phosphatase	28723893	0	O
PTPN2	28723893	0	B-Gene
in	28723893	0	O
tumour	28723893	0	O
cells	28723893	0	O
increased	28723893	0	B-PosReg
the	28723893	0	O
efficacy	28723893	0	O
of	28723893	0	O
immunotherapy	28723893	0	O
by	28723893	0	O
enhancing	28723893	0	B-PosReg
interferon	28723893	0	O
-	28723893	0	O
γ	28723893	0	O
-	28723893	0	O
mediated	28723893	0	O
effects	28723893	0	O
on	28723893	0	O
antigen	28723893	0	O
presentation	28723893	0	O
and	28723893	0	O
growth	28723893	0	O
suppression	28723893	0	O
.	28723893	0	O
In	28723893	0	O
vivo	28723893	0	O
genetic	28723893	0	O
screens	28723893	0	O
in	28723893	0	O
tumour	28723893	0	O
models	28723893	0	O
can	28723893	0	O
identify	28723893	0	O
new	28723893	0	O
immunotherapy	28723893	0	O
targets	28723893	0	O
in	28723893	0	O
unanticipated	28723893	0	O
pathways	28723893	0	O
.	28723893	0	O

Genetic	28728825	3	O
Diseases	28728825	3	O
of	28728825	3	O
PIEZO1	28728825	3	O
and	28728825	3	O
PIEZO2	28728825	3	O
Dysfunction	28728825	3	O
.	28728825	3	O
Mutations	28728825	3	O
in	28728825	3	O
the	28728825	3	O
genes	28728825	3	O
encoding	28728825	3	O
the	28728825	3	O
mechanosensitive	28728825	3	O
cation	28728825	3	O
channels	28728825	3	O
PIEZO1	28728825	3	O
and	28728825	3	O
PIEZO2	28728825	3	O
are	28728825	3	O
responsible	28728825	3	O
for	28728825	3	O
multiple	28728825	3	O
hereditary	28728825	3	O
human	28728825	3	O
diseases	28728825	3	O
.	28728825	3	O
Loss	28728825	3	B-NegReg
-	28728825	3	I-NegReg
of	28728825	3	I-NegReg
-	28728825	3	I-NegReg
function	28728825	3	I-NegReg
mutations	28728825	3	B-Var
in	28728825	3	O
the	28728825	3	O
human	28728825	3	O
PIEZO1	28728825	3	B-Gene
gene	28728825	3	O
cause	28728825	3	O
autosomal	28728825	3	B-Disease
recessive	28728825	3	I-Disease
congenital	28728825	3	I-Disease
lymphatic	28728825	3	I-Disease
dysplasia	28728825	3	I-Disease
.	28728825	3	O
Gain	28728825	3	B-PosReg
-	28728825	3	I-PosReg
of	28728825	3	I-PosReg
-	28728825	3	I-PosReg
function	28728825	3	I-PosReg
mutations	28728825	3	B-Var
in	28728825	3	O
the	28728825	3	O
human	28728825	3	O
PIEZO1	28728825	3	B-Gene
gene	28728825	3	O
cause	28728825	3	O
the	28728825	3	O
autosomal	28728825	3	B-Disease
dominant	28728825	3	I-Disease
hemolytic	28728825	3	I-Disease
anemia	28728825	3	I-Disease
,	28728825	3	O
hereditary	28728825	3	B-Disease
xerocytosis	28728825	3	I-Disease
(	28728825	3	O
also	28728825	3	O
known	28728825	3	O
as	28728825	3	O
dehydrated	28728825	3	B-Disease
stomatocytosis	28728825	3	I-Disease
)	28728825	3	I-Disease
.	28728825	3	O
Loss	28728825	3	B-NegReg
-	28728825	3	I-NegReg
of	28728825	3	I-NegReg
-	28728825	3	I-NegReg
function	28728825	3	I-NegReg
mutations	28728825	3	B-Var
in	28728825	3	O
the	28728825	3	O
human	28728825	3	O
PIEZO2	28728825	3	B-Gene
gene	28728825	3	O
cause	28728825	3	O
an	28728825	3	O
autosomal	28728825	3	B-Disease
recessive	28728825	3	I-Disease
syndrome	28728825	3	I-Disease
of	28728825	3	I-Disease
muscular	28728825	3	I-Disease
atrophy	28728825	3	I-Disease
with	28728825	3	O
perinatal	28728825	3	O
respiratory	28728825	3	O
distress	28728825	3	O
,	28728825	3	O
arthrogryposis	28728825	3	B-Disease
,	28728825	3	O
and	28728825	3	O
scoliosis	28728825	3	B-Disease
.	28728825	3	O
Gain	28728825	3	B-PosReg
-	28728825	3	I-PosReg
of	28728825	3	I-PosReg
-	28728825	3	I-PosReg
function	28728825	3	I-PosReg
mutations	28728825	3	B-Var
in	28728825	3	O
the	28728825	3	O
human	28728825	3	O
PIEZO2	28728825	3	B-Gene
gene	28728825	3	O
cause	28728825	3	O
three	28728825	3	O
clinical	28728825	3	O
types	28728825	3	O
of	28728825	3	O
autosomal	28728825	3	B-Disease
dominant	28728825	3	I-Disease
distal	28728825	3	I-Disease
arthrogryposis	28728825	3	I-Disease
.	28728825	3	O
This	28728825	3	O
chapter	28728825	3	O
will	28728825	3	O
review	28728825	3	O
the	28728825	3	O
hereditary	28728825	3	O
diseases	28728825	3	O
caused	28728825	3	O
by	28728825	3	O
mutations	28728825	3	O
in	28728825	3	O
the	28728825	3	O
PIEZO	28728825	3	O
genes	28728825	3	O
and	28728825	3	O
will	28728825	3	O
discuss	28728825	3	O
additional	28728825	3	O
physiological	28728825	3	O
systems	28728825	3	O
in	28728825	3	O
which	28728825	3	O
PIEZO	28728825	3	O
channel	28728825	3	O
dysfunction	28728825	3	O
may	28728825	3	O
contribute	28728825	3	O
to	28728825	3	O
human	28728825	3	O
disease	28728825	3	O
pathophysiology	28728825	3	O
.	28728825	3	O

Differential	28734073	2	O
calcium	28734073	2	O
sensitivity	28734073	2	O
in	28734073	2	O
NaV	28734073	2	O
1.5	28734073	2	O
mixed	28734073	2	O
syndrome	28734073	2	O
mutants	28734073	2	O
.	28734073	2	O
KEY	28734073	2	O
POINTS	28734073	2	O
:	28734073	2	O
SCN5a	28734073	2	B-Gene
mutations	28734073	2	B-Var
may	28734073	2	O
express	28734073	2	O
gain	28734073	2	B-PosReg
-	28734073	2	I-PosReg
of	28734073	2	I-PosReg
-	28734073	2	I-PosReg
function	28734073	2	I-PosReg
(	28734073	2	B-Disease
Long	28734073	2	I-Disease
QT	28734073	2	I-Disease
Syndrome-3	28734073	2	I-Disease
)	28734073	2	I-Disease
,	28734073	2	O
loss	28734073	2	B-NegReg
-	28734073	2	I-NegReg
of	28734073	2	I-NegReg
-	28734073	2	I-NegReg
function	28734073	2	I-NegReg
(	28734073	2	B-Disease
Brugada	28734073	2	I-Disease
Syndrome	28734073	2	I-Disease
1	28734073	2	I-Disease
)	28734073	2	I-Disease
or	28734073	2	O
both	28734073	2	O
(	28734073	2	O
mixed	28734073	2	O
syndromes	28734073	2	O
)	28734073	2	O
,	28734073	2	O
depending	28734073	2	O
on	28734073	2	O
the	28734073	2	O
mutation	28734073	2	O
and	28734073	2	O
environmental	28734073	2	O
triggers	28734073	2	O
.	28734073	2	O
One	28734073	2	O
such	28734073	2	O
trigger	28734073	2	O
may	28734073	2	O
be	28734073	2	O
an	28734073	2	O
increase	28734073	2	O
in	28734073	2	O
cytosolic	28734073	2	O
calcium	28734073	2	O
,	28734073	2	O
accompanying	28734073	2	O
exercise	28734073	2	O
.	28734073	2	O
Many	28734073	2	O
mixed	28734073	2	O
syndromes	28734073	2	O
mutants	28734073	2	O
,	28734073	2	O
including	28734073	2	O
KPQ	28734073	2	O
,	28734073	2	O
E1784K	28734073	2	O
,	28734073	2	O
1795	28734073	2	O
insD	28734073	2	O
and	28734073	2	O
Q1909R	28734073	2	O
,	28734073	2	O
are	28734073	2	O
found	28734073	2	O
in	28734073	2	O
calcium	28734073	2	O
-	28734073	2	O
sensitive	28734073	2	O
regions	28734073	2	O
.	28734073	2	O
Elevated	28734073	2	O
cytosolic	28734073	2	O
calcium	28734073	2	O
attenuates	28734073	2	O
gain	28734073	2	O
-	28734073	2	O
of	28734073	2	O
-	28734073	2	O
function	28734073	2	O
properties	28734073	2	O
in	28734073	2	O
KPQ	28734073	2	O
,	28734073	2	O
1795	28734073	2	O
insD	28734073	2	O
and	28734073	2	O
Q1909R	28734073	2	O
,	28734073	2	O
but	28734073	2	O
not	28734073	2	O
in	28734073	2	O
E1784K	28734073	2	O
.	28734073	2	O
By	28734073	2	O
contrast	28734073	2	O
,	28734073	2	O
elevated	28734073	2	O
cytosolic	28734073	2	O
calcium	28734073	2	O
further	28734073	2	O
exacerbates	28734073	2	O
gain	28734073	2	O
-	28734073	2	O
of	28734073	2	O
-	28734073	2	O
function	28734073	2	O
in	28734073	2	O
E1784K	28734073	2	O
by	28734073	2	O
destabilizing	28734073	2	O
slow	28734073	2	O
inactivation	28734073	2	O
.	28734073	2	O
Action	28734073	2	O
potential	28734073	2	O
modelling	28734073	2	O
,	28734073	2	O
using	28734073	2	O
a	28734073	2	O
modified	28734073	2	O
O	28734073	2	O
'	28734073	2	O
Hara	28734073	2	O
Rudy	28734073	2	O
model	28734073	2	O
,	28734073	2	O
suggests	28734073	2	O
that	28734073	2	O
elevated	28734073	2	O
heart	28734073	2	O
rate	28734073	2	O
rescues	28734073	2	O
action	28734073	2	O
potential	28734073	2	O
duration	28734073	2	O
in	28734073	2	O
KPQ	28734073	2	O
,	28734073	2	O
1795	28734073	2	O
insD	28734073	2	O
and	28734073	2	O
Q1909R	28734073	2	O
,	28734073	2	O
but	28734073	2	O
not	28734073	2	O
in	28734073	2	O
E1784K	28734073	2	O
.	28734073	2	O
Action	28734073	2	O
potential	28734073	2	O
simulations	28734073	2	O
suggest	28734073	2	O
that	28734073	2	O
E1784K	28734073	2	O
carriers	28734073	2	O
have	28734073	2	O
an	28734073	2	O
increased	28734073	2	O
intracellular	28734073	2	O
sodium	28734073	2	O
-	28734073	2	O
to	28734073	2	O
-	28734073	2	O
calcium	28734073	2	O
ratio	28734073	2	O
under	28734073	2	O
bradycardia	28734073	2	O
and	28734073	2	O
tachycardia	28734073	2	O
conditions	28734073	2	O
.	28734073	2	O
Elevated	28734073	2	O
cytosolic	28734073	2	O
calcium	28734073	2	O
,	28734073	2	O
which	28734073	2	O
is	28734073	2	O
common	28734073	2	O
during	28734073	2	O
high	28734073	2	O
heart	28734073	2	O
rates	28734073	2	O
,	28734073	2	O
ameliorates	28734073	2	O
or	28734073	2	O
exacerbates	28734073	2	O
the	28734073	2	O
mixed	28734073	2	O
syndrome	28734073	2	O
phenotype	28734073	2	O
depending	28734073	2	O
on	28734073	2	O
the	28734073	2	O
genetic	28734073	2	O
signature	28734073	2	O
.	28734073	2	O
ABSTRACT	28734073	2	O
:	28734073	2	O
Inherited	28734073	2	O
arrhythmias	28734073	2	O
may	28734073	2	O
arise	28734073	2	O
from	28734073	2	O
mutations	28734073	2	O
in	28734073	2	O
the	28734073	2	O
gene	28734073	2	O
for	28734073	2	O
SCN5a	28734073	2	O
,	28734073	2	O
which	28734073	2	O
encodes	28734073	2	O
the	28734073	2	O
cardiac	28734073	2	O
voltage	28734073	2	O
-	28734073	2	O
gated	28734073	2	O
sodium	28734073	2	O
channel	28734073	2	O
,	28734073	2	O
NaV	28734073	2	O
1.5	28734073	2	O
.	28734073	2	O
Mutants	28734073	2	O
in	28734073	2	O
NaV	28734073	2	O
1.5	28734073	2	O
result	28734073	2	O
in	28734073	2	O
Brugada	28734073	2	O
Syndrome	28734073	2	O
(	28734073	2	O
BrS1	28734073	2	O
)	28734073	2	O
,	28734073	2	O
Long	28734073	2	O
-	28734073	2	O
QT	28734073	2	O
Syndrome	28734073	2	O
(	28734073	2	O
LQT3	28734073	2	O
)	28734073	2	O
or	28734073	2	O
mixed	28734073	2	O
syndromes	28734073	2	O
(	28734073	2	O
an	28734073	2	O
overlap	28734073	2	O
of	28734073	2	O
BrS1	28734073	2	O
/	28734073	2	O
LQT3	28734073	2	O
)	28734073	2	O
.	28734073	2	O
Exercise	28734073	2	O
is	28734073	2	O
a	28734073	2	O
potential	28734073	2	O
arrhythmogenic	28734073	2	O
trigger	28734073	2	O
in	28734073	2	O
mixed	28734073	2	O
syndromes	28734073	2	O
.	28734073	2	O
We	28734073	2	O
aimed	28734073	2	O
to	28734073	2	O
determine	28734073	2	O
the	28734073	2	O
effects	28734073	2	O
of	28734073	2	O
elevated	28734073	2	O
cytosolic	28734073	2	O
calcium	28734073	2	O
,	28734073	2	O
which	28734073	2	O
is	28734073	2	O
common	28734073	2	O
during	28734073	2	O
exercise	28734073	2	O
,	28734073	2	O
in	28734073	2	O
mixed	28734073	2	O
syndrome	28734073	2	O
NaV	28734073	2	O
1.5	28734073	2	O
mutants	28734073	2	O
.	28734073	2	O
We	28734073	2	O
used	28734073	2	O
whole	28734073	2	O
-	28734073	2	O
cell	28734073	2	O
patch	28734073	2	O
clamp	28734073	2	O
to	28734073	2	O
assess	28734073	2	O
the	28734073	2	O
biophysical	28734073	2	O
properties	28734073	2	O
of	28734073	2	O
NaV	28734073	2	O
1.5	28734073	2	O
wild	28734073	2	O
-	28734073	2	O
type	28734073	2	O
(	28734073	2	O
WT	28734073	2	O
)	28734073	2	O
,	28734073	2	O
KPQ	28734073	2	O
,	28734073	2	O
E1784K	28734073	2	O
,	28734073	2	O
1795	28734073	2	O
insD	28734073	2	O
and	28734073	2	O
Q1909R	28734073	2	O
mutants	28734073	2	O
in	28734073	2	O
human	28734073	2	O
embryonic	28734073	2	O
kidney	28734073	2	O
293	28734073	2	O
cells	28734073	2	O
transiently	28734073	2	O
transfected	28734073	2	O
with	28734073	2	O
the	28734073	2	O
NaV	28734073	2	O
1.5	28734073	2	O
α	28734073	2	O
subunit	28734073	2	O
(	28734073	2	O
WT	28734073	2	O
or	28734073	2	O
mutants	28734073	2	O
)	28734073	2	O
,	28734073	2	O
β1	28734073	2	O
subunit	28734073	2	O
and	28734073	2	O
enhanced	28734073	2	O
green	28734073	2	O
fluorescent	28734073	2	O
protein	28734073	2	O
.	28734073	2	O
Voltage	28734073	2	O
-	28734073	2	O
dependence	28734073	2	O
and	28734073	2	O
kinetics	28734073	2	O
were	28734073	2	O
measured	28734073	2	O
at	28734073	2	O
cytosolic	28734073	2	O
calcium	28734073	2	O
levels	28734073	2	O
of	28734073	2	O
approximately	28734073	2	O
0	28734073	2	O
,	28734073	2	O
500	28734073	2	O
and	28734073	2	O
2500	28734073	2	O
nm	28734073	2	O
.	28734073	2	O
In	28734073	2	O
silico	28734073	2	O
,	28734073	2	O
action	28734073	2	O
potential	28734073	2	O
(	28734073	2	O
AP	28734073	2	O
)	28734073	2	O
model	28734073	2	O
simulations	28734073	2	O
were	28734073	2	O
performed	28734073	2	O
using	28734073	2	O
a	28734073	2	O
modified	28734073	2	O
O	28734073	2	O
'	28734073	2	O
Hara	28734073	2	O
Rudy	28734073	2	O
model	28734073	2	O
.	28734073	2	O
Elevated	28734073	2	O
cytosolic	28734073	2	O
calcium	28734073	2	O
attenuates	28734073	2	O
the	28734073	2	O
late	28734073	2	O
sodium	28734073	2	O
current	28734073	2	O
in	28734073	2	O
KPQ	28734073	2	O
,	28734073	2	O
1795	28734073	2	O
insD	28734073	2	O
and	28734073	2	O
Q1909R	28734073	2	O
,	28734073	2	O
but	28734073	2	O
not	28734073	2	O
in	28734073	2	O
E1784K	28734073	2	O
.	28734073	2	O
Elevated	28734073	2	O
cytosolic	28734073	2	O
calcium	28734073	2	O
restores	28734073	2	O
steady	28734073	2	O
-	28734073	2	O
state	28734073	2	O
slow	28734073	2	O
inactivation	28734073	2	O
(	28734073	2	O
SSSI	28734073	2	O
)	28734073	2	O
to	28734073	2	O
the	28734073	2	O
WT	28734073	2	O
-	28734073	2	O
form	28734073	2	O
in	28734073	2	O
Q1909R	28734073	2	O
,	28734073	2	O
but	28734073	2	O
depolarized	28734073	2	O
SSSI	28734073	2	O
in	28734073	2	O
E1784K	28734073	2	O
.	28734073	2	O
Our	28734073	2	O
AP	28734073	2	O
simulations	28734073	2	O
showed	28734073	2	O
a	28734073	2	O
frequency	28734073	2	O
-	28734073	2	O
dependent	28734073	2	O
reduction	28734073	2	O
of	28734073	2	O
AP	28734073	2	O
duration	28734073	2	O
in	28734073	2	O
KPQ	28734073	2	O
,	28734073	2	O
1795	28734073	2	O
insD	28734073	2	O
and	28734073	2	O
Q1909R	28734073	2	O
carriers	28734073	2	O
.	28734073	2	O
In	28734073	2	O
E1784K	28734073	2	O
,	28734073	2	O
AP	28734073	2	O
duration	28734073	2	O
is	28734073	2	O
relatively	28734073	2	O
prolonged	28734073	2	O
at	28734073	2	O
both	28734073	2	O
low	28734073	2	O
and	28734073	2	O
high	28734073	2	O
heart	28734073	2	O
rates	28734073	2	O
,	28734073	2	O
resulting	28734073	2	O
in	28734073	2	O
a	28734073	2	O
sodium	28734073	2	O
overload	28734073	2	O
.	28734073	2	O
Cellular	28734073	2	O
perturbations	28734073	2	O
during	28734073	2	O
exercise	28734073	2	O
may	28734073	2	O
affect	28734073	2	O
BrS1	28734073	2	O
/	28734073	2	O
LQT3	28734073	2	O
patients	28734073	2	O
differently	28734073	2	O
depending	28734073	2	O
on	28734073	2	O
their	28734073	2	O
individual	28734073	2	O
genetic	28734073	2	O
signature	28734073	2	O
.	28734073	2	O
Thus	28734073	2	O
,	28734073	2	O
exercise	28734073	2	O
may	28734073	2	O
be	28734073	2	O
therapeutic	28734073	2	O
or	28734073	2	O
may	28734073	2	O
be	28734073	2	O
an	28734073	2	O
arrhythmogenic	28734073	2	O
trigger	28734073	2	O
in	28734073	2	O
some	28734073	2	O
SCN5a	28734073	2	O
patients	28734073	2	O
.	28734073	2	O

D242N	28739325	3	O
,	28739325	3	O
a	28739325	3	O
KV7.1	28739325	3	O
LQTS	28739325	3	O
mutation	28739325	3	O
uncovers	28739325	3	O
a	28739325	3	O
key	28739325	3	O
residue	28739325	3	O
for	28739325	3	O
IKs	28739325	3	O
voltage	28739325	3	O
dependence	28739325	3	O
.	28739325	3	O
KV7.1	28739325	3	O
and	28739325	3	O
KCNE1	28739325	3	O
co	28739325	3	O
-	28739325	3	O
assemble	28739325	3	O
to	28739325	3	O
give	28739325	3	O
rise	28739325	3	O
to	28739325	3	O
the	28739325	3	O
IKs	28739325	3	O
current	28739325	3	O
,	28739325	3	O
one	28739325	3	O
of	28739325	3	O
the	28739325	3	O
most	28739325	3	O
important	28739325	3	O
repolarizing	28739325	3	O
currents	28739325	3	O
of	28739325	3	O
the	28739325	3	O
cardiac	28739325	3	O
action	28739325	3	O
potential	28739325	3	O
.	28739325	3	O
Its	28739325	3	O
relevance	28739325	3	O
is	28739325	3	O
underscored	28739325	3	O
by	28739325	3	O
the	28739325	3	O
identification	28739325	3	O
of	28739325	3	O
>	28739325	3	O
500	28739325	3	O
mutations	28739325	3	B-Var
in	28739325	3	O
KV7.1	28739325	3	B-Gene
and	28739325	3	O
,	28739325	3	O
at	28739325	3	O
least	28739325	3	O
,	28739325	3	O
36	28739325	3	O
in	28739325	3	O
KCNE1	28739325	3	B-Gene
,	28739325	3	O
that	28739325	3	O
cause	28739325	3	B-Reg
Long	28739325	3	B-Disease
QT	28739325	3	I-Disease
Syndrome	28739325	3	I-Disease
(	28739325	3	O
LQTS	28739325	3	O
)	28739325	3	O
.	28739325	3	O
The	28739325	3	O
aim	28739325	3	O
of	28739325	3	O
this	28739325	3	O
study	28739325	3	O
was	28739325	3	O
to	28739325	3	O
characterize	28739325	3	O
the	28739325	3	O
biophysical	28739325	3	O
and	28739325	3	O
cellular	28739325	3	O
consequences	28739325	3	O
of	28739325	3	O
the	28739325	3	O
D242N	28739325	3	B-Var
KV7.1	28739325	3	B-Gene
mutation	28739325	3	O
associated	28739325	3	B-Reg
with	28739325	3	O
the	28739325	3	O
LQTS	28739325	3	B-Disease
.	28739325	3	O
The	28739325	3	O
mutation	28739325	3	B-Var
is	28739325	3	O
located	28739325	3	O
in	28739325	3	O
the	28739325	3	O
S4	28739325	3	O
transmembrane	28739325	3	O
segment	28739325	3	O
,	28739325	3	O
within	28739325	3	O
the	28739325	3	O
voltage	28739325	3	O
sensor	28739325	3	O
of	28739325	3	O
the	28739325	3	O
KV7.1	28739325	3	O
channel	28739325	3	O
,	28739325	3	O
disrupting	28739325	3	B-NegReg
the	28739325	3	O
conserved	28739325	3	O
charge	28739325	3	O
balance	28739325	3	O
of	28739325	3	O
this	28739325	3	O
region	28739325	3	O
.	28739325	3	O
Perforated	28739325	3	O
patch	28739325	3	O
-	28739325	3	O
clamp	28739325	3	O
experiments	28739325	3	O
show	28739325	3	O
that	28739325	3	O
,	28739325	3	O
unexpectedly	28739325	3	O
,	28739325	3	O
the	28739325	3	O
mutation	28739325	3	B-Var
did	28739325	3	O
not	28739325	3	O
disrupt	28739325	3	O
the	28739325	3	O
voltage	28739325	3	O
-	28739325	3	O
dependent	28739325	3	O
activation	28739325	3	O
but	28739325	3	O
it	28739325	3	O
removed	28739325	3	B-NegReg
the	28739325	3	O
inactivation	28739325	3	O
and	28739325	3	O
slowed	28739325	3	B-NegReg
the	28739325	3	O
activation	28739325	3	O
kinetics	28739325	3	O
of	28739325	3	O
D242N	28739325	3	O
KV7.1	28739325	3	O
channels	28739325	3	O
.	28739325	3	O
Biotinylation	28739325	3	O
of	28739325	3	O
cell	28739325	3	O
-	28739325	3	O
surface	28739325	3	O
protein	28739325	3	O
and	28739325	3	O
co	28739325	3	O
-	28739325	3	O
immunoprecipitation	28739325	3	O
experiments	28739325	3	O
revealed	28739325	3	O
that	28739325	3	O
neither	28739325	3	O
plasma	28739325	3	O
membrane	28739325	3	O
targeting	28739325	3	O
nor	28739325	3	O
co	28739325	3	O
-	28739325	3	O
assembly	28739325	3	O
between	28739325	3	O
KV7.1	28739325	3	O
and	28739325	3	O
KCNE1	28739325	3	O
was	28739325	3	O
altered	28739325	3	O
by	28739325	3	O
the	28739325	3	O
mutation	28739325	3	O
.	28739325	3	O
However	28739325	3	O
,	28739325	3	O
the	28739325	3	O
association	28739325	3	O
of	28739325	3	O
D242N	28739325	3	O
KV7.1	28739325	3	O
with	28739325	3	O
KCNE1	28739325	3	O
strongly	28739325	3	O
shifted	28739325	3	O
the	28739325	3	O
voltage	28739325	3	O
dependence	28739325	3	O
of	28739325	3	O
activation	28739325	3	O
to	28739325	3	O
more	28739325	3	O
depolarized	28739325	3	O
potentials	28739325	3	O
(	28739325	3	O
50	28739325	3	O
mV	28739325	3	O
)	28739325	3	O
,	28739325	3	O
hindering	28739325	3	O
IKs	28739325	3	O
current	28739325	3	O
at	28739325	3	O
physiologically	28739325	3	O
relevant	28739325	3	O
membrane	28739325	3	O
potentials	28739325	3	O
.	28739325	3	O
Both	28739325	3	O
functional	28739325	3	O
and	28739325	3	O
computational	28739325	3	O
analysis	28739325	3	O
suggest	28739325	3	O
that	28739325	3	O
the	28739325	3	O
clinical	28739325	3	O
phenotype	28739325	3	O
of	28739325	3	O
the	28739325	3	O
LQTS	28739325	3	O
patients	28739325	3	O
carrying	28739325	3	O
the	28739325	3	O
D242N	28739325	3	B-Var
mutation	28739325	3	O
is	28739325	3	O
due	28739325	3	O
to	28739325	3	O
impaired	28739325	3	B-NegReg
action	28739325	3	O
potential	28739325	3	O
adaptation	28739325	3	O
to	28739325	3	O
exercise	28739325	3	O
and	28739325	3	O
,	28739325	3	O
in	28739325	3	O
particular	28739325	3	O
,	28739325	3	O
to	28739325	3	O
increase	28739325	3	B-PosReg
in	28739325	3	O
heart	28739325	3	O
rate	28739325	3	O
.	28739325	3	O
Moreover	28739325	3	O
,	28739325	3	O
our	28739325	3	O
data	28739325	3	O
identify	28739325	3	O
D242	28739325	3	O
aminoacidic	28739325	3	O
position	28739325	3	O
as	28739325	3	O
a	28739325	3	O
potential	28739325	3	O
residue	28739325	3	O
involved	28739325	3	O
in	28739325	3	O
the	28739325	3	O
KCNE1	28739325	3	O
-	28739325	3	O
mediated	28739325	3	O
regulation	28739325	3	O
of	28739325	3	O
the	28739325	3	O
voltage	28739325	3	O
dependence	28739325	3	O
of	28739325	3	O
activation	28739325	3	O
of	28739325	3	O
the	28739325	3	O
KV7.1	28739325	3	O
channel	28739325	3	O
.	28739325	3	O

A	28739660	0	O
Gene	28739660	0	O
Implicated	28739660	0	O
in	28739660	0	O
Activation	28739660	0	O
of	28739660	0	O
Retinoic	28739660	0	O
Acid	28739660	0	O
Receptor	28739660	0	O
Targets	28739660	0	O
is	28739660	0	O
a	28739660	0	O
Novel	28739660	0	O
Renal	28739660	0	O
Agenesis	28739660	0	O
Gene	28739660	0	O
in	28739660	0	O
Humans	28739660	0	O
.	28739660	0	O
Renal	28739660	0	B-Disease
agenesis	28739660	0	I-Disease
(	28739660	0	O
RA	28739660	0	O
)	28739660	0	O
is	28739660	0	O
one	28739660	0	O
of	28739660	0	O
the	28739660	0	O
more	28739660	0	O
extreme	28739660	0	O
examples	28739660	0	O
of	28739660	0	O
congenital	28739660	0	O
anomalies	28739660	0	O
of	28739660	0	O
the	28739660	0	O
kidney	28739660	0	O
and	28739660	0	O
urinary	28739660	0	O
tract	28739660	0	O
(	28739660	0	O
CAKUT	28739660	0	O
)	28739660	0	O
.	28739660	0	O
Bilateral	28739660	0	O
renal	28739660	0	O
agenesis	28739660	0	O
is	28739660	0	O
almost	28739660	0	O
invariably	28739660	0	O
fatal	28739660	0	O
at	28739660	0	O
birth	28739660	0	O
,	28739660	0	O
and	28739660	0	O
unilateral	28739660	0	O
renal	28739660	0	O
agenesis	28739660	0	O
can	28739660	0	O
lead	28739660	0	O
to	28739660	0	O
future	28739660	0	O
health	28739660	0	O
issues	28739660	0	O
including	28739660	0	O
end	28739660	0	O
stage	28739660	0	O
renal	28739660	0	O
disease	28739660	0	O
.	28739660	0	O
Genetic	28739660	0	O
investigations	28739660	0	O
have	28739660	0	O
identified	28739660	0	O
several	28739660	0	O
gene	28739660	0	O
variants	28739660	0	B-Var
which	28739660	0	O
cause	28739660	0	B-Reg
RA	28739660	0	B-Disease
,	28739660	0	O
including	28739660	0	O
EYA1	28739660	0	O
,	28739660	0	O
LHX1	28739660	0	O
,	28739660	0	O
and	28739660	0	O
WT1	28739660	0	O
However	28739660	0	O
,	28739660	0	O
whereas	28739660	0	O
compound	28739660	0	O
null	28739660	0	O
mutations	28739660	0	O
of	28739660	0	O
genes	28739660	0	O
encoding	28739660	0	O
α	28739660	0	O
and	28739660	0	O
γ	28739660	0	O
retinoic	28739660	0	O
acid	28739660	0	O
receptors	28739660	0	O
(	28739660	0	O
RARs	28739660	0	O
)	28739660	0	O
cause	28739660	0	O
RA	28739660	0	O
in	28739660	0	O
mice	28739660	0	O
,	28739660	0	O
to	28739660	0	O
date	28739660	0	O
there	28739660	0	O
have	28739660	0	O
been	28739660	0	O
no	28739660	0	O
reports	28739660	0	O
of	28739660	0	O
variants	28739660	0	O
in	28739660	0	O
RAR	28739660	0	O
genes	28739660	0	O
causing	28739660	0	O
RA	28739660	0	O
in	28739660	0	O
humans	28739660	0	O
.	28739660	0	O
In	28739660	0	O
this	28739660	0	O
study	28739660	0	O
,	28739660	0	O
we	28739660	0	O
carried	28739660	0	O
out	28739660	0	O
whole	28739660	0	O
exome	28739660	0	O
sequence	28739660	0	O
analysis	28739660	0	O
of	28739660	0	O
two	28739660	0	O
families	28739660	0	O
showing	28739660	0	O
inheritance	28739660	0	O
of	28739660	0	O
an	28739660	0	O
RA	28739660	0	O
phenotype	28739660	0	O
,	28739660	0	O
and	28739660	0	O
in	28739660	0	O
both	28739660	0	O
identified	28739660	0	O
a	28739660	0	O
single	28739660	0	O
candidate	28739660	0	O
gene	28739660	0	O
,	28739660	0	O
GREB1L	28739660	0	O
Analysis	28739660	0	O
of	28739660	0	O
a	28739660	0	O
zebrafish	28739660	0	O
greb1l	28739660	0	O
loss	28739660	0	B-NegReg
-	28739660	0	I-NegReg
of	28739660	0	I-NegReg
-	28739660	0	I-NegReg
function	28739660	0	I-NegReg
mutant	28739660	0	B-Var
revealed	28739660	0	O
defects	28739660	0	O
in	28739660	0	O
the	28739660	0	O
pronephric	28739660	0	O
kidney	28739660	0	O
just	28739660	0	O
prior	28739660	0	O
to	28739660	0	O
death	28739660	0	O
,	28739660	0	O
and	28739660	0	O
F0	28739660	0	O
CRISPR	28739660	0	O
/	28739660	0	O
Cas9	28739660	0	O
mutagenesis	28739660	0	B-Var
of	28739660	0	O
Greb1l	28739660	0	O
in	28739660	0	O
the	28739660	0	O
mouse	28739660	0	O
revealed	28739660	0	B-Reg
kidney	28739660	0	O
agenesis	28739660	0	O
phenotypes	28739660	0	O
,	28739660	0	O
implicating	28739660	0	O
Greb1l	28739660	0	O
in	28739660	0	O
this	28739660	0	O
disorder	28739660	0	O
.	28739660	0	O
GREB1L	28739660	0	O
resides	28739660	0	O
in	28739660	0	O
a	28739660	0	O
chromatin	28739660	0	O
complex	28739660	0	O
with	28739660	0	O
RAR	28739660	0	O
members	28739660	0	O
,	28739660	0	O
and	28739660	0	O
our	28739660	0	O
data	28739660	0	O
implicate	28739660	0	O
GREB1L	28739660	0	O
as	28739660	0	O
a	28739660	0	O
coactivator	28739660	0	O
for	28739660	0	O
RARs	28739660	0	O
.	28739660	0	O
This	28739660	0	O
study	28739660	0	O
is	28739660	0	O
the	28739660	0	O
first	28739660	0	O
to	28739660	0	O
associate	28739660	0	O
a	28739660	0	O
component	28739660	0	O
of	28739660	0	O
the	28739660	0	O
RAR	28739660	0	O
pathway	28739660	0	O
with	28739660	0	O
renal	28739660	0	O
agenesis	28739660	0	O
in	28739660	0	O
humans	28739660	0	O
.	28739660	0	O

Novel	28742244	0	O
PRPS1	28742244	0	O
gain	28742244	0	O
-	28742244	0	O
of	28742244	0	O
-	28742244	0	O
function	28742244	0	O
mutation	28742244	0	O
in	28742244	0	O
a	28742244	0	O
patient	28742244	0	O
with	28742244	0	O
congenital	28742244	0	O
hyperuricemia	28742244	0	O
and	28742244	0	O
facial	28742244	0	O
anomalies	28742244	0	O
.	28742244	0	O
Phosphoribosylpyrophosphate	28742244	0	O
synthetase	28742244	0	O
(	28742244	0	O
PRPPS	28742244	0	O
)	28742244	0	O
superactivity	28742244	0	O
(	28742244	0	O
OMIM	28742244	0	O
300661	28742244	0	O
)	28742244	0	O
is	28742244	0	O
a	28742244	0	O
rare	28742244	0	O
inborn	28742244	0	O
error	28742244	0	O
of	28742244	0	O
purine	28742244	0	O
metabolism	28742244	0	O
that	28742244	0	O
is	28742244	0	O
caused	28742244	0	O
by	28742244	0	O
gain	28742244	0	O
-	28742244	0	O
of	28742244	0	O
-	28742244	0	O
function	28742244	0	O
mutations	28742244	0	O
in	28742244	0	O
the	28742244	0	O
X	28742244	0	O
-	28742244	0	O
chromosomal	28742244	0	O
gene	28742244	0	O
PRPS1	28742244	0	O
(	28742244	0	O
Xq22.3	28742244	0	O
)	28742244	0	O
.	28742244	0	O
Clinical	28742244	0	O
characteristics	28742244	0	O
include	28742244	0	O
congenital	28742244	0	O
hyperuricemia	28742244	0	O
and	28742244	0	O
hyperuricosuria	28742244	0	O
,	28742244	0	O
gouty	28742244	0	O
arthritis	28742244	0	O
,	28742244	0	O
urolithiasis	28742244	0	O
,	28742244	0	O
developmental	28742244	0	O
delay	28742244	0	O
,	28742244	0	O
hypotonia	28742244	0	O
,	28742244	0	O
recurrent	28742244	0	O
infections	28742244	0	O
,	28742244	0	O
short	28742244	0	O
stature	28742244	0	O
,	28742244	0	O
and	28742244	0	O
hearing	28742244	0	O
loss	28742244	0	O
.	28742244	0	O
Only	28742244	0	O
eight	28742244	0	O
families	28742244	0	O
with	28742244	0	O
PRPPS	28742244	0	O
superactivity	28742244	0	O
and	28742244	0	O
PRPS1	28742244	0	O
gain	28742244	0	O
-	28742244	0	O
of	28742244	0	O
-	28742244	0	O
function	28742244	0	O
mutations	28742244	0	O
have	28742244	0	O
been	28742244	0	O
reported	28742244	0	O
to	28742244	0	O
date	28742244	0	O
.	28742244	0	O
We	28742244	0	O
report	28742244	0	O
on	28742244	0	O
a	28742244	0	O
7	28742244	0	O
-	28742244	0	O
year	28742244	0	O
-	28742244	0	O
old	28742244	0	O
boy	28742244	0	O
with	28742244	0	O
congenital	28742244	0	O
hyperuricemia	28742244	0	O
,	28742244	0	O
urolithiasis	28742244	0	O
,	28742244	0	O
developmental	28742244	0	O
delay	28742244	0	O
,	28742244	0	O
short	28742244	0	O
stature	28742244	0	O
,	28742244	0	O
hypospadias	28742244	0	O
,	28742244	0	O
and	28742244	0	O
facial	28742244	0	O
dysmorphisms	28742244	0	O
.	28742244	0	O
His	28742244	0	O
mother	28742244	0	O
also	28742244	0	O
suffered	28742244	0	O
from	28742244	0	O
hyperuricemia	28742244	0	O
that	28742244	0	O
was	28742244	0	O
diagnosed	28742244	0	O
at	28742244	0	O
age	28742244	0	O
13	28742244	0	O
years	28742244	0	O
.	28742244	0	O
A	28742244	0	O
novel	28742244	0	O
PRPS1	28742244	0	O
missense	28742244	0	O
mutation	28742244	0	O
(	28742244	0	O
c.573	28742244	0	O
G	28742244	0	O
>	28742244	0	O
C	28742244	0	O
,	28742244	0	O
p.	28742244	0	O
[	28742244	0	O
Leu191Phe	28742244	0	O
]	28742244	0	O
)	28742244	0	O
was	28742244	0	O
detected	28742244	0	O
in	28742244	0	O
the	28742244	0	O
proband	28742244	0	O
and	28742244	0	O
his	28742244	0	O
mother	28742244	0	O
.	28742244	0	O
Enzyme	28742244	0	O
activity	28742244	0	O
analysis	28742244	0	O
confirmed	28742244	0	O
superactivity	28742244	0	O
of	28742244	0	O
PRPP	28742244	0	O
synthetase	28742244	0	O
.	28742244	0	O
Analysis	28742244	0	O
of	28742244	0	O
the	28742244	0	O
crystal	28742244	0	O
structure	28742244	0	O
of	28742244	0	O
human	28742244	0	O
PRPPS	28742244	0	O
suggests	28742244	0	O
that	28742244	0	O
the	28742244	0	O
Leu191Phe	28742244	0	B-Gene
mutation	28742244	0	B-Var
affects	28742244	0	B-Reg
the	28742244	0	O
architecture	28742244	0	O
of	28742244	0	O
both	28742244	0	O
allosteric	28742244	0	O
sites	28742244	0	O
,	28742244	0	O
thereby	28742244	0	O
preventing	28742244	0	B-NegReg
the	28742244	0	O
allosteric	28742244	0	O
inhibition	28742244	0	O
of	28742244	0	O
the	28742244	0	O
enzyme	28742244	0	O
.	28742244	0	O
The	28742244	0	O
family	28742244	0	O
reported	28742244	0	O
here	28742244	0	O
broadens	28742244	0	O
the	28742244	0	O
clinical	28742244	0	O
spectrum	28742244	0	O
of	28742244	0	O
PRPPS	28742244	0	O
superactivity	28742244	0	O
and	28742244	0	O
indicates	28742244	0	O
that	28742244	0	O
this	28742244	0	O
rare	28742244	0	O
metabolic	28742244	0	O
disorder	28742244	0	O
might	28742244	0	O
be	28742244	0	O
associated	28742244	0	O
with	28742244	0	O
a	28742244	0	O
recognizable	28742244	0	O
facial	28742244	0	O
gestalt	28742244	0	O
.	28742244	0	O

Naturally	28743761	0	B-Var
-	28743761	0	I-Var
Segregating	28743761	0	I-Var
Variation	28743761	0	I-Var
at	28743761	0	O
Ugt86Dd	28743761	0	B-Gene
Contributes	28743761	0	B-PosReg
to	28743761	0	O
Nicotine	28743761	0	O
Resistance	28743761	0	O
in	28743761	0	O
Drosophila	28743761	0	O
melanogaster	28743761	0	O
.	28743761	0	O
Identifying	28743761	0	O
the	28743761	0	O
sequence	28743761	0	O
polymorphisms	28743761	0	O
underlying	28743761	0	O
complex	28743761	0	O
trait	28743761	0	O
variation	28743761	0	O
is	28743761	0	O
a	28743761	0	O
key	28743761	0	O
goal	28743761	0	O
of	28743761	0	O
genetics	28743761	0	O
research	28743761	0	O
,	28743761	0	O
since	28743761	0	O
knowing	28743761	0	O
the	28743761	0	O
precise	28743761	0	O
causative	28743761	0	O
molecular	28743761	0	O
events	28743761	0	O
allows	28743761	0	O
insight	28743761	0	O
into	28743761	0	O
the	28743761	0	O
pathways	28743761	0	O
governing	28743761	0	O
trait	28743761	0	O
variation	28743761	0	O
.	28743761	0	O
Genetic	28743761	0	O
analysis	28743761	0	O
of	28743761	0	O
complex	28743761	0	O
traits	28743761	0	O
in	28743761	0	O
model	28743761	0	O
systems	28743761	0	O
regularly	28743761	0	O
starts	28743761	0	O
by	28743761	0	O
constructing	28743761	0	O
QTL	28743761	0	O
maps	28743761	0	O
,	28743761	0	O
but	28743761	0	O
generally	28743761	0	O
fails	28743761	0	O
to	28743761	0	O
identify	28743761	0	O
causative	28743761	0	O
sequence	28743761	0	O
polymorphisms	28743761	0	O
.	28743761	0	O
Previously	28743761	0	O
we	28743761	0	O
mapped	28743761	0	O
a	28743761	0	O
series	28743761	0	O
of	28743761	0	O
QTL	28743761	0	O
contributing	28743761	0	O
to	28743761	0	O
resistance	28743761	0	O
to	28743761	0	O
nicotine	28743761	0	O
in	28743761	0	O
a	28743761	0	O
Drosophila	28743761	0	O
melanogaster	28743761	0	O
multiparental	28743761	0	O
mapping	28743761	0	O
resource	28743761	0	O
,	28743761	0	O
and	28743761	0	O
here	28743761	0	O
use	28743761	0	O
a	28743761	0	O
battery	28743761	0	O
of	28743761	0	O
functional	28743761	0	O
tests	28743761	0	O
to	28743761	0	O
resolve	28743761	0	O
QTL	28743761	0	O
to	28743761	0	O
the	28743761	0	O
molecular	28743761	0	O
level	28743761	0	O
.	28743761	0	O
One	28743761	0	O
large	28743761	0	O
-	28743761	0	O
effect	28743761	0	O
QTL	28743761	0	O
resided	28743761	0	O
over	28743761	0	O
a	28743761	0	O
cluster	28743761	0	O
of	28743761	0	O
UDP	28743761	0	O
-	28743761	0	O
glucuronosyltransferases	28743761	0	O
,	28743761	0	O
and	28743761	0	O
quantitative	28743761	0	O
complementation	28743761	0	O
tests	28743761	0	O
using	28743761	0	O
deficiencies	28743761	0	O
eliminating	28743761	0	O
subsets	28743761	0	O
of	28743761	0	O
these	28743761	0	O
detoxification	28743761	0	O
genes	28743761	0	O
revealed	28743761	0	O
allelic	28743761	0	O
variation	28743761	0	O
impacting	28743761	0	O
resistance	28743761	0	O
.	28743761	0	O
RNAseq	28743761	0	O
showed	28743761	0	O
that	28743761	0	O
Ugt86Dd	28743761	0	O
had	28743761	0	O
significantly	28743761	0	O
higher	28743761	0	O
expression	28743761	0	O
in	28743761	0	O
genotypes	28743761	0	O
that	28743761	0	O
are	28743761	0	O
more	28743761	0	O
resistant	28743761	0	O
to	28743761	0	O
nicotine	28743761	0	O
,	28743761	0	O
and	28743761	0	O
anterior	28743761	0	O
midgut	28743761	0	O
-	28743761	0	O
specific	28743761	0	O
RNAi	28743761	0	O
of	28743761	0	O
this	28743761	0	O
gene	28743761	0	O
reduced	28743761	0	O
resistance	28743761	0	O
.	28743761	0	O
We	28743761	0	O
discovered	28743761	0	O
a	28743761	0	O
segregating	28743761	0	O
22	28743761	0	O
-	28743761	0	O
bp	28743761	0	O
frameshift	28743761	0	B-Var
deletion	28743761	0	I-Var
in	28743761	0	O
Ugt86Dd	28743761	0	B-Gene
,	28743761	0	O
and	28743761	0	O
accounting	28743761	0	O
for	28743761	0	O
the	28743761	0	O
InDel	28743761	0	O
during	28743761	0	O
mapping	28743761	0	O
largely	28743761	0	O
eliminates	28743761	0	B-NegReg
the	28743761	0	O
QTL	28743761	0	O
,	28743761	0	O
implying	28743761	0	O
the	28743761	0	O
event	28743761	0	O
explains	28743761	0	O
the	28743761	0	O
bulk	28743761	0	O
of	28743761	0	O
the	28743761	0	O
effect	28743761	0	O
of	28743761	0	O
the	28743761	0	O
mapped	28743761	0	O
locus	28743761	0	O
.	28743761	0	O
CRISPR	28743761	0	O
/	28743761	0	O
Cas9	28743761	0	O
editing	28743761	0	O
a	28743761	0	O
relatively	28743761	0	O
resistant	28743761	0	O
genotype	28743761	0	O
to	28743761	0	O
generate	28743761	0	O
lesions	28743761	0	B-Var
in	28743761	0	O
Ugt86Dd	28743761	0	B-Gene
that	28743761	0	O
recapitulate	28743761	0	O
the	28743761	0	O
naturally	28743761	0	O
-	28743761	0	O
occurring	28743761	0	O
putative	28743761	0	O
loss	28743761	0	B-NegReg
-	28743761	0	I-NegReg
of	28743761	0	I-NegReg
-	28743761	0	I-NegReg
function	28743761	0	I-NegReg
allele	28743761	0	O
leads	28743761	0	O
to	28743761	0	O
a	28743761	0	O
large	28743761	0	O
reduction	28743761	0	B-NegReg
in	28743761	0	O
resistance	28743761	0	O
.	28743761	0	O
Despite	28743761	0	O
this	28743761	0	O
major	28743761	0	O
effect	28743761	0	O
of	28743761	0	O
the	28743761	0	O
deletion	28743761	0	O
,	28743761	0	O
the	28743761	0	O
allele	28743761	0	O
appears	28743761	0	O
to	28743761	0	O
be	28743761	0	O
very	28743761	0	O
rare	28743761	0	O
in	28743761	0	O
wild	28743761	0	O
-	28743761	0	O
caught	28743761	0	O
populations	28743761	0	O
,	28743761	0	O
and	28743761	0	O
likely	28743761	0	O
explains	28743761	0	O
only	28743761	0	O
a	28743761	0	O
small	28743761	0	O
fraction	28743761	0	O
of	28743761	0	O
the	28743761	0	O
natural	28743761	0	O
variation	28743761	0	O
for	28743761	0	O
the	28743761	0	O
trait	28743761	0	O
.	28743761	0	O
Nonetheless	28743761	0	O
,	28743761	0	O
this	28743761	0	O
putatively	28743761	0	O
causative	28743761	0	O
coding	28743761	0	O
InDel	28743761	0	O
can	28743761	0	O
be	28743761	0	O
a	28743761	0	O
launchpad	28743761	0	O
for	28743761	0	O
future	28743761	0	O
mechanistic	28743761	0	O
exploration	28743761	0	O
of	28743761	0	O
xenobiotic	28743761	0	O
detoxification	28743761	0	O
.	28743761	0	O

Sequence	28747428	0	B-Var
exchange	28747428	0	I-Var
between	28747428	0	O
R	28747428	0	B-Gene
genes	28747428	0	O
converts	28747428	0	B-Reg
virus	28747428	0	O
resistance	28747428	0	O
into	28747428	0	O
nematode	28747428	0	O
resistance	28747428	0	O
,	28747428	0	O
and	28747428	0	O
vice	28747428	0	O
versa	28747428	0	O
.	28747428	0	O
Plants	28747428	0	O
have	28747428	0	O
evolved	28747428	0	O
a	28747428	0	O
limited	28747428	0	O
repertoire	28747428	0	O
of	28747428	0	O
NB	28747428	0	O
-	28747428	0	O
LRR	28747428	0	O
disease	28747428	0	O
resistance	28747428	0	O
(	28747428	0	O
R	28747428	0	O
)	28747428	0	O
genes	28747428	0	O
to	28747428	0	O
protect	28747428	0	O
themselves	28747428	0	O
against	28747428	0	O
a	28747428	0	O
myriad	28747428	0	O
of	28747428	0	O
pathogens	28747428	0	O
.	28747428	0	O
This	28747428	0	O
limitation	28747428	0	O
is	28747428	0	O
thought	28747428	0	O
to	28747428	0	O
be	28747428	0	O
counterbalanced	28747428	0	O
by	28747428	0	O
the	28747428	0	O
rapid	28747428	0	O
evolution	28747428	0	O
of	28747428	0	O
NB	28747428	0	O
-	28747428	0	O
LRR	28747428	0	O
proteins	28747428	0	O
,	28747428	0	O
as	28747428	0	O
only	28747428	0	O
few	28747428	0	O
sequence	28747428	0	O
changes	28747428	0	B-Var
have	28747428	0	O
been	28747428	0	O
shown	28747428	0	O
to	28747428	0	O
be	28747428	0	O
sufficient	28747428	0	O
to	28747428	0	O
alter	28747428	0	B-Reg
resistance	28747428	0	O
specificities	28747428	0	O
towards	28747428	0	O
novel	28747428	0	O
strains	28747428	0	O
of	28747428	0	O
a	28747428	0	O
pathogen	28747428	0	O
.	28747428	0	O
However	28747428	0	O
,	28747428	0	O
little	28747428	0	O
is	28747428	0	O
known	28747428	0	O
about	28747428	0	O
the	28747428	0	O
flexibility	28747428	0	O
of	28747428	0	O
NB	28747428	0	O
-	28747428	0	O
LRR	28747428	0	O
genes	28747428	0	O
to	28747428	0	O
switch	28747428	0	O
resistance	28747428	0	O
specificities	28747428	0	O
between	28747428	0	O
phylogenetically	28747428	0	O
unrelated	28747428	0	O
pathogens	28747428	0	O
.	28747428	0	O
To	28747428	0	O
investigate	28747428	0	O
this	28747428	0	O
,	28747428	0	O
we	28747428	0	O
created	28747428	0	O
domain	28747428	0	O
swaps	28747428	0	O
between	28747428	0	O
the	28747428	0	O
close	28747428	0	O
homologs	28747428	0	O
Gpa2	28747428	0	O
and	28747428	0	O
Rx1	28747428	0	O
,	28747428	0	O
which	28747428	0	O
confer	28747428	0	O
resistance	28747428	0	O
in	28747428	0	O
potato	28747428	0	O
to	28747428	0	O
the	28747428	0	O
cyst	28747428	0	O
nematode	28747428	0	O
Globodera	28747428	0	O
pallida	28747428	0	O
and	28747428	0	O
Potato	28747428	0	O
virus	28747428	0	O
X	28747428	0	O
(	28747428	0	O
PVX	28747428	0	O
)	28747428	0	O
,	28747428	0	O
respectively	28747428	0	O
.	28747428	0	O
The	28747428	0	O
genetic	28747428	0	O
fusion	28747428	0	O
of	28747428	0	O
the	28747428	0	O
CC	28747428	0	O
-	28747428	0	O
NB	28747428	0	O
-	28747428	0	O
ARC	28747428	0	O
of	28747428	0	O
Gpa2	28747428	0	O
with	28747428	0	O
the	28747428	0	O
LRR	28747428	0	O
of	28747428	0	O
Rx1	28747428	0	O
(	28747428	0	O
Gpa2CN	28747428	0	O
/	28747428	0	O
Rx1L	28747428	0	O
)	28747428	0	O
resulted	28747428	0	O
in	28747428	0	O
autoactivity	28747428	0	O
,	28747428	0	O
but	28747428	0	O
lowering	28747428	0	O
the	28747428	0	O
protein	28747428	0	O
levels	28747428	0	O
restored	28747428	0	O
its	28747428	0	O
specific	28747428	0	O
activation	28747428	0	O
response	28747428	0	O
including	28747428	0	O
extreme	28747428	0	O
resistance	28747428	0	O
to	28747428	0	O
PVX	28747428	0	O
in	28747428	0	O
potato	28747428	0	O
shoots	28747428	0	O
.	28747428	0	O
The	28747428	0	O
reciprocal	28747428	0	O
construct	28747428	0	O
(	28747428	0	O
Rx1CN	28747428	0	O
/	28747428	0	O
Gpa2L	28747428	0	O
)	28747428	0	O
showed	28747428	0	O
a	28747428	0	O
loss	28747428	0	O
-	28747428	0	O
of	28747428	0	O
-	28747428	0	O
function	28747428	0	O
phenotype	28747428	0	O
,	28747428	0	O
but	28747428	0	O
exchange	28747428	0	B-Var
of	28747428	0	O
the	28747428	0	O
first	28747428	0	O
3	28747428	0	O
LRR	28747428	0	O
repeats	28747428	0	O
of	28747428	0	O
Rx1	28747428	0	B-Gene
was	28747428	0	O
sufficient	28747428	0	O
to	28747428	0	O
regain	28747428	0	B-PosReg
a	28747428	0	O
wild	28747428	0	O
type	28747428	0	O
resistance	28747428	0	O
response	28747428	0	O
to	28747428	0	O
G.	28747428	0	O
pallida	28747428	0	O
in	28747428	0	O
the	28747428	0	O
roots	28747428	0	O
.	28747428	0	O
These	28747428	0	O
data	28747428	0	O
demonstrate	28747428	0	O
that	28747428	0	O
exchanging	28747428	0	B-Var
the	28747428	0	O
recognition	28747428	0	O
moiety	28747428	0	O
in	28747428	0	O
the	28747428	0	O
LRR	28747428	0	O
is	28747428	0	O
sufficient	28747428	0	O
to	28747428	0	O
convert	28747428	0	B-Reg
extreme	28747428	0	O
virus	28747428	0	O
resistance	28747428	0	O
in	28747428	0	O
the	28747428	0	O
leaves	28747428	0	O
into	28747428	0	O
mild	28747428	0	O
nematode	28747428	0	O
resistance	28747428	0	O
in	28747428	0	O
the	28747428	0	O
roots	28747428	0	O
,	28747428	0	O
and	28747428	0	O
vice	28747428	0	O
versa	28747428	0	O
.	28747428	0	O
In	28747428	0	O
addition	28747428	0	O
,	28747428	0	O
we	28747428	0	O
show	28747428	0	O
that	28747428	0	O
the	28747428	0	O
CC	28747428	0	O
-	28747428	0	O
NB	28747428	0	O
-	28747428	0	O
ARC	28747428	0	O
can	28747428	0	O
operate	28747428	0	O
independently	28747428	0	O
of	28747428	0	O
the	28747428	0	O
recognition	28747428	0	O
specificities	28747428	0	O
defined	28747428	0	O
by	28747428	0	O
the	28747428	0	O
LRR	28747428	0	O
domain	28747428	0	O
,	28747428	0	O
either	28747428	0	O
above	28747428	0	O
or	28747428	0	O
belowground	28747428	0	O
.	28747428	0	O
These	28747428	0	O
data	28747428	0	O
show	28747428	0	O
the	28747428	0	O
versatility	28747428	0	O
of	28747428	0	O
NB	28747428	0	O
-	28747428	0	O
LRR	28747428	0	O
genes	28747428	0	O
to	28747428	0	O
generate	28747428	0	O
resistances	28747428	0	O
to	28747428	0	O
unrelated	28747428	0	O
pathogens	28747428	0	O
with	28747428	0	O
completely	28747428	0	O
different	28747428	0	O
lifestyles	28747428	0	O
and	28747428	0	O
routes	28747428	0	O
of	28747428	0	O
invasion	28747428	0	O
.	28747428	0	O

Lethal	28747464	1	O
digenic	28747464	1	O
mutations	28747464	1	B-Var
in	28747464	1	O
the	28747464	1	O
K	28747464	1	O
(	28747464	1	O
)	28747464	1	O
channels	28747464	1	O
Kir4.1	28747464	1	O
(	28747464	1	B-Gene
KCNJ10	28747464	1	I-Gene
)	28747464	1	I-Gene
and	28747464	1	O
SLACK	28747464	1	O
(	28747464	1	B-Gene
KCNT1	28747464	1	I-Gene
)	28747464	1	I-Gene
associated	28747464	1	B-Reg
with	28747464	1	O
severe	28747464	1	O
-	28747464	1	O
disabling	28747464	1	O
seizures	28747464	1	B-Disease
and	28747464	1	O
neurodevelopmental	28747464	1	B-Disease
delay	28747464	1	I-Disease
.	28747464	1	O
A	28747464	1	O
2	28747464	1	O
-	28747464	1	O
year	28747464	1	O
-	28747464	1	O
old	28747464	1	O
boy	28747464	1	O
presented	28747464	1	O
profound	28747464	1	O
developmental	28747464	1	O
delay	28747464	1	O
,	28747464	1	O
failure	28747464	1	O
to	28747464	1	O
thrive	28747464	1	O
,	28747464	1	O
ataxia	28747464	1	O
,	28747464	1	O
hypotonia	28747464	1	O
and	28747464	1	O
tonic	28747464	1	O
-	28747464	1	O
clonic	28747464	1	O
seizures	28747464	1	O
that	28747464	1	O
caused	28747464	1	O
the	28747464	1	O
death	28747464	1	O
of	28747464	1	O
the	28747464	1	O
patient	28747464	1	O
.	28747464	1	O
Targeted	28747464	1	O
and	28747464	1	O
whole	28747464	1	O
-	28747464	1	O
exome	28747464	1	O
sequencing	28747464	1	O
revealed	28747464	1	O
two	28747464	1	O
heterozygous	28747464	1	O
missense	28747464	1	O
variants	28747464	1	O
:	28747464	1	O
a	28747464	1	O
novel	28747464	1	O
mutation	28747464	1	O
in	28747464	1	O
KCNJ10	28747464	1	O
gene	28747464	1	O
that	28747464	1	O
encodes	28747464	1	O
for	28747464	1	O
the	28747464	1	O
inwardly	28747464	1	O
-	28747464	1	O
rectifying	28747464	1	O
K	28747464	1	O
(	28747464	1	O
)	28747464	1	O
channel	28747464	1	O
Kir4.1	28747464	1	O
and	28747464	1	O
another	28747464	1	O
previously	28747464	1	O
characterized	28747464	1	O
mutation	28747464	1	O
in	28747464	1	O
KCNT1	28747464	1	O
that	28747464	1	O
encodes	28747464	1	O
for	28747464	1	O
the	28747464	1	O
Na	28747464	1	O
(	28747464	1	O
)	28747464	1	O
-	28747464	1	O
activated	28747464	1	O
K	28747464	1	O
(	28747464	1	O
)	28747464	1	O
channel	28747464	1	O
known	28747464	1	O
as	28747464	1	O
Slo2.2	28747464	1	O
or	28747464	1	O
SLACK	28747464	1	O
.	28747464	1	O
The	28747464	1	O
objectives	28747464	1	O
of	28747464	1	O
this	28747464	1	O
study	28747464	1	O
were	28747464	1	O
to	28747464	1	O
perform	28747464	1	O
the	28747464	1	O
clinical	28747464	1	O
and	28747464	1	O
genetic	28747464	1	O
characterization	28747464	1	O
of	28747464	1	O
the	28747464	1	O
proband	28747464	1	O
and	28747464	1	O
his	28747464	1	O
family	28747464	1	O
and	28747464	1	O
to	28747464	1	O
examine	28747464	1	O
the	28747464	1	O
functional	28747464	1	O
consequence	28747464	1	O
of	28747464	1	O
the	28747464	1	O
Kir4.1	28747464	1	O
mutation	28747464	1	O
.	28747464	1	O
The	28747464	1	O
mutant	28747464	1	O
and	28747464	1	O
wild	28747464	1	O
-	28747464	1	O
type	28747464	1	O
KCNJ10	28747464	1	O
constructs	28747464	1	O
were	28747464	1	O
generated	28747464	1	O
and	28747464	1	O
heterologously	28747464	1	O
expressed	28747464	1	O
in	28747464	1	O
Xenopus	28747464	1	O
laevis	28747464	1	O
oocytes	28747464	1	O
,	28747464	1	O
and	28747464	1	O
whole	28747464	1	O
-	28747464	1	O
cell	28747464	1	O
K	28747464	1	O
(	28747464	1	O
)	28747464	1	O
currents	28747464	1	O
were	28747464	1	O
measured	28747464	1	O
using	28747464	1	O
the	28747464	1	O
two	28747464	1	O
-	28747464	1	O
electrode	28747464	1	O
voltage	28747464	1	O
-	28747464	1	O
clamp	28747464	1	O
technique	28747464	1	O
.	28747464	1	O
The	28747464	1	O
KCNJ10	28747464	1	B-Gene
mutation	28747464	1	B-Var
c.652	28747464	1	O
C	28747464	1	O
>	28747464	1	O
T	28747464	1	O
resulted	28747464	1	B-Reg
in	28747464	1	I-Reg
a	28747464	1	O
p.L218F	28747464	1	O
substitution	28747464	1	B-Var
at	28747464	1	O
a	28747464	1	O
highly	28747464	1	O
conserved	28747464	1	O
residue	28747464	1	O
site	28747464	1	O
.	28747464	1	O
Wild	28747464	1	O
-	28747464	1	O
type	28747464	1	O
KCNJ10	28747464	1	O
expression	28747464	1	O
yielded	28747464	1	O
robust	28747464	1	O
Kir	28747464	1	O
currents	28747464	1	O
,	28747464	1	O
while	28747464	1	O
currents	28747464	1	O
from	28747464	1	O
oocytes	28747464	1	O
expressing	28747464	1	O
the	28747464	1	O
mutation	28747464	1	O
were	28747464	1	O
reduced	28747464	1	O
.	28747464	1	O
Western	28747464	1	O
Blot	28747464	1	O
analysis	28747464	1	O
revealed	28747464	1	O
reduced	28747464	1	B-NegReg
protein	28747464	1	O
expression	28747464	1	O
by	28747464	1	O
the	28747464	1	O
mutation	28747464	1	B-Var
.	28747464	1	O
Kir5.1	28747464	1	O
subunits	28747464	1	O
display	28747464	1	O
selective	28747464	1	O
heteromultimerization	28747464	1	O
with	28747464	1	O
Kir4.1	28747464	1	O
constituting	28747464	1	O
channels	28747464	1	O
with	28747464	1	O
unique	28747464	1	O
kinetics	28747464	1	O
.	28747464	1	O
The	28747464	1	O
effect	28747464	1	O
of	28747464	1	O
the	28747464	1	O
mutation	28747464	1	O
on	28747464	1	O
Kir4.1	28747464	1	O
/	28747464	1	O
5.1	28747464	1	O
channel	28747464	1	O
activity	28747464	1	O
was	28747464	1	O
twofold	28747464	1	O
:	28747464	1	O
a	28747464	1	O
reduction	28747464	1	O
in	28747464	1	O
current	28747464	1	O
amplitudes	28747464	1	O
and	28747464	1	O
an	28747464	1	O
increase	28747464	1	O
in	28747464	1	O
the	28747464	1	O
pH	28747464	1	O
-	28747464	1	O
dependent	28747464	1	O
inhibition	28747464	1	O
.	28747464	1	O
We	28747464	1	O
thus	28747464	1	O
report	28747464	1	O
a	28747464	1	O
novel	28747464	1	O
loss	28747464	1	B-NegReg
-	28747464	1	I-NegReg
of	28747464	1	I-NegReg
-	28747464	1	I-NegReg
function	28747464	1	I-NegReg
mutation	28747464	1	B-Var
in	28747464	1	O
Kir4.1	28747464	1	O
found	28747464	1	O
in	28747464	1	O
a	28747464	1	O
patient	28747464	1	O
with	28747464	1	O
a	28747464	1	O
co	28747464	1	O
-	28747464	1	O
exiting	28747464	1	O
mutation	28747464	1	B-Var
in	28747464	1	O
SLACK	28747464	1	O
channels	28747464	1	O
that	28747464	1	O
results	28747464	1	B-Reg
in	28747464	1	I-Reg
a	28747464	1	O
fatal	28747464	1	B-Disease
disease	28747464	1	I-Disease
.	28747464	1	O

A	28748849	4	O
Novel	28748849	4	O
Missense	28748849	4	B-Var
Mutation	28748849	4	I-Var
in	28748849	4	O
Peripheral	28748849	4	O
Myelin	28748849	4	O
Protein-22	28748849	4	O
Causes	28748849	4	B-Reg
Charcot	28748849	4	B-Disease
-	28748849	4	I-Disease
Marie	28748849	4	I-Disease
-	28748849	4	I-Disease
Tooth	28748849	4	I-Disease
Disease	28748849	4	I-Disease
.	28748849	4	O
BACKGROUND	28748849	4	O
:	28748849	4	O
Charcot	28748849	4	O
-	28748849	4	O
Marie	28748849	4	O
-	28748849	4	O
Tooth	28748849	4	O
disease	28748849	4	O
(	28748849	4	O
CMT	28748849	4	O
)	28748849	4	O
is	28748849	4	O
the	28748849	4	O
most	28748849	4	O
common	28748849	4	O
inherited	28748849	4	O
peripheral	28748849	4	O
neuropathy	28748849	4	O
.	28748849	4	O
A	28748849	4	O
great	28748849	4	O
number	28748849	4	O
of	28748849	4	O
causative	28748849	4	O
genes	28748849	4	O
have	28748849	4	O
been	28748849	4	O
described	28748849	4	O
in	28748849	4	O
CMT	28748849	4	O
,	28748849	4	O
and	28748849	4	O
among	28748849	4	O
them	28748849	4	O
,	28748849	4	O
the	28748849	4	O
heterozygous	28748849	4	O
duplication	28748849	4	O
of	28748849	4	O
peripheral	28748849	4	O
myelin	28748849	4	O
protein-22	28748849	4	O
(	28748849	4	O
PMP22	28748849	4	O
)	28748849	4	O
is	28748849	4	O
the	28748849	4	O
major	28748849	4	O
cause	28748849	4	O
.	28748849	4	O
Although	28748849	4	O
the	28748849	4	O
missense	28748849	4	B-Var
mutation	28748849	4	I-Var
in	28748849	4	O
PMP22	28748849	4	B-Gene
is	28748849	4	O
rarely	28748849	4	O
reported	28748849	4	O
,	28748849	4	O
it	28748849	4	O
has	28748849	4	O
been	28748849	4	O
demonstrated	28748849	4	O
to	28748849	4	O
be	28748849	4	O
associated	28748849	4	B-Reg
with	28748849	4	O
CMT	28748849	4	B-Disease
.	28748849	4	O
This	28748849	4	O
study	28748849	4	O
described	28748849	4	O
a	28748849	4	O
novel	28748849	4	O
missense	28748849	4	B-Var
mutation	28748849	4	I-Var
of	28748849	4	O
PMP22	28748849	4	B-Gene
in	28748849	4	B-Reg
a	28748849	4	O
Chinese	28748849	4	O
family	28748849	4	O
with	28748849	4	O
CMT	28748849	4	B-Disease
phenotype	28748849	4	O
.	28748849	4	O
METHODS	28748849	4	O
:	28748849	4	O
Targeted	28748849	4	O
next	28748849	4	O
-	28748849	4	O
generation	28748849	4	O
sequencing	28748849	4	O
(	28748849	4	O
NGS	28748849	4	O
)	28748849	4	O
was	28748849	4	O
used	28748849	4	O
to	28748849	4	O
screen	28748849	4	O
the	28748849	4	O
causative	28748849	4	O
genes	28748849	4	O
in	28748849	4	O
a	28748849	4	O
family	28748849	4	O
featured	28748849	4	O
with	28748849	4	O
an	28748849	4	O
autosomal	28748849	4	O
dominant	28748849	4	O
demyelinating	28748849	4	O
form	28748849	4	O
of	28748849	4	O
CMT	28748849	4	O
.	28748849	4	O
The	28748849	4	O
potential	28748849	4	O
variants	28748849	4	O
identified	28748849	4	O
by	28748849	4	O
targeted	28748849	4	O
NGS	28748849	4	O
were	28748849	4	O
verified	28748849	4	O
by	28748849	4	O
Sanger	28748849	4	O
sequencing	28748849	4	O
and	28748849	4	O
classified	28748849	4	O
according	28748849	4	O
to	28748849	4	O
the	28748849	4	O
American	28748849	4	O
College	28748849	4	O
of	28748849	4	O
Medical	28748849	4	O
Genetics	28748849	4	O
and	28748849	4	O
Genomics	28748849	4	O
standards	28748849	4	O
and	28748849	4	O
guidelines	28748849	4	O
.	28748849	4	O
Further	28748849	4	O
cell	28748849	4	O
transfection	28748849	4	O
studies	28748849	4	O
were	28748849	4	O
performed	28748849	4	O
to	28748849	4	O
characterize	28748849	4	O
the	28748849	4	O
function	28748849	4	O
of	28748849	4	O
the	28748849	4	O
novel	28748849	4	O
variant	28748849	4	O
.	28748849	4	O
RESULTS	28748849	4	O
:	28748849	4	O
Using	28748849	4	O
targeted	28748849	4	O
NGS	28748849	4	O
,	28748849	4	O
a	28748849	4	O
novel	28748849	4	O
heterozygous	28748849	4	O
missense	28748849	4	O
variant	28748849	4	O
in	28748849	4	O
PMP22	28748849	4	O
(	28748849	4	O
c.320	28748849	4	O
G	28748849	4	O
>	28748849	4	O
A	28748849	4	O
,	28748849	4	O
p.G107D	28748849	4	O
)	28748849	4	O
was	28748849	4	O
identified	28748849	4	O
.	28748849	4	O
In	28748849	4	O
vitro	28748849	4	O
cell	28748849	4	O
functional	28748849	4	O
studies	28748849	4	O
revealed	28748849	4	O
that	28748849	4	O
mutant	28748849	4	O
PMP22	28748849	4	B-Gene
protein	28748849	4	O
carrying	28748849	4	O
p.G107D	28748849	4	B-Var
mutation	28748849	4	O
lost	28748849	4	B-NegReg
the	28748849	4	O
ability	28748849	4	O
to	28748849	4	O
reach	28748849	4	O
the	28748849	4	O
plasma	28748849	4	O
membrane	28748849	4	O
,	28748849	4	O
was	28748849	4	O
mainly	28748849	4	O
retained	28748849	4	O
in	28748849	4	O
the	28748849	4	O
endoplasmic	28748849	4	O
reticulum	28748849	4	O
,	28748849	4	O
and	28748849	4	O
induced	28748849	4	B-Reg
cell	28748849	4	O
apoptosis	28748849	4	O
.	28748849	4	O
CONCLUSIONS	28748849	4	O
:	28748849	4	O
This	28748849	4	O
study	28748849	4	O
supported	28748849	4	O
the	28748849	4	O
notion	28748849	4	O
that	28748849	4	O
missense	28748849	4	B-Var
mutations	28748849	4	I-Var
in	28748849	4	O
PMP22	28748849	4	B-Gene
give	28748849	4	O
rise	28748849	4	O
to	28748849	4	O
a	28748849	4	O
CMT	28748849	4	B-Disease
phenotype	28748849	4	O
,	28748849	4	O
possibly	28748849	4	O
through	28748849	4	O
a	28748849	4	O
toxic	28748849	4	B-PosReg
gain	28748849	4	I-PosReg
-	28748849	4	I-PosReg
of	28748849	4	I-PosReg
-	28748849	4	I-PosReg
function	28748849	4	I-PosReg
mechanism	28748849	4	O
.	28748849	4	O

POSITIVE	28751317	0	O
REGULATOR	28751317	0	O
OF	28751317	0	O
IRON	28751317	0	O
HOMEOSTASIS	28751317	0	O
1	28751317	0	O
(	28751317	0	O
OsPRI1	28751317	0	O
)	28751317	0	O
positively	28751317	0	O
regulates	28751317	0	O
iron	28751317	0	O
homeostasis	28751317	0	O
in	28751317	0	O
rice	28751317	0	O
.	28751317	0	O
OsHRZ1	28751317	0	O
is	28751317	0	O
a	28751317	0	O
potential	28751317	0	O
iron	28751317	0	O
-	28751317	0	O
binding	28751317	0	O
sensor	28751317	0	O
.	28751317	0	O
However	28751317	0	O
,	28751317	0	O
it	28751317	0	O
is	28751317	0	O
unclear	28751317	0	O
how	28751317	0	O
OsHRZ1	28751317	0	O
transmits	28751317	0	O
signals	28751317	0	O
.	28751317	0	O
In	28751317	0	O
this	28751317	0	O
study	28751317	0	O
,	28751317	0	O
we	28751317	0	O
reveal	28751317	0	O
that	28751317	0	O
OsPRI1	28751317	0	O
interacts	28751317	0	O
with	28751317	0	O
OsHRZ1	28751317	0	O
.	28751317	0	O
A	28751317	0	O
loss	28751317	0	B-NegReg
-	28751317	0	I-NegReg
of	28751317	0	I-NegReg
-	28751317	0	I-NegReg
function	28751317	0	I-NegReg
mutation	28751317	0	B-Var
to	28751317	0	O
OsPRI1	28751317	0	B-Gene
increased	28751317	0	B-PosReg
the	28751317	0	O
sensitivity	28751317	0	O
of	28751317	0	O
plants	28751317	0	O
to	28751317	0	O
Fe	28751317	0	O
-	28751317	0	O
deficient	28751317	0	O
conditions	28751317	0	O
and	28751317	0	O
downregulated	28751317	0	B-NegReg
the	28751317	0	O
expression	28751317	0	O
of	28751317	0	O
Fe	28751317	0	O
-	28751317	0	O
deficiency	28751317	0	O
-	28751317	0	O
responsive	28751317	0	O
genes	28751317	0	O
.	28751317	0	O
Yeast	28751317	0	O
one	28751317	0	O
-	28751317	0	O
hybrid	28751317	0	O
and	28751317	0	O
electrophoretic	28751317	0	O
mobility	28751317	0	O
shift	28751317	0	O
assay	28751317	0	O
results	28751317	0	O
suggested	28751317	0	O
that	28751317	0	O
OsPRI1	28751317	0	O
binds	28751317	0	O
to	28751317	0	O
the	28751317	0	O
OsIRO2	28751317	0	O
and	28751317	0	O
OsIRO3	28751317	0	O
promoters	28751317	0	O
.	28751317	0	O
In	28751317	0	O
vitro	28751317	0	O
ubiquitination	28751317	0	O
experiments	28751317	0	O
indicated	28751317	0	O
that	28751317	0	O
OsPRI1	28751317	0	O
is	28751317	0	O
ubiquitinated	28751317	0	O
by	28751317	0	O
OsHRZ1	28751317	0	O
.	28751317	0	O
Cell	28751317	0	O
-	28751317	0	O
free	28751317	0	O
degradation	28751317	0	O
assays	28751317	0	O
revealed	28751317	0	O
that	28751317	0	O
the	28751317	0	O
stability	28751317	0	O
of	28751317	0	O
OsPRI1	28751317	0	O
decreased	28751317	0	O
in	28751317	0	O
wild	28751317	0	O
type	28751317	0	O
roots	28751317	0	O
,	28751317	0	O
but	28751317	0	O
increased	28751317	0	B-PosReg
in	28751317	0	O
the	28751317	0	O
hrz1-2	28751317	0	B-Gene
mutant	28751317	0	B-Var
,	28751317	0	O
suggesting	28751317	0	O
OsHRZ1	28751317	0	O
is	28751317	0	O
responsible	28751317	0	O
for	28751317	0	O
the	28751317	0	O
instability	28751317	0	O
of	28751317	0	O
OsPRI1	28751317	0	O
.	28751317	0	O
The	28751317	0	O
hrz1-2	28751317	0	O
seedlings	28751317	0	O
were	28751317	0	O
insensitive	28751317	0	O
to	28751317	0	O
Fe	28751317	0	O
-	28751317	0	O
deficient	28751317	0	O
conditions	28751317	0	O
.	28751317	0	O
When	28751317	0	O
the	28751317	0	O
pri1-1	28751317	0	B-Gene
mutation	28751317	0	B-Var
was	28751317	0	O
introduced	28751317	0	O
into	28751317	0	O
hrz1-2	28751317	0	B-Gene
mutants	28751317	0	B-Var
,	28751317	0	O
the	28751317	0	O
pri1hrz1	28751317	0	O
double	28751317	0	O
mutant	28751317	0	O
was	28751317	0	O
more	28751317	0	B-PosReg
sensitive	28751317	0	O
to	28751317	0	O
Fe	28751317	0	O
deficiency	28751317	0	O
than	28751317	0	O
the	28751317	0	O
hrz1-2	28751317	0	O
mutant	28751317	0	O
.	28751317	0	O
Additionally	28751317	0	O
,	28751317	0	O
the	28751317	0	O
expression	28751317	0	O
levels	28751317	0	O
of	28751317	0	O
Fe	28751317	0	O
-	28751317	0	O
deficiency	28751317	0	O
-	28751317	0	O
responsive	28751317	0	O
genes	28751317	0	O
were	28751317	0	O
lower	28751317	0	O
in	28751317	0	O
the	28751317	0	O
hrz1pri1	28751317	0	O
double	28751317	0	O
mutant	28751317	0	O
than	28751317	0	O
in	28751317	0	O
the	28751317	0	O
hrz1-2	28751317	0	O
mutant	28751317	0	O
.	28751317	0	O
Collectively	28751317	0	O
,	28751317	0	O
these	28751317	0	O
results	28751317	0	O
imply	28751317	0	O
that	28751317	0	O
OsPRI1	28751317	0	O
,	28751317	0	O
which	28751317	0	O
is	28751317	0	O
ubiquitinated	28751317	0	O
by	28751317	0	O
OsHRZ1	28751317	0	O
,	28751317	0	O
mediates	28751317	0	O
rice	28751317	0	O
responses	28751317	0	O
to	28751317	0	O
Fe	28751317	0	O
-	28751317	0	O
deficiency	28751317	0	O
by	28751317	0	O
positively	28751317	0	O
regulating	28751317	0	O
OsIRO2	28751317	0	O
and	28751317	0	O
OsIRO3	28751317	0	O
expression	28751317	0	O
as	28751317	0	O
part	28751317	0	O
of	28751317	0	O
the	28751317	0	O
OsHRZ1	28751317	0	O
-	28751317	0	O
OsPRI1	28751317	0	O
-	28751317	0	O
OsIRO2	28751317	0	O
/	28751317	0	O
3	28751317	0	O
signal	28751317	0	O
transduction	28751317	0	O
cascade	28751317	0	O
.	28751317	0	O

Loss	28751559	1	B-NegReg
-	28751559	1	I-NegReg
of	28751559	1	I-NegReg
-	28751559	1	I-NegReg
function	28751559	1	I-NegReg
but	28751559	1	O
not	28751559	1	O
dominant	28751559	1	O
-	28751559	1	O
negative	28751559	1	O
intragenic	28751559	1	O
IKZF1	28751559	1	B-Gene
deletions	28751559	1	B-Var
are	28751559	1	O
associated	28751559	1	O
with	28751559	1	O
an	28751559	1	O
adverse	28751559	1	O
prognosis	28751559	1	O
in	28751559	1	O
adult	28751559	1	O
BCR	28751559	1	O
-	28751559	1	O
ABL	28751559	1	O
-	28751559	1	O
negative	28751559	1	O
acute	28751559	1	B-Disease
lymphoblastic	28751559	1	I-Disease
leukemia	28751559	1	I-Disease
.	28751559	1	O
Genetic	28751559	1	O
alterations	28751559	1	O
of	28751559	1	O
the	28751559	1	O
transcription	28751559	1	O
factor	28751559	1	O
IKZF1	28751559	1	O
(	28751559	1	O
"	28751559	1	O
IKAROS	28751559	1	O
"	28751559	1	O
)	28751559	1	O
are	28751559	1	O
detected	28751559	1	O
in	28751559	1	O
around	28751559	1	O
15	28751559	1	O
-	28751559	1	O
30%	28751559	1	O
of	28751559	1	O
cases	28751559	1	O
of	28751559	1	O
BCR	28751559	1	O
-	28751559	1	O
ABL	28751559	1	O
-	28751559	1	O
negative	28751559	1	O
B	28751559	1	O
-	28751559	1	O
cell	28751559	1	O
precursor	28751559	1	O
acute	28751559	1	O
lymphoblastic	28751559	1	O
leukemia	28751559	1	O
(	28751559	1	O
ALL	28751559	1	O
)	28751559	1	O
.	28751559	1	O
Different	28751559	1	O
types	28751559	1	O
of	28751559	1	O
intragenic	28751559	1	O
deletions	28751559	1	B-Var
have	28751559	1	O
been	28751559	1	O
observed	28751559	1	O
,	28751559	1	O
resulting	28751559	1	O
in	28751559	1	O
a	28751559	1	O
functionally	28751559	1	O
inactivated	28751559	1	O
allele	28751559	1	O
(	28751559	1	B-NegReg
"	28751559	1	I-NegReg
loss	28751559	1	I-NegReg
-	28751559	1	I-NegReg
of	28751559	1	I-NegReg
-	28751559	1	I-NegReg
function	28751559	1	I-NegReg
"	28751559	1	I-NegReg
)	28751559	1	I-NegReg
or	28751559	1	O
in	28751559	1	O
"	28751559	1	B-NegReg
dominant	28751559	1	I-NegReg
-	28751559	1	I-NegReg
negative	28751559	1	I-NegReg
"	28751559	1	I-NegReg
isoforms	28751559	1	O
.	28751559	1	O
The	28751559	1	O
prognostic	28751559	1	O
impact	28751559	1	O
of	28751559	1	O
these	28751559	1	O
alterations	28751559	1	O
especially	28751559	1	O
in	28751559	1	O
adult	28751559	1	O
acute	28751559	1	O
lymphoblastic	28751559	1	O
leukemia	28751559	1	O
is	28751559	1	O
not	28751559	1	O
well	28751559	1	O
defined	28751559	1	O
.	28751559	1	O
We	28751559	1	O
analyzed	28751559	1	O
482	28751559	1	O
well	28751559	1	O
-	28751559	1	O
characterized	28751559	1	O
cases	28751559	1	O
of	28751559	1	O
adult	28751559	1	O
BCR	28751559	1	O
-	28751559	1	O
ABL	28751559	1	O
-	28751559	1	O
negative	28751559	1	O
B	28751559	1	O
-	28751559	1	O
precursor	28751559	1	O
acute	28751559	1	O
lymphoblastic	28751559	1	O
leukemia	28751559	1	O
uniformly	28751559	1	O
treated	28751559	1	O
in	28751559	1	O
the	28751559	1	O
framework	28751559	1	O
of	28751559	1	O
the	28751559	1	O
GMALL	28751559	1	O
studies	28751559	1	O
and	28751559	1	O
detected	28751559	1	O
IKZF1	28751559	1	O
alterations	28751559	1	O
in	28751559	1	O
128	28751559	1	O
cases	28751559	1	O
(	28751559	1	O
27%	28751559	1	O
)	28751559	1	O
.	28751559	1	O
In	28751559	1	O
20%	28751559	1	O
,	28751559	1	O
the	28751559	1	O
IKZF1	28751559	1	O
alteration	28751559	1	O
was	28751559	1	O
present	28751559	1	O
in	28751559	1	O
a	28751559	1	O
large	28751559	1	O
fraction	28751559	1	O
of	28751559	1	O
leukemic	28751559	1	O
cells	28751559	1	O
(	28751559	1	O
"	28751559	1	O
high	28751559	1	O
deletion	28751559	1	O
load	28751559	1	O
"	28751559	1	O
)	28751559	1	O
while	28751559	1	O
in	28751559	1	O
7%	28751559	1	O
it	28751559	1	O
was	28751559	1	O
detected	28751559	1	O
only	28751559	1	O
in	28751559	1	O
small	28751559	1	O
subclones	28751559	1	O
(	28751559	1	O
"	28751559	1	O
low	28751559	1	O
deletion	28751559	1	O
load	28751559	1	O
"	28751559	1	O
)	28751559	1	O
.	28751559	1	O
Some	28751559	1	O
patients	28751559	1	O
showed	28751559	1	O
more	28751559	1	O
than	28751559	1	O
one	28751559	1	O
IKZF1	28751559	1	O
alteration	28751559	1	O
(	28751559	1	O
8%	28751559	1	O
)	28751559	1	O
.	28751559	1	O
Patients	28751559	1	O
exhibiting	28751559	1	O
a	28751559	1	O
loss	28751559	1	O
-	28751559	1	O
of	28751559	1	O
-	28751559	1	O
function	28751559	1	O
isoform	28751559	1	O
with	28751559	1	O
high	28751559	1	B-Var
deletion	28751559	1	I-Var
load	28751559	1	I-Var
had	28751559	1	O
a	28751559	1	O
shorter	28751559	1	B-NegReg
overall	28751559	1	O
survival	28751559	1	O
(	28751559	1	O
OS	28751559	1	O
at	28751559	1	O
5	28751559	1	O
years	28751559	1	O
28%	28751559	1	O
vs.59	28751559	1	O
,	28751559	1	O
p	28751559	1	O
<	28751559	1	O
0.0001	28751559	1	O
)	28751559	1	O
,	28751559	1	O
also	28751559	1	O
significant	28751559	1	O
in	28751559	1	O
a	28751559	1	O
subgroup	28751559	1	O
analysis	28751559	1	O
of	28751559	1	O
standard	28751559	1	O
risk	28751559	1	O
patients	28751559	1	O
according	28751559	1	O
to	28751559	1	O
GMALL	28751559	1	O
classification	28751559	1	O
(	28751559	1	O
OS	28751559	1	O
at	28751559	1	O
5	28751559	1	O
years	28751559	1	O
37%	28751559	1	O
vs.68	28751559	1	O
,	28751559	1	O
p	28751559	1	O
=	28751559	1	O
0.0002	28751559	1	O
)	28751559	1	O
.	28751559	1	O
Low	28751559	1	O
deletion	28751559	1	O
load	28751559	1	O
or	28751559	1	O
dominant	28751559	1	O
-	28751559	1	O
negative	28751559	1	O
IKZF1	28751559	1	O
alterations	28751559	1	O
had	28751559	1	O
no	28751559	1	O
prognostic	28751559	1	O
impact	28751559	1	O
.	28751559	1	O
The	28751559	1	O
results	28751559	1	O
thus	28751559	1	O
suggest	28751559	1	O
that	28751559	1	O
there	28751559	1	O
is	28751559	1	O
a	28751559	1	O
clear	28751559	1	O
distinction	28751559	1	O
between	28751559	1	O
loss	28751559	1	O
-	28751559	1	O
of	28751559	1	O
-	28751559	1	O
function	28751559	1	O
and	28751559	1	O
dominant	28751559	1	O
-	28751559	1	O
negative	28751559	1	O
IKZF1	28751559	1	O
deletions	28751559	1	O
.	28751559	1	O
Affected	28751559	1	O
patients	28751559	1	O
should	28751559	1	O
thus	28751559	1	O
be	28751559	1	O
monitored	28751559	1	O
for	28751559	1	O
minimal	28751559	1	O
residual	28751559	1	O
disease	28751559	1	O
carefully	28751559	1	O
to	28751559	1	O
detect	28751559	1	O
incipient	28751559	1	O
relapses	28751559	1	O
at	28751559	1	O
an	28751559	1	O
early	28751559	1	O
stage	28751559	1	O
and	28751559	1	O
they	28751559	1	O
are	28751559	1	O
potential	28751559	1	O
candidates	28751559	1	O
for	28751559	1	O
alternative	28751559	1	O
or	28751559	1	O
intensified	28751559	1	O
treatment	28751559	1	O
regimes	28751559	1	O
.	28751559	1	O
Registered	28751559	1	O
at	28751559	1	O
http	28751559	1	O
:	28751559	1	O
/	28751559	1	O
/	28751559	1	O
www	28751559	1	O
.	28751559	1	O
clinicaltrials	28751559	1	O
.	28751559	1	O
gov	28751559	1	O
:	28751559	1	O
NCT00199056	28751559	1	O
,	28751559	1	O
NCT00198991	28751559	1	O
.	28751559	1	O

Stress	28754659	0	O
-	28754659	0	O
Induced	28754659	0	O
Sleep	28754659	0	O
After	28754659	0	O
Exposure	28754659	0	O
to	28754659	0	O
Ultraviolet	28754659	0	O
Light	28754659	0	O
Is	28754659	0	O
Promoted	28754659	0	O
by	28754659	0	O
p53	28754659	0	O
in	28754659	0	O
Caenorhabditis	28754659	0	O
elegans	28754659	0	O
.	28754659	0	O
Stress	28754659	0	O
-	28754659	0	O
induced	28754659	0	O
sleep	28754659	0	O
(	28754659	0	O
SIS	28754659	0	O
)	28754659	0	O
in	28754659	0	O
C.	28754659	0	O
elegans	28754659	0	O
is	28754659	0	O
important	28754659	0	O
for	28754659	0	O
restoration	28754659	0	O
of	28754659	0	O
cellular	28754659	0	O
homeostasis	28754659	0	O
and	28754659	0	O
is	28754659	0	O
a	28754659	0	O
useful	28754659	0	O
model	28754659	0	O
to	28754659	0	O
study	28754659	0	O
the	28754659	0	O
function	28754659	0	O
and	28754659	0	O
regulation	28754659	0	O
of	28754659	0	O
sleep	28754659	0	O
.	28754659	0	O
SIS	28754659	0	O
is	28754659	0	O
triggered	28754659	0	O
when	28754659	0	O
epidermal	28754659	0	O
growth	28754659	0	O
factor	28754659	0	O
(	28754659	0	O
EGF	28754659	0	O
)	28754659	0	O
activates	28754659	0	O
the	28754659	0	O
ALA	28754659	0	O
neuron	28754659	0	O
,	28754659	0	O
which	28754659	0	O
then	28754659	0	O
releases	28754659	0	O
neuropeptides	28754659	0	O
to	28754659	0	O
promote	28754659	0	O
sleep	28754659	0	O
.	28754659	0	O
To	28754659	0	O
further	28754659	0	O
understand	28754659	0	O
this	28754659	0	O
behavior	28754659	0	O
,	28754659	0	O
we	28754659	0	O
established	28754659	0	O
a	28754659	0	O
new	28754659	0	O
model	28754659	0	O
of	28754659	0	O
stress	28754659	0	O
-	28754659	0	O
induced	28754659	0	O
sleep	28754659	0	O
using	28754659	0	O
irradiation	28754659	0	O
by	28754659	0	O
ultraviolet	28754659	0	O
C	28754659	0	O
(	28754659	0	O
UVC	28754659	0	O
)	28754659	0	O
light	28754659	0	O
.	28754659	0	O
While	28754659	0	O
UVC	28754659	0	O
irradiation	28754659	0	O
requires	28754659	0	O
ALA	28754659	0	O
signaling	28754659	0	O
and	28754659	0	O
leads	28754659	0	O
to	28754659	0	O
a	28754659	0	O
sleep	28754659	0	O
state	28754659	0	O
similar	28754659	0	O
to	28754659	0	O
that	28754659	0	O
induced	28754659	0	O
by	28754659	0	O
heat	28754659	0	O
and	28754659	0	O
other	28754659	0	O
stressors	28754659	0	O
,	28754659	0	O
it	28754659	0	O
does	28754659	0	O
not	28754659	0	O
induce	28754659	0	O
the	28754659	0	O
proteostatic	28754659	0	O
stress	28754659	0	O
seen	28754659	0	O
with	28754659	0	O
heat	28754659	0	O
exposure	28754659	0	O
.	28754659	0	O
Based	28754659	0	O
on	28754659	0	O
the	28754659	0	O
known	28754659	0	O
genotoxic	28754659	0	O
effects	28754659	0	O
of	28754659	0	O
UVC	28754659	0	O
irradiation	28754659	0	O
,	28754659	0	O
we	28754659	0	O
tested	28754659	0	O
two	28754659	0	O
genes	28754659	0	O
-	28754659	0	O
atl-1	28754659	0	O
and	28754659	0	O
cep-1	28754659	0	O
-	28754659	0	O
which	28754659	0	O
encode	28754659	0	O
proteins	28754659	0	O
that	28754659	0	O
act	28754659	0	O
in	28754659	0	O
the	28754659	0	O
DNA	28754659	0	O
damage	28754659	0	O
response	28754659	0	O
pathway	28754659	0	O
.	28754659	0	O
Loss	28754659	0	O
of	28754659	0	O
function	28754659	0	O
mutants	28754659	0	O
of	28754659	0	O
atl-1	28754659	0	O
had	28754659	0	O
no	28754659	0	O
defect	28754659	0	O
in	28754659	0	O
UVC	28754659	0	O
induced	28754659	0	O
SIS	28754659	0	O
but	28754659	0	O
a	28754659	0	O
partial	28754659	0	O
loss	28754659	0	B-NegReg
of	28754659	0	I-NegReg
function	28754659	0	I-NegReg
mutant	28754659	0	B-Var
of	28754659	0	O
cep-1	28754659	0	B-Gene
,	28754659	0	O
gk138	28754659	0	O
,	28754659	0	O
had	28754659	0	O
decreased	28754659	0	B-NegReg
movement	28754659	0	O
quiescence	28754659	0	O
following	28754659	0	O
UVC	28754659	0	O
irradiation	28754659	0	O
.	28754659	0	O
Germline	28754659	0	O
ablation	28754659	0	O
experiments	28754659	0	O
and	28754659	0	O
tissue	28754659	0	O
-	28754659	0	O
specific	28754659	0	O
RNA	28754659	0	O
interference	28754659	0	O
experiments	28754659	0	O
showed	28754659	0	O
that	28754659	0	O
cep-1	28754659	0	O
is	28754659	0	O
required	28754659	0	O
somatically	28754659	0	O
in	28754659	0	O
neurons	28754659	0	O
for	28754659	0	O
its	28754659	0	O
effect	28754659	0	O
on	28754659	0	O
SIS	28754659	0	O
.	28754659	0	O
The	28754659	0	O
cep-1	28754659	0	B-Gene
(	28754659	0	I-Gene
gk138	28754659	0	I-Gene
)	28754659	0	I-Gene
mutant	28754659	0	B-Var
suppressed	28754659	0	B-NegReg
body	28754659	0	O
movement	28754659	0	O
quiescence	28754659	0	O
controlled	28754659	0	O
by	28754659	0	O
EGF	28754659	0	O
,	28754659	0	O
indicating	28754659	0	O
that	28754659	0	O
CEP-1	28754659	0	O
acts	28754659	0	O
downstream	28754659	0	O
or	28754659	0	O
in	28754659	0	O
parallel	28754659	0	O
to	28754659	0	O
ALA	28754659	0	O
activation	28754659	0	O
to	28754659	0	O
promote	28754659	0	O
quiescence	28754659	0	O
in	28754659	0	O
response	28754659	0	O
to	28754659	0	O
ultraviolet	28754659	0	O
light	28754659	0	O
.	28754659	0	O

PCSK9	28758421	0	B-Gene
deficiency	28758421	0	B-Var
results	28758421	0	O
in	28758421	0	O
increased	28758421	0	B-PosReg
ectopic	28758421	0	O
fat	28758421	0	O
accumulation	28758421	0	O
in	28758421	0	O
experimental	28758421	0	O
models	28758421	0	O
and	28758421	0	O
in	28758421	0	O
humans	28758421	0	O
.	28758421	0	O
Background	28758421	0	O
Proprotein	28758421	0	O
convertase	28758421	0	O
subtilisin	28758421	0	O
kexin	28758421	0	O
type	28758421	0	O
9	28758421	0	O
(	28758421	0	O
PCSK9	28758421	0	O
)	28758421	0	O
regulates	28758421	0	O
low	28758421	0	O
-	28758421	0	O
density	28758421	0	O
lipoprotein	28758421	0	O
and	28758421	0	O
very	28758421	0	O
low	28758421	0	O
-	28758421	0	O
density	28758421	0	O
lipoprotein	28758421	0	O
receptor	28758421	0	O
expression	28758421	0	O
in	28758421	0	O
several	28758421	0	O
tissues	28758421	0	O
.	28758421	0	O
Here	28758421	0	O
we	28758421	0	O
evaluated	28758421	0	O
whether	28758421	0	O
PCSK9	28758421	0	O
may	28758421	0	O
modulate	28758421	0	O
the	28758421	0	O
handling	28758421	0	O
of	28758421	0	O
triglycerides	28758421	0	O
in	28758421	0	O
the	28758421	0	O
liver	28758421	0	O
and	28758421	0	O
peripheral	28758421	0	O
tissues	28758421	0	O
.	28758421	0	O
Methods	28758421	0	O
Subjects	28758421	0	O
from	28758421	0	O
the	28758421	0	O
PLIC	28758421	0	O
cohort	28758421	0	O
were	28758421	0	O
genotyped	28758421	0	O
for	28758421	0	O
the	28758421	0	O
loss	28758421	0	O
-	28758421	0	O
of	28758421	0	O
-	28758421	0	O
function	28758421	0	O
PCSK9	28758421	0	O
R46L	28758421	0	O
variant	28758421	0	O
and	28758421	0	O
characterized	28758421	0	O
for	28758421	0	O
clinical	28758421	0	O
and	28758421	0	O
biochemical	28758421	0	O
parameters	28758421	0	O
,	28758421	0	O
total	28758421	0	O
and	28758421	0	O
android	28758421	0	O
fat	28758421	0	O
mass	28758421	0	O
,	28758421	0	O
hepatic	28758421	0	O
steatosis	28758421	0	O
and	28758421	0	O
epicardial	28758421	0	O
fat	28758421	0	O
thickness	28758421	0	O
.	28758421	0	O
Visceral	28758421	0	O
adipose	28758421	0	O
tissue	28758421	0	O
and	28758421	0	O
subcutaneous	28758421	0	O
adipose	28758421	0	O
tissue	28758421	0	O
in	28758421	0	O
PCSK9	28758421	0	O
KO	28758421	0	O
and	28758421	0	O
wild	28758421	0	O
type	28758421	0	O
mice	28758421	0	O
were	28758421	0	O
quantified	28758421	0	O
by	28758421	0	O
nuclear	28758421	0	O
magnetic	28758421	0	O
resonance	28758421	0	O
imaging	28758421	0	O
.	28758421	0	O
Results	28758421	0	O
Carriers	28758421	0	O
of	28758421	0	O
the	28758421	0	O
R46L	28758421	0	O
variant	28758421	0	O
(	28758421	0	O
n	28758421	0	O
=	28758421	0	O
13	28758421	0	O
)	28758421	0	O
had	28758421	0	O
lower	28758421	0	O
low	28758421	0	O
-	28758421	0	O
density	28758421	0	O
lipoprotein	28758421	0	O
cholesterol	28758421	0	O
levels	28758421	0	O
,	28758421	0	O
higher	28758421	0	O
body	28758421	0	O
mass	28758421	0	O
index	28758421	0	O
and	28758421	0	O
increased	28758421	0	O
percentage	28758421	0	O
of	28758421	0	O
total	28758421	0	O
and	28758421	0	O
android	28758421	0	O
fat	28758421	0	O
masses	28758421	0	O
compared	28758421	0	O
with	28758421	0	O
non	28758421	0	O
-	28758421	0	O
carriers	28758421	0	O
(	28758421	0	O
n	28758421	0	O
=	28758421	0	O
521	28758421	0	O
)	28758421	0	O
.	28758421	0	O
R46L	28758421	0	B-Gene
variant	28758421	0	B-Var
associated	28758421	0	O
with	28758421	0	O
a	28758421	0	O
two	28758421	0	O
-	28758421	0	O
fold	28758421	0	O
increase	28758421	0	B-PosReg
prevalence	28758421	0	O
of	28758421	0	O
hepatic	28758421	0	O
steatosis	28758421	0	O
and	28758421	0	O
higher	28758421	0	O
epicardial	28758421	0	O
fat	28758421	0	O
thickness	28758421	0	O
.	28758421	0	O
These	28758421	0	O
observations	28758421	0	O
were	28758421	0	O
replicated	28758421	0	O
in	28758421	0	O
PCSK9	28758421	0	O
KO	28758421	0	O
mice	28758421	0	O
,	28758421	0	O
which	28758421	0	O
showed	28758421	0	O
increased	28758421	0	O
visceral	28758421	0	O
adipose	28758421	0	O
tissue	28758421	0	O
(	28758421	0	O
but	28758421	0	O
not	28758421	0	O
subcutaneous	28758421	0	O
adipose	28758421	0	O
tissue	28758421	0	O
)	28758421	0	O
when	28758421	0	O
fed	28758421	0	O
chow	28758421	0	O
or	28758421	0	O
high	28758421	0	O
-	28758421	0	O
fat	28758421	0	O
diet	28758421	0	O
for	28758421	0	O
20	28758421	0	O
weeks	28758421	0	O
,	28758421	0	O
compared	28758421	0	O
with	28758421	0	O
wild	28758421	0	O
type	28758421	0	O
mice	28758421	0	O
.	28758421	0	O
Conclusions	28758421	0	O
These	28758421	0	O
data	28758421	0	O
suggest	28758421	0	O
that	28758421	0	O
genetically	28758421	0	O
determined	28758421	0	O
PCSK9	28758421	0	B-Gene
deficiency	28758421	0	B-Var
might	28758421	0	O
be	28758421	0	O
associated	28758421	0	B-Reg
with	28758421	0	O
ectopic	28758421	0	O
fat	28758421	0	O
accumulation	28758421	0	O
.	28758421	0	O

[	28777843	4	O
Genetic	28777843	4	O
and	28777843	4	O
prenatal	28777843	4	O
diagnosis	28777843	4	O
for	28777843	4	O
a	28777843	4	O
haemophilia	28777843	4	B-Disease
A	28777843	4	I-Disease
family	28777843	4	O
with	28777843	4	B-Reg
two	28777843	4	O
novel	28777843	4	O
mutations	28777843	4	B-Var
of	28777843	4	O
F8	28777843	4	B-Gene
gene	28777843	4	O
]	28777843	4	O
.	28777843	4	O
OBJECTIVE	28777843	4	O
:	28777843	4	O
To	28777843	4	O
conduct	28777843	4	O
genetic	28777843	4	O
diagnosis	28777843	4	O
for	28777843	4	O
a	28777843	4	O
family	28777843	4	O
affected	28777843	4	O
with	28777843	4	O
hamophilia	28777843	4	O
A.	28777843	4	O
METHODS	28777843	4	O
:	28777843	4	O
Potential	28777843	4	O
mutations	28777843	4	O
of	28777843	4	O
the	28777843	4	O
F8	28777843	4	O
gene	28777843	4	O
were	28777843	4	O
analyzed	28777843	4	O
with	28777843	4	O
PCR	28777843	4	O
and	28777843	4	O
Sanger	28777843	4	O
sequencing	28777843	4	O
.	28777843	4	O
Carriers	28777843	4	O
of	28777843	4	O
the	28777843	4	O
mutation	28777843	4	O
were	28777843	4	O
identified	28777843	4	O
through	28777843	4	O
linkage	28777843	4	O
analysis	28777843	4	O
using	28777843	4	O
short	28777843	4	O
tandem	28777843	4	O
repeat	28777843	4	O
(	28777843	4	O
STR	28777843	4	O
)	28777843	4	O
markers	28777843	4	O
.	28777843	4	O
Suspected	28777843	4	O
mutations	28777843	4	O
were	28777843	4	O
verified	28777843	4	O
among	28777843	4	O
100	28777843	4	O
healthy	28777843	4	O
controls	28777843	4	O
to	28777843	4	O
rule	28777843	4	O
out	28777843	4	O
genetic	28777843	4	O
polymorphism	28777843	4	O
.	28777843	4	O
Prenatal	28777843	4	O
diagnosis	28777843	4	O
was	28777843	4	O
provided	28777843	4	O
based	28777843	4	O
on	28777843	4	O
the	28777843	4	O
above	28777843	4	O
results	28777843	4	O
.	28777843	4	O
RESULTS	28777843	4	O
:	28777843	4	O
Sequencing	28777843	4	O
analysis	28777843	4	O
has	28777843	4	O
identified	28777843	4	O
two	28777843	4	O
mutations	28777843	4	O
,	28777843	4	O
c.1	28777843	4	O
A	28777843	4	O
>	28777843	4	O
T	28777843	4	O
and	28777843	4	O
c.4	28777843	4	O
C	28777843	4	O
>	28777843	4	O
T	28777843	4	O
,	28777843	4	O
which	28777843	4	O
have	28777843	4	O
replaced	28777843	4	O
the	28777843	4	O
start	28777843	4	O
codon	28777843	4	O
(	28777843	4	O
ATG	28777843	4	O
)	28777843	4	O
with	28777843	4	O
leucine	28777843	4	O
(	28777843	4	O
TTG	28777843	4	O
)	28777843	4	O
and	28777843	4	O
glutamine	28777843	4	O
(	28777843	4	O
GAA	28777843	4	O
)	28777843	4	O
with	28777843	4	O
the	28777843	4	O
stop	28777843	4	O
codon	28777843	4	O
(	28777843	4	O
TAA	28777843	4	O
)	28777843	4	O
,	28777843	4	O
respectively	28777843	4	O
.	28777843	4	O
The	28777843	4	O
same	28777843	4	O
mutations	28777843	4	O
were	28777843	4	O
not	28777843	4	O
found	28777843	4	O
among	28777843	4	O
the	28777843	4	O
100	28777843	4	O
healthy	28777843	4	O
controls	28777843	4	O
.	28777843	4	O
The	28777843	4	O
patient	28777843	4	O
'	28777843	4	O
s	28777843	4	O
mother	28777843	4	O
and	28777843	4	O
sister	28777843	4	O
were	28777843	4	O
heterozygous	28777843	4	O
for	28777843	4	O
the	28777843	4	O
same	28777843	4	O
mutations	28777843	4	O
.	28777843	4	O
Upon	28777843	4	O
prenatal	28777843	4	O
diagnosis	28777843	4	O
,	28777843	4	O
the	28777843	4	O
fetus	28777843	4	O
was	28777843	4	O
determined	28777843	4	O
as	28777843	4	O
a	28777843	4	O
male	28777843	4	O
and	28777843	4	O
did	28777843	4	O
not	28777843	4	O
harbor	28777843	4	O
the	28777843	4	O
above	28777843	4	O
mutations	28777843	4	O
.	28777843	4	O
Linkage	28777843	4	O
analysis	28777843	4	O
also	28777843	4	O
confirmed	28777843	4	O
that	28777843	4	O
the	28777843	4	O
fetus	28777843	4	O
has	28777843	4	O
inherited	28777843	4	O
the	28777843	4	O
non	28777843	4	O
-	28777843	4	O
risk	28777843	4	O
X	28777843	4	O
chromosome	28777843	4	O
from	28777843	4	O
his	28777843	4	O
maternal	28777843	4	O
grandfather	28777843	4	O
.	28777843	4	O
CONCLUSION	28777843	4	O
:	28777843	4	O
Detection	28777843	4	O
of	28777843	4	O
pathogenic	28777843	4	O
mutations	28777843	4	O
can	28777843	4	O
enable	28777843	4	O
prenatal	28777843	4	O
diagnosis	28777843	4	O
for	28777843	4	O
the	28777843	4	O
disease	28777843	4	O
.	28777843	4	O

A	28783725	2	O
Braf	28783725	2	B-Gene
kinase	28783725	2	O
-	28783725	2	O
inactive	28783725	2	O
mutant	28783725	2	B-Var
induces	28783725	2	B-Reg
lung	28783725	2	B-Disease
adenocarcinoma	28783725	2	I-Disease
.	28783725	2	O
The	28783725	2	O
initiating	28783725	2	O
oncogenic	28783725	2	O
event	28783725	2	O
in	28783725	2	O
almost	28783725	2	O
half	28783725	2	O
of	28783725	2	O
human	28783725	2	O
lung	28783725	2	O
adenocarcinomas	28783725	2	O
is	28783725	2	O
still	28783725	2	O
unknown	28783725	2	O
,	28783725	2	O
a	28783725	2	O
fact	28783725	2	O
that	28783725	2	O
complicates	28783725	2	O
the	28783725	2	O
development	28783725	2	O
of	28783725	2	O
selective	28783725	2	O
targeted	28783725	2	O
therapies	28783725	2	O
.	28783725	2	O
Yet	28783725	2	O
these	28783725	2	O
tumours	28783725	2	O
harbour	28783725	2	O
a	28783725	2	O
number	28783725	2	O
of	28783725	2	O
alterations	28783725	2	O
without	28783725	2	O
obvious	28783725	2	O
oncogenic	28783725	2	O
function	28783725	2	O
including	28783725	2	O
BRAF	28783725	2	O
-	28783725	2	O
inactivating	28783725	2	O
mutations	28783725	2	O
.	28783725	2	O
Inactivating	28783725	2	O
BRAF	28783725	2	O
mutants	28783725	2	O
in	28783725	2	O
lung	28783725	2	O
predominate	28783725	2	O
over	28783725	2	O
the	28783725	2	O
activating	28783725	2	O
V600E	28783725	2	O
mutant	28783725	2	O
that	28783725	2	O
is	28783725	2	O
frequently	28783725	2	O
observed	28783725	2	O
in	28783725	2	O
other	28783725	2	O
tumour	28783725	2	O
types	28783725	2	O
.	28783725	2	O
Here	28783725	2	O
we	28783725	2	O
demonstrate	28783725	2	O
that	28783725	2	O
the	28783725	2	O
expression	28783725	2	O
of	28783725	2	O
an	28783725	2	O
endogenous	28783725	2	O
Braf	28783725	2	O
(	28783725	2	O
D631A	28783725	2	O
)	28783725	2	O
kinase	28783725	2	O
-	28783725	2	O
inactive	28783725	2	O
isoform	28783725	2	O
in	28783725	2	O
mice	28783725	2	O
(	28783725	2	O
corresponding	28783725	2	O
to	28783725	2	O
the	28783725	2	O
human	28783725	2	O
BRAF	28783725	2	O
(	28783725	2	O
D594A	28783725	2	O
)	28783725	2	O
mutation	28783725	2	O
)	28783725	2	O
triggers	28783725	2	O
lung	28783725	2	O
adenocarcinoma	28783725	2	O
in	28783725	2	O
vivo	28783725	2	O
,	28783725	2	O
indicating	28783725	2	O
that	28783725	2	O
BRAF	28783725	2	O
-	28783725	2	O
inactivating	28783725	2	O
mutations	28783725	2	O
are	28783725	2	O
initiating	28783725	2	O
events	28783725	2	O
in	28783725	2	O
lung	28783725	2	O
oncogenesis	28783725	2	O
.	28783725	2	O
Moreover	28783725	2	O
,	28783725	2	O
inactivating	28783725	2	O
BRAF	28783725	2	O
mutations	28783725	2	O
have	28783725	2	O
also	28783725	2	O
been	28783725	2	O
identified	28783725	2	O
in	28783725	2	O
a	28783725	2	O
subset	28783725	2	O
of	28783725	2	O
KRAS	28783725	2	O
-	28783725	2	O
driven	28783725	2	O
human	28783725	2	O
lung	28783725	2	O
tumours	28783725	2	O
.	28783725	2	O
Co	28783725	2	O
-	28783725	2	O
expression	28783725	2	O
of	28783725	2	O
Kras	28783725	2	B-Var
(	28783725	2	I-Var
G12V	28783725	2	I-Var
)	28783725	2	I-Var
and	28783725	2	O
Braf	28783725	2	B-Var
(	28783725	2	I-Var
D631A	28783725	2	I-Var
)	28783725	2	I-Var
in	28783725	2	O
mouse	28783725	2	O
lung	28783725	2	O
cells	28783725	2	O
markedly	28783725	2	O
enhances	28783725	2	B-PosReg
tumour	28783725	2	O
initiation	28783725	2	O
,	28783725	2	O
a	28783725	2	O
phenomenon	28783725	2	O
mediated	28783725	2	O
by	28783725	2	O
Craf	28783725	2	O
kinase	28783725	2	O
activity	28783725	2	O
,	28783725	2	O
and	28783725	2	O
effectively	28783725	2	O
accelerates	28783725	2	O
tumour	28783725	2	O
progression	28783725	2	O
when	28783725	2	O
activated	28783725	2	O
in	28783725	2	O
advanced	28783725	2	O
lung	28783725	2	O
adenocarcinomas	28783725	2	O
.	28783725	2	O
We	28783725	2	O
also	28783725	2	O
report	28783725	2	O
a	28783725	2	O
key	28783725	2	O
role	28783725	2	O
for	28783725	2	O
the	28783725	2	O
wild	28783725	2	O
-	28783725	2	O
type	28783725	2	O
Braf	28783725	2	O
kinase	28783725	2	O
in	28783725	2	O
sustaining	28783725	2	O
Kras	28783725	2	O
(	28783725	2	O
G12V	28783725	2	O
)	28783725	2	O
/	28783725	2	O
Braf	28783725	2	O
(	28783725	2	O
D631A	28783725	2	O
)	28783725	2	O
-	28783725	2	O
driven	28783725	2	O
tumours	28783725	2	O
.	28783725	2	O
Ablation	28783725	2	O
of	28783725	2	O
the	28783725	2	O
wild	28783725	2	O
-	28783725	2	O
type	28783725	2	O
Braf	28783725	2	O
allele	28783725	2	O
prevents	28783725	2	O
the	28783725	2	O
development	28783725	2	O
of	28783725	2	O
lung	28783725	2	O
adenocarcinoma	28783725	2	O
by	28783725	2	O
inducing	28783725	2	O
a	28783725	2	O
further	28783725	2	O
increase	28783725	2	O
in	28783725	2	O
MAPK	28783725	2	O
signalling	28783725	2	O
that	28783725	2	O
results	28783725	2	O
in	28783725	2	O
oncogenic	28783725	2	O
toxicity	28783725	2	O
;	28783725	2	O
this	28783725	2	O
effect	28783725	2	O
can	28783725	2	O
be	28783725	2	O
abolished	28783725	2	O
by	28783725	2	O
pharmacological	28783725	2	O
inhibition	28783725	2	O
of	28783725	2	O
Mek	28783725	2	O
to	28783725	2	O
restore	28783725	2	O
tumour	28783725	2	O
growth	28783725	2	O
.	28783725	2	O
However	28783725	2	O
,	28783725	2	O
the	28783725	2	O
loss	28783725	2	B-Var
of	28783725	2	O
wild	28783725	2	O
-	28783725	2	O
type	28783725	2	O
Braf	28783725	2	B-Gene
also	28783725	2	O
induces	28783725	2	B-Reg
transdifferentiation	28783725	2	O
of	28783725	2	O
club	28783725	2	O
cells	28783725	2	O
,	28783725	2	O
which	28783725	2	O
leads	28783725	2	B-Reg
to	28783725	2	I-Reg
the	28783725	2	O
rapid	28783725	2	O
development	28783725	2	O
of	28783725	2	O
lethal	28783725	2	O
intrabronchiolar	28783725	2	O
lesions	28783725	2	O
.	28783725	2	O
These	28783725	2	O
observations	28783725	2	O
indicate	28783725	2	O
that	28783725	2	O
the	28783725	2	O
signal	28783725	2	O
intensity	28783725	2	O
of	28783725	2	O
the	28783725	2	O
MAPK	28783725	2	O
pathway	28783725	2	O
is	28783725	2	O
a	28783725	2	O
critical	28783725	2	O
determinant	28783725	2	O
not	28783725	2	O
only	28783725	2	O
in	28783725	2	O
tumour	28783725	2	O
development	28783725	2	O
,	28783725	2	O
but	28783725	2	O
also	28783725	2	O
in	28783725	2	O
dictating	28783725	2	O
the	28783725	2	O
nature	28783725	2	O
of	28783725	2	O
the	28783725	2	O
cancer	28783725	2	O
-	28783725	2	O
initiating	28783725	2	O
cell	28783725	2	O
and	28783725	2	O
ultimately	28783725	2	O
the	28783725	2	O
resulting	28783725	2	O
tumour	28783725	2	O
phenotype	28783725	2	O
.	28783725	2	O

Characterization	28800850	0	O
of	28800850	0	O
the	28800850	0	O
autophagy	28800850	0	O
-	28800850	0	O
related	28800850	0	O
gene	28800850	0	O
BmATG8	28800850	0	O
in	28800850	0	O
Bipolaris	28800850	0	O
maydis	28800850	0	O
.	28800850	0	O
Autophagy	28800850	0	O
is	28800850	0	O
involved	28800850	0	O
in	28800850	0	O
cellular	28800850	0	O
development	28800850	0	O
and	28800850	0	O
the	28800850	0	O
maintenance	28800850	0	O
of	28800850	0	O
viability	28800850	0	O
under	28800850	0	O
nutrient	28800850	0	O
deprivation	28800850	0	O
in	28800850	0	O
a	28800850	0	O
wide	28800850	0	O
range	28800850	0	O
of	28800850	0	O
eukaryotes	28800850	0	O
.	28800850	0	O
A	28800850	0	O
filamentous	28800850	0	O
ascomycete	28800850	0	O
Bipolaris	28800850	0	O
maydis	28800850	0	O
,	28800850	0	O
responsible	28800850	0	O
for	28800850	0	O
southern	28800850	0	O
corn	28800850	0	O
leaf	28800850	0	O
blight	28800850	0	O
,	28800850	0	O
is	28800850	0	O
also	28800850	0	O
studied	28800850	0	O
as	28800850	0	O
a	28800850	0	O
model	28800850	0	O
fungus	28800850	0	O
for	28800850	0	O
sexual	28800850	0	O
reproduction	28800850	0	O
in	28800850	0	O
filamentous	28800850	0	O
ascomycetes	28800850	0	O
that	28800850	0	O
form	28800850	0	O
filiform	28800850	0	O
ascospores	28800850	0	O
.	28800850	0	O
In	28800850	0	O
order	28800850	0	O
to	28800850	0	O
clarify	28800850	0	O
the	28800850	0	O
roles	28800850	0	O
of	28800850	0	O
autophagy	28800850	0	O
in	28800850	0	O
various	28800850	0	O
stages	28800850	0	O
of	28800850	0	O
the	28800850	0	O
life	28800850	0	O
cycle	28800850	0	O
of	28800850	0	O
B.	28800850	0	O
maydis	28800850	0	O
,	28800850	0	O
we	28800850	0	O
constructed	28800850	0	O
null	28800850	0	O
mutants	28800850	0	O
of	28800850	0	O
BmATG8	28800850	0	O
,	28800850	0	O
an	28800850	0	O
orthologue	28800850	0	O
of	28800850	0	O
the	28800850	0	O
Saccharomyces	28800850	0	O
cerevisiae	28800850	0	O
autophagy	28800850	0	O
gene	28800850	0	O
ATG8	28800850	0	O
in	28800850	0	O
B.	28800850	0	O
maydis	28800850	0	O
.	28800850	0	O
Deletion	28800850	0	B-Var
of	28800850	0	O
BmATG8	28800850	0	B-Gene
impaired	28800850	0	B-NegReg
localization	28800850	0	O
of	28800850	0	O
cytosolic	28800850	0	O
components	28800850	0	O
to	28800850	0	O
the	28800850	0	O
vacuole	28800850	0	O
under	28800850	0	O
nitrogen	28800850	0	O
starvation	28800850	0	O
,	28800850	0	O
suggesting	28800850	0	O
that	28800850	0	O
autophagy	28800850	0	O
was	28800850	0	O
deficient	28800850	0	B-NegReg
in	28800850	0	O
the	28800850	0	O
null	28800850	0	O
mutants	28800850	0	O
.	28800850	0	O
Additionally	28800850	0	O
,	28800850	0	O
fluorescent	28800850	0	O
microscopic	28800850	0	O
observations	28800850	0	O
on	28800850	0	O
a	28800850	0	O
eGFP	28800850	0	O
-	28800850	0	O
fused	28800850	0	O
BmATG8	28800850	0	O
expressing	28800850	0	O
strain	28800850	0	O
showed	28800850	0	O
that	28800850	0	O
BmATG8	28800850	0	O
is	28800850	0	O
associated	28800850	0	O
with	28800850	0	O
autophagy	28800850	0	O
-	28800850	0	O
related	28800850	0	O
structures	28800850	0	O
.	28800850	0	O
In	28800850	0	O
vegetative	28800850	0	O
growth	28800850	0	O
,	28800850	0	O
ΔBmATG8	28800850	0	B-Gene
strains	28800850	0	O
showed	28800850	0	O
a	28800850	0	O
reduction	28800850	0	B-NegReg
in	28800850	0	O
conidiation	28800850	0	O
and	28800850	0	O
aerial	28800850	0	O
mycelial	28800850	0	O
growth	28800850	0	O
.	28800850	0	O
Interestingly	28800850	0	O
,	28800850	0	O
the	28800850	0	O
mutant	28800850	0	O
conidia	28800850	0	O
indicated	28800850	0	O
loss	28800850	0	O
of	28800850	0	O
the	28800850	0	O
germination	28800850	0	O
rate	28800850	0	O
under	28800850	0	O
starvation	28800850	0	O
conditions	28800850	0	O
and	28800850	0	O
affected	28800850	0	O
longevity	28800850	0	O
.	28800850	0	O
However	28800850	0	O
,	28800850	0	O
germinated	28800850	0	O
mutant	28800850	0	O
conidia	28800850	0	O
were	28800850	0	O
still	28800850	0	O
capable	28800850	0	O
of	28800850	0	O
infecting	28800850	0	O
the	28800850	0	O
host	28800850	0	O
plant	28800850	0	O
via	28800850	0	O
appressoria	28800850	0	O
.	28800850	0	O
In	28800850	0	O
sexual	28800850	0	O
reproduction	28800850	0	O
,	28800850	0	O
ascospores	28800850	0	O
with	28800850	0	O
ΔBmATG8	28800850	0	O
genetic	28800850	0	O
background	28800850	0	O
were	28800850	0	O
aborted	28800850	0	O
.	28800850	0	O
Our	28800850	0	O
results	28800850	0	O
revealed	28800850	0	O
that	28800850	0	O
autophagy	28800850	0	O
plays	28800850	0	O
a	28800850	0	O
crucial	28800850	0	O
role	28800850	0	O
in	28800850	0	O
the	28800850	0	O
function	28800850	0	O
of	28800850	0	O
conidia	28800850	0	O
,	28800850	0	O
not	28800850	0	O
in	28800850	0	O
host	28800850	0	O
infection	28800850	0	O
via	28800850	0	O
appressoria	28800850	0	O
in	28800850	0	O
B.	28800850	0	O
maydis	28800850	0	O
.	28800850	0	O
In	28800850	0	O
addition	28800850	0	O
,	28800850	0	O
conservation	28800850	0	O
of	28800850	0	O
the	28800850	0	O
importance	28800850	0	O
of	28800850	0	O
autophagy	28800850	0	O
in	28800850	0	O
ascospore	28800850	0	O
development	28800850	0	O
is	28800850	0	O
suggested	28800850	0	O
among	28800850	0	O
ascomycetes	28800850	0	O
including	28800850	0	O
species	28800850	0	O
that	28800850	0	O
form	28800850	0	O
bitunicate	28800850	0	O
ascus	28800850	0	O
.	28800850	0	O

Loss	28833578	1	O
-	28833578	1	O
of	28833578	1	O
-	28833578	1	O
function	28833578	1	O
mutations	28833578	1	O
in	28833578	1	O
filaggrin	28833578	1	O
gene	28833578	1	O
and	28833578	1	O
malignant	28833578	1	O
melanoma	28833578	1	O
:	28833578	1	O
a	28833578	1	O
case	28833578	1	O
control	28833578	1	O
study	28833578	1	O
.	28833578	1	O
BACKGROUND	28833578	1	O
:	28833578	1	O
Loss	28833578	1	B-NegReg
-	28833578	1	I-NegReg
of	28833578	1	I-NegReg
-	28833578	1	I-NegReg
function	28833578	1	I-NegReg
mutations	28833578	1	B-Var
in	28833578	1	O
filaggrin	28833578	1	O
gene	28833578	1	O
(	28833578	1	B-Gene
FLG	28833578	1	I-Gene
)	28833578	1	I-Gene
have	28833578	1	O
been	28833578	1	O
suggested	28833578	1	O
to	28833578	1	O
increase	28833578	1	O
the	28833578	1	O
susceptibility	28833578	1	O
of	28833578	1	O
skin	28833578	1	B-Disease
malignancies	28833578	1	I-Disease
due	28833578	1	O
to	28833578	1	O
reduced	28833578	1	B-NegReg
levels	28833578	1	O
of	28833578	1	O
epidermal	28833578	1	O
filaggrin	28833578	1	O
and	28833578	1	O
its	28833578	1	O
degradation	28833578	1	O
products	28833578	1	O
,	28833578	1	O
urocanic	28833578	1	O
acid	28833578	1	O
,	28833578	1	O
which	28833578	1	O
may	28833578	1	O
be	28833578	1	O
protective	28833578	1	O
against	28833578	1	O
ultraviolet	28833578	1	O
irradiation	28833578	1	O
.	28833578	1	O
OBJECTIVE	28833578	1	O
:	28833578	1	O
We	28833578	1	O
aimed	28833578	1	O
to	28833578	1	O
investigate	28833578	1	O
the	28833578	1	O
association	28833578	1	O
between	28833578	1	O
FLG	28833578	1	O
mutation	28833578	1	O
status	28833578	1	O
and	28833578	1	O
the	28833578	1	O
occurrence	28833578	1	O
of	28833578	1	O
malignant	28833578	1	O
melanoma	28833578	1	O
(	28833578	1	O
MM	28833578	1	O
)	28833578	1	O
in	28833578	1	O
Danish	28833578	1	O
adults	28833578	1	O
.	28833578	1	O
METHODS	28833578	1	O
:	28833578	1	O
The	28833578	1	O
prevalence	28833578	1	O
of	28833578	1	O
FLG	28833578	1	O
mutations	28833578	1	O
in	28833578	1	O
a	28833578	1	O
sample	28833578	1	O
of	28833578	1	O
MM	28833578	1	O
biopsies	28833578	1	O
was	28833578	1	O
compared	28833578	1	O
with	28833578	1	O
a	28833578	1	O
FLG	28833578	1	O
genotyped	28833578	1	O
cohort	28833578	1	O
from	28833578	1	O
two	28833578	1	O
general	28833578	1	O
population	28833578	1	O
studies	28833578	1	O
.	28833578	1	O
Pearson	28833578	1	O
'	28833578	1	O
s	28833578	1	O
chi	28833578	1	O
-	28833578	1	O
square	28833578	1	O
and	28833578	1	O
Fisher	28833578	1	O
'	28833578	1	O
s	28833578	1	O
exact	28833578	1	O
tests	28833578	1	O
were	28833578	1	O
used	28833578	1	O
to	28833578	1	O
compare	28833578	1	O
the	28833578	1	O
two	28833578	1	O
groups	28833578	1	O
.	28833578	1	O
RESULTS	28833578	1	O
:	28833578	1	O
A	28833578	1	O
total	28833578	1	O
of	28833578	1	O
867	28833578	1	O
MM	28833578	1	O
biopsies	28833578	1	O
and	28833578	1	O
9965	28833578	1	O
general	28833578	1	O
population	28833578	1	O
controls	28833578	1	O
were	28833578	1	O
genotyped	28833578	1	O
,	28833578	1	O
respectively	28833578	1	O
.	28833578	1	O
In	28833578	1	O
the	28833578	1	O
MM	28833578	1	O
sample	28833578	1	O
2	28833578	1	O
(	28833578	1	O
0.23%	28833578	1	O
)	28833578	1	O
individuals	28833578	1	O
were	28833578	1	O
homozygous	28833578	1	O
and	28833578	1	O
80	28833578	1	O
(	28833578	1	O
9.4%	28833578	1	O
)	28833578	1	O
heterozygous	28833578	1	O
mutation	28833578	1	O
carriers	28833578	1	O
.	28833578	1	O
In	28833578	1	O
the	28833578	1	O
general	28833578	1	O
population	28833578	1	O
controls	28833578	1	O
the	28833578	1	O
prevalence	28833578	1	O
of	28833578	1	O
FLG	28833578	1	O
mutations	28833578	1	O
was	28833578	1	O
18	28833578	1	O
(	28833578	1	O
0.18%	28833578	1	O
)	28833578	1	O
and	28833578	1	O
835	28833578	1	O
(	28833578	1	O
8.4%	28833578	1	O
)	28833578	1	O
for	28833578	1	O
homozygous	28833578	1	O
and	28833578	1	O
heterozygous	28833578	1	O
mutations	28833578	1	O
,	28833578	1	O
respectively	28833578	1	O
.	28833578	1	O
Fisher	28833578	1	O
'	28833578	1	O
s	28833578	1	O
exact	28833578	1	O
test	28833578	1	O
and	28833578	1	O
Pearson	28833578	1	O
'	28833578	1	O
s	28833578	1	O
chi	28833578	1	O
square	28833578	1	O
test	28833578	1	O
yielded	28833578	1	O
non	28833578	1	O
-	28833578	1	O
significant	28833578	1	O
p	28833578	1	O
-	28833578	1	O
values	28833578	1	O
when	28833578	1	O
the	28833578	1	O
groups	28833578	1	O
were	28833578	1	O
compared	28833578	1	O
.	28833578	1	O
CONCLUSION	28833578	1	O
:	28833578	1	O
FLG	28833578	1	O
mutation	28833578	1	O
was	28833578	1	O
not	28833578	1	O
associated	28833578	1	O
with	28833578	1	O
MM	28833578	1	O
in	28833578	1	O
the	28833578	1	O
studied	28833578	1	O
populations	28833578	1	O
.	28833578	1	O
This	28833578	1	O
finding	28833578	1	O
indicates	28833578	1	O
that	28833578	1	O
epidermal	28833578	1	O
deficiency	28833578	1	O
of	28833578	1	O
filaggrin	28833578	1	O
and	28833578	1	O
its	28833578	1	O
degradation	28833578	1	O
products	28833578	1	O
do	28833578	1	O
not	28833578	1	O
influence	28833578	1	O
the	28833578	1	O
risk	28833578	1	O
of	28833578	1	O
MM	28833578	1	O
significantly	28833578	1	O
.	28833578	1	O
This	28833578	1	O
article	28833578	1	O
is	28833578	1	O
protected	28833578	1	O
by	28833578	1	O
copyright	28833578	1	O
.	28833578	1	O
All	28833578	1	O
rights	28833578	1	O
reserved	28833578	1	O
.	28833578	1	O

A	28834165	2	O
gain	28834165	2	B-PosReg
-	28834165	2	I-PosReg
of	28834165	2	I-PosReg
-	28834165	2	I-PosReg
function	28834165	2	I-PosReg
mutation	28834165	2	B-Var
in	28834165	2	O
TNFRSF13B	28834165	2	B-Gene
is	28834165	2	O
a	28834165	2	O
candidate	28834165	2	O
for	28834165	2	O
predisposition	28834165	2	O
to	28834165	2	O
familial	28834165	2	B-Disease
or	28834165	2	I-Disease
sporadic	28834165	2	I-Disease
immune	28834165	2	I-Disease
thrombocytopenia	28834165	2	I-Disease
.	28834165	2	O
BACKGROUND	28834165	2	O
:	28834165	2	O
Most	28834165	2	O
immune	28834165	2	B-Disease
thrombocytopenia	28834165	2	I-Disease
(	28834165	2	O
ITP	28834165	2	O
)	28834165	2	O
is	28834165	2	O
sporadic	28834165	2	O
but	28834165	2	O
a	28834165	2	O
positive	28834165	2	O
family	28834165	2	O
history	28834165	2	O
of	28834165	2	O
ITP	28834165	2	O
in	28834165	2	O
some	28834165	2	O
patients	28834165	2	O
suggests	28834165	2	O
that	28834165	2	O
hereditary	28834165	2	O
forms	28834165	2	O
exist	28834165	2	O
.	28834165	2	O
Due	28834165	2	O
to	28834165	2	O
the	28834165	2	O
rarity	28834165	2	O
of	28834165	2	O
familial	28834165	2	O
ITP	28834165	2	O
families	28834165	2	O
available	28834165	2	O
for	28834165	2	O
study	28834165	2	O
and	28834165	2	O
the	28834165	2	O
heterogeneity	28834165	2	O
of	28834165	2	O
sporadic	28834165	2	O
ITP	28834165	2	O
,	28834165	2	O
family	28834165	2	O
linkage	28834165	2	O
analysis	28834165	2	O
or	28834165	2	O
genome	28834165	2	O
wide	28834165	2	O
association	28834165	2	O
studies	28834165	2	O
are	28834165	2	O
limited	28834165	2	O
.	28834165	2	O
OBJECTIVES	28834165	2	O
:	28834165	2	O
Based	28834165	2	O
on	28834165	2	O
one	28834165	2	O
ITP	28834165	2	O
pedigree	28834165	2	O
,	28834165	2	O
we	28834165	2	O
try	28834165	2	O
to	28834165	2	O
identify	28834165	2	O
the	28834165	2	O
predisposing	28834165	2	O
gene	28834165	2	O
in	28834165	2	O
familial	28834165	2	O
or	28834165	2	O
sporadic	28834165	2	O
ITP	28834165	2	O
and	28834165	2	O
reveal	28834165	2	O
the	28834165	2	O
way	28834165	2	O
in	28834165	2	O
which	28834165	2	O
it	28834165	2	O
causes	28834165	2	O
thrombocytopenia	28834165	2	O
.	28834165	2	O
METHODS	28834165	2	O
:	28834165	2	O
Gene	28834165	2	O
expression	28834165	2	O
profiling	28834165	2	O
analysis	28834165	2	O
and	28834165	2	O
whole	28834165	2	O
-	28834165	2	O
exome	28834165	2	O
sequencing	28834165	2	O
was	28834165	2	O
performed	28834165	2	O
on	28834165	2	O
samples	28834165	2	O
from	28834165	2	O
familial	28834165	2	O
ITP	28834165	2	O
members	28834165	2	O
,	28834165	2	O
sporadic	28834165	2	O
ITP	28834165	2	O
cases	28834165	2	O
and	28834165	2	O
healthy	28834165	2	O
individuals	28834165	2	O
.	28834165	2	O
We	28834165	2	O
also	28834165	2	O
evaluated	28834165	2	O
the	28834165	2	O
influence	28834165	2	O
of	28834165	2	O
potential	28834165	2	O
pathogenic	28834165	2	O
mutation	28834165	2	O
on	28834165	2	O
immune	28834165	2	O
function	28834165	2	O
and	28834165	2	O
megakaryocyte	28834165	2	O
apoptosis	28834165	2	O
.	28834165	2	O
RESULTS	28834165	2	O
:	28834165	2	O
Whole	28834165	2	O
-	28834165	2	O
exome	28834165	2	O
sequencing	28834165	2	O
identified	28834165	2	O
a	28834165	2	O
potential	28834165	2	O
pathologic	28834165	2	B-Reg
p.G76S	28834165	2	B-Var
heterozygous	28834165	2	O
mutation	28834165	2	O
on	28834165	2	O
the	28834165	2	O
TNFRSF13B	28834165	2	B-Gene
gene	28834165	2	O
in	28834165	2	O
familial	28834165	2	B-Disease
ITP	28834165	2	I-Disease
patients	28834165	2	O
.	28834165	2	O
ITP	28834165	2	O
patients	28834165	2	O
harboring	28834165	2	O
G76S	28834165	2	B-Var
mutation	28834165	2	O
displayed	28834165	2	O
upregulated	28834165	2	B-PosReg
"	28834165	2	O
cytokine	28834165	2	O
-	28834165	2	O
cytokine	28834165	2	O
receptor	28834165	2	O
interaction	28834165	2	O
"	28834165	2	O
signal	28834165	2	O
,	28834165	2	O
increased	28834165	2	B-PosReg
serum	28834165	2	O
TNFα	28834165	2	O
,	28834165	2	O
IL-17	28834165	2	O
α	28834165	2	O
,	28834165	2	O
IFNγ	28834165	2	O
and	28834165	2	O
BAFF	28834165	2	O
levels	28834165	2	O
,	28834165	2	O
and	28834165	2	O
enhanced	28834165	2	B-PosReg
binding	28834165	2	O
capacity	28834165	2	O
of	28834165	2	O
APRIL	28834165	2	O
ligand	28834165	2	O
to	28834165	2	O
B	28834165	2	O
cells	28834165	2	O
.	28834165	2	O
Additionally	28834165	2	O
,	28834165	2	O
EBV	28834165	2	O
-	28834165	2	O
transformed	28834165	2	O
B	28834165	2	O
cells	28834165	2	O
with	28834165	2	O
the	28834165	2	O
G76S	28834165	2	B-Var
mutation	28834165	2	O
could	28834165	2	O
induce	28834165	2	B-PosReg
human	28834165	2	O
megakaryocyte	28834165	2	O
line	28834165	2	O
(	28834165	2	O
Meg-01	28834165	2	O
)	28834165	2	O
apoptosis	28834165	2	O
significantly	28834165	2	O
.	28834165	2	O
CONCLUSION	28834165	2	O
:	28834165	2	O
p.G76S	28834165	2	B-Var
mutation	28834165	2	O
on	28834165	2	O
TNFRSF13B	28834165	2	B-Gene
gene	28834165	2	O
is	28834165	2	O
responsible	28834165	2	B-Reg
for	28834165	2	O
ITP	28834165	2	B-Disease
,	28834165	2	O
and	28834165	2	O
is	28834165	2	O
a	28834165	2	O
genetic	28834165	2	O
predisposing	28834165	2	O
factor	28834165	2	O
for	28834165	2	O
familial	28834165	2	O
or	28834165	2	O
sporadic	28834165	2	O
ITP	28834165	2	O
.	28834165	2	O
This	28834165	2	O
article	28834165	2	O
is	28834165	2	O
protected	28834165	2	O
by	28834165	2	O
copyright	28834165	2	O
.	28834165	2	O
All	28834165	2	O
rights	28834165	2	O
reserved	28834165	2	O
.	28834165	2	O

A	28836768	0	O
single	28836768	0	O
active	28836768	0	O
site	28836768	0	O
mutation	28836768	0	O
in	28836768	0	O
the	28836768	0	O
pikromycin	28836768	0	O
thioesterase	28836768	0	O
generates	28836768	0	O
a	28836768	0	O
more	28836768	0	O
effective	28836768	0	O
macrocyclization	28836768	0	O
catalyst	28836768	0	O
.	28836768	0	O
Macrolactonization	28836768	0	O
of	28836768	0	O
natural	28836768	0	O
product	28836768	0	O
analogs	28836768	0	O
presents	28836768	0	O
a	28836768	0	O
significant	28836768	0	O
challenge	28836768	0	O
to	28836768	0	O
both	28836768	0	O
biosynthetic	28836768	0	O
assembly	28836768	0	O
and	28836768	0	O
synthetic	28836768	0	O
chemistry	28836768	0	O
.	28836768	0	O
In	28836768	0	O
the	28836768	0	O
preceding	28836768	0	O
paper	28836768	0	O
,	28836768	0	O
we	28836768	0	O
identified	28836768	0	O
a	28836768	0	O
thioesterase	28836768	0	O
(	28836768	0	O
TE	28836768	0	O
)	28836768	0	O
domain	28836768	0	O
catalytic	28836768	0	O
bottleneck	28836768	0	O
in	28836768	0	O
the	28836768	0	O
processing	28836768	0	O
of	28836768	0	O
un	28836768	0	O
-	28836768	0	O
natural	28836768	0	O
substrates	28836768	0	O
in	28836768	0	O
the	28836768	0	O
pikromycin	28836768	0	O
(	28836768	0	O
Pik	28836768	0	O
)	28836768	0	O
system	28836768	0	O
,	28836768	0	O
preventing	28836768	0	O
the	28836768	0	O
formation	28836768	0	O
of	28836768	0	O
epimerized	28836768	0	O
macrolactones	28836768	0	O
.	28836768	0	O
Here	28836768	0	O
,	28836768	0	O
we	28836768	0	O
perform	28836768	0	O
molecular	28836768	0	O
dynamics	28836768	0	O
(	28836768	0	O
MD	28836768	0	O
)	28836768	0	O
simulations	28836768	0	O
showing	28836768	0	O
the	28836768	0	O
epimerized	28836768	0	O
hexaketide	28836768	0	O
was	28836768	0	O
accommodated	28836768	0	O
within	28836768	0	O
the	28836768	0	O
Pik	28836768	0	O
TE	28836768	0	O
active	28836768	0	O
site	28836768	0	O
;	28836768	0	O
however	28836768	0	O
,	28836768	0	O
intrinsic	28836768	0	O
conformational	28836768	0	O
preferences	28836768	0	O
of	28836768	0	O
the	28836768	0	O
substrate	28836768	0	O
resulted	28836768	0	O
in	28836768	0	O
predominately	28836768	0	O
unproductive	28836768	0	O
conformations	28836768	0	O
,	28836768	0	O
in	28836768	0	O
agreement	28836768	0	O
with	28836768	0	O
the	28836768	0	O
observed	28836768	0	O
hydrolysis	28836768	0	O
.	28836768	0	O
Accordingly	28836768	0	O
,	28836768	0	O
we	28836768	0	O
engineered	28836768	0	O
the	28836768	0	O
stereospecific	28836768	0	O
Pik	28836768	0	O
TE	28836768	0	O
to	28836768	0	O
yield	28836768	0	O
a	28836768	0	O
variant	28836768	0	O
(	28836768	0	O
TES148C	28836768	0	O
)	28836768	0	O
with	28836768	0	O
improved	28836768	0	O
reaction	28836768	0	O
kinetics	28836768	0	O
and	28836768	0	O
gain	28836768	0	O
-	28836768	0	O
of	28836768	0	O
-	28836768	0	O
function	28836768	0	O
processing	28836768	0	O
of	28836768	0	O
an	28836768	0	O
unnatural	28836768	0	O
,	28836768	0	O
epimerized	28836768	0	O
hexaketide	28836768	0	O
.	28836768	0	O
Quantum	28836768	0	O
mechanical	28836768	0	O
(	28836768	0	O
QM	28836768	0	O
)	28836768	0	O
comparison	28836768	0	O
of	28836768	0	O
model	28836768	0	O
TES148C	28836768	0	O
and	28836768	0	O
TEWT	28836768	0	O
reaction	28836768	0	O
coordinate	28836768	0	O
diagrams	28836768	0	O
revealed	28836768	0	O
a	28836768	0	O
change	28836768	0	O
in	28836768	0	O
mechanism	28836768	0	O
from	28836768	0	O
a	28836768	0	O
stepwise	28836768	0	O
addition	28836768	0	O
-	28836768	0	O
elimination	28836768	0	O
(	28836768	0	O
TEWT	28836768	0	O
)	28836768	0	O
to	28836768	0	O
a	28836768	0	O
lower	28836768	0	O
energy	28836768	0	O
concerted	28836768	0	O
acyl	28836768	0	O
substitution	28836768	0	O
(	28836768	0	O
TES148C	28836768	0	O
)	28836768	0	O
,	28836768	0	O
accounting	28836768	0	O
for	28836768	0	O
the	28836768	0	O
gain	28836768	0	O
-	28836768	0	O
of	28836768	0	O
-	28836768	0	O
function	28836768	0	O
and	28836768	0	O
improved	28836768	0	O
reaction	28836768	0	O
kinetics	28836768	0	O
.	28836768	0	O
Finally	28836768	0	O
,	28836768	0	O
we	28836768	0	O
introduced	28836768	0	O
the	28836768	0	O
S148C	28836768	0	B-Var
mutation	28836768	0	O
into	28836768	0	O
a	28836768	0	O
polyketide	28836768	0	O
synthase	28836768	0	O
module	28836768	0	O
(	28836768	0	O
PikAIII	28836768	0	O
-	28836768	0	O
TE	28836768	0	O
)	28836768	0	O
to	28836768	0	O
impart	28836768	0	O
increased	28836768	0	B-PosReg
substrate	28836768	0	O
flexibility	28836768	0	O
,	28836768	0	O
enabling	28836768	0	B-PosReg
the	28836768	0	O
production	28836768	0	O
of	28836768	0	O
diastereomeric	28836768	0	O
macrolactones	28836768	0	O
.	28836768	0	O

A	28838926	0	O
comprehensive	28838926	0	O
functional	28838926	0	O
assessment	28838926	0	O
of	28838926	0	O
carboxylesterase	28838926	0	O
1	28838926	0	O
nonsynonymous	28838926	0	O
polymorphisms	28838926	0	O
.	28838926	0	O
Carboxylesterase	28838926	0	O
1	28838926	0	O
(	28838926	0	O
CES1	28838926	0	O
)	28838926	0	O
is	28838926	0	O
the	28838926	0	O
predominant	28838926	0	O
human	28838926	0	O
hepatic	28838926	0	O
hydrolase	28838926	0	O
responsible	28838926	0	O
for	28838926	0	O
the	28838926	0	O
metabolism	28838926	0	O
of	28838926	0	O
many	28838926	0	O
clinically	28838926	0	O
important	28838926	0	O
medications	28838926	0	O
.	28838926	0	O
CES1	28838926	0	O
expression	28838926	0	O
and	28838926	0	O
activity	28838926	0	O
vary	28838926	0	O
markedly	28838926	0	O
among	28838926	0	O
individuals	28838926	0	O
;	28838926	0	O
and	28838926	0	O
genetic	28838926	0	O
variation	28838926	0	O
is	28838926	0	O
a	28838926	0	O
major	28838926	0	O
contributing	28838926	0	O
factor	28838926	0	O
to	28838926	0	O
CES1	28838926	0	O
interindividual	28838926	0	O
variability	28838926	0	O
.	28838926	0	O
In	28838926	0	O
the	28838926	0	O
present	28838926	0	O
study	28838926	0	O
,	28838926	0	O
we	28838926	0	O
comprehensively	28838926	0	O
examined	28838926	0	O
the	28838926	0	O
functions	28838926	0	O
of	28838926	0	O
CES1	28838926	0	O
nonsynonymous	28838926	0	O
single	28838926	0	O
nucleotide	28838926	0	O
polymorphisms	28838926	0	O
(	28838926	0	O
nsSNPs	28838926	0	O
)	28838926	0	O
and	28838926	0	O
haplotypes	28838926	0	O
using	28838926	0	O
transfected	28838926	0	O
cell	28838926	0	O
lines	28838926	0	O
and	28838926	0	O
individual	28838926	0	O
human	28838926	0	O
liver	28838926	0	O
tissues	28838926	0	O
.	28838926	0	O
The	28838926	0	O
20	28838926	0	O
candidate	28838926	0	O
variants	28838926	0	O
include	28838926	0	O
CES1	28838926	0	O
nsSNPs	28838926	0	O
with	28838926	0	O
a	28838926	0	O
minor	28838926	0	O
allele	28838926	0	O
frequency	28838926	0	O
(	28838926	0	O
MAF	28838926	0	O
)	28838926	0	O
>	28838926	0	O
0.5%	28838926	0	O
in	28838926	0	O
a	28838926	0	O
given	28838926	0	O
population	28838926	0	O
or	28838926	0	O
located	28838926	0	O
in	28838926	0	O
close	28838926	0	O
proximity	28838926	0	O
to	28838926	0	O
the	28838926	0	O
CES1	28838926	0	O
active	28838926	0	O
site	28838926	0	O
.	28838926	0	O
Five	28838926	0	O
nsSNPs	28838926	0	O
including	28838926	0	O
L40Ter	28838926	0	O
(	28838926	0	B-Var
rs151291296	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
G142E	28838926	0	O
(	28838926	0	B-Var
rs121912777	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
G147C	28838926	0	O
(	28838926	0	B-Var
rs146456965	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
Y170D	28838926	0	O
(	28838926	0	B-Var
rs148947808	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
and	28838926	0	O
R171C	28838926	0	O
(	28838926	0	B-Var
rs201065375	28838926	0	I-Var
)	28838926	0	I-Var
were	28838926	0	O
found	28838926	0	O
to	28838926	0	O
be	28838926	0	O
loss	28838926	0	B-NegReg
-	28838926	0	I-NegReg
of	28838926	0	I-NegReg
-	28838926	0	I-NegReg
function	28838926	0	I-NegReg
variants	28838926	0	O
for	28838926	0	O
metabolizing	28838926	0	O
the	28838926	0	O
CES1	28838926	0	O
substrates	28838926	0	O
clopidogrel	28838926	0	O
,	28838926	0	O
enalapril	28838926	0	O
,	28838926	0	O
and	28838926	0	O
sacubitril	28838926	0	O
.	28838926	0	O
Additionally	28838926	0	O
,	28838926	0	O
the	28838926	0	O
A158V	28838926	0	O
(	28838926	0	B-Var
rs202121317	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
R199H	28838926	0	O
(	28838926	0	B-Var
rs2307243	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
E220G	28838926	0	O
(	28838926	0	B-Var
rs200707504	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
and	28838926	0	O
T290M	28838926	0	O
(	28838926	0	B-Var
rs202001817	28838926	0	I-Var
)	28838926	0	I-Var
decreased	28838926	0	B-NegReg
CES1	28838926	0	O
activity	28838926	0	O
to	28838926	0	O
a	28838926	0	O
lesser	28838926	0	O
extent	28838926	0	O
in	28838926	0	O
a	28838926	0	O
substrate	28838926	0	O
-	28838926	0	O
dependent	28838926	0	O
manner	28838926	0	O
.	28838926	0	O
Several	28838926	0	O
nsSNPs	28838926	0	O
including	28838926	0	O
the	28838926	0	O
L40Ter	28838926	0	O
(	28838926	0	B-Var
rs151291296	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
G147C	28838926	0	O
(	28838926	0	B-Var
rs146456965	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
Y170D	28838926	0	O
(	28838926	0	B-Var
rs148947808	28838926	0	I-Var
)	28838926	0	I-Var
,	28838926	0	O
and	28838926	0	O
R171C	28838926	0	O
(	28838926	0	B-Var
rs201065375	28838926	0	I-Var
)	28838926	0	I-Var
significantly	28838926	0	O
reduced	28838926	0	B-NegReg
CES1	28838926	0	O
protein	28838926	0	O
and	28838926	0	O
/	28838926	0	O
or	28838926	0	O
mRNA	28838926	0	O
expressions	28838926	0	O
in	28838926	0	O
the	28838926	0	O
transfected	28838926	0	O
cells	28838926	0	O
.	28838926	0	O
Functions	28838926	0	O
of	28838926	0	O
the	28838926	0	O
common	28838926	0	O
nonsynonymous	28838926	0	O
haplotypes	28838926	0	O
D203E	28838926	0	O
-	28838926	0	O
A269S	28838926	0	O
and	28838926	0	O
S75N	28838926	0	O
-	28838926	0	O
D203E	28838926	0	O
-	28838926	0	O
A269S	28838926	0	O
were	28838926	0	O
evaluated	28838926	0	O
using	28838926	0	O
cells	28838926	0	O
stably	28838926	0	O
expressing	28838926	0	O
the	28838926	0	O
haplotypes	28838926	0	O
and	28838926	0	O
a	28838926	0	O
large	28838926	0	O
set	28838926	0	O
of	28838926	0	O
human	28838926	0	O
livers	28838926	0	O
.	28838926	0	O
Neither	28838926	0	O
CES1	28838926	0	O
expression	28838926	0	O
nor	28838926	0	O
activity	28838926	0	O
were	28838926	0	O
affected	28838926	0	O
by	28838926	0	O
the	28838926	0	O
two	28838926	0	O
haplotypes	28838926	0	O
.	28838926	0	O
In	28838926	0	O
sum	28838926	0	O
,	28838926	0	O
the	28838926	0	O
study	28838926	0	O
revealed	28838926	0	O
several	28838926	0	O
functional	28838926	0	O
nsSNPs	28838926	0	O
with	28838926	0	O
impaired	28838926	0	O
activity	28838926	0	O
on	28838926	0	O
the	28838926	0	O
metabolism	28838926	0	O
of	28838926	0	O
CES1	28838926	0	O
substrate	28838926	0	O
drugs	28838926	0	O
.	28838926	0	O
Clinical	28838926	0	O
investigations	28838926	0	O
are	28838926	0	O
warranted	28838926	0	O
to	28838926	0	O
determine	28838926	0	O
whether	28838926	0	O
these	28838926	0	O
nsSNPs	28838926	0	O
can	28838926	0	O
serve	28838926	0	O
as	28838926	0	O
biomarkers	28838926	0	O
for	28838926	0	O
the	28838926	0	O
prediction	28838926	0	O
of	28838926	0	O
therapeutic	28838926	0	O
outcomes	28838926	0	O
of	28838926	0	O
drugs	28838926	0	O
metabolized	28838926	0	O
by	28838926	0	O
CES1	28838926	0	O
.	28838926	0	O

Progranulin	28845019	1	O
haploinsufficiency	28845019	1	B-Var
reduces	28845019	1	B-NegReg
amyloid	28845019	1	O
beta	28845019	1	O
deposition	28845019	1	O
in	28845019	1	O
Alzheimer	28845019	1	B-Disease
'	28845019	1	I-Disease
s	28845019	1	I-Disease
disease	28845019	1	I-Disease
model	28845019	1	O
mice	28845019	1	O
.	28845019	1	O
Granulin	28845019	1	O
(	28845019	1	O
Grn	28845019	1	O
)	28845019	1	O
mutations	28845019	1	O
were	28845019	1	O
identified	28845019	1	O
in	28845019	1	O
familial	28845019	1	O
frontotemporal	28845019	1	B-Disease
lobar	28845019	1	I-Disease
degeneration	28845019	1	I-Disease
(	28845019	1	O
FTLD	28845019	1	O
)	28845019	1	O
patients	28845019	1	O
with	28845019	1	O
TAR	28845019	1	O
DNA	28845019	1	O
-	28845019	1	O
binding	28845019	1	O
protein	28845019	1	O
of	28845019	1	O
43	28845019	1	O
kd	28845019	1	O
(	28845019	1	O
TDP-43	28845019	1	O
)	28845019	1	O
pathology	28845019	1	O
.	28845019	1	O
Grn	28845019	1	O
transcript	28845019	1	O
haploinsufficiency	28845019	1	B-Var
is	28845019	1	O
proposed	28845019	1	O
as	28845019	1	O
a	28845019	1	O
disease	28845019	1	O
mechanism	28845019	1	O
that	28845019	1	O
leads	28845019	1	O
to	28845019	1	O
the	28845019	1	O
loss	28845019	1	B-NegReg
of	28845019	1	I-NegReg
functional	28845019	1	I-NegReg
progranulin	28845019	1	O
(	28845019	1	O
PGRN	28845019	1	O
)	28845019	1	O
protein	28845019	1	O
.	28845019	1	O
Thus	28845019	1	O
,	28845019	1	O
these	28845019	1	O
mutations	28845019	1	B-Var
are	28845019	1	O
strongly	28845019	1	O
involved	28845019	1	B-Reg
in	28845019	1	O
FTLD	28845019	1	B-Disease
pathogenesis	28845019	1	O
.	28845019	1	O
Moreover	28845019	1	O
,	28845019	1	O
recent	28845019	1	O
findings	28845019	1	O
indicate	28845019	1	O
that	28845019	1	O
Grn	28845019	1	O
mutations	28845019	1	B-Var
are	28845019	1	O
associated	28845019	1	B-Reg
with	28845019	1	O
other	28845019	1	O
neurodegenerative	28845019	1	O
disorders	28845019	1	O
with	28845019	1	O
tau	28845019	1	O
pathology	28845019	1	O
,	28845019	1	O
including	28845019	1	O
Alzheimer	28845019	1	B-Disease
'	28845019	1	I-Disease
s	28845019	1	I-Disease
disease	28845019	1	I-Disease
.	28845019	1	O
To	28845019	1	O
investigate	28845019	1	O
the	28845019	1	O
influence	28845019	1	O
of	28845019	1	O
PGRN	28845019	1	O
on	28845019	1	O
amyloid	28845019	1	O
beta	28845019	1	O
(	28845019	1	O
Aβ	28845019	1	O
)	28845019	1	O
accumulation	28845019	1	O
,	28845019	1	O
amyloid	28845019	1	O
precursor	28845019	1	O
protein	28845019	1	O
(	28845019	1	O
APP	28845019	1	O
)	28845019	1	O
transgenic	28845019	1	O
mice	28845019	1	O
were	28845019	1	O
interbred	28845019	1	O
with	28845019	1	O
Grn	28845019	1	O
-	28845019	1	O
deficient	28845019	1	O
mice	28845019	1	O
,	28845019	1	O
producing	28845019	1	O
APP	28845019	1	O
transgenic	28845019	1	O
mice	28845019	1	O
harboring	28845019	1	O
the	28845019	1	O
Grn	28845019	1	O
hemizygote	28845019	1	O
(	28845019	1	O
APP	28845019	1	O
/	28845019	1	O
Grn	28845019	1	O
/	28845019	1	O
-	28845019	1	O
)	28845019	1	O
.	28845019	1	O
Brains	28845019	1	O
were	28845019	1	O
collected	28845019	1	O
from	28845019	1	O
16	28845019	1	O
-	28845019	1	O
18	28845019	1	O
-	28845019	1	O
month	28845019	1	O
-	28845019	1	O
old	28845019	1	O
APP	28845019	1	O
and	28845019	1	O
APP	28845019	1	O
/	28845019	1	O
Grn	28845019	1	O
/	28845019	1	O
-	28845019	1	O
mice	28845019	1	O
and	28845019	1	O
sequential	28845019	1	O
extraction	28845019	1	O
of	28845019	1	O
proteins	28845019	1	O
,	28845019	1	O
immunoblotting	28845019	1	O
and	28845019	1	O
immunohistochemical	28845019	1	O
analysis	28845019	1	O
were	28845019	1	O
performed	28845019	1	O
.	28845019	1	O
Immunohistochemical	28845019	1	O
analysis	28845019	1	O
showed	28845019	1	O
that	28845019	1	O
the	28845019	1	O
number	28845019	1	O
and	28845019	1	O
area	28845019	1	O
of	28845019	1	O
Aβ	28845019	1	O
plaque	28845019	1	O
was	28845019	1	O
significantly	28845019	1	O
decreased	28845019	1	O
in	28845019	1	O
APP	28845019	1	O
/	28845019	1	O
Grn	28845019	1	O
/	28845019	1	O
-	28845019	1	O
mice	28845019	1	O
as	28845019	1	O
compared	28845019	1	O
to	28845019	1	O
APP	28845019	1	O
mice	28845019	1	O
.	28845019	1	O
Immunoblotting	28845019	1	O
analysis	28845019	1	O
revealed	28845019	1	O
that	28845019	1	O
Aβ	28845019	1	O
was	28845019	1	O
reduced	28845019	1	O
in	28845019	1	O
the	28845019	1	O
sarkosyl	28845019	1	O
-	28845019	1	O
insoluble	28845019	1	O
fraction	28845019	1	O
of	28845019	1	O
16	28845019	1	O
-	28845019	1	O
18	28845019	1	O
-	28845019	1	O
month	28845019	1	O
-	28845019	1	O
old	28845019	1	O
APP	28845019	1	O
/	28845019	1	O
Grn	28845019	1	O
/	28845019	1	O
-	28845019	1	O
mice	28845019	1	O
as	28845019	1	O
compared	28845019	1	O
with	28845019	1	O
that	28845019	1	O
of	28845019	1	O
APP	28845019	1	O
transgenic	28845019	1	O
mice	28845019	1	O
.	28845019	1	O
Our	28845019	1	O
data	28845019	1	O
suggest	28845019	1	O
that	28845019	1	O
PGRN	28845019	1	O
haploinsufficiency	28845019	1	B-Var
may	28845019	1	O
decrease	28845019	1	B-NegReg
accumulation	28845019	1	O
of	28845019	1	O
Aβ	28845019	1	O
.	28845019	1	O

Comprehensive	28859693	4	O
analysis	28859693	4	O
for	28859693	4	O
genetic	28859693	4	O
diagnosis	28859693	4	O
of	28859693	4	O
Dystrophinopathies	28859693	4	O
in	28859693	4	O
Japan	28859693	4	O
.	28859693	4	O
BACKGROUND	28859693	4	O
:	28859693	4	O
Duchenne	28859693	4	B-Disease
muscular	28859693	4	I-Disease
dystrophy	28859693	4	I-Disease
(	28859693	4	O
DMD	28859693	4	O
)	28859693	4	O
is	28859693	4	O
the	28859693	4	O
most	28859693	4	O
common	28859693	4	O
disease	28859693	4	O
in	28859693	4	O
children	28859693	4	O
caused	28859693	4	B-Reg
by	28859693	4	I-Reg
mutations	28859693	4	B-Var
in	28859693	4	O
the	28859693	4	O
DMD	28859693	4	B-Gene
gene	28859693	4	O
,	28859693	4	O
and	28859693	4	O
DMD	28859693	4	O
and	28859693	4	O
Becker	28859693	4	O
muscular	28859693	4	O
dystrophy	28859693	4	O
(	28859693	4	O
BMD	28859693	4	O
)	28859693	4	O
are	28859693	4	O
collectively	28859693	4	O
called	28859693	4	O
dystrophinopathies	28859693	4	O
.	28859693	4	O
Dystrophinopathies	28859693	4	O
show	28859693	4	O
a	28859693	4	O
complex	28859693	4	O
mutation	28859693	4	O
spectrum	28859693	4	O
.	28859693	4	O
The	28859693	4	O
importance	28859693	4	O
of	28859693	4	O
mutation	28859693	4	O
databases	28859693	4	O
,	28859693	4	O
with	28859693	4	O
clinical	28859693	4	O
phenotypes	28859693	4	O
and	28859693	4	O
protein	28859693	4	O
studies	28859693	4	O
of	28859693	4	O
patients	28859693	4	O
,	28859693	4	O
is	28859693	4	O
increasingly	28859693	4	O
recognized	28859693	4	O
as	28859693	4	O
a	28859693	4	O
reference	28859693	4	O
for	28859693	4	O
genetic	28859693	4	O
diagnosis	28859693	4	O
and	28859693	4	O
for	28859693	4	O
the	28859693	4	O
development	28859693	4	O
of	28859693	4	O
gene	28859693	4	O
therapy	28859693	4	O
.	28859693	4	O
METHODS	28859693	4	O
:	28859693	4	O
We	28859693	4	O
used	28859693	4	O
the	28859693	4	O
data	28859693	4	O
from	28859693	4	O
the	28859693	4	O
Japanese	28859693	4	O
Registry	28859693	4	O
of	28859693	4	O
Muscular	28859693	4	O
Dystrophy	28859693	4	O
(	28859693	4	O
Remudy	28859693	4	O
)	28859693	4	O
compiled	28859693	4	O
during	28859693	4	O
from	28859693	4	O
July	28859693	4	O
2009	28859693	4	O
to	28859693	4	O
March	28859693	4	O
2017	28859693	4	O
,	28859693	4	O
and	28859693	4	O
reviewed	28859693	4	O
1497	28859693	4	O
patients	28859693	4	O
with	28859693	4	O
dystrophinopathies	28859693	4	O
.	28859693	4	O
RESULTS	28859693	4	O
:	28859693	4	O
The	28859693	4	O
spectrum	28859693	4	O
of	28859693	4	O
identified	28859693	4	O
mutations	28859693	4	O
contained	28859693	4	O
exon	28859693	4	O
deletions	28859693	4	O
(	28859693	4	O
61%	28859693	4	O
)	28859693	4	O
,	28859693	4	O
exon	28859693	4	O
duplications	28859693	4	O
(	28859693	4	O
13%	28859693	4	O
)	28859693	4	O
,	28859693	4	O
nonsense	28859693	4	O
mutations	28859693	4	O
(	28859693	4	O
13%	28859693	4	O
)	28859693	4	O
,	28859693	4	O
small	28859693	4	O
deletions	28859693	4	O
(	28859693	4	O
5%	28859693	4	O
)	28859693	4	O
,	28859693	4	O
small	28859693	4	O
insertions	28859693	4	O
(	28859693	4	O
3%	28859693	4	O
)	28859693	4	O
,	28859693	4	O
splice	28859693	4	O
-	28859693	4	O
site	28859693	4	O
mutations	28859693	4	O
(	28859693	4	O
4%	28859693	4	O
)	28859693	4	O
,	28859693	4	O
and	28859693	4	O
missense	28859693	4	O
mutations	28859693	4	O
(	28859693	4	O
1%	28859693	4	O
)	28859693	4	O
.	28859693	4	O
Exon	28859693	4	O
deletions	28859693	4	O
were	28859693	4	O
found	28859693	4	O
most	28859693	4	O
frequently	28859693	4	O
in	28859693	4	O
the	28859693	4	O
central	28859693	4	O
hot	28859693	4	O
spot	28859693	4	O
region	28859693	4	O
between	28859693	4	O
exons	28859693	4	O
45	28859693	4	O
-	28859693	4	O
52	28859693	4	O
(	28859693	4	O
42%	28859693	4	O
)	28859693	4	O
,	28859693	4	O
and	28859693	4	O
most	28859693	4	O
duplications	28859693	4	O
were	28859693	4	O
detected	28859693	4	O
in	28859693	4	O
the	28859693	4	O
proximal	28859693	4	O
hot	28859693	4	O
spot	28859693	4	O
region	28859693	4	O
between	28859693	4	O
exons	28859693	4	O
3	28859693	4	O
-	28859693	4	O
25	28859693	4	O
(	28859693	4	O
47%	28859693	4	O
)	28859693	4	O
.	28859693	4	O
In	28859693	4	O
the	28859693	4	O
371	28859693	4	O
patients	28859693	4	O
harboring	28859693	4	O
a	28859693	4	O
small	28859693	4	O
mutation	28859693	4	O
,	28859693	4	O
194	28859693	4	O
mutations	28859693	4	O
were	28859693	4	O
reported	28859693	4	O
and	28859693	4	O
187	28859693	4	O
mutations	28859693	4	O
were	28859693	4	O
unreported	28859693	4	O
.	28859693	4	O
CONCLUSIONS	28859693	4	O
:	28859693	4	O
We	28859693	4	O
report	28859693	4	O
the	28859693	4	O
largest	28859693	4	O
dystrophinopathies	28859693	4	O
mutation	28859693	4	O
dataset	28859693	4	O
in	28859693	4	O
Japan	28859693	4	O
from	28859693	4	O
a	28859693	4	O
national	28859693	4	O
patient	28859693	4	O
registry	28859693	4	O
,	28859693	4	O
"	28859693	4	O
Remudy	28859693	4	O
"	28859693	4	O
.	28859693	4	O
This	28859693	4	O
dataset	28859693	4	O
provides	28859693	4	O
a	28859693	4	O
useful	28859693	4	O
reference	28859693	4	O
to	28859693	4	O
support	28859693	4	O
the	28859693	4	O
genetic	28859693	4	O
diagnosis	28859693	4	O
and	28859693	4	O
treatment	28859693	4	O
of	28859693	4	O
dystrophinopathy	28859693	4	O
.	28859693	4	O

Gait	28867506	0	O
disturbance	28867506	0	O
and	28867506	0	O
lower	28867506	0	O
limb	28867506	0	O
pain	28867506	0	O
in	28867506	0	O
a	28867506	0	O
patient	28867506	0	O
with	28867506	0	O
PIK3CA	28867506	0	O
-	28867506	0	O
related	28867506	0	O
disorder	28867506	0	O
.	28867506	0	O
Post	28867506	0	O
-	28867506	0	O
zygotic	28867506	0	O
activating	28867506	0	O
mutations	28867506	0	O
in	28867506	0	O
PIK3CA	28867506	0	O
and	28867506	0	O
other	28867506	0	O
genes	28867506	0	O
encoding	28867506	0	O
members	28867506	0	O
of	28867506	0	O
PI3K	28867506	0	O
-	28867506	0	O
AKT	28867506	0	O
-	28867506	0	O
mTOR	28867506	0	O
pathway	28867506	0	O
have	28867506	0	O
been	28867506	0	O
found	28867506	0	O
in	28867506	0	O
various	28867506	0	O
overgrowth	28867506	0	O
syndromes	28867506	0	O
that	28867506	0	O
have	28867506	0	O
been	28867506	0	O
grouped	28867506	0	O
together	28867506	0	O
as	28867506	0	O
PIK3CA	28867506	0	O
-	28867506	0	O
related	28867506	0	O
overgrowth	28867506	0	O
spectrum	28867506	0	O
(	28867506	0	O
PROS	28867506	0	O
)	28867506	0	O
.	28867506	0	O
We	28867506	0	O
report	28867506	0	O
a	28867506	0	O
female	28867506	0	O
patient	28867506	0	O
with	28867506	0	O
gait	28867506	0	O
disturbance	28867506	0	O
,	28867506	0	O
leg	28867506	0	O
pain	28867506	0	O
,	28867506	0	O
isolated	28867506	0	O
macrodactyly	28867506	0	O
of	28867506	0	O
the	28867506	0	O
foot	28867506	0	O
,	28867506	0	O
and	28867506	0	O
mild	28867506	0	O
intellectual	28867506	0	O
disability	28867506	0	O
.	28867506	0	O
Imaging	28867506	0	O
of	28867506	0	O
the	28867506	0	O
lower	28867506	0	O
limb	28867506	0	O
showed	28867506	0	O
a	28867506	0	O
lipoblastoma	28867506	0	O
of	28867506	0	O
the	28867506	0	O
right	28867506	0	O
thigh	28867506	0	O
.	28867506	0	O
A	28867506	0	O
mosaic	28867506	0	O
gain	28867506	0	B-PosReg
-	28867506	0	I-PosReg
of	28867506	0	I-PosReg
-	28867506	0	I-PosReg
function	28867506	0	I-PosReg
mutation	28867506	0	O
in	28867506	0	O
the	28867506	0	O
catalytic	28867506	0	O
domain	28867506	0	O
of	28867506	0	O
PIK3CA	28867506	0	B-Gene
(	28867506	0	B-Var
c.3140	28867506	0	I-Var
A	28867506	0	I-Var
>	28867506	0	I-Var
G	28867506	0	I-Var
;	28867506	0	I-Var
p.His1047Arg	28867506	0	B-Var
)	28867506	0	I-Var
was	28867506	0	O
detected	28867506	0	O
in	28867506	0	O
the	28867506	0	O
adipose	28867506	0	O
tissue	28867506	0	O
and	28867506	0	O
in	28867506	0	O
skin	28867506	0	O
cultured	28867506	0	O
fibroblasts	28867506	0	O
from	28867506	0	O
the	28867506	0	O
macrodactyly	28867506	0	O
but	28867506	0	O
not	28867506	0	O
in	28867506	0	O
blood	28867506	0	O
.	28867506	0	O
The	28867506	0	O
leg	28867506	0	O
pain	28867506	0	O
and	28867506	0	O
the	28867506	0	O
severe	28867506	0	O
walking	28867506	0	O
disturbance	28867506	0	O
improved	28867506	0	O
slightly	28867506	0	O
over	28867506	0	O
time	28867506	0	O
and	28867506	0	O
serial	28867506	0	O
MRI	28867506	0	O
of	28867506	0	O
the	28867506	0	O
lower	28867506	0	O
limbs	28867506	0	O
suggested	28867506	0	O
that	28867506	0	O
the	28867506	0	O
size	28867506	0	O
of	28867506	0	O
the	28867506	0	O
lipoblastoma	28867506	0	O
relative	28867506	0	O
to	28867506	0	O
the	28867506	0	O
lower	28867506	0	O
limb	28867506	0	O
muscles	28867506	0	O
or	28867506	0	O
to	28867506	0	O
the	28867506	0	O
whole	28867506	0	O
lower	28867506	0	O
limb	28867506	0	O
was	28867506	0	O
unchanged	28867506	0	O
as	28867506	0	O
consequence	28867506	0	O
of	28867506	0	O
limb	28867506	0	O
growth	28867506	0	O
.	28867506	0	O
This	28867506	0	O
case	28867506	0	O
report	28867506	0	O
illustrates	28867506	0	O
that	28867506	0	O
pain	28867506	0	O
and	28867506	0	O
gait	28867506	0	O
disturbance	28867506	0	O
can	28867506	0	O
be	28867506	0	O
features	28867506	0	O
of	28867506	0	O
PROS	28867506	0	O
and	28867506	0	O
highlights	28867506	0	O
the	28867506	0	O
need	28867506	0	O
of	28867506	0	O
better	28867506	0	O
knowledge	28867506	0	O
about	28867506	0	O
the	28867506	0	O
natural	28867506	0	O
history	28867506	0	O
of	28867506	0	O
the	28867506	0	O
disease	28867506	0	O
.	28867506	0	O

A	28877480	0	O
Defective	28877480	0	O
mRNA	28877480	0	O
Cleavage	28877480	0	O
and	28877480	0	O
Polyadenylation	28877480	0	O
Complex	28877480	0	O
Facilitates	28877480	0	O
Expansions	28877480	0	O
of	28877480	0	O
Transcribed	28877480	0	O
(	28877480	0	O
GAA	28877480	0	O
)	28877480	0	O
n	28877480	0	O
Repeats	28877480	0	O
Associated	28877480	0	O
with	28877480	0	O
Friedreich	28877480	0	O
'	28877480	0	O
s	28877480	0	O
Ataxia	28877480	0	O
.	28877480	0	O
Expansions	28877480	0	O
of	28877480	0	O
microsatellite	28877480	0	O
repeats	28877480	0	O
are	28877480	0	O
responsible	28877480	0	O
for	28877480	0	O
numerous	28877480	0	O
hereditary	28877480	0	O
diseases	28877480	0	O
in	28877480	0	O
humans	28877480	0	O
,	28877480	0	O
including	28877480	0	O
myotonic	28877480	0	O
dystrophy	28877480	0	O
and	28877480	0	O
Friedreich	28877480	0	O
'	28877480	0	O
s	28877480	0	O
ataxia	28877480	0	O
.	28877480	0	O
Whereas	28877480	0	O
the	28877480	0	O
length	28877480	0	O
of	28877480	0	O
an	28877480	0	O
expandable	28877480	0	O
repeat	28877480	0	O
is	28877480	0	O
the	28877480	0	O
main	28877480	0	O
factor	28877480	0	O
determining	28877480	0	O
disease	28877480	0	O
inheritance	28877480	0	O
,	28877480	0	O
recent	28877480	0	O
data	28877480	0	O
point	28877480	0	O
to	28877480	0	O
genomic	28877480	0	O
trans	28877480	0	O
modifiers	28877480	0	O
that	28877480	0	O
can	28877480	0	O
impact	28877480	0	O
the	28877480	0	O
likelihood	28877480	0	O
of	28877480	0	O
expansions	28877480	0	O
and	28877480	0	O
disease	28877480	0	O
progression	28877480	0	O
.	28877480	0	O
Detection	28877480	0	O
of	28877480	0	O
these	28877480	0	O
modifiers	28877480	0	O
may	28877480	0	O
lead	28877480	0	O
to	28877480	0	O
understanding	28877480	0	O
and	28877480	0	O
treating	28877480	0	O
repeat	28877480	0	O
expansion	28877480	0	O
diseases	28877480	0	O
.	28877480	0	O
Here	28877480	0	O
,	28877480	0	O
we	28877480	0	O
describe	28877480	0	O
a	28877480	0	O
method	28877480	0	O
for	28877480	0	O
the	28877480	0	O
rapid	28877480	0	O
,	28877480	0	O
genome	28877480	0	O
-	28877480	0	O
wide	28877480	0	O
identification	28877480	0	O
of	28877480	0	O
trans	28877480	0	O
modifiers	28877480	0	O
for	28877480	0	O
repeat	28877480	0	O
expansion	28877480	0	O
in	28877480	0	O
a	28877480	0	O
yeast	28877480	0	O
experimental	28877480	0	O
system	28877480	0	O
.	28877480	0	O
Using	28877480	0	O
this	28877480	0	O
method	28877480	0	O
,	28877480	0	O
we	28877480	0	O
found	28877480	0	O
that	28877480	0	O
missense	28877480	0	B-Var
mutations	28877480	0	I-Var
in	28877480	0	O
the	28877480	0	O
endoribonuclease	28877480	0	O
subunit	28877480	0	O
(	28877480	0	B-Gene
Ysh1	28877480	0	I-Gene
)	28877480	0	I-Gene
of	28877480	0	O
the	28877480	0	O
mRNA	28877480	0	O
cleavage	28877480	0	O
and	28877480	0	O
polyadenylation	28877480	0	O
complex	28877480	0	O
dramatically	28877480	0	O
increase	28877480	0	B-PosReg
the	28877480	0	O
rate	28877480	0	O
of	28877480	0	O
(	28877480	0	O
GAA	28877480	0	O
)	28877480	0	O
n	28877480	0	O
repeat	28877480	0	O
expansions	28877480	0	O
but	28877480	0	O
only	28877480	0	O
when	28877480	0	O
they	28877480	0	O
are	28877480	0	O
actively	28877480	0	O
transcribed	28877480	0	O
.	28877480	0	O
These	28877480	0	O
expansions	28877480	0	O
correlate	28877480	0	O
with	28877480	0	O
slower	28877480	0	B-NegReg
transcription	28877480	0	O
elongation	28877480	0	O
caused	28877480	0	O
by	28877480	0	O
the	28877480	0	O
ysh1	28877480	0	B-Gene
mutation	28877480	0	B-Var
.	28877480	0	O
These	28877480	0	O
results	28877480	0	O
reveal	28877480	0	O
an	28877480	0	O
interplay	28877480	0	O
between	28877480	0	O
RNA	28877480	0	O
processing	28877480	0	O
and	28877480	0	O
repeat	28877480	0	O
-	28877480	0	O
mediated	28877480	0	O
genome	28877480	0	O
instability	28877480	0	O
,	28877480	0	O
confirming	28877480	0	O
the	28877480	0	O
validity	28877480	0	O
of	28877480	0	O
our	28877480	0	O
approach	28877480	0	O
.	28877480	0	O

Loss	28886269	1	O
-	28886269	1	O
of	28886269	1	O
-	28886269	1	O
Function	28886269	1	O
GRHL3	28886269	1	O
Variants	28886269	1	O
Detected	28886269	1	O
in	28886269	1	O
African	28886269	1	O
Patients	28886269	1	O
with	28886269	1	O
Isolated	28886269	1	O
Cleft	28886269	1	O
Palate	28886269	1	O
.	28886269	1	O
In	28886269	1	O
contrast	28886269	1	O
to	28886269	1	O
the	28886269	1	O
progress	28886269	1	O
that	28886269	1	O
has	28886269	1	O
been	28886269	1	O
made	28886269	1	O
toward	28886269	1	O
understanding	28886269	1	O
the	28886269	1	O
genetic	28886269	1	O
etiology	28886269	1	O
of	28886269	1	O
cleft	28886269	1	O
lip	28886269	1	O
with	28886269	1	O
or	28886269	1	O
without	28886269	1	O
cleft	28886269	1	O
palate	28886269	1	O
,	28886269	1	O
relatively	28886269	1	O
little	28886269	1	O
is	28886269	1	O
known	28886269	1	O
about	28886269	1	O
the	28886269	1	O
genetic	28886269	1	O
etiology	28886269	1	O
for	28886269	1	O
cleft	28886269	1	B-Disease
palate	28886269	1	I-Disease
only	28886269	1	I-Disease
(	28886269	1	O
CPO	28886269	1	O
)	28886269	1	O
.	28886269	1	O
A	28886269	1	O
common	28886269	1	O
coding	28886269	1	O
variant	28886269	1	O
of	28886269	1	O
grainyhead	28886269	1	O
like	28886269	1	O
transcription	28886269	1	O
factor	28886269	1	O
3	28886269	1	O
(	28886269	1	O
GRHL3	28886269	1	O
)	28886269	1	O
was	28886269	1	O
recently	28886269	1	O
shown	28886269	1	O
to	28886269	1	O
be	28886269	1	O
associated	28886269	1	O
with	28886269	1	O
risk	28886269	1	O
for	28886269	1	O
CPO	28886269	1	O
in	28886269	1	O
Europeans	28886269	1	O
.	28886269	1	O
Mutations	28886269	1	O
in	28886269	1	O
this	28886269	1	O
gene	28886269	1	O
were	28886269	1	O
also	28886269	1	O
reported	28886269	1	O
in	28886269	1	O
families	28886269	1	O
with	28886269	1	O
Van	28886269	1	O
der	28886269	1	O
Woude	28886269	1	O
syndrome	28886269	1	O
.	28886269	1	O
To	28886269	1	O
identify	28886269	1	O
rare	28886269	1	O
mutations	28886269	1	O
in	28886269	1	O
GRHL3	28886269	1	O
that	28886269	1	O
might	28886269	1	O
explain	28886269	1	O
the	28886269	1	O
missing	28886269	1	O
heritability	28886269	1	O
for	28886269	1	O
CPO	28886269	1	O
,	28886269	1	O
we	28886269	1	O
sequenced	28886269	1	O
GRHL3	28886269	1	O
in	28886269	1	O
cases	28886269	1	O
of	28886269	1	O
CPO	28886269	1	O
from	28886269	1	O
Africa	28886269	1	O
.	28886269	1	O
We	28886269	1	O
recruited	28886269	1	O
participants	28886269	1	O
from	28886269	1	O
Ghana	28886269	1	O
,	28886269	1	O
Ethiopia	28886269	1	O
,	28886269	1	O
and	28886269	1	O
Nigeria	28886269	1	O
.	28886269	1	O
This	28886269	1	O
cohort	28886269	1	O
included	28886269	1	O
case	28886269	1	O
-	28886269	1	O
parent	28886269	1	O
trios	28886269	1	O
,	28886269	1	O
cases	28886269	1	O
and	28886269	1	O
other	28886269	1	O
family	28886269	1	O
members	28886269	1	O
,	28886269	1	O
as	28886269	1	O
well	28886269	1	O
as	28886269	1	O
controls	28886269	1	O
.	28886269	1	O
We	28886269	1	O
sequenced	28886269	1	O
exons	28886269	1	O
of	28886269	1	O
this	28886269	1	O
gene	28886269	1	O
in	28886269	1	O
DNA	28886269	1	O
from	28886269	1	O
a	28886269	1	O
total	28886269	1	O
of	28886269	1	O
134	28886269	1	O
nonsyndromic	28886269	1	O
cases	28886269	1	O
.	28886269	1	O
When	28886269	1	O
possible	28886269	1	O
,	28886269	1	O
we	28886269	1	O
sequenced	28886269	1	O
them	28886269	1	O
in	28886269	1	O
parents	28886269	1	O
to	28886269	1	O
identify	28886269	1	O
de	28886269	1	O
novo	28886269	1	O
mutations	28886269	1	O
.	28886269	1	O
Five	28886269	1	O
novel	28886269	1	O
mutations	28886269	1	O
were	28886269	1	O
identified	28886269	1	O
:	28886269	1	O
2	28886269	1	O
missense	28886269	1	O
(	28886269	1	O
c.497	28886269	1	O
C	28886269	1	O
>	28886269	1	O
A	28886269	1	O
;	28886269	1	O
p.Pro166His	28886269	1	O
and	28886269	1	O
c.1229	28886269	1	O
A	28886269	1	O
>	28886269	1	O
G	28886269	1	O
;	28886269	1	O
p.Asp410Gly	28886269	1	O
)	28886269	1	O
,	28886269	1	O
1	28886269	1	O
splice	28886269	1	O
site	28886269	1	O
(	28886269	1	O
c.1282	28886269	1	O
A	28886269	1	O
>	28886269	1	O
C	28886269	1	O
p.Ser428Arg	28886269	1	O
)	28886269	1	O
,	28886269	1	O
1	28886269	1	O
frameshift	28886269	1	O
(	28886269	1	O
c.470	28886269	1	O
delC	28886269	1	O
;	28886269	1	O
p.Gly158Alafster55	28886269	1	O
)	28886269	1	O
,	28886269	1	O
and	28886269	1	O
1	28886269	1	O
nonsense	28886269	1	O
(	28886269	1	O
c.1677	28886269	1	O
C	28886269	1	O
>	28886269	1	O
A	28886269	1	O
;	28886269	1	O
p.Tyr559Ter	28886269	1	O
)	28886269	1	O
.	28886269	1	O
These	28886269	1	O
mutations	28886269	1	O
were	28886269	1	O
absent	28886269	1	O
from	28886269	1	O
270	28886269	1	O
sequenced	28886269	1	O
controls	28886269	1	O
and	28886269	1	O
from	28886269	1	O
all	28886269	1	O
public	28886269	1	O
exome	28886269	1	O
and	28886269	1	O
whole	28886269	1	O
genome	28886269	1	O
databases	28886269	1	O
,	28886269	1	O
including	28886269	1	O
the	28886269	1	O
1000	28886269	1	O
Genomes	28886269	1	O
database	28886269	1	O
(	28886269	1	O
which	28886269	1	O
includes	28886269	1	O
data	28886269	1	O
from	28886269	1	O
Africa	28886269	1	O
)	28886269	1	O
.	28886269	1	O
However	28886269	1	O
,	28886269	1	O
4	28886269	1	O
of	28886269	1	O
the	28886269	1	O
5	28886269	1	O
mutations	28886269	1	O
were	28886269	1	O
present	28886269	1	O
in	28886269	1	O
unaffected	28886269	1	O
mothers	28886269	1	O
,	28886269	1	O
indicating	28886269	1	O
that	28886269	1	O
their	28886269	1	O
penetrance	28886269	1	O
is	28886269	1	O
incomplete	28886269	1	O
.	28886269	1	O
Interestingly	28886269	1	O
,	28886269	1	O
1	28886269	1	O
mutation	28886269	1	B-Var
damaged	28886269	1	B-NegReg
a	28886269	1	O
predicted	28886269	1	O
sumoylation	28886269	1	O
site	28886269	1	O
,	28886269	1	O
and	28886269	1	O
another	28886269	1	O
disrupted	28886269	1	B-NegReg
a	28886269	1	O
predicted	28886269	1	O
CK1	28886269	1	O
phosphorylation	28886269	1	O
site	28886269	1	O
.	28886269	1	O
Overexpression	28886269	1	O
assays	28886269	1	O
in	28886269	1	O
zebrafish	28886269	1	O
and	28886269	1	O
reporter	28886269	1	O
assays	28886269	1	O
in	28886269	1	O
vitro	28886269	1	O
indicated	28886269	1	O
that	28886269	1	O
4	28886269	1	O
variants	28886269	1	O
were	28886269	1	O
functionally	28886269	1	O
null	28886269	1	O
or	28886269	1	O
hypomorphic	28886269	1	O
,	28886269	1	O
while	28886269	1	O
1	28886269	1	O
was	28886269	1	O
dominant	28886269	1	O
negative	28886269	1	O
.	28886269	1	O
This	28886269	1	O
study	28886269	1	O
provides	28886269	1	O
evidence	28886269	1	O
that	28886269	1	O
,	28886269	1	O
as	28886269	1	O
in	28886269	1	O
Caucasian	28886269	1	O
populations	28886269	1	O
,	28886269	1	O
mutations	28886269	1	B-Var
in	28886269	1	O
GRHL3	28886269	1	B-Gene
contribute	28886269	1	O
to	28886269	1	O
the	28886269	1	O
risk	28886269	1	B-Reg
of	28886269	1	O
nonsyndromic	28886269	1	O
CPO	28886269	1	B-Disease
in	28886269	1	O
the	28886269	1	O
African	28886269	1	O
population	28886269	1	O
.	28886269	1	O

The	28887372	2	O
apolipoprotein	28887372	2	O
C	28887372	2	O
-	28887372	2	O
III	28887372	2	O
(	28887372	2	B-Var
Gln38Lys	28887372	2	I-Var
)	28887372	2	I-Var
variant	28887372	2	O
associated	28887372	2	O
with	28887372	2	O
human	28887372	2	B-Disease
hypertriglyceridemia	28887372	2	I-Disease
is	28887372	2	O
a	28887372	2	O
gain	28887372	2	B-PosReg
-	28887372	2	I-PosReg
of	28887372	2	I-PosReg
-	28887372	2	I-PosReg
function	28887372	2	I-PosReg
mutation	28887372	2	O
.	28887372	2	O
Recent	28887372	2	O
cell	28887372	2	O
culture	28887372	2	O
and	28887372	2	O
animal	28887372	2	O
studies	28887372	2	O
have	28887372	2	O
suggested	28887372	2	O
that	28887372	2	O
expression	28887372	2	O
of	28887372	2	O
human	28887372	2	O
apo	28887372	2	O
C	28887372	2	O
-	28887372	2	O
III	28887372	2	O
in	28887372	2	O
the	28887372	2	O
liver	28887372	2	O
has	28887372	2	O
a	28887372	2	O
profound	28887372	2	O
impact	28887372	2	O
on	28887372	2	O
the	28887372	2	O
triacylglycerol	28887372	2	O
(	28887372	2	O
TAG	28887372	2	O
)	28887372	2	O
-	28887372	2	O
rich	28887372	2	O
VLDL1	28887372	2	O
production	28887372	2	O
under	28887372	2	O
lipid	28887372	2	O
-	28887372	2	O
rich	28887372	2	O
conditions	28887372	2	O
.	28887372	2	O
The	28887372	2	O
apoC	28887372	2	O
-	28887372	2	O
III	28887372	2	O
Gln38Lys	28887372	2	O
variant	28887372	2	O
was	28887372	2	O
identified	28887372	2	O
in	28887372	2	O
subjects	28887372	2	O
of	28887372	2	O
Mexican	28887372	2	O
origin	28887372	2	O
with	28887372	2	O
moderate	28887372	2	O
hypertriglyceridemia	28887372	2	O
.	28887372	2	O
We	28887372	2	O
postulated	28887372	2	O
that	28887372	2	O
Gln38Lys	28887372	2	O
(	28887372	2	O
C3QK	28887372	2	O
)	28887372	2	O
,	28887372	2	O
being	28887372	2	O
a	28887372	2	O
gain	28887372	2	O
-	28887372	2	O
of	28887372	2	O
-	28887372	2	O
function	28887372	2	O
mutation	28887372	2	O
,	28887372	2	O
promotes	28887372	2	O
hepatic	28887372	2	O
VLDL1	28887372	2	O
assembly	28887372	2	O
/	28887372	2	O
secretion	28887372	2	O
.	28887372	2	O
To	28887372	2	O
test	28887372	2	O
this	28887372	2	O
hypothesis	28887372	2	O
,	28887372	2	O
we	28887372	2	O
expressed	28887372	2	O
C3QK	28887372	2	O
in	28887372	2	O
McA	28887372	2	O
-	28887372	2	O
RH7777	28887372	2	O
cells	28887372	2	O
and	28887372	2	O
apoc3	28887372	2	O
-	28887372	2	O
null	28887372	2	O
mice	28887372	2	O
to	28887372	2	O
contrast	28887372	2	O
its	28887372	2	O
effect	28887372	2	O
with	28887372	2	O
WT	28887372	2	O
apoC	28887372	2	O
-	28887372	2	O
III	28887372	2	O
(	28887372	2	O
C3WT	28887372	2	O
)	28887372	2	O
.	28887372	2	O
In	28887372	2	O
both	28887372	2	O
model	28887372	2	O
systems	28887372	2	O
,	28887372	2	O
C3QK	28887372	2	O
expression	28887372	2	O
increased	28887372	2	O
the	28887372	2	O
secretion	28887372	2	O
of	28887372	2	O
VLDL1	28887372	2	O
-	28887372	2	O
TAG	28887372	2	O
(	28887372	2	O
by	28887372	2	O
230%	28887372	2	O
)	28887372	2	O
under	28887372	2	O
lipid	28887372	2	O
-	28887372	2	O
rich	28887372	2	O
conditions	28887372	2	O
.	28887372	2	O
Metabolic	28887372	2	O
labeling	28887372	2	O
experiments	28887372	2	O
with	28887372	2	O
C3QK	28887372	2	O
cells	28887372	2	O
showed	28887372	2	O
an	28887372	2	O
increase	28887372	2	O
in	28887372	2	O
de	28887372	2	O
novo	28887372	2	O
lipogenesis	28887372	2	O
(	28887372	2	O
DNL	28887372	2	O
)	28887372	2	O
.	28887372	2	O
Fasting	28887372	2	O
plasma	28887372	2	O
concentration	28887372	2	O
of	28887372	2	O
TAG	28887372	2	O
,	28887372	2	O
cholesterol	28887372	2	O
,	28887372	2	O
cholesteryl	28887372	2	O
ester	28887372	2	O
,	28887372	2	O
and	28887372	2	O
FA	28887372	2	O
were	28887372	2	O
increased	28887372	2	O
in	28887372	2	O
C3QK	28887372	2	O
mice	28887372	2	O
as	28887372	2	O
compared	28887372	2	O
with	28887372	2	O
C3WT	28887372	2	O
mice	28887372	2	O
.	28887372	2	O
Liver	28887372	2	O
of	28887372	2	O
C3QK	28887372	2	B-Var
mice	28887372	2	O
also	28887372	2	O
displayed	28887372	2	O
an	28887372	2	O
increase	28887372	2	B-PosReg
in	28887372	2	O
DNL	28887372	2	O
and	28887372	2	O
expression	28887372	2	O
of	28887372	2	O
lipogenic	28887372	2	B-Gene
genes	28887372	2	I-Gene
as	28887372	2	O
compared	28887372	2	O
with	28887372	2	O
that	28887372	2	O
in	28887372	2	O
C3WT	28887372	2	O
mice	28887372	2	O
.	28887372	2	O
These	28887372	2	O
results	28887372	2	O
suggest	28887372	2	O
that	28887372	2	O
C3QK	28887372	2	B-Var
variant	28887372	2	O
is	28887372	2	O
a	28887372	2	O
gain	28887372	2	O
-	28887372	2	O
of	28887372	2	O
-	28887372	2	O
function	28887372	2	O
mutation	28887372	2	O
that	28887372	2	O
can	28887372	2	O
stimulate	28887372	2	B-PosReg
VLDL1	28887372	2	O
production	28887372	2	O
,	28887372	2	O
through	28887372	2	O
enhanced	28887372	2	B-PosReg
DNL	28887372	2	O
.	28887372	2	O

The	28889099	1	O
Impact	28889099	1	O
of	28889099	1	O
Heterozygous	28889099	1	O
KCNK3	28889099	1	O
Mutations	28889099	1	O
Associated	28889099	1	O
With	28889099	1	O
Pulmonary	28889099	1	O
Arterial	28889099	1	O
Hypertension	28889099	1	O
on	28889099	1	O
Channel	28889099	1	O
Function	28889099	1	O
and	28889099	1	O
Pharmacological	28889099	1	O
Recovery	28889099	1	O
.	28889099	1	O
BACKGROUND	28889099	1	O
:	28889099	1	O
Heterozygous	28889099	1	O
loss	28889099	1	O
of	28889099	1	O
function	28889099	1	O
mutations	28889099	1	B-Var
in	28889099	1	O
the	28889099	1	O
KCNK3	28889099	1	B-Gene
gene	28889099	1	O
cause	28889099	1	B-Reg
hereditary	28889099	1	O
pulmonary	28889099	1	B-Disease
arterial	28889099	1	I-Disease
hypertension	28889099	1	I-Disease
(	28889099	1	O
PAH	28889099	1	O
)	28889099	1	O
.	28889099	1	O
KCNK3	28889099	1	O
encodes	28889099	1	O
an	28889099	1	O
acid	28889099	1	O
-	28889099	1	O
sensitive	28889099	1	O
potassium	28889099	1	O
channel	28889099	1	O
,	28889099	1	O
which	28889099	1	O
contributes	28889099	1	O
to	28889099	1	O
the	28889099	1	O
resting	28889099	1	O
potential	28889099	1	O
of	28889099	1	O
human	28889099	1	O
pulmonary	28889099	1	O
artery	28889099	1	O
smooth	28889099	1	O
muscle	28889099	1	O
cells	28889099	1	O
.	28889099	1	O
KCNK3	28889099	1	O
is	28889099	1	O
widely	28889099	1	O
expressed	28889099	1	O
in	28889099	1	O
the	28889099	1	O
body	28889099	1	O
,	28889099	1	O
and	28889099	1	O
dimerizes	28889099	1	O
with	28889099	1	O
other	28889099	1	O
KCNK3	28889099	1	O
subunits	28889099	1	O
,	28889099	1	O
or	28889099	1	O
the	28889099	1	O
closely	28889099	1	O
related	28889099	1	O
,	28889099	1	O
acid	28889099	1	O
-	28889099	1	O
sensitive	28889099	1	O
KCNK9	28889099	1	O
channel	28889099	1	O
.	28889099	1	O
METHODS	28889099	1	O
AND	28889099	1	O
RESULTS	28889099	1	O
:	28889099	1	O
We	28889099	1	O
engineered	28889099	1	O
homomeric	28889099	1	O
and	28889099	1	O
heterodimeric	28889099	1	O
mutant	28889099	1	O
and	28889099	1	O
nonmutant	28889099	1	O
KCNK3	28889099	1	O
channels	28889099	1	O
associated	28889099	1	O
with	28889099	1	O
PAH	28889099	1	O
.	28889099	1	O
Using	28889099	1	O
whole	28889099	1	O
-	28889099	1	O
cell	28889099	1	O
patch	28889099	1	O
-	28889099	1	O
clamp	28889099	1	O
electrophysiology	28889099	1	O
in	28889099	1	O
human	28889099	1	O
pulmonary	28889099	1	O
artery	28889099	1	O
smooth	28889099	1	O
muscle	28889099	1	O
and	28889099	1	O
COS7	28889099	1	O
cell	28889099	1	O
lines	28889099	1	O
,	28889099	1	O
we	28889099	1	O
determined	28889099	1	O
that	28889099	1	O
homomeric	28889099	1	O
and	28889099	1	O
heterodimeric	28889099	1	O
mutant	28889099	1	O
channels	28889099	1	O
in	28889099	1	O
heterozygous	28889099	1	O
KCNK3	28889099	1	O
conditions	28889099	1	O
lead	28889099	1	O
to	28889099	1	O
mutation	28889099	1	O
-	28889099	1	O
specific	28889099	1	O
severity	28889099	1	O
of	28889099	1	O
channel	28889099	1	O
dysfunction	28889099	1	O
.	28889099	1	O
Both	28889099	1	O
wildtype	28889099	1	O
and	28889099	1	O
mutant	28889099	1	O
KCNK3	28889099	1	O
channels	28889099	1	O
were	28889099	1	O
activated	28889099	1	O
by	28889099	1	O
ONO	28889099	1	O
-	28889099	1	O
RS-082	28889099	1	O
(	28889099	1	O
10	28889099	1	O
μmol	28889099	1	O
/	28889099	1	O
L	28889099	1	O
)	28889099	1	O
,	28889099	1	O
causing	28889099	1	O
cell	28889099	1	O
hyperpolarization	28889099	1	O
.	28889099	1	O
We	28889099	1	O
observed	28889099	1	O
robust	28889099	1	O
gene	28889099	1	O
expression	28889099	1	O
of	28889099	1	O
KCNK3	28889099	1	O
in	28889099	1	O
healthy	28889099	1	O
and	28889099	1	O
familial	28889099	1	O
PAH	28889099	1	O
patient	28889099	1	O
lungs	28889099	1	O
,	28889099	1	O
but	28889099	1	O
no	28889099	1	O
quantifiable	28889099	1	O
expression	28889099	1	O
of	28889099	1	O
KCNK9	28889099	1	O
,	28889099	1	O
and	28889099	1	O
demonstrated	28889099	1	O
in	28889099	1	O
functional	28889099	1	O
studies	28889099	1	O
that	28889099	1	O
KCNK9	28889099	1	O
minimizes	28889099	1	O
the	28889099	1	O
impact	28889099	1	O
of	28889099	1	O
select	28889099	1	O
KCNK3	28889099	1	O
mutations	28889099	1	O
when	28889099	1	O
the	28889099	1	O
2	28889099	1	O
channel	28889099	1	O
subunits	28889099	1	O
co	28889099	1	O
-	28889099	1	O
assemble	28889099	1	O
.	28889099	1	O
CONCLUSIONS	28889099	1	O
:	28889099	1	O
Heterozygous	28889099	1	O
KCNK3	28889099	1	B-Gene
mutations	28889099	1	B-Var
in	28889099	1	O
PAH	28889099	1	O
lead	28889099	1	O
to	28889099	1	O
variable	28889099	1	O
loss	28889099	1	B-NegReg
of	28889099	1	O
channel	28889099	1	O
function	28889099	1	O
via	28889099	1	O
distinct	28889099	1	O
mechanisms	28889099	1	O
.	28889099	1	O
Homomeric	28889099	1	O
and	28889099	1	O
heterodimeric	28889099	1	O
mutant	28889099	1	O
KCNK3	28889099	1	O
channels	28889099	1	O
represent	28889099	1	O
novel	28889099	1	O
therapeutic	28889099	1	O
substrates	28889099	1	O
in	28889099	1	O
PAH	28889099	1	O
.	28889099	1	O
Pharmacological	28889099	1	O
and	28889099	1	O
pH	28889099	1	O
-	28889099	1	O
dependent	28889099	1	O
activation	28889099	1	O
of	28889099	1	O
wildtype	28889099	1	O
and	28889099	1	O
mutant	28889099	1	O
KCNK3	28889099	1	O
channels	28889099	1	O
in	28889099	1	O
pulmonary	28889099	1	O
artery	28889099	1	O
smooth	28889099	1	O
muscle	28889099	1	O
cells	28889099	1	O
leads	28889099	1	O
to	28889099	1	O
membrane	28889099	1	O
hyperpolarization	28889099	1	O
.	28889099	1	O
Co	28889099	1	O
-	28889099	1	O
assembly	28889099	1	O
of	28889099	1	O
KCNK3	28889099	1	O
with	28889099	1	O
KCNK9	28889099	1	O
subunits	28889099	1	O
may	28889099	1	O
provide	28889099	1	O
protection	28889099	1	O
against	28889099	1	O
KCNK3	28889099	1	O
loss	28889099	1	O
of	28889099	1	O
function	28889099	1	O
in	28889099	1	O
tissues	28889099	1	O
where	28889099	1	O
both	28889099	1	O
KCNK9	28889099	1	O
and	28889099	1	O
KCNK3	28889099	1	O
are	28889099	1	O
expressed	28889099	1	O
,	28889099	1	O
contributing	28889099	1	O
to	28889099	1	O
the	28889099	1	O
lung	28889099	1	O
-	28889099	1	O
specific	28889099	1	O
phenotype	28889099	1	O
observed	28889099	1	O
clinically	28889099	1	O
in	28889099	1	O
patients	28889099	1	O
with	28889099	1	O
PAH	28889099	1	O
because	28889099	1	O
of	28889099	1	O
KCNK3	28889099	1	O
mutations	28889099	1	O
.	28889099	1	O

De	28905509	1	O
novo	28905509	1	O
SETD5	28905509	1	B-Gene
loss	28905509	1	B-NegReg
-	28905509	1	I-NegReg
of	28905509	1	I-NegReg
-	28905509	1	I-NegReg
function	28905509	1	I-NegReg
variant	28905509	1	B-Var
as	28905509	1	O
a	28905509	1	O
cause	28905509	1	O
for	28905509	1	O
intellectual	28905509	1	B-Disease
disability	28905509	1	I-Disease
in	28905509	1	O
a	28905509	1	O
10	28905509	1	O
-	28905509	1	O
year	28905509	1	O
old	28905509	1	O
boy	28905509	1	O
with	28905509	1	O
an	28905509	1	O
aberrant	28905509	1	O
blind	28905509	1	O
ending	28905509	1	O
bronchus	28905509	1	O
.	28905509	1	O
Although	28905509	1	O
rare	28905509	1	O
,	28905509	1	O
3	28905509	1	O
p	28905509	1	O
microdeletion	28905509	1	O
cases	28905509	1	O
have	28905509	1	O
been	28905509	1	O
well	28905509	1	O
described	28905509	1	O
in	28905509	1	O
the	28905509	1	O
clinical	28905509	1	O
literature	28905509	1	O
.	28905509	1	O
The	28905509	1	O
clinical	28905509	1	O
phenotype	28905509	1	O
includes	28905509	1	O
;	28905509	1	O
intellectual	28905509	1	O
disability	28905509	1	O
(	28905509	1	O
ID	28905509	1	O
)	28905509	1	O
,	28905509	1	O
growth	28905509	1	O
retardation	28905509	1	O
,	28905509	1	O
facial	28905509	1	O
dysmorphism	28905509	1	O
,	28905509	1	O
and	28905509	1	O
cardiac	28905509	1	O
malformations	28905509	1	O
.	28905509	1	O
Advances	28905509	1	O
in	28905509	1	O
chromosome	28905509	1	O
microarray	28905509	1	O
(	28905509	1	O
CMA	28905509	1	O
)	28905509	1	O
testing	28905509	1	O
narrowed	28905509	1	O
the	28905509	1	O
3	28905509	1	O
p25	28905509	1	O
critical	28905509	1	O
region	28905509	1	O
to	28905509	1	O
a	28905509	1	O
124	28905509	1	O
kb	28905509	1	O
region	28905509	1	O
,	28905509	1	O
and	28905509	1	O
recent	28905509	1	O
Whole	28905509	1	O
Exome	28905509	1	O
Sequencing	28905509	1	O
(	28905509	1	O
WES	28905509	1	O
)	28905509	1	O
studies	28905509	1	O
have	28905509	1	O
suggested	28905509	1	O
that	28905509	1	O
the	28905509	1	O
SETD5	28905509	1	O
gene	28905509	1	O
contributes	28905509	1	O
significantly	28905509	1	O
to	28905509	1	O
the	28905509	1	O
3	28905509	1	O
p25	28905509	1	O
phenotype	28905509	1	O
.	28905509	1	O
Loss	28905509	1	B-NegReg
-	28905509	1	I-NegReg
of	28905509	1	I-NegReg
-	28905509	1	I-NegReg
Function	28905509	1	I-NegReg
(	28905509	1	O
LoF	28905509	1	O
)	28905509	1	O
variants	28905509	1	B-Var
in	28905509	1	O
SETD5	28905509	1	B-Gene
are	28905509	1	O
now	28905509	1	O
considered	28905509	1	O
a	28905509	1	O
likely	28905509	1	O
cause	28905509	1	O
of	28905509	1	O
ID	28905509	1	B-Disease
.	28905509	1	O
We	28905509	1	O
report	28905509	1	O
here	28905509	1	O
a	28905509	1	O
patient	28905509	1	O
with	28905509	1	O
a	28905509	1	O
frameshift	28905509	1	O
LoF	28905509	1	O
variant	28905509	1	O
in	28905509	1	O
exon	28905509	1	O
12	28905509	1	O
of	28905509	1	O
SETD5	28905509	1	O
.	28905509	1	O
This	28905509	1	O
patient	28905509	1	O
has	28905509	1	O
features	28905509	1	O
overlapping	28905509	1	O
with	28905509	1	O
other	28905509	1	O
patients	28905509	1	O
described	28905509	1	O
with	28905509	1	O
LoF	28905509	1	O
SETD5	28905509	1	O
variants	28905509	1	O
to	28905509	1	O
include	28905509	1	O
;	28905509	1	O
similar	28905509	1	O
facial	28905509	1	O
morphology	28905509	1	O
,	28905509	1	O
feeding	28905509	1	O
difficulties	28905509	1	O
,	28905509	1	O
ID	28905509	1	O
,	28905509	1	O
behavioral	28905509	1	O
abnormalities	28905509	1	O
and	28905509	1	O
leg	28905509	1	O
length	28905509	1	O
discrepancy	28905509	1	O
.	28905509	1	O
In	28905509	1	O
addition	28905509	1	O
,	28905509	1	O
he	28905509	1	O
presents	28905509	1	O
with	28905509	1	O
an	28905509	1	O
aberrant	28905509	1	O
blind	28905509	1	O
ending	28905509	1	O
bronchus	28905509	1	O
.	28905509	1	O
This	28905509	1	O
report	28905509	1	O
adds	28905509	1	O
to	28905509	1	O
publications	28905509	1	O
describing	28905509	1	O
intragenic	28905509	1	O
mutations	28905509	1	O
in	28905509	1	O
SETD5	28905509	1	O
and	28905509	1	O
supports	28905509	1	O
the	28905509	1	O
assertion	28905509	1	O
that	28905509	1	O
de	28905509	1	O
novo	28905509	1	O
LoF	28905509	1	O
mutations	28905509	1	O
in	28905509	1	O
SETD5	28905509	1	O
present	28905509	1	O
with	28905509	1	O
an	28905509	1	O
overlapping	28905509	1	O
but	28905509	1	O
distinct	28905509	1	O
phenotype	28905509	1	O
in	28905509	1	O
comparison	28905509	1	O
with	28905509	1	O
3	28905509	1	O
p25	28905509	1	O
microdeletion	28905509	1	O
syndromes	28905509	1	O
.	28905509	1	O

Signal	28914637	2	O
transducer	28914637	2	O
and	28914637	2	O
activator	28914637	2	O
of	28914637	2	O
transcription	28914637	2	O
gain	28914637	2	O
-	28914637	2	O
of	28914637	2	O
-	28914637	2	O
function	28914637	2	O
primary	28914637	2	O
immunodeficiency	28914637	2	O
/	28914637	2	O
immunodysregulation	28914637	2	O
disorders	28914637	2	O
.	28914637	2	O
PURPOSE	28914637	2	O
OF	28914637	2	O
REVIEW	28914637	2	O
:	28914637	2	O
To	28914637	2	O
describe	28914637	2	O
primary	28914637	2	B-Disease
immunodeficiencies	28914637	2	I-Disease
caused	28914637	2	O
by	28914637	2	O
gain	28914637	2	B-PosReg
-	28914637	2	I-PosReg
of	28914637	2	I-PosReg
-	28914637	2	I-PosReg
function	28914637	2	I-PosReg
(	28914637	2	O
GOF	28914637	2	O
)	28914637	2	O
mutations	28914637	2	B-Var
of	28914637	2	O
signal	28914637	2	O
transducer	28914637	2	O
and	28914637	2	O
activator	28914637	2	O
of	28914637	2	O
transcription	28914637	2	O
(	28914637	2	B-Gene
STAT	28914637	2	I-Gene
)	28914637	2	I-Gene
genes	28914637	2	O
,	28914637	2	O
a	28914637	2	O
group	28914637	2	O
of	28914637	2	O
genetically	28914637	2	O
determined	28914637	2	O
disorders	28914637	2	O
characterized	28914637	2	O
by	28914637	2	O
susceptibility	28914637	2	O
to	28914637	2	O
infections	28914637	2	O
and	28914637	2	O
,	28914637	2	O
in	28914637	2	O
many	28914637	2	O
cases	28914637	2	O
,	28914637	2	O
autoimmune	28914637	2	O
manifestations	28914637	2	O
.	28914637	2	O
RECENT	28914637	2	O
FINDINGS	28914637	2	O
:	28914637	2	O
GOF	28914637	2	O
mutations	28914637	2	B-Var
affecting	28914637	2	O
STAT1	28914637	2	B-Gene
result	28914637	2	O
in	28914637	2	O
increased	28914637	2	B-PosReg
STAT	28914637	2	O
tyrosine	28914637	2	O
phosphorylation	28914637	2	O
and	28914637	2	O
secondarily	28914637	2	O
increased	28914637	2	B-PosReg
response	28914637	2	O
to	28914637	2	O
STAT1	28914637	2	O
-	28914637	2	O
signaling	28914637	2	O
cytokines	28914637	2	O
,	28914637	2	O
such	28914637	2	O
as	28914637	2	O
interferons	28914637	2	O
.	28914637	2	O
In	28914637	2	O
contrast	28914637	2	O
,	28914637	2	O
STAT3	28914637	2	O
hyperactivity	28914637	2	O
is	28914637	2	O
not	28914637	2	O
usually	28914637	2	O
related	28914637	2	O
to	28914637	2	O
hyperphosphorylation	28914637	2	O
but	28914637	2	O
rather	28914637	2	O
to	28914637	2	O
increased	28914637	2	O
STAT3	28914637	2	O
-	28914637	2	O
mediated	28914637	2	O
transcriptional	28914637	2	O
activity	28914637	2	O
.	28914637	2	O
In	28914637	2	O
both	28914637	2	O
cases	28914637	2	O
,	28914637	2	O
heterozygous	28914637	2	O
STAT1	28914637	2	O
and	28914637	2	O
STAT3	28914637	2	O
GOF	28914637	2	O
mutations	28914637	2	O
trigger	28914637	2	O
a	28914637	2	O
distinct	28914637	2	O
set	28914637	2	O
of	28914637	2	O
genes	28914637	2	O
in	28914637	2	O
target	28914637	2	O
cells	28914637	2	O
that	28914637	2	O
lead	28914637	2	O
to	28914637	2	O
abnormal	28914637	2	O
functioning	28914637	2	O
of	28914637	2	O
antimicrobial	28914637	2	O
response	28914637	2	O
and	28914637	2	O
/	28914637	2	O
or	28914637	2	O
autoimmunity	28914637	2	O
and	28914637	2	O
result	28914637	2	O
in	28914637	2	O
autosomal	28914637	2	O
dominant	28914637	2	O
diseases	28914637	2	O
.	28914637	2	O
SUMMARY	28914637	2	O
:	28914637	2	O
Clinical	28914637	2	O
manifestations	28914637	2	O
of	28914637	2	O
patients	28914637	2	O
with	28914637	2	O
STAT1	28914637	2	O
GOF	28914637	2	O
are	28914637	2	O
characterized	28914637	2	O
by	28914637	2	O
mucocutaneous	28914637	2	O
candidiasis	28914637	2	O
and	28914637	2	O
recurrent	28914637	2	O
lower	28914637	2	O
tract	28914637	2	O
respiratory	28914637	2	O
infections	28914637	2	O
.	28914637	2	O
In	28914637	2	O
addition	28914637	2	O
,	28914637	2	O
many	28914637	2	O
patients	28914637	2	O
have	28914637	2	O
thyroiditis	28914637	2	O
,	28914637	2	O
type	28914637	2	O
1	28914637	2	O
diabetes	28914637	2	O
mellitus	28914637	2	O
,	28914637	2	O
autoimmune	28914637	2	O
cytopenias	28914637	2	O
,	28914637	2	O
cancer	28914637	2	O
or	28914637	2	O
aneurysms	28914637	2	O
.	28914637	2	O
Patients	28914637	2	O
with	28914637	2	O
germline	28914637	2	O
STAT3	28914637	2	O
GOF	28914637	2	O
mutations	28914637	2	O
have	28914637	2	O
an	28914637	2	O
increased	28914637	2	O
frequency	28914637	2	O
of	28914637	2	O
early	28914637	2	O
-	28914637	2	O
onset	28914637	2	O
multiorgan	28914637	2	O
autoimmunity	28914637	2	O
(	28914637	2	O
i.e.	28914637	2	O
autoimmune	28914637	2	O
enteropathy	28914637	2	O
,	28914637	2	O
type	28914637	2	O
1	28914637	2	O
diabetes	28914637	2	O
mellitus	28914637	2	O
,	28914637	2	O
autoimmune	28914637	2	O
interstitial	28914637	2	O
lung	28914637	2	O
disease	28914637	2	O
and	28914637	2	O
autoimmune	28914637	2	O
cytopenias	28914637	2	O
)	28914637	2	O
,	28914637	2	O
lymphoproliferation	28914637	2	O
,	28914637	2	O
short	28914637	2	O
stature	28914637	2	O
and	28914637	2	O
,	28914637	2	O
less	28914637	2	O
frequently	28914637	2	O
,	28914637	2	O
severe	28914637	2	O
recurrent	28914637	2	O
infections	28914637	2	O
.	28914637	2	O
Treatment	28914637	2	O
options	28914637	2	O
range	28914637	2	O
from	28914637	2	O
antimicrobial	28914637	2	O
therapy	28914637	2	O
,	28914637	2	O
intravenous	28914637	2	O
or	28914637	2	O
subcutaneous	28914637	2	O
immunoglobulin	28914637	2	O
and	28914637	2	O
immunosuppressive	28914637	2	O
drugs	28914637	2	O
.	28914637	2	O
Some	28914637	2	O
patients	28914637	2	O
with	28914637	2	O
STAT1	28914637	2	O
GOF	28914637	2	O
disorder	28914637	2	O
have	28914637	2	O
undergone	28914637	2	O
hematopoietic	28914637	2	O
stem	28914637	2	O
cell	28914637	2	O
transplantation	28914637	2	O
,	28914637	2	O
although	28914637	2	O
these	28914637	2	O
have	28914637	2	O
been	28914637	2	O
difficult	28914637	2	O
because	28914637	2	O
of	28914637	2	O
the	28914637	2	O
underlying	28914637	2	O
proinflammatory	28914637	2	O
milieu	28914637	2	O
from	28914637	2	O
the	28914637	2	O
mutation	28914637	2	O
.	28914637	2	O

GNPTAB	28918368	0	O
missense	28918368	0	O
mutations	28918368	0	O
cause	28918368	0	O
loss	28918368	0	O
of	28918368	0	O
GlcNAc-1	28918368	0	O
-	28918368	0	O
phosphotransferase	28918368	0	O
activity	28918368	0	O
in	28918368	0	O
mucolipidosis	28918368	0	O
type	28918368	0	O
II	28918368	0	O
through	28918368	0	O
distinct	28918368	0	O
mechanisms	28918368	0	O
.	28918368	0	O
Mucolipidoses	28918368	0	O
(	28918368	0	O
ML	28918368	0	O
)	28918368	0	O
II	28918368	0	O
and	28918368	0	O
III	28918368	0	O
alpha	28918368	0	O
/	28918368	0	O
beta	28918368	0	O
are	28918368	0	O
lysosomal	28918368	0	O
storage	28918368	0	O
diseases	28918368	0	O
caused	28918368	0	O
by	28918368	0	O
pathogenic	28918368	0	O
mutations	28918368	0	O
in	28918368	0	O
GNPTAB	28918368	0	O
encoding	28918368	0	O
the	28918368	0	O
α	28918368	0	O
β	28918368	0	O
-	28918368	0	O
subunit	28918368	0	O
precursor	28918368	0	O
of	28918368	0	O
GlcNAc-1	28918368	0	O
-	28918368	0	O
phosphotransferase	28918368	0	O
.	28918368	0	O
To	28918368	0	O
determine	28918368	0	O
genotype	28918368	0	O
-	28918368	0	O
phenotype	28918368	0	O
correlation	28918368	0	O
and	28918368	0	O
functional	28918368	0	O
analysis	28918368	0	O
of	28918368	0	O
mutant	28918368	0	O
GlcNAc-1	28918368	0	O
-	28918368	0	O
phosphotransferase	28918368	0	O
,	28918368	0	O
13	28918368	0	O
Brazilian	28918368	0	O
patients	28918368	0	O
clinically	28918368	0	O
and	28918368	0	O
biochemical	28918368	0	O
diagnosed	28918368	0	O
for	28918368	0	O
MLII	28918368	0	O
or	28918368	0	O
III	28918368	0	O
alpha	28918368	0	O
/	28918368	0	O
beta	28918368	0	O
were	28918368	0	O
studied	28918368	0	O
.	28918368	0	O
By	28918368	0	O
sequencing	28918368	0	O
of	28918368	0	O
genomic	28918368	0	O
GNPTAB	28918368	0	B-Gene
of	28918368	0	O
the	28918368	0	O
MLII	28918368	0	O
and	28918368	0	O
MLIII	28918368	0	O
alpha	28918368	0	O
/	28918368	0	O
beta	28918368	0	O
patients	28918368	0	O
we	28918368	0	O
identified	28918368	0	O
six	28918368	0	O
novel	28918368	0	O
mutations	28918368	0	O
:	28918368	0	O
p.D76G	28918368	0	B-Var
,	28918368	0	O
p.S385L	28918368	0	B-Var
,	28918368	0	O
p.Q278Kfs*3	28918368	0	B-Var
,	28918368	0	O
p.H588Qfs*27	28918368	0	B-Var
,	28918368	0	O
p.N642Lfs*10	28918368	0	B-Var
and	28918368	0	O
p.Y1111*	28918368	0	B-Var
.	28918368	0	O
Expression	28918368	0	O
analysis	28918368	0	O
by	28918368	0	O
western	28918368	0	O
blotting	28918368	0	O
and	28918368	0	O
immunofluorescence	28918368	0	O
microscopy	28918368	0	O
revealed	28918368	0	O
that	28918368	0	O
the	28918368	0	O
mutant	28918368	0	O
α	28918368	0	O
β	28918368	0	O
-	28918368	0	O
subunit	28918368	0	O
precursor	28918368	0	O
p.D76G	28918368	0	B-Var
is	28918368	0	O
retained	28918368	0	O
in	28918368	0	O
the	28918368	0	O
endoplasmic	28918368	0	O
reticulum	28918368	0	O
whereas	28918368	0	O
the	28918368	0	O
mutant	28918368	0	O
p.S385L	28918368	0	B-Var
is	28918368	0	O
correctly	28918368	0	O
transported	28918368	0	O
to	28918368	0	O
the	28918368	0	O
cis	28918368	0	O
-	28918368	0	O
Golgi	28918368	0	O
apparatus	28918368	0	O
and	28918368	0	O
proteolytically	28918368	0	O
processed	28918368	0	O
.	28918368	0	O
Both	28918368	0	O
mutations	28918368	0	O
lead	28918368	0	O
to	28918368	0	O
complete	28918368	0	O
loss	28918368	0	B-NegReg
of	28918368	0	O
GlcNAc-1	28918368	0	O
-	28918368	0	O
phosphotransferase	28918368	0	O
activity	28918368	0	O
,	28918368	0	O
consistent	28918368	0	O
with	28918368	0	O
the	28918368	0	O
severe	28918368	0	O
clinical	28918368	0	O
MLII	28918368	0	O
phenotype	28918368	0	O
of	28918368	0	O
the	28918368	0	O
patients	28918368	0	O
.	28918368	0	O
Our	28918368	0	O
study	28918368	0	O
expands	28918368	0	O
the	28918368	0	O
genotypic	28918368	0	O
spectrum	28918368	0	O
of	28918368	0	O
MLII	28918368	0	O
and	28918368	0	O
provides	28918368	0	O
novel	28918368	0	O
insights	28918368	0	O
into	28918368	0	O
structural	28918368	0	O
requirements	28918368	0	O
to	28918368	0	O
ensure	28918368	0	O
GlcNAc-1	28918368	0	O
-	28918368	0	O
phosphotransferase	28918368	0	O
activity	28918368	0	O
.	28918368	0	O

Altered	28921675	2	O
Cav1.2	28921675	2	O
function	28921675	2	O
in	28921675	2	O
the	28921675	2	O
Timothy	28921675	2	O
syndrome	28921675	2	O
mouse	28921675	2	O
model	28921675	2	O
produces	28921675	2	O
ascending	28921675	2	O
serotonergic	28921675	2	O
abnormalities	28921675	2	O
.	28921675	2	O
Polymorphism	28921675	2	O
in	28921675	2	O
the	28921675	2	O
gene	28921675	2	O
CACNA1C	28921675	2	O
,	28921675	2	O
encoding	28921675	2	O
the	28921675	2	O
pore	28921675	2	O
-	28921675	2	O
forming	28921675	2	O
subunit	28921675	2	O
of	28921675	2	O
Cav1.2	28921675	2	O
L	28921675	2	O
-	28921675	2	O
type	28921675	2	O
calcium	28921675	2	O
channels	28921675	2	O
,	28921675	2	O
has	28921675	2	O
one	28921675	2	O
of	28921675	2	O
the	28921675	2	O
strongest	28921675	2	O
genetic	28921675	2	O
linkages	28921675	2	O
to	28921675	2	O
schizophrenia	28921675	2	O
,	28921675	2	O
bipolar	28921675	2	O
disorder	28921675	2	O
and	28921675	2	O
major	28921675	2	O
depressive	28921675	2	O
disorder	28921675	2	O
:	28921675	2	O
psychopathologies	28921675	2	O
in	28921675	2	O
which	28921675	2	O
serotonin	28921675	2	O
signaling	28921675	2	O
has	28921675	2	O
been	28921675	2	O
implicated	28921675	2	O
.	28921675	2	O
Additionally	28921675	2	O
,	28921675	2	O
a	28921675	2	O
gain	28921675	2	B-PosReg
-	28921675	2	I-PosReg
of	28921675	2	I-PosReg
-	28921675	2	I-PosReg
function	28921675	2	I-PosReg
mutation	28921675	2	B-Var
in	28921675	2	O
CACNA1C	28921675	2	B-Gene
is	28921675	2	O
responsible	28921675	2	O
for	28921675	2	O
the	28921675	2	O
neurodevelopmental	28921675	2	O
disorder	28921675	2	O
Timothy	28921675	2	B-Disease
syndrome	28921675	2	I-Disease
that	28921675	2	O
presents	28921675	2	O
with	28921675	2	O
prominent	28921675	2	O
behavioral	28921675	2	O
features	28921675	2	O
on	28921675	2	O
the	28921675	2	O
autism	28921675	2	O
spectrum	28921675	2	O
.	28921675	2	O
Given	28921675	2	O
an	28921675	2	O
emerging	28921675	2	O
role	28921675	2	O
for	28921675	2	O
serotonin	28921675	2	O
in	28921675	2	O
the	28921675	2	O
etiology	28921675	2	O
of	28921675	2	O
autism	28921675	2	O
spectrum	28921675	2	O
disorders	28921675	2	O
(	28921675	2	O
ASD	28921675	2	O
)	28921675	2	O
,	28921675	2	O
we	28921675	2	O
investigate	28921675	2	O
the	28921675	2	O
relationship	28921675	2	O
between	28921675	2	O
Cav1.2	28921675	2	O
and	28921675	2	O
the	28921675	2	O
ascending	28921675	2	O
serotonin	28921675	2	O
system	28921675	2	O
in	28921675	2	O
the	28921675	2	O
Timothy	28921675	2	O
syndrome	28921675	2	O
type	28921675	2	O
2	28921675	2	O
(	28921675	2	O
TS2	28921675	2	O
-	28921675	2	O
neo	28921675	2	O
)	28921675	2	O
mouse	28921675	2	O
,	28921675	2	O
which	28921675	2	O
displays	28921675	2	O
behavioral	28921675	2	O
features	28921675	2	O
consistent	28921675	2	O
with	28921675	2	O
the	28921675	2	O
core	28921675	2	O
triad	28921675	2	O
of	28921675	2	O
ASD	28921675	2	O
.	28921675	2	O
We	28921675	2	O
find	28921675	2	O
that	28921675	2	O
TS2	28921675	2	O
-	28921675	2	O
neo	28921675	2	O
mice	28921675	2	O
exhibit	28921675	2	O
enhanced	28921675	2	O
serotonin	28921675	2	O
tissue	28921675	2	O
content	28921675	2	O
and	28921675	2	O
axon	28921675	2	O
innervation	28921675	2	O
of	28921675	2	O
the	28921675	2	O
dorsal	28921675	2	O
striatum	28921675	2	O
,	28921675	2	O
as	28921675	2	O
well	28921675	2	O
as	28921675	2	O
decreased	28921675	2	O
serotonin	28921675	2	O
turnover	28921675	2	O
in	28921675	2	O
the	28921675	2	O
amygdala	28921675	2	O
.	28921675	2	O
These	28921675	2	O
regionally	28921675	2	O
specific	28921675	2	O
alterations	28921675	2	O
are	28921675	2	O
accompanied	28921675	2	O
by	28921675	2	O
an	28921675	2	O
enhanced	28921675	2	O
active	28921675	2	O
coping	28921675	2	O
response	28921675	2	O
during	28921675	2	O
acute	28921675	2	O
stress	28921675	2	O
(	28921675	2	O
forced	28921675	2	O
swim	28921675	2	O
)	28921675	2	O
,	28921675	2	O
serotonin	28921675	2	O
neuron	28921675	2	O
Fos	28921675	2	O
activity	28921675	2	O
in	28921675	2	O
the	28921675	2	O
caudal	28921675	2	O
dorsal	28921675	2	O
raphe	28921675	2	O
,	28921675	2	O
and	28921675	2	O
serotonin	28921675	2	O
type	28921675	2	O
1	28921675	2	O
A	28921675	2	O
receptor	28921675	2	O
-	28921675	2	O
dependent	28921675	2	O
feedback	28921675	2	O
inhibition	28921675	2	O
of	28921675	2	O
the	28921675	2	O
rostral	28921675	2	O
dorsal	28921675	2	O
raphe	28921675	2	O
nuclei	28921675	2	O
.	28921675	2	O
Collectively	28921675	2	O
,	28921675	2	O
these	28921675	2	O
results	28921675	2	O
suggest	28921675	2	O
that	28921675	2	O
the	28921675	2	O
global	28921675	2	O
gain	28921675	2	O
-	28921675	2	O
of	28921675	2	O
-	28921675	2	O
function	28921675	2	O
Cav1.2	28921675	2	O
mutation	28921675	2	O
associated	28921675	2	O
with	28921675	2	O
Timothy	28921675	2	O
syndrome	28921675	2	O
has	28921675	2	O
pleiotropic	28921675	2	O
effects	28921675	2	O
on	28921675	2	O
the	28921675	2	O
ascending	28921675	2	O
serotonin	28921675	2	O
system	28921675	2	O
including	28921675	2	O
neuroanatomical	28921675	2	O
changes	28921675	2	O
,	28921675	2	O
regional	28921675	2	O
differences	28921675	2	O
in	28921675	2	O
forebrain	28921675	2	O
serotonin	28921675	2	O
metabolism	28921675	2	O
and	28921675	2	O
feedback	28921675	2	O
regulatory	28921675	2	O
control	28921675	2	O
mechanisms	28921675	2	O
within	28921675	2	O
the	28921675	2	O
dorsal	28921675	2	O
raphe	28921675	2	O
.	28921675	2	O
Altered	28921675	2	O
activity	28921675	2	O
of	28921675	2	O
the	28921675	2	O
ascending	28921675	2	O
serotonin	28921675	2	O
system	28921675	2	O
continues	28921675	2	O
to	28921675	2	O
emerge	28921675	2	O
as	28921675	2	O
a	28921675	2	O
common	28921675	2	O
neural	28921675	2	O
signature	28921675	2	O
across	28921675	2	O
several	28921675	2	O
ASD	28921675	2	O
mouse	28921675	2	O
models	28921675	2	O
,	28921675	2	O
and	28921675	2	O
the	28921675	2	O
capacity	28921675	2	O
for	28921675	2	O
Cav1.2	28921675	2	O
L	28921675	2	O
-	28921675	2	O
type	28921675	2	O
calcium	28921675	2	O
channels	28921675	2	O
to	28921675	2	O
impact	28921675	2	O
both	28921675	2	O
serotonin	28921675	2	O
structure	28921675	2	O
and	28921675	2	O
function	28921675	2	O
has	28921675	2	O
important	28921675	2	O
implications	28921675	2	O
for	28921675	2	O
several	28921675	2	O
neuropsychiatric	28921675	2	O
conditions	28921675	2	O
.	28921675	2	O

Localization	28924058	0	O
of	28924058	0	O
Cdc7	28924058	0	O
Protein	28924058	0	O
Kinase	28924058	0	O
During	28924058	0	O
DNA	28924058	0	O
Replication	28924058	0	O
in	28924058	0	O
Saccharomyces	28924058	0	O
cerevisiae	28924058	0	O
.	28924058	0	O
DDK	28924058	0	O
,	28924058	0	O
a	28924058	0	O
conserved	28924058	0	O
serine	28924058	0	O
-	28924058	0	O
threonine	28924058	0	O
protein	28924058	0	O
kinase	28924058	0	O
composed	28924058	0	O
of	28924058	0	O
a	28924058	0	O
regulatory	28924058	0	O
subunit	28924058	0	O
,	28924058	0	O
Dbf4	28924058	0	O
,	28924058	0	O
and	28924058	0	O
a	28924058	0	O
catalytic	28924058	0	O
subunit	28924058	0	O
,	28924058	0	O
Cdc7	28924058	0	O
,	28924058	0	O
is	28924058	0	O
essential	28924058	0	O
for	28924058	0	O
DNA	28924058	0	O
replication	28924058	0	O
initiation	28924058	0	O
during	28924058	0	O
S	28924058	0	O
phase	28924058	0	O
of	28924058	0	O
the	28924058	0	O
cell	28924058	0	O
cycle	28924058	0	O
through	28924058	0	O
MCM2-7	28924058	0	O
helicase	28924058	0	O
phosphorylation	28924058	0	O
.	28924058	0	O
The	28924058	0	O
biological	28924058	0	O
significance	28924058	0	O
of	28924058	0	O
DDK	28924058	0	O
is	28924058	0	O
well	28924058	0	O
characterized	28924058	0	O
,	28924058	0	O
but	28924058	0	O
the	28924058	0	O
full	28924058	0	O
mechanism	28924058	0	O
of	28924058	0	O
how	28924058	0	O
DDK	28924058	0	O
associates	28924058	0	O
with	28924058	0	O
substrates	28924058	0	O
remains	28924058	0	O
unclear	28924058	0	O
.	28924058	0	O
Cdc7	28924058	0	O
is	28924058	0	O
bound	28924058	0	O
to	28924058	0	O
chromatin	28924058	0	O
in	28924058	0	O
the	28924058	0	O
Saccharomyces	28924058	0	O
cerevisiae	28924058	0	O
genome	28924058	0	O
throughout	28924058	0	O
the	28924058	0	O
cell	28924058	0	O
cycle	28924058	0	O
,	28924058	0	O
but	28924058	0	O
there	28924058	0	O
is	28924058	0	O
little	28924058	0	O
empirical	28924058	0	O
evidence	28924058	0	O
as	28924058	0	O
to	28924058	0	O
specific	28924058	0	O
Cdc7	28924058	0	O
binding	28924058	0	O
locations	28924058	0	O
.	28924058	0	O
Using	28924058	0	O
biochemical	28924058	0	O
and	28924058	0	O
genetic	28924058	0	O
techniques	28924058	0	O
,	28924058	0	O
this	28924058	0	O
study	28924058	0	O
investigated	28924058	0	O
the	28924058	0	O
specific	28924058	0	O
localization	28924058	0	O
of	28924058	0	O
Cdc7	28924058	0	O
on	28924058	0	O
chromatin	28924058	0	O
.	28924058	0	O
The	28924058	0	O
Calling	28924058	0	O
Cards	28924058	0	O
method	28924058	0	O
,	28924058	0	O
using	28924058	0	O
Ty5	28924058	0	O
retrotransposons	28924058	0	O
as	28924058	0	O
a	28924058	0	O
marker	28924058	0	O
for	28924058	0	O
DNA	28924058	0	O
-	28924058	0	O
protein	28924058	0	O
binding	28924058	0	O
,	28924058	0	O
suggests	28924058	0	O
Cdc7	28924058	0	O
kinase	28924058	0	O
is	28924058	0	O
preferentially	28924058	0	O
bound	28924058	0	O
to	28924058	0	O
genomic	28924058	0	O
DNA	28924058	0	O
known	28924058	0	O
to	28924058	0	O
replicate	28924058	0	O
early	28924058	0	O
in	28924058	0	O
S	28924058	0	O
phase	28924058	0	O
,	28924058	0	O
including	28924058	0	O
centromeres	28924058	0	O
and	28924058	0	O
origins	28924058	0	O
of	28924058	0	O
replication	28924058	0	O
.	28924058	0	O
We	28924058	0	O
also	28924058	0	O
discovered	28924058	0	O
Cdc7	28924058	0	O
binding	28924058	0	O
throughout	28924058	0	O
the	28924058	0	O
genome	28924058	0	O
,	28924058	0	O
which	28924058	0	O
may	28924058	0	O
be	28924058	0	O
necessary	28924058	0	O
to	28924058	0	O
initiate	28924058	0	O
other	28924058	0	O
cellular	28924058	0	O
processes	28924058	0	O
,	28924058	0	O
including	28924058	0	O
meiotic	28924058	0	O
recombination	28924058	0	O
and	28924058	0	O
translesion	28924058	0	O
synthesis	28924058	0	O
.	28924058	0	O
A	28924058	0	O
kinase	28924058	0	O
dead	28924058	0	O
Cdc7	28924058	0	B-Gene
point	28924058	0	B-Var
mutation	28924058	0	I-Var
increases	28924058	0	B-PosReg
the	28924058	0	O
Ty5	28924058	0	O
retrotransposon	28924058	0	O
integration	28924058	0	O
efficiency	28924058	0	O
and	28924058	0	O
a	28924058	0	O
55	28924058	0	O
-	28924058	0	O
amino	28924058	0	O
acid	28924058	0	O
C	28924058	0	O
-	28924058	0	O
terminal	28924058	0	O
truncation	28924058	0	O
of	28924058	0	O
Cdc7	28924058	0	B-Gene
,	28924058	0	O
unable	28924058	0	B-NegReg
to	28924058	0	O
bind	28924058	0	O
Dbf4	28924058	0	B-Gene
,	28924058	0	O
reduces	28924058	0	B-NegReg
Cdc7	28924058	0	B-Gene
binding	28924058	0	O
suggesting	28924058	0	O
a	28924058	0	O
requirement	28924058	0	O
for	28924058	0	O
Dbf4	28924058	0	O
to	28924058	0	O
stabilize	28924058	0	O
Cdc7	28924058	0	O
on	28924058	0	O
chromatin	28924058	0	O
during	28924058	0	O
S	28924058	0	O
phase	28924058	0	O
.	28924058	0	O
Chromatin	28924058	0	O
immunoprecipitation	28924058	0	O
demonstrates	28924058	0	O
that	28924058	0	O
Cdc7	28924058	0	O
binding	28924058	0	O
near	28924058	0	O
specific	28924058	0	O
origins	28924058	0	O
changes	28924058	0	O
during	28924058	0	O
S	28924058	0	O
phase	28924058	0	O
.	28924058	0	O
Our	28924058	0	O
results	28924058	0	O
suggest	28924058	0	O
a	28924058	0	O
model	28924058	0	O
where	28924058	0	O
Cdc7	28924058	0	O
is	28924058	0	O
loosely	28924058	0	O
bound	28924058	0	O
to	28924058	0	O
chromatin	28924058	0	O
during	28924058	0	O
G1	28924058	0	O
At	28924058	0	O
the	28924058	0	O
G1	28924058	0	O
/	28924058	0	O
S	28924058	0	O
transition	28924058	0	O
,	28924058	0	O
Cdc7	28924058	0	O
binding	28924058	0	O
to	28924058	0	O
chromatin	28924058	0	O
is	28924058	0	O
increased	28924058	0	O
and	28924058	0	O
stabilized	28924058	0	O
,	28924058	0	O
preferentially	28924058	0	O
at	28924058	0	O
sites	28924058	0	O
that	28924058	0	O
may	28924058	0	O
become	28924058	0	O
origins	28924058	0	O
,	28924058	0	O
in	28924058	0	O
order	28924058	0	O
to	28924058	0	O
carry	28924058	0	O
out	28924058	0	O
a	28924058	0	O
variety	28924058	0	O
of	28924058	0	O
cellular	28924058	0	O
processes	28924058	0	O
.	28924058	0	O

Gain	28929581	2	B-PosReg
-	28929581	2	I-PosReg
of	28929581	2	I-PosReg
-	28929581	2	I-PosReg
function	28929581	2	I-PosReg
mutation	28929581	2	B-Var
in	28929581	2	O
PTPN11	28929581	2	B-Gene
in	28929581	2	O
histiocytic	28929581	2	B-Disease
sarcomas	28929581	2	I-Disease
of	28929581	2	O
Bernese	28929581	2	O
Mountain	28929581	2	O
Dogs	28929581	2	O
.	28929581	2	O
Histiocytic	28929581	2	O
sarcoma	28929581	2	O
(	28929581	2	O
HS	28929581	2	O
)	28929581	2	O
is	28929581	2	O
an	28929581	2	O
aggressive	28929581	2	O
malignant	28929581	2	O
neoplasm	28929581	2	O
of	28929581	2	O
dendritic	28929581	2	O
cell	28929581	2	O
origin	28929581	2	O
that	28929581	2	O
is	28929581	2	O
common	28929581	2	O
in	28929581	2	O
certain	28929581	2	O
breeds	28929581	2	O
of	28929581	2	O
dogs	28929581	2	O
.	28929581	2	O
High	28929581	2	O
prevalence	28929581	2	O
of	28929581	2	O
fatal	28929581	2	O
,	28929581	2	O
disseminated	28929581	2	O
HS	28929581	2	O
has	28929581	2	O
been	28929581	2	O
described	28929581	2	O
in	28929581	2	O
Bernese	28929581	2	O
Mountain	28929581	2	O
Dogs	28929581	2	O
(	28929581	2	O
BMDs	28929581	2	O
)	28929581	2	O
.	28929581	2	O
Support	28929581	2	O
for	28929581	2	O
genetic	28929581	2	O
predisposition	28929581	2	O
to	28929581	2	O
develop	28929581	2	O
HS	28929581	2	O
has	28929581	2	O
been	28929581	2	O
presented	28929581	2	O
in	28929581	2	O
several	28929581	2	O
studies	28929581	2	O
,	28929581	2	O
but	28929581	2	O
to	28929581	2	O
date	28929581	2	O
,	28929581	2	O
causative	28929581	2	O
genetic	28929581	2	O
events	28929581	2	O
have	28929581	2	O
not	28929581	2	O
been	28929581	2	O
reported	28929581	2	O
.	28929581	2	O
In	28929581	2	O
addition	28929581	2	O
,	28929581	2	O
no	28929581	2	O
driver	28929581	2	O
mutations	28929581	2	O
have	28929581	2	O
been	28929581	2	O
identified	28929581	2	O
in	28929581	2	O
tumours	28929581	2	O
.	28929581	2	O
Recently	28929581	2	O
,	28929581	2	O
E76K	28929581	2	B-Var
gain	28929581	2	B-PosReg
-	28929581	2	I-PosReg
of	28929581	2	I-PosReg
-	28929581	2	I-PosReg
function	28929581	2	I-PosReg
mutation	28929581	2	O
in	28929581	2	O
SHP2	28929581	2	O
encoded	28929581	2	O
by	28929581	2	O
the	28929581	2	O
PTPN11	28929581	2	B-Gene
gene	28929581	2	O
has	28929581	2	O
been	28929581	2	O
described	28929581	2	O
in	28929581	2	O
human	28929581	2	O
histiocytic	28929581	2	B-Disease
malignancies	28929581	2	I-Disease
.	28929581	2	O
In	28929581	2	O
our	28929581	2	O
study	28929581	2	O
,	28929581	2	O
we	28929581	2	O
identified	28929581	2	O
the	28929581	2	O
PTPN11E76K	28929581	2	O
in	28929581	2	O
HS	28929581	2	O
of	28929581	2	O
BMDs	28929581	2	O
.	28929581	2	O
Amplification	28929581	2	O
of	28929581	2	O
exon	28929581	2	O
3	28929581	2	O
of	28929581	2	O
the	28929581	2	O
PTPN11	28929581	2	O
gene	28929581	2	O
followed	28929581	2	O
by	28929581	2	O
Sanger	28929581	2	O
sequencing	28929581	2	O
was	28929581	2	O
used	28929581	2	O
to	28929581	2	O
detect	28929581	2	O
the	28929581	2	O
mutation	28929581	2	O
and	28929581	2	O
estimate	28929581	2	O
the	28929581	2	O
prevalence	28929581	2	O
in	28929581	2	O
HS	28929581	2	O
from	28929581	2	O
30	28929581	2	O
BMDs	28929581	2	O
,	28929581	2	O
13	28929581	2	O
Golden	28929581	2	O
Retrievers	28929581	2	O
and	28929581	2	O
10	28929581	2	O
other	28929581	2	O
dog	28929581	2	O
breeds	28929581	2	O
.	28929581	2	O
The	28929581	2	O
overall	28929581	2	O
prevalence	28929581	2	O
of	28929581	2	O
PTPN11E76K	28929581	2	O
in	28929581	2	O
HS	28929581	2	O
of	28929581	2	O
BMDs	28929581	2	O
was	28929581	2	O
36.67%	28929581	2	O
compared	28929581	2	O
with	28929581	2	O
8.69%	28929581	2	O
in	28929581	2	O
other	28929581	2	O
breeds	28929581	2	O
.	28929581	2	O
No	28929581	2	O
mutation	28929581	2	O
was	28929581	2	O
identified	28929581	2	O
in	28929581	2	O
normal	28929581	2	O
tissues	28929581	2	O
from	28929581	2	O
10	28929581	2	O
BMDs	28929581	2	O
with	28929581	2	O
HS	28929581	2	O
that	28929581	2	O
carried	28929581	2	O
the	28929581	2	O
mutation	28929581	2	O
and	28929581	2	O
12	28929581	2	O
control	28929581	2	O
dogs	28929581	2	O
with	28929581	2	O
no	28929581	2	O
neoplastic	28929581	2	O
disease	28929581	2	O
,	28929581	2	O
including	28929581	2	O
6	28929581	2	O
BMDs	28929581	2	O
.	28929581	2	O
Increased	28929581	2	O
immunoreactivity	28929581	2	O
for	28929581	2	O
AKT	28929581	2	O
,	28929581	2	O
phosphorylated	28929581	2	O
ERK1	28929581	2	O
/	28929581	2	O
2	28929581	2	O
and	28929581	2	O
phosphorylated	28929581	2	O
AKT	28929581	2	O
in	28929581	2	O
a	28929581	2	O
small	28929581	2	O
subset	28929581	2	O
of	28929581	2	O
BMDs	28929581	2	O
with	28929581	2	O
PTPN11E76K	28929581	2	O
suggests	28929581	2	O
that	28929581	2	O
a	28929581	2	O
gain	28929581	2	O
-	28929581	2	O
of	28929581	2	O
-	28929581	2	O
function	28929581	2	O
might	28929581	2	O
be	28929581	2	O
mediated	28929581	2	O
by	28929581	2	O
the	28929581	2	O
ERK	28929581	2	O
and	28929581	2	O
AKT	28929581	2	O
pathways	28929581	2	O
.	28929581	2	O
These	28929581	2	O
data	28929581	2	O
suggest	28929581	2	O
PTPN11E76K	28929581	2	O
as	28929581	2	O
an	28929581	2	O
important	28929581	2	O
driver	28929581	2	O
mutation	28929581	2	O
of	28929581	2	O
HS	28929581	2	O
in	28929581	2	O
BMDs	28929581	2	O
.	28929581	2	O
This	28929581	2	O
information	28929581	2	O
may	28929581	2	O
not	28929581	2	O
only	28929581	2	O
aid	28929581	2	O
in	28929581	2	O
unravelling	28929581	2	O
the	28929581	2	O
tumourigenic	28929581	2	O
events	28929581	2	O
associated	28929581	2	O
with	28929581	2	O
HS	28929581	2	O
in	28929581	2	O
BMDs	28929581	2	O
,	28929581	2	O
but	28929581	2	O
also	28929581	2	O
help	28929581	2	O
in	28929581	2	O
identifying	28929581	2	O
more	28929581	2	O
promising	28929581	2	O
therapeutic	28929581	2	O
strategies	28929581	2	O
.	28929581	2	O

Homozygous	28934391	1	O
KIDINS220	28934391	1	B-Gene
loss	28934391	1	B-NegReg
-	28934391	1	I-NegReg
of	28934391	1	I-NegReg
-	28934391	1	I-NegReg
function	28934391	1	I-NegReg
variants	28934391	1	B-Var
in	28934391	1	O
fetuses	28934391	1	O
with	28934391	1	O
cerebral	28934391	1	O
ventriculomegaly	28934391	1	O
and	28934391	1	O
limb	28934391	1	O
contractures	28934391	1	O
.	28934391	1	O
Heterozygous	28934391	1	B-Var
mutations	28934391	1	I-Var
in	28934391	1	O
KIDINS220	28934391	1	B-Gene
were	28934391	1	O
recently	28934391	1	O
suggested	28934391	1	O
a	28934391	1	O
cause	28934391	1	B-Reg
of	28934391	1	O
spastic	28934391	1	B-Disease
paraplegia	28934391	1	I-Disease
,	28934391	1	O
intellectual	28934391	1	B-Disease
disability	28934391	1	I-Disease
,	28934391	1	O
nystagmus	28934391	1	B-Disease
and	28934391	1	O
obesity	28934391	1	B-Disease
.	28934391	1	O
All	28934391	1	O
patients	28934391	1	O
carried	28934391	1	O
terminal	28934391	1	O
nonsense	28934391	1	O
de	28934391	1	O
novo	28934391	1	O
mutations	28934391	1	O
that	28934391	1	O
seemed	28934391	1	O
to	28934391	1	O
escape	28934391	1	O
nonsense	28934391	1	O
-	28934391	1	O
mediated	28934391	1	O
mRNA	28934391	1	O
decay	28934391	1	O
.	28934391	1	O
The	28934391	1	O
mechanism	28934391	1	O
for	28934391	1	O
pathogenicity	28934391	1	O
is	28934391	1	O
yet	28934391	1	O
unexplained	28934391	1	O
,	28934391	1	O
as	28934391	1	O
it	28934391	1	O
seems	28934391	1	O
that	28934391	1	O
heterozygous	28934391	1	O
loss	28934391	1	O
-	28934391	1	O
of	28934391	1	O
-	28934391	1	O
function	28934391	1	O
variants	28934391	1	O
of	28934391	1	O
KIDINS220	28934391	1	O
are	28934391	1	O
generally	28934391	1	O
well	28934391	1	O
tolerated	28934391	1	O
.	28934391	1	O
We	28934391	1	O
present	28934391	1	O
a	28934391	1	O
consanguineous	28934391	1	O
couple	28934391	1	O
who	28934391	1	O
experienced	28934391	1	O
four	28934391	1	O
pregnancy	28934391	1	O
terminations	28934391	1	O
due	28934391	1	O
to	28934391	1	O
repeated	28934391	1	O
findings	28934391	1	O
in	28934391	1	O
the	28934391	1	O
fetuses	28934391	1	O
comprising	28934391	1	O
enlarged	28934391	1	O
cerebral	28934391	1	O
ventricles	28934391	1	O
and	28934391	1	O
limb	28934391	1	O
contractures	28934391	1	O
.	28934391	1	O
Exome	28934391	1	O
sequencing	28934391	1	O
in	28934391	1	O
two	28934391	1	O
of	28934391	1	O
the	28934391	1	O
aborted	28934391	1	O
fetuses	28934391	1	O
revealed	28934391	1	O
a	28934391	1	O
shared	28934391	1	O
homozygous	28934391	1	O
frameshift	28934391	1	O
variant	28934391	1	O
in	28934391	1	O
exon	28934391	1	O
24	28934391	1	O
in	28934391	1	O
KIDINS220	28934391	1	O
.	28934391	1	O
Sanger	28934391	1	O
sequencing	28934391	1	O
of	28934391	1	O
the	28934391	1	O
variant	28934391	1	O
in	28934391	1	O
available	28934391	1	O
family	28934391	1	O
members	28934391	1	O
showed	28934391	1	O
complete	28934391	1	O
segregation	28934391	1	O
with	28934391	1	O
the	28934391	1	O
affection	28934391	1	O
status	28934391	1	O
,	28934391	1	O
resulting	28934391	1	O
in	28934391	1	O
a	28934391	1	O
LOD	28934391	1	O
score	28934391	1	O
of	28934391	1	O
2.5	28934391	1	O
under	28934391	1	O
an	28934391	1	O
autozygous	28934391	1	O
inheritance	28934391	1	O
model	28934391	1	O
.	28934391	1	O
mRNA	28934391	1	O
studies	28934391	1	O
revealed	28934391	1	O
destruction	28934391	1	O
of	28934391	1	O
the	28934391	1	O
original	28934391	1	O
splice	28934391	1	O
site	28934391	1	O
,	28934391	1	O
resulting	28934391	1	O
in	28934391	1	O
an	28934391	1	O
out	28934391	1	O
-	28934391	1	O
of	28934391	1	O
-	28934391	1	O
frame	28934391	1	O
transcript	28934391	1	O
and	28934391	1	O
introduction	28934391	1	O
of	28934391	1	O
a	28934391	1	O
premature	28934391	1	O
termination	28934391	1	O
codon	28934391	1	O
in	28934391	1	O
exon	28934391	1	O
25	28934391	1	O
.	28934391	1	O
Premature	28934391	1	O
termination	28934391	1	O
codons	28934391	1	O
in	28934391	1	O
this	28934391	1	O
position	28934391	1	O
are	28934391	1	O
likely	28934391	1	O
to	28934391	1	O
cause	28934391	1	O
activation	28934391	1	O
of	28934391	1	O
nonsense	28934391	1	O
-	28934391	1	O
mediated	28934391	1	O
mRNA	28934391	1	O
decay	28934391	1	O
and	28934391	1	O
result	28934391	1	O
in	28934391	1	O
complete	28934391	1	O
absence	28934391	1	O
of	28934391	1	O
KIDINS220	28934391	1	O
protein	28934391	1	O
in	28934391	1	O
individuals	28934391	1	O
homozygous	28934391	1	O
for	28934391	1	O
the	28934391	1	O
variant	28934391	1	O
.	28934391	1	O
The	28934391	1	O
phenotype	28934391	1	O
of	28934391	1	O
the	28934391	1	O
presented	28934391	1	O
fetuses	28934391	1	O
overlaps	28934391	1	O
with	28934391	1	O
findings	28934391	1	O
in	28934391	1	O
functional	28934391	1	O
studies	28934391	1	O
of	28934391	1	O
knockout	28934391	1	O
Kidins220	28934391	1	O
mice	28934391	1	O
embryos	28934391	1	O
that	28934391	1	O
are	28934391	1	O
non	28934391	1	O
-	28934391	1	O
viable	28934391	1	O
with	28934391	1	O
enlarged	28934391	1	O
cerebral	28934391	1	O
ventricles	28934391	1	O
.	28934391	1	O
The	28934391	1	O
human	28934391	1	O
fetuses	28934391	1	O
also	28934391	1	O
exhibit	28934391	1	O
several	28934391	1	O
similarities	28934391	1	O
to	28934391	1	O
the	28934391	1	O
milder	28934391	1	O
phenotype	28934391	1	O
described	28934391	1	O
in	28934391	1	O
patients	28934391	1	O
with	28934391	1	O
heterozygous	28934391	1	O
KIDINS220	28934391	1	O
mutations	28934391	1	O
.	28934391	1	O
We	28934391	1	O
hence	28934391	1	O
propose	28934391	1	O
that	28934391	1	O
the	28934391	1	O
identified	28934391	1	O
homozygous	28934391	1	O
loss	28934391	1	O
-	28934391	1	O
of	28934391	1	O
-	28934391	1	O
function	28934391	1	O
variant	28934391	1	O
in	28934391	1	O
KIDINS220	28934391	1	O
causes	28934391	1	O
the	28934391	1	O
phenotype	28934391	1	O
in	28934391	1	O
the	28934391	1	O
presented	28934391	1	O
fetuses	28934391	1	O
,	28934391	1	O
and	28934391	1	O
that	28934391	1	O
this	28934391	1	O
represents	28934391	1	O
a	28934391	1	O
hitherto	28934391	1	O
undescribed	28934391	1	O
severe	28934391	1	O
autosomal	28934391	1	O
recessive	28934391	1	O
neurodevelopmental	28934391	1	O
disorder	28934391	1	O
.	28934391	1	O

The	28939416	0	O
GNASR201C	28939416	0	B-Var
mutation	28939416	0	O
associated	28939416	0	O
with	28939416	0	O
clonal	28939416	0	O
hematopoiesis	28939416	0	O
supports	28939416	0	B-PosReg
transplantable	28939416	0	O
hematopoietic	28939416	0	O
stem	28939416	0	O
cell	28939416	0	O
activity	28939416	0	O
.	28939416	0	O
Genome	28939416	0	O
sequencing	28939416	0	O
efforts	28939416	0	O
have	28939416	0	O
identified	28939416	0	O
virtually	28939416	0	O
all	28939416	0	O
of	28939416	0	O
the	28939416	0	O
important	28939416	0	O
mutations	28939416	0	O
in	28939416	0	O
adult	28939416	0	O
myeloid	28939416	0	O
malignancies	28939416	0	O
.	28939416	0	O
More	28939416	0	O
recently	28939416	0	O
,	28939416	0	O
population	28939416	0	O
studies	28939416	0	O
have	28939416	0	O
identified	28939416	0	O
cancer	28939416	0	O
-	28939416	0	O
associated	28939416	0	O
variants	28939416	0	O
in	28939416	0	O
the	28939416	0	O
blood	28939416	0	O
of	28939416	0	O
otherwise	28939416	0	O
healthy	28939416	0	O
individuals	28939416	0	O
as	28939416	0	O
they	28939416	0	O
age	28939416	0	O
,	28939416	0	O
a	28939416	0	O
phenomenon	28939416	0	O
termed	28939416	0	O
clonal	28939416	0	O
hematopoiesis	28939416	0	O
of	28939416	0	O
indeterminate	28939416	0	O
potential	28939416	0	O
(	28939416	0	O
CHIP	28939416	0	O
)	28939416	0	O
.	28939416	0	O
This	28939416	0	O
suggests	28939416	0	O
that	28939416	0	O
these	28939416	0	O
mutations	28939416	0	O
may	28939416	0	O
occur	28939416	0	O
in	28939416	0	O
hematopoietic	28939416	0	O
stem	28939416	0	O
cells	28939416	0	O
(	28939416	0	O
HSCs	28939416	0	O
)	28939416	0	O
long	28939416	0	O
before	28939416	0	O
any	28939416	0	O
clinical	28939416	0	O
presentation	28939416	0	O
but	28939416	0	O
are	28939416	0	O
not	28939416	0	O
necessarily	28939416	0	O
harbingers	28939416	0	O
of	28939416	0	O
transformation	28939416	0	O
because	28939416	0	O
only	28939416	0	O
a	28939416	0	O
fraction	28939416	0	O
of	28939416	0	O
individuals	28939416	0	O
with	28939416	0	O
CHIP	28939416	0	O
develop	28939416	0	O
hematopoietic	28939416	0	O
pathologies	28939416	0	O
.	28939416	0	O
Delineation	28939416	0	O
between	28939416	0	O
CHIP	28939416	0	O
variants	28939416	0	O
that	28939416	0	O
predispose	28939416	0	O
for	28939416	0	O
disease	28939416	0	O
versus	28939416	0	O
those	28939416	0	O
that	28939416	0	O
are	28939416	0	O
more	28939416	0	O
benign	28939416	0	O
could	28939416	0	O
be	28939416	0	O
used	28939416	0	O
as	28939416	0	O
a	28939416	0	O
prognostic	28939416	0	O
factor	28939416	0	O
to	28939416	0	O
identify	28939416	0	O
individuals	28939416	0	O
at	28939416	0	O
greater	28939416	0	O
risk	28939416	0	O
for	28939416	0	O
transformation	28939416	0	O
.	28939416	0	O
To	28939416	0	O
achieve	28939416	0	O
this	28939416	0	O
,	28939416	0	O
the	28939416	0	O
biological	28939416	0	O
impact	28939416	0	O
of	28939416	0	O
CHIP	28939416	0	O
variants	28939416	0	O
on	28939416	0	O
HSC	28939416	0	O
function	28939416	0	O
must	28939416	0	O
be	28939416	0	O
validated	28939416	0	O
.	28939416	0	O
One	28939416	0	O
variant	28939416	0	O
that	28939416	0	O
has	28939416	0	O
been	28939416	0	O
identified	28939416	0	O
recurrently	28939416	0	O
in	28939416	0	O
CHIP	28939416	0	O
is	28939416	0	O
a	28939416	0	O
gain	28939416	0	B-PosReg
-	28939416	0	I-PosReg
of	28939416	0	I-PosReg
-	28939416	0	I-PosReg
function	28939416	0	I-PosReg
missense	28939416	0	B-Var
mutation	28939416	0	I-Var
in	28939416	0	O
the	28939416	0	O
imprinted	28939416	0	O
gene	28939416	0	O
GNAS	28939416	0	B-Gene
(	28939416	0	O
Guanine	28939416	0	O
Nucleotide	28939416	0	O
Binding	28939416	0	O
Protein	28939416	0	O
,	28939416	0	O
Alpha	28939416	0	O
Stimulating	28939416	0	O
)	28939416	0	O
.	28939416	0	O
In	28939416	0	O
this	28939416	0	O
study	28939416	0	O
,	28939416	0	O
we	28939416	0	O
examined	28939416	0	O
the	28939416	0	O
effect	28939416	0	O
of	28939416	0	O
the	28939416	0	O
GNASR201C	28939416	0	O
variant	28939416	0	O
on	28939416	0	O
HSC	28939416	0	O
function	28939416	0	O
.	28939416	0	O
Ectopic	28939416	0	O
expression	28939416	0	O
of	28939416	0	O
GNASR201C	28939416	0	B-Var
supported	28939416	0	B-PosReg
transplantable	28939416	0	O
HSC	28939416	0	O
activity	28939416	0	O
and	28939416	0	O
improved	28939416	0	B-PosReg
lymphoid	28939416	0	O
output	28939416	0	O
in	28939416	0	O
secondary	28939416	0	O
recipients	28939416	0	O
.	28939416	0	O
Because	28939416	0	O
declining	28939416	0	O
lymphoid	28939416	0	O
output	28939416	0	O
is	28939416	0	O
a	28939416	0	O
hallmark	28939416	0	O
of	28939416	0	O
aging	28939416	0	O
,	28939416	0	O
GNASR201C	28939416	0	O
mutations	28939416	0	O
may	28939416	0	O
sustain	28939416	0	O
lymphoid	28939416	0	O
-	28939416	0	O
biased	28939416	0	O
HSCs	28939416	0	O
over	28939416	0	O
time	28939416	0	O
and	28939416	0	O
maintain	28939416	0	O
them	28939416	0	O
in	28939416	0	O
a	28939416	0	O
developmental	28939416	0	O
state	28939416	0	O
favorable	28939416	0	O
for	28939416	0	O
transformation	28939416	0	O
.	28939416	0	O

N1366S	28940424	2	O
mutation	28940424	2	O
of	28940424	2	O
human	28940424	2	O
skeletal	28940424	2	O
muscle	28940424	2	O
sodium	28940424	2	O
channel	28940424	2	O
causes	28940424	2	O
paramyotonia	28940424	2	O
congenita	28940424	2	O
.	28940424	2	O
KEY	28940424	2	O
POINTS	28940424	2	O
:	28940424	2	O
Paramyotonia	28940424	2	B-Disease
congenita	28940424	2	I-Disease
is	28940424	2	O
a	28940424	2	O
hereditary	28940424	2	O
channelopathy	28940424	2	O
caused	28940424	2	B-Reg
by	28940424	2	O
missense	28940424	2	B-Var
mutations	28940424	2	I-Var
in	28940424	2	O
the	28940424	2	O
SCN4A	28940424	2	B-Gene
gene	28940424	2	O
,	28940424	2	O
which	28940424	2	O
encodes	28940424	2	O
the	28940424	2	O
α	28940424	2	O
subunit	28940424	2	O
of	28940424	2	O
the	28940424	2	O
human	28940424	2	O
skeletal	28940424	2	O
muscle	28940424	2	O
voltage	28940424	2	O
-	28940424	2	O
gated	28940424	2	O
sodium	28940424	2	O
channel	28940424	2	O
NaV1.4	28940424	2	O
.	28940424	2	O
Affected	28940424	2	O
individuals	28940424	2	O
suffered	28940424	2	O
from	28940424	2	O
myotonia	28940424	2	O
and	28940424	2	O
paralysis	28940424	2	O
of	28940424	2	O
muscles	28940424	2	O
,	28940424	2	O
which	28940424	2	O
were	28940424	2	O
aggravated	28940424	2	O
by	28940424	2	O
exposure	28940424	2	O
to	28940424	2	O
cold	28940424	2	O
.	28940424	2	O
We	28940424	2	O
report	28940424	2	O
a	28940424	2	O
three	28940424	2	O
-	28940424	2	O
generation	28940424	2	O
Chinese	28940424	2	O
family	28940424	2	O
with	28940424	2	O
patients	28940424	2	O
presenting	28940424	2	O
paramyotonia	28940424	2	O
congenita	28940424	2	O
and	28940424	2	O
identify	28940424	2	O
a	28940424	2	O
novel	28940424	2	O
N1366S	28940424	2	O
mutation	28940424	2	O
of	28940424	2	O
NaV1.4	28940424	2	O
.	28940424	2	O
Whole	28940424	2	O
-	28940424	2	O
cell	28940424	2	O
electrophysiological	28940424	2	O
recordings	28940424	2	O
of	28940424	2	O
the	28940424	2	O
N1366S	28940424	2	O
channel	28940424	2	O
reveal	28940424	2	O
a	28940424	2	O
gain	28940424	2	O
-	28940424	2	O
of	28940424	2	O
-	28940424	2	O
function	28940424	2	O
change	28940424	2	O
of	28940424	2	O
gating	28940424	2	O
in	28940424	2	O
response	28940424	2	O
to	28940424	2	O
cold	28940424	2	O
.	28940424	2	O
Modelling	28940424	2	O
and	28940424	2	O
molecular	28940424	2	O
dynamic	28940424	2	O
simulation	28940424	2	O
data	28940424	2	O
suggest	28940424	2	O
that	28940424	2	O
an	28940424	2	O
arginine	28940424	2	O
-	28940424	2	O
to	28940424	2	O
-	28940424	2	O
serine	28940424	2	O
substitution	28940424	2	O
at	28940424	2	O
position	28940424	2	O
1366	28940424	2	O
increases	28940424	2	O
the	28940424	2	O
distance	28940424	2	O
from	28940424	2	O
N1366	28940424	2	O
to	28940424	2	O
R1454	28940424	2	O
and	28940424	2	O
disrupts	28940424	2	O
the	28940424	2	O
hydrogen	28940424	2	O
bond	28940424	2	O
formed	28940424	2	O
between	28940424	2	O
them	28940424	2	O
at	28940424	2	O
low	28940424	2	O
temperature	28940424	2	O
.	28940424	2	O
We	28940424	2	O
demonstrate	28940424	2	O
that	28940424	2	O
N1366S	28940424	2	O
is	28940424	2	O
a	28940424	2	O
disease	28940424	2	O
-	28940424	2	O
causing	28940424	2	O
mutation	28940424	2	O
and	28940424	2	O
that	28940424	2	O
the	28940424	2	O
temperature	28940424	2	O
-	28940424	2	O
sensitive	28940424	2	O
alteration	28940424	2	O
of	28940424	2	O
N1366S	28940424	2	O
channel	28940424	2	O
activity	28940424	2	O
may	28940424	2	O
be	28940424	2	O
responsible	28940424	2	O
for	28940424	2	O
the	28940424	2	O
pronounced	28940424	2	O
paramyotonia	28940424	2	O
congenita	28940424	2	O
symptoms	28940424	2	O
of	28940424	2	O
these	28940424	2	O
patients	28940424	2	O
.	28940424	2	O
ABSTRACT	28940424	2	O
:	28940424	2	O
Paramyotonia	28940424	2	B-Disease
congenita	28940424	2	I-Disease
is	28940424	2	O
an	28940424	2	O
autosomal	28940424	2	O
dominant	28940424	2	O
skeletal	28940424	2	O
muscle	28940424	2	O
channelopathy	28940424	2	O
caused	28940424	2	B-Reg
by	28940424	2	O
missense	28940424	2	B-Var
mutations	28940424	2	I-Var
in	28940424	2	O
SCN4A	28940424	2	B-Gene
,	28940424	2	O
the	28940424	2	O
gene	28940424	2	O
encoding	28940424	2	O
the	28940424	2	O
α	28940424	2	O
subunit	28940424	2	O
of	28940424	2	O
the	28940424	2	O
human	28940424	2	O
skeletal	28940424	2	O
muscle	28940424	2	O
voltage	28940424	2	O
-	28940424	2	O
gated	28940424	2	O
sodium	28940424	2	O
channel	28940424	2	O
NaV1.4	28940424	2	O
.	28940424	2	O
We	28940424	2	O
report	28940424	2	O
a	28940424	2	O
three	28940424	2	O
-	28940424	2	O
generation	28940424	2	O
family	28940424	2	O
in	28940424	2	O
which	28940424	2	O
six	28940424	2	O
members	28940424	2	O
present	28940424	2	O
clinical	28940424	2	O
symptoms	28940424	2	O
of	28940424	2	O
paramyotonia	28940424	2	O
congenita	28940424	2	O
characterized	28940424	2	O
by	28940424	2	O
a	28940424	2	O
marked	28940424	2	O
worsening	28940424	2	O
of	28940424	2	O
myotonia	28940424	2	O
by	28940424	2	O
cold	28940424	2	O
and	28940424	2	O
by	28940424	2	O
the	28940424	2	O
presence	28940424	2	O
of	28940424	2	O
clear	28940424	2	O
episodes	28940424	2	O
of	28940424	2	O
paralysis	28940424	2	O
.	28940424	2	O
We	28940424	2	O
identified	28940424	2	O
a	28940424	2	O
novel	28940424	2	O
mutation	28940424	2	O
in	28940424	2	O
SCN4A	28940424	2	O
(	28940424	2	O
Asn1366Ser	28940424	2	O
,	28940424	2	O
N1366S	28940424	2	O
)	28940424	2	O
in	28940424	2	O
all	28940424	2	O
patients	28940424	2	O
in	28940424	2	O
the	28940424	2	O
family	28940424	2	O
but	28940424	2	O
not	28940424	2	O
in	28940424	2	O
healthy	28940424	2	O
relatives	28940424	2	O
or	28940424	2	O
in	28940424	2	O
500	28940424	2	O
normal	28940424	2	O
control	28940424	2	O
subjects	28940424	2	O
.	28940424	2	O
Functional	28940424	2	O
analysis	28940424	2	O
of	28940424	2	O
the	28940424	2	O
channel	28940424	2	O
protein	28940424	2	O
expressed	28940424	2	O
in	28940424	2	O
HEK293	28940424	2	O
cells	28940424	2	O
by	28940424	2	O
whole	28940424	2	O
-	28940424	2	O
cell	28940424	2	O
patch	28940424	2	O
clamp	28940424	2	O
recording	28940424	2	O
revealed	28940424	2	O
that	28940424	2	O
the	28940424	2	O
N1366S	28940424	2	O
mutation	28940424	2	O
led	28940424	2	O
to	28940424	2	O
significant	28940424	2	O
alterations	28940424	2	O
in	28940424	2	O
the	28940424	2	O
gating	28940424	2	O
process	28940424	2	O
of	28940424	2	O
the	28940424	2	O
NaV1.4	28940424	2	O
channel	28940424	2	O
.	28940424	2	O
The	28940424	2	O
N1366S	28940424	2	B-Var
mutant	28940424	2	O
displayed	28940424	2	O
a	28940424	2	O
cold	28940424	2	O
-	28940424	2	O
induced	28940424	2	O
hyperpolarizing	28940424	2	O
shift	28940424	2	O
in	28940424	2	O
the	28940424	2	O
voltage	28940424	2	O
dependence	28940424	2	O
of	28940424	2	O
activation	28940424	2	O
and	28940424	2	O
a	28940424	2	O
depolarizing	28940424	2	O
shift	28940424	2	O
in	28940424	2	O
fast	28940424	2	O
inactivation	28940424	2	O
,	28940424	2	O
as	28940424	2	O
well	28940424	2	O
as	28940424	2	O
a	28940424	2	O
reduced	28940424	2	B-NegReg
rate	28940424	2	O
of	28940424	2	O
fast	28940424	2	O
inactivation	28940424	2	O
and	28940424	2	O
accelerated	28940424	2	B-PosReg
recovery	28940424	2	O
from	28940424	2	O
fast	28940424	2	O
inactivation	28940424	2	O
.	28940424	2	O
In	28940424	2	O
addition	28940424	2	O
,	28940424	2	O
homology	28940424	2	O
modelling	28940424	2	O
and	28940424	2	O
molecular	28940424	2	O
dynamic	28940424	2	O
simulation	28940424	2	O
of	28940424	2	O
N1366S	28940424	2	O
and	28940424	2	O
wild	28940424	2	O
-	28940424	2	O
type	28940424	2	O
NaV1.4	28940424	2	O
channels	28940424	2	O
indicated	28940424	2	O
that	28940424	2	O
the	28940424	2	O
arginine	28940424	2	O
-	28940424	2	O
to	28940424	2	O
-	28940424	2	O
serine	28940424	2	O
substitution	28940424	2	O
disrupted	28940424	2	O
the	28940424	2	O
hydrogen	28940424	2	O
bond	28940424	2	O
formed	28940424	2	O
between	28940424	2	O
N1366	28940424	2	O
and	28940424	2	O
R1454	28940424	2	O
.	28940424	2	O
Together	28940424	2	O
,	28940424	2	O
our	28940424	2	O
results	28940424	2	O
suggest	28940424	2	O
that	28940424	2	O
N1366S	28940424	2	B-Var
is	28940424	2	O
a	28940424	2	O
gain	28940424	2	B-PosReg
-	28940424	2	I-PosReg
of	28940424	2	I-PosReg
-	28940424	2	I-PosReg
function	28940424	2	I-PosReg
mutation	28940424	2	O
of	28940424	2	O
NaV1.4	28940424	2	O
at	28940424	2	O
low	28940424	2	O
temperature	28940424	2	O
and	28940424	2	O
the	28940424	2	O
mutation	28940424	2	O
may	28940424	2	O
be	28940424	2	O
responsible	28940424	2	O
for	28940424	2	O
the	28940424	2	O
clinical	28940424	2	O
symptoms	28940424	2	O
of	28940424	2	O
paramyotonia	28940424	2	B-Disease
congenita	28940424	2	I-Disease
in	28940424	2	O
the	28940424	2	O
affected	28940424	2	O
family	28940424	2	O
and	28940424	2	O
constitute	28940424	2	O
a	28940424	2	O
basis	28940424	2	O
for	28940424	2	O
studies	28940424	2	O
into	28940424	2	O
its	28940424	2	O
pathogenesis	28940424	2	O
.	28940424	2	O

Loss	28941020	1	B-NegReg
-	28941020	1	I-NegReg
of	28941020	1	I-NegReg
-	28941020	1	I-NegReg
function	28941020	1	I-NegReg
variants	28941020	1	B-Var
in	28941020	1	O
NFIA	28941020	1	B-Gene
provide	28941020	1	O
further	28941020	1	O
support	28941020	1	O
that	28941020	1	O
NFIA	28941020	1	O
is	28941020	1	O
a	28941020	1	O
critical	28941020	1	O
gene	28941020	1	O
in	28941020	1	O
1	28941020	1	B-Disease
p32	28941020	1	I-Disease
-	28941020	1	I-Disease
p31	28941020	1	I-Disease
deletion	28941020	1	I-Disease
syndrome	28941020	1	I-Disease
:	28941020	1	I-Disease
A	28941020	1	O
four	28941020	1	O
patient	28941020	1	O
series	28941020	1	O
.	28941020	1	O
The	28941020	1	O
association	28941020	1	O
between	28941020	1	O
1	28941020	1	O
p32	28941020	1	O
-	28941020	1	O
p31	28941020	1	O
contiguous	28941020	1	O
gene	28941020	1	O
deletions	28941020	1	O
and	28941020	1	O
a	28941020	1	O
distinct	28941020	1	O
phenotype	28941020	1	O
that	28941020	1	O
includes	28941020	1	O
anomalies	28941020	1	O
of	28941020	1	O
the	28941020	1	O
corpus	28941020	1	O
callosum	28941020	1	O
,	28941020	1	O
ventriculomegaly	28941020	1	O
,	28941020	1	O
developmental	28941020	1	O
delay	28941020	1	O
,	28941020	1	O
seizures	28941020	1	O
,	28941020	1	O
and	28941020	1	O
dysmorphic	28941020	1	O
features	28941020	1	O
has	28941020	1	O
been	28941020	1	O
long	28941020	1	O
recognized	28941020	1	O
and	28941020	1	O
described	28941020	1	O
.	28941020	1	O
Recently	28941020	1	O
,	28941020	1	O
the	28941020	1	O
observation	28941020	1	O
of	28941020	1	O
overlapping	28941020	1	O
phenotypes	28941020	1	O
in	28941020	1	O
patients	28941020	1	O
with	28941020	1	O
chromosome	28941020	1	O
translocations	28941020	1	O
that	28941020	1	O
disrupt	28941020	1	O
NFIA	28941020	1	O
(	28941020	1	O
Nuclear	28941020	1	O
factor	28941020	1	O
I	28941020	1	O
/	28941020	1	O
A	28941020	1	O
)	28941020	1	O
,	28941020	1	O
a	28941020	1	O
gene	28941020	1	O
within	28941020	1	O
this	28941020	1	O
deleted	28941020	1	O
region	28941020	1	O
,	28941020	1	O
and	28941020	1	O
NFIA	28941020	1	O
intragenic	28941020	1	O
deletions	28941020	1	O
has	28941020	1	O
led	28941020	1	O
to	28941020	1	O
the	28941020	1	O
hypothesis	28941020	1	O
that	28941020	1	O
NFIA	28941020	1	O
is	28941020	1	O
a	28941020	1	O
critical	28941020	1	O
gene	28941020	1	O
within	28941020	1	O
this	28941020	1	O
region	28941020	1	O
.	28941020	1	O
The	28941020	1	O
wide	28941020	1	O
application	28941020	1	O
and	28941020	1	O
increasing	28941020	1	O
accessibility	28941020	1	O
of	28941020	1	O
whole	28941020	1	O
exome	28941020	1	O
sequencing	28941020	1	O
(	28941020	1	O
WES	28941020	1	O
)	28941020	1	O
has	28941020	1	O
helped	28941020	1	O
identify	28941020	1	O
new	28941020	1	O
cases	28941020	1	O
to	28941020	1	O
support	28941020	1	O
this	28941020	1	O
hypothesis	28941020	1	O
.	28941020	1	O
Here	28941020	1	O
,	28941020	1	O
we	28941020	1	O
describe	28941020	1	O
four	28941020	1	O
patients	28941020	1	O
with	28941020	1	O
loss	28941020	1	O
-	28941020	1	O
of	28941020	1	O
-	28941020	1	O
function	28941020	1	O
variants	28941020	1	O
in	28941020	1	O
the	28941020	1	O
NFIA	28941020	1	O
gene	28941020	1	O
identified	28941020	1	O
through	28941020	1	O
WES	28941020	1	O
.	28941020	1	O
The	28941020	1	O
clinical	28941020	1	O
presentation	28941020	1	O
of	28941020	1	O
these	28941020	1	O
patients	28941020	1	O
significantly	28941020	1	O
overlaps	28941020	1	O
with	28941020	1	O
the	28941020	1	O
phenotype	28941020	1	O
described	28941020	1	O
in	28941020	1	O
previously	28941020	1	O
reported	28941020	1	O
cases	28941020	1	O
of	28941020	1	O
1	28941020	1	O
p32	28941020	1	O
-	28941020	1	O
p31	28941020	1	O
deletion	28941020	1	O
syndrome	28941020	1	O
,	28941020	1	O
NFIA	28941020	1	O
gene	28941020	1	O
disruptions	28941020	1	O
and	28941020	1	O
intragenic	28941020	1	O
NFIA	28941020	1	O
deletions	28941020	1	O
.	28941020	1	O
Our	28941020	1	O
cohort	28941020	1	O
includes	28941020	1	O
a	28941020	1	O
mother	28941020	1	O
and	28941020	1	O
daughter	28941020	1	O
as	28941020	1	O
well	28941020	1	O
as	28941020	1	O
an	28941020	1	O
unrelated	28941020	1	O
individual	28941020	1	O
who	28941020	1	O
share	28941020	1	O
the	28941020	1	O
same	28941020	1	O
nonsense	28941020	1	O
variant	28941020	1	O
(	28941020	1	O
c.205	28941020	1	O
C	28941020	1	O
>	28941020	1	O
T	28941020	1	O
,	28941020	1	O
p.Arg69Ter	28941020	1	O
;	28941020	1	O
NM_001145512.1	28941020	1	O
)	28941020	1	O
.	28941020	1	O
We	28941020	1	O
also	28941020	1	O
report	28941020	1	O
a	28941020	1	O
patient	28941020	1	O
with	28941020	1	O
a	28941020	1	O
frameshift	28941020	1	O
NFIA	28941020	1	O
variant	28941020	1	O
(	28941020	1	O
c.159	28941020	1	O
_160dupCC	28941020	1	O
,	28941020	1	O
p.Gln54ProfsTer49	28941020	1	O
)	28941020	1	O
.	28941020	1	O
We	28941020	1	O
have	28941020	1	O
compared	28941020	1	O
published	28941020	1	O
cases	28941020	1	O
of	28941020	1	O
1	28941020	1	O
p32	28941020	1	O
-	28941020	1	O
p31	28941020	1	O
microdeletion	28941020	1	O
syndrome	28941020	1	O
,	28941020	1	O
translocations	28941020	1	O
resulting	28941020	1	O
in	28941020	1	O
NFIA	28941020	1	O
gene	28941020	1	O
disruption	28941020	1	O
,	28941020	1	O
intragenic	28941020	1	O
deletions	28941020	1	O
,	28941020	1	O
and	28941020	1	O
loss	28941020	1	O
-	28941020	1	O
of	28941020	1	O
-	28941020	1	O
function	28941020	1	O
mutations	28941020	1	O
(	28941020	1	O
including	28941020	1	O
our	28941020	1	O
four	28941020	1	O
patients	28941020	1	O
)	28941020	1	O
to	28941020	1	O
reveal	28941020	1	O
that	28941020	1	O
abnormalities	28941020	1	O
of	28941020	1	O
the	28941020	1	O
corpus	28941020	1	O
callosum	28941020	1	O
,	28941020	1	O
ventriculomegaly	28941020	1	O
/	28941020	1	O
hydrocephalus	28941020	1	O
,	28941020	1	O
macrocephaly	28941020	1	O
,	28941020	1	O
Chiari	28941020	1	O
I	28941020	1	O
malformation	28941020	1	O
,	28941020	1	O
dysmorphic	28941020	1	O
features	28941020	1	O
,	28941020	1	O
developmental	28941020	1	O
delay	28941020	1	O
,	28941020	1	O
hypotonia	28941020	1	O
,	28941020	1	O
and	28941020	1	O
urinary	28941020	1	O
tract	28941020	1	O
defects	28941020	1	O
are	28941020	1	O
common	28941020	1	O
findings	28941020	1	O
.	28941020	1	O
The	28941020	1	O
consistent	28941020	1	O
overlap	28941020	1	O
in	28941020	1	O
clinical	28941020	1	O
presentation	28941020	1	O
provides	28941020	1	O
further	28941020	1	O
evidence	28941020	1	O
of	28941020	1	O
the	28941020	1	O
critical	28941020	1	O
role	28941020	1	O
of	28941020	1	O
NFIA	28941020	1	O
haploinsufficiency	28941020	1	O
in	28941020	1	O
the	28941020	1	O
development	28941020	1	O
of	28941020	1	O
the	28941020	1	O
1	28941020	1	O
p32	28941020	1	O
-	28941020	1	O
p31	28941020	1	O
microdeletion	28941020	1	O
syndrome	28941020	1	O
phenotype	28941020	1	O
.	28941020	1	O

Clcn7F318L	28942122	1	O
/	28942122	1	O
as	28942122	1	O
a	28942122	1	O
new	28942122	1	O
mouse	28942122	1	O
model	28942122	1	O
of	28942122	1	O
Albers	28942122	1	O
-	28942122	1	O
Schönberg	28942122	1	O
disease	28942122	1	O
.	28942122	1	O
Dominant	28942122	1	O
negative	28942122	1	B-NegReg
mutations	28942122	1	B-Var
in	28942122	1	O
CLCN7	28942122	1	B-Gene
,	28942122	1	O
which	28942122	1	O
encodes	28942122	1	O
a	28942122	1	O
homodimeric	28942122	1	O
chloride	28942122	1	O
channel	28942122	1	O
needed	28942122	1	O
for	28942122	1	O
matrix	28942122	1	O
acidification	28942122	1	O
by	28942122	1	O
osteoclasts	28942122	1	O
,	28942122	1	O
cause	28942122	1	O
Albers	28942122	1	B-Disease
-	28942122	1	I-Disease
Schönberg	28942122	1	I-Disease
disease	28942122	1	I-Disease
(	28942122	1	O
also	28942122	1	O
known	28942122	1	O
as	28942122	1	O
autosomal	28942122	1	O
dominant	28942122	1	O
osteopetrosis	28942122	1	O
type	28942122	1	O
2	28942122	1	O
)	28942122	1	O
.	28942122	1	O
More	28942122	1	O
than	28942122	1	O
25	28942122	1	O
different	28942122	1	O
CLCN7	28942122	1	O
mutations	28942122	1	O
have	28942122	1	O
been	28942122	1	O
identified	28942122	1	O
in	28942122	1	O
patients	28942122	1	O
affected	28942122	1	O
with	28942122	1	O
Albers	28942122	1	O
-	28942122	1	O
Schönberg	28942122	1	O
disease	28942122	1	O
,	28942122	1	O
but	28942122	1	O
only	28942122	1	O
one	28942122	1	O
mutation	28942122	1	O
(	28942122	1	O
Clcn7G213R	28942122	1	O
)	28942122	1	O
has	28942122	1	O
been	28942122	1	O
introduced	28942122	1	O
in	28942122	1	O
mice	28942122	1	O
to	28942122	1	O
create	28942122	1	O
an	28942122	1	O
animal	28942122	1	O
model	28942122	1	O
of	28942122	1	O
this	28942122	1	O
disease	28942122	1	O
.	28942122	1	O
Here	28942122	1	O
we	28942122	1	O
describe	28942122	1	O
a	28942122	1	O
mouse	28942122	1	O
with	28942122	1	O
a	28942122	1	O
different	28942122	1	O
osteopetrosis	28942122	1	O
-	28942122	1	O
causing	28942122	1	O
mutation	28942122	1	O
(	28942122	1	O
Clcn7F318L	28942122	1	O
)	28942122	1	O
.	28942122	1	O
Compared	28942122	1	O
to	28942122	1	O
Clcn7	28942122	1	O
/	28942122	1	O
mice	28942122	1	O
,	28942122	1	O
12	28942122	1	O
-	28942122	1	O
week	28942122	1	O
-	28942122	1	O
old	28942122	1	O
Clcn7F318L	28942122	1	O
/	28942122	1	O
mice	28942122	1	O
have	28942122	1	O
significantly	28942122	1	O
increased	28942122	1	B-PosReg
trabecular	28942122	1	O
bone	28942122	1	O
volume	28942122	1	O
,	28942122	1	O
consistent	28942122	1	O
with	28942122	1	O
Clcn7F318L	28942122	1	B-Var
acting	28942122	1	O
as	28942122	1	O
a	28942122	1	O
dominant	28942122	1	O
negative	28942122	1	B-NegReg
mutation	28942122	1	O
.	28942122	1	O
Clcn7F318L	28942122	1	O
/	28942122	1	O
F318L	28942122	1	O
and	28942122	1	O
Clcn7F318L	28942122	1	O
/	28942122	1	O
G213R	28942122	1	O
mice	28942122	1	O
die	28942122	1	O
by	28942122	1	O
1	28942122	1	O
month	28942122	1	O
of	28942122	1	O
age	28942122	1	O
and	28942122	1	O
resemble	28942122	1	O
Clcn7	28942122	1	O
knockout	28942122	1	O
mice	28942122	1	O
,	28942122	1	O
which	28942122	1	O
indicate	28942122	1	O
that	28942122	1	O
p.F318L	28942122	1	B-Var
mutant	28942122	1	O
protein	28942122	1	O
is	28942122	1	O
non	28942122	1	O
-	28942122	1	O
functional	28942122	1	O
and	28942122	1	O
p.F318L	28942122	1	O
and	28942122	1	O
p.G213R	28942122	1	O
mutant	28942122	1	O
proteins	28942122	1	O
do	28942122	1	O
not	28942122	1	O
complement	28942122	1	O
one	28942122	1	O
another	28942122	1	O
.	28942122	1	O
Since	28942122	1	O
it	28942122	1	O
has	28942122	1	O
been	28942122	1	O
reported	28942122	1	O
that	28942122	1	O
treatment	28942122	1	O
with	28942122	1	O
interferon	28942122	1	O
gamma	28942122	1	O
(	28942122	1	O
IFN	28942122	1	O
-	28942122	1	O
G	28942122	1	O
)	28942122	1	O
improves	28942122	1	O
bone	28942122	1	O
properties	28942122	1	O
in	28942122	1	O
Clcn7G213R	28942122	1	O
/	28942122	1	O
mice	28942122	1	O
,	28942122	1	O
we	28942122	1	O
treated	28942122	1	O
Clcn7F318L	28942122	1	O
/	28942122	1	O
mice	28942122	1	O
with	28942122	1	O
IFN	28942122	1	O
-	28942122	1	O
G	28942122	1	O
and	28942122	1	O
observed	28942122	1	O
a	28942122	1	O
decrease	28942122	1	O
in	28942122	1	O
osteoclast	28942122	1	O
number	28942122	1	O
and	28942122	1	O
mineral	28942122	1	O
apposition	28942122	1	O
rate	28942122	1	O
,	28942122	1	O
but	28942122	1	O
no	28942122	1	O
overall	28942122	1	O
improvement	28942122	1	O
in	28942122	1	O
bone	28942122	1	O
properties	28942122	1	O
.	28942122	1	O
Our	28942122	1	O
results	28942122	1	O
suggest	28942122	1	O
that	28942122	1	O
the	28942122	1	O
benefits	28942122	1	O
of	28942122	1	O
IFN	28942122	1	O
-	28942122	1	O
G	28942122	1	O
therapy	28942122	1	O
in	28942122	1	O
patients	28942122	1	O
with	28942122	1	O
Albers	28942122	1	O
-	28942122	1	O
Schönberg	28942122	1	O
disease	28942122	1	O
may	28942122	1	O
be	28942122	1	O
mutation	28942122	1	O
-	28942122	1	O
specific	28942122	1	O
.	28942122	1	O

Highlighting	28967976	1	O
Interleukin-36	28967976	1	O
Signalling	28967976	1	O
in	28967976	1	O
Plaque	28967976	1	O
Psoriasis	28967976	1	O
and	28967976	1	O
Pustular	28967976	1	O
Psoriasis	28967976	1	O
.	28967976	1	O
Plaque	28967976	1	O
psoriasis	28967976	1	O
and	28967976	1	O
pustular	28967976	1	O
psoriasis	28967976	1	O
are	28967976	1	O
overlapping	28967976	1	O
,	28967976	1	O
but	28967976	1	O
distinct	28967976	1	O
,	28967976	1	O
disorders	28967976	1	O
.	28967976	1	O
The	28967976	1	O
therapeutic	28967976	1	O
response	28967976	1	O
to	28967976	1	O
biologics	28967976	1	O
supports	28967976	1	O
the	28967976	1	O
pivotal	28967976	1	O
role	28967976	1	O
of	28967976	1	O
the	28967976	1	O
tumour	28967976	1	O
necrosis	28967976	1	O
alpha	28967976	1	O
(	28967976	1	O
TNF	28967976	1	O
-	28967976	1	O
?	28967976	1	O
)	28967976	1	O
/	28967976	1	O
interleukin	28967976	1	O
(	28967976	1	O
IL	28967976	1	O
)	28967976	1	O
-	28967976	1	O
23	28967976	1	O
/	28967976	1	O
IL-17	28967976	1	O
/	28967976	1	O
IL-22	28967976	1	O
axis	28967976	1	O
in	28967976	1	O
the	28967976	1	O
pathogenesis	28967976	1	O
of	28967976	1	O
these	28967976	1	O
disorders	28967976	1	O
.	28967976	1	O
Recently	28967976	1	O
,	28967976	1	O
functional	28967976	1	O
activation	28967976	1	O
of	28967976	1	O
the	28967976	1	O
IL-36	28967976	1	O
receptor	28967976	1	O
(	28967976	1	O
IL-36	28967976	1	O
R	28967976	1	O
)	28967976	1	O
was	28967976	1	O
discovered	28967976	1	O
to	28967976	1	O
be	28967976	1	O
another	28967976	1	O
driving	28967976	1	O
force	28967976	1	O
in	28967976	1	O
the	28967976	1	O
pathogenesis	28967976	1	O
of	28967976	1	O
psoriasis	28967976	1	O
.	28967976	1	O
This	28967976	1	O
was	28967976	1	O
first	28967976	1	O
highlighted	28967976	1	O
by	28967976	1	O
the	28967976	1	O
discovery	28967976	1	O
that	28967976	1	O
a	28967976	1	O
loss	28967976	1	B-NegReg
-	28967976	1	I-NegReg
of	28967976	1	I-NegReg
-	28967976	1	I-NegReg
function	28967976	1	I-NegReg
mutation	28967976	1	B-Var
of	28967976	1	O
the	28967976	1	O
IL-36	28967976	1	O
R	28967976	1	O
antagonist	28967976	1	O
(	28967976	1	B-Gene
IL-36	28967976	1	I-Gene
Ra	28967976	1	I-Gene
)	28967976	1	I-Gene
causes	28967976	1	O
pustular	28967976	1	B-Disease
psoriasis	28967976	1	I-Disease
.	28967976	1	O
Although	28967976	1	O
the	28967976	1	O
TNF	28967976	1	O
-	28967976	1	O
?	28967976	1	O
/	28967976	1	O
IL-23	28967976	1	O
/	28967976	1	O
IL-17	28967976	1	O
/	28967976	1	O
IL-22	28967976	1	O
axis	28967976	1	O
and	28967976	1	O
the	28967976	1	O
functional	28967976	1	O
activation	28967976	1	O
of	28967976	1	O
IL-36	28967976	1	O
R	28967976	1	O
are	28967976	1	O
fundamentally	28967976	1	O
involved	28967976	1	O
in	28967976	1	O
plaque	28967976	1	O
psoriasis	28967976	1	O
and	28967976	1	O
pustular	28967976	1	O
psoriasis	28967976	1	O
,	28967976	1	O
respectively	28967976	1	O
,	28967976	1	O
the	28967976	1	O
2	28967976	1	O
pathways	28967976	1	O
are	28967976	1	O
closely	28967976	1	O
related	28967976	1	O
and	28967976	1	O
mutually	28967976	1	O
reinforced	28967976	1	O
,	28967976	1	O
resulting	28967976	1	O
in	28967976	1	O
full	28967976	1	O
-	28967976	1	O
blown	28967976	1	O
clinical	28967976	1	O
manifestations	28967976	1	O
.	28967976	1	O
This	28967976	1	O
review	28967976	1	O
summarizes	28967976	1	O
current	28967976	1	O
topics	28967976	1	O
on	28967976	1	O
how	28967976	1	O
IL-36	28967976	1	O
agonists	28967976	1	O
(	28967976	1	O
IL-36	28967976	1	O
?	28967976	1	O
,	28967976	1	O
IL-36	28967976	1	O
?	28967976	1	O
,	28967976	1	O
IL-36	28967976	1	O
?	28967976	1	O
)	28967976	1	O
signal	28967976	1	O
IL-36	28967976	1	O
R	28967976	1	O
,	28967976	1	O
the	28967976	1	O
pathological	28967976	1	O
expression	28967976	1	O
of	28967976	1	O
IL-36	28967976	1	O
agonists	28967976	1	O
and	28967976	1	O
IL-36	28967976	1	O
Ra	28967976	1	O
in	28967976	1	O
plaque	28967976	1	O
and	28967976	1	O
pustular	28967976	1	O
psoriatic	28967976	1	O
lesions	28967976	1	O
,	28967976	1	O
and	28967976	1	O
the	28967976	1	O
cross	28967976	1	O
-	28967976	1	O
talk	28967976	1	O
between	28967976	1	O
the	28967976	1	O
TNF	28967976	1	O
-	28967976	1	O
?	28967976	1	O
/	28967976	1	O
IL-23	28967976	1	O
/	28967976	1	O
IL-17	28967976	1	O
/	28967976	1	O
IL-22	28967976	1	O
axis	28967976	1	O
and	28967976	1	O
the	28967976	1	O
functional	28967976	1	O
activation	28967976	1	O
of	28967976	1	O
IL-36	28967976	1	O
R	28967976	1	O
in	28967976	1	O
the	28967976	1	O
epidermal	28967976	1	O
milieu	28967976	1	O
.	28967976	1	O

CCR5Δ32	28969941	0	O
(	28969941	0	O
rs333	28969941	0	O
)	28969941	0	O
polymorphism	28969941	0	O
is	28969941	0	O
associated	28969941	0	O
with	28969941	0	O
decreased	28969941	0	O
risk	28969941	0	O
of	28969941	0	O
chronic	28969941	0	O
and	28969941	0	O
aggressive	28969941	0	O
periodontitis	28969941	0	O
:	28969941	0	O
A	28969941	0	O
case	28969941	0	O
-	28969941	0	O
control	28969941	0	O
analysis	28969941	0	O
based	28969941	0	O
in	28969941	0	O
disease	28969941	0	O
resistance	28969941	0	O
and	28969941	0	O
susceptibility	28969941	0	O
phenotypes	28969941	0	O
.	28969941	0	O
Chronic	28969941	0	O
and	28969941	0	O
aggressive	28969941	0	O
periodontitis	28969941	0	O
are	28969941	0	O
infectious	28969941	0	O
diseases	28969941	0	O
characterized	28969941	0	O
by	28969941	0	O
the	28969941	0	O
irreversible	28969941	0	O
destruction	28969941	0	O
of	28969941	0	O
periodontal	28969941	0	O
tissues	28969941	0	O
,	28969941	0	O
which	28969941	0	O
is	28969941	0	O
mediated	28969941	0	O
by	28969941	0	O
the	28969941	0	O
host	28969941	0	O
inflammatory	28969941	0	O
immune	28969941	0	O
response	28969941	0	O
triggered	28969941	0	O
by	28969941	0	O
periodontal	28969941	0	O
infection	28969941	0	O
.	28969941	0	O
The	28969941	0	O
chemokine	28969941	0	O
receptor	28969941	0	O
CCR5	28969941	0	O
play	28969941	0	O
an	28969941	0	O
important	28969941	0	O
role	28969941	0	O
in	28969941	0	O
disease	28969941	0	O
pathogenesis	28969941	0	O
,	28969941	0	O
contributing	28969941	0	O
to	28969941	0	O
pro	28969941	0	O
-	28969941	0	O
inflammatory	28969941	0	O
response	28969941	0	O
and	28969941	0	O
osteoclastogenesis	28969941	0	O
.	28969941	0	O
CCR5Δ32	28969941	0	O
(	28969941	0	B-Var
rs333	28969941	0	I-Var
)	28969941	0	I-Var
is	28969941	0	O
a	28969941	0	O
loss	28969941	0	B-NegReg
-	28969941	0	I-NegReg
of	28969941	0	I-NegReg
-	28969941	0	I-NegReg
function	28969941	0	I-NegReg
mutation	28969941	0	O
in	28969941	0	O
the	28969941	0	O
CCR5	28969941	0	B-Gene
gene	28969941	0	O
,	28969941	0	O
which	28969941	0	O
can	28969941	0	O
potentially	28969941	0	O
modulate	28969941	0	B-Reg
the	28969941	0	O
host	28969941	0	O
response	28969941	0	O
and	28969941	0	O
,	28969941	0	O
consequently	28969941	0	O
periodontitis	28969941	0	O
outcome	28969941	0	O
.	28969941	0	O
Thus	28969941	0	O
,	28969941	0	O
we	28969941	0	O
investigated	28969941	0	O
the	28969941	0	O
effect	28969941	0	O
of	28969941	0	O
the	28969941	0	O
CCR5Δ32	28969941	0	O
mutation	28969941	0	O
over	28969941	0	O
the	28969941	0	O
risk	28969941	0	O
to	28969941	0	O
suffer	28969941	0	O
periodontitis	28969941	0	O
in	28969941	0	O
a	28969941	0	O
cohort	28969941	0	O
of	28969941	0	O
Brazilian	28969941	0	O
patients	28969941	0	O
(	28969941	0	O
total	28969941	0	O
N	28969941	0	O
=	28969941	0	O
699	28969941	0	O
)	28969941	0	O
,	28969941	0	O
representative	28969941	0	O
of	28969941	0	O
disease	28969941	0	O
susceptibility	28969941	0	O
(	28969941	0	O
chronic	28969941	0	O
periodontitis	28969941	0	O
,	28969941	0	O
N	28969941	0	O
=	28969941	0	O
197	28969941	0	O
;	28969941	0	O
and	28969941	0	O
aggressive	28969941	0	O
periodontitis	28969941	0	O
,	28969941	0	O
N	28969941	0	O
=	28969941	0	O
91	28969941	0	O
)	28969941	0	O
or	28969941	0	O
resistance	28969941	0	O
(	28969941	0	O
chronic	28969941	0	O
gingivitis	28969941	0	O
,	28969941	0	O
N	28969941	0	O
=	28969941	0	O
193	28969941	0	O
)	28969941	0	O
phenotypes	28969941	0	O
,	28969941	0	O
and	28969941	0	O
healthy	28969941	0	O
subjects	28969941	0	O
(	28969941	0	O
N	28969941	0	O
=	28969941	0	O
218	28969941	0	O
)	28969941	0	O
.	28969941	0	O
Additionally	28969941	0	O
,	28969941	0	O
we	28969941	0	O
assayed	28969941	0	O
the	28969941	0	O
influence	28969941	0	O
of	28969941	0	O
CCR5Δ32	28969941	0	O
in	28969941	0	O
the	28969941	0	O
expression	28969941	0	O
of	28969941	0	O
the	28969941	0	O
biomarkers	28969941	0	O
TNFα	28969941	0	O
,	28969941	0	O
IL-1	28969941	0	O
β	28969941	0	O
,	28969941	0	O
IL-10	28969941	0	O
,	28969941	0	O
IL-6	28969941	0	O
,	28969941	0	O
IFN	28969941	0	O
-	28969941	0	O
γ	28969941	0	O
and	28969941	0	O
T	28969941	0	O
-	28969941	0	O
bet	28969941	0	O
,	28969941	0	O
and	28969941	0	O
key	28969941	0	O
periodontal	28969941	0	O
pathogens	28969941	0	O
P.	28969941	0	O
gingivalis	28969941	0	O
,	28969941	0	O
T.	28969941	0	O
forsythia	28969941	0	O
,	28969941	0	O
and	28969941	0	O
T.	28969941	0	O
denticola	28969941	0	O
.	28969941	0	O
In	28969941	0	O
the	28969941	0	O
association	28969941	0	O
analysis	28969941	0	O
of	28969941	0	O
resistant	28969941	0	O
versus	28969941	0	O
susceptible	28969941	0	O
subjects	28969941	0	O
,	28969941	0	O
CCR5Δ32	28969941	0	O
mutant	28969941	0	O
allele	28969941	0	O
-	28969941	0	O
carriers	28969941	0	O
proved	28969941	0	O
significantly	28969941	0	O
protected	28969941	0	O
against	28969941	0	O
chronic	28969941	0	O
(	28969941	0	O
OR	28969941	0	O
0.49	28969941	0	O
;	28969941	0	O
95%	28969941	0	O
CI	28969941	0	O
0.29	28969941	0	O
-	28969941	0	O
0.83	28969941	0	O
;	28969941	0	O
p	28969941	0	O
-	28969941	0	O
value	28969941	0	O
0.01	28969941	0	O
)	28969941	0	O
and	28969941	0	O
aggressive	28969941	0	O
(	28969941	0	O
OR	28969941	0	O
0.46	28969941	0	O
;	28969941	0	O
95%	28969941	0	O
CI	28969941	0	O
0.22	28969941	0	O
-	28969941	0	O
0.94	28969941	0	O
;	28969941	0	O
p	28969941	0	O
-	28969941	0	O
value	28969941	0	O
0.03	28969941	0	O
)	28969941	0	O
periodontitis	28969941	0	O
.	28969941	0	O
Further	28969941	0	O
,	28969941	0	O
heterozygous	28969941	0	O
subjects	28969941	0	O
exhibited	28969941	0	O
significantly	28969941	0	O
decreased	28969941	0	B-NegReg
expression	28969941	0	O
of	28969941	0	O
TNFα	28969941	0	O
in	28969941	0	O
periodontal	28969941	0	O
tissues	28969941	0	O
,	28969941	0	O
pointing	28969941	0	O
to	28969941	0	O
a	28969941	0	O
functional	28969941	0	O
effect	28969941	0	O
of	28969941	0	O
the	28969941	0	O
mutation	28969941	0	B-Var
in	28969941	0	O
periodontal	28969941	0	O
tissues	28969941	0	O
during	28969941	0	O
the	28969941	0	O
progression	28969941	0	O
of	28969941	0	O
the	28969941	0	O
disease	28969941	0	O
.	28969941	0	O
Conversely	28969941	0	O
,	28969941	0	O
no	28969941	0	O
significant	28969941	0	O
changes	28969941	0	O
were	28969941	0	O
observed	28969941	0	O
in	28969941	0	O
the	28969941	0	O
presence	28969941	0	O
or	28969941	0	O
quantity	28969941	0	O
of	28969941	0	O
the	28969941	0	O
periodontal	28969941	0	O
pathogens	28969941	0	O
P.	28969941	0	O
gingivalis	28969941	0	O
,	28969941	0	O
T.	28969941	0	O
forsythia	28969941	0	O
,	28969941	0	O
and	28969941	0	O
T.	28969941	0	O
denticola	28969941	0	O
in	28969941	0	O
the	28969941	0	O
subgingival	28969941	0	O
biofilm	28969941	0	O
that	28969941	0	O
could	28969941	0	O
be	28969941	0	O
attributable	28969941	0	O
to	28969941	0	O
the	28969941	0	O
mutant	28969941	0	O
genotype	28969941	0	O
.	28969941	0	O

Diverse	28972032	4	O
phenotype	28972032	4	O
of	28972032	4	O
hypokalaemic	28972032	4	O
periodic	28972032	4	O
paralysis	28972032	4	O
within	28972032	4	O
a	28972032	4	O
family	28972032	4	O
.	28972032	4	O
Hypokalaemic	28972032	4	O
periodic	28972032	4	O
paralysis	28972032	4	O
typically	28972032	4	O
presents	28972032	4	O
with	28972032	4	O
intermittent	28972032	4	O
mild	28972032	4	O
-	28972032	4	O
to	28972032	4	O
-	28972032	4	O
moderate	28972032	4	O
weakness	28972032	4	O
lasting	28972032	4	O
hours	28972032	4	O
to	28972032	4	O
days	28972032	4	O
.	28972032	4	O
We	28972032	4	O
report	28972032	4	O
a	28972032	4	O
case	28972032	4	O
with	28972032	4	O
an	28972032	4	O
uncommon	28972032	4	O
phenotype	28972032	4	O
of	28972032	4	O
late	28972032	4	O
-	28972032	4	O
onset	28972032	4	O
myopathy	28972032	4	O
without	28972032	4	O
episodic	28972032	4	O
paralytic	28972032	4	O
attacks	28972032	4	O
.	28972032	4	O
Initial	28972032	4	O
work	28972032	4	O
-	28972032	4	O
up	28972032	4	O
including	28972032	4	O
muscle	28972032	4	O
biopsy	28972032	4	O
was	28972032	4	O
inconclusive	28972032	4	O
.	28972032	4	O
A	28972032	4	O
subsequent	28972032	4	O
review	28972032	4	O
of	28972032	4	O
the	28972032	4	O
right	28972032	4	O
deltoid	28972032	4	O
biopsy	28972032	4	O
,	28972032	4	O
long	28972032	4	O
exercise	28972032	4	O
testing	28972032	4	O
and	28972032	4	O
repeated	28972032	4	O
family	28972032	4	O
history	28972032	4	O
was	28972032	4	O
helpful	28972032	4	O
,	28972032	4	O
followed	28972032	4	O
by	28972032	4	O
appropriate	28972032	4	O
genetic	28972032	4	O
testing	28972032	4	O
.	28972032	4	O
We	28972032	4	O
identified	28972032	4	O
a	28972032	4	O
heterozygous	28972032	4	O
pathogenic	28972032	4	O
mutation	28972032	4	O
in	28972032	4	O
calcium	28972032	4	O
ion	28972032	4	O
channel	28972032	4	O
(	28972032	4	B-Var
CACNA1S	28972032	4	I-Var
:	28972032	4	I-Var
c.1583	28972032	4	I-Var
G	28972032	4	I-Var
>	28972032	4	I-Var
A	28972032	4	I-Var
p.Arg528His	28972032	4	I-Var
)	28972032	4	I-Var
causing	28972032	4	B-Reg
hypokalaemic	28972032	4	B-Disease
periodic	28972032	4	I-Disease
paralysis	28972032	4	I-Disease
.	28972032	4	O
Myopathy	28972032	4	O
can	28972032	4	O
present	28972032	4	O
without	28972032	4	O
episodic	28972032	4	O
paralysis	28972032	4	O
and	28972032	4	O
the	28972032	4	O
frequency	28972032	4	O
of	28972032	4	O
paralytic	28972032	4	O
episodes	28972032	4	O
does	28972032	4	O
not	28972032	4	O
correlate	28972032	4	O
well	28972032	4	O
with	28972032	4	O
the	28972032	4	O
development	28972032	4	O
and	28972032	4	O
progression	28972032	4	O
of	28972032	4	O
a	28972032	4	O
fixed	28972032	4	O
myopathy	28972032	4	O
.	28972032	4	O
Our	28972032	4	O
report	28972032	4	O
also	28972032	4	O
highlights	28972032	4	O
the	28972032	4	O
intrafamilial	28972032	4	O
phenotypic	28972032	4	O
variation	28972032	4	O
of	28972032	4	O
hypokalaemic	28972032	4	B-Disease
periodic	28972032	4	I-Disease
paralysis	28972032	4	I-Disease
secondary	28972032	4	O
to	28972032	4	B-Reg
a	28972032	4	O
CACNA1S	28972032	4	B-Gene
gene	28972032	4	O
mutation	28972032	4	B-Var
.	28972032	4	O

Tacrolimus	28973643	1	O
rescues	28973643	1	O
the	28973643	1	O
signaling	28973643	1	O
and	28973643	1	O
gene	28973643	1	O
expression	28973643	1	O
signature	28973643	1	O
of	28973643	1	O
endothelial	28973643	1	O
ALK1	28973643	1	O
loss	28973643	1	O
-	28973643	1	O
of	28973643	1	O
-	28973643	1	O
function	28973643	1	O
and	28973643	1	O
improves	28973643	1	O
HHT	28973643	1	O
vascular	28973643	1	O
pathology	28973643	1	O
.	28973643	1	O
Hereditary	28973643	1	B-Disease
hemorrhagic	28973643	1	I-Disease
telangiectasia	28973643	1	I-Disease
(	28973643	1	O
HHT	28973643	1	O
)	28973643	1	O
is	28973643	1	O
a	28973643	1	O
highly	28973643	1	O
debilitating	28973643	1	O
and	28973643	1	O
life	28973643	1	O
-	28973643	1	O
threatening	28973643	1	O
genetic	28973643	1	O
vascular	28973643	1	O
disorder	28973643	1	O
arising	28973643	1	O
from	28973643	1	O
endothelial	28973643	1	O
cell	28973643	1	O
(	28973643	1	O
EC	28973643	1	O
)	28973643	1	O
proliferation	28973643	1	O
and	28973643	1	O
hypervascularization	28973643	1	O
,	28973643	1	O
for	28973643	1	O
which	28973643	1	O
no	28973643	1	O
cure	28973643	1	O
exists	28973643	1	O
.	28973643	1	O
Because	28973643	1	O
HHT	28973643	1	B-Disease
is	28973643	1	O
caused	28973643	1	O
by	28973643	1	O
loss	28973643	1	B-NegReg
-	28973643	1	I-NegReg
of	28973643	1	I-NegReg
-	28973643	1	I-NegReg
function	28973643	1	I-NegReg
mutations	28973643	1	B-Var
in	28973643	1	O
bone	28973643	1	O
morphogenetic	28973643	1	O
protein	28973643	1	O
9	28973643	1	O
(	28973643	1	O
BMP9	28973643	1	O
)	28973643	1	O
-	28973643	1	O
ALK1	28973643	1	O
-	28973643	1	O
Smad1	28973643	1	O
/	28973643	1	O
5	28973643	1	O
/	28973643	1	O
8	28973643	1	O
signaling	28973643	1	O
,	28973643	1	O
interventions	28973643	1	O
aimed	28973643	1	O
at	28973643	1	O
activating	28973643	1	O
this	28973643	1	O
pathway	28973643	1	O
are	28973643	1	O
of	28973643	1	O
therapeutic	28973643	1	O
value	28973643	1	O
.	28973643	1	O
We	28973643	1	O
interrogated	28973643	1	O
the	28973643	1	O
whole	28973643	1	O
-	28973643	1	O
transcriptome	28973643	1	O
in	28973643	1	O
human	28973643	1	O
umbilical	28973643	1	O
vein	28973643	1	O
ECs	28973643	1	O
(	28973643	1	O
HUVECs	28973643	1	O
)	28973643	1	O
and	28973643	1	O
found	28973643	1	O
that	28973643	1	O
ALK1	28973643	1	O
signaling	28973643	1	O
inhibition	28973643	1	O
was	28973643	1	O
associated	28973643	1	O
with	28973643	1	O
a	28973643	1	O
specific	28973643	1	O
pro	28973643	1	O
-	28973643	1	O
angiogenic	28973643	1	O
gene	28973643	1	O
expression	28973643	1	O
signature	28973643	1	O
,	28973643	1	O
which	28973643	1	O
included	28973643	1	O
a	28973643	1	O
significant	28973643	1	O
elevation	28973643	1	O
of	28973643	1	O
DLL4	28973643	1	O
expression	28973643	1	O
.	28973643	1	O
By	28973643	1	O
screening	28973643	1	O
the	28973643	1	O
NIH	28973643	1	O
clinical	28973643	1	O
collections	28973643	1	O
of	28973643	1	O
FDA	28973643	1	O
-	28973643	1	O
approved	28973643	1	O
drugs	28973643	1	O
,	28973643	1	O
we	28973643	1	O
identified	28973643	1	O
tacrolimus	28973643	1	O
(	28973643	1	O
FK-506	28973643	1	O
)	28973643	1	O
as	28973643	1	O
the	28973643	1	O
most	28973643	1	O
potent	28973643	1	O
activator	28973643	1	O
of	28973643	1	O
ALK1	28973643	1	O
signaling	28973643	1	O
in	28973643	1	O
BMP9	28973643	1	O
-	28973643	1	O
challenged	28973643	1	O
C2C12	28973643	1	O
reporter	28973643	1	O
cells	28973643	1	O
.	28973643	1	O
In	28973643	1	O
HUVECs	28973643	1	O
,	28973643	1	O
tacrolimus	28973643	1	O
activated	28973643	1	O
Smad1	28973643	1	O
/	28973643	1	O
5	28973643	1	O
/	28973643	1	O
8	28973643	1	O
and	28973643	1	O
opposed	28973643	1	O
the	28973643	1	O
pro	28973643	1	O
-	28973643	1	O
angiogenic	28973643	1	O
gene	28973643	1	O
expression	28973643	1	O
signature	28973643	1	O
associated	28973643	1	O
with	28973643	1	O
ALK1	28973643	1	O
loss	28973643	1	O
-	28973643	1	O
of	28973643	1	O
-	28973643	1	O
function	28973643	1	O
,	28973643	1	O
by	28973643	1	O
notably	28973643	1	O
reducing	28973643	1	O
Dll4	28973643	1	O
expression	28973643	1	O
.	28973643	1	O
In	28973643	1	O
these	28973643	1	O
cells	28973643	1	O
,	28973643	1	O
tacrolimus	28973643	1	O
also	28973643	1	O
inhibited	28973643	1	O
Akt	28973643	1	O
and	28973643	1	O
p38	28973643	1	O
stimulation	28973643	1	O
by	28973643	1	O
vascular	28973643	1	O
endothelial	28973643	1	O
growth	28973643	1	O
factor	28973643	1	O
,	28973643	1	O
a	28973643	1	O
major	28973643	1	O
driver	28973643	1	O
of	28973643	1	O
angiogenesis	28973643	1	O
.	28973643	1	O
In	28973643	1	O
the	28973643	1	O
BMP9	28973643	1	O
/	28973643	1	O
10	28973643	1	O
-	28973643	1	O
immunodepleted	28973643	1	O
postnatal	28973643	1	O
retina	28973643	1	O
-	28973643	1	O
a	28973643	1	O
mouse	28973643	1	O
model	28973643	1	O
of	28973643	1	O
HHT	28973643	1	O
vascular	28973643	1	O
pathology	28973643	1	O
-	28973643	1	O
tacrolimus	28973643	1	O
activated	28973643	1	O
endothelial	28973643	1	O
Smad1	28973643	1	O
/	28973643	1	O
5	28973643	1	O
/	28973643	1	O
8	28973643	1	O
and	28973643	1	O
prevented	28973643	1	O
the	28973643	1	O
Dll4	28973643	1	O
overexpression	28973643	1	O
and	28973643	1	O
hypervascularization	28973643	1	O
associated	28973643	1	O
with	28973643	1	O
this	28973643	1	O
model	28973643	1	O
.	28973643	1	O
Finally	28973643	1	O
,	28973643	1	O
tacrolimus	28973643	1	O
stimulated	28973643	1	O
Smad1	28973643	1	O
/	28973643	1	O
5	28973643	1	O
/	28973643	1	O
8	28973643	1	O
signaling	28973643	1	O
in	28973643	1	O
C2C12	28973643	1	O
cells	28973643	1	O
expressing	28973643	1	O
BMP9	28973643	1	O
-	28973643	1	O
unresponsive	28973643	1	O
ALK1	28973643	1	O
HHT	28973643	1	O
mutants	28973643	1	O
and	28973643	1	O
in	28973643	1	O
HHT	28973643	1	O
patient	28973643	1	O
blood	28973643	1	O
outgrowth	28973643	1	O
ECs	28973643	1	O
.	28973643	1	O
Tacrolimus	28973643	1	O
repurposing	28973643	1	O
has	28973643	1	O
therefore	28973643	1	O
therapeutic	28973643	1	O
potential	28973643	1	O
in	28973643	1	O
HHT	28973643	1	O
.	28973643	1	O

Zebrafish	28985365	1	O
cdc6	28985365	1	O
hypomorphic	28985365	1	O
mutation	28985365	1	O
causes	28985365	1	O
Meier	28985365	1	O
-	28985365	1	O
Gorlin	28985365	1	O
syndrome	28985365	1	O
-	28985365	1	O
like	28985365	1	O
phenotype	28985365	1	O
.	28985365	1	O
Cell	28985365	1	O
Division	28985365	1	O
Cycle	28985365	1	O
6	28985365	1	O
(	28985365	1	O
Cdc6	28985365	1	O
)	28985365	1	O
is	28985365	1	O
a	28985365	1	O
component	28985365	1	O
of	28985365	1	O
pre	28985365	1	O
-	28985365	1	O
replicative	28985365	1	O
complex	28985365	1	O
(	28985365	1	O
preRC	28985365	1	O
)	28985365	1	O
forming	28985365	1	O
on	28985365	1	O
DNA	28985365	1	O
replication	28985365	1	O
origins	28985365	1	O
in	28985365	1	O
eukaryotes	28985365	1	O
.	28985365	1	O
Recessive	28985365	1	O
mutations	28985365	1	B-Var
in	28985365	1	O
ORC1	28985365	1	B-Gene
,	28985365	1	O
ORC4	28985365	1	B-Gene
,	28985365	1	O
ORC6	28985365	1	B-Gene
,	28985365	1	O
CDT1	28985365	1	B-Gene
or	28985365	1	O
CDC6	28985365	1	B-Gene
of	28985365	1	O
the	28985365	1	O
preRC	28985365	1	O
in	28985365	1	O
human	28985365	1	O
cause	28985365	1	B-Reg
Meier	28985365	1	B-Disease
-	28985365	1	I-Disease
Gorlin	28985365	1	I-Disease
syndrome	28985365	1	I-Disease
(	28985365	1	O
MGS	28985365	1	O
)	28985365	1	O
that	28985365	1	O
is	28985365	1	O
characterized	28985365	1	O
by	28985365	1	O
impaired	28985365	1	O
post	28985365	1	O
-	28985365	1	O
natal	28985365	1	O
growth	28985365	1	O
,	28985365	1	O
short	28985365	1	O
stature	28985365	1	O
and	28985365	1	O
microcephaly	28985365	1	O
.	28985365	1	O
However	28985365	1	O
,	28985365	1	O
vertebrate	28985365	1	O
models	28985365	1	O
of	28985365	1	O
MGS	28985365	1	O
have	28985365	1	O
not	28985365	1	O
been	28985365	1	O
reported	28985365	1	O
.	28985365	1	O
Through	28985365	1	O
N	28985365	1	O
-	28985365	1	O
ethyl	28985365	1	O
-	28985365	1	O
N	28985365	1	O
-	28985365	1	O
nitrosourea	28985365	1	O
mutagenesis	28985365	1	O
and	28985365	1	O
Cas9	28985365	1	O
knockout	28985365	1	O
,	28985365	1	O
we	28985365	1	O
generate	28985365	1	O
several	28985365	1	O
cdc6	28985365	1	O
mutant	28985365	1	O
lines	28985365	1	O
in	28985365	1	O
zebrafish	28985365	1	O
.	28985365	1	O
Loss	28985365	1	B-NegReg
-	28985365	1	I-NegReg
of	28985365	1	I-NegReg
-	28985365	1	I-NegReg
function	28985365	1	I-NegReg
mutations	28985365	1	B-Var
of	28985365	1	O
cdc6	28985365	1	B-Gene
,	28985365	1	O
as	28985365	1	O
manifested	28985365	1	O
by	28985365	1	O
cdc6tsu4305	28985365	1	O
and	28985365	1	O
cdc6tsu7cd	28985365	1	O
mutants	28985365	1	O
,	28985365	1	O
lead	28985365	1	O
to	28985365	1	O
embryonic	28985365	1	O
lethality	28985365	1	O
due	28985365	1	O
to	28985365	1	O
cell	28985365	1	O
cycle	28985365	1	O
arrest	28985365	1	O
at	28985365	1	O
the	28985365	1	O
S	28985365	1	O
phase	28985365	1	O
and	28985365	1	O
extensive	28985365	1	O
apoptosis	28985365	1	O
.	28985365	1	O
Embryos	28985365	1	O
homozygous	28985365	1	O
for	28985365	1	O
a	28985365	1	O
cdc6	28985365	1	O
hypomorphic	28985365	1	O
mutation	28985365	1	O
,	28985365	1	O
cdc6tsu21cd	28985365	1	O
,	28985365	1	O
develop	28985365	1	O
normally	28985365	1	O
during	28985365	1	O
embryogenesis	28985365	1	O
.	28985365	1	O
Later	28985365	1	O
on	28985365	1	O
,	28985365	1	O
compared	28985365	1	O
with	28985365	1	O
their	28985365	1	O
wild	28985365	1	O
-	28985365	1	O
type	28985365	1	O
(	28985365	1	O
WT	28985365	1	O
)	28985365	1	O
siblings	28985365	1	O
,	28985365	1	O
cdc6tsu21cd	28985365	1	B-Var
mutant	28985365	1	I-Var
fish	28985365	1	O
show	28985365	1	O
growth	28985365	1	O
retardation	28985365	1	O
,	28985365	1	O
and	28985365	1	O
their	28985365	1	O
body	28985365	1	O
weight	28985365	1	O
and	28985365	1	O
length	28985365	1	O
in	28985365	1	O
adulthood	28985365	1	O
are	28985365	1	O
greatly	28985365	1	O
reduced	28985365	1	B-NegReg
,	28985365	1	O
which	28985365	1	O
resemble	28985365	1	O
human	28985365	1	O
MGS	28985365	1	O
.	28985365	1	O
Surprisingly	28985365	1	O
,	28985365	1	O
cdc6tsu21cd	28985365	1	B-Var
mutant	28985365	1	I-Var
fish	28985365	1	O
become	28985365	1	O
males	28985365	1	O
with	28985365	1	O
a	28985365	1	O
short	28985365	1	O
life	28985365	1	O
and	28985365	1	O
fail	28985365	1	O
to	28985365	1	O
mate	28985365	1	O
with	28985365	1	O
WT	28985365	1	O
females	28985365	1	O
,	28985365	1	O
suggesting	28985365	1	O
defective	28985365	1	B-NegReg
reproduction	28985365	1	O
.	28985365	1	O
Overexpression	28985365	1	O
of	28985365	1	O
Cdc6	28985365	1	O
mutant	28985365	1	O
forms	28985365	1	O
,	28985365	1	O
which	28985365	1	O
mimic	28985365	1	O
human	28985365	1	O
CDC6	28985365	1	B-Gene
(	28985365	1	I-Gene
T323R	28985365	1	I-Gene
)	28985365	1	I-Gene
mutation	28985365	1	B-Var
found	28985365	1	O
in	28985365	1	O
a	28985365	1	O
MGS	28985365	1	O
patient	28985365	1	O
,	28985365	1	O
in	28985365	1	O
zebrafish	28985365	1	O
cdc6tsu4305	28985365	1	O
mutant	28985365	1	O
embryos	28985365	1	O
partially	28985365	1	O
represses	28985365	1	B-NegReg
cell	28985365	1	O
death	28985365	1	O
phenotype	28985365	1	O
,	28985365	1	O
suggesting	28985365	1	O
that	28985365	1	O
the	28985365	1	O
human	28985365	1	O
CDC6	28985365	1	O
(	28985365	1	O
T323R	28985365	1	O
)	28985365	1	O
mutation	28985365	1	O
is	28985365	1	O
a	28985365	1	O
hypomorph	28985365	1	O
.	28985365	1	O
cdc6tsu21cd	28985365	1	O
mutant	28985365	1	O
fish	28985365	1	O
will	28985365	1	O
be	28985365	1	O
useful	28985365	1	O
to	28985365	1	O
detect	28985365	1	O
more	28985365	1	O
tissue	28985365	1	O
defects	28985365	1	O
and	28985365	1	O
develop	28985365	1	O
medical	28985365	1	O
treatment	28985365	1	O
strategies	28985365	1	O
for	28985365	1	O
MGS	28985365	1	O
patients	28985365	1	O
.	28985365	1	O

Three	28987752	2	O
Cases	28987752	2	O
of	28987752	2	O
KCNT1	28987752	2	O
Mutations	28987752	2	O
:	28987752	2	O
Malignant	28987752	2	O
Migrating	28987752	2	O
Partial	28987752	2	O
Seizures	28987752	2	O
in	28987752	2	O
Infancy	28987752	2	O
with	28987752	2	O
Massive	28987752	2	O
Systemic	28987752	2	O
to	28987752	2	O
Pulmonary	28987752	2	O
Collateral	28987752	2	O
Arteries	28987752	2	O
.	28987752	2	O
KCNT1	28987752	2	B-Gene
mutations	28987752	2	B-Var
are	28987752	2	O
gain	28987752	2	B-PosReg
-	28987752	2	I-PosReg
of	28987752	2	I-PosReg
-	28987752	2	I-PosReg
function	28987752	2	I-PosReg
mutations	28987752	2	O
in	28987752	2	O
potassium	28987752	2	O
channels	28987752	2	O
resulting	28987752	2	O
in	28987752	2	O
severe	28987752	2	O
infantile	28987752	2	B-Disease
epilepsy	28987752	2	I-Disease
.	28987752	2	O
Herein	28987752	2	O
we	28987752	2	O
describe	28987752	2	O
3	28987752	2	O
infants	28987752	2	O
with	28987752	2	O
malignant	28987752	2	O
migrating	28987752	2	O
partial	28987752	2	O
seizures	28987752	2	O
with	28987752	2	O
KCNT1	28987752	2	O
mutations	28987752	2	O
accompanied	28987752	2	O
by	28987752	2	O
massive	28987752	2	O
systemic	28987752	2	O
to	28987752	2	O
pulmonary	28987752	2	O
collateral	28987752	2	O
arteries	28987752	2	O
with	28987752	2	O
life	28987752	2	O
-	28987752	2	O
threatening	28987752	2	O
hemoptysis	28987752	2	O
and	28987752	2	O
heart	28987752	2	O
failure	28987752	2	O
.	28987752	2	O

Homozygous	28988429	1	B-Var
indel	28988429	1	I-Var
mutation	28988429	1	I-Var
in	28988429	1	O
CDH11	28988429	1	B-Gene
as	28988429	1	O
the	28988429	1	O
probable	28988429	1	O
cause	28988429	1	B-Reg
of	28988429	1	O
Elsahy	28988429	1	B-Disease
-	28988429	1	I-Disease
Waters	28988429	1	I-Disease
syndrome	28988429	1	I-Disease
.	28988429	1	O
Two	28988429	1	O
sisters	28988429	1	O
from	28988429	1	O
a	28988429	1	O
consanguineous	28988429	1	O
couple	28988429	1	O
were	28988429	1	O
seen	28988429	1	O
in	28988429	1	O
genetics	28988429	1	O
department	28988429	1	O
for	28988429	1	O
facial	28988429	1	O
dysmorphic	28988429	1	O
features	28988429	1	O
and	28988429	1	O
glaucoma	28988429	1	O
.	28988429	1	O
They	28988429	1	O
both	28988429	1	O
had	28988429	1	O
broad	28988429	1	O
foreheads	28988429	1	O
,	28988429	1	O
hypertelorism	28988429	1	O
,	28988429	1	O
megalocorneas	28988429	1	O
,	28988429	1	O
thick	28988429	1	O
eyebrows	28988429	1	O
with	28988429	1	O
synophrys	28988429	1	O
,	28988429	1	O
flat	28988429	1	O
malar	28988429	1	O
regions	28988429	1	O
,	28988429	1	O
broad	28988429	1	O
and	28988429	1	O
bulbous	28988429	1	O
noses	28988429	1	O
,	28988429	1	O
and	28988429	1	O
mild	28988429	1	O
prognathism	28988429	1	O
.	28988429	1	O
Both	28988429	1	O
had	28988429	1	O
glaucoma	28988429	1	O
,	28988429	1	O
younger	28988429	1	O
one	28988429	1	O
also	28988429	1	O
had	28988429	1	O
cataracts	28988429	1	O
and	28988429	1	O
phthisis	28988429	1	O
bulbi	28988429	1	O
.	28988429	1	O
Other	28988429	1	O
findings	28988429	1	O
included	28988429	1	O
bilateral	28988429	1	O
partial	28988429	1	O
cutaneous	28988429	1	O
syndactyly	28988429	1	O
of	28988429	1	O
2	28988429	1	O
nd	28988429	1	O
and	28988429	1	O
3	28988429	1	O
rd	28988429	1	O
fingers	28988429	1	O
,	28988429	1	O
history	28988429	1	O
of	28988429	1	O
impacted	28988429	1	O
teeth	28988429	1	O
with	28988429	1	O
dentigerous	28988429	1	O
cyst	28988429	1	O
in	28988429	1	O
the	28988429	1	O
elder	28988429	1	O
one	28988429	1	O
,	28988429	1	O
and	28988429	1	O
intellectual	28988429	1	O
disability	28988429	1	O
(	28988429	1	O
mild	28988429	1	O
and	28988429	1	O
borderline	28988429	1	O
)	28988429	1	O
.	28988429	1	O
The	28988429	1	O
sisters	28988429	1	O
were	28988429	1	O
considered	28988429	1	O
to	28988429	1	O
have	28988429	1	O
Elsahy	28988429	1	O
-	28988429	1	O
Waters	28988429	1	O
syndrome	28988429	1	O
.	28988429	1	O
In	28988429	1	O
order	28988429	1	O
to	28988429	1	O
elucidate	28988429	1	O
the	28988429	1	O
underlying	28988429	1	O
molecular	28988429	1	O
cause	28988429	1	O
,	28988429	1	O
sisters	28988429	1	O
and	28988429	1	O
their	28988429	1	O
healthy	28988429	1	O
parents	28988429	1	O
were	28988429	1	O
genotyped	28988429	1	O
by	28988429	1	O
SNP	28988429	1	O
arrays	28988429	1	O
,	28988429	1	O
followed	28988429	1	O
by	28988429	1	O
homozygosity	28988429	1	O
mapping	28988429	1	O
.	28988429	1	O
Homozygous	28988429	1	O
regions	28988429	1	O
were	28988429	1	O
further	28988429	1	O
analyzed	28988429	1	O
by	28988429	1	O
exome	28988429	1	O
sequencing	28988429	1	O
in	28988429	1	O
one	28988429	1	O
affected	28988429	1	O
individual	28988429	1	O
.	28988429	1	O
A	28988429	1	O
homozygous	28988429	1	O
indel	28988429	1	O
variant	28988429	1	O
segregating	28988429	1	O
with	28988429	1	O
the	28988429	1	O
condition	28988429	1	O
was	28988429	1	O
detected	28988429	1	O
in	28988429	1	O
CDH11	28988429	1	O
(	28988429	1	O
c.1116	28988429	1	O
_1117delinsGATCATCAG	28988429	1	O
,	28988429	1	O
p.(Ile372MetfsTer9)	28988429	1	O
)	28988429	1	O
,	28988429	1	O
which	28988429	1	O
was	28988429	1	O
then	28988429	1	O
validated	28988429	1	O
by	28988429	1	O
using	28988429	1	O
Sanger	28988429	1	O
sequencing	28988429	1	O
.	28988429	1	O
CDH11	28988429	1	O
encodes	28988429	1	O
cadherin	28988429	1	O
11	28988429	1	O
(	28988429	1	O
osteo	28988429	1	O
-	28988429	1	O
cadherin	28988429	1	O
)	28988429	1	O
that	28988429	1	O
regulates	28988429	1	O
cell	28988429	1	O
-	28988429	1	O
cell	28988429	1	O
adhesion	28988429	1	O
,	28988429	1	O
cell	28988429	1	O
polarization	28988429	1	O
and	28988429	1	O
migration	28988429	1	O
,	28988429	1	O
as	28988429	1	O
well	28988429	1	O
as	28988429	1	O
osteogenic	28988429	1	O
differentiation	28988429	1	O
.	28988429	1	O
Further	28988429	1	O
experiments	28988429	1	O
revealed	28988429	1	O
that	28988429	1	O
CDH11	28988429	1	O
expression	28988429	1	O
was	28988429	1	O
decreased	28988429	1	O
in	28988429	1	O
patient	28988429	1	O
-	28988429	1	O
derived	28988429	1	O
fibroblasts	28988429	1	O
as	28988429	1	O
compared	28988429	1	O
to	28988429	1	O
the	28988429	1	O
heterozygous	28988429	1	O
parent	28988429	1	O
and	28988429	1	O
another	28988429	1	O
healthy	28988429	1	O
donor	28988429	1	O
.	28988429	1	O
Immunostaining	28988429	1	O
showed	28988429	1	O
absence	28988429	1	O
of	28988429	1	O
the	28988429	1	O
protein	28988429	1	O
expression	28988429	1	O
in	28988429	1	O
patient	28988429	1	O
fibroblasts	28988429	1	O
.	28988429	1	O
In	28988429	1	O
addition	28988429	1	O
,	28988429	1	O
cell	28988429	1	O
proliferation	28988429	1	O
rate	28988429	1	O
was	28988429	1	O
slow	28988429	1	B-NegReg
and	28988429	1	O
osteogenic	28988429	1	O
differentiation	28988429	1	O
potential	28988429	1	O
was	28988429	1	O
delayed	28988429	1	B-NegReg
.	28988429	1	O
We	28988429	1	O
consider	28988429	1	O
that	28988429	1	O
this	28988429	1	O
study	28988429	1	O
reveals	28988429	1	O
loss	28988429	1	O
-	28988429	1	O
of	28988429	1	O
-	28988429	1	O
function	28988429	1	O
mutations	28988429	1	B-Var
in	28988429	1	O
CDH11	28988429	1	B-Gene
as	28988429	1	O
a	28988429	1	O
probable	28988429	1	O
cause	28988429	1	O
of	28988429	1	O
this	28988429	1	O
phenotype	28988429	1	O
.	28988429	1	O
Next	28988429	1	O
generation	28988429	1	O
sequencing	28988429	1	O
in	28988429	1	O
further	28988429	1	O
patients	28988429	1	O
would	28988429	1	O
both	28988429	1	O
prove	28988429	1	O
this	28988429	1	O
gene	28988429	1	O
as	28988429	1	O
causative	28988429	1	O
,	28988429	1	O
and	28988429	1	O
finely	28988429	1	O
delineate	28988429	1	O
this	28988429	1	O
clinical	28988429	1	O
spectrum	28988429	1	O
further	28988429	1	O
contributing	28988429	1	O
in	28988429	1	O
identification	28988429	1	O
of	28988429	1	O
other	28988429	1	O
possibly	28988429	1	O
involved	28988429	1	O
gene	28988429	1	O
(	28988429	1	O
s	28988429	1	O
)	28988429	1	O
.	28988429	1	O

The	29016901	0	O
Roles	29016901	0	O
of	29016901	0	O
the	29016901	0	O
Sole	29016901	0	O
Activator	29016901	0	O
-	29016901	0	O
Type	29016901	0	O
Auxin	29016901	0	O
Response	29016901	0	O
Factor	29016901	0	O
in	29016901	0	O
Pattern	29016901	0	O
Formation	29016901	0	O
of	29016901	0	O
Marchantia	29016901	0	O
polymorpha	29016901	0	O
.	29016901	0	O
Cell	29016901	0	O
division	29016901	0	O
patterning	29016901	0	O
is	29016901	0	O
important	29016901	0	O
to	29016901	0	O
determine	29016901	0	O
body	29016901	0	O
shape	29016901	0	O
in	29016901	0	O
plants	29016901	0	O
.	29016901	0	O
Nuclear	29016901	0	O
auxin	29016901	0	O
signaling	29016901	0	O
mediated	29016901	0	O
by	29016901	0	O
AUXIN	29016901	0	O
RESPONSE	29016901	0	O
FACTOR	29016901	0	O
(	29016901	0	O
ARF	29016901	0	O
)	29016901	0	O
transcription	29016901	0	O
factors	29016901	0	O
affects	29016901	0	O
plant	29016901	0	O
growth	29016901	0	O
and	29016901	0	O
development	29016901	0	O
through	29016901	0	O
regulation	29016901	0	O
of	29016901	0	O
cell	29016901	0	O
division	29016901	0	O
,	29016901	0	O
elongation	29016901	0	O
and	29016901	0	O
differentiation	29016901	0	O
.	29016901	0	O
The	29016901	0	O
evolutionary	29016901	0	O
origin	29016901	0	O
of	29016901	0	O
the	29016901	0	O
ARF	29016901	0	O
-	29016901	0	O
mediated	29016901	0	O
pathway	29016901	0	O
dates	29016901	0	O
back	29016901	0	O
to	29016901	0	O
at	29016901	0	O
least	29016901	0	O
the	29016901	0	O
common	29016901	0	O
ancestor	29016901	0	O
of	29016901	0	O
bryophytes	29016901	0	O
and	29016901	0	O
other	29016901	0	O
land	29016901	0	O
plants	29016901	0	O
.	29016901	0	O
The	29016901	0	O
liverwort	29016901	0	O
Marchantia	29016901	0	O
polymorpha	29016901	0	O
has	29016901	0	O
three	29016901	0	O
phylogenetically	29016901	0	O
distinct	29016901	0	O
ARFs	29016901	0	O
:	29016901	0	O
MpARF1	29016901	0	O
,	29016901	0	O
the	29016901	0	O
sole	29016901	0	O
'	29016901	0	O
activator	29016901	0	O
'	29016901	0	O
ARF	29016901	0	O
;	29016901	0	O
and	29016901	0	O
MpARF2	29016901	0	O
and	29016901	0	O
MpARF3	29016901	0	O
,	29016901	0	O
two	29016901	0	O
'	29016901	0	O
repressor	29016901	0	O
'	29016901	0	O
ARFs	29016901	0	O
.	29016901	0	O
Genetic	29016901	0	O
screens	29016901	0	O
for	29016901	0	O
auxin	29016901	0	O
-	29016901	0	O
resistant	29016901	0	O
mutants	29016901	0	O
revealed	29016901	0	O
that	29016901	0	O
loss	29016901	0	O
of	29016901	0	O
MpARF1	29016901	0	O
function	29016901	0	O
conferred	29016901	0	O
auxin	29016901	0	O
insensitivity	29016901	0	O
.	29016901	0	O
Mparf1	29016901	0	B-Gene
mutants	29016901	0	B-Var
showed	29016901	0	O
reduced	29016901	0	B-NegReg
auxin	29016901	0	B-Gene
-	29016901	0	I-Gene
inducible	29016901	0	I-Gene
gene	29016901	0	I-Gene
expression	29016901	0	O
and	29016901	0	O
various	29016901	0	O
developmental	29016901	0	O
defects	29016901	0	O
,	29016901	0	O
including	29016901	0	O
thallus	29016901	0	O
twisting	29016901	0	O
and	29016901	0	O
gemma	29016901	0	O
malformation	29016901	0	O
.	29016901	0	O
We	29016901	0	O
further	29016901	0	O
investigated	29016901	0	O
the	29016901	0	O
role	29016901	0	O
of	29016901	0	O
MpARF1	29016901	0	O
in	29016901	0	O
gemma	29016901	0	O
development	29016901	0	O
,	29016901	0	O
which	29016901	0	O
is	29016901	0	O
traceable	29016901	0	O
at	29016901	0	O
the	29016901	0	O
cellular	29016901	0	O
level	29016901	0	O
.	29016901	0	O
In	29016901	0	O
wild	29016901	0	O
-	29016901	0	O
type	29016901	0	O
plants	29016901	0	O
,	29016901	0	O
a	29016901	0	O
gemma	29016901	0	O
initial	29016901	0	O
first	29016901	0	O
undergoes	29016901	0	O
several	29016901	0	O
transverse	29016901	0	O
divisions	29016901	0	O
to	29016901	0	O
generate	29016901	0	O
a	29016901	0	O
single	29016901	0	O
-	29016901	0	O
celled	29016901	0	O
stalk	29016901	0	O
and	29016901	0	O
a	29016901	0	O
gemma	29016901	0	O
proper	29016901	0	O
,	29016901	0	O
followed	29016901	0	O
by	29016901	0	O
rather	29016901	0	O
synchronous	29016901	0	O
longitudinal	29016901	0	O
divisions	29016901	0	O
in	29016901	0	O
the	29016901	0	O
latter	29016901	0	O
.	29016901	0	O
Mparf1	29016901	0	O
mutants	29016901	0	O
often	29016901	0	O
contained	29016901	0	O
multicelled	29016901	0	O
stalks	29016901	0	O
and	29016901	0	O
showed	29016901	0	O
defects	29016901	0	O
in	29016901	0	O
the	29016901	0	O
execution	29016901	0	O
and	29016901	0	O
timing	29016901	0	O
of	29016901	0	O
the	29016901	0	O
longitudinal	29016901	0	O
divisions	29016901	0	O
.	29016901	0	O
While	29016901	0	O
wild	29016901	0	O
-	29016901	0	O
type	29016901	0	O
gemmae	29016901	0	O
finally	29016901	0	O
generate	29016901	0	O
two	29016901	0	O
meristem	29016901	0	O
notches	29016901	0	O
,	29016901	0	O
Mparf1	29016901	0	O
gemmae	29016901	0	O
displayed	29016901	0	O
various	29016901	0	O
numbers	29016901	0	O
of	29016901	0	O
ectopic	29016901	0	O
meristems	29016901	0	O
.	29016901	0	O
These	29016901	0	O
results	29016901	0	O
suggest	29016901	0	O
that	29016901	0	O
MpARF1	29016901	0	O
regulates	29016901	0	O
formative	29016901	0	O
cell	29016901	0	O
divisions	29016901	0	O
and	29016901	0	O
axis	29016901	0	O
formation	29016901	0	O
through	29016901	0	O
auxin	29016901	0	O
responses	29016901	0	O
.	29016901	0	O
The	29016901	0	O
mechanism	29016901	0	O
for	29016901	0	O
activator	29016901	0	O
ARF	29016901	0	O
regulation	29016901	0	O
of	29016901	0	O
pattern	29016901	0	O
formation	29016901	0	O
may	29016901	0	O
be	29016901	0	O
shared	29016901	0	O
in	29016901	0	O
land	29016901	0	O
plants	29016901	0	O
and	29016901	0	O
therefore	29016901	0	O
important	29016901	0	O
for	29016901	0	O
the	29016901	0	O
general	29016901	0	O
acquisition	29016901	0	O
of	29016901	0	O
three	29016901	0	O
-	29016901	0	O
dimensional	29016901	0	O
body	29016901	0	O
plans	29016901	0	O
.	29016901	0	O

Loss	29019082	0	O
of	29019082	0	O
the	29019082	0	O
nutrient	29019082	0	O
sensor	29019082	0	O
TAS1R3	29019082	0	O
leads	29019082	0	O
to	29019082	0	O
reduced	29019082	0	O
bone	29019082	0	O
resorption	29019082	0	O
.	29019082	0	O
The	29019082	0	O
taste	29019082	0	O
receptor	29019082	0	O
type	29019082	0	O
1	29019082	0	O
(	29019082	0	O
TAS1R	29019082	0	O
)	29019082	0	O
family	29019082	0	O
of	29019082	0	O
heterotrimeric	29019082	0	O
G	29019082	0	O
protein	29019082	0	O
-	29019082	0	O
coupled	29019082	0	O
receptors	29019082	0	O
participates	29019082	0	O
in	29019082	0	O
monitoring	29019082	0	O
energy	29019082	0	O
and	29019082	0	O
nutrient	29019082	0	O
status	29019082	0	O
.	29019082	0	O
TAS1R	29019082	0	O
member	29019082	0	O
3	29019082	0	O
(	29019082	0	O
TAS1R3	29019082	0	O
)	29019082	0	O
is	29019082	0	O
a	29019082	0	O
bi	29019082	0	O
-	29019082	0	O
functional	29019082	0	O
protein	29019082	0	O
that	29019082	0	O
recognizes	29019082	0	O
amino	29019082	0	O
acids	29019082	0	O
such	29019082	0	O
as	29019082	0	O
L	29019082	0	O
-	29019082	0	O
glycine	29019082	0	O
and	29019082	0	O
L	29019082	0	O
-	29019082	0	O
glutamate	29019082	0	O
or	29019082	0	O
sweet	29019082	0	O
molecules	29019082	0	O
such	29019082	0	O
as	29019082	0	O
sucrose	29019082	0	O
and	29019082	0	O
fructose	29019082	0	O
when	29019082	0	O
dimerized	29019082	0	O
with	29019082	0	O
TAS1R	29019082	0	O
member	29019082	0	O
1	29019082	0	O
(	29019082	0	O
TAS1R1	29019082	0	O
)	29019082	0	O
or	29019082	0	O
TAS1R	29019082	0	O
member	29019082	0	O
2	29019082	0	O
(	29019082	0	O
TAS1R2	29019082	0	O
)	29019082	0	O
,	29019082	0	O
respectively	29019082	0	O
.	29019082	0	O
It	29019082	0	O
was	29019082	0	O
recently	29019082	0	O
reported	29019082	0	O
that	29019082	0	O
deletion	29019082	0	B-Var
of	29019082	0	O
TAS1R3	29019082	0	B-Gene
expression	29019082	0	O
in	29019082	0	O
Tas1R3	29019082	0	O
mutant	29019082	0	O
mice	29019082	0	O
leads	29019082	0	O
to	29019082	0	O
increased	29019082	0	B-PosReg
cortical	29019082	0	O
bone	29019082	0	O
mass	29019082	0	O
but	29019082	0	O
the	29019082	0	O
underlying	29019082	0	O
cellular	29019082	0	O
mechanism	29019082	0	O
leading	29019082	0	O
to	29019082	0	O
this	29019082	0	O
phenotype	29019082	0	O
remains	29019082	0	O
unclear	29019082	0	O
.	29019082	0	O
Here	29019082	0	O
,	29019082	0	O
we	29019082	0	O
independently	29019082	0	O
corroborate	29019082	0	O
the	29019082	0	O
increased	29019082	0	B-PosReg
thickness	29019082	0	O
of	29019082	0	O
cortical	29019082	0	O
bone	29019082	0	O
in	29019082	0	O
femurs	29019082	0	O
of	29019082	0	O
20	29019082	0	O
-	29019082	0	O
week	29019082	0	O
-	29019082	0	O
old	29019082	0	O
male	29019082	0	O
Tas1R3	29019082	0	B-Gene
mutant	29019082	0	B-Var
mice	29019082	0	O
and	29019082	0	O
confirm	29019082	0	O
that	29019082	0	O
Tas1R3	29019082	0	O
is	29019082	0	O
expressed	29019082	0	O
in	29019082	0	O
the	29019082	0	O
bone	29019082	0	O
environment	29019082	0	O
.	29019082	0	O
Tas1R3	29019082	0	O
is	29019082	0	O
expressed	29019082	0	O
in	29019082	0	O
undifferentiated	29019082	0	O
bone	29019082	0	O
marrow	29019082	0	O
stromal	29019082	0	O
cells	29019082	0	O
(	29019082	0	O
BMSCs	29019082	0	O
)	29019082	0	O
in	29019082	0	O
vitro	29019082	0	O
and	29019082	0	O
its	29019082	0	O
expression	29019082	0	O
is	29019082	0	O
maintained	29019082	0	O
during	29019082	0	O
BMP2	29019082	0	O
-	29019082	0	O
induced	29019082	0	O
osteogenic	29019082	0	O
differentiation	29019082	0	O
.	29019082	0	O
However	29019082	0	O
,	29019082	0	O
levels	29019082	0	O
of	29019082	0	O
the	29019082	0	O
bone	29019082	0	O
formation	29019082	0	O
marker	29019082	0	O
procollagen	29019082	0	O
type	29019082	0	O
I	29019082	0	O
N	29019082	0	O
-	29019082	0	O
terminal	29019082	0	O
propeptide	29019082	0	O
(	29019082	0	O
PINP	29019082	0	O
)	29019082	0	O
are	29019082	0	O
unchanged	29019082	0	O
in	29019082	0	O
the	29019082	0	O
serum	29019082	0	O
of	29019082	0	O
20	29019082	0	O
-	29019082	0	O
week	29019082	0	O
-	29019082	0	O
old	29019082	0	O
Tas1R3	29019082	0	O
mutant	29019082	0	O
mice	29019082	0	O
as	29019082	0	O
compared	29019082	0	O
to	29019082	0	O
controls	29019082	0	O
.	29019082	0	O
In	29019082	0	O
contrast	29019082	0	O
,	29019082	0	O
levels	29019082	0	O
of	29019082	0	O
the	29019082	0	O
bone	29019082	0	O
resorption	29019082	0	O
marker	29019082	0	O
collagen	29019082	0	O
type	29019082	0	O
I	29019082	0	O
C	29019082	0	O
-	29019082	0	O
telopeptide	29019082	0	O
are	29019082	0	O
reduced	29019082	0	B-NegReg
greater	29019082	0	O
than	29019082	0	O
60%	29019082	0	O
in	29019082	0	O
Tas1R3	29019082	0	B-Gene
mutant	29019082	0	B-Var
mice	29019082	0	O
.	29019082	0	O
Consistent	29019082	0	O
with	29019082	0	O
this	29019082	0	O
,	29019082	0	O
Tas1R3	29019082	0	O
and	29019082	0	O
its	29019082	0	O
putative	29019082	0	O
signaling	29019082	0	O
partner	29019082	0	O
Tas1R2	29019082	0	O
are	29019082	0	O
expressed	29019082	0	O
in	29019082	0	O
primary	29019082	0	O
osteoclasts	29019082	0	O
and	29019082	0	O
their	29019082	0	O
expression	29019082	0	O
levels	29019082	0	O
positively	29019082	0	O
correlate	29019082	0	O
with	29019082	0	O
differentiation	29019082	0	O
status	29019082	0	O
.	29019082	0	O
Collectively	29019082	0	O
,	29019082	0	O
these	29019082	0	O
findings	29019082	0	O
suggest	29019082	0	O
that	29019082	0	O
high	29019082	0	B-PosReg
bone	29019082	0	O
mass	29019082	0	O
in	29019082	0	O
Tas1R3	29019082	0	B-Gene
mutant	29019082	0	B-Var
mice	29019082	0	O
is	29019082	0	O
due	29019082	0	O
to	29019082	0	O
uncoupled	29019082	0	O
bone	29019082	0	O
remodeling	29019082	0	O
with	29019082	0	O
reduced	29019082	0	B-NegReg
osteoclast	29019082	0	O
function	29019082	0	O
and	29019082	0	O
provide	29019082	0	O
rationale	29019082	0	O
for	29019082	0	O
future	29019082	0	O
experiments	29019082	0	O
examining	29019082	0	O
the	29019082	0	O
cell	29019082	0	O
-	29019082	0	O
type	29019082	0	O
-	29019082	0	O
dependent	29019082	0	O
role	29019082	0	O
for	29019082	0	O
TAS1R	29019082	0	O
family	29019082	0	O
members	29019082	0	O
in	29019082	0	O
nutrient	29019082	0	O
sensing	29019082	0	O
in	29019082	0	O
postnatal	29019082	0	O
bone	29019082	0	O
remodeling	29019082	0	O
.	29019082	0	O

Molecular	29024003	0	O
characterization	29024003	0	O
of	29024003	0	O
the	29024003	0	O
llama	29024003	0	O
FGF5	29024003	0	O
gene	29024003	0	O
and	29024003	0	O
identification	29024003	0	O
of	29024003	0	O
putative	29024003	0	O
loss	29024003	0	O
of	29024003	0	O
function	29024003	0	O
mutations	29024003	0	O
.	29024003	0	O
Llama	29024003	0	O
,	29024003	0	O
the	29024003	0	O
most	29024003	0	O
numerous	29024003	0	O
domestic	29024003	0	O
camelid	29024003	0	O
in	29024003	0	O
Argentina	29024003	0	O
,	29024003	0	O
has	29024003	0	O
good	29024003	0	O
fiber	29024003	0	O
-	29024003	0	O
production	29024003	0	O
ability	29024003	0	O
.	29024003	0	O
Although	29024003	0	O
a	29024003	0	O
few	29024003	0	O
genes	29024003	0	O
related	29024003	0	O
to	29024003	0	O
other	29024003	0	O
productive	29024003	0	O
traits	29024003	0	O
have	29024003	0	O
been	29024003	0	O
characterized	29024003	0	O
,	29024003	0	O
the	29024003	0	O
molecular	29024003	0	O
genetic	29024003	0	O
basis	29024003	0	O
of	29024003	0	O
fiber	29024003	0	O
growth	29024003	0	O
control	29024003	0	O
in	29024003	0	O
camelids	29024003	0	O
is	29024003	0	O
still	29024003	0	O
poorly	29024003	0	O
understood	29024003	0	O
.	29024003	0	O
Fibroblast	29024003	0	O
growth	29024003	0	O
factor	29024003	0	O
5	29024003	0	O
(	29024003	0	O
FGF5	29024003	0	O
)	29024003	0	O
is	29024003	0	O
a	29024003	0	O
secreted	29024003	0	O
signaling	29024003	0	O
protein	29024003	0	O
that	29024003	0	O
controls	29024003	0	O
hair	29024003	0	O
growth	29024003	0	O
in	29024003	0	O
humans	29024003	0	O
and	29024003	0	O
other	29024003	0	O
mammals	29024003	0	O
.	29024003	0	O
Mutations	29024003	0	O
in	29024003	0	O
the	29024003	0	O
FGF5	29024003	0	O
gene	29024003	0	O
have	29024003	0	O
been	29024003	0	O
associated	29024003	0	O
with	29024003	0	O
long	29024003	0	O
-	29024003	0	O
hair	29024003	0	O
phenotypes	29024003	0	O
in	29024003	0	O
several	29024003	0	O
species	29024003	0	O
.	29024003	0	O
Here	29024003	0	O
,	29024003	0	O
we	29024003	0	O
sequenced	29024003	0	O
the	29024003	0	O
llama	29024003	0	O
FGF5	29024003	0	O
gene	29024003	0	O
,	29024003	0	O
which	29024003	0	O
consists	29024003	0	O
of	29024003	0	O
three	29024003	0	O
exons	29024003	0	O
encoding	29024003	0	O
813	29024003	0	O
bp	29024003	0	O
.	29024003	0	O
cDNA	29024003	0	O
analysis	29024003	0	O
from	29024003	0	O
hair	29024003	0	O
follicles	29024003	0	O
revealed	29024003	0	O
the	29024003	0	O
expression	29024003	0	O
of	29024003	0	O
two	29024003	0	O
FGF5	29024003	0	O
alternative	29024003	0	O
spliced	29024003	0	O
transcripts	29024003	0	O
,	29024003	0	O
in	29024003	0	O
one	29024003	0	O
of	29024003	0	O
which	29024003	0	O
exon	29024003	0	O
2	29024003	0	O
is	29024003	0	O
absent	29024003	0	O
.	29024003	0	O
DNA	29024003	0	O
variation	29024003	0	O
analysis	29024003	0	O
showed	29024003	0	O
four	29024003	0	O
polymorphisms	29024003	0	O
in	29024003	0	O
the	29024003	0	O
coding	29024003	0	O
region	29024003	0	O
:	29024003	0	O
a	29024003	0	O
synonymous	29024003	0	O
SNP	29024003	0	O
(	29024003	0	O
c.210	29024003	0	O
A	29024003	0	O
>	29024003	0	O
G	29024003	0	O
)	29024003	0	O
,	29024003	0	O
a	29024003	0	O
single	29024003	0	O
base	29024003	0	O
deletion	29024003	0	O
(	29024003	0	B-Var
c.348	29024003	0	I-Var
delA	29024003	0	I-Var
)	29024003	0	I-Var
,	29024003	0	O
a	29024003	0	O
12	29024003	0	O
-	29024003	0	O
bp	29024003	0	O
insertion	29024003	0	O
(	29024003	0	O
c.351	29024003	0	O
_352insCATATAACATAG	29024003	0	O
)	29024003	0	O
and	29024003	0	O
a	29024003	0	O
non	29024003	0	O
-	29024003	0	O
sense	29024003	0	O
mutation	29024003	0	O
(	29024003	0	O
c.499	29024003	0	O
C	29024003	0	O
>	29024003	0	O
T	29024003	0	O
)	29024003	0	O
.	29024003	0	O
The	29024003	0	O
deletion	29024003	0	O
was	29024003	0	O
always	29024003	0	O
found	29024003	0	O
together	29024003	0	O
with	29024003	0	O
the	29024003	0	O
insertion	29024003	0	O
forming	29024003	0	O
a	29024003	0	O
haplotype	29024003	0	O
and	29024003	0	O
producing	29024003	0	O
a	29024003	0	O
putative	29024003	0	O
truncated	29024003	0	O
protein	29024003	0	O
of	29024003	0	O
123	29024003	0	O
amino	29024003	0	O
acids	29024003	0	O
.	29024003	0	O
The	29024003	0	O
c.499	29024003	0	B-Var
C	29024003	0	I-Var
>	29024003	0	I-Var
T	29024003	0	I-Var
mutation	29024003	0	O
also	29024003	0	O
leads	29024003	0	O
to	29024003	0	O
a	29024003	0	O
premature	29024003	0	O
stop	29024003	0	O
codon	29024003	0	O
at	29024003	0	O
position	29024003	0	O
168	29024003	0	O
.	29024003	0	O
In	29024003	0	O
both	29024003	0	O
cases	29024003	0	O
,	29024003	0	O
critical	29024003	0	O
functional	29024003	0	O
domains	29024003	0	O
of	29024003	0	O
FGF5	29024003	0	B-Gene
,	29024003	0	O
including	29024003	0	O
one	29024003	0	O
heparin	29024003	0	O
binding	29024003	0	O
site	29024003	0	O
,	29024003	0	O
are	29024003	0	O
lost	29024003	0	B-NegReg
.	29024003	0	O
All	29024003	0	O
animals	29024003	0	O
analyzed	29024003	0	O
were	29024003	0	O
homozygous	29024003	0	O
for	29024003	0	O
one	29024003	0	O
of	29024003	0	O
the	29024003	0	O
deleterious	29024003	0	O
mutations	29024003	0	O
or	29024003	0	O
compound	29024003	0	O
heterozygous	29024003	0	O
for	29024003	0	O
both	29024003	0	O
(	29024003	0	O
i.e.	29024003	0	O
c.348	29024003	0	O
delA	29024003	0	O
,	29024003	0	O
c.351	29024003	0	O
_352insCATATAACATAG	29024003	0	O
/	29024003	0	O
c.499	29024003	0	O
T	29024003	0	O
)	29024003	0	O
.	29024003	0	O
Sequencing	29024003	0	O
of	29024003	0	O
guanaco	29024003	0	O
samples	29024003	0	O
showed	29024003	0	O
that	29024003	0	O
the	29024003	0	O
FGF5	29024003	0	O
gene	29024003	0	O
encodes	29024003	0	O
a	29024003	0	O
full	29024003	0	O
-	29024003	0	O
length	29024003	0	O
270	29024003	0	O
-	29024003	0	O
amino	29024003	0	O
acid	29024003	0	O
protein	29024003	0	O
.	29024003	0	O
These	29024003	0	O
results	29024003	0	O
suggest	29024003	0	O
that	29024003	0	O
FGF5	29024003	0	O
is	29024003	0	O
likely	29024003	0	O
functional	29024003	0	O
in	29024003	0	O
short	29024003	0	O
-	29024003	0	O
haired	29024003	0	O
wild	29024003	0	O
species	29024003	0	O
and	29024003	0	O
non	29024003	0	O
-	29024003	0	O
functional	29024003	0	O
in	29024003	0	O
the	29024003	0	O
domestic	29024003	0	O
fiber	29024003	0	O
-	29024003	0	O
producing	29024003	0	O
species	29024003	0	O
,	29024003	0	O
the	29024003	0	O
llama	29024003	0	O
.	29024003	0	O

Differential	29024177	1	O
regulation	29024177	1	O
of	29024177	1	O
two	29024177	1	O
FLNA	29024177	1	O
transcripts	29024177	1	O
explains	29024177	1	O
some	29024177	1	O
of	29024177	1	O
the	29024177	1	O
phenotypic	29024177	1	O
heterogeneity	29024177	1	O
in	29024177	1	O
the	29024177	1	O
loss	29024177	1	O
-	29024177	1	O
of	29024177	1	O
-	29024177	1	O
function	29024177	1	O
filaminopathies	29024177	1	O
.	29024177	1	O
Loss	29024177	1	B-NegReg
-	29024177	1	I-NegReg
of	29024177	1	I-NegReg
-	29024177	1	I-NegReg
function	29024177	1	I-NegReg
mutations	29024177	1	B-Var
in	29024177	1	O
the	29024177	1	O
X	29024177	1	O
-	29024177	1	O
linked	29024177	1	O
gene	29024177	1	O
FLNA	29024177	1	B-Gene
can	29024177	1	O
lead	29024177	1	O
to	29024177	1	O
abnormal	29024177	1	O
neuronal	29024177	1	O
migration	29024177	1	O
,	29024177	1	O
vascular	29024177	1	O
and	29024177	1	O
cardiac	29024177	1	O
defects	29024177	1	O
,	29024177	1	O
and	29024177	1	O
congenital	29024177	1	B-Disease
intestinal	29024177	1	I-Disease
pseudo	29024177	1	I-Disease
-	29024177	1	I-Disease
obstruction	29024177	1	I-Disease
(	29024177	1	O
CIPO	29024177	1	O
)	29024177	1	O
,	29024177	1	O
the	29024177	1	O
latter	29024177	1	O
characterized	29024177	1	O
by	29024177	1	O
anomalous	29024177	1	O
intestinal	29024177	1	O
smooth	29024177	1	O
muscle	29024177	1	O
layering	29024177	1	O
.	29024177	1	O
Survival	29024177	1	O
in	29024177	1	O
male	29024177	1	O
hemizygotes	29024177	1	O
for	29024177	1	O
such	29024177	1	O
mutations	29024177	1	O
is	29024177	1	O
dependent	29024177	1	O
on	29024177	1	O
retention	29024177	1	O
of	29024177	1	O
residual	29024177	1	O
FLNA	29024177	1	O
function	29024177	1	O
but	29024177	1	O
it	29024177	1	O
is	29024177	1	O
unclear	29024177	1	O
why	29024177	1	O
a	29024177	1	O
subgroup	29024177	1	O
of	29024177	1	O
males	29024177	1	O
with	29024177	1	O
mutations	29024177	1	O
in	29024177	1	O
the	29024177	1	O
5	29024177	1	O
'	29024177	1	O
end	29024177	1	O
of	29024177	1	O
the	29024177	1	O
gene	29024177	1	O
can	29024177	1	O
present	29024177	1	O
with	29024177	1	O
CIPO	29024177	1	O
alone	29024177	1	O
.	29024177	1	O
Here	29024177	1	O
,	29024177	1	O
we	29024177	1	O
demonstrate	29024177	1	O
evidence	29024177	1	O
for	29024177	1	O
the	29024177	1	O
presence	29024177	1	O
of	29024177	1	O
two	29024177	1	O
FLNA	29024177	1	O
isoforms	29024177	1	O
differing	29024177	1	O
by	29024177	1	O
28	29024177	1	O
residues	29024177	1	O
at	29024177	1	O
the	29024177	1	O
N	29024177	1	O
-	29024177	1	O
terminus	29024177	1	O
initiated	29024177	1	O
at	29024177	1	O
ATG	29024177	1	O
1	29024177	1	O
and	29024177	1	O
ATG	29024177	1	O
82	29024177	1	O
.	29024177	1	O
A	29024177	1	O
male	29024177	1	O
with	29024177	1	O
CIPO	29024177	1	O
(	29024177	1	O
c.18	29024177	1	O
_19del	29024177	1	O
)	29024177	1	O
exclusively	29024177	1	O
expressed	29024177	1	O
FLNA	29024177	1	O
ATG	29024177	1	O
82	29024177	1	O
,	29024177	1	O
implicating	29024177	1	O
the	29024177	1	O
longer	29024177	1	O
protein	29024177	1	O
isoform	29024177	1	O
(	29024177	1	O
ATG	29024177	1	O
1	29024177	1	O
)	29024177	1	O
in	29024177	1	O
smooth	29024177	1	O
muscle	29024177	1	O
development	29024177	1	O
.	29024177	1	O
In	29024177	1	O
contrast	29024177	1	O
,	29024177	1	O
mutations	29024177	1	O
leading	29024177	1	O
to	29024177	1	O
reduction	29024177	1	O
of	29024177	1	O
both	29024177	1	O
isoforms	29024177	1	O
are	29024177	1	O
associated	29024177	1	O
with	29024177	1	O
compound	29024177	1	O
phenotypes	29024177	1	O
affecting	29024177	1	O
the	29024177	1	O
brain	29024177	1	O
,	29024177	1	O
heart	29024177	1	O
,	29024177	1	O
and	29024177	1	O
intestine	29024177	1	O
.	29024177	1	O
RNA	29024177	1	O
-	29024177	1	O
seq	29024177	1	O
data	29024177	1	O
revealed	29024177	1	O
three	29024177	1	O
distinct	29024177	1	O
transcription	29024177	1	O
start	29024177	1	O
sites	29024177	1	O
,	29024177	1	O
two	29024177	1	O
of	29024177	1	O
which	29024177	1	O
produce	29024177	1	O
a	29024177	1	O
protein	29024177	1	O
isoform	29024177	1	O
utilizing	29024177	1	O
ATG	29024177	1	O
1	29024177	1	O
while	29024177	1	O
the	29024177	1	O
third	29024177	1	O
utilizes	29024177	1	O
ATG	29024177	1	O
82	29024177	1	O
.	29024177	1	O
Transcripts	29024177	1	O
sponsoring	29024177	1	O
translational	29024177	1	O
initiation	29024177	1	O
at	29024177	1	O
ATG	29024177	1	O
1	29024177	1	O
predominate	29024177	1	O
in	29024177	1	O
intestinal	29024177	1	O
smooth	29024177	1	O
muscle	29024177	1	O
,	29024177	1	O
and	29024177	1	O
are	29024177	1	O
more	29024177	1	O
abundant	29024177	1	O
compared	29024177	1	O
with	29024177	1	O
the	29024177	1	O
level	29024177	1	O
measured	29024177	1	O
in	29024177	1	O
fibroblasts	29024177	1	O
.	29024177	1	O
Together	29024177	1	O
these	29024177	1	O
observations	29024177	1	O
describe	29024177	1	O
a	29024177	1	O
new	29024177	1	O
mechanism	29024177	1	O
of	29024177	1	O
tissue	29024177	1	O
-	29024177	1	O
specific	29024177	1	O
regulation	29024177	1	O
of	29024177	1	O
FLNA	29024177	1	O
that	29024177	1	O
could	29024177	1	O
reflect	29024177	1	O
the	29024177	1	O
differing	29024177	1	O
mechanical	29024177	1	O
requirements	29024177	1	O
of	29024177	1	O
these	29024177	1	O
cell	29024177	1	O
types	29024177	1	O
during	29024177	1	O
development	29024177	1	O
.	29024177	1	O

A	29036710	0	O
disulfide	29036710	0	O
bond	29036710	0	O
A	29036710	0	O
-	29036710	0	O
like	29036710	0	O
oxidoreductase	29036710	0	O
is	29036710	0	O
a	29036710	0	O
strong	29036710	0	O
candidate	29036710	0	O
gene	29036710	0	O
for	29036710	0	O
self	29036710	0	O
-	29036710	0	O
incompatibility	29036710	0	O
in	29036710	0	O
apricot	29036710	0	O
(	29036710	0	O
Prunus	29036710	0	O
armeniaca	29036710	0	O
)	29036710	0	O
pollen	29036710	0	O
.	29036710	0	O
S	29036710	0	O
-	29036710	0	O
RNase	29036710	0	O
based	29036710	0	O
gametophytic	29036710	0	O
self	29036710	0	O
-	29036710	0	O
incompatibility	29036710	0	O
(	29036710	0	O
SI	29036710	0	O
)	29036710	0	O
is	29036710	0	O
a	29036710	0	O
widespread	29036710	0	O
prezygotic	29036710	0	O
reproductive	29036710	0	O
barrier	29036710	0	O
in	29036710	0	O
flowering	29036710	0	O
plants	29036710	0	O
.	29036710	0	O
In	29036710	0	O
the	29036710	0	O
Solanaceae	29036710	0	O
,	29036710	0	O
Plantaginaceae	29036710	0	O
and	29036710	0	O
Rosaceae	29036710	0	O
gametophytic	29036710	0	O
SI	29036710	0	O
is	29036710	0	O
controlled	29036710	0	O
by	29036710	0	O
the	29036710	0	O
pistil	29036710	0	O
-	29036710	0	O
specific	29036710	0	O
S	29036710	0	O
-	29036710	0	O
RNases	29036710	0	O
and	29036710	0	O
the	29036710	0	O
pollen	29036710	0	O
S	29036710	0	O
-	29036710	0	O
locus	29036710	0	O
F	29036710	0	O
-	29036710	0	O
box	29036710	0	O
proteins	29036710	0	O
but	29036710	0	O
non	29036710	0	O
-	29036710	0	O
S	29036710	0	O
-	29036710	0	O
specific	29036710	0	O
factors	29036710	0	O
,	29036710	0	O
namely	29036710	0	O
modifiers	29036710	0	O
,	29036710	0	O
are	29036710	0	O
also	29036710	0	O
required	29036710	0	O
.	29036710	0	O
In	29036710	0	O
apricot	29036710	0	O
,	29036710	0	O
Prunus	29036710	0	O
armeniaca	29036710	0	O
(	29036710	0	O
Rosaceae	29036710	0	O
)	29036710	0	O
,	29036710	0	O
we	29036710	0	O
previously	29036710	0	O
mapped	29036710	0	O
two	29036710	0	O
pollen	29036710	0	O
-	29036710	0	O
part	29036710	0	O
mutations	29036710	0	B-Var
that	29036710	0	O
confer	29036710	0	B-Reg
self	29036710	0	O
-	29036710	0	O
compatibility	29036710	0	O
in	29036710	0	O
cultivars	29036710	0	O
Canino	29036710	0	O
and	29036710	0	O
Katy	29036710	0	O
at	29036710	0	O
the	29036710	0	O
distal	29036710	0	O
end	29036710	0	O
of	29036710	0	O
chromosome	29036710	0	O
3	29036710	0	O
(	29036710	0	O
M	29036710	0	O
-	29036710	0	O
locus	29036710	0	O
)	29036710	0	O
unlinked	29036710	0	O
to	29036710	0	O
the	29036710	0	O
S	29036710	0	O
-	29036710	0	O
locus	29036710	0	O
.	29036710	0	O
Here	29036710	0	O
,	29036710	0	O
we	29036710	0	O
used	29036710	0	O
high	29036710	0	O
-	29036710	0	O
resolution	29036710	0	O
mapping	29036710	0	O
to	29036710	0	O
identify	29036710	0	O
the	29036710	0	O
M	29036710	0	O
-	29036710	0	O
locus	29036710	0	O
with	29036710	0	O
an	29036710	0	O
134	29036710	0	O
kb	29036710	0	O
segment	29036710	0	O
containing	29036710	0	O
ParM-1	29036710	0	O
-	29036710	0	O
16	29036710	0	O
genes	29036710	0	O
.	29036710	0	O
Gene	29036710	0	O
expression	29036710	0	O
analysis	29036710	0	O
identified	29036710	0	O
four	29036710	0	O
genes	29036710	0	O
preferentially	29036710	0	O
expressed	29036710	0	O
in	29036710	0	O
anthers	29036710	0	O
as	29036710	0	O
modifier	29036710	0	O
gene	29036710	0	O
candidates	29036710	0	O
,	29036710	0	O
ParM-6	29036710	0	O
,	29036710	0	O
-	29036710	0	O
7	29036710	0	O
,	29036710	0	O
-	29036710	0	O
9	29036710	0	O
and	29036710	0	O
-	29036710	0	O
14	29036710	0	O
.	29036710	0	O
Variant	29036710	0	O
calling	29036710	0	O
of	29036710	0	O
WGS	29036710	0	O
Illumina	29036710	0	O
data	29036710	0	O
from	29036710	0	O
Canino	29036710	0	O
,	29036710	0	O
Katy	29036710	0	O
,	29036710	0	O
and	29036710	0	O
10	29036710	0	O
self	29036710	0	O
-	29036710	0	O
incompatible	29036710	0	O
cultivars	29036710	0	O
detected	29036710	0	O
a	29036710	0	O
358	29036710	0	O
bp	29036710	0	O
miniature	29036710	0	O
inverted	29036710	0	O
-	29036710	0	O
repeat	29036710	0	O
transposable	29036710	0	O
element	29036710	0	O
(	29036710	0	O
MITE	29036710	0	O
)	29036710	0	O
insertion	29036710	0	O
in	29036710	0	O
ParM-7	29036710	0	O
shared	29036710	0	O
only	29036710	0	O
by	29036710	0	O
self	29036710	0	O
-	29036710	0	O
compatible	29036710	0	O
apricots	29036710	0	O
,	29036710	0	O
supporting	29036710	0	O
ParM-7	29036710	0	O
as	29036710	0	O
strong	29036710	0	O
candidate	29036710	0	O
gene	29036710	0	O
required	29036710	0	O
for	29036710	0	O
SI	29036710	0	O
.	29036710	0	O
ParM-7	29036710	0	O
encodes	29036710	0	O
a	29036710	0	O
disulfide	29036710	0	O
bond	29036710	0	O
A	29036710	0	O
-	29036710	0	O
like	29036710	0	O
oxidoreductase	29036710	0	O
protein	29036710	0	O
,	29036710	0	O
which	29036710	0	O
we	29036710	0	O
named	29036710	0	O
ParMDO	29036710	0	O
.	29036710	0	O
The	29036710	0	O
MITE	29036710	0	B-Gene
insertion	29036710	0	B-Var
truncates	29036710	0	B-NegReg
the	29036710	0	O
ParMDO	29036710	0	O
ORF	29036710	0	O
and	29036710	0	O
produces	29036710	0	O
a	29036710	0	O
loss	29036710	0	B-NegReg
of	29036710	0	O
SI	29036710	0	O
function	29036710	0	O
,	29036710	0	O
suggesting	29036710	0	O
that	29036710	0	O
pollen	29036710	0	O
rejection	29036710	0	O
in	29036710	0	O
Prunus	29036710	0	O
is	29036710	0	O
dependent	29036710	0	O
on	29036710	0	O
redox	29036710	0	O
regulation	29036710	0	O
.	29036710	0	O
Based	29036710	0	O
on	29036710	0	O
phylogentic	29036710	0	O
analyses	29036710	0	O
we	29036710	0	O
also	29036710	0	O
suggest	29036710	0	O
that	29036710	0	O
ParMDO	29036710	0	O
may	29036710	0	O
have	29036710	0	O
originated	29036710	0	O
from	29036710	0	O
a	29036710	0	O
tandem	29036710	0	O
duplication	29036710	0	O
followed	29036710	0	O
by	29036710	0	O
subfunctionalization	29036710	0	O
and	29036710	0	O
pollen	29036710	0	O
-	29036710	0	O
specific	29036710	0	O
expression	29036710	0	O
.	29036710	0	O

The	29038237	2	O
Gain	29038237	2	B-PosReg
-	29038237	2	I-PosReg
of	29038237	2	I-PosReg
-	29038237	2	I-PosReg
Function	29038237	2	I-PosReg
Integrin	29038237	2	O
β3	29038237	2	O
Pro33	29038237	2	O
Variant	29038237	2	B-Var
Alters	29038237	2	O
the	29038237	2	O
Serotonin	29038237	2	O
System	29038237	2	O
in	29038237	2	O
the	29038237	2	O
Mouse	29038237	2	O
Brain	29038237	2	O
.	29038237	2	O
Engagement	29038237	2	O
of	29038237	2	O
integrins	29038237	2	O
by	29038237	2	O
the	29038237	2	O
extracellular	29038237	2	O
matrix	29038237	2	O
initiates	29038237	2	O
signaling	29038237	2	O
cascades	29038237	2	O
that	29038237	2	O
drive	29038237	2	O
a	29038237	2	O
variety	29038237	2	O
of	29038237	2	O
cellular	29038237	2	O
functions	29038237	2	O
,	29038237	2	O
including	29038237	2	O
neuronal	29038237	2	O
migration	29038237	2	O
and	29038237	2	O
axonal	29038237	2	O
pathfinding	29038237	2	O
in	29038237	2	O
the	29038237	2	O
brain	29038237	2	O
.	29038237	2	O
Multiple	29038237	2	O
lines	29038237	2	O
of	29038237	2	O
evidence	29038237	2	O
link	29038237	2	O
the	29038237	2	O
ITGB3	29038237	2	O
gene	29038237	2	O
encoding	29038237	2	O
the	29038237	2	O
integrin	29038237	2	O
β3	29038237	2	O
subunit	29038237	2	O
with	29038237	2	O
the	29038237	2	O
serotonin	29038237	2	O
(	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
)	29038237	2	O
system	29038237	2	O
,	29038237	2	O
likely	29038237	2	O
via	29038237	2	O
its	29038237	2	O
modulation	29038237	2	O
of	29038237	2	O
the	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
transporter	29038237	2	O
(	29038237	2	O
SERT	29038237	2	O
)	29038237	2	O
.	29038237	2	O
The	29038237	2	O
ITGB3	29038237	2	B-Gene
coding	29038237	2	O
polymorphism	29038237	2	O
Leu33Pro	29038237	2	B-Var
(	29038237	2	O
rs5918	29038237	2	O
,	29038237	2	O
PlA2	29038237	2	O
)	29038237	2	O
produces	29038237	2	O
hyperactive	29038237	2	B-PosReg
αvβ3	29038237	2	O
receptors	29038237	2	O
that	29038237	2	O
influence	29038237	2	B-Reg
whole	29038237	2	O
-	29038237	2	O
blood	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
levels	29038237	2	O
and	29038237	2	O
may	29038237	2	O
influence	29038237	2	B-Reg
the	29038237	2	O
risk	29038237	2	O
for	29038237	2	O
autism	29038237	2	B-Disease
spectrum	29038237	2	I-Disease
disorder	29038237	2	I-Disease
(	29038237	2	O
ASD	29038237	2	O
)	29038237	2	O
.	29038237	2	O
Using	29038237	2	O
a	29038237	2	O
phenome	29038237	2	O
-	29038237	2	O
wide	29038237	2	O
scan	29038237	2	O
of	29038237	2	O
psychiatric	29038237	2	O
diagnoses	29038237	2	O
,	29038237	2	O
we	29038237	2	O
found	29038237	2	O
significant	29038237	2	O
,	29038237	2	O
male	29038237	2	O
-	29038237	2	O
specific	29038237	2	O
associations	29038237	2	O
between	29038237	2	O
the	29038237	2	O
Pro33	29038237	2	O
allele	29038237	2	O
and	29038237	2	O
attention	29038237	2	O
-	29038237	2	O
deficit	29038237	2	O
hyperactivity	29038237	2	O
disorder	29038237	2	O
and	29038237	2	O
ASDs	29038237	2	O
.	29038237	2	O
Here	29038237	2	O
,	29038237	2	O
we	29038237	2	O
used	29038237	2	O
knock	29038237	2	O
-	29038237	2	O
in	29038237	2	O
(	29038237	2	O
KI	29038237	2	O
)	29038237	2	O
mice	29038237	2	O
expressing	29038237	2	O
an	29038237	2	O
Itgb3	29038237	2	B-Gene
variant	29038237	2	B-Var
that	29038237	2	O
phenocopies	29038237	2	O
the	29038237	2	O
human	29038237	2	O
Pro33	29038237	2	O
variant	29038237	2	O
to	29038237	2	O
elucidate	29038237	2	O
the	29038237	2	O
consequences	29038237	2	O
of	29038237	2	O
constitutively	29038237	2	O
enhanced	29038237	2	B-PosReg
αvβ3	29038237	2	O
signaling	29038237	2	O
to	29038237	2	O
the	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
system	29038237	2	O
in	29038237	2	O
the	29038237	2	O
brain	29038237	2	O
.	29038237	2	O
KI	29038237	2	O
mice	29038237	2	O
displayed	29038237	2	O
deficits	29038237	2	O
in	29038237	2	O
multiple	29038237	2	O
behaviors	29038237	2	O
,	29038237	2	O
including	29038237	2	O
anxiety	29038237	2	O
,	29038237	2	O
repetitive	29038237	2	O
,	29038237	2	O
and	29038237	2	O
social	29038237	2	O
behaviors	29038237	2	O
.	29038237	2	O
Anatomical	29038237	2	O
studies	29038237	2	O
revealed	29038237	2	O
a	29038237	2	O
significant	29038237	2	O
decrease	29038237	2	O
in	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
synapses	29038237	2	O
in	29038237	2	O
the	29038237	2	O
midbrain	29038237	2	O
,	29038237	2	O
accompanied	29038237	2	O
by	29038237	2	O
decreases	29038237	2	O
in	29038237	2	O
SERT	29038237	2	O
activity	29038237	2	O
and	29038237	2	O
reduced	29038237	2	O
localization	29038237	2	O
of	29038237	2	O
SERTs	29038237	2	O
to	29038237	2	O
integrin	29038237	2	O
adhesion	29038237	2	O
complexes	29038237	2	O
in	29038237	2	O
synapses	29038237	2	O
of	29038237	2	O
KI	29038237	2	O
mice	29038237	2	O
.	29038237	2	O
Inhibition	29038237	2	O
of	29038237	2	O
focal	29038237	2	O
adhesion	29038237	2	O
kinase	29038237	2	O
(	29038237	2	O
FAK	29038237	2	O
)	29038237	2	O
rescued	29038237	2	O
SERT	29038237	2	O
function	29038237	2	O
in	29038237	2	O
synapses	29038237	2	O
of	29038237	2	O
KI	29038237	2	O
mice	29038237	2	O
,	29038237	2	O
demonstrating	29038237	2	O
that	29038237	2	O
constitutive	29038237	2	O
active	29038237	2	O
FAK	29038237	2	O
signaling	29038237	2	O
downstream	29038237	2	O
of	29038237	2	O
the	29038237	2	O
Pro32Pro33	29038237	2	O
integrin	29038237	2	O
αvβ3	29038237	2	O
suppresses	29038237	2	O
SERT	29038237	2	O
activity	29038237	2	O
.	29038237	2	O
Our	29038237	2	O
studies	29038237	2	O
identify	29038237	2	O
a	29038237	2	O
complex	29038237	2	O
regulation	29038237	2	O
of	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
homeostasis	29038237	2	O
and	29038237	2	O
behaviors	29038237	2	O
by	29038237	2	O
integrin	29038237	2	O
αvβ3	29038237	2	O
,	29038237	2	O
revealing	29038237	2	O
an	29038237	2	O
important	29038237	2	O
role	29038237	2	O
for	29038237	2	O
integrins	29038237	2	O
in	29038237	2	O
modulating	29038237	2	O
risk	29038237	2	O
for	29038237	2	O
neuropsychiatric	29038237	2	O
disorders	29038237	2	O
.	29038237	2	O
SIGNIFICANCE	29038237	2	O
STATEMENT	29038237	2	O
The	29038237	2	O
integrin	29038237	2	O
β3	29038237	2	O
Leu33Pro	29038237	2	O
coding	29038237	2	O
polymorphism	29038237	2	O
has	29038237	2	O
been	29038237	2	O
associated	29038237	2	O
with	29038237	2	O
autism	29038237	2	O
spectrum	29038237	2	O
disorders	29038237	2	O
(	29038237	2	O
ASDs	29038237	2	O
)	29038237	2	O
within	29038237	2	O
a	29038237	2	O
subgroup	29038237	2	O
of	29038237	2	O
patients	29038237	2	O
with	29038237	2	O
elevated	29038237	2	O
blood	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
levels	29038237	2	O
,	29038237	2	O
linking	29038237	2	O
integrin	29038237	2	O
β3	29038237	2	O
,	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
,	29038237	2	O
and	29038237	2	O
ASD	29038237	2	O
risk	29038237	2	O
.	29038237	2	O
We	29038237	2	O
capitalized	29038237	2	O
on	29038237	2	O
these	29038237	2	O
interactions	29038237	2	O
to	29038237	2	O
demonstrate	29038237	2	O
that	29038237	2	O
the	29038237	2	O
Pro33	29038237	2	O
coding	29038237	2	O
variation	29038237	2	O
in	29038237	2	O
the	29038237	2	O
murine	29038237	2	O
integrin	29038237	2	O
β3	29038237	2	O
recapitulates	29038237	2	O
the	29038237	2	O
sex	29038237	2	O
-	29038237	2	O
dependent	29038237	2	O
neurochemical	29038237	2	O
and	29038237	2	O
behavioral	29038237	2	O
attributes	29038237	2	O
of	29038237	2	O
ASD	29038237	2	O
.	29038237	2	O
Using	29038237	2	O
state	29038237	2	O
-	29038237	2	O
of	29038237	2	O
-	29038237	2	O
the	29038237	2	O
-	29038237	2	O
art	29038237	2	O
techniques	29038237	2	O
,	29038237	2	O
we	29038237	2	O
show	29038237	2	O
that	29038237	2	O
presynaptic	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
function	29038237	2	O
is	29038237	2	O
altered	29038237	2	O
in	29038237	2	O
these	29038237	2	O
mice	29038237	2	O
,	29038237	2	O
and	29038237	2	O
that	29038237	2	O
the	29038237	2	O
localization	29038237	2	O
of	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
transporters	29038237	2	O
to	29038237	2	O
specific	29038237	2	O
compartments	29038237	2	O
within	29038237	2	O
the	29038237	2	O
synapse	29038237	2	O
,	29038237	2	O
disrupted	29038237	2	O
by	29038237	2	O
the	29038237	2	O
integrin	29038237	2	O
β3	29038237	2	O
Pro33	29038237	2	O
mutation	29038237	2	O
,	29038237	2	O
is	29038237	2	O
critical	29038237	2	O
for	29038237	2	O
appropriate	29038237	2	O
reuptake	29038237	2	O
of	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
.	29038237	2	O
Our	29038237	2	O
studies	29038237	2	O
provide	29038237	2	O
fundamental	29038237	2	O
insight	29038237	2	O
into	29038237	2	O
the	29038237	2	O
genetic	29038237	2	O
network	29038237	2	O
regulating	29038237	2	O
5	29038237	2	O
-	29038237	2	O
HT	29038237	2	O
neurotransmission	29038237	2	O
in	29038237	2	O
the	29038237	2	O
CNS	29038237	2	O
that	29038237	2	O
is	29038237	2	O
also	29038237	2	O
associated	29038237	2	O
with	29038237	2	O
ASD	29038237	2	O
risk	29038237	2	O
.	29038237	2	O

Parkin	29040870	2	B-Gene
absence	29040870	2	B-Var
accelerates	29040870	2	B-PosReg
microtubule	29040870	2	O
aging	29040870	2	O
in	29040870	2	O
dopaminergic	29040870	2	O
neurons	29040870	2	O
.	29040870	2	O
Loss	29040870	2	B-NegReg
-	29040870	2	I-NegReg
of	29040870	2	I-NegReg
-	29040870	2	I-NegReg
function	29040870	2	I-NegReg
caused	29040870	2	O
by	29040870	2	O
mutations	29040870	2	B-Var
in	29040870	2	O
the	29040870	2	O
parkin	29040870	2	O
gene	29040870	2	O
(	29040870	2	B-Gene
PARK2	29040870	2	I-Gene
)	29040870	2	I-Gene
lead	29040870	2	O
to	29040870	2	O
early	29040870	2	B-Disease
-	29040870	2	I-Disease
onset	29040870	2	I-Disease
familial	29040870	2	I-Disease
Parkinson	29040870	2	I-Disease
'	29040870	2	I-Disease
s	29040870	2	I-Disease
disease	29040870	2	I-Disease
.	29040870	2	O
Recently	29040870	2	O
,	29040870	2	O
mechanistic	29040870	2	O
studies	29040870	2	O
proved	29040870	2	O
the	29040870	2	O
ability	29040870	2	O
of	29040870	2	O
parkin	29040870	2	O
in	29040870	2	O
regulating	29040870	2	O
mitochondria	29040870	2	O
homeostasis	29040870	2	O
and	29040870	2	O
microtubule	29040870	2	O
(	29040870	2	O
MT	29040870	2	O
)	29040870	2	O
stability	29040870	2	O
.	29040870	2	O
Looking	29040870	2	O
at	29040870	2	O
these	29040870	2	O
systems	29040870	2	O
during	29040870	2	O
aging	29040870	2	O
of	29040870	2	O
PARK2	29040870	2	O
knockout	29040870	2	O
mice	29040870	2	O
,	29040870	2	O
we	29040870	2	O
found	29040870	2	O
that	29040870	2	O
loss	29040870	2	B-Var
of	29040870	2	O
parkin	29040870	2	B-Gene
induced	29040870	2	O
an	29040870	2	O
accelerated	29040870	2	B-PosReg
(	29040870	2	O
over	29040870	2	O
)	29040870	2	O
acetylation	29040870	2	O
of	29040870	2	O
MT	29040870	2	O
system	29040870	2	O
both	29040870	2	O
in	29040870	2	O
dopaminergic	29040870	2	O
neuron	29040870	2	O
cell	29040870	2	O
bodies	29040870	2	O
and	29040870	2	O
fibers	29040870	2	O
,	29040870	2	O
localized	29040870	2	O
in	29040870	2	O
the	29040870	2	O
substantia	29040870	2	O
nigra	29040870	2	O
and	29040870	2	O
corpus	29040870	2	O
striatum	29040870	2	O
,	29040870	2	O
respectively	29040870	2	O
.	29040870	2	O
Interestingly	29040870	2	O
,	29040870	2	O
in	29040870	2	O
PARK2	29040870	2	O
knockout	29040870	2	O
mice	29040870	2	O
,	29040870	2	O
changes	29040870	2	O
of	29040870	2	O
MT	29040870	2	O
stability	29040870	2	O
preceded	29040870	2	O
the	29040870	2	O
alteration	29040870	2	O
of	29040870	2	O
mitochondria	29040870	2	O
transport	29040870	2	O
.	29040870	2	O
Moreover	29040870	2	O
,	29040870	2	O
in	29040870	2	O
-	29040870	2	O
cell	29040870	2	O
experiments	29040870	2	O
confirmed	29040870	2	O
that	29040870	2	O
loss	29040870	2	B-Var
of	29040870	2	O
parkin	29040870	2	B-Gene
affects	29040870	2	B-Reg
mitochondria	29040870	2	O
mobility	29040870	2	O
and	29040870	2	O
showed	29040870	2	O
that	29040870	2	O
this	29040870	2	O
defect	29040870	2	O
depends	29040870	2	O
on	29040870	2	O
MT	29040870	2	O
system	29040870	2	O
as	29040870	2	O
it	29040870	2	O
is	29040870	2	O
rescued	29040870	2	O
by	29040870	2	O
paclitaxel	29040870	2	O
,	29040870	2	O
a	29040870	2	O
well	29040870	2	O
-	29040870	2	O
known	29040870	2	O
MT	29040870	2	O
-	29040870	2	O
targeted	29040870	2	O
agent	29040870	2	O
.	29040870	2	O
Furthermore	29040870	2	O
,	29040870	2	O
both	29040870	2	O
in	29040870	2	O
PC12	29040870	2	O
neuronal	29040870	2	O
cells	29040870	2	O
and	29040870	2	O
in	29040870	2	O
patients	29040870	2	O
'	29040870	2	O
induced	29040870	2	O
pluripotent	29040870	2	O
stem	29040870	2	O
cell	29040870	2	O
-	29040870	2	O
derived	29040870	2	O
midbrain	29040870	2	O
neurons	29040870	2	O
,	29040870	2	O
we	29040870	2	O
observed	29040870	2	O
that	29040870	2	O
parkin	29040870	2	O
deficiencies	29040870	2	O
cause	29040870	2	O
the	29040870	2	O
fragmentation	29040870	2	O
of	29040870	2	O
stable	29040870	2	O
MTs	29040870	2	O
.	29040870	2	O
Therefore	29040870	2	O
,	29040870	2	O
we	29040870	2	O
suggest	29040870	2	O
that	29040870	2	O
parkin	29040870	2	O
acts	29040870	2	O
as	29040870	2	O
a	29040870	2	O
regulator	29040870	2	O
of	29040870	2	O
MT	29040870	2	O
system	29040870	2	O
during	29040870	2	O
neuronal	29040870	2	O
aging	29040870	2	O
,	29040870	2	O
and	29040870	2	O
we	29040870	2	O
endorse	29040870	2	O
the	29040870	2	O
hypothesis	29040870	2	O
that	29040870	2	O
MT	29040870	2	O
dysfunction	29040870	2	O
may	29040870	2	O
be	29040870	2	O
crucial	29040870	2	O
in	29040870	2	O
the	29040870	2	O
pathogenesis	29040870	2	O
of	29040870	2	O
Parkinson	29040870	2	O
'	29040870	2	O
s	29040870	2	O
disease	29040870	2	O
.	29040870	2	O

Parkinson	29054882	1	B-Disease
'	29054882	1	I-Disease
s	29054882	1	I-Disease
Disease	29054882	1	I-Disease
-	29054882	1	I-Disease
Associated	29054882	1	I-Disease
LRRK2	29054882	1	B-Gene
Hyperactive	29054882	1	O
Kinase	29054882	1	O
Mutant	29054882	1	B-Var
Disrupts	29054882	1	B-NegReg
Synaptic	29054882	1	O
Vesicle	29054882	1	O
Trafficking	29054882	1	O
in	29054882	1	O
Ventral	29054882	1	O
Midbrain	29054882	1	O
Neurons	29054882	1	O
.	29054882	1	O
Parkinson	29054882	1	O
'	29054882	1	O
s	29054882	1	O
disease	29054882	1	O
(	29054882	1	O
PD	29054882	1	O
)	29054882	1	O
is	29054882	1	O
characterized	29054882	1	O
pathologically	29054882	1	O
by	29054882	1	O
the	29054882	1	O
selective	29054882	1	O
loss	29054882	1	O
of	29054882	1	O
substantia	29054882	1	O
nigra	29054882	1	O
(	29054882	1	O
SN	29054882	1	O
)	29054882	1	O
dopaminergic	29054882	1	O
(	29054882	1	O
DAergic	29054882	1	O
)	29054882	1	O
neurons	29054882	1	O
.	29054882	1	O
Recent	29054882	1	O
evidence	29054882	1	O
has	29054882	1	O
suggested	29054882	1	O
a	29054882	1	O
role	29054882	1	O
of	29054882	1	O
LRRK2	29054882	1	O
,	29054882	1	O
linked	29054882	1	O
to	29054882	1	O
the	29054882	1	O
most	29054882	1	O
frequent	29054882	1	O
familial	29054882	1	O
PD	29054882	1	O
,	29054882	1	O
in	29054882	1	O
regulating	29054882	1	O
synaptic	29054882	1	O
vesicle	29054882	1	O
(	29054882	1	O
SV	29054882	1	O
)	29054882	1	O
trafficking	29054882	1	O
.	29054882	1	O
However	29054882	1	O
,	29054882	1	O
the	29054882	1	O
mechanism	29054882	1	O
whereby	29054882	1	O
LRRK2	29054882	1	B-Gene
mutants	29054882	1	B-Var
contribute	29054882	1	B-Reg
to	29054882	1	O
nigral	29054882	1	O
vulnerability	29054882	1	O
remains	29054882	1	O
unclear	29054882	1	O
.	29054882	1	O
Here	29054882	1	O
we	29054882	1	O
show	29054882	1	O
that	29054882	1	O
the	29054882	1	O
most	29054882	1	O
common	29054882	1	O
PD	29054882	1	O
mutation	29054882	1	B-Var
LRRK2	29054882	1	B-Gene
G2019S	29054882	1	O
impairs	29054882	1	B-NegReg
SV	29054882	1	O
endocytosis	29054882	1	O
in	29054882	1	O
ventral	29054882	1	O
midbrain	29054882	1	O
(	29054882	1	O
MB	29054882	1	O
)	29054882	1	O
neurons	29054882	1	O
,	29054882	1	O
including	29054882	1	O
DA	29054882	1	O
neurons	29054882	1	O
,	29054882	1	O
and	29054882	1	O
the	29054882	1	O
slowed	29054882	1	O
endocytosis	29054882	1	O
can	29054882	1	O
be	29054882	1	O
rescued	29054882	1	O
by	29054882	1	O
inhibition	29054882	1	O
of	29054882	1	O
LRRK2	29054882	1	O
kinase	29054882	1	O
activity	29054882	1	O
.	29054882	1	O
A	29054882	1	O
similar	29054882	1	O
endocytic	29054882	1	O
defect	29054882	1	O
,	29054882	1	O
however	29054882	1	O
,	29054882	1	O
was	29054882	1	O
not	29054882	1	O
observed	29054882	1	O
in	29054882	1	O
LRRK2	29054882	1	O
mutant	29054882	1	O
neurons	29054882	1	O
from	29054882	1	O
the	29054882	1	O
neocortex	29054882	1	O
(	29054882	1	O
hereafter	29054882	1	O
,	29054882	1	O
cortical	29054882	1	O
neurons	29054882	1	O
)	29054882	1	O
or	29054882	1	O
the	29054882	1	O
hippocampus	29054882	1	O
,	29054882	1	O
suggesting	29054882	1	O
a	29054882	1	O
brain	29054882	1	O
region	29054882	1	O
-	29054882	1	O
specific	29054882	1	O
vulnerability	29054882	1	O
to	29054882	1	O
the	29054882	1	O
G2019S	29054882	1	O
mutation	29054882	1	O
.	29054882	1	O
Additionally	29054882	1	O
,	29054882	1	O
we	29054882	1	O
found	29054882	1	O
MB	29054882	1	O
-	29054882	1	O
specific	29054882	1	O
impairment	29054882	1	B-NegReg
of	29054882	1	O
SV	29054882	1	O
endocytosis	29054882	1	O
in	29054882	1	O
neurons	29054882	1	O
carrying	29054882	1	O
heterozygous	29054882	1	O
deletion	29054882	1	B-Var
of	29054882	1	O
SYNJ1	29054882	1	B-Gene
(	29054882	1	O
PARK20	29054882	1	O
)	29054882	1	O
,	29054882	1	O
a	29054882	1	O
gene	29054882	1	O
that	29054882	1	O
is	29054882	1	O
associated	29054882	1	O
with	29054882	1	O
recessive	29054882	1	O
Parkinsonism	29054882	1	O
.	29054882	1	O
Combining	29054882	1	O
SYNJ1	29054882	1	B-Var
/	29054882	1	I-Var
-	29054882	1	I-Var
and	29054882	1	O
LRRK2	29054882	1	B-Var
G2019S	29054882	1	I-Var
does	29054882	1	O
not	29054882	1	O
exacerbate	29054882	1	O
SV	29054882	1	O
endocytosis	29054882	1	O
but	29054882	1	O
impairs	29054882	1	B-NegReg
sustained	29054882	1	O
exocytosis	29054882	1	O
in	29054882	1	O
MB	29054882	1	O
neurons	29054882	1	O
and	29054882	1	O
alters	29054882	1	B-Reg
specific	29054882	1	O
motor	29054882	1	O
functions	29054882	1	O
of	29054882	1	O
1	29054882	1	O
-	29054882	1	O
year	29054882	1	O
-	29054882	1	O
old	29054882	1	O
male	29054882	1	O
mice	29054882	1	O
.	29054882	1	O
Interestingly	29054882	1	O
,	29054882	1	O
we	29054882	1	O
show	29054882	1	O
that	29054882	1	O
LRRK2	29054882	1	B-Var
directly	29054882	1	O
phosphorylates	29054882	1	O
synaptojanin1	29054882	1	O
in	29054882	1	O
vitro	29054882	1	O
,	29054882	1	O
resulting	29054882	1	B-Reg
in	29054882	1	I-Reg
the	29054882	1	O
disruption	29054882	1	O
of	29054882	1	O
endophilin	29054882	1	O
-	29054882	1	O
synaptojanin1	29054882	1	O
interaction	29054882	1	O
required	29054882	1	O
for	29054882	1	O
SV	29054882	1	O
endocytosis	29054882	1	O
.	29054882	1	O
Our	29054882	1	O
work	29054882	1	O
suggests	29054882	1	O
a	29054882	1	O
merge	29054882	1	O
of	29054882	1	O
LRRK2	29054882	1	O
and	29054882	1	O
SYNJ1	29054882	1	O
pathogenic	29054882	1	O
pathways	29054882	1	O
in	29054882	1	O
deregulating	29054882	1	O
SV	29054882	1	O
trafficking	29054882	1	O
in	29054882	1	O
MB	29054882	1	O
neurons	29054882	1	O
as	29054882	1	O
an	29054882	1	O
underlying	29054882	1	O
molecular	29054882	1	O
mechanism	29054882	1	O
of	29054882	1	O
early	29054882	1	O
PD	29054882	1	O
pathogenesis	29054882	1	O
.	29054882	1	O
SIGNIFICANCE	29054882	1	O
STATEMENT	29054882	1	O
Understanding	29054882	1	O
midbrain	29054882	1	O
dopaminergic	29054882	1	O
(	29054882	1	O
DAergic	29054882	1	O
)	29054882	1	O
neuron	29054882	1	O
-	29054882	1	O
selective	29054882	1	O
vulnerability	29054882	1	O
in	29054882	1	O
PD	29054882	1	O
is	29054882	1	O
essential	29054882	1	O
for	29054882	1	O
the	29054882	1	O
development	29054882	1	O
of	29054882	1	O
targeted	29054882	1	O
therapeutics	29054882	1	O
.	29054882	1	O
We	29054882	1	O
report	29054882	1	O
,	29054882	1	O
for	29054882	1	O
the	29054882	1	O
first	29054882	1	O
time	29054882	1	O
,	29054882	1	O
a	29054882	1	O
nerve	29054882	1	O
terminal	29054882	1	O
impairment	29054882	1	O
in	29054882	1	O
SV	29054882	1	O
trafficking	29054882	1	O
selectively	29054882	1	O
in	29054882	1	O
MB	29054882	1	O
neurons	29054882	1	O
but	29054882	1	O
not	29054882	1	O
cortical	29054882	1	O
neurons	29054882	1	O
caused	29054882	1	O
by	29054882	1	O
two	29054882	1	O
PARK	29054882	1	O
genes	29054882	1	O
:	29054882	1	O
LRRK2	29054882	1	O
(	29054882	1	O
PARK8	29054882	1	O
)	29054882	1	O
and	29054882	1	O
SYNJ1	29054882	1	O
(	29054882	1	O
PARK20	29054882	1	O
)	29054882	1	O
.	29054882	1	O
We	29054882	1	O
demonstrate	29054882	1	O
that	29054882	1	O
the	29054882	1	O
enhanced	29054882	1	B-PosReg
kinase	29054882	1	O
activity	29054882	1	O
resulting	29054882	1	O
from	29054882	1	O
the	29054882	1	O
most	29054882	1	O
frequent	29054882	1	O
G2019S	29054882	1	B-Var
mutation	29054882	1	O
in	29054882	1	O
LRRK2	29054882	1	B-Gene
is	29054882	1	O
the	29054882	1	O
key	29054882	1	O
to	29054882	1	O
this	29054882	1	O
impairment	29054882	1	O
.	29054882	1	O
We	29054882	1	O
provide	29054882	1	O
evidence	29054882	1	O
suggesting	29054882	1	O
that	29054882	1	O
LRRK2	29054882	1	B-Gene
G2019S	29054882	1	B-Var
and	29054882	1	O
SYNJ1	29054882	1	B-Gene
loss	29054882	1	B-NegReg
of	29054882	1	I-NegReg
function	29054882	1	I-NegReg
share	29054882	1	O
a	29054882	1	O
similar	29054882	1	O
pathogenic	29054882	1	O
pathway	29054882	1	O
in	29054882	1	O
deregulating	29054882	1	O
DAergic	29054882	1	O
neuron	29054882	1	O
SV	29054882	1	O
endocytosis	29054882	1	O
and	29054882	1	O
that	29054882	1	O
they	29054882	1	O
play	29054882	1	B-Reg
additive	29054882	1	I-Reg
roles	29054882	1	I-Reg
in	29054882	1	O
facilitating	29054882	1	O
each	29054882	1	O
other	29054882	1	O
'	29054882	1	O
s	29054882	1	O
pathogenic	29054882	1	O
functions	29054882	1	O
in	29054882	1	O
PD	29054882	1	B-Disease
.	29054882	1	O

From	29058783	0	O
mutational	29058783	0	O
inactivation	29058783	0	O
to	29058783	0	O
aberrant	29058783	0	O
gain	29058783	0	O
-	29058783	0	O
of	29058783	0	O
-	29058783	0	O
function	29058783	0	O
:	29058783	0	O
Unraveling	29058783	0	O
the	29058783	0	O
structural	29058783	0	O
basis	29058783	0	O
of	29058783	0	O
mutant	29058783	0	O
p53	29058783	0	O
oncogenic	29058783	0	O
transition	29058783	0	O
.	29058783	0	O
Various	29058783	0	O
evidence	29058783	0	O
has	29058783	0	O
revealed	29058783	0	O
that	29058783	0	O
mutations	29058783	0	B-Var
in	29058783	0	O
p53	29058783	0	B-Gene
exert	29058783	0	O
activities	29058783	0	O
that	29058783	0	O
go	29058783	0	O
beyond	29058783	0	O
simply	29058783	0	O
inactivation	29058783	0	B-PosReg
of	29058783	0	O
wildtype	29058783	0	O
functions	29058783	0	O
but	29058783	0	O
rather	29058783	0	O
elicits	29058783	0	B-Reg
downstream	29058783	0	O
interactions	29058783	0	O
that	29058783	0	O
promote	29058783	0	B-PosReg
malignancy	29058783	0	B-Disease
described	29058783	0	O
as	29058783	0	O
mutant	29058783	0	B-Var
p53	29058783	0	B-Gene
gain	29058783	0	B-PosReg
-	29058783	0	I-PosReg
of	29058783	0	I-PosReg
-	29058783	0	I-PosReg
function	29058783	0	I-PosReg
(	29058783	0	O
GOF	29058783	0	O
)	29058783	0	O
.	29058783	0	O
Here	29058783	0	O
we	29058783	0	O
report	29058783	0	O
the	29058783	0	O
first	29058783	0	O
account	29058783	0	O
of	29058783	0	O
the	29058783	0	O
dynamics	29058783	0	O
of	29058783	0	O
mutation	29058783	0	O
-	29058783	0	O
induced	29058783	0	O
structural	29058783	0	O
transition	29058783	0	O
of	29058783	0	O
native	29058783	0	O
p53	29058783	0	O
to	29058783	0	O
an	29058783	0	O
aberrant	29058783	0	O
gain	29058783	0	O
-	29058783	0	O
of	29058783	0	O
-	29058783	0	O
function	29058783	0	O
state	29058783	0	O
,	29058783	0	O
studying	29058783	0	O
the	29058783	0	O
wildtype	29058783	0	O
(	29058783	0	O
WT	29058783	0	O
)	29058783	0	O
and	29058783	0	O
high	29058783	0	O
incidence	29058783	0	O
contact	29058783	0	O
(	29058783	0	B-Var
R273C	29058783	0	I-Var
)	29058783	0	I-Var
and	29058783	0	O
structural	29058783	0	O
(	29058783	0	B-Var
R175H	29058783	0	I-Var
)	29058783	0	I-Var
mutant	29058783	0	O
p53	29058783	0	B-Gene
(	29058783	0	O
mutp53	29058783	0	O
)	29058783	0	O
through	29058783	0	O
molecular	29058783	0	O
dynamics	29058783	0	O
simulation	29058783	0	O
.	29058783	0	O
Result	29058783	0	O
analysis	29058783	0	O
revealed	29058783	0	O
that	29058783	0	O
both	29058783	0	O
mutants	29058783	0	O
exhibited	29058783	0	B-Reg
structural	29058783	0	B-Var
distortion	29058783	0	I-Var
and	29058783	0	O
reduced	29058783	0	B-NegReg
flexibility	29058783	0	O
,	29058783	0	O
indicative	29058783	0	O
of	29058783	0	O
rigidity	29058783	0	O
and	29058783	0	O
kinetic	29058783	0	O
stability	29058783	0	O
.	29058783	0	O
In	29058783	0	O
addition	29058783	0	O
,	29058783	0	O
surface	29058783	0	O
analysis	29058783	0	O
revealed	29058783	0	O
an	29058783	0	O
increase	29058783	0	O
in	29058783	0	O
the	29058783	0	O
accessible	29058783	0	O
surface	29058783	0	O
area	29058783	0	O
in	29058783	0	O
the	29058783	0	O
p53	29058783	0	O
mutants	29058783	0	O
.	29058783	0	O
This	29058783	0	O
suggests	29058783	0	O
that	29058783	0	O
the	29058783	0	O
GOF	29058783	0	O
transition	29058783	0	O
involves	29058783	0	O
protein	29058783	0	O
unfolding	29058783	0	O
and	29058783	0	O
exposure	29058783	0	O
of	29058783	0	O
buried	29058783	0	O
hydrophobic	29058783	0	O
surface	29058783	0	O
essential	29058783	0	O
for	29058783	0	O
interaction	29058783	0	O
with	29058783	0	O
HSF-1	29058783	0	O
oncogenic	29058783	0	O
partner	29058783	0	O
and	29058783	0	O
wildtype	29058783	0	O
p63	29058783	0	O
,	29058783	0	O
and	29058783	0	O
p73	29058783	0	O
homologs	29058783	0	O
.	29058783	0	O
Further	29058783	0	O
validation	29058783	0	O
revealed	29058783	0	O
binding	29058783	0	O
cavities	29058783	0	O
,	29058783	0	O
similar	29058783	0	O
in	29058783	0	O
the	29058783	0	O
mutants	29058783	0	O
but	29058783	0	O
dissimilar	29058783	0	O
to	29058783	0	O
the	29058783	0	O
WT	29058783	0	O
.	29058783	0	O
Taken	29058783	0	O
together	29058783	0	O
,	29058783	0	O
this	29058783	0	O
study	29058783	0	O
complements	29058783	0	O
experimental	29058783	0	O
findings	29058783	0	O
and	29058783	0	O
reveals	29058783	0	O
the	29058783	0	O
interplay	29058783	0	O
between	29058783	0	O
mutation	29058783	0	B-Reg
-	29058783	0	I-Reg
induced	29058783	0	I-Reg
structural	29058783	0	B-Var
distortion	29058783	0	I-Var
,	29058783	0	O
loss	29058783	0	B-NegReg
of	29058783	0	O
flexibility	29058783	0	O
,	29058783	0	O
rigidity	29058783	0	O
,	29058783	0	O
enhanced	29058783	0	B-PosReg
stability	29058783	0	O
,	29058783	0	O
protein	29058783	0	O
unfolding	29058783	0	O
and	29058783	0	O
ultimately	29058783	0	O
,	29058783	0	O
exposure	29058783	0	O
of	29058783	0	O
binding	29058783	0	O
surfaces	29058783	0	O
as	29058783	0	O
conformational	29058783	0	O
attributes	29058783	0	O
that	29058783	0	O
characterize	29058783	0	O
mutP53	29058783	0	O
structure	29058783	0	O
-	29058783	0	O
GOF	29058783	0	O
activities	29058783	0	O
.	29058783	0	O
This	29058783	0	O
insight	29058783	0	O
is	29058783	0	O
,	29058783	0	O
therefore	29058783	0	O
,	29058783	0	O
of	29058783	0	O
great	29058783	0	O
importance	29058783	0	O
as	29058783	0	O
it	29058783	0	O
opens	29058783	0	O
up	29058783	0	O
a	29058783	0	O
novel	29058783	0	O
therapeutic	29058783	0	O
approach	29058783	0	O
toward	29058783	0	O
the	29058783	0	O
structure	29058783	0	O
based	29058783	0	O
targeting	29058783	0	O
of	29058783	0	O
mutP53	29058783	0	O
oncogenic	29058783	0	O
involvement	29058783	0	O
beyond	29058783	0	O
wildtype	29058783	0	O
inactivation	29058783	0	O
.	29058783	0	O
Furthermore	29058783	0	O
,	29058783	0	O
"	29058783	0	O
exposed	29058783	0	O
"	29058783	0	O
binding	29058783	0	O
site	29058783	0	O
information	29058783	0	O
obtained	29058783	0	O
from	29058783	0	O
this	29058783	0	O
study	29058783	0	O
can	29058783	0	O
be	29058783	0	O
explored	29058783	0	O
for	29058783	0	O
structure	29058783	0	O
-	29058783	0	O
based	29058783	0	O
design	29058783	0	O
of	29058783	0	O
substances	29058783	0	O
best	29058783	0	O
described	29058783	0	O
as	29058783	0	O
"	29058783	0	O
destabilizers	29058783	0	O
"	29058783	0	O
to	29058783	0	O
disrupt	29058783	0	O
the	29058783	0	O
GOF	29058783	0	O
interaction	29058783	0	O
of	29058783	0	O
mutp53	29058783	0	O
.	29058783	0	O

Gain	29064616	2	B-PosReg
-	29064616	2	I-PosReg
of	29064616	2	I-PosReg
-	29064616	2	I-PosReg
function	29064616	2	I-PosReg
HCN2	29064616	2	B-Gene
variants	29064616	2	B-Var
in	29064616	2	O
genetic	29064616	2	O
epilepsy	29064616	2	B-Disease
.	29064616	2	O
Genetic	29064616	2	O
generalized	29064616	2	O
epilepsy	29064616	2	O
(	29064616	2	O
GGE	29064616	2	O
)	29064616	2	O
is	29064616	2	O
a	29064616	2	O
common	29064616	2	O
epilepsy	29064616	2	O
syndrome	29064616	2	O
that	29064616	2	O
encompasses	29064616	2	O
seizure	29064616	2	O
disorders	29064616	2	O
characterized	29064616	2	O
by	29064616	2	O
spike	29064616	2	O
-	29064616	2	O
and	29064616	2	O
-	29064616	2	O
wave	29064616	2	O
discharges	29064616	2	O
(	29064616	2	O
SWDs	29064616	2	O
)	29064616	2	O
.	29064616	2	O
Pacemaker	29064616	2	O
hyperpolarization	29064616	2	O
-	29064616	2	O
activated	29064616	2	O
cyclic	29064616	2	O
nucleotide	29064616	2	O
-	29064616	2	O
gated	29064616	2	O
channels	29064616	2	O
(	29064616	2	O
HCN	29064616	2	O
)	29064616	2	O
are	29064616	2	O
considered	29064616	2	O
integral	29064616	2	O
to	29064616	2	O
SWD	29064616	2	O
genesis	29064616	2	O
,	29064616	2	O
making	29064616	2	O
them	29064616	2	O
an	29064616	2	O
ideal	29064616	2	O
gene	29064616	2	O
candidate	29064616	2	O
for	29064616	2	O
GGE	29064616	2	O
.	29064616	2	O
We	29064616	2	O
identified	29064616	2	O
HCN2	29064616	2	O
missense	29064616	2	O
variants	29064616	2	O
from	29064616	2	O
a	29064616	2	O
large	29064616	2	O
cohort	29064616	2	O
of	29064616	2	O
585	29064616	2	O
GGE	29064616	2	O
patients	29064616	2	O
,	29064616	2	O
recruited	29064616	2	O
by	29064616	2	O
the	29064616	2	O
Epilepsy	29064616	2	O
Phenome	29064616	2	O
-	29064616	2	O
Genome	29064616	2	O
Project	29064616	2	O
(	29064616	2	O
EPGP	29064616	2	O
)	29064616	2	O
,	29064616	2	O
and	29064616	2	O
performed	29064616	2	O
functional	29064616	2	O
analysis	29064616	2	O
using	29064616	2	O
two	29064616	2	O
-	29064616	2	O
electrode	29064616	2	O
voltage	29064616	2	O
clamp	29064616	2	O
recordings	29064616	2	O
from	29064616	2	O
Xenopus	29064616	2	O
oocytes	29064616	2	O
.	29064616	2	O
The	29064616	2	O
p.S632W	29064616	2	O
variant	29064616	2	O
was	29064616	2	O
identified	29064616	2	O
in	29064616	2	O
a	29064616	2	O
patient	29064616	2	O
with	29064616	2	O
idiopathic	29064616	2	O
photosensitive	29064616	2	O
occipital	29064616	2	O
epilepsy	29064616	2	O
and	29064616	2	O
segregated	29064616	2	O
in	29064616	2	O
the	29064616	2	O
family	29064616	2	O
.	29064616	2	O
This	29064616	2	O
variant	29064616	2	O
was	29064616	2	O
also	29064616	2	O
independently	29064616	2	O
identified	29064616	2	O
in	29064616	2	O
an	29064616	2	O
unrelated	29064616	2	O
patient	29064616	2	O
with	29064616	2	O
childhood	29064616	2	O
absence	29064616	2	O
seizures	29064616	2	O
from	29064616	2	O
a	29064616	2	O
European	29064616	2	O
cohort	29064616	2	O
of	29064616	2	O
238	29064616	2	O
familial	29064616	2	O
GGE	29064616	2	O
cases	29064616	2	O
.	29064616	2	O
The	29064616	2	O
p.V246M	29064616	2	O
variant	29064616	2	O
was	29064616	2	O
identified	29064616	2	O
in	29064616	2	O
a	29064616	2	O
patient	29064616	2	O
with	29064616	2	O
photo	29064616	2	O
-	29064616	2	O
sensitive	29064616	2	O
GGE	29064616	2	O
and	29064616	2	O
his	29064616	2	O
father	29064616	2	O
diagnosed	29064616	2	O
with	29064616	2	O
juvenile	29064616	2	O
myoclonic	29064616	2	O
epilepsy	29064616	2	O
.	29064616	2	O
Functional	29064616	2	O
studies	29064616	2	O
revealed	29064616	2	O
that	29064616	2	O
both	29064616	2	O
p.S632W	29064616	2	B-Var
and	29064616	2	O
p.V246M	29064616	2	B-Var
had	29064616	2	O
an	29064616	2	O
identical	29064616	2	O
functional	29064616	2	O
impact	29064616	2	O
including	29064616	2	O
a	29064616	2	O
depolarizing	29064616	2	O
shift	29064616	2	O
in	29064616	2	O
the	29064616	2	O
voltage	29064616	2	O
dependence	29064616	2	O
of	29064616	2	O
activation	29064616	2	B-PosReg
that	29064616	2	O
is	29064616	2	O
consistent	29064616	2	O
with	29064616	2	O
a	29064616	2	O
gain	29064616	2	O
-	29064616	2	O
of	29064616	2	O
-	29064616	2	O
function	29064616	2	O
.	29064616	2	O
In	29064616	2	O
contrast	29064616	2	O
,	29064616	2	O
no	29064616	2	O
biophysical	29064616	2	O
changes	29064616	2	O
resulted	29064616	2	O
from	29064616	2	O
the	29064616	2	O
introduction	29064616	2	O
of	29064616	2	O
common	29064616	2	O
population	29064616	2	O
variants	29064616	2	O
,	29064616	2	O
p.E280K	29064616	2	O
and	29064616	2	O
p.A705T	29064616	2	O
,	29064616	2	O
and	29064616	2	O
the	29064616	2	O
p.R756C	29064616	2	O
variant	29064616	2	O
from	29064616	2	O
EPGP	29064616	2	O
that	29064616	2	O
did	29064616	2	O
not	29064616	2	O
segregate	29064616	2	O
with	29064616	2	O
disease	29064616	2	O
.	29064616	2	O
Our	29064616	2	O
data	29064616	2	O
suggest	29064616	2	O
that	29064616	2	O
HCN2	29064616	2	B-Gene
variants	29064616	2	B-Var
can	29064616	2	O
confer	29064616	2	O
susceptibility	29064616	2	O
to	29064616	2	O
GGE	29064616	2	O
via	29064616	2	O
a	29064616	2	O
gain	29064616	2	B-PosReg
-	29064616	2	I-PosReg
of	29064616	2	I-PosReg
-	29064616	2	I-PosReg
function	29064616	2	I-PosReg
mechanism	29064616	2	O
.	29064616	2	O

Polymorphism	29067933	2	O
of	29067933	2	O
glutathione	29067933	2	O
S	29067933	2	O
-	29067933	2	O
transferase	29067933	2	O
M1	29067933	2	O
and	29067933	2	O
T1	29067933	2	O
genes	29067933	2	O
and	29067933	2	O
susceptibility	29067933	2	O
to	29067933	2	O
psoriasis	29067933	2	O
disease	29067933	2	O
:	29067933	2	O
A	29067933	2	O
study	29067933	2	O
from	29067933	2	O
North	29067933	2	O
India	29067933	2	O
.	29067933	2	O
BACKGROUND	29067933	2	O
:	29067933	2	O
Increased	29067933	2	O
oxidative	29067933	2	O
stress	29067933	2	O
and	29067933	2	O
resulting	29067933	2	O
inflammation	29067933	2	O
has	29067933	2	O
been	29067933	2	O
emphasized	29067933	2	O
as	29067933	2	O
a	29067933	2	O
factor	29067933	2	O
in	29067933	2	O
the	29067933	2	O
pathogenesis	29067933	2	O
of	29067933	2	O
many	29067933	2	O
diseases	29067933	2	O
including	29067933	2	O
psoriasis	29067933	2	O
.	29067933	2	O
Glutathione	29067933	2	O
S	29067933	2	O
-	29067933	2	O
transferases	29067933	2	O
(	29067933	2	O
GSTs	29067933	2	O
)	29067933	2	O
protect	29067933	2	O
against	29067933	2	O
oxidative	29067933	2	O
stress	29067933	2	O
,	29067933	2	O
inflammation	29067933	2	O
,	29067933	2	O
and	29067933	2	O
genotoxicity	29067933	2	O
.	29067933	2	O
Polymorphisms	29067933	2	B-Var
in	29067933	2	O
the	29067933	2	O
GST	29067933	2	B-Gene
genes	29067933	2	O
may	29067933	2	O
lead	29067933	2	B-Reg
to	29067933	2	I-Reg
an	29067933	2	O
imbalance	29067933	2	O
in	29067933	2	O
pro	29067933	2	O
-	29067933	2	O
and	29067933	2	O
antioxidant	29067933	2	O
systems	29067933	2	O
resulting	29067933	2	O
in	29067933	2	O
the	29067933	2	O
increased	29067933	2	B-PosReg
production	29067933	2	O
of	29067933	2	O
reactive	29067933	2	O
oxygen	29067933	2	O
species	29067933	2	O
that	29067933	2	O
could	29067933	2	O
influence	29067933	2	B-Reg
the	29067933	2	O
pathogenesis	29067933	2	O
of	29067933	2	O
psoriasis	29067933	2	B-Disease
.	29067933	2	O
AIM	29067933	2	O
:	29067933	2	O
The	29067933	2	O
aim	29067933	2	O
of	29067933	2	O
this	29067933	2	O
study	29067933	2	O
was	29067933	2	O
to	29067933	2	O
investigate	29067933	2	O
the	29067933	2	O
association	29067933	2	O
between	29067933	2	O
GSTs	29067933	2	O
(	29067933	2	O
GSTM1	29067933	2	O
and	29067933	2	O
GSTT1	29067933	2	O
)	29067933	2	O
gene	29067933	2	O
polymorphism	29067933	2	O
in	29067933	2	O
patients	29067933	2	O
with	29067933	2	O
chronic	29067933	2	O
plaque	29067933	2	O
psoriasis	29067933	2	O
as	29067933	2	O
a	29067933	2	O
factor	29067933	2	O
in	29067933	2	O
the	29067933	2	O
susceptibility	29067933	2	O
and	29067933	2	O
development	29067933	2	O
of	29067933	2	O
psoriasis	29067933	2	O
.	29067933	2	O
MATERIALS	29067933	2	O
AND	29067933	2	O
METHODS	29067933	2	O
:	29067933	2	O
We	29067933	2	O
assessed	29067933	2	O
128	29067933	2	O
patients	29067933	2	O
with	29067933	2	O
psoriasis	29067933	2	O
and	29067933	2	O
250	29067933	2	O
age	29067933	2	O
-	29067933	2	O
and	29067933	2	O
sex	29067933	2	O
-	29067933	2	O
matched	29067933	2	O
healthy	29067933	2	O
controls	29067933	2	O
.	29067933	2	O
Genomic	29067933	2	O
DNA	29067933	2	O
was	29067933	2	O
extracted	29067933	2	O
from	29067933	2	O
peripheral	29067933	2	O
blood	29067933	2	O
by	29067933	2	O
the	29067933	2	O
phenol	29067933	2	O
chloroform	29067933	2	O
method	29067933	2	O
.	29067933	2	O
The	29067933	2	O
null	29067933	2	O
GSTT1	29067933	2	O
and	29067933	2	O
GSTM1	29067933	2	O
genotypes	29067933	2	O
were	29067933	2	O
identified	29067933	2	O
by	29067933	2	O
multiplex	29067933	2	O
polymerase	29067933	2	O
chain	29067933	2	O
reaction	29067933	2	O
(	29067933	2	O
PCR	29067933	2	O
)	29067933	2	O
method	29067933	2	O
.	29067933	2	O
RESULTS	29067933	2	O
:	29067933	2	O
The	29067933	2	O
null	29067933	2	O
genotype	29067933	2	O
of	29067933	2	O
GSTM1	29067933	2	O
and	29067933	2	O
GSTT1	29067933	2	O
was	29067933	2	O
seen	29067933	2	O
in	29067933	2	O
45.3%	29067933	2	O
and	29067933	2	O
40.6%	29067933	2	O
in	29067933	2	O
psoriasis	29067933	2	O
patients	29067933	2	O
whereas	29067933	2	O
in	29067933	2	O
the	29067933	2	O
controls	29067933	2	O
it	29067933	2	O
was	29067933	2	O
34.4%	29067933	2	O
and	29067933	2	O
20.0%	29067933	2	O
,	29067933	2	O
respectively	29067933	2	O
.	29067933	2	O
A	29067933	2	O
significant	29067933	2	O
association	29067933	2	O
was	29067933	2	O
seen	29067933	2	O
between	29067933	2	O
the	29067933	2	O
null	29067933	2	O
alleles	29067933	2	O
of	29067933	2	O
the	29067933	2	O
GSTT1	29067933	2	O
(	29067933	2	O
OR	29067933	2	O
=	29067933	2	O
2.74	29067933	2	O
)	29067933	2	O
and	29067933	2	O
GSTM1	29067933	2	O
(	29067933	2	O
OR	29067933	2	O
=	29067933	2	O
1.58	29067933	2	O
)	29067933	2	O
alone	29067933	2	O
or	29067933	2	O
in	29067933	2	O
combination	29067933	2	O
with	29067933	2	O
tobacco	29067933	2	O
use	29067933	2	O
(	29067933	2	O
P	29067933	2	O
<	29067933	2	O
0.001	29067933	2	O
)	29067933	2	O
and	29067933	2	O
psoriasis	29067933	2	O
risk	29067933	2	O
.	29067933	2	O
The	29067933	2	O
presence	29067933	2	B-Var
of	29067933	2	O
both	29067933	2	O
null	29067933	2	O
genotypes	29067933	2	O
of	29067933	2	O
GSTM1	29067933	2	B-Gene
and	29067933	2	O
GSTT1	29067933	2	B-Gene
further	29067933	2	O
increased	29067933	2	B-PosReg
the	29067933	2	O
risk	29067933	2	O
of	29067933	2	O
psoriasis	29067933	2	B-Disease
(	29067933	2	O
OR	29067933	2	O
=	29067933	2	O
3.52	29067933	2	O
)	29067933	2	O
when	29067933	2	O
compared	29067933	2	O
with	29067933	2	O
the	29067933	2	O
positive	29067933	2	O
genotypes	29067933	2	O
of	29067933	2	O
GSTM1	29067933	2	O
and	29067933	2	O
GSTT1	29067933	2	O
.	29067933	2	O
LIMITATIONS	29067933	2	O
:	29067933	2	O
A	29067933	2	O
major	29067933	2	O
limitation	29067933	2	O
of	29067933	2	O
this	29067933	2	O
study	29067933	2	O
was	29067933	2	O
the	29067933	2	O
small	29067933	2	O
sample	29067933	2	O
size	29067933	2	O
.	29067933	2	O
A	29067933	2	O
large	29067933	2	O
epidemiological	29067933	2	O
study	29067933	2	O
is	29067933	2	O
necessary	29067933	2	O
to	29067933	2	O
confirm	29067933	2	O
these	29067933	2	O
findings	29067933	2	O
.	29067933	2	O
CONCLUSIONS	29067933	2	O
:	29067933	2	O
The	29067933	2	O
null	29067933	2	O
genotype	29067933	2	O
of	29067933	2	O
GSTT1	29067933	2	O
is	29067933	2	O
a	29067933	2	O
strong	29067933	2	O
predisposing	29067933	2	O
factor	29067933	2	O
for	29067933	2	O
psoriasis	29067933	2	O
in	29067933	2	O
North	29067933	2	O
India	29067933	2	O
.	29067933	2	O

Loss	29086445	0	O
-	29086445	0	O
of	29086445	0	O
-	29086445	0	O
function	29086445	0	O
of	29086445	0	O
ASPARTIC	29086445	0	O
PEPTIDASE	29086445	0	O
NODULE	29086445	0	O
-	29086445	0	O
INDUCED	29086445	0	O
1	29086445	0	O
(	29086445	0	O
APN1	29086445	0	O
)	29086445	0	O
in	29086445	0	O
Lotus	29086445	0	O
japonicus	29086445	0	O
restricts	29086445	0	O
efficient	29086445	0	O
nitrogen	29086445	0	O
-	29086445	0	O
fixing	29086445	0	O
symbiosis	29086445	0	O
with	29086445	0	O
specific	29086445	0	O
Mesorhizobium	29086445	0	O
loti	29086445	0	O
strains	29086445	0	O
.	29086445	0	O
The	29086445	0	O
nitrogen	29086445	0	O
-	29086445	0	O
fixing	29086445	0	O
symbiosis	29086445	0	O
of	29086445	0	O
legumes	29086445	0	O
and	29086445	0	O
Rhizobium	29086445	0	O
bacteria	29086445	0	O
is	29086445	0	O
established	29086445	0	O
by	29086445	0	O
complex	29086445	0	O
interactions	29086445	0	O
between	29086445	0	O
the	29086445	0	O
two	29086445	0	O
symbiotic	29086445	0	O
partners	29086445	0	O
.	29086445	0	O
Legume	29086445	0	O
Fix	29086445	0	O
-	29086445	0	O
mutants	29086445	0	O
form	29086445	0	O
apparently	29086445	0	O
normal	29086445	0	O
nodules	29086445	0	O
with	29086445	0	O
endosymbiotic	29086445	0	O
rhizobia	29086445	0	O
but	29086445	0	O
fail	29086445	0	O
to	29086445	0	O
induce	29086445	0	O
rhizobial	29086445	0	O
nitrogen	29086445	0	O
fixation	29086445	0	O
.	29086445	0	O
These	29086445	0	O
mutants	29086445	0	O
are	29086445	0	O
useful	29086445	0	O
for	29086445	0	O
identifying	29086445	0	O
the	29086445	0	O
legume	29086445	0	O
genes	29086445	0	O
involved	29086445	0	O
in	29086445	0	O
the	29086445	0	O
interactions	29086445	0	O
essential	29086445	0	O
for	29086445	0	O
symbiotic	29086445	0	O
nitrogen	29086445	0	O
fixation	29086445	0	O
.	29086445	0	O
We	29086445	0	O
describe	29086445	0	O
here	29086445	0	O
a	29086445	0	O
Fix	29086445	0	O
-	29086445	0	O
mutant	29086445	0	O
of	29086445	0	O
Lotus	29086445	0	O
japonicus	29086445	0	O
,	29086445	0	O
apn1	29086445	0	O
,	29086445	0	O
which	29086445	0	O
showed	29086445	0	O
a	29086445	0	O
very	29086445	0	O
specific	29086445	0	O
symbiotic	29086445	0	O
phenotype	29086445	0	O
.	29086445	0	O
It	29086445	0	O
formed	29086445	0	O
ineffective	29086445	0	O
nodules	29086445	0	O
when	29086445	0	O
inoculated	29086445	0	O
with	29086445	0	O
the	29086445	0	O
Mesorhizobium	29086445	0	O
loti	29086445	0	O
strain	29086445	0	O
TONO	29086445	0	O
.	29086445	0	O
In	29086445	0	O
these	29086445	0	O
nodules	29086445	0	O
,	29086445	0	O
infected	29086445	0	O
cells	29086445	0	O
disintegrated	29086445	0	O
and	29086445	0	O
successively	29086445	0	O
became	29086445	0	O
necrotic	29086445	0	O
,	29086445	0	O
indicating	29086445	0	B-Reg
premature	29086445	0	O
senescence	29086445	0	O
typical	29086445	0	O
of	29086445	0	O
Fix	29086445	0	B-Var
-	29086445	0	I-Var
mutants	29086445	0	I-Var
.	29086445	0	O
However	29086445	0	O
,	29086445	0	O
it	29086445	0	O
formed	29086445	0	O
effective	29086445	0	O
nodules	29086445	0	O
when	29086445	0	O
inoculated	29086445	0	O
with	29086445	0	O
the	29086445	0	O
M.	29086445	0	O
loti	29086445	0	O
strain	29086445	0	O
MAFF303099	29086445	0	O
.	29086445	0	O
Among	29086445	0	O
nine	29086445	0	O
different	29086445	0	O
M.	29086445	0	O
loti	29086445	0	O
strains	29086445	0	O
tested	29086445	0	O
,	29086445	0	O
four	29086445	0	O
formed	29086445	0	O
ineffective	29086445	0	O
nodules	29086445	0	O
and	29086445	0	O
five	29086445	0	O
formed	29086445	0	O
effective	29086445	0	O
nodules	29086445	0	O
on	29086445	0	O
apn1	29086445	0	O
roots	29086445	0	O
.	29086445	0	O
The	29086445	0	O
identified	29086445	0	O
causal	29086445	0	O
gene	29086445	0	O
,	29086445	0	O
ASPARTIC	29086445	0	O
PEPTIDASE	29086445	0	O
NODULE	29086445	0	O
-	29086445	0	O
INDUCED	29086445	0	O
1	29086445	0	O
(	29086445	0	O
LjAPN1	29086445	0	O
)	29086445	0	O
,	29086445	0	O
encodes	29086445	0	O
a	29086445	0	O
nepenthesin	29086445	0	O
-	29086445	0	O
type	29086445	0	O
aspartic	29086445	0	O
peptidase	29086445	0	O
.	29086445	0	O
The	29086445	0	O
well	29086445	0	O
characterized	29086445	0	O
Arabidopsis	29086445	0	O
aspartic	29086445	0	O
peptidase	29086445	0	O
CDR1	29086445	0	O
could	29086445	0	O
complement	29086445	0	O
the	29086445	0	O
strain	29086445	0	O
-	29086445	0	O
specific	29086445	0	O
Fix	29086445	0	O
-	29086445	0	O
phenotype	29086445	0	O
of	29086445	0	O
apn1	29086445	0	O
.	29086445	0	O
LjAPN1	29086445	0	O
is	29086445	0	O
a	29086445	0	O
typical	29086445	0	O
late	29086445	0	O
nodulin	29086445	0	O
;	29086445	0	O
its	29086445	0	O
gene	29086445	0	O
expression	29086445	0	O
was	29086445	0	O
exclusively	29086445	0	O
induced	29086445	0	O
during	29086445	0	O
nodule	29086445	0	O
development	29086445	0	O
.	29086445	0	O
LjAPN1	29086445	0	O
was	29086445	0	O
most	29086445	0	O
abundantly	29086445	0	O
expressed	29086445	0	O
in	29086445	0	O
the	29086445	0	O
infected	29086445	0	O
cells	29086445	0	O
in	29086445	0	O
the	29086445	0	O
nodules	29086445	0	O
.	29086445	0	O
Our	29086445	0	O
findings	29086445	0	O
indicate	29086445	0	O
that	29086445	0	O
LjAPN1	29086445	0	O
is	29086445	0	O
required	29086445	0	O
for	29086445	0	O
the	29086445	0	O
development	29086445	0	O
and	29086445	0	O
persistence	29086445	0	O
of	29086445	0	O
functional	29086445	0	O
(	29086445	0	O
nitrogen	29086445	0	O
-	29086445	0	O
fixing	29086445	0	O
)	29086445	0	O
symbiosis	29086445	0	O
in	29086445	0	O
a	29086445	0	O
rhizobial	29086445	0	O
strain	29086445	0	O
-	29086445	0	O
dependent	29086445	0	O
manner	29086445	0	O
,	29086445	0	O
and	29086445	0	O
thus	29086445	0	O
determines	29086445	0	O
compatibility	29086445	0	O
between	29086445	0	O
M.	29086445	0	O
loti	29086445	0	O
and	29086445	0	O
L.	29086445	0	O
japonicus	29086445	0	O
at	29086445	0	O
the	29086445	0	O
level	29086445	0	O
of	29086445	0	O
nitrogen	29086445	0	O
fixation	29086445	0	O
.	29086445	0	O

[	29087092	2	O
FILAGGRIN	29087092	2	O
GENE	29087092	2	O
NULL	29087092	2	O
-	29087092	2	O
MUTATIONS	29087092	2	O
AND	29087092	2	O
ATOPIC	29087092	2	O
DISEASES	29087092	2	O
]	29087092	2	O
.	29087092	2	O
Null	29087092	2	B-Var
-	29087092	2	I-Var
mutations	29087092	2	I-Var
which	29087092	2	O
cause	29087092	2	O
loss	29087092	2	B-NegReg
of	29087092	2	I-NegReg
function	29087092	2	I-NegReg
of	29087092	2	O
the	29087092	2	O
gene	29087092	2	O
encoding	29087092	2	O
filaggrin	29087092	2	O
(	29087092	2	B-Gene
FLG	29087092	2	I-Gene
)	29087092	2	I-Gene
have	29087092	2	O
been	29087092	2	O
strongly	29087092	2	O
linked	29087092	2	B-Reg
to	29087092	2	O
the	29087092	2	O
development	29087092	2	O
of	29087092	2	O
atopic	29087092	2	O
disorders	29087092	2	O
,	29087092	2	O
predominantly	29087092	2	O
atopic	29087092	2	B-Disease
eczema	29087092	2	I-Disease
/	29087092	2	I-Disease
dermatitis	29087092	2	I-Disease
syndrome	29087092	2	I-Disease
(	29087092	2	O
AEDS	29087092	2	O
)	29087092	2	O
.	29087092	2	O
Filaggrin	29087092	2	O
plays	29087092	2	O
a	29087092	2	O
key	29087092	2	O
role	29087092	2	O
in	29087092	2	O
epidermal	29087092	2	O
barrier	29087092	2	O
function	29087092	2	O
by	29087092	2	O
upholding	29087092	2	O
epidermal	29087092	2	O
structure	29087092	2	O
and	29087092	2	O
moisturization	29087092	2	O
.	29087092	2	O
Up	29087092	2	O
to	29087092	2	O
now	29087092	2	O
,	29087092	2	O
around	29087092	2	O
40	29087092	2	O
variants	29087092	2	O
of	29087092	2	O
FLG	29087092	2	O
null	29087092	2	O
-	29087092	2	O
mutations	29087092	2	O
have	29087092	2	O
been	29087092	2	O
genotyped	29087092	2	O
among	29087092	2	O
different	29087092	2	O
world	29087092	2	O
populations	29087092	2	O
.	29087092	2	O
FLG	29087092	2	O
null	29087092	2	O
-	29087092	2	O
mutations	29087092	2	O
are	29087092	2	O
present	29087092	2	O
in	29087092	2	O
up	29087092	2	O
to	29087092	2	O
10%	29087092	2	O
of	29087092	2	O
the	29087092	2	O
Caucasian	29087092	2	O
population	29087092	2	O
in	29087092	2	O
Western	29087092	2	O
Europe	29087092	2	O
and	29087092	2	O
North	29087092	2	O
America	29087092	2	O
,	29087092	2	O
with	29087092	2	O
R05X	29087092	2	O
and	29087092	2	O
2282	29087092	2	O
del4	29087092	2	O
as	29087092	2	O
the	29087092	2	O
most	29087092	2	O
common	29087092	2	O
null	29087092	2	O
-	29087092	2	O
mutations	29087092	2	O
.	29087092	2	O
Epidemiological	29087092	2	O
studies	29087092	2	O
conducted	29087092	2	O
in	29087092	2	O
Europe	29087092	2	O
indicate	29087092	2	O
a	29087092	2	O
latitude	29087092	2	O
dependent	29087092	2	O
distribution	29087092	2	O
of	29087092	2	O
common	29087092	2	O
FLG	29087092	2	O
null	29087092	2	O
-	29087092	2	O
mutations	29087092	2	O
with	29087092	2	O
a	29087092	2	O
decreasing	29087092	2	O
north	29087092	2	O
-	29087092	2	O
south	29087092	2	O
gradient	29087092	2	O
of	29087092	2	O
R501X	29087092	2	O
and	29087092	2	O
2282	29087092	2	O
del4	29087092	2	O
mutation	29087092	2	O
frequencies	29087092	2	O
.	29087092	2	O
FLG	29087092	2	B-Gene
null	29087092	2	B-Var
-	29087092	2	I-Var
mutation	29087092	2	I-Var
carriers	29087092	2	O
are	29087092	2	O
prone	29087092	2	O
to	29087092	2	O
develop	29087092	2	B-PosReg
unspecific	29087092	2	B-Disease
skin	29087092	2	I-Disease
symptoms	29087092	2	I-Disease
related	29087092	2	O
to	29087092	2	O
atopic	29087092	2	O
and	29087092	2	O
non	29087092	2	O
-	29087092	2	O
atopic	29087092	2	O
skin	29087092	2	O
disorders	29087092	2	O
due	29087092	2	O
to	29087092	2	O
their	29087092	2	O
defect	29087092	2	O
of	29087092	2	O
epidermal	29087092	2	O
barrier	29087092	2	O
function	29087092	2	O
,	29087092	2	O
which	29087092	2	O
allows	29087092	2	O
greater	29087092	2	O
skin	29087092	2	O
penetration	29087092	2	O
of	29087092	2	O
various	29087092	2	O
hazards	29087092	2	O
.	29087092	2	O
Epidemiological	29087092	2	O
studies	29087092	2	O
indicate	29087092	2	O
an	29087092	2	O
association	29087092	2	O
of	29087092	2	O
FLG	29087092	2	B-Gene
null	29087092	2	B-Var
-	29087092	2	I-Var
mutations	29087092	2	I-Var
with	29087092	2	O
AEDS	29087092	2	B-Disease
,	29087092	2	O
whereas	29087092	2	O
results	29087092	2	O
regarding	29087092	2	O
an	29087092	2	O
association	29087092	2	O
of	29087092	2	O
FLG	29087092	2	O
null	29087092	2	O
-	29087092	2	O
mutations	29087092	2	O
with	29087092	2	O
sensitization	29087092	2	O
to	29087092	2	O
common	29087092	2	O
inhalant	29087092	2	O
allergens	29087092	2	O
and	29087092	2	O
development	29087092	2	O
of	29087092	2	O
rhinitis	29087092	2	O
and	29087092	2	O
asthma	29087092	2	O
are	29087092	2	O
incoherent	29087092	2	O
.	29087092	2	O
A	29087092	2	O
study	29087092	2	O
conducted	29087092	2	O
in	29087092	2	O
Croatia	29087092	2	O
found	29087092	2	O
a	29087092	2	O
low	29087092	2	O
frequency	29087092	2	O
of	29087092	2	O
FLG	29087092	2	O
null	29087092	2	O
-	29087092	2	O
mutations	29087092	2	O
in	29087092	2	O
general	29087092	2	O
population	29087092	2	O
(	29087092	2	O
2.6%	29087092	2	O
)	29087092	2	O
and	29087092	2	O
did	29087092	2	O
not	29087092	2	O
confirm	29087092	2	O
FLG	29087092	2	O
null	29087092	2	O
-	29087092	2	O
mutations	29087092	2	O
as	29087092	2	O
an	29087092	2	O
etiological	29087092	2	O
factor	29087092	2	O
for	29087092	2	O
atopy	29087092	2	O
and	29087092	2	O
atopic	29087092	2	O
disease	29087092	2	O
in	29087092	2	O
the	29087092	2	O
studied	29087092	2	O
population	29087092	2	O
.	29087092	2	O

Genetic	29088233	4	O
anticipation	29088233	4	O
in	29088233	4	O
Swedish	29088233	4	O
Lynch	29088233	4	O
syndrome	29088233	4	O
families	29088233	4	O
.	29088233	4	O
Among	29088233	4	O
hereditary	29088233	4	O
colorectal	29088233	4	O
cancer	29088233	4	O
predisposing	29088233	4	O
syndromes	29088233	4	O
,	29088233	4	O
Lynch	29088233	4	B-Disease
syndrome	29088233	4	I-Disease
(	29088233	4	O
LS	29088233	4	O
)	29088233	4	O
caused	29088233	4	B-Reg
by	29088233	4	I-Reg
mutations	29088233	4	B-Var
in	29088233	4	O
DNA	29088233	4	O
mismatch	29088233	4	O
repair	29088233	4	O
genes	29088233	4	O
MLH1	29088233	4	B-Gene
,	29088233	4	O
MSH2	29088233	4	B-Gene
,	29088233	4	O
MSH6	29088233	4	B-Gene
or	29088233	4	O
PMS2	29088233	4	B-Gene
is	29088233	4	O
the	29088233	4	O
most	29088233	4	O
common	29088233	4	O
.	29088233	4	O
Patients	29088233	4	O
with	29088233	4	O
LS	29088233	4	O
have	29088233	4	O
an	29088233	4	O
increased	29088233	4	O
risk	29088233	4	O
of	29088233	4	O
early	29088233	4	O
onset	29088233	4	O
colon	29088233	4	O
and	29088233	4	O
endometrial	29088233	4	O
cancer	29088233	4	O
,	29088233	4	O
but	29088233	4	O
also	29088233	4	O
other	29088233	4	O
tumors	29088233	4	O
that	29088233	4	O
generally	29088233	4	O
have	29088233	4	O
an	29088233	4	O
earlier	29088233	4	O
onset	29088233	4	O
compared	29088233	4	O
to	29088233	4	O
the	29088233	4	O
general	29088233	4	O
population	29088233	4	O
.	29088233	4	O
However	29088233	4	O
,	29088233	4	O
age	29088233	4	O
at	29088233	4	O
first	29088233	4	O
primary	29088233	4	O
cancer	29088233	4	O
varies	29088233	4	O
within	29088233	4	O
families	29088233	4	O
and	29088233	4	O
genetic	29088233	4	O
anticipation	29088233	4	O
,	29088233	4	O
i.e.	29088233	4	O
decreasing	29088233	4	O
age	29088233	4	O
at	29088233	4	O
onset	29088233	4	O
in	29088233	4	O
successive	29088233	4	O
generations	29088233	4	O
,	29088233	4	O
has	29088233	4	O
been	29088233	4	O
suggested	29088233	4	O
in	29088233	4	O
LS	29088233	4	O
.	29088233	4	O
Anticipation	29088233	4	O
is	29088233	4	O
a	29088233	4	O
well	29088233	4	O
-	29088233	4	O
known	29088233	4	O
phenomenon	29088233	4	O
in	29088233	4	O
e.	29088233	4	O
g	29088233	4	O
neurodegenerative	29088233	4	O
diseases	29088233	4	O
and	29088233	4	O
several	29088233	4	O
reports	29088233	4	O
have	29088233	4	O
studied	29088233	4	O
anticipation	29088233	4	O
in	29088233	4	O
heritable	29088233	4	O
cancer	29088233	4	O
.	29088233	4	O
The	29088233	4	O
purpose	29088233	4	O
of	29088233	4	O
this	29088233	4	O
study	29088233	4	O
is	29088233	4	O
to	29088233	4	O
determine	29088233	4	O
whether	29088233	4	O
anticipation	29088233	4	O
can	29088233	4	O
be	29088233	4	O
shown	29088233	4	O
in	29088233	4	O
a	29088233	4	O
nationwide	29088233	4	O
cohort	29088233	4	O
of	29088233	4	O
Swedish	29088233	4	O
LS	29088233	4	O
families	29088233	4	O
referred	29088233	4	O
to	29088233	4	O
the	29088233	4	O
regional	29088233	4	O
departments	29088233	4	O
of	29088233	4	O
clinical	29088233	4	O
genetics	29088233	4	O
in	29088233	4	O
Lund	29088233	4	O
,	29088233	4	O
Stockholm	29088233	4	O
,	29088233	4	O
Linköping	29088233	4	O
,	29088233	4	O
Uppsala	29088233	4	O
and	29088233	4	O
Umeå	29088233	4	O
between	29088233	4	O
the	29088233	4	O
years	29088233	4	O
1990	29088233	4	O
-	29088233	4	O
2013	29088233	4	O
.	29088233	4	O
We	29088233	4	O
analyzed	29088233	4	O
a	29088233	4	O
homogenous	29088233	4	O
group	29088233	4	O
of	29088233	4	O
mutation	29088233	4	O
carriers	29088233	4	O
,	29088233	4	O
utilizing	29088233	4	O
information	29088233	4	O
from	29088233	4	O
both	29088233	4	O
affected	29088233	4	O
and	29088233	4	O
non	29088233	4	O
-	29088233	4	O
affected	29088233	4	O
family	29088233	4	O
members	29088233	4	O
.	29088233	4	O
In	29088233	4	O
total	29088233	4	O
,	29088233	4	O
239	29088233	4	O
families	29088233	4	O
with	29088233	4	O
a	29088233	4	O
mismatch	29088233	4	O
repair	29088233	4	O
gene	29088233	4	O
mutation	29088233	4	O
(	29088233	4	O
96	29088233	4	O
MLH1	29088233	4	O
families	29088233	4	O
,	29088233	4	O
90	29088233	4	O
MSH2	29088233	4	O
families	29088233	4	O
including	29088233	4	O
one	29088233	4	O
family	29088233	4	O
with	29088233	4	O
an	29088233	4	O
EPCAM	29088233	4	O
-	29088233	4	O
MSH2	29088233	4	O
deletion	29088233	4	O
,	29088233	4	O
39	29088233	4	O
MSH6	29088233	4	O
families	29088233	4	O
,	29088233	4	O
12	29088233	4	O
PMS2	29088233	4	O
families	29088233	4	O
,	29088233	4	O
and	29088233	4	O
2	29088233	4	O
MLH1	29088233	4	O
PMS2	29088233	4	O
families	29088233	4	O
)	29088233	4	O
comprising	29088233	4	O
1028	29088233	4	O
at	29088233	4	O
-	29088233	4	O
risk	29088233	4	O
carriers	29088233	4	O
were	29088233	4	O
identified	29088233	4	O
among	29088233	4	O
the	29088233	4	O
Swedish	29088233	4	O
LS	29088233	4	O
families	29088233	4	O
,	29088233	4	O
of	29088233	4	O
which	29088233	4	O
1003	29088233	4	O
mutation	29088233	4	O
carriers	29088233	4	O
had	29088233	4	O
available	29088233	4	O
follow	29088233	4	O
-	29088233	4	O
up	29088233	4	O
information	29088233	4	O
and	29088233	4	O
could	29088233	4	O
be	29088233	4	O
included	29088233	4	O
in	29088233	4	O
the	29088233	4	O
study	29088233	4	O
.	29088233	4	O
Using	29088233	4	O
a	29088233	4	O
normal	29088233	4	O
random	29088233	4	O
effects	29088233	4	O
model	29088233	4	O
(	29088233	4	O
NREM	29088233	4	O
)	29088233	4	O
we	29088233	4	O
estimate	29088233	4	O
a	29088233	4	O
2.1	29088233	4	O
year	29088233	4	O
decrease	29088233	4	O
in	29088233	4	O
age	29088233	4	O
of	29088233	4	O
diagnosis	29088233	4	O
per	29088233	4	O
generation	29088233	4	O
.	29088233	4	O
An	29088233	4	O
alternative	29088233	4	O
analysis	29088233	4	O
using	29088233	4	O
a	29088233	4	O
mixed	29088233	4	O
-	29088233	4	O
effects	29088233	4	O
Cox	29088233	4	O
proportional	29088233	4	O
hazards	29088233	4	O
model	29088233	4	O
(	29088233	4	O
COX	29088233	4	O
-	29088233	4	O
R	29088233	4	O
)	29088233	4	O
estimates	29088233	4	O
a	29088233	4	O
hazard	29088233	4	O
ratio	29088233	4	O
of	29088233	4	O
exp	29088233	4	O
(	29088233	4	O
0.171	29088233	4	O
)	29088233	4	O
,	29088233	4	O
or	29088233	4	O
about	29088233	4	O
1.19	29088233	4	O
,	29088233	4	O
for	29088233	4	O
age	29088233	4	O
of	29088233	4	O
diagnosis	29088233	4	O
between	29088233	4	O
consecutive	29088233	4	O
generations	29088233	4	O
.	29088233	4	O
LS	29088233	4	O
-	29088233	4	O
associated	29088233	4	O
gene	29088233	4	O
-	29088233	4	O
specific	29088233	4	O
anticipation	29088233	4	O
effects	29088233	4	O
are	29088233	4	O
evident	29088233	4	O
for	29088233	4	O
MSH2	29088233	4	O
(	29088233	4	O
2.6	29088233	4	O
years	29088233	4	O
/	29088233	4	O
generation	29088233	4	O
for	29088233	4	O
NREM	29088233	4	O
and	29088233	4	O
hazard	29088233	4	O
ratio	29088233	4	O
of	29088233	4	O
1.33	29088233	4	O
for	29088233	4	O
COX	29088233	4	O
-	29088233	4	O
R	29088233	4	O
)	29088233	4	O
and	29088233	4	O
PMS2	29088233	4	O
(	29088233	4	O
7.3	29088233	4	O
years	29088233	4	O
/	29088233	4	O
generation	29088233	4	O
and	29088233	4	O
hazard	29088233	4	O
ratio	29088233	4	O
of	29088233	4	O
1.86	29088233	4	O
)	29088233	4	O
.	29088233	4	O
The	29088233	4	O
estimated	29088233	4	O
anticipation	29088233	4	O
effects	29088233	4	O
for	29088233	4	O
MLH1	29088233	4	O
and	29088233	4	O
MSH6	29088233	4	O
are	29088233	4	O
smaller	29088233	4	O
.	29088233	4	O

FGF	29097598	0	O
-	29097598	0	O
FGFR	29097598	0	O
Mediates	29097598	0	O
the	29097598	0	O
Activity	29097598	0	O
-	29097598	0	O
Dependent	29097598	0	O
Dendritogenesis	29097598	0	O
of	29097598	0	O
Layer	29097598	0	O
IV	29097598	0	O
Neurons	29097598	0	O
during	29097598	0	O
Barrel	29097598	0	O
Formation	29097598	0	O
.	29097598	0	O
Fibroblast	29097598	0	O
growth	29097598	0	O
factors	29097598	0	O
(	29097598	0	O
FGFs	29097598	0	O
)	29097598	0	O
and	29097598	0	O
FGF	29097598	0	O
receptors	29097598	0	O
(	29097598	0	O
FGFRs	29097598	0	O
)	29097598	0	O
are	29097598	0	O
known	29097598	0	O
for	29097598	0	O
their	29097598	0	O
potent	29097598	0	O
effects	29097598	0	O
on	29097598	0	O
cell	29097598	0	O
proliferation	29097598	0	O
/	29097598	0	O
differentiation	29097598	0	O
and	29097598	0	O
cortical	29097598	0	O
patterning	29097598	0	O
in	29097598	0	O
the	29097598	0	O
developing	29097598	0	O
brain	29097598	0	O
.	29097598	0	O
However	29097598	0	O
,	29097598	0	O
little	29097598	0	O
is	29097598	0	O
known	29097598	0	O
regarding	29097598	0	O
the	29097598	0	O
roles	29097598	0	O
of	29097598	0	O
FGFs	29097598	0	O
/	29097598	0	O
FGFRs	29097598	0	O
in	29097598	0	O
cortical	29097598	0	O
circuit	29097598	0	O
formation	29097598	0	O
.	29097598	0	O
Here	29097598	0	O
we	29097598	0	O
show	29097598	0	O
that	29097598	0	O
Fgfr1	29097598	0	O
/	29097598	0	O
2	29097598	0	O
/	29097598	0	O
3	29097598	0	O
and	29097598	0	O
Fgf7	29097598	0	O
/	29097598	0	O
9	29097598	0	O
/	29097598	0	O
10	29097598	0	O
/	29097598	0	O
22	29097598	0	O
mRNAs	29097598	0	O
are	29097598	0	O
expressed	29097598	0	O
in	29097598	0	O
the	29097598	0	O
developing	29097598	0	O
primary	29097598	0	O
somatosensory	29097598	0	O
(	29097598	0	O
S1	29097598	0	O
)	29097598	0	O
barrel	29097598	0	O
cortex	29097598	0	O
.	29097598	0	O
Barrel	29097598	0	O
cortex	29097598	0	O
layer	29097598	0	O
IV	29097598	0	O
spiny	29097598	0	O
stellate	29097598	0	O
cells	29097598	0	O
(	29097598	0	O
bSCs	29097598	0	O
)	29097598	0	O
are	29097598	0	O
the	29097598	0	O
primary	29097598	0	O
recipients	29097598	0	O
of	29097598	0	O
ascending	29097598	0	O
sensory	29097598	0	O
information	29097598	0	O
via	29097598	0	O
thalamocortical	29097598	0	O
axons	29097598	0	O
(	29097598	0	O
TCAs	29097598	0	O
)	29097598	0	O
.	29097598	0	O
Detail	29097598	0	O
quantification	29097598	0	O
revealed	29097598	0	O
distinctive	29097598	0	O
phases	29097598	0	O
for	29097598	0	O
bSC	29097598	0	O
dendritogenesis	29097598	0	O
:	29097598	0	O
orienting	29097598	0	O
dendrites	29097598	0	O
toward	29097598	0	O
TCAs	29097598	0	O
,	29097598	0	O
adding	29097598	0	O
de	29097598	0	O
novo	29097598	0	O
dendritic	29097598	0	O
segments	29097598	0	O
,	29097598	0	O
and	29097598	0	O
elongating	29097598	0	O
dendritic	29097598	0	O
length	29097598	0	O
,	29097598	0	O
while	29097598	0	O
maintaining	29097598	0	O
dendritic	29097598	0	O
patterns	29097598	0	O
.	29097598	0	O
Deleting	29097598	0	O
Fgfr1	29097598	0	O
/	29097598	0	O
2	29097598	0	O
/	29097598	0	O
3	29097598	0	O
in	29097598	0	O
bSCs	29097598	0	O
had	29097598	0	O
minimal	29097598	0	O
impact	29097598	0	O
on	29097598	0	O
dendritic	29097598	0	O
polarity	29097598	0	O
but	29097598	0	O
transiently	29097598	0	O
increased	29097598	0	O
the	29097598	0	O
number	29097598	0	O
of	29097598	0	O
dendritic	29097598	0	O
segments	29097598	0	O
.	29097598	0	O
However	29097598	0	O
,	29097598	0	O
6	29097598	0	O
d	29097598	0	O
later	29097598	0	O
,	29097598	0	O
FGFR1	29097598	0	O
/	29097598	0	O
2	29097598	0	O
/	29097598	0	O
3	29097598	0	O
loss	29097598	0	O
of	29097598	0	O
function	29097598	0	O
reduced	29097598	0	O
dendritic	29097598	0	O
branch	29097598	0	O
numbers	29097598	0	O
.	29097598	0	O
These	29097598	0	O
data	29097598	0	O
suggest	29097598	0	O
that	29097598	0	O
FGFs	29097598	0	O
/	29097598	0	O
FGFRs	29097598	0	O
have	29097598	0	O
a	29097598	0	O
role	29097598	0	O
in	29097598	0	O
stabilizing	29097598	0	O
dendritic	29097598	0	O
patterning	29097598	0	O
.	29097598	0	O
Depolarization	29097598	0	O
of	29097598	0	O
cultured	29097598	0	O
mouse	29097598	0	O
cortical	29097598	0	O
neurons	29097598	0	O
upregulated	29097598	0	O
the	29097598	0	O
levels	29097598	0	O
of	29097598	0	O
several	29097598	0	O
Fgf	29097598	0	O
/	29097598	0	O
Fgfr	29097598	0	O
mRNAs	29097598	0	O
within	29097598	0	O
2	29097598	0	O
h.	29097598	0	O
In	29097598	0	O
vivo	29097598	0	O
,	29097598	0	O
within	29097598	0	O
6	29097598	0	O
h	29097598	0	O
of	29097598	0	O
systemic	29097598	0	O
kainic	29097598	0	O
acid	29097598	0	O
administration	29097598	0	O
at	29097598	0	O
postnatal	29097598	0	O
day	29097598	0	O
6	29097598	0	O
,	29097598	0	O
mRNA	29097598	0	O
levels	29097598	0	O
of	29097598	0	O
Fgf9	29097598	0	O
,	29097598	0	O
Fgf10	29097598	0	O
,	29097598	0	O
Fgfr2c	29097598	0	O
,	29097598	0	O
and	29097598	0	O
Fgfr3b	29097598	0	O
in	29097598	0	O
S1	29097598	0	O
cortices	29097598	0	O
were	29097598	0	O
enhanced	29097598	0	O
,	29097598	0	O
and	29097598	0	O
this	29097598	0	O
was	29097598	0	O
accompanied	29097598	0	O
by	29097598	0	O
exuberant	29097598	0	O
dendritogenesis	29097598	0	O
of	29097598	0	O
bSCs	29097598	0	O
by	29097598	0	O
24	29097598	0	O
h.	29097598	0	O
Deleting	29097598	0	O
Fgfr1	29097598	0	O
/	29097598	0	O
2	29097598	0	O
/	29097598	0	O
3	29097598	0	O
abolished	29097598	0	O
kainic	29097598	0	O
acid	29097598	0	O
-	29097598	0	O
induced	29097598	0	O
bSC	29097598	0	O
dendritic	29097598	0	O
overgrowth	29097598	0	O
.	29097598	0	O
Finally	29097598	0	O
,	29097598	0	O
FGF9	29097598	0	O
/	29097598	0	O
10	29097598	0	O
gain	29097598	0	O
of	29097598	0	O
function	29097598	0	O
also	29097598	0	O
resulted	29097598	0	O
in	29097598	0	O
extensive	29097598	0	O
dendritogenesis	29097598	0	O
.	29097598	0	O
Together	29097598	0	O
,	29097598	0	O
our	29097598	0	O
data	29097598	0	O
suggest	29097598	0	O
that	29097598	0	O
FGFs	29097598	0	O
/	29097598	0	O
FGFRs	29097598	0	O
can	29097598	0	O
be	29097598	0	O
regulated	29097598	0	O
by	29097598	0	O
glutamate	29097598	0	O
transmission	29097598	0	O
to	29097598	0	O
modulate	29097598	0	O
/	29097598	0	O
stabilize	29097598	0	O
bSC	29097598	0	O
dendritic	29097598	0	O
complexity	29097598	0	O
.	29097598	0	O
Both	29097598	0	O
male	29097598	0	O
and	29097598	0	O
female	29097598	0	O
mice	29097598	0	O
were	29097598	0	O
used	29097598	0	O
for	29097598	0	O
our	29097598	0	O
study	29097598	0	O
.	29097598	0	O
SIGNIFICANCE	29097598	0	O
STATEMENT	29097598	0	O
Glutamatergic	29097598	0	O
transmission	29097598	0	O
plays	29097598	0	O
critical	29097598	0	O
roles	29097598	0	O
in	29097598	0	O
cortical	29097598	0	O
circuit	29097598	0	O
formation	29097598	0	O
.	29097598	0	O
Its	29097598	0	O
dysregulation	29097598	0	O
has	29097598	0	O
been	29097598	0	O
proposed	29097598	0	O
as	29097598	0	O
a	29097598	0	O
core	29097598	0	O
factor	29097598	0	O
in	29097598	0	O
the	29097598	0	O
etiology	29097598	0	O
of	29097598	0	O
many	29097598	0	O
neurological	29097598	0	O
diseases	29097598	0	O
.	29097598	0	O
We	29097598	0	O
found	29097598	0	O
that	29097598	0	O
excessive	29097598	0	O
glutamate	29097598	0	O
transmission	29097598	0	O
upregulated	29097598	0	O
mRNA	29097598	0	O
expression	29097598	0	O
of	29097598	0	O
Fgfrs	29097598	0	O
and	29097598	0	O
their	29097598	0	O
ligands	29097598	0	O
Fgfs	29097598	0	O
Deleting	29097598	0	B-Var
Fgfr1	29097598	0	B-Gene
/	29097598	0	I-Gene
2	29097598	0	I-Gene
/	29097598	0	I-Gene
3	29097598	0	I-Gene
not	29097598	0	O
only	29097598	0	O
impaired	29097598	0	B-NegReg
bSC	29097598	0	O
dendritogenesis	29097598	0	O
but	29097598	0	O
also	29097598	0	O
abolished	29097598	0	B-NegReg
glutamate	29097598	0	O
transmission	29097598	0	O
-	29097598	0	O
induced	29097598	0	O
dendritic	29097598	0	O
overgrowth	29097598	0	O
.	29097598	0	O
Overexpressing	29097598	0	O
FGF9	29097598	0	O
or	29097598	0	O
FGF10	29097598	0	O
in	29097598	0	O
cortical	29097598	0	O
glutamatergic	29097598	0	O
neurons	29097598	0	O
results	29097598	0	O
in	29097598	0	O
excessive	29097598	0	O
dendritic	29097598	0	O
outgrowth	29097598	0	O
within	29097598	0	O
24	29097598	0	O
h	29097598	0	O
,	29097598	0	O
resembling	29097598	0	O
the	29097598	0	O
changes	29097598	0	O
induced	29097598	0	O
by	29097598	0	O
excessive	29097598	0	O
glutamate	29097598	0	O
transmission	29097598	0	O
.	29097598	0	O
Our	29097598	0	O
findings	29097598	0	O
provide	29097598	0	O
strong	29097598	0	O
evidence	29097598	0	O
for	29097598	0	O
the	29097598	0	O
physiological	29097598	0	O
role	29097598	0	O
of	29097598	0	O
fibroblast	29097598	0	O
growth	29097598	0	O
factors	29097598	0	O
(	29097598	0	O
FGFs	29097598	0	O
)	29097598	0	O
and	29097598	0	O
FGF	29097598	0	O
receptors	29097598	0	O
(	29097598	0	O
FGFRs	29097598	0	O
)	29097598	0	O
in	29097598	0	O
establishing	29097598	0	O
and	29097598	0	O
maintaining	29097598	0	O
cortical	29097598	0	O
circuits	29097598	0	O
.	29097598	0	O
Perturbing	29097598	0	O
the	29097598	0	O
expression	29097598	0	O
levels	29097598	0	O
of	29097598	0	O
FGFs	29097598	0	O
/	29097598	0	O
FGFRs	29097598	0	O
by	29097598	0	O
excessive	29097598	0	O
glutamatergic	29097598	0	O
neurotransmission	29097598	0	O
could	29097598	0	O
lead	29097598	0	O
to	29097598	0	O
abnormal	29097598	0	O
neuronal	29097598	0	O
circuits	29097598	0	O
,	29097598	0	O
which	29097598	0	O
may	29097598	0	O
contribute	29097598	0	O
to	29097598	0	O
neurological	29097598	0	O
and	29097598	0	O
psychiatric	29097598	0	O
disease	29097598	0	O
.	29097598	0	O

Why	29099487	2	O
are	29099487	2	O
there	29099487	2	O
hotspot	29099487	2	O
mutations	29099487	2	O
in	29099487	2	O
the	29099487	2	O
TP53	29099487	2	O
gene	29099487	2	O
in	29099487	2	O
human	29099487	2	O
cancers	29099487	2	O
?	29099487	2	O
The	29099487	2	O
p53	29099487	2	O
gene	29099487	2	O
contains	29099487	2	O
homozygous	29099487	2	O
mutations	29099487	2	O
in	29099487	2	O
50	29099487	2	O
-	29099487	2	O
60%	29099487	2	O
of	29099487	2	O
human	29099487	2	O
cancers	29099487	2	O
.	29099487	2	O
About	29099487	2	O
90%	29099487	2	O
of	29099487	2	O
these	29099487	2	O
mutations	29099487	2	O
encode	29099487	2	O
missense	29099487	2	O
mutant	29099487	2	O
proteins	29099487	2	O
that	29099487	2	O
span	29099487	2	O
190	29099487	2	O
different	29099487	2	O
codons	29099487	2	O
localized	29099487	2	O
in	29099487	2	O
the	29099487	2	O
DNA	29099487	2	O
-	29099487	2	O
binding	29099487	2	O
domain	29099487	2	O
of	29099487	2	O
the	29099487	2	O
gene	29099487	2	O
and	29099487	2	O
protein	29099487	2	O
.	29099487	2	O
These	29099487	2	O
mutations	29099487	2	B-Var
produce	29099487	2	O
a	29099487	2	O
protein	29099487	2	O
with	29099487	2	O
a	29099487	2	O
reduced	29099487	2	O
capacity	29099487	2	O
to	29099487	2	O
bind	29099487	2	O
to	29099487	2	O
a	29099487	2	O
specific	29099487	2	O
DNA	29099487	2	O
sequence	29099487	2	O
that	29099487	2	O
regulates	29099487	2	B-Reg
the	29099487	2	O
p53	29099487	2	O
transcriptional	29099487	2	O
pathway	29099487	2	O
.	29099487	2	O
Eight	29099487	2	O
of	29099487	2	O
these	29099487	2	O
mutations	29099487	2	O
are	29099487	2	O
localized	29099487	2	O
in	29099487	2	O
codons	29099487	2	O
that	29099487	2	O
account	29099487	2	O
for	29099487	2	O
28%	29099487	2	O
of	29099487	2	O
the	29099487	2	O
total	29099487	2	O
p53	29099487	2	O
mutations	29099487	2	O
and	29099487	2	O
these	29099487	2	O
alleles	29099487	2	O
appear	29099487	2	O
to	29099487	2	O
be	29099487	2	O
selected	29099487	2	O
for	29099487	2	O
preferentially	29099487	2	O
in	29099487	2	O
human	29099487	2	O
cancers	29099487	2	O
of	29099487	2	O
many	29099487	2	O
tissue	29099487	2	O
types	29099487	2	O
.	29099487	2	O
This	29099487	2	O
article	29099487	2	O
explores	29099487	2	O
the	29099487	2	O
question	29099487	2	O
'	29099487	2	O
Why	29099487	2	O
are	29099487	2	O
there	29099487	2	O
hotspot	29099487	2	O
mutations	29099487	2	O
in	29099487	2	O
the	29099487	2	O
p53	29099487	2	O
gene	29099487	2	O
in	29099487	2	O
human	29099487	2	O
cancers	29099487	2	O
?	29099487	2	O
'	29099487	2	O
Four	29099487	2	O
possible	29099487	2	O
reasons	29099487	2	O
for	29099487	2	O
this	29099487	2	O
are	29099487	2	O
considered	29099487	2	O
;	29099487	2	O
(	29099487	2	O
1	29099487	2	O
)	29099487	2	O
the	29099487	2	O
hotspot	29099487	2	O
mutant	29099487	2	B-Var
alleles	29099487	2	O
produce	29099487	2	O
a	29099487	2	O
protein	29099487	2	O
that	29099487	2	O
has	29099487	2	O
a	29099487	2	O
highly	29099487	2	O
altered	29099487	2	B-Reg
structure	29099487	2	O
,	29099487	2	O
(	29099487	2	O
2	29099487	2	O
)	29099487	2	O
environmental	29099487	2	O
mutagens	29099487	2	O
produce	29099487	2	O
allele	29099487	2	O
-	29099487	2	O
specific	29099487	2	O
changes	29099487	2	O
in	29099487	2	O
the	29099487	2	O
p53	29099487	2	O
gene	29099487	2	O
,	29099487	2	O
(	29099487	2	O
3	29099487	2	O
)	29099487	2	O
these	29099487	2	O
mutations	29099487	2	O
arise	29099487	2	O
at	29099487	2	O
selected	29099487	2	O
sites	29099487	2	O
in	29099487	2	O
the	29099487	2	O
gene	29099487	2	O
due	29099487	2	O
to	29099487	2	O
a	29099487	2	O
specific	29099487	2	O
DNA	29099487	2	O
sequence	29099487	2	O
,	29099487	2	O
such	29099487	2	O
as	29099487	2	O
a	29099487	2	O
methylated	29099487	2	O
cytosine	29099487	2	O
residue	29099487	2	O
in	29099487	2	O
a	29099487	2	O
CpG	29099487	2	O
dinucleotide	29099487	2	O
,	29099487	2	O
which	29099487	2	O
has	29099487	2	O
a	29099487	2	O
higher	29099487	2	O
mutation	29099487	2	O
rate	29099487	2	O
changing	29099487	2	O
C	29099487	2	O
to	29099487	2	O
T	29099487	2	O
nucleotides	29099487	2	O
,	29099487	2	O
(	29099487	2	O
4	29099487	2	O
)	29099487	2	O
along	29099487	2	O
with	29099487	2	O
the	29099487	2	O
observed	29099487	2	O
change	29099487	2	O
in	29099487	2	O
mutant	29099487	2	O
p53	29099487	2	O
proteins	29099487	2	O
,	29099487	2	O
which	29099487	2	O
produce	29099487	2	O
a	29099487	2	O
loss	29099487	2	O
of	29099487	2	O
function	29099487	2	O
(	29099487	2	O
DNA	29099487	2	O
binding	29099487	2	O
and	29099487	2	O
transcription	29099487	2	O
)	29099487	2	O
,	29099487	2	O
some	29099487	2	O
mutant	29099487	2	B-Var
proteins	29099487	2	O
have	29099487	2	O
an	29099487	2	O
allele	29099487	2	O
-	29099487	2	O
specific	29099487	2	O
gain	29099487	2	B-PosReg
of	29099487	2	I-PosReg
function	29099487	2	I-PosReg
that	29099487	2	O
promotes	29099487	2	O
cancer	29099487	2	B-Disease
.	29099487	2	O
Evidence	29099487	2	O
is	29099487	2	O
presented	29099487	2	O
that	29099487	2	O
demonstrates	29099487	2	O
the	29099487	2	O
first	29099487	2	O
three	29099487	2	O
possibilities	29099487	2	O
all	29099487	2	O
contribute	29099487	2	O
some	29099487	2	O
property	29099487	2	O
to	29099487	2	O
this	29099487	2	O
list	29099487	2	O
of	29099487	2	O
hotspot	29099487	2	O
mutations	29099487	2	O
.	29099487	2	O
The	29099487	2	O
fourth	29099487	2	O
possibility	29099487	2	O
remains	29099487	2	O
to	29099487	2	O
be	29099487	2	O
tested	29099487	2	O
.	29099487	2	O

Mutant	29099488	0	O
p53	29099488	0	O
partners	29099488	0	O
in	29099488	0	O
crime	29099488	0	O
.	29099488	0	O
Mutant	29099488	0	B-Var
p53	29099488	0	B-Gene
proteins	29099488	0	O
impart	29099488	0	O
changes	29099488	0	B-Reg
in	29099488	0	O
cellular	29099488	0	O
behavior	29099488	0	O
and	29099488	0	O
function	29099488	0	O
through	29099488	0	O
interactions	29099488	0	O
with	29099488	0	O
proteins	29099488	0	O
that	29099488	0	O
alter	29099488	0	O
gene	29099488	0	O
expression	29099488	0	O
.	29099488	0	O
The	29099488	0	O
milieu	29099488	0	O
of	29099488	0	O
intracellular	29099488	0	O
proteins	29099488	0	O
available	29099488	0	O
to	29099488	0	O
interact	29099488	0	O
with	29099488	0	O
mutant	29099488	0	O
p53	29099488	0	O
is	29099488	0	O
context	29099488	0	O
specific	29099488	0	O
and	29099488	0	O
changes	29099488	0	O
with	29099488	0	O
disease	29099488	0	O
,	29099488	0	O
cell	29099488	0	O
type	29099488	0	O
,	29099488	0	O
and	29099488	0	O
environmental	29099488	0	O
conditions	29099488	0	O
.	29099488	0	O
Varying	29099488	0	O
conformations	29099488	0	O
of	29099488	0	O
mutant	29099488	0	B-Var
p53	29099488	0	B-Gene
largely	29099488	0	O
dictate	29099488	0	B-Reg
protein	29099488	0	O
-	29099488	0	O
protein	29099488	0	O
interactions	29099488	0	O
as	29099488	0	O
different	29099488	0	O
point	29099488	0	O
mutations	29099488	0	O
within	29099488	0	O
protein	29099488	0	O
-	29099488	0	O
coding	29099488	0	O
regions	29099488	0	O
greatly	29099488	0	O
alter	29099488	0	O
the	29099488	0	O
extent	29099488	0	O
and	29099488	0	O
array	29099488	0	O
of	29099488	0	O
gain	29099488	0	O
-	29099488	0	O
of	29099488	0	O
-	29099488	0	O
function	29099488	0	O
(	29099488	0	O
GOF	29099488	0	O
)	29099488	0	O
activities	29099488	0	O
.	29099488	0	O
Given	29099488	0	O
such	29099488	0	O
variables	29099488	0	O
,	29099488	0	O
how	29099488	0	O
can	29099488	0	O
knowledge	29099488	0	O
regarding	29099488	0	O
p53	29099488	0	O
missense	29099488	0	O
mutations	29099488	0	O
be	29099488	0	O
translated	29099488	0	O
into	29099488	0	O
predicting	29099488	0	O
or	29099488	0	O
altering	29099488	0	O
biologic	29099488	0	O
activity	29099488	0	O
for	29099488	0	O
therapy	29099488	0	O
?	29099488	0	O
How	29099488	0	O
may	29099488	0	O
knowledge	29099488	0	O
regarding	29099488	0	O
mutant	29099488	0	O
p53	29099488	0	O
functions	29099488	0	O
within	29099488	0	O
certain	29099488	0	O
disease	29099488	0	O
contexts	29099488	0	O
be	29099488	0	O
harnessed	29099488	0	O
to	29099488	0	O
blunt	29099488	0	O
or	29099488	0	O
ablate	29099488	0	O
mutant	29099488	0	O
p53	29099488	0	O
GOF	29099488	0	O
for	29099488	0	O
therapy	29099488	0	O
?	29099488	0	O
In	29099488	0	O
this	29099488	0	O
article	29099488	0	O
,	29099488	0	O
we	29099488	0	O
review	29099488	0	O
known	29099488	0	O
proteins	29099488	0	O
that	29099488	0	O
interact	29099488	0	O
with	29099488	0	O
mutant	29099488	0	B-Var
p53	29099488	0	B-Gene
and	29099488	0	O
result	29099488	0	O
in	29099488	0	O
the	29099488	0	O
activation	29099488	0	B-PosReg
of	29099488	0	O
genes	29099488	0	B-Gene
that	29099488	0	O
contribute	29099488	0	O
to	29099488	0	O
p53	29099488	0	O
GOF	29099488	0	O
with	29099488	0	O
particular	29099488	0	O
emphasis	29099488	0	O
on	29099488	0	O
context	29099488	0	O
dependency	29099488	0	O
and	29099488	0	O
an	29099488	0	O
evolving	29099488	0	O
appreciation	29099488	0	O
of	29099488	0	O
GOF	29099488	0	O
mechanisms	29099488	0	O
.	29099488	0	O

Exceptional	29118224	0	O
Response	29118224	0	O
to	29118224	0	O
Temsirolimus	29118224	0	O
in	29118224	0	O
a	29118224	0	O
Metastatic	29118224	0	O
Clear	29118224	0	O
Cell	29118224	0	O
Renal	29118224	0	O
Cell	29118224	0	O
Carcinoma	29118224	0	O
With	29118224	0	O
an	29118224	0	O
Early	29118224	0	O
Novel	29118224	0	O
MTOR	29118224	0	O
-	29118224	0	O
Activating	29118224	0	O
Mutation	29118224	0	O
.	29118224	0	O
mTOR	29118224	0	O
pathway	29118224	0	O
inhibitors	29118224	0	O
are	29118224	0	O
important	29118224	0	O
drugs	29118224	0	O
for	29118224	0	O
the	29118224	0	O
treatment	29118224	0	O
of	29118224	0	O
advanced	29118224	0	O
renal	29118224	0	O
cell	29118224	0	O
carcinoma	29118224	0	O
(	29118224	0	O
RCC	29118224	0	O
)	29118224	0	O
.	29118224	0	O
However	29118224	0	O
,	29118224	0	O
no	29118224	0	O
valid	29118224	0	O
predictive	29118224	0	O
markers	29118224	0	O
have	29118224	0	O
been	29118224	0	O
identified	29118224	0	O
to	29118224	0	O
guide	29118224	0	O
treatment	29118224	0	O
selection	29118224	0	O
and	29118224	0	O
identify	29118224	0	O
patients	29118224	0	O
who	29118224	0	O
are	29118224	0	O
sensitive	29118224	0	O
to	29118224	0	O
these	29118224	0	O
drugs	29118224	0	O
.	29118224	0	O
Mutations	29118224	0	O
activating	29118224	0	O
the	29118224	0	O
mTOR	29118224	0	O
pathway	29118224	0	O
have	29118224	0	O
been	29118224	0	O
suggested	29118224	0	O
to	29118224	0	O
predict	29118224	0	O
response	29118224	0	O
;	29118224	0	O
however	29118224	0	O
,	29118224	0	O
their	29118224	0	O
predictive	29118224	0	O
value	29118224	0	O
is	29118224	0	O
still	29118224	0	O
unclear	29118224	0	O
.	29118224	0	O
Here	29118224	0	O
,	29118224	0	O
we	29118224	0	O
present	29118224	0	O
the	29118224	0	O
genomic	29118224	0	O
and	29118224	0	O
functional	29118224	0	O
characterization	29118224	0	O
of	29118224	0	O
a	29118224	0	O
patient	29118224	0	O
with	29118224	0	O
metastatic	29118224	0	O
clear	29118224	0	O
cell	29118224	0	O
RCC	29118224	0	O
(	29118224	0	O
ccRCC	29118224	0	O
)	29118224	0	O
who	29118224	0	O
experienced	29118224	0	O
a	29118224	0	O
partial	29118224	0	O
response	29118224	0	O
to	29118224	0	O
temsirolimus	29118224	0	O
after	29118224	0	O
a	29118224	0	O
poor	29118224	0	O
response	29118224	0	O
to	29118224	0	O
2	29118224	0	O
previous	29118224	0	O
lines	29118224	0	O
of	29118224	0	O
treatment	29118224	0	O
.	29118224	0	O
At	29118224	0	O
the	29118224	0	O
time	29118224	0	O
of	29118224	0	O
publication	29118224	0	O
,	29118224	0	O
the	29118224	0	O
patient	29118224	0	O
was	29118224	0	O
disease	29118224	0	O
-	29118224	0	O
free	29118224	0	O
8	29118224	0	O
years	29118224	0	O
after	29118224	0	O
temsirolimus	29118224	0	O
treatment	29118224	0	O
.	29118224	0	O
Multiregion	29118224	0	O
whole	29118224	0	O
-	29118224	0	O
exome	29118224	0	O
sequencing	29118224	0	O
(	29118224	0	O
WES	29118224	0	O
)	29118224	0	O
on	29118224	0	O
3	29118224	0	O
regions	29118224	0	O
of	29118224	0	O
the	29118224	0	O
primary	29118224	0	O
tumor	29118224	0	O
,	29118224	0	O
1	29118224	0	O
metastasis	29118224	0	O
,	29118224	0	O
and	29118224	0	O
blood	29118224	0	O
revealed	29118224	0	O
tumor	29118224	0	O
mutations	29118224	0	O
in	29118224	0	O
driver	29118224	0	O
genes	29118224	0	O
in	29118224	0	O
ccRCC	29118224	0	O
:	29118224	0	O
a	29118224	0	O
missense	29118224	0	O
mutation	29118224	0	O
in	29118224	0	O
VHL	29118224	0	O
(	29118224	0	O
p.W88L	29118224	0	O
)	29118224	0	O
,	29118224	0	O
a	29118224	0	O
loss	29118224	0	O
-	29118224	0	O
of	29118224	0	O
-	29118224	0	O
function	29118224	0	O
mutation	29118224	0	O
in	29118224	0	O
BAP1	29118224	0	O
(	29118224	0	O
p.E454Rfs*15	29118224	0	O
)	29118224	0	O
,	29118224	0	O
and	29118224	0	O
a	29118224	0	O
novel	29118224	0	O
missense	29118224	0	O
mutation	29118224	0	O
in	29118224	0	O
MTOR	29118224	0	O
(	29118224	0	O
p.Y1974H	29118224	0	O
)	29118224	0	O
.	29118224	0	O
The	29118224	0	O
MTOR	29118224	0	O
mutation	29118224	0	O
was	29118224	0	O
present	29118224	0	O
in	29118224	0	O
all	29118224	0	O
tumor	29118224	0	O
regions	29118224	0	O
,	29118224	0	O
with	29118224	0	O
similar	29118224	0	O
allele	29118224	0	O
frequency	29118224	0	O
as	29118224	0	O
the	29118224	0	O
VHL	29118224	0	O
mutation	29118224	0	O
,	29118224	0	O
and	29118224	0	O
in	29118224	0	O
vitro	29118224	0	O
functional	29118224	0	O
assessment	29118224	0	O
of	29118224	0	O
the	29118224	0	O
MTOR	29118224	0	B-Gene
variant	29118224	0	B-Var
demonstrated	29118224	0	O
that	29118224	0	O
it	29118224	0	O
increased	29118224	0	B-PosReg
mTORC1	29118224	0	O
activity	29118224	0	O
.	29118224	0	O
Consistently	29118224	0	O
,	29118224	0	O
immunohistochemistry	29118224	0	O
in	29118224	0	O
the	29118224	0	O
tumor	29118224	0	O
samples	29118224	0	O
demonstrated	29118224	0	O
increased	29118224	0	O
levels	29118224	0	O
of	29118224	0	O
phospho	29118224	0	O
-	29118224	0	O
S6	29118224	0	O
.	29118224	0	O
In	29118224	0	O
conclusion	29118224	0	O
,	29118224	0	O
multiregion	29118224	0	O
WES	29118224	0	O
identified	29118224	0	O
a	29118224	0	O
novel	29118224	0	O
MTOR	29118224	0	B-Gene
mutation	29118224	0	B-Var
acquired	29118224	0	O
early	29118224	0	O
during	29118224	0	O
tumor	29118224	0	O
development	29118224	0	O
as	29118224	0	O
the	29118224	0	O
event	29118224	0	O
leading	29118224	0	B-Reg
to	29118224	0	I-Reg
a	29118224	0	O
high	29118224	0	O
sensitivity	29118224	0	O
to	29118224	0	O
temsirolimus	29118224	0	O
treatment	29118224	0	O
.	29118224	0	O
This	29118224	0	O
study	29118224	0	O
supports	29118224	0	O
tumor	29118224	0	O
multiregion	29118224	0	O
sequencing	29118224	0	O
to	29118224	0	O
detect	29118224	0	O
truncal	29118224	0	O
mutations	29118224	0	O
in	29118224	0	O
the	29118224	0	O
mTOR	29118224	0	O
pathway	29118224	0	O
to	29118224	0	O
identify	29118224	0	O
patients	29118224	0	O
sensitive	29118224	0	O
to	29118224	0	O
mTOR	29118224	0	O
inhibitors	29118224	0	O
.	29118224	0	O

Loss	29121062	1	O
of	29121062	1	O
function	29121062	1	O
JAK1	29121062	1	O
mutations	29121062	1	O
occur	29121062	1	O
at	29121062	1	O
high	29121062	1	O
frequency	29121062	1	O
in	29121062	1	O
cancers	29121062	1	O
with	29121062	1	O
microsatellite	29121062	1	O
instability	29121062	1	O
and	29121062	1	O
are	29121062	1	O
suggestive	29121062	1	O
of	29121062	1	O
immune	29121062	1	O
evasion	29121062	1	O
.	29121062	1	O
Immune	29121062	1	O
evasion	29121062	1	O
is	29121062	1	O
a	29121062	1	O
well	29121062	1	O
-	29121062	1	O
recognized	29121062	1	O
hallmark	29121062	1	O
of	29121062	1	O
cancer	29121062	1	O
and	29121062	1	O
recent	29121062	1	O
studies	29121062	1	O
with	29121062	1	O
immunotherapy	29121062	1	O
agents	29121062	1	O
have	29121062	1	O
suggested	29121062	1	O
that	29121062	1	O
tumors	29121062	1	O
with	29121062	1	O
increased	29121062	1	O
numbers	29121062	1	O
of	29121062	1	O
neoantigens	29121062	1	O
elicit	29121062	1	O
greater	29121062	1	O
immune	29121062	1	O
responses	29121062	1	O
.	29121062	1	O
We	29121062	1	O
hypothesized	29121062	1	O
that	29121062	1	O
the	29121062	1	O
immune	29121062	1	O
system	29121062	1	O
presents	29121062	1	O
a	29121062	1	O
common	29121062	1	O
selective	29121062	1	O
pressure	29121062	1	O
on	29121062	1	O
high	29121062	1	O
mutation	29121062	1	O
burden	29121062	1	O
tumors	29121062	1	O
and	29121062	1	O
therefore	29121062	1	O
immune	29121062	1	O
evasion	29121062	1	O
mutations	29121062	1	O
would	29121062	1	O
be	29121062	1	O
enriched	29121062	1	O
in	29121062	1	O
high	29121062	1	O
mutation	29121062	1	O
burden	29121062	1	O
tumors	29121062	1	O
.	29121062	1	O
The	29121062	1	O
JAK	29121062	1	O
family	29121062	1	O
of	29121062	1	O
kinases	29121062	1	O
is	29121062	1	O
required	29121062	1	O
for	29121062	1	O
the	29121062	1	O
signaling	29121062	1	O
of	29121062	1	O
a	29121062	1	O
host	29121062	1	O
of	29121062	1	O
immune	29121062	1	O
modulators	29121062	1	O
in	29121062	1	O
tumor	29121062	1	O
,	29121062	1	O
stromal	29121062	1	O
,	29121062	1	O
and	29121062	1	O
immune	29121062	1	O
cells	29121062	1	O
.	29121062	1	O
Therefore	29121062	1	O
,	29121062	1	O
we	29121062	1	O
analyzed	29121062	1	O
alterations	29121062	1	O
in	29121062	1	O
this	29121062	1	O
family	29121062	1	O
for	29121062	1	O
the	29121062	1	O
hypothesized	29121062	1	O
signature	29121062	1	O
of	29121062	1	O
an	29121062	1	O
immune	29121062	1	O
evasion	29121062	1	O
mutation	29121062	1	O
.	29121062	1	O
Here	29121062	1	O
,	29121062	1	O
we	29121062	1	O
searched	29121062	1	O
a	29121062	1	O
database	29121062	1	O
of	29121062	1	O
61	29121062	1	O
,	29121062	1	O
704	29121062	1	O
unique	29121062	1	O
solid	29121062	1	O
tumors	29121062	1	O
for	29121062	1	O
alterations	29121062	1	O
in	29121062	1	O
the	29121062	1	O
JAK	29121062	1	O
family	29121062	1	O
kinases	29121062	1	O
(	29121062	1	O
JAK1	29121062	1	O
/	29121062	1	O
2	29121062	1	O
/	29121062	1	O
3	29121062	1	O
,	29121062	1	O
TYK2	29121062	1	O
)	29121062	1	O
.	29121062	1	O
We	29121062	1	O
used	29121062	1	O
The	29121062	1	O
Cancer	29121062	1	O
Genome	29121062	1	O
Atlas	29121062	1	O
and	29121062	1	O
Cancer	29121062	1	O
Cell	29121062	1	O
Line	29121062	1	O
Encyclopedia	29121062	1	O
data	29121062	1	O
to	29121062	1	O
confirm	29121062	1	O
and	29121062	1	O
extend	29121062	1	O
our	29121062	1	O
findings	29121062	1	O
by	29121062	1	O
analyzing	29121062	1	O
gene	29121062	1	O
expression	29121062	1	O
patterns	29121062	1	O
.	29121062	1	O
Recurrent	29121062	1	O
frameshift	29121062	1	B-Var
mutations	29121062	1	I-Var
in	29121062	1	O
JAK1	29121062	1	B-Gene
were	29121062	1	O
associated	29121062	1	B-Reg
with	29121062	1	O
high	29121062	1	O
mutation	29121062	1	O
burden	29121062	1	O
and	29121062	1	O
microsatellite	29121062	1	O
instability	29121062	1	O
.	29121062	1	O
These	29121062	1	O
mutations	29121062	1	B-Var
occurred	29121062	1	B-Reg
in	29121062	1	O
multiple	29121062	1	O
tumor	29121062	1	O
types	29121062	1	O
including	29121062	1	O
endometrial	29121062	1	B-Disease
,	29121062	1	O
colorectal	29121062	1	B-Disease
,	29121062	1	O
stomach	29121062	1	B-Disease
,	29121062	1	O
and	29121062	1	O
prostate	29121062	1	B-Disease
carcinomas	29121062	1	B-Disease
.	29121062	1	O
Analyzing	29121062	1	O
gene	29121062	1	O
expression	29121062	1	O
signatures	29121062	1	O
in	29121062	1	O
endometrial	29121062	1	O
and	29121062	1	O
stomach	29121062	1	O
adenocarcinomas	29121062	1	O
revealed	29121062	1	O
that	29121062	1	O
tumors	29121062	1	O
with	29121062	1	O
a	29121062	1	O
JAK1	29121062	1	O
frameshift	29121062	1	O
exhibited	29121062	1	O
reduced	29121062	1	O
expression	29121062	1	O
of	29121062	1	O
interferon	29121062	1	O
response	29121062	1	O
signatures	29121062	1	O
and	29121062	1	O
multiple	29121062	1	O
anti	29121062	1	O
-	29121062	1	O
tumor	29121062	1	O
immune	29121062	1	O
signatures	29121062	1	O
.	29121062	1	O
Importantly	29121062	1	O
,	29121062	1	O
endometrial	29121062	1	O
cancer	29121062	1	O
cell	29121062	1	O
lines	29121062	1	O
exhibited	29121062	1	O
similar	29121062	1	O
gene	29121062	1	O
expression	29121062	1	O
changes	29121062	1	O
that	29121062	1	O
were	29121062	1	O
expected	29121062	1	O
to	29121062	1	O
be	29121062	1	O
tumor	29121062	1	O
cell	29121062	1	O
intrinsic	29121062	1	O
(	29121062	1	O
e.g.	29121062	1	O
interferon	29121062	1	O
response	29121062	1	O
)	29121062	1	O
but	29121062	1	O
not	29121062	1	O
those	29121062	1	O
expected	29121062	1	O
to	29121062	1	O
be	29121062	1	O
tumor	29121062	1	O
cell	29121062	1	O
extrinsic	29121062	1	O
(	29121062	1	O
e.g.	29121062	1	O
NK	29121062	1	O
cells	29121062	1	O
)	29121062	1	O
.	29121062	1	O
From	29121062	1	O
these	29121062	1	O
data	29121062	1	O
,	29121062	1	O
we	29121062	1	O
derive	29121062	1	O
two	29121062	1	O
primary	29121062	1	O
conclusions	29121062	1	O
:	29121062	1	O
1	29121062	1	O
)	29121062	1	O
JAK1	29121062	1	O
frameshifts	29121062	1	O
are	29121062	1	O
loss	29121062	1	O
of	29121062	1	O
function	29121062	1	O
alterations	29121062	1	O
that	29121062	1	O
represent	29121062	1	O
a	29121062	1	O
potential	29121062	1	O
pan	29121062	1	O
-	29121062	1	O
cancer	29121062	1	O
adaptation	29121062	1	O
to	29121062	1	O
immune	29121062	1	O
responses	29121062	1	O
against	29121062	1	O
tumors	29121062	1	O
with	29121062	1	O
microsatellite	29121062	1	O
instability	29121062	1	O
;	29121062	1	O
2	29121062	1	O
)	29121062	1	O
The	29121062	1	O
mechanism	29121062	1	O
by	29121062	1	O
which	29121062	1	O
JAK1	29121062	1	B-Var
loss	29121062	1	B-NegReg
of	29121062	1	I-NegReg
function	29121062	1	I-NegReg
contributes	29121062	1	O
to	29121062	1	O
tumor	29121062	1	O
immune	29121062	1	O
evasion	29121062	1	O
is	29121062	1	O
likely	29121062	1	O
associated	29121062	1	O
with	29121062	1	O
loss	29121062	1	O
of	29121062	1	O
the	29121062	1	O
JAK1	29121062	1	O
-	29121062	1	O
mediated	29121062	1	O
interferon	29121062	1	O
response	29121062	1	O
.	29121062	1	O

Gain	29124309	2	B-PosReg
of	29124309	2	I-PosReg
function	29124309	2	I-PosReg
of	29124309	2	O
TMEM16E	29124309	2	B-Gene
/	29124309	2	I-Gene
ANO5	29124309	2	I-Gene
scrambling	29124309	2	O
activity	29124309	2	O
caused	29124309	2	O
by	29124309	2	O
a	29124309	2	O
mutation	29124309	2	B-Var
associated	29124309	2	O
with	29124309	2	O
gnathodiaphyseal	29124309	2	B-Disease
dysplasia	29124309	2	I-Disease
.	29124309	2	O
Mutations	29124309	2	B-Var
in	29124309	2	O
the	29124309	2	O
human	29124309	2	O
TMEM16E	29124309	2	B-Gene
(	29124309	2	O
ANO5	29124309	2	O
)	29124309	2	O
gene	29124309	2	O
are	29124309	2	O
associated	29124309	2	B-Reg
both	29124309	2	O
with	29124309	2	O
the	29124309	2	O
bone	29124309	2	B-Disease
disease	29124309	2	I-Disease
gnathodiaphyseal	29124309	2	B-Disease
dysplasia	29124309	2	I-Disease
(	29124309	2	O
GDD	29124309	2	O
;	29124309	2	O
OMIM	29124309	2	O
:	29124309	2	O
166260	29124309	2	O
)	29124309	2	O
and	29124309	2	O
muscle	29124309	2	B-Disease
dystrophies	29124309	2	I-Disease
(	29124309	2	O
OMIM	29124309	2	O
:	29124309	2	O
611307	29124309	2	O
,	29124309	2	O
613319	29124309	2	O
)	29124309	2	O
.	29124309	2	O
However	29124309	2	O
,	29124309	2	O
the	29124309	2	O
physiological	29124309	2	O
function	29124309	2	O
of	29124309	2	O
TMEM16E	29124309	2	O
has	29124309	2	O
remained	29124309	2	O
unclear	29124309	2	O
.	29124309	2	O
We	29124309	2	O
show	29124309	2	O
here	29124309	2	O
that	29124309	2	O
human	29124309	2	O
TMEM16E	29124309	2	O
,	29124309	2	O
when	29124309	2	O
overexpressed	29124309	2	O
in	29124309	2	O
mammalian	29124309	2	O
cell	29124309	2	O
lines	29124309	2	O
,	29124309	2	O
displayed	29124309	2	O
partial	29124309	2	O
plasma	29124309	2	O
membrane	29124309	2	O
localization	29124309	2	O
and	29124309	2	O
gave	29124309	2	O
rise	29124309	2	O
to	29124309	2	O
phospholipid	29124309	2	O
scrambling	29124309	2	O
(	29124309	2	O
PLS	29124309	2	O
)	29124309	2	O
as	29124309	2	O
well	29124309	2	O
as	29124309	2	O
non	29124309	2	O
-	29124309	2	O
selective	29124309	2	O
ionic	29124309	2	O
currents	29124309	2	O
with	29124309	2	O
slow	29124309	2	O
time	29124309	2	O
-	29124309	2	O
dependent	29124309	2	O
activation	29124309	2	O
at	29124309	2	O
highly	29124309	2	O
depolarized	29124309	2	O
membrane	29124309	2	O
potentials	29124309	2	O
.	29124309	2	O
While	29124309	2	O
the	29124309	2	O
activity	29124309	2	O
of	29124309	2	O
wild	29124309	2	O
-	29124309	2	O
type	29124309	2	O
TMEM16E	29124309	2	O
depended	29124309	2	O
on	29124309	2	O
elevated	29124309	2	O
cytosolic	29124309	2	O
Ca2	29124309	2	O
levels	29124309	2	O
,	29124309	2	O
a	29124309	2	O
mutant	29124309	2	O
form	29124309	2	O
carrying	29124309	2	O
the	29124309	2	O
GDD	29124309	2	O
-	29124309	2	O
causing	29124309	2	O
T513I	29124309	2	O
substitution	29124309	2	O
showed	29124309	2	O
PLS	29124309	2	O
and	29124309	2	O
large	29124309	2	O
time	29124309	2	O
-	29124309	2	O
dependent	29124309	2	O
ion	29124309	2	O
currents	29124309	2	O
even	29124309	2	O
at	29124309	2	O
low	29124309	2	O
cytosolic	29124309	2	O
Ca2	29124309	2	O
concentrations	29124309	2	O
.	29124309	2	O
Contrarily	29124309	2	O
,	29124309	2	O
mutation	29124309	2	O
of	29124309	2	O
the	29124309	2	O
homologous	29124309	2	O
position	29124309	2	O
in	29124309	2	O
the	29124309	2	O
Ca2	29124309	2	O
-	29124309	2	O
activated	29124309	2	O
Cl	29124309	2	O
-	29124309	2	O
channel	29124309	2	O
TMEM16B	29124309	2	O
paralog	29124309	2	O
hardly	29124309	2	O
affected	29124309	2	O
its	29124309	2	O
function	29124309	2	O
.	29124309	2	O
In	29124309	2	O
summary	29124309	2	O
,	29124309	2	O
these	29124309	2	O
data	29124309	2	O
provide	29124309	2	O
the	29124309	2	O
first	29124309	2	O
direct	29124309	2	O
demonstration	29124309	2	O
of	29124309	2	O
Ca2	29124309	2	O
-	29124309	2	O
dependent	29124309	2	O
PLS	29124309	2	O
activity	29124309	2	O
for	29124309	2	O
TMEM16E	29124309	2	O
and	29124309	2	O
suggest	29124309	2	O
a	29124309	2	O
gain	29124309	2	O
-	29124309	2	O
of	29124309	2	O
-	29124309	2	O
function	29124309	2	O
phenotype	29124309	2	O
related	29124309	2	O
to	29124309	2	O
a	29124309	2	O
GDD	29124309	2	O
mutation	29124309	2	O
.	29124309	2	O

Multiple	29133401	0	O
Legionella	29133401	0	O
pneumophila	29133401	0	O
effector	29133401	0	O
virulence	29133401	0	O
phenotypes	29133401	0	O
revealed	29133401	0	O
through	29133401	0	O
high	29133401	0	O
-	29133401	0	O
throughput	29133401	0	O
analysis	29133401	0	O
of	29133401	0	O
targeted	29133401	0	O
mutant	29133401	0	O
libraries	29133401	0	O
.	29133401	0	O
Legionella	29133401	0	O
pneumophila	29133401	0	O
is	29133401	0	O
the	29133401	0	O
causative	29133401	0	O
agent	29133401	0	O
of	29133401	0	O
a	29133401	0	O
severe	29133401	0	O
pneumonia	29133401	0	O
called	29133401	0	O
Legionnaires	29133401	0	O
'	29133401	0	O
disease	29133401	0	O
.	29133401	0	O
A	29133401	0	O
single	29133401	0	O
strain	29133401	0	O
of	29133401	0	O
L.	29133401	0	O
pneumophila	29133401	0	O
encodes	29133401	0	O
a	29133401	0	O
repertoire	29133401	0	O
of	29133401	0	O
over	29133401	0	O
300	29133401	0	O
different	29133401	0	O
effector	29133401	0	O
proteins	29133401	0	O
that	29133401	0	O
are	29133401	0	O
delivered	29133401	0	O
into	29133401	0	O
host	29133401	0	O
cells	29133401	0	O
by	29133401	0	O
the	29133401	0	O
Dot	29133401	0	O
/	29133401	0	O
Icm	29133401	0	O
type	29133401	0	O
IV	29133401	0	O
secretion	29133401	0	O
system	29133401	0	O
during	29133401	0	O
infection	29133401	0	O
.	29133401	0	O
The	29133401	0	O
large	29133401	0	O
number	29133401	0	O
of	29133401	0	O
L.	29133401	0	O
pneumophila	29133401	0	O
effectors	29133401	0	O
has	29133401	0	O
been	29133401	0	O
a	29133401	0	O
limiting	29133401	0	O
factor	29133401	0	O
in	29133401	0	O
assessing	29133401	0	O
the	29133401	0	O
importance	29133401	0	O
of	29133401	0	O
individual	29133401	0	O
effectors	29133401	0	O
for	29133401	0	O
virulence	29133401	0	O
.	29133401	0	O
Here	29133401	0	O
,	29133401	0	O
a	29133401	0	O
transposon	29133401	0	O
insertion	29133401	0	O
sequencing	29133401	0	O
technology	29133401	0	O
called	29133401	0	O
INSeq	29133401	0	O
was	29133401	0	O
used	29133401	0	O
to	29133401	0	O
analyze	29133401	0	O
replication	29133401	0	O
of	29133401	0	O
a	29133401	0	O
pool	29133401	0	O
of	29133401	0	O
effector	29133401	0	O
mutants	29133401	0	O
in	29133401	0	O
parallel	29133401	0	O
both	29133401	0	O
in	29133401	0	O
a	29133401	0	O
mouse	29133401	0	O
model	29133401	0	O
of	29133401	0	O
infection	29133401	0	O
and	29133401	0	O
in	29133401	0	O
cultured	29133401	0	O
host	29133401	0	O
cells	29133401	0	O
.	29133401	0	O
Loss	29133401	0	B-NegReg
-	29133401	0	I-NegReg
of	29133401	0	I-NegReg
-	29133401	0	I-NegReg
function	29133401	0	I-NegReg
mutations	29133401	0	B-Var
in	29133401	0	O
genes	29133401	0	O
encoding	29133401	0	O
effector	29133401	0	O
proteins	29133401	0	O
resulted	29133401	0	O
in	29133401	0	O
host	29133401	0	O
-	29133401	0	O
specific	29133401	0	O
or	29133401	0	O
broad	29133401	0	O
virulence	29133401	0	O
phenotypes	29133401	0	O
.	29133401	0	O
Screen	29133401	0	O
results	29133401	0	O
were	29133401	0	O
validated	29133401	0	O
for	29133401	0	O
several	29133401	0	O
effector	29133401	0	O
mutants	29133401	0	O
displaying	29133401	0	O
different	29133401	0	O
virulence	29133401	0	O
phenotypes	29133401	0	O
using	29133401	0	O
genetic	29133401	0	O
complementation	29133401	0	O
studies	29133401	0	O
and	29133401	0	O
infection	29133401	0	O
assays	29133401	0	O
.	29133401	0	O
Specifically	29133401	0	O
,	29133401	0	O
loss	29133401	0	B-NegReg
-	29133401	0	I-NegReg
of	29133401	0	I-NegReg
-	29133401	0	I-NegReg
function	29133401	0	I-NegReg
mutations	29133401	0	B-Var
in	29133401	0	O
the	29133401	0	O
gene	29133401	0	O
encoding	29133401	0	O
LegC4	29133401	0	B-Gene
resulted	29133401	0	O
in	29133401	0	O
enhanced	29133401	0	B-PosReg
L.	29133401	0	O
pneumophila	29133401	0	O
in	29133401	0	O
the	29133401	0	O
lungs	29133401	0	O
of	29133401	0	O
infected	29133401	0	O
mice	29133401	0	O
but	29133401	0	O
not	29133401	0	O
within	29133401	0	O
cultured	29133401	0	O
host	29133401	0	O
cells	29133401	0	O
,	29133401	0	O
which	29133401	0	O
indicates	29133401	0	O
LegC4	29133401	0	B-Var
augments	29133401	0	B-PosReg
bacterial	29133401	0	O
clearance	29133401	0	O
by	29133401	0	O
the	29133401	0	O
host	29133401	0	O
immune	29133401	0	O
system	29133401	0	O
.	29133401	0	O
The	29133401	0	O
effector	29133401	0	O
proteins	29133401	0	O
RavY	29133401	0	O
and	29133401	0	O
Lpg2505	29133401	0	O
were	29133401	0	O
important	29133401	0	O
for	29133401	0	O
efficient	29133401	0	O
replication	29133401	0	O
within	29133401	0	O
both	29133401	0	O
mammalian	29133401	0	O
and	29133401	0	O
protozoan	29133401	0	O
hosts	29133401	0	O
.	29133401	0	O
Further	29133401	0	O
analysis	29133401	0	O
of	29133401	0	O
Lpg2505	29133401	0	O
revealed	29133401	0	O
that	29133401	0	O
this	29133401	0	O
protein	29133401	0	O
functions	29133401	0	O
as	29133401	0	O
a	29133401	0	O
metaeffector	29133401	0	O
that	29133401	0	O
counteracts	29133401	0	O
host	29133401	0	O
cytotoxicity	29133401	0	O
displayed	29133401	0	O
by	29133401	0	O
the	29133401	0	O
effector	29133401	0	O
protein	29133401	0	O
SidI	29133401	0	O
.	29133401	0	O
Thus	29133401	0	O
,	29133401	0	O
this	29133401	0	O
study	29133401	0	O
identified	29133401	0	O
a	29133401	0	O
large	29133401	0	O
cohort	29133401	0	O
of	29133401	0	O
effectors	29133401	0	O
that	29133401	0	O
contribute	29133401	0	O
to	29133401	0	O
L.	29133401	0	O
pneumophila	29133401	0	O
virulence	29133401	0	O
positively	29133401	0	O
or	29133401	0	O
negatively	29133401	0	O
and	29133401	0	O
has	29133401	0	O
demonstrated	29133401	0	O
regulation	29133401	0	O
of	29133401	0	O
effector	29133401	0	O
protein	29133401	0	O
activities	29133401	0	O
by	29133401	0	O
cognate	29133401	0	O
metaeffectors	29133401	0	O
as	29133401	0	O
being	29133401	0	O
critical	29133401	0	O
for	29133401	0	O
host	29133401	0	O
pathogenesis	29133401	0	O
.	29133401	0	O

A	29141982	0	O
Partial	29141982	0	O
Loss	29141982	0	B-NegReg
-	29141982	0	I-NegReg
of	29141982	0	I-NegReg
-	29141982	0	I-NegReg
Function	29141982	0	I-NegReg
Variant	29141982	0	B-Var
in	29141982	0	O
AKT2	29141982	0	B-Gene
Is	29141982	0	O
Associated	29141982	0	O
With	29141982	0	O
Reduced	29141982	0	B-NegReg
Insulin	29141982	0	O
-	29141982	0	O
Mediated	29141982	0	O
Glucose	29141982	0	O
Uptake	29141982	0	O
in	29141982	0	O
Multiple	29141982	0	O
Insulin	29141982	0	O
-	29141982	0	O
Sensitive	29141982	0	O
Tissues	29141982	0	O
:	29141982	0	O
A	29141982	0	O
Genotype	29141982	0	O
-	29141982	0	O
Based	29141982	0	O
Callback	29141982	0	O
Positron	29141982	0	O
Emission	29141982	0	O
Tomography	29141982	0	O
Study	29141982	0	O
.	29141982	0	O
Rare	29141982	0	O
fully	29141982	0	O
penetrant	29141982	0	O
mutations	29141982	0	O
in	29141982	0	O
AKT2	29141982	0	O
are	29141982	0	O
an	29141982	0	O
established	29141982	0	O
cause	29141982	0	O
of	29141982	0	O
monogenic	29141982	0	O
disorders	29141982	0	O
of	29141982	0	O
glucose	29141982	0	O
metabolism	29141982	0	O
.	29141982	0	O
Recently	29141982	0	O
,	29141982	0	O
a	29141982	0	O
novel	29141982	0	O
partial	29141982	0	O
loss	29141982	0	O
-	29141982	0	O
of	29141982	0	O
-	29141982	0	O
function	29141982	0	O
AKT2	29141982	0	O
coding	29141982	0	O
variant	29141982	0	O
(	29141982	0	O
p.Pro50Thr	29141982	0	O
)	29141982	0	O
was	29141982	0	O
identified	29141982	0	O
that	29141982	0	O
is	29141982	0	O
nearly	29141982	0	O
specific	29141982	0	O
to	29141982	0	O
Finns	29141982	0	O
(	29141982	0	O
frequency	29141982	0	O
1.1%	29141982	0	O
)	29141982	0	O
,	29141982	0	O
with	29141982	0	O
the	29141982	0	O
low	29141982	0	O
-	29141982	0	O
frequency	29141982	0	O
allele	29141982	0	O
associated	29141982	0	O
with	29141982	0	O
an	29141982	0	O
increase	29141982	0	O
in	29141982	0	O
fasting	29141982	0	O
plasma	29141982	0	O
insulin	29141982	0	O
level	29141982	0	O
and	29141982	0	O
risk	29141982	0	O
of	29141982	0	O
type	29141982	0	O
2	29141982	0	O
diabetes	29141982	0	O
.	29141982	0	O
The	29141982	0	O
effects	29141982	0	O
of	29141982	0	O
the	29141982	0	O
p.Pro50Thr	29141982	0	O
AKT2	29141982	0	O
variant	29141982	0	O
(	29141982	0	O
p.P50T	29141982	0	O
/	29141982	0	O
AKT2	29141982	0	O
)	29141982	0	O
on	29141982	0	O
insulin	29141982	0	O
-	29141982	0	O
stimulated	29141982	0	O
glucose	29141982	0	O
uptake	29141982	0	O
(	29141982	0	O
GU	29141982	0	O
)	29141982	0	O
in	29141982	0	O
the	29141982	0	O
whole	29141982	0	O
body	29141982	0	O
and	29141982	0	O
in	29141982	0	O
different	29141982	0	O
tissues	29141982	0	O
have	29141982	0	O
not	29141982	0	O
previously	29141982	0	O
been	29141982	0	O
investigated	29141982	0	O
.	29141982	0	O
We	29141982	0	O
identified	29141982	0	O
carriers	29141982	0	O
(	29141982	0	O
N	29141982	0	O
=	29141982	0	O
20	29141982	0	O
)	29141982	0	O
and	29141982	0	O
matched	29141982	0	O
noncarriers	29141982	0	O
(	29141982	0	O
N	29141982	0	O
=	29141982	0	O
25	29141982	0	O
)	29141982	0	O
for	29141982	0	O
this	29141982	0	O
allele	29141982	0	O
in	29141982	0	O
the	29141982	0	O
population	29141982	0	O
-	29141982	0	O
based	29141982	0	O
Metabolic	29141982	0	O
Syndrome	29141982	0	O
in	29141982	0	O
Men	29141982	0	O
(	29141982	0	O
METSIM	29141982	0	O
)	29141982	0	O
study	29141982	0	O
and	29141982	0	O
invited	29141982	0	O
these	29141982	0	O
individuals	29141982	0	O
back	29141982	0	O
for	29141982	0	O
positron	29141982	0	O
emission	29141982	0	O
tomography	29141982	0	O
study	29141982	0	O
with	29141982	0	O
[	29141982	0	O
18	29141982	0	O
F	29141982	0	O
]	29141982	0	O
-	29141982	0	O
fluorodeoxyglucose	29141982	0	O
during	29141982	0	O
euglycemic	29141982	0	O
hyperinsulinemia	29141982	0	O
.	29141982	0	O
When	29141982	0	O
we	29141982	0	O
compared	29141982	0	O
p.P50T	29141982	0	O
/	29141982	0	O
AKT2	29141982	0	O
carriers	29141982	0	O
to	29141982	0	O
noncarriers	29141982	0	O
,	29141982	0	O
we	29141982	0	O
found	29141982	0	O
a	29141982	0	O
39.4%	29141982	0	O
reduction	29141982	0	O
in	29141982	0	O
whole	29141982	0	O
-	29141982	0	O
body	29141982	0	O
GU	29141982	0	O
(	29141982	0	O
P	29141982	0	O
=	29141982	0	O
0.006	29141982	0	O
)	29141982	0	O
and	29141982	0	O
a	29141982	0	O
55.6%	29141982	0	O
increase	29141982	0	O
in	29141982	0	O
the	29141982	0	O
rate	29141982	0	O
of	29141982	0	O
endogenous	29141982	0	O
glucose	29141982	0	O
production	29141982	0	O
(	29141982	0	O
P	29141982	0	O
=	29141982	0	O
0.038	29141982	0	O
)	29141982	0	O
.	29141982	0	O
We	29141982	0	O
found	29141982	0	O
significant	29141982	0	O
reductions	29141982	0	O
in	29141982	0	O
GU	29141982	0	O
in	29141982	0	O
multiple	29141982	0	O
tissues	29141982	0	O
-	29141982	0	O
skeletal	29141982	0	O
muscle	29141982	0	O
(	29141982	0	O
36.4%	29141982	0	O
)	29141982	0	O
,	29141982	0	O
liver	29141982	0	O
(	29141982	0	O
16.1%	29141982	0	O
)	29141982	0	O
,	29141982	0	O
brown	29141982	0	O
adipose	29141982	0	O
(	29141982	0	O
29.7%	29141982	0	O
)	29141982	0	O
,	29141982	0	O
and	29141982	0	O
bone	29141982	0	O
marrow	29141982	0	O
(	29141982	0	O
32.9%	29141982	0	O
)	29141982	0	O
-	29141982	0	O
and	29141982	0	O
increases	29141982	0	O
of	29141982	0	O
16.8	29141982	0	O
-	29141982	0	O
19.1%	29141982	0	O
in	29141982	0	O
seven	29141982	0	O
tested	29141982	0	O
brain	29141982	0	O
regions	29141982	0	O
.	29141982	0	O
These	29141982	0	O
data	29141982	0	O
demonstrate	29141982	0	O
that	29141982	0	O
the	29141982	0	O
p.P50T	29141982	0	B-Var
substitution	29141982	0	O
of	29141982	0	O
AKT2	29141982	0	B-Gene
influences	29141982	0	B-Reg
insulin	29141982	0	O
-	29141982	0	O
mediated	29141982	0	O
GU	29141982	0	O
in	29141982	0	O
multiple	29141982	0	O
insulin	29141982	0	O
-	29141982	0	O
sensitive	29141982	0	O
tissues	29141982	0	O
and	29141982	0	O
may	29141982	0	O
explain	29141982	0	O
,	29141982	0	O
at	29141982	0	O
least	29141982	0	O
in	29141982	0	O
part	29141982	0	O
,	29141982	0	O
the	29141982	0	O
increased	29141982	0	O
risk	29141982	0	O
of	29141982	0	O
type	29141982	0	O
2	29141982	0	O
diabetes	29141982	0	O
in	29141982	0	O
p.P50T	29141982	0	O
/	29141982	0	O
AKT2	29141982	0	O
carriers	29141982	0	O
.	29141982	0	O

Common	29146049	1	O
and	29146049	1	O
rare	29146049	1	O
TBK1	29146049	1	B-Gene
variants	29146049	1	B-Var
in	29146049	1	B-Reg
early	29146049	1	B-Disease
-	29146049	1	I-Disease
onset	29146049	1	I-Disease
Alzheimer	29146049	1	I-Disease
disease	29146049	1	I-Disease
in	29146049	1	O
a	29146049	1	O
European	29146049	1	O
cohort	29146049	1	O
.	29146049	1	O
TANK	29146049	1	O
-	29146049	1	O
binding	29146049	1	O
kinase	29146049	1	O
1	29146049	1	O
(	29146049	1	B-Gene
TBK1	29146049	1	I-Gene
)	29146049	1	I-Gene
loss	29146049	1	B-NegReg
-	29146049	1	I-NegReg
of	29146049	1	I-NegReg
-	29146049	1	I-NegReg
function	29146049	1	I-NegReg
(	29146049	1	O
LoF	29146049	1	O
)	29146049	1	O
mutations	29146049	1	B-Var
are	29146049	1	O
known	29146049	1	O
to	29146049	1	O
cause	29146049	1	O
frontotemporal	29146049	1	B-Disease
dementia	29146049	1	I-Disease
(	29146049	1	O
FTD	29146049	1	O
)	29146049	1	O
and	29146049	1	O
amyotrophic	29146049	1	B-Disease
lateral	29146049	1	I-Disease
sclerosis	29146049	1	I-Disease
(	29146049	1	O
ALS	29146049	1	O
)	29146049	1	O
,	29146049	1	O
often	29146049	1	O
combined	29146049	1	O
with	29146049	1	O
memory	29146049	1	O
deficits	29146049	1	O
early	29146049	1	O
in	29146049	1	O
the	29146049	1	O
disease	29146049	1	O
course	29146049	1	O
.	29146049	1	O
We	29146049	1	O
performed	29146049	1	O
targeted	29146049	1	O
resequencing	29146049	1	O
of	29146049	1	O
TBK1	29146049	1	O
in	29146049	1	O
1253	29146049	1	O
early	29146049	1	O
onset	29146049	1	O
Alzheimer	29146049	1	O
'	29146049	1	O
s	29146049	1	O
disease	29146049	1	O
(	29146049	1	O
EOAD	29146049	1	O
)	29146049	1	O
patients	29146049	1	O
from	29146049	1	O
8	29146049	1	O
European	29146049	1	O
countries	29146049	1	O
to	29146049	1	O
investigate	29146049	1	O
whether	29146049	1	O
pathogenic	29146049	1	O
TBK1	29146049	1	O
mutations	29146049	1	O
are	29146049	1	O
enriched	29146049	1	O
among	29146049	1	O
patients	29146049	1	O
with	29146049	1	O
clinical	29146049	1	O
diagnosis	29146049	1	O
of	29146049	1	O
EOAD	29146049	1	O
.	29146049	1	O
Variant	29146049	1	O
frequencies	29146049	1	O
were	29146049	1	O
compared	29146049	1	O
against	29146049	1	O
2117	29146049	1	O
origin	29146049	1	O
-	29146049	1	O
matched	29146049	1	O
controls	29146049	1	O
.	29146049	1	O
We	29146049	1	O
identified	29146049	1	O
only	29146049	1	O
1	29146049	1	O
LoF	29146049	1	O
mutation	29146049	1	O
(	29146049	1	O
p.Thr79del	29146049	1	O
)	29146049	1	O
in	29146049	1	O
a	29146049	1	O
patient	29146049	1	O
clinically	29146049	1	O
diagnosed	29146049	1	O
with	29146049	1	O
Alzheimer	29146049	1	O
'	29146049	1	O
s	29146049	1	O
disease	29146049	1	O
and	29146049	1	O
a	29146049	1	O
positive	29146049	1	O
family	29146049	1	O
history	29146049	1	O
of	29146049	1	O
ALS	29146049	1	O
.	29146049	1	O
We	29146049	1	O
did	29146049	1	O
not	29146049	1	O
observe	29146049	1	O
enrichment	29146049	1	O
of	29146049	1	O
rare	29146049	1	O
variants	29146049	1	O
in	29146049	1	O
EOAD	29146049	1	O
patients	29146049	1	O
compared	29146049	1	O
to	29146049	1	O
controls	29146049	1	O
,	29146049	1	O
nor	29146049	1	O
of	29146049	1	O
rare	29146049	1	O
variants	29146049	1	O
affecting	29146049	1	O
NFκB	29146049	1	O
induction	29146049	1	O
.	29146049	1	O
Of	29146049	1	O
3	29146049	1	O
common	29146049	1	O
coding	29146049	1	O
variants	29146049	1	O
,	29146049	1	O
rs7486100	29146049	1	O
showed	29146049	1	O
evidence	29146049	1	O
of	29146049	1	O
association	29146049	1	O
(	29146049	1	O
OR	29146049	1	O
1.46	29146049	1	O
[	29146049	1	O
95%	29146049	1	O
CI	29146049	1	O
1.13	29146049	1	O
-	29146049	1	O
1.9	29146049	1	O
]	29146049	1	O
;	29146049	1	O
p	29146049	1	O
-	29146049	1	O
value	29146049	1	O
0.01	29146049	1	O
)	29146049	1	O
.	29146049	1	O
Homozygous	29146049	1	O
carriers	29146049	1	O
of	29146049	1	O
the	29146049	1	O
risk	29146049	1	O
allele	29146049	1	O
showed	29146049	1	O
reduced	29146049	1	O
expression	29146049	1	O
of	29146049	1	O
TBK1	29146049	1	O
(	29146049	1	O
p	29146049	1	O
-	29146049	1	O
value	29146049	1	O
0.03	29146049	1	O
)	29146049	1	O
.	29146049	1	O
Our	29146049	1	O
findings	29146049	1	O
are	29146049	1	O
not	29146049	1	O
indicative	29146049	1	O
of	29146049	1	O
a	29146049	1	O
significant	29146049	1	O
role	29146049	1	O
for	29146049	1	O
TBK1	29146049	1	O
mutations	29146049	1	O
in	29146049	1	O
EOAD	29146049	1	O
.	29146049	1	O
The	29146049	1	O
association	29146049	1	O
between	29146049	1	O
common	29146049	1	O
variants	29146049	1	O
in	29146049	1	O
TBK1	29146049	1	O
,	29146049	1	O
disease	29146049	1	O
risk	29146049	1	O
and	29146049	1	O
reduced	29146049	1	O
TBK1	29146049	1	O
expression	29146049	1	O
warrants	29146049	1	O
follow	29146049	1	O
-	29146049	1	O
up	29146049	1	O
in	29146049	1	O
FTD	29146049	1	O
/	29146049	1	O
ALS	29146049	1	O
cohorts	29146049	1	O
.	29146049	1	O

Polymorphisms	29154202	3	O
in	29154202	3	O
inflammasome	29154202	3	O
genes	29154202	3	O
and	29154202	3	O
risk	29154202	3	O
of	29154202	3	O
asthma	29154202	3	O
in	29154202	3	O
Brazilian	29154202	3	O
children	29154202	3	O
.	29154202	3	O
Considering	29154202	3	O
its	29154202	3	O
role	29154202	3	O
in	29154202	3	O
inflammation	29154202	3	O
and	29154202	3	O
recently	29154202	3	O
described	29154202	3	O
"	29154202	3	O
alternative	29154202	3	O
"	29154202	3	O
roles	29154202	3	O
in	29154202	3	O
epithelial	29154202	3	O
homeostasis	29154202	3	O
and	29154202	3	O
Th1	29154202	3	O
/	29154202	3	O
Th2	29154202	3	O
balance	29154202	3	O
,	29154202	3	O
we	29154202	3	O
hypothesize	29154202	3	O
that	29154202	3	O
inflammasome	29154202	3	O
genetics	29154202	3	O
could	29154202	3	O
contribute	29154202	3	O
to	29154202	3	O
the	29154202	3	O
development	29154202	3	O
of	29154202	3	O
asthma	29154202	3	O
.	29154202	3	O
Selected	29154202	3	O
functional	29154202	3	O
polymorphisms	29154202	3	O
in	29154202	3	O
inflammasome	29154202	3	O
genes	29154202	3	O
are	29154202	3	O
evaluated	29154202	3	O
in	29154202	3	O
a	29154202	3	O
cohort	29154202	3	O
of	29154202	3	O
asthmatic	29154202	3	O
children	29154202	3	O
and	29154202	3	O
their	29154202	3	O
families	29154202	3	O
.	29154202	3	O
Gain	29154202	3	B-PosReg
-	29154202	3	I-PosReg
of	29154202	3	I-PosReg
-	29154202	3	I-PosReg
function	29154202	3	I-PosReg
NLRP1	29154202	3	B-Gene
variants	29154202	3	B-Var
rs11651270	29154202	3	B-Var
,	29154202	3	O
rs12150220	29154202	3	B-Var
and	29154202	3	O
rs2670660	29154202	3	B-Var
resulted	29154202	3	O
significantly	29154202	3	O
associated	29154202	3	O
to	29154202	3	O
asthma	29154202	3	B-Disease
in	29154202	3	O
trios	29154202	3	O
(	29154202	3	O
TDT	29154202	3	O
)	29154202	3	O
analysis	29154202	3	O
;	29154202	3	O
and	29154202	3	O
rs11651270	29154202	3	B-Var
and	29154202	3	O
rs2670660	29154202	3	B-Var
also	29154202	3	O
with	29154202	3	B-Reg
asthma	29154202	3	B-Disease
severity	29154202	3	O
and	29154202	3	O
total	29154202	3	O
IgE	29154202	3	O
level	29154202	3	O
in	29154202	3	O
asthmatic	29154202	3	O
children	29154202	3	O
.	29154202	3	O
NLRP1	29154202	3	O
activators	29154202	3	O
in	29154202	3	O
humans	29154202	3	O
are	29154202	3	O
still	29154202	3	O
unknown	29154202	3	O
,	29154202	3	O
however	29154202	3	O
we	29154202	3	O
hypothesized	29154202	3	O
that	29154202	3	O
individuals	29154202	3	O
with	29154202	3	O
gain	29154202	3	B-PosReg
-	29154202	3	I-PosReg
of	29154202	3	I-PosReg
-	29154202	3	I-PosReg
function	29154202	3	I-PosReg
SNPs	29154202	3	B-Var
in	29154202	3	O
NLRP1	29154202	3	B-Gene
could	29154202	3	O
be	29154202	3	O
more	29154202	3	O
prone	29154202	3	B-PosReg
in	29154202	3	O
activating	29154202	3	O
inflammasome	29154202	3	O
in	29154202	3	O
the	29154202	3	O
presence	29154202	3	O
of	29154202	3	O
asthma	29154202	3	O
-	29154202	3	O
related	29154202	3	O
cell	29154202	3	O
stressors	29154202	3	O
(	29154202	3	O
i.e.	29154202	3	O
ER	29154202	3	O
stress	29154202	3	O
or	29154202	3	O
ROS	29154202	3	O
)	29154202	3	O
,	29154202	3	O
and	29154202	3	O
this	29154202	3	O
activation	29154202	3	O
contribute	29154202	3	O
to	29154202	3	O
exacerbate	29154202	3	B-PosReg
inflammatory	29154202	3	O
response	29154202	3	O
and	29154202	3	O
asthma	29154202	3	O
development	29154202	3	O
.	29154202	3	O
Gain	29154202	3	O
-	29154202	3	O
of	29154202	3	O
-	29154202	3	O
function	29154202	3	O
IL1A	29154202	3	B-Gene
rs17561	29154202	3	B-Var
resulted	29154202	3	O
significantly	29154202	3	O
associated	29154202	3	O
with	29154202	3	O
a	29154202	3	O
reduced	29154202	3	B-NegReg
pulmonary	29154202	3	O
capacity	29154202	3	O
in	29154202	3	O
asthmatic	29154202	3	O
children	29154202	3	O
.	29154202	3	O
IL18	29154202	3	B-Gene
rs5744256	29154202	3	B-Var
which	29154202	3	O
lead	29154202	3	O
to	29154202	3	O
lower	29154202	3	B-NegReg
serum	29154202	3	O
level	29154202	3	O
of	29154202	3	O
IL-18	29154202	3	O
appeared	29154202	3	O
to	29154202	3	O
be	29154202	3	O
associated	29154202	3	O
to	29154202	3	O
a	29154202	3	O
worse	29154202	3	O
response	29154202	3	O
to	29154202	3	O
bronchodilators	29154202	3	O
.	29154202	3	O
Concluding	29154202	3	O
,	29154202	3	O
this	29154202	3	O
work	29154202	3	O
provides	29154202	3	O
evidences	29154202	3	O
about	29154202	3	O
the	29154202	3	O
contribution	29154202	3	O
of	29154202	3	O
inflammasome	29154202	3	O
genetics	29154202	3	O
in	29154202	3	O
the	29154202	3	O
development	29154202	3	O
of	29154202	3	O
paediatric	29154202	3	O
asthma	29154202	3	O
,	29154202	3	O
both	29154202	3	O
considering	29154202	3	O
its	29154202	3	O
inflammatory	29154202	3	O
role	29154202	3	O
in	29154202	3	O
alveolar	29154202	3	O
macrophages	29154202	3	O
(	29154202	3	O
i.e.	29154202	3	O
:	29154202	3	O
NLRP1	29154202	3	O
)	29154202	3	O
or	29154202	3	O
its	29154202	3	O
homeostatic	29154202	3	O
role	29154202	3	O
in	29154202	3	O
lung	29154202	3	O
epithelial	29154202	3	O
cells	29154202	3	O
(	29154202	3	O
i.e.	29154202	3	O
:	29154202	3	O
IL1A	29154202	3	O
,	29154202	3	O
IL18	29154202	3	O
)	29154202	3	O
.	29154202	3	O

EYS	29159838	4	O
mutation	29159838	4	O
update	29159838	4	O
:	29159838	4	O
In	29159838	4	O
silico	29159838	4	O
assessment	29159838	4	O
of	29159838	4	O
271	29159838	4	O
reported	29159838	4	O
and	29159838	4	O
26	29159838	4	O
novel	29159838	4	O
variants	29159838	4	O
in	29159838	4	O
patients	29159838	4	O
with	29159838	4	O
retinitis	29159838	4	O
pigmentosa	29159838	4	O
.	29159838	4	O
Mutations	29159838	4	B-Var
in	29159838	4	O
Eyes	29159838	4	O
shut	29159838	4	O
homolog	29159838	4	O
(	29159838	4	B-Gene
EYS	29159838	4	I-Gene
)	29159838	4	I-Gene
are	29159838	4	O
one	29159838	4	O
of	29159838	4	O
the	29159838	4	O
most	29159838	4	O
common	29159838	4	O
causes	29159838	4	B-Reg
of	29159838	4	O
autosomal	29159838	4	B-Disease
recessive	29159838	4	I-Disease
(	29159838	4	I-Disease
ar	29159838	4	I-Disease
)	29159838	4	I-Disease
retinitis	29159838	4	I-Disease
pigmentosa	29159838	4	I-Disease
(	29159838	4	O
RP	29159838	4	O
)	29159838	4	O
,	29159838	4	O
a	29159838	4	O
progressive	29159838	4	O
blinding	29159838	4	O
disorder	29159838	4	O
.	29159838	4	O
The	29159838	4	O
exact	29159838	4	O
function	29159838	4	O
of	29159838	4	O
the	29159838	4	O
EYS	29159838	4	O
protein	29159838	4	O
and	29159838	4	O
the	29159838	4	O
pathogenic	29159838	4	O
mechanisms	29159838	4	O
underlying	29159838	4	O
EYS	29159838	4	O
-	29159838	4	O
associated	29159838	4	O
RP	29159838	4	O
are	29159838	4	O
still	29159838	4	O
poorly	29159838	4	O
understood	29159838	4	O
,	29159838	4	O
which	29159838	4	O
hampers	29159838	4	O
the	29159838	4	O
interpretation	29159838	4	O
of	29159838	4	O
the	29159838	4	O
causality	29159838	4	O
of	29159838	4	O
many	29159838	4	O
EYS	29159838	4	O
variants	29159838	4	O
discovered	29159838	4	O
to	29159838	4	O
date	29159838	4	O
.	29159838	4	O
We	29159838	4	O
collected	29159838	4	O
all	29159838	4	O
reported	29159838	4	O
EYS	29159838	4	O
variants	29159838	4	O
present	29159838	4	O
in	29159838	4	O
377	29159838	4	O
arRP	29159838	4	O
index	29159838	4	O
cases	29159838	4	O
published	29159838	4	O
before	29159838	4	O
June	29159838	4	O
2017	29159838	4	O
,	29159838	4	O
and	29159838	4	O
uploaded	29159838	4	O
them	29159838	4	O
in	29159838	4	O
the	29159838	4	O
Leiden	29159838	4	O
Open	29159838	4	O
Variation	29159838	4	O
Database	29159838	4	O
(	29159838	4	O
www	29159838	4	O
.	29159838	4	O
LOVD	29159838	4	O
.	29159838	4	O
nl	29159838	4	O
/	29159838	4	O
EYS	29159838	4	O
)	29159838	4	O
.	29159838	4	O
We	29159838	4	O
also	29159838	4	O
describe	29159838	4	O
36	29159838	4	O
additional	29159838	4	O
index	29159838	4	O
cases	29159838	4	O
,	29159838	4	O
carrying	29159838	4	O
26	29159838	4	O
novel	29159838	4	O
variants	29159838	4	O
.	29159838	4	O
Of	29159838	4	O
the	29159838	4	O
297	29159838	4	O
unique	29159838	4	O
EYS	29159838	4	O
variants	29159838	4	O
identified	29159838	4	O
,	29159838	4	O
almost	29159838	4	O
half	29159838	4	O
(	29159838	4	O
n	29159838	4	O
=	29159838	4	O
130	29159838	4	O
)	29159838	4	O
are	29159838	4	O
predicted	29159838	4	O
to	29159838	4	O
result	29159838	4	O
in	29159838	4	O
premature	29159838	4	O
truncation	29159838	4	O
of	29159838	4	O
the	29159838	4	O
EYS	29159838	4	O
protein	29159838	4	O
.	29159838	4	O
Classification	29159838	4	O
of	29159838	4	O
all	29159838	4	O
variants	29159838	4	O
using	29159838	4	O
the	29159838	4	O
American	29159838	4	O
College	29159838	4	O
of	29159838	4	O
Medical	29159838	4	O
Genetics	29159838	4	O
and	29159838	4	O
Genomics	29159838	4	O
guidelines	29159838	4	O
revealed	29159838	4	O
that	29159838	4	O
the	29159838	4	O
predicted	29159838	4	O
pathogenicity	29159838	4	O
of	29159838	4	O
these	29159838	4	O
variants	29159838	4	O
cover	29159838	4	O
the	29159838	4	O
complete	29159838	4	O
spectrum	29159838	4	O
ranging	29159838	4	O
from	29159838	4	O
likely	29159838	4	O
benign	29159838	4	O
to	29159838	4	O
pathogenic	29159838	4	O
,	29159838	4	O
although	29159838	4	O
especially	29159838	4	O
missense	29159838	4	O
variants	29159838	4	O
largely	29159838	4	O
fall	29159838	4	O
in	29159838	4	O
the	29159838	4	O
category	29159838	4	O
of	29159838	4	O
uncertain	29159838	4	O
significance	29159838	4	O
.	29159838	4	O
Besides	29159838	4	O
the	29159838	4	O
identification	29159838	4	O
of	29159838	4	O
likely	29159838	4	O
benign	29159838	4	O
alleles	29159838	4	O
previously	29159838	4	O
reported	29159838	4	O
as	29159838	4	O
being	29159838	4	O
probably	29159838	4	O
pathogenic	29159838	4	O
,	29159838	4	O
our	29159838	4	O
comprehensive	29159838	4	O
analysis	29159838	4	O
underscores	29159838	4	O
the	29159838	4	O
need	29159838	4	O
of	29159838	4	O
functional	29159838	4	O
assays	29159838	4	O
to	29159838	4	O
assess	29159838	4	O
the	29159838	4	O
causality	29159838	4	O
of	29159838	4	O
EYS	29159838	4	O
variants	29159838	4	O
,	29159838	4	O
in	29159838	4	O
order	29159838	4	O
to	29159838	4	O
improve	29159838	4	O
molecular	29159838	4	O
diagnostics	29159838	4	O
and	29159838	4	O
counseling	29159838	4	O
of	29159838	4	O
patients	29159838	4	O
with	29159838	4	O
EYS	29159838	4	O
-	29159838	4	O
associated	29159838	4	O
RP	29159838	4	O
.	29159838	4	O

MED13L	29159987	1	B-Gene
loss	29159987	1	B-NegReg
-	29159987	1	I-NegReg
of	29159987	1	I-NegReg
-	29159987	1	I-NegReg
function	29159987	1	I-NegReg
variants	29159987	1	B-Var
in	29159987	1	O
two	29159987	1	O
patients	29159987	1	O
with	29159987	1	O
syndromic	29159987	1	O
Pierre	29159987	1	B-Disease
Robin	29159987	1	I-Disease
sequence	29159987	1	I-Disease
.	29159987	1	O
We	29159987	1	O
report	29159987	1	O
two	29159987	1	O
unrelated	29159987	1	O
patients	29159987	1	O
with	29159987	1	O
Pierre	29159987	1	O
Robin	29159987	1	O
sequence	29159987	1	O
(	29159987	1	O
PRS	29159987	1	O
)	29159987	1	O
and	29159987	1	O
a	29159987	1	O
strikingly	29159987	1	O
similar	29159987	1	O
combination	29159987	1	O
of	29159987	1	O
associated	29159987	1	O
features	29159987	1	O
.	29159987	1	O
Whole	29159987	1	O
exome	29159987	1	O
sequencing	29159987	1	O
was	29159987	1	O
performed	29159987	1	O
for	29159987	1	O
both	29159987	1	O
patients	29159987	1	O
.	29159987	1	O
No	29159987	1	O
single	29159987	1	O
gene	29159987	1	O
containing	29159987	1	O
likely	29159987	1	O
pathogenic	29159987	1	O
point	29159987	1	O
mutations	29159987	1	O
in	29159987	1	O
both	29159987	1	O
patients	29159987	1	O
could	29159987	1	O
be	29159987	1	O
identified	29159987	1	O
,	29159987	1	O
but	29159987	1	O
the	29159987	1	O
finding	29159987	1	O
of	29159987	1	O
an	29159987	1	O
essential	29159987	1	O
splice	29159987	1	O
site	29159987	1	O
mutation	29159987	1	O
in	29159987	1	O
mediator	29159987	1	O
complex	29159987	1	O
subunit	29159987	1	O
13	29159987	1	O
like	29159987	1	O
(	29159987	1	O
MED13L	29159987	1	O
)	29159987	1	O
in	29159987	1	O
one	29159987	1	O
patient	29159987	1	O
prompted	29159987	1	O
the	29159987	1	O
investigation	29159987	1	O
of	29159987	1	O
copy	29159987	1	O
number	29159987	1	O
variants	29159987	1	O
in	29159987	1	O
MED13L	29159987	1	O
in	29159987	1	O
the	29159987	1	O
other	29159987	1	O
,	29159987	1	O
leading	29159987	1	O
to	29159987	1	O
the	29159987	1	O
identification	29159987	1	O
of	29159987	1	O
an	29159987	1	O
intragenic	29159987	1	O
deletion	29159987	1	O
.	29159987	1	O
Disruption	29159987	1	B-Var
of	29159987	1	O
MED13L	29159987	1	B-Gene
,	29159987	1	O
encoding	29159987	1	O
a	29159987	1	O
component	29159987	1	O
of	29159987	1	O
the	29159987	1	O
Mediator	29159987	1	O
complex	29159987	1	O
,	29159987	1	O
is	29159987	1	O
increasingly	29159987	1	O
recognized	29159987	1	O
as	29159987	1	O
the	29159987	1	O
cause	29159987	1	B-Reg
of	29159987	1	O
an	29159987	1	O
intellectual	29159987	1	B-Disease
disability	29159987	1	I-Disease
syndrome	29159987	1	I-Disease
with	29159987	1	O
associated	29159987	1	O
facial	29159987	1	B-Disease
dysmorphism	29159987	1	I-Disease
.	29159987	1	O
Our	29159987	1	O
findings	29159987	1	O
suggest	29159987	1	O
that	29159987	1	O
MED13L	29159987	1	O
-	29159987	1	O
related	29159987	1	O
disorders	29159987	1	O
are	29159987	1	O
a	29159987	1	O
possible	29159987	1	O
differential	29159987	1	O
diagnosis	29159987	1	O
for	29159987	1	O
syndromic	29159987	1	O
PRS	29159987	1	O
.	29159987	1	O

Loss	29167417	1	B-Var
-	29167417	1	I-Var
of	29167417	1	I-Var
-	29167417	1	I-Var
activity	29167417	1	I-Var
-	29167417	1	I-Var
mutation	29167417	1	I-Var
in	29167417	1	O
the	29167417	1	O
cardiac	29167417	1	O
chloride	29167417	1	O
-	29167417	1	O
bicarbonate	29167417	1	O
exchanger	29167417	1	O
AE3	29167417	1	O
causes	29167417	1	O
short	29167417	1	B-Disease
QT	29167417	1	I-Disease
syndrome	29167417	1	I-Disease
.	29167417	1	O
Patients	29167417	1	O
with	29167417	1	O
short	29167417	1	O
QT	29167417	1	O
syndrome	29167417	1	O
(	29167417	1	O
SQTS	29167417	1	O
)	29167417	1	O
may	29167417	1	O
present	29167417	1	O
with	29167417	1	O
syncope	29167417	1	O
,	29167417	1	O
ventricular	29167417	1	O
fibrillation	29167417	1	O
or	29167417	1	O
sudden	29167417	1	O
cardiac	29167417	1	O
death	29167417	1	O
.	29167417	1	O
Six	29167417	1	O
SQTS	29167417	1	O
susceptibility	29167417	1	O
genes	29167417	1	O
,	29167417	1	O
encoding	29167417	1	O
cation	29167417	1	O
channels	29167417	1	O
,	29167417	1	O
explain	29167417	1	O
<	29167417	1	O
25%	29167417	1	O
of	29167417	1	O
SQTS	29167417	1	O
cases	29167417	1	O
.	29167417	1	O
Here	29167417	1	O
we	29167417	1	O
identify	29167417	1	O
a	29167417	1	O
missense	29167417	1	B-Var
mutation	29167417	1	I-Var
in	29167417	1	O
the	29167417	1	O
anion	29167417	1	O
exchanger	29167417	1	O
(	29167417	1	O
AE3	29167417	1	O
)	29167417	1	O
-	29167417	1	O
encoding	29167417	1	O
SLC4A3	29167417	1	B-Gene
gene	29167417	1	O
in	29167417	1	O
two	29167417	1	O
unrelated	29167417	1	O
families	29167417	1	O
with	29167417	1	O
SQTS	29167417	1	O
.	29167417	1	O
The	29167417	1	O
mutation	29167417	1	O
causes	29167417	1	O
reduced	29167417	1	B-NegReg
surface	29167417	1	O
expression	29167417	1	O
of	29167417	1	O
AE3	29167417	1	O
and	29167417	1	O
reduced	29167417	1	B-NegReg
membrane	29167417	1	O
bicarbonate	29167417	1	O
transport	29167417	1	O
.	29167417	1	O
Slc4a3	29167417	1	O
knockdown	29167417	1	O
in	29167417	1	O
zebrafish	29167417	1	O
causes	29167417	1	O
increased	29167417	1	O
cardiac	29167417	1	O
pHi	29167417	1	O
,	29167417	1	O
short	29167417	1	O
QTc	29167417	1	O
,	29167417	1	O
and	29167417	1	O
reduced	29167417	1	O
systolic	29167417	1	O
duration	29167417	1	O
,	29167417	1	O
which	29167417	1	O
is	29167417	1	O
rescued	29167417	1	O
by	29167417	1	O
wildtype	29167417	1	O
but	29167417	1	O
not	29167417	1	O
mutated	29167417	1	O
SLC4A3	29167417	1	O
.	29167417	1	O
Mechanistic	29167417	1	O
analyses	29167417	1	O
suggest	29167417	1	O
that	29167417	1	O
an	29167417	1	O
increase	29167417	1	O
in	29167417	1	O
pHi	29167417	1	O
and	29167417	1	O
decrease	29167417	1	O
in	29167417	1	O
[	29167417	1	O
Cl	29167417	1	O
-	29167417	1	O
]	29167417	1	O
i	29167417	1	O
shortened	29167417	1	O
the	29167417	1	O
action	29167417	1	O
potential	29167417	1	O
duration	29167417	1	O
.	29167417	1	O
However	29167417	1	O
,	29167417	1	O
other	29167417	1	O
mechanisms	29167417	1	O
may	29167417	1	O
also	29167417	1	O
play	29167417	1	O
a	29167417	1	O
role	29167417	1	O
.	29167417	1	O
Altered	29167417	1	O
anion	29167417	1	O
transport	29167417	1	O
represents	29167417	1	O
a	29167417	1	O
mechanism	29167417	1	O
for	29167417	1	O
development	29167417	1	O
of	29167417	1	O
arrhythmia	29167417	1	O
and	29167417	1	O
may	29167417	1	O
provide	29167417	1	O
new	29167417	1	O
therapeutic	29167417	1	O
possibilities	29167417	1	O
.	29167417	1	O

In	29172679	0	O
Silico	29172679	0	O
Approach	29172679	0	O
to	29172679	0	O
Investigate	29172679	0	O
the	29172679	0	O
Structural	29172679	0	O
and	29172679	0	O
Functional	29172679	0	O
Attributes	29172679	0	O
of	29172679	0	O
Familial	29172679	0	O
Hypercholesterolemia	29172679	0	O
Variants	29172679	0	O
Reported	29172679	0	O
in	29172679	0	O
the	29172679	0	O
Saudi	29172679	0	O
Population	29172679	0	O
.	29172679	0	O
Familial	29172679	0	B-Disease
hypercholesterolemia	29172679	0	I-Disease
(	29172679	0	O
FH	29172679	0	O
)	29172679	0	O
is	29172679	0	O
a	29172679	0	O
metabolic	29172679	0	O
disorder	29172679	0	O
that	29172679	0	O
leads	29172679	0	O
primarily	29172679	0	O
to	29172679	0	O
premature	29172679	0	O
cardiovascular	29172679	0	O
diseases	29172679	0	O
,	29172679	0	O
the	29172679	0	O
main	29172679	0	O
cause	29172679	0	O
of	29172679	0	O
mortality	29172679	0	O
in	29172679	0	O
Saudi	29172679	0	O
Arabia	29172679	0	O
(	29172679	0	O
SA	29172679	0	O
)	29172679	0	O
.	29172679	0	O
FH	29172679	0	O
is	29172679	0	O
underreported	29172679	0	O
and	29172679	0	O
underdiagnosed	29172679	0	O
in	29172679	0	O
SA	29172679	0	O
with	29172679	0	O
statistical	29172679	0	O
evidence	29172679	0	O
of	29172679	0	O
high	29172679	0	O
expected	29172679	0	O
prevalence	29172679	0	O
in	29172679	0	O
such	29172679	0	O
a	29172679	0	O
consanguineous	29172679	0	O
community	29172679	0	O
.	29172679	0	O
Lacking	29172679	0	O
knowledge	29172679	0	O
of	29172679	0	O
which	29172679	0	O
and	29172679	0	O
how	29172679	0	O
these	29172679	0	O
alterations	29172679	0	O
are	29172679	0	O
actually	29172679	0	O
impacting	29172679	0	O
lipid	29172679	0	O
metabolism	29172679	0	O
is	29172679	0	O
one	29172679	0	O
of	29172679	0	O
the	29172679	0	O
main	29172679	0	O
reasons	29172679	0	O
why	29172679	0	O
FH	29172679	0	O
is	29172679	0	O
insufficiently	29172679	0	O
diagnosed	29172679	0	O
in	29172679	0	O
the	29172679	0	O
region	29172679	0	O
.	29172679	0	O
The	29172679	0	O
aim	29172679	0	O
of	29172679	0	O
this	29172679	0	O
study	29172679	0	O
was	29172679	0	O
to	29172679	0	O
develop	29172679	0	O
a	29172679	0	O
fast	29172679	0	O
prediction	29172679	0	O
approach	29172679	0	O
using	29172679	0	O
an	29172679	0	O
integrated	29172679	0	O
bioinformatics	29172679	0	O
method	29172679	0	O
for	29172679	0	O
future	29172679	0	O
screening	29172679	0	O
of	29172679	0	O
the	29172679	0	O
potential	29172679	0	O
causative	29172679	0	O
variants	29172679	0	O
from	29172679	0	O
national	29172679	0	O
registries	29172679	0	O
.	29172679	0	O
A	29172679	0	O
total	29172679	0	O
of	29172679	0	O
21	29172679	0	O
variants	29172679	0	O
were	29172679	0	O
detected	29172679	0	O
with	29172679	0	O
majority	29172679	0	O
rate	29172679	0	O
in	29172679	0	O
LDLR	29172679	0	O
(	29172679	0	O
81%	29172679	0	O
)	29172679	0	O
.	29172679	0	O
Variants	29172679	0	O
were	29172679	0	O
classified	29172679	0	O
based	29172679	0	O
on	29172679	0	O
the	29172679	0	O
type	29172679	0	O
of	29172679	0	O
mutation	29172679	0	O
.	29172679	0	O
Missense	29172679	0	O
variants	29172679	0	O
resulting	29172679	0	O
in	29172679	0	O
amino	29172679	0	O
acid	29172679	0	O
changes	29172679	0	O
,	29172679	0	O
c.1429	29172679	0	B-Var
G	29172679	0	I-Var
>	29172679	0	I-Var
A	29172679	0	I-Var
(	29172679	0	O
p.D477N	29172679	0	O
)	29172679	0	O
,	29172679	0	O
c.1474	29172679	0	B-Var
G	29172679	0	I-Var
>	29172679	0	I-Var
A	29172679	0	I-Var
(	29172679	0	O
p.D492N	29172679	0	O
)	29172679	0	O
,	29172679	0	O
c.1731	29172679	0	B-Var
G	29172679	0	I-Var
>	29172679	0	I-Var
T	29172679	0	I-Var
(	29172679	0	O
p.W577C	29172679	0	O
)	29172679	0	O
,	29172679	0	O
and	29172679	0	O
c.1783	29172679	0	B-Var
C	29172679	0	I-Var
>	29172679	0	I-Var
T	29172679	0	I-Var
(	29172679	0	O
p.R595W	29172679	0	O
)	29172679	0	O
in	29172679	0	O
LDLR	29172679	0	B-Gene
gene	29172679	0	O
,	29172679	0	O
in	29172679	0	O
addition	29172679	0	O
to	29172679	0	O
c.9835	29172679	0	B-Var
A	29172679	0	I-Var
>	29172679	0	I-Var
G	29172679	0	I-Var
(	29172679	0	O
p.S3279G	29172679	0	O
)	29172679	0	O
in	29172679	0	O
APOB	29172679	0	B-Gene
,	29172679	0	O
were	29172679	0	O
shown	29172679	0	O
to	29172679	0	O
be	29172679	0	O
deleterious	29172679	0	O
by	29172679	0	O
concordant	29172679	0	O
analysis	29172679	0	O
.	29172679	0	O
Furthermore	29172679	0	O
,	29172679	0	O
functional	29172679	0	O
interaction	29172679	0	O
deformities	29172679	0	B-Reg
showed	29172679	0	O
a	29172679	0	O
significant	29172679	0	O
loss	29172679	0	B-NegReg
and	29172679	0	O
gain	29172679	0	B-PosReg
of	29172679	0	O
energies	29172679	0	O
in	29172679	0	O
the	29172679	0	O
mutated	29172679	0	O
proteins	29172679	0	O
.	29172679	0	O
These	29172679	0	O
findings	29172679	0	O
will	29172679	0	O
help	29172679	0	O
in	29172679	0	O
distinguishing	29172679	0	O
the	29172679	0	O
most	29172679	0	O
harmful	29172679	0	O
mutations	29172679	0	O
needed	29172679	0	O
to	29172679	0	O
be	29172679	0	O
screened	29172679	0	O
for	29172679	0	O
clinically	29172679	0	O
diagnosed	29172679	0	O
FH	29172679	0	O
patients	29172679	0	O
in	29172679	0	O
SA	29172679	0	O
.	29172679	0	O
Such	29172679	0	O
computational	29172679	0	O
research	29172679	0	O
is	29172679	0	O
necessary	29172679	0	O
to	29172679	0	O
avoid	29172679	0	O
time	29172679	0	O
consumption	29172679	0	O
and	29172679	0	O
the	29172679	0	O
usage	29172679	0	O
of	29172679	0	O
expensive	29172679	0	O
biological	29172679	0	O
experiments	29172679	0	O
.	29172679	0	O
This	29172679	0	O
can	29172679	0	O
be	29172679	0	O
a	29172679	0	O
fast	29172679	0	O
track	29172679	0	O
to	29172679	0	O
facilitate	29172679	0	O
the	29172679	0	O
future	29172679	0	O
filtering	29172679	0	O
and	29172679	0	O
screening	29172679	0	O
of	29172679	0	O
causative	29172679	0	O
mutations	29172679	0	O
from	29172679	0	O
national	29172679	0	O
registries	29172679	0	O
.	29172679	0	O

Effects	29199454	0	O
of	29199454	0	O
null	29199454	0	O
mutation	29199454	0	O
of	29199454	0	O
the	29199454	0	O
heat	29199454	0	O
-	29199454	0	O
shock	29199454	0	O
gene	29199454	0	O
htpG	29199454	0	O
on	29199454	0	O
the	29199454	0	O
production	29199454	0	O
of	29199454	0	O
virulence	29199454	0	O
factors	29199454	0	O
by	29199454	0	O
Pseudomonas	29199454	0	O
aeruginosa	29199454	0	O
.	29199454	0	O
AIM	29199454	0	O
:	29199454	0	O
Pseudomonas	29199454	0	O
aeruginosa	29199454	0	O
is	29199454	0	O
one	29199454	0	O
of	29199454	0	O
the	29199454	0	O
most	29199454	0	O
clinically	29199454	0	O
important	29199454	0	O
opportunistic	29199454	0	O
pathogen	29199454	0	O
in	29199454	0	O
humans	29199454	0	O
.	29199454	0	O
The	29199454	0	O
aim	29199454	0	O
of	29199454	0	O
the	29199454	0	O
project	29199454	0	O
was	29199454	0	O
to	29199454	0	O
study	29199454	0	O
effects	29199454	0	O
of	29199454	0	O
HtpG	29199454	0	O
on	29199454	0	O
the	29199454	0	O
selected	29199454	0	O
virulence	29199454	0	O
factors	29199454	0	O
responsible	29199454	0	O
for	29199454	0	O
pathogenesis	29199454	0	O
and	29199454	0	O
biofilm	29199454	0	O
formation	29199454	0	O
of	29199454	0	O
P.	29199454	0	O
aeruginosa	29199454	0	O
.	29199454	0	O
METHODOLOGY	29199454	0	O
:	29199454	0	O
By	29199454	0	O
characterizing	29199454	0	O
a	29199454	0	O
htpG	29199454	0	O
null	29199454	0	O
mutant	29199454	0	O
of	29199454	0	O
P.	29199454	0	O
aeruginosa	29199454	0	O
,	29199454	0	O
we	29199454	0	O
have	29199454	0	O
identified	29199454	0	O
the	29199454	0	O
role	29199454	0	O
of	29199454	0	O
HtpG	29199454	0	O
in	29199454	0	O
the	29199454	0	O
production	29199454	0	O
of	29199454	0	O
selected	29199454	0	O
factors	29199454	0	O
.	29199454	0	O
RESULTS	29199454	0	O
:	29199454	0	O
We	29199454	0	O
showed	29199454	0	O
that	29199454	0	O
ΔhtpG	29199454	0	B-Gene
mutant	29199454	0	B-Var
affects	29199454	0	O
many	29199454	0	O
physiological	29199454	0	O
processes	29199454	0	O
containing	29199454	0	O
:	29199454	0	O
decreased	29199454	0	B-NegReg
activity	29199454	0	O
of	29199454	0	O
the	29199454	0	O
LasA	29199454	0	O
protease	29199454	0	O
,	29199454	0	O
reduction	29199454	0	B-NegReg
of	29199454	0	O
biofilm	29199454	0	O
formation	29199454	0	O
,	29199454	0	O
decreased	29199454	0	B-NegReg
motility	29199454	0	O
,	29199454	0	O
and	29199454	0	O
diminished	29199454	0	B-NegReg
amount	29199454	0	O
of	29199454	0	O
rhamnolipids	29199454	0	O
and	29199454	0	O
pyoverdine	29199454	0	O
/	29199454	0	O
pyocyanin	29199454	0	O
.	29199454	0	O
These	29199454	0	O
defects	29199454	0	O
were	29199454	0	O
most	29199454	0	O
evident	29199454	0	O
when	29199454	0	O
the	29199454	0	O
ΔhtpG	29199454	0	O
strain	29199454	0	O
was	29199454	0	O
cultured	29199454	0	O
at	29199454	0	O
42	29199454	0	O
C.	29199454	0	O
CONCLUSION	29199454	0	O
:	29199454	0	O
Our	29199454	0	O
findings	29199454	0	O
demonstrate	29199454	0	O
the	29199454	0	O
unexplored	29199454	0	O
role	29199454	0	O
of	29199454	0	O
HtpG	29199454	0	O
in	29199454	0	O
the	29199454	0	O
pathogenicity	29199454	0	O
of	29199454	0	O
P.	29199454	0	O
aeruginosa	29199454	0	O
,	29199454	0	O
and	29199454	0	O
indicate	29199454	0	O
potential	29199454	0	O
targets	29199454	0	O
for	29199454	0	O
antibacterial	29199454	0	O
therapeutics	29199454	0	O
.	29199454	0	O
[	29199454	0	O
Formula	29199454	0	O
:	29199454	0	O
see	29199454	0	O
text	29199454	0	O
]	29199454	0	O
.	29199454	0	O

Ciliopathy	29220510	1	O
-	29220510	1	O
associated	29220510	1	O
mutations	29220510	1	B-Var
of	29220510	1	O
IFT122	29220510	1	B-Gene
impair	29220510	1	B-NegReg
ciliary	29220510	1	O
protein	29220510	1	O
trafficking	29220510	1	O
but	29220510	1	O
not	29220510	1	O
ciliogenesis	29220510	1	O
.	29220510	1	O
The	29220510	1	O
intraflagellar	29220510	1	O
transport	29220510	1	O
(	29220510	1	O
IFT	29220510	1	O
)	29220510	1	O
machinery	29220510	1	O
containing	29220510	1	O
the	29220510	1	O
IFT	29220510	1	O
-	29220510	1	O
A	29220510	1	O
and	29220510	1	O
IFT	29220510	1	O
-	29220510	1	O
B	29220510	1	O
complexes	29220510	1	O
mediates	29220510	1	O
ciliary	29220510	1	O
protein	29220510	1	O
trafficking	29220510	1	O
.	29220510	1	O
Mutations	29220510	1	B-Var
in	29220510	1	O
the	29220510	1	O
genes	29220510	1	O
encoding	29220510	1	O
the	29220510	1	O
six	29220510	1	O
subunits	29220510	1	O
of	29220510	1	O
the	29220510	1	O
IFT	29220510	1	O
-	29220510	1	O
A	29220510	1	O
complex	29220510	1	O
(	29220510	1	B-Gene
IFT43	29220510	1	I-Gene
,	29220510	1	O
IFT121	29220510	1	B-Gene
,	29220510	1	O
IFT122	29220510	1	B-Gene
,	29220510	1	O
IFT139	29220510	1	B-Gene
,	29220510	1	O
IFT140	29220510	1	B-Gene
,	29220510	1	O
and	29220510	1	O
IFT144	29220510	1	B-Gene
)	29220510	1	I-Gene
are	29220510	1	O
known	29220510	1	O
to	29220510	1	O
cause	29220510	1	B-Reg
skeletal	29220510	1	O
ciliopathies	29220510	1	O
,	29220510	1	O
including	29220510	1	O
cranioectodermal	29220510	1	B-Disease
dysplasia	29220510	1	I-Disease
(	29220510	1	O
CED	29220510	1	O
)	29220510	1	O
.	29220510	1	O
As	29220510	1	O
the	29220510	1	O
IFT122	29220510	1	O
subunit	29220510	1	O
connects	29220510	1	O
the	29220510	1	O
core	29220510	1	O
and	29220510	1	O
peripheral	29220510	1	O
subcomplexes	29220510	1	O
of	29220510	1	O
the	29220510	1	O
IFT	29220510	1	O
-	29220510	1	O
A	29220510	1	O
complex	29220510	1	O
,	29220510	1	O
it	29220510	1	O
is	29220510	1	O
expected	29220510	1	O
to	29220510	1	O
play	29220510	1	O
a	29220510	1	O
pivotal	29220510	1	O
role	29220510	1	O
in	29220510	1	O
the	29220510	1	O
complex	29220510	1	O
.	29220510	1	O
Indeed	29220510	1	O
,	29220510	1	O
we	29220510	1	O
here	29220510	1	O
showed	29220510	1	O
that	29220510	1	O
knockout	29220510	1	O
(	29220510	1	O
KO	29220510	1	O
)	29220510	1	O
of	29220510	1	O
the	29220510	1	O
IFT122	29220510	1	O
gene	29220510	1	O
in	29220510	1	O
hTERT	29220510	1	O
-	29220510	1	O
RPE1	29220510	1	O
cells	29220510	1	O
using	29220510	1	O
the	29220510	1	O
CRISPR	29220510	1	O
/	29220510	1	O
Cas9	29220510	1	O
system	29220510	1	O
led	29220510	1	O
to	29220510	1	O
a	29220510	1	O
severe	29220510	1	O
ciliogenesis	29220510	1	O
defect	29220510	1	O
,	29220510	1	O
whereas	29220510	1	O
KO	29220510	1	O
of	29220510	1	O
other	29220510	1	O
IFT	29220510	1	O
-	29220510	1	O
A	29220510	1	O
genes	29220510	1	O
had	29220510	1	O
minor	29220510	1	O
effects	29220510	1	O
on	29220510	1	O
ciliogenesis	29220510	1	O
but	29220510	1	O
impaired	29220510	1	O
ciliary	29220510	1	O
protein	29220510	1	O
trafficking	29220510	1	O
.	29220510	1	O
Exogenous	29220510	1	O
expression	29220510	1	O
of	29220510	1	O
not	29220510	1	O
only	29220510	1	O
wild	29220510	1	O
-	29220510	1	O
type	29220510	1	O
IFT122	29220510	1	O
but	29220510	1	O
also	29220510	1	O
its	29220510	1	O
CED	29220510	1	O
-	29220510	1	O
associated	29220510	1	O
missense	29220510	1	O
mutants	29220510	1	O
,	29220510	1	O
which	29220510	1	O
fail	29220510	1	O
to	29220510	1	O
interact	29220510	1	O
with	29220510	1	O
other	29220510	1	O
IFT	29220510	1	O
-	29220510	1	O
A	29220510	1	O
subunits	29220510	1	O
,	29220510	1	O
rescued	29220510	1	O
the	29220510	1	O
ciliogenesis	29220510	1	O
defect	29220510	1	O
of	29220510	1	O
IFT122	29220510	1	O
-	29220510	1	O
KO	29220510	1	O
cells	29220510	1	O
.	29220510	1	O
However	29220510	1	O
,	29220510	1	O
IFT122	29220510	1	O
-	29220510	1	O
KO	29220510	1	O
cells	29220510	1	O
expressing	29220510	1	O
CED	29220510	1	O
-	29220510	1	O
type	29220510	1	O
IFT122	29220510	1	B-Gene
mutants	29220510	1	B-Var
showed	29220510	1	O
defects	29220510	1	B-NegReg
in	29220510	1	O
ciliary	29220510	1	O
protein	29220510	1	O
trafficking	29220510	1	O
,	29220510	1	O
such	29220510	1	O
as	29220510	1	O
ciliary	29220510	1	O
entry	29220510	1	O
of	29220510	1	O
Smoothened	29220510	1	O
in	29220510	1	O
response	29220510	1	O
to	29220510	1	O
Hedgehog	29220510	1	O
signaling	29220510	1	O
activation	29220510	1	O
.	29220510	1	O
The	29220510	1	O
trafficking	29220510	1	O
defects	29220510	1	O
partially	29220510	1	O
resembled	29220510	1	O
those	29220510	1	O
observed	29220510	1	O
in	29220510	1	O
IFT144	29220510	1	O
-	29220510	1	O
KO	29220510	1	O
cells	29220510	1	O
,	29220510	1	O
which	29220510	1	O
demonstrate	29220510	1	O
failed	29220510	1	O
assembly	29220510	1	O
of	29220510	1	O
the	29220510	1	O
functional	29220510	1	O
IFT	29220510	1	O
-	29220510	1	O
A	29220510	1	O
complex	29220510	1	O
at	29220510	1	O
the	29220510	1	O
base	29220510	1	O
of	29220510	1	O
cilia	29220510	1	O
.	29220510	1	O
These	29220510	1	O
observations	29220510	1	O
make	29220510	1	O
it	29220510	1	O
likely	29220510	1	O
that	29220510	1	O
,	29220510	1	O
although	29220510	1	O
IFT122	29220510	1	O
is	29220510	1	O
essential	29220510	1	O
for	29220510	1	O
ciliogenesis	29220510	1	O
,	29220510	1	O
CED	29220510	1	O
-	29220510	1	O
type	29220510	1	O
missense	29220510	1	O
mutations	29220510	1	O
underlie	29220510	1	O
a	29220510	1	O
skeletal	29220510	1	O
ciliopathy	29220510	1	O
phenotype	29220510	1	O
by	29220510	1	O
perturbing	29220510	1	O
ciliary	29220510	1	O
protein	29220510	1	O
trafficking	29220510	1	O
with	29220510	1	O
minor	29220510	1	O
effects	29220510	1	O
on	29220510	1	O
ciliogenesis	29220510	1	O
per	29220510	1	O
se	29220510	1	O
.	29220510	1	O

A	29222010	1	O
novel	29222010	1	O
NR2F2	29222010	1	B-Gene
loss	29222010	1	B-NegReg
-	29222010	1	I-NegReg
of	29222010	1	I-NegReg
-	29222010	1	I-NegReg
function	29222010	1	I-NegReg
mutation	29222010	1	B-Var
predisposes	29222010	1	O
to	29222010	1	O
congenital	29222010	1	B-Disease
heart	29222010	1	I-Disease
defect	29222010	1	I-Disease
.	29222010	1	O
Congenital	29222010	1	O
heart	29222010	1	O
defect	29222010	1	O
(	29222010	1	O
CHD	29222010	1	O
)	29222010	1	O
is	29222010	1	O
the	29222010	1	O
most	29222010	1	O
common	29222010	1	O
type	29222010	1	O
of	29222010	1	O
birth	29222010	1	O
defect	29222010	1	O
in	29222010	1	O
humans	29222010	1	O
and	29222010	1	O
a	29222010	1	O
leading	29222010	1	O
cause	29222010	1	O
of	29222010	1	O
infant	29222010	1	O
morbidity	29222010	1	O
and	29222010	1	O
mortality	29222010	1	O
.	29222010	1	O
Previous	29222010	1	O
studies	29222010	1	O
have	29222010	1	O
demonstrated	29222010	1	O
that	29222010	1	O
genetic	29222010	1	O
defects	29222010	1	O
play	29222010	1	O
a	29222010	1	O
pivotal	29222010	1	O
role	29222010	1	O
in	29222010	1	O
the	29222010	1	O
pathogenesis	29222010	1	O
of	29222010	1	O
CHD	29222010	1	O
.	29222010	1	O
However	29222010	1	O
,	29222010	1	O
the	29222010	1	O
genetic	29222010	1	O
basis	29222010	1	O
of	29222010	1	O
CHD	29222010	1	O
remains	29222010	1	O
poorly	29222010	1	O
understood	29222010	1	O
due	29222010	1	O
to	29222010	1	O
substantial	29222010	1	O
genetic	29222010	1	O
heterogeneity	29222010	1	O
.	29222010	1	O
In	29222010	1	O
this	29222010	1	O
study	29222010	1	O
,	29222010	1	O
the	29222010	1	O
coding	29222010	1	O
exons	29222010	1	O
and	29222010	1	O
splicing	29222010	1	O
boundaries	29222010	1	O
of	29222010	1	O
the	29222010	1	O
NR2F2	29222010	1	O
gene	29222010	1	O
,	29222010	1	O
which	29222010	1	O
encodes	29222010	1	O
a	29222010	1	O
pleiotropic	29222010	1	O
transcription	29222010	1	O
factor	29222010	1	O
required	29222010	1	O
for	29222010	1	O
normal	29222010	1	O
cardiovascular	29222010	1	O
development	29222010	1	O
,	29222010	1	O
were	29222010	1	O
sequenced	29222010	1	O
in	29222010	1	O
168	29222010	1	O
unrelated	29222010	1	O
patients	29222010	1	O
with	29222010	1	O
CHD	29222010	1	O
,	29222010	1	O
and	29222010	1	O
a	29222010	1	O
novel	29222010	1	O
mutation	29222010	1	O
(	29222010	1	O
c.247	29222010	1	O
G	29222010	1	O
>	29222010	1	O
T	29222010	1	O
,	29222010	1	O
equivalent	29222010	1	O
to	29222010	1	O
p.G83X	29222010	1	O
)	29222010	1	O
was	29222010	1	O
detected	29222010	1	O
in	29222010	1	O
a	29222010	1	O
patient	29222010	1	O
with	29222010	1	O
double	29222010	1	O
outlet	29222010	1	O
right	29222010	1	O
ventricle	29222010	1	O
as	29222010	1	O
well	29222010	1	O
as	29222010	1	O
ventricular	29222010	1	O
septal	29222010	1	O
defect	29222010	1	O
.	29222010	1	O
Genetic	29222010	1	O
scanning	29222010	1	O
of	29222010	1	O
the	29222010	1	O
mutation	29222010	1	O
carrier	29222010	1	O
'	29222010	1	O
s	29222010	1	O
relatives	29222010	1	O
available	29222010	1	O
showed	29222010	1	O
that	29222010	1	O
the	29222010	1	O
mutation	29222010	1	O
was	29222010	1	O
present	29222010	1	O
in	29222010	1	O
all	29222010	1	O
affected	29222010	1	O
family	29222010	1	O
members	29222010	1	O
but	29222010	1	O
absent	29222010	1	O
in	29222010	1	O
unaffected	29222010	1	O
family	29222010	1	O
members	29222010	1	O
.	29222010	1	O
Analysis	29222010	1	O
of	29222010	1	O
the	29222010	1	O
index	29222010	1	O
patient	29222010	1	O
'	29222010	1	O
s	29222010	1	O
pedigree	29222010	1	O
displayed	29222010	1	O
that	29222010	1	O
the	29222010	1	O
mutation	29222010	1	O
co	29222010	1	O
-	29222010	1	O
segregated	29222010	1	O
with	29222010	1	O
CHD	29222010	1	O
,	29222010	1	O
which	29222010	1	O
was	29222010	1	O
transmitted	29222010	1	O
as	29222010	1	O
an	29222010	1	O
autosomal	29222010	1	O
dominant	29222010	1	O
trait	29222010	1	O
with	29222010	1	O
complete	29222010	1	O
penetrance	29222010	1	O
.	29222010	1	O
The	29222010	1	O
nonsense	29222010	1	O
mutation	29222010	1	O
was	29222010	1	O
absent	29222010	1	O
in	29222010	1	O
230	29222010	1	O
unrelated	29222010	1	O
,	29222010	1	O
ethnically	29222010	1	O
-	29222010	1	O
matched	29222010	1	O
healthy	29222010	1	O
individuals	29222010	1	O
used	29222010	1	O
as	29222010	1	O
controls	29222010	1	O
.	29222010	1	O
Functional	29222010	1	O
deciphers	29222010	1	O
by	29222010	1	O
using	29222010	1	O
a	29222010	1	O
dual	29222010	1	O
-	29222010	1	O
luciferase	29222010	1	O
reporter	29222010	1	O
assay	29222010	1	O
system	29222010	1	O
revealed	29222010	1	O
that	29222010	1	O
the	29222010	1	O
mutant	29222010	1	B-Var
NR2F2	29222010	1	B-Gene
protein	29222010	1	O
had	29222010	1	O
no	29222010	1	B-NegReg
transcriptional	29222010	1	O
activity	29222010	1	O
as	29222010	1	O
compared	29222010	1	O
with	29222010	1	O
its	29222010	1	O
wild	29222010	1	O
-	29222010	1	O
type	29222010	1	O
counterpart	29222010	1	O
.	29222010	1	O
Furthermore	29222010	1	O
,	29222010	1	O
the	29222010	1	O
mutation	29222010	1	B-Var
abrogated	29222010	1	B-NegReg
the	29222010	1	O
synergistic	29222010	1	O
transcriptional	29222010	1	O
activation	29222010	1	O
between	29222010	1	O
NR2F2	29222010	1	B-Gene
and	29222010	1	O
GATA4	29222010	1	B-Gene
,	29222010	1	O
another	29222010	1	O
core	29222010	1	O
cardiac	29222010	1	O
transcription	29222010	1	O
factor	29222010	1	O
associated	29222010	1	O
with	29222010	1	O
CHD	29222010	1	O
.	29222010	1	O
This	29222010	1	O
study	29222010	1	O
firstly	29222010	1	O
associates	29222010	1	O
NR2F2	29222010	1	O
loss	29222010	1	O
-	29222010	1	O
of	29222010	1	O
-	29222010	1	O
function	29222010	1	O
mutation	29222010	1	O
with	29222010	1	O
an	29222010	1	O
increased	29222010	1	O
susceptibility	29222010	1	O
to	29222010	1	O
double	29222010	1	O
outlet	29222010	1	O
right	29222010	1	O
ventricle	29222010	1	O
in	29222010	1	O
humans	29222010	1	O
,	29222010	1	O
which	29222010	1	O
provides	29222010	1	O
further	29222010	1	O
significant	29222010	1	O
insight	29222010	1	O
into	29222010	1	O
the	29222010	1	O
molecular	29222010	1	O
mechanisms	29222010	1	O
underpinning	29222010	1	O
CHD	29222010	1	O
,	29222010	1	O
suggesting	29222010	1	O
potential	29222010	1	O
implications	29222010	1	O
for	29222010	1	O
genetic	29222010	1	O
counseling	29222010	1	O
of	29222010	1	O
CHD	29222010	1	O
families	29222010	1	O
and	29222010	1	O
personalized	29222010	1	O
treatment	29222010	1	O
of	29222010	1	O
CHD	29222010	1	O
patients	29222010	1	O
.	29222010	1	O

HOP-1	29242286	0	O
Presenilin	29242286	0	O
Deficiency	29242286	0	O
Causes	29242286	0	O
a	29242286	0	O
Late	29242286	0	O
-	29242286	0	O
Onset	29242286	0	O
Notch	29242286	0	O
Signaling	29242286	0	O
Phenotype	29242286	0	O
That	29242286	0	O
Affects	29242286	0	O
Adult	29242286	0	O
Germline	29242286	0	O
Function	29242286	0	O
in	29242286	0	O
Caenorhabditis	29242286	0	O
elegans	29242286	0	O
.	29242286	0	O
Functionally	29242286	0	O
redundant	29242286	0	O
genes	29242286	0	O
present	29242286	0	O
a	29242286	0	O
puzzle	29242286	0	O
as	29242286	0	O
to	29242286	0	O
their	29242286	0	O
evolutionary	29242286	0	O
preservation	29242286	0	O
,	29242286	0	O
and	29242286	0	O
offer	29242286	0	O
an	29242286	0	O
interesting	29242286	0	O
opportunity	29242286	0	O
for	29242286	0	O
molecular	29242286	0	O
specialization	29242286	0	O
.	29242286	0	O
In	29242286	0	O
Caenorhabditis	29242286	0	O
elegans	29242286	0	O
,	29242286	0	O
either	29242286	0	O
one	29242286	0	O
of	29242286	0	O
two	29242286	0	O
presenilin	29242286	0	O
genes	29242286	0	O
(	29242286	0	O
sel-12	29242286	0	O
or	29242286	0	O
hop-1	29242286	0	O
)	29242286	0	O
facilitate	29242286	0	O
Notch	29242286	0	O
activation	29242286	0	O
,	29242286	0	O
providing	29242286	0	O
the	29242286	0	O
catalytic	29242286	0	O
subunit	29242286	0	O
for	29242286	0	O
the	29242286	0	O
γ	29242286	0	O
secretase	29242286	0	O
proteolytic	29242286	0	O
enzyme	29242286	0	O
complex	29242286	0	O
.	29242286	0	O
For	29242286	0	O
all	29242286	0	O
known	29242286	0	O
Notch	29242286	0	O
signaling	29242286	0	O
events	29242286	0	O
,	29242286	0	O
sel-12	29242286	0	O
can	29242286	0	O
mediate	29242286	0	O
Notch	29242286	0	O
activation	29242286	0	O
,	29242286	0	O
so	29242286	0	O
the	29242286	0	O
conservation	29242286	0	O
of	29242286	0	O
hop-1	29242286	0	O
remains	29242286	0	O
a	29242286	0	O
mystery	29242286	0	O
.	29242286	0	O
Here	29242286	0	O
,	29242286	0	O
we	29242286	0	O
uncover	29242286	0	O
a	29242286	0	O
novel	29242286	0	O
"	29242286	0	O
late	29242286	0	O
-	29242286	0	O
onset	29242286	0	O
"	29242286	0	O
germline	29242286	0	O
Notch	29242286	0	O
phenotype	29242286	0	O
in	29242286	0	O
which	29242286	0	O
HOP-1	29242286	0	O
-	29242286	0	O
deficient	29242286	0	O
worms	29242286	0	O
fail	29242286	0	O
to	29242286	0	O
maintain	29242286	0	O
proliferating	29242286	0	O
germline	29242286	0	O
stem	29242286	0	O
cells	29242286	0	O
during	29242286	0	O
adulthood	29242286	0	O
.	29242286	0	O
Either	29242286	0	O
SEL-12	29242286	0	O
or	29242286	0	O
HOP-1	29242286	0	O
presenilin	29242286	0	O
can	29242286	0	O
impart	29242286	0	O
sufficient	29242286	0	O
Notch	29242286	0	O
signaling	29242286	0	O
for	29242286	0	O
the	29242286	0	O
establishment	29242286	0	O
and	29242286	0	O
expansion	29242286	0	O
of	29242286	0	O
the	29242286	0	O
germline	29242286	0	O
,	29242286	0	O
but	29242286	0	O
maintenance	29242286	0	O
of	29242286	0	O
an	29242286	0	O
adult	29242286	0	O
stem	29242286	0	O
cell	29242286	0	O
pool	29242286	0	O
relies	29242286	0	O
exclusively	29242286	0	O
on	29242286	0	O
HOP-1	29242286	0	O
-	29242286	0	O
mediated	29242286	0	O
Notch	29242286	0	O
signaling	29242286	0	O
.	29242286	0	O
We	29242286	0	O
also	29242286	0	O
show	29242286	0	O
that	29242286	0	O
HOP-1	29242286	0	O
is	29242286	0	O
necessary	29242286	0	O
for	29242286	0	O
maximum	29242286	0	O
fecundity	29242286	0	O
and	29242286	0	O
reproductive	29242286	0	O
span	29242286	0	O
.	29242286	0	O
The	29242286	0	O
low	29242286	0	O
-	29242286	0	O
fecundity	29242286	0	O
phenotype	29242286	0	O
of	29242286	0	O
hop-1	29242286	0	B-Gene
mutants	29242286	0	B-Var
can	29242286	0	O
be	29242286	0	O
phenocopied	29242286	0	O
by	29242286	0	O
switching	29242286	0	B-NegReg
off	29242286	0	I-NegReg
glp-1	29242286	0	O
/	29242286	0	O
Notch	29242286	0	O
function	29242286	0	O
during	29242286	0	O
the	29242286	0	O
last	29242286	0	O
stage	29242286	0	O
of	29242286	0	O
larval	29242286	0	O
development	29242286	0	O
.	29242286	0	O
We	29242286	0	O
propose	29242286	0	O
that	29242286	0	O
at	29242286	0	O
the	29242286	0	O
end	29242286	0	O
of	29242286	0	O
larval	29242286	0	O
development	29242286	0	O
,	29242286	0	O
dual	29242286	0	O
presenilin	29242286	0	O
usage	29242286	0	O
switches	29242286	0	O
exclusively	29242286	0	O
to	29242286	0	O
HOP-1	29242286	0	O
,	29242286	0	O
perhaps	29242286	0	O
offering	29242286	0	O
opportunities	29242286	0	O
for	29242286	0	O
differential	29242286	0	O
regulation	29242286	0	O
of	29242286	0	O
the	29242286	0	O
germline	29242286	0	O
during	29242286	0	O
adulthood	29242286	0	O
.	29242286	0	O
Additional	29242286	0	O
defects	29242286	0	B-NegReg
in	29242286	0	O
oocyte	29242286	0	O
size	29242286	0	O
and	29242286	0	O
production	29242286	0	O
rate	29242286	0	O
in	29242286	0	O
hop-1	29242286	0	B-Gene
and	29242286	0	O
glp-1	29242286	0	B-Gene
mutants	29242286	0	B-Var
indicate	29242286	0	O
that	29242286	0	O
the	29242286	0	O
process	29242286	0	O
of	29242286	0	O
oogenesis	29242286	0	O
is	29242286	0	O
compromised	29242286	0	O
when	29242286	0	O
germline	29242286	0	O
Notch	29242286	0	O
signaling	29242286	0	O
is	29242286	0	O
switched	29242286	0	O
off	29242286	0	O
.	29242286	0	O
We	29242286	0	O
calculate	29242286	0	O
that	29242286	0	O
in	29242286	0	O
wild	29242286	0	O
-	29242286	0	O
type	29242286	0	O
adults	29242286	0	O
,	29242286	0	O
as	29242286	0	O
much	29242286	0	O
as	29242286	0	O
86%	29242286	0	O
of	29242286	0	O
cells	29242286	0	O
derived	29242286	0	O
from	29242286	0	O
the	29242286	0	O
stem	29242286	0	O
cell	29242286	0	O
pool	29242286	0	O
function	29242286	0	O
to	29242286	0	O
support	29242286	0	O
oogenesis	29242286	0	O
.	29242286	0	O
This	29242286	0	O
work	29242286	0	O
suggests	29242286	0	O
that	29242286	0	O
an	29242286	0	O
important	29242286	0	O
role	29242286	0	O
for	29242286	0	O
Notch	29242286	0	O
signaling	29242286	0	O
in	29242286	0	O
the	29242286	0	O
adult	29242286	0	O
germline	29242286	0	O
is	29242286	0	O
to	29242286	0	O
furnish	29242286	0	O
a	29242286	0	O
large	29242286	0	O
and	29242286	0	O
continuous	29242286	0	O
supply	29242286	0	O
of	29242286	0	O
nurse	29242286	0	O
cells	29242286	0	O
to	29242286	0	O
support	29242286	0	O
the	29242286	0	O
efficiency	29242286	0	O
of	29242286	0	O
oogenesis	29242286	0	O
.	29242286	0	O

Mild	29242289	0	O
Telomere	29242289	0	O
Dysfunction	29242289	0	O
as	29242289	0	O
a	29242289	0	O
Force	29242289	0	O
for	29242289	0	O
Altering	29242289	0	O
the	29242289	0	O
Adaptive	29242289	0	O
Potential	29242289	0	O
of	29242289	0	O
Subtelomeric	29242289	0	O
Genes	29242289	0	O
.	29242289	0	O
Subtelomeric	29242289	0	O
regions	29242289	0	O
have	29242289	0	O
several	29242289	0	O
unusual	29242289	0	O
characteristics	29242289	0	O
,	29242289	0	O
including	29242289	0	O
complex	29242289	0	O
repetitive	29242289	0	O
structures	29242289	0	O
,	29242289	0	O
increased	29242289	0	O
rates	29242289	0	O
of	29242289	0	O
evolution	29242289	0	O
,	29242289	0	O
and	29242289	0	O
enrichment	29242289	0	O
for	29242289	0	O
genes	29242289	0	O
involved	29242289	0	O
in	29242289	0	O
niche	29242289	0	O
adaptation	29242289	0	O
.	29242289	0	O
The	29242289	0	O
adaptive	29242289	0	O
telomere	29242289	0	O
failure	29242289	0	O
hypothesis	29242289	0	O
suggests	29242289	0	O
that	29242289	0	O
certain	29242289	0	O
environmental	29242289	0	O
stresses	29242289	0	O
can	29242289	0	O
induce	29242289	0	O
a	29242289	0	O
low	29242289	0	O
level	29242289	0	O
of	29242289	0	O
telomere	29242289	0	O
failure	29242289	0	O
,	29242289	0	O
potentially	29242289	0	O
leading	29242289	0	O
to	29242289	0	O
elevated	29242289	0	O
subtelomeric	29242289	0	O
recombination	29242289	0	O
that	29242289	0	O
could	29242289	0	O
result	29242289	0	O
in	29242289	0	O
adaptive	29242289	0	O
mutational	29242289	0	O
changes	29242289	0	O
within	29242289	0	O
subtelomeric	29242289	0	O
genes	29242289	0	O
.	29242289	0	O
Here	29242289	0	O
,	29242289	0	O
we	29242289	0	O
tested	29242289	0	O
a	29242289	0	O
key	29242289	0	O
prediction	29242289	0	O
of	29242289	0	O
the	29242289	0	O
adaptive	29242289	0	O
telomere	29242289	0	O
failure	29242289	0	O
hypothesis	29242289	0	O
-	29242289	0	O
that	29242289	0	O
telomere	29242289	0	O
dysfunction	29242289	0	O
mild	29242289	0	O
enough	29242289	0	O
to	29242289	0	O
have	29242289	0	O
little	29242289	0	O
or	29242289	0	O
no	29242289	0	O
overall	29242289	0	O
effect	29242289	0	O
on	29242289	0	O
cell	29242289	0	O
fitness	29242289	0	O
could	29242289	0	O
still	29242289	0	O
lead	29242289	0	O
to	29242289	0	O
substantial	29242289	0	O
increases	29242289	0	O
in	29242289	0	O
the	29242289	0	O
mutation	29242289	0	O
rates	29242289	0	O
of	29242289	0	O
subtelomeric	29242289	0	O
genes	29242289	0	O
.	29242289	0	O
Our	29242289	0	O
results	29242289	0	O
show	29242289	0	O
that	29242289	0	O
a	29242289	0	O
mutant	29242289	0	O
of	29242289	0	O
Kluyveromyces	29242289	0	O
lactis	29242289	0	O
with	29242289	0	O
stably	29242289	0	O
short	29242289	0	O
telomeres	29242289	0	O
produced	29242289	0	O
a	29242289	0	O
large	29242289	0	O
increase	29242289	0	O
in	29242289	0	O
the	29242289	0	O
frequency	29242289	0	O
of	29242289	0	O
mutations	29242289	0	O
affecting	29242289	0	O
the	29242289	0	O
native	29242289	0	O
subtelomeric	29242289	0	O
β	29242289	0	O
-	29242289	0	O
galactosidase	29242289	0	O
(	29242289	0	O
LAC4	29242289	0	O
)	29242289	0	O
gene	29242289	0	O
.	29242289	0	O
All	29242289	0	O
lac4	29242289	0	B-Gene
mutants	29242289	0	B-Var
examined	29242289	0	O
from	29242289	0	O
strains	29242289	0	O
with	29242289	0	O
severe	29242289	0	O
telomere	29242289	0	O
dysfunction	29242289	0	O
underwent	29242289	0	B-Reg
terminal	29242289	0	O
deletion	29242289	0	O
/	29242289	0	O
duplication	29242289	0	O
events	29242289	0	O
consistent	29242289	0	O
with	29242289	0	O
being	29242289	0	O
due	29242289	0	O
to	29242289	0	O
break	29242289	0	O
-	29242289	0	O
induced	29242289	0	O
replication	29242289	0	O
.	29242289	0	O
In	29242289	0	O
contrast	29242289	0	O
,	29242289	0	O
although	29242289	0	O
cells	29242289	0	O
with	29242289	0	O
mild	29242289	0	O
telomere	29242289	0	O
dysfunction	29242289	0	O
also	29242289	0	O
exhibited	29242289	0	O
similar	29242289	0	O
terminal	29242289	0	O
deletion	29242289	0	O
and	29242289	0	O
duplication	29242289	0	O
events	29242289	0	O
,	29242289	0	O
up	29242289	0	O
to	29242289	0	O
50%	29242289	0	O
of	29242289	0	O
lac4	29242289	0	B-Gene
mutants	29242289	0	B-Var
from	29242289	0	O
this	29242289	0	O
background	29242289	0	O
unexpectedly	29242289	0	O
contained	29242289	0	B-Reg
base	29242289	0	O
changes	29242289	0	O
within	29242289	0	O
the	29242289	0	O
LAC4	29242289	0	O
coding	29242289	0	O
region	29242289	0	O
.	29242289	0	O
This	29242289	0	O
mutational	29242289	0	O
bias	29242289	0	O
for	29242289	0	O
producing	29242289	0	O
base	29242289	0	O
changes	29242289	0	O
demonstrates	29242289	0	O
that	29242289	0	O
mild	29242289	0	O
telomere	29242289	0	O
dysfunction	29242289	0	O
can	29242289	0	O
be	29242289	0	O
well	29242289	0	O
suited	29242289	0	O
as	29242289	0	O
a	29242289	0	O
force	29242289	0	O
for	29242289	0	O
altering	29242289	0	O
the	29242289	0	O
adaptive	29242289	0	O
potential	29242289	0	O
of	29242289	0	O
subtelomeric	29242289	0	O
genes	29242289	0	O
.	29242289	0	O

Association	29253601	4	O
of	29253601	4	O
the	29253601	4	O
AADAC	29253601	4	O
gene	29253601	4	O
and	29253601	4	O
Tourette	29253601	4	O
syndrome	29253601	4	O
in	29253601	4	O
a	29253601	4	O
Han	29253601	4	O
Chinese	29253601	4	O
cohort	29253601	4	O
.	29253601	4	O
Tourette	29253601	4	B-Disease
syndrome	29253601	4	I-Disease
(	29253601	4	O
TS	29253601	4	O
)	29253601	4	O
is	29253601	4	O
a	29253601	4	O
complex	29253601	4	O
neuropsychiatric	29253601	4	O
disorder	29253601	4	O
with	29253601	4	O
chronic	29253601	4	O
motor	29253601	4	O
and	29253601	4	O
vocal	29253601	4	O
tics	29253601	4	O
.	29253601	4	O
Though	29253601	4	O
the	29253601	4	O
etiology	29253601	4	O
is	29253601	4	O
elusive	29253601	4	O
,	29253601	4	O
strong	29253601	4	O
evidence	29253601	4	O
for	29253601	4	O
a	29253601	4	O
genetic	29253601	4	O
contribution	29253601	4	O
to	29253601	4	O
TS	29253601	4	O
has	29253601	4	O
been	29253601	4	O
established	29253601	4	O
.	29253601	4	O
To	29253601	4	O
date	29253601	4	O
,	29253601	4	O
various	29253601	4	O
chromosomal	29253601	4	O
or	29253601	4	O
genetic	29253601	4	O
alterations	29253601	4	O
have	29253601	4	O
been	29253601	4	O
implicated	29253601	4	O
in	29253601	4	O
its	29253601	4	O
pathogenesis	29253601	4	O
.	29253601	4	O
Recently	29253601	4	O
,	29253601	4	O
the	29253601	4	O
deletion	29253601	4	O
in	29253601	4	O
the	29253601	4	O
arylacetamide	29253601	4	O
deacetylase	29253601	4	O
gene	29253601	4	O
(	29253601	4	O
AADAC	29253601	4	O
)	29253601	4	O
was	29253601	4	O
reported	29253601	4	O
to	29253601	4	O
be	29253601	4	O
associated	29253601	4	O
with	29253601	4	O
TS	29253601	4	O
.	29253601	4	O
To	29253601	4	O
investigate	29253601	4	O
the	29253601	4	O
association	29253601	4	O
between	29253601	4	O
the	29253601	4	O
AADAC	29253601	4	O
gene	29253601	4	O
variants	29253601	4	O
and	29253601	4	O
TS	29253601	4	O
,	29253601	4	O
we	29253601	4	O
conducted	29253601	4	O
genetic	29253601	4	O
analysis	29253601	4	O
of	29253601	4	O
the	29253601	4	O
AADAC	29253601	4	O
gene	29253601	4	O
in	29253601	4	O
200	29253601	4	O
Han	29253601	4	O
Chinese	29253601	4	O
patients	29253601	4	O
and	29253601	4	O
300	29253601	4	O
ethnicity	29253601	4	O
-	29253601	4	O
matched	29253601	4	O
normal	29253601	4	O
controls	29253601	4	O
.	29253601	4	O
Two	29253601	4	O
variants	29253601	4	O
,	29253601	4	O
including	29253601	4	O
a	29253601	4	O
heterozygous	29253601	4	O
splice	29253601	4	O
-	29253601	4	O
site	29253601	4	O
variant	29253601	4	O
,	29253601	4	O
c.361	29253601	4	O
1	29253601	4	O
G	29253601	4	O
>	29253601	4	O
A	29253601	4	O
(	29253601	4	O
rs762169706	29253601	4	O
)	29253601	4	O
,	29253601	4	O
and	29253601	4	O
a	29253601	4	O
missense	29253601	4	O
variant	29253601	4	O
,	29253601	4	O
c.744	29253601	4	O
A	29253601	4	O
>	29253601	4	O
T	29253601	4	O
(	29253601	4	O
p.R248S	29253601	4	O
,	29253601	4	O
rs186388618	29253601	4	O
)	29253601	4	O
,	29253601	4	O
were	29253601	4	O
identified	29253601	4	O
in	29253601	4	O
two	29253601	4	O
unrelated	29253601	4	O
patients	29253601	4	O
.	29253601	4	O
The	29253601	4	O
c.361	29253601	4	B-Var
1	29253601	4	I-Var
G	29253601	4	I-Var
>	29253601	4	I-Var
A	29253601	4	I-Var
variant	29253601	4	O
,	29253601	4	O
absent	29253601	4	O
in	29253601	4	O
300	29253601	4	O
ethnicity	29253601	4	O
-	29253601	4	O
matched	29253601	4	O
controls	29253601	4	O
,	29253601	4	O
led	29253601	4	B-Reg
to	29253601	4	I-Reg
the	29253601	4	O
deletion	29253601	4	B-Var
of	29253601	4	O
exon	29253601	4	O
2	29253601	4	O
in	29253601	4	O
AADAC	29253601	4	O
mRNA	29253601	4	O
,	29253601	4	O
probably	29253601	4	O
associated	29253601	4	B-Reg
with	29253601	4	I-Reg
development	29253601	4	O
of	29253601	4	O
TS	29253601	4	B-Disease
.	29253601	4	O
The	29253601	4	O
c.744	29253601	4	O
A	29253601	4	O
>	29253601	4	O
T	29253601	4	O
variant	29253601	4	O
,	29253601	4	O
predicted	29253601	4	O
to	29253601	4	O
be	29253601	4	O
damaging	29253601	4	O
,	29253601	4	O
was	29253601	4	O
identified	29253601	4	O
in	29253601	4	O
two	29253601	4	O
normal	29253601	4	O
controls	29253601	4	O
.	29253601	4	O
The	29253601	4	O
findings	29253601	4	O
indicate	29253601	4	O
that	29253601	4	O
the	29253601	4	O
AADAC	29253601	4	B-Gene
gene	29253601	4	O
c.361	29253601	4	B-Var
1	29253601	4	I-Var
G	29253601	4	I-Var
>	29253601	4	I-Var
A	29253601	4	I-Var
variant	29253601	4	O
may	29253601	4	O
be	29253601	4	O
a	29253601	4	O
potential	29253601	4	O
candidate	29253601	4	B-Reg
factor	29253601	4	I-Reg
for	29253601	4	O
TS	29253601	4	B-Disease
development	29253601	4	O
,	29253601	4	O
though	29253601	4	O
further	29253601	4	O
investigations	29253601	4	O
are	29253601	4	O
warranted	29253601	4	O
.	29253601	4	O

Patients	29255178	1	O
with	29255178	1	O
a	29255178	1	O
Kabuki	29255178	1	O
syndrome	29255178	1	O
phenotype	29255178	1	O
demonstrate	29255178	1	O
DNA	29255178	1	O
methylation	29255178	1	O
abnormalities	29255178	1	O
.	29255178	1	O
Kabuki	29255178	1	B-Disease
syndrome	29255178	1	I-Disease
is	29255178	1	O
a	29255178	1	O
monogenic	29255178	1	O
disorder	29255178	1	O
caused	29255178	1	O
by	29255178	1	O
loss	29255178	1	B-NegReg
of	29255178	1	I-NegReg
function	29255178	1	I-NegReg
variants	29255178	1	B-Var
in	29255178	1	O
either	29255178	1	O
of	29255178	1	O
two	29255178	1	O
genes	29255178	1	O
encoding	29255178	1	O
histone	29255178	1	O
-	29255178	1	O
modifying	29255178	1	O
enzymes	29255178	1	O
.	29255178	1	O
We	29255178	1	O
performed	29255178	1	O
targeted	29255178	1	O
sequencing	29255178	1	O
in	29255178	1	O
a	29255178	1	O
cohort	29255178	1	O
of	29255178	1	O
27	29255178	1	O
probands	29255178	1	O
with	29255178	1	O
a	29255178	1	O
clinical	29255178	1	O
diagnosis	29255178	1	O
of	29255178	1	O
Kabuki	29255178	1	O
syndrome	29255178	1	O
.	29255178	1	O
Of	29255178	1	O
these	29255178	1	O
,	29255178	1	O
12	29255178	1	O
had	29255178	1	O
causative	29255178	1	O
variants	29255178	1	O
in	29255178	1	O
the	29255178	1	O
two	29255178	1	O
known	29255178	1	O
Kabuki	29255178	1	O
syndrome	29255178	1	O
genes	29255178	1	O
.	29255178	1	O
In	29255178	1	O
2	29255178	1	O
,	29255178	1	O
we	29255178	1	O
identified	29255178	1	O
presumptive	29255178	1	O
loss	29255178	1	O
of	29255178	1	O
function	29255178	1	O
de	29255178	1	O
novo	29255178	1	O
variants	29255178	1	B-Var
in	29255178	1	O
KMT2A	29255178	1	B-Gene
(	29255178	1	O
missense	29255178	1	O
and	29255178	1	O
splice	29255178	1	O
site	29255178	1	O
variants	29255178	1	O
)	29255178	1	O
,	29255178	1	O
a	29255178	1	O
gene	29255178	1	O
that	29255178	1	O
encodes	29255178	1	O
another	29255178	1	O
histone	29255178	1	O
modifying	29255178	1	O
enzyme	29255178	1	O
previously	29255178	1	O
exclusively	29255178	1	O
associated	29255178	1	B-Reg
with	29255178	1	O
Wiedermann	29255178	1	B-Disease
-	29255178	1	I-Disease
Steiner	29255178	1	I-Disease
syndrome	29255178	1	I-Disease
.	29255178	1	O
Although	29255178	1	O
Kabuki	29255178	1	O
syndrome	29255178	1	O
is	29255178	1	O
a	29255178	1	O
disorder	29255178	1	O
of	29255178	1	O
histone	29255178	1	O
modification	29255178	1	O
,	29255178	1	O
we	29255178	1	O
also	29255178	1	O
find	29255178	1	O
alterations	29255178	1	O
in	29255178	1	O
DNA	29255178	1	O
methylation	29255178	1	O
among	29255178	1	O
individuals	29255178	1	O
with	29255178	1	O
a	29255178	1	O
Kabuki	29255178	1	O
syndrome	29255178	1	O
diagnosis	29255178	1	O
relative	29255178	1	O
to	29255178	1	O
matched	29255178	1	O
normal	29255178	1	O
controls	29255178	1	O
,	29255178	1	O
regardless	29255178	1	O
of	29255178	1	O
whether	29255178	1	O
they	29255178	1	O
carry	29255178	1	O
a	29255178	1	O
variant	29255178	1	O
in	29255178	1	O
KMT2A	29255178	1	O
or	29255178	1	O
KMT2D	29255178	1	O
or	29255178	1	O
not	29255178	1	O
.	29255178	1	O
Furthermore	29255178	1	O
,	29255178	1	O
we	29255178	1	O
observed	29255178	1	O
characteristic	29255178	1	O
global	29255178	1	O
abnormalities	29255178	1	O
of	29255178	1	O
DNA	29255178	1	O
methylation	29255178	1	O
that	29255178	1	O
distinguished	29255178	1	O
patients	29255178	1	O
with	29255178	1	O
a	29255178	1	O
loss	29255178	1	O
of	29255178	1	O
function	29255178	1	O
variant	29255178	1	O
in	29255178	1	O
KMT2D	29255178	1	O
or	29255178	1	O
missense	29255178	1	O
or	29255178	1	O
splice	29255178	1	O
site	29255178	1	O
variants	29255178	1	O
in	29255178	1	O
either	29255178	1	O
KMT2D	29255178	1	O
or	29255178	1	O
KMT2A	29255178	1	O
from	29255178	1	O
normal	29255178	1	O
controls	29255178	1	O
.	29255178	1	O
Our	29255178	1	O
results	29255178	1	O
provide	29255178	1	O
new	29255178	1	O
insights	29255178	1	O
into	29255178	1	O
the	29255178	1	O
relationship	29255178	1	O
of	29255178	1	O
genotype	29255178	1	O
to	29255178	1	O
epigenotype	29255178	1	O
and	29255178	1	O
phenotype	29255178	1	O
and	29255178	1	O
indicate	29255178	1	O
cross	29255178	1	O
-	29255178	1	O
talk	29255178	1	O
between	29255178	1	O
histone	29255178	1	O
and	29255178	1	O
DNA	29255178	1	O
methylation	29255178	1	O
machineries	29255178	1	O
exposed	29255178	1	O
by	29255178	1	O
inborn	29255178	1	O
errors	29255178	1	O
of	29255178	1	O
the	29255178	1	O
epigenetic	29255178	1	O
apparatus	29255178	1	O
.	29255178	1	O

A	29255182	1	O
novel	29255182	1	O
homozygous	29255182	1	O
ARL13B	29255182	1	B-Gene
variant	29255182	1	B-Var
in	29255182	1	O
patients	29255182	1	O
with	29255182	1	O
Joubert	29255182	1	O
syndrome	29255182	1	O
impairs	29255182	1	B-NegReg
its	29255182	1	O
guanine	29255182	1	O
nucleotide	29255182	1	O
-	29255182	1	O
exchange	29255182	1	O
factor	29255182	1	O
activity	29255182	1	O
.	29255182	1	O
ARL13B	29255182	1	O
encodes	29255182	1	O
for	29255182	1	O
the	29255182	1	O
ADP	29255182	1	O
-	29255182	1	O
ribosylation	29255182	1	O
factor	29255182	1	O
-	29255182	1	O
like	29255182	1	O
13	29255182	1	O
B	29255182	1	O
GTPase	29255182	1	O
,	29255182	1	O
which	29255182	1	O
is	29255182	1	O
required	29255182	1	O
for	29255182	1	O
normal	29255182	1	O
cilia	29255182	1	O
structure	29255182	1	O
and	29255182	1	O
Sonic	29255182	1	O
hedgehog	29255182	1	O
(	29255182	1	O
Shh	29255182	1	O
)	29255182	1	O
signaling	29255182	1	O
.	29255182	1	O
Disruptions	29255182	1	O
in	29255182	1	O
cilia	29255182	1	O
structure	29255182	1	O
or	29255182	1	O
function	29255182	1	O
lead	29255182	1	O
to	29255182	1	O
a	29255182	1	O
class	29255182	1	O
of	29255182	1	O
human	29255182	1	O
disorders	29255182	1	O
called	29255182	1	O
ciliopathies	29255182	1	O
.	29255182	1	O
Joubert	29255182	1	O
syndrome	29255182	1	O
is	29255182	1	O
characterized	29255182	1	O
by	29255182	1	O
a	29255182	1	O
wide	29255182	1	O
spectrum	29255182	1	O
of	29255182	1	O
symptoms	29255182	1	O
,	29255182	1	O
including	29255182	1	O
a	29255182	1	O
variable	29255182	1	O
degree	29255182	1	O
of	29255182	1	O
intellectual	29255182	1	O
disability	29255182	1	O
,	29255182	1	O
ataxia	29255182	1	O
,	29255182	1	O
and	29255182	1	O
ocular	29255182	1	O
abnormalities	29255182	1	O
.	29255182	1	O
Here	29255182	1	O
we	29255182	1	O
report	29255182	1	O
a	29255182	1	O
novel	29255182	1	O
homozygous	29255182	1	O
missense	29255182	1	O
variant	29255182	1	O
c.	29255182	1	O
[	29255182	1	O
223	29255182	1	O
G	29255182	1	O
>	29255182	1	O
A	29255182	1	O
]	29255182	1	O
(	29255182	1	O
p.(Gly75Arg)	29255182	1	O
in	29255182	1	O
the	29255182	1	O
ARL13B	29255182	1	O
gene	29255182	1	O
,	29255182	1	O
which	29255182	1	O
was	29255182	1	O
identified	29255182	1	O
by	29255182	1	O
whole	29255182	1	O
-	29255182	1	O
exome	29255182	1	O
sequencing	29255182	1	O
of	29255182	1	O
a	29255182	1	O
trio	29255182	1	O
from	29255182	1	O
a	29255182	1	O
consanguineous	29255182	1	O
family	29255182	1	O
with	29255182	1	O
multiple	29255182	1	O
-	29255182	1	O
affected	29255182	1	O
individuals	29255182	1	O
suffering	29255182	1	O
from	29255182	1	O
intellectual	29255182	1	O
disability	29255182	1	O
,	29255182	1	O
ataxia	29255182	1	O
,	29255182	1	O
ocular	29255182	1	O
defects	29255182	1	O
,	29255182	1	O
and	29255182	1	O
epilepsy	29255182	1	O
.	29255182	1	O
The	29255182	1	O
same	29255182	1	O
variant	29255182	1	O
was	29255182	1	O
also	29255182	1	O
identified	29255182	1	O
in	29255182	1	O
a	29255182	1	O
second	29255182	1	O
family	29255182	1	O
.	29255182	1	O
We	29255182	1	O
saw	29255182	1	O
a	29255182	1	O
striking	29255182	1	O
difference	29255182	1	O
in	29255182	1	O
the	29255182	1	O
severity	29255182	1	O
of	29255182	1	O
ataxia	29255182	1	O
between	29255182	1	O
affected	29255182	1	O
male	29255182	1	O
and	29255182	1	O
female	29255182	1	O
individuals	29255182	1	O
in	29255182	1	O
both	29255182	1	O
families	29255182	1	O
.	29255182	1	O
Both	29255182	1	O
ARL13B	29255182	1	O
and	29255182	1	O
ARL13B	29255182	1	O
-	29255182	1	O
c.	29255182	1	O
[	29255182	1	O
223	29255182	1	O
G	29255182	1	O
>	29255182	1	O
A	29255182	1	O
]	29255182	1	O
(	29255182	1	O
p.(Gly75Arg)	29255182	1	O
expression	29255182	1	O
rescued	29255182	1	O
the	29255182	1	O
cilia	29255182	1	O
length	29255182	1	O
and	29255182	1	O
Shh	29255182	1	O
defects	29255182	1	O
displayed	29255182	1	O
by	29255182	1	O
Arl13b	29255182	1	O
hennin	29255182	1	O
(	29255182	1	O
null	29255182	1	O
)	29255182	1	O
cells	29255182	1	O
,	29255182	1	O
indicating	29255182	1	O
that	29255182	1	O
the	29255182	1	O
variant	29255182	1	O
did	29255182	1	O
not	29255182	1	O
disrupt	29255182	1	O
either	29255182	1	O
ARL13B	29255182	1	O
function	29255182	1	O
.	29255182	1	O
In	29255182	1	O
contrast	29255182	1	O
,	29255182	1	O
ARL13B	29255182	1	B-Var
-	29255182	1	I-Var
c.	29255182	1	I-Var
[	29255182	1	I-Var
223	29255182	1	I-Var
G	29255182	1	I-Var
>	29255182	1	I-Var
A	29255182	1	I-Var
]	29255182	1	I-Var
(	29255182	1	O
p.(Gly75Arg)	29255182	1	O
displayed	29255182	1	O
a	29255182	1	O
marked	29255182	1	O
loss	29255182	1	B-NegReg
of	29255182	1	O
ARL3	29255182	1	O
guanine	29255182	1	O
nucleotide	29255182	1	O
-	29255182	1	O
exchange	29255182	1	O
factor	29255182	1	O
activity	29255182	1	O
,	29255182	1	O
with	29255182	1	O
retention	29255182	1	O
of	29255182	1	O
its	29255182	1	O
GTPase	29255182	1	O
activities	29255182	1	O
,	29255182	1	O
highlighting	29255182	1	O
the	29255182	1	O
correlation	29255182	1	O
between	29255182	1	O
its	29255182	1	O
loss	29255182	1	O
of	29255182	1	O
function	29255182	1	O
as	29255182	1	O
an	29255182	1	O
ARL3	29255182	1	O
guanine	29255182	1	O
nucleotide	29255182	1	O
-	29255182	1	O
exchange	29255182	1	O
factor	29255182	1	O
and	29255182	1	O
Joubert	29255182	1	B-Disease
syndrome	29255182	1	I-Disease
.	29255182	1	O

Cantu	29275331	2	O
syndrome	29275331	2	O
-	29275331	2	O
associated	29275331	2	O
SUR2	29275331	2	O
(	29275331	2	B-Gene
ABCC9	29275331	2	I-Gene
)	29275331	2	I-Gene
mutations	29275331	2	B-Var
in	29275331	2	O
distinct	29275331	2	O
structural	29275331	2	O
domains	29275331	2	O
result	29275331	2	O
in	29275331	2	O
KATP	29275331	2	O
channel	29275331	2	O
gain	29275331	2	B-PosReg
-	29275331	2	I-PosReg
of	29275331	2	I-PosReg
-	29275331	2	I-PosReg
function	29275331	2	I-PosReg
by	29275331	2	O
differential	29275331	2	O
mechanisms	29275331	2	O
.	29275331	2	O
The	29275331	2	O
complex	29275331	2	O
disorder	29275331	2	O
Cantu	29275331	2	B-Disease
syndrome	29275331	2	I-Disease
(	29275331	2	O
CS	29275331	2	O
)	29275331	2	O
arises	29275331	2	O
from	29275331	2	O
gain	29275331	2	B-PosReg
-	29275331	2	I-PosReg
of	29275331	2	I-PosReg
-	29275331	2	I-PosReg
function	29275331	2	I-PosReg
mutations	29275331	2	B-Var
in	29275331	2	O
either	29275331	2	O
KCNJ8	29275331	2	B-Gene
or	29275331	2	O
ABCC9	29275331	2	B-Gene
,	29275331	2	O
the	29275331	2	O
genes	29275331	2	O
encoding	29275331	2	O
the	29275331	2	O
Kir6.1	29275331	2	O
and	29275331	2	O
SUR2	29275331	2	O
subunits	29275331	2	O
of	29275331	2	O
ATP	29275331	2	O
-	29275331	2	O
sensitive	29275331	2	O
potassium	29275331	2	O
(	29275331	2	O
KATP	29275331	2	O
)	29275331	2	O
channels	29275331	2	O
,	29275331	2	O
respectively	29275331	2	O
.	29275331	2	O
Recent	29275331	2	O
reports	29275331	2	O
indicate	29275331	2	O
that	29275331	2	O
such	29275331	2	O
mutations	29275331	2	B-Var
can	29275331	2	O
increase	29275331	2	B-PosReg
channel	29275331	2	O
activity	29275331	2	O
by	29275331	2	O
multiple	29275331	2	O
molecular	29275331	2	O
mechanisms	29275331	2	O
.	29275331	2	O
In	29275331	2	O
this	29275331	2	O
study	29275331	2	O
,	29275331	2	O
we	29275331	2	O
determined	29275331	2	O
the	29275331	2	O
mechanism	29275331	2	O
by	29275331	2	O
which	29275331	2	O
KATP	29275331	2	O
function	29275331	2	O
is	29275331	2	O
altered	29275331	2	B-Reg
by	29275331	2	O
several	29275331	2	O
substitutions	29275331	2	O
in	29275331	2	O
distinct	29275331	2	O
structural	29275331	2	O
domains	29275331	2	O
of	29275331	2	O
SUR2	29275331	2	B-Gene
:	29275331	2	I-Gene
D207E	29275331	2	B-Var
in	29275331	2	O
the	29275331	2	O
intracellular	29275331	2	O
L0	29275331	2	O
-	29275331	2	O
linker	29275331	2	O
and	29275331	2	O
Y985S	29275331	2	B-Var
,	29275331	2	O
G989E	29275331	2	B-Var
,	29275331	2	O
M1060I	29275331	2	B-Var
,	29275331	2	O
and	29275331	2	O
R1154Q	29275331	2	B-Var
/	29275331	2	I-Var
R1154W	29275331	2	I-Var
in	29275331	2	O
TMD2	29275331	2	O
.	29275331	2	O
We	29275331	2	O
engineered	29275331	2	O
substitutions	29275331	2	O
at	29275331	2	O
their	29275331	2	O
equivalent	29275331	2	O
positions	29275331	2	O
in	29275331	2	O
rat	29275331	2	O
SUR2A	29275331	2	O
(	29275331	2	O
D207E	29275331	2	O
,	29275331	2	O
Y981S	29275331	2	O
,	29275331	2	O
G985E	29275331	2	O
,	29275331	2	O
M1056I	29275331	2	O
,	29275331	2	O
and	29275331	2	O
R1150Q	29275331	2	O
/	29275331	2	O
R1150W	29275331	2	O
)	29275331	2	O
and	29275331	2	O
investigated	29275331	2	O
functional	29275331	2	O
consequences	29275331	2	O
using	29275331	2	O
macroscopic	29275331	2	O
rubidium	29275331	2	O
(	29275331	2	O
86	29275331	2	O
Rb	29275331	2	O
)	29275331	2	O
efflux	29275331	2	O
assays	29275331	2	O
and	29275331	2	O
patch	29275331	2	O
-	29275331	2	O
clamp	29275331	2	O
electrophysiology	29275331	2	O
.	29275331	2	O
Our	29275331	2	O
results	29275331	2	O
indicate	29275331	2	O
that	29275331	2	O
D207E	29275331	2	B-Var
increases	29275331	2	B-PosReg
KATP	29275331	2	O
channel	29275331	2	O
activity	29275331	2	O
by	29275331	2	O
increasing	29275331	2	B-PosReg
intrinsic	29275331	2	O
stability	29275331	2	O
of	29275331	2	O
the	29275331	2	O
open	29275331	2	O
state	29275331	2	O
,	29275331	2	O
whereas	29275331	2	O
the	29275331	2	O
cluster	29275331	2	O
of	29275331	2	O
Y981S	29275331	2	B-Var
/	29275331	2	I-Var
G985E	29275331	2	I-Var
/	29275331	2	I-Var
M1056I	29275331	2	I-Var
substitutions	29275331	2	O
,	29275331	2	O
as	29275331	2	O
well	29275331	2	O
as	29275331	2	O
R1150Q	29275331	2	B-Var
/	29275331	2	I-Var
R1150W	29275331	2	I-Var
,	29275331	2	O
augmented	29275331	2	B-PosReg
Mg	29275331	2	O
-	29275331	2	O
nucleotide	29275331	2	O
activation	29275331	2	O
.	29275331	2	O
We	29275331	2	O
also	29275331	2	O
tested	29275331	2	O
the	29275331	2	O
responses	29275331	2	O
of	29275331	2	O
these	29275331	2	O
channel	29275331	2	O
variants	29275331	2	O
to	29275331	2	O
inhibition	29275331	2	O
by	29275331	2	O
the	29275331	2	O
sulfonylurea	29275331	2	O
drug	29275331	2	O
glibenclamide	29275331	2	O
,	29275331	2	O
a	29275331	2	O
potential	29275331	2	O
pharmacotherapy	29275331	2	O
for	29275331	2	O
CS	29275331	2	O
.	29275331	2	O
None	29275331	2	O
of	29275331	2	O
the	29275331	2	O
D207E	29275331	2	O
,	29275331	2	O
Y981S	29275331	2	O
,	29275331	2	O
G985E	29275331	2	O
,	29275331	2	O
or	29275331	2	O
M1056I	29275331	2	O
substitutions	29275331	2	O
had	29275331	2	O
a	29275331	2	O
significant	29275331	2	O
effect	29275331	2	O
on	29275331	2	O
glibenclamide	29275331	2	O
sensitivity	29275331	2	O
.	29275331	2	O
However	29275331	2	O
,	29275331	2	O
Gln	29275331	2	O
and	29275331	2	O
Trp	29275331	2	O
substitution	29275331	2	O
at	29275331	2	O
Arg-1150	29275331	2	O
significantly	29275331	2	O
decreased	29275331	2	O
glibenclamide	29275331	2	O
potency	29275331	2	O
.	29275331	2	O
In	29275331	2	O
summary	29275331	2	O
,	29275331	2	O
these	29275331	2	O
results	29275331	2	O
provide	29275331	2	O
additional	29275331	2	O
confirmation	29275331	2	O
that	29275331	2	O
mutations	29275331	2	O
in	29275331	2	O
CS	29275331	2	O
-	29275331	2	O
associated	29275331	2	O
SUR2	29275331	2	O
mutations	29275331	2	O
result	29275331	2	O
in	29275331	2	O
KATP	29275331	2	O
gain	29275331	2	O
-	29275331	2	O
of	29275331	2	O
-	29275331	2	O
function	29275331	2	O
.	29275331	2	O
They	29275331	2	O
help	29275331	2	O
link	29275331	2	O
CS	29275331	2	O
genotypes	29275331	2	O
to	29275331	2	O
phenotypes	29275331	2	O
and	29275331	2	O
shed	29275331	2	O
light	29275331	2	O
on	29275331	2	O
the	29275331	2	O
underlying	29275331	2	O
molecular	29275331	2	O
mechanisms	29275331	2	O
,	29275331	2	O
including	29275331	2	O
consequences	29275331	2	O
for	29275331	2	O
inhibitory	29275331	2	O
drug	29275331	2	O
sensitivity	29275331	2	O
,	29275331	2	O
insights	29275331	2	O
that	29275331	2	O
may	29275331	2	O
inform	29275331	2	O
the	29275331	2	O
development	29275331	2	O
of	29275331	2	O
therapeutic	29275331	2	O
approaches	29275331	2	O
to	29275331	2	O
manage	29275331	2	O
CS	29275331	2	O
.	29275331	2	O

Arabidopsis	29309666	0	O
Phospholipase	29309666	0	O
C3	29309666	0	O
is	29309666	0	O
Involved	29309666	0	O
in	29309666	0	O
Lateral	29309666	0	O
Root	29309666	0	O
Initiation	29309666	0	O
and	29309666	0	O
ABA	29309666	0	O
Responses	29309666	0	O
in	29309666	0	O
Seed	29309666	0	O
Germination	29309666	0	O
and	29309666	0	O
Stomatal	29309666	0	O
Closure	29309666	0	O
.	29309666	0	O
Phospholipase	29309666	0	O
C	29309666	0	O
(	29309666	0	O
PLC	29309666	0	O
)	29309666	0	O
is	29309666	0	O
well	29309666	0	O
known	29309666	0	O
for	29309666	0	O
its	29309666	0	O
role	29309666	0	O
in	29309666	0	O
animal	29309666	0	O
signaling	29309666	0	O
,	29309666	0	O
where	29309666	0	O
it	29309666	0	O
generates	29309666	0	O
the	29309666	0	O
second	29309666	0	O
messengers	29309666	0	O
,	29309666	0	O
inositol	29309666	0	O
1	29309666	0	O
,	29309666	0	O
4	29309666	0	O
,	29309666	0	O
5	29309666	0	O
-	29309666	0	O
trisphosphate	29309666	0	O
(	29309666	0	O
IP3	29309666	0	O
)	29309666	0	O
and	29309666	0	O
diacylglycerol	29309666	0	O
(	29309666	0	O
DAG	29309666	0	O
)	29309666	0	O
,	29309666	0	O
by	29309666	0	O
hydrolyzing	29309666	0	O
the	29309666	0	O
minor	29309666	0	O
phospholipid	29309666	0	O
,	29309666	0	O
phosphatidylinositol	29309666	0	O
4	29309666	0	O
,	29309666	0	O
5	29309666	0	O
-	29309666	0	O
bisphosphate	29309666	0	O
(	29309666	0	O
PIP2	29309666	0	O
)	29309666	0	O
,	29309666	0	O
upon	29309666	0	O
receptor	29309666	0	O
stimulation	29309666	0	O
.	29309666	0	O
In	29309666	0	O
plants	29309666	0	O
,	29309666	0	O
PLC	29309666	0	O
'	29309666	0	O
s	29309666	0	O
role	29309666	0	O
is	29309666	0	O
still	29309666	0	O
unclear	29309666	0	O
,	29309666	0	O
especially	29309666	0	O
because	29309666	0	O
the	29309666	0	O
primary	29309666	0	O
targets	29309666	0	O
of	29309666	0	O
both	29309666	0	O
second	29309666	0	O
messengers	29309666	0	O
are	29309666	0	O
lacking	29309666	0	O
,	29309666	0	O
i.e.	29309666	0	O
the	29309666	0	O
ligand	29309666	0	O
-	29309666	0	O
gated	29309666	0	O
Ca2	29309666	0	O
channel	29309666	0	O
and	29309666	0	O
protein	29309666	0	O
kinase	29309666	0	O
C	29309666	0	O
,	29309666	0	O
and	29309666	0	O
because	29309666	0	O
PIP2	29309666	0	O
levels	29309666	0	O
are	29309666	0	O
extremely	29309666	0	O
low	29309666	0	O
.	29309666	0	O
Nonetheless	29309666	0	O
,	29309666	0	O
the	29309666	0	O
Arabidopsis	29309666	0	O
genome	29309666	0	O
encodes	29309666	0	O
nine	29309666	0	O
PLCs	29309666	0	O
.	29309666	0	O
We	29309666	0	O
used	29309666	0	O
a	29309666	0	O
reversed	29309666	0	O
-	29309666	0	O
genetic	29309666	0	O
approach	29309666	0	O
to	29309666	0	O
explore	29309666	0	O
PLC	29309666	0	O
'	29309666	0	O
s	29309666	0	O
function	29309666	0	O
in	29309666	0	O
Arabidopsis	29309666	0	O
,	29309666	0	O
and	29309666	0	O
report	29309666	0	O
here	29309666	0	O
that	29309666	0	O
PLC3	29309666	0	B-Gene
is	29309666	0	O
required	29309666	0	O
for	29309666	0	O
proper	29309666	0	O
root	29309666	0	O
development	29309666	0	O
,	29309666	0	O
seed	29309666	0	O
germination	29309666	0	O
and	29309666	0	O
stomatal	29309666	0	O
opening	29309666	0	O
.	29309666	0	O
Two	29309666	0	O
independent	29309666	0	O
knock	29309666	0	B-Var
-	29309666	0	I-Var
down	29309666	0	I-Var
mutants	29309666	0	I-Var
,	29309666	0	O
plc3-2	29309666	0	O
and	29309666	0	O
plc3-3	29309666	0	O
,	29309666	0	O
were	29309666	0	O
found	29309666	0	O
to	29309666	0	O
exhibit	29309666	0	O
reduced	29309666	0	B-NegReg
lateral	29309666	0	O
root	29309666	0	O
densities	29309666	0	O
by	29309666	0	O
10	29309666	0	O
-	29309666	0	O
20%	29309666	0	O
.	29309666	0	O
Mutant	29309666	0	B-Var
seeds	29309666	0	O
germinated	29309666	0	O
more	29309666	0	O
slowly	29309666	0	B-NegReg
but	29309666	0	O
were	29309666	0	O
less	29309666	0	O
sensitive	29309666	0	O
to	29309666	0	O
ABA	29309666	0	O
to	29309666	0	O
prevent	29309666	0	O
germination	29309666	0	O
.	29309666	0	O
Guard	29309666	0	O
cells	29309666	0	O
of	29309666	0	O
plc3	29309666	0	O
were	29309666	0	O
also	29309666	0	O
compromised	29309666	0	O
in	29309666	0	O
ABA	29309666	0	O
-	29309666	0	O
dependent	29309666	0	O
stomatal	29309666	0	O
closure	29309666	0	O
.	29309666	0	O
Promoter	29309666	0	O
-	29309666	0	O
β	29309666	0	O
-	29309666	0	O
glucuronidase	29309666	0	O
(	29309666	0	O
GUS	29309666	0	O
)	29309666	0	O
analyses	29309666	0	O
confirmed	29309666	0	O
PLC3	29309666	0	O
expression	29309666	0	O
in	29309666	0	O
guard	29309666	0	O
cells	29309666	0	O
and	29309666	0	O
germinating	29309666	0	O
seeds	29309666	0	O
,	29309666	0	O
and	29309666	0	O
revealed	29309666	0	O
that	29309666	0	O
the	29309666	0	O
majority	29309666	0	O
is	29309666	0	O
expressed	29309666	0	O
in	29309666	0	O
vascular	29309666	0	O
tissue	29309666	0	O
,	29309666	0	O
most	29309666	0	O
probably	29309666	0	O
phloem	29309666	0	O
companion	29309666	0	O
cells	29309666	0	O
,	29309666	0	O
in	29309666	0	O
roots	29309666	0	O
,	29309666	0	O
leaves	29309666	0	O
and	29309666	0	O
flowers	29309666	0	O
.	29309666	0	O
In	29309666	0	O
vivo	29309666	0	O
32	29309666	0	O
Pi	29309666	0	O
labeling	29309666	0	O
revealed	29309666	0	O
that	29309666	0	O
ABA	29309666	0	O
stimulated	29309666	0	O
the	29309666	0	O
formation	29309666	0	O
of	29309666	0	O
PIP2	29309666	0	O
in	29309666	0	O
germinating	29309666	0	O
seeds	29309666	0	O
and	29309666	0	O
guard	29309666	0	O
cell	29309666	0	O
-	29309666	0	O
enriched	29309666	0	O
leaf	29309666	0	O
peels	29309666	0	O
,	29309666	0	O
which	29309666	0	O
was	29309666	0	O
significantly	29309666	0	O
reduced	29309666	0	B-NegReg
in	29309666	0	O
plc3	29309666	0	B-Gene
mutants	29309666	0	B-Var
.	29309666	0	O
Overexpression	29309666	0	O
of	29309666	0	O
PLC3	29309666	0	O
had	29309666	0	O
no	29309666	0	O
effect	29309666	0	O
on	29309666	0	O
root	29309666	0	O
system	29309666	0	O
architecture	29309666	0	O
or	29309666	0	O
seed	29309666	0	O
germination	29309666	0	O
,	29309666	0	O
but	29309666	0	O
increased	29309666	0	O
the	29309666	0	O
plant	29309666	0	O
'	29309666	0	O
s	29309666	0	O
tolerance	29309666	0	O
to	29309666	0	O
drought	29309666	0	O
.	29309666	0	O
Our	29309666	0	O
results	29309666	0	O
provide	29309666	0	O
genetic	29309666	0	O
evidence	29309666	0	O
for	29309666	0	O
PLC	29309666	0	O
'	29309666	0	O
s	29309666	0	O
involvement	29309666	0	O
in	29309666	0	O
plant	29309666	0	O
development	29309666	0	O
and	29309666	0	O
ABA	29309666	0	O
signaling	29309666	0	O
,	29309666	0	O
and	29309666	0	O
confirm	29309666	0	O
earlier	29309666	0	O
observations	29309666	0	O
that	29309666	0	O
overexpression	29309666	0	O
increases	29309666	0	O
drought	29309666	0	O
tolerance	29309666	0	O
.	29309666	0	O
Potential	29309666	0	O
molecular	29309666	0	O
mechanisms	29309666	0	O
for	29309666	0	O
the	29309666	0	O
above	29309666	0	O
observations	29309666	0	O
are	29309666	0	O
discussed	29309666	0	O
.	29309666	0	O

Rare	29317596	1	O
loss	29317596	1	B-NegReg
of	29317596	1	I-NegReg
function	29317596	1	I-NegReg
mutations	29317596	1	B-Var
in	29317596	1	O
N	29317596	1	O
-	29317596	1	O
methyl	29317596	1	O
-	29317596	1	O
D	29317596	1	O
-	29317596	1	O
aspartate	29317596	1	O
glutamate	29317596	1	O
receptors	29317596	1	O
and	29317596	1	O
their	29317596	1	O
contributions	29317596	1	O
to	29317596	1	O
schizophrenia	29317596	1	B-Disease
susceptibility	29317596	1	O
.	29317596	1	O
In	29317596	1	O
schizophrenia	29317596	1	O
(	29317596	1	O
SCZ	29317596	1	O
)	29317596	1	O
and	29317596	1	O
autism	29317596	1	O
spectrum	29317596	1	O
disorder	29317596	1	O
(	29317596	1	O
ASD	29317596	1	O
)	29317596	1	O
,	29317596	1	O
the	29317596	1	O
dysregulation	29317596	1	O
of	29317596	1	O
glutamate	29317596	1	O
transmission	29317596	1	O
through	29317596	1	O
N	29317596	1	O
-	29317596	1	O
methyl	29317596	1	O
-	29317596	1	O
D	29317596	1	O
-	29317596	1	O
aspartate	29317596	1	O
receptors	29317596	1	O
(	29317596	1	O
NMDARs	29317596	1	O
)	29317596	1	O
has	29317596	1	O
been	29317596	1	O
implicated	29317596	1	O
as	29317596	1	O
a	29317596	1	O
potential	29317596	1	O
etiological	29317596	1	O
mechanism	29317596	1	O
.	29317596	1	O
Previous	29317596	1	O
studies	29317596	1	O
have	29317596	1	O
accumulated	29317596	1	O
evidence	29317596	1	O
supporting	29317596	1	O
NMDAR	29317596	1	O
-	29317596	1	O
encoding	29317596	1	O
genes	29317596	1	O
'	29317596	1	O
role	29317596	1	O
in	29317596	1	O
etiology	29317596	1	O
of	29317596	1	O
SCZ	29317596	1	O
and	29317596	1	O
ASD	29317596	1	O
.	29317596	1	O
We	29317596	1	O
performed	29317596	1	O
a	29317596	1	O
screening	29317596	1	O
study	29317596	1	O
for	29317596	1	O
exonic	29317596	1	O
regions	29317596	1	O
of	29317596	1	O
GRIN1	29317596	1	O
,	29317596	1	O
GRIN2A	29317596	1	O
,	29317596	1	O
GRIN2C	29317596	1	O
,	29317596	1	O
GRIN2D	29317596	1	O
,	29317596	1	O
GRIN3A	29317596	1	O
,	29317596	1	O
and	29317596	1	O
GRIN3B	29317596	1	O
,	29317596	1	O
which	29317596	1	O
encode	29317596	1	O
NMDAR	29317596	1	O
subunits	29317596	1	O
,	29317596	1	O
in	29317596	1	O
562	29317596	1	O
participates	29317596	1	O
(	29317596	1	O
370	29317596	1	O
SCZ	29317596	1	O
and	29317596	1	O
192	29317596	1	O
ASD	29317596	1	O
)	29317596	1	O
.	29317596	1	O
Forty	29317596	1	O
rare	29317596	1	O
variants	29317596	1	O
were	29317596	1	O
identified	29317596	1	O
including	29317596	1	O
38	29317596	1	O
missense	29317596	1	O
,	29317596	1	O
1	29317596	1	O
frameshift	29317596	1	O
mutation	29317596	1	O
in	29317596	1	O
GRIN2C	29317596	1	O
and	29317596	1	O
1	29317596	1	O
splice	29317596	1	O
site	29317596	1	O
mutation	29317596	1	O
in	29317596	1	O
GRIN2D	29317596	1	O
.	29317596	1	O
We	29317596	1	O
conducted	29317596	1	O
in	29317596	1	O
silico	29317596	1	O
analysis	29317596	1	O
for	29317596	1	O
all	29317596	1	O
variants	29317596	1	O
and	29317596	1	O
detected	29317596	1	O
seven	29317596	1	O
missense	29317596	1	O
variants	29317596	1	O
with	29317596	1	O
deleterious	29317596	1	O
prediction	29317596	1	O
.	29317596	1	O
De	29317596	1	O
novo	29317596	1	O
analysis	29317596	1	O
was	29317596	1	O
conducted	29317596	1	O
if	29317596	1	O
pedigree	29317596	1	O
samples	29317596	1	O
were	29317596	1	O
available	29317596	1	O
.	29317596	1	O
The	29317596	1	O
splice	29317596	1	O
site	29317596	1	O
mutation	29317596	1	O
in	29317596	1	O
GRIN2D	29317596	1	O
is	29317596	1	O
predicted	29317596	1	O
to	29317596	1	O
result	29317596	1	O
in	29317596	1	O
intron	29317596	1	O
retention	29317596	1	O
by	29317596	1	O
minigene	29317596	1	O
assay	29317596	1	O
.	29317596	1	O
Furthermore	29317596	1	O
,	29317596	1	O
the	29317596	1	O
frameshift	29317596	1	O
mutation	29317596	1	O
in	29317596	1	O
GRIN2C	29317596	1	O
and	29317596	1	O
splice	29317596	1	O
site	29317596	1	O
mutation	29317596	1	O
in	29317596	1	O
GRIN2D	29317596	1	O
were	29317596	1	O
genotyped	29317596	1	O
in	29317596	1	O
an	29317596	1	O
independent	29317596	1	O
sample	29317596	1	O
set	29317596	1	O
comprising	29317596	1	O
1877	29317596	1	O
SCZ	29317596	1	O
cases	29317596	1	O
,	29317596	1	O
382	29317596	1	O
ASD	29317596	1	O
cases	29317596	1	O
,	29317596	1	O
and	29317596	1	O
2040	29317596	1	O
controls	29317596	1	O
.	29317596	1	O
Both	29317596	1	O
of	29317596	1	O
them	29317596	1	O
were	29317596	1	O
revealed	29317596	1	O
to	29317596	1	O
be	29317596	1	O
singleton	29317596	1	O
.	29317596	1	O
Our	29317596	1	O
study	29317596	1	O
gives	29317596	1	O
evidence	29317596	1	O
in	29317596	1	O
support	29317596	1	O
of	29317596	1	O
the	29317596	1	O
view	29317596	1	O
that	29317596	1	O
ultra	29317596	1	O
-	29317596	1	O
rare	29317596	1	O
variants	29317596	1	O
with	29317596	1	O
loss	29317596	1	B-NegReg
of	29317596	1	I-NegReg
function	29317596	1	I-NegReg
(	29317596	1	B-Var
frameshift	29317596	1	I-Var
,	29317596	1	O
nonsense	29317596	1	B-Var
or	29317596	1	I-Var
splice	29317596	1	I-Var
site	29317596	1	I-Var
)	29317596	1	I-Var
in	29317596	1	O
NMDARs	29317596	1	B-Gene
genes	29317596	1	O
may	29317596	1	O
contribute	29317596	1	O
to	29317596	1	O
possible	29317596	1	O
risk	29317596	1	O
of	29317596	1	O
SCZ	29317596	1	B-Disease
.	29317596	1	O

FRUCTOKINASE	29319227	0	O
-	29319227	0	O
LIKE	29319227	0	O
PROTEIN	29319227	0	O
1	29319227	0	O
interacts	29319227	0	O
with	29319227	0	O
TRXz	29319227	0	O
to	29319227	0	O
regulate	29319227	0	O
chloroplast	29319227	0	O
development	29319227	0	O
in	29319227	0	O
rice	29319227	0	O
.	29319227	0	O
Chloroplast	29319227	0	O
genes	29319227	0	O
are	29319227	0	O
transcribed	29319227	0	O
by	29319227	0	O
the	29319227	0	O
plastid	29319227	0	O
-	29319227	0	O
encoded	29319227	0	O
RNA	29319227	0	O
polymerase	29319227	0	O
(	29319227	0	O
PEP	29319227	0	O
)	29319227	0	O
or	29319227	0	O
nucleus	29319227	0	O
-	29319227	0	O
encoded	29319227	0	O
RNA	29319227	0	O
polymerase	29319227	0	O
.	29319227	0	O
FRUCTOKINASE	29319227	0	O
-	29319227	0	O
LIKE	29319227	0	O
PROTEINS	29319227	0	O
(	29319227	0	O
FLNs	29319227	0	O
)	29319227	0	O
are	29319227	0	O
phosphofructokinase	29319227	0	O
-	29319227	0	O
B	29319227	0	O
(	29319227	0	O
PfkB	29319227	0	O
)	29319227	0	O
-	29319227	0	O
type	29319227	0	O
carbohydrate	29319227	0	O
kinases	29319227	0	O
that	29319227	0	O
act	29319227	0	O
as	29319227	0	O
part	29319227	0	O
of	29319227	0	O
the	29319227	0	O
PEP	29319227	0	O
complex	29319227	0	O
;	29319227	0	O
however	29319227	0	O
,	29319227	0	O
the	29319227	0	O
molecular	29319227	0	O
mechanisms	29319227	0	O
underlying	29319227	0	O
FLN	29319227	0	O
activity	29319227	0	O
in	29319227	0	O
rice	29319227	0	O
remain	29319227	0	O
elusive	29319227	0	O
.	29319227	0	O
Previously	29319227	0	O
,	29319227	0	O
we	29319227	0	O
identified	29319227	0	O
and	29319227	0	O
characterized	29319227	0	O
a	29319227	0	O
heat	29319227	0	O
-	29319227	0	O
stress	29319227	0	O
sensitive	29319227	0	O
albino	29319227	0	O
(	29319227	0	O
hsa1	29319227	0	O
)	29319227	0	O
mutant	29319227	0	O
in	29319227	0	O
rice	29319227	0	O
.	29319227	0	O
Map	29319227	0	O
-	29319227	0	O
based	29319227	0	O
cloning	29319227	0	O
revealed	29319227	0	O
that	29319227	0	O
HSA1	29319227	0	O
encodes	29319227	0	O
a	29319227	0	O
putative	29319227	0	O
OsFLN2	29319227	0	O
.	29319227	0	O
Here	29319227	0	O
,	29319227	0	O
we	29319227	0	O
further	29319227	0	O
demonstrated	29319227	0	O
that	29319227	0	O
knockdown	29319227	0	O
or	29319227	0	O
knockout	29319227	0	O
of	29319227	0	O
the	29319227	0	O
OsFLN1	29319227	0	O
,	29319227	0	O
a	29319227	0	O
close	29319227	0	O
homolog	29319227	0	O
of	29319227	0	O
HSA1	29319227	0	O
/	29319227	0	O
OsFLN2	29319227	0	O
,	29319227	0	O
considerably	29319227	0	O
inhibits	29319227	0	O
chloroplast	29319227	0	O
biogenesis	29319227	0	O
and	29319227	0	O
the	29319227	0	O
fln1	29319227	0	O
knockout	29319227	0	O
mutants	29319227	0	O
,	29319227	0	O
created	29319227	0	O
by	29319227	0	O
clustered	29319227	0	O
regularly	29319227	0	O
interspaced	29319227	0	O
short	29319227	0	O
palindromic	29319227	0	O
repeats	29319227	0	O
(	29319227	0	O
CRISPR	29319227	0	O
)	29319227	0	O
and	29319227	0	O
CRISPR	29319227	0	O
-	29319227	0	O
associate	29319227	0	O
protein	29319227	0	O
9	29319227	0	O
,	29319227	0	O
exhibit	29319227	0	O
severe	29319227	0	O
albino	29319227	0	O
phenotype	29319227	0	O
and	29319227	0	O
seedling	29319227	0	O
lethality	29319227	0	O
.	29319227	0	O
Moreover	29319227	0	O
,	29319227	0	O
OsFLN1	29319227	0	O
localizes	29319227	0	O
to	29319227	0	O
the	29319227	0	O
chloroplast	29319227	0	O
.	29319227	0	O
Yeast	29319227	0	O
two	29319227	0	O
-	29319227	0	O
hybrid	29319227	0	O
,	29319227	0	O
pull	29319227	0	O
-	29319227	0	O
down	29319227	0	O
and	29319227	0	O
bimolecular	29319227	0	O
fluorescence	29319227	0	O
complementation	29319227	0	O
experiments	29319227	0	O
revealed	29319227	0	O
that	29319227	0	O
OsFLN1	29319227	0	O
and	29319227	0	O
HSA1	29319227	0	O
/	29319227	0	O
OsFLN2	29319227	0	O
interact	29319227	0	O
with	29319227	0	O
THIOREDOXINZ	29319227	0	O
(	29319227	0	O
OsTRXz	29319227	0	O
)	29319227	0	O
to	29319227	0	O
regulate	29319227	0	O
chloroplast	29319227	0	O
development	29319227	0	O
.	29319227	0	O
In	29319227	0	O
agreement	29319227	0	O
with	29319227	0	O
this	29319227	0	O
,	29319227	0	O
knockout	29319227	0	O
of	29319227	0	O
OsTRXz	29319227	0	O
resulted	29319227	0	O
in	29319227	0	O
a	29319227	0	O
similar	29319227	0	O
albino	29319227	0	O
and	29319227	0	O
seedling	29319227	0	O
lethality	29319227	0	O
phenotype	29319227	0	O
to	29319227	0	O
that	29319227	0	O
of	29319227	0	O
the	29319227	0	O
fln1	29319227	0	O
mutants	29319227	0	O
.	29319227	0	O
Quantitative	29319227	0	O
reverse	29319227	0	O
transcription	29319227	0	O
polymerase	29319227	0	O
chain	29319227	0	O
reaction	29319227	0	O
and	29319227	0	O
immunoblot	29319227	0	O
analysis	29319227	0	O
revealed	29319227	0	O
that	29319227	0	O
the	29319227	0	O
transcription	29319227	0	O
and	29319227	0	O
translation	29319227	0	O
of	29319227	0	O
PEP	29319227	0	B-Gene
-	29319227	0	I-Gene
dependent	29319227	0	I-Gene
genes	29319227	0	I-Gene
were	29319227	0	O
strongly	29319227	0	O
inhibited	29319227	0	B-NegReg
in	29319227	0	O
fln1	29319227	0	B-Gene
and	29319227	0	O
trxz	29319227	0	O
mutants	29319227	0	B-Var
,	29319227	0	O
indicating	29319227	0	O
that	29319227	0	O
loss	29319227	0	O
of	29319227	0	O
OsFLN1	29319227	0	O
,	29319227	0	O
HSA1	29319227	0	O
/	29319227	0	O
OsFLN2	29319227	0	O
,	29319227	0	O
or	29319227	0	O
OsTRXz	29319227	0	O
function	29319227	0	O
perturbs	29319227	0	B-NegReg
the	29319227	0	O
stability	29319227	0	O
of	29319227	0	O
the	29319227	0	O
transcriptionally	29319227	0	O
active	29319227	0	O
chromosome	29319227	0	O
complex	29319227	0	O
and	29319227	0	O
PEP	29319227	0	O
activity	29319227	0	O
.	29319227	0	O
These	29319227	0	O
results	29319227	0	O
show	29319227	0	O
that	29319227	0	O
OsFLN1	29319227	0	O
and	29319227	0	O
HSA1	29319227	0	O
/	29319227	0	O
OsFLN2	29319227	0	O
contribute	29319227	0	O
to	29319227	0	O
chloroplast	29319227	0	O
biogenesis	29319227	0	O
and	29319227	0	O
plant	29319227	0	O
growth	29319227	0	O
.	29319227	0	O

The	29323748	2	O
gain	29323748	2	B-PosReg
-	29323748	2	I-PosReg
of	29323748	2	I-PosReg
-	29323748	2	I-PosReg
function	29323748	2	I-PosReg
mutation	29323748	2	O
E76K	29323748	2	B-Var
in	29323748	2	O
SHP2	29323748	2	B-Gene
promotes	29323748	2	B-PosReg
CAC	29323748	2	B-Disease
tumorigenesis	29323748	2	O
and	29323748	2	O
induces	29323748	2	B-PosReg
EMT	29323748	2	O
via	29323748	2	O
the	29323748	2	O
Wnt	29323748	2	O
/	29323748	2	O
β	29323748	2	O
-	29323748	2	O
catenin	29323748	2	O
signaling	29323748	2	O
pathway	29323748	2	O
.	29323748	2	O
SHP2	29323748	2	O
is	29323748	2	O
encoded	29323748	2	O
by	29323748	2	O
the	29323748	2	O
protein	29323748	2	O
tyrosine	29323748	2	O
phosphatase	29323748	2	O
11	29323748	2	O
(	29323748	2	O
Ptpn11	29323748	2	O
)	29323748	2	O
gene	29323748	2	O
.	29323748	2	O
Several	29323748	2	O
gain	29323748	2	O
-	29323748	2	O
of	29323748	2	O
-	29323748	2	O
function	29323748	2	O
(	29323748	2	O
GOF	29323748	2	O
)	29323748	2	O
mutations	29323748	2	O
in	29323748	2	O
Ptpn11	29323748	2	O
have	29323748	2	O
been	29323748	2	O
identified	29323748	2	O
in	29323748	2	O
human	29323748	2	O
hematopoietic	29323748	2	O
malignancies	29323748	2	O
and	29323748	2	O
solid	29323748	2	O
tumors	29323748	2	O
.	29323748	2	O
In	29323748	2	O
addition	29323748	2	O
,	29323748	2	O
the	29323748	2	O
mutation	29323748	2	B-Var
rate	29323748	2	O
for	29323748	2	O
SHP2	29323748	2	B-Gene
is	29323748	2	O
the	29323748	2	O
highest	29323748	2	B-Reg
for	29323748	2	O
colorectal	29323748	2	B-Disease
cancer	29323748	2	I-Disease
(	29323748	2	O
CRC	29323748	2	O
)	29323748	2	O
among	29323748	2	O
solid	29323748	2	O
tumors	29323748	2	O
.	29323748	2	O
The	29323748	2	O
E76K	29323748	2	O
GOF	29323748	2	O
mutation	29323748	2	O
is	29323748	2	O
the	29323748	2	O
most	29323748	2	O
common	29323748	2	O
and	29323748	2	O
active	29323748	2	O
SHP2	29323748	2	O
mutation	29323748	2	O
;	29323748	2	O
however	29323748	2	O
,	29323748	2	O
the	29323748	2	O
pathogenic	29323748	2	O
effects	29323748	2	O
and	29323748	2	O
function	29323748	2	O
of	29323748	2	O
this	29323748	2	O
mutation	29323748	2	O
in	29323748	2	O
CRC	29323748	2	O
tumor	29323748	2	O
progression	29323748	2	O
have	29323748	2	O
not	29323748	2	O
been	29323748	2	O
well	29323748	2	O
characterized	29323748	2	O
.	29323748	2	O
The	29323748	2	O
Wnt	29323748	2	O
/	29323748	2	O
β	29323748	2	O
-	29323748	2	O
catenin	29323748	2	O
(	29323748	2	O
CTNNB1	29323748	2	O
)	29323748	2	O
signaling	29323748	2	O
pathway	29323748	2	O
is	29323748	2	O
crucial	29323748	2	O
for	29323748	2	O
CRC	29323748	2	O
,	29323748	2	O
and	29323748	2	O
excessive	29323748	2	O
activation	29323748	2	O
of	29323748	2	O
this	29323748	2	O
pathway	29323748	2	O
has	29323748	2	O
been	29323748	2	O
observed	29323748	2	O
in	29323748	2	O
several	29323748	2	O
tumors	29323748	2	O
.	29323748	2	O
We	29323748	2	O
used	29323748	2	O
Ptpn11E76K	29323748	2	O
conditional	29323748	2	O
knock	29323748	2	O
-	29323748	2	O
in	29323748	2	O
mice	29323748	2	O
to	29323748	2	O
study	29323748	2	O
this	29323748	2	O
GOF	29323748	2	O
mutation	29323748	2	O
in	29323748	2	O
colitis	29323748	2	O
-	29323748	2	O
associated	29323748	2	O
CRC	29323748	2	O
(	29323748	2	O
CAC	29323748	2	O
)	29323748	2	O
and	29323748	2	O
used	29323748	2	O
the	29323748	2	O
CRC	29323748	2	O
cell	29323748	2	O
lines	29323748	2	O
HT29	29323748	2	O
and	29323748	2	O
HCT116	29323748	2	O
to	29323748	2	O
determine	29323748	2	O
the	29323748	2	O
relationship	29323748	2	O
between	29323748	2	O
SHP2	29323748	2	O
and	29323748	2	O
Wnt	29323748	2	O
/	29323748	2	O
β	29323748	2	O
-	29323748	2	O
catenin	29323748	2	O
signaling	29323748	2	O
.	29323748	2	O
Ptpn11E76K	29323748	2	B-Var
conditional	29323748	2	O
knock	29323748	2	O
-	29323748	2	O
in	29323748	2	O
mice	29323748	2	O
exhibited	29323748	2	O
aggravated	29323748	2	B-PosReg
inflammation	29323748	2	O
and	29323748	2	O
increased	29323748	2	B-PosReg
CAC	29323748	2	B-Disease
tumorigenesis	29323748	2	O
.	29323748	2	O
In	29323748	2	O
vitro	29323748	2	O
,	29323748	2	O
SHP2E76K	29323748	2	B-Var
and	29323748	2	O
SHP2WT	29323748	2	O
promoted	29323748	2	B-PosReg
malignant	29323748	2	O
biological	29323748	2	O
behaviors	29323748	2	O
of	29323748	2	O
CRC	29323748	2	O
cells	29323748	2	O
and	29323748	2	O
induced	29323748	2	B-PosReg
epithelial	29323748	2	O
-	29323748	2	O
mesenchymal	29323748	2	O
transition	29323748	2	O
(	29323748	2	O
EMT	29323748	2	O
)	29323748	2	O
via	29323748	2	O
the	29323748	2	O
Wnt	29323748	2	O
/	29323748	2	O
β	29323748	2	O
-	29323748	2	O
catenin	29323748	2	O
signaling	29323748	2	O
pathway	29323748	2	O
.	29323748	2	O
Together	29323748	2	O
,	29323748	2	O
our	29323748	2	O
results	29323748	2	O
showed	29323748	2	O
that	29323748	2	O
SHP2E76K	29323748	2	B-Var
acts	29323748	2	O
as	29323748	2	O
an	29323748	2	O
oncogene	29323748	2	O
that	29323748	2	O
promotes	29323748	2	B-PosReg
the	29323748	2	O
tumorigenesis	29323748	2	O
and	29323748	2	O
metastasis	29323748	2	O
of	29323748	2	O
CRC	29323748	2	B-Disease
.	29323748	2	O

New	29334984	0	O
insights	29334984	0	O
into	29334984	0	O
ANGPLT3	29334984	0	O
in	29334984	0	O
controlling	29334984	0	O
lipoprotein	29334984	0	O
metabolism	29334984	0	O
and	29334984	0	O
risk	29334984	0	O
of	29334984	0	O
cardiovascular	29334984	0	O
diseases	29334984	0	O
.	29334984	0	O
Dyslipidemia	29334984	0	O
,	29334984	0	O
characterized	29334984	0	O
by	29334984	0	O
elevation	29334984	0	O
of	29334984	0	O
plasma	29334984	0	O
low	29334984	0	O
density	29334984	0	O
lipoprotein	29334984	0	O
cholesterol	29334984	0	O
(	29334984	0	O
LDL	29334984	0	O
-	29334984	0	O
C	29334984	0	O
)	29334984	0	O
,	29334984	0	O
triglyceride	29334984	0	O
(	29334984	0	O
TG	29334984	0	O
)	29334984	0	O
and	29334984	0	O
reduction	29334984	0	O
of	29334984	0	O
plasma	29334984	0	O
high	29334984	0	O
density	29334984	0	O
lipoprotein	29334984	0	O
cholesterol	29334984	0	O
(	29334984	0	O
HDL	29334984	0	O
-	29334984	0	O
C	29334984	0	O
)	29334984	0	O
,	29334984	0	O
has	29334984	0	O
been	29334984	0	O
verified	29334984	0	O
as	29334984	0	O
a	29334984	0	O
causal	29334984	0	O
risk	29334984	0	O
factor	29334984	0	O
for	29334984	0	O
cardiovascular	29334984	0	O
diseases	29334984	0	O
(	29334984	0	O
CVD	29334984	0	O
)	29334984	0	O
,	29334984	0	O
leading	29334984	0	O
to	29334984	0	O
a	29334984	0	O
high	29334984	0	O
mortality	29334984	0	O
rate	29334984	0	O
in	29334984	0	O
general	29334984	0	O
population	29334984	0	O
.	29334984	0	O
It	29334984	0	O
is	29334984	0	O
important	29334984	0	O
to	29334984	0	O
understand	29334984	0	O
the	29334984	0	O
molecular	29334984	0	O
metabolism	29334984	0	O
underlying	29334984	0	O
dyslipidemia	29334984	0	O
in	29334984	0	O
order	29334984	0	O
to	29334984	0	O
reduce	29334984	0	O
the	29334984	0	O
risk	29334984	0	O
and	29334984	0	O
to	29334984	0	O
develop	29334984	0	O
effective	29334984	0	O
therapeutic	29334984	0	O
approaches	29334984	0	O
against	29334984	0	O
CVD	29334984	0	O
.	29334984	0	O
ANGPTL3	29334984	0	O
(	29334984	0	O
human	29334984	0	O
)	29334984	0	O
or	29334984	0	O
Angptl3	29334984	0	O
(	29334984	0	O
mouse	29334984	0	O
)	29334984	0	O
,	29334984	0	O
one	29334984	0	O
member	29334984	0	O
of	29334984	0	O
the	29334984	0	O
angiopoietin	29334984	0	O
-	29334984	0	O
like	29334984	0	O
protein	29334984	0	O
(	29334984	0	O
ANGPTL	29334984	0	O
)	29334984	0	O
family	29334984	0	O
,	29334984	0	O
has	29334984	0	O
been	29334984	0	O
identified	29334984	0	O
as	29334984	0	O
an	29334984	0	O
important	29334984	0	O
regulator	29334984	0	O
of	29334984	0	O
lipid	29334984	0	O
metabolism	29334984	0	O
by	29334984	0	O
inhibiting	29334984	0	O
LPL	29334984	0	O
and	29334984	0	O
EL	29334984	0	O
activity	29334984	0	O
.	29334984	0	O
Results	29334984	0	O
have	29334984	0	O
demonstrated	29334984	0	O
that	29334984	0	O
inactivation	29334984	0	O
of	29334984	0	O
Angptl3	29334984	0	O
in	29334984	0	O
mice	29334984	0	O
could	29334984	0	O
obviously	29334984	0	O
reduce	29334984	0	O
the	29334984	0	O
level	29334984	0	O
of	29334984	0	O
TG	29334984	0	O
,	29334984	0	O
LDL	29334984	0	O
-	29334984	0	O
C	29334984	0	O
and	29334984	0	O
the	29334984	0	O
atherosclerotic	29334984	0	O
lesion	29334984	0	O
size	29334984	0	O
,	29334984	0	O
leading	29334984	0	O
to	29334984	0	O
a	29334984	0	O
lower	29334984	0	O
risk	29334984	0	O
for	29334984	0	O
dyslipidemia	29334984	0	O
and	29334984	0	O
CVD	29334984	0	O
.	29334984	0	O
Additionally	29334984	0	O
,	29334984	0	O
in	29334984	0	O
humans	29334984	0	O
,	29334984	0	O
carriers	29334984	0	O
with	29334984	0	O
homozygous	29334984	0	O
LOF	29334984	0	B-NegReg
mutations	29334984	0	B-Var
in	29334984	0	O
ANGPTL3	29334984	0	B-Gene
have	29334984	0	O
lower	29334984	0	B-NegReg
plasma	29334984	0	O
LDL	29334984	0	O
-	29334984	0	O
C	29334984	0	O
,	29334984	0	O
TG	29334984	0	O
levels	29334984	0	O
and	29334984	0	O
lower	29334984	0	O
risk	29334984	0	O
of	29334984	0	O
atherosclerosis	29334984	0	O
compared	29334984	0	O
to	29334984	0	O
the	29334984	0	O
non	29334984	0	O
-	29334984	0	O
carriers	29334984	0	O
.	29334984	0	O
Here	29334984	0	O
,	29334984	0	O
we	29334984	0	O
collect	29334984	0	O
the	29334984	0	O
latest	29334984	0	O
data	29334984	0	O
and	29334984	0	O
results	29334984	0	O
,	29334984	0	O
giving	29334984	0	O
a	29334984	0	O
new	29334984	0	O
insight	29334984	0	O
into	29334984	0	O
the	29334984	0	O
important	29334984	0	O
role	29334984	0	O
of	29334984	0	O
ANGPTL3	29334984	0	O
in	29334984	0	O
controlling	29334984	0	O
lipoprotein	29334984	0	O
metabolism	29334984	0	O
.	29334984	0	O
Finally	29334984	0	O
,	29334984	0	O
we	29334984	0	O
introduce	29334984	0	O
two	29334984	0	O
update	29334984	0	O
reports	29334984	0	O
on	29334984	0	O
the	29334984	0	O
antisense	29334984	0	O
oligonucleotide	29334984	0	O
and	29334984	0	O
monoclonal	29334984	0	O
antibody	29334984	0	O
-	29334984	0	O
based	29334984	0	O
inactivation	29334984	0	O
of	29334984	0	O
ANGPTL3	29334984	0	O
in	29334984	0	O
human	29334984	0	O
clinical	29334984	0	O
trials	29334984	0	O
,	29334984	0	O
to	29334984	0	O
identify	29334984	0	O
that	29334984	0	O
ANGPTL3	29334984	0	O
could	29334984	0	O
be	29334984	0	O
a	29334984	0	O
novel	29334984	0	O
and	29334984	0	O
effective	29334984	0	O
target	29334984	0	O
for	29334984	0	O
the	29334984	0	O
treatment	29334984	0	O
of	29334984	0	O
dyslipidemia	29334984	0	O
and	29334984	0	O
CVD	29334984	0	O
.	29334984	0	O

Clonal	29342136	2	O
evolution	29342136	2	O
mechanisms	29342136	2	B-Reg
in	29342136	2	O
NT5C2	29342136	2	B-Gene
mutant	29342136	2	B-Disease
-	29342136	2	I-Disease
relapsed	29342136	2	I-Disease
acute	29342136	2	I-Disease
lymphoblastic	29342136	2	I-Disease
leukaemia	29342136	2	I-Disease
.	29342136	2	O
Relapsed	29342136	2	B-Disease
acute	29342136	2	I-Disease
lymphoblastic	29342136	2	I-Disease
leukaemia	29342136	2	I-Disease
(	29342136	2	O
ALL	29342136	2	O
)	29342136	2	O
is	29342136	2	O
associated	29342136	2	O
with	29342136	2	O
resistance	29342136	2	O
to	29342136	2	O
chemotherapy	29342136	2	O
and	29342136	2	O
poor	29342136	2	O
prognosis	29342136	2	O
.	29342136	2	O
Gain	29342136	2	B-PosReg
-	29342136	2	I-PosReg
of	29342136	2	I-PosReg
-	29342136	2	I-PosReg
function	29342136	2	I-PosReg
mutations	29342136	2	B-Var
in	29342136	2	O
the	29342136	2	O
5	29342136	2	O
'	29342136	2	O
-	29342136	2	O
nucleotidase	29342136	2	O
,	29342136	2	O
cytosolic	29342136	2	O
II	29342136	2	O
(	29342136	2	B-Gene
NT5C2	29342136	2	I-Gene
)	29342136	2	I-Gene
gene	29342136	2	O
induce	29342136	2	B-PosReg
resistance	29342136	2	O
to	29342136	2	O
6	29342136	2	O
-	29342136	2	O
mercaptopurine	29342136	2	O
and	29342136	2	O
are	29342136	2	O
selectively	29342136	2	O
present	29342136	2	O
in	29342136	2	O
relapsed	29342136	2	O
ALL	29342136	2	O
.	29342136	2	O
Yet	29342136	2	O
,	29342136	2	O
the	29342136	2	O
mechanisms	29342136	2	O
involved	29342136	2	O
in	29342136	2	O
NT5C2	29342136	2	O
mutation	29342136	2	O
-	29342136	2	O
driven	29342136	2	O
clonal	29342136	2	O
evolution	29342136	2	O
during	29342136	2	O
the	29342136	2	O
initiation	29342136	2	O
of	29342136	2	O
leukaemia	29342136	2	O
,	29342136	2	O
disease	29342136	2	O
progression	29342136	2	O
and	29342136	2	O
relapse	29342136	2	O
remain	29342136	2	O
unknown	29342136	2	O
.	29342136	2	O
Here	29342136	2	O
we	29342136	2	O
use	29342136	2	O
a	29342136	2	O
conditional	29342136	2	O
-	29342136	2	O
and	29342136	2	O
-	29342136	2	O
inducible	29342136	2	O
leukaemia	29342136	2	O
model	29342136	2	O
to	29342136	2	O
demonstrate	29342136	2	O
that	29342136	2	O
expression	29342136	2	O
of	29342136	2	O
NT5C2	29342136	2	B-Var
(	29342136	2	I-Var
R367Q	29342136	2	I-Var
)	29342136	2	I-Var
,	29342136	2	O
a	29342136	2	O
highly	29342136	2	O
prevalent	29342136	2	O
relapsed	29342136	2	B-Disease
-	29342136	2	I-Disease
ALL	29342136	2	I-Disease
NT5C2	29342136	2	B-Gene
mutation	29342136	2	O
,	29342136	2	O
induces	29342136	2	B-PosReg
resistance	29342136	2	O
to	29342136	2	O
chemotherapy	29342136	2	O
with	29342136	2	O
6	29342136	2	O
-	29342136	2	O
mercaptopurine	29342136	2	O
at	29342136	2	O
the	29342136	2	O
cost	29342136	2	O
of	29342136	2	O
impaired	29342136	2	O
leukaemia	29342136	2	O
cell	29342136	2	O
growth	29342136	2	O
and	29342136	2	O
leukaemia	29342136	2	O
-	29342136	2	O
initiating	29342136	2	O
cell	29342136	2	O
activity	29342136	2	O
.	29342136	2	O
The	29342136	2	O
loss	29342136	2	B-NegReg
-	29342136	2	I-NegReg
of	29342136	2	I-NegReg
-	29342136	2	I-NegReg
fitness	29342136	2	I-NegReg
phenotype	29342136	2	O
of	29342136	2	O
NT5C2	29342136	2	B-Var
/	29342136	2	I-Var
R367Q	29342136	2	I-Var
mutant	29342136	2	O
cells	29342136	2	O
is	29342136	2	O
associated	29342136	2	O
with	29342136	2	O
excess	29342136	2	B-PosReg
export	29342136	2	O
of	29342136	2	O
purines	29342136	2	O
to	29342136	2	O
the	29342136	2	O
extracellular	29342136	2	O
space	29342136	2	O
and	29342136	2	O
depletion	29342136	2	O
of	29342136	2	O
the	29342136	2	O
intracellular	29342136	2	O
purine	29342136	2	O
-	29342136	2	O
nucleotide	29342136	2	O
pool	29342136	2	O
.	29342136	2	O
Consequently	29342136	2	O
,	29342136	2	O
blocking	29342136	2	O
guanosine	29342136	2	O
synthesis	29342136	2	O
by	29342136	2	O
inhibition	29342136	2	O
of	29342136	2	O
inosine-5	29342136	2	O
'	29342136	2	O
-	29342136	2	O
monophosphate	29342136	2	O
dehydrogenase	29342136	2	O
(	29342136	2	O
IMPDH	29342136	2	O
)	29342136	2	O
induced	29342136	2	O
increased	29342136	2	O
cytotoxicity	29342136	2	O
against	29342136	2	O
NT5C2	29342136	2	O
-	29342136	2	O
mutant	29342136	2	O
leukaemia	29342136	2	O
lymphoblasts	29342136	2	O
.	29342136	2	O
These	29342136	2	O
results	29342136	2	O
identify	29342136	2	O
the	29342136	2	O
fitness	29342136	2	O
cost	29342136	2	O
of	29342136	2	O
NT5C2	29342136	2	O
mutation	29342136	2	O
and	29342136	2	O
resistance	29342136	2	O
to	29342136	2	O
chemotherapy	29342136	2	O
as	29342136	2	O
key	29342136	2	O
evolutionary	29342136	2	O
drivers	29342136	2	O
that	29342136	2	O
shape	29342136	2	O
clonal	29342136	2	O
evolution	29342136	2	O
in	29342136	2	O
relapsed	29342136	2	O
ALL	29342136	2	O
and	29342136	2	O
support	29342136	2	O
a	29342136	2	O
role	29342136	2	O
for	29342136	2	O
IMPDH	29342136	2	O
inhibition	29342136	2	O
in	29342136	2	O
the	29342136	2	O
treatment	29342136	2	O
of	29342136	2	O
ALL	29342136	2	O
.	29342136	2	O

The	29343685	0	O
protective	29343685	0	O
role	29343685	0	O
of	29343685	0	O
DOT1L	29343685	0	O
in	29343685	0	O
UV	29343685	0	O
-	29343685	0	O
induced	29343685	0	O
melanomagenesis	29343685	0	O
.	29343685	0	O
The	29343685	0	O
DOT1L	29343685	0	O
histone	29343685	0	O
H3	29343685	0	O
lysine	29343685	0	O
79	29343685	0	O
(	29343685	0	O
H3K79	29343685	0	O
)	29343685	0	O
methyltransferase	29343685	0	O
plays	29343685	0	O
an	29343685	0	O
oncogenic	29343685	0	O
role	29343685	0	O
in	29343685	0	O
MLL	29343685	0	O
-	29343685	0	O
rearranged	29343685	0	O
leukemogenesis	29343685	0	O
.	29343685	0	O
Here	29343685	0	O
,	29343685	0	O
we	29343685	0	O
demonstrate	29343685	0	O
that	29343685	0	O
,	29343685	0	O
in	29343685	0	O
contrast	29343685	0	O
to	29343685	0	O
MLL	29343685	0	O
-	29343685	0	O
rearranged	29343685	0	O
leukemia	29343685	0	O
,	29343685	0	O
DOT1L	29343685	0	O
plays	29343685	0	O
a	29343685	0	O
protective	29343685	0	O
role	29343685	0	O
in	29343685	0	O
ultraviolet	29343685	0	O
radiation	29343685	0	O
(	29343685	0	O
UVR	29343685	0	O
)	29343685	0	O
-	29343685	0	O
induced	29343685	0	O
melanoma	29343685	0	O
development	29343685	0	O
.	29343685	0	O
Specifically	29343685	0	O
,	29343685	0	O
the	29343685	0	O
DOT1L	29343685	0	B-Gene
gene	29343685	0	O
is	29343685	0	O
located	29343685	0	O
in	29343685	0	O
a	29343685	0	O
frequently	29343685	0	O
deleted	29343685	0	O
region	29343685	0	O
and	29343685	0	O
undergoes	29343685	0	O
somatic	29343685	0	O
mutation	29343685	0	O
in	29343685	0	O
human	29343685	0	O
melanoma	29343685	0	O
.	29343685	0	O
Specific	29343685	0	O
mutations	29343685	0	B-Var
functionally	29343685	0	O
compromise	29343685	0	B-NegReg
DOT1L	29343685	0	B-Gene
methyltransferase	29343685	0	O
enzyme	29343685	0	O
activity	29343685	0	O
leading	29343685	0	O
to	29343685	0	O
reduced	29343685	0	B-NegReg
H3K79	29343685	0	O
methylation	29343685	0	O
.	29343685	0	O
Importantly	29343685	0	O
,	29343685	0	O
in	29343685	0	O
the	29343685	0	O
absence	29343685	0	O
of	29343685	0	O
DOT1L	29343685	0	O
,	29343685	0	O
UVR	29343685	0	O
-	29343685	0	O
induced	29343685	0	O
DNA	29343685	0	O
damage	29343685	0	O
is	29343685	0	O
inefficiently	29343685	0	O
repaired	29343685	0	O
,	29343685	0	O
so	29343685	0	O
that	29343685	0	O
DOT1L	29343685	0	B-Gene
loss	29343685	0	B-NegReg
promotes	29343685	0	B-PosReg
melanoma	29343685	0	O
development	29343685	0	O
in	29343685	0	O
mice	29343685	0	O
after	29343685	0	O
exposure	29343685	0	O
to	29343685	0	O
UVR	29343685	0	O
.	29343685	0	O
Mechanistically	29343685	0	O
,	29343685	0	O
DOT1L	29343685	0	O
facilitates	29343685	0	O
DNA	29343685	0	O
damage	29343685	0	O
repair	29343685	0	O
,	29343685	0	O
with	29343685	0	O
DOT1L	29343685	0	O
-	29343685	0	O
methylated	29343685	0	O
H3K79	29343685	0	O
involvement	29343685	0	O
in	29343685	0	O
binding	29343685	0	O
and	29343685	0	O
recruiting	29343685	0	O
XPC	29343685	0	O
to	29343685	0	O
the	29343685	0	O
DNA	29343685	0	O
damage	29343685	0	O
site	29343685	0	O
for	29343685	0	O
nucleotide	29343685	0	O
excision	29343685	0	O
repair	29343685	0	O
(	29343685	0	O
NER	29343685	0	O
)	29343685	0	O
.	29343685	0	O
This	29343685	0	O
study	29343685	0	O
indicates	29343685	0	O
that	29343685	0	O
DOT1L	29343685	0	O
plays	29343685	0	O
a	29343685	0	O
protective	29343685	0	O
role	29343685	0	O
in	29343685	0	O
UVR	29343685	0	O
-	29343685	0	O
induced	29343685	0	O
melanomagenesis	29343685	0	O
.	29343685	0	O

Biallelic	29343805	1	B-Var
variants	29343805	1	I-Var
in	29343805	1	O
KIF14	29343805	1	B-Gene
cause	29343805	1	B-Reg
intellectual	29343805	1	B-Disease
disability	29343805	1	I-Disease
with	29343805	1	O
microcephaly	29343805	1	B-Disease
.	29343805	1	O
Kinesin	29343805	1	O
proteins	29343805	1	O
are	29343805	1	O
critical	29343805	1	O
for	29343805	1	O
various	29343805	1	O
cellular	29343805	1	O
functions	29343805	1	O
such	29343805	1	O
as	29343805	1	O
intracellular	29343805	1	O
transport	29343805	1	O
and	29343805	1	O
cell	29343805	1	O
division	29343805	1	O
,	29343805	1	O
and	29343805	1	O
many	29343805	1	O
members	29343805	1	O
of	29343805	1	O
the	29343805	1	O
family	29343805	1	O
have	29343805	1	O
been	29343805	1	O
linked	29343805	1	O
to	29343805	1	O
monogenic	29343805	1	O
disorders	29343805	1	O
and	29343805	1	O
cancer	29343805	1	O
.	29343805	1	O
We	29343805	1	O
report	29343805	1	O
eight	29343805	1	O
individuals	29343805	1	O
with	29343805	1	O
intellectual	29343805	1	O
disability	29343805	1	O
and	29343805	1	O
microcephaly	29343805	1	O
from	29343805	1	O
four	29343805	1	O
unrelated	29343805	1	O
families	29343805	1	O
with	29343805	1	O
parental	29343805	1	O
consanguinity	29343805	1	O
.	29343805	1	O
In	29343805	1	O
the	29343805	1	O
affected	29343805	1	O
individuals	29343805	1	O
of	29343805	1	O
each	29343805	1	O
family	29343805	1	O
,	29343805	1	O
homozygosity	29343805	1	O
for	29343805	1	O
likely	29343805	1	O
pathogenic	29343805	1	O
variants	29343805	1	O
in	29343805	1	O
KIF14	29343805	1	B-Gene
were	29343805	1	O
detected	29343805	1	O
;	29343805	1	O
two	29343805	1	O
loss	29343805	1	B-NegReg
-	29343805	1	I-NegReg
of	29343805	1	I-NegReg
-	29343805	1	I-NegReg
function	29343805	1	I-NegReg
(	29343805	1	B-Var
p.Asn83Ilefs*3	29343805	1	I-Var
and	29343805	1	O
p.Ser1478fs	29343805	1	B-Var
)	29343805	1	I-Var
,	29343805	1	O
and	29343805	1	O
two	29343805	1	O
missense	29343805	1	B-Reg
substitutions	29343805	1	I-Reg
(	29343805	1	B-Var
p.Ser841Phe	29343805	1	I-Var
and	29343805	1	O
p.Gly459Arg	29343805	1	B-Var
)	29343805	1	I-Var
.	29343805	1	O
KIF14	29343805	1	O
is	29343805	1	O
a	29343805	1	O
mitotic	29343805	1	O
motor	29343805	1	O
protein	29343805	1	O
that	29343805	1	O
is	29343805	1	O
required	29343805	1	O
for	29343805	1	O
spindle	29343805	1	O
localization	29343805	1	O
of	29343805	1	O
the	29343805	1	O
mitotic	29343805	1	O
citron	29343805	1	O
rho	29343805	1	O
-	29343805	1	O
interacting	29343805	1	O
kinase	29343805	1	O
,	29343805	1	O
CIT	29343805	1	B-Gene
,	29343805	1	O
also	29343805	1	O
mutated	29343805	1	B-Var
in	29343805	1	B-Reg
microcephaly	29343805	1	B-Disease
.	29343805	1	O
Our	29343805	1	O
results	29343805	1	O
demonstrate	29343805	1	O
the	29343805	1	O
involvement	29343805	1	O
of	29343805	1	O
KIF14	29343805	1	O
in	29343805	1	O
development	29343805	1	O
and	29343805	1	O
reveal	29343805	1	O
a	29343805	1	O
wide	29343805	1	O
phenotypic	29343805	1	O
variability	29343805	1	O
ranging	29343805	1	O
from	29343805	1	O
fetal	29343805	1	O
lethality	29343805	1	O
to	29343805	1	O
moderate	29343805	1	O
developmental	29343805	1	O
delay	29343805	1	O
and	29343805	1	O
microcephaly	29343805	1	O
.	29343805	1	O

APOC3	29348120	0	B-Gene
Loss	29348120	0	B-NegReg
-	29348120	0	I-NegReg
of	29348120	0	I-NegReg
-	29348120	0	I-NegReg
Function	29348120	0	I-NegReg
Mutations	29348120	0	B-Var
,	29348120	0	O
Remnant	29348120	0	O
Cholesterol	29348120	0	O
,	29348120	0	O
Low	29348120	0	O
-	29348120	0	O
Density	29348120	0	O
Lipoprotein	29348120	0	O
Cholesterol	29348120	0	O
,	29348120	0	O
and	29348120	0	O
Cardiovascular	29348120	0	O
Risk	29348120	0	O
:	29348120	0	O
Mediation	29348120	0	O
-	29348120	0	O
and	29348120	0	O
Meta	29348120	0	O
-	29348120	0	O
Analyses	29348120	0	O
of	29348120	0	O
137	29348120	0	O
895	29348120	0	O
Individuals	29348120	0	O
.	29348120	0	O
OBJECTIVE	29348120	0	O
:	29348120	0	O
Loss	29348120	0	B-NegReg
-	29348120	0	I-NegReg
of	29348120	0	I-NegReg
-	29348120	0	I-NegReg
function	29348120	0	I-NegReg
mutations	29348120	0	B-Var
in	29348120	0	O
APOC3	29348120	0	B-Gene
associate	29348120	0	O
with	29348120	0	O
low	29348120	0	B-NegReg
remnant	29348120	0	O
cholesterol	29348120	0	O
levels	29348120	0	O
and	29348120	0	O
low	29348120	0	O
risk	29348120	0	O
of	29348120	0	O
ischemic	29348120	0	O
vascular	29348120	0	O
disease	29348120	0	O
(	29348120	0	O
IVD	29348120	0	O
)	29348120	0	O
.	29348120	0	O
Because	29348120	0	O
some	29348120	0	O
studies	29348120	0	O
show	29348120	0	O
an	29348120	0	O
additional	29348120	0	O
association	29348120	0	O
with	29348120	0	O
low	29348120	0	O
levels	29348120	0	O
of	29348120	0	O
low	29348120	0	O
-	29348120	0	O
density	29348120	0	O
lipoprotein	29348120	0	O
cholesterol	29348120	0	O
(	29348120	0	O
LDL	29348120	0	O
-	29348120	0	O
C	29348120	0	O
)	29348120	0	O
,	29348120	0	O
low	29348120	0	O
LDL	29348120	0	O
-	29348120	0	O
C	29348120	0	O
may	29348120	0	O
explain	29348120	0	O
the	29348120	0	O
low	29348120	0	O
risk	29348120	0	O
of	29348120	0	O
IVD	29348120	0	O
in	29348120	0	O
APOC3	29348120	0	O
loss	29348120	0	O
-	29348120	0	O
of	29348120	0	O
-	29348120	0	O
function	29348120	0	O
heterozygotes	29348120	0	O
.	29348120	0	O
We	29348120	0	O
tested	29348120	0	O
to	29348120	0	O
what	29348120	0	O
extent	29348120	0	O
the	29348120	0	O
low	29348120	0	O
risk	29348120	0	O
of	29348120	0	O
IVD	29348120	0	O
in	29348120	0	O
APOC3	29348120	0	O
loss	29348120	0	O
-	29348120	0	O
of	29348120	0	O
-	29348120	0	O
function	29348120	0	O
heterozygotes	29348120	0	O
is	29348120	0	O
mediated	29348120	0	O
by	29348120	0	O
low	29348120	0	O
plasma	29348120	0	O
remnant	29348120	0	O
cholesterol	29348120	0	O
and	29348120	0	O
LDL	29348120	0	O
-	29348120	0	O
C.	29348120	0	O
APPROACH	29348120	0	O
AND	29348120	0	O
RESULTS	29348120	0	O
:	29348120	0	O
In	29348120	0	O
APOC3	29348120	0	O
loss	29348120	0	O
-	29348120	0	O
of	29348120	0	O
-	29348120	0	O
function	29348120	0	O
heterozygotes	29348120	0	O
versus	29348120	0	O
noncarriers	29348120	0	O
,	29348120	0	O
we	29348120	0	O
first	29348120	0	O
determined	29348120	0	O
remnant	29348120	0	O
cholesterol	29348120	0	O
and	29348120	0	O
LDL	29348120	0	O
-	29348120	0	O
C	29348120	0	O
levels	29348120	0	O
in	29348120	0	O
meta	29348120	0	O
-	29348120	0	O
analyses	29348120	0	O
of	29348120	0	O
137	29348120	0	O
895	29348120	0	O
individuals	29348120	0	O
.	29348120	0	O
Second	29348120	0	O
,	29348120	0	O
we	29348120	0	O
determined	29348120	0	O
whether	29348120	0	O
the	29348120	0	O
association	29348120	0	O
with	29348120	0	O
LDL	29348120	0	O
-	29348120	0	O
C	29348120	0	O
was	29348120	0	O
masked	29348120	0	O
by	29348120	0	O
lipid	29348120	0	O
-	29348120	0	O
lowering	29348120	0	O
therapy	29348120	0	O
.	29348120	0	O
Finally	29348120	0	O
,	29348120	0	O
using	29348120	0	O
mediation	29348120	0	O
analysis	29348120	0	O
,	29348120	0	O
we	29348120	0	O
determined	29348120	0	O
the	29348120	0	O
fraction	29348120	0	O
of	29348120	0	O
the	29348120	0	O
low	29348120	0	O
risk	29348120	0	O
of	29348120	0	O
IVD	29348120	0	O
and	29348120	0	O
ischemic	29348120	0	O
heart	29348120	0	O
disease	29348120	0	O
mediated	29348120	0	O
by	29348120	0	O
remnant	29348120	0	O
cholesterol	29348120	0	O
and	29348120	0	O
LDL	29348120	0	O
-	29348120	0	O
C.	29348120	0	O
In	29348120	0	O
meta	29348120	0	O
-	29348120	0	O
analyses	29348120	0	O
,	29348120	0	O
remnant	29348120	0	O
cholesterol	29348120	0	O
was	29348120	0	O
43%	29348120	0	O
lower	29348120	0	O
(	29348120	0	O
95%	29348120	0	O
confidence	29348120	0	O
interval	29348120	0	O
,	29348120	0	O
40%	29348120	0	O
-	29348120	0	O
47%	29348120	0	O
)	29348120	0	O
,	29348120	0	O
and	29348120	0	O
LDL	29348120	0	O
-	29348120	0	O
C	29348120	0	O
was	29348120	0	O
4%	29348120	0	O
lower	29348120	0	O
(	29348120	0	O
1%	29348120	0	O
-	29348120	0	O
6%	29348120	0	O
)	29348120	0	O
in	29348120	0	O
loss	29348120	0	O
-	29348120	0	O
of	29348120	0	O
-	29348120	0	O
function	29348120	0	O
heterozygotes	29348120	0	O
(	29348120	0	O
n	29348120	0	O
=	29348120	0	O
776	29348120	0	O
)	29348120	0	O
versus	29348120	0	O
noncarriers	29348120	0	O
.	29348120	0	O
In	29348120	0	O
the	29348120	0	O
general	29348120	0	O
population	29348120	0	O
,	29348120	0	O
LDL	29348120	0	O
-	29348120	0	O
C	29348120	0	O
was	29348120	0	O
3%	29348120	0	O
lower	29348120	0	O
in	29348120	0	O
loss	29348120	0	O
-	29348120	0	O
of	29348120	0	O
-	29348120	0	O
function	29348120	0	O
heterozygotes	29348120	0	O
versus	29348120	0	O
noncarriers	29348120	0	O
,	29348120	0	O
4%	29348120	0	O
lower	29348120	0	O
when	29348120	0	O
correcting	29348120	0	O
for	29348120	0	O
lipid	29348120	0	O
-	29348120	0	O
lowering	29348120	0	O
therapy	29348120	0	O
,	29348120	0	O
and	29348120	0	O
3%	29348120	0	O
lower	29348120	0	O
in	29348120	0	O
untreated	29348120	0	O
individuals	29348120	0	O
(	29348120	0	O
P	29348120	0	O
values	29348120	0	O
,	29348120	0	O
0.06	29348120	0	O
-	29348120	0	O
0.008	29348120	0	O
)	29348120	0	O
.	29348120	0	O
Remnant	29348120	0	O
cholesterol	29348120	0	O
mediated	29348120	0	O
37%	29348120	0	O
of	29348120	0	O
the	29348120	0	O
observed	29348120	0	O
41%	29348120	0	O
lower	29348120	0	O
risk	29348120	0	O
of	29348120	0	O
IVD	29348120	0	O
and	29348120	0	O
54%	29348120	0	O
of	29348120	0	O
the	29348120	0	O
observed	29348120	0	O
36%	29348120	0	O
lower	29348120	0	O
risk	29348120	0	O
of	29348120	0	O
ischemic	29348120	0	O
heart	29348120	0	O
disease	29348120	0	O
;	29348120	0	O
corresponding	29348120	0	O
values	29348120	0	O
mediated	29348120	0	O
by	29348120	0	O
LDL	29348120	0	O
-	29348120	0	O
C	29348120	0	O
were	29348120	0	O
1%	29348120	0	O
and	29348120	0	O
2%	29348120	0	O
.	29348120	0	O
CONCLUSIONS	29348120	0	O
:	29348120	0	O
The	29348120	0	O
low	29348120	0	O
risk	29348120	0	O
of	29348120	0	O
IVD	29348120	0	O
observed	29348120	0	O
in	29348120	0	O
APOC3	29348120	0	B-Gene
loss	29348120	0	B-NegReg
-	29348120	0	I-NegReg
of	29348120	0	I-NegReg
-	29348120	0	I-NegReg
function	29348120	0	I-NegReg
heterozygotes	29348120	0	O
is	29348120	0	O
mainly	29348120	0	O
mediated	29348120	0	O
by	29348120	0	O
the	29348120	0	O
associated	29348120	0	O
low	29348120	0	B-NegReg
remnant	29348120	0	O
cholesterol	29348120	0	O
and	29348120	0	O
not	29348120	0	O
by	29348120	0	O
low	29348120	0	O
LDL	29348120	0	O
-	29348120	0	O
C.	29348120	0	O
Furthermore	29348120	0	O
,	29348120	0	O
the	29348120	0	O
contribution	29348120	0	O
of	29348120	0	O
LDL	29348120	0	O
-	29348120	0	O
C	29348120	0	O
to	29348120	0	O
IVD	29348120	0	O
risk	29348120	0	O
was	29348120	0	O
not	29348120	0	O
masked	29348120	0	O
by	29348120	0	O
lipid	29348120	0	O
-	29348120	0	O
lowering	29348120	0	O
therapy	29348120	0	O
.	29348120	0	O
This	29348120	0	O
suggests	29348120	0	O
APOC3	29348120	0	O
and	29348120	0	O
remnant	29348120	0	O
cholesterol	29348120	0	O
as	29348120	0	O
important	29348120	0	O
new	29348120	0	O
targets	29348120	0	O
for	29348120	0	O
reducing	29348120	0	O
cardiovascular	29348120	0	O
risk	29348120	0	O
.	29348120	0	O

Key	29358613	1	O
apoptotic	29358613	1	B-Gene
genes	29358613	1	I-Gene
APAF1	29358613	1	B-Gene
and	29358613	1	O
CASP9	29358613	1	B-Gene
implicated	29358613	1	O
in	29358613	1	O
recurrent	29358613	1	O
folate	29358613	1	O
-	29358613	1	O
resistant	29358613	1	O
neural	29358613	1	O
tube	29358613	1	O
defects	29358613	1	O
.	29358613	1	O
Neural	29358613	1	O
tube	29358613	1	O
defects	29358613	1	O
(	29358613	1	O
NTDs	29358613	1	O
)	29358613	1	O
remain	29358613	1	O
one	29358613	1	O
of	29358613	1	O
the	29358613	1	O
most	29358613	1	O
serious	29358613	1	O
birth	29358613	1	O
defects	29358613	1	O
,	29358613	1	O
and	29358613	1	O
although	29358613	1	O
genes	29358613	1	O
in	29358613	1	O
several	29358613	1	O
pathways	29358613	1	O
have	29358613	1	O
been	29358613	1	O
implicated	29358613	1	O
as	29358613	1	O
risk	29358613	1	O
factors	29358613	1	O
for	29358613	1	O
neural	29358613	1	O
tube	29358613	1	O
defects	29358613	1	O
via	29358613	1	O
knockout	29358613	1	O
mouse	29358613	1	O
models	29358613	1	O
,	29358613	1	O
very	29358613	1	O
few	29358613	1	O
molecular	29358613	1	O
causes	29358613	1	O
in	29358613	1	O
humans	29358613	1	O
have	29358613	1	O
been	29358613	1	O
identified	29358613	1	O
.	29358613	1	O
Whole	29358613	1	O
exome	29358613	1	O
sequencing	29358613	1	O
identified	29358613	1	O
deleterious	29358613	1	O
variants	29358613	1	O
in	29358613	1	O
key	29358613	1	O
apoptotic	29358613	1	O
genes	29358613	1	O
in	29358613	1	O
two	29358613	1	O
families	29358613	1	O
with	29358613	1	O
recurrent	29358613	1	O
neural	29358613	1	O
tube	29358613	1	O
defects	29358613	1	O
.	29358613	1	O
Functional	29358613	1	O
studies	29358613	1	O
in	29358613	1	O
fibroblasts	29358613	1	O
indicate	29358613	1	O
that	29358613	1	O
these	29358613	1	O
variants	29358613	1	B-Var
are	29358613	1	O
loss	29358613	1	B-NegReg
-	29358613	1	I-NegReg
of	29358613	1	I-NegReg
-	29358613	1	I-NegReg
function	29358613	1	I-NegReg
,	29358613	1	O
as	29358613	1	O
apoptosis	29358613	1	O
is	29358613	1	O
significantly	29358613	1	O
reduced	29358613	1	B-NegReg
.	29358613	1	O
This	29358613	1	O
is	29358613	1	O
the	29358613	1	O
first	29358613	1	O
report	29358613	1	O
of	29358613	1	O
variants	29358613	1	B-Var
in	29358613	1	O
apoptotic	29358613	1	B-Gene
genes	29358613	1	I-Gene
contributing	29358613	1	B-Reg
to	29358613	1	O
neural	29358613	1	B-Disease
tube	29358613	1	I-Disease
defect	29358613	1	I-Disease
risk	29358613	1	O
in	29358613	1	O
humans	29358613	1	O
.	29358613	1	O

Congenital	29358614	1	O
diaphragmatic	29358614	1	O
hernia	29358614	1	O
as	29358614	1	O
a	29358614	1	O
part	29358614	1	O
of	29358614	1	O
Nance	29358614	1	O
-	29358614	1	O
Horan	29358614	1	O
syndrome	29358614	1	O
?	29358614	1	O
Nance	29358614	1	O
-	29358614	1	O
Horan	29358614	1	O
syndrome	29358614	1	O
is	29358614	1	O
a	29358614	1	O
rare	29358614	1	O
X	29358614	1	O
-	29358614	1	O
linked	29358614	1	O
developmental	29358614	1	O
disorder	29358614	1	O
characterized	29358614	1	O
by	29358614	1	O
bilateral	29358614	1	O
congenital	29358614	1	O
cataract	29358614	1	O
,	29358614	1	O
dental	29358614	1	O
anomalies	29358614	1	O
,	29358614	1	O
facial	29358614	1	O
dysmorphism	29358614	1	O
,	29358614	1	O
and	29358614	1	O
intellectual	29358614	1	O
disability	29358614	1	O
.	29358614	1	O
Here	29358614	1	O
,	29358614	1	O
we	29358614	1	O
identify	29358614	1	O
a	29358614	1	O
patient	29358614	1	O
with	29358614	1	O
Nance	29358614	1	B-Disease
-	29358614	1	I-Disease
Horan	29358614	1	I-Disease
syndrome	29358614	1	I-Disease
caused	29358614	1	B-Reg
by	29358614	1	I-Reg
a	29358614	1	O
new	29358614	1	O
nonsense	29358614	1	B-Var
NHS	29358614	1	B-Gene
variant	29358614	1	O
.	29358614	1	O
In	29358614	1	O
addition	29358614	1	O
,	29358614	1	O
the	29358614	1	O
patient	29358614	1	O
presented	29358614	1	O
congenital	29358614	1	B-Disease
diaphragmatic	29358614	1	I-Disease
hernia	29358614	1	I-Disease
.	29358614	1	O
NHS	29358614	1	O
gene	29358614	1	O
expression	29358614	1	O
in	29358614	1	O
murine	29358614	1	O
fetal	29358614	1	O
diaphragm	29358614	1	O
was	29358614	1	O
demonstrated	29358614	1	O
,	29358614	1	O
suggesting	29358614	1	O
a	29358614	1	O
possible	29358614	1	O
involvement	29358614	1	O
of	29358614	1	O
NHS	29358614	1	O
in	29358614	1	O
diaphragm	29358614	1	O
development	29358614	1	O
.	29358614	1	O
Congenital	29358614	1	B-Disease
diaphragmatic	29358614	1	I-Disease
hernia	29358614	1	I-Disease
could	29358614	1	O
result	29358614	1	B-Reg
from	29358614	1	I-Reg
NHS	29358614	1	B-Gene
loss	29358614	1	B-NegReg
of	29358614	1	I-NegReg
function	29358614	1	I-NegReg
in	29358614	1	O
pleuroperitoneal	29358614	1	O
fold	29358614	1	O
or	29358614	1	O
in	29358614	1	O
somites	29358614	1	O
-	29358614	1	O
derived	29358614	1	O
muscle	29358614	1	O
progenitor	29358614	1	O
cells	29358614	1	O
leading	29358614	1	O
to	29358614	1	O
an	29358614	1	O
impairment	29358614	1	O
of	29358614	1	O
their	29358614	1	O
cells	29358614	1	O
migration	29358614	1	O
.	29358614	1	O

[	29367526	1	O
The	29367526	1	O
formation	29367526	1	O
of	29367526	1	O
skin	29367526	1	O
barrier	29367526	1	O
and	29367526	1	O
defective	29367526	1	O
barrier	29367526	1	O
-	29367526	1	O
associated	29367526	1	O
skin	29367526	1	O
diseases	29367526	1	O
]	29367526	1	O
.	29367526	1	O
Since	29367526	1	O
the	29367526	1	O
discovery	29367526	1	O
of	29367526	1	O
loss	29367526	1	B-NegReg
-	29367526	1	I-NegReg
of	29367526	1	I-NegReg
-	29367526	1	I-NegReg
function	29367526	1	I-NegReg
mutations	29367526	1	B-Var
in	29367526	1	O
filaggrin	29367526	1	O
(	29367526	1	B-Gene
FLG	29367526	1	I-Gene
)	29367526	1	I-Gene
gene	29367526	1	O
in	29367526	1	O
atopic	29367526	1	B-Disease
dermatitis	29367526	1	I-Disease
(	29367526	1	O
AD	29367526	1	O
)	29367526	1	O
individuals	29367526	1	O
,	29367526	1	O
significant	29367526	1	O
attention	29367526	1	O
has	29367526	1	O
been	29367526	1	O
paid	29367526	1	O
against	29367526	1	O
the	29367526	1	O
skin	29367526	1	O
barrier	29367526	1	O
as	29367526	1	O
an	29367526	1	O
initial	29367526	1	O
starting	29367526	1	O
point	29367526	1	O
of	29367526	1	O
atopic	29367526	1	O
march	29367526	1	O
.	29367526	1	O
Although	29367526	1	O
FLG	29367526	1	O
is	29367526	1	O
a	29367526	1	O
significant	29367526	1	O
cornification	29367526	1	O
-	29367526	1	O
associated	29367526	1	O
gene	29367526	1	O
,	29367526	1	O
skin	29367526	1	O
barrier	29367526	1	O
formation	29367526	1	O
is	29367526	1	O
a	29367526	1	O
complex	29367526	1	O
process	29367526	1	O
mediated	29367526	1	O
by	29367526	1	O
an	29367526	1	O
array	29367526	1	O
of	29367526	1	O
genes	29367526	1	O
with	29367526	1	O
specific	29367526	1	O
functions	29367526	1	O
.	29367526	1	O
In	29367526	1	O
this	29367526	1	O
article	29367526	1	O
,	29367526	1	O
the	29367526	1	O
mechanism	29367526	1	O
of	29367526	1	O
physical	29367526	1	O
skin	29367526	1	O
barrier	29367526	1	O
formation	29367526	1	O
is	29367526	1	O
reviewed	29367526	1	O
in	29367526	1	O
detail	29367526	1	O
,	29367526	1	O
focusing	29367526	1	O
on	29367526	1	O
specific	29367526	1	O
gene	29367526	1	O
functions	29367526	1	O
and	29367526	1	O
inherited	29367526	1	O
disorders	29367526	1	O
caused	29367526	1	O
by	29367526	1	O
genetic	29367526	1	O
aberrations	29367526	1	O
.	29367526	1	O
Additionally	29367526	1	O
,	29367526	1	O
the	29367526	1	O
mechanism	29367526	1	O
of	29367526	1	O
percutaneous	29367526	1	O
sensitization	29367526	1	O
with	29367526	1	O
environmental	29367526	1	O
allergens	29367526	1	O
in	29367526	1	O
association	29367526	1	O
with	29367526	1	O
FLG	29367526	1	O
-	29367526	1	O
deficiency	29367526	1	O
is	29367526	1	O
reviewed	29367526	1	O
in	29367526	1	O
order	29367526	1	O
to	29367526	1	O
clarify	29367526	1	O
the	29367526	1	O
link	29367526	1	O
between	29367526	1	O
defective	29367526	1	O
skin	29367526	1	O
barrier	29367526	1	O
and	29367526	1	O
atopic	29367526	1	O
march	29367526	1	O
.	29367526	1	O
Finally	29367526	1	O
,	29367526	1	O
updated	29367526	1	O
knowledge	29367526	1	O
of	29367526	1	O
psoriasis	29367526	1	O
pathophysiology	29367526	1	O
in	29367526	1	O
connection	29367526	1	O
with	29367526	1	O
genetic	29367526	1	O
defect	29367526	1	O
in	29367526	1	O
skin	29367526	1	O
barrier	29367526	1	O
is	29367526	1	O
reviewed	29367526	1	O
.	29367526	1	O
This	29367526	1	O
article	29367526	1	O
would	29367526	1	O
provide	29367526	1	O
a	29367526	1	O
novel	29367526	1	O
opportunity	29367526	1	O
to	29367526	1	O
understand	29367526	1	O
the	29367526	1	O
allergic	29367526	1	O
/	29367526	1	O
autoimmune	29367526	1	O
disorders	29367526	1	O
from	29367526	1	O
the	29367526	1	O
viewpoint	29367526	1	O
of	29367526	1	O
non	29367526	1	O
-	29367526	1	O
classical	29367526	1	O
immune	29367526	1	O
cells	29367526	1	O
.	29367526	1	O

Tryptophan	29367674	0	O
hydroxylase	29367674	0	O
(	29367674	0	B-Gene
TRH	29367674	0	I-Gene
)	29367674	0	I-Gene
loss	29367674	0	B-NegReg
of	29367674	0	I-NegReg
function	29367674	0	I-NegReg
mutations	29367674	0	B-Var
induce	29367674	0	O
growth	29367674	0	O
and	29367674	0	O
behavioral	29367674	0	O
defects	29367674	0	O
in	29367674	0	O
Daphnia	29367674	0	O
magna	29367674	0	O
.	29367674	0	O
Tryptophan	29367674	0	O
hydroxylase	29367674	0	O
(	29367674	0	O
TRH	29367674	0	O
)	29367674	0	O
is	29367674	0	O
the	29367674	0	O
rate	29367674	0	O
limiting	29367674	0	O
enzyme	29367674	0	O
in	29367674	0	O
the	29367674	0	O
serotonin	29367674	0	O
synthesis	29367674	0	O
.	29367674	0	O
CRISPR	29367674	0	O
-	29367674	0	O
Cas9	29367674	0	O
technology	29367674	0	O
was	29367674	0	O
used	29367674	0	O
to	29367674	0	O
generate	29367674	0	O
seven	29367674	0	O
indel	29367674	0	O
TRH	29367674	0	O
mutants	29367674	0	O
in	29367674	0	O
Daphnia	29367674	0	O
magna	29367674	0	O
.	29367674	0	O
Mono	29367674	0	O
-	29367674	0	O
allelic	29367674	0	O
indel	29367674	0	O
TRH	29367674	0	O
-	29367674	0	O
/	29367674	0	O
clones	29367674	0	O
showed	29367674	0	O
normal	29367674	0	O
levels	29367674	0	O
of	29367674	0	O
serotonin	29367674	0	O
,	29367674	0	O
measured	29367674	0	O
by	29367674	0	O
both	29367674	0	O
immunohistochemistry	29367674	0	O
and	29367674	0	O
mass	29367674	0	O
spectrometry	29367674	0	O
(	29367674	0	O
LC	29367674	0	O
-	29367674	0	O
MS	29367674	0	O
/	29367674	0	O
MS	29367674	0	O
)	29367674	0	O
,	29367674	0	O
whereas	29367674	0	O
bi	29367674	0	O
-	29367674	0	O
allelic	29367674	0	O
indel	29367674	0	O
TRH	29367674	0	O
-	29367674	0	O
/	29367674	0	O
-	29367674	0	O
clones	29367674	0	O
showed	29367674	0	O
no	29367674	0	O
detectable	29367674	0	O
levels	29367674	0	O
of	29367674	0	O
serotonin	29367674	0	O
.	29367674	0	O
Life	29367674	0	O
history	29367674	0	O
and	29367674	0	O
behavioral	29367674	0	O
responses	29367674	0	O
of	29367674	0	O
TRH	29367674	0	O
-	29367674	0	O
/	29367674	0	O
-	29367674	0	O
clones	29367674	0	O
showed	29367674	0	O
the	29367674	0	O
anti	29367674	0	O
-	29367674	0	O
phenotype	29367674	0	O
of	29367674	0	O
those	29367674	0	O
exposed	29367674	0	O
to	29367674	0	O
selective	29367674	0	O
serotonin	29367674	0	O
reuptake	29367674	0	O
inhibitors	29367674	0	O
(	29367674	0	O
SSRI	29367674	0	O
)	29367674	0	O
.	29367674	0	O
Mutants	29367674	0	B-Var
lacking	29367674	0	B-NegReg
serotonin	29367674	0	O
grew	29367674	0	O
less	29367674	0	B-NegReg
and	29367674	0	O
hence	29367674	0	O
reproduced	29367674	0	O
latter	29367674	0	O
,	29367674	0	O
produced	29367674	0	O
smaller	29367674	0	B-NegReg
clutches	29367674	0	O
of	29367674	0	O
smaller	29367674	0	B-NegReg
offspring	29367674	0	O
and	29367674	0	O
responded	29367674	0	O
to	29367674	0	O
a	29367674	0	O
greater	29367674	0	O
extent	29367674	0	O
to	29367674	0	O
light	29367674	0	O
than	29367674	0	O
wild	29367674	0	O
type	29367674	0	O
individuals	29367674	0	O
.	29367674	0	O
Mono	29367674	0	O
-	29367674	0	O
allelic	29367674	0	O
indel	29367674	0	O
TRH	29367674	0	O
-	29367674	0	O
/	29367674	0	O
individuals	29367674	0	O
showed	29367674	0	O
the	29367674	0	O
intermediate	29367674	0	O
phenotype	29367674	0	O
.	29367674	0	O
The	29367674	0	O
SSRI	29367674	0	O
fluoxetine	29367674	0	O
enhanced	29367674	0	O
offspring	29367674	0	O
production	29367674	0	O
in	29367674	0	O
all	29367674	0	O
clones	29367674	0	O
and	29367674	0	O
decreased	29367674	0	O
the	29367674	0	O
response	29367674	0	O
to	29367674	0	O
light	29367674	0	O
only	29367674	0	O
in	29367674	0	O
those	29367674	0	O
clones	29367674	0	O
having	29367674	0	O
serotonin	29367674	0	O
,	29367674	0	O
thus	29367674	0	O
indication	29367674	0	O
that	29367674	0	O
behavioral	29367674	0	O
effects	29367674	0	O
of	29367674	0	O
this	29367674	0	O
drug	29367674	0	O
in	29367674	0	O
D.	29367674	0	O
magna	29367674	0	O
are	29367674	0	O
associated	29367674	0	O
to	29367674	0	O
serotonin	29367674	0	O
.	29367674	0	O
Results	29367674	0	O
obtained	29367674	0	O
with	29367674	0	O
the	29367674	0	O
TRH	29367674	0	O
mutants	29367674	0	O
are	29367674	0	O
in	29367674	0	O
line	29367674	0	O
with	29367674	0	O
reported	29367674	0	O
ones	29367674	0	O
in	29367674	0	O
TRH	29367674	0	O
knockouts	29367674	0	O
of	29367674	0	O
Caenorhabditis	29367674	0	O
elegans	29367674	0	O
,	29367674	0	O
Drosophila	29367674	0	O
and	29367674	0	O
mice	29367674	0	O
,	29367674	0	O
indicating	29367674	0	O
that	29367674	0	O
there	29367674	0	O
is	29367674	0	O
one	29367674	0	O
gene	29367674	0	O
encoding	29367674	0	O
TRH	29367674	0	O
,	29367674	0	O
which	29367674	0	O
is	29367674	0	O
the	29367674	0	O
serotonin	29367674	0	O
limiting	29367674	0	O
enzyme	29367674	0	O
in	29367674	0	O
both	29367674	0	O
the	29367674	0	O
central	29367674	0	O
and	29367674	0	O
the	29367674	0	O
periphery	29367674	0	O
nervous	29367674	0	O
system	29367674	0	O
in	29367674	0	O
Daphnia	29367674	0	O
and	29367674	0	O
that	29367674	0	O
deprivation	29367674	0	O
of	29367674	0	O
serotonin	29367674	0	O
increases	29367674	0	O
anxiety	29367674	0	O
-	29367674	0	O
like	29367674	0	O
behavior	29367674	0	O
.	29367674	0	O

Reversal	29373985	1	O
of	29373985	1	O
end	29373985	1	O
-	29373985	1	O
stage	29373985	1	O
heart	29373985	1	O
failure	29373985	1	O
in	29373985	1	O
juvenile	29373985	1	O
hemochromatosis	29373985	1	O
with	29373985	1	O
iron	29373985	1	O
chelation	29373985	1	O
therapy	29373985	1	O
:	29373985	1	O
a	29373985	1	O
case	29373985	1	O
report	29373985	1	O
.	29373985	1	O
BACKGROUND	29373985	1	O
:	29373985	1	O
Juvenile	29373985	1	O
hemochromatosis	29373985	1	O
is	29373985	1	O
the	29373985	1	O
most	29373985	1	O
severe	29373985	1	O
form	29373985	1	O
of	29373985	1	O
iron	29373985	1	O
overloading	29373985	1	O
phenotype	29373985	1	O
.	29373985	1	O
Although	29373985	1	O
rare	29373985	1	O
,	29373985	1	O
it	29373985	1	O
should	29373985	1	O
be	29373985	1	O
suspected	29373985	1	O
in	29373985	1	O
patients	29373985	1	O
who	29373985	1	O
present	29373985	1	O
with	29373985	1	O
hypogonadotropic	29373985	1	O
hypogonadism	29373985	1	O
,	29373985	1	O
diabetes	29373985	1	O
mellitus	29373985	1	O
,	29373985	1	O
or	29373985	1	O
cardiomyopathy	29373985	1	O
without	29373985	1	O
a	29373985	1	O
clear	29373985	1	O
cause	29373985	1	O
.	29373985	1	O
CASE	29373985	1	O
PRESENTATION	29373985	1	O
:	29373985	1	O
A	29373985	1	O
young	29373985	1	O
Serbian	29373985	1	O
male	29373985	1	O
presenting	29373985	1	O
with	29373985	1	O
end	29373985	1	O
-	29373985	1	O
stage	29373985	1	O
heart	29373985	1	O
failure	29373985	1	O
was	29373985	1	O
referred	29373985	1	O
for	29373985	1	O
extracorporeal	29373985	1	O
membrane	29373985	1	O
oxygenation	29373985	1	O
.	29373985	1	O
An	29373985	1	O
endomyocardial	29373985	1	O
biopsy	29373985	1	O
revealed	29373985	1	O
cytoplasmic	29373985	1	O
iron	29373985	1	O
deposits	29373985	1	O
in	29373985	1	O
myocytes	29373985	1	O
.	29373985	1	O
His	29373985	1	O
condition	29373985	1	O
was	29373985	1	O
stabilized	29373985	1	O
with	29373985	1	O
biventricular	29373985	1	O
assist	29373985	1	O
devices	29373985	1	O
and	29373985	1	O
he	29373985	1	O
was	29373985	1	O
listed	29373985	1	O
for	29373985	1	O
heart	29373985	1	O
transplantation	29373985	1	O
.	29373985	1	O
Iron	29373985	1	O
chelation	29373985	1	O
therapy	29373985	1	O
was	29373985	1	O
commenced	29373985	1	O
and	29373985	1	O
resulted	29373985	1	O
in	29373985	1	O
rapid	29373985	1	O
removal	29373985	1	O
of	29373985	1	O
iron	29373985	1	O
burden	29373985	1	O
.	29373985	1	O
Serial	29373985	1	O
outpatient	29373985	1	O
echocardiograms	29373985	1	O
demonstrated	29373985	1	O
myocardial	29373985	1	O
recovery	29373985	1	O
such	29373985	1	O
that	29373985	1	O
a	29373985	1	O
successful	29373985	1	O
biventricular	29373985	1	O
assist	29373985	1	O
device	29373985	1	O
explant	29373985	1	O
occurred	29373985	1	O
131	29373985	1	O
days	29373985	1	O
after	29373985	1	O
initial	29373985	1	O
implant	29373985	1	O
.	29373985	1	O
Targeted	29373985	1	O
gene	29373985	1	O
sequencing	29373985	1	O
revealed	29373985	1	O
a	29373985	1	O
loss	29373985	1	B-NegReg
-	29373985	1	I-NegReg
of	29373985	1	I-NegReg
-	29373985	1	I-NegReg
function	29373985	1	I-NegReg
mutation	29373985	1	B-Var
within	29373985	1	O
the	29373985	1	O
HJV	29373985	1	B-Gene
gene	29373985	1	O
,	29373985	1	O
which	29373985	1	O
is	29373985	1	O
consistent	29373985	1	O
with	29373985	1	O
juvenile	29373985	1	B-Disease
hemochromatosis	29373985	1	I-Disease
.	29373985	1	O
CONCLUSIONS	29373985	1	O
:	29373985	1	O
This	29373985	1	O
rare	29373985	1	O
case	29373985	1	O
of	29373985	1	O
a	29373985	1	O
patient	29373985	1	O
with	29373985	1	O
juvenile	29373985	1	B-Disease
hemochromatosis	29373985	1	I-Disease
associated	29373985	1	B-Reg
with	29373985	1	O
a	29373985	1	O
HJV	29373985	1	B-Gene
mutation	29373985	1	B-Var
provides	29373985	1	O
histologic	29373985	1	O
evidence	29373985	1	O
documenting	29373985	1	O
the	29373985	1	O
reversal	29373985	1	O
of	29373985	1	O
associated	29373985	1	O
end	29373985	1	O
-	29373985	1	O
stage	29373985	1	O
heart	29373985	1	O
failure	29373985	1	O
,	29373985	1	O
requiring	29373985	1	O
emergent	29373985	1	O
mechanical	29373985	1	O
circulatory	29373985	1	O
support	29373985	1	O
,	29373985	1	O
with	29373985	1	O
iron	29373985	1	O
chelation	29373985	1	O
therapy	29373985	1	O
.	29373985	1	O

MeCP2	29405930	4	O
as	29405930	4	O
an	29405930	4	O
Activator	29405930	4	O
of	29405930	4	O
Gene	29405930	4	O
Expression	29405930	4	O
.	29405930	4	O
Rett	29405930	4	B-Disease
syndrome	29405930	4	I-Disease
is	29405930	4	O
a	29405930	4	O
neurodevelopmental	29405930	4	O
disorder	29405930	4	O
that	29405930	4	O
primarily	29405930	4	O
affects	29405930	4	O
females	29405930	4	O
and	29405930	4	O
is	29405930	4	O
caused	29405930	4	B-Reg
by	29405930	4	I-Reg
mutations	29405930	4	B-Var
in	29405930	4	O
the	29405930	4	O
methyl	29405930	4	O
-	29405930	4	O
CpG	29405930	4	O
-	29405930	4	O
binding	29405930	4	O
-	29405930	4	O
protein	29405930	4	O
2	29405930	4	O
(	29405930	4	B-Gene
MECP2	29405930	4	I-Gene
)	29405930	4	I-Gene
gene	29405930	4	O
.	29405930	4	O
Initially	29405930	4	O
,	29405930	4	O
MeCP2	29405930	4	O
had	29405930	4	O
been	29405930	4	O
shown	29405930	4	O
to	29405930	4	O
be	29405930	4	O
a	29405930	4	O
repressor	29405930	4	O
of	29405930	4	O
gene	29405930	4	O
transcription	29405930	4	O
.	29405930	4	O
In	29405930	4	O
their	29405930	4	O
2008	29405930	4	O
paper	29405930	4	O
,	29405930	4	O
Chahrour	29405930	4	O
and	29405930	4	O
colleagues	29405930	4	O
(	29405930	4	O
DOI	29405930	4	O
:	29405930	4	O
10.1126	29405930	4	O
/	29405930	4	O
science.1153252	29405930	4	O
)	29405930	4	O
reported	29405930	4	O
that	29405930	4	O
MeCP2	29405930	4	O
could	29405930	4	O
also	29405930	4	O
function	29405930	4	O
as	29405930	4	O
a	29405930	4	O
transcriptional	29405930	4	O
activator	29405930	4	O
.	29405930	4	O

TRPV1	29424270	0	B-Gene
gain	29424270	0	B-PosReg
-	29424270	0	I-PosReg
of	29424270	0	I-PosReg
-	29424270	0	I-PosReg
function	29424270	0	I-PosReg
mutation	29424270	0	B-Var
impairs	29424270	0	B-NegReg
pain	29424270	0	O
and	29424270	0	O
itch	29424270	0	O
sensations	29424270	0	O
in	29424270	0	O
mice	29424270	0	O
.	29424270	0	O
Transient	29424270	0	O
receptor	29424270	0	O
potential	29424270	0	O
vanilloid	29424270	0	O
1	29424270	0	O
(	29424270	0	O
TRPV1	29424270	0	O
)	29424270	0	O
is	29424270	0	O
a	29424270	0	O
non	29424270	0	O
-	29424270	0	O
selective	29424270	0	O
cation	29424270	0	O
channel	29424270	0	O
,	29424270	0	O
which	29424270	0	O
can	29424270	0	O
detect	29424270	0	O
various	29424270	0	O
noxious	29424270	0	O
stimuli	29424270	0	O
that	29424270	0	O
cause	29424270	0	O
pain	29424270	0	O
,	29424270	0	O
inflammation	29424270	0	O
,	29424270	0	O
hyperalgesia	29424270	0	O
,	29424270	0	O
and	29424270	0	O
itch	29424270	0	O
.	29424270	0	O
TRPV1	29424270	0	O
knock	29424270	0	O
-	29424270	0	O
out	29424270	0	O
mice	29424270	0	O
show	29424270	0	O
deficiency	29424270	0	O
in	29424270	0	O
nociception	29424270	0	O
,	29424270	0	O
but	29424270	0	O
the	29424270	0	O
in	29424270	0	O
vivo	29424270	0	O
effects	29424270	0	O
of	29424270	0	O
persistent	29424270	0	O
activation	29424270	0	O
of	29424270	0	O
TRPV1	29424270	0	O
are	29424270	0	O
not	29424270	0	O
completely	29424270	0	O
understood	29424270	0	O
.	29424270	0	O
Here	29424270	0	O
,	29424270	0	O
we	29424270	0	O
generated	29424270	0	O
TRPV1	29424270	0	O
knock	29424270	0	O
-	29424270	0	O
in	29424270	0	O
mice	29424270	0	O
with	29424270	0	O
a	29424270	0	O
G564S	29424270	0	O
mutation	29424270	0	O
.	29424270	0	O
In	29424270	0	O
the	29424270	0	O
heterologous	29424270	0	O
expression	29424270	0	O
system	29424270	0	O
,	29424270	0	O
an	29424270	0	O
electrophysiological	29424270	0	O
study	29424270	0	O
showed	29424270	0	O
that	29424270	0	O
the	29424270	0	O
G564S	29424270	0	B-Var
mutation	29424270	0	I-Var
in	29424270	0	O
mouse	29424270	0	O
TRPV1	29424270	0	B-Gene
caused	29424270	0	O
increased	29424270	0	B-PosReg
basal	29424270	0	O
current	29424270	0	O
and	29424270	0	O
a	29424270	0	O
leftward	29424270	0	O
shift	29424270	0	O
of	29424270	0	O
voltage	29424270	0	O
dependence	29424270	0	O
.	29424270	0	O
Intriguingly	29424270	0	O
,	29424270	0	O
using	29424270	0	O
behavioral	29424270	0	O
analysis	29424270	0	O
,	29424270	0	O
we	29424270	0	O
found	29424270	0	O
that	29424270	0	O
knock	29424270	0	O
-	29424270	0	O
in	29424270	0	O
mice	29424270	0	O
showed	29424270	0	O
a	29424270	0	O
thermosensory	29424270	0	O
defect	29424270	0	B-NegReg
,	29424270	0	O
impaired	29424270	0	B-NegReg
inflammatory	29424270	0	O
thermal	29424270	0	O
pain	29424270	0	O
,	29424270	0	O
and	29424270	0	O
capsaicin	29424270	0	O
sensitivity	29424270	0	O
.	29424270	0	O
We	29424270	0	O
also	29424270	0	O
demonstrated	29424270	0	O
an	29424270	0	O
attenuated	29424270	0	O
behavioral	29424270	0	O
response	29424270	0	O
to	29424270	0	O
the	29424270	0	O
pruritic	29424270	0	O
agent	29424270	0	O
histamine	29424270	0	O
in	29424270	0	O
the	29424270	0	O
knock	29424270	0	O
-	29424270	0	O
in	29424270	0	O
mice	29424270	0	O
.	29424270	0	O
Indeed	29424270	0	O
,	29424270	0	O
calcium	29424270	0	O
imaging	29424270	0	O
together	29424270	0	O
with	29424270	0	O
electrophysiology	29424270	0	O
showed	29424270	0	O
that	29424270	0	O
the	29424270	0	O
overactive	29424270	0	O
mutant	29424270	0	O
had	29424270	0	O
decreased	29424270	0	O
capsaicin	29424270	0	O
sensitivity	29424270	0	O
.	29424270	0	O
Western	29424270	0	O
blot	29424270	0	O
analysis	29424270	0	O
revealed	29424270	0	O
that	29424270	0	O
the	29424270	0	O
G564S	29424270	0	B-Var
mutant	29424270	0	I-Var
reduced	29424270	0	B-NegReg
TRPV1	29424270	0	O
phosphorylation	29424270	0	O
and	29424270	0	O
cell	29424270	0	O
membrane	29424270	0	O
trafficking	29424270	0	O
.	29424270	0	O
Together	29424270	0	O
,	29424270	0	O
we	29424270	0	O
have	29424270	0	O
generated	29424270	0	O
a	29424270	0	O
mouse	29424270	0	O
model	29424270	0	O
with	29424270	0	O
a	29424270	0	O
gain	29424270	0	B-PosReg
-	29424270	0	I-PosReg
of	29424270	0	I-PosReg
-	29424270	0	I-PosReg
function	29424270	0	I-PosReg
mutation	29424270	0	B-Var
in	29424270	0	O
Trpv1	29424270	0	B-Gene
gene	29424270	0	O
and	29424270	0	O
demonstrated	29424270	0	O
that	29424270	0	O
the	29424270	0	O
pain	29424270	0	O
and	29424270	0	O
histamine	29424270	0	O
-	29424270	0	O
dependent	29424270	0	O
itch	29424270	0	O
sensations	29424270	0	O
in	29424270	0	O
these	29424270	0	O
mice	29424270	0	O
are	29424270	0	O
impaired	29424270	0	B-NegReg
due	29424270	0	O
to	29424270	0	O
a	29424270	0	O
decreased	29424270	0	B-NegReg
phosphorylation	29424270	0	O
level	29424270	0	O
and	29424270	0	O
reduced	29424270	0	B-NegReg
membrane	29424270	0	O
localization	29424270	0	O
of	29424270	0	O
TRPV1	29424270	0	O
.	29424270	0	O

Loss	29429573	1	B-NegReg
-	29429573	1	I-NegReg
of	29429573	1	I-NegReg
-	29429573	1	I-NegReg
Function	29429573	1	I-NegReg
Mutations	29429573	1	B-Var
in	29429573	1	O
UNC45A	29429573	1	B-Gene
Cause	29429573	1	O
a	29429573	1	O
Syndrome	29429573	1	B-Disease
Associating	29429573	1	O
Cholestasis	29429573	1	B-Disease
,	29429573	1	O
Diarrhea	29429573	1	B-Disease
,	29429573	1	O
Impaired	29429573	1	B-Disease
Hearing	29429573	1	I-Disease
,	29429573	1	O
and	29429573	1	O
Bone	29429573	1	B-Disease
Fragility	29429573	1	I-Disease
.	29429573	1	O
Despite	29429573	1	O
the	29429573	1	O
rapid	29429573	1	O
discovery	29429573	1	O
of	29429573	1	O
genes	29429573	1	O
for	29429573	1	O
rare	29429573	1	O
genetic	29429573	1	O
disorders	29429573	1	O
,	29429573	1	O
we	29429573	1	O
continue	29429573	1	O
to	29429573	1	O
encounter	29429573	1	O
individuals	29429573	1	O
presenting	29429573	1	O
with	29429573	1	O
syndromic	29429573	1	O
manifestations	29429573	1	O
.	29429573	1	O
Here	29429573	1	O
,	29429573	1	O
we	29429573	1	O
have	29429573	1	O
studied	29429573	1	O
four	29429573	1	O
affected	29429573	1	O
people	29429573	1	O
in	29429573	1	O
three	29429573	1	O
families	29429573	1	O
presenting	29429573	1	O
with	29429573	1	O
cholestasis	29429573	1	B-Disease
,	29429573	1	O
congenital	29429573	1	B-Disease
diarrhea	29429573	1	I-Disease
,	29429573	1	O
impaired	29429573	1	B-Disease
hearing	29429573	1	I-Disease
,	29429573	1	O
and	29429573	1	O
bone	29429573	1	B-Disease
fragility	29429573	1	I-Disease
.	29429573	1	O
Whole	29429573	1	O
-	29429573	1	O
exome	29429573	1	O
sequencing	29429573	1	O
of	29429573	1	O
all	29429573	1	O
affected	29429573	1	O
individuals	29429573	1	O
and	29429573	1	O
their	29429573	1	O
parents	29429573	1	O
identified	29429573	1	O
biallelic	29429573	1	B-Var
mutations	29429573	1	I-Var
in	29429573	1	O
Unc-45	29429573	1	O
Myosin	29429573	1	O
Chaperone	29429573	1	O
A	29429573	1	O
(	29429573	1	B-Gene
UNC45A	29429573	1	I-Gene
)	29429573	1	I-Gene
as	29429573	1	O
a	29429573	1	O
likely	29429573	1	O
driver	29429573	1	O
for	29429573	1	O
this	29429573	1	O
disorder	29429573	1	O
.	29429573	1	O
Subsequent	29429573	1	O
in	29429573	1	O
vitro	29429573	1	O
and	29429573	1	O
in	29429573	1	O
vivo	29429573	1	O
functional	29429573	1	O
studies	29429573	1	O
of	29429573	1	O
the	29429573	1	O
candidate	29429573	1	O
gene	29429573	1	O
indicated	29429573	1	O
a	29429573	1	O
loss	29429573	1	B-NegReg
-	29429573	1	I-NegReg
of	29429573	1	I-NegReg
-	29429573	1	I-NegReg
function	29429573	1	I-NegReg
paradigm	29429573	1	O
,	29429573	1	O
wherein	29429573	1	O
mutations	29429573	1	O
attenuated	29429573	1	B-NegReg
or	29429573	1	O
abolished	29429573	1	B-NegReg
protein	29429573	1	O
activity	29429573	1	O
with	29429573	1	O
concomitant	29429573	1	O
defects	29429573	1	B-NegReg
in	29429573	1	O
gut	29429573	1	O
development	29429573	1	O
and	29429573	1	O
function	29429573	1	O
.	29429573	1	O

Genetic	29440357	0	O
Suppression	29440357	0	O
of	29440357	0	O
Basement	29440357	0	O
Membrane	29440357	0	O
Defects	29440357	0	O
in	29440357	0	O
Caenorhabditis	29440357	0	O
elegans	29440357	0	O
by	29440357	0	O
Gain	29440357	0	O
of	29440357	0	O
Function	29440357	0	O
in	29440357	0	O
Extracellular	29440357	0	O
Matrix	29440357	0	O
and	29440357	0	O
Cell	29440357	0	O
-	29440357	0	O
Matrix	29440357	0	O
Attachment	29440357	0	O
Genes	29440357	0	O
.	29440357	0	O
Basement	29440357	0	O
membranes	29440357	0	O
are	29440357	0	O
extracellular	29440357	0	O
matrices	29440357	0	O
essential	29440357	0	O
for	29440357	0	O
embryonic	29440357	0	O
development	29440357	0	O
in	29440357	0	O
animals	29440357	0	O
.	29440357	0	O
Peroxidasins	29440357	0	O
are	29440357	0	O
extracellular	29440357	0	O
peroxidases	29440357	0	O
implicated	29440357	0	O
in	29440357	0	O
the	29440357	0	O
unique	29440357	0	O
sulfilimine	29440357	0	O
cross	29440357	0	O
-	29440357	0	O
links	29440357	0	O
between	29440357	0	O
type	29440357	0	O
IV	29440357	0	O
basement	29440357	0	O
membrane	29440357	0	O
collagens	29440357	0	O
.	29440357	0	O
Loss	29440357	0	B-NegReg
of	29440357	0	I-NegReg
function	29440357	0	I-NegReg
in	29440357	0	O
the	29440357	0	O
Caenorhabditis	29440357	0	O
elegans	29440357	0	O
peroxidasin	29440357	0	O
PXN-2	29440357	0	O
results	29440357	0	O
in	29440357	0	O
fully	29440357	0	O
penetrant	29440357	0	O
embryonic	29440357	0	O
or	29440357	0	O
larval	29440357	0	O
lethality	29440357	0	O
.	29440357	0	O
Using	29440357	0	O
genetic	29440357	0	O
suppressor	29440357	0	O
screening	29440357	0	O
,	29440357	0	O
we	29440357	0	O
find	29440357	0	O
that	29440357	0	O
the	29440357	0	O
requirement	29440357	0	O
for	29440357	0	O
PXN-2	29440357	0	O
in	29440357	0	O
development	29440357	0	O
can	29440357	0	O
be	29440357	0	O
bypassed	29440357	0	O
by	29440357	0	O
gain	29440357	0	O
of	29440357	0	O
function	29440357	0	O
in	29440357	0	O
multiple	29440357	0	O
genes	29440357	0	O
encoding	29440357	0	O
other	29440357	0	O
basement	29440357	0	O
membrane	29440357	0	O
components	29440357	0	O
,	29440357	0	O
or	29440357	0	O
proteins	29440357	0	O
implicated	29440357	0	O
in	29440357	0	O
cell	29440357	0	O
-	29440357	0	O
matrix	29440357	0	O
attachment	29440357	0	O
.	29440357	0	O
We	29440357	0	O
identify	29440357	0	O
multiple	29440357	0	O
alleles	29440357	0	O
of	29440357	0	O
let-805	29440357	0	O
,	29440357	0	O
encoding	29440357	0	O
the	29440357	0	O
transmembrane	29440357	0	O
protein	29440357	0	O
myotactin	29440357	0	O
,	29440357	0	O
which	29440357	0	O
suppress	29440357	0	O
phenotypes	29440357	0	O
of	29440357	0	O
pxn-2	29440357	0	O
null	29440357	0	O
mutants	29440357	0	O
and	29440357	0	O
of	29440357	0	O
other	29440357	0	O
basement	29440357	0	O
membrane	29440357	0	O
mutants	29440357	0	O
such	29440357	0	O
as	29440357	0	O
F	29440357	0	O
-	29440357	0	O
spondin	29440357	0	O
/	29440357	0	O
spon-1	29440357	0	O
These	29440357	0	O
let-805	29440357	0	O
suppressor	29440357	0	O
alleles	29440357	0	O
cause	29440357	0	O
missense	29440357	0	O
alterations	29440357	0	O
in	29440357	0	O
two	29440357	0	O
pairs	29440357	0	O
of	29440357	0	O
FNIII	29440357	0	O
repeats	29440357	0	O
in	29440357	0	O
the	29440357	0	O
extracellular	29440357	0	O
domain	29440357	0	O
;	29440357	0	O
they	29440357	0	O
act	29440357	0	O
dominantly	29440357	0	O
and	29440357	0	O
have	29440357	0	O
no	29440357	0	O
detectable	29440357	0	O
phenotypes	29440357	0	O
alone	29440357	0	O
,	29440357	0	O
suggesting	29440357	0	O
they	29440357	0	O
cause	29440357	0	O
gain	29440357	0	O
of	29440357	0	O
function	29440357	0	O
.	29440357	0	O
We	29440357	0	O
also	29440357	0	O
identify	29440357	0	O
suppressor	29440357	0	O
missense	29440357	0	O
mutations	29440357	0	O
affecting	29440357	0	O
basement	29440357	0	O
membrane	29440357	0	O
components	29440357	0	O
type	29440357	0	O
IV	29440357	0	O
collagen	29440357	0	O
(	29440357	0	O
emb-9	29440357	0	O
,	29440357	0	O
let-2	29440357	0	O
)	29440357	0	O
and	29440357	0	O
perlecan	29440357	0	O
(	29440357	0	O
unc-52	29440357	0	O
)	29440357	0	O
,	29440357	0	O
as	29440357	0	O
well	29440357	0	O
as	29440357	0	O
a	29440357	0	O
mutation	29440357	0	O
affecting	29440357	0	O
spectraplakin	29440357	0	O
(	29440357	0	O
vab-10	29440357	0	O
)	29440357	0	O
,	29440357	0	O
a	29440357	0	O
component	29440357	0	O
of	29440357	0	O
the	29440357	0	O
epidermal	29440357	0	O
cytoskeleton	29440357	0	O
.	29440357	0	O
These	29440357	0	O
suppressor	29440357	0	O
alleles	29440357	0	O
do	29440357	0	O
not	29440357	0	O
bypass	29440357	0	O
the	29440357	0	O
developmental	29440357	0	O
requirement	29440357	0	O
for	29440357	0	O
core	29440357	0	O
structural	29440357	0	O
proteins	29440357	0	O
of	29440357	0	O
the	29440357	0	O
basement	29440357	0	O
membrane	29440357	0	O
such	29440357	0	O
as	29440357	0	O
laminin	29440357	0	O
or	29440357	0	O
type	29440357	0	O
IV	29440357	0	O
collagen	29440357	0	O
.	29440357	0	O
In	29440357	0	O
conclusion	29440357	0	O
,	29440357	0	O
putative	29440357	0	O
gain	29440357	0	O
-	29440357	0	O
of	29440357	0	O
-	29440357	0	O
function	29440357	0	O
alterations	29440357	0	O
in	29440357	0	O
matrix	29440357	0	O
proteins	29440357	0	O
or	29440357	0	O
in	29440357	0	O
cell	29440357	0	O
-	29440357	0	O
matrix	29440357	0	O
receptors	29440357	0	O
can	29440357	0	O
overcome	29440357	0	O
the	29440357	0	O
requirement	29440357	0	O
for	29440357	0	O
certain	29440357	0	O
basement	29440357	0	O
membrane	29440357	0	O
proteins	29440357	0	O
in	29440357	0	O
embryonic	29440357	0	O
development	29440357	0	O
,	29440357	0	O
revealing	29440357	0	O
previously	29440357	0	O
unknown	29440357	0	O
plasticity	29440357	0	O
in	29440357	0	O
the	29440357	0	O
genetic	29440357	0	O
requirements	29440357	0	O
for	29440357	0	O
the	29440357	0	O
extracellular	29440357	0	O
matrix	29440357	0	O
.	29440357	0	O

Bi	29449721	1	B-Var
-	29449721	1	I-Var
allelic	29449721	1	I-Var
inactivating	29449721	1	I-Var
variants	29449721	1	I-Var
in	29449721	1	O
the	29449721	1	O
COCH	29449721	1	B-Gene
gene	29449721	1	O
cause	29449721	1	B-Reg
autosomal	29449721	1	B-Disease
recessive	29449721	1	I-Disease
prelingual	29449721	1	I-Disease
hearing	29449721	1	I-Disease
impairment	29449721	1	I-Disease
.	29449721	1	O
Pathogenic	29449721	1	O
variant	29449721	1	O
in	29449721	1	O
COCH	29449721	1	O
are	29449721	1	O
a	29449721	1	O
known	29449721	1	O
cause	29449721	1	O
of	29449721	1	O
DFNA9	29449721	1	O
autosomal	29449721	1	O
dominant	29449721	1	O
progressive	29449721	1	O
hearing	29449721	1	O
loss	29449721	1	O
and	29449721	1	O
vestibular	29449721	1	O
dysfunction	29449721	1	O
with	29449721	1	O
adult	29449721	1	O
onset	29449721	1	O
.	29449721	1	O
Hitherto	29449721	1	O
,	29449721	1	O
only	29449721	1	O
dominant	29449721	1	O
nonsynonymous	29449721	1	O
variants	29449721	1	O
and	29449721	1	O
in	29449721	1	O
-	29449721	1	O
frame	29449721	1	O
deletions	29449721	1	O
with	29449721	1	O
a	29449721	1	O
presumed	29449721	1	O
dominant	29449721	1	O
negative	29449721	1	O
or	29449721	1	O
gain	29449721	1	O
-	29449721	1	O
of	29449721	1	O
-	29449721	1	O
function	29449721	1	O
effect	29449721	1	O
have	29449721	1	O
been	29449721	1	O
described	29449721	1	O
.	29449721	1	O
Here	29449721	1	O
,	29449721	1	O
we	29449721	1	O
describe	29449721	1	O
two	29449721	1	O
brothers	29449721	1	O
with	29449721	1	O
congenital	29449721	1	O
prelingual	29449721	1	O
deafness	29449721	1	O
and	29449721	1	O
a	29449721	1	O
homozygous	29449721	1	O
nonsense	29449721	1	O
c.292	29449721	1	B-Var
C	29449721	1	I-Var
>	29449721	1	I-Var
T	29449721	1	I-Var
(	29449721	1	I-Var
p.Arg98*	29449721	1	I-Var
)	29449721	1	I-Var
COCH	29449721	1	B-Gene
variant	29449721	1	O
,	29449721	1	O
suggesting	29449721	1	O
a	29449721	1	O
loss	29449721	1	B-NegReg
-	29449721	1	I-NegReg
of	29449721	1	I-NegReg
-	29449721	1	I-NegReg
function	29449721	1	I-NegReg
effect	29449721	1	O
.	29449721	1	O
Vestibular	29449721	1	B-Disease
dysfunction	29449721	1	I-Disease
starting	29449721	1	O
in	29449721	1	O
the	29449721	1	O
first	29449721	1	O
decade	29449721	1	O
was	29449721	1	O
observed	29449721	1	O
in	29449721	1	O
the	29449721	1	O
older	29449721	1	O
patient	29449721	1	O
.	29449721	1	O
The	29449721	1	O
heterozygous	29449721	1	O
parents	29449721	1	O
and	29449721	1	O
sibling	29449721	1	O
have	29449721	1	O
normal	29449721	1	O
hearing	29449721	1	O
and	29449721	1	O
vestibular	29449721	1	O
function	29449721	1	O
,	29449721	1	O
except	29449721	1	O
for	29449721	1	O
the	29449721	1	O
mother	29449721	1	O
,	29449721	1	O
who	29449721	1	O
shows	29449721	1	O
vestibular	29449721	1	O
hyporeflexia	29449721	1	O
and	29449721	1	O
abnormal	29449721	1	O
smooth	29449721	1	O
pursuit	29449721	1	O
tests	29449721	1	O
,	29449721	1	O
most	29449721	1	O
likely	29449721	1	O
due	29449721	1	O
to	29449721	1	O
concomitant	29449721	1	O
disease	29449721	1	O
.	29449721	1	O
This	29449721	1	O
is	29449721	1	O
the	29449721	1	O
first	29449721	1	O
report	29449721	1	O
of	29449721	1	O
autosomal	29449721	1	O
recessive	29449721	1	O
inheritance	29449721	1	O
of	29449721	1	O
cochlea	29449721	1	O
-	29449721	1	O
vestibular	29449721	1	O
dysfunction	29449721	1	O
caused	29449721	1	O
by	29449721	1	O
a	29449721	1	O
pathogenic	29449721	1	O
variant	29449721	1	O
in	29449721	1	O
the	29449721	1	O
COCH	29449721	1	O
gene	29449721	1	O
.	29449721	1	O
An	29449721	1	O
earlier	29449721	1	O
onset	29449721	1	O
of	29449721	1	O
hearing	29449721	1	O
impairment	29449721	1	O
and	29449721	1	O
vestibular	29449721	1	O
dysfunction	29449721	1	O
compared	29449721	1	O
to	29449721	1	O
the	29449721	1	O
dominant	29449721	1	O
hearing	29449721	1	O
loss	29449721	1	O
causing	29449721	1	O
COCH	29449721	1	O
variants	29449721	1	O
is	29449721	1	O
observed	29449721	1	O
.	29449721	1	O

Serum	29452565	0	O
vitamin	29452565	0	O
C	29452565	0	O
levels	29452565	0	O
modulate	29452565	0	O
the	29452565	0	O
lifespan	29452565	0	O
and	29452565	0	O
endoplasmic	29452565	0	O
reticulum	29452565	0	O
stress	29452565	0	O
response	29452565	0	O
pathways	29452565	0	O
in	29452565	0	O
mice	29452565	0	O
synthesizing	29452565	0	O
a	29452565	0	O
nonfunctional	29452565	0	O
mutant	29452565	0	O
WRN	29452565	0	O
protein	29452565	0	O
.	29452565	0	O
Werner	29452565	0	B-Disease
syndrome	29452565	0	I-Disease
(	29452565	0	O
WS	29452565	0	O
)	29452565	0	O
is	29452565	0	O
a	29452565	0	O
premature	29452565	0	O
aging	29452565	0	O
disorder	29452565	0	O
caused	29452565	0	B-Reg
by	29452565	0	I-Reg
mutations	29452565	0	B-Var
in	29452565	0	O
a	29452565	0	O
RecQ	29452565	0	O
-	29452565	0	O
family	29452565	0	O
DNA	29452565	0	O
helicase	29452565	0	O
(	29452565	0	O
WRN	29452565	0	O
)	29452565	0	O
.	29452565	0	O
Mice	29452565	0	O
lacking	29452565	0	O
part	29452565	0	O
of	29452565	0	O
the	29452565	0	O
helicase	29452565	0	O
domain	29452565	0	O
of	29452565	0	O
the	29452565	0	O
WRN	29452565	0	O
ortholog	29452565	0	O
exhibit	29452565	0	O
several	29452565	0	O
phenotypic	29452565	0	O
features	29452565	0	O
of	29452565	0	O
WS	29452565	0	O
.	29452565	0	O
In	29452565	0	O
this	29452565	0	O
study	29452565	0	O
,	29452565	0	O
we	29452565	0	O
generated	29452565	0	O
a	29452565	0	O
Wrn	29452565	0	O
mutant	29452565	0	O
line	29452565	0	O
that	29452565	0	O
,	29452565	0	O
like	29452565	0	O
humans	29452565	0	O
,	29452565	0	O
relies	29452565	0	O
entirely	29452565	0	O
on	29452565	0	O
dietary	29452565	0	O
sources	29452565	0	O
of	29452565	0	O
vitamin	29452565	0	O
C	29452565	0	O
(	29452565	0	O
ascorbate	29452565	0	O
)	29452565	0	O
to	29452565	0	O
survive	29452565	0	O
,	29452565	0	O
by	29452565	0	O
crossing	29452565	0	O
them	29452565	0	O
to	29452565	0	O
mice	29452565	0	O
that	29452565	0	O
lack	29452565	0	O
the	29452565	0	O
gulonolactone	29452565	0	O
oxidase	29452565	0	O
enzyme	29452565	0	O
required	29452565	0	O
for	29452565	0	O
ascorbate	29452565	0	O
synthesis	29452565	0	O
.	29452565	0	O
In	29452565	0	O
the	29452565	0	O
presence	29452565	0	O
of	29452565	0	O
0.01%	29452565	0	O
ascorbate	29452565	0	O
(	29452565	0	O
w	29452565	0	O
/	29452565	0	O
v	29452565	0	O
)	29452565	0	O
in	29452565	0	O
drinking	29452565	0	O
water	29452565	0	O
,	29452565	0	O
double	29452565	0	O
-	29452565	0	O
mutant	29452565	0	O
mice	29452565	0	O
exhibited	29452565	0	O
a	29452565	0	O
severe	29452565	0	O
reduction	29452565	0	O
in	29452565	0	O
lifespan	29452565	0	O
,	29452565	0	O
small	29452565	0	O
size	29452565	0	O
,	29452565	0	O
sterility	29452565	0	O
,	29452565	0	O
osteopenia	29452565	0	O
,	29452565	0	O
and	29452565	0	O
metabolic	29452565	0	O
profiles	29452565	0	O
different	29452565	0	O
from	29452565	0	O
wild	29452565	0	O
-	29452565	0	O
type	29452565	0	O
(	29452565	0	O
WT	29452565	0	O
)	29452565	0	O
mice	29452565	0	O
.	29452565	0	O
Although	29452565	0	O
increasing	29452565	0	O
the	29452565	0	O
dose	29452565	0	O
of	29452565	0	O
ascorbate	29452565	0	O
to	29452565	0	O
0.4%	29452565	0	O
improved	29452565	0	O
dramatically	29452565	0	O
the	29452565	0	O
phenotypes	29452565	0	O
of	29452565	0	O
double	29452565	0	O
-	29452565	0	O
mutant	29452565	0	O
mice	29452565	0	O
,	29452565	0	O
the	29452565	0	O
metabolic	29452565	0	O
and	29452565	0	O
cytokine	29452565	0	O
profiles	29452565	0	O
were	29452565	0	O
different	29452565	0	O
from	29452565	0	O
age	29452565	0	O
-	29452565	0	O
matched	29452565	0	O
WT	29452565	0	O
mice	29452565	0	O
.	29452565	0	O
Finally	29452565	0	O
,	29452565	0	O
double	29452565	0	O
-	29452565	0	O
mutant	29452565	0	O
mice	29452565	0	O
treated	29452565	0	O
with	29452565	0	O
0.01%	29452565	0	O
ascorbate	29452565	0	O
revealed	29452565	0	O
a	29452565	0	O
permanent	29452565	0	O
activation	29452565	0	O
of	29452565	0	O
all	29452565	0	O
the	29452565	0	O
3	29452565	0	O
branches	29452565	0	O
of	29452565	0	O
the	29452565	0	O
ER	29452565	0	O
stress	29452565	0	O
response	29452565	0	O
pathways	29452565	0	O
due	29452565	0	O
to	29452565	0	O
a	29452565	0	O
severe	29452565	0	O
chronic	29452565	0	O
oxidative	29452565	0	O
stress	29452565	0	O
in	29452565	0	O
the	29452565	0	O
ER	29452565	0	O
compartment	29452565	0	O
.	29452565	0	O
In	29452565	0	O
addition	29452565	0	O
,	29452565	0	O
markers	29452565	0	O
associated	29452565	0	O
with	29452565	0	O
the	29452565	0	O
ubiquitin	29452565	0	O
-	29452565	0	O
proteasome	29452565	0	O
-	29452565	0	O
dependent	29452565	0	O
ER	29452565	0	O
-	29452565	0	O
associated	29452565	0	O
degradation	29452565	0	O
pathway	29452565	0	O
were	29452565	0	O
increased	29452565	0	O
.	29452565	0	O
Augmenting	29452565	0	O
the	29452565	0	O
dose	29452565	0	O
of	29452565	0	O
ascorbate	29452565	0	O
reversed	29452565	0	O
the	29452565	0	O
activation	29452565	0	O
of	29452565	0	O
this	29452565	0	O
pathway	29452565	0	O
to	29452565	0	O
WT	29452565	0	O
levels	29452565	0	O
rendering	29452565	0	O
this	29452565	0	O
pathway	29452565	0	O
a	29452565	0	O
potential	29452565	0	O
therapeutic	29452565	0	O
target	29452565	0	O
in	29452565	0	O
WS	29452565	0	O
.	29452565	0	O
-	29452565	0	O
Aumailley	29452565	0	O
,	29452565	0	O
L.	29452565	0	O
,	29452565	0	O
Dubois	29452565	0	O
,	29452565	0	O
M.	29452565	0	O
J.	29452565	0	O
,	29452565	0	O
Brennan	29452565	0	O
,	29452565	0	O
T.	29452565	0	O
A.	29452565	0	O
,	29452565	0	O
Garand	29452565	0	O
,	29452565	0	O
C.	29452565	0	O
,	29452565	0	O
Paquet	29452565	0	O
,	29452565	0	O
E.	29452565	0	O
R.	29452565	0	O
,	29452565	0	O
Pignolo	29452565	0	O
,	29452565	0	O
R.	29452565	0	O
J.	29452565	0	O
,	29452565	0	O
Marette	29452565	0	O
,	29452565	0	O
A.	29452565	0	O
,	29452565	0	O
Lebel	29452565	0	O
,	29452565	0	O
M.	29452565	0	O
Serum	29452565	0	O
vitamin	29452565	0	O
C	29452565	0	O
levels	29452565	0	O
modulate	29452565	0	O
the	29452565	0	O
lifespan	29452565	0	O
and	29452565	0	O
endoplasmic	29452565	0	O
reticulum	29452565	0	O
stress	29452565	0	O
response	29452565	0	O
pathways	29452565	0	O
in	29452565	0	O
mice	29452565	0	O
synthesizing	29452565	0	O
a	29452565	0	O
nonfunctional	29452565	0	O
mutant	29452565	0	O
WRN	29452565	0	O
protein	29452565	0	O
.	29452565	0	O

CgPDR1	29464833	0	B-Gene
gain	29464833	0	B-PosReg
-	29464833	0	I-PosReg
of	29464833	0	I-PosReg
-	29464833	0	I-PosReg
function	29464833	0	I-PosReg
mutations	29464833	0	B-Var
lead	29464833	0	B-Reg
to	29464833	0	I-Reg
azole	29464833	0	O
-	29464833	0	O
resistance	29464833	0	O
and	29464833	0	O
increased	29464833	0	B-PosReg
adhesion	29464833	0	O
in	29464833	0	O
clinical	29464833	0	O
Candida	29464833	0	O
glabrata	29464833	0	O
strains	29464833	0	O
.	29464833	0	O
Recently	29464833	0	O
,	29464833	0	O
Candida	29464833	0	O
glabrata	29464833	0	O
has	29464833	0	O
emerged	29464833	0	O
as	29464833	0	O
a	29464833	0	O
health	29464833	0	O
-	29464833	0	O
threatening	29464833	0	O
pathogen	29464833	0	O
and	29464833	0	O
the	29464833	0	O
rising	29464833	0	O
resistance	29464833	0	O
to	29464833	0	O
antifungal	29464833	0	O
agent	29464833	0	O
in	29464833	0	O
C.	29464833	0	O
glabrata	29464833	0	O
often	29464833	0	O
leads	29464833	0	O
to	29464833	0	O
clinical	29464833	0	O
treatment	29464833	0	O
failure	29464833	0	O
.	29464833	0	O
To	29464833	0	O
investigate	29464833	0	O
the	29464833	0	O
evolution	29464833	0	O
of	29464833	0	O
drug	29464833	0	O
resistance	29464833	0	O
and	29464833	0	O
adherence	29464833	0	O
ability	29464833	0	O
in	29464833	0	O
four	29464833	0	O
paired	29464833	0	O
clinical	29464833	0	O
isolates	29464833	0	O
collected	29464833	0	O
before	29464833	0	O
and	29464833	0	O
after	29464833	0	O
antifungal	29464833	0	O
treatment	29464833	0	O
.	29464833	0	O
Sequence	29464833	0	O
analysis	29464833	0	O
,	29464833	0	O
gene	29464833	0	O
disruption	29464833	0	O
,	29464833	0	O
drug	29464833	0	O
-	29464833	0	O
susceptibility	29464833	0	O
,	29464833	0	O
adhesion	29464833	0	O
tests	29464833	0	O
and	29464833	0	O
real	29464833	0	O
-	29464833	0	O
time	29464833	0	O
quantitative	29464833	0	O
PCR	29464833	0	O
were	29464833	0	O
performed	29464833	0	O
.	29464833	0	O
The	29464833	0	O
azole	29464833	0	O
-	29464833	0	O
susceptible	29464833	0	O
strains	29464833	0	O
acquired	29464833	0	O
azole	29464833	0	O
resistance	29464833	0	O
after	29464833	0	O
antifungal	29464833	0	O
therapy	29464833	0	O
.	29464833	0	O
Four	29464833	0	O
gain	29464833	0	O
-	29464833	0	O
of	29464833	0	O
-	29464833	0	O
function	29464833	0	O
(	29464833	0	O
GOF	29464833	0	O
)	29464833	0	O
mutations	29464833	0	O
in	29464833	0	O
CgPDR1	29464833	0	O
were	29464833	0	O
revealed	29464833	0	O
by	29464833	0	O
sequence	29464833	0	O
analysis	29464833	0	O
,	29464833	0	O
namely	29464833	0	O
G1099D	29464833	0	O
,	29464833	0	O
G346D	29464833	0	O
,	29464833	0	O
L344S	29464833	0	O
and	29464833	0	O
P927S	29464833	0	O
,	29464833	0	O
the	29464833	0	O
last	29464833	0	O
being	29464833	0	O
reported	29464833	0	O
for	29464833	0	O
the	29464833	0	O
first	29464833	0	O
time	29464833	0	O
.	29464833	0	O
CDR1	29464833	0	O
,	29464833	0	O
CDR2	29464833	0	O
and	29464833	0	O
SNQ2	29464833	0	O
efflux	29464833	0	O
pump	29464833	0	O
gene	29464833	0	O
expression	29464833	0	O
levels	29464833	0	O
were	29464833	0	O
elevated	29464833	0	B-PosReg
in	29464833	0	O
strains	29464833	0	O
harbouring	29464833	0	O
GOF	29464833	0	B-PosReg
mutations	29464833	0	B-Var
in	29464833	0	O
CgPDR1	29464833	0	B-Gene
,	29464833	0	O
resulting	29464833	0	O
in	29464833	0	O
decreased	29464833	0	B-NegReg
azole	29464833	0	O
susceptibility	29464833	0	O
.	29464833	0	O
CgPDR1	29464833	0	O
alleles	29464833	0	O
with	29464833	0	O
distinct	29464833	0	O
GOF	29464833	0	O
mutations	29464833	0	O
displayed	29464833	0	O
different	29464833	0	O
expression	29464833	0	O
profiles	29464833	0	O
for	29464833	0	O
the	29464833	0	O
drug	29464833	0	O
-	29464833	0	O
related	29464833	0	O
genes	29464833	0	O
.	29464833	0	O
CgPDR1GOF	29464833	0	B-PosReg
mutations	29464833	0	B-Var
led	29464833	0	O
to	29464833	0	O
increased	29464833	0	B-PosReg
efflux	29464833	0	O
pumps	29464833	0	O
expression	29464833	0	O
levels	29464833	0	O
in	29464833	0	O
a	29464833	0	O
strain	29464833	0	O
background	29464833	0	O
independent	29464833	0	O
way	29464833	0	O
.	29464833	0	O
Hyperactive	29464833	0	O
Pdr1G1099D	29464833	0	O
and	29464833	0	O
Pdr1P927S	29464833	0	O
displayed	29464833	0	O
strain	29464833	0	O
background	29464833	0	O
-	29464833	0	O
dependent	29464833	0	O
increased	29464833	0	O
adherence	29464833	0	O
to	29464833	0	O
host	29464833	0	O
cells	29464833	0	O
via	29464833	0	O
upregulation	29464833	0	O
of	29464833	0	O
EPA1	29464833	0	O
transcription	29464833	0	O
.	29464833	0	O
Interestingly	29464833	0	O
,	29464833	0	O
the	29464833	0	O
drug	29464833	0	O
transporter	29464833	0	O
gene	29464833	0	O
expression	29464833	0	O
levels	29464833	0	O
did	29464833	0	O
not	29464833	0	O
always	29464833	0	O
correspond	29464833	0	O
with	29464833	0	O
that	29464833	0	O
of	29464833	0	O
the	29464833	0	O
adhesin	29464833	0	O
EPA1	29464833	0	O
gene	29464833	0	O
.	29464833	0	O
GOF	29464833	0	B-PosReg
mutations	29464833	0	B-Var
in	29464833	0	O
CgPDR1	29464833	0	B-Gene
conferred	29464833	0	B-Reg
drug	29464833	0	O
resistance	29464833	0	O
and	29464833	0	O
increased	29464833	0	B-PosReg
adherence	29464833	0	O
in	29464833	0	O
the	29464833	0	O
clinical	29464833	0	O
strains	29464833	0	O
,	29464833	0	O
possibly	29464833	0	O
endowing	29464833	0	O
C.	29464833	0	O
glabrata	29464833	0	O
with	29464833	0	O
increased	29464833	0	O
viability	29464833	0	O
and	29464833	0	O
pathogenicity	29464833	0	O
.	29464833	0	O

Biallelic	29478781	2	B-Var
Mutations	29478781	2	I-Var
in	29478781	2	O
ATP5F1D	29478781	2	B-Gene
,	29478781	2	O
which	29478781	2	O
Encodes	29478781	2	O
a	29478781	2	O
Subunit	29478781	2	O
of	29478781	2	O
ATP	29478781	2	O
Synthase	29478781	2	O
,	29478781	2	O
Cause	29478781	2	B-Reg
a	29478781	2	O
Metabolic	29478781	2	O
Disorder	29478781	2	O
.	29478781	2	O
ATP	29478781	2	O
synthase	29478781	2	O
,	29478781	2	O
H	29478781	2	O
transporting	29478781	2	O
,	29478781	2	O
mitochondrial	29478781	2	O
F1	29478781	2	O
complex	29478781	2	O
,	29478781	2	O
δ	29478781	2	O
subunit	29478781	2	O
(	29478781	2	O
ATP5F1D	29478781	2	O
;	29478781	2	O
formerly	29478781	2	O
ATP5D	29478781	2	O
)	29478781	2	O
is	29478781	2	O
a	29478781	2	O
subunit	29478781	2	O
of	29478781	2	O
mitochondrial	29478781	2	O
ATP	29478781	2	O
synthase	29478781	2	O
and	29478781	2	O
plays	29478781	2	O
an	29478781	2	O
important	29478781	2	O
role	29478781	2	O
in	29478781	2	O
coupling	29478781	2	O
proton	29478781	2	O
translocation	29478781	2	O
and	29478781	2	O
ATP	29478781	2	O
production	29478781	2	O
.	29478781	2	O
Here	29478781	2	O
,	29478781	2	O
we	29478781	2	O
describe	29478781	2	O
two	29478781	2	O
individuals	29478781	2	O
,	29478781	2	O
each	29478781	2	O
with	29478781	2	O
homozygous	29478781	2	O
missense	29478781	2	B-Var
variants	29478781	2	I-Var
in	29478781	2	O
ATP5F1D	29478781	2	B-Gene
,	29478781	2	O
who	29478781	2	O
presented	29478781	2	B-Reg
with	29478781	2	O
episodic	29478781	2	O
lethargy	29478781	2	O
,	29478781	2	O
metabolic	29478781	2	O
acidosis	29478781	2	O
,	29478781	2	O
3	29478781	2	O
-	29478781	2	O
methylglutaconic	29478781	2	O
aciduria	29478781	2	O
,	29478781	2	O
and	29478781	2	O
hyperammonemia	29478781	2	B-Disease
.	29478781	2	O
Subject	29478781	2	O
1	29478781	2	O
,	29478781	2	O
homozygous	29478781	2	O
for	29478781	2	O
c.245	29478781	2	O
C	29478781	2	O
>	29478781	2	O
T	29478781	2	O
(	29478781	2	O
p.Pro82Leu	29478781	2	O
)	29478781	2	O
,	29478781	2	O
presented	29478781	2	O
with	29478781	2	O
recurrent	29478781	2	O
metabolic	29478781	2	O
decompensation	29478781	2	O
starting	29478781	2	O
in	29478781	2	O
the	29478781	2	O
neonatal	29478781	2	O
period	29478781	2	O
,	29478781	2	O
and	29478781	2	O
subject	29478781	2	O
2	29478781	2	O
,	29478781	2	O
homozygous	29478781	2	O
for	29478781	2	O
c.317	29478781	2	O
T	29478781	2	O
>	29478781	2	O
G	29478781	2	O
(	29478781	2	O
p.Val106Gly	29478781	2	O
)	29478781	2	O
,	29478781	2	O
presented	29478781	2	O
with	29478781	2	O
acute	29478781	2	O
encephalopathy	29478781	2	O
in	29478781	2	O
childhood	29478781	2	O
.	29478781	2	O
Cultured	29478781	2	O
skin	29478781	2	O
fibroblasts	29478781	2	O
from	29478781	2	O
these	29478781	2	O
individuals	29478781	2	O
exhibited	29478781	2	O
impaired	29478781	2	O
assembly	29478781	2	O
of	29478781	2	O
F1FO	29478781	2	O
ATP	29478781	2	O
synthase	29478781	2	O
and	29478781	2	O
subsequent	29478781	2	O
reduced	29478781	2	O
complex	29478781	2	O
V	29478781	2	O
activity	29478781	2	O
.	29478781	2	O
Cells	29478781	2	O
from	29478781	2	O
subject	29478781	2	O
1	29478781	2	O
also	29478781	2	O
exhibited	29478781	2	O
a	29478781	2	O
significant	29478781	2	O
decrease	29478781	2	O
in	29478781	2	O
mitochondrial	29478781	2	O
cristae	29478781	2	O
.	29478781	2	O
Knockdown	29478781	2	O
of	29478781	2	O
Drosophila	29478781	2	O
ATPsynδ	29478781	2	O
,	29478781	2	O
the	29478781	2	O
ATP5F1D	29478781	2	O
homolog	29478781	2	O
,	29478781	2	O
in	29478781	2	O
developing	29478781	2	O
eyes	29478781	2	O
and	29478781	2	O
brains	29478781	2	O
caused	29478781	2	O
a	29478781	2	O
near	29478781	2	O
complete	29478781	2	O
loss	29478781	2	O
of	29478781	2	O
the	29478781	2	O
fly	29478781	2	O
head	29478781	2	O
,	29478781	2	O
a	29478781	2	O
phenotype	29478781	2	O
that	29478781	2	O
was	29478781	2	O
fully	29478781	2	O
rescued	29478781	2	O
by	29478781	2	O
wild	29478781	2	O
-	29478781	2	O
type	29478781	2	O
human	29478781	2	O
ATP5F1D	29478781	2	O
.	29478781	2	O
In	29478781	2	O
contrast	29478781	2	O
,	29478781	2	O
expression	29478781	2	O
of	29478781	2	O
the	29478781	2	O
ATP5F1D	29478781	2	O
c.245	29478781	2	O
C	29478781	2	O
>	29478781	2	O
T	29478781	2	O
and	29478781	2	O
c.317	29478781	2	O
T	29478781	2	O
>	29478781	2	O
G	29478781	2	O
variants	29478781	2	B-Var
rescued	29478781	2	B-PosReg
the	29478781	2	O
head	29478781	2	O
-	29478781	2	O
size	29478781	2	O
phenotype	29478781	2	O
but	29478781	2	O
recapitulated	29478781	2	B-NegReg
the	29478781	2	O
eye	29478781	2	O
and	29478781	2	O
antennae	29478781	2	O
defects	29478781	2	O
seen	29478781	2	O
in	29478781	2	O
other	29478781	2	O
genetic	29478781	2	O
models	29478781	2	O
of	29478781	2	O
mitochondrial	29478781	2	O
oxidative	29478781	2	O
phosphorylation	29478781	2	O
deficiency	29478781	2	O
.	29478781	2	O
Our	29478781	2	O
data	29478781	2	O
establish	29478781	2	O
c.245	29478781	2	O
C	29478781	2	O
>	29478781	2	O
T	29478781	2	O
(	29478781	2	O
p.Pro82Leu	29478781	2	O
)	29478781	2	O
and	29478781	2	O
c.317	29478781	2	O
T	29478781	2	O
>	29478781	2	O
G	29478781	2	O
(	29478781	2	O
p.Val106Gly	29478781	2	O
)	29478781	2	O
in	29478781	2	O
ATP5F1D	29478781	2	O
as	29478781	2	O
pathogenic	29478781	2	O
variants	29478781	2	B-Var
leading	29478781	2	B-Reg
to	29478781	2	I-Reg
a	29478781	2	O
Mendelian	29478781	2	B-Disease
mitochondrial	29478781	2	I-Disease
disease	29478781	2	I-Disease
featuring	29478781	2	O
episodic	29478781	2	O
metabolic	29478781	2	O
decompensation	29478781	2	O
.	29478781	2	O

Multifocal	29506689	2	O
atrial	29506689	2	O
and	29506689	2	O
ventricular	29506689	2	O
premature	29506689	2	O
contractions	29506689	2	O
with	29506689	2	O
an	29506689	2	O
increased	29506689	2	O
risk	29506689	2	O
of	29506689	2	O
dilated	29506689	2	B-Disease
cardiomyopathy	29506689	2	I-Disease
caused	29506689	2	O
by	29506689	2	O
a	29506689	2	O
Nav1.5	29506689	2	B-Gene
gain	29506689	2	B-PosReg
-	29506689	2	I-PosReg
of	29506689	2	I-PosReg
-	29506689	2	I-PosReg
function	29506689	2	I-PosReg
mutation	29506689	2	O
(	29506689	2	B-Var
G213D	29506689	2	I-Var
)	29506689	2	I-Var
.	29506689	2	O
BACKGROUND	29506689	2	O
:	29506689	2	O
SCN5A	29506689	2	O
mutations	29506689	2	B-Var
can	29506689	2	O
lead	29506689	2	B-Reg
to	29506689	2	I-Reg
different	29506689	2	O
cardiac	29506689	2	B-Disease
diseases	29506689	2	I-Disease
.	29506689	2	O
Recently	29506689	2	O
,	29506689	2	O
SCN5A	29506689	2	O
mutations	29506689	2	O
have	29506689	2	O
been	29506689	2	O
linked	29506689	2	O
to	29506689	2	O
the	29506689	2	O
clinical	29506689	2	O
entity	29506689	2	O
multifocal	29506689	2	O
ectopic	29506689	2	O
Purkinje	29506689	2	O
-	29506689	2	O
related	29506689	2	O
premature	29506689	2	O
contractions	29506689	2	O
(	29506689	2	O
MEPPC	29506689	2	O
)	29506689	2	O
characterized	29506689	2	O
by	29506689	2	O
ventricular	29506689	2	O
ectopy	29506689	2	O
and	29506689	2	O
dilated	29506689	2	O
cardiomyopathy	29506689	2	O
.	29506689	2	O
METHODS	29506689	2	O
RESULTS	29506689	2	O
:	29506689	2	O
A	29506689	2	O
family	29506689	2	O
with	29506689	2	O
a	29506689	2	O
uniform	29506689	2	O
MEPPC	29506689	2	O
-	29506689	2	O
like	29506689	2	O
phenotype	29506689	2	O
,	29506689	2	O
associated	29506689	2	O
with	29506689	2	O
complex	29506689	2	O
atrial	29506689	2	O
and	29506689	2	O
ventricular	29506689	2	O
arrhythmias	29506689	2	O
and	29506689	2	O
dilated	29506689	2	O
cardiomyopathy	29506689	2	O
caused	29506689	2	O
by	29506689	2	O
a	29506689	2	O
high	29506689	2	O
frequency	29506689	2	O
of	29506689	2	O
ventricular	29506689	2	O
ectopy	29506689	2	O
was	29506689	2	O
clinically	29506689	2	O
assessed	29506689	2	O
.	29506689	2	O
Screening	29506689	2	O
of	29506689	2	O
the	29506689	2	O
SCN5A	29506689	2	B-Gene
gene	29506689	2	O
revealed	29506689	2	O
a	29506689	2	O
missense	29506689	2	B-Var
mutation	29506689	2	I-Var
in	29506689	2	O
the	29506689	2	O
linker	29506689	2	O
between	29506689	2	O
segments	29506689	2	O
3	29506689	2	O
and	29506689	2	O
4	29506689	2	O
in	29506689	2	O
domain	29506689	2	O
1	29506689	2	O
of	29506689	2	O
the	29506689	2	O
Nav1.5	29506689	2	O
protein	29506689	2	O
,	29506689	2	O
resulting	29506689	2	B-Reg
in	29506689	2	I-Reg
a	29506689	2	O
glycine	29506689	2	O
to	29506689	2	O
aspartate	29506689	2	O
substitution	29506689	2	O
at	29506689	2	O
position	29506689	2	O
213	29506689	2	O
(	29506689	2	B-Var
G213D	29506689	2	I-Var
)	29506689	2	I-Var
.	29506689	2	O
The	29506689	2	O
phenotype	29506689	2	O
co	29506689	2	O
-	29506689	2	O
segregated	29506689	2	O
with	29506689	2	O
the	29506689	2	O
missense	29506689	2	O
mutation	29506689	2	O
.	29506689	2	O
Electrophysiological	29506689	2	O
studies	29506689	2	O
of	29506689	2	O
wild	29506689	2	O
type	29506689	2	O
(	29506689	2	O
WT	29506689	2	O
)	29506689	2	O
hNav1.5	29506689	2	O
and	29506689	2	O
hNav1.5	29506689	2	O
_G213D	29506689	2	O
expressed	29506689	2	O
in	29506689	2	O
CHO	29506689	2	O
-	29506689	2	O
K	29506689	2	O
cells	29506689	2	O
showed	29506689	2	O
that	29506689	2	O
the	29506689	2	O
voltage	29506689	2	O
of	29506689	2	O
half	29506689	2	O
-	29506689	2	O
maximal	29506689	2	O
activation	29506689	2	O
(	29506689	2	O
V½	29506689	2	O
)	29506689	2	O
was	29506689	2	O
significantly	29506689	2	O
more	29506689	2	O
negative	29506689	2	O
for	29506689	2	O
hNav1.5	29506689	2	O
_G213D	29506689	2	O
compared	29506689	2	O
to	29506689	2	O
WT	29506689	2	O
(	29506689	2	O
V½	29506689	2	O
=	29506689	2	O
-	29506689	2	O
38.7	29506689	2	O
0.5	29506689	2	O
mV	29506689	2	O
for	29506689	2	O
WT	29506689	2	O
and	29506689	2	O
V½	29506689	2	O
=	29506689	2	O
-	29506689	2	O
42.4	29506689	2	O
0.5	29506689	2	O
mV	29506689	2	O
for	29506689	2	O
G213D	29506689	2	O
;	29506689	2	O
P	29506689	2	O
<	29506689	2	O
0.001	29506689	2	O
)	29506689	2	O
.	29506689	2	O
This	29506689	2	O
suggests	29506689	2	O
activation	29506689	2	O
of	29506689	2	O
Nav1.5	29506689	2	O
_G231D	29506689	2	O
at	29506689	2	O
more	29506689	2	O
negative	29506689	2	O
potentials	29506689	2	O
.	29506689	2	O
The	29506689	2	O
V½	29506689	2	O
of	29506689	2	O
steady	29506689	2	O
-	29506689	2	O
state	29506689	2	O
inactivation	29506689	2	O
was	29506689	2	O
significantly	29506689	2	O
shifted	29506689	2	O
towards	29506689	2	O
more	29506689	2	O
positive	29506689	2	O
values	29506689	2	O
for	29506689	2	O
Nav1.5	29506689	2	O
_G213D	29506689	2	O
(	29506689	2	O
V½	29506689	2	O
=	29506689	2	O
-	29506689	2	O
86.7	29506689	2	O
0.2	29506689	2	O
mV	29506689	2	O
for	29506689	2	O
WT	29506689	2	O
and	29506689	2	O
-	29506689	2	O
82.2	29506689	2	O
0.3	29506689	2	O
mV	29506689	2	O
for	29506689	2	O
G213D	29506689	2	O
;	29506689	2	O
P	29506689	2	O
<	29506689	2	O
0.001	29506689	2	O
)	29506689	2	O
,	29506689	2	O
also	29506689	2	O
contributing	29506689	2	O
to	29506689	2	O
a	29506689	2	O
gain	29506689	2	O
-	29506689	2	O
of	29506689	2	O
-	29506689	2	O
function	29506689	2	O
phenotype	29506689	2	O
.	29506689	2	O
Flecainide	29506689	2	O
and	29506689	2	O
amiodarone	29506689	2	O
markedly	29506689	2	O
reduced	29506689	2	O
premature	29506689	2	O
atrial	29506689	2	O
and	29506689	2	O
ventricular	29506689	2	O
contractions	29506689	2	O
in	29506689	2	O
four	29506689	2	O
patients	29506689	2	O
.	29506689	2	O
CONCLUSION	29506689	2	O
:	29506689	2	O
The	29506689	2	O
Nav1.5	29506689	2	B-Var
_G213D	29506689	2	I-Var
mutation	29506689	2	O
is	29506689	2	O
associated	29506689	2	O
with	29506689	2	O
a	29506689	2	O
gain	29506689	2	B-PosReg
-	29506689	2	I-PosReg
of	29506689	2	I-PosReg
-	29506689	2	I-PosReg
function	29506689	2	I-PosReg
phenotype	29506689	2	O
,	29506689	2	O
multifocal	29506689	2	O
atrial	29506689	2	O
and	29506689	2	O
ventricular	29506689	2	O
ectopy	29506689	2	O
and	29506689	2	O
dilated	29506689	2	B-Disease
cardiomyopathy	29506689	2	I-Disease
.	29506689	2	O
Since	29506689	2	O
patients	29506689	2	O
with	29506689	2	O
a	29506689	2	O
MEPPC	29506689	2	O
-	29506689	2	O
like	29506689	2	O
phenotype	29506689	2	O
may	29506689	2	O
specifically	29506689	2	O
benefit	29506689	2	O
from	29506689	2	O
Class-1	29506689	2	O
antiarrhythmic	29506689	2	O
drugs	29506689	2	O
or	29506689	2	O
amiodarone	29506689	2	O
,	29506689	2	O
clinical	29506689	2	O
identification	29506689	2	O
of	29506689	2	O
this	29506689	2	O
disease	29506689	2	O
entity	29506689	2	O
is	29506689	2	O
important	29506689	2	O
.	29506689	2	O

Impact	29509167	0	O
of	29509167	0	O
CYP2C19	29509167	0	O
Polymorphisms	29509167	0	O
on	29509167	0	O
Clinical	29509167	0	O
Outcomes	29509167	0	O
and	29509167	0	O
Antiplatelet	29509167	0	O
Potency	29509167	0	O
of	29509167	0	O
Clopidogrel	29509167	0	O
in	29509167	0	O
Caucasian	29509167	0	O
Poststroke	29509167	0	O
Survivors	29509167	0	O
.	29509167	0	O
BACKGROUND	29509167	0	O
:	29509167	0	O
Variable	29509167	0	O
response	29509167	0	O
after	29509167	0	O
clopidogrel	29509167	0	O
is	29509167	0	O
well	29509167	0	O
documented	29509167	0	O
and	29509167	0	O
may	29509167	0	O
affect	29509167	0	O
major	29509167	0	O
adverse	29509167	0	O
clinical	29509167	0	O
events	29509167	0	O
after	29509167	0	O
stroke	29509167	0	O
.	29509167	0	O
Impact	29509167	0	O
of	29509167	0	O
CYP2C19	29509167	0	O
genetic	29509167	0	O
polymorphisms	29509167	0	O
is	29509167	0	O
an	29509167	0	O
established	29509167	0	O
marker	29509167	0	O
linked	29509167	0	O
to	29509167	0	O
variable	29509167	0	O
response	29509167	0	O
after	29509167	0	O
clopidogrel	29509167	0	O
.	29509167	0	O
However	29509167	0	O
,	29509167	0	O
the	29509167	0	O
association	29509167	0	O
of	29509167	0	O
certain	29509167	0	O
genetic	29509167	0	O
polymorphisms	29509167	0	O
with	29509167	0	O
prediction	29509167	0	O
of	29509167	0	O
major	29509167	0	O
adverse	29509167	0	O
clinical	29509167	0	O
events	29509167	0	O
following	29509167	0	O
stroke	29509167	0	O
still	29509167	0	O
remains	29509167	0	O
controversial	29509167	0	O
,	29509167	0	O
especially	29509167	0	O
in	29509167	0	O
Caucasians	29509167	0	O
.	29509167	0	O
STUDY	29509167	0	O
QUESTION	29509167	0	O
:	29509167	0	O
The	29509167	0	O
primary	29509167	0	O
aim	29509167	0	O
was	29509167	0	O
to	29509167	0	O
evaluate	29509167	0	O
the	29509167	0	O
impact	29509167	0	O
of	29509167	0	O
CYP2C19	29509167	0	O
allele	29509167	0	O
*	29509167	0	O
2	29509167	0	O
in	29509167	0	O
heterozygote	29509167	0	O
form	29509167	0	O
on	29509167	0	O
major	29509167	0	O
adverse	29509167	0	O
clinical	29509167	0	O
events	29509167	0	O
in	29509167	0	O
Caucasian	29509167	0	O
poststroke	29509167	0	O
survivors	29509167	0	O
treated	29509167	0	O
with	29509167	0	O
clopidogrel	29509167	0	O
.	29509167	0	O
The	29509167	0	O
secondary	29509167	0	O
aim	29509167	0	O
was	29509167	0	O
to	29509167	0	O
analyze	29509167	0	O
the	29509167	0	O
potential	29509167	0	O
link	29509167	0	O
between	29509167	0	O
CYP2C19	29509167	0	O
genetic	29509167	0	O
polymorphism	29509167	0	O
and	29509167	0	O
variable	29509167	0	O
response	29509167	0	O
after	29509167	0	O
clopidogrel	29509167	0	O
.	29509167	0	O
STUDY	29509167	0	O
DESIGN	29509167	0	O
:	29509167	0	O
One	29509167	0	O
hundred	29509167	0	O
thirty	29509167	0	O
patients	29509167	0	O
of	29509167	0	O
Caucasian	29509167	0	O
origin	29509167	0	O
following	29509167	0	O
documented	29509167	0	O
ischemic	29509167	0	O
stroke	29509167	0	O
were	29509167	0	O
included	29509167	0	O
.	29509167	0	O
Platelet	29509167	0	O
reactivity	29509167	0	O
was	29509167	0	O
assessed	29509167	0	O
by	29509167	0	O
light	29509167	0	O
transmittance	29509167	0	O
aggregometry	29509167	0	O
(	29509167	0	O
LTA	29509167	0	O
)	29509167	0	O
and	29509167	0	O
matched	29509167	0	O
with	29509167	0	O
various	29509167	0	O
CYP2C19	29509167	0	O
loss	29509167	0	O
-	29509167	0	O
of	29509167	0	O
-	29509167	0	O
function	29509167	0	O
genetic	29509167	0	O
polymorphisms	29509167	0	O
and	29509167	0	O
major	29509167	0	O
adverse	29509167	0	O
clinical	29509167	0	O
events	29509167	0	O
(	29509167	0	O
composite	29509167	0	O
of	29509167	0	O
vascular	29509167	0	O
deaths	29509167	0	O
,	29509167	0	O
stroke	29509167	0	O
/	29509167	0	O
transient	29509167	0	O
ischemic	29509167	0	O
attack	29509167	0	O
,	29509167	0	O
and	29509167	0	O
myocardial	29509167	0	O
infarction	29509167	0	O
)	29509167	0	O
.	29509167	0	O
RESULTS	29509167	0	O
:	29509167	0	O
Over	29509167	0	O
the	29509167	0	O
mean	29509167	0	O
follow	29509167	0	O
-	29509167	0	O
up	29509167	0	O
of	29509167	0	O
14.9	29509167	0	O
months	29509167	0	O
,	29509167	0	O
19	29509167	0	O
patients	29509167	0	O
experienced	29509167	0	O
major	29509167	0	O
adverse	29509167	0	O
clinical	29509167	0	O
events	29509167	0	O
.	29509167	0	O
The	29509167	0	O
risk	29509167	0	O
of	29509167	0	O
major	29509167	0	O
adverse	29509167	0	O
clinical	29509167	0	O
events	29509167	0	O
was	29509167	0	O
nearly	29509167	0	O
3	29509167	0	O
-	29509167	0	O
fold	29509167	0	O
in	29509167	0	O
loss	29509167	0	B-NegReg
-	29509167	0	I-NegReg
of	29509167	0	I-NegReg
-	29509167	0	I-NegReg
function	29509167	0	I-NegReg
allele	29509167	0	B-Var
carriers	29509167	0	O
(	29509167	0	O
hazard	29509167	0	O
ratio	29509167	0	O
=	29509167	0	O
2.904	29509167	0	O
;	29509167	0	O
95%	29509167	0	O
confidence	29509167	0	O
interval	29509167	0	O
,	29509167	0	O
1.083	29509167	0	O
-	29509167	0	O
7.786	29509167	0	O
;	29509167	0	O
P	29509167	0	O
=	29509167	0	O
0.013	29509167	0	O
)	29509167	0	O
,	29509167	0	O
whereas	29509167	0	O
the	29509167	0	O
risk	29509167	0	O
of	29509167	0	O
ischemic	29509167	0	O
stroke	29509167	0	O
or	29509167	0	O
transient	29509167	0	O
ischemic	29509167	0	O
attack	29509167	0	O
alone	29509167	0	O
was	29509167	0	O
also	29509167	0	O
higher	29509167	0	O
(	29509167	0	O
hazard	29509167	0	O
ratio	29509167	0	O
=	29509167	0	O
3.170	29509167	0	O
;	29509167	0	O
95%	29509167	0	O
confidence	29509167	0	O
interval	29509167	0	O
,	29509167	0	O
1.281	29509167	0	O
-	29509167	0	O
7.849	29509167	0	O
;	29509167	0	O
P	29509167	0	O
=	29509167	0	O
0.034	29509167	0	O
)	29509167	0	O
.	29509167	0	O
Platelet	29509167	0	O
activity	29509167	0	O
was	29509167	0	O
strongly	29509167	0	O
associated	29509167	0	O
with	29509167	0	O
allele	29509167	0	B-Var
*	29509167	0	I-Var
2	29509167	0	I-Var
status	29509167	0	I-Var
(	29509167	0	O
rs	29509167	0	O
=	29509167	0	O
0.21	29509167	0	O
,	29509167	0	O
P	29509167	0	O
=	29509167	0	O
0.016	29509167	0	O
)	29509167	0	O
but	29509167	0	O
not	29509167	0	O
with	29509167	0	O
other	29509167	0	O
genetic	29509167	0	O
polymorphisms	29509167	0	O
.	29509167	0	O
Carriers	29509167	0	O
of	29509167	0	O
allele	29509167	0	O
*	29509167	0	O
2	29509167	0	O
exhibited	29509167	0	O
lower	29509167	0	O
platelet	29509167	0	O
response	29509167	0	O
to	29509167	0	O
adenosine	29509167	0	O
diphosphate	29509167	0	O
-	29509167	0	O
mean	29509167	0	O
LTA	29509167	0	O
(	29509167	0	O
30.1%	29509167	0	O
vs.42	29509167	0	O
.0	29509167	0	O
;	29509167	0	O
P	29509167	0	O
=	29509167	0	O
0.017	29509167	0	O
)	29509167	0	O
.	29509167	0	O
There	29509167	0	O
were	29509167	0	O
no	29509167	0	O
significant	29509167	0	O
differences	29509167	0	O
in	29509167	0	O
LTA	29509167	0	O
results	29509167	0	O
with	29509167	0	O
other	29509167	0	O
agonists	29509167	0	O
.	29509167	0	O
Strong	29509167	0	O
association	29509167	0	O
of	29509167	0	O
increase	29509167	0	O
in	29509167	0	O
adenosine	29509167	0	O
diphosphate	29509167	0	O
-	29509167	0	O
induced	29509167	0	O
aggregation	29509167	0	O
with	29509167	0	O
diabetes	29509167	0	O
mellitus	29509167	0	O
(	29509167	0	O
rs	29509167	0	O
=	29509167	0	O
0.20	29509167	0	O
,	29509167	0	O
P	29509167	0	O
=	29509167	0	O
0.023	29509167	0	O
)	29509167	0	O
,	29509167	0	O
increasing	29509167	0	O
age	29509167	0	O
(	29509167	0	O
rs	29509167	0	O
=	29509167	0	O
0.23	29509167	0	O
,	29509167	0	O
P	29509167	0	O
=	29509167	0	O
0.008	29509167	0	O
)	29509167	0	O
,	29509167	0	O
and	29509167	0	O
conversely	29509167	0	O
diminishing	29509167	0	O
over	29509167	0	O
increased	29509167	0	O
weight	29509167	0	O
(	29509167	0	O
rs	29509167	0	O
=	29509167	0	O
0.23	29509167	0	O
,	29509167	0	O
P	29509167	0	O
=	29509167	0	O
0.009	29509167	0	O
)	29509167	0	O
was	29509167	0	O
also	29509167	0	O
detected	29509167	0	O
.	29509167	0	O
The	29509167	0	O
carriers	29509167	0	O
of	29509167	0	O
other	29509167	0	O
gene	29509167	0	O
allele	29509167	0	O
variants	29509167	0	O
lack	29509167	0	O
uniformed	29509167	0	O
impact	29509167	0	O
on	29509167	0	O
variable	29509167	0	O
response	29509167	0	O
after	29509167	0	O
clopidogrel	29509167	0	O
.	29509167	0	O
CONCLUSIONS	29509167	0	O
:	29509167	0	O
Even	29509167	0	O
heterozygous	29509167	0	O
CYP2C19	29509167	0	O
*	29509167	0	B-Gene
2	29509167	0	I-Gene
allele	29509167	0	I-Gene
carriers	29509167	0	B-Var
among	29509167	0	O
Caucasian	29509167	0	O
patients	29509167	0	O
after	29509167	0	O
ischemic	29509167	0	O
stroke	29509167	0	O
had	29509167	0	O
a	29509167	0	O
higher	29509167	0	O
risk	29509167	0	B-PosReg
of	29509167	0	O
major	29509167	0	O
adverse	29509167	0	O
clinical	29509167	0	O
events	29509167	0	O
.	29509167	0	O
The	29509167	0	O
LTA	29509167	0	O
,	29509167	0	O
however	29509167	0	O
,	29509167	0	O
did	29509167	0	O
not	29509167	0	O
predict	29509167	0	O
major	29509167	0	O
adverse	29509167	0	O
clinical	29509167	0	O
events	29509167	0	O
.	29509167	0	O
The	29509167	0	O
exact	29509167	0	O
clinical	29509167	0	O
utility	29509167	0	O
of	29509167	0	O
these	29509167	0	O
findings	29509167	0	O
is	29509167	0	O
still	29509167	0	O
uncertain	29509167	0	O
and	29509167	0	O
requires	29509167	0	O
large	29509167	0	O
outcome	29509167	0	O
-	29509167	0	O
driven	29509167	0	O
randomized	29509167	0	O
trial	29509167	0	O
in	29509167	0	O
Caucasians	29509167	0	O
for	29509167	0	O
proof	29509167	0	O
of	29509167	0	O
concept	29509167	0	O
.	29509167	0	O

The	29513733	1	O
Arabidopsis	29513733	1	O
thaliana	29513733	1	O
Mediator	29513733	1	O
subunit	29513733	1	O
MED8	29513733	1	O
regulates	29513733	1	O
plant	29513733	1	O
immunity	29513733	1	O
to	29513733	1	O
Botrytis	29513733	1	O
Cinerea	29513733	1	O
through	29513733	1	O
interacting	29513733	1	O
with	29513733	1	O
the	29513733	1	O
basic	29513733	1	O
helix	29513733	1	O
-	29513733	1	O
loop	29513733	1	O
-	29513733	1	O
helix	29513733	1	O
(	29513733	1	O
bHLH	29513733	1	O
)	29513733	1	O
transcription	29513733	1	O
factor	29513733	1	O
FAMA	29513733	1	O
.	29513733	1	O
The	29513733	1	O
Mediator	29513733	1	O
complex	29513733	1	O
is	29513733	1	O
at	29513733	1	O
the	29513733	1	O
core	29513733	1	O
of	29513733	1	O
transcriptional	29513733	1	O
regulation	29513733	1	O
and	29513733	1	O
plays	29513733	1	O
a	29513733	1	O
central	29513733	1	O
role	29513733	1	O
in	29513733	1	O
plant	29513733	1	O
immunity	29513733	1	O
.	29513733	1	O
The	29513733	1	O
MEDIATOR25	29513733	1	O
(	29513733	1	O
MED25	29513733	1	O
)	29513733	1	O
subunit	29513733	1	O
of	29513733	1	O
Arabidopsis	29513733	1	O
thaliana	29513733	1	O
regulates	29513733	1	O
jasmonate	29513733	1	O
-	29513733	1	O
dependent	29513733	1	O
resistance	29513733	1	O
to	29513733	1	O
Botrytis	29513733	1	O
cinerea	29513733	1	O
through	29513733	1	O
interacting	29513733	1	O
with	29513733	1	O
the	29513733	1	O
basic	29513733	1	O
helix	29513733	1	O
-	29513733	1	O
loop	29513733	1	O
-	29513733	1	O
helix	29513733	1	O
(	29513733	1	O
bHLH	29513733	1	O
)	29513733	1	O
transcription	29513733	1	O
factor	29513733	1	O
of	29513733	1	O
jasmonate	29513733	1	O
signaling	29513733	1	O
,	29513733	1	O
MYC2	29513733	1	O
.	29513733	1	O
Another	29513733	1	O
Mediator	29513733	1	O
subunit	29513733	1	O
,	29513733	1	O
MED8	29513733	1	O
,	29513733	1	O
acts	29513733	1	O
independently	29513733	1	O
or	29513733	1	O
together	29513733	1	O
with	29513733	1	O
MED25	29513733	1	O
in	29513733	1	O
plant	29513733	1	O
immunity	29513733	1	O
.	29513733	1	O
However	29513733	1	O
,	29513733	1	O
unlike	29513733	1	O
MED25	29513733	1	O
,	29513733	1	O
the	29513733	1	O
underlying	29513733	1	O
action	29513733	1	O
mechanisms	29513733	1	O
of	29513733	1	O
MED8	29513733	1	O
in	29513733	1	O
regulating	29513733	1	O
B.	29513733	1	O
cinerea	29513733	1	O
resistance	29513733	1	O
are	29513733	1	O
still	29513733	1	O
unknown	29513733	1	O
.	29513733	1	O
Here	29513733	1	O
,	29513733	1	O
we	29513733	1	O
demonstrated	29513733	1	O
that	29513733	1	O
MED8	29513733	1	O
regulated	29513733	1	O
plant	29513733	1	O
immunity	29513733	1	O
to	29513733	1	O
B.	29513733	1	O
cinerea	29513733	1	O
through	29513733	1	O
interacting	29513733	1	O
with	29513733	1	O
another	29513733	1	O
bHLH	29513733	1	O
transcription	29513733	1	O
factor	29513733	1	O
,	29513733	1	O
FAMA	29513733	1	O
,	29513733	1	O
which	29513733	1	O
was	29513733	1	O
previously	29513733	1	O
shown	29513733	1	O
to	29513733	1	O
control	29513733	1	O
the	29513733	1	O
final	29513733	1	O
proliferation	29513733	1	O
/	29513733	1	O
differentiation	29513733	1	O
switch	29513733	1	O
during	29513733	1	O
stomatal	29513733	1	O
development	29513733	1	O
.	29513733	1	O
Our	29513733	1	O
research	29513733	1	O
demonstrates	29513733	1	O
that	29513733	1	O
FAMA	29513733	1	O
is	29513733	1	O
also	29513733	1	O
an	29513733	1	O
essential	29513733	1	O
component	29513733	1	O
of	29513733	1	O
B.	29513733	1	O
cinerea	29513733	1	O
resistance	29513733	1	O
.	29513733	1	O
The	29513733	1	O
fama	29513733	1	B-Gene
loss	29513733	1	B-NegReg
-	29513733	1	I-NegReg
of	29513733	1	I-NegReg
-	29513733	1	I-NegReg
function	29513733	1	I-NegReg
mutants	29513733	1	B-Var
(	29513733	1	O
fama-1	29513733	1	O
and	29513733	1	O
fama-2	29513733	1	O
)	29513733	1	O
increased	29513733	1	B-PosReg
susceptibility	29513733	1	O
to	29513733	1	O
B.	29513733	1	O
cinerea	29513733	1	O
infection	29513733	1	O
and	29513733	1	O
reduced	29513733	1	B-NegReg
defense	29513733	1	O
-	29513733	1	O
gene	29513733	1	O
expression	29513733	1	O
.	29513733	1	O
On	29513733	1	O
the	29513733	1	O
contrary	29513733	1	O
,	29513733	1	O
transgenic	29513733	1	O
lines	29513733	1	O
constitutively	29513733	1	O
overexpressing	29513733	1	O
FAMA	29513733	1	O
showed	29513733	1	O
opposite	29513733	1	O
B.	29513733	1	O
cinerea	29513733	1	O
responses	29513733	1	O
compared	29513733	1	O
with	29513733	1	O
the	29513733	1	O
fama	29513733	1	O
loss	29513733	1	O
-	29513733	1	O
of	29513733	1	O
-	29513733	1	O
function	29513733	1	O
mutants	29513733	1	O
.	29513733	1	O
FAMA	29513733	1	O
-	29513733	1	O
overexpressed	29513733	1	O
plants	29513733	1	O
displayed	29513733	1	O
enhanced	29513733	1	O
resistance	29513733	1	O
to	29513733	1	O
B.	29513733	1	O
cinerea	29513733	1	O
infection	29513733	1	O
and	29513733	1	O
increased	29513733	1	O
expression	29513733	1	O
levels	29513733	1	O
of	29513733	1	O
defensin	29513733	1	O
genes	29513733	1	O
following	29513733	1	O
B.	29513733	1	O
cinerea	29513733	1	O
treatment	29513733	1	O
.	29513733	1	O
Genetic	29513733	1	O
analysis	29513733	1	O
of	29513733	1	O
MED8	29513733	1	O
and	29513733	1	O
FAMA	29513733	1	O
suggested	29513733	1	O
that	29513733	1	O
FAMA	29513733	1	O
-	29513733	1	O
regulated	29513733	1	O
pathogen	29513733	1	O
resistance	29513733	1	O
was	29513733	1	O
dependent	29513733	1	O
on	29513733	1	O
MED8	29513733	1	O
.	29513733	1	O
In	29513733	1	O
addition	29513733	1	O
,	29513733	1	O
MED8	29513733	1	O
and	29513733	1	O
FAMA	29513733	1	O
were	29513733	1	O
both	29513733	1	O
associated	29513733	1	O
with	29513733	1	O
the	29513733	1	O
G	29513733	1	O
-	29513733	1	O
box	29513733	1	O
region	29513733	1	O
in	29513733	1	O
the	29513733	1	O
promoter	29513733	1	O
of	29513733	1	O
ORA59	29513733	1	O
.	29513733	1	O
Our	29513733	1	O
findings	29513733	1	O
indicate	29513733	1	O
that	29513733	1	O
the	29513733	1	O
MED8	29513733	1	O
subunit	29513733	1	O
of	29513733	1	O
the	29513733	1	O
A.	29513733	1	O
thaliana	29513733	1	O
Mediator	29513733	1	O
regulates	29513733	1	O
plant	29513733	1	O
immunity	29513733	1	O
to	29513733	1	O
B.	29513733	1	O
cinerea	29513733	1	O
through	29513733	1	O
interacting	29513733	1	O
with	29513733	1	O
the	29513733	1	O
transcription	29513733	1	O
factor	29513733	1	O
FAMA	29513733	1	O
,	29513733	1	O
which	29513733	1	O
was	29513733	1	O
discovered	29513733	1	O
to	29513733	1	O
be	29513733	1	O
a	29513733	1	O
key	29513733	1	O
component	29513733	1	O
in	29513733	1	O
B.	29513733	1	O
cinerea	29513733	1	O
resistance	29513733	1	O
.	29513733	1	O

A	29514032	2	O
Gain	29514032	2	O
-	29514032	2	O
of	29514032	2	O
-	29514032	2	O
Function	29514032	2	O
Mutation	29514032	2	O
in	29514032	2	O
EPO	29514032	2	O
in	29514032	2	O
Familial	29514032	2	O
Erythrocytosis	29514032	2	O
.	29514032	2	O
Familial	29514032	2	B-Disease
erythrocytosis	29514032	2	I-Disease
with	29514032	2	O
elevated	29514032	2	O
erythropoietin	29514032	2	O
levels	29514032	2	O
is	29514032	2	O
frequently	29514032	2	O
caused	29514032	2	B-Reg
by	29514032	2	O
mutations	29514032	2	B-Var
in	29514032	2	O
genes	29514032	2	O
that	29514032	2	O
regulate	29514032	2	O
oxygen	29514032	2	O
-	29514032	2	O
dependent	29514032	2	O
transcription	29514032	2	O
of	29514032	2	O
the	29514032	2	O
gene	29514032	2	O
encoding	29514032	2	O
erythropoietin	29514032	2	O
(	29514032	2	O
EPO	29514032	2	B-Gene
)	29514032	2	I-Gene
.	29514032	2	O
We	29514032	2	O
identified	29514032	2	O
a	29514032	2	O
mutation	29514032	2	O
in	29514032	2	O
EPO	29514032	2	O
that	29514032	2	O
cosegregated	29514032	2	O
with	29514032	2	O
disease	29514032	2	O
with	29514032	2	O
a	29514032	2	O
logarithm	29514032	2	O
of	29514032	2	O
the	29514032	2	O
odds	29514032	2	O
(	29514032	2	O
LOD	29514032	2	O
)	29514032	2	O
score	29514032	2	O
of	29514032	2	O
3.3	29514032	2	O
in	29514032	2	O
a	29514032	2	O
family	29514032	2	O
with	29514032	2	O
autosomal	29514032	2	O
dominant	29514032	2	O
erythrocytosis	29514032	2	O
.	29514032	2	O
This	29514032	2	O
mutation	29514032	2	B-Var
,	29514032	2	O
a	29514032	2	O
single	29514032	2	O
-	29514032	2	O
nucleotide	29514032	2	O
deletion	29514032	2	O
(	29514032	2	O
c.32	29514032	2	O
delG	29514032	2	O
)	29514032	2	O
,	29514032	2	O
introduces	29514032	2	O
a	29514032	2	O
frameshift	29514032	2	O
in	29514032	2	O
exon	29514032	2	O
2	29514032	2	O
that	29514032	2	O
interrupts	29514032	2	B-NegReg
translation	29514032	2	O
of	29514032	2	O
the	29514032	2	O
main	29514032	2	O
EPO	29514032	2	O
messenger	29514032	2	O
RNA	29514032	2	O
(	29514032	2	O
mRNA	29514032	2	O
)	29514032	2	O
transcript	29514032	2	O
but	29514032	2	O
initiates	29514032	2	O
excess	29514032	2	O
production	29514032	2	O
of	29514032	2	O
erythropoietin	29514032	2	O
from	29514032	2	O
what	29514032	2	O
is	29514032	2	O
normally	29514032	2	O
a	29514032	2	O
noncoding	29514032	2	O
EPO	29514032	2	O
mRNA	29514032	2	O
transcribed	29514032	2	O
from	29514032	2	O
an	29514032	2	O
alternative	29514032	2	O
promoter	29514032	2	O
located	29514032	2	O
in	29514032	2	O
intron	29514032	2	O
1	29514032	2	O
.	29514032	2	O
(	29514032	2	O
Funded	29514032	2	O
by	29514032	2	O
the	29514032	2	O
Gebert	29514032	2	O
Rüf	29514032	2	O
Foundation	29514032	2	O
and	29514032	2	O
others	29514032	2	O
.	29514032	2	O
)	29514032	2	O
.	29514032	2	O

Inactivation	29526646	2	B-Var
of	29526646	2	O
Fgfr2	29526646	2	B-Gene
gene	29526646	2	O
in	29526646	2	O
mouse	29526646	2	O
secondary	29526646	2	O
palate	29526646	2	O
mesenchymal	29526646	2	O
cells	29526646	2	O
leads	29526646	2	B-Reg
to	29526646	2	I-Reg
cleft	29526646	2	B-Disease
palate	29526646	2	I-Disease
.	29526646	2	O
Numerous	29526646	2	O
studies	29526646	2	O
have	29526646	2	O
been	29526646	2	O
conducted	29526646	2	O
to	29526646	2	O
understand	29526646	2	O
the	29526646	2	O
molecular	29526646	2	O
mechanisms	29526646	2	O
controlling	29526646	2	O
mammalian	29526646	2	O
secondary	29526646	2	O
palate	29526646	2	O
development	29526646	2	O
such	29526646	2	O
as	29526646	2	O
growth	29526646	2	O
,	29526646	2	O
reorientation	29526646	2	O
and	29526646	2	O
fusion	29526646	2	O
.	29526646	2	O
However	29526646	2	O
,	29526646	2	O
little	29526646	2	O
is	29526646	2	O
known	29526646	2	O
about	29526646	2	O
the	29526646	2	O
signaling	29526646	2	O
factors	29526646	2	O
regulating	29526646	2	O
palate	29526646	2	O
initiation	29526646	2	O
.	29526646	2	O
Mouse	29526646	2	O
fibroblast	29526646	2	O
growth	29526646	2	O
factor	29526646	2	O
(	29526646	2	O
FGF	29526646	2	O
)	29526646	2	O
receptor	29526646	2	O
2	29526646	2	O
gene	29526646	2	O
(	29526646	2	O
Fgfr2	29526646	2	O
)	29526646	2	O
is	29526646	2	O
expressed	29526646	2	O
on	29526646	2	O
E11.5	29526646	2	O
in	29526646	2	O
the	29526646	2	O
palate	29526646	2	O
outgrowth	29526646	2	O
within	29526646	2	O
the	29526646	2	O
maxillary	29526646	2	O
process	29526646	2	O
,	29526646	2	O
in	29526646	2	O
a	29526646	2	O
region	29526646	2	O
that	29526646	2	O
is	29526646	2	O
responsible	29526646	2	O
for	29526646	2	O
palate	29526646	2	O
cell	29526646	2	O
specification	29526646	2	O
and	29526646	2	O
shelf	29526646	2	O
initiation	29526646	2	O
.	29526646	2	O
Fgfr2	29526646	2	O
continues	29526646	2	O
to	29526646	2	O
express	29526646	2	O
in	29526646	2	O
palate	29526646	2	O
on	29526646	2	O
E12.5	29526646	2	O
and	29526646	2	O
E13.5	29526646	2	O
in	29526646	2	O
both	29526646	2	O
epithelial	29526646	2	O
and	29526646	2	O
mesenchymal	29526646	2	O
cells	29526646	2	O
,	29526646	2	O
and	29526646	2	O
inactivation	29526646	2	B-Var
of	29526646	2	O
Fgfr2	29526646	2	B-Gene
expression	29526646	2	O
in	29526646	2	O
mesenchymal	29526646	2	O
cells	29526646	2	O
using	29526646	2	O
floxed	29526646	2	O
Fgfr2	29526646	2	O
allele	29526646	2	O
and	29526646	2	O
Osr2	29526646	2	O
-	29526646	2	O
Cre	29526646	2	O
leads	29526646	2	B-Reg
to	29526646	2	I-Reg
cleft	29526646	2	B-Disease
palate	29526646	2	I-Disease
at	29526646	2	O
various	29526646	2	O
stages	29526646	2	O
including	29526646	2	O
reorientation	29526646	2	O
,	29526646	2	O
horizontal	29526646	2	O
growth	29526646	2	O
and	29526646	2	O
fusion	29526646	2	O
.	29526646	2	O
Notably	29526646	2	O
,	29526646	2	O
some	29526646	2	O
mutant	29526646	2	O
embryos	29526646	2	O
displayed	29526646	2	O
no	29526646	2	O
sign	29526646	2	O
of	29526646	2	O
palate	29526646	2	O
shelf	29526646	2	O
formation	29526646	2	O
suggesting	29526646	2	O
that	29526646	2	O
FGF	29526646	2	O
receptor	29526646	2	O
2	29526646	2	O
mediated	29526646	2	O
FGF	29526646	2	O
signaling	29526646	2	O
may	29526646	2	O
play	29526646	2	O
an	29526646	2	O
important	29526646	2	O
role	29526646	2	O
in	29526646	2	O
palate	29526646	2	O
initiation	29526646	2	O
.	29526646	2	O

MIB-1	29531012	1	O
Is	29531012	1	O
Required	29531012	1	O
for	29531012	1	O
Spermatogenesis	29531012	1	O
and	29531012	1	O
Facilitates	29531012	1	O
LIN-12	29531012	1	O
and	29531012	1	O
GLP-1	29531012	1	O
Activity	29531012	1	O
in	29531012	1	O
Caenorhabditis	29531012	1	O
elegans	29531012	1	O
.	29531012	1	O
Covalent	29531012	1	O
attachment	29531012	1	O
of	29531012	1	O
ubiquitin	29531012	1	O
to	29531012	1	O
substrate	29531012	1	O
proteins	29531012	1	O
changes	29531012	1	O
their	29531012	1	O
function	29531012	1	O
or	29531012	1	O
marks	29531012	1	O
them	29531012	1	O
for	29531012	1	O
proteolysis	29531012	1	O
,	29531012	1	O
and	29531012	1	O
the	29531012	1	O
specificity	29531012	1	O
of	29531012	1	O
ubiquitin	29531012	1	O
attachment	29531012	1	O
is	29531012	1	O
mediated	29531012	1	O
by	29531012	1	O
the	29531012	1	O
numerous	29531012	1	O
E3	29531012	1	O
ligases	29531012	1	O
encoded	29531012	1	O
by	29531012	1	O
animals	29531012	1	O
.	29531012	1	O
Mind	29531012	1	O
Bomb	29531012	1	O
is	29531012	1	O
an	29531012	1	O
essential	29531012	1	O
E3	29531012	1	O
ligase	29531012	1	O
during	29531012	1	O
Notch	29531012	1	O
pathway	29531012	1	O
signaling	29531012	1	O
in	29531012	1	O
insects	29531012	1	O
and	29531012	1	O
vertebrates	29531012	1	O
.	29531012	1	O
While	29531012	1	O
Caenorhabditis	29531012	1	O
elegans	29531012	1	O
encodes	29531012	1	O
a	29531012	1	O
Mind	29531012	1	O
Bomb	29531012	1	O
homolog	29531012	1	O
(	29531012	1	O
mib-1	29531012	1	O
)	29531012	1	O
,	29531012	1	O
it	29531012	1	O
has	29531012	1	O
never	29531012	1	O
been	29531012	1	O
recovered	29531012	1	O
in	29531012	1	O
the	29531012	1	O
extensive	29531012	1	O
Notch	29531012	1	O
suppressor	29531012	1	O
/	29531012	1	O
enhancer	29531012	1	O
screens	29531012	1	O
that	29531012	1	O
have	29531012	1	O
identified	29531012	1	O
numerous	29531012	1	O
pathway	29531012	1	O
components	29531012	1	O
.	29531012	1	O
Here	29531012	1	O
,	29531012	1	O
we	29531012	1	O
show	29531012	1	O
that	29531012	1	O
C.	29531012	1	O
elegans	29531012	1	O
mib-1	29531012	1	B-Gene
null	29531012	1	O
mutants	29531012	1	B-Var
have	29531012	1	O
a	29531012	1	O
spermatogenesis	29531012	1	B-Disease
-	29531012	1	I-Disease
defective	29531012	1	I-Disease
phenotype	29531012	1	I-Disease
that	29531012	1	O
results	29531012	1	B-Reg
in	29531012	1	I-Reg
a	29531012	1	O
heterogeneous	29531012	1	O
mixture	29531012	1	O
of	29531012	1	O
arrested	29531012	1	O
spermatocytes	29531012	1	O
,	29531012	1	O
defective	29531012	1	O
spermatids	29531012	1	O
,	29531012	1	O
and	29531012	1	O
motility	29531012	1	O
-	29531012	1	O
impaired	29531012	1	O
spermatozoa	29531012	1	O
.	29531012	1	O
mib-1	29531012	1	O
mutants	29531012	1	O
also	29531012	1	O
have	29531012	1	O
chromosome	29531012	1	O
segregation	29531012	1	O
defects	29531012	1	O
during	29531012	1	O
meiosis	29531012	1	O
,	29531012	1	O
molecular	29531012	1	O
null	29531012	1	O
mutants	29531012	1	O
are	29531012	1	O
intrinsically	29531012	1	O
temperature	29531012	1	O
-	29531012	1	O
sensitive	29531012	1	O
,	29531012	1	O
and	29531012	1	O
many	29531012	1	O
mib-1	29531012	1	O
spermatids	29531012	1	O
contain	29531012	1	O
large	29531012	1	O
amounts	29531012	1	O
of	29531012	1	O
tubulin	29531012	1	O
.	29531012	1	O
These	29531012	1	O
phenotypic	29531012	1	O
features	29531012	1	O
are	29531012	1	O
similar	29531012	1	O
to	29531012	1	O
the	29531012	1	O
endogenous	29531012	1	O
RNA	29531012	1	O
intereference	29531012	1	O
(	29531012	1	O
RNAi	29531012	1	O
)	29531012	1	O
mutants	29531012	1	O
,	29531012	1	O
but	29531012	1	O
mib-1	29531012	1	O
mutants	29531012	1	O
do	29531012	1	O
not	29531012	1	O
affect	29531012	1	O
RNAi	29531012	1	O
.	29531012	1	O
MIB-1	29531012	1	O
protein	29531012	1	O
is	29531012	1	O
expressed	29531012	1	O
throughout	29531012	1	O
the	29531012	1	O
germ	29531012	1	O
line	29531012	1	O
with	29531012	1	O
peak	29531012	1	O
expression	29531012	1	O
in	29531012	1	O
spermatocytes	29531012	1	O
followed	29531012	1	O
by	29531012	1	O
segregation	29531012	1	O
into	29531012	1	O
the	29531012	1	O
residual	29531012	1	O
body	29531012	1	O
during	29531012	1	O
spermatid	29531012	1	O
formation	29531012	1	O
.	29531012	1	O
C.	29531012	1	O
elegans	29531012	1	O
mib-1	29531012	1	O
expression	29531012	1	O
,	29531012	1	O
while	29531012	1	O
upregulated	29531012	1	O
during	29531012	1	O
spermatogenesis	29531012	1	O
,	29531012	1	O
also	29531012	1	O
occurs	29531012	1	O
somatically	29531012	1	O
,	29531012	1	O
including	29531012	1	O
in	29531012	1	O
vulva	29531012	1	O
precursor	29531012	1	O
cells	29531012	1	O
.	29531012	1	O
Here	29531012	1	O
,	29531012	1	O
we	29531012	1	O
show	29531012	1	O
that	29531012	1	O
mib-1	29531012	1	B-Gene
mutants	29531012	1	B-Var
suppress	29531012	1	B-NegReg
both	29531012	1	O
lin-12	29531012	1	B-Gene
and	29531012	1	O
glp-1	29531012	1	B-Gene
(	29531012	1	O
C.	29531012	1	O
elegans	29531012	1	O
Notch	29531012	1	O
)	29531012	1	O
gain	29531012	1	B-PosReg
-	29531012	1	I-PosReg
of	29531012	1	I-PosReg
-	29531012	1	I-PosReg
function	29531012	1	I-PosReg
mutants	29531012	1	B-Var
,	29531012	1	O
restoring	29531012	1	B-PosReg
anchor	29531012	1	O
cell	29531012	1	O
formation	29531012	1	O
and	29531012	1	O
a	29531012	1	O
functional	29531012	1	O
vulva	29531012	1	O
to	29531012	1	O
the	29531012	1	O
former	29531012	1	O
and	29531012	1	O
partly	29531012	1	O
restoring	29531012	1	O
oocyte	29531012	1	O
production	29531012	1	O
to	29531012	1	O
the	29531012	1	O
latter	29531012	1	O
.	29531012	1	O
However	29531012	1	O
,	29531012	1	O
suppressed	29531012	1	O
hermaphrodites	29531012	1	O
are	29531012	1	O
only	29531012	1	O
observed	29531012	1	O
when	29531012	1	O
grown	29531012	1	O
at	29531012	1	O
25	29531012	1	O
,	29531012	1	O
and	29531012	1	O
they	29531012	1	O
are	29531012	1	O
self	29531012	1	O
-	29531012	1	O
sterile	29531012	1	O
.	29531012	1	O
This	29531012	1	O
probably	29531012	1	O
explains	29531012	1	O
why	29531012	1	O
mib-1	29531012	1	O
was	29531012	1	O
not	29531012	1	O
previously	29531012	1	O
recovered	29531012	1	O
as	29531012	1	O
a	29531012	1	O
Notch	29531012	1	O
pathway	29531012	1	O
component	29531012	1	O
in	29531012	1	O
suppressor	29531012	1	O
/	29531012	1	O
enhancer	29531012	1	O
selection	29531012	1	O
experiments	29531012	1	O
.	29531012	1	O

The	29544460	2	O
curious	29544460	2	O
case	29544460	2	O
of	29544460	2	O
Gαs	29544460	2	O
gain	29544460	2	O
-	29544460	2	O
of	29544460	2	O
-	29544460	2	O
function	29544460	2	O
in	29544460	2	O
neoplasia	29544460	2	O
.	29544460	2	O
BACKGROUND	29544460	2	O
:	29544460	2	O
Mutations	29544460	2	B-Var
activating	29544460	2	B-PosReg
the	29544460	2	O
α	29544460	2	O
subunit	29544460	2	O
of	29544460	2	O
heterotrimeric	29544460	2	O
Gs	29544460	2	O
protein	29544460	2	O
are	29544460	2	O
associated	29544460	2	O
with	29544460	2	O
a	29544460	2	O
number	29544460	2	O
of	29544460	2	O
highly	29544460	2	O
specific	29544460	2	O
pathological	29544460	2	O
molecular	29544460	2	O
phenotypes	29544460	2	O
.	29544460	2	O
One	29544460	2	O
of	29544460	2	O
the	29544460	2	O
best	29544460	2	O
characterized	29544460	2	O
is	29544460	2	O
the	29544460	2	O
McCune	29544460	2	B-Disease
Albright	29544460	2	I-Disease
syndrome	29544460	2	I-Disease
.	29544460	2	O
The	29544460	2	O
disease	29544460	2	O
presents	29544460	2	O
with	29544460	2	O
an	29544460	2	O
increased	29544460	2	O
incidence	29544460	2	O
of	29544460	2	O
neoplasias	29544460	2	O
in	29544460	2	O
specific	29544460	2	O
tissues	29544460	2	O
.	29544460	2	O
MAIN	29544460	2	O
BODY	29544460	2	O
:	29544460	2	O
A	29544460	2	O
similar	29544460	2	O
repertoire	29544460	2	O
of	29544460	2	O
neoplasms	29544460	2	O
can	29544460	2	O
develop	29544460	2	O
whether	29544460	2	O
mutations	29544460	2	O
occur	29544460	2	O
spontaneously	29544460	2	O
in	29544460	2	O
somatic	29544460	2	O
tissues	29544460	2	O
during	29544460	2	O
fetal	29544460	2	O
development	29544460	2	O
or	29544460	2	O
after	29544460	2	O
birth	29544460	2	O
.	29544460	2	O
Glands	29544460	2	O
are	29544460	2	O
the	29544460	2	O
most	29544460	2	O
"	29544460	2	O
permissive	29544460	2	O
"	29544460	2	O
tissues	29544460	2	O
,	29544460	2	O
recently	29544460	2	O
found	29544460	2	O
to	29544460	2	O
include	29544460	2	O
the	29544460	2	O
entire	29544460	2	O
gastrointestinal	29544460	2	O
tract	29544460	2	O
.	29544460	2	O
High	29544460	2	O
frequency	29544460	2	O
of	29544460	2	O
activating	29544460	2	B-PosReg
Gαs	29544460	2	B-Gene
mutations	29544460	2	B-Var
is	29544460	2	O
associated	29544460	2	O
with	29544460	2	O
precise	29544460	2	O
diagnoses	29544460	2	O
(	29544460	2	O
e.g.	29544460	2	O
,	29544460	2	O
IPMN	29544460	2	B-Disease
,	29544460	2	O
Pyloric	29544460	2	B-Disease
gland	29544460	2	I-Disease
adenoma	29544460	2	I-Disease
,	29544460	2	O
pituitary	29544460	2	B-Disease
toxic	29544460	2	I-Disease
adenoma	29544460	2	I-Disease
)	29544460	2	I-Disease
.	29544460	2	O
Typically	29544460	2	O
,	29544460	2	O
most	29544460	2	O
neoplastic	29544460	2	O
lesions	29544460	2	O
,	29544460	2	O
from	29544460	2	O
thyroid	29544460	2	O
to	29544460	2	O
pancreas	29544460	2	O
,	29544460	2	O
remain	29544460	2	O
well	29544460	2	O
differentiated	29544460	2	O
but	29544460	2	O
may	29544460	2	O
be	29544460	2	O
a	29544460	2	O
precursor	29544460	2	O
to	29544460	2	O
aggressive	29544460	2	O
cancer	29544460	2	O
.	29544460	2	O
CONCLUSIONS	29544460	2	O
:	29544460	2	O
Here	29544460	2	O
we	29544460	2	O
propose	29544460	2	O
the	29544460	2	O
possibility	29544460	2	O
that	29544460	2	O
gain	29544460	2	B-PosReg
-	29544460	2	I-PosReg
of	29544460	2	I-PosReg
-	29544460	2	I-PosReg
function	29544460	2	I-PosReg
mutations	29544460	2	B-Var
of	29544460	2	O
Gαs	29544460	2	B-Gene
interfere	29544460	2	B-NegReg
with	29544460	2	O
signals	29544460	2	O
in	29544460	2	O
the	29544460	2	O
microenvironment	29544460	2	O
of	29544460	2	O
permissive	29544460	2	O
tissues	29544460	2	O
and	29544460	2	O
lead	29544460	2	B-Reg
to	29544460	2	I-Reg
a	29544460	2	O
transversal	29544460	2	O
neoplastic	29544460	2	O
phenotype	29544460	2	O
.	29544460	2	O

Dissecting	29546444	0	O
the	29546444	0	O
genetic	29546444	0	O
basis	29546444	0	O
of	29546444	0	O
heavy	29546444	0	O
panicle	29546444	0	O
hybrid	29546444	0	O
rice	29546444	0	O
uncovered	29546444	0	O
Gn1a	29546444	0	O
and	29546444	0	O
GS3	29546444	0	O
as	29546444	0	O
key	29546444	0	O
genes	29546444	0	O
.	29546444	0	O
KEY	29546444	0	O
MESSAGE	29546444	0	O
:	29546444	0	O
Shuhui498	29546444	0	O
(	29546444	0	O
R498	29546444	0	O
)	29546444	0	O
is	29546444	0	O
an	29546444	0	O
elite	29546444	0	O
parent	29546444	0	O
of	29546444	0	O
heavy	29546444	0	O
panicle	29546444	0	O
hybrid	29546444	0	O
rice	29546444	0	O
by	29546444	0	O
pyramiding	29546444	0	O
the	29546444	0	O
rare	29546444	0	O
gn1a	29546444	0	O
and	29546444	0	O
null	29546444	0	O
gs3	29546444	0	O
alleles	29546444	0	O
.	29546444	0	O
This	29546444	0	O
finding	29546444	0	O
reveals	29546444	0	O
the	29546444	0	O
genetic	29546444	0	O
basis	29546444	0	O
and	29546444	0	O
great	29546444	0	O
potential	29546444	0	O
application	29546444	0	O
in	29546444	0	O
future	29546444	0	O
breeding	29546444	0	O
of	29546444	0	O
R498	29546444	0	O
.	29546444	0	O
The	29546444	0	O
heavy	29546444	0	O
panicle	29546444	0	O
trait	29546444	0	O
,	29546444	0	O
defined	29546444	0	O
as	29546444	0	O
5	29546444	0	O
g	29546444	0	O
or	29546444	0	O
more	29546444	0	O
of	29546444	0	O
grain	29546444	0	O
weight	29546444	0	O
per	29546444	0	O
panicle	29546444	0	O
,	29546444	0	O
is	29546444	0	O
one	29546444	0	O
of	29546444	0	O
the	29546444	0	O
target	29546444	0	O
traits	29546444	0	O
in	29546444	0	O
super	29546444	0	O
-	29546444	0	O
high	29546444	0	O
-	29546444	0	O
yield	29546444	0	O
rice	29546444	0	O
breeding	29546444	0	O
programs	29546444	0	O
.	29546444	0	O
The	29546444	0	O
use	29546444	0	O
of	29546444	0	O
heavy	29546444	0	O
panicle	29546444	0	O
-	29546444	0	O
type	29546444	0	O
hybrid	29546444	0	O
rice	29546444	0	O
has	29546444	0	O
been	29546444	0	O
shown	29546444	0	O
to	29546444	0	O
be	29546444	0	O
a	29546444	0	O
successful	29546444	0	O
strategy	29546444	0	O
for	29546444	0	O
super	29546444	0	O
-	29546444	0	O
high	29546444	0	O
-	29546444	0	O
yield	29546444	0	O
breeding	29546444	0	O
programs	29546444	0	O
,	29546444	0	O
particularly	29546444	0	O
under	29546444	0	O
the	29546444	0	O
environmental	29546444	0	O
conditions	29546444	0	O
of	29546444	0	O
high	29546444	0	O
humidity	29546444	0	O
and	29546444	0	O
deficient	29546444	0	O
solar	29546444	0	O
radiation	29546444	0	O
in	29546444	0	O
southwestern	29546444	0	O
China	29546444	0	O
.	29546444	0	O
However	29546444	0	O
,	29546444	0	O
the	29546444	0	O
genetic	29546444	0	O
components	29546444	0	O
of	29546444	0	O
the	29546444	0	O
heavy	29546444	0	O
panicle	29546444	0	O
trait	29546444	0	O
in	29546444	0	O
hybrid	29546444	0	O
rice	29546444	0	O
remain	29546444	0	O
elusive	29546444	0	O
.	29546444	0	O
Here	29546444	0	O
,	29546444	0	O
we	29546444	0	O
report	29546444	0	O
that	29546444	0	O
the	29546444	0	O
combination	29546444	0	O
of	29546444	0	O
loss	29546444	0	B-NegReg
-	29546444	0	I-NegReg
of	29546444	0	I-NegReg
-	29546444	0	I-NegReg
function	29546444	0	I-NegReg
mutations	29546444	0	B-Var
in	29546444	0	O
Grain	29546444	0	O
number	29546444	0	O
1	29546444	0	O
a	29546444	0	O
(	29546444	0	B-Gene
Gn1a	29546444	0	I-Gene
)	29546444	0	I-Gene
and	29546444	0	O
Grain	29546444	0	O
Size	29546444	0	O
3	29546444	0	O
(	29546444	0	B-Gene
GS3	29546444	0	I-Gene
)	29546444	0	I-Gene
is	29546444	0	O
responsible	29546444	0	B-Reg
for	29546444	0	O
the	29546444	0	O
heavy	29546444	0	O
panicle	29546444	0	O
phenotype	29546444	0	O
of	29546444	0	O
the	29546444	0	O
elite	29546444	0	O
hybrid	29546444	0	O
rice	29546444	0	O
restorer	29546444	0	O
line	29546444	0	O
Shuhui498	29546444	0	O
(	29546444	0	O
R498	29546444	0	O
)	29546444	0	O
.	29546444	0	O
The	29546444	0	O
null	29546444	0	O
gn1a	29546444	0	O
allele	29546444	0	O
is	29546444	0	O
the	29546444	0	O
determinant	29546444	0	O
factor	29546444	0	O
for	29546444	0	O
heavy	29546444	0	O
panicles	29546444	0	O
through	29546444	0	O
increased	29546444	0	O
grain	29546444	0	O
number	29546444	0	O
,	29546444	0	O
while	29546444	0	O
gs3	29546444	0	O
is	29546444	0	O
associated	29546444	0	O
with	29546444	0	O
grain	29546444	0	O
size	29546444	0	O
and	29546444	0	O
weight	29546444	0	O
.	29546444	0	O
R498	29546444	0	O
pyramided	29546444	0	O
the	29546444	0	O
two	29546444	0	O
major	29546444	0	O
null	29546444	0	O
alleles	29546444	0	O
,	29546444	0	O
resulting	29546444	0	O
in	29546444	0	O
heavy	29546444	0	O
panicles	29546444	0	O
with	29546444	0	O
a	29546444	0	O
high	29546444	0	O
grain	29546444	0	O
number	29546444	0	O
and	29546444	0	O
large	29546444	0	O
grains	29546444	0	O
.	29546444	0	O
Clustering	29546444	0	O
analysis	29546444	0	O
revealed	29546444	0	O
that	29546444	0	O
the	29546444	0	O
null	29546444	0	O
gn1aR498	29546444	0	O
allele	29546444	0	O
is	29546444	0	O
a	29546444	0	O
rare	29546444	0	O
haplotype	29546444	0	O
which	29546444	0	O
has	29546444	0	O
been	29546444	0	O
innovatively	29546444	0	O
utilized	29546444	0	O
in	29546444	0	O
R498	29546444	0	O
,	29546444	0	O
underscoring	29546444	0	O
the	29546444	0	O
great	29546444	0	O
potential	29546444	0	O
of	29546444	0	O
R498	29546444	0	O
for	29546444	0	O
breeding	29546444	0	O
purposes	29546444	0	O
.	29546444	0	O
Our	29546444	0	O
research	29546444	0	O
thus	29546444	0	O
sheds	29546444	0	O
light	29546444	0	O
on	29546444	0	O
the	29546444	0	O
distinct	29546444	0	O
genetic	29546444	0	O
compositions	29546444	0	O
of	29546444	0	O
heavy	29546444	0	O
panicle	29546444	0	O
-	29546444	0	O
type	29546444	0	O
rice	29546444	0	O
and	29546444	0	O
may	29546444	0	O
potentially	29546444	0	O
facilitate	29546444	0	O
super	29546444	0	O
-	29546444	0	O
high	29546444	0	O
-	29546444	0	O
yield	29546444	0	O
rice	29546444	0	O
breeding	29546444	0	O
.	29546444	0	O

A	29562163	1	O
Protein	29562163	1	O
-	29562163	1	O
Truncating	29562163	1	O
HSD17B13	29562163	1	O
Variant	29562163	1	O
and	29562163	1	O
Protection	29562163	1	O
from	29562163	1	O
Chronic	29562163	1	O
Liver	29562163	1	O
Disease	29562163	1	O
.	29562163	1	O
BACKGROUND	29562163	1	O
:	29562163	1	O
Elucidation	29562163	1	O
of	29562163	1	O
the	29562163	1	O
genetic	29562163	1	O
factors	29562163	1	O
underlying	29562163	1	O
chronic	29562163	1	O
liver	29562163	1	O
disease	29562163	1	O
may	29562163	1	O
reveal	29562163	1	O
new	29562163	1	O
therapeutic	29562163	1	O
targets	29562163	1	O
.	29562163	1	O
METHODS	29562163	1	O
:	29562163	1	O
We	29562163	1	O
used	29562163	1	O
exome	29562163	1	O
sequence	29562163	1	O
data	29562163	1	O
and	29562163	1	O
electronic	29562163	1	O
health	29562163	1	O
records	29562163	1	O
from	29562163	1	O
46	29562163	1	O
,	29562163	1	O
544	29562163	1	O
participants	29562163	1	O
in	29562163	1	O
the	29562163	1	O
DiscovEHR	29562163	1	O
human	29562163	1	O
genetics	29562163	1	O
study	29562163	1	O
to	29562163	1	O
identify	29562163	1	O
genetic	29562163	1	O
variants	29562163	1	O
associated	29562163	1	O
with	29562163	1	O
serum	29562163	1	O
levels	29562163	1	O
of	29562163	1	O
alanine	29562163	1	O
aminotransferase	29562163	1	O
(	29562163	1	O
ALT	29562163	1	O
)	29562163	1	O
and	29562163	1	O
aspartate	29562163	1	O
aminotransferase	29562163	1	O
(	29562163	1	O
AST	29562163	1	O
)	29562163	1	O
.	29562163	1	O
Variants	29562163	1	B-Var
that	29562163	1	O
were	29562163	1	O
replicated	29562163	1	O
in	29562163	1	O
three	29562163	1	O
additional	29562163	1	O
cohorts	29562163	1	O
(	29562163	1	O
12	29562163	1	O
,	29562163	1	O
527	29562163	1	O
persons	29562163	1	O
)	29562163	1	O
were	29562163	1	O
evaluated	29562163	1	O
for	29562163	1	O
association	29562163	1	O
with	29562163	1	O
clinical	29562163	1	O
diagnoses	29562163	1	O
of	29562163	1	O
chronic	29562163	1	B-Disease
liver	29562163	1	I-Disease
disease	29562163	1	I-Disease
in	29562163	1	O
DiscovEHR	29562163	1	O
study	29562163	1	O
participants	29562163	1	O
and	29562163	1	O
two	29562163	1	O
independent	29562163	1	O
cohorts	29562163	1	O
(	29562163	1	O
total	29562163	1	O
of	29562163	1	O
37	29562163	1	O
,	29562163	1	O
173	29562163	1	O
persons	29562163	1	O
)	29562163	1	O
and	29562163	1	O
with	29562163	1	O
histopathological	29562163	1	O
severity	29562163	1	O
of	29562163	1	O
liver	29562163	1	O
disease	29562163	1	O
in	29562163	1	O
2391	29562163	1	O
human	29562163	1	O
liver	29562163	1	O
samples	29562163	1	O
.	29562163	1	O
RESULTS	29562163	1	O
:	29562163	1	O
A	29562163	1	O
splice	29562163	1	B-Var
variant	29562163	1	I-Var
(	29562163	1	O
rs72613567	29562163	1	O
:	29562163	1	O
TA	29562163	1	O
)	29562163	1	O
in	29562163	1	O
HSD17B13	29562163	1	B-Gene
,	29562163	1	O
encoding	29562163	1	O
the	29562163	1	O
hepatic	29562163	1	O
lipid	29562163	1	O
droplet	29562163	1	O
protein	29562163	1	O
hydroxysteroid	29562163	1	O
17	29562163	1	O
-	29562163	1	O
beta	29562163	1	O
dehydrogenase	29562163	1	O
13	29562163	1	O
,	29562163	1	O
was	29562163	1	O
associated	29562163	1	O
with	29562163	1	O
reduced	29562163	1	B-NegReg
levels	29562163	1	O
of	29562163	1	O
ALT	29562163	1	O
(	29562163	1	O
P	29562163	1	O
=	29562163	1	O
4.2	29562163	1	O
10	29562163	1	O
-	29562163	1	O
12	29562163	1	O
)	29562163	1	O
and	29562163	1	O
AST	29562163	1	O
(	29562163	1	O
P	29562163	1	O
=	29562163	1	O
6.2	29562163	1	O
10	29562163	1	O
-	29562163	1	O
10	29562163	1	O
)	29562163	1	O
.	29562163	1	O
Among	29562163	1	O
DiscovEHR	29562163	1	O
study	29562163	1	O
participants	29562163	1	O
,	29562163	1	O
this	29562163	1	O
variant	29562163	1	B-Var
was	29562163	1	O
associated	29562163	1	O
with	29562163	1	O
a	29562163	1	O
reduced	29562163	1	B-NegReg
risk	29562163	1	O
of	29562163	1	O
alcoholic	29562163	1	B-Disease
liver	29562163	1	I-Disease
disease	29562163	1	I-Disease
(	29562163	1	O
by	29562163	1	O
42%	29562163	1	O
[	29562163	1	O
95%	29562163	1	O
confidence	29562163	1	O
interval	29562163	1	O
CI	29562163	1	O
,	29562163	1	O
20	29562163	1	O
to	29562163	1	O
58	29562163	1	O
]	29562163	1	O
among	29562163	1	O
heterozygotes	29562163	1	O
and	29562163	1	O
by	29562163	1	O
53%	29562163	1	O
[	29562163	1	O
95%	29562163	1	O
CI	29562163	1	O
,	29562163	1	O
3	29562163	1	O
to	29562163	1	O
77	29562163	1	O
]	29562163	1	O
among	29562163	1	O
homozygotes	29562163	1	O
)	29562163	1	O
,	29562163	1	O
nonalcoholic	29562163	1	B-Disease
liver	29562163	1	I-Disease
disease	29562163	1	I-Disease
(	29562163	1	O
by	29562163	1	O
17%	29562163	1	O
[	29562163	1	O
95%	29562163	1	O
CI	29562163	1	O
,	29562163	1	O
8	29562163	1	O
to	29562163	1	O
25	29562163	1	O
]	29562163	1	O
among	29562163	1	O
heterozygotes	29562163	1	O
and	29562163	1	O
by	29562163	1	O
30%	29562163	1	O
[	29562163	1	O
95%	29562163	1	O
CI	29562163	1	O
,	29562163	1	O
13	29562163	1	O
to	29562163	1	O
43	29562163	1	O
]	29562163	1	O
among	29562163	1	O
homozygotes	29562163	1	O
)	29562163	1	O
,	29562163	1	O
alcoholic	29562163	1	B-Disease
cirrhosis	29562163	1	I-Disease
(	29562163	1	O
by	29562163	1	O
42%	29562163	1	O
[	29562163	1	O
95%	29562163	1	O
CI	29562163	1	O
,	29562163	1	O
14	29562163	1	O
to	29562163	1	O
61	29562163	1	O
]	29562163	1	O
among	29562163	1	O
heterozygotes	29562163	1	O
and	29562163	1	O
by	29562163	1	O
73%	29562163	1	O
[	29562163	1	O
95%	29562163	1	O
CI	29562163	1	O
,	29562163	1	O
15	29562163	1	O
to	29562163	1	O
91	29562163	1	O
]	29562163	1	O
among	29562163	1	O
homozygotes	29562163	1	O
)	29562163	1	O
,	29562163	1	O
and	29562163	1	O
nonalcoholic	29562163	1	B-Disease
cirrhosis	29562163	1	I-Disease
(	29562163	1	O
by	29562163	1	O
26%	29562163	1	O
[	29562163	1	O
95%	29562163	1	O
CI	29562163	1	O
,	29562163	1	O
7	29562163	1	O
to	29562163	1	O
40	29562163	1	O
]	29562163	1	O
among	29562163	1	O
heterozygotes	29562163	1	O
and	29562163	1	O
by	29562163	1	O
49%	29562163	1	O
[	29562163	1	O
95%	29562163	1	O
CI	29562163	1	O
,	29562163	1	O
15	29562163	1	O
to	29562163	1	O
69	29562163	1	O
]	29562163	1	O
among	29562163	1	O
homozygotes	29562163	1	O
)	29562163	1	O
.	29562163	1	O
Associations	29562163	1	O
were	29562163	1	O
confirmed	29562163	1	O
in	29562163	1	O
two	29562163	1	O
independent	29562163	1	O
cohorts	29562163	1	O
.	29562163	1	O
The	29562163	1	O
rs72613567	29562163	1	O
:	29562163	1	O
TA	29562163	1	O
variant	29562163	1	B-Var
was	29562163	1	O
associated	29562163	1	O
with	29562163	1	O
a	29562163	1	O
reduced	29562163	1	B-NegReg
risk	29562163	1	O
of	29562163	1	O
nonalcoholic	29562163	1	B-Disease
steatohepatitis	29562163	1	I-Disease
,	29562163	1	O
but	29562163	1	O
not	29562163	1	O
steatosis	29562163	1	O
,	29562163	1	O
in	29562163	1	O
human	29562163	1	O
liver	29562163	1	O
samples	29562163	1	O
.	29562163	1	O
The	29562163	1	O
rs72613567	29562163	1	O
:	29562163	1	O
TA	29562163	1	O
variant	29562163	1	B-Var
mitigated	29562163	1	B-NegReg
liver	29562163	1	B-Disease
injury	29562163	1	I-Disease
associated	29562163	1	O
with	29562163	1	O
the	29562163	1	O
risk	29562163	1	O
-	29562163	1	O
increasing	29562163	1	O
PNPLA3	29562163	1	O
p.I148M	29562163	1	O
allele	29562163	1	O
and	29562163	1	O
resulted	29562163	1	O
in	29562163	1	O
an	29562163	1	O
unstable	29562163	1	O
and	29562163	1	O
truncated	29562163	1	O
protein	29562163	1	O
with	29562163	1	O
reduced	29562163	1	O
enzymatic	29562163	1	O
activity	29562163	1	O
.	29562163	1	O
CONCLUSIONS	29562163	1	O
:	29562163	1	O
A	29562163	1	O
loss	29562163	1	B-NegReg
-	29562163	1	I-NegReg
of	29562163	1	I-NegReg
-	29562163	1	I-NegReg
function	29562163	1	I-NegReg
variant	29562163	1	B-Var
in	29562163	1	O
HSD17B13	29562163	1	B-Gene
was	29562163	1	O
associated	29562163	1	O
with	29562163	1	O
a	29562163	1	O
reduced	29562163	1	B-NegReg
risk	29562163	1	O
of	29562163	1	O
chronic	29562163	1	B-Disease
liver	29562163	1	I-Disease
disease	29562163	1	I-Disease
and	29562163	1	O
of	29562163	1	O
progression	29562163	1	O
from	29562163	1	O
steatosis	29562163	1	O
to	29562163	1	O
steatohepatitis	29562163	1	O
.	29562163	1	O
(	29562163	1	O
Funded	29562163	1	O
by	29562163	1	O
Regeneron	29562163	1	O
Pharmaceuticals	29562163	1	O
and	29562163	1	O
others	29562163	1	O
.	29562163	1	O
)	29562163	1	O
.	29562163	1	O

Gain	29572350	2	O
-	29572350	2	O
of	29572350	2	O
-	29572350	2	O
function	29572350	2	O
mutations	29572350	2	O
in	29572350	2	O
granulocyte	29572350	2	O
colony	29572350	2	O
-	29572350	2	O
stimulating	29572350	2	O
factor	29572350	2	O
receptor	29572350	2	O
(	29572350	2	O
CSF3R	29572350	2	O
)	29572350	2	O
reveal	29572350	2	O
distinct	29572350	2	O
mechanisms	29572350	2	O
of	29572350	2	O
CSF3R	29572350	2	O
activation	29572350	2	O
.	29572350	2	O
Granulocyte	29572350	2	O
colony	29572350	2	O
-	29572350	2	O
stimulating	29572350	2	O
factor	29572350	2	O
(	29572350	2	O
G	29572350	2	O
-	29572350	2	O
CSF	29572350	2	O
or	29572350	2	O
CSF3	29572350	2	O
)	29572350	2	O
and	29572350	2	O
its	29572350	2	O
receptor	29572350	2	O
CSF3R	29572350	2	O
regulate	29572350	2	O
granulopoiesis	29572350	2	O
,	29572350	2	O
neutrophil	29572350	2	O
function	29572350	2	O
,	29572350	2	O
and	29572350	2	O
hematopoietic	29572350	2	O
stem	29572350	2	O
cell	29572350	2	O
mobilization	29572350	2	O
.	29572350	2	O
Recent	29572350	2	O
studies	29572350	2	O
have	29572350	2	O
uncovered	29572350	2	O
an	29572350	2	O
oncogenic	29572350	2	O
role	29572350	2	O
of	29572350	2	O
mutations	29572350	2	B-Var
in	29572350	2	O
the	29572350	2	O
CSF3R	29572350	2	B-Gene
gene	29572350	2	O
in	29572350	2	O
many	29572350	2	O
hematologic	29572350	2	B-Disease
malignancies	29572350	2	I-Disease
.	29572350	2	O
To	29572350	2	O
find	29572350	2	O
additional	29572350	2	O
CSF3R	29572350	2	O
mutations	29572350	2	O
that	29572350	2	O
give	29572350	2	O
rise	29572350	2	O
to	29572350	2	O
cell	29572350	2	O
transformation	29572350	2	O
,	29572350	2	O
we	29572350	2	O
performed	29572350	2	O
a	29572350	2	O
cellular	29572350	2	O
transformation	29572350	2	O
assay	29572350	2	O
in	29572350	2	O
which	29572350	2	O
murine	29572350	2	O
interleukin	29572350	2	O
3	29572350	2	O
(	29572350	2	O
IL-3	29572350	2	O
)	29572350	2	O
-	29572350	2	O
dependent	29572350	2	O
Ba	29572350	2	O
/	29572350	2	O
F3	29572350	2	O
cells	29572350	2	O
were	29572350	2	O
transduced	29572350	2	O
with	29572350	2	O
WT	29572350	2	O
CSF3R	29572350	2	O
plasmid	29572350	2	O
and	29572350	2	O
screened	29572350	2	O
for	29572350	2	O
spontaneous	29572350	2	O
growth	29572350	2	O
in	29572350	2	O
the	29572350	2	O
absence	29572350	2	O
of	29572350	2	O
IL-3	29572350	2	O
.	29572350	2	O
Any	29572350	2	O
outgrowth	29572350	2	O
clones	29572350	2	O
were	29572350	2	O
sequenced	29572350	2	O
to	29572350	2	O
identify	29572350	2	O
CSF3R	29572350	2	O
mutations	29572350	2	O
with	29572350	2	O
transformation	29572350	2	O
capacity	29572350	2	O
.	29572350	2	O
We	29572350	2	O
identified	29572350	2	O
several	29572350	2	O
novel	29572350	2	O
mutations	29572350	2	B-Var
and	29572350	2	O
determined	29572350	2	O
that	29572350	2	O
they	29572350	2	O
transform	29572350	2	B-Reg
cells	29572350	2	O
via	29572350	2	O
four	29572350	2	O
distinct	29572350	2	O
mechanisms	29572350	2	O
:	29572350	2	O
1	29572350	2	O
)	29572350	2	O
cysteine	29572350	2	O
-	29572350	2	O
and	29572350	2	O
disulfide	29572350	2	O
bond	29572350	2	O
-	29572350	2	O
mediated	29572350	2	O
dimerization	29572350	2	O
(	29572350	2	O
S581C	29572350	2	O
)	29572350	2	O
;	29572350	2	O
2	29572350	2	O
)	29572350	2	O
polar	29572350	2	B-Var
,	29572350	2	O
noncharged	29572350	2	I-Var
amino	29572350	2	I-Var
acid	29572350	2	I-Var
substitution	29572350	2	I-Var
at	29572350	2	O
the	29572350	2	O
transmembrane	29572350	2	O
helix	29572350	2	O
dimer	29572350	2	O
interface	29572350	2	O
at	29572350	2	O
residue	29572350	2	O
Thr-640	29572350	2	O
;	29572350	2	O
3	29572350	2	O
)	29572350	2	O
increased	29572350	2	B-PosReg
internalization	29572350	2	O
by	29572350	2	O
a	29572350	2	O
Glu-524	29572350	2	O
substitution	29572350	2	O
that	29572350	2	O
mimics	29572350	2	O
a	29572350	2	O
low	29572350	2	O
G	29572350	2	O
-	29572350	2	O
CSF	29572350	2	O
dose	29572350	2	O
;	29572350	2	O
and	29572350	2	O
4	29572350	2	O
)	29572350	2	O
hydrophobic	29572350	2	B-Var
amino	29572350	2	I-Var
acid	29572350	2	I-Var
substitutions	29572350	2	I-Var
in	29572350	2	O
the	29572350	2	O
membrane	29572350	2	O
-	29572350	2	O
proximal	29572350	2	O
residues	29572350	2	O
Thr-612	29572350	2	O
,	29572350	2	O
Thr-615	29572350	2	O
,	29572350	2	O
and	29572350	2	O
Thr-618	29572350	2	O
.	29572350	2	O
Furthermore	29572350	2	O
,	29572350	2	O
the	29572350	2	O
change	29572350	2	O
in	29572350	2	O
signaling	29572350	2	O
activation	29572350	2	O
was	29572350	2	O
related	29572350	2	O
to	29572350	2	O
an	29572350	2	O
altered	29572350	2	O
CSF3R	29572350	2	O
localization	29572350	2	O
.	29572350	2	O
We	29572350	2	O
also	29572350	2	O
found	29572350	2	O
that	29572350	2	O
CSF3R	29572350	2	O
-	29572350	2	O
induced	29572350	2	O
STAT3	29572350	2	O
and	29572350	2	O
ERK	29572350	2	O
activations	29572350	2	O
require	29572350	2	O
CSF3R	29572350	2	O
internalization	29572350	2	O
,	29572350	2	O
whereas	29572350	2	O
STAT5	29572350	2	O
activation	29572350	2	O
occurred	29572350	2	O
at	29572350	2	O
the	29572350	2	O
cell	29572350	2	O
surface	29572350	2	O
.	29572350	2	O
Cumulatively	29572350	2	O
,	29572350	2	O
we	29572350	2	O
have	29572350	2	O
expanded	29572350	2	O
the	29572350	2	O
regions	29572350	2	O
of	29572350	2	O
the	29572350	2	O
CSF3R	29572350	2	O
extracellular	29572350	2	O
and	29572350	2	O
transmembrane	29572350	2	O
domains	29572350	2	O
in	29572350	2	O
which	29572350	2	O
missense	29572350	2	B-Var
mutations	29572350	2	I-Var
exhibit	29572350	2	B-PosReg
leukemogenic	29572350	2	B-Disease
capacity	29572350	2	O
and	29572350	2	O
have	29572350	2	O
further	29572350	2	O
elucidated	29572350	2	O
the	29572350	2	O
mechanistic	29572350	2	O
underpinnings	29572350	2	O
that	29572350	2	O
underlie	29572350	2	O
altered	29572350	2	O
CSF3R	29572350	2	O
expression	29572350	2	O
,	29572350	2	O
dimerization	29572350	2	O
,	29572350	2	O
and	29572350	2	O
signaling	29572350	2	O
activation	29572350	2	O
.	29572350	2	O

Biallelic	29575631	1	O
loss	29575631	1	B-NegReg
-	29575631	1	I-NegReg
of	29575631	1	I-NegReg
-	29575631	1	I-NegReg
function	29575631	1	I-NegReg
WNT5A	29575631	1	B-Gene
mutations	29575631	1	B-Var
in	29575631	1	O
an	29575631	1	O
infant	29575631	1	O
with	29575631	1	O
severe	29575631	1	O
and	29575631	1	O
atypical	29575631	1	O
manifestations	29575631	1	O
of	29575631	1	O
Robinow	29575631	1	B-Disease
syndrome	29575631	1	I-Disease
.	29575631	1	O
Robinow	29575631	1	O
syndrome	29575631	1	O
(	29575631	1	O
RS	29575631	1	O
)	29575631	1	O
is	29575631	1	O
a	29575631	1	O
well	29575631	1	O
-	29575631	1	O
recognized	29575631	1	O
Mendelian	29575631	1	O
disorder	29575631	1	O
known	29575631	1	O
to	29575631	1	O
demonstrate	29575631	1	O
both	29575631	1	O
autosomal	29575631	1	O
dominant	29575631	1	O
and	29575631	1	O
autosomal	29575631	1	O
recessive	29575631	1	O
inheritance	29575631	1	O
.	29575631	1	O
Typical	29575631	1	O
manifestations	29575631	1	O
include	29575631	1	O
short	29575631	1	O
stature	29575631	1	O
,	29575631	1	O
characteristic	29575631	1	O
facies	29575631	1	O
,	29575631	1	O
and	29575631	1	O
skeletal	29575631	1	O
anomalies	29575631	1	O
.	29575631	1	O
Recessive	29575631	1	O
inheritance	29575631	1	O
has	29575631	1	O
been	29575631	1	O
associated	29575631	1	O
with	29575631	1	O
mutations	29575631	1	O
in	29575631	1	O
ROR2	29575631	1	O
while	29575631	1	O
dominant	29575631	1	O
inheritance	29575631	1	O
has	29575631	1	O
been	29575631	1	O
observed	29575631	1	O
for	29575631	1	O
mutations	29575631	1	O
in	29575631	1	O
WNT5A	29575631	1	O
,	29575631	1	O
DVL1	29575631	1	O
,	29575631	1	O
and	29575631	1	O
DVL3	29575631	1	O
.	29575631	1	O
Through	29575631	1	O
trio	29575631	1	O
whole	29575631	1	O
genome	29575631	1	O
sequencing	29575631	1	O
,	29575631	1	O
we	29575631	1	O
identified	29575631	1	O
a	29575631	1	O
homozygous	29575631	1	B-Var
frameshifting	29575631	1	I-Var
single	29575631	1	I-Var
nucleotide	29575631	1	I-Var
deletion	29575631	1	I-Var
in	29575631	1	O
WNT5A	29575631	1	B-Gene
in	29575631	1	O
a	29575631	1	O
previously	29575631	1	O
reported	29575631	1	O
,	29575631	1	O
deceased	29575631	1	O
infant	29575631	1	O
with	29575631	1	O
a	29575631	1	O
unique	29575631	1	O
constellation	29575631	1	O
of	29575631	1	O
features	29575631	1	O
comprising	29575631	1	O
a	29575631	1	O
46	29575631	1	O
,	29575631	1	O
XY	29575631	1	O
disorder	29575631	1	O
of	29575631	1	O
sex	29575631	1	O
development	29575631	1	O
with	29575631	1	O
multiple	29575631	1	O
congenital	29575631	1	O
malformations	29575631	1	O
including	29575631	1	O
congenital	29575631	1	B-Disease
diaphragmatic	29575631	1	I-Disease
hernia	29575631	1	I-Disease
,	29575631	1	O
ambiguous	29575631	1	B-Disease
genitalia	29575631	1	I-Disease
,	29575631	1	O
dysmorphic	29575631	1	B-Disease
facies	29575631	1	I-Disease
,	29575631	1	O
shortened	29575631	1	B-Disease
long	29575631	1	I-Disease
bones	29575631	1	I-Disease
,	29575631	1	O
adactyly	29575631	1	B-Disease
,	29575631	1	O
and	29575631	1	O
ventricular	29575631	1	B-Disease
septal	29575631	1	I-Disease
defect	29575631	1	I-Disease
.	29575631	1	O
The	29575631	1	O
parents	29575631	1	O
,	29575631	1	O
who	29575631	1	O
are	29575631	1	O
both	29575631	1	O
heterozygous	29575631	1	O
for	29575631	1	O
the	29575631	1	O
deletion	29575631	1	O
,	29575631	1	O
appear	29575631	1	O
clinically	29575631	1	O
unaffected	29575631	1	O
.	29575631	1	O
In	29575631	1	O
conjunction	29575631	1	O
with	29575631	1	O
published	29575631	1	O
observations	29575631	1	O
of	29575631	1	O
Wnt5a	29575631	1	O
double	29575631	1	O
knockout	29575631	1	O
mice	29575631	1	O
,	29575631	1	O
we	29575631	1	O
provide	29575631	1	O
evidence	29575631	1	O
for	29575631	1	O
the	29575631	1	O
possibility	29575631	1	O
of	29575631	1	O
autosomal	29575631	1	O
recessive	29575631	1	O
inheritance	29575631	1	O
in	29575631	1	O
association	29575631	1	O
with	29575631	1	O
WNT5A	29575631	1	O
loss	29575631	1	O
-	29575631	1	O
of	29575631	1	O
-	29575631	1	O
function	29575631	1	O
mutations	29575631	1	O
in	29575631	1	O
RS	29575631	1	O
.	29575631	1	O

Molecular	29578119	4	O
Analysis	29578119	4	O
-	29578119	4	O
Based	29578119	4	O
Genetic	29578119	4	O
Characterization	29578119	4	O
of	29578119	4	O
a	29578119	4	O
Cohort	29578119	4	O
of	29578119	4	O
Patients	29578119	4	O
with	29578119	4	O
Duchenne	29578119	4	O
and	29578119	4	O
Becker	29578119	4	O
Muscular	29578119	4	O
Dystrophy	29578119	4	O
in	29578119	4	O
Eastern	29578119	4	O
China	29578119	4	O
.	29578119	4	O
Background	29578119	4	O
:	29578119	4	O
Duchenne	29578119	4	B-Disease
muscular	29578119	4	I-Disease
dystrophy	29578119	4	I-Disease
(	29578119	4	O
DMD	29578119	4	O
)	29578119	4	O
and	29578119	4	O
Becker	29578119	4	B-Disease
muscular	29578119	4	I-Disease
dystrophy	29578119	4	I-Disease
(	29578119	4	O
BMD	29578119	4	O
)	29578119	4	O
are	29578119	4	O
common	29578119	4	O
X	29578119	4	O
-	29578119	4	O
linked	29578119	4	O
recessive	29578119	4	O
neuromuscular	29578119	4	O
disorders	29578119	4	O
caused	29578119	4	B-Reg
by	29578119	4	I-Reg
mutations	29578119	4	B-Var
in	29578119	4	O
dystrophin	29578119	4	B-Gene
gene	29578119	4	I-Gene
.	29578119	4	O
Multiplex	29578119	4	O
polymerase	29578119	4	O
chain	29578119	4	O
reaction	29578119	4	O
(	29578119	4	O
multiplex	29578119	4	O
PCR	29578119	4	O
)	29578119	4	O
and	29578119	4	O
multiplex	29578119	4	O
ligation	29578119	4	O
-	29578119	4	O
dependent	29578119	4	O
probe	29578119	4	O
amplification	29578119	4	O
(	29578119	4	O
MLPA	29578119	4	O
)	29578119	4	O
are	29578119	4	O
the	29578119	4	O
most	29578119	4	O
common	29578119	4	O
methods	29578119	4	O
for	29578119	4	O
detecting	29578119	4	O
dystrophin	29578119	4	O
gene	29578119	4	O
mutations	29578119	4	O
.	29578119	4	O
This	29578119	4	O
study	29578119	4	O
aimed	29578119	4	O
to	29578119	4	O
contrast	29578119	4	O
the	29578119	4	O
two	29578119	4	O
methods	29578119	4	O
and	29578119	4	O
discern	29578119	4	O
the	29578119	4	O
genetic	29578119	4	O
characterization	29578119	4	O
of	29578119	4	O
patients	29578119	4	O
with	29578119	4	O
DMD	29578119	4	O
/	29578119	4	O
BMD	29578119	4	O
in	29578119	4	O
Eastern	29578119	4	O
China	29578119	4	O
.	29578119	4	O
Methods	29578119	4	O
:	29578119	4	O
We	29578119	4	O
collected	29578119	4	O
121	29578119	4	O
probands	29578119	4	O
,	29578119	4	O
64	29578119	4	O
mothers	29578119	4	O
of	29578119	4	O
probands	29578119	4	O
,	29578119	4	O
and	29578119	4	O
15	29578119	4	O
fetuses	29578119	4	O
in	29578119	4	O
our	29578119	4	O
study	29578119	4	O
.	29578119	4	O
The	29578119	4	O
dystrophin	29578119	4	O
gene	29578119	4	O
was	29578119	4	O
detected	29578119	4	O
by	29578119	4	O
multiplex	29578119	4	O
PCR	29578119	4	O
primarily	29578119	4	O
in	29578119	4	O
28	29578119	4	O
probands	29578119	4	O
,	29578119	4	O
and	29578119	4	O
MLPA	29578119	4	O
was	29578119	4	O
used	29578119	4	O
in	29578119	4	O
multiplex	29578119	4	O
PCR	29578119	4	O
-	29578119	4	O
negative	29578119	4	O
cases	29578119	4	O
subsequently	29578119	4	O
.	29578119	4	O
The	29578119	4	O
dystrophin	29578119	4	O
gene	29578119	4	O
of	29578119	4	O
the	29578119	4	O
remaining	29578119	4	O
93	29578119	4	O
probands	29578119	4	O
and	29578119	4	O
62	29578119	4	O
female	29578119	4	O
potential	29578119	4	O
carriers	29578119	4	O
was	29578119	4	O
tested	29578119	4	O
by	29578119	4	O
MLPA	29578119	4	O
directly	29578119	4	O
.	29578119	4	O
In	29578119	4	O
fetuses	29578119	4	O
,	29578119	4	O
multiplex	29578119	4	O
PCR	29578119	4	O
and	29578119	4	O
MLPA	29578119	4	O
were	29578119	4	O
performed	29578119	4	O
on	29578119	4	O
4	29578119	4	O
fetuses	29578119	4	O
and	29578119	4	O
10	29578119	4	O
fetuses	29578119	4	O
,	29578119	4	O
respectively	29578119	4	O
.	29578119	4	O
In	29578119	4	O
addition	29578119	4	O
,	29578119	4	O
sequencing	29578119	4	O
was	29578119	4	O
also	29578119	4	O
performed	29578119	4	O
in	29578119	4	O
4	29578119	4	O
probands	29578119	4	O
with	29578119	4	O
negative	29578119	4	O
MLPA	29578119	4	O
.	29578119	4	O
Results	29578119	4	O
:	29578119	4	O
We	29578119	4	O
found	29578119	4	O
that	29578119	4	O
61.98%	29578119	4	O
of	29578119	4	O
the	29578119	4	O
subjects	29578119	4	O
had	29578119	4	O
genetic	29578119	4	O
mutations	29578119	4	O
including	29578119	4	O
deletions	29578119	4	O
(	29578119	4	O
50.41%	29578119	4	O
)	29578119	4	O
and	29578119	4	O
duplications	29578119	4	O
(	29578119	4	O
11.57%	29578119	4	O
)	29578119	4	O
.	29578119	4	O
There	29578119	4	O
were	29578119	4	O
43.75%	29578119	4	O
of	29578119	4	O
mothers	29578119	4	O
as	29578119	4	O
carriers	29578119	4	O
of	29578119	4	O
the	29578119	4	O
mutation	29578119	4	O
.	29578119	4	O
In	29578119	4	O
15	29578119	4	O
fetuses	29578119	4	O
,	29578119	4	O
2	29578119	4	O
out	29578119	4	O
of	29578119	4	O
7	29578119	4	O
male	29578119	4	O
fetuses	29578119	4	O
were	29578119	4	O
found	29578119	4	O
to	29578119	4	O
be	29578119	4	O
unhealthy	29578119	4	O
and	29578119	4	O
2	29578119	4	O
out	29578119	4	O
of	29578119	4	O
8	29578119	4	O
female	29578119	4	O
fetuses	29578119	4	O
were	29578119	4	O
found	29578119	4	O
to	29578119	4	O
be	29578119	4	O
carriers	29578119	4	O
.	29578119	4	O
Exons	29578119	4	O
3	29578119	4	O
-	29578119	4	O
26	29578119	4	O
and	29578119	4	O
45	29578119	4	O
-	29578119	4	O
52	29578119	4	O
have	29578119	4	O
the	29578119	4	O
maximum	29578119	4	O
frequency	29578119	4	O
in	29578119	4	O
mutation	29578119	4	O
regions	29578119	4	O
.	29578119	4	O
In	29578119	4	O
the	29578119	4	O
frequency	29578119	4	O
of	29578119	4	O
exons	29578119	4	O
individually	29578119	4	O
,	29578119	4	O
exon	29578119	4	O
47	29578119	4	O
and	29578119	4	O
exon	29578119	4	O
50	29578119	4	O
were	29578119	4	O
the	29578119	4	O
most	29578119	4	O
common	29578119	4	O
in	29578119	4	O
deleted	29578119	4	O
regions	29578119	4	O
and	29578119	4	O
exons	29578119	4	O
5	29578119	4	O
,	29578119	4	O
6	29578119	4	O
,	29578119	4	O
and	29578119	4	O
7	29578119	4	O
were	29578119	4	O
found	29578119	4	O
most	29578119	4	O
frequently	29578119	4	O
in	29578119	4	O
duplicated	29578119	4	O
regions	29578119	4	O
.	29578119	4	O
Conclusions	29578119	4	O
:	29578119	4	O
MLPA	29578119	4	O
has	29578119	4	O
better	29578119	4	O
productivity	29578119	4	O
and	29578119	4	O
sensitivity	29578119	4	O
than	29578119	4	O
multiplex	29578119	4	O
PCR	29578119	4	O
.	29578119	4	O
Prenatal	29578119	4	O
diagnosis	29578119	4	O
should	29578119	4	O
be	29578119	4	O
applied	29578119	4	O
in	29578119	4	O
DMD	29578119	4	O
high	29578119	4	O
-	29578119	4	O
risk	29578119	4	O
fetuses	29578119	4	O
to	29578119	4	O
reduce	29578119	4	O
the	29578119	4	O
disease	29578119	4	O
incidence	29578119	4	O
.	29578119	4	O
Furthermore	29578119	4	O
,	29578119	4	O
it	29578119	4	O
is	29578119	4	O
the	29578119	4	O
responsibility	29578119	4	O
of	29578119	4	O
physicians	29578119	4	O
to	29578119	4	O
inform	29578119	4	O
female	29578119	4	O
carriers	29578119	4	O
the	29578119	4	O
importance	29578119	4	O
of	29578119	4	O
prenatal	29578119	4	O
diagnosis	29578119	4	O
.	29578119	4	O

Species	29580901	1	O
-	29580901	1	O
conserved	29580901	1	O
SYNGAP1	29580901	1	O
phenotypes	29580901	1	O
associated	29580901	1	O
with	29580901	1	O
neurodevelopmental	29580901	1	O
disorders	29580901	1	O
.	29580901	1	O
SYNGAP1	29580901	1	B-Gene
loss	29580901	1	B-NegReg
-	29580901	1	I-NegReg
of	29580901	1	I-NegReg
-	29580901	1	I-NegReg
function	29580901	1	I-NegReg
variants	29580901	1	B-Var
are	29580901	1	O
causally	29580901	1	O
associated	29580901	1	O
with	29580901	1	O
intellectual	29580901	1	B-Disease
disability	29580901	1	I-Disease
,	29580901	1	O
severe	29580901	1	B-Disease
epilepsy	29580901	1	I-Disease
,	29580901	1	O
autism	29580901	1	B-Disease
spectrum	29580901	1	I-Disease
disorder	29580901	1	I-Disease
and	29580901	1	O
schizophrenia	29580901	1	B-Disease
.	29580901	1	O
While	29580901	1	O
there	29580901	1	O
are	29580901	1	O
hundreds	29580901	1	O
of	29580901	1	O
genetic	29580901	1	O
risk	29580901	1	O
factors	29580901	1	O
for	29580901	1	O
neurodevelopmental	29580901	1	O
disorders	29580901	1	O
(	29580901	1	O
NDDs	29580901	1	O
)	29580901	1	O
,	29580901	1	O
this	29580901	1	O
gene	29580901	1	O
is	29580901	1	O
somewhat	29580901	1	O
unique	29580901	1	O
because	29580901	1	O
of	29580901	1	O
the	29580901	1	O
frequency	29580901	1	O
and	29580901	1	O
penetrance	29580901	1	O
of	29580901	1	O
loss	29580901	1	O
-	29580901	1	O
of	29580901	1	O
-	29580901	1	O
function	29580901	1	O
variants	29580901	1	O
found	29580901	1	O
in	29580901	1	O
patients	29580901	1	O
combined	29580901	1	O
with	29580901	1	O
the	29580901	1	O
range	29580901	1	O
of	29580901	1	O
brain	29580901	1	O
disorders	29580901	1	O
associated	29580901	1	O
with	29580901	1	O
SYNGAP1	29580901	1	O
pathogenicity	29580901	1	O
.	29580901	1	O
These	29580901	1	O
clinical	29580901	1	O
findings	29580901	1	O
indicate	29580901	1	O
that	29580901	1	O
SYNGAP1	29580901	1	O
regulates	29580901	1	O
fundamental	29580901	1	O
neurodevelopmental	29580901	1	O
processes	29580901	1	O
that	29580901	1	O
are	29580901	1	O
necessary	29580901	1	O
for	29580901	1	O
brain	29580901	1	O
development	29580901	1	O
.	29580901	1	O
Here	29580901	1	O
,	29580901	1	O
we	29580901	1	O
describe	29580901	1	O
four	29580901	1	O
phenotypic	29580901	1	O
domains	29580901	1	O
that	29580901	1	O
are	29580901	1	O
controlled	29580901	1	O
by	29580901	1	O
Syngap1	29580901	1	O
expression	29580901	1	O
across	29580901	1	O
vertebrate	29580901	1	O
species	29580901	1	O
.	29580901	1	O
Two	29580901	1	O
domains	29580901	1	O
,	29580901	1	O
the	29580901	1	O
maturation	29580901	1	O
of	29580901	1	O
cognitive	29580901	1	O
functions	29580901	1	O
and	29580901	1	O
maintenance	29580901	1	O
of	29580901	1	O
excitatory	29580901	1	O
-	29580901	1	O
inhibitory	29580901	1	O
balance	29580901	1	O
,	29580901	1	O
are	29580901	1	O
defined	29580901	1	O
exclusively	29580901	1	O
through	29580901	1	O
a	29580901	1	O
review	29580901	1	O
of	29580901	1	O
the	29580901	1	O
current	29580901	1	O
literature	29580901	1	O
.	29580901	1	O
Two	29580901	1	O
additional	29580901	1	O
domains	29580901	1	O
are	29580901	1	O
defined	29580901	1	O
by	29580901	1	O
integrating	29580901	1	O
the	29580901	1	O
current	29580901	1	O
literature	29580901	1	O
with	29580901	1	O
new	29580901	1	O
data	29580901	1	O
indicating	29580901	1	O
that	29580901	1	O
SYNGAP1	29580901	1	O
/	29580901	1	O
Syngap1	29580901	1	O
regulates	29580901	1	O
innate	29580901	1	O
survival	29580901	1	O
behaviors	29580901	1	O
and	29580901	1	O
brain	29580901	1	O
structure	29580901	1	O
.	29580901	1	O
These	29580901	1	O
four	29580901	1	O
phenotypic	29580901	1	O
domains	29580901	1	O
are	29580901	1	O
commonly	29580901	1	O
disrupted	29580901	1	O
in	29580901	1	O
NDDs	29580901	1	O
,	29580901	1	O
suggesting	29580901	1	O
that	29580901	1	O
a	29580901	1	O
deeper	29580901	1	O
understanding	29580901	1	O
of	29580901	1	O
developmental	29580901	1	O
Syngap1	29580901	1	O
functions	29580901	1	O
will	29580901	1	O
be	29580901	1	O
generalizable	29580901	1	O
to	29580901	1	O
other	29580901	1	O
NDDs	29580901	1	O
of	29580901	1	O
known	29580901	1	O
or	29580901	1	O
unknown	29580901	1	O
etiology	29580901	1	O
.	29580901	1	O
Therefore	29580901	1	O
,	29580901	1	O
we	29580901	1	O
discuss	29580901	1	O
the	29580901	1	O
known	29580901	1	O
molecular	29580901	1	O
and	29580901	1	O
cellular	29580901	1	O
functions	29580901	1	O
of	29580901	1	O
Syngap1	29580901	1	O
and	29580901	1	O
consider	29580901	1	O
how	29580901	1	O
these	29580901	1	O
functions	29580901	1	O
may	29580901	1	O
contribute	29580901	1	O
to	29580901	1	O
the	29580901	1	O
emergence	29580901	1	O
of	29580901	1	O
disease	29580901	1	O
-	29580901	1	O
relevant	29580901	1	O
phenotypes	29580901	1	O
.	29580901	1	O
Finally	29580901	1	O
,	29580901	1	O
we	29580901	1	O
identify	29580901	1	O
major	29580901	1	O
unexplored	29580901	1	O
areas	29580901	1	O
of	29580901	1	O
Syngap1	29580901	1	O
neurobiology	29580901	1	O
and	29580901	1	O
discuss	29580901	1	O
how	29580901	1	O
a	29580901	1	O
deeper	29580901	1	O
understanding	29580901	1	O
of	29580901	1	O
this	29580901	1	O
gene	29580901	1	O
may	29580901	1	O
uncover	29580901	1	O
general	29580901	1	O
principles	29580901	1	O
of	29580901	1	O
NDD	29580901	1	O
pathobiology	29580901	1	O
.	29580901	1	O

Loss	29593095	1	O
-	29593095	1	O
of	29593095	1	O
-	29593095	1	O
function	29593095	1	O
PCSK9	29593095	1	O
mutants	29593095	1	O
evade	29593095	1	O
the	29593095	1	O
unfolded	29593095	1	O
protein	29593095	1	O
response	29593095	1	O
sensor	29593095	1	O
GRP78	29593095	1	O
and	29593095	1	O
fail	29593095	1	O
to	29593095	1	O
induce	29593095	1	O
endoplasmic	29593095	1	O
reticulum	29593095	1	O
stress	29593095	1	O
when	29593095	1	O
retained	29593095	1	O
.	29593095	1	O
The	29593095	1	O
proprotein	29593095	1	O
convertase	29593095	1	O
subtilisin	29593095	1	O
/	29593095	1	O
kexin	29593095	1	O
type-9	29593095	1	O
(	29593095	1	B-Var
PCSK9	29593095	1	I-Var
)	29593095	1	I-Var
plays	29593095	1	O
a	29593095	1	O
central	29593095	1	O
role	29593095	1	O
in	29593095	1	O
cardiovascular	29593095	1	B-Disease
disease	29593095	1	I-Disease
(	29593095	1	O
CVD	29593095	1	O
)	29593095	1	O
by	29593095	1	O
degrading	29593095	1	B-NegReg
hepatic	29593095	1	O
low	29593095	1	O
-	29593095	1	O
density	29593095	1	O
lipoprotein	29593095	1	O
receptor	29593095	1	O
(	29593095	1	O
LDLR	29593095	1	O
)	29593095	1	O
.	29593095	1	O
As	29593095	1	O
such	29593095	1	O
,	29593095	1	O
loss	29593095	1	B-NegReg
-	29593095	1	I-NegReg
of	29593095	1	I-NegReg
-	29593095	1	I-NegReg
function	29593095	1	I-NegReg
(	29593095	1	O
LOF	29593095	1	O
)	29593095	1	O
PCSK9	29593095	1	B-Gene
variants	29593095	1	B-Var
that	29593095	1	O
fail	29593095	1	O
to	29593095	1	O
exit	29593095	1	O
the	29593095	1	O
endoplasmic	29593095	1	O
reticulum	29593095	1	O
(	29593095	1	O
ER	29593095	1	O
)	29593095	1	O
increase	29593095	1	B-PosReg
hepatic	29593095	1	O
LDLR	29593095	1	O
levels	29593095	1	O
and	29593095	1	O
lower	29593095	1	B-NegReg
the	29593095	1	O
risk	29593095	1	O
of	29593095	1	O
developing	29593095	1	O
CVD	29593095	1	O
.	29593095	1	O
The	29593095	1	O
retention	29593095	1	O
of	29593095	1	O
misfolded	29593095	1	O
protein	29593095	1	O
in	29593095	1	O
the	29593095	1	O
ER	29593095	1	O
can	29593095	1	O
cause	29593095	1	O
ER	29593095	1	O
stress	29593095	1	O
and	29593095	1	O
activate	29593095	1	O
the	29593095	1	O
unfolded	29593095	1	O
protein	29593095	1	O
response	29593095	1	O
(	29593095	1	O
UPR	29593095	1	O
)	29593095	1	O
.	29593095	1	O
In	29593095	1	O
this	29593095	1	O
study	29593095	1	O
,	29593095	1	O
we	29593095	1	O
investigated	29593095	1	O
whether	29593095	1	O
a	29593095	1	O
variety	29593095	1	O
of	29593095	1	O
LOF	29593095	1	O
PCSK9	29593095	1	O
variants	29593095	1	O
that	29593095	1	O
are	29593095	1	O
retained	29593095	1	O
in	29593095	1	O
the	29593095	1	O
ER	29593095	1	O
can	29593095	1	O
cause	29593095	1	O
ER	29593095	1	O
stress	29593095	1	O
and	29593095	1	O
hepatic	29593095	1	O
cytotoxicity	29593095	1	O
.	29593095	1	O
Although	29593095	1	O
overexpression	29593095	1	B-PosReg
of	29593095	1	O
these	29593095	1	O
PCSK9	29593095	1	B-Gene
variants	29593095	1	B-Var
caused	29593095	1	O
an	29593095	1	O
accumulation	29593095	1	B-PosReg
in	29593095	1	O
the	29593095	1	O
ER	29593095	1	O
of	29593095	1	O
hepatocytes	29593095	1	O
,	29593095	1	O
UPR	29593095	1	O
activation	29593095	1	O
or	29593095	1	O
apoptosis	29593095	1	O
was	29593095	1	O
not	29593095	1	O
observed	29593095	1	O
.	29593095	1	O
Furthermore	29593095	1	O
,	29593095	1	O
ER	29593095	1	O
retention	29593095	1	O
of	29593095	1	O
endogenous	29593095	1	O
PCSK9	29593095	1	O
via	29593095	1	O
splice	29593095	1	O
switching	29593095	1	O
also	29593095	1	O
failed	29593095	1	O
to	29593095	1	O
induce	29593095	1	O
the	29593095	1	O
UPR	29593095	1	O
.	29593095	1	O
Consistent	29593095	1	O
with	29593095	1	O
these	29593095	1	O
in	29593095	1	O
vitro	29593095	1	O
studies	29593095	1	O
,	29593095	1	O
overexpression	29593095	1	O
of	29593095	1	O
PCSK9	29593095	1	O
in	29593095	1	O
the	29593095	1	O
livers	29593095	1	O
of	29593095	1	O
mice	29593095	1	O
had	29593095	1	O
no	29593095	1	O
impact	29593095	1	O
on	29593095	1	O
UPR	29593095	1	O
activation	29593095	1	O
.	29593095	1	O
To	29593095	1	O
elucidate	29593095	1	O
the	29593095	1	O
cellular	29593095	1	O
mechanism	29593095	1	O
to	29593095	1	O
explain	29593095	1	O
these	29593095	1	O
surprising	29593095	1	O
findings	29593095	1	O
,	29593095	1	O
we	29593095	1	O
observed	29593095	1	O
that	29593095	1	O
the	29593095	1	O
94	29593095	1	O
-	29593095	1	O
kDa	29593095	1	O
glucose	29593095	1	O
-	29593095	1	O
regulated	29593095	1	O
protein	29593095	1	O
(	29593095	1	O
GRP94	29593095	1	O
)	29593095	1	O
sequesters	29593095	1	O
PCSK9	29593095	1	O
away	29593095	1	O
from	29593095	1	O
the	29593095	1	O
78	29593095	1	O
-	29593095	1	O
kDa	29593095	1	O
glucose	29593095	1	O
-	29593095	1	O
regulated	29593095	1	O
protein	29593095	1	O
(	29593095	1	O
GRP78	29593095	1	O
)	29593095	1	O
,	29593095	1	O
the	29593095	1	O
major	29593095	1	O
activator	29593095	1	O
of	29593095	1	O
the	29593095	1	O
UPR	29593095	1	O
.	29593095	1	O
As	29593095	1	O
a	29593095	1	O
result	29593095	1	O
,	29593095	1	O
GRP94	29593095	1	O
knockdown	29593095	1	O
increased	29593095	1	O
the	29593095	1	O
stability	29593095	1	O
of	29593095	1	O
GRP78	29593095	1	O
-	29593095	1	O
PCSK9	29593095	1	O
complex	29593095	1	O
and	29593095	1	O
resulted	29593095	1	O
in	29593095	1	O
UPR	29593095	1	O
activation	29593095	1	O
following	29593095	1	O
overexpression	29593095	1	O
of	29593095	1	O
ER	29593095	1	O
-	29593095	1	O
retained	29593095	1	O
PCSK9	29593095	1	O
variants	29593095	1	O
relative	29593095	1	O
to	29593095	1	O
WT	29593095	1	O
secreted	29593095	1	O
controls	29593095	1	O
.	29593095	1	O
Given	29593095	1	O
that	29593095	1	O
overexpression	29593095	1	O
of	29593095	1	O
these	29593095	1	O
LOF	29593095	1	O
PCSK9	29593095	1	O
variants	29593095	1	O
does	29593095	1	O
not	29593095	1	O
cause	29593095	1	O
UPR	29593095	1	O
activation	29593095	1	O
under	29593095	1	O
normal	29593095	1	O
homeostatic	29593095	1	O
conditions	29593095	1	O
,	29593095	1	O
therapeutic	29593095	1	O
strategies	29593095	1	O
aimed	29593095	1	O
at	29593095	1	O
blocking	29593095	1	O
the	29593095	1	O
autocatalytic	29593095	1	O
cleavage	29593095	1	O
of	29593095	1	O
PCSK9	29593095	1	O
in	29593095	1	O
the	29593095	1	O
ER	29593095	1	O
represent	29593095	1	O
a	29593095	1	O
viable	29593095	1	O
strategy	29593095	1	O
for	29593095	1	O
reducing	29593095	1	O
circulating	29593095	1	O
PCSK9	29593095	1	O
.	29593095	1	O

CBL	29600428	1	B-Gene
mutation	29600428	1	B-Var
and	29600428	1	O
MEFV	29600428	1	B-Gene
single	29600428	1	B-Var
-	29600428	1	I-Var
nucleotide	29600428	1	I-Var
variant	29600428	1	I-Var
are	29600428	1	O
important	29600428	1	O
genetic	29600428	1	O
predictors	29600428	1	O
of	29600428	1	O
tumor	29600428	1	B-Disease
reduction	29600428	1	B-NegReg
in	29600428	1	O
glucocorticoid	29600428	1	O
-	29600428	1	O
treated	29600428	1	O
patients	29600428	1	O
with	29600428	1	O
chronic	29600428	1	B-Disease
myelomonocytic	29600428	1	I-Disease
leukemia	29600428	1	I-Disease
.	29600428	1	O
Glucocorticoid	29600428	1	O
(	29600428	1	O
GC	29600428	1	O
)	29600428	1	O
therapy	29600428	1	O
occasionally	29600428	1	O
relieves	29600428	1	O
tumor	29600428	1	O
-	29600428	1	O
related	29600428	1	O
fever	29600428	1	O
and	29600428	1	O
promotes	29600428	1	O
tumor	29600428	1	O
reduction	29600428	1	O
in	29600428	1	O
patients	29600428	1	O
with	29600428	1	O
chronic	29600428	1	O
myelomonocytic	29600428	1	O
leukemia	29600428	1	O
(	29600428	1	O
CMML	29600428	1	O
)	29600428	1	O
.	29600428	1	O
A	29600428	1	O
mutation	29600428	1	O
analysis	29600428	1	O
of	29600428	1	O
24	29600428	1	O
patients	29600428	1	O
with	29600428	1	O
CMML	29600428	1	O
revealed	29600428	1	O
the	29600428	1	O
relationship	29600428	1	O
of	29600428	1	O
GC	29600428	1	O
effectiveness	29600428	1	O
,	29600428	1	O
defined	29600428	1	O
as	29600428	1	O
a	29600428	1	O
monocyte	29600428	1	O
reduction	29600428	1	O
of	29600428	1	O
>	29600428	1	O
50%	29600428	1	O
within	29600428	1	O
3	29600428	1	O
days	29600428	1	O
of	29600428	1	O
methylprednisolone	29600428	1	O
administration	29600428	1	O
,	29600428	1	O
with	29600428	1	O
the	29600428	1	O
MEFV	29600428	1	O
single	29600428	1	O
-	29600428	1	O
nucleotide	29600428	1	O
variant	29600428	1	O
(	29600428	1	O
SNV	29600428	1	O
)	29600428	1	O
and	29600428	1	O
CBL	29600428	1	O
mutation	29600428	1	O
.	29600428	1	O
Lipopolysaccharide	29600428	1	O
-	29600428	1	O
stimulated	29600428	1	O
monocytes	29600428	1	O
harboring	29600428	1	O
MEFV	29600428	1	O
E148Q	29600428	1	O
produced	29600428	1	O
greater	29600428	1	O
amounts	29600428	1	O
of	29600428	1	O
IL-1	29600428	1	O
β	29600428	1	O
and	29600428	1	O
TNF	29600428	1	O
-	29600428	1	O
α	29600428	1	O
than	29600428	1	O
did	29600428	1	O
wild	29600428	1	O
-	29600428	1	O
type	29600428	1	O
monocytes	29600428	1	O
;	29600428	1	O
this	29600428	1	O
was	29600428	1	O
effectively	29600428	1	O
suppressed	29600428	1	O
by	29600428	1	O
GC	29600428	1	O
.	29600428	1	O
Primary	29600428	1	O
CMML	29600428	1	O
cells	29600428	1	O
harboring	29600428	1	O
the	29600428	1	O
MEFV	29600428	1	O
SNV	29600428	1	O
and	29600428	1	O
CBL	29600428	1	O
mutation	29600428	1	O
,	29600428	1	O
and	29600428	1	O
the	29600428	1	O
myelomonocytic	29600428	1	O
leukemia	29600428	1	O
cell	29600428	1	O
line	29600428	1	O
GDM-1	29600428	1	O
,	29600428	1	O
harboring	29600428	1	O
the	29600428	1	O
CBL	29600428	1	O
mutation	29600428	1	O
,	29600428	1	O
were	29600428	1	O
both	29600428	1	O
more	29600428	1	O
significantly	29600428	1	O
suppressed	29600428	1	O
than	29600428	1	O
non	29600428	1	O
-	29600428	1	O
mutated	29600428	1	O
cells	29600428	1	O
following	29600428	1	O
GC	29600428	1	O
treatment	29600428	1	O
in	29600428	1	O
the	29600428	1	O
presence	29600428	1	O
of	29600428	1	O
GM	29600428	1	O
-	29600428	1	O
CSF	29600428	1	O
.	29600428	1	O
A	29600428	1	O
loss	29600428	1	B-NegReg
-	29600428	1	I-NegReg
of	29600428	1	I-NegReg
-	29600428	1	I-NegReg
function	29600428	1	I-NegReg
CBL	29600428	1	B-Gene
mutation	29600428	1	B-Var
prolonged	29600428	1	B-PosReg
STAT5	29600428	1	O
phosphorylation	29600428	1	O
after	29600428	1	O
GM	29600428	1	O
-	29600428	1	O
CSF	29600428	1	O
stimulation	29600428	1	O
,	29600428	1	O
which	29600428	1	O
was	29600428	1	O
rapidly	29600428	1	O
terminated	29600428	1	O
in	29600428	1	O
both	29600428	1	O
patient	29600428	1	O
samples	29600428	1	O
and	29600428	1	O
GDM-1	29600428	1	O
cells	29600428	1	O
.	29600428	1	O
In	29600428	1	O
conclusion	29600428	1	O
,	29600428	1	O
GC	29600428	1	O
therapy	29600428	1	O
effectively	29600428	1	O
treats	29600428	1	O
CMML	29600428	1	O
cells	29600428	1	O
harboring	29600428	1	O
the	29600428	1	O
MEFV	29600428	1	O
SNV	29600428	1	O
and	29600428	1	O
CBL	29600428	1	O
mutation	29600428	1	O
by	29600428	1	O
reducing	29600428	1	O
inflammatory	29600428	1	O
cytokine	29600428	1	O
production	29600428	1	O
and	29600428	1	O
terminating	29600428	1	O
prolonged	29600428	1	O
STAT5	29600428	1	O
phosphorylation	29600428	1	O
in	29600428	1	O
the	29600428	1	O
GM	29600428	1	O
-	29600428	1	O
CSF	29600428	1	O
signaling	29600428	1	O
pathway	29600428	1	O
.	29600428	1	O

Identification	29621572	0	O
of	29621572	0	O
a	29621572	0	O
unique	29621572	0	O
loss	29621572	0	B-NegReg
-	29621572	0	I-NegReg
of	29621572	0	I-NegReg
-	29621572	0	I-NegReg
function	29621572	0	I-NegReg
mutation	29621572	0	B-Var
in	29621572	0	O
IGF1R	29621572	0	B-Gene
and	29621572	0	O
a	29621572	0	O
crosstalk	29621572	0	B-Reg
between	29621572	0	O
IGF1R	29621572	0	B-Gene
and	29621572	0	O
Wnt	29621572	0	O
/	29621572	0	O
β	29621572	0	O
-	29621572	0	O
catenin	29621572	0	O
signaling	29621572	0	O
pathways	29621572	0	O
.	29621572	0	O
IGF1R	29621572	0	O
is	29621572	0	O
a	29621572	0	O
ubiquitous	29621572	0	O
receptor	29621572	0	O
tyrosine	29621572	0	O
kinase	29621572	0	O
that	29621572	0	O
plays	29621572	0	O
critical	29621572	0	O
roles	29621572	0	O
in	29621572	0	O
cell	29621572	0	O
proliferation	29621572	0	O
,	29621572	0	O
growth	29621572	0	O
and	29621572	0	O
survival	29621572	0	O
.	29621572	0	O
Clinical	29621572	0	O
studies	29621572	0	O
have	29621572	0	O
demonstrated	29621572	0	O
upregulation	29621572	0	O
of	29621572	0	O
IGF1R	29621572	0	O
mediated	29621572	0	O
signaling	29621572	0	O
in	29621572	0	O
a	29621572	0	O
number	29621572	0	O
of	29621572	0	O
malignancies	29621572	0	O
including	29621572	0	O
colon	29621572	0	O
,	29621572	0	O
breast	29621572	0	O
,	29621572	0	O
and	29621572	0	O
lung	29621572	0	O
cancers	29621572	0	O
.	29621572	0	O
Overexpression	29621572	0	O
of	29621572	0	O
the	29621572	0	O
IGF1R	29621572	0	O
in	29621572	0	O
these	29621572	0	O
malignancies	29621572	0	O
is	29621572	0	O
associated	29621572	0	O
with	29621572	0	O
a	29621572	0	O
poor	29621572	0	O
prognosis	29621572	0	O
and	29621572	0	O
overall	29621572	0	O
survival	29621572	0	O
.	29621572	0	O
IGF1R	29621572	0	O
specific	29621572	0	O
kinase	29621572	0	O
inhibitors	29621572	0	O
have	29621572	0	O
failed	29621572	0	O
in	29621572	0	O
multiple	29621572	0	O
clinical	29621572	0	O
trials	29621572	0	O
partly	29621572	0	O
because	29621572	0	O
of	29621572	0	O
the	29621572	0	O
complex	29621572	0	O
nature	29621572	0	O
of	29621572	0	O
IGF1R	29621572	0	O
signaling	29621572	0	O
.	29621572	0	O
Thus	29621572	0	O
identifying	29621572	0	O
new	29621572	0	O
binding	29621572	0	O
partners	29621572	0	O
and	29621572	0	O
allosteric	29621572	0	O
sites	29621572	0	O
on	29621572	0	O
IGF1R	29621572	0	O
are	29621572	0	O
emerging	29621572	0	O
areas	29621572	0	O
of	29621572	0	O
research	29621572	0	O
.	29621572	0	O
More	29621572	0	O
recently	29621572	0	O
,	29621572	0	O
IGF1R	29621572	0	O
has	29621572	0	O
been	29621572	0	O
shown	29621572	0	O
to	29621572	0	O
translocate	29621572	0	O
into	29621572	0	O
the	29621572	0	O
nucleus	29621572	0	O
and	29621572	0	O
perform	29621572	0	O
many	29621572	0	O
functions	29621572	0	O
.	29621572	0	O
In	29621572	0	O
this	29621572	0	O
study	29621572	0	O
,	29621572	0	O
we	29621572	0	O
generated	29621572	0	O
a	29621572	0	O
library	29621572	0	O
of	29621572	0	O
IGF1R	29621572	0	O
deletion	29621572	0	O
and	29621572	0	O
point	29621572	0	O
mutants	29621572	0	O
to	29621572	0	O
examine	29621572	0	O
IGF1R	29621572	0	O
subcellular	29621572	0	O
localization	29621572	0	O
and	29621572	0	O
activation	29621572	0	O
of	29621572	0	O
downstream	29621572	0	O
signaling	29621572	0	O
pathways	29621572	0	O
.	29621572	0	O
We	29621572	0	O
show	29621572	0	O
that	29621572	0	O
the	29621572	0	O
nuclear	29621572	0	O
localization	29621572	0	O
of	29621572	0	O
IGF1R	29621572	0	O
is	29621572	0	O
primarily	29621572	0	O
defined	29621572	0	O
by	29621572	0	O
its	29621572	0	O
cytoplasmic	29621572	0	O
domain	29621572	0	O
.	29621572	0	O
We	29621572	0	O
identified	29621572	0	O
a	29621572	0	O
cross	29621572	0	O
-	29621572	0	O
talk	29621572	0	O
between	29621572	0	O
IGF1R	29621572	0	O
and	29621572	0	O
Wnt	29621572	0	O
/	29621572	0	O
β	29621572	0	O
-	29621572	0	O
catenin	29621572	0	O
signaling	29621572	0	O
pathways	29621572	0	O
and	29621572	0	O
showed	29621572	0	O
,	29621572	0	O
for	29621572	0	O
the	29621572	0	O
first	29621572	0	O
time	29621572	0	O
,	29621572	0	O
that	29621572	0	O
IGF1R	29621572	0	O
is	29621572	0	O
associated	29621572	0	O
with	29621572	0	O
upregulation	29621572	0	O
of	29621572	0	O
TCF	29621572	0	O
-	29621572	0	O
mediated	29621572	0	O
β	29621572	0	O
-	29621572	0	O
catenin	29621572	0	O
transcriptional	29621572	0	O
activity	29621572	0	O
.	29621572	0	O
Using	29621572	0	O
loss	29621572	0	O
-	29621572	0	O
of	29621572	0	O
-	29621572	0	O
function	29621572	0	O
mutants	29621572	0	O
,	29621572	0	O
deletion	29621572	0	O
analysis	29621572	0	O
and	29621572	0	O
IGF1R	29621572	0	O
specific	29621572	0	O
inhibitor	29621572	0	O
(	29621572	0	O
s	29621572	0	O
)	29621572	0	O
,	29621572	0	O
we	29621572	0	O
show	29621572	0	O
that	29621572	0	O
cytoplasmic	29621572	0	O
and	29621572	0	O
nuclear	29621572	0	O
activities	29621572	0	O
are	29621572	0	O
two	29621572	0	O
independent	29621572	0	O
functions	29621572	0	O
of	29621572	0	O
IGF1R	29621572	0	O
.	29621572	0	O
Furthermore	29621572	0	O
,	29621572	0	O
we	29621572	0	O
identified	29621572	0	O
a	29621572	0	O
unique	29621572	0	O
loss	29621572	0	O
-	29621572	0	O
of	29621572	0	O
-	29621572	0	O
function	29621572	0	O
mutation	29621572	0	O
in	29621572	0	O
IGF1R	29621572	0	O
.	29621572	0	O
This	29621572	0	O
unique	29621572	0	O
loss	29621572	0	O
-	29621572	0	O
of	29621572	0	O
-	29621572	0	O
function	29621572	0	O
mutant	29621572	0	O
retains	29621572	0	O
only	29621572	0	O
nuclear	29621572	0	O
functions	29621572	0	O
and	29621572	0	O
sits	29621572	0	O
in	29621572	0	O
a	29621572	0	O
pocket	29621572	0	O
,	29621572	0	O
outside	29621572	0	O
ATP	29621572	0	O
and	29621572	0	O
substrate	29621572	0	O
binding	29621572	0	O
region	29621572	0	O
,	29621572	0	O
that	29621572	0	O
is	29621572	0	O
suited	29621572	0	O
for	29621572	0	O
designing	29621572	0	O
allosteric	29621572	0	O
inhibitors	29621572	0	O
of	29621572	0	O
IGF1R	29621572	0	O
.	29621572	0	O

Investigation	29660342	0	O
of	29660342	0	O
TRPV1	29660342	0	O
loss	29660342	0	O
-	29660342	0	O
of	29660342	0	O
-	29660342	0	O
function	29660342	0	O
phenotypes	29660342	0	O
in	29660342	0	O
TRPV1	29660342	0	O
Leu206Stop	29660342	0	O
mice	29660342	0	O
generated	29660342	0	O
by	29660342	0	O
N	29660342	0	O
-	29660342	0	O
ethyl	29660342	0	O
-	29660342	0	O
N	29660342	0	O
-	29660342	0	O
nitrosourea	29660342	0	O
mutagenesis	29660342	0	O
.	29660342	0	O
N	29660342	0	O
-	29660342	0	O
ethyl	29660342	0	O
-	29660342	0	O
N	29660342	0	O
-	29660342	0	O
nitrosourea	29660342	0	O
(	29660342	0	O
ENU	29660342	0	O
)	29660342	0	O
random	29660342	0	O
mutagenesis	29660342	0	O
was	29660342	0	O
used	29660342	0	O
to	29660342	0	O
generate	29660342	0	O
a	29660342	0	O
mouse	29660342	0	O
model	29660342	0	O
for	29660342	0	O
the	29660342	0	O
analysis	29660342	0	O
of	29660342	0	O
the	29660342	0	O
transient	29660342	0	O
receptor	29660342	0	O
potential	29660342	0	O
vanilloid	29660342	0	O
1	29660342	0	O
(	29660342	0	B-Gene
TRPV1	29660342	0	I-Gene
)	29660342	0	I-Gene
cation	29660342	0	O
channel	29660342	0	O
.	29660342	0	O
A	29660342	0	O
transversion	29660342	0	O
from	29660342	0	O
T	29660342	0	O
A	29660342	0	O
in	29660342	0	O
exon	29660342	0	O
4	29660342	0	O
led	29660342	0	O
to	29660342	0	O
a	29660342	0	O
Leu206Stop	29660342	0	B-Var
mutation	29660342	0	O
generating	29660342	0	O
a	29660342	0	O
loss	29660342	0	B-NegReg
-	29660342	0	I-NegReg
of	29660342	0	I-NegReg
-	29660342	0	I-NegReg
function	29660342	0	I-NegReg
mutant	29660342	0	O
.	29660342	0	O
The	29660342	0	O
TRPV1	29660342	0	O
agonist	29660342	0	O
capsaicin	29660342	0	O
was	29660342	0	O
used	29660342	0	O
to	29660342	0	O
analyze	29660342	0	O
functional	29660342	0	O
and	29660342	0	O
nociceptive	29660342	0	O
parameters	29660342	0	O
in	29660342	0	O
vitro	29660342	0	O
and	29660342	0	O
in	29660342	0	O
vivo	29660342	0	O
in	29660342	0	O
TRPV1	29660342	0	O
Leu206Stop	29660342	0	O
mice	29660342	0	O
and	29660342	0	O
congenic	29660342	0	O
C3HeB	29660342	0	O
/	29660342	0	O
FeJ	29660342	0	O
controls	29660342	0	O
.	29660342	0	O
Capsaicin	29660342	0	O
-	29660342	0	O
induced	29660342	0	O
[	29660342	0	O
Ca2	29660342	0	O
]	29660342	0	O
i	29660342	0	O
changes	29660342	0	O
in	29660342	0	O
small	29660342	0	O
diameter	29660342	0	O
DRG	29660342	0	O
neurons	29660342	0	O
were	29660342	0	O
significantly	29660342	0	O
diminished	29660342	0	B-NegReg
in	29660342	0	O
TRPV1	29660342	0	B-Gene
Leu206Stop	29660342	0	B-Var
mice	29660342	0	O
and	29660342	0	O
administration	29660342	0	O
of	29660342	0	O
capsaicin	29660342	0	O
induced	29660342	0	O
neither	29660342	0	O
hypothermia	29660342	0	O
nor	29660342	0	O
nocifensive	29660342	0	O
behaviour	29660342	0	O
in	29660342	0	O
vivo	29660342	0	O
.	29660342	0	O
TRPV1	29660342	0	O
Leu206Stop	29660342	0	O
mice	29660342	0	O
were	29660342	0	O
tested	29660342	0	O
in	29660342	0	O
the	29660342	0	O
spinal	29660342	0	O
nerve	29660342	0	O
ligation	29660342	0	O
of	29660342	0	O
mononeuropathic	29660342	0	O
pain	29660342	0	O
and	29660342	0	O
developed	29660342	0	O
mechanical	29660342	0	O
hypersensitivity	29660342	0	O
two	29660342	0	O
weeks	29660342	0	O
after	29660342	0	O
nerve	29660342	0	O
injury	29660342	0	O
.	29660342	0	O
In	29660342	0	O
the	29660342	0	O
open	29660342	0	O
field	29660342	0	O
test	29660342	0	O
,	29660342	0	O
a	29660342	0	O
significant	29660342	0	O
increase	29660342	0	B-PosReg
in	29660342	0	O
spontaneous	29660342	0	O
locomotion	29660342	0	O
was	29660342	0	O
detected	29660342	0	O
in	29660342	0	O
TRPV1	29660342	0	B-Gene
Leu206Stop	29660342	0	B-Var
mice	29660342	0	O
as	29660342	0	O
compared	29660342	0	O
to	29660342	0	O
wildtype	29660342	0	O
controls	29660342	0	O
.	29660342	0	O
TRPV1	29660342	0	O
knockout	29660342	0	O
mice	29660342	0	O
have	29660342	0	O
been	29660342	0	O
reported	29660342	0	O
to	29660342	0	O
carry	29660342	0	O
a	29660342	0	O
similar	29660342	0	O
phenotype	29660342	0	O
regarding	29660342	0	O
capsaicin	29660342	0	O
-	29660342	0	O
evoked	29660342	0	O
responses	29660342	0	O
in	29660342	0	O
vitro	29660342	0	O
and	29660342	0	O
in	29660342	0	O
vivo	29660342	0	O
.	29660342	0	O
However	29660342	0	O
,	29660342	0	O
in	29660342	0	O
contrast	29660342	0	O
to	29660342	0	O
TRPV1	29660342	0	O
Leu206Stop	29660342	0	O
mice	29660342	0	O
,	29660342	0	O
TRPV1	29660342	0	O
knockout	29660342	0	O
mice	29660342	0	O
did	29660342	0	O
not	29660342	0	O
differ	29660342	0	O
in	29660342	0	O
spontaneous	29660342	0	O
locomotion	29660342	0	O
as	29660342	0	O
compared	29660342	0	O
to	29660342	0	O
congenic	29660342	0	O
C57BL	29660342	0	O
/	29660342	0	O
6	29660342	0	O
mice	29660342	0	O
,	29660342	0	O
suggesting	29660342	0	O
subtle	29660342	0	O
ENU	29660342	0	O
-	29660342	0	O
dependent	29660342	0	O
or	29660342	0	O
independent	29660342	0	O
strain	29660342	0	O
differences	29660342	0	O
between	29660342	0	O
TRPV1	29660342	0	O
Leu206Stop	29660342	0	O
mice	29660342	0	O
and	29660342	0	O
their	29660342	0	O
wildtype	29660342	0	O
controls	29660342	0	O
.	29660342	0	O
In	29660342	0	O
summary	29660342	0	O
,	29660342	0	O
these	29660342	0	O
data	29660342	0	O
revealed	29660342	0	O
a	29660342	0	O
target	29660342	0	O
-	29660342	0	O
related	29660342	0	O
(	29660342	0	O
i.e.	29660342	0	O
capsaicin	29660342	0	O
-	29660342	0	O
evoked	29660342	0	O
)	29660342	0	O
phenotype	29660342	0	O
of	29660342	0	O
TRPV1	29660342	0	O
Leu206Stop	29660342	0	O
mice	29660342	0	O
closely	29660342	0	O
resembling	29660342	0	O
that	29660342	0	O
of	29660342	0	O
published	29660342	0	O
TRPV1	29660342	0	O
knockout	29660342	0	O
mice	29660342	0	O
.	29660342	0	O
However	29660342	0	O
,	29660342	0	O
since	29660342	0	O
ENU	29660342	0	O
-	29660342	0	O
mutant	29660342	0	O
mice	29660342	0	O
are	29660342	0	O
congenic	29660342	0	O
with	29660342	0	O
the	29660342	0	O
mouse	29660342	0	O
strain	29660342	0	O
initially	29660342	0	O
used	29660342	0	O
in	29660342	0	O
random	29660342	0	O
mutagenesis	29660342	0	O
,	29660342	0	O
direct	29660342	0	O
phenotypic	29660342	0	O
comparison	29660342	0	O
with	29660342	0	O
the	29660342	0	O
respective	29660342	0	O
wildtype	29660342	0	O
controls	29660342	0	O
is	29660342	0	O
possible	29660342	0	O
,	29660342	0	O
and	29660342	0	O
the	29660342	0	O
time	29660342	0	O
-	29660342	0	O
consuming	29660342	0	O
backcrossing	29660342	0	O
in	29660342	0	O
lines	29660342	0	O
with	29660342	0	O
targeted	29660342	0	O
mutations	29660342	0	O
is	29660342	0	O
avoided	29660342	0	O
.	29660342	0	O

Biallelic	29666004	2	O
TP53	29666004	2	B-Gene
gain	29666004	2	B-PosReg
of	29666004	2	I-PosReg
function	29666004	2	I-PosReg
mutations	29666004	2	B-Var
in	29666004	2	O
rapidly	29666004	2	B-Disease
progressing	29666004	2	I-Disease
solid	29666004	2	I-Disease
tumors	29666004	2	I-Disease
.	29666004	2	O
Recent	29666004	2	O
studies	29666004	2	O
are	29666004	2	O
discovering	29666004	2	O
TP53	29666004	2	B-Gene
mutations	29666004	2	B-Var
with	29666004	2	O
gain	29666004	2	B-PosReg
of	29666004	2	I-PosReg
function	29666004	2	I-PosReg
(	29666004	2	O
GOF	29666004	2	O
)	29666004	2	O
properties	29666004	2	O
that	29666004	2	O
promote	29666004	2	O
tumorigenesis	29666004	2	O
via	29666004	2	O
a	29666004	2	O
variety	29666004	2	O
of	29666004	2	O
mechanisms	29666004	2	O
.	29666004	2	O
To	29666004	2	O
our	29666004	2	O
knowledge	29666004	2	O
,	29666004	2	O
all	29666004	2	O
reported	29666004	2	O
compound	29666004	2	O
mutations	29666004	2	O
are	29666004	2	O
allelic	29666004	2	O
.	29666004	2	O
We	29666004	2	O
identified	29666004	2	O
two	29666004	2	O
patients	29666004	2	O
with	29666004	2	O
biallelic	29666004	2	O
GOF	29666004	2	O
TP53	29666004	2	O
mutations	29666004	2	O
in	29666004	2	O
their	29666004	2	O
tumors	29666004	2	O
and	29666004	2	O
a	29666004	2	O
third	29666004	2	O
with	29666004	2	O
allelic	29666004	2	O
compound	29666004	2	O
variants	29666004	2	O
.	29666004	2	O
The	29666004	2	O
correlation	29666004	2	O
with	29666004	2	O
p53	29666004	2	O
expression	29666004	2	O
was	29666004	2	O
also	29666004	2	O
examined	29666004	2	O
.	29666004	2	O
Genomic	29666004	2	O
DNA	29666004	2	O
was	29666004	2	O
extracted	29666004	2	O
from	29666004	2	O
formalin	29666004	2	O
-	29666004	2	O
fixed	29666004	2	O
,	29666004	2	O
paraffin	29666004	2	O
-	29666004	2	O
embedded	29666004	2	O
tissue	29666004	2	O
and	29666004	2	O
mutational	29666004	2	O
analysis	29666004	2	O
was	29666004	2	O
performed	29666004	2	O
using	29666004	2	O
Ion	29666004	2	O
AmpliSeq	29666004	2	O
Cancer	29666004	2	O
HotSpot	29666004	2	O
Panel	29666004	2	O
V2	29666004	2	O
.	29666004	2	O
Biallelic	29666004	2	O
GOF	29666004	2	B-PosReg
mutations	29666004	2	O
(	29666004	2	B-Var
p.R273H	29666004	2	I-Var
and	29666004	2	O
p.R273C	29666004	2	B-Var
)	29666004	2	I-Var
were	29666004	2	O
identified	29666004	2	O
in	29666004	2	O
a	29666004	2	O
19	29666004	2	O
-	29666004	2	O
year	29666004	2	O
-	29666004	2	O
old	29666004	2	O
male	29666004	2	O
with	29666004	2	O
glioblastoma	29666004	2	B-Disease
(	29666004	2	O
allele	29666004	2	O
frequencies	29666004	2	O
94%	29666004	2	O
and	29666004	2	O
48%	29666004	2	O
)	29666004	2	O
and	29666004	2	O
a	29666004	2	O
54	29666004	2	O
-	29666004	2	O
year	29666004	2	O
-	29666004	2	O
old	29666004	2	O
with	29666004	2	O
pT3	29666004	2	O
penile	29666004	2	O
squamous	29666004	2	O
cell	29666004	2	O
carcinoma	29666004	2	O
(	29666004	2	O
allele	29666004	2	O
frequencies	29666004	2	O
19%	29666004	2	O
and	29666004	2	O
27%	29666004	2	O
)	29666004	2	O
.	29666004	2	O
Immunohistochemistry	29666004	2	O
showed	29666004	2	O
nuclear	29666004	2	O
accumulation	29666004	2	O
of	29666004	2	O
p53	29666004	2	O
.	29666004	2	O
The	29666004	2	O
third	29666004	2	O
patient	29666004	2	O
,	29666004	2	O
a	29666004	2	O
62	29666004	2	O
-	29666004	2	O
year	29666004	2	O
-	29666004	2	O
old	29666004	2	O
female	29666004	2	O
with	29666004	2	O
metastatic	29666004	2	B-Disease
lung	29666004	2	I-Disease
adenocarcinoma	29666004	2	I-Disease
,	29666004	2	O
had	29666004	2	O
allelic	29666004	2	O
p.P278S	29666004	2	B-Var
(	29666004	2	B-PosReg
GOF	29666004	2	I-PosReg
)	29666004	2	I-PosReg
and	29666004	2	O
p.R283L	29666004	2	B-Var
(	29666004	2	B-Reg
non	29666004	2	I-Reg
-	29666004	2	I-Reg
GOF	29666004	2	I-Reg
)	29666004	2	I-Reg
variants	29666004	2	O
at	29666004	2	O
frequencies	29666004	2	O
of	29666004	2	O
61%	29666004	2	O
but	29666004	2	O
with	29666004	2	O
null	29666004	2	O
staining	29666004	2	O
for	29666004	2	O
p53	29666004	2	O
.	29666004	2	O
Germline	29666004	2	O
testing	29666004	2	O
for	29666004	2	O
Patient	29666004	2	O
1	29666004	2	O
confirmed	29666004	2	O
wildtype	29666004	2	O
TP53	29666004	2	O
.	29666004	2	O
No	29666004	2	O
other	29666004	2	O
variants	29666004	2	O
were	29666004	2	O
discovered	29666004	2	O
among	29666004	2	O
the	29666004	2	O
genes	29666004	2	O
tested	29666004	2	O
in	29666004	2	O
these	29666004	2	O
cases	29666004	2	O
.	29666004	2	O
All	29666004	2	O
patients	29666004	2	O
succumbed	29666004	2	O
within	29666004	2	O
two	29666004	2	O
years	29666004	2	O
of	29666004	2	O
diagnosis	29666004	2	O
despite	29666004	2	O
aggressive	29666004	2	O
treatment	29666004	2	O
.	29666004	2	O
In	29666004	2	O
conclusion	29666004	2	O
,	29666004	2	O
implementation	29666004	2	O
of	29666004	2	O
TP53	29666004	2	O
mutation	29666004	2	O
analysis	29666004	2	O
in	29666004	2	O
clinical	29666004	2	O
practice	29666004	2	O
may	29666004	2	O
predict	29666004	2	O
patient	29666004	2	O
outcome	29666004	2	O
,	29666004	2	O
and	29666004	2	O
inhibition	29666004	2	O
of	29666004	2	O
GOF	29666004	2	O
p53	29666004	2	O
could	29666004	2	O
represent	29666004	2	O
an	29666004	2	O
attractive	29666004	2	O
target	29666004	2	O
for	29666004	2	O
therapy	29666004	2	O
.	29666004	2	O

Protein	29844158	3	O
kinase	29844158	3	O
Cα	29844158	3	O
gain	29844158	3	B-PosReg
-	29844158	3	I-PosReg
of	29844158	3	I-PosReg
-	29844158	3	I-PosReg
function	29844158	3	I-PosReg
variant	29844158	3	B-Var
in	29844158	3	O
Alzheimer	29844158	3	B-Disease
'	29844158	3	I-Disease
s	29844158	3	I-Disease
disease	29844158	3	I-Disease
displays	29844158	3	O
enhanced	29844158	3	B-PosReg
catalysis	29844158	3	O
by	29844158	3	O
a	29844158	3	O
mechanism	29844158	3	O
that	29844158	3	O
evades	29844158	3	O
down	29844158	3	O
-	29844158	3	O
regulation	29844158	3	O
.	29844158	3	O
Conventional	29844158	3	O
protein	29844158	3	O
kinase	29844158	3	O
C	29844158	3	O
(	29844158	3	O
PKC	29844158	3	O
)	29844158	3	O
family	29844158	3	O
members	29844158	3	O
are	29844158	3	O
reversibly	29844158	3	O
activated	29844158	3	O
by	29844158	3	O
binding	29844158	3	O
to	29844158	3	O
the	29844158	3	O
second	29844158	3	O
messengers	29844158	3	O
Ca2	29844158	3	O
and	29844158	3	O
diacylglycerol	29844158	3	O
,	29844158	3	O
events	29844158	3	O
that	29844158	3	O
break	29844158	3	O
autoinhibitory	29844158	3	O
constraints	29844158	3	O
to	29844158	3	O
allow	29844158	3	O
the	29844158	3	O
enzyme	29844158	3	O
to	29844158	3	O
adopt	29844158	3	O
an	29844158	3	O
active	29844158	3	O
,	29844158	3	O
but	29844158	3	O
degradation	29844158	3	O
-	29844158	3	O
sensitive	29844158	3	O
,	29844158	3	O
conformation	29844158	3	O
.	29844158	3	O
Perturbing	29844158	3	O
these	29844158	3	O
autoinhibitory	29844158	3	O
constraints	29844158	3	O
,	29844158	3	O
resulting	29844158	3	O
in	29844158	3	O
protein	29844158	3	O
destabilization	29844158	3	O
,	29844158	3	O
is	29844158	3	O
one	29844158	3	O
of	29844158	3	O
many	29844158	3	O
mechanisms	29844158	3	O
by	29844158	3	O
which	29844158	3	O
PKC	29844158	3	O
function	29844158	3	O
is	29844158	3	O
lost	29844158	3	O
in	29844158	3	O
cancer	29844158	3	O
.	29844158	3	O
Here	29844158	3	O
,	29844158	3	O
we	29844158	3	O
address	29844158	3	O
how	29844158	3	O
a	29844158	3	O
gain	29844158	3	B-PosReg
-	29844158	3	I-PosReg
of	29844158	3	I-PosReg
-	29844158	3	I-PosReg
function	29844158	3	I-PosReg
germline	29844158	3	B-Var
mutation	29844158	3	I-Var
in	29844158	3	O
PKCα	29844158	3	O
in	29844158	3	O
Alzheimer	29844158	3	B-Disease
'	29844158	3	I-Disease
s	29844158	3	I-Disease
disease	29844158	3	I-Disease
(	29844158	3	O
AD	29844158	3	O
)	29844158	3	O
enhances	29844158	3	B-PosReg
signaling	29844158	3	O
without	29844158	3	O
increasing	29844158	3	O
vulnerability	29844158	3	O
to	29844158	3	O
down	29844158	3	O
-	29844158	3	O
regulation	29844158	3	O
.	29844158	3	O
Biochemical	29844158	3	O
analyses	29844158	3	O
of	29844158	3	O
purified	29844158	3	O
protein	29844158	3	O
demonstrate	29844158	3	O
that	29844158	3	O
this	29844158	3	O
mutation	29844158	3	B-Var
results	29844158	3	O
in	29844158	3	O
an	29844158	3	O
30%	29844158	3	O
increase	29844158	3	B-PosReg
in	29844158	3	O
the	29844158	3	O
catalytic	29844158	3	O
rate	29844158	3	O
of	29844158	3	O
the	29844158	3	O
activated	29844158	3	O
enzyme	29844158	3	O
,	29844158	3	O
with	29844158	3	O
no	29844158	3	O
changes	29844158	3	O
in	29844158	3	O
the	29844158	3	O
concentrations	29844158	3	O
of	29844158	3	O
Ca2	29844158	3	O
or	29844158	3	O
lipid	29844158	3	O
required	29844158	3	O
for	29844158	3	O
half	29844158	3	O
-	29844158	3	O
maximal	29844158	3	O
activation	29844158	3	O
.	29844158	3	O
Molecular	29844158	3	O
dynamics	29844158	3	O
simulations	29844158	3	O
reveal	29844158	3	O
that	29844158	3	O
this	29844158	3	O
mutation	29844158	3	B-Var
has	29844158	3	O
both	29844158	3	O
localized	29844158	3	O
and	29844158	3	O
allosteric	29844158	3	O
effects	29844158	3	O
,	29844158	3	O
most	29844158	3	O
notably	29844158	3	O
decreasing	29844158	3	B-NegReg
the	29844158	3	O
dynamics	29844158	3	O
of	29844158	3	O
the	29844158	3	O
C	29844158	3	O
-	29844158	3	O
helix	29844158	3	O
,	29844158	3	O
a	29844158	3	O
key	29844158	3	O
determinant	29844158	3	O
in	29844158	3	O
the	29844158	3	O
catalytic	29844158	3	O
turnover	29844158	3	O
of	29844158	3	O
kinases	29844158	3	O
.	29844158	3	O
Consistent	29844158	3	O
with	29844158	3	O
this	29844158	3	O
mutation	29844158	3	O
not	29844158	3	O
altering	29844158	3	O
autoinhibitory	29844158	3	O
constraints	29844158	3	O
,	29844158	3	O
live	29844158	3	O
-	29844158	3	O
cell	29844158	3	O
imaging	29844158	3	O
studies	29844158	3	O
reveal	29844158	3	O
that	29844158	3	O
the	29844158	3	O
basal	29844158	3	O
signaling	29844158	3	O
output	29844158	3	O
of	29844158	3	O
PKCα	29844158	3	O
-	29844158	3	O
M489V	29844158	3	O
is	29844158	3	O
unchanged	29844158	3	O
.	29844158	3	O
However	29844158	3	O
,	29844158	3	O
the	29844158	3	O
mutant	29844158	3	B-Var
enzyme	29844158	3	O
in	29844158	3	O
cells	29844158	3	O
displays	29844158	3	O
increased	29844158	3	B-PosReg
sensitivity	29844158	3	O
to	29844158	3	O
an	29844158	3	O
inhibitor	29844158	3	O
that	29844158	3	O
is	29844158	3	O
ineffective	29844158	3	O
toward	29844158	3	O
scaffolded	29844158	3	O
PKC	29844158	3	O
,	29844158	3	O
suggesting	29844158	3	O
the	29844158	3	O
altered	29844158	3	O
dynamics	29844158	3	O
of	29844158	3	O
the	29844158	3	O
kinase	29844158	3	O
domain	29844158	3	O
may	29844158	3	O
influence	29844158	3	B-Reg
protein	29844158	3	O
interactions	29844158	3	O
.	29844158	3	O
Finally	29844158	3	O
,	29844158	3	O
we	29844158	3	O
show	29844158	3	O
that	29844158	3	O
phosphorylation	29844158	3	O
of	29844158	3	O
a	29844158	3	O
key	29844158	3	O
PKC	29844158	3	O
substrate	29844158	3	O
,	29844158	3	O
myristoylated	29844158	3	O
alanine	29844158	3	O
-	29844158	3	O
rich	29844158	3	O
C	29844158	3	O
-	29844158	3	O
kinase	29844158	3	O
substrate	29844158	3	O
,	29844158	3	O
is	29844158	3	O
increased	29844158	3	B-PosReg
in	29844158	3	O
brains	29844158	3	O
of	29844158	3	O
CRISPR	29844158	3	O
-	29844158	3	O
Cas9	29844158	3	O
genome	29844158	3	O
-	29844158	3	O
edited	29844158	3	O
mice	29844158	3	O
containing	29844158	3	O
the	29844158	3	O
PKCα	29844158	3	B-Var
-	29844158	3	I-Var
M489V	29844158	3	I-Var
mutation	29844158	3	I-Var
.	29844158	3	O
Our	29844158	3	O
results	29844158	3	O
unveil	29844158	3	O
how	29844158	3	O
an	29844158	3	O
AD	29844158	3	B-Reg
-	29844158	3	I-Reg
associated	29844158	3	I-Reg
mutation	29844158	3	B-Var
in	29844158	3	O
PKCα	29844158	3	O
permits	29844158	3	O
enhanced	29844158	3	B-PosReg
agonist	29844158	3	O
-	29844158	3	O
dependent	29844158	3	O
signaling	29844158	3	O
via	29844158	3	O
a	29844158	3	O
mechanism	29844158	3	O
that	29844158	3	O
evades	29844158	3	B-NegReg
the	29844158	3	O
cell	29844158	3	O
'	29844158	3	O
s	29844158	3	O
homeostatic	29844158	3	O
down	29844158	3	O
-	29844158	3	O
regulation	29844158	3	O
of	29844158	3	O
constitutively	29844158	3	O
active	29844158	3	O
PKCα	29844158	3	O
.	29844158	3	O

Gain	29852244	3	B-PosReg
-	29852244	3	I-PosReg
of	29852244	3	I-PosReg
-	29852244	3	I-PosReg
function	29852244	3	I-PosReg
KCNJ6	29852244	3	B-Gene
Mutation	29852244	3	B-Var
in	29852244	3	O
a	29852244	3	O
Severe	29852244	3	B-Disease
Hyperkinetic	29852244	3	I-Disease
Movement	29852244	3	I-Disease
Disorder	29852244	3	I-Disease
Phenotype	29852244	3	O
.	29852244	3	O
Here	29852244	3	O
,	29852244	3	O
we	29852244	3	O
describe	29852244	3	O
a	29852244	3	O
fourth	29852244	3	O
case	29852244	3	O
of	29852244	3	O
a	29852244	3	O
human	29852244	3	O
with	29852244	3	O
a	29852244	3	O
de	29852244	3	O
novo	29852244	3	O
KCNJ6	29852244	3	B-Gene
(	29852244	3	O
GIRK2	29852244	3	O
)	29852244	3	O
mutation	29852244	3	B-Var
,	29852244	3	O
who	29852244	3	O
presented	29852244	3	B-Reg
with	29852244	3	O
clinical	29852244	3	O
findings	29852244	3	O
of	29852244	3	O
severe	29852244	3	B-Disease
hyperkinetic	29852244	3	I-Disease
movement	29852244	3	I-Disease
disorder	29852244	3	I-Disease
and	29852244	3	O
developmental	29852244	3	O
delay	29852244	3	O
,	29852244	3	O
similar	29852244	3	O
to	29852244	3	O
the	29852244	3	O
Keppen	29852244	3	O
-	29852244	3	O
Lubinsky	29852244	3	O
syndrome	29852244	3	O
but	29852244	3	O
without	29852244	3	O
lipodystrophy	29852244	3	O
.	29852244	3	O
Whole	29852244	3	O
-	29852244	3	O
exome	29852244	3	O
sequencing	29852244	3	O
of	29852244	3	O
the	29852244	3	O
patient	29852244	3	O
'	29852244	3	O
s	29852244	3	O
DNA	29852244	3	O
revealed	29852244	3	O
a	29852244	3	O
heterozygous	29852244	3	O
de	29852244	3	O
novo	29852244	3	O
variant	29852244	3	O
in	29852244	3	O
the	29852244	3	O
KCNJ6	29852244	3	B-Gene
(	29852244	3	B-Var
c.512	29852244	3	I-Var
T	29852244	3	I-Var
>	29852244	3	I-Var
G	29852244	3	I-Var
,	29852244	3	O
p.Leu171Arg	29852244	3	B-Var
)	29852244	3	I-Var
.	29852244	3	O
We	29852244	3	O
conducted	29852244	3	O
in	29852244	3	O
vitro	29852244	3	O
functional	29852244	3	O
studies	29852244	3	O
to	29852244	3	O
determine	29852244	3	O
if	29852244	3	O
this	29852244	3	O
Leu	29852244	3	O
-	29852244	3	O
to	29852244	3	O
-	29852244	3	O
Arg	29852244	3	O
mutation	29852244	3	O
alters	29852244	3	O
the	29852244	3	O
function	29852244	3	O
of	29852244	3	O
GIRK2	29852244	3	O
channels	29852244	3	O
.	29852244	3	O
Heterologous	29852244	3	O
expression	29852244	3	O
of	29852244	3	O
the	29852244	3	O
mutant	29852244	3	B-Var
GIRK2	29852244	3	B-Gene
channel	29852244	3	O
alone	29852244	3	O
produced	29852244	3	B-PosReg
an	29852244	3	O
aberrant	29852244	3	O
basal	29852244	3	O
inward	29852244	3	O
current	29852244	3	O
that	29852244	3	O
lacked	29852244	3	B-NegReg
G	29852244	3	O
protein	29852244	3	O
activation	29852244	3	O
,	29852244	3	O
lost	29852244	3	B-NegReg
K	29852244	3	O
selectivity	29852244	3	O
and	29852244	3	O
gained	29852244	3	B-PosReg
Ca2	29852244	3	O
permeability	29852244	3	O
.	29852244	3	O
Notably	29852244	3	O
,	29852244	3	O
the	29852244	3	O
inward	29852244	3	O
current	29852244	3	O
was	29852244	3	O
inhibited	29852244	3	O
by	29852244	3	O
the	29852244	3	O
Na	29852244	3	O
channel	29852244	3	O
blocker	29852244	3	O
QX-314	29852244	3	O
,	29852244	3	O
similar	29852244	3	O
to	29852244	3	O
the	29852244	3	O
previously	29852244	3	O
reported	29852244	3	O
weaver	29852244	3	O
mutation	29852244	3	O
in	29852244	3	O
murine	29852244	3	O
GIRK2	29852244	3	O
.	29852244	3	O
Expression	29852244	3	O
of	29852244	3	O
a	29852244	3	O
tandem	29852244	3	O
dimer	29852244	3	O
containing	29852244	3	O
GIRK1	29852244	3	O
and	29852244	3	O
GIRK2	29852244	3	O
(	29852244	3	O
p.Leu171Arg	29852244	3	O
)	29852244	3	O
did	29852244	3	O
not	29852244	3	O
lead	29852244	3	O
to	29852244	3	O
any	29852244	3	O
currents	29852244	3	O
,	29852244	3	O
suggesting	29852244	3	O
heterotetramers	29852244	3	O
are	29852244	3	O
not	29852244	3	O
functional	29852244	3	O
.	29852244	3	O
In	29852244	3	O
neurons	29852244	3	O
expressing	29852244	3	O
p.Leu171Arg	29852244	3	B-Var
GIRK2	29852244	3	B-Gene
channels	29852244	3	O
,	29852244	3	O
these	29852244	3	O
changes	29852244	3	O
in	29852244	3	O
channel	29852244	3	O
properties	29852244	3	O
would	29852244	3	O
be	29852244	3	O
expected	29852244	3	O
to	29852244	3	O
generate	29852244	3	O
a	29852244	3	O
sustained	29852244	3	O
depolarization	29852244	3	B-NegReg
,	29852244	3	O
instead	29852244	3	O
of	29852244	3	O
the	29852244	3	O
normal	29852244	3	O
G	29852244	3	O
protein	29852244	3	O
-	29852244	3	O
gated	29852244	3	O
inhibitory	29852244	3	O
response	29852244	3	O
,	29852244	3	O
which	29852244	3	O
could	29852244	3	O
be	29852244	3	O
mitigated	29852244	3	O
by	29852244	3	O
expression	29852244	3	O
of	29852244	3	O
other	29852244	3	O
GIRK	29852244	3	O
subunits	29852244	3	O
.	29852244	3	O
The	29852244	3	O
identification	29852244	3	O
of	29852244	3	O
the	29852244	3	O
p.Leu171Arg	29852244	3	O
GIRK2	29852244	3	O
mutation	29852244	3	O
potentially	29852244	3	O
expands	29852244	3	O
the	29852244	3	O
Keppen	29852244	3	O
-	29852244	3	O
Lubinsky	29852244	3	O
syndrome	29852244	3	O
phenotype	29852244	3	O
to	29852244	3	O
include	29852244	3	O
severe	29852244	3	O
dystonia	29852244	3	O
and	29852244	3	O
ballismus	29852244	3	O
.	29852244	3	O
Our	29852244	3	O
study	29852244	3	O
suggests	29852244	3	O
screening	29852244	3	O
for	29852244	3	O
dominant	29852244	3	O
KCNJ6	29852244	3	O
mutations	29852244	3	O
in	29852244	3	O
the	29852244	3	O
evaluation	29852244	3	O
of	29852244	3	O
patients	29852244	3	O
with	29852244	3	O
severe	29852244	3	O
movement	29852244	3	O
disorders	29852244	3	O
,	29852244	3	O
which	29852244	3	O
could	29852244	3	O
provide	29852244	3	O
evidence	29852244	3	O
to	29852244	3	O
support	29852244	3	O
a	29852244	3	O
causal	29852244	3	O
role	29852244	3	O
of	29852244	3	O
KCNJ6	29852244	3	O
in	29852244	3	O
neurological	29852244	3	O
channelopathies	29852244	3	O
.	29852244	3	O

A	29892959	4	O
novel	29892959	4	O
mutation	29892959	4	B-Var
in	29892959	4	O
RDH5	29892959	4	B-Gene
gene	29892959	4	O
causes	29892959	4	B-Reg
retinitis	29892959	4	B-Disease
pigmentosa	29892959	4	I-Disease
in	29892959	4	O
consanguineous	29892959	4	O
Pakistani	29892959	4	O
family	29892959	4	O
.	29892959	4	O
Retinitis	29892959	4	O
pigmentosa	29892959	4	O
(	29892959	4	O
RP	29892959	4	O
)	29892959	4	O
is	29892959	4	O
the	29892959	4	O
most	29892959	4	O
frequent	29892959	4	O
genetically	29892959	4	O
and	29892959	4	O
clinically	29892959	4	O
heterogeneous	29892959	4	O
inherited	29892959	4	O
retinal	29892959	4	O
degeneration	29892959	4	O
.	29892959	4	O
To	29892959	4	O
date	29892959	4	O
,	29892959	4	O
more	29892959	4	O
than	29892959	4	O
80	29892959	4	O
genes	29892959	4	O
have	29892959	4	O
been	29892959	4	O
identified	29892959	4	O
that	29892959	4	O
cause	29892959	4	O
autosomal	29892959	4	O
dominant	29892959	4	O
,	29892959	4	O
autosomal	29892959	4	O
recessive	29892959	4	O
and	29892959	4	O
X	29892959	4	O
linked	29892959	4	O
RP	29892959	4	O
.	29892959	4	O
However	29892959	4	O
,	29892959	4	O
locus	29892959	4	O
and	29892959	4	O
allelic	29892959	4	O
heterogeneity	29892959	4	O
of	29892959	4	O
RP	29892959	4	O
has	29892959	4	O
not	29892959	4	O
been	29892959	4	O
fully	29892959	4	O
captured	29892959	4	O
yet	29892959	4	O
.	29892959	4	O
This	29892959	4	O
heterogeneity	29892959	4	O
and	29892959	4	O
lack	29892959	4	O
of	29892959	4	O
an	29892959	4	O
accurate	29892959	4	O
genotype	29892959	4	O
phenotype	29892959	4	O
correlation	29892959	4	O
makes	29892959	4	O
molecular	29892959	4	O
dissection	29892959	4	O
of	29892959	4	O
the	29892959	4	O
disease	29892959	4	O
more	29892959	4	O
difficult	29892959	4	O
.	29892959	4	O
The	29892959	4	O
present	29892959	4	O
study	29892959	4	O
was	29892959	4	O
designed	29892959	4	O
to	29892959	4	O
characterize	29892959	4	O
the	29892959	4	O
underlying	29892959	4	O
pathogenic	29892959	4	O
variants	29892959	4	O
of	29892959	4	O
RP	29892959	4	O
in	29892959	4	O
Pakistan	29892959	4	O
.	29892959	4	O
For	29892959	4	O
this	29892959	4	O
purpose	29892959	4	O
,	29892959	4	O
a	29892959	4	O
large	29892959	4	O
consanguineous	29892959	4	O
family	29892959	4	O
with	29892959	4	O
RP	29892959	4	O
phenotype	29892959	4	O
showing	29892959	4	O
autosomal	29892959	4	O
recessive	29892959	4	O
mode	29892959	4	O
of	29892959	4	O
inheritance	29892959	4	O
was	29892959	4	O
selected	29892959	4	O
after	29892959	4	O
a	29892959	4	O
complete	29892959	4	O
ophthalmological	29892959	4	O
examination	29892959	4	O
.	29892959	4	O
Next	29892959	4	O
generation	29892959	4	O
sequencing	29892959	4	O
was	29892959	4	O
used	29892959	4	O
for	29892959	4	O
the	29892959	4	O
identification	29892959	4	O
of	29892959	4	O
molecular	29892959	4	O
determinant	29892959	4	O
followed	29892959	4	O
by	29892959	4	O
Sanger	29892959	4	O
-	29892959	4	O
sequencing	29892959	4	O
for	29892959	4	O
confirmation	29892959	4	O
.	29892959	4	O
After	29892959	4	O
sequence	29892959	4	O
analysis	29892959	4	O
a	29892959	4	O
novel	29892959	4	O
homozygous	29892959	4	O
missense	29892959	4	O
mutation	29892959	4	O
,	29892959	4	O
(	29892959	4	B-Var
c.602	29892959	4	I-Var
C	29892959	4	I-Var
>	29892959	4	I-Var
T	29892959	4	I-Var
)	29892959	4	I-Var
in	29892959	4	O
exon	29892959	4	O
4	29892959	4	O
of	29892959	4	O
the	29892959	4	O
RDH5	29892959	4	B-Gene
gene	29892959	4	O
(	29892959	4	O
MIM	29892959	4	O
:	29892959	4	O
601617	29892959	4	O
)	29892959	4	O
was	29892959	4	O
identified	29892959	4	O
.	29892959	4	O
This	29892959	4	O
mutation	29892959	4	O
resulted	29892959	4	B-Reg
in	29892959	4	I-Reg
substitution	29892959	4	O
of	29892959	4	O
phenyl	29892959	4	O
alanine	29892959	4	O
for	29892959	4	O
serine	29892959	4	O
at	29892959	4	O
amino	29892959	4	O
acid	29892959	4	O
201	29892959	4	O
(	29892959	4	B-Var
p.Ser201Phe	29892959	4	I-Var
)	29892959	4	I-Var
of	29892959	4	O
the	29892959	4	O
RDH5	29892959	4	B-Gene
gene	29892959	4	O
.	29892959	4	O
The	29892959	4	O
same	29892959	4	O
mutation	29892959	4	O
was	29892959	4	O
not	29892959	4	O
detected	29892959	4	O
in	29892959	4	O
the	29892959	4	O
200	29892959	4	O
ethnically	29892959	4	O
-	29892959	4	O
matched	29892959	4	O
control	29892959	4	O
samples	29892959	4	O
by	29892959	4	O
Sanger	29892959	4	O
sequencing	29892959	4	O
.	29892959	4	O
The	29892959	4	O
identified	29892959	4	O
mutant	29892959	4	O
allele	29892959	4	O
segregated	29892959	4	O
in	29892959	4	O
homozygous	29892959	4	O
fashion	29892959	4	O
in	29892959	4	O
all	29892959	4	O
the	29892959	4	O
affected	29892959	4	O
individuals	29892959	4	O
of	29892959	4	O
pedigree	29892959	4	O
.	29892959	4	O
Identification	29892959	4	O
of	29892959	4	O
this	29892959	4	O
mutation	29892959	4	O
reveals	29892959	4	O
the	29892959	4	O
allelic	29892959	4	O
heterogeneity	29892959	4	O
of	29892959	4	O
RDH5	29892959	4	O
in	29892959	4	O
patients	29892959	4	O
with	29892959	4	O
RP	29892959	4	O
phenotype	29892959	4	O
.	29892959	4	O
The	29892959	4	O
findings	29892959	4	O
of	29892959	4	O
this	29892959	4	O
study	29892959	4	O
demonstrate	29892959	4	O
the	29892959	4	O
clinical	29892959	4	O
significance	29892959	4	O
of	29892959	4	O
next	29892959	4	O
generation	29892959	4	O
sequencing	29892959	4	O
to	29892959	4	O
understand	29892959	4	O
the	29892959	4	O
molecular	29892959	4	O
basis	29892959	4	O
of	29892959	4	O
diseases	29892959	4	O
and	29892959	4	O
would	29892959	4	O
help	29892959	4	O
to	29892959	4	O
reveal	29892959	4	O
new	29892959	4	O
proteins	29892959	4	O
and	29892959	4	O
their	29892959	4	O
function	29892959	4	O
in	29892959	4	O
visual	29892959	4	O
cycle	29892959	4	O
will	29892959	4	O
pave	29892959	4	O
the	29892959	4	O
way	29892959	4	O
for	29892959	4	O
early	29892959	4	O
diagnosis	29892959	4	O
,	29892959	4	O
genetic	29892959	4	O
counseling	29892959	4	O
and	29892959	4	O
better	29892959	4	O
therapeutic	29892959	4	O
inventions	29892959	4	O
.	29892959	4	O

Quantitative	29899451	0	O
phosphoproteomic	29899451	0	O
analysis	29899451	0	O
of	29899451	0	O
the	29899451	0	O
molecular	29899451	0	O
substrates	29899451	0	O
of	29899451	0	O
sleep	29899451	0	O
need	29899451	0	O
.	29899451	0	O
Sleep	29899451	0	O
and	29899451	0	O
wake	29899451	0	O
have	29899451	0	O
global	29899451	0	O
effects	29899451	0	O
on	29899451	0	O
brain	29899451	0	O
physiology	29899451	0	O
,	29899451	0	O
from	29899451	0	O
molecular	29899451	0	O
changes1-4	29899451	0	O
and	29899451	0	O
neuronal	29899451	0	O
activities	29899451	0	O
to	29899451	0	O
synaptic	29899451	0	O
plasticity3-7	29899451	0	O
.	29899451	0	O
Sleep	29899451	0	O
-	29899451	0	O
wake	29899451	0	O
homeostasis	29899451	0	O
is	29899451	0	O
maintained	29899451	0	O
by	29899451	0	O
the	29899451	0	O
generation	29899451	0	O
of	29899451	0	O
a	29899451	0	O
sleep	29899451	0	O
need	29899451	0	O
that	29899451	0	O
accumulates	29899451	0	O
during	29899451	0	O
waking	29899451	0	O
and	29899451	0	O
dissipates	29899451	0	O
during	29899451	0	O
sleep8-11	29899451	0	O
.	29899451	0	O
Here	29899451	0	O
we	29899451	0	O
investigate	29899451	0	O
the	29899451	0	O
molecular	29899451	0	O
basis	29899451	0	O
of	29899451	0	O
sleep	29899451	0	O
need	29899451	0	O
using	29899451	0	O
quantitative	29899451	0	O
phosphoproteomic	29899451	0	O
analysis	29899451	0	O
of	29899451	0	O
the	29899451	0	O
sleep	29899451	0	O
-	29899451	0	O
deprived	29899451	0	O
and	29899451	0	O
Sleepy	29899451	0	O
mouse	29899451	0	O
models	29899451	0	O
of	29899451	0	O
increased	29899451	0	O
sleep	29899451	0	O
need	29899451	0	O
.	29899451	0	O
Sleep	29899451	0	O
deprivation	29899451	0	O
induces	29899451	0	O
cumulative	29899451	0	O
phosphorylation	29899451	0	O
of	29899451	0	O
the	29899451	0	O
brain	29899451	0	O
proteome	29899451	0	O
,	29899451	0	O
which	29899451	0	O
dissipates	29899451	0	O
during	29899451	0	O
sleep	29899451	0	O
.	29899451	0	O
Sleepy	29899451	0	O
mice	29899451	0	O
,	29899451	0	O
owing	29899451	0	O
to	29899451	0	O
a	29899451	0	O
gain	29899451	0	B-PosReg
-	29899451	0	I-PosReg
of	29899451	0	I-PosReg
-	29899451	0	I-PosReg
function	29899451	0	I-PosReg
mutation	29899451	0	B-Var
in	29899451	0	O
the	29899451	0	O
Sik3	29899451	0	B-Gene
gene	29899451	0	O
12	29899451	0	O
,	29899451	0	O
have	29899451	0	O
a	29899451	0	O
constitutively	29899451	0	O
high	29899451	0	O
sleep	29899451	0	O
need	29899451	0	O
despite	29899451	0	O
increased	29899451	0	O
sleep	29899451	0	O
amount	29899451	0	O
.	29899451	0	O
The	29899451	0	O
brain	29899451	0	O
proteome	29899451	0	O
of	29899451	0	O
these	29899451	0	O
mice	29899451	0	O
exhibits	29899451	0	O
hyperphosphorylation	29899451	0	O
,	29899451	0	O
similar	29899451	0	O
to	29899451	0	O
that	29899451	0	O
seen	29899451	0	O
in	29899451	0	O
the	29899451	0	O
brain	29899451	0	O
of	29899451	0	O
sleep	29899451	0	O
-	29899451	0	O
deprived	29899451	0	O
mice	29899451	0	O
.	29899451	0	O
Comparison	29899451	0	O
of	29899451	0	O
the	29899451	0	O
two	29899451	0	O
models	29899451	0	O
identifies	29899451	0	O
80	29899451	0	O
mostly	29899451	0	O
synaptic	29899451	0	O
sleep	29899451	0	O
-	29899451	0	O
need	29899451	0	O
-	29899451	0	O
index	29899451	0	O
phosphoproteins	29899451	0	O
(	29899451	0	O
SNIPPs	29899451	0	O
)	29899451	0	O
,	29899451	0	O
in	29899451	0	O
which	29899451	0	O
phosphorylation	29899451	0	O
states	29899451	0	O
closely	29899451	0	O
parallel	29899451	0	O
changes	29899451	0	O
of	29899451	0	O
sleep	29899451	0	O
need	29899451	0	O
.	29899451	0	O
SLEEPY	29899451	0	O
,	29899451	0	O
the	29899451	0	O
mutant	29899451	0	B-Var
SIK3	29899451	0	B-Gene
protein	29899451	0	O
,	29899451	0	O
preferentially	29899451	0	B-PosReg
associates	29899451	0	O
with	29899451	0	O
and	29899451	0	O
phosphorylates	29899451	0	O
SNIPPs	29899451	0	O
.	29899451	0	O
Inhibition	29899451	0	O
of	29899451	0	O
SIK3	29899451	0	O
activity	29899451	0	O
reduces	29899451	0	O
phosphorylation	29899451	0	O
of	29899451	0	O
SNIPPs	29899451	0	O
and	29899451	0	O
slow	29899451	0	O
wave	29899451	0	O
activity	29899451	0	O
during	29899451	0	O
non	29899451	0	O
-	29899451	0	O
rapid	29899451	0	O
-	29899451	0	O
eye	29899451	0	O
-	29899451	0	O
movement	29899451	0	O
sleep	29899451	0	O
,	29899451	0	O
the	29899451	0	O
best	29899451	0	O
known	29899451	0	O
measurable	29899451	0	O
index	29899451	0	O
of	29899451	0	O
sleep	29899451	0	O
need	29899451	0	O
,	29899451	0	O
in	29899451	0	O
both	29899451	0	O
Sleepy	29899451	0	O
mice	29899451	0	O
and	29899451	0	O
sleep	29899451	0	O
-	29899451	0	O
deprived	29899451	0	O
wild	29899451	0	O
-	29899451	0	O
type	29899451	0	O
mice	29899451	0	O
.	29899451	0	O
Our	29899451	0	O
results	29899451	0	O
suggest	29899451	0	O
that	29899451	0	O
phosphorylation	29899451	0	O
of	29899451	0	O
SNIPPs	29899451	0	O
accumulates	29899451	0	O
and	29899451	0	O
dissipates	29899451	0	O
in	29899451	0	O
relation	29899451	0	O
to	29899451	0	O
sleep	29899451	0	O
need	29899451	0	O
,	29899451	0	O
and	29899451	0	O
therefore	29899451	0	O
SNIPP	29899451	0	O
phosphorylation	29899451	0	O
is	29899451	0	O
a	29899451	0	O
molecular	29899451	0	O
signature	29899451	0	O
of	29899451	0	O
sleep	29899451	0	O
need	29899451	0	O
.	29899451	0	O
Whereas	29899451	0	O
waking	29899451	0	O
encodes	29899451	0	O
memories	29899451	0	O
by	29899451	0	O
potentiating	29899451	0	O
synapses	29899451	0	O
,	29899451	0	O
sleep	29899451	0	O
consolidates	29899451	0	O
memories	29899451	0	O
and	29899451	0	O
restores	29899451	0	O
synaptic	29899451	0	O
homeostasis	29899451	0	O
by	29899451	0	O
globally	29899451	0	O
downscaling	29899451	0	O
excitatory	29899451	0	O
synapses4-6	29899451	0	O
.	29899451	0	O
Thus	29899451	0	O
,	29899451	0	O
the	29899451	0	O
phosphorylation	29899451	0	O
-	29899451	0	O
dephosphorylation	29899451	0	O
cycle	29899451	0	O
of	29899451	0	O
SNIPPs	29899451	0	O
may	29899451	0	O
represent	29899451	0	O
a	29899451	0	O
major	29899451	0	O
regulatory	29899451	0	O
mechanism	29899451	0	O
that	29899451	0	O
underlies	29899451	0	O
both	29899451	0	O
synaptic	29899451	0	O
homeostasis	29899451	0	O
and	29899451	0	O
sleep	29899451	0	O
-	29899451	0	O
wake	29899451	0	O
homeostasis	29899451	0	O
.	29899451	0	O

Multiple	29941455	0	O
regions	29941455	0	O
in	29941455	0	O
the	29941455	0	O
extracellular	29941455	0	O
domain	29941455	0	O
of	29941455	0	O
the	29941455	0	O
glycine	29941455	0	O
receptor	29941455	0	O
determine	29941455	0	O
receptor	29941455	0	O
activity	29941455	0	O
.	29941455	0	O
Glycine	29941455	0	O
receptors	29941455	0	O
(	29941455	0	O
GlyRs	29941455	0	O
)	29941455	0	O
are	29941455	0	O
Cys	29941455	0	O
-	29941455	0	O
loop	29941455	0	O
receptors	29941455	0	O
that	29941455	0	O
mediate	29941455	0	O
fast	29941455	0	O
synaptic	29941455	0	O
inhibition	29941455	0	O
in	29941455	0	O
the	29941455	0	O
brain	29941455	0	O
stem	29941455	0	O
and	29941455	0	O
spinal	29941455	0	O
cord	29941455	0	O
.	29941455	0	O
They	29941455	0	O
are	29941455	0	O
involved	29941455	0	O
in	29941455	0	O
the	29941455	0	O
generation	29941455	0	O
of	29941455	0	O
motor	29941455	0	O
rhythm	29941455	0	O
,	29941455	0	O
reflex	29941455	0	O
circuit	29941455	0	O
coordination	29941455	0	O
,	29941455	0	O
and	29941455	0	O
sensory	29941455	0	O
signal	29941455	0	O
processing	29941455	0	O
and	29941455	0	O
therefore	29941455	0	O
represent	29941455	0	O
targets	29941455	0	O
for	29941455	0	O
therapeutic	29941455	0	O
interventions	29941455	0	O
.	29941455	0	O
The	29941455	0	O
extracellular	29941455	0	O
domains	29941455	0	O
(	29941455	0	O
ECDs	29941455	0	O
)	29941455	0	O
of	29941455	0	O
Cys	29941455	0	O
-	29941455	0	O
loop	29941455	0	O
receptors	29941455	0	O
typically	29941455	0	O
contain	29941455	0	O
many	29941455	0	O
aromatic	29941455	0	O
amino	29941455	0	O
acids	29941455	0	O
,	29941455	0	O
but	29941455	0	O
only	29941455	0	O
those	29941455	0	O
in	29941455	0	O
the	29941455	0	O
receptor	29941455	0	O
binding	29941455	0	O
pocket	29941455	0	O
have	29941455	0	O
been	29941455	0	O
extensively	29941455	0	O
studied	29941455	0	O
.	29941455	0	O
Here	29941455	0	O
,	29941455	0	O
we	29941455	0	O
show	29941455	0	O
that	29941455	0	O
many	29941455	0	O
Phe	29941455	0	O
residues	29941455	0	O
in	29941455	0	O
the	29941455	0	O
ECD	29941455	0	O
that	29941455	0	O
are	29941455	0	O
not	29941455	0	O
located	29941455	0	O
in	29941455	0	O
the	29941455	0	O
binding	29941455	0	O
pocket	29941455	0	O
are	29941455	0	O
also	29941455	0	O
involved	29941455	0	O
in	29941455	0	O
GlyR	29941455	0	O
function	29941455	0	O
.	29941455	0	O
We	29941455	0	O
examined	29941455	0	O
these	29941455	0	O
Phe	29941455	0	O
residues	29941455	0	O
by	29941455	0	O
creating	29941455	0	O
several	29941455	0	O
GlyR	29941455	0	O
variants	29941455	0	O
,	29941455	0	O
characterizing	29941455	0	O
these	29941455	0	O
variants	29941455	0	O
with	29941455	0	O
the	29941455	0	O
two	29941455	0	O
-	29941455	0	O
electrode	29941455	0	O
voltage	29941455	0	O
clamp	29941455	0	O
technique	29941455	0	O
in	29941455	0	O
Xenopus	29941455	0	O
oocytes	29941455	0	O
,	29941455	0	O
and	29941455	0	O
interpreting	29941455	0	O
changes	29941455	0	O
in	29941455	0	O
receptor	29941455	0	O
parameters	29941455	0	O
by	29941455	0	O
using	29941455	0	O
currently	29941455	0	O
available	29941455	0	O
structural	29941455	0	O
information	29941455	0	O
on	29941455	0	O
the	29941455	0	O
open	29941455	0	O
and	29941455	0	O
closed	29941455	0	O
states	29941455	0	O
of	29941455	0	O
the	29941455	0	O
GlyR	29941455	0	O
.	29941455	0	O
Substitution	29941455	0	B-Var
of	29941455	0	I-Var
six	29941455	0	I-Var
of	29941455	0	I-Var
the	29941455	0	I-Var
eight	29941455	0	I-Var
Phe	29941455	0	I-Var
residues	29941455	0	I-Var
in	29941455	0	I-Var
the	29941455	0	I-Var
ECD	29941455	0	I-Var
with	29941455	0	I-Var
Ala	29941455	0	I-Var
resulted	29941455	0	O
in	29941455	0	O
loss	29941455	0	B-NegReg
of	29941455	0	O
function	29941455	0	O
or	29941455	0	O
significantly	29941455	0	O
increased	29941455	0	B-PosReg
the	29941455	0	O
EC50	29941455	0	O
and	29941455	0	O
also	29941455	0	O
altered	29941455	0	B-Reg
the	29941455	0	O
maximal	29941455	0	O
response	29941455	0	O
to	29941455	0	O
the	29941455	0	O
partial	29941455	0	O
GlyR	29941455	0	O
agonist	29941455	0	O
taurine	29941455	0	O
compared	29941455	0	O
with	29941455	0	O
glycine	29941455	0	O
in	29941455	0	O
those	29941455	0	O
receptor	29941455	0	O
variants	29941455	0	O
that	29941455	0	O
were	29941455	0	O
functional	29941455	0	O
.	29941455	0	O
Substitutions	29941455	0	O
with	29941455	0	O
other	29941455	0	O
amino	29941455	0	O
acids	29941455	0	O
,	29941455	0	O
combined	29941455	0	O
with	29941455	0	O
examination	29941455	0	O
of	29941455	0	O
nearby	29941455	0	O
residues	29941455	0	O
that	29941455	0	O
could	29941455	0	O
potentially	29941455	0	O
interact	29941455	0	O
with	29941455	0	O
these	29941455	0	O
Phe	29941455	0	O
residues	29941455	0	O
,	29941455	0	O
suggested	29941455	0	O
interactions	29941455	0	O
that	29941455	0	O
could	29941455	0	O
be	29941455	0	O
important	29941455	0	O
for	29941455	0	O
GlyR	29941455	0	O
function	29941455	0	O
,	29941455	0	O
and	29941455	0	O
possibly	29941455	0	O
similar	29941455	0	O
interactions	29941455	0	O
could	29941455	0	O
contribute	29941455	0	O
to	29941455	0	O
the	29941455	0	O
function	29941455	0	O
of	29941455	0	O
other	29941455	0	O
members	29941455	0	O
of	29941455	0	O
the	29941455	0	O
Cys	29941455	0	O
-	29941455	0	O
loop	29941455	0	O
receptor	29941455	0	O
family	29941455	0	O
.	29941455	0	O
Overall	29941455	0	O
,	29941455	0	O
our	29941455	0	O
results	29941455	0	O
suggest	29941455	0	O
that	29941455	0	O
many	29941455	0	O
ECD	29941455	0	O
regions	29941455	0	O
are	29941455	0	O
important	29941455	0	O
for	29941455	0	O
GlyR	29941455	0	O
function	29941455	0	O
and	29941455	0	O
that	29941455	0	O
these	29941455	0	O
regions	29941455	0	O
could	29941455	0	O
inform	29941455	0	O
the	29941455	0	O
design	29941455	0	O
of	29941455	0	O
therapeutic	29941455	0	O
agents	29941455	0	O
targeting	29941455	0	O
GlyR	29941455	0	O
activity	29941455	0	O
.	29941455	0	O

RES	29969449	0	O
complex	29969449	0	O
is	29969449	0	O
associated	29969449	0	O
with	29969449	0	O
intron	29969449	0	O
definition	29969449	0	O
and	29969449	0	O
required	29969449	0	O
for	29969449	0	O
zebrafish	29969449	0	O
early	29969449	0	O
embryogenesis	29969449	0	O
.	29969449	0	O
Pre	29969449	0	O
-	29969449	0	O
mRNA	29969449	0	O
splicing	29969449	0	O
is	29969449	0	O
a	29969449	0	O
critical	29969449	0	O
step	29969449	0	O
of	29969449	0	O
gene	29969449	0	O
expression	29969449	0	O
in	29969449	0	O
eukaryotes	29969449	0	O
.	29969449	0	O
Transcriptome	29969449	0	O
-	29969449	0	O
wide	29969449	0	O
splicing	29969449	0	O
patterns	29969449	0	O
are	29969449	0	O
complex	29969449	0	O
and	29969449	0	O
primarily	29969449	0	O
regulated	29969449	0	O
by	29969449	0	O
a	29969449	0	O
diverse	29969449	0	O
set	29969449	0	O
of	29969449	0	O
recognition	29969449	0	O
elements	29969449	0	O
and	29969449	0	O
associated	29969449	0	O
RNA	29969449	0	O
-	29969449	0	O
binding	29969449	0	O
proteins	29969449	0	O
.	29969449	0	O
The	29969449	0	O
retention	29969449	0	O
and	29969449	0	O
splicing	29969449	0	O
(	29969449	0	O
RES	29969449	0	O
)	29969449	0	O
complex	29969449	0	O
is	29969449	0	O
formed	29969449	0	O
by	29969449	0	O
three	29969449	0	O
different	29969449	0	O
proteins	29969449	0	O
(	29969449	0	O
Bud13p	29969449	0	O
,	29969449	0	O
Pml1p	29969449	0	O
and	29969449	0	O
Snu17p	29969449	0	O
)	29969449	0	O
and	29969449	0	O
is	29969449	0	O
involved	29969449	0	O
in	29969449	0	O
splicing	29969449	0	O
in	29969449	0	O
yeast	29969449	0	O
.	29969449	0	O
However	29969449	0	O
,	29969449	0	O
the	29969449	0	O
importance	29969449	0	O
of	29969449	0	O
the	29969449	0	O
RES	29969449	0	O
complex	29969449	0	O
for	29969449	0	O
vertebrate	29969449	0	O
splicing	29969449	0	O
,	29969449	0	O
the	29969449	0	O
intronic	29969449	0	O
features	29969449	0	O
associated	29969449	0	O
with	29969449	0	O
its	29969449	0	O
activity	29969449	0	O
,	29969449	0	O
and	29969449	0	O
its	29969449	0	O
role	29969449	0	O
in	29969449	0	O
development	29969449	0	O
are	29969449	0	O
unknown	29969449	0	O
.	29969449	0	O
In	29969449	0	O
this	29969449	0	O
study	29969449	0	O
,	29969449	0	O
we	29969449	0	O
have	29969449	0	O
generated	29969449	0	O
loss	29969449	0	B-NegReg
-	29969449	0	I-NegReg
of	29969449	0	I-NegReg
-	29969449	0	I-NegReg
function	29969449	0	I-NegReg
mutants	29969449	0	B-Var
for	29969449	0	O
the	29969449	0	O
three	29969449	0	O
components	29969449	0	O
of	29969449	0	O
the	29969449	0	O
RES	29969449	0	O
complex	29969449	0	O
in	29969449	0	O
zebrafish	29969449	0	O
and	29969449	0	O
showed	29969449	0	O
that	29969449	0	O
they	29969449	0	O
are	29969449	0	O
required	29969449	0	O
during	29969449	0	O
early	29969449	0	O
development	29969449	0	O
.	29969449	0	O
The	29969449	0	O
mutants	29969449	0	O
showed	29969449	0	O
a	29969449	0	O
marked	29969449	0	O
neural	29969449	0	O
phenotype	29969449	0	O
with	29969449	0	O
increased	29969449	0	B-PosReg
cell	29969449	0	O
death	29969449	0	O
in	29969449	0	O
the	29969449	0	O
brain	29969449	0	O
and	29969449	0	O
a	29969449	0	O
decrease	29969449	0	B-NegReg
in	29969449	0	O
differentiated	29969449	0	O
neurons	29969449	0	O
.	29969449	0	O
Transcriptomic	29969449	0	O
analysis	29969449	0	O
of	29969449	0	O
bud13	29969449	0	B-Gene
,	29969449	0	O
snip1	29969449	0	B-Gene
(	29969449	0	I-Gene
pml1	29969449	0	I-Gene
)	29969449	0	I-Gene
and	29969449	0	O
rbmx2	29969449	0	B-Gene
(	29969449	0	I-Gene
snu17	29969449	0	I-Gene
)	29969449	0	I-Gene
mutants	29969449	0	B-Var
revealed	29969449	0	O
a	29969449	0	O
global	29969449	0	O
defect	29969449	0	B-NegReg
in	29969449	0	O
intron	29969449	0	O
splicing	29969449	0	O
,	29969449	0	O
with	29969449	0	O
strong	29969449	0	O
mis	29969449	0	O
-	29969449	0	O
splicing	29969449	0	O
of	29969449	0	O
a	29969449	0	O
subset	29969449	0	O
of	29969449	0	O
introns	29969449	0	O
.	29969449	0	O
We	29969449	0	O
found	29969449	0	O
these	29969449	0	O
RES	29969449	0	O
-	29969449	0	O
dependent	29969449	0	O
introns	29969449	0	O
were	29969449	0	O
short	29969449	0	O
,	29969449	0	O
rich	29969449	0	O
in	29969449	0	O
GC	29969449	0	O
and	29969449	0	O
flanked	29969449	0	O
by	29969449	0	O
GC	29969449	0	O
depleted	29969449	0	O
exons	29969449	0	O
,	29969449	0	O
all	29969449	0	O
of	29969449	0	O
which	29969449	0	O
are	29969449	0	O
features	29969449	0	O
associated	29969449	0	O
with	29969449	0	O
intron	29969449	0	O
definition	29969449	0	O
.	29969449	0	O
Using	29969449	0	O
these	29969449	0	O
features	29969449	0	O
,	29969449	0	O
we	29969449	0	O
developed	29969449	0	O
and	29969449	0	O
validated	29969449	0	O
a	29969449	0	O
predictive	29969449	0	O
model	29969449	0	O
that	29969449	0	O
classifies	29969449	0	O
RES	29969449	0	O
dependent	29969449	0	O
introns	29969449	0	O
.	29969449	0	O
Altogether	29969449	0	O
,	29969449	0	O
our	29969449	0	O
study	29969449	0	O
uncovers	29969449	0	O
the	29969449	0	O
essential	29969449	0	O
role	29969449	0	O
of	29969449	0	O
the	29969449	0	O
RES	29969449	0	O
complex	29969449	0	O
during	29969449	0	O
vertebrate	29969449	0	O
development	29969449	0	O
and	29969449	0	O
provides	29969449	0	O
new	29969449	0	O
insights	29969449	0	O
into	29969449	0	O
its	29969449	0	O
function	29969449	0	O
during	29969449	0	O
splicing	29969449	0	O
.	29969449	0	O

Mutant	29970031	0	B-Var
p53	29970031	0	B-Gene
gain	29970031	0	B-PosReg
of	29970031	0	I-PosReg
function	29970031	0	I-PosReg
induces	29970031	0	B-Reg
HER2	29970031	0	O
over	29970031	0	O
-	29970031	0	O
expression	29970031	0	O
in	29970031	0	O
cancer	29970031	0	O
cells	29970031	0	O
.	29970031	0	O
BACKGROUND	29970031	0	O
:	29970031	0	O
HER2	29970031	0	O
over	29970031	0	O
-	29970031	0	O
expression	29970031	0	O
is	29970031	0	O
related	29970031	0	O
with	29970031	0	O
a	29970031	0	O
poor	29970031	0	O
prognosis	29970031	0	O
in	29970031	0	O
patients	29970031	0	O
with	29970031	0	O
invasive	29970031	0	O
breast	29970031	0	O
cancer	29970031	0	O
tumors	29970031	0	O
.	29970031	0	O
Clinical	29970031	0	O
associations	29970031	0	O
have	29970031	0	O
reported	29970031	0	O
that	29970031	0	O
somatic	29970031	0	O
mutations	29970031	0	O
of	29970031	0	O
p53	29970031	0	O
more	29970031	0	O
frequently	29970031	0	O
detected	29970031	0	O
in	29970031	0	O
cases	29970031	0	O
of	29970031	0	O
sporadic	29970031	0	O
breast	29970031	0	O
cancer	29970031	0	O
of	29970031	0	O
the	29970031	0	O
HER2	29970031	0	O
subtypes	29970031	0	O
,	29970031	0	O
besides	29970031	0	O
a	29970031	0	O
high	29970031	0	O
percentage	29970031	0	O
of	29970031	0	O
HER2	29970031	0	O
-	29970031	0	O
amplifying	29970031	0	O
tumors	29970031	0	O
carry	29970031	0	O
germline	29970031	0	O
mutations	29970031	0	O
of	29970031	0	O
p53	29970031	0	O
.	29970031	0	O
The	29970031	0	O
mechanisms	29970031	0	O
responsible	29970031	0	O
for	29970031	0	O
the	29970031	0	O
acquisition	29970031	0	O
of	29970031	0	O
oncogenic	29970031	0	O
functions	29970031	0	O
of	29970031	0	O
p53	29970031	0	O
mutant	29970031	0	O
proteins	29970031	0	O
(	29970031	0	O
mtp53	29970031	0	O
)	29970031	0	O
,	29970031	0	O
known	29970031	0	O
as	29970031	0	O
Gain	29970031	0	O
of	29970031	0	O
Function	29970031	0	O
(	29970031	0	O
GOF	29970031	0	O
)	29970031	0	O
,	29970031	0	O
over	29970031	0	O
HER2	29970031	0	O
expression	29970031	0	O
have	29970031	0	O
not	29970031	0	O
been	29970031	0	O
reported	29970031	0	O
.	29970031	0	O
The	29970031	0	O
objective	29970031	0	O
of	29970031	0	O
this	29970031	0	O
study	29970031	0	O
was	29970031	0	O
to	29970031	0	O
evaluate	29970031	0	O
a	29970031	0	O
possible	29970031	0	O
relationship	29970031	0	O
between	29970031	0	O
p53	29970031	0	O
mutants	29970031	0	O
and	29970031	0	O
HER2	29970031	0	O
regulation	29970031	0	O
.	29970031	0	O
METHODS	29970031	0	O
:	29970031	0	O
HER2	29970031	0	O
expression	29970031	0	O
(	29970031	0	O
transcription	29970031	0	O
and	29970031	0	O
protein	29970031	0	O
)	29970031	0	O
,	29970031	0	O
as	29970031	0	O
well	29970031	0	O
as	29970031	0	O
HER2	29970031	0	O
protein	29970031	0	O
stabilization	29970031	0	O
have	29970031	0	O
been	29970031	0	O
evaluated	29970031	0	O
after	29970031	0	O
inducing	29970031	0	O
or	29970031	0	O
silencing	29970031	0	O
of	29970031	0	O
p53	29970031	0	O
mutants	29970031	0	O
'	29970031	0	O
expression	29970031	0	O
in	29970031	0	O
cell	29970031	0	O
lines	29970031	0	O
.	29970031	0	O
Finally	29970031	0	O
,	29970031	0	O
we	29970031	0	O
evaluated	29970031	0	O
the	29970031	0	O
interaction	29970031	0	O
of	29970031	0	O
the	29970031	0	O
p53	29970031	0	O
mutants	29970031	0	O
over	29970031	0	O
the	29970031	0	O
HER2	29970031	0	O
receptor	29970031	0	O
promoter	29970031	0	O
.	29970031	0	O
RESULTS	29970031	0	O
:	29970031	0	O
Higher	29970031	0	B-PosReg
HER2	29970031	0	O
expression	29970031	0	O
in	29970031	0	O
cell	29970031	0	O
lines	29970031	0	O
harboring	29970031	0	O
endogenous	29970031	0	O
mtp53	29970031	0	B-Var
compared	29970031	0	O
with	29970031	0	O
wt	29970031	0	O
or	29970031	0	O
null	29970031	0	O
expression	29970031	0	O
of	29970031	0	O
p53	29970031	0	O
cell	29970031	0	O
lines	29970031	0	O
.	29970031	0	O
Transfection	29970031	0	O
of	29970031	0	O
p53	29970031	0	B-Gene
mutants	29970031	0	O
(	29970031	0	B-Var
R248Q	29970031	0	I-Var
and	29970031	0	O
R273C	29970031	0	B-Var
)	29970031	0	I-Var
in	29970031	0	O
cell	29970031	0	O
lines	29970031	0	O
increased	29970031	0	B-PosReg
the	29970031	0	O
expression	29970031	0	O
of	29970031	0	O
HER2	29970031	0	O
.	29970031	0	O
Silencing	29970031	0	O
of	29970031	0	O
p53	29970031	0	O
mutants	29970031	0	O
,	29970031	0	O
decrease	29970031	0	O
HER2	29970031	0	O
expression	29970031	0	O
.	29970031	0	O
The	29970031	0	O
p53	29970031	0	B-Gene
mutants	29970031	0	O
R248Q	29970031	0	B-Var
and	29970031	0	O
R273C	29970031	0	B-Var
significantly	29970031	0	O
increase	29970031	0	B-PosReg
the	29970031	0	O
luciferase	29970031	0	O
activity	29970031	0	O
on	29970031	0	O
the	29970031	0	O
HER2	29970031	0	O
promoter	29970031	0	O
,	29970031	0	O
and	29970031	0	O
both	29970031	0	O
mutants	29970031	0	O
also	29970031	0	O
promote	29970031	0	B-PosReg
acetylation	29970031	0	O
of	29970031	0	O
H3	29970031	0	O
and	29970031	0	O
H4	29970031	0	O
histones	29970031	0	O
binding	29970031	0	O
in	29970031	0	O
it	29970031	0	O
.	29970031	0	O
CONCLUSIONS	29970031	0	O
:	29970031	0	O
These	29970031	0	O
findings	29970031	0	O
show	29970031	0	O
for	29970031	0	O
the	29970031	0	O
first	29970031	0	O
time	29970031	0	O
that	29970031	0	O
p53	29970031	0	B-Gene
mutants	29970031	0	B-Var
induce	29970031	0	B-Reg
over	29970031	0	O
-	29970031	0	O
expression	29970031	0	O
of	29970031	0	O
HER2	29970031	0	O
at	29970031	0	O
transcriptional	29970031	0	O
level	29970031	0	O
of	29970031	0	O
the	29970031	0	O
HER2	29970031	0	O
protein	29970031	0	O
.	29970031	0	O
Our	29970031	0	O
results	29970031	0	O
could	29970031	0	O
have	29970031	0	O
clinical	29970031	0	O
implications	29970031	0	O
in	29970031	0	O
breast	29970031	0	O
cancer	29970031	0	O
and	29970031	0	O
other	29970031	0	O
types	29970031	0	O
of	29970031	0	O
cancer	29970031	0	O
where	29970031	0	O
HER2	29970031	0	O
is	29970031	0	O
over	29970031	0	O
-	29970031	0	O
expressed	29970031	0	O
and	29970031	0	O
used	29970031	0	O
as	29970031	0	O
a	29970031	0	O
therapy	29970031	0	O
target	29970031	0	O
.	29970031	0	O

Identification	29973161	4	O
of	29973161	4	O
deletion	29973161	4	B-Var
-	29973161	4	I-Var
duplication	29973161	4	I-Var
in	29973161	4	O
HEXA	29973161	4	B-Gene
gene	29973161	4	O
in	29973161	4	O
five	29973161	4	O
children	29973161	4	O
with	29973161	4	B-Reg
Tay	29973161	4	B-Disease
-	29973161	4	I-Disease
Sachs	29973161	4	I-Disease
disease	29973161	4	I-Disease
from	29973161	4	O
India	29973161	4	O
.	29973161	4	O
BACKGROUND	29973161	4	O
:	29973161	4	O
Tay	29973161	4	B-Disease
-	29973161	4	I-Disease
Sachs	29973161	4	I-Disease
disease	29973161	4	I-Disease
(	29973161	4	O
TSD	29973161	4	O
)	29973161	4	O
is	29973161	4	O
a	29973161	4	O
sphingolipid	29973161	4	O
storage	29973161	4	O
disorder	29973161	4	O
caused	29973161	4	B-Reg
by	29973161	4	I-Reg
mutations	29973161	4	B-Var
in	29973161	4	O
the	29973161	4	O
HEXA	29973161	4	B-Gene
gene	29973161	4	O
.	29973161	4	O
To	29973161	4	O
date	29973161	4	O
,	29973161	4	O
nearly	29973161	4	O
170	29973161	4	O
mutations	29973161	4	O
of	29973161	4	O
HEXA	29973161	4	O
have	29973161	4	O
been	29973161	4	O
described	29973161	4	O
,	29973161	4	O
including	29973161	4	O
only	29973161	4	O
one	29973161	4	O
7.6	29973161	4	O
kb	29973161	4	O
large	29973161	4	O
deletion	29973161	4	O
.	29973161	4	O
METHODS	29973161	4	O
:	29973161	4	O
Multiplex	29973161	4	O
Ligation	29973161	4	O
-	29973161	4	O
dependent	29973161	4	O
Probe	29973161	4	O
Amplification	29973161	4	O
(	29973161	4	O
MLPA	29973161	4	O
)	29973161	4	O
study	29973161	4	O
was	29973161	4	O
carried	29973161	4	O
out	29973161	4	O
in	29973161	4	O
5	29973161	4	O
unrelated	29973161	4	O
patients	29973161	4	O
for	29973161	4	O
copy	29973161	4	O
number	29973161	4	O
changes	29973161	4	O
where	29973161	4	O
heterozygous	29973161	4	O
and	29973161	4	O
/	29973161	4	O
or	29973161	4	O
homozygous	29973161	4	O
disease	29973161	4	O
causing	29973161	4	O
mutation	29973161	4	O
/	29973161	4	O
s	29973161	4	O
could	29973161	4	O
not	29973161	4	O
be	29973161	4	O
identified	29973161	4	O
in	29973161	4	O
the	29973161	4	O
coding	29973161	4	O
region	29973161	4	O
by	29973161	4	O
sequencing	29973161	4	O
of	29973161	4	O
HEXA	29973161	4	O
gene	29973161	4	O
.	29973161	4	O
RESULTS	29973161	4	O
:	29973161	4	O
The	29973161	4	O
study	29973161	4	O
has	29973161	4	O
identified	29973161	4	O
the	29973161	4	O
presence	29973161	4	O
of	29973161	4	O
a	29973161	4	O
homozygous	29973161	4	O
deletion	29973161	4	O
of	29973161	4	O
exon-2	29973161	4	O
and	29973161	4	O
exon-3	29973161	4	O
in	29973161	4	O
two	29973161	4	O
patients	29973161	4	O
,	29973161	4	O
two	29973161	4	O
patient	29973161	4	O
showed	29973161	4	O
compound	29973161	4	O
heterozygosity	29973161	4	O
with	29973161	4	O
exon	29973161	4	O
1	29973161	4	O
deletion	29973161	4	O
combined	29973161	4	O
with	29973161	4	O
missense	29973161	4	O
mutation	29973161	4	O
p.E462V	29973161	4	O
and	29973161	4	O
one	29973161	4	O
patient	29973161	4	O
was	29973161	4	O
identified	29973161	4	O
with	29973161	4	O
duplication	29973161	4	O
of	29973161	4	O
exon-1	29973161	4	O
with	29973161	4	O
novel	29973161	4	O
variants	29973161	4	O
c.1527	29973161	4	O
-	29973161	4	O
2	29973161	4	O
A	29973161	4	O
>	29973161	4	O
T	29973161	4	O
as	29973161	4	O
a	29973161	4	O
second	29973161	4	O
allele	29973161	4	O
.	29973161	4	O
CONCLUSION	29973161	4	O
:	29973161	4	O
This	29973161	4	O
is	29973161	4	O
the	29973161	4	O
first	29973161	4	O
report	29973161	4	O
of	29973161	4	O
deletion	29973161	4	O
/	29973161	4	O
duplication	29973161	4	O
in	29973161	4	O
HEXA	29973161	4	O
gene	29973161	4	O
providing	29973161	4	O
a	29973161	4	O
new	29973161	4	O
insight	29973161	4	O
into	29973161	4	O
the	29973161	4	O
molecular	29973161	4	O
basis	29973161	4	O
of	29973161	4	O
TSD	29973161	4	O
and	29973161	4	O
use	29973161	4	O
of	29973161	4	O
MLPA	29973161	4	O
assay	29973161	4	O
for	29973161	4	O
detecting	29973161	4	O
large	29973161	4	O
copy	29973161	4	O
number	29973161	4	O
changes	29973161	4	O
in	29973161	4	O
the	29973161	4	O
HEXA	29973161	4	O
gene	29973161	4	O
.	29973161	4	O

Two	30031150	4	O
siblings	30031150	4	O
with	30031150	4	O
11	30031150	4	O
qter	30031150	4	O
deletion	30031150	4	O
syndrome	30031150	4	O
that	30031150	4	O
had	30031150	4	O
been	30031150	4	O
rescued	30031150	4	O
in	30031150	4	O
their	30031150	4	O
mother	30031150	4	O
by	30031150	4	O
uniparental	30031150	4	O
disomy	30031150	4	O
.	30031150	4	O
Jacobsen	30031150	4	B-Disease
syndrome	30031150	4	I-Disease
refers	30031150	4	O
to	30031150	4	O
a	30031150	4	O
congenital	30031150	4	O
anomaly	30031150	4	O
caused	30031150	4	B-Reg
by	30031150	4	I-Reg
deletion	30031150	4	B-Var
at	30031150	4	O
11	30031150	4	B-Gene
q23.3	30031150	4	I-Gene
-	30031150	4	I-Gene
qter	30031150	4	I-Gene
.	30031150	4	O
We	30031150	4	O
here	30031150	4	O
describe	30031150	4	O
two	30031150	4	O
siblings	30031150	4	O
with	30031150	4	O
the	30031150	4	O
same	30031150	4	O
11	30031150	4	O
q23.3	30031150	4	O
-	30031150	4	O
qter	30031150	4	O
deletion	30031150	4	O
.	30031150	4	O
Both	30031150	4	O
parents	30031150	4	O
were	30031150	4	O
healthy	30031150	4	O
with	30031150	4	O
a	30031150	4	O
normal	30031150	4	O
karyotype	30031150	4	O
.	30031150	4	O
Cytogenetic	30031150	4	O
microarray	30031150	4	O
analysis	30031150	4	O
revealed	30031150	4	O
no	30031150	4	O
mosaicism	30031150	4	O
in	30031150	4	O
either	30031150	4	O
parent	30031150	4	O
but	30031150	4	O
the	30031150	4	O
mother	30031150	4	O
showed	30031150	4	O
uniparental	30031150	4	O
disomy	30031150	4	O
encompassing	30031150	4	O
the	30031150	4	O
deleted	30031150	4	O
region	30031150	4	O
found	30031150	4	O
in	30031150	4	O
the	30031150	4	O
two	30031150	4	O
siblings	30031150	4	O
.	30031150	4	O
The	30031150	4	O
pattern	30031150	4	O
of	30031150	4	O
X	30031150	4	O
chromosome	30031150	4	O
inactivation	30031150	4	O
was	30031150	4	O
almost	30031150	4	O
completely	30031150	4	O
skewed	30031150	4	O
in	30031150	4	O
the	30031150	4	O
mother	30031150	4	O
.	30031150	4	O
These	30031150	4	O
data	30031150	4	O
suggested	30031150	4	O
that	30031150	4	O
the	30031150	4	O
mother	30031150	4	O
was	30031150	4	O
a	30031150	4	O
carrier	30031150	4	O
of	30031150	4	O
the	30031150	4	O
11	30031150	4	O
q23.3	30031150	4	O
-	30031150	4	O
qter	30031150	4	O
deletion	30031150	4	O
but	30031150	4	O
that	30031150	4	O
this	30031150	4	O
had	30031150	4	O
been	30031150	4	O
rescued	30031150	4	O
by	30031150	4	O
disomy	30031150	4	O
formation	30031150	4	O
during	30031150	4	O
early	30031150	4	O
embryogenesis	30031150	4	O
except	30031150	4	O
for	30031150	4	O
her	30031150	4	O
germinal	30031150	4	O
cells	30031150	4	O
.	30031150	4	O

Genotyping	30036279	4	O
of	30036279	4	O
five	30036279	4	O
Pakistani	30036279	4	O
patients	30036279	4	O
with	30036279	4	O
severe	30036279	4	O
inherited	30036279	4	O
factor	30036279	4	O
X	30036279	4	O
deficiency	30036279	4	O
:	30036279	4	O
identification	30036279	4	O
of	30036279	4	O
two	30036279	4	O
novel	30036279	4	O
mutations	30036279	4	O
.	30036279	4	O
:	30036279	4	O
Congenital	30036279	4	B-Disease
factor	30036279	4	I-Disease
X	30036279	4	I-Disease
deficiency	30036279	4	I-Disease
is	30036279	4	O
a	30036279	4	O
rare	30036279	4	O
coagulation	30036279	4	O
defect	30036279	4	O
characterized	30036279	4	O
by	30036279	4	O
variable	30036279	4	O
bleeding	30036279	4	O
tendency	30036279	4	O
.	30036279	4	O
The	30036279	4	O
aim	30036279	4	O
of	30036279	4	O
the	30036279	4	O
study	30036279	4	O
was	30036279	4	O
to	30036279	4	O
give	30036279	4	O
a	30036279	4	O
first	30036279	4	O
insight	30036279	4	O
of	30036279	4	B-Reg
F10	30036279	4	B-Gene
gene	30036279	4	O
mutations	30036279	4	B-Var
in	30036279	4	O
Pakistani	30036279	4	O
probands	30036279	4	O
.	30036279	4	O
Direct	30036279	4	O
sequencing	30036279	4	O
and	30036279	4	O
/	30036279	4	O
or	30036279	4	O
next	30036279	4	O
-	30036279	4	O
generation	30036279	4	O
sequencing	30036279	4	O
was	30036279	4	O
performed	30036279	4	O
on	30036279	4	O
the	30036279	4	O
coding	30036279	4	O
regions	30036279	4	O
,	30036279	4	O
boundaries	30036279	4	O
and	30036279	4	O
5	30036279	4	O
'	30036279	4	O
and	30036279	4	O
3	30036279	4	O
'	30036279	4	O
untranslated	30036279	4	O
regions	30036279	4	O
of	30036279	4	O
the	30036279	4	O
F10	30036279	4	O
gene	30036279	4	O
in	30036279	4	O
five	30036279	4	O
severe	30036279	4	O
factor	30036279	4	O
X	30036279	4	O
-	30036279	4	O
deficient	30036279	4	O
patients	30036279	4	O
from	30036279	4	O
Pakistan	30036279	4	O
.	30036279	4	O
All	30036279	4	O
patients	30036279	4	O
were	30036279	4	O
born	30036279	4	O
from	30036279	4	O
consanguineous	30036279	4	O
marriages	30036279	4	O
and	30036279	4	O
displayed	30036279	4	O
FX	30036279	4	O
:	30036279	4	O
C	30036279	4	O
levels	30036279	4	O
below	30036279	4	O
2%	30036279	4	O
.	30036279	4	O
Sequencing	30036279	4	O
revealed	30036279	4	O
five	30036279	4	O
different	30036279	4	O
substitutions	30036279	4	O
,	30036279	4	O
including	30036279	4	O
three	30036279	4	O
previously	30036279	4	O
reported	30036279	4	O
p.Ala15Asp	30036279	4	O
,	30036279	4	O
p.Gly406Ser	30036279	4	O
,	30036279	4	O
and	30036279	4	O
p.Gly420Arg	30036279	4	O
missense	30036279	4	O
variants	30036279	4	O
,	30036279	4	O
and	30036279	4	O
also	30036279	4	O
two	30036279	4	O
novel	30036279	4	O
variants	30036279	4	O
:	30036279	4	O
p.Cys57Arg	30036279	4	O
and	30036279	4	O
p.Gln175*	30036279	4	O
.	30036279	4	O
Though	30036279	4	O
one	30036279	4	O
genotype	30036279	4	O
could	30036279	4	O
not	30036279	4	O
be	30036279	4	O
characterized	30036279	4	O
,	30036279	4	O
we	30036279	4	O
were	30036279	4	O
able	30036279	4	O
to	30036279	4	O
confirm	30036279	4	O
the	30036279	4	O
inherited	30036279	4	O
nature	30036279	4	O
of	30036279	4	O
the	30036279	4	O
defect	30036279	4	O
using	30036279	4	O
familial	30036279	4	O
studies	30036279	4	O
.	30036279	4	O
As	30036279	4	O
the	30036279	4	O
copy	30036279	4	O
number	30036279	4	O
variations	30036279	4	O
were	30036279	4	O
ruled	30036279	4	O
out	30036279	4	O
,	30036279	4	O
we	30036279	4	O
hypothesized	30036279	4	O
the	30036279	4	O
presence	30036279	4	O
of	30036279	4	O
deep	30036279	4	O
intronic	30036279	4	O
mutants	30036279	4	O
that	30036279	4	O
might	30036279	4	O
have	30036279	4	O
escaped	30036279	4	O
detection	30036279	4	O
from	30036279	4	O
sequencing	30036279	4	O
or	30036279	4	O
abnormalities	30036279	4	O
in	30036279	4	O
epigenetic	30036279	4	O
regulation	30036279	4	O
.	30036279	4	O
Three	30036279	4	O
patients	30036279	4	O
presented	30036279	4	O
with	30036279	4	O
severe	30036279	4	O
clinical	30036279	4	O
symptoms	30036279	4	O
,	30036279	4	O
in	30036279	4	O
the	30036279	4	O
early	30036279	4	O
days	30036279	4	O
of	30036279	4	O
life	30036279	4	O
,	30036279	4	O
whereas	30036279	4	O
two	30036279	4	O
presented	30036279	4	O
only	30036279	4	O
with	30036279	4	O
trauma	30036279	4	O
-	30036279	4	O
provoked	30036279	4	O
bleeds	30036279	4	O
and	30036279	4	O
bruises	30036279	4	O
later	30036279	4	O
in	30036279	4	O
life	30036279	4	O
.	30036279	4	O
Those	30036279	4	O
patients	30036279	4	O
with	30036279	4	O
milder	30036279	4	O
forms	30036279	4	O
bore	30036279	4	O
the	30036279	4	O
p.Gly406Ser	30036279	4	O
at	30036279	4	O
the	30036279	4	O
homozygous	30036279	4	O
state	30036279	4	O
and	30036279	4	O
F10	30036279	4	O
unknown	30036279	4	O
alleles	30036279	4	O
,	30036279	4	O
respectively	30036279	4	O
.	30036279	4	O
F10	30036279	4	O
mutation	30036279	4	O
spectrum	30036279	4	O
in	30036279	4	O
Pakistan	30036279	4	O
is	30036279	4	O
heterogeneous	30036279	4	O
as	30036279	4	O
seen	30036279	4	O
in	30036279	4	O
other	30036279	4	O
populations	30036279	4	O
.	30036279	4	O
Identification	30036279	4	O
of	30036279	4	O
the	30036279	4	O
F10	30036279	4	O
mutations	30036279	4	O
is	30036279	4	O
important	30036279	4	O
for	30036279	4	O
genetic	30036279	4	O
counseling	30036279	4	O
and	30036279	4	O
prenatal	30036279	4	O
diagnosis	30036279	4	O
in	30036279	4	O
subsequent	30036279	4	O
pregnancies	30036279	4	O
.	30036279	4	O

Mice	30038024	0	O
harboring	30038024	0	O
the	30038024	0	O
human	30038024	0	O
SLC30A8	30038024	0	B-Gene
R138X	30038024	0	O
loss	30038024	0	B-NegReg
-	30038024	0	I-NegReg
of	30038024	0	I-NegReg
-	30038024	0	I-NegReg
function	30038024	0	I-NegReg
mutation	30038024	0	B-Var
have	30038024	0	O
increased	30038024	0	B-PosReg
insulin	30038024	0	O
secretory	30038024	0	O
capacity	30038024	0	O
.	30038024	0	O
SLC30A8	30038024	0	O
encodes	30038024	0	O
a	30038024	0	O
zinc	30038024	0	O
transporter	30038024	0	O
that	30038024	0	O
is	30038024	0	O
primarily	30038024	0	O
expressed	30038024	0	O
in	30038024	0	O
the	30038024	0	O
pancreatic	30038024	0	O
islets	30038024	0	O
of	30038024	0	O
Langerhans	30038024	0	O
.	30038024	0	O
In	30038024	0	O
β	30038024	0	O
-	30038024	0	O
cells	30038024	0	O
it	30038024	0	O
transports	30038024	0	O
zinc	30038024	0	O
into	30038024	0	O
insulin	30038024	0	O
-	30038024	0	O
containing	30038024	0	O
secretory	30038024	0	O
granules	30038024	0	O
.	30038024	0	O
Loss	30038024	0	O
-	30038024	0	O
of	30038024	0	O
-	30038024	0	O
function	30038024	0	O
(	30038024	0	O
LOF	30038024	0	O
)	30038024	0	O
mutations	30038024	0	O
in	30038024	0	O
SLC30A8	30038024	0	O
protect	30038024	0	O
against	30038024	0	O
type	30038024	0	O
2	30038024	0	O
diabetes	30038024	0	O
in	30038024	0	O
humans	30038024	0	O
.	30038024	0	O
In	30038024	0	O
this	30038024	0	O
study	30038024	0	O
,	30038024	0	O
we	30038024	0	O
generated	30038024	0	O
a	30038024	0	O
knockin	30038024	0	O
mouse	30038024	0	O
model	30038024	0	O
carrying	30038024	0	O
one	30038024	0	O
of	30038024	0	O
the	30038024	0	O
most	30038024	0	O
common	30038024	0	O
human	30038024	0	O
LOF	30038024	0	O
mutations	30038024	0	O
for	30038024	0	O
SLC30A8	30038024	0	O
,	30038024	0	O
R138X	30038024	0	O
.	30038024	0	O
The	30038024	0	O
R138X	30038024	0	O
mice	30038024	0	O
had	30038024	0	O
normal	30038024	0	O
body	30038024	0	O
weight	30038024	0	O
,	30038024	0	O
glucose	30038024	0	O
tolerance	30038024	0	O
,	30038024	0	O
and	30038024	0	O
pancreatic	30038024	0	O
β	30038024	0	O
-	30038024	0	O
cell	30038024	0	O
mass	30038024	0	O
.	30038024	0	O
Interestingly	30038024	0	O
,	30038024	0	O
in	30038024	0	O
hyperglycemic	30038024	0	O
conditions	30038024	0	O
induced	30038024	0	O
by	30038024	0	O
the	30038024	0	O
insulin	30038024	0	O
receptor	30038024	0	O
antagonist	30038024	0	O
S961	30038024	0	O
,	30038024	0	O
the	30038024	0	O
R138X	30038024	0	B-Var
mice	30038024	0	O
showed	30038024	0	O
a	30038024	0	O
50%	30038024	0	O
increase	30038024	0	B-PosReg
in	30038024	0	O
insulin	30038024	0	O
secretion	30038024	0	O
.	30038024	0	O
This	30038024	0	O
effect	30038024	0	O
was	30038024	0	O
not	30038024	0	O
associated	30038024	0	O
with	30038024	0	O
enhanced	30038024	0	O
β	30038024	0	O
-	30038024	0	O
cell	30038024	0	O
proliferation	30038024	0	O
or	30038024	0	O
mass	30038024	0	O
.	30038024	0	O
Our	30038024	0	O
data	30038024	0	O
suggest	30038024	0	O
that	30038024	0	O
the	30038024	0	O
SLC30A8	30038024	0	B-Gene
R138X	30038024	0	O
LOF	30038024	0	B-NegReg
mutation	30038024	0	B-Var
may	30038024	0	O
exert	30038024	0	O
beneficial	30038024	0	B-PosReg
effects	30038024	0	I-PosReg
on	30038024	0	O
glucose	30038024	0	O
metabolism	30038024	0	O
by	30038024	0	O
increasing	30038024	0	B-PosReg
the	30038024	0	O
capacity	30038024	0	O
of	30038024	0	O
β	30038024	0	O
-	30038024	0	O
cells	30038024	0	O
to	30038024	0	O
secrete	30038024	0	O
insulin	30038024	0	O
under	30038024	0	O
hyperglycemic	30038024	0	O
conditions	30038024	0	O
.	30038024	0	O

The	30042232	2	O
lateral	30042232	2	O
meningocele	30042232	2	O
syndrome	30042232	2	O
mutation	30042232	2	O
causes	30042232	2	O
marked	30042232	2	O
osteopenia	30042232	2	O
in	30042232	2	O
mice	30042232	2	O
.	30042232	2	O
Lateral	30042232	2	O
meningocele	30042232	2	O
syndrome	30042232	2	O
(	30042232	2	O
LMS	30042232	2	O
)	30042232	2	O
is	30042232	2	O
a	30042232	2	O
rare	30042232	2	O
genetic	30042232	2	O
disorder	30042232	2	O
characterized	30042232	2	O
by	30042232	2	O
neurological	30042232	2	O
complications	30042232	2	O
and	30042232	2	O
osteoporosis	30042232	2	O
.	30042232	2	O
LMS	30042232	2	B-Disease
is	30042232	2	O
associated	30042232	2	O
with	30042232	2	O
mutations	30042232	2	B-Var
in	30042232	2	I-Var
exon	30042232	2	I-Var
33	30042232	2	I-Var
of	30042232	2	O
NOTCH3	30042232	2	B-Gene
leading	30042232	2	O
to	30042232	2	O
a	30042232	2	O
truncated	30042232	2	O
protein	30042232	2	O
lacking	30042232	2	B-NegReg
sequences	30042232	2	O
for	30042232	2	O
NOTCH3	30042232	2	O
degradation	30042232	2	O
and	30042232	2	O
presumably	30042232	2	O
causing	30042232	2	O
NOTCH3	30042232	2	B-Gene
gain	30042232	2	B-PosReg
of	30042232	2	I-PosReg
function	30042232	2	I-PosReg
.	30042232	2	O
To	30042232	2	O
create	30042232	2	O
a	30042232	2	O
mouse	30042232	2	O
model	30042232	2	O
reproducing	30042232	2	O
human	30042232	2	O
LMS	30042232	2	O
-	30042232	2	O
associated	30042232	2	O
mutations	30042232	2	O
,	30042232	2	O
we	30042232	2	O
utilized	30042232	2	O
CRISPR	30042232	2	O
/	30042232	2	O
Cas9	30042232	2	O
to	30042232	2	O
introduce	30042232	2	O
a	30042232	2	O
tandem	30042232	2	O
termination	30042232	2	O
codon	30042232	2	O
at	30042232	2	O
bases	30042232	2	O
6691	30042232	2	O
-	30042232	2	O
6696	30042232	2	O
(	30042232	2	O
ACCAAG	30042232	2	O
TAATGA	30042232	2	O
)	30042232	2	O
and	30042232	2	O
verified	30042232	2	O
this	30042232	2	O
mutation	30042232	2	O
(	30042232	2	O
Notch3tm1.1	30042232	2	O
Ecan	30042232	2	O
)	30042232	2	O
by	30042232	2	O
DNA	30042232	2	O
sequencing	30042232	2	O
of	30042232	2	O
F1	30042232	2	O
mice	30042232	2	O
.	30042232	2	O
One	30042232	2	O
-	30042232	2	O
month	30042232	2	O
-	30042232	2	O
old	30042232	2	O
male	30042232	2	O
and	30042232	2	O
female	30042232	2	O
heterozygous	30042232	2	O
Notch3tm1.1	30042232	2	B-Var
Ecan	30042232	2	I-Var
mice	30042232	2	O
had	30042232	2	O
cancellous	30042232	2	O
and	30042232	2	O
cortical	30042232	2	O
bone	30042232	2	O
osteopenia	30042232	2	B-NegReg
but	30042232	2	O
exhibited	30042232	2	O
no	30042232	2	O
obvious	30042232	2	O
neurological	30042232	2	O
alterations	30042232	2	O
,	30042232	2	O
and	30042232	2	O
histopathology	30042232	2	O
of	30042232	2	O
multiple	30042232	2	O
organs	30042232	2	O
revealed	30042232	2	O
no	30042232	2	O
abnormalities	30042232	2	O
.	30042232	2	O
Microcomputed	30042232	2	O
tomography	30042232	2	O
of	30042232	2	O
these	30042232	2	O
mutants	30042232	2	B-Var
revealed	30042232	2	O
a	30042232	2	O
35	30042232	2	O
-	30042232	2	O
60%	30042232	2	O
decrease	30042232	2	B-NegReg
in	30042232	2	O
cancellous	30042232	2	O
bone	30042232	2	O
volume	30042232	2	O
associated	30042232	2	O
with	30042232	2	O
a	30042232	2	O
reduction	30042232	2	B-NegReg
in	30042232	2	O
trabecular	30042232	2	O
number	30042232	2	O
and	30042232	2	O
decreased	30042232	2	B-NegReg
connectivity	30042232	2	O
.	30042232	2	O
During	30042232	2	O
maturation	30042232	2	O
,	30042232	2	O
cancellous	30042232	2	O
and	30042232	2	O
cortical	30042232	2	O
bones	30042232	2	O
were	30042232	2	O
restored	30042232	2	O
in	30042232	2	O
female	30042232	2	O
but	30042232	2	O
not	30042232	2	O
in	30042232	2	O
male	30042232	2	O
mice	30042232	2	O
,	30042232	2	O
which	30042232	2	O
exhibited	30042232	2	O
cancellous	30042232	2	O
bone	30042232	2	O
osteopenia	30042232	2	O
at	30042232	2	O
4	30042232	2	O
months	30042232	2	O
.	30042232	2	O
Cancellous	30042232	2	O
bone	30042232	2	O
histomorphometry	30042232	2	O
revealed	30042232	2	O
increased	30042232	2	O
osteoblast	30042232	2	O
and	30042232	2	O
osteocyte	30042232	2	O
numbers	30042232	2	O
and	30042232	2	O
a	30042232	2	O
modest	30042232	2	O
increase	30042232	2	O
in	30042232	2	O
osteoclast	30042232	2	O
surface	30042232	2	O
and	30042232	2	O
bone	30042232	2	O
formation	30042232	2	O
rate	30042232	2	O
.	30042232	2	O
Notch3tm1.1	30042232	2	B-Var
Ecan	30042232	2	I-Var
calvarial	30042232	2	O
osteoblasts	30042232	2	O
had	30042232	2	O
increased	30042232	2	B-PosReg
proliferation	30042232	2	O
and	30042232	2	O
increased	30042232	2	B-PosReg
bone	30042232	2	O
γ	30042232	2	O
-	30042232	2	O
carboxyglutamate	30042232	2	O
protein	30042232	2	O
(	30042232	2	O
Bglap	30042232	2	O
)	30042232	2	O
and	30042232	2	O
TNF	30042232	2	B-Gene
superfamily	30042232	2	I-Gene
member	30042232	2	I-Gene
11	30042232	2	I-Gene
(	30042232	2	I-Gene
Tnfsf11	30042232	2	I-Gene
)	30042232	2	I-Gene
mRNA	30042232	2	O
levels	30042232	2	O
and	30042232	2	O
lower	30042232	2	B-NegReg
Tnfrsf11b	30042232	2	O
levels	30042232	2	O
.	30042232	2	O
Tnfsf11	30042232	2	O
mRNA	30042232	2	O
was	30042232	2	O
increased	30042232	2	O
in	30042232	2	O
osteocyte	30042232	2	O
-	30042232	2	O
rich	30042232	2	O
femora	30042232	2	O
from	30042232	2	O
Notch3tm1.1	30042232	2	O
Ecan	30042232	2	O
mice	30042232	2	O
.	30042232	2	O
Cultures	30042232	2	O
of	30042232	2	O
bone	30042232	2	O
marrow	30042232	2	O
-	30042232	2	O
derived	30042232	2	O
macrophages	30042232	2	O
from	30042232	2	O
Notch3tm1.1	30042232	2	O
Ecan	30042232	2	O
mice	30042232	2	O
revealed	30042232	2	O
increased	30042232	2	O
osteoclast	30042232	2	O
formation	30042232	2	O
,	30042232	2	O
particularly	30042232	2	O
in	30042232	2	O
cocultures	30042232	2	O
with	30042232	2	O
osteoblasts	30042232	2	O
from	30042232	2	O
Notch3tm1.1	30042232	2	O
Ecan	30042232	2	O
mice	30042232	2	O
.	30042232	2	O
In	30042232	2	O
conclusion	30042232	2	O
,	30042232	2	O
the	30042232	2	O
Notch3tm1.1	30042232	2	B-Var
Ecan	30042232	2	I-Var
mutation	30042232	2	I-Var
causes	30042232	2	O
osteopenia	30042232	2	B-Disease
despite	30042232	2	O
an	30042232	2	O
increase	30042232	2	B-PosReg
in	30042232	2	O
osteoblast	30042232	2	O
proliferation	30042232	2	O
and	30042232	2	O
function	30042232	2	O
and	30042232	2	O
is	30042232	2	O
associated	30042232	2	O
with	30042232	2	O
enhanced	30042232	2	B-PosReg
Tnfsf11	30042232	2	B-Gene
expression	30042232	2	O
in	30042232	2	O
osteoblasts	30042232	2	O
and	30042232	2	O
osteocytes	30042232	2	O
.	30042232	2	O

Spectrum	30081849	4	O
of	30081849	4	O
MECP2	30081849	4	B-Gene
mutations	30081849	4	B-Var
in	30081849	4	O
Vietnamese	30081849	4	O
patients	30081849	4	O
with	30081849	4	B-Reg
RETT	30081849	4	B-Disease
syndrome	30081849	4	I-Disease
.	30081849	4	O
BACKGROUND	30081849	4	O
:	30081849	4	O
Rett	30081849	4	O
syndrome	30081849	4	O
(	30081849	4	O
RTT	30081849	4	O
)	30081849	4	O
is	30081849	4	O
a	30081849	4	O
severe	30081849	4	O
neurodevelopmental	30081849	4	O
disorder	30081849	4	O
in	30081849	4	O
children	30081849	4	O
characterized	30081849	4	O
by	30081849	4	O
a	30081849	4	O
normal	30081849	4	O
neurodevelopmental	30081849	4	O
process	30081849	4	O
in	30081849	4	O
the	30081849	4	O
first	30081849	4	O
6	30081849	4	O
-	30081849	4	O
18	30081849	4	O
months	30081849	4	O
followed	30081849	4	O
by	30081849	4	O
a	30081849	4	O
period	30081849	4	O
of	30081849	4	O
motor	30081849	4	O
and	30081849	4	O
vocal	30081849	4	O
deterioration	30081849	4	O
with	30081849	4	O
stereotypic	30081849	4	O
hand	30081849	4	O
movements	30081849	4	O
.	30081849	4	O
Incidence	30081849	4	O
of	30081849	4	O
RTT	30081849	4	B-Disease
is	30081849	4	O
mostly	30081849	4	O
due	30081849	4	B-Reg
to	30081849	4	I-Reg
de	30081849	4	O
novo	30081849	4	O
mutation	30081849	4	B-Var
in	30081849	4	O
the	30081849	4	O
MECP2	30081849	4	B-Gene
gene	30081849	4	O
(	30081849	4	O
methyl	30081849	4	O
-	30081849	4	O
CpG	30081849	4	O
-	30081849	4	O
binding	30081849	4	O
protein	30081849	4	O
2	30081849	4	O
)	30081849	4	O
.	30081849	4	O
METHODS	30081849	4	O
:	30081849	4	O
The	30081849	4	O
study	30081849	4	O
assessed	30081849	4	O
27	30081849	4	O
female	30081849	4	O
patients	30081849	4	O
presented	30081849	4	O
with	30081849	4	O
classical	30081849	4	O
RTT	30081849	4	O
phenotype	30081849	4	O
age	30081849	4	O
range	30081849	4	O
from	30081849	4	O
18	30081849	4	O
months	30081849	4	O
to	30081849	4	O
48	30081849	4	O
months	30081849	4	O
.	30081849	4	O
Specialist	30081849	4	O
carried	30081849	4	O
out	30081849	4	O
the	30081849	4	O
clinical	30081849	4	O
evaluation	30081849	4	O
and	30081849	4	O
diagnosis	30081849	4	O
according	30081849	4	O
to	30081849	4	O
RTT	30081849	4	O
diagnosis	30081849	4	O
criteria	30081849	4	O
.	30081849	4	O
Blood	30081849	4	O
samples	30081849	4	O
from	30081849	4	O
patients	30081849	4	O
were	30081849	4	O
then	30081849	4	O
collected	30081849	4	O
for	30081849	4	O
genomic	30081849	4	O
DNA	30081849	4	O
extraction	30081849	4	O
.	30081849	4	O
We	30081849	4	O
next	30081849	4	O
performed	30081849	4	O
MECP2	30081849	4	O
gene	30081849	4	O
amplification	30081849	4	O
and	30081849	4	O
sequencing	30081849	4	O
of	30081849	4	O
the	30081849	4	O
whole	30081849	4	O
coding	30081849	4	O
region	30081849	4	O
to	30081849	4	O
screen	30081849	4	O
for	30081849	4	O
mutations	30081849	4	O
.	30081849	4	O
RESULT	30081849	4	O
:	30081849	4	O
MECP2	30081849	4	O
mutation	30081849	4	O
was	30081849	4	O
found	30081849	4	O
in	30081849	4	O
20	30081849	4	O
patients	30081849	4	O
(	30081849	4	O
74%	30081849	4	O
)	30081849	4	O
including	30081849	4	O
:	30081849	4	O
2	30081849	4	O
missense	30081849	4	O
,	30081849	4	O
4	30081849	4	O
nonsense	30081849	4	O
,	30081849	4	O
6	30081849	4	O
frameshift	30081849	4	O
and	30081849	4	O
2	30081849	4	O
deletion	30081849	4	O
mutation	30081849	4	O
.	30081849	4	O
The	30081849	4	O
study	30081849	4	O
identified	30081849	4	O
14	30081849	4	O
pathogenic	30081849	4	O
mutations	30081849	4	O
which	30081849	4	O
we	30081849	4	O
found	30081849	4	O
4	30081849	4	O
mutation	30081849	4	O
,	30081849	4	O
to	30081849	4	O
our	30081849	4	O
knowledge	30081849	4	O
and	30081849	4	O
extensive	30081849	4	O
search	30081849	4	O
,	30081849	4	O
not	30081849	4	O
priory	30081849	4	O
reported	30081849	4	O
in	30081849	4	O
any	30081849	4	O
mutation	30081849	4	O
database	30081849	4	O
or	30081849	4	O
publication	30081849	4	O
:	30081849	4	O
c.1384	30081849	4	O
-	30081849	4	O
1385	30081849	4	O
DelGT	30081849	4	O
,	30081849	4	O
c.1205	30081849	4	O
insT	30081849	4	O
,	30081849	4	O
c.717	30081849	4	O
delC	30081849	4	O
and	30081849	4	O
c.1132	30081849	4	O
_1207del77	30081849	4	O
.	30081849	4	O
High	30081849	4	O
percentage	30081849	4	O
of	30081849	4	O
C	30081849	4	O
>	30081849	4	O
T	30081849	4	O
(	30081849	4	O
70%	30081849	4	O
)	30081849	4	O
in	30081849	4	O
CpG	30081849	4	O
sites	30081849	4	O
mutation	30081849	4	O
was	30081849	4	O
found	30081849	4	O
.	30081849	4	O
CONCLUSION	30081849	4	O
:	30081849	4	O
Our	30081849	4	O
result	30081849	4	O
reveals	30081849	4	O
a	30081849	4	O
high	30081849	4	O
percentage	30081849	4	O
of	30081849	4	O
C	30081849	4	O
>	30081849	4	O
T	30081849	4	O
mutation	30081849	4	O
in	30081849	4	O
CpG	30081849	4	O
hot	30081849	4	O
spot	30081849	4	O
,	30081849	4	O
which	30081849	4	O
is	30081849	4	O
more	30081849	4	O
prone	30081849	4	O
to	30081849	4	O
modification	30081849	4	O
and	30081849	4	O
more	30081849	4	O
likely	30081849	4	O
to	30081849	4	O
be	30081849	4	O
detected	30081849	4	O
in	30081849	4	O
RTT	30081849	4	O
as	30081849	4	O
a	30081849	4	O
disorder	30081849	4	O
is	30081849	4	O
strictly	30081849	4	O
due	30081849	4	O
to	30081849	4	O
de	30081849	4	O
novo	30081849	4	O
mutations	30081849	4	O
.	30081849	4	O
The	30081849	4	O
study	30081849	4	O
is	30081849	4	O
the	30081849	4	O
first	30081849	4	O
to	30081849	4	O
identify	30081849	4	O
the	30081849	4	O
mutation	30081849	4	O
spectrum	30081849	4	O
of	30081849	4	O
MECP2	30081849	4	O
gene	30081849	4	O
in	30081849	4	O
Vietnamese	30081849	4	O
patients	30081849	4	O
and	30081849	4	O
also	30081849	4	O
an	30081849	4	O
important	30081849	4	O
step	30081849	4	O
toward	30081849	4	O
better	30081849	4	O
diagnosis	30081849	4	O
and	30081849	4	O
care	30081849	4	O
for	30081849	4	O
RTT	30081849	4	O
patients	30081849	4	O
in	30081849	4	O
Vietnam	30081849	4	O
.	30081849	4	O

Clinical	30128655	4	O
presentation	30128655	4	O
and	30128655	4	O
natural	30128655	4	O
history	30128655	4	O
of	30128655	4	O
infantile	30128655	4	O
-	30128655	4	O
onset	30128655	4	O
ascending	30128655	4	O
spastic	30128655	4	O
paralysis	30128655	4	O
from	30128655	4	O
three	30128655	4	O
families	30128655	4	O
with	30128655	4	O
an	30128655	4	O
ALS2	30128655	4	O
founder	30128655	4	O
variant	30128655	4	O
.	30128655	4	O
Biallelic	30128655	4	B-Var
mutations	30128655	4	I-Var
of	30128655	4	O
the	30128655	4	O
alsin	30128655	4	O
Rho	30128655	4	O
guanine	30128655	4	O
nucleotide	30128655	4	O
exchange	30128655	4	O
factor	30128655	4	O
(	30128655	4	B-Gene
ALS2	30128655	4	I-Gene
)	30128655	4	I-Gene
gene	30128655	4	O
cause	30128655	4	B-Reg
a	30128655	4	O
group	30128655	4	O
of	30128655	4	O
overlapping	30128655	4	O
autosomal	30128655	4	O
recessive	30128655	4	O
neurodegenerative	30128655	4	O
disorders	30128655	4	O
including	30128655	4	O
infantile	30128655	4	B-Disease
-	30128655	4	I-Disease
onset	30128655	4	I-Disease
ascending	30128655	4	I-Disease
hereditary	30128655	4	I-Disease
spastic	30128655	4	I-Disease
paralysis	30128655	4	I-Disease
(	30128655	4	O
IAHSP	30128655	4	O
)	30128655	4	O
,	30128655	4	O
juvenile	30128655	4	B-Disease
primary	30128655	4	I-Disease
lateral	30128655	4	I-Disease
sclerosis	30128655	4	I-Disease
(	30128655	4	O
JPLS	30128655	4	O
)	30128655	4	O
,	30128655	4	O
and	30128655	4	O
juvenile	30128655	4	B-Disease
amyotrophic	30128655	4	I-Disease
lateral	30128655	4	I-Disease
sclerosis	30128655	4	I-Disease
(	30128655	4	O
JALS	30128655	4	O
/	30128655	4	O
ALS2	30128655	4	O
)	30128655	4	O
,	30128655	4	O
caused	30128655	4	B-Reg
by	30128655	4	I-Reg
retrograde	30128655	4	O
degeneration	30128655	4	O
of	30128655	4	O
the	30128655	4	O
upper	30128655	4	O
motor	30128655	4	O
neurons	30128655	4	O
of	30128655	4	O
the	30128655	4	O
pyramidal	30128655	4	O
tracts	30128655	4	O
.	30128655	4	O
Here	30128655	4	O
,	30128655	4	O
we	30128655	4	O
describe	30128655	4	O
11	30128655	4	O
individuals	30128655	4	O
with	30128655	4	O
IAHSP	30128655	4	O
,	30128655	4	O
aged	30128655	4	O
2	30128655	4	O
-	30128655	4	O
48	30128655	4	O
years	30128655	4	O
,	30128655	4	O
with	30128655	4	O
IAHSP	30128655	4	B-Disease
from	30128655	4	O
three	30128655	4	O
unrelated	30128655	4	O
consanguineous	30128655	4	O
Iranian	30128655	4	O
families	30128655	4	O
carrying	30128655	4	B-Reg
the	30128655	4	O
homozygous	30128655	4	O
c.1640	30128655	4	B-Var
1	30128655	4	I-Var
G	30128655	4	I-Var
>	30128655	4	I-Var
A	30128655	4	I-Var
founder	30128655	4	O
mutation	30128655	4	O
in	30128655	4	O
ALS2	30128655	4	B-Gene
.	30128655	4	O
Three	30128655	4	O
affected	30128655	4	O
siblings	30128655	4	O
from	30128655	4	O
one	30128655	4	O
family	30128655	4	O
exhibit	30128655	4	O
generalized	30128655	4	O
dystonia	30128655	4	O
which	30128655	4	O
has	30128655	4	O
not	30128655	4	O
been	30128655	4	O
previously	30128655	4	O
described	30128655	4	O
in	30128655	4	O
families	30128655	4	O
with	30128655	4	O
IAHSP	30128655	4	O
and	30128655	4	O
has	30128655	4	O
only	30128655	4	O
been	30128655	4	O
reported	30128655	4	O
in	30128655	4	O
three	30128655	4	O
unrelated	30128655	4	O
consanguineous	30128655	4	O
families	30128655	4	O
with	30128655	4	O
JALS	30128655	4	O
/	30128655	4	O
ALS2	30128655	4	O
.	30128655	4	O
We	30128655	4	O
report	30128655	4	O
the	30128655	4	O
oldest	30128655	4	O
individuals	30128655	4	O
with	30128655	4	O
IAHSP	30128655	4	O
to	30128655	4	O
date	30128655	4	O
and	30128655	4	O
provide	30128655	4	O
evidence	30128655	4	O
that	30128655	4	O
these	30128655	4	O
patients	30128655	4	O
survive	30128655	4	O
well	30128655	4	O
into	30128655	4	O
their	30128655	4	O
late	30128655	4	O
40	30128655	4	O
s	30128655	4	O
with	30128655	4	O
preserved	30128655	4	O
cognition	30128655	4	O
and	30128655	4	O
normal	30128655	4	O
eye	30128655	4	O
movements	30128655	4	O
.	30128655	4	O
Our	30128655	4	O
study	30128655	4	O
delineates	30128655	4	O
the	30128655	4	O
phenotypic	30128655	4	O
spectrum	30128655	4	O
of	30128655	4	O
IAHSP	30128655	4	O
and	30128655	4	O
ALS2	30128655	4	O
-	30128655	4	O
related	30128655	4	O
disorders	30128655	4	O
and	30128655	4	O
provides	30128655	4	O
valuable	30128655	4	O
insights	30128655	4	O
into	30128655	4	O
the	30128655	4	O
natural	30128655	4	O
disease	30128655	4	O
course	30128655	4	O
.	30128655	4	O

Altered	30185553	0	O
ER	30185553	0	O
-	30185553	0	O
mitochondria	30185553	0	O
contact	30185553	0	O
impacts	30185553	0	O
mitochondria	30185553	0	O
calcium	30185553	0	O
homeostasis	30185553	0	O
and	30185553	0	O
contributes	30185553	0	O
to	30185553	0	O
neurodegeneration	30185553	0	O
in	30185553	0	O
vivo	30185553	0	O
in	30185553	0	O
disease	30185553	0	O
models	30185553	0	O
.	30185553	0	O
Calcium	30185553	0	O
(	30185553	0	O
Ca2	30185553	0	O
)	30185553	0	O
homeostasis	30185553	0	O
is	30185553	0	O
essential	30185553	0	O
for	30185553	0	O
neuronal	30185553	0	O
function	30185553	0	O
and	30185553	0	O
survival	30185553	0	O
.	30185553	0	O
Altered	30185553	0	O
Ca2	30185553	0	O
homeostasis	30185553	0	O
has	30185553	0	O
been	30185553	0	O
consistently	30185553	0	O
observed	30185553	0	O
in	30185553	0	O
neurological	30185553	0	O
diseases	30185553	0	O
.	30185553	0	O
How	30185553	0	O
Ca2	30185553	0	O
homeostasis	30185553	0	O
is	30185553	0	O
achieved	30185553	0	O
in	30185553	0	O
various	30185553	0	O
cellular	30185553	0	O
compartments	30185553	0	O
of	30185553	0	O
disease	30185553	0	O
-	30185553	0	O
relevant	30185553	0	O
cell	30185553	0	O
types	30185553	0	O
is	30185553	0	O
not	30185553	0	O
well	30185553	0	O
understood	30185553	0	O
.	30185553	0	O
Here	30185553	0	O
we	30185553	0	O
show	30185553	0	O
in	30185553	0	O
Drosophila	30185553	0	O
Parkinson	30185553	0	O
'	30185553	0	O
s	30185553	0	O
disease	30185553	0	O
(	30185553	0	O
PD	30185553	0	O
)	30185553	0	O
models	30185553	0	O
that	30185553	0	O
Ca2	30185553	0	O
transport	30185553	0	O
from	30185553	0	O
the	30185553	0	O
endoplasmic	30185553	0	O
reticulum	30185553	0	O
(	30185553	0	O
ER	30185553	0	O
)	30185553	0	O
to	30185553	0	O
mitochondria	30185553	0	O
through	30185553	0	O
the	30185553	0	O
ER	30185553	0	O
-	30185553	0	O
mitochondria	30185553	0	O
contact	30185553	0	O
site	30185553	0	O
(	30185553	0	O
ERMCS	30185553	0	O
)	30185553	0	O
critically	30185553	0	O
regulates	30185553	0	O
mitochondrial	30185553	0	O
Ca2	30185553	0	O
(	30185553	0	O
mito	30185553	0	O
-	30185553	0	O
Ca2	30185553	0	O
)	30185553	0	O
homeostasis	30185553	0	O
in	30185553	0	O
dopaminergic	30185553	0	O
(	30185553	0	O
DA	30185553	0	O
)	30185553	0	O
neurons	30185553	0	O
,	30185553	0	O
and	30185553	0	O
that	30185553	0	O
the	30185553	0	O
PD	30185553	0	O
-	30185553	0	O
associated	30185553	0	O
PINK1	30185553	0	O
protein	30185553	0	O
modulates	30185553	0	O
this	30185553	0	O
process	30185553	0	O
.	30185553	0	O
In	30185553	0	O
PINK1	30185553	0	B-Gene
mutant	30185553	0	B-Var
DA	30185553	0	O
neurons	30185553	0	O
,	30185553	0	O
the	30185553	0	O
ERMCS	30185553	0	O
is	30185553	0	O
strengthened	30185553	0	B-PosReg
and	30185553	0	O
mito	30185553	0	O
-	30185553	0	O
Ca2	30185553	0	O
level	30185553	0	O
is	30185553	0	O
elevated	30185553	0	B-PosReg
,	30185553	0	O
resulting	30185553	0	O
in	30185553	0	O
mitochondrial	30185553	0	O
enlargement	30185553	0	B-PosReg
and	30185553	0	O
neuronal	30185553	0	O
death	30185553	0	B-NegReg
.	30185553	0	O
Miro	30185553	0	O
,	30185553	0	O
a	30185553	0	O
well	30185553	0	O
-	30185553	0	O
characterized	30185553	0	O
component	30185553	0	O
of	30185553	0	O
the	30185553	0	O
mitochondrial	30185553	0	O
trafficking	30185553	0	O
machinery	30185553	0	O
,	30185553	0	O
mediates	30185553	0	O
the	30185553	0	O
effects	30185553	0	O
of	30185553	0	O
PINK1	30185553	0	O
on	30185553	0	O
mito	30185553	0	O
-	30185553	0	O
Ca2	30185553	0	O
and	30185553	0	O
mitochondrial	30185553	0	O
morphology	30185553	0	O
,	30185553	0	O
apparently	30185553	0	O
in	30185553	0	O
a	30185553	0	O
transport	30185553	0	O
-	30185553	0	O
independent	30185553	0	O
manner	30185553	0	O
.	30185553	0	O
Miro	30185553	0	O
overexpression	30185553	0	O
mimics	30185553	0	O
PINK1	30185553	0	O
loss	30185553	0	O
-	30185553	0	O
of	30185553	0	O
-	30185553	0	O
function	30185553	0	O
effect	30185553	0	O
,	30185553	0	O
whereas	30185553	0	O
inhibition	30185553	0	O
of	30185553	0	O
Miro	30185553	0	O
or	30185553	0	O
components	30185553	0	O
of	30185553	0	O
the	30185553	0	O
ERMCS	30185553	0	O
,	30185553	0	O
or	30185553	0	O
pharmacological	30185553	0	O
modulation	30185553	0	O
of	30185553	0	O
ERMCS	30185553	0	O
function	30185553	0	O
,	30185553	0	O
rescued	30185553	0	O
PINK1	30185553	0	O
mutant	30185553	0	O
phenotypes	30185553	0	O
.	30185553	0	O
Mito	30185553	0	O
-	30185553	0	O
Ca2	30185553	0	O
homeostasis	30185553	0	O
is	30185553	0	O
also	30185553	0	O
altered	30185553	0	O
in	30185553	0	O
the	30185553	0	O
LRRK2	30185553	0	O
-	30185553	0	O
G2019S	30185553	0	O
model	30185553	0	O
of	30185553	0	O
PD	30185553	0	O
and	30185553	0	O
the	30185553	0	O
PAR-1	30185553	0	O
/	30185553	0	O
MARK	30185553	0	O
model	30185553	0	O
of	30185553	0	O
neurodegeneration	30185553	0	O
,	30185553	0	O
and	30185553	0	O
genetic	30185553	0	O
or	30185553	0	O
pharmacological	30185553	0	O
restoration	30185553	0	O
of	30185553	0	O
mito	30185553	0	O
-	30185553	0	O
Ca2	30185553	0	O
level	30185553	0	O
is	30185553	0	O
beneficial	30185553	0	O
in	30185553	0	O
these	30185553	0	O
models	30185553	0	O
.	30185553	0	O
Our	30185553	0	O
results	30185553	0	O
highlight	30185553	0	O
the	30185553	0	O
importance	30185553	0	O
of	30185553	0	O
mito	30185553	0	O
-	30185553	0	O
Ca2	30185553	0	O
homeostasis	30185553	0	O
maintained	30185553	0	O
by	30185553	0	O
Miro	30185553	0	O
and	30185553	0	O
the	30185553	0	O
ERMCS	30185553	0	O
to	30185553	0	O
mitochondrial	30185553	0	O
physiology	30185553	0	O
and	30185553	0	O
neuronal	30185553	0	O
integrity	30185553	0	O
.	30185553	0	O
Targeting	30185553	0	O
this	30185553	0	O
mito	30185553	0	O
-	30185553	0	O
Ca2	30185553	0	O
homeostasis	30185553	0	O
pathway	30185553	0	O
holds	30185553	0	O
promise	30185553	0	O
for	30185553	0	O
a	30185553	0	O
therapeutic	30185553	0	O
strategy	30185553	0	O
for	30185553	0	O
neurodegenerative	30185553	0	O
diseases	30185553	0	O
.	30185553	0	O

Loss	30388729	0	O
of	30388729	0	O
Function	30388729	0	O
in	30388729	0	O
Zeaxanthin	30388729	0	O
Epoxidase	30388729	0	O
of	30388729	0	O
Dunaliella	30388729	0	O
tertiolecta	30388729	0	O
Caused	30388729	0	O
by	30388729	0	O
a	30388729	0	O
Single	30388729	0	O
Amino	30388729	0	O
Acid	30388729	0	O
Mutation	30388729	0	O
within	30388729	0	O
the	30388729	0	O
Substrate	30388729	0	O
-	30388729	0	O
Binding	30388729	0	O
Site	30388729	0	O
.	30388729	0	O
The	30388729	0	O
zea1	30388729	0	O
mutant	30388729	0	O
of	30388729	0	O
marine	30388729	0	O
microalga	30388729	0	O
Dunaliella	30388729	0	O
tertiolecta	30388729	0	O
accumulates	30388729	0	O
zeaxanthin	30388729	0	O
under	30388729	0	O
normal	30388729	0	O
growth	30388729	0	O
conditions	30388729	0	O
,	30388729	0	O
and	30388729	0	O
its	30388729	0	O
phenotype	30388729	0	O
has	30388729	0	O
been	30388729	0	O
speculated	30388729	0	O
to	30388729	0	O
be	30388729	0	O
related	30388729	0	O
to	30388729	0	O
zeaxanthin	30388729	0	O
epoxidase	30388729	0	O
(	30388729	0	O
ZEP	30388729	0	O
)	30388729	0	O
.	30388729	0	O
In	30388729	0	O
this	30388729	0	O
study	30388729	0	O
,	30388729	0	O
we	30388729	0	O
isolated	30388729	0	O
the	30388729	0	O
ZEP	30388729	0	O
gene	30388729	0	O
from	30388729	0	O
both	30388729	0	O
wild	30388729	0	O
-	30388729	0	O
type	30388729	0	O
D.	30388729	0	O
tertiolecta	30388729	0	O
and	30388729	0	O
the	30388729	0	O
mutant	30388729	0	O
.	30388729	0	O
We	30388729	0	O
found	30388729	0	O
that	30388729	0	O
the	30388729	0	O
zea1	30388729	0	O
mutant	30388729	0	O
has	30388729	0	O
a	30388729	0	O
point	30388729	0	B-Var
mutation	30388729	0	I-Var
of	30388729	0	O
the	30388729	0	O
1337	30388729	0	O
th	30388729	0	O
nucleotide	30388729	0	O
of	30388729	0	O
the	30388729	0	O
ZEP	30388729	0	B-Gene
sequence	30388729	0	O
(	30388729	0	O
a	30388729	0	O
change	30388729	0	O
from	30388729	0	O
guanine	30388729	0	O
to	30388729	0	O
adenine	30388729	0	O
)	30388729	0	O
,	30388729	0	O
resulting	30388729	0	O
in	30388729	0	O
a	30388729	0	O
change	30388729	0	B-Reg
of	30388729	0	O
glycine	30388729	0	O
to	30388729	0	O
aspartate	30388729	0	O
in	30388729	0	O
a	30388729	0	O
highly	30388729	0	O
conserved	30388729	0	O
region	30388729	0	O
in	30388729	0	O
the	30388729	0	O
catalytic	30388729	0	O
domain	30388729	0	O
.	30388729	0	O
Similar	30388729	0	O
expression	30388729	0	O
levels	30388729	0	O
of	30388729	0	O
ZEP	30388729	0	O
mRNA	30388729	0	O
and	30388729	0	O
protein	30388729	0	O
in	30388729	0	O
both	30388729	0	O
wild	30388729	0	O
-	30388729	0	O
type	30388729	0	O
and	30388729	0	O
zea1	30388729	0	O
were	30388729	0	O
confirmed	30388729	0	O
by	30388729	0	O
using	30388729	0	O
qRT	30388729	0	O
-	30388729	0	O
PCR	30388729	0	O
and	30388729	0	O
western	30388729	0	O
blot	30388729	0	O
analysis	30388729	0	O
,	30388729	0	O
respectively	30388729	0	O
.	30388729	0	O
Additionally	30388729	0	O
,	30388729	0	O
the	30388729	0	O
enzyme	30388729	0	O
activity	30388729	0	O
analysis	30388729	0	O
of	30388729	0	O
ZEPs	30388729	0	O
in	30388729	0	O
the	30388729	0	O
presence	30388729	0	O
of	30388729	0	O
cofactors	30388729	0	O
showed	30388729	0	O
that	30388729	0	O
the	30388729	0	O
inactivation	30388729	0	O
of	30388729	0	O
ZEP	30388729	0	O
in	30388729	0	O
zea1	30388729	0	O
was	30388729	0	O
not	30388729	0	O
caused	30388729	0	O
by	30388729	0	O
deficiency	30388729	0	O
in	30388729	0	O
the	30388729	0	O
levels	30388729	0	O
of	30388729	0	O
cofactors	30388729	0	O
.	30388729	0	O
From	30388729	0	O
the	30388729	0	O
predicted	30388729	0	O
three	30388729	0	O
-	30388729	0	O
dimensional	30388729	0	O
ZEP	30388729	0	O
structure	30388729	0	O
of	30388729	0	O
zea1	30388729	0	O
,	30388729	0	O
we	30388729	0	O
observed	30388729	0	O
a	30388729	0	O
conformational	30388729	0	O
change	30388729	0	O
on	30388729	0	O
the	30388729	0	O
substrate	30388729	0	O
-	30388729	0	O
binding	30388729	0	O
site	30388729	0	O
in	30388729	0	O
the	30388729	0	O
ZEP	30388729	0	O
.	30388729	0	O
A	30388729	0	O
comparative	30388729	0	O
analysis	30388729	0	O
of	30388729	0	O
the	30388729	0	O
ZEP	30388729	0	O
structures	30388729	0	O
suggested	30388729	0	O
that	30388729	0	O
the	30388729	0	O
conformational	30388729	0	O
change	30388729	0	O
induced	30388729	0	O
by	30388729	0	O
a	30388729	0	O
single	30388729	0	B-Var
amino	30388729	0	I-Var
acid	30388729	0	I-Var
mutation	30388729	0	I-Var
might	30388729	0	O
impact	30388729	0	B-NegReg
the	30388729	0	O
interaction	30388729	0	O
between	30388729	0	O
the	30388729	0	O
substrate	30388729	0	O
and	30388729	0	O
substrate	30388729	0	O
-	30388729	0	O
binding	30388729	0	O
site	30388729	0	O
,	30388729	0	O
resulting	30388729	0	O
in	30388729	0	O
loss	30388729	0	B-NegReg
of	30388729	0	O
zeaxanthin	30388729	0	O
epoxidase	30388729	0	O
function	30388729	0	O
.	30388729	0	O

LZTR1	30442766	0	O
is	30442766	0	O
a	30442766	0	O
regulator	30442766	0	O
of	30442766	0	O
RAS	30442766	0	O
ubiquitination	30442766	0	O
and	30442766	0	O
signaling	30442766	0	O
.	30442766	0	O
In	30442766	0	O
genetic	30442766	0	O
screens	30442766	0	O
aimed	30442766	0	O
at	30442766	0	O
understanding	30442766	0	O
drug	30442766	0	O
resistance	30442766	0	O
mechanisms	30442766	0	O
in	30442766	0	O
chronic	30442766	0	O
myeloid	30442766	0	O
leukemia	30442766	0	O
cells	30442766	0	O
,	30442766	0	O
inactivation	30442766	0	B-Var
of	30442766	0	O
the	30442766	0	O
cullin	30442766	0	O
3	30442766	0	O
adapter	30442766	0	O
protein	30442766	0	O
-	30442766	0	O
encoding	30442766	0	O
leucine	30442766	0	B-Gene
zipper	30442766	0	I-Gene
-	30442766	0	I-Gene
like	30442766	0	I-Gene
transcription	30442766	0	I-Gene
regulator	30442766	0	I-Gene
1	30442766	0	I-Gene
(	30442766	0	I-Gene
LZTR1	30442766	0	I-Gene
)	30442766	0	I-Gene
gene	30442766	0	O
led	30442766	0	O
to	30442766	0	O
enhanced	30442766	0	B-PosReg
mitogen	30442766	0	O
-	30442766	0	O
activated	30442766	0	O
protein	30442766	0	O
kinase	30442766	0	O
(	30442766	0	O
MAPK	30442766	0	O
)	30442766	0	O
pathway	30442766	0	O
activity	30442766	0	O
and	30442766	0	O
reduced	30442766	0	B-NegReg
sensitivity	30442766	0	O
to	30442766	0	O
tyrosine	30442766	0	O
kinase	30442766	0	O
inhibitors	30442766	0	O
.	30442766	0	O
Knockdown	30442766	0	O
of	30442766	0	O
the	30442766	0	O
Drosophila	30442766	0	O
LZTR1	30442766	0	O
ortholog	30442766	0	O
CG3711	30442766	0	O
resulted	30442766	0	O
in	30442766	0	O
a	30442766	0	O
Ras	30442766	0	O
-	30442766	0	O
dependent	30442766	0	O
gain	30442766	0	O
-	30442766	0	O
of	30442766	0	O
-	30442766	0	O
function	30442766	0	O
phenotype	30442766	0	O
.	30442766	0	O
Endogenous	30442766	0	O
human	30442766	0	O
LZTR1	30442766	0	O
associates	30442766	0	O
with	30442766	0	O
the	30442766	0	O
main	30442766	0	O
RAS	30442766	0	O
isoforms	30442766	0	O
.	30442766	0	O
Inactivation	30442766	0	B-Var
of	30442766	0	O
LZTR1	30442766	0	B-Gene
led	30442766	0	O
to	30442766	0	O
decreased	30442766	0	B-NegReg
ubiquitination	30442766	0	O
and	30442766	0	O
enhanced	30442766	0	B-PosReg
plasma	30442766	0	O
membrane	30442766	0	O
localization	30442766	0	O
of	30442766	0	O
endogenous	30442766	0	O
KRAS	30442766	0	O
(	30442766	0	O
V	30442766	0	O
-	30442766	0	O
Ki	30442766	0	O
-	30442766	0	O
ras2	30442766	0	O
Kirsten	30442766	0	O
rat	30442766	0	O
sarcoma	30442766	0	O
viral	30442766	0	O
oncogene	30442766	0	O
homolog	30442766	0	O
)	30442766	0	O
.	30442766	0	O
We	30442766	0	O
propose	30442766	0	O
that	30442766	0	O
LZTR1	30442766	0	O
acts	30442766	0	O
as	30442766	0	O
a	30442766	0	O
conserved	30442766	0	O
regulator	30442766	0	O
of	30442766	0	O
RAS	30442766	0	O
ubiquitination	30442766	0	O
and	30442766	0	O
MAPK	30442766	0	O
pathway	30442766	0	O
activation	30442766	0	O
.	30442766	0	O
Because	30442766	0	O
LZTR1	30442766	0	O
disease	30442766	0	O
mutations	30442766	0	O
failed	30442766	0	O
to	30442766	0	O
revert	30442766	0	O
loss	30442766	0	O
-	30442766	0	O
of	30442766	0	O
-	30442766	0	O
function	30442766	0	O
phenotypes	30442766	0	O
,	30442766	0	O
our	30442766	0	O
findings	30442766	0	O
provide	30442766	0	O
a	30442766	0	O
molecular	30442766	0	O
rationale	30442766	0	O
for	30442766	0	O
LZTR1	30442766	0	O
involvement	30442766	0	O
in	30442766	0	O
a	30442766	0	O
variety	30442766	0	O
of	30442766	0	O
inherited	30442766	0	O
and	30442766	0	O
acquired	30442766	0	O
human	30442766	0	O
disorders	30442766	0	O
.	30442766	0	O

Molecular	30454682	4	O
genetics	30454682	4	O
of	30454682	4	O
the	30454682	4	O
POMT1	30454682	4	O
-	30454682	4	O
related	30454682	4	O
muscular	30454682	4	O
dystrophy	30454682	4	O
-	30454682	4	O
dystroglycanopathies	30454682	4	O
.	30454682	4	O
Protein	30454682	4	O
O	30454682	4	O
-	30454682	4	O
mannosyltransferase	30454682	4	O
1	30454682	4	O
(	30454682	4	O
POMT1	30454682	4	O
)	30454682	4	O
is	30454682	4	O
a	30454682	4	O
critical	30454682	4	O
enzyme	30454682	4	O
participating	30454682	4	O
in	30454682	4	O
the	30454682	4	O
first	30454682	4	O
step	30454682	4	O
of	30454682	4	O
protein	30454682	4	O
O	30454682	4	O
-	30454682	4	O
mannosylation	30454682	4	O
.	30454682	4	O
Mutations	30454682	4	B-Var
in	30454682	4	O
the	30454682	4	O
coding	30454682	4	O
gene	30454682	4	O
,	30454682	4	O
POMT1	30454682	4	B-Gene
,	30454682	4	O
have	30454682	4	O
been	30454682	4	O
described	30454682	4	O
to	30454682	4	O
be	30454682	4	O
related	30454682	4	O
to	30454682	4	O
a	30454682	4	O
series	30454682	4	O
of	30454682	4	O
autosomal	30454682	4	O
recessive	30454682	4	O
disorders	30454682	4	O
associated	30454682	4	O
with	30454682	4	O
defective	30454682	4	B-NegReg
alpha	30454682	4	O
-	30454682	4	O
dystroglycan	30454682	4	O
glycosylation	30454682	4	O
,	30454682	4	O
later	30454682	4	O
termed	30454682	4	O
muscular	30454682	4	B-Disease
dystrophy	30454682	4	I-Disease
-	30454682	4	I-Disease
dystroglycanopathies	30454682	4	I-Disease
(	30454682	4	O
MDDGs	30454682	4	O
)	30454682	4	O
.	30454682	4	O
MDDGs	30454682	4	O
are	30454682	4	O
characterized	30454682	4	O
by	30454682	4	O
a	30454682	4	O
broad	30454682	4	O
phenotypic	30454682	4	O
spectrum	30454682	4	O
of	30454682	4	O
congenital	30454682	4	O
muscular	30454682	4	O
dystrophy	30454682	4	O
or	30454682	4	O
later	30454682	4	O
-	30454682	4	O
onset	30454682	4	O
limb	30454682	4	O
-	30454682	4	O
girdle	30454682	4	O
muscular	30454682	4	O
dystrophy	30454682	4	O
,	30454682	4	O
accompanied	30454682	4	O
by	30454682	4	O
variable	30454682	4	O
degrees	30454682	4	O
of	30454682	4	O
intellectual	30454682	4	O
disability	30454682	4	O
,	30454682	4	O
brain	30454682	4	O
defects	30454682	4	O
,	30454682	4	O
and	30454682	4	O
ocular	30454682	4	O
abnormalities	30454682	4	O
.	30454682	4	O
To	30454682	4	O
date	30454682	4	O
,	30454682	4	O
at	30454682	4	O
least	30454682	4	O
76	30454682	4	O
disease	30454682	4	O
-	30454682	4	O
associated	30454682	4	O
mutations	30454682	4	O
in	30454682	4	O
the	30454682	4	O
POMT1	30454682	4	O
gene	30454682	4	O
,	30454682	4	O
including	30454682	4	O
missense	30454682	4	O
,	30454682	4	O
nonsense	30454682	4	O
,	30454682	4	O
splicing	30454682	4	O
,	30454682	4	O
deletion	30454682	4	O
,	30454682	4	O
insertion	30454682	4	O
/	30454682	4	O
duplication	30454682	4	O
,	30454682	4	O
and	30454682	4	O
insertion	30454682	4	O
-	30454682	4	O
deletion	30454682	4	O
mutations	30454682	4	O
,	30454682	4	O
have	30454682	4	O
been	30454682	4	O
reported	30454682	4	O
in	30454682	4	O
the	30454682	4	O
literature	30454682	4	O
.	30454682	4	O
In	30454682	4	O
this	30454682	4	O
review	30454682	4	O
,	30454682	4	O
we	30454682	4	O
highlight	30454682	4	O
the	30454682	4	O
present	30454682	4	O
knowledge	30454682	4	O
of	30454682	4	O
the	30454682	4	O
identified	30454682	4	O
disease	30454682	4	O
-	30454682	4	O
associated	30454682	4	O
POMT1	30454682	4	O
gene	30454682	4	O
mutations	30454682	4	O
and	30454682	4	O
genetic	30454682	4	O
animal	30454682	4	O
models	30454682	4	O
related	30454682	4	O
to	30454682	4	O
the	30454682	4	O
POMT1	30454682	4	O
gene	30454682	4	O
.	30454682	4	O
This	30454682	4	O
review	30454682	4	O
may	30454682	4	O
help	30454682	4	O
further	30454682	4	O
normative	30454682	4	O
classification	30454682	4	O
of	30454682	4	O
phenotypes	30454682	4	O
,	30454682	4	O
assist	30454682	4	O
in	30454682	4	O
definite	30454682	4	O
clinical	30454682	4	O
and	30454682	4	O
genetic	30454682	4	O
diagnoses	30454682	4	O
,	30454682	4	O
and	30454682	4	O
genetic	30454682	4	O
counseling	30454682	4	O
,	30454682	4	O
and	30454682	4	O
may	30454682	4	O
comprehensively	30454682	4	O
improve	30454682	4	O
our	30454682	4	O
understanding	30454682	4	O
of	30454682	4	O
the	30454682	4	O
basis	30454682	4	O
of	30454682	4	O
complex	30454682	4	O
phenotypes	30454682	4	O
and	30454682	4	O
possible	30454682	4	O
pathogenic	30454682	4	O
mechanisms	30454682	4	O
involved	30454682	4	O
.	30454682	4	O

HDX	30560918	0	O
-	30560918	0	O
MS	30560918	0	O
reveals	30560918	0	O
dysregulated	30560918	0	O
checkpoints	30560918	0	O
that	30560918	0	O
compromise	30560918	0	O
discrimination	30560918	0	O
against	30560918	0	O
self	30560918	0	O
RNA	30560918	0	O
during	30560918	0	O
RIG	30560918	0	O
-	30560918	0	O
I	30560918	0	O
mediated	30560918	0	O
autoimmunity	30560918	0	O
.	30560918	0	O
Retinoic	30560918	0	O
acid	30560918	0	O
inducible	30560918	0	O
gene	30560918	0	O
-	30560918	0	O
I	30560918	0	O
(	30560918	0	O
RIG	30560918	0	O
-	30560918	0	O
I	30560918	0	O
)	30560918	0	O
ensures	30560918	0	O
immune	30560918	0	O
surveillance	30560918	0	O
of	30560918	0	O
viral	30560918	0	O
RNAs	30560918	0	O
bearing	30560918	0	O
a	30560918	0	O
5	30560918	0	O
'	30560918	0	O
-	30560918	0	O
triphosphate	30560918	0	O
(	30560918	0	O
5	30560918	0	O
'	30560918	0	O
ppp	30560918	0	O
)	30560918	0	O
moiety	30560918	0	O
.	30560918	0	O
Mutations	30560918	0	O
in	30560918	0	O
RIG	30560918	0	B-Gene
-	30560918	0	I-Gene
I	30560918	0	I-Gene
(	30560918	0	B-Var
C268F	30560918	0	I-Var
and	30560918	0	O
E373A	30560918	0	B-Var
)	30560918	0	I-Var
lead	30560918	0	O
to	30560918	0	O
impaired	30560918	0	B-NegReg
ATPase	30560918	0	O
activity	30560918	0	O
,	30560918	0	O
thereby	30560918	0	O
driving	30560918	0	O
hyperactive	30560918	0	B-PosReg
signaling	30560918	0	O
associated	30560918	0	O
with	30560918	0	O
autoimmune	30560918	0	O
diseases	30560918	0	O
.	30560918	0	O
Here	30560918	0	O
we	30560918	0	O
report	30560918	0	O
,	30560918	0	O
using	30560918	0	O
hydrogen	30560918	0	O
/	30560918	0	O
deuterium	30560918	0	O
exchange	30560918	0	O
,	30560918	0	O
mechanistic	30560918	0	O
models	30560918	0	O
for	30560918	0	O
dysregulated	30560918	0	O
RIG	30560918	0	O
-	30560918	0	O
I	30560918	0	O
proofreading	30560918	0	O
that	30560918	0	O
ultimately	30560918	0	O
result	30560918	0	O
in	30560918	0	O
the	30560918	0	O
improper	30560918	0	O
recognition	30560918	0	O
of	30560918	0	O
cellular	30560918	0	O
RNAs	30560918	0	O
bearing	30560918	0	O
7	30560918	0	O
-	30560918	0	O
methylguanosine	30560918	0	O
and	30560918	0	O
N1-2	30560918	0	O
'	30560918	0	O
-	30560918	0	O
O	30560918	0	O
-	30560918	0	O
methylation	30560918	0	O
(	30560918	0	O
Cap1	30560918	0	O
)	30560918	0	O
on	30560918	0	O
the	30560918	0	O
5	30560918	0	O
'	30560918	0	O
end	30560918	0	O
.	30560918	0	O
Cap1	30560918	0	O
-	30560918	0	O
RNA	30560918	0	O
compromises	30560918	0	O
its	30560918	0	O
ability	30560918	0	O
to	30560918	0	O
stabilize	30560918	0	O
RIG	30560918	0	O
-	30560918	0	O
I	30560918	0	O
helicase	30560918	0	O
and	30560918	0	O
blunts	30560918	0	O
caspase	30560918	0	O
activation	30560918	0	O
and	30560918	0	O
recruitment	30560918	0	O
domains	30560918	0	O
(	30560918	0	O
CARD	30560918	0	O
)	30560918	0	O
partial	30560918	0	O
opening	30560918	0	O
by	30560918	0	O
threefold	30560918	0	O
.	30560918	0	O
RIG	30560918	0	B-Gene
-	30560918	0	I-Gene
I	30560918	0	I-Gene
H830A	30560918	0	B-Var
mutation	30560918	0	I-Var
restores	30560918	0	B-PosReg
Cap1	30560918	0	O
-	30560918	0	O
helicase	30560918	0	O
engagement	30560918	0	O
as	30560918	0	O
well	30560918	0	O
as	30560918	0	O
CARDs	30560918	0	O
partial	30560918	0	O
opening	30560918	0	O
event	30560918	0	O
to	30560918	0	O
a	30560918	0	O
level	30560918	0	O
comparable	30560918	0	O
to	30560918	0	O
that	30560918	0	O
of	30560918	0	O
5	30560918	0	O
'	30560918	0	O
ppp	30560918	0	O
.	30560918	0	O
However	30560918	0	O
,	30560918	0	O
E373A	30560918	0	B-Var
RIG	30560918	0	B-Gene
-	30560918	0	I-Gene
I	30560918	0	I-Gene
locks	30560918	0	O
the	30560918	0	O
receptor	30560918	0	O
in	30560918	0	O
an	30560918	0	O
ATP	30560918	0	O
-	30560918	0	O
bound	30560918	0	O
state	30560918	0	O
,	30560918	0	O
resulting	30560918	0	O
in	30560918	0	O
enhanced	30560918	0	B-PosReg
Cap1	30560918	0	O
-	30560918	0	O
helicase	30560918	0	O
engagement	30560918	0	O
and	30560918	0	O
a	30560918	0	O
sequential	30560918	0	O
CARDs	30560918	0	O
stimulation	30560918	0	O
.	30560918	0	O
C268F	30560918	0	B-Var
mutation	30560918	0	I-Var
renders	30560918	0	O
a	30560918	0	O
more	30560918	0	B-PosReg
tethered	30560918	0	O
ring	30560918	0	O
architecture	30560918	0	O
and	30560918	0	O
results	30560918	0	B-Reg
in	30560918	0	I-Reg
constitutive	30560918	0	O
CARDs	30560918	0	O
signaling	30560918	0	O
in	30560918	0	O
an	30560918	0	O
ATP	30560918	0	O
-	30560918	0	O
independent	30560918	0	O
manner	30560918	0	O
.	30560918	0	O

WRKY12	30617455	0	O
represses	30617455	0	O
GSH1	30617455	0	O
expression	30617455	0	O
to	30617455	0	O
negatively	30617455	0	O
regulate	30617455	0	O
cadmium	30617455	0	O
tolerance	30617455	0	O
in	30617455	0	O
Arabidopsis	30617455	0	O
.	30617455	0	O
KEY	30617455	0	O
MESSAGE	30617455	0	O
:	30617455	0	O
The	30617455	0	O
WRKY	30617455	0	O
transcription	30617455	0	O
factor	30617455	0	O
WRKY12	30617455	0	O
negatively	30617455	0	O
regulates	30617455	0	O
Cd	30617455	0	O
tolerance	30617455	0	O
in	30617455	0	O
Arabidopsis	30617455	0	O
via	30617455	0	O
the	30617455	0	O
glutathione	30617455	0	O
-	30617455	0	O
dependent	30617455	0	O
phytochelatin	30617455	0	O
synthesis	30617455	0	O
pathway	30617455	0	O
by	30617455	0	O
directly	30617455	0	O
targeting	30617455	0	O
GSH1	30617455	0	O
and	30617455	0	O
indirectly	30617455	0	O
repressing	30617455	0	O
phytochelatin	30617455	0	O
synthesis	30617455	0	O
-	30617455	0	O
related	30617455	0	O
gene	30617455	0	O
expression	30617455	0	O
.	30617455	0	O
Cadmium	30617455	0	O
(	30617455	0	O
Cd	30617455	0	O
)	30617455	0	O
is	30617455	0	O
a	30617455	0	O
widespread	30617455	0	O
pollutant	30617455	0	O
toxic	30617455	0	O
to	30617455	0	O
plants	30617455	0	O
.	30617455	0	O
The	30617455	0	O
glutathione	30617455	0	O
(	30617455	0	O
GSH	30617455	0	O
)	30617455	0	O
-	30617455	0	O
dependent	30617455	0	O
phytochelatin	30617455	0	O
(	30617455	0	O
PC	30617455	0	O
)	30617455	0	O
synthesis	30617455	0	O
pathway	30617455	0	O
plays	30617455	0	O
key	30617455	0	O
roles	30617455	0	O
in	30617455	0	O
Cd	30617455	0	O
detoxification	30617455	0	O
.	30617455	0	O
However	30617455	0	O
,	30617455	0	O
its	30617455	0	O
regulatory	30617455	0	O
mechanism	30617455	0	O
remains	30617455	0	O
largely	30617455	0	O
unknown	30617455	0	O
.	30617455	0	O
Here	30617455	0	O
,	30617455	0	O
we	30617455	0	O
showed	30617455	0	O
a	30617455	0	O
previously	30617455	0	O
unknown	30617455	0	O
function	30617455	0	O
of	30617455	0	O
the	30617455	0	O
WRKY	30617455	0	O
transcription	30617455	0	O
factor	30617455	0	O
WRKY12	30617455	0	O
in	30617455	0	O
the	30617455	0	O
regulation	30617455	0	O
of	30617455	0	O
Cd	30617455	0	O
tolerance	30617455	0	O
by	30617455	0	O
repressing	30617455	0	O
the	30617455	0	O
expression	30617455	0	O
of	30617455	0	O
PC	30617455	0	O
synthesis	30617455	0	O
-	30617455	0	O
related	30617455	0	O
genes	30617455	0	O
.	30617455	0	O
The	30617455	0	O
expression	30617455	0	O
of	30617455	0	O
WRKY12	30617455	0	O
was	30617455	0	O
inhibited	30617455	0	O
by	30617455	0	O
Cd	30617455	0	O
stress	30617455	0	O
.	30617455	0	O
Enhanced	30617455	0	B-PosReg
Cd	30617455	0	O
tolerance	30617455	0	O
was	30617455	0	O
observed	30617455	0	O
in	30617455	0	O
the	30617455	0	O
WRKY12	30617455	0	B-Gene
loss	30617455	0	B-NegReg
-	30617455	0	I-NegReg
of	30617455	0	I-NegReg
-	30617455	0	I-NegReg
function	30617455	0	I-NegReg
mutants	30617455	0	B-Var
,	30617455	0	O
whereas	30617455	0	O
increased	30617455	0	O
Cd	30617455	0	O
sensitivity	30617455	0	O
was	30617455	0	O
found	30617455	0	O
in	30617455	0	O
the	30617455	0	O
WRKY12	30617455	0	O
-	30617455	0	O
overexpressing	30617455	0	O
plants	30617455	0	O
.	30617455	0	O
Overexpression	30617455	0	O
and	30617455	0	O
loss	30617455	0	B-NegReg
-	30617455	0	I-NegReg
of	30617455	0	I-NegReg
-	30617455	0	I-NegReg
function	30617455	0	I-NegReg
of	30617455	0	O
WRKY12	30617455	0	B-Gene
were	30617455	0	O
associated	30617455	0	O
respectively	30617455	0	O
with	30617455	0	O
increased	30617455	0	O
and	30617455	0	O
decreased	30617455	0	B-NegReg
Cd	30617455	0	O
accumulation	30617455	0	O
by	30617455	0	O
repressing	30617455	0	O
or	30617455	0	O
releasing	30617455	0	B-PosReg
the	30617455	0	O
expression	30617455	0	O
of	30617455	0	O
the	30617455	0	O
genes	30617455	0	O
involved	30617455	0	O
in	30617455	0	O
the	30617455	0	O
PC	30617455	0	O
synthesis	30617455	0	O
pathway	30617455	0	O
.	30617455	0	O
Transient	30617455	0	O
expression	30617455	0	O
assay	30617455	0	O
showed	30617455	0	O
that	30617455	0	O
WRKY12	30617455	0	O
repressed	30617455	0	O
the	30617455	0	O
expression	30617455	0	O
of	30617455	0	O
GSH1	30617455	0	B-Gene
,	30617455	0	O
GSH2	30617455	0	B-Gene
,	30617455	0	O
PCS1	30617455	0	B-Gene
,	30617455	0	O
and	30617455	0	O
PCS2	30617455	0	B-Gene
.	30617455	0	O
Further	30617455	0	O
analysis	30617455	0	O
indicated	30617455	0	O
that	30617455	0	O
WRKY12	30617455	0	O
could	30617455	0	O
directly	30617455	0	O
bind	30617455	0	O
to	30617455	0	O
the	30617455	0	O
W	30617455	0	O
-	30617455	0	O
box	30617455	0	O
of	30617455	0	O
the	30617455	0	O
promoter	30617455	0	O
in	30617455	0	O
GSH1	30617455	0	O
but	30617455	0	O
not	30617455	0	O
in	30617455	0	O
GSH2	30617455	0	O
,	30617455	0	O
PCS1	30617455	0	O
,	30617455	0	O
and	30617455	0	O
PCS2	30617455	0	O
in	30617455	0	O
vivo	30617455	0	O
.	30617455	0	O
Together	30617455	0	O
,	30617455	0	O
our	30617455	0	O
results	30617455	0	O
suggest	30617455	0	O
that	30617455	0	O
WRKY12	30617455	0	O
directly	30617455	0	O
targets	30617455	0	O
GSH1	30617455	0	O
and	30617455	0	O
indirectly	30617455	0	O
represses	30617455	0	O
PC	30617455	0	O
synthesis	30617455	0	O
-	30617455	0	O
related	30617455	0	O
gene	30617455	0	O
expression	30617455	0	O
to	30617455	0	O
negatively	30617455	0	O
regulate	30617455	0	O
Cd	30617455	0	O
accumulation	30617455	0	O
and	30617455	0	O
tolerance	30617455	0	O
in	30617455	0	O
Arabidopsis	30617455	0	O
.	30617455	0	O

Segmental	30702381	4	O
uniparental	30702381	4	O
disomy	30702381	4	O
as	30702381	4	O
a	30702381	4	O
rare	30702381	4	O
cause	30702381	4	O
of	30702381	4	O
congenital	30702381	4	O
severe	30702381	4	O
factor	30702381	4	O
XIII	30702381	4	O
deficiency	30702381	4	O
in	30702381	4	O
a	30702381	4	O
girl	30702381	4	O
with	30702381	4	O
only	30702381	4	O
one	30702381	4	O
heterozygous	30702381	4	O
carrier	30702381	4	O
parent	30702381	4	O
.	30702381	4	O
Uniparental	30702381	4	B-Disease
disomy	30702381	4	I-Disease
(	30702381	4	O
UPD	30702381	4	O
)	30702381	4	O
refers	30702381	4	O
to	30702381	4	O
a	30702381	4	O
situation	30702381	4	O
when	30702381	4	O
a	30702381	4	O
person	30702381	4	O
inherits	30702381	4	O
both	30702381	4	O
homologs	30702381	4	O
of	30702381	4	O
a	30702381	4	O
region	30702381	4	O
or	30702381	4	O
complete	30702381	4	O
part	30702381	4	O
of	30702381	4	O
a	30702381	4	O
chromosome	30702381	4	O
from	30702381	4	O
only	30702381	4	O
one	30702381	4	O
parent	30702381	4	O
.	30702381	4	O
Here	30702381	4	O
,	30702381	4	O
we	30702381	4	O
present	30702381	4	O
an	30702381	4	O
unusual	30702381	4	O
case	30702381	4	O
of	30702381	4	O
UPD	30702381	4	O
in	30702381	4	O
congenital	30702381	4	O
severe	30702381	4	O
factor	30702381	4	O
(	30702381	4	O
F	30702381	4	O
)	30702381	4	O
XIII	30702381	4	O
deficiency	30702381	4	O
.	30702381	4	O
A	30702381	4	O
6	30702381	4	O
-	30702381	4	O
year	30702381	4	O
-	30702381	4	O
old	30702381	4	O
girl	30702381	4	O
experienced	30702381	4	O
cephalhematoma	30702381	4	O
and	30702381	4	O
umbilical	30702381	4	O
bleeding	30702381	4	O
after	30702381	4	O
birth	30702381	4	O
and	30702381	4	O
easy	30702381	4	O
bruising	30702381	4	O
,	30702381	4	O
and	30702381	4	O
postextraction	30702381	4	O
bleeding	30702381	4	O
since	30702381	4	O
early	30702381	4	O
infancy	30702381	4	O
.	30702381	4	O
FXIII	30702381	4	O
activity	30702381	4	O
was	30702381	4	O
0%	30702381	4	O
[	30702381	4	O
mother	30702381	4	O
53.7%	30702381	4	O
and	30702381	4	O
father	30702381	4	O
132.5%	30702381	4	O
(	30702381	4	O
normal	30702381	4	O
70	30702381	4	O
-	30702381	4	O
140%	30702381	4	O
)	30702381	4	O
]	30702381	4	O
and	30702381	4	O
the	30702381	4	O
FXIII	30702381	4	O
antigen	30702381	4	O
level	30702381	4	O
was	30702381	4	O
2.5%	30702381	4	O
[	30702381	4	O
mother	30702381	4	O
38.9%	30702381	4	O
and	30702381	4	O
father	30702381	4	O
151%	30702381	4	O
(	30702381	4	O
normal	30702381	4	O
75	30702381	4	O
-	30702381	4	O
155%	30702381	4	O
)	30702381	4	O
]	30702381	4	O
.	30702381	4	O
The	30702381	4	O
washed	30702381	4	O
platelet	30702381	4	O
FXIII	30702381	4	O
activity	30702381	4	O
was	30702381	4	O
0.1%	30702381	4	O
in	30702381	4	O
the	30702381	4	O
patient	30702381	4	O
(	30702381	4	O
normal	30702381	4	O
64	30702381	4	O
-	30702381	4	O
144%	30702381	4	O
)	30702381	4	O
,	30702381	4	O
suggesting	30702381	4	O
a	30702381	4	O
deficiency	30702381	4	O
of	30702381	4	O
FXIII	30702381	4	O
-	30702381	4	O
A	30702381	4	O
subunit	30702381	4	O
.	30702381	4	O
The	30702381	4	O
FXIII	30702381	4	O
-	30702381	4	O
A	30702381	4	O
subunit	30702381	4	O
genetic	30702381	4	O
analysis	30702381	4	O
detected	30702381	4	O
a	30702381	4	O
homozygous	30702381	4	O
p.Arg382Ser	30702381	4	O
mutation	30702381	4	O
.	30702381	4	O
A	30702381	4	O
similar	30702381	4	O
heterozygous	30702381	4	O
mutation	30702381	4	O
was	30702381	4	O
detected	30702381	4	O
in	30702381	4	O
the	30702381	4	O
mother	30702381	4	O
but	30702381	4	O
surprisingly	30702381	4	O
,	30702381	4	O
not	30702381	4	O
in	30702381	4	O
the	30702381	4	O
father	30702381	4	O
.	30702381	4	O
Kinship	30702381	4	O
was	30702381	4	O
confirmed	30702381	4	O
by	30702381	4	O
a	30702381	4	O
paternity	30702381	4	O
test	30702381	4	O
.	30702381	4	O
To	30702381	4	O
confirm	30702381	4	O
the	30702381	4	O
possibility	30702381	4	O
of	30702381	4	O
UPD	30702381	4	O
,	30702381	4	O
a	30702381	4	O
test	30702381	4	O
using	30702381	4	O
four	30702381	4	O
markers	30702381	4	O
in	30702381	4	O
the	30702381	4	O
vicinity	30702381	4	O
of	30702381	4	O
the	30702381	4	O
F13A1	30702381	4	B-Gene
gene	30702381	4	O
revealed	30702381	4	O
that	30702381	4	O
she	30702381	4	O
inherited	30702381	4	O
duplicate	30702381	4	B-Var
mutations	30702381	4	I-Var
from	30702381	4	O
a	30702381	4	O
heterozygous	30702381	4	O
mutation	30702381	4	O
in	30702381	4	O
her	30702381	4	O
mother	30702381	4	O
,	30702381	4	O
presenting	30702381	4	O
a	30702381	4	O
unique	30702381	4	O
case	30702381	4	B-Reg
of	30702381	4	I-Reg
unusual	30702381	4	O
maternal	30702381	4	O
segmental	30702381	4	O
UPD	30702381	4	B-Disease
in	30702381	4	O
otherwise	30702381	4	O
unexplained	30702381	4	O
congenital	30702381	4	O
(	30702381	4	O
homozygous	30702381	4	O
)	30702381	4	O
severe	30702381	4	O
FXIII	30702381	4	B-Disease
deficiency	30702381	4	I-Disease
.	30702381	4	O
UPD	30702381	4	O
as	30702381	4	O
a	30702381	4	O
rare	30702381	4	O
cause	30702381	4	O
of	30702381	4	O
autosomal	30702381	4	O
recessive	30702381	4	O
bleeding	30702381	4	O
disorder	30702381	4	O
when	30702381	4	O
only	30702381	4	O
one	30702381	4	O
parent	30702381	4	O
is	30702381	4	O
affected	30702381	4	O
is	30702381	4	O
critical	30702381	4	O
for	30702381	4	O
genetic	30702381	4	O
counseling	30702381	4	O
.	30702381	4	O

